,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11662,GO:0044456,3.231560939125e-25,1,38,697,synapse part,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;TENM2;GABRA2;NRGN;SYN2;GNG3;KCNC2;KCNK9;GRIN1;DDN;SV2B;CCK;SLC6A17;GRIN2B
17771,GO:0097458,1.6277343815971e-24,1,49,1418,neuron part,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;EEF1A2;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;SLC4A10;GABRB2;TENM2;GABRA2;NRGN;SYN2;GNG3;FABP7;KCNC2;KCNK9;NPTX1;ENC1;GRIN1;DDN;SV2B;CCK;SLC6A17;GRIN2B
11916,GO:0045202,1.53605639633956e-23,1,39,828,synapse,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;NEFH;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;TENM2;GABRA2;NRGN;SYN2;GNG3;KCNC2;KCNK9;GRIN1;DDN;SV2B;CCK;SLC6A17;GRIN2B
3702,GO:0007268,3.5175590391116e-23,1,34,598,chemical synaptic transmission,BP,CACNG3;SYT13;GABRA1;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CELF4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;SHC3;GABRA2;NRGN;SYN2;NPTX1;NEUROD2;GRIN1;SV2B;GRIN2B
18106,GO:0098916,3.5175590391116e-23,1,34,598,anterograde trans-synaptic signaling,BP,CACNG3;SYT13;GABRA1;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CELF4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;SHC3;GABRA2;NRGN;SYN2;NPTX1;NEUROD2;GRIN1;SV2B;GRIN2B
18242,GO:0099537,4.20920439169941e-23,1,34,601,trans-synaptic signaling,BP,CACNG3;SYT13;GABRA1;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CELF4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;SHC3;GABRA2;NRGN;SYN2;NPTX1;NEUROD2;GRIN1;SV2B;GRIN2B
18241,GO:0099536,4.47924858167965e-23,1,34,602,synaptic signaling,BP,CACNG3;SYT13;GABRA1;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CELF4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;SHC3;GABRA2;NRGN;SYN2;NPTX1;NEUROD2;GRIN1;SV2B;GRIN2B
10993,GO:0043005,9.23429179326572e-20,1,40,1134,neuron projection,CC,CAMK1G;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RPH3A;NEFH;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;SLC4A10;GABRB2;TENM2;GABRA2;NRGN;GNG3;KCNC2;NPTX1;GRIN1;DDN;SV2B;CCK;GRIN2B
3701,GO:0007267,2.60361514388937e-18,1,42,1434,cell-cell signaling,BP,CACNG3;SYT13;GABRA1;NNAT;PTPRN;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CELF4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;GAD2;UNC13C;CXCL14;GABRB2;SHC3;GABRA2;NRGN;SYN2;VSNL1;KCNC2;NPTX1;NEUROD2;PCSK1;GRIN1;SV2B;NMB;GRIN2B
18029,GO:0098793,4.26180884314268e-18,1,24,355,presynapse,CC,SYT13;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;DNM1;SLC30A3;CNR1;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRA2;SYN2;KCNC2;KCNK9;GRIN1;SV2B;CCK;SLC6A17
17560,GO:0097060,7.80295273453696e-17,1,22,299,synaptic membrane,CC,CACNG3;GABRA1;SYT1;CAMK2A;RIMS1;DNM1;NEURL1;GABRA4;GABRG2;CNR1;IQSEC3;SNAP25;CHRM3;GAD2;UNC13C;GABRB2;TENM2;GABRA2;KCNC2;GRIN1;DDN;GRIN2B
7168,GO:0030133,4.02403504045275e-16,1,22,354,transport vesicle,CC,SYT13;PTPRN;SYT1;RPH3A;CHGA;SLC17A7;DNM1;SLC30A3;VGF;SNAP25;SYT4;GAD2;UNC13C;GABRA2;NRGN;SYN2;KCNK9;NPTX1;PCSK1;GRIN1;SV2B;SLC6A17
18030,GO:0098794,1.01509923631818e-13,1,22,430,postsynapse,CC,CACNG3;GABRA1;CAMK2A;NEFH;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;IQSEC3;HPCA;SNAP25;CHRM3;GABRB2;TENM2;GABRA2;NRGN;GNG3;KCNC2;GRIN1;DDN;GRIN2B
3849,GO:0008021,1.30459807903548e-13,1,15,166,synaptic vesicle,CC,SYT1;RPH3A;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;GAD2;UNC13C;GABRA2;SYN2;KCNK9;GRIN1;SV2B;SLC6A17
7353,GO:0030424,2.83683462602984e-13,1,23,514,axon,CC,PTPRN;NGEF;SYT1;NEFH;STMN2;NEFM;SLC17A7;NPTX2;DNM1;GABRG2;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;TENM2;NRGN;KCNC2;GRIN1;CCK
10984,GO:0042995,3.95517068951409e-13,1,41,1861,cell projection,CC,CAMK1G;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RPH3A;NEFH;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;SLC4A10;GABRB2;TENM2;GABRA2;NRGN;GNG3;FABP7;KCNC2;NPTX1;GRIN1;DDN;SV2B;CCK;GRIN2B
15752,GO:0070382,4.60179978458166e-13,1,15,180,exocytic vesicle,CC,SYT1;RPH3A;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;GAD2;UNC13C;GABRA2;SYN2;KCNK9;GRIN1;SV2B;SLC6A17
18445,GO:0120025,5.95648481312801e-13,1,40,1793,plasma membrane bounded cell projection,CC,CAMK1G;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RPH3A;NEFH;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;SLC4A10;GABRB2;TENM2;GABRA2;NRGN;GNG3;KCNC2;NPTX1;GRIN1;DDN;SV2B;CCK;GRIN2B
10289,GO:0036477,6.73730294661728e-13,1,26,721,somatodendritic compartment,CC,CACNG3;GABRA1;PTPRN;EEF1A2;STMN2;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;HPCA;SLC12A5;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;GABRA2;NRGN;GNG3;FABP7;KCNC2;ENC1;GRIN1;DDN;CCK
7449,GO:0030658,1.01374397410801e-11,1,14,184,transport vesicle membrane,CC,PTPRN;SYT1;RPH3A;CHGA;SLC17A7;SLC30A3;SYT4;GAD2;UNC13C;GABRA2;NRGN;SYN2;SV2B;SLC6A17
7459,GO:0030672,1.27144081266654e-11,1,11,90,synaptic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;GAD2;UNC13C;GABRA2;SYN2;SV2B;SLC6A17
18218,GO:0099501,1.27144081266654e-11,1,11,90,exocytic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;GAD2;UNC13C;GABRA2;SYN2;SV2B;SLC6A17
17939,GO:0098590,2.33545949536973e-11,1,28,967,plasma membrane region,CC,CACNG3;GABRA1;SYT1;CAMK2A;RIMS1;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;CHRM3;GAD2;UNC13C;SLC14A1;SLC4A10;GABRB2;TENM2;MAL2;GABRA2;KCNC2;GRIN1;DDN;GRIN2B
11664,GO:0044459,5.06916639703873e-11,1,43,2392,plasma membrane part,CC,CACNG3;SYT13;GABRA1;SYT1;CAMK2A;RIMS1;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;CHRM3;GAD2;UNC13C;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;MAL2;GABRA2;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;DDN;SELL;SLC6A17;GRIN2B
7450,GO:0030659,8.39336142163722e-11,1,23,706,cytoplasmic vesicle membrane,CC,CACNG3;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;GAD2;UNC13C;GABRB2;GABRA2;NRGN;SYN2;SV2B;SELL;SLC6A17
5114,GO:0012506,1.66465685683337e-10,0.999999999977804,23,725,vesicle membrane,CC,CACNG3;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;GAD2;UNC13C;GABRB2;GABRA2;NRGN;SYN2;SV2B;SELL;SLC6A17
13540,GO:0050877,1.87472522418561e-10,0.999999999973904,24,800,nervous system process,BP,CACNG3;GABRA1;RIMS1;CRYM;SLC17A7;NPTX2;DNM1;GABRA4;GABRG2;CNR1;SLC12A5;SNAP25;SYT4;TBR1;GABRB2;SHC3;GABRA2;NRGN;FABP7;ADCY1;NEUROD2;GRIN1;CCK;GRIN2B
3445,GO:0006836,3.29731634302186e-10,0.999999999974596,14,228,neurotransmitter transport,BP,SYT13;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;SNAP25;SYT4;GAD2;UNC13C;GABRA2;SYN2;SV2B;SLC6A17
3748,GO:0007399,4.55500457545239e-10,0.999999999910984,39,2088,nervous system development,BP,NNAT;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CNR1;GDA;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;TBR1;SLC4A10;GABRB2;TENM2;MAL2;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
11921,GO:0045211,5.97794823294355e-10,0.999999999951875,14,229,postsynaptic membrane,CC,CACNG3;GABRA1;DNM1;NEURL1;GABRA4;GABRG2;IQSEC3;CHRM3;GABRB2;TENM2;GABRA2;KCNC2;GRIN1;GRIN2B
3821,GO:0007610,1.27224144946697e-09,0.99999999982533,19,523,behavior,BP,SLC17A7;NPTX2;DNM1;GABRG2;CNR1;PRLHR;SLC12A5;SNAP25;SYT4;MRAP2;TBR1;SLC4A10;SHC3;NRGN;ADCY1;NEUROD2;GRIN1;CCK;GRIN2B
18539,GO:0150034,1.29644235667193e-09,0.999999999880594,14,253,distal axon,CC,PTPRN;NGEF;SYT1;STMN2;NPTX2;CNR1;PACSIN1;SNAP25;CHRM3;UNC13C;TENM2;KCNC2;GRIN1;CCK
13149,GO:0048666,1.79126359670073e-09,0.999999999662767,26,1002,neuron development,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SLC4A10;GABRB2;TENM2;SHC3;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
13490,GO:0050804,2.90067694173956e-09,0.999999999685563,15,316,modulation of chemical synaptic transmission,BP,CACNG3;SYT1;CAMK2A;RIMS1;CELF4;NEURL1;CNR1;VGF;SNAP25;SYT4;UNC13C;NRGN;NEUROD2;GRIN1;GRIN2B
18208,GO:0099177,2.90067694173956e-09,0.999999999685563,15,316,regulation of trans-synaptic signaling,BP,CACNG3;SYT1;CAMK2A;RIMS1;CELF4;NEURL1;CNR1;VGF;SNAP25;SYT4;UNC13C;NRGN;NEUROD2;GRIN1;GRIN2B
7354,GO:0030425,2.92917492794472e-09,0.999999999576397,19,541,dendrite,CC,GABRA1;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;HPCA;SLC12A5;SYT4;CHRM3;SLC4A10;TENM2;GABRA2;NRGN;GNG3;KCNC2;GRIN1;DDN;CCK
17763,GO:0097447,2.98240608431777e-09,0.999999999568206,19,542,dendritic tree,CC,GABRA1;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;HPCA;SLC12A5;SYT4;CHRM3;SLC4A10;TENM2;GABRA2;NRGN;GNG3;KCNC2;GRIN1;DDN;CCK
3822,GO:0007611,3.66407895949115e-09,0.999999999671687,13,223,learning or memory,BP,SLC17A7;NPTX2;CNR1;SLC12A5;SNAP25;SYT4;TBR1;SHC3;NRGN;ADCY1;NEUROD2;GRIN1;GRIN2B
8508,GO:0032590,4.71263399996687e-09,0.999999999891265,7,37,dendrite membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;GABRA2;KCNC2;DDN
7095,GO:0023061,5.76067581974211e-09,0.999999999284658,16,397,signal release,BP,SYT13;NNAT;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;CNR1;VGF;SNAP25;SYT4;GAD2;UNC13C;SYN2;VSNL1;KCNC2
7130,GO:0030054,6.86355570757602e-09,0.999999998544202,27,1169,cell junction,CC,GABRA1;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;NEURL1;GABRA4;GABRG2;SLC30A3;PACSIN1;SNAP25;SYT4;CHRM3;GAD2;UNC13C;GABRB2;TENM2;GABRA2;SYN2;FABP7;KCNC2;GRIN1;SV2B;SLC6A17;GRIN2B
8928,GO:0033267,7.20833165108927e-09,0.999999999161928,15,338,axon part,CC,PTPRN;NGEF;SYT1;STMN2;NPTX2;DNM1;CNR1;PACSIN1;SNAP25;CHRM3;UNC13C;TENM2;KCNC2;GRIN1;CCK
2498,GO:0005230,1.49560376399428e-08,0.99999999942084,8,67,extracellular ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GABRA2;GRIN1;GRIN2B
13550,GO:0050890,1.51578377401061e-08,0.999999998451408,13,253,cognition,BP,SLC17A7;NPTX2;CNR1;SLC12A5;SNAP25;SYT4;TBR1;SHC3;NRGN;ADCY1;NEUROD2;GRIN1;GRIN2B
14144,GO:0051932,1.53745277507994e-08,0.999999999559429,7,43,synaptic transmission, GABAergic,BP,GABRA1;DNM1;GABRA4;GABRG2;CNR1;GABRB2;GABRA2
12933,GO:0048167,1.59209456193034e-08,0.999999998753047,11,164,regulation of synaptic plasticity,BP,CAMK2A;RIMS1;NEURL1;VGF;SNAP25;SYT4;UNC13C;NRGN;NEUROD2;GRIN1;GRIN2B
16611,GO:0071944,1.66385221303295e-08,0.999999994942599,55,4325,cell periphery,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;GABRB2;TENM2;MAL2;SHC3;GABRA2;GNG3;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;GRIN1;DDN;SV2B;SELL;SLC6A17;GRIN2B
18220,GO:0099504,1.74612505249093e-08,0.999999998834862,10,127,synaptic vesicle cycle,BP,SYT13;SYT1;RIMS1;RPH3A;SLC17A7;DNM1;PACSIN1;SNAP25;SYT4;UNC13C
2824,GO:0005886,2.26678419668474e-08,0.999999993024629,54,4229,plasma membrane,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;GABRB2;TENM2;MAL2;SHC3;GABRA2;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;GRIN1;DDN;SV2B;SELL;SLC6A17;GRIN2B
7205,GO:0030182,2.36546939656309e-08,0.999999994629117,27,1223,neuron differentiation,BP,NNAT;NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SLC4A10;GABRB2;TENM2;SHC3;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
15522,GO:0065008,2.92387219773854e-08,0.999999991211481,46,3311,regulation of biological quality,BP,CACNG3;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;CELF4;CRYM;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;PRLHR;SLC12A5;VGF;SNAP25;SYT4;CHRM3;MRAP2;GAD2;UNC13C;SLC4A10;GABRB2;GABRA2;CHST9;NRGN;SYN2;GNG3;VSNL1;ADCY1;KCNC2;KCNK9;NEUROD2;PCSK1;GRIN1;NELL2;CCK;GRIN2B
3703,GO:0007269,3.13137109293899e-08,0.999999997760755,10,138,neurotransmitter secretion,BP,SYT13;SYT1;CAMK2A;RIMS1;RPH3A;SNAP25;SYT4;GAD2;UNC13C;SYN2
18292,GO:0099643,3.13137109293899e-08,0.999999997760755,10,138,signal release from synapse,BP,SYT13;SYT1;CAMK2A;RIMS1;RPH3A;SNAP25;SYT4;GAD2;UNC13C;SYN2
11665,GO:0044463,3.18540158992809e-08,0.999999992654024,27,1252,cell projection part,CC,GABRA1;PTPRN;NGEF;SYT1;STMN2;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;UNC13C;SLC4A10;TENM2;GABRA2;NRGN;GNG3;KCNC2;GRIN1;DDN;CCK
18452,GO:0120038,3.18540158992809e-08,0.999999992654024,27,1252,plasma membrane bounded cell projection part,CC,GABRA1;PTPRN;NGEF;SYT1;STMN2;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;HPCA;SLC12A5;PACSIN1;SNAP25;SYT4;CHRM3;UNC13C;SLC4A10;TENM2;GABRA2;NRGN;GNG3;KCNC2;GRIN1;DDN;CCK
2825,GO:0005887,3.84301018781291e-08,0.999999990825121,28,1382,integral component of plasma membrane,CC,CACNG3;SYT13;GABRA1;EPHB6;GABRA4;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;SLC12A5;CALY;SNAP25;CHRM3;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;GABRA2;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;SELL;SLC6A17;GRIN2B
2501,GO:0005237,4.08092188116201e-08,0.999999999551839,5,15,inhibitory extracellular ligand-gated ion channel activity,MF,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
18239,GO:0099531,5.59302802269545e-08,0.999999995729752,10,148,presynaptic process involved in chemical synaptic transmission,BP,SYT13;SYT1;CAMK2A;RIMS1;RPH3A;SNAP25;SYT4;GAD2;UNC13C;SYN2
2300,GO:0004890,5.69491677221432e-08,0.999999999316661,5,16,GABA-A receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
19372,GO:1902711,5.69491677221432e-08,0.999999999316661,5,16,GABA-A receptor complex,CC,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
8507,GO:0032589,7.9607366984211e-08,0.999999997027657,7,53,neuron projection membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;GABRA2;KCNC2;DDN
10876,GO:0042734,8.19804100756249e-08,0.999999995803973,8,77,presynaptic membrane,CC,SYT1;CAMK2A;RIMS1;CNR1;SNAP25;GAD2;UNC13C;KCNC2
19371,GO:1902710,8.27878108238674e-08,0.999999998908966,5,17,GABA receptor complex,CC,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
7736,GO:0031226,8.426473430124e-08,0.999999979022708,28,1436,intrinsic component of plasma membrane,CC,CACNG3;SYT13;GABRA1;EPHB6;GABRA4;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;SLC12A5;CALY;SNAP25;CHRM3;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;GABRA2;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;SELL;SLC6A17;GRIN2B
11563,GO:0044297,1.00035728636702e-07,0.99999998441694,16,487,cell body,CC,PTPRN;EEF1A2;STMN2;NPTX2;NEURL1;HPCA;SLC12A5;SYT4;SLC4A10;NRGN;GNG3;FABP7;KCNC2;ENC1;DDN;CCK
18186,GO:0099095,1.13441229212673e-07,0.999999998381815,5,18,ligand-gated anion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRA2
11009,GO:0043025,1.18779472858968e-07,0.999999982561204,15,425,neuronal cell body,CC,PTPRN;EEF1A2;STMN2;NPTX2;NEURL1;HPCA;SLC12A5;SYT4;SLC4A10;NRGN;FABP7;KCNC2;ENC1;DDN;CCK
18259,GO:0099565,1.31226027503126e-07,0.999999990866701,9,120,chemical synaptic transmission, postsynaptic,BP,GABRA1;RIMS1;CELF4;SLC17A7;GABRA4;GABRG2;GABRA2;GRIN1;GRIN2B
6128,GO:0016917,1.60807239242826e-07,0.999999997504606,5,19,GABA receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
7003,GO:0022008,1.67866554923596e-07,0.999999956680518,28,1439,neurogenesis,BP,NNAT;NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SLC4A10;GABRB2;TENM2;SHC3;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
13178,GO:0048699,1.68996074236579e-07,0.99999995736619,27,1346,generation of neurons,BP,NNAT;NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SLC4A10;GABRB2;TENM2;SHC3;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
11571,GO:0044306,1.73907492441941e-07,0.999999987427293,9,131,neuron projection terminus,CC,PTPRN;SYT1;PACSIN1;SYT4;CHRM3;UNC13C;KCNC2;GRIN1;CCK
14520,GO:0060078,1.91758685342798e-07,0.99999998599776,9,125,regulation of postsynaptic membrane potential,BP,GABRA1;RIMS1;CELF4;SLC17A7;GABRA4;GABRG2;GABRA2;GRIN1;GRIN2B
7091,GO:0023052,2.39866968441571e-07,0.999999919114882,60,5421,signaling,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CHGA;CELF4;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;SLC12A5;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;NRGN;SYN2;GNG3;VSNL1;ADCY1;KCNC2;NPTX1;NEUROD2;ZCCHC12;PCSK1;GRIN1;SV2B;CCK;NMB;GRIN2B
3621,GO:0007154,2.52549850499408e-07,0.999999914670184,60,5433,cell communication,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CHGA;CELF4;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;SLC12A5;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;NRGN;SYN2;GNG3;VSNL1;ADCY1;KCNC2;NPTX1;NEUROD2;ZCCHC12;PCSK1;GRIN1;SV2B;CCK;NMB;GRIN2B
18219,GO:0099503,2.60325177841698e-07,0.999999946059629,20,865,secretory vesicle,CC,PTPRN;SYT1;RPH3A;CHGA;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;GABRA2;SYN2;KCNK9;PCSK1;GRIN1;SV2B;SELL;SLC6A17
3437,GO:0006821,2.60901905767257e-07,0.999999984156984,8,95,chloride transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;SLC4A10;GABRB2;GABRA2
7849,GO:0031410,3.0300770664191e-07,0.999999911654448,33,2073,cytoplasmic vesicle,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;GABRB2;GABRA2;NRGN;SYN2;KCNK9;NPTX1;PCSK1;GRIN1;SV2B;SELL;SLC6A17
17875,GO:0097708,3.14993987761028e-07,0.99999990798585,33,2076,intracellular vesicle,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;GABRB2;GABRA2;NRGN;SYN2;KCNK9;NPTX1;PCSK1;GRIN1;SV2B;SELL;SLC6A17
3672,GO:0007214,3.26333632219577e-07,0.999999993967617,5,22,gamma-aminobutyric acid signaling pathway,BP,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
5148,GO:0014047,3.28020577103542e-07,0.999999989414148,6,41,glutamate secretion,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;CCK
18150,GO:0099003,3.39493680743494e-07,0.99999997334239,9,134,vesicle-mediated transport in synapse,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;PACSIN1;SNAP25;SYT4;UNC13C
473,GO:0001505,3.72946404869335e-07,0.999999954008388,12,283,regulation of neurotransmitter levels,BP,SYT13;SYT1;CAMK2A;RIMS1;RPH3A;SLC17A7;SNAP25;SYT4;GAD2;UNC13C;GABRA2;SYN2
7721,GO:0031175,3.99479536638334e-07,0.999999911459799,21,885,neuron projection development,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SHC3;ADCY1;NPTX1;ENC1;GRIN1;CCK
4143,GO:0008503,3.9962582166687e-07,0.999999996876526,4,10,benzodiazepine receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRA2
7066,GO:0022851,7.35989452429187e-07,0.999999993004742,4,11,GABA-gated chloride ion channel activity,MF,GABRA1;GABRA4;GABRG2;GABRA2
3649,GO:0007186,7.44044930943185e-07,0.999999848566108,18,761,G-protein coupled receptor signaling pathway,BP,GABRA1;NGEF;CAMK2A;CHGA;GABRA4;GABRG2;RGS4;CNR1;PRLHR;CALY;CHRM3;MRAP2;GABRB2;GABRA2;GNG3;ADCY1;CCK;NMB
19288,GO:1902476,8.15264736287661e-07,0.999999955426701,7,75,chloride transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;GABRB2;GABRA2
11392,GO:0043679,8.3647930327148e-07,0.999999939973343,8,116,axon terminus,CC,PTPRN;SYT1;PACSIN1;CHRM3;UNC13C;KCNC2;GRIN1;CCK
11644,GO:0044433,8.5276754500072e-07,0.999999775501082,25,1360,cytoplasmic vesicle part,CC,CACNG3;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;GABRB2;GABRA2;NRGN;SYN2;PCSK1;SV2B;SELL;SLC6A17
1370,GO:0003008,1.01877048253374e-06,0.999999722312455,26,1444,system process,BP,CACNG3;GABRA1;RIMS1;CHGA;CRYM;SLC17A7;NPTX2;DNM1;GABRA4;GABRG2;CNR1;SLC12A5;SNAP25;SYT4;CHRM3;TBR1;GABRB2;SHC3;GABRA2;NRGN;FABP7;ADCY1;NEUROD2;GRIN1;CCK;GRIN2B
7058,GO:0022839,1.05167969439604e-06,0.99999985636277,12,305,ion gated channel activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
13062,GO:0048489,1.09816301556741e-06,0.999999918253173,8,115,synaptic vesicle transport,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4;UNC13C
17782,GO:0097480,1.09816301556741e-06,0.999999918253173,8,115,establishment of synaptic vesicle localization,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4;UNC13C
7056,GO:0022836,1.15770326589006e-06,0.999999840359632,12,308,gated channel activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
7051,GO:0022824,1.23275664036916e-06,0.999999948942142,6,51,transmitter-gated ion channel activity,MF,GABRA1;GABRA4;GABRG2;GABRA2;GRIN1;GRIN2B
7055,GO:0022835,1.23275664036916e-06,0.999999948942142,6,51,transmitter-gated channel activity,MF,GABRA1;GABRA4;GABRG2;GABRA2;GRIN1;GRIN2B
3444,GO:0006835,1.46349000629483e-06,0.999999912018869,7,83,dicarboxylic acid transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;SLC13A5;CCK
5314,GO:0015108,1.50927615537019e-06,0.999999908891151,7,82,chloride transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;GABRB2;GABRA2
5414,GO:0015318,1.58754044358835e-06,0.999999658651058,18,740,inorganic molecular entity transmembrane transporter activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC12A5;SLC14A1;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
3436,GO:0006820,1.63112383820177e-06,0.999999702544779,15,523,anion transport,BP,GABRA1;SYT1;RIMS1;SLC17A7;GABRA4;GABRG2;SLC12A5;SNAP25;SYT4;SLC13A5;SLC4A10;GABRB2;GABRA2;CCK;SLC6A17
17781,GO:0097479,1.79822838793305e-06,0.999999856501933,8,122,synaptic vesicle localization,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4;UNC13C
5692,GO:0016079,1.81592256486969e-06,0.999999887027185,7,85,synaptic vesicle exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;SNAP25;SYT4;UNC13C
7424,GO:0030594,1.88002013435507e-06,0.999999882157847,7,89,neurotransmitter receptor activity,MF,GABRA1;GABRA4;GABRG2;CHRM3;GABRA2;GRIN1;GRIN2B
7057,GO:0022838,2.19194955542402e-06,0.999999646833299,13,389,substrate-specific channel activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
10700,GO:0042391,2.31424682841891e-06,0.999999625095086,13,398,regulation of membrane potential,BP,GABRA1;RIMS1;CELF4;SLC17A7;GABRA4;GABRG2;CNR1;GABRB2;GABRA2;KCNK9;GRIN1;CCK;GRIN2B
3430,GO:0006811,2.36420970877959e-06,0.999999338694187,25,1404,ion transport,BP,CACNG3;GABRA1;SYT1;CAMK2A;RIMS1;SLC17A7;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;KCNS1;SLC12A5;SNAP25;SYT4;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;CCK;SLC6A17;GRIN2B
9490,GO:0034702,2.51733854140902e-06,0.999999662667145,11,273,ion channel complex,CC,CACNG3;GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;GABRA2;KCNC2;GRIN1;GRIN2B
9644,GO:0035249,2.80771732869313e-06,0.999999812929086,7,88,synaptic transmission, glutamatergic,BP,CACNG3;SYT1;SLC17A7;CNR1;UNC13C;SHC3;GRIN1
5543,GO:0015800,3.08787440250933e-06,0.999999848261421,6,59,acidic amino acid transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;CCK
17977,GO:0098661,3.18350081468578e-06,0.999999783412879,7,91,inorganic anion transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;GABRB2;GABRA2
5390,GO:0015267,3.35760969409917e-06,0.99999943659801,13,407,channel activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
7048,GO:0022803,3.35760969409917e-06,0.99999943659801,13,407,passive transmembrane transporter activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
5395,GO:0015276,3.42460083904028e-06,0.999999700732427,8,131,ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GABRA2;GRIN1;GRIN2B
7054,GO:0022834,3.42460083904028e-06,0.999999700732427,8,131,ligand-gated channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GABRA2;GRIN1;GRIN2B
18237,GO:0099529,3.87228178167871e-06,0.999999872960112,5,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRA4;GABRG2;GABRA2;GRIN1
20134,GO:1904315,3.87228178167871e-06,0.999999872960112,5,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRA4;GABRG2;GABRA2;GRIN1
3759,GO:0007417,3.93356943852472e-06,0.99999905586244,19,870,central nervous system development,BP,NNAT;SYT1;SLC17A7;NEURL1;GABRA4;HPCA;SYT4;TBR1;SLC4A10;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;GRIN1;SLC6A17;GRIN2B
8289,GO:0032279,4.30973352446018e-06,0.999999458428132,10,226,asymmetric synapse,CC,CACNG3;CAMK2A;NEFH;DNM1;NEURL1;CHRM3;NRGN;GNG3;GRIN1;GRIN2B
7279,GO:0030285,4.34282423512322e-06,0.999999926636429,4,17,integral component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SYT4;GABRA2
17973,GO:0098656,4.3735574909048e-06,0.99999944905338,10,234,anion transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;SLC13A5;SLC4A10;GABRB2;GABRA2;SLC6A17
13225,GO:0048791,4.70306024236215e-06,0.99999983890352,5,36,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT13;SYT1;RIMS1;RPH3A;SYT4
18143,GO:0098984,4.794419424755e-06,0.99999938988949,10,229,neuron to neuron synapse,CC,CACNG3;CAMK2A;NEFH;DNM1;NEURL1;CHRM3;NRGN;GNG3;GRIN1;GRIN2B
19294,GO:1902495,5.21541092871813e-06,0.99999924349893,11,295,transmembrane transporter complex,CC,CACNG3;GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;GABRA2;KCNC2;GRIN1;GRIN2B
18127,GO:0098960,5.31234795264311e-06,0.999999812878459,5,37,postsynaptic neurotransmitter receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRA2;GRIN1
5311,GO:0015103,5.50530407887458e-06,0.999999485080849,8,141,inorganic anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;SLC4A10;GABRB2;GABRA2
14707,GO:0060359,5.60967238337102e-06,0.999999580810802,7,106,response to ammonium ion,BP,GABRA1;GABRG2;CNR1;CHRM3;GABRB2;KCNC2;GRIN1
11637,GO:0044425,6.03305013554577e-06,0.999997676242775,56,5327,membrane part,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;EEF1A2;ST8SIA5;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;TESPA1;GAD2;UNC13C;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;MAL2;GABRA2;TMEM132D;CHST9;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;DDN;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
4022,GO:0008306,6.15488742276607e-06,0.999999655779582,6,67,associative learning,BP,NPTX2;SNAP25;TBR1;NRGN;NEUROD2;GRIN1
3761,GO:0007420,6.22319767868341e-06,0.999998652863674,16,649,brain development,BP,NNAT;SYT1;SLC17A7;NEURL1;HPCA;SYT4;TBR1;SLC4A10;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;GRIN1;SLC6A17;GRIN2B
20940,GO:1990351,6.38570854263709e-06,0.999999052892537,11,303,transporter complex,CC,CACNG3;GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;GABRA2;KCNC2;GRIN1;GRIN2B
7069,GO:0022857,8.03331143235185e-06,0.999997967688935,19,921,transmembrane transporter activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC12A5;SLC14A1;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SV2B;SLC6A17;GRIN2B
2514,GO:0005254,8.56222775544121e-06,0.999999490689445,6,71,chloride channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GABRA2
9495,GO:0034707,8.68259849273666e-06,0.99999965744995,5,42,chloride channel complex,CC,GABRA1;GABRA4;GABRG2;GABRB2;GABRA2
6238,GO:0017156,9.46202473758325e-06,0.999999232311345,7,109,calcium ion regulated exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;SNAP25;SYT4;UNC13C
2487,GO:0005216,1.02398939408259e-05,0.999998238474337,12,380,ion channel activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
5499,GO:0015698,1.13613451293218e-05,0.999998821113053,8,156,inorganic anion transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;SLC4A10;GABRB2;GABRA2
3838,GO:0007631,1.15065662682456e-05,0.999999273599177,6,82,feeding behavior,BP,CNR1;PRLHR;MRAP2;TBR1;GRIN1;CCK
14676,GO:0060322,1.31309158713154e-05,0.999996974291013,16,688,head development,BP,NNAT;SYT1;SLC17A7;NEURL1;HPCA;SYT4;TBR1;SLC4A10;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;GRIN1;SLC6A17;GRIN2B
16301,GO:0071420,1.31343649496746e-05,0.999999906115733,3,7,cellular response to histamine,BP,GABRA1;GABRG2;GABRB2
7752,GO:0031256,1.36755328943757e-05,0.99999854312251,8,158,leading edge membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;PACSIN1;GABRA2;KCNC2;DDN
5297,GO:0015075,1.44839714635621e-05,0.999996469659028,17,783,ion transmembrane transporter activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC12A5;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
13195,GO:0048731,1.45482255998586e-05,0.999994291188994,46,3992,system development,BP,NNAT;PTPRN;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;CELF4;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CNR1;GDA;HPCA;SLC12A5;PACSIN1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;DMRT2;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
17976,GO:0098660,1.47690293611245e-05,0.999996562101601,16,710,inorganic ion transmembrane transport,BP,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC12A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;GRIN2B
6191,GO:0017075,1.50924084049335e-05,0.999999633535527,4,22,syntaxin-1 binding,MF,SYT1;SNAP25;SYT4;UNC13C
11587,GO:0044327,1.54503450254049e-05,0.999999875381273,3,8,dendritic spine head,CC,DNM1;HPCA;NRGN
2513,GO:0005253,1.97578843638659e-05,0.999998625435705,6,83,anion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GABRA2
17927,GO:0098563,2.09826099740527e-05,0.999999433426985,4,26,intrinsic component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SYT4;GABRA2
3429,GO:0006810,2.13215153587857e-05,0.99999141862017,48,4422,transport,BP,CACNG3;SYT13;GABRA1;NNAT;PTPRN;SYT1;CAMK2A;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;CRYM;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;GAD2;UNC13C;SLC14A1;SLC13A5;SLC4A10;GABRB2;MAL2;GABRA2;SYN2;VSNL1;KCNC2;KCNK9;GRIN1;SV2B;CCK;SELL;SLC6A17;GRIN2B
3461,GO:0006865,2.22199339844651e-05,0.999997928900786,7,126,amino acid transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;CCK;SLC6A17
16185,GO:0071242,2.27081531963443e-05,0.999998886085608,5,53,cellular response to ammonium ion,BP,GABRA1;GABRG2;CHRM3;GABRB2;KCNC2
12687,GO:0046903,2.41085599582551e-05,0.99999254617717,23,1426,secretion,BP,SYT13;NNAT;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;SLC17A7;NEURL1;CNR1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;GAD2;UNC13C;SYN2;VSNL1;KCNC2;CCK;SELL
5169,GO:0014069,2.56927222590996e-05,0.999996486431467,9,221,postsynaptic density,CC,CACNG3;CAMK2A;NEFH;DNM1;NEURL1;NRGN;GNG3;GRIN1;GRIN2B
18450,GO:0120035,2.57148472477703e-05,0.999994378489077,14,561,regulation of plasma membrane bounded cell projection organization,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;TENM2;ENC1;GRIN1;GRIN2B
18451,GO:0120036,2.58161564660196e-05,0.999991983577769,23,1351,plasma membrane bounded cell projection organization,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;TENM2;SHC3;ADCY1;NPTX1;ENC1;GRIN1;CCK;GRIN2B
9535,GO:0034776,2.63576651577833e-05,0.999999733186397,3,9,response to histamine,BP,GABRA1;GABRG2;GABRB2
18264,GO:0099572,2.66831664282603e-05,0.999996332747066,9,222,postsynaptic specialization,CC,CACNG3;CAMK2A;NEFH;DNM1;NEURL1;NRGN;GNG3;GRIN1;GRIN2B
12665,GO:0046873,2.67986347679256e-05,0.999994903439484,12,412,metal ion transmembrane transporter activity,MF,CACNG3;SLC17A7;SLC30A3;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
10758,GO:0042493,2.76954336975861e-05,0.999992878167051,17,869,response to drug,BP,SYT1;SLC17A7;GABRA4;IGFBP2;CNR1;HPCA;SLC12A5;SYT4;CHRM3;GAD2;SLC13A5;ADCY1;KCNC2;GRIN1;SELL;SLC6A17;GRIN2B
6699,GO:0019905,2.82215283227496e-05,0.99999790252414,6,87,syntaxin binding,MF,SYT13;SYT1;RPH3A;SNAP25;SYT4;UNC13C
9040,GO:0033604,2.91536980145931e-05,0.999999683796684,3,10,negative regulation of catecholamine secretion,BP,CHGA;CNR1;SYT4
4148,GO:0008509,3.01743198062357e-05,0.999995210429052,10,297,anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC12A5;SLC13A5;SLC4A10;GABRB2;GABRA2;SLC6A17
3823,GO:0007612,3.03243498416274e-05,0.999997028875385,7,129,learning,BP,NPTX2;SLC12A5;SNAP25;TBR1;NRGN;NEUROD2;GRIN1
7817,GO:0031344,3.07054102206065e-05,0.999993173978515,14,570,regulation of cell projection organization,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;TENM2;ENC1;GRIN1;GRIN2B
5092,GO:0010975,3.53828005553867e-05,0.999993069157975,12,427,regulation of neuron projection development,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;ENC1;GRIN1
18270,GO:0099590,3.53925249443533e-05,0.999999578847696,3,11,neurotransmitter receptor internalization,BP,CACNG3;DNM1;SNAP25
7114,GO:0030030,3.58687654115521e-05,0.999988608046223,23,1381,cell projection organization,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;TENM2;SHC3;ADCY1;NPTX1;ENC1;GRIN1;CCK;GRIN2B
13770,GO:0051234,3.88725936195381e-05,0.999983896487977,48,4516,establishment of localization,BP,CACNG3;SYT13;GABRA1;NNAT;PTPRN;SYT1;CAMK2A;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;CRYM;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;GAD2;UNC13C;SLC14A1;SLC13A5;SLC4A10;GABRB2;MAL2;GABRA2;SYN2;VSNL1;KCNC2;KCNK9;GRIN1;SV2B;CCK;SELL;SLC6A17;GRIN2B
13492,GO:0050806,4.15899618361125e-05,0.999995705120428,7,140,positive regulation of synaptic transmission,BP,CACNG3;SYT1;RIMS1;SNAP25;NRGN;GRIN1;GRIN2B
2608,GO:0005516,4.16604573681756e-05,0.999994783732437,8,183,calmodulin binding,MF,CAMK1G;SYT1;CAMK2A;RGS4;UNC13C;NRGN;ADCY1;GRIN1
5947,GO:0016595,4.27038114913314e-05,0.999999472960639,3,10,glutamate binding,MF,GAD2;GRIN1;GRIN2B
12616,GO:0046717,4.56099920076434e-05,0.999996284654157,6,99,acid secretion,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;CCK
14156,GO:0051952,5.13393257510977e-05,0.999996976409144,5,64,regulation of amine transport,BP,SYT1;CHGA;CNR1;SYT4;CCK
14593,GO:0060198,5.15787048380198e-05,0.999999287503718,3,12,clathrin-sculpted vesicle,CC,SYT1;SLC17A7;GAD2
9089,GO:0033693,5.22026904878935e-05,1,2,2,neurofilament bundle assembly,BP,NEFH;NEFM
13049,GO:0048468,5.32700450915365e-05,0.999981189408131,27,1841,cell development,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;CELF4;STMN2;NEFM;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TBR1;SLC4A10;GABRB2;TENM2;SHC3;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
9247,GO:0034220,6.63068496624336e-05,0.999980949322988,18,980,ion transmembrane transport,BP,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC12A5;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
3708,GO:0007275,6.65266227501737e-05,0.999971701720076,48,4496,multicellular organism development,BP,NNAT;PTPRN;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;CELF4;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;NEURL1;GABRA4;GABRG2;CNR1;GDA;HPCA;SLC12A5;PACSIN1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;DMRT2;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
13336,GO:0050433,6.92122535973283e-05,0.999997375370092,4,36,regulation of catecholamine secretion,BP,SYT1;CHGA;CNR1;SYT4
8740,GO:0032940,6.99842941838221e-05,0.999977823665486,21,1322,secretion by cell,BP,SYT13;NNAT;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;SLC17A7;CNR1;VGF;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;SYN2;VSNL1;KCNC2;CCK;SELL
11108,GO:0043197,7.11143789140893e-05,0.999991985493256,7,148,dendritic spine,CC,DNM1;NEURL1;HPCA;TENM2;NRGN;GRIN1;DDN
2486,GO:0005215,7.71458158199284e-05,0.99997678314473,19,1089,transporter activity,MF,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC12A5;SLC14A1;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SV2B;SLC6A17;GRIN2B
11106,GO:0043195,7.72656807974339e-05,0.999995024639104,5,67,terminal bouton,CC,SYT1;UNC13C;KCNC2;GRIN1;CCK
11574,GO:0044309,7.81414871748821e-05,0.999991055750586,7,150,neuron spine,CC,DNM1;NEURL1;HPCA;TENM2;NRGN;GRIN1;DDN
5568,GO:0015837,8.18004262433817e-05,0.999994654138476,5,71,amine transport,BP,SYT1;CHGA;CNR1;SYT4;CCK
8458,GO:0032501,8.5072262424268e-05,0.999963019580742,57,5878,multicellular organismal process,BP,CACNG3;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;CHGA;CELF4;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;CNR1;GDA;PRLHR;HPCA;SLC12A5;PACSIN1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;GABRA2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;DMRT2;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
11115,GO:0043204,9.52341475028857e-05,0.999991086132569,6,114,perikaryon,CC,PTPRN;NEURL1;HPCA;KCNC2;DDN;CCK
4963,GO:0010817,9.6114472913127e-05,0.99998063539421,11,436,regulation of hormone levels,BP,NNAT;PTPRN;CRYM;CNR1;PRLHR;VGF;SNAP25;CHST9;VSNL1;KCNC2;PCSK1
13335,GO:0050432,0.000101900436381663,0.999995700841011,4,39,catecholamine secretion,BP,SYT1;CHGA;CNR1;SYT4
7271,GO:0030276,0.000102792075903043,0.999992959115653,5,68,clathrin binding,MF,SYT13;SYT1;RPH3A;CALY;SYT4
12113,GO:0045664,0.000117670514171498,0.999971915434521,13,566,regulation of neuron differentiation,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;NEUROD2;ENC1;GRIN1
13489,GO:0050803,0.000122864544496229,0.999984847349633,7,158,regulation of synapse structure or activity,BP,NGEF;SLC17A7;DNM1;NEURL1;NEUROD2;GRIN1;GRIN2B
6240,GO:0017158,0.000132276423011117,0.999990410910517,5,72,regulation of calcium ion-dependent exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;SYT4
19752,GO:1903530,0.000133779851051102,0.999967625098981,13,607,regulation of secretion by cell,BP,SYT13;NNAT;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;CNR1;SNAP25;SYT4;VSNL1;KCNC2;CCK
7326,GO:0030348,0.000135134394398834,0.999999700311651,2,3,syntaxin-3 binding,MF,SYT1;SYT4
5657,GO:0016020,0.000141453657251623,0.999938556553342,67,7580,membrane,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;EEF1A2;ST8SIA5;STMN2;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;TESPA1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;GABRB2;TENM2;MAL2;SHC3;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;GRIN1;DDN;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
3431,GO:0006812,0.000144360265196266,0.999957303449055,17,966,cation transport,BP,CACNG3;SYT1;CAMK2A;SLC17A7;SLC30A3;CNR1;HPCA;KCNS1;SLC12A5;SYT4;SLC13A5;SLC4A10;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
72,GO:0000149,0.000155893865878463,0.999983992403804,6,121,SNARE binding,MF,SYT13;SYT1;RPH3A;SNAP25;SYT4;UNC13C
15453,GO:0061792,0.000167974508910778,0.999999584348426,2,3,secretory granule maturation,BP,PTPRN;SYT4
7073,GO:0022890,0.000170360482556934,0.999960411226449,12,517,inorganic cation transmembrane transporter activity,MF,CACNG3;SLC17A7;SLC30A3;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
10613,GO:0042221,0.000189367694081705,0.999917655410061,40,3737,response to chemical,BP,GABRA1;PTPRN;SYT1;CAMK2A;SNCB;NEFH;CHGA;EEF1A2;STMN2;SLC17A7;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;CNR1;HPCA;SLC12A5;VGF;SYT4;CHRM3;CHI3L1;TBR1;GAD2;SLC13A5;CXCL14;GABRB2;SHC3;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;GRIN1;CCK;SELL;SLC6A17;GRIN2B
7140,GO:0030073,0.000189387629265634,0.999974849564711,7,183,insulin secretion,BP,NNAT;PTPRN;CNR1;VGF;SNAP25;VSNL1;KCNC2
13997,GO:0051650,0.000199458104994326,0.999968464787886,8,238,establishment of vesicle localization,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4;UNC13C
19925,GO:1903861,0.000220643970429421,0.999994667376008,3,17,positive regulation of dendrite extension,BP,SYT1;RIMS1;SYT4
14594,GO:0060199,0.0002296784294171,0.999999059901899,2,4,clathrin-sculpted glutamate transport vesicle,CC,SYT1;SLC17A7
14597,GO:0060203,0.0002296784294171,0.999999059901899,2,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SYT1;SLC17A7
13232,GO:0048812,0.000232110236213818,0.999940518612648,13,597,neuron projection morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
18040,GO:0098805,0.000233754416203101,0.999916898864319,22,1513,whole membrane,CC,CACNG3;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;GAD2;UNC13C;MAL2;GABRA2;NRGN;SYN2;ADCY1;SV2B;SELL;SLC6A17
2626,GO:0005544,0.000256337288780696,0.999986060241752,4,47,calcium-dependent phospholipid binding,MF,SYT13;SYT1;RPH3A;SYT4
13647,GO:0051046,0.000269514437792388,0.999929784332326,13,652,regulation of secretion,BP,SYT13;NNAT;SYT1;CAMK2A;RIMS1;RPH3A;CHGA;CNR1;SNAP25;SYT4;VSNL1;KCNC2;CCK
14157,GO:0051953,0.000271130075207159,0.999992815818063,3,20,negative regulation of amine transport,BP,CHGA;CNR1;SYT4
5093,GO:0010976,0.000274406935791979,0.999954483523989,8,244,positive regulation of neuron projection development,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;ENC1
12883,GO:0048013,0.000275561151602034,0.999976411937497,5,87,ephrin receptor signaling pathway,BP,NGEF;EPHB6;DNM1;GRIN1;GRIN2B
18171,GO:0099072,0.000275914686186727,0.999992645086894,3,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,CACNG3;DNM1;SNAP25
13995,GO:0051648,0.000286448901970156,0.999952160927384,8,250,vesicle localization,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4;UNC13C
14148,GO:0051937,0.0002898528500345,0.999983645746294,4,51,catecholamine transport,BP,SYT1;CHGA;CNR1;SYT4
18453,GO:0120039,0.000290579039957302,0.999923731467449,13,611,plasma membrane bounded cell projection morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
5404,GO:0015294,0.000293561086999116,0.999974553051163,5,84,solute:cation symporter activity,MF,SLC17A7;SLC12A5;SLC13A5;SLC4A10;SLC6A17
13257,GO:0048858,0.000294371089978861,0.999922628725215,13,612,cell projection morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
2605,GO:0005509,0.0002972704769044,0.999926470194486,12,553,calcium ion binding,MF,SYT13;SYT1;SNCB;RPH3A;HPCA;SYT4;UNC13C;TENM2;VSNL1;GRIN1;NELL2;SELL
7062,GO:0022843,0.000301993826691469,0.99996483762933,6,132,voltage-gated cation channel activity,MF,CACNG3;KCNS1;KCNC2;KCNK9;GRIN1;GRIN2B
12115,GO:0045666,0.000323482041307854,0.999937631639432,9,319,positive regulation of neuron differentiation,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
19923,GO:1903859,0.000333361018427607,0.999990518204874,3,20,regulation of dendrite extension,BP,SYT1;RIMS1;SYT4
5147,GO:0014046,0.000344110563922461,0.999989998761951,3,22,dopamine secretion,BP,SYT1;CNR1;SYT4
5159,GO:0014059,0.000344110563922461,0.999989998761951,3,22,regulation of dopamine secretion,BP,SYT1;CNR1;SYT4
2500,GO:0005234,0.00036987088427893,0.999989165748773,3,19,extracellularly glutamate-gated ion channel activity,MF,SLC17A7;GRIN1;GRIN2B
8774,GO:0032990,0.000374613298577898,0.99989895054766,13,630,cell part morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
7509,GO:0030816,0.000376214235424894,0.999988543081351,3,26,positive regulation of cAMP metabolic process,BP,CHGA;HPCA;MRAP2
14424,GO:0055085,0.000382351840595287,0.999865238005788,20,1347,transmembrane transport,BP,CACNG3;GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC12A5;SLC14A1;SLC13A5;SLC4A10;GABRB2;GABRA2;KCNC2;KCNK9;GRIN1;SV2B;SLC6A17;GRIN2B
4032,GO:0008324,0.000391933950323427,0.99989996228308,12,570,cation transmembrane transporter activity,MF,CACNG3;SLC17A7;SLC30A3;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9;GRIN1;SLC6A17;GRIN2B
7819,GO:0031346,0.0003935092500178,0.999922024721616,9,326,positive regulation of cell projection organization,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;TENM2;ENC1
5575,GO:0015849,0.000399033701460762,0.999929869497368,8,269,organic acid transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;SLC13A5;CCK;SLC6A17
12708,GO:0046942,0.000399033701460762,0.999929869497368,8,269,carboxylic acid transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;SLC13A5;CCK;SLC6A17
8124,GO:0031982,0.000441284870297101,0.99979966298035,39,3801,vesicle,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;CRYM;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;GDA;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GAD2;UNC13C;GABRB2;MAL2;GABRA2;NRGN;SYN2;ADCY1;KCNC2;KCNK9;NPTX1;PCSK1;GRIN1;SV2B;SELL;CPNE4;SLC6A17
20795,GO:1905809,0.000448153024786795,0.999985736484315,3,22,negative regulation of synapse organization,BP,NGEF;NEUROD2;GRIN2B
11862,GO:0045110,0.000461780088072891,0.999996878140449,2,5,intermediate filament bundle assembly,BP,NEFH;NEFM
12934,GO:0048168,0.000465128325490403,0.99997021866494,4,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;NEURL1;SYT4;GRIN1
4631,GO:0009914,0.000469947702918044,0.99991527062145,8,283,hormone transport,BP,NNAT;PTPRN;CRYM;CNR1;VGF;SNAP25;VSNL1;KCNC2
14001,GO:0051656,0.000472042261090715,0.999894116718122,10,422,establishment of organelle localization,BP,SYT13;SYT1;RIMS1;RPH3A;NEFH;CHGA;DNM1;SNAP25;SYT4;UNC13C
7355,GO:0030426,0.000489172401490837,0.999937467732566,6,145,growth cone,CC,NGEF;STMN2;NPTX2;CNR1;SNAP25;TENM2
563,GO:0001661,0.0004944680224887,0.999996539596152,2,5,conditioned taste aversion,BP,TBR1;GRIN1
15115,GO:0061025,0.000510214919251976,0.999919856170269,7,215,membrane fusion,BP,SYT13;SYT1;RIMS1;RPH3A;DNM1;SNAP25;SYT4
7139,GO:0030072,0.000519812504179879,0.999918066765648,7,219,peptide hormone secretion,BP,NNAT;PTPRN;CNR1;VGF;SNAP25;VSNL1;KCNC2
17749,GO:0097418,0.000523262379579272,0.999996231795245,2,5,neurofibrillary tangle,CC,NEFH;NEFM
7064,GO:0022849,0.000577864908277366,0.999995624351647,2,5,glutamate-gated calcium ion channel activity,MF,GRIN1;GRIN2B
13255,GO:0048856,0.000589919840117695,0.999718366151642,48,4897,anatomical structure development,BP,NNAT;PTPRN;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;CELF4;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;NEURL1;GABRA4;GABRG2;CNR1;GDA;HPCA;SLC12A5;PACSIN1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;DMRT2;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
7356,GO:0030427,0.000598617514871992,0.999920414636745,6,150,site of polarized growth,CC,NGEF;STMN2;NPTX2;CNR1;SNAP25;TENM2
5572,GO:0015844,0.000609144125584727,0.999957749997174,4,62,monoamine transport,BP,SYT1;CHGA;CNR1;SYT4
4671,GO:0010038,0.000614496448934639,0.999884468343967,8,304,response to metal ion,BP,SYT1;SNCB;SLC30A3;IGFBP2;HPCA;ADCY1;KCNC2;NEUROD2
13650,GO:0051049,0.0006240103218401,0.999760550386444,22,1627,regulation of transport,BP,CACNG3;SYT13;NNAT;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;CHGA;DNM1;SLC30A3;CNR1;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;VSNL1;KCNC2;GRIN1;CCK
16205,GO:0071277,0.000635407625719616,0.999955520996116,4,59,cellular response to calcium ion,BP,SYT1;HPCA;ADCY1;NEUROD2
6707,GO:0019932,0.00063995463618509,0.99987896011053,8,298,second-messenger-mediated signaling,BP,CHGA;HPCA;MRAP2;ADCY1;KCNC2;NEUROD2;GRIN1;GRIN2B
11136,GO:0043235,0.000677071458025311,0.999855117861366,9,351,receptor complex,CC,CACNG3;GABRA1;EPHB6;GABRA4;GABRG2;GABRB2;GABRA2;GRIN1;GRIN2B
13461,GO:0050767,0.000752340193994948,0.999780944369678,13,687,regulation of neurogenesis,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;NEUROD2;ENC1;GRIN1
5674,GO:0016050,0.000752346269421166,0.999836492706538,9,370,vesicle organization,BP,SYT13;PTPRN;SYT1;RPH3A;SLC17A7;DNM1;SNAP25;SYT4;UNC13C
14521,GO:0060079,0.000760356718427874,0.999918137154013,5,105,excitatory postsynaptic potential,BP,RIMS1;CELF4;SLC17A7;GRIN1;GRIN2B
5430,GO:0015370,0.000764835855250173,0.999943731696537,4,59,solute:sodium symporter activity,MF,SLC17A7;SLC13A5;SLC4A10;SLC6A17
3824,GO:0007613,0.000768958271381719,0.999917025180153,5,104,memory,BP,SLC17A7;CNR1;SYT4;ADCY1;GRIN1
6860,GO:0021700,0.000785119228279788,0.999867185200609,7,228,developmental maturation,BP,PTPRN;SLC17A7;NEURL1;SYT4;UNC13C;NEUROD2;GRIN1
8459,GO:0032502,0.000805098801288968,0.999607479364547,50,5253,developmental process,BP,NNAT;PTPRN;NGEF;SYT1;CAMK2A;RBFOX1;RIMS1;NEFH;CELF4;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;NEURL1;GABRA4;GABRG2;IGFBP2;CNR1;GDA;HPCA;SLC12A5;PACSIN1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;TESPA1;TBR1;UNC13C;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;DMRT2;GRIN1;MYT1L;CCK;SLC6A17;GRIN2B
13555,GO:0050896,0.000812637804802963,0.999607138871594,63,7357,response to stimulus,BP,CACNG3;CAMK1G;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RIMS1;NEFH;CHGA;EEF1A2;CELF4;STMN2;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;SLC12A5;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;NRGN;GNG3;VSNL1;FABP7;ADCY1;KCNC2;NEUROD2;ZCCHC12;GRIN1;CCK;SELL;SLC6A17;NMB;GRIN2B
17937,GO:0098588,0.00081542854451142,0.999668556180056,24,1879,bounding membrane of organelle,CC,CACNG3;CAMK1G;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;ST8SIA5;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;GAD2;UNC13C;GABRA2;CHST9;NRGN;SYN2;TMEM130;SV2B;SELL;SLC6A17
5604,GO:0015893,0.000820423458838635,0.999883768650925,6,175,drug transport,BP,SYT1;SLC17A7;CNR1;SYT4;SLC13A5;SLC6A17
7677,GO:0031090,0.000846860211431073,0.999626391913496,30,2671,organelle membrane,CC,CACNG3;CAMK1G;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;ST8SIA5;SLC17A7;DNM1;GABRG2;SLC30A3;CNR1;PACSIN1;CALY;SNAP25;SYT4;GAD2;UNC13C;GABRB2;GABRA2;CHST9;NRGN;SYN2;TMEM130;SV2B;SELL;SLC6A17
5113,GO:0012505,0.000875028585907735,0.999583930862467,40,3945,endomembrane system,CC,CAMK1G;SYT13;PTPRN;SYT1;RBFOX1;RPH3A;CHGA;ST8SIA5;STMN2;SLC17A7;DNM1;PTPN5;SLC30A3;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;CXCL14;TENM2;MAL2;GABRA2;CHST9;NRGN;SYN2;TMEM130;KCNK9;NPTX1;PCSK1;CREG2;GRIN1;DDN;SV2B;SELL;SLC6A17
7749,GO:0031252,0.000925762130783434,0.999792797462135,9,366,cell leading edge,CC,GABRA1;STMN2;GABRA4;GABRG2;HPCA;PACSIN1;GABRA2;KCNC2;DDN
7750,GO:0031253,0.00093341406250621,0.999812858625069,8,296,cell projection membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;PACSIN1;GABRA2;KCNC2;DDN
6239,GO:0017157,0.000993430563661393,0.999853968776858,6,174,regulation of exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;SYT4;VSNL1
17783,GO:0097484,0.00100704699691998,0.999956523376997,3,29,dendrite extension,BP,SYT1;RIMS1;SYT4
19640,GO:1903305,0.00103555836617124,0.999880226126917,5,116,regulation of regulated secretory pathway,BP,SYT13;SYT1;RIMS1;RPH3A;SYT4
15218,GO:0061200,0.00106162501744007,0.999986943726133,2,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,SYT1;GAD2
15219,GO:0061202,0.00106162501744007,0.999986943726133,2,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,SYT1;GAD2
2821,GO:0005883,0.00108873985478594,0.999986944847823,2,7,neurofilament,CC,NEFH;NEFM
21713,GO:2001023,0.00119274706324157,0.999900214957288,4,74,regulation of response to drug,BP,SYT1;GABRA4;CNR1;SYT4
2354,GO:0004972,0.001196876849797,0.999984941368334,2,7,NMDA glutamate receptor activity,MF,GRIN1;GRIN2B
14518,GO:0060076,0.00121590239468098,0.999943946955089,3,29,excitatory synapse,CC,SYT1;SLC17A7;GRIN1
5506,GO:0015711,0.00121723491183632,0.999716372740187,9,399,organic anion transport,BP,SYT1;RIMS1;SLC17A7;SNAP25;SYT4;SLC13A5;SLC4A10;CCK;SLC6A17
10801,GO:0042583,0.00122087722873541,0.999983881535333,2,8,chromaffin granule,CC,SYT1;CHGA
5590,GO:0015872,0.00124859971700215,0.999941261275898,3,34,dopamine transport,BP,SYT1;CNR1;SYT4
4712,GO:0010243,0.00125114468937176,0.999595871470683,14,855,response to organonitrogen compound,BP,GABRA1;PTPRN;CAMK2A;NEURL1;GABRG2;CNR1;HPCA;VGF;GABRB2;GNG3;ADCY1;KCNC2;GRIN1;SELL
5403,GO:0015293,0.00125622363645779,0.999848215736341,5,117,symporter activity,MF,SLC17A7;SLC12A5;SLC13A5;SLC4A10;SLC6A17
5150,GO:0014049,0.00129277321191721,0.999982429088846,2,8,positive regulation of glutamate secretion,BP,SYT4;CCK
19011,GO:1901698,0.00129832987339165,0.999561514084759,15,957,response to nitrogen compound,BP,GABRA1;PTPRN;CAMK2A;NEURL1;GABRG2;CNR1;HPCA;VGF;CHRM3;GABRB2;GNG3;ADCY1;KCNC2;GRIN1;SELL
17240,GO:0090129,0.0013558049882612,0.999981121245589,2,8,positive regulation of synapse maturation,BP,NEURL1;NEUROD2
2504,GO:0005244,0.00139323905514359,0.999781128171981,6,179,voltage-gated ion channel activity,MF,CACNG3;KCNS1;KCNC2;KCNK9;GRIN1;GRIN2B
7053,GO:0022832,0.00139323905514359,0.999781128171981,6,179,voltage-gated channel activity,MF,CACNG3;KCNS1;KCNC2;KCNK9;GRIN1;GRIN2B
18139,GO:0098976,0.00144049374066307,0.99997931465613,2,8,excitatory chemical synaptic transmission,BP,GRIN1;GRIN2B
5298,GO:0015077,0.0014774952045823,0.999681219616125,8,329,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9;SLC6A17
18060,GO:0098839,0.00149280967351274,0.999925548286153,3,32,postsynaptic density membrane,CC,CACNG3;GRIN1;GRIN2B
15545,GO:0070050,0.00152391324017519,0.999976330493117,2,10,neuron cellular homeostasis,BP,SLC17A7;NELL2
20531,GO:1905114,0.00154239494502289,0.999564749943193,11,583,cell surface receptor signaling pathway involved in cell-cell signaling,BP,GABRA1;CAMK2A;RIMS1;CELF4;SLC17A7;GABRA4;GABRG2;IGFBP2;GABRA2;GRIN1;GRIN2B
7734,GO:0031224,0.00159872667251123,0.999207352448935,41,4199,intrinsic component of membrane,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;EPHB6;GABRA4;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;SLC12A5;CALY;SNAP25;SYT4;CHRM3;MRAP2;GAD2;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;MAL2;GABRA2;TMEM132D;CHST9;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
8089,GO:0031915,0.00159982932097835,0.99997507577722,2,9,positive regulation of synaptic plasticity,BP,SNAP25;NEUROD2
7096,GO:0030001,0.00163072520562604,0.999481710669437,13,772,metal ion transport,BP,CACNG3;CAMK2A;SLC17A7;SLC30A3;HPCA;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9;GRIN1;GRIN2B
18286,GO:0099634,0.00164148907398513,0.999915194308241,3,33,postsynaptic specialization membrane,CC,CACNG3;GRIN1;GRIN2B
13463,GO:0050769,0.00167489434935742,0.999591132157528,9,404,positive regulation of neurogenesis,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
3826,GO:0007616,0.00168693579796677,0.999911840271127,3,34,long-term memory,BP,SLC17A7;ADCY1;GRIN1
5694,GO:0016081,0.00173025813118283,0.999971946957358,2,9,synaptic vesicle docking,BP,SNAP25;UNC13C
7494,GO:0030801,0.0017525743378017,0.999905962035429,3,43,positive regulation of cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
13736,GO:0051179,0.00177615666797243,0.999092154392041,51,5638,localization,BP,CACNG3;SYT13;GABRA1;NNAT;PTPRN;SYT1;CAMK2A;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;CRYM;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;SLC4A10;CXCL14;GABRB2;MAL2;GABRA2;SYN2;VSNL1;KCNC2;KCNK9;GRIN1;SV2B;CCK;SELL;SLC6A17;GRIN2B
5658,GO:0016021,0.00187048695692371,0.999067245590575,40,4090,integral component of membrane,CC,CACNG3;SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;EPHB6;GABRA4;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;SLC12A5;CALY;SNAP25;SYT4;CHRM3;MRAP2;SLC14A1;SLC13A5;SLC4A10;GABRB2;TENM2;MAL2;GABRA2;TMEM132D;CHST9;ADCY1;KCNC2;TMEM130;KCNK9;GRIN1;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
13974,GO:0051602,0.00187459604290793,0.999897525469767,3,39,response to electrical stimulus,BP,EEF1A2;HPCA;NEUROD2
12670,GO:0046879,0.00191304782545923,0.999621311119024,7,274,hormone secretion,BP,NNAT;PTPRN;CNR1;VGF;SNAP25;VSNL1;KCNC2
13220,GO:0048786,0.00196977540867131,0.999891305023382,3,34,presynaptic active zone,CC,RIMS1;SLC17A7;UNC13C
12154,GO:0045744,0.00202152818356753,0.999886373233572,3,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;RGS4;MRAP2
14164,GO:0051960,0.00205163461906254,0.999330514226455,13,765,regulation of nervous system development,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;NEUROD2;ENC1;GRIN1
18055,GO:0098831,0.00213039833395307,0.999961596603612,2,9,presynaptic active zone cytoplasmic component,CC,RIMS1;UNC13C
17239,GO:0090128,0.00221260277188666,0.999958447621095,2,10,regulation of synapse maturation,BP,NEURL1;NEUROD2
12317,GO:0046058,0.00224259061300689,0.999776131492806,4,85,cAMP metabolic process,BP,CHGA;HPCA;MRAP2;ADCY1
14646,GO:0060284,0.0022964391212305,0.999240655273361,13,782,regulation of cell development,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TBR1;NEUROD2;ENC1;GRIN1
18046,GO:0098815,0.00241438794992871,0.99985593434374,3,38,modulation of excitatory postsynaptic potential,BP,RIMS1;CELF4;GRIN1
4669,GO:0010035,0.00242430618784453,0.99937418813301,9,464,response to inorganic substance,BP,SYT1;SNCB;EEF1A2;SLC30A3;IGFBP2;HPCA;ADCY1;KCNC2;NEUROD2
5738,GO:0016188,0.00246076033045356,0.999950365743318,2,11,synaptic vesicle maturation,BP,SLC17A7;UNC13C
13494,GO:0050808,0.00254883348702366,0.999469359012839,7,263,synapse organization,BP,NGEF;SNCB;NEURL1;UNC13C;NEUROD2;GRIN1;GRIN2B
13061,GO:0048488,0.00260607574210841,0.999840020434657,3,39,synaptic vesicle endocytosis,BP,SYT1;DNM1;PACSIN1
9491,GO:0034703,0.00279558836323531,0.999494676912019,6,204,cation channel complex,CC,CACNG3;KCNS1;SNAP25;KCNC2;GRIN1;GRIN2B
16193,GO:0071257,0.00288091070682721,0.999936131905707,2,12,cellular response to electrical stimulus,BP,HPCA;NEUROD2
17978,GO:0098662,0.00292753815365807,0.999101962537707,11,637,inorganic cation transmembrane transport,BP,CACNG3;SLC17A7;SLC30A3;HPCA;KCNS1;SLC12A5;SLC4A10;KCNC2;KCNK9;GRIN1;GRIN2B
3491,GO:0006906,0.00299745907437122,0.999555965213716,5,148,vesicle fusion,BP,SYT13;SYT1;RPH3A;SNAP25;SYT4
19758,GO:1903539,0.00302090038455283,0.999931383233689,2,12,protein localization to postsynaptic membrane,BP,SNAP25;GRIN1
6231,GO:0017146,0.00302639066569056,0.999932147399357,2,11,NMDA selective glutamate receptor complex,CC,GRIN1;GRIN2B
14550,GO:0060134,0.00311358741156785,0.999928175789909,2,12,prepulse inhibition,BP,FABP7;GRIN1
11160,GO:0043269,0.00326051387936386,0.999049064703546,10,554,regulation of ion transport,BP,CACNG3;SYT1;CAMK2A;CNR1;HPCA;KCNS1;SYT4;KCNC2;GRIN1;CCK
11118,GO:0043209,0.00327452278065577,0.99950428763383,5,158,myelin sheath,CC,NEFH;EEF1A2;DNM1;PACSIN1;SNAP25
5826,GO:0016358,0.00329123839366572,0.999385084771781,6,206,dendrite development,BP,NGEF;CAMK2A;NEURL1;SLC12A5;PACSIN1;GRIN1
4857,GO:0010646,0.00330663956251403,0.998364429465832,32,3103,regulation of cell communication,BP,CACNG3;NNAT;NGEF;SYT1;CAMK2A;RIMS1;CHGA;CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;UNC13C;CXCL14;NRGN;GNG3;VSNL1;KCNC2;NEUROD2;GRIN1;CCK;NMB;GRIN2B
7642,GO:0031045,0.00335430811583089,0.999918681021666,2,13,dense core granule,CC,SYT1;SYT4
4477,GO:0009306,0.00338046643918901,0.99908251932694,9,474,protein secretion,BP,NNAT;PTPRN;CNR1;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
17269,GO:0090174,0.00345628828913533,0.999470442735581,5,153,organelle membrane fusion,BP,SYT13;SYT1;RPH3A;SNAP25;SYT4
7454,GO:0030665,0.00348127728381118,0.99960591567034,4,99,clathrin-coated vesicle membrane,CC,SYT1;SLC17A7;GAD2;NRGN
13485,GO:0050796,0.00355880756127374,0.999450820189151,5,156,regulation of insulin secretion,BP,NNAT;CNR1;SNAP25;VSNL1;KCNC2
2480,GO:0005184,0.0035665754365779,0.999906539651171,2,20,neuropeptide hormone activity,MF,VGF;CCK
11650,GO:0044444,0.00357293769231112,0.998149724361059,68,8577,cytoplasmic part,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;GABRA2;CHST9;NRGN;SYN2;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;PCSK1;CREG2;GRIN1;DDN;SV2B;SELL;SLC6A17
13811,GO:0051291,0.00362833931928165,0.999584403196616,4,100,protein heterooligomerization,BP,SYT1;KCNC2;GRIN1;GRIN2B
16184,GO:0071241,0.00367283910610747,0.999428613438425,5,163,cellular response to inorganic substance,BP,SYT1;HPCA;ADCY1;KCNC2;NEUROD2
2499,GO:0005231,0.00370608602246425,0.999740161802348,3,46,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7;GRIN1;GRIN2B
10596,GO:0042165,0.0037607447300449,0.999734232904477,3,49,neurotransmitter binding,MF,CHRM3;GRIN1;GRIN2B
13006,GO:0048306,0.00383949589363382,0.999725612069538,3,54,calcium-dependent protein binding,MF,SYT1;STMN2;SNAP25
13493,GO:0050807,0.00384775093886522,0.999395862013537,5,148,regulation of synapse organization,BP,NGEF;NEURL1;NEUROD2;GRIN1;GRIN2B
4897,GO:0010720,0.00384849420673107,0.998934937611849,9,461,positive regulation of cell development,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
5149,GO:0014048,0.0038922366692271,0.999897168216195,2,14,regulation of glutamate secretion,BP,SYT4;CCK
14161,GO:0051957,0.00391989181229862,0.999896060709609,2,14,positive regulation of amino acid transport,BP,SYT4;CCK
7512,GO:0030819,0.00392512528812373,0.999893558128367,2,17,positive regulation of cAMP biosynthetic process,BP,HPCA;MRAP2
14166,GO:0051962,0.00396641603115659,0.99889729175296,9,458,positive regulation of nervous system development,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
5946,GO:0016594,0.00418724044298567,0.999884189177443,2,15,glycine binding,MF,GRIN1;GRIN2B
11861,GO:0045109,0.00420838885376945,0.999883302776663,2,15,intermediate filament organization,BP,NEFH;NEFM
7090,GO:0023051,0.00428158283070824,0.99784132870985,32,3154,regulation of signaling,BP,CACNG3;NNAT;NGEF;SYT1;CAMK2A;RIMS1;CHGA;CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;UNC13C;CXCL14;NRGN;GNG3;VSNL1;KCNC2;NEUROD2;GRIN1;CCK;NMB;GRIN2B
12761,GO:0047127,0.00434466039589783,1,1,1,thiomorpholine-carboxylate dehydrogenase activity,MF,CRYM
7517,GO:0030824,0.00438948554951934,1,1,1,negative regulation of cGMP metabolic process,BP,HPCA
7520,GO:0030827,0.00438948554951934,1,1,1,negative regulation of cGMP biosynthetic process,BP,HPCA
7771,GO:0031283,0.00438948554951934,1,1,1,negative regulation of guanylate cyclase activity,BP,HPCA
19097,GO:1901986,0.00438948554951934,1,1,1,response to ketamine,BP,HPCA
20002,GO:1904008,0.00438948554951934,1,1,1,response to monosodium glutamate,BP,HPCA
20003,GO:1904009,0.00438948554951934,1,1,1,cellular response to monosodium glutamate,BP,HPCA
20004,GO:1904010,0.00438948554951934,1,1,1,response to Aroclor 1254,BP,HPCA
3651,GO:0007188,0.00440503523108359,0.999284392851657,5,170,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,CHGA;CNR1;CHRM3;MRAP2;ADCY1
3632,GO:0007165,0.00453956523557172,0.997561809834897,45,4994,signal transduction,BP,CACNG3;CAMK1G;GABRA1;PTPRN;NGEF;CAMK2A;RIMS1;CHGA;CELF4;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;VGF;CALY;CHRM3;CHI3L1;MRAP2;TESPA1;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;NRGN;GNG3;ADCY1;KCNC2;NEUROD2;ZCCHC12;GRIN1;CCK;NMB;GRIN2B
10280,GO:0036465,0.00458663850268631,0.999652379458858,3,48,synaptic vesicle recycling,BP,SYT1;DNM1;PACSIN1
4034,GO:0008328,0.0046085934591217,0.999649817357209,3,49,ionotropic glutamate receptor complex,CC,CACNG3;GRIN1;GRIN2B
14519,GO:0060077,0.00462237266711959,0.999865492406688,2,15,inhibitory synapse,CC,IQSEC3;GAD2
326,GO:0000902,0.00472791136297245,0.998227538694667,14,939,cell morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;TENM2;SHC3;ADCY1;NPTX1;GRIN1;CCK
5695,GO:0016082,0.00478848459078203,0.999858105520744,2,15,synaptic vesicle priming,BP,SNAP25;UNC13C
13996,GO:0051649,0.0049197734351657,0.997751813772697,22,1938,establishment of localization in cell,BP,CACNG3;SYT13;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;CHGA;SLC17A7;DNM1;HPCA;PACSIN1;CALY;SNAP25;SYT4;GAD2;UNC13C;SYN2;VSNL1;GRIN1;GRIN2B
1273,GO:0002790,0.00495935729890002,0.998572002801487,9,505,peptide secretion,BP,NNAT;PTPRN;CNR1;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
2994,GO:0006171,0.00496230664995937,0.999611351786604,3,54,cAMP biosynthetic process,BP,HPCA;MRAP2;ADCY1
2478,GO:0005179,0.00497150847740832,0.999607409141005,3,68,hormone activity,MF,VGF;CCK;NMB
18081,GO:0098878,0.00504820344525572,0.999603053726884,3,51,neurotransmitter receptor complex,CC,CACNG3;GRIN1;GRIN2B
15339,GO:0061564,0.00513094970186526,0.998515568306528,9,471,axon development,BP,NEFH;NEFM;CNR1;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
17758,GO:0097440,0.00524568378442771,0.999837086780209,2,15,apical dendrite,CC,NEURL1;SLC4A10
12699,GO:0046928,0.00548920655055174,0.999554870801642,3,52,regulation of neurotransmitter secretion,BP,CAMK2A;RIMS1;SYT4
17119,GO:0086030,0.00553395049731901,1,1,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
12991,GO:0048284,0.00557938571539724,0.999041201821156,5,174,organelle fusion,BP,SYT13;SYT1;RPH3A;SNAP25;SYT4
5472,GO:0015633,0.00563789549118325,1,1,1,zinc-transporting ATPase activity,MF,SLC30A3
12019,GO:0045471,0.00566381449749709,0.999262397567712,4,116,response to ethanol,BP,CNR1;KCNC2;GRIN1;GRIN2B
2299,GO:0004888,0.00568405426882652,0.998092909391773,11,719,transmembrane signaling receptor activity,MF,GABRA1;EPHB6;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;GABRB2;GABRA2;GRIN1;GRIN2B
18285,GO:0099632,0.00572189278424968,0.999810611425166,2,18,protein transport within plasma membrane,BP,CACNG3;SNAP25
18287,GO:0099637,0.00572189278424968,0.999810611425166,2,18,neurotransmitter receptor transport,BP,CACNG3;SNAP25
7507,GO:0030814,0.00576883731381624,0.999521327110296,3,60,regulation of cAMP metabolic process,BP,CHGA;HPCA;MRAP2
5949,GO:0016597,0.00579531658161581,0.999519174490933,3,57,amino acid binding,MF,GAD2;GRIN1;GRIN2B
21298,GO:2000287,0.00594158802462751,1,1,1,positive regulation of myotome development,BP,DMRT2
21300,GO:2000290,0.00594158802462751,1,1,1,regulation of myotome development,BP,DMRT2
18032,GO:0098796,0.00609104969532802,0.997646523853906,14,1047,membrane protein complex,CC,CACNG3;GABRA1;SYT1;DNM1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;GABRA2;GNG3;KCNC2;GRIN1;GRIN2B
13965,GO:0051592,0.00619194460188183,0.999173555426393,4,112,response to calcium ion,BP,SYT1;HPCA;ADCY1;NEUROD2
17345,GO:0090276,0.00625544776851423,0.998894699996055,5,181,regulation of peptide hormone secretion,BP,NNAT;CNR1;SNAP25;VSNL1;KCNC2
2862,GO:0005954,0.0063970919248494,1,1,1,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G
4406,GO:0009187,0.00651552076810227,0.999117204223454,4,115,cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2;ADCY1
14516,GO:0060074,0.0066466887578468,0.999763613113647,2,17,synapse maturation,BP,NEURL1;NEUROD2
14009,GO:0051668,0.00681151968048894,0.999065842450429,4,112,localization within membrane,BP,CACNG3;DNM1;SNAP25;MAL2
11903,GO:0045183,0.00690432694819996,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
3874,GO:0008068,0.00713935575893675,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
17742,GO:0097401,0.00713935575893675,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
17972,GO:0098655,0.00714360642212765,0.99752659181575,11,719,cation transmembrane transport,BP,CACNG3;SLC17A7;SLC30A3;HPCA;KCNS1;SLC12A5;SLC4A10;KCNC2;KCNK9;GRIN1;GRIN2B
3804,GO:0007584,0.00725796606022356,0.998669987440698,5,192,response to nutrient,BP,IGFBP2;CNR1;HPCA;GRIN1;SELL
3650,GO:0007187,0.00734643036573667,0.998649479947402,5,196,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CHGA;CNR1;CHRM3;MRAP2;ADCY1
10364,GO:0038060,0.00739132411247083,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,KCNC2
13988,GO:0051640,0.00740546976251585,0.997567377307093,10,613,organelle localization,BP,SYT13;SYT1;RIMS1;RPH3A;NEFH;CHGA;DNM1;SNAP25;SYT4;UNC13C
20317,GO:1904692,0.00747613172032473,1,1,1,positive regulation of type B pancreatic cell proliferation,BP,PTPRN
4710,GO:0010226,0.00748111851821536,0.999711839343997,2,21,response to lithium ion,BP,IGFBP2;ADCY1
12938,GO:0048174,0.00750182316552803,1,1,1,negative regulation of short-term neuronal synaptic plasticity,BP,SYT4
15450,GO:0061782,0.00750182316552803,1,1,1,vesicle fusion with vesicle,BP,SYT4
20665,GO:1905432,0.00750182316552803,1,1,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
20666,GO:1905433,0.00750182316552803,1,1,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
6384,GO:0018964,0.00750764993009846,1,1,1,propylene metabolic process,BP,GRIN1
18006,GO:0098746,0.00753629853253589,1,1,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
2982,GO:0006147,0.00758439569815839,1,1,1,guanine catabolic process,BP,GDA
4269,GO:0008892,0.00758439569815839,1,1,1,guanine deaminase activity,MF,GDA
10512,GO:0040040,0.00763941026546047,1,1,1,thermosensory behavior,BP,SLC12A5
13051,GO:0048471,0.00779371525097794,0.997420068632449,10,626,perinuclear region of cytoplasm,CC,CHGA;STMN2;NEURL1;KCNS1;PACSIN1;SNAP25;SYT4;CHI3L1;GAD2;MAL2
8697,GO:0032879,0.00797112958122465,0.996039489644427,25,2357,regulation of localization,BP,CACNG3;SYT13;NNAT;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;CHGA;DNM1;SLC30A3;CNR1;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;MRAP2;TBR1;CXCL14;VSNL1;KCNC2;GRIN1;CCK
5170,GO:0014070,0.00809886966142453,0.997004936347667,12,837,response to organic cyclic compound,BP,GABRA1;PTPRN;GABRG2;IGFBP2;CNR1;HPCA;VGF;GABRB2;ADCY1;KCNC2;GRIN1;SELL
4000,GO:0008277,0.00809897071493071,0.998830738146409,4,123,regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA;DNM1;RGS4;MRAP2
15521,GO:0065007,0.00813722062166422,0.995814389584304,77,10209,biological regulation,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;CRYM;STMN2;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;FABP7;ADCY1;KCNC2;KCNK9;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;NELL2;MYT1L;CCK;SELL;NMB;GRIN2B
16852,GO:0072347,0.00815458799672115,0.999231629881625,3,64,response to anesthetic,BP,CNR1;HPCA;GRIN1
2769,GO:0005794,0.00862651079193642,0.996218146054736,17,1379,Golgi apparatus,CC,CAMK1G;PTPRN;SYT1;RBFOX1;RPH3A;ST8SIA5;STMN2;DNM1;VGF;SNAP25;SYT4;GAD2;CXCL14;TENM2;CHST9;TMEM130;CREG2
8707,GO:0032892,0.00866496797247381,0.999638556069819,2,22,positive regulation of organic acid transport,BP,SYT4;CCK
2352,GO:0004970,0.00890969697371427,0.999627334038057,2,19,ionotropic glutamate receptor activity,MF,GRIN1;GRIN2B
13651,GO:0051050,0.00907349016335987,0.996593030012521,12,856,positive regulation of transport,BP,NNAT;SYT1;CAMK2A;DNM1;SLC30A3;HPCA;CALY;SYT4;VSNL1;KCNC2;GRIN1;CCK
12282,GO:0045981,0.00923147213295082,0.999086912540593,3,72,positive regulation of nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
18732,GO:1900544,0.00923147213295082,0.999086912540593,3,72,positive regulation of purine nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
11569,GO:0044304,0.00925124041258692,0.999088212698088,3,62,main axon,CC,DNM1;KCNC2;CCK
12272,GO:0045956,0.00930399493898871,0.999597285627091,2,22,positive regulation of calcium ion-dependent exocytosis,BP,SYT1;SYT4
8050,GO:0031780,0.00949452089750434,0.999977587325778,1,2,corticotropin hormone receptor binding,MF,MRAP2
8053,GO:0031783,0.00949452089750434,0.999977587325778,1,2,type 5 melanocortin receptor binding,MF,MRAP2
14894,GO:0060627,0.00971857899349668,0.997126810219038,8,451,regulation of vesicle-mediated transport,BP,SYT13;SYT1;RIMS1;RPH3A;PACSIN1;CALY;SYT4;VSNL1
14170,GO:0051966,0.00983099331280653,0.999008827861534,3,63,regulation of synaptic transmission, glutamatergic,BP,CACNG3;SYT1;CNR1
8773,GO:0032989,0.0101268952807038,0.995840442162816,14,1030,cellular component morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;TBR1;TENM2;SHC3;ADCY1;NPTX1;GRIN1;CCK
12989,GO:0048278,0.0101822488012846,0.998957363631281,3,69,vesicle docking,BP,SYT1;SNAP25;UNC13C
6710,GO:0019935,0.010224832824243,0.998418759317318,4,134,cyclic-nucleotide-mediated signaling,BP,CHGA;MRAP2;ADCY1;KCNC2
13790,GO:0051259,0.0102557049395525,0.996938525497254,8,469,protein complex oligomerization,BP,SYT1;LNX1;DNM1;KCNS1;KCNC2;GRIN1;CCK;GRIN2B
8660,GO:0032809,0.0107216710795588,0.999498765929844,2,23,neuronal cell body membrane,CC,HPCA;KCNC2
11564,GO:0044298,0.0107216710795588,0.999498765929844,2,23,cell body membrane,CC,HPCA;KCNC2
13810,GO:0051290,0.0113086297101513,0.999449673273402,2,28,protein heterotetramerization,BP,GRIN1;GRIN2B
8512,GO:0032594,0.0114255503620879,0.999443409279163,2,26,protein transport within lipid bilayer,BP,CACNG3;SNAP25
777,GO:0001964,0.0114403979364241,0.999445143176791,2,24,startle response,BP,FABP7;GRIN1
5401,GO:0015291,0.0116957588132049,0.997592120279832,5,198,secondary active transmembrane transporter activity,MF,SLC17A7;SLC12A5;SLC13A5;SLC4A10;SLC6A17
8964,GO:0033363,0.0117081256598641,0.999423729678753,2,25,secretory granule organization,BP,PTPRN;SYT4
19074,GO:1901899,0.0117179589654676,0.999965822272288,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
12155,GO:0045745,0.0117243343043405,0.999419799780397,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA;MRAP2
16189,GO:0071248,0.0117844196987057,0.998099168412745,4,141,cellular response to metal ion,BP,SYT1;HPCA;ADCY1;NEUROD2
9891,GO:0035674,0.0119946616581084,0.999964184048824,1,2,tricarboxylic acid transmembrane transport,BP,SLC13A5
4409,GO:0009190,0.0120141126982649,0.998689417779105,3,76,cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
14281,GO:0052652,0.0120141126982649,0.998689417779105,3,76,cyclic purine nucleotide metabolic process,BP,HPCA;MRAP2;ADCY1
14650,GO:0060291,0.0120382253357118,0.998688647905151,3,70,long-term synaptic potentiation,BP,SNAP25;NRGN;GRIN2B
13150,GO:0048667,0.0121943354943958,0.995946912107711,9,537,cell morphogenesis involved in neuron differentiation,BP,NGEF;CAMK2A;NEFH;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
10582,GO:0042137,0.0123573946265491,0.999961978029205,1,2,sequestering of neurotransmitter,BP,SLC17A7
11161,GO:0043270,0.0123949898479307,0.99740891233313,5,214,positive regulation of ion transport,BP,CAMK2A;SYT4;KCNC2;GRIN1;CCK
13467,GO:0050773,0.0124885224572747,0.997954693181821,4,127,regulation of dendrite development,BP,NGEF;NEURL1;PACSIN1;GRIN1
1804,GO:0004084,0.0125209581423058,0.99996096158839,1,2,branched-chain-amino-acid transaminase activity,MF,BCAT1
4321,GO:0009082,0.0125209581423058,0.99996096158839,1,2,branched-chain amino acid biosynthetic process,BP,BCAT1
4330,GO:0009098,0.0125209581423058,0.99996096158839,1,2,leucine biosynthetic process,BP,BCAT1
4331,GO:0009099,0.0125209581423058,0.99996096158839,1,2,valine biosynthetic process,BP,BCAT1
14282,GO:0052654,0.0125209581423058,0.99996096158839,1,2,L-leucine transaminase activity,MF,BCAT1
14283,GO:0052655,0.0125209581423058,0.99996096158839,1,2,L-valine transaminase activity,MF,BCAT1
14284,GO:0052656,0.0125209581423058,0.99996096158839,1,2,L-isoleucine transaminase activity,MF,BCAT1
3477,GO:0006887,0.0125693822053842,0.995282875078695,11,808,exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;CHGA;SNAP25;SYT4;CHI3L1;UNC13C;VSNL1;SELL
11820,GO:0045055,0.012760615792917,0.995446615995211,10,706,regulated exocytosis,BP,SYT13;SYT1;RIMS1;RPH3A;CHGA;SNAP25;SYT4;CHI3L1;UNC13C;SELL
7492,GO:0030799,0.0128897986597208,0.998555144551854,3,80,regulation of cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
4737,GO:0010387,0.0129013020624612,0.999958545819052,1,2,COP9 signalosome assembly,BP,TESPA1
12245,GO:0045921,0.0129190889144083,0.998552457907401,3,76,positive regulation of exocytosis,BP,SYT1;SYT4;VSNL1
20663,GO:1905429,0.0130671834597566,0.999957469354299,1,2,response to glycine,BP,GRIN1
21447,GO:2000503,0.0130937625705252,0.999943102869136,1,3,positive regulation of natural killer cell chemotaxis,BP,CXCL14
18746,GO:1900738,0.0131410544053928,0.999942689898122,1,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
21588,GO:2000707,0.0133577486026762,0.999955550292191,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
21420,GO:2000463,0.0133696308800541,0.999294645851663,2,25,positive regulation of excitatory postsynaptic potential,BP,RIMS1;GRIN1
2511,GO:0005251,0.013480613792764,0.999283963397828,2,26,delayed rectifier potassium channel activity,MF,KCNS1;KCNC2
2625,GO:0005543,0.01356512125257,0.996130246163124,7,379,phospholipid binding,MF,SYT13;SYT1;RPH3A;PACSIN1;SYT4;UNC13C;NRGN
2516,GO:0005261,0.0136418907077336,0.996554050072261,6,285,cation channel activity,MF,CACNG3;KCNS1;KCNC2;KCNK9;GRIN1;GRIN2B
16088,GO:0070996,0.0136514908502347,0.99993813693603,1,3,type 1 melanocortin receptor binding,MF,MRAP2
7497,GO:0030804,0.0136731724474159,0.99926002326104,2,32,positive regulation of cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2
12935,GO:0048169,0.0137449719800876,0.999262452129001,2,26,regulation of long-term neuronal synaptic plasticity,BP,NEURL1;GRIN1
14158,GO:0051954,0.0137761912223603,0.999256694831683,2,28,positive regulation of amine transport,BP,SYT4;CCK
14727,GO:0060384,0.0138651906208285,0.999254410885924,2,25,innervation,BP,GABRB2;NPTX1
21832,GO:2001257,0.0140244660292102,0.997619472272725,4,141,regulation of cation channel activity,BP,CACNG3;HPCA;KCNS1;KCNC2
11262,GO:0043449,0.0140905369506417,0.999950521116487,1,2,cellular alkene metabolic process,BP,GRIN1
3652,GO:0007189,0.0144533137392663,0.998308827455396,3,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,CHGA;MRAP2;ADCY1
7175,GO:0030141,0.0146500240131892,0.994658654925013,10,736,secretory granule,CC,PTPRN;SYT1;RPH3A;CHGA;SNAP25;SYT4;CHI3L1;PCSK1;SV2B;SELL
5171,GO:0014072,0.0146601112079161,0.999179730819354,2,30,response to isoquinoline alkaloid,BP,CNR1;GRIN1
11167,GO:0043278,0.0146601112079161,0.999179730819354,2,30,response to morphine,BP,CNR1;GRIN1
8208,GO:0032127,0.0147292903577452,0.999945915837606,1,2,dense core granule membrane,CC,SYT4
10341,GO:0038023,0.0149274317096176,0.99425573146621,11,817,signaling receptor activity,MF,GABRA1;EPHB6;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;GABRB2;GABRA2;GRIN1;GRIN2B
14529,GO:0060089,0.0149274317096176,0.99425573146621,11,817,molecular transducer activity,MF,GABRA1;EPHB6;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;GABRB2;GABRA2;GRIN1;GRIN2B
4051,GO:0008355,0.014965010438302,0.999944164192362,1,2,olfactory learning,BP,GRIN1
10936,GO:0042835,0.0149745412839199,0.999944092776612,1,2,BRE binding,MF,CELF4
21053,GO:1990742,0.0149773689078426,0.999944071580046,1,2,microvesicle,CC,SYT4
20990,GO:1990502,0.0150600422925159,0.999943450050427,1,2,dense core granule maturation,BP,PTPRN
14159,GO:0051955,0.0151883209213842,0.99913743484478,2,28,regulation of amino acid transport,BP,SYT4;CCK
15114,GO:0061024,0.0152179285813932,0.994127837751905,11,803,membrane organization,BP,CACNG3;SYT13;SYT1;CAMK2A;RIMS1;RPH3A;DNM1;PACSIN1;SNAP25;SYT4;MAL2
2148,GO:0004683,0.0152905064667509,0.999128565862947,2,28,calmodulin-dependent protein kinase activity,MF,CAMK1G;CAMK2A
5760,GO:0016234,0.0155174351159599,0.998138566394766,3,77,inclusion body,CC,SNCB;NEFH;NEFM
9634,GO:0035235,0.0155522528805797,0.999109545039415,2,26,ionotropic glutamate receptor signaling pathway,BP,GRIN1;GRIN2B
4013,GO:0008294,0.0155953024716651,0.999939342259173,1,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,ADCY1
19012,GO:1901699,0.0161841131203963,0.994359660916149,9,586,cellular response to nitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;CHRM3;GABRB2;GNG3;ADCY1;KCNC2
5497,GO:0015696,0.0162706889343102,0.99800889397541,3,85,ammonium transport,BP,SYT1;CNR1;SYT4
3001,GO:0006182,0.0163522055417959,0.999029360729086,2,31,cGMP biosynthetic process,BP,HPCA;ADCY1
7986,GO:0031667,0.0165140011130427,0.995099796792009,7,416,response to nutrient levels,BP,IGFBP2;CNR1;HPCA;VGF;GRIN1;CCK;SELL
13916,GO:0051491,0.0166157248247532,0.999010701629429,2,28,positive regulation of filopodium assembly,BP,NEURL1;TENM2
12674,GO:0046883,0.0166225536291302,0.996258333293542,5,232,regulation of hormone secretion,BP,NNAT;CNR1;SNAP25;VSNL1;KCNC2
18273,GO:0099604,0.0167081170228541,0.999004348286196,2,27,ligand-gated calcium channel activity,MF,GRIN1;GRIN2B
6476,GO:0019233,0.0168642584445516,0.997909049337751,3,84,sensory perception of pain,BP,CNR1;GRIN1;CCK
8049,GO:0031779,0.0170172963976417,0.999891742109827,1,4,melanocortin receptor binding,MF,MRAP2
8051,GO:0031781,0.0170172963976417,0.999891742109827,1,4,type 3 melanocortin receptor binding,MF,MRAP2
8052,GO:0031782,0.0170172963976417,0.999891742109827,1,4,type 4 melanocortin receptor binding,MF,MRAP2
5301,GO:0015081,0.0171790506107088,0.996904254769063,4,139,sodium ion transmembrane transporter activity,MF,SLC17A7;SLC13A5;SLC4A10;SLC6A17
7699,GO:0031117,0.0174424896879808,0.999898833702793,1,3,positive regulation of microtubule depolymerization,BP,STMN2
3873,GO:0008066,0.0174719418516771,0.998933998331934,2,27,glutamate receptor activity,MF,GRIN1;GRIN2B
7955,GO:0031623,0.0175493794893926,0.9977909222822,3,85,receptor internalization,BP,CACNG3;DNM1;SNAP25
6607,GO:0019722,0.0176832690332596,0.996781222546087,4,153,calcium-mediated signaling,BP,HPCA;NEUROD2;GRIN1;GRIN2B
3828,GO:0007618,0.017738378048741,0.998899234883038,2,32,mating,BP,CNR1;GRIN1
5971,GO:0016639,0.0177948537784862,0.999894688123926,1,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,CRYM
19753,GO:1903531,0.0179214297015409,0.996723370334291,4,158,negative regulation of secretion by cell,BP,CHGA;CNR1;SYT4;VSNL1
11857,GO:0045104,0.0179679098786267,0.998879141523947,2,31,intermediate filament cytoskeleton organization,BP,NEFH;NEFM
13961,GO:0051588,0.0181774275738646,0.997682174421157,3,84,regulation of neurotransmitter transport,BP,CAMK2A;RIMS1;SYT4
14595,GO:0060200,0.0182451233529136,0.999889268528511,1,3,clathrin-sculpted acetylcholine transport vesicle,CC,SYT1
14596,GO:0060201,0.0182451233529136,0.999889268528511,1,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,SYT1
5300,GO:0015079,0.0183254272506146,0.996629936978853,4,149,potassium ion transmembrane transporter activity,MF,KCNS1;SLC12A5;KCNC2;KCNK9
18179,GO:0099082,0.0187380512135438,0.999883178244084,1,3,retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
2287,GO:0004871,0.0190303103863135,0.991532109656478,14,1181,signal transducer activity,MF,GABRA1;SLC17A7;EPHB6;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;GABRB2;SHC3;GABRA2;GNG3;GRIN1;GRIN2B
7452,GO:0030662,0.0191442098200068,0.996428908928514,4,162,coated vesicle membrane,CC,SYT1;SLC17A7;GAD2;NRGN
18787,GO:1901079,0.0191805324424365,0.999877571173429,1,3,positive regulation of relaxation of muscle,BP,CHGA
11856,GO:0045103,0.0192147530345906,0.998756182501626,2,32,intermediate filament-based process,BP,NEFH;NEFM
17595,GO:0097120,0.0192288220395664,0.998754789849767,2,32,receptor localization to synapse,BP,CACNG3;SNAP25
7182,GO:0030154,0.0194427074535712,0.988937262715283,32,3453,cell differentiation,BP,NNAT;NGEF;SYT1;CAMK2A;RIMS1;NEFH;CELF4;STMN2;NEFM;EPHB6;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;SHC3;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
13280,GO:0048936,0.0194940237868891,0.999873518400179,1,3,peripheral nervous system neuron axonogenesis,BP,NEFH
21121,GO:1990926,0.0195079771647645,0.999873336465178,1,3,short-term synaptic potentiation,BP,SNAP25
8034,GO:0031749,0.0195134030507217,0.99987326568263,1,3,D2 dopamine receptor binding,MF,DNM1
5389,GO:0015265,0.0195893301369738,0.999872273094992,1,3,urea channel activity,MF,SLC14A1
4009,GO:0008289,0.0196683877333176,0.992913786378142,9,622,lipid binding,MF,SYT13;SYT1;RPH3A;PACSIN1;SYT4;UNC13C;NRGN;FABP7;SELL
18741,GO:1900673,0.019877229127294,0.999868473925455,1,3,olefin metabolic process,BP,GRIN1
14034,GO:0051716,0.0199060074370255,0.988050795192589,50,6151,cellular response to stimulus,BP,CACNG3;CAMK1G;GABRA1;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;NEFH;CHGA;CELF4;STMN2;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;VGF;CALY;CHRM3;CHI3L1;MRAP2;TESPA1;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;GRIN1;CCK;NMB;GRIN2B
5332,GO:0015141,0.0199218000340363,0.999867880737114,1,3,succinate transmembrane transporter activity,MF,SLC13A5
5522,GO:0015744,0.0199218000340363,0.999867880737114,1,3,succinate transport,BP,SLC13A5
16303,GO:0071422,0.0199218000340363,0.999867880737114,1,3,succinate transmembrane transport,BP,SLC13A5
19469,GO:1902951,0.0199256045404565,0.999867830041053,1,3,negative regulation of dendritic spine maintenance,BP,GRIN2B
2411,GO:0005085,0.0199559078798677,0.994514887822181,6,305,guanyl-nucleotide exchange factor activity,MF,NGEF;CAMK2A;IQSEC3;SHC3;GRIN1;GRIN2B
13272,GO:0048878,0.0199566333456406,0.99164244411902,12,961,chemical homeostasis,BP,PTPRN;SLC30A3;CNR1;SLC12A5;VGF;SLC4A10;GNG3;VSNL1;ADCY1;GRIN1;CCK;GRIN2B
2334,GO:0004949,0.0199781115661858,0.99986712936866,1,3,cannabinoid receptor activity,MF,CNR1
4858,GO:0010647,0.0201788790607751,0.990263155280285,17,1558,positive regulation of cell communication,BP,CACNG3;NNAT;SYT1;RIMS1;CHGA;EPHB6;NEURL1;SNAP25;CHI3L1;MRAP2;TESPA1;NRGN;GNG3;VSNL1;NEUROD2;GRIN1;GRIN2B
1918,GO:0004351,0.0202400468008351,0.999863606087909,1,3,glutamate decarboxylase activity,MF,GAD2
3232,GO:0006540,0.0202894065766025,0.999862936941196,1,3,glutamate decarboxylation to succinate,BP,GAD2
2509,GO:0005249,0.020394164289433,0.997284724744534,3,84,voltage-gated potassium channel activity,MF,KCNS1;KCNC2;KCNK9
19891,GO:1903793,0.0204211441661175,0.998630942707523,2,34,positive regulation of anion transport,BP,SYT4;CCK
18744,GO:1900736,0.0204724779704965,0.999843086820868,1,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
3877,GO:0008076,0.0205766064037076,0.99724982192563,3,86,voltage-gated potassium channel complex,CC,KCNS1;SNAP25;KCNC2
2801,GO:0005853,0.0205786033822185,0.99984144860105,1,4,eukaryotic translation elongation factor 1 complex,CC,EEF1A2
15177,GO:0061110,0.0207368785218845,0.999856795367385,1,3,dense core granule biogenesis,BP,CHGA
21586,GO:2000705,0.0207368785218845,0.999856795367385,1,3,regulation of dense core granule biogenesis,BP,CHGA
5559,GO:0015820,0.0210147560433981,0.999852913090681,1,3,leucine transport,BP,SLC6A17
7783,GO:0031301,0.0210282975007967,0.995964114341086,4,166,integral component of organelle membrane,CC,SYT1;SLC17A7;SYT4;GABRA2
7092,GO:0023056,0.0210301476677059,0.989803037805696,17,1565,positive regulation of signaling,BP,CACNG3;NNAT;SYT1;RIMS1;CHGA;EPHB6;NEURL1;SNAP25;CHI3L1;MRAP2;TESPA1;NRGN;GNG3;VSNL1;NEUROD2;GRIN1;GRIN2B
564,GO:0001662,0.0211728600446431,0.998551232976635,2,35,behavioral fear response,BP,NEUROD2;CCK
933,GO:0002209,0.0211728600446431,0.998551232976635,2,35,behavioral defense response,BP,NEUROD2;CCK
16271,GO:0071377,0.0211980155772514,0.998548597960595,2,35,cellular response to glucagon stimulus,BP,GNG3;ADCY1
21445,GO:2000501,0.0212050064752851,0.999820442517532,1,5,regulation of natural killer cell chemotaxis,BP,CXCL14
6805,GO:0021586,0.021245625631274,0.999849647697217,1,3,pons maturation,BP,GRIN1
9038,GO:0033602,0.021714815307754,0.999842899976345,1,3,negative regulation of dopamine secretion,BP,CNR1
3673,GO:0007215,0.0217433934742386,0.997033556110158,3,85,glutamate receptor signaling pathway,BP,CACNG3;GRIN1;GRIN2B
5415,GO:0015319,0.0218231109436499,0.999841321258592,1,3,sodium:inorganic phosphate symporter activity,MF,SLC17A7
15096,GO:0060996,0.0218968683080099,0.997005447748051,3,84,dendritic spine development,BP,NGEF;NEURL1;SLC12A5
21304,GO:2000297,0.0220973565190703,0.999837287689417,1,3,negative regulation of synapse maturation,BP,NEUROD2
4655,GO:0009991,0.0223143149589427,0.992964159882796,7,444,response to extracellular stimulus,BP,IGFBP2;CNR1;HPCA;VGF;GRIN1;CCK;SELL
5737,GO:0016185,0.0224260951441616,0.999832385247284,1,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
18064,GO:0098844,0.0224260951441616,0.999832385247284,1,3,postsynaptic endocytic zone membrane,CC,DNM1
18084,GO:0098884,0.0224260951441616,0.999832385247284,1,3,postsynaptic neurotransmitter receptor internalization,BP,DNM1
18294,GO:0099738,0.0224450969503678,0.998417881927664,2,34,cell cortex region,CC,RIMS1;UNC13C
15537,GO:0070032,0.0225163376523601,0.999810026277316,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,SNAP25
17760,GO:0097442,0.0225824917957033,0.99983002711567,1,3,CA3 pyramidal cell dendrite,CC,SLC4A10
18253,GO:0099552,0.0227308646689337,0.999827774581261,1,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,CNR1
18254,GO:0099553,0.0227308646689337,0.999827774581261,1,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,CNR1
10732,GO:0042445,0.022891981372511,0.995488835356414,4,177,hormone metabolic process,BP,CRYM;PRLHR;CHST9;PCSK1
5173,GO:0014075,0.0229142851605456,0.998362896575465,2,36,response to amine,BP,KCNC2;GRIN1
5484,GO:0015672,0.0230316866944308,0.992692063847487,7,436,monovalent inorganic cation transport,BP,SLC17A7;KCNS1;SLC12A5;SLC13A5;SLC4A10;KCNC2;KCNK9
15452,GO:0061789,0.0232578524430274,0.999819652943282,1,3,dense core granule priming,BP,UNC13C
17693,GO:0097305,0.0235122869947943,0.995330917217737,4,171,response to alcohol,BP,CNR1;KCNC2;GRIN1;GRIN2B
10813,GO:0042596,0.0236942086209561,0.998274808426018,2,37,fear response,BP,NEUROD2;CCK
7171,GO:0030136,0.0237599176849693,0.99526778869053,4,168,clathrin-coated vesicle,CC,SYT1;SLC17A7;GAD2;NRGN
12846,GO:0047756,0.0238520022145605,0.999786697487182,1,4,chondroitin 4-sulfotransferase activity,MF,CHST9
2534,GO:0005310,0.0241128894113812,0.998232005563861,2,35,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7;SLC13A5
4761,GO:0010469,0.0242813183415066,0.993011489541811,6,393,regulation of signaling receptor activity,BP,CACNG3;NEURL1;VGF;CXCL14;CCK;NMB
12340,GO:0046098,0.0243118009810321,0.999778350848792,1,4,guanine metabolic process,BP,GDA
642,GO:0001784,0.0243613996561099,0.998204000777254,2,35,phosphotyrosine residue binding,MF,PTPN5;SHC3
3814,GO:0007600,0.0244057415515004,0.992162481790803,7,451,sensory perception,BP,RIMS1;CRYM;DNM1;CNR1;GABRB2;GRIN1;CCK
7445,GO:0030644,0.0245653839208813,0.999773678351822,1,4,cellular chloride ion homeostasis,BP,SLC12A5
2414,GO:0005088,0.0245932806091989,0.99388338988829,5,234,Ras guanyl-nucleotide exchange factor activity,MF,NGEF;CAMK2A;SHC3;GRIN1;GRIN2B
4096,GO:0008430,0.0248289100673745,0.999768770451106,1,4,selenium binding,MF,RPH3A
9736,GO:0035418,0.0249448434074965,0.998137639813427,2,35,protein localization to synapse,BP,SNAP25;GRIN1
9493,GO:0034705,0.0254537819972043,0.996306794828358,3,93,potassium channel complex,CC,KCNS1;SNAP25;KCNC2
644,GO:0001786,0.0255160749380449,0.998067345667374,2,37,phosphatidylserine binding,MF,SYT1;SYT4
8088,GO:0031914,0.0255620361309233,0.999754836746776,1,4,negative regulation of synaptic plasticity,BP,UNC13C
7170,GO:0030135,0.0258930815451211,0.993467470402468,5,259,coated vesicle,CC,SYT1;SLC17A7;PACSIN1;GAD2;NRGN
13649,GO:0051048,0.0260099518806624,0.994671432719376,4,178,negative regulation of secretion,BP,CHGA;CNR1;SYT4;VSNL1
18082,GO:0098881,0.0261108404081235,0.999744136467933,1,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,SNAP25
18131,GO:0098967,0.0261108404081235,0.999744136467933,1,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,SNAP25
14584,GO:0060179,0.0261589829052206,0.999743186786186,1,4,male mating behavior,BP,GRIN1
18243,GO:0099538,0.0263239797562038,0.999739918482705,1,4,synaptic signaling via neuropeptide,BP,SYT4
18244,GO:0099540,0.0263239797562038,0.999739918482705,1,4,trans-synaptic signaling by neuropeptide,BP,SYT4
3448,GO:0006842,0.0267658835800949,0.999731062167272,1,4,tricarboxylic acid transport,BP,SLC13A5
5329,GO:0015137,0.0267658835800949,0.999731062167272,1,4,citrate transmembrane transporter activity,MF,SLC13A5
5333,GO:0015142,0.0267658835800949,0.999731062167272,1,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A5
5523,GO:0015746,0.0267658835800949,0.999731062167272,1,4,citrate transport,BP,SLC13A5
16596,GO:0071918,0.0269477099073676,0.999727374581724,1,4,urea transmembrane transport,BP,SLC14A1
18829,GO:1901215,0.0269553507324568,0.994418381594209,4,175,negative regulation of neuron death,BP,SNCB;CHGA;GABRB2;GRIN1
7510,GO:0030817,0.0273836070220441,0.99783573074005,2,42,regulation of cAMP biosynthetic process,BP,HPCA;MRAP2
15144,GO:0061055,0.0275808852344323,0.999714334983782,1,4,myotome development,BP,DMRT2
6872,GO:0021759,0.0276305444032335,0.999713299269594,1,4,globus pallidus development,BP,KCNC2
7782,GO:0031300,0.027655416377826,0.99422604620432,4,181,intrinsic component of organelle membrane,CC,SYT1;SLC17A7;SYT4;GABRA2
5546,GO:0015803,0.0277692952321471,0.999710395366835,1,4,branched-chain amino acid transport,BP,SLC6A17
8135,GO:0031999,0.0285589121684665,0.999693587548183,1,4,negative regulation of fatty acid beta-oxidation,BP,CNR1
17722,GO:0097366,0.0290198417348032,0.997634025348685,2,42,response to bronchodilator,BP,KCNC2;GRIN1
4307,GO:0009063,0.0291916929974614,0.995523466038688,3,110,cellular amino acid catabolic process,BP,BCAT1;CRYM;GAD2
13627,GO:0051020,0.029194472581964,0.988737646856629,9,622,GTPase binding,MF,PTPRN;NGEF;CAMK2A;RIMS1;RPH3A;IQSEC3;SHC3;GRIN1;GRIN2B
18828,GO:1901214,0.0293978440567472,0.992333064591256,5,264,regulation of neuron death,BP,SNCB;CHGA;GABRB2;GRIN1;GRIN2B
2537,GO:0005315,0.0294746640428806,0.999673493561553,1,4,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
7576,GO:0030900,0.0295153139939911,0.99112574767963,6,347,forebrain development,BP,TBR1;SLC4A10;NRGN;FABP7;KCNC2;GRIN1
7939,GO:0031584,0.0296417014429587,0.999647920696092,1,5,activation of phospholipase D activity,BP,HPCA
2981,GO:0006145,0.0296736634676927,0.999669041517472,1,4,purine nucleobase catabolic process,BP,GDA
15567,GO:0070081,0.0297299543133337,0.999645808168263,1,5,clathrin-sculpted monoamine transport vesicle,CC,SYT1
15568,GO:0070083,0.0297299543133337,0.999645808168263,1,5,clathrin-sculpted monoamine transport vesicle membrane,CC,SYT1
494,GO:0001537,0.0298707700055673,0.999642424186696,1,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,CHST9
12162,GO:0045762,0.0300160173638668,0.999638916641214,1,5,positive regulation of adenylate cyclase activity,BP,HPCA
6876,GO:0021764,0.0301350989759391,0.99965860070957,1,4,amygdala development,BP,TBR1
13914,GO:0051489,0.0303158060468028,0.997476637989472,2,39,regulation of filopodium assembly,BP,NEURL1;TENM2
11570,GO:0044305,0.0305007024952423,0.999650211632785,1,4,calyx of Held,CC,UNC13C
12322,GO:0046068,0.0305555400123459,0.997438936547166,2,42,cGMP metabolic process,BP,HPCA;ADCY1
18408,GO:0106071,0.0305653624987492,0.999625493857577,1,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
12255,GO:0045933,0.0308433663114894,0.997397592017018,2,44,positive regulation of muscle contraction,BP,CHGA;CHRM3
3754,GO:0007409,0.0309118096957146,0.989579970532627,7,435,axonogenesis,BP,NEFH;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
11111,GO:0043200,0.031571746510054,0.995015225761035,3,104,response to amino acid,BP,NEURL1;HPCA;GRIN1
6609,GO:0019725,0.0317779827052623,0.98687512823168,10,805,cellular homeostasis,BP,PTPRN;SLC17A7;SLC30A3;SLC12A5;SLC4A10;GNG3;VSNL1;GRIN1;NELL2;GRIN2B
17929,GO:0098574,0.0319595600020696,0.999590313548127,1,5,cytoplasmic side of lysosomal membrane,CC,EEF1A2
8705,GO:0032890,0.0319725761322148,0.997254060263989,2,42,regulation of organic acid transport,BP,SYT4;CCK
19013,GO:1901700,0.0319763162625367,0.984364983217116,15,1404,response to oxygen-containing compound,BP,PTPRN;CAMK2A;NEURL1;IGFBP2;CNR1;HPCA;VGF;CHRM3;GNG3;VSNL1;ADCY1;KCNC2;GRIN1;SELL;GRIN2B
177,GO:0000381,0.0320792367658388,0.997239958187635,2,42,regulation of alternative mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
16493,GO:0071705,0.0321148181221772,0.982799071011735,20,2055,nitrogen compound transport,BP,CACNG3;NNAT;PTPRN;SYT1;RBFOX1;RIMS1;RPH3A;CHGA;SLC17A7;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;VSNL1;KCNC2;CCK;SLC6A17
13989,GO:0051641,0.0322377438329753,0.981898439647212,24,2541,cellular localization,BP,CACNG3;SYT13;PTPRN;SYT1;CAMK2A;RIMS1;RPH3A;NEFH;CHGA;SLC17A7;DNM1;HPCA;PACSIN1;CALY;SNAP25;SYT4;MRAP2;GAD2;UNC13C;MAL2;SYN2;VSNL1;GRIN1;GRIN2B
4453,GO:0009249,0.0324034877767177,0.999539668465559,1,8,protein lipoylation,BP,NNAT
5576,GO:0015850,0.0324152950369899,0.992889880879552,4,189,organic hydroxy compound transport,BP,SYT1;CHGA;CNR1;SYT4
3836,GO:0007626,0.0325450131393177,0.99285790840506,4,177,locomotory behavior,BP,DNM1;SNAP25;SLC4A10;GRIN1
13422,GO:0050708,0.0329009740085016,0.989851500924376,6,371,regulation of protein secretion,BP,NNAT;CNR1;SNAP25;SYT4;VSNL1;KCNC2
19567,GO:1903136,0.032901645345903,0.999547706413054,1,6,cuprous ion binding,MF,SNCB
14745,GO:0060405,0.0340136157599496,0.99953556529913,1,5,regulation of penile erection,BP,CNR1
17759,GO:0097441,0.0340380466726053,0.999534893177516,1,5,basal dendrite,CC,SLC4A10
8165,GO:0032051,0.0340710367187055,0.999533984802505,1,5,clathrin light chain binding,MF,CALY
3919,GO:0008146,0.0345131068510815,0.996901755466292,2,46,sulfotransferase activity,MF,SULT4A1;CHST9
14728,GO:0060385,0.0345425640803005,0.999520903140669,1,5,axonogenesis involved in innervation,BP,NPTX1
12593,GO:0046677,0.0346520842421574,0.99055606636487,5,290,response to antibiotic,BP,CNR1;ADCY1;KCNC2;GRIN1;GRIN2B
2581,GO:0005436,0.0347131034033182,0.999516126609117,1,5,sodium:phosphate symporter activity,MF,SLC17A7
5416,GO:0015321,0.0347131034033182,0.999516126609117,1,5,sodium-dependent phosphate transmembrane transporter activity,MF,SLC17A7
13483,GO:0050794,0.0348053508236062,0.978765367492046,68,9109,regulation of cellular process,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;CRYM;STMN2;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;TMEM132D;NRGN;GNG3;VSNL1;FABP7;ADCY1;KCNC2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;NMB;GRIN2B
19642,GO:1903307,0.0348581657841495,0.99685393230801,2,46,positive regulation of regulated secretory pathway,BP,SYT1;SYT4
15606,GO:0070142,0.0350370421271119,0.999506987414151,1,5,synaptic vesicle budding,BP,DNM1
13613,GO:0051001,0.0351007154926747,0.99948476961927,1,6,negative regulation of nitric-oxide synthase activity,BP,CNR1
16529,GO:0071804,0.0351150966163426,0.992106923030131,4,183,cellular potassium ion transport,BP,KCNS1;SLC12A5;KCNC2;KCNK9
16530,GO:0071805,0.0351150966163426,0.992106923030131,4,183,potassium ion transmembrane transport,BP,KCNS1;SLC12A5;KCNC2;KCNK9
13078,GO:0048522,0.0352010532050893,0.978355957486008,38,4509,positive regulation of cellular process,BP,CACNG3;NNAT;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;CHGA;EEF1A2;CELF4;STMN2;EPHB6;NEURL1;IGFBP2;CNR1;HPCA;PACSIN1;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;CXCL14;TENM2;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ENC1;DMRT2;GRIN1;DDN;CCK;GRIN2B
12936,GO:0048170,0.0352470247589745,0.999501016887309,1,5,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1
9101,GO:0033762,0.0352975350971728,0.996792657252224,2,46,response to glucagon,BP,GNG3;ADCY1
5570,GO:0015840,0.0354883991941118,0.999473243186058,1,6,urea transport,BP,SLC14A1
17983,GO:0098693,0.0355838724283669,0.996762367870484,2,42,regulation of synaptic vesicle cycle,BP,RIMS1;DNM1
2062,GO:0004568,0.0357824713325875,0.999464413697273,1,6,chitinase activity,MF,CHI3L1
2912,GO:0006030,0.0357824713325875,0.999464413697273,1,6,chitin metabolic process,BP,CHI3L1
2913,GO:0006032,0.0357824713325875,0.999464413697273,1,6,chitin catabolic process,BP,CHI3L1
5366,GO:0015204,0.0359543636205502,0.999459218169017,1,6,urea transmembrane transporter activity,MF,SLC14A1
9939,GO:0035747,0.0359939680066189,0.99944269573992,1,7,natural killer cell chemotaxis,BP,CXCL14
565,GO:0001664,0.0359962225051503,0.991834023925352,4,211,G-protein coupled receptor binding,MF,DNM1;MRAP2;CXCL14;GNG3
7724,GO:0031201,0.0362067392776775,0.996658009209529,2,49,SNARE complex,CC,SYT1;SNAP25
11962,GO:0045309,0.036292778317747,0.996657141387869,2,44,protein phosphorylated amino acid binding,MF,PTPN5;SHC3
12159,GO:0045759,0.0365317025605834,0.999441581537715,1,6,negative regulation of action potential,BP,CNR1
11566,GO:0044300,0.0365388730784802,0.999463482608154,1,5,cerebellar mossy fiber,CC,SLC17A7
7954,GO:0031622,0.036626985815946,0.999438643201972,1,6,positive regulation of fever generation,BP,CNR1
19907,GO:1903825,0.0367133693556191,0.993852193869261,3,107,organic acid transmembrane transport,BP,SLC17A7;SLC13A5;SLC6A17
20501,GO:1905039,0.0367133693556191,0.993852193869261,3,107,carboxylic acid transmembrane transport,BP,SLC17A7;SLC13A5;SLC6A17
18245,GO:0099541,0.0367860380084445,0.999456143827102,1,5,trans-synaptic signaling by lipid,BP,CNR1
18246,GO:0099542,0.0367860380084445,0.999456143827102,1,5,trans-synaptic signaling by endocannabinoid,BP,CNR1
3667,GO:0007207,0.0370497493542458,0.999425511670369,1,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
9393,GO:0034481,0.0372661413139335,0.999418730655413,1,6,chondroitin sulfotransferase activity,MF,CHST9
8994,GO:0033500,0.0375061111374284,0.991388964771894,4,194,carbohydrate homeostasis,BP,PTPRN;CNR1;VGF;VSNL1
10810,GO:0042593,0.0375061111374284,0.991388964771894,4,194,glucose homeostasis,BP,PTPRN;CNR1;VGF;VSNL1
17926,GO:0098562,0.0375513847679901,0.991376745177473,4,191,cytoplasmic side of membrane,CC,EEF1A2;NPTX2;SNAP25;GNG3
18063,GO:0098843,0.0377135737823589,0.999404581482762,1,6,postsynaptic endocytic zone,CC,DNM1
18153,GO:0099011,0.0379335160910447,0.999421409838601,1,5,neuronal dense core vesicle exocytosis,BP,UNC13C
18233,GO:0099525,0.0379335160910447,0.999421409838601,1,5,presynaptic dense core vesicle exocytosis,BP,UNC13C
327,GO:0000904,0.0381514021542359,0.984557855165376,9,659,cell morphogenesis involved in differentiation,BP,NGEF;CAMK2A;NEFH;TBR1;SHC3;ADCY1;NPTX1;GRIN1;CCK
2278,GO:0004859,0.0382445908054935,0.999357294038122,1,8,phospholipase inhibitor activity,MF,SNCB
10947,GO:0042895,0.038300963424199,0.999385744138538,1,6,antibiotic transmembrane transporter activity,MF,SLC13A5
3490,GO:0006904,0.0384125059766131,0.996341332500287,2,48,vesicle docking involved in exocytosis,BP,SNAP25;UNC13C
18122,GO:0098943,0.0384455757880795,0.999363576395482,1,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,CACNG3
1316,GO:0002866,0.038557276606687,0.999359844583828,1,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
13265,GO:0048869,0.0386070895116556,0.976638768127202,32,3636,cellular developmental process,BP,NNAT;NGEF;SYT1;CAMK2A;RIMS1;NEFH;CELF4;STMN2;NEFM;EPHB6;NPTX2;NEURL1;CNR1;SLC12A5;PACSIN1;SNAP25;SYT4;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;TENM2;SHC3;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;GRIN1;MYT1L;CCK
3659,GO:0007197,0.0387873564276629,0.999369920196895,1,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
6126,GO:0016907,0.0387873564276629,0.999369920196895,1,6,G-protein coupled acetylcholine receptor activity,MF,CHRM3
11107,GO:0043196,0.0392313432678556,0.999337089543694,1,7,varicosity,CC,DNM1
14497,GO:0060052,0.0392605774724828,0.999354328575539,1,6,neurofilament cytoskeleton organization,BP,NEFH
1788,GO:0004062,0.0395315575193882,0.999312966781673,1,8,aryl sulfotransferase activity,MF,SULT4A1
19132,GO:1902075,0.0398061897395885,0.999317365049103,1,7,cellular response to salt,BP,HPCA
19426,GO:1902866,0.0400457904751047,0.999328030238535,1,6,regulation of retina development in camera-type eye,BP,CELF4
2541,GO:0005326,0.0402050464147964,0.996079815447927,2,46,neurotransmitter transporter activity,MF,SLC17A7;SLC6A17
15718,GO:0070324,0.0403108251701687,0.999299807527784,1,7,thyroid hormone binding,MF,CRYM
10802,GO:0042584,0.0405831853835055,0.999309724276948,1,6,chromaffin granule membrane,CC,SYT1
6804,GO:0021578,0.0407684589586172,0.999303355099353,1,6,hindbrain maturation,BP,GRIN1
6824,GO:0021626,0.0407684589586172,0.999303355099353,1,6,central nervous system maturation,BP,GRIN1
11114,GO:0043203,0.0408046855578867,0.999282405556035,1,7,axon hillock,CC,CCK
7812,GO:0031339,0.0408049855937917,0.999302095908939,1,6,negative regulation of vesicle fusion,BP,SYT4
12351,GO:0046113,0.0408281759044416,0.999301295864624,1,6,nucleobase catabolic process,BP,GDA
12043,GO:0045576,0.0408754024550398,0.995963786305075,2,52,mast cell activation,BP,CHGA;CNR1
17113,GO:0086023,0.0413325010165029,0.999283781855009,1,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,CHGA
13793,GO:0051262,0.0413418188253048,0.992731860390352,3,125,protein tetramerization,BP,DNM1;GRIN1;GRIN2B
1641,GO:0003828,0.0413429033283494,0.999283418287259,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA5
15102,GO:0061002,0.0414347107113207,0.999280205490746,1,6,negative regulation of dendritic spine morphogenesis,BP,NGEF
5068,GO:0010942,0.0415374667872408,0.983918797389155,8,614,positive regulation of cell death,BP,NGEF;CAMK2A;EEF1A2;NEURL1;CNR1;GRIN1;CCK;GRIN2B
12736,GO:0046982,0.0419766033861625,0.986282676949054,6,403,protein heterodimerization activity,MF,SYT1;SYT4;GAD2;TENM2;KCNK9;NEUROD2
7813,GO:0031340,0.0419769875171257,0.999240228025567,1,7,positive regulation of vesicle fusion,BP,SYT1
17677,GO:0097264,0.0419998089205126,0.999260268951583,1,6,self proteolysis,BP,TENM2
6286,GO:0018107,0.0420874810853864,0.992560932407733,3,112,peptidyl-threonine phosphorylation,BP,CAMK1G;CAMK2A;CHI3L1
11902,GO:0045182,0.0421071934931954,0.995781665221186,2,49,translation regulator activity,MF,CELF4;NEURL1
5813,GO:0016323,0.0421419710252885,0.989965496606985,4,191,basolateral plasma membrane,CC,CHRM3;SLC14A1;SLC4A10;KCNC2
1274,GO:0002791,0.0422740154887174,0.986163591105313,6,397,regulation of peptide secretion,BP,NNAT;CNR1;SNAP25;SYT4;VSNL1;KCNC2
2518,GO:0005267,0.0422888065455167,0.992507299910969,3,116,potassium channel activity,MF,KCNS1;KCNC2;KCNK9
18762,GO:1901016,0.0425483477531033,0.99571321051104,2,49,regulation of potassium ion transmembrane transporter activity,BP,KCNS1;KCNC2
8618,GO:0032762,0.0426238418416089,0.999216430894801,1,7,mast cell cytokine production,BP,CHGA
3869,GO:0008061,0.0428318170608882,0.999208700406351,1,7,chitin binding,MF,CHI3L1
18409,GO:0106072,0.0429850413723227,0.999202980330271,1,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
2722,GO:0005737,0.043301279321649,0.973724943784003,73,10141,cytoplasm,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;GABRA2;CHST9;NRGN;SYN2;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;ENC1;PCSK1;CREG2;GRIN1;DDN;SV2B;SELL;SLC6A17
6954,GO:0021902,0.0433705327018405,0.999210758719716,1,6,commitment of neuronal cell to specific neuron type in forebrain,BP,TBR1
4152,GO:0008514,0.0434832708492755,0.989539189312028,4,198,organic anion transmembrane transporter activity,MF,SLC17A7;SLC13A5;SLC4A10;SLC6A17
15721,GO:0070327,0.0436664256637316,0.99917728948274,1,7,thyroid hormone transport,BP,CRYM
16089,GO:0070997,0.0438177138405442,0.987283436787898,5,295,neuron death,BP,SNCB;CHGA;GABRB2;GRIN1;GRIN2B
7953,GO:0031620,0.0438626529043443,0.999169814053723,1,7,regulation of fever generation,BP,CNR1
15523,GO:0065009,0.0440562428143896,0.973995962221083,26,2919,regulation of molecular function,BP,CACNG3;NGEF;CAMK2A;SNCB;RIMS1;EEF1A2;EPHB6;NEURL1;RGS4;CNR1;IQSEC3;HPCA;KCNS1;VGF;CHI3L1;CXCL14;SHC3;TMEM132D;GNG3;ADCY1;KCNC2;NEUROD2;GRIN1;CCK;NMB;GRIN2B
6708,GO:0019933,0.0440819798102194,0.992052590778022,3,125,cAMP-mediated signaling,BP,CHGA;MRAP2;ADCY1
5205,GO:0014807,0.0442329620600729,0.999155613114612,1,7,regulation of somitogenesis,BP,DMRT2
6938,GO:0021879,0.0446282934284615,0.995379759295194,2,51,forebrain neuron differentiation,BP,TBR1;SLC4A10
19301,GO:1902513,0.0446847796396079,0.99913812040683,1,7,regulation of organelle transport along microtubule,BP,NEFH
14127,GO:0051901,0.0449261369748537,0.999110794165749,1,8,positive regulation of mitochondrial depolarization,BP,CCK
20991,GO:1990504,0.0452866092044472,0.999138813410661,1,6,dense core granule exocytosis,BP,UNC13C
2517,GO:0005262,0.0453321797861929,0.991750167703109,3,112,calcium channel activity,MF,CACNG3;GRIN1;GRIN2B
13074,GO:0048518,0.0455480872808042,0.971122446072309,41,5037,positive regulation of biological process,BP,CACNG3;NNAT;PTPRN;NGEF;SYT1;CAMK2A;RIMS1;CHGA;EEF1A2;CELF4;STMN2;EPHB6;DNM1;NEURL1;SLC30A3;IGFBP2;CNR1;HPCA;PACSIN1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;CXCL14;TENM2;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ENC1;DMRT2;GRIN1;DDN;CCK;GRIN2B
18125,GO:0098953,0.0456284417422128,0.99908252400511,1,8,receptor diffusion trapping,BP,CACNG3
18134,GO:0098970,0.0456284417422128,0.99908252400511,1,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,CACNG3
18283,GO:0099628,0.0456284417422128,0.99908252400511,1,8,neurotransmitter receptor diffusion trapping,BP,CACNG3
11117,GO:0043208,0.0456308042245979,0.99910090239213,1,7,glycosphingolipid binding,MF,SELL
19072,GO:1901897,0.0460274886302773,0.999085057846824,1,7,regulation of relaxation of cardiac muscle,BP,CHGA
7503,GO:0030810,0.0463206350785045,0.995093700892189,2,56,positive regulation of nucleotide biosynthetic process,BP,HPCA;MRAP2
18707,GO:1900373,0.0463206350785045,0.995093700892189,2,56,positive regulation of purine nucleotide biosynthetic process,BP,HPCA;MRAP2
13222,GO:0048788,0.0464954013382784,0.999091780697644,1,6,cytoskeleton of presynaptic active zone,CC,RIMS1
16491,GO:0071702,0.0465782192314294,0.973336463439609,22,2399,organic substance transport,BP,CACNG3;NNAT;PTPRN;SYT1;RBFOX1;RIMS1;RPH3A;CHGA;SLC17A7;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;SLC13A5;SLC4A10;VSNL1;KCNC2;CCK;SLC6A17
20878,GO:1990089,0.0469405454207905,0.995001628080377,2,52,response to nerve growth factor,BP,STMN2;KCNC2
10422,GO:0038171,0.047317859456115,0.999032541915287,1,7,cannabinoid signaling pathway,BP,CNR1
18107,GO:0098917,0.0475728676552911,0.999021986801982,1,7,retrograde trans-synaptic signaling,BP,SYT4
1389,GO:0003056,0.0476108387449585,0.999020410138831,1,7,regulation of vascular smooth muscle contraction,BP,CHRM3
7495,GO:0030802,0.0477236554377286,0.994857348774557,2,58,regulation of cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2
9956,GO:0035773,0.0478213236127153,0.994847995443932,2,55,insulin secretion involved in cellular response to glucose stimulus,BP,PTPRN;VSNL1
12059,GO:0045597,0.0478757915900848,0.97879650327268,10,831,positive regulation of cell differentiation,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;TESPA1;NEUROD2;ENC1
8131,GO:0031995,0.0480007717284741,0.998983696885671,1,8,insulin-like growth factor II binding,MF,IGFBP2
16299,GO:0071417,0.0481304464946962,0.982159873703369,7,496,cellular response to organonitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;GABRB2;GNG3;ADCY1
12595,GO:0046683,0.0482306060212314,0.990992785353835,3,123,response to organophosphorus,BP,PTPRN;VGF;SELL
2360,GO:0004983,0.0484251626189889,0.998965474436245,1,8,neuropeptide Y receptor activity,MF,PRLHR
18251,GO:0099550,0.0484995800640425,0.998983137460072,1,7,trans-synaptic signaling, modulating synaptic transmission,BP,CNR1
11039,GO:0043084,0.0485238205605782,0.998982110906059,1,7,penile erection,BP,CNR1
3243,GO:0006551,0.0487314364282915,0.998952221166604,1,8,leucine metabolic process,BP,BCAT1
11597,GO:0044341,0.0487924650412522,0.998970698805313,1,7,sodium-dependent phosphate transport,BP,SLC17A7
6930,GO:0021860,0.0492369182495457,0.998951675856678,1,7,pyramidal neuron development,BP,SLC4A10
20329,GO:1904714,0.0500531656509823,0.99889403991498,1,8,regulation of chaperone-mediated autophagy,BP,EEF1A2
19702,GO:1903423,0.0501919909348759,0.998910196867658,1,7,positive regulation of synaptic vesicle recycling,BP,DNM1
7770,GO:0031282,0.0505414961478564,0.998854512825007,1,9,regulation of guanylate cyclase activity,BP,HPCA
5464,GO:0015556,0.0505552724970421,0.998871517430683,1,8,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A5
17985,GO:0098700,0.0505558731054894,0.998871490351165,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
12409,GO:0046322,0.0505670558028995,0.998870986098501,1,8,negative regulation of fatty acid oxidation,BP,CNR1
5562,GO:0015824,0.0506294865014257,0.998890922156873,1,7,proline transport,BP,SLC6A17
176,GO:0000380,0.0508043061383988,0.994344626679603,2,54,alternative mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
18207,GO:0099175,0.0508188460225033,0.994347885609937,2,52,regulation of postsynapse organization,BP,NGEF;GRIN2B
3432,GO:0006813,0.0510724367838709,0.987061911191678,4,207,potassium ion transport,BP,KCNS1;SLC12A5;KCNC2;KCNK9
1568,GO:0003373,0.0510742630328496,0.998871149928313,1,7,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1569,GO:0003374,0.0510742630328496,0.998871149928313,1,7,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
6278,GO:0018065,0.0513746490547652,0.998779655061583,1,12,protein-cofactor linkage,BP,NNAT
8380,GO:0032412,0.051540406513277,0.986901566697499,4,213,regulation of ion transmembrane transporter activity,BP,CACNG3;HPCA;KCNS1;KCNC2
18781,GO:1901072,0.0515613171767335,0.998807347787992,1,9,glucosamine-containing compound catabolic process,BP,CHI3L1
6619,GO:0019755,0.051575234229068,0.998806697434175,1,9,one-carbon compound transport,BP,SLC14A1
625,GO:0001766,0.0516869694666425,0.99880146941226,1,9,membrane raft polarization,BP,MAL2
7936,GO:0031580,0.0516869694666425,0.99880146941226,1,9,membrane raft distribution,BP,MAL2
17607,GO:0097151,0.0519576374216362,0.998831351334752,1,7,positive regulation of inhibitory postsynaptic potential,BP,RIMS1
18052,GO:0098828,0.0519576374216362,0.998831351334752,1,7,modulation of inhibitory postsynaptic potential,BP,RIMS1
13146,GO:0048663,0.0520225545264415,0.994122377355196,2,58,neuron fate commitment,BP,TBR1;MYT1L
10533,GO:0042048,0.0520266775279434,0.998828211222962,1,7,olfactory behavior,BP,GRIN1
14437,GO:0055102,0.0524228416589923,0.998739178854799,1,11,lipase inhibitor activity,MF,SNCB
21157,GO:2000026,0.0524906487354213,0.971497672956384,17,1706,regulation of multicellular organismal development,BP,NGEF;SYT1;RIMS1;CELF4;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;CHI3L1;TESPA1;TBR1;NEUROD2;ENC1;DMRT2;GRIN1
21737,GO:2001056,0.0525096806136567,0.98984273013584,3,137,positive regulation of cysteine-type endopeptidase activity,BP,GRIN1;CCK;GRIN2B
10946,GO:0042891,0.0526885075296718,0.998773245325246,1,8,antibiotic transport,BP,SLC13A5
8148,GO:0032024,0.053012826208088,0.993945498705063,2,59,positive regulation of insulin secretion,BP,NNAT;VSNL1
15815,GO:0070492,0.0531071900257469,0.998734001857119,1,9,oligosaccharide binding,MF,SELL
15981,GO:0070838,0.05349549263522,0.981468189791263,6,409,divalent metal ion transport,BP,CACNG3;CAMK2A;SLC30A3;HPCA;GRIN1;GRIN2B
18262,GO:0099569,0.0536134060250407,0.998754856914836,1,7,presynaptic cytoskeleton,CC,RIMS1
5556,GO:0015816,0.0536356830168636,0.998728268727851,1,8,glycine transport,BP,SLC6A17
6781,GO:0021548,0.0537503054986833,0.99872276979482,1,8,pons development,BP,GRIN1
10809,GO:0042592,0.0538540187060351,0.971734751001265,15,1500,homeostatic process,BP,PTPRN;SLC17A7;SLC30A3;CNR1;SLC12A5;VGF;MRAP2;SLC4A10;GNG3;VSNL1;ADCY1;GRIN1;NELL2;CCK;GRIN2B
8314,GO:0032328,0.0540264917443396,0.998709470184772,1,8,alanine transport,BP,SLC6A17
11307,GO:0043524,0.0542938933760094,0.989362940755011,3,131,negative regulation of neuron apoptotic process,BP,SNCB;GABRB2;GRIN1
6162,GO:0017016,0.054401492541285,0.979289769197689,7,486,Ras GTPase binding,MF,NGEF;CAMK2A;RIMS1;RPH3A;SHC3;GRIN1;GRIN2B
10417,GO:0038166,0.0544687651933479,0.998667548947088,1,9,angiotensin-activated signaling pathway,BP,CAMK2A
1313,GO:0002863,0.0545514929356815,0.998647031491516,1,10,positive regulation of inflammatory response to antigenic stimulus,BP,CNR1
15304,GO:0061469,0.0545833568044189,0.998682440644459,1,8,regulation of type B pancreatic cell proliferation,BP,PTPRN
19754,GO:1903532,0.0547580856653417,0.983101409049994,5,322,positive regulation of secretion by cell,BP,NNAT;SYT1;SYT4;VSNL1;CCK
7075,GO:0022898,0.0548211215265306,0.985785400533176,4,218,regulation of transmembrane transporter activity,BP,CACNG3;HPCA;KCNS1;KCNC2
16910,GO:0072511,0.0548804650503123,0.980868868296073,6,412,divalent inorganic cation transport,BP,CACNG3;CAMK2A;SLC30A3;HPCA;GRIN1;GRIN2B
2632,GO:0005575,0.0554846329067435,1,98,14935,cellular_component,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;NELL2;SV2B;C11ORF87;MYT1L;MPPED1;CCK;SELL;CPNE4;SLC6A17;NMB;GRIN2B
8834,GO:0033089,0.0559456858208516,0.998593502672202,1,9,positive regulation of T cell differentiation in thymus,BP,TESPA1
18019,GO:0098772,0.0559553376554545,0.970472162782351,15,1531,molecular function regulator,MF,CACNG3;NGEF;CAMK2A;SNCB;RIMS1;RGS4;IQSEC3;KCNS1;VGF;CXCL14;SHC3;GRIN1;CCK;NMB;GRIN2B
12652,GO:0046847,0.0559645703414631,0.993429185555972,2,54,filopodium assembly,BP,NEURL1;TENM2
7398,GO:0030534,0.0560734865612012,0.988874085483802,3,129,adult behavior,BP,DNM1;GABRG2;GRIN1
3264,GO:0006573,0.0560960923509704,0.998585847161017,1,9,valine metabolic process,BP,BCAT1
6929,GO:0021859,0.0566040328716842,0.99858195430358,1,8,pyramidal neuron differentiation,BP,SLC4A10
19468,GO:1902950,0.0567029508374883,0.99855474307482,1,9,regulation of dendritic spine maintenance,BP,GRIN2B
12522,GO:0046541,0.0567713180644417,0.998533426949784,1,10,saliva secretion,BP,CHRM3
7049,GO:0022804,0.0571899272259026,0.982145347641292,5,303,active transmembrane transporter activity,MF,SLC17A7;SLC12A5;SLC13A5;SLC4A10;SLC6A17
3230,GO:0006538,0.0573038107698098,0.998523605617505,1,9,glutamate catabolic process,BP,GAD2
5080,GO:0010959,0.0574324934793816,0.982040934722826,5,322,regulation of metal ion transport,BP,CAMK2A;HPCA;KCNS1;KCNC2;GRIN1
7811,GO:0031338,0.0574697431616578,0.993143256653103,2,57,regulation of vesicle fusion,BP,SYT1;SYT4
15161,GO:0061088,0.0577663340265165,0.998499405819291,1,9,regulation of sequestering of zinc ion,BP,SLC30A3
14486,GO:0060041,0.0578565944963817,0.98837787778837,3,127,retina development in camera-type eye,BP,CELF4;SLC17A7;HPCA
14007,GO:0051665,0.0582478213508419,0.998455270501894,1,10,membrane raft localization,BP,MAL2
506,GO:0001553,0.0585946091718686,0.998455566574763,1,9,luteinization,BP,PTPRN
18133,GO:0098969,0.0585981285420339,0.998455378922724,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,SNAP25
19759,GO:1903540,0.0585981285420339,0.998455378922724,1,9,establishment of protein localization to postsynaptic membrane,BP,SNAP25
7578,GO:0030902,0.0589700931481037,0.988060739243951,3,129,hindbrain development,BP,TBR1;NEUROD2;GRIN1
5433,GO:0015377,0.0590000818319201,0.998457904167378,1,8,cation:chloride symporter activity,MF,SLC12A5
5435,GO:0015379,0.0590000818319201,0.998457904167378,1,8,potassium:chloride symporter activity,MF,SLC12A5
8192,GO:0032096,0.059068318562974,0.998395188434164,1,11,negative regulation of response to food,BP,CCK
8195,GO:0032099,0.059068318562974,0.998395188434164,1,11,negative regulation of appetite,BP,CCK
6043,GO:0016782,0.0591161762387856,0.992813794290118,2,65,transferase activity, transferring sulfur-containing groups,MF,SULT4A1;CHST9
3818,GO:0007605,0.0591238192787753,0.988012326908155,3,133,sensory perception of sound,BP,CRYM;DNM1;GABRB2
1130,GO:0002551,0.0592663045945763,0.998400149061495,1,10,mast cell chemotaxis,BP,CHGA
6702,GO:0019911,0.0593027163416031,0.998398160115505,1,10,structural constituent of myelin sheath,MF,MAL2
20070,GO:1904181,0.0596429948834475,0.998379511718327,1,10,positive regulation of membrane depolarization,BP,CCK
2422,GO:0005102,0.0600744334752136,0.969422533523346,13,1300,signaling receptor binding,MF,SYT1;CAMK2A;DNM1;IGFBP2;VGF;MRAP2;TESPA1;CXCL14;SHC3;GNG3;GRIN1;CCK;NMB
1314,GO:0002864,0.0601728920887702,0.998333902717531,1,11,regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
5549,GO:0015807,0.0603543937811404,0.992591879473857,2,60,L-amino acid transport,BP,SLC17A7;SLC6A17
6236,GO:0017153,0.0604057962948499,0.998357452193376,1,9,sodium:dicarboxylate symporter activity,MF,SLC13A5
14693,GO:0060341,0.0608153064369312,0.973141907900944,9,760,regulation of cellular localization,BP,CAMK2A;RIMS1;NEFH;DNM1;HPCA;SYT4;MRAP2;VSNL1;GRIN1
2628,GO:0005546,0.0610056123211892,0.992467221819144,2,60,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT1;RPH3A
4870,GO:0010663,0.0611770628369126,0.998314732458229,1,9,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4873,GO:0010666,0.0611770628369126,0.998314732458229,1,9,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
7978,GO:0031652,0.0614265701726762,0.998279958384824,1,10,positive regulation of heat generation,BP,CNR1
15513,GO:0062013,0.0614680768340714,0.987329223726252,3,143,positive regulation of small molecule metabolic process,BP,CHGA;HPCA;MRAP2
18033,GO:0098797,0.0615824660990529,0.975891001951908,7,532,plasma membrane protein complex,CC,CACNG3;KCNS1;SNAP25;GNG3;KCNC2;GRIN1;GRIN2B
8624,GO:0032769,0.061850594531623,0.998255843635999,1,10,negative regulation of monooxygenase activity,BP,CNR1
6317,GO:0018210,0.0619259810189045,0.987210500888203,3,131,peptidyl-threonine modification,BP,CAMK1G;CAMK2A;CHI3L1
11038,GO:0043083,0.0619959062442767,0.998268762670048,1,9,synaptic cleft,CC,GRIN1
6935,GO:0021872,0.062001650496009,0.992272099255056,2,61,forebrain generation of neurons,BP,TBR1;SLC4A10
12271,GO:0045955,0.0623819259704937,0.998246871771847,1,9,negative regulation of calcium ion-dependent exocytosis,BP,SYT4
3528,GO:0006971,0.0624368801735688,0.998243743901404,1,9,hypotonic response,BP,SLC12A5
562,GO:0001660,0.0624978644154739,0.998218701090278,1,10,fever generation,BP,CNR1
8783,GO:0033004,0.0626937121362993,0.998189633656582,1,11,negative regulation of mast cell activation,BP,CNR1
2551,GO:0005342,0.0628030108695763,0.986948174735292,3,137,organic acid transmembrane transporter activity,MF,SLC17A7;SLC13A5;SLC6A17
12709,GO:0046943,0.0628030108695763,0.986948174735292,3,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7;SLC13A5;SLC6A17
17165,GO:0086103,0.0630608355819349,0.99818606989082,1,10,G-protein coupled receptor signaling pathway involved in heart process,BP,CHGA
2987,GO:0006163,0.0630710358881297,0.977233737528793,6,467,purine nucleotide metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
2567,GO:0005372,0.0632342038091395,0.998157901967912,1,11,water transmembrane transporter activity,MF,SLC14A1
13233,GO:0048813,0.0632996041747032,0.986814545269398,3,128,dendrite morphogenesis,BP,NGEF;CAMK2A;GRIN1
18407,GO:0106070,0.0633505121944808,0.998169161268821,1,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
3714,GO:0007288,0.0635845977973599,0.998155438808381,1,10,sperm axoneme assembly,BP,NEURL1
8207,GO:0032119,0.0640259453485861,0.998110909674116,1,11,sequestering of zinc ion,BP,SLC30A3
14783,GO:0060452,0.0642412352052071,0.998098026670014,1,11,positive regulation of cardiac muscle contraction,BP,CHGA
7097,GO:0030002,0.0647033813842788,0.99808912856428,1,10,cellular anion homeostasis,BP,SLC12A5
7305,GO:0030320,0.0647033813842788,0.99808912856428,1,10,cellular monovalent inorganic anion homeostasis,BP,SLC12A5
7295,GO:0030307,0.065170963476694,0.986245935295267,3,142,positive regulation of cell growth,BP,SYT1;RIMS1;SYT4
8377,GO:0032409,0.0651710077480915,0.982115139285085,4,231,regulation of transporter activity,BP,CACNG3;HPCA;KCNS1;KCNC2
13701,GO:0051130,0.0652188950101139,0.967296293835543,12,1121,positive regulation of cellular component organization,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;CALY;SYT4;TENM2;NEUROD2;ENC1;CCK
17764,GO:0097449,0.065247021773478,0.998056473550044,1,10,astrocyte projection,CC,SYT4
6709,GO:0019934,0.0653040675708389,0.99805303051588,1,10,cGMP-mediated signaling,BP,KCNC2
18080,GO:0098877,0.0655390452126752,0.99803881535035,1,10,neurotransmitter receptor transport to plasma membrane,BP,SNAP25
16848,GO:0072341,0.0656365728411862,0.991535521800393,2,68,modified amino acid binding,MF,SYT1;SYT4
18785,GO:1901077,0.0656811570583109,0.998010707168496,1,11,regulation of relaxation of muscle,BP,CHGA
3636,GO:0007169,0.0658161504318658,0.972035264172104,8,645,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NGEF;EPHB6;DNM1;NEURL1;IGFBP2;SHC3;GRIN1;GRIN2B
8010,GO:0031702,0.0661226861056339,0.99800327804266,1,10,type 1 angiotensin receptor binding,MF,GNG3
4149,GO:0008510,0.0661388499843708,0.998026449460366,1,9,sodium:bicarbonate symporter activity,MF,SLC4A10
17812,GO:0097531,0.0663802512610531,0.997967587988358,1,11,mast cell migration,BP,CHGA
5172,GO:0014074,0.0665054457619169,0.985852168953699,3,139,response to purine-containing compound,BP,PTPRN;VGF;SELL
12151,GO:0045741,0.0665805371040164,0.997975170814343,1,10,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
5678,GO:0016054,0.0666359440672662,0.981567503870404,4,250,organic acid catabolic process,BP,BCAT1;CRYM;CNR1;GAD2
12447,GO:0046395,0.0666359440672662,0.981567503870404,4,250,carboxylic acid catabolic process,BP,BCAT1;CRYM;CNR1;GAD2
11032,GO:0043065,0.0667740596186097,0.973372528505381,7,561,positive regulation of apoptotic process,BP,NGEF;CAMK2A;EEF1A2;NEURL1;CNR1;GRIN1;CCK
4635,GO:0009931,0.0668834471014519,0.997956464537368,1,10,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
14422,GO:0055082,0.0669576593777649,0.971443504301602,8,674,cellular chemical homeostasis,BP,PTPRN;SLC30A3;SLC12A5;SLC4A10;GNG3;VSNL1;GRIN1;GRIN2B
18518,GO:0140131,0.0674008340889573,0.997886693958848,1,12,positive regulation of lymphocyte chemotaxis,BP,CXCL14
6937,GO:0021877,0.0674906565806945,0.99791870033135,1,10,forebrain neuron fate commitment,BP,TBR1
13648,GO:0051047,0.0675114256574674,0.977905070787329,5,342,positive regulation of secretion,BP,NNAT;SYT1;SYT4;VSNL1;CCK
2961,GO:0006105,0.0675740687060897,0.997892858166399,1,11,succinate metabolic process,BP,GAD2
13775,GO:0051240,0.0676902326023594,0.96405957961171,14,1389,positive regulation of multicellular organismal process,BP,SYT1;RIMS1;CHGA;STMN2;NEURL1;CNR1;PACSIN1;SYT4;CHRM3;CHI3L1;TESPA1;NEUROD2;ENC1;DMRT2
12700,GO:0046929,0.0683406348071168,0.997865241363632,1,10,negative regulation of neurotransmitter secretion,BP,SYT4
19093,GO:1901981,0.0683409571885773,0.985301378315444,3,138,phosphatidylinositol phosphate binding,MF,SYT1;RPH3A;NRGN
11373,GO:0043627,0.0684532462992035,0.990962806299046,2,68,response to estrogen,BP,PTPRN;IGFBP2
5072,GO:0010950,0.0687160457421439,0.985169055023526,3,154,positive regulation of endopeptidase activity,BP,GRIN1;CCK;GRIN2B
9009,GO:0033555,0.0687630771233347,0.990904602635076,2,66,multicellular organismal response to stress,BP,NEUROD2;CCK
7697,GO:0031115,0.0687798892288208,0.997815970898884,1,11,negative regulation of microtubule polymerization,BP,STMN2
17419,GO:0090394,0.0688038892301258,0.997835812121578,1,10,negative regulation of excitatory postsynaptic potential,BP,CELF4
10653,GO:0042301,0.0688682853969385,0.997810278806951,1,11,phosphate ion binding,MF,RPH3A
2820,GO:0005882,0.0692584751827128,0.990799328117796,2,67,intermediate filament,CC,NEFH;NEFM
5302,GO:0015085,0.0697983600307612,0.984865395111859,3,133,calcium ion transmembrane transporter activity,MF,CACNG3;GRIN1;GRIN2B
19128,GO:1902065,0.0699475102435361,0.99774017079141,1,11,response to L-glutamate,BP,HPCA
11035,GO:0043068,0.0701982342845724,0.97168709785907,7,567,positive regulation of programmed cell death,BP,NGEF;CAMK2A;EEF1A2;NEURL1;CNR1;GRIN1;CCK
13528,GO:0050862,0.0704643345890677,0.997687509035293,1,12,positive regulation of T cell receptor signaling pathway,BP,TESPA1
12426,GO:0046348,0.0712095174498214,0.997621522217157,1,13,amino sugar catabolic process,BP,CHI3L1
8201,GO:0032105,0.0714525019000777,0.997605040731572,1,13,negative regulation of response to extracellular stimulus,BP,CCK
8204,GO:0032108,0.0714525019000777,0.997605040731572,1,13,negative regulation of response to nutrient levels,BP,CCK
8009,GO:0031701,0.071596548499199,0.997630853984921,1,11,angiotensin receptor binding,MF,GNG3
1595,GO:0003674,0.0719821890110461,0.975284949792201,95,14275,molecular_function,MF,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;NELL2;SV2B;C11ORF87;MYT1L;MPPED1;CCK;SELL;CPNE4;SLC6A17;NMB;GRIN2B
4556,GO:0009642,0.0722457571640547,0.997587088916934,1,11,response to light intensity,BP,KCNC2
2606,GO:0005513,0.072356658472917,0.99755986635706,1,12,detection of calcium ion,BP,SYT1
5406,GO:0015296,0.072618560657445,0.99758559909857,1,10,anion:cation symporter activity,MF,SLC12A5
13107,GO:0048583,0.0728897901637742,0.953490759424845,30,3621,regulation of response to stimulus,BP,CACNG3;NGEF;SYT1;CAMK2A;RIMS1;CHGA;CELF4;EPHB6;DNM1;NEURL1;GABRA4;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;CXCL14;GNG3;VSNL1;FABP7;NEUROD2;GRIN1;CCK;SELL;NMB
4997,GO:0010857,0.0731582437394765,0.997524879119208,1,11,calcium-dependent protein kinase activity,MF,CAMK2A
780,GO:0001967,0.0732032046662314,0.997521792807285,1,11,suckling behavior,BP,GRIN1
15098,GO:0060998,0.0738352435478081,0.989846462708524,2,63,regulation of dendritic spine development,BP,NGEF;NEURL1
13591,GO:0050954,0.0741754989940537,0.983492029327146,3,147,sensory perception of mechanical stimulus,BP,CRYM;DNM1;GABRB2
825,GO:0002031,0.0751130513793699,0.997349662972228,1,13,G-protein coupled receptor internalization,BP,DNM1
7976,GO:0031650,0.0754728155909377,0.997341982520685,1,12,regulation of heat generation,BP,CNR1
19131,GO:1902074,0.0755918138550242,0.997315277875547,1,13,response to salt,BP,HPCA
15400,GO:0061684,0.0759019032980595,0.997311229262183,1,12,chaperone-mediated autophagy,BP,EEF1A2
13491,GO:0050805,0.0759472819641391,0.989378436434544,2,66,negative regulation of synaptic transmission,BP,CELF4;SYT4
5317,GO:0015114,0.0760225427775812,0.9973243064992,1,11,phosphate ion transmembrane transporter activity,MF,SLC17A7
13773,GO:0051238,0.0764278080385739,0.997238751812545,1,14,sequestering of metal ion,BP,SLC30A3
3246,GO:0006554,0.0765021705592153,0.997267901747047,1,12,lysine catabolic process,BP,CRYM
15100,GO:0061000,0.0768787487364411,0.997262788330034,1,11,negative regulation of dendritic spine development,BP,NGEF
7760,GO:0031267,0.0773291089043751,0.96812432343737,7,528,small GTPase binding,MF,NGEF;CAMK2A;RIMS1;RPH3A;SHC3;GRIN1;GRIN2B
18897,GO:1901379,0.0775868341192091,0.989007808282977,2,69,regulation of potassium ion transmembrane transport,BP,KCNS1;KCNC2
13676,GO:0051094,0.0777390810689112,0.959870672577023,12,1157,positive regulation of developmental process,BP,SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;CHI3L1;TESPA1;NEUROD2;ENC1;DMRT2
7060,GO:0022841,0.0782176306481949,0.997105936231124,1,14,potassium ion leak channel activity,MF,KCNK9
20137,GO:1904321,0.0783842811770251,0.997152868736297,1,11,response to forskolin,BP,ADCY1
20138,GO:1904322,0.0783842811770251,0.997152868736297,1,11,cellular response to forskolin,BP,ADCY1
18544,GO:1900006,0.0787081210860564,0.98877217354066,2,65,positive regulation of dendrite development,BP,NEURL1;PACSIN1
3797,GO:0007565,0.0787415186198797,0.982027864610237,3,157,female pregnancy,BP,IGFBP2;CNR1;PRLHR
6732,GO:0019992,0.0788163328962324,0.997097524487864,1,12,diacylglycerol binding,MF,UNC13C
2607,GO:0005515,0.0789160507367889,0.949074998272049,72,10177,protein binding,MF,CAMK1G;SYT13;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;RBFOX1;RIMS1;RPH3A;NEFH;EEF1A2;ST8SIA5;CRYM;STMN2;NEFM;EPHB6;DNM1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;MRAP2;TESPA1;TBR1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;TMEM132D;NRGN;GNG3;VSNL1;IGFN1;ADCY1;KCNC2;KCNK9;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;NELL2;SV2B;C11ORF87;CCK;SELL;CPNE4;NMB;GRIN2B
7670,GO:0031083,0.0790266408377934,0.997044848059161,1,14,BLOC-1 complex,CC,SNAP25
12057,GO:0045595,0.0790316650204219,0.956163908483065,15,1540,regulation of cell differentiation,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;TESPA1;TBR1;CXCL14;NEUROD2;ENC1;GRIN1
7307,GO:0030322,0.0790794876185543,0.997040834737872,1,14,stabilization of membrane potential,BP,KCNK9
17561,GO:0097061,0.0791262671730862,0.988675073719981,2,66,dendritic spine organization,BP,NGEF;GRIN2B
16916,GO:0072521,0.0795078159488548,0.969574981292957,6,494,purine-containing compound metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
17346,GO:0090277,0.0802181541800102,0.988395104523331,2,77,positive regulation of peptide hormone secretion,BP,NNAT;VSNL1
13610,GO:0050998,0.0802285763358436,0.996990939126842,1,12,nitric-oxide synthase binding,MF,DNM1
9870,GO:0035641,0.0807726000724182,0.996928573269357,1,13,locomotory exploration behavior,BP,SLC4A10
14149,GO:0051938,0.0813498767704688,0.996904899883397,1,12,L-glutamate import,BP,SLC17A7
12286,GO:0045989,0.0815153473993946,0.996852800932471,1,14,positive regulation of striated muscle contraction,BP,CHGA
5519,GO:0015740,0.0816203083901123,0.996883961935722,1,12,C4-dicarboxylate transport,BP,SLC13A5
17898,GO:0097756,0.0817695220119559,0.988059876064237,2,71,negative regulation of blood vessel diameter,BP,CHGA;CHRM3
17251,GO:0090148,0.0819454863515451,0.996858688856841,1,12,membrane fission,BP,DNM1
14408,GO:0055064,0.0820001799718982,0.99685442767888,1,12,chloride ion homeostasis,BP,SLC12A5
6839,GO:0021675,0.0820899613453808,0.987989845244699,2,70,nerve development,BP,GABRB2;NPTX1
7032,GO:0022604,0.0820970121376798,0.968343897219956,6,441,regulation of cell morphogenesis,BP,NGEF;SYT1;RIMS1;SYT4;TBR1;GRIN1
4572,GO:0009719,0.0822303820064247,0.955023066626066,14,1435,response to endogenous stimulus,BP,GABRA1;PTPRN;CAMK2A;STMN2;NEURL1;GABRG2;IGFBP2;VGF;CHRM3;GABRB2;GNG3;ADCY1;KCNC2;ZCCHC12
3676,GO:0007218,0.0825829183929181,0.987832552743648,2,86,neuropeptide signaling pathway,BP,PRLHR;NMB
20892,GO:1990138,0.0826258305434989,0.980778085823403,3,146,neuron projection extension,BP,SYT1;RIMS1;SYT4
3245,GO:0006553,0.0829774812789651,0.996755853370876,1,13,lysine metabolic process,BP,CRYM
5344,GO:0015171,0.0830480495737327,0.987762928153197,2,72,amino acid transmembrane transporter activity,MF,SLC17A7;SLC6A17
15308,GO:0061478,0.0830605450208031,0.996771225439952,1,12,response to platelet aggregation inhibitor,BP,ADCY1
1544,GO:0003333,0.0830815803107405,0.987758471141544,2,71,amino acid transmembrane transport,BP,SLC17A7;SLC6A17
11105,GO:0043194,0.0834693056238559,0.996738852318754,1,12,axon initial segment,CC,CCK
13134,GO:0048639,0.0835566954998833,0.980463911153039,3,151,positive regulation of developmental growth,BP,SYT1;RIMS1;SYT4
8130,GO:0031994,0.0837922470759164,0.996690794247417,1,13,insulin-like growth factor I binding,MF,IGFBP2
10919,GO:0042802,0.0838150106673052,0.954017100816071,14,1486,identical protein binding,MF,BCAT1;SYT1;CAMK2A;CRYM;DNM1;HPCA;PACSIN1;SULT4A1;SYT4;MRAP2;TENM2;KCNK9;DMRT2;PCSK1
5116,GO:0012510,0.0840637738033206,0.99664967784631,1,14,trans-Golgi network transport vesicle membrane,CC,NRGN
11053,GO:0043112,0.0840806232101492,0.980280955855739,3,158,receptor metabolic process,BP,CACNG3;DNM1;SNAP25
13278,GO:0048934,0.0841276301987028,0.99666382010489,1,13,peripheral nervous system neuron differentiation,BP,NEFH
13279,GO:0048935,0.0841276301987028,0.99666382010489,1,13,peripheral nervous system neuron development,BP,NEFH
19904,GO:1903818,0.0841318031326225,0.996663483772699,1,13,positive regulation of voltage-gated potassium channel activity,BP,KCNC2
13474,GO:0050780,0.084254072774044,0.996653621252654,1,13,dopamine receptor binding,MF,DNM1
18730,GO:1900542,0.0854028309340735,0.979834477657414,3,163,regulation of purine nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
12894,GO:0048024,0.0855503329074796,0.987173662088493,2,74,regulation of mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
13844,GO:0051349,0.0856219973922366,0.996504910434059,1,15,positive regulation of lyase activity,BP,HPCA
18394,GO:0106027,0.0857978999972946,0.987132669140126,2,69,neuron projection organization,BP,NGEF;GRIN2B
18484,GO:0140029,0.0860647041887562,0.987046268971697,2,76,exocytic process,BP,SNAP25;UNC13C
11477,GO:0044070,0.0865637330728697,0.98693794835094,2,73,regulation of anion transport,BP,SYT4;CCK
21075,GO:1990778,0.0867167324685875,0.973812394873804,4,251,protein localization to cell periphery,BP,PACSIN1;SNAP25;MRAP2;GRIN1
3455,GO:0006855,0.0868529687693213,0.986872850864915,2,72,drug transmembrane transport,BP,SLC17A7;SLC13A5
3841,GO:0007635,0.0870316191105135,0.996425525456222,1,13,chemosensory behavior,BP,GRIN1
1944,GO:0004383,0.0871998269614462,0.996435685559092,1,12,guanylate cyclase activity,MF,ADCY1
3876,GO:0008074,0.0871998269614462,0.996435685559092,1,12,guanylate cyclase complex, soluble,CC,ADCY1
8191,GO:0032095,0.0875811546290962,0.996310532166413,1,17,regulation of response to food,BP,CCK
7847,GO:0031406,0.0877192062265863,0.979047357755985,3,170,carboxylic acid binding,MF,GAD2;GRIN1;GRIN2B
5074,GO:0010952,0.0877844981771682,0.979024095447596,3,171,positive regulation of peptidase activity,BP,GRIN1;CCK;GRIN2B
3808,GO:0007589,0.0883196943105953,0.986506867094794,2,77,body fluid secretion,BP,NEURL1;CHRM3
12896,GO:0048026,0.0883375169269284,0.99627583907549,1,15,positive regulation of mRNA splicing, via spliceosome,BP,CELF4
3443,GO:0006833,0.0887134166038732,0.996243537117745,1,15,water transport,BP,SLC14A1
16508,GO:0071732,0.088835749528316,0.996232993645002,1,15,cellular response to nitric oxide,BP,KCNC2
325,GO:0000900,0.0889620658093342,0.996262412200347,1,13,translation repressor activity, mRNA regulatory element binding,MF,CELF4
7818,GO:0031345,0.089942986734446,0.978306822050846,3,158,negative regulation of cell projection organization,BP,NGEF;STMN2;GRIN2B
19065,GO:1901881,0.0900417667837203,0.996128232681033,1,15,positive regulation of protein depolymerization,BP,STMN2
7769,GO:0031281,0.0907589880387981,0.996048183745561,1,16,positive regulation of cyclase activity,BP,HPCA
4044,GO:0008344,0.0907733990764858,0.985917128273373,2,76,adult locomotory behavior,BP,DNM1;GRIN1
11095,GO:0043177,0.090782795359561,0.978000777263659,3,172,organic acid binding,MF,GAD2;GRIN1;GRIN2B
13479,GO:0050789,0.0910489925710119,0.939634631872887,69,9666,regulation of biological process,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;NGEF;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;CRYM;STMN2;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;UNC13C;STAC2;CXCL14;GABRB2;TENM2;SHC3;ZNF385D;GABRA2;TMEM132D;NRGN;GNG3;VSNL1;FABP7;ADCY1;KCNC2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;SELL;NMB;GRIN2B
7059,GO:0022840,0.0916329708835547,0.995970363772432,1,16,leak channel activity,MF,KCNK9
7061,GO:0022842,0.0916329708835547,0.995970363772432,1,16,narrow pore channel activity,MF,KCNK9
2979,GO:0006140,0.091676280632693,0.977696960872899,3,169,regulation of nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
7519,GO:0030826,0.0917202343417629,0.995947196662878,1,17,regulation of cGMP biosynthetic process,BP,HPCA
823,GO:0002029,0.0917559712077887,0.995959348691749,1,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1
7016,GO:0022401,0.0917559712077887,0.995959348691749,1,16,negative adaptation of signaling pathway,BP,DNM1
19210,GO:1902259,0.0917914693879372,0.995973599512573,1,15,regulation of delayed rectifier potassium channel activity,BP,KCNS1
18972,GO:1901623,0.0920788394658524,0.99591488629081,1,17,regulation of lymphocyte chemotaxis,BP,CXCL14
13759,GO:0051219,0.0920840874335907,0.985603415323639,2,74,phosphoprotein binding,MF,PTPN5;SHC3
8509,GO:0032591,0.0920890285347653,0.995990200806804,1,13,dendritic spine membrane,CC,DDN
3655,GO:0007193,0.0922612587747134,0.98555290661658,2,76,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,CHRM3;ADCY1
10786,GO:0042562,0.0923229055497504,0.985518860473057,2,82,hormone binding,MF,CRYM;CHRM3
4550,GO:0009628,0.0925959330774802,0.952161046180851,11,1095,response to abiotic stimulus,BP,CAMK2A;EEF1A2;IGFBP2;HPCA;SLC12A5;VGF;CHI3L1;SLC4A10;KCNC2;NEUROD2;GRIN1
5669,GO:0016043,0.0931027219842238,0.936682577649255,43,5560,cellular component organization,BP,CACNG3;SYT13;PTPRN;NGEF;SYT1;CAMK2A;LNX1;SNCB;RIMS1;RPH3A;NEFH;CHGA;CELF4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;IGFBP2;CNR1;IQSEC3;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;TESPA1;TBR1;UNC13C;TENM2;MAL2;SHC3;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;GRIN1;MAP7D2;CCK;GRIN2B
1753,GO:0004016,0.0941127950915785,0.995808738926844,1,13,adenylate cyclase activity,MF,ADCY1
15921,GO:0070679,0.0941397001109149,0.995806298435106,1,13,inositol 1,4,5 trisphosphate binding,MF,RPH3A
7961,GO:0031629,0.0944157677073413,0.995717343818149,1,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,SNAP25
18217,GO:0099500,0.0944157677073413,0.995717343818149,1,16,vesicle fusion to plasma membrane,BP,SNAP25
15517,GO:0065003,0.0944372618543361,0.946191844231818,15,1652,protein-containing complex assembly,BP,SYT1;LNX1;RIMS1;CELF4;STMN2;DNM1;KCNS1;CALY;SNAP25;TESPA1;UNC13C;KCNC2;GRIN1;CCK;GRIN2B
3671,GO:0007213,0.0946169448010663,0.995698742742725,1,16,G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
2535,GO:0005313,0.0946490557598913,0.9957354974414,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
5345,GO:0015172,0.0946490557598913,0.9957354974414,1,14,acidic amino acid transmembrane transporter activity,MF,SLC17A7
5975,GO:0016646,0.0946846444844503,0.995692473753515,1,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,CRYM
4771,GO:0010499,0.0947037092718885,0.995624471146935,1,21,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1
3434,GO:0006816,0.0951919341383734,0.965596569662342,5,368,calcium ion transport,BP,CACNG3;CAMK2A;HPCA;GRIN1;GRIN2B
11821,GO:0045056,0.0955024037710097,0.995635248180792,1,15,transcytosis,BP,MAL2
8194,GO:0032098,0.0959344715172326,0.995530806160086,1,19,regulation of appetite,BP,CCK
3830,GO:0007620,0.0965137345445011,0.995521307864177,1,16,copulation,BP,CNR1
13468,GO:0050774,0.0966917149874019,0.995523814283328,1,15,negative regulation of dendrite morphogenesis,BP,NGEF
7094,GO:0023058,0.0977181052968095,0.995389282985089,1,17,adaptation of signaling pathway,BP,DNM1
12561,GO:0046625,0.0979292061670819,0.995386472800959,1,16,sphingolipid binding,MF,SELL
10597,GO:0042166,0.0984723953900676,0.995334178517462,1,16,acetylcholine binding,MF,CHRM3
14628,GO:0060259,0.0991097213921214,0.99525450009716,1,17,regulation of feeding behavior,BP,CNR1
13762,GO:0051223,0.099109989213803,0.956679020171791,7,611,regulation of protein transport,BP,NNAT;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
1311,GO:0002861,0.0991760339342919,0.995217797302537,1,19,regulation of inflammatory response to antigenic stimulus,BP,CNR1
13242,GO:0048839,0.0991953852398564,0.975062094970859,3,165,inner ear development,BP,HPCA;CXCL14;GABRB2
6692,GO:0019898,0.0993108387417821,0.968580051915945,4,264,extrinsic component of membrane,CC,RPH3A;HPCA;SNAP25;GNG3
12888,GO:0048018,0.0996485633520588,0.968398117802741,4,320,receptor ligand activity,MF,VGF;CXCL14;CCK;NMB
11598,GO:0044342,0.0997496099483033,0.995210011667404,1,16,type B pancreatic cell proliferation,BP,PTPRN
4801,GO:0010562,0.099781832319935,0.949444170798978,10,971,positive regulation of phosphorus metabolic process,BP,CHGA;EEF1A2;EPHB6;NEURL1;HPCA;CHI3L1;MRAP2;GNG3;ADCY1;CCK
12259,GO:0045937,0.099781832319935,0.949444170798978,10,971,positive regulation of phosphate metabolic process,BP,CHGA;EEF1A2;EPHB6;NEURL1;HPCA;CHI3L1;MRAP2;GNG3;ADCY1;CCK
20035,GO:1904062,0.100145006259288,0.968217700607172,4,273,regulation of cation transmembrane transport,BP,CACNG3;HPCA;KCNS1;KCNC2
12937,GO:0048172,0.100255552419934,0.995181158171099,1,15,regulation of short-term neuronal synaptic plasticity,BP,SYT4
11431,GO:0043950,0.100379769956057,0.995098762136847,1,19,positive regulation of cAMP-mediated signaling,BP,MRAP2
6382,GO:0018958,0.100783355901885,0.983374193828342,2,83,phenol-containing compound metabolic process,BP,SNCB;CRYM
19700,GO:1903421,0.101421057854625,0.995066246948253,1,15,regulation of synaptic vesicle recycling,BP,DNM1
12985,GO:0048268,0.101478437552499,0.995039240993863,1,16,clathrin coat assembly,BP,CALY
14522,GO:0060080,0.101597661092111,0.995048712226678,1,15,inhibitory postsynaptic potential,BP,RIMS1
13652,GO:0051051,0.101686496067392,0.962515045254924,5,391,negative regulation of transport,BP,CHGA;CNR1;PACSIN1;SYT4;VSNL1
10560,GO:0042104,0.102027958780515,0.994933309384987,1,19,positive regulation of activated T cell proliferation,BP,IGFBP2
18496,GO:0140056,0.102120065011124,0.974002666104553,3,170,organelle localization by membrane tethering,BP,SYT1;SNAP25;UNC13C
17736,GO:0097386,0.102352407450244,0.994951728333406,1,16,glial cell projection,CC,SYT4
14099,GO:0051861,0.10262177119718,0.994905369649819,1,17,glycolipid binding,MF,SELL
4132,GO:0008483,0.102652327543226,0.994902275534232,1,17,transaminase activity,MF,BCAT1
13509,GO:0050832,0.102966368780255,0.994789686278013,1,23,defense response to fungus,BP,CHGA
13607,GO:0050995,0.103471227415279,0.994818990370534,1,17,negative regulation of lipid catabolic process,BP,CNR1
11383,GO:0043649,0.10353477107415,0.994795106992201,1,18,dicarboxylic acid catabolic process,BP,GAD2
13234,GO:0048814,0.103610736689199,0.982655225808512,2,77,regulation of dendrite morphogenesis,BP,NGEF;GRIN1
14165,GO:0051961,0.103843724768448,0.96663718022107,4,264,negative regulation of nervous system development,BP,NGEF;STMN2;SYT4;NEUROD2
1061,GO:0002438,0.103871343194836,0.9947448784253,1,19,acute inflammatory response to antigenic stimulus,BP,CNR1
18449,GO:0120034,0.103994277021378,0.982538881979793,2,81,positive regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
16507,GO:0071731,0.104280778390423,0.994718322689971,1,18,response to nitric oxide,BP,KCNC2
7456,GO:0030667,0.10432194225889,0.966420244544853,4,276,secretory granule membrane,CC,SYT1;SNAP25;SYT4;SELL
11258,GO:0043434,0.104330644703659,0.961251050762879,5,382,response to peptide hormone,BP,PTPRN;CAMK2A;VGF;GNG3;ADCY1
4628,GO:0009898,0.105527187314842,0.97275940670981,3,170,cytoplasmic side of plasma membrane,CC,NPTX2;SNAP25;GNG3
2627,GO:0005545,0.105553247188988,0.994647480749159,1,15,1-phosphatidylinositol binding,MF,SYT1
14126,GO:0051900,0.105589533726605,0.994582202638158,1,18,regulation of mitochondrial depolarization,BP,CCK
1627,GO:0003746,0.105683876225977,0.994572320682673,1,18,translation elongation factor activity,MF,EEF1A2
11432,GO:0043951,0.105702908491064,0.994588454311115,1,17,negative regulation of cAMP-mediated signaling,BP,MRAP2
16555,GO:0071855,0.105953948520169,0.994476704063783,1,23,neuropeptide receptor binding,MF,MRAP2
8134,GO:0031998,0.106258256859465,0.994550889015931,1,16,regulation of fatty acid beta-oxidation,BP,CNR1
14447,GO:0055119,0.106438758873049,0.994511294381754,1,17,relaxation of cardiac muscle,BP,CHGA
16014,GO:0070887,0.106711800686415,0.931938940285561,23,2789,cellular response to chemical stimulus,BP,GABRA1;PTPRN;SYT1;CAMK2A;NEFH;CHGA;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;HPCA;CHRM3;CHI3L1;CXCL14;GABRB2;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;GRIN1
11340,GO:0043567,0.107126239715024,0.99442007196367,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
11157,GO:0043266,0.107442747063419,0.981609554300212,2,83,regulation of potassium ion transport,BP,KCNS1;KCNC2
8150,GO:0032026,0.107507013693319,0.994419369458389,1,16,response to magnesium ion,BP,KCNC2
9237,GO:0034199,0.108148583429186,0.99435116353095,1,16,activation of protein kinase A activity,BP,ADCY1
10706,GO:0042403,0.108789198130435,0.994261018290528,1,17,thyroid hormone metabolic process,BP,CRYM
18693,GO:1900273,0.10884564617413,0.994276568583857,1,16,positive regulation of long-term synaptic potentiation,BP,NRGN
17562,GO:0097062,0.109018618406525,0.994236277946166,1,17,dendritic spine maintenance,BP,GRIN2B
6086,GO:0016849,0.109032009596283,0.994256538808429,1,16,phosphorus-oxygen lyase activity,MF,ADCY1
19163,GO:1902170,0.109408398720059,0.994174694253701,1,18,cellular response to reactive nitrogen species,BP,KCNC2
4188,GO:0008585,0.109630525434612,0.981007736525403,2,85,female gonad development,BP,PTPRN;VGF
4650,GO:0009975,0.109632465495455,0.994191755486631,1,16,cyclase activity,MF,ADCY1
17526,GO:0097009,0.110262312358357,0.99408146608084,1,18,energy homeostasis,BP,MRAP2
3688,GO:0007250,0.110344247742299,0.994072479999039,1,18,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
7975,GO:0031649,0.110814131294165,0.994020809263121,1,18,heat generation,BP,CNR1
3827,GO:0007617,0.110884858723362,0.994013011471181,1,18,mating behavior,BP,GRIN1
13849,GO:0051354,0.110984433730154,0.993968057418482,1,20,negative regulation of oxidoreductase activity,BP,CNR1
18038,GO:0098802,0.111072221539784,0.970690263563057,3,174,plasma membrane receptor complex,CC,CACNG3;GRIN1;GRIN2B
3662,GO:0007200,0.111354412316271,0.98050471916827,2,94,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA;CHRM3
13449,GO:0050750,0.111442610539204,0.993951332860055,1,18,low-density lipoprotein particle receptor binding,MF,SYT1
2483,GO:0005200,0.111553319044339,0.980465169006955,2,89,structural constituent of cytoskeleton,MF,NEFH;NEFM
4653,GO:0009987,0.111696411844196,0.938921993954417,89,13224,cellular process,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MAP7D2;NELL2;SV2B;MYT1L;CCK;SELL;NMB;GRIN2B
7669,GO:0031082,0.111726091055183,0.993901738817214,1,19,BLOC complex,CC,SNAP25
7460,GO:0030673,0.111836659128151,0.993950693697541,1,16,axolemma,CC,KCNC2
11714,GO:0044706,0.111949634086849,0.970344689893545,3,184,multi-multicellular organism process,BP,IGFBP2;CNR1;PRLHR
3435,GO:0006817,0.111964811641,0.993913629193093,1,17,phosphate ion transport,BP,SLC17A7
6033,GO:0016769,0.112379502017986,0.993828652971293,1,19,transferase activity, transferring nitrogenous groups,MF,BCAT1
17697,GO:0097320,0.112523095998449,0.993851455694634,1,17,plasma membrane tubulation,BP,PACSIN1
18959,GO:1901606,0.11286494184059,0.980079337808283,2,96,alpha-amino acid catabolic process,BP,CRYM;GAD2
15703,GO:0070300,0.112886757117825,0.993790099712328,1,18,phosphatidic acid binding,MF,NRGN
16572,GO:0071880,0.112936434534679,0.993784514042056,1,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,CHGA
15876,GO:0070588,0.113274900079332,0.962481766393818,4,275,calcium ion transmembrane transport,BP,CACNG3;HPCA;GRIN1;GRIN2B
816,GO:0002021,0.11433788676469,0.993606878676765,1,19,response to dietary excess,BP,VGF
2376,GO:0005005,0.114475995331222,0.993631373852625,1,17,transmembrane-ephrin receptor activity,MF,EPHB6
7020,GO:0022406,0.11452284053372,0.969374224435797,3,179,membrane docking,BP,SYT1;SNAP25;UNC13C
8827,GO:0033081,0.115846146217787,0.993415760141519,1,20,regulation of T cell differentiation in thymus,BP,TESPA1
14111,GO:0051882,0.115898409609482,0.993409685630056,1,20,mitochondrial depolarization,BP,CCK
4595,GO:0009791,0.115926270882009,0.979259091099312,2,84,post-embryonic development,BP,GABRG2;SLC4A10
17216,GO:0090087,0.115954975711374,0.947355918979485,7,639,regulation of peptide transport,BP,NNAT;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
5454,GO:0015464,0.116150422381188,0.99339797507863,1,19,acetylcholine receptor activity,MF,CHRM3
14141,GO:0051928,0.116427062769155,0.979085294596597,2,93,positive regulation of calcium ion transport,BP,CAMK2A;GRIN1
3485,GO:0006897,0.116574959751681,0.947008652635835,7,629,endocytosis,BP,CACNG3;SYT1;DNM1;PACSIN1;CALY;SNAP25;SYT4
13791,GO:0051260,0.11728723902683,0.960660201697572,4,294,protein homooligomerization,BP,SYT1;LNX1;KCNS1;KCNC2
12525,GO:0046545,0.117316299187106,0.978845450088742,2,89,development of primary female sexual characteristics,BP,PTPRN;VGF
12246,GO:0045922,0.117540667229352,0.993235362589835,1,19,negative regulation of fatty acid metabolic process,BP,CNR1
2571,GO:0005385,0.118056393085826,0.993174513606141,1,19,zinc ion transmembrane transporter activity,MF,SLC30A3
8423,GO:0032461,0.11846018049746,0.99309176193128,1,21,positive regulation of protein oligomerization,BP,CCK
11306,GO:0043523,0.118750599739965,0.967738165246793,3,184,regulation of neuron apoptotic process,BP,SNCB;GABRB2;GRIN1
12895,GO:0048025,0.118823225008072,0.993083510312671,1,19,negative regulation of mRNA splicing, via spliceosome,BP,CELF4
3850,GO:0008022,0.118989703358287,0.967646743026157,3,183,protein C-terminus binding,MF,SYT1;RBFOX1;DNM1
13561,GO:0050905,0.119102150116493,0.978340752344991,2,87,neuromuscular process,BP,FABP7;GRIN1
4868,GO:0010661,0.119718333489751,0.99297648599871,1,19,positive regulation of muscle cell apoptotic process,BP,CAMK2A
2666,GO:0005623,0.11978693534666,0.944510593743322,93,13967,cell,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;NELL2;SV2B;MYT1L;CCK;SELL;SLC6A17;GRIN2B
5741,GO:0016192,0.120398712596417,0.927626167168161,16,1807,vesicle-mediated transport,BP,CACNG3;SYT13;SYT1;RIMS1;RPH3A;CHGA;DNM1;PACSIN1;CALY;SNAP25;SYT4;CHI3L1;UNC13C;MAL2;VSNL1;SELL
13523,GO:0050857,0.120479520320456,0.992865836273395,1,20,positive regulation of antigen receptor-mediated signaling pathway,BP,TESPA1
13962,GO:0051589,0.120721361818707,0.99285553592626,1,19,negative regulation of neurotransmitter transport,BP,SYT4
4312,GO:0009068,0.120803991822493,0.992809216392704,1,21,aspartate family amino acid catabolic process,BP,CRYM
20171,GO:1904385,0.121523699947999,0.992738716091932,1,20,cellular response to angiotensin,BP,CAMK2A
9149,GO:0034035,0.121625814961445,0.992692854242356,1,22,purine ribonucleoside bisphosphate metabolic process,BP,SULT4A1
13331,GO:0050427,0.121625814961445,0.992692854242356,1,22,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,SULT4A1
7403,GO:0030545,0.122033886228995,0.958457266246743,4,343,receptor regulator activity,MF,VGF;CXCL14;CCK;NMB
4057,GO:0008373,0.122047580848433,0.992674494953306,1,20,sialyltransferase activity,MF,ST8SIA5
17798,GO:0097503,0.122047580848433,0.992674494953306,1,20,sialylation,BP,ST8SIA5
10830,GO:0042629,0.122070857945932,0.992654026700605,1,21,mast cell granule,CC,CHGA
4322,GO:0009083,0.122087265192359,0.992652005447749,1,21,branched-chain amino acid catabolic process,BP,BCAT1
778,GO:0001965,0.122574744629391,0.992591818646528,1,21,G-protein alpha-subunit binding,MF,RGS4
5222,GO:0014829,0.122753388082256,0.992607187612671,1,19,vascular smooth muscle contraction,BP,CHRM3
3697,GO:0007263,0.122876013756565,0.99255449375384,1,21,nitric oxide mediated signal transduction,BP,KCNC2
19641,GO:1903306,0.123186966738836,0.992533797640835,1,20,negative regulation of regulated secretory pathway,BP,SYT4
19458,GO:1902936,0.123301310331812,0.9771067401626,2,90,phosphatidylinositol bisphosphate binding,MF,SYT1;RPH3A
5382,GO:0015238,0.123594093448519,0.977016797716821,2,91,drug transmembrane transporter activity,MF,SLC17A7;SLC13A5
7516,GO:0030823,0.123806215814801,0.992422166023913,1,22,regulation of cGMP metabolic process,BP,HPCA
8200,GO:0032104,0.124087594062596,0.992371761392372,1,23,regulation of response to extracellular stimulus,BP,CCK
8203,GO:0032107,0.124087594062596,0.992371761392372,1,23,regulation of response to nutrient levels,BP,CCK
13964,GO:0051591,0.124340990207857,0.976799867516447,2,90,response to cAMP,BP,PTPRN;VGF
16402,GO:0071577,0.124789596282385,0.992333521088907,1,20,zinc ion transmembrane transport,BP,SLC30A3
17522,GO:0095500,0.124853252778026,0.992307088320897,1,21,acetylcholine receptor signaling pathway,BP,CHRM3
19913,GO:1903831,0.124853252778026,0.992307088320897,1,21,signal transduction involved in cellular response to ammonium ion,BP,CHRM3
20536,GO:1905144,0.124853252778026,0.992307088320897,1,21,response to acetylcholine,BP,CHRM3
20537,GO:1905145,0.124853252778026,0.992307088320897,1,21,cellular response to acetylcholine,BP,CHRM3
18958,GO:1901605,0.125515174739323,0.965050553303673,3,201,alpha-amino acid metabolic process,BP,BCAT1;CRYM;GAD2
12111,GO:0045662,0.126243399243836,0.992097860165761,1,23,negative regulation of myoblast differentiation,BP,CXCL14
7768,GO:0031280,0.126513360440875,0.992096087617911,1,21,negative regulation of cyclase activity,BP,HPCA
2374,GO:0005003,0.126597119011682,0.992125238687512,1,19,ephrin receptor activity,MF,EPHB6
10531,GO:0042044,0.126888975314867,0.992047931110385,1,21,fluid transport,BP,SLC14A1
5970,GO:0016638,0.127530323197217,0.991965350831349,1,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,CRYM
15643,GO:0070201,0.127779657189351,0.940583258640033,7,653,regulation of establishment of protein localization,BP,NNAT;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
7935,GO:0031579,0.127903906245333,0.991899470580126,1,22,membrane raft organization,BP,MAL2
16568,GO:0071875,0.128509808892441,0.991838367189515,1,21,adrenergic receptor signaling pathway,BP,CHGA
4667,GO:0010033,0.128598322241441,0.915986141036283,23,2846,response to organic substance,BP,GABRA1;PTPRN;CAMK2A;NEFH;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;CNR1;HPCA;VGF;CHRM3;CHI3L1;GABRB2;GNG3;VSNL1;ADCY1;KCNC2;ZCCHC12;GRIN1;SELL;GRIN2B
2980,GO:0006144,0.128882655850294,0.991771914128424,1,22,purine nucleobase metabolic process,BP,GDA
15719,GO:0070325,0.129256659739649,0.991740840260786,1,21,lipoprotein particle receptor binding,MF,SYT1
15155,GO:0061082,0.129315639337635,0.991715151189924,1,22,myeloid leukocyte cytokine production,BP,CHGA
11168,GO:0043279,0.129840072179566,0.975127631633421,2,96,response to alkaloid,BP,CNR1;GRIN1
19338,GO:1902600,0.130523929996446,0.974875862539946,2,110,proton transmembrane transport,BP,SLC17A7;SLC4A10
7201,GO:0030175,0.131034247125051,0.974786057237179,2,90,filopodium,CC,NPTX2;TENM2
18780,GO:1901071,0.131449535625626,0.991432406357778,1,22,glucosamine-containing compound metabolic process,BP,CHI3L1
3353,GO:0006688,0.13150166002069,0.991425437378309,1,22,glycosphingolipid biosynthetic process,BP,ST8SIA5
7013,GO:0022037,0.131951015010837,0.974497067011028,2,92,metencephalon development,BP,NEUROD2;GRIN1
2412,GO:0005086,0.132096632058357,0.991385043163961,1,20,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC3
18027,GO:0098791,0.132459125860692,0.934425260564945,8,765,Golgi subcompartment,CC,CAMK1G;RBFOX1;ST8SIA5;SNAP25;SYT4;GAD2;CHST9;TMEM130
7496,GO:0030803,0.132587654118692,0.991279563180878,1,22,negative regulation of cyclic nucleotide biosynthetic process,BP,HPCA
15514,GO:0062014,0.132720163424506,0.974234563237194,2,99,negative regulation of small molecule metabolic process,BP,CNR1;HPCA
11347,GO:0043583,0.133746951971456,0.961731492925468,3,191,ear development,BP,HPCA;CXCL14;GABRB2
6546,GO:0019433,0.134006062642886,0.991038498094235,1,25,triglyceride catabolic process,BP,FABP7
420,GO:0001101,0.134365754105057,0.952697790677754,4,307,response to acid chemical,BP,NEURL1;IGFBP2;HPCA;GRIN1
18764,GO:1901018,0.134710540963342,0.990990669228157,1,22,positive regulation of potassium ion transmembrane transporter activity,BP,KCNC2
4554,GO:0009636,0.134901839559213,0.945806128373713,5,442,response to toxic substance,BP,CNR1;HPCA;KCNC2;GRIN1;GRIN2B
13423,GO:0050709,0.135162317200592,0.973469590143871,2,101,negative regulation of protein secretion,BP,SYT4;VSNL1
3843,GO:0008009,0.135291629766254,0.990781806630314,1,32,chemokine activity,MF,CXCL14
11345,GO:0043576,0.135395173852175,0.990916134365918,1,21,regulation of respiratory gaseous exchange,BP,GRIN1
1188,GO:0002675,0.135706933335204,0.990803533585798,1,25,positive regulation of acute inflammatory response,BP,CNR1
3564,GO:0007026,0.13572640599086,0.990850670737759,1,22,negative regulation of microtubule depolymerization,BP,STMN2
19546,GO:1903077,0.135873561512659,0.990830296651272,1,22,negative regulation of protein localization to plasma membrane,BP,MRAP2
3757,GO:0007413,0.136074374712539,0.990844227012693,1,20,axonal fasciculation,BP,CNR1
18396,GO:0106030,0.136074374712539,0.990844227012693,1,20,neuron projection fasciculation,BP,CNR1
21389,GO:2000403,0.136454600602392,0.990685029310127,1,26,positive regulation of lymphocyte migration,BP,CXCL14
13845,GO:0051350,0.136544502421985,0.990718818818481,1,23,negative regulation of lyase activity,BP,HPCA
14139,GO:0051924,0.136617903146421,0.960532766523574,3,199,regulation of calcium ion transport,BP,CAMK2A;HPCA;GRIN1
4374,GO:0009150,0.136798397084095,0.944802483293884,5,450,purine ribonucleotide metabolic process,BP,CHGA;HPCA;SULT4A1;MRAP2;ADCY1
17920,GO:0098552,0.137851930382238,0.944259185971703,5,425,side of membrane,CC,EEF1A2;NPTX2;SNAP25;GNG3;SELL
16550,GO:0071840,0.138677266468523,0.901749789271175,43,5763,cellular component organization or biogenesis,BP,CACNG3;SYT13;PTPRN;NGEF;SYT1;CAMK2A;LNX1;SNCB;RIMS1;RPH3A;NEFH;CHGA;CELF4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;IGFBP2;CNR1;IQSEC3;KCNS1;SLC12A5;PACSIN1;CALY;SNAP25;SYT4;TESPA1;TBR1;UNC13C;TENM2;MAL2;SHC3;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;GRIN1;MAP7D2;CCK;GRIN2B
15983,GO:0070840,0.138860668656298,0.990455058700616,1,20,dynein complex binding,MF,NEFH
14423,GO:0055083,0.138989357959252,0.990414046783049,1,21,monovalent inorganic anion homeostasis,BP,SLC12A5
13402,GO:0050685,0.139556560437269,0.990275989346424,1,24,positive regulation of mRNA processing,BP,CELF4
5974,GO:0016645,0.139676826666567,0.990258767912816,1,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,CRYM
13558,GO:0050901,0.140082927168946,0.990200497875375,1,24,leukocyte tethering or rolling,BP,SELL
11043,GO:0043090,0.140222418697195,0.990217390654941,1,22,amino acid import,BP,SLC17A7
9869,GO:0035640,0.140407700794939,0.990171482052254,1,23,exploration behavior,BP,SLC4A10
9957,GO:0035774,0.14053285052131,0.990119400083802,1,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
11863,GO:0045111,0.14063704363114,0.971738225371047,2,101,intermediate filament cytoskeleton,CC,NEFH;NEFM
3442,GO:0006829,0.140776716141802,0.990118334228469,1,23,zinc ion transport,BP,SLC30A3
21073,GO:1990776,0.141399839198526,0.990028244847727,1,23,response to angiotensin,BP,CAMK2A
14898,GO:0060632,0.141543470117878,0.990007417887075,1,23,regulation of microtubule-based movement,BP,NEFH
4320,GO:0009081,0.141786971093045,0.989953990313739,1,24,branched-chain amino acid metabolic process,BP,BCAT1
13110,GO:0048588,0.142422851835524,0.958112883967625,3,190,developmental cell growth,BP,SYT1;RIMS1;SYT4
18205,GO:0099173,0.1425429856359,0.971148601629866,2,95,postsynapse organization,BP,NGEF;GRIN2B
3474,GO:0006884,0.142600092151411,0.989873438646875,1,22,cell volume homeostasis,BP,SLC12A5
13487,GO:0050801,0.142961536722137,0.931624701051489,7,676,ion homeostasis,BP,SLC30A3;SLC12A5;SLC4A10;GNG3;GRIN1;CCK;GRIN2B
4344,GO:0009117,0.143091337180972,0.93596507472658,6,587,nucleotide metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
10890,GO:0042755,0.143226591116091,0.989726256086723,1,25,eating behavior,BP,CCK
99,GO:0000188,0.14336170503898,0.98972331284864,1,24,inactivation of MAPK activity,BP,RGS4
8841,GO:0033119,0.143641239801388,0.989682075610077,1,24,negative regulation of RNA splicing,BP,CELF4
16908,GO:0072509,0.144165984713611,0.989623107308658,1,23,divalent inorganic cation transmembrane transporter activity,MF,SLC30A3
5313,GO:0015106,0.144280992028214,0.98964885300864,1,21,bicarbonate transmembrane transporter activity,MF,SLC4A10
18185,GO:0099094,0.144497870907282,0.970506729313598,2,97,ligand-gated cation channel activity,MF,GRIN1;GRIN2B
820,GO:0002026,0.145247555990535,0.989443418119892,1,24,regulation of the force of heart contraction,BP,CHGA
7172,GO:0030137,0.145247976378025,0.989425915560208,1,25,COPI-coated vesicle,CC,PACSIN1
788,GO:0001975,0.14526205232654,0.989441251200072,1,24,response to amphetamine,BP,GRIN1
3465,GO:0006873,0.145606855244573,0.934535009262722,6,558,cellular ion homeostasis,BP,SLC30A3;SLC12A5;SLC4A10;GNG3;GRIN1;GRIN2B
1275,GO:0002792,0.146255994575019,0.969894783220867,2,107,negative regulation of peptide secretion,BP,SYT4;VSNL1
16975,GO:0072606,0.146394576662593,0.989237167060153,1,26,interleukin-8 secretion,BP,CHI3L1
11485,GO:0044093,0.146526472834901,0.911957301610388,14,1577,positive regulation of molecular function,BP,CAMK2A;EEF1A2;EPHB6;NEURL1;RGS4;HPCA;CHI3L1;GNG3;ADCY1;KCNC2;NEUROD2;GRIN1;CCK;GRIN2B
12587,GO:0046660,0.146827869010679,0.969724501788786,2,102,female sex differentiation,BP,PTPRN;VGF
12678,GO:0046887,0.147627641662477,0.969432853314384,2,110,positive regulation of hormone secretion,BP,NNAT;VSNL1
20163,GO:1904376,0.148221746482306,0.988993904244867,1,24,negative regulation of protein localization to cell periphery,BP,MRAP2
13774,GO:0051239,0.14822599506738,0.902828057289552,21,2551,regulation of multicellular organismal process,BP,CACNG3;NGEF;SYT1;RIMS1;CHGA;CELF4;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;CHRM3;CHI3L1;TESPA1;TBR1;NEUROD2;ENC1;DMRT2;GRIN1;CCK
3397,GO:0006753,0.148604241074985,0.932791838531901,6,594,nucleoside phosphate metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
5555,GO:0015813,0.148651181243601,0.988948039197006,1,23,L-glutamate transmembrane transport,BP,SLC17A7
4216,GO:0008637,0.149377542606873,0.968839485661571,2,114,apoptotic mitochondrial changes,BP,CAMK2A;CCK
21316,GO:2000311,0.149377612509137,0.988816530401148,1,24,regulation of AMPA receptor activity,BP,CACNG3
7966,GO:0031640,0.149803450015902,0.988614480015444,1,34,killing of cells of other organism,BP,CHGA
11611,GO:0044364,0.149803450015902,0.988614480015444,1,34,disruption of cells of other organism,BP,CHGA
2542,GO:0005328,0.15070536149184,0.988631337405384,1,23,neurotransmitter:sodium symporter activity,MF,SLC6A17
21714,GO:2001024,0.15076936703913,0.988582173487958,1,25,negative regulation of response to drug,BP,CNR1
7743,GO:0031234,0.150904673243581,0.968359419676495,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNAP25;GNG3
4460,GO:0009259,0.151059508456008,0.937126226366905,5,465,ribonucleotide metabolic process,BP,CHGA;HPCA;SULT4A1;MRAP2;ADCY1
3433,GO:0006814,0.151114374142486,0.954365015936098,3,197,sodium ion transport,BP,SLC17A7;SLC13A5;SLC4A10
17208,GO:0090079,0.151130193257233,0.988544720747003,1,24,translation regulator activity, nucleic acid binding,MF,CELF4
3921,GO:0008150,0.151837223337033,0.931981579176345,94,14255,biological_process,BP,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;TMEM132D;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MAP7D2;NELL2;SV2B;MYT1L;MPPED1;CCK;SELL;SLC6A17;NMB;GRIN2B
3665,GO:0007205,0.151883853095638,0.988407701166838,1,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,CCK
18236,GO:0099528,0.152034027643593,0.988366449641365,1,26,G-protein coupled neurotransmitter receptor activity,MF,CHRM3
2583,GO:0005452,0.152111708379105,0.988390984831361,1,24,inorganic anion exchanger activity,MF,SLC4A10
7332,GO:0030371,0.15244514710358,0.988338510616472,1,24,translation repressor activity,MF,CELF4
13870,GO:0051402,0.152470282212402,0.953755424875014,3,207,neuron apoptotic process,BP,SNCB;GABRB2;GRIN1
11805,GO:0045026,0.152766234806696,0.988218978110812,1,28,plasma membrane fusion,BP,SNAP25
9071,GO:0033674,0.152873363984804,0.930334095101183,6,541,positive regulation of kinase activity,BP,EEF1A2;EPHB6;NEURL1;CHI3L1;GNG3;ADCY1
7493,GO:0030800,0.153656805550706,0.988109240896357,1,26,negative regulation of cyclic nucleotide metabolic process,BP,HPCA
12737,GO:0046983,0.153677458299814,0.915101599930783,10,1103,protein dimerization activity,MF,SYT1;CAMK2A;CRYM;DNM1;SYT4;GAD2;TENM2;KCNK9;NEUROD2;DMRT2
16239,GO:0071333,0.153840956567102,0.967358388926152,2,108,cellular response to glucose stimulus,BP,PTPRN;VSNL1
1967,GO:0004435,0.155495738655742,0.987874326950573,1,23,phosphatidylinositol phospholipase C activity,MF,CHRM3
5881,GO:0016486,0.155949122419714,0.987740822254702,1,26,peptide hormone processing,BP,PCSK1
8291,GO:0032281,0.156507714306816,0.987632841098773,1,27,AMPA glutamate receptor complex,CC,CACNG3
6922,GO:0021846,0.156577318922817,0.987657521088876,1,25,cell proliferation in forebrain,BP,FABP7
17205,GO:0090075,0.157812051820075,0.987419424939629,1,27,relaxation of muscle,BP,CHGA
6996,GO:0021987,0.157817090774941,0.966017308561363,2,103,cerebral cortex development,BP,TBR1;GRIN1
16237,GO:0071331,0.158317248385064,0.965817826932456,2,110,cellular response to hexose stimulus,BP,PTPRN;VSNL1
15437,GO:0061756,0.158884562995023,0.987242486162624,1,27,leukocyte adhesion to vascular endothelial cell,BP,SELL
18984,GO:1901652,0.159517704152119,0.932468546361076,5,441,response to peptide,BP,PTPRN;CAMK2A;VGF;GNG3;ADCY1
3634,GO:0007167,0.159723280635721,0.913976796228908,9,923,enzyme linked receptor protein signaling pathway,BP,NGEF;EPHB6;DNM1;NEURL1;IGFBP2;SHC3;ZCCHC12;GRIN1;GRIN2B
21209,GO:2000116,0.160468208265462,0.950175708558021,3,227,regulation of cysteine-type endopeptidase activity,BP,GRIN1;CCK;GRIN2B
17380,GO:0090314,0.160476544338444,0.986977423563269,1,27,positive regulation of protein targeting to membrane,BP,HPCA
7254,GO:0030246,0.160662252995041,0.950095888035178,3,222,carbohydrate binding,MF,NPTX2;CHI3L1;SELL
7223,GO:0030206,0.160920175026249,0.986941088044424,1,25,chondroitin sulfate biosynthetic process,BP,CHST9
16235,GO:0071326,0.160922973781596,0.964908439615793,2,111,cellular response to monosaccharide stimulus,BP,PTPRN;VSNL1
4548,GO:0009620,0.16100846571727,0.986801701957013,1,33,response to fungus,BP,CHGA
12244,GO:0045920,0.161633816263688,0.98678291869324,1,27,negative regulation of exocytosis,BP,SYT4
2552,GO:0005343,0.161693610102887,0.986791292698366,1,26,organic acid:sodium symporter activity,MF,SLC13A5
21307,GO:2000300,0.161867980731408,0.986781869868952,1,25,regulation of synaptic vesicle exocytosis,BP,RIMS1
7696,GO:0031114,0.162036601700273,0.986733405471773,1,26,regulation of microtubule depolymerization,BP,STMN2
7145,GO:0030100,0.162213886322051,0.949407671602139,3,215,regulation of endocytosis,BP,PACSIN1;CALY;SYT4
4309,GO:0009065,0.162664219981187,0.986591094815892,1,28,glutamine family amino acid catabolic process,BP,GAD2
3472,GO:0006882,0.163624227024846,0.98636801063655,1,32,cellular zinc ion homeostasis,BP,SLC30A3
9674,GO:0035296,0.163756213107776,0.963908999850403,2,112,regulation of tube diameter,BP,CHGA;CHRM3
17892,GO:0097746,0.163756213107776,0.963908999850403,2,112,regulation of blood vessel diameter,BP,CHGA;CHRM3
7694,GO:0031112,0.163792348884037,0.986416025764685,1,27,positive regulation of microtubule polymerization or depolymerization,BP,STMN2
6601,GO:0019693,0.163972779510249,0.929948332432995,5,479,ribose phosphate metabolic process,BP,CHGA;HPCA;SULT4A1;MRAP2;ADCY1
2611,GO:0005520,0.164230787029009,0.986306700141618,1,29,insulin-like growth factor binding,MF,IGFBP2
6480,GO:0019239,0.164238936183217,0.986289932286868,1,30,deaminase activity,MF,GDA
7381,GO:0030507,0.164330652650258,0.986363368795702,1,25,spectrin binding,MF,PTPRN
82,GO:0000165,0.164358791437738,0.914394127764879,8,824,MAPK cascade,BP,CAMK2A;EPHB6;RGS4;CHI3L1;SHC3;GNG3;GRIN1;GRIN2B
13148,GO:0048665,0.16491891070606,0.986187978666758,1,29,neuron fate specification,BP,MYT1L
6065,GO:0016814,0.164980471694701,0.986177330980117,1,29,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,GDA
3642,GO:0007176,0.165120101856902,0.98618768362808,1,27,regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
3113,GO:0006376,0.165633170614473,0.986098904369712,1,27,mRNA splice site selection,BP,CELF4
4467,GO:0009266,0.166429654092983,0.947489620346257,3,216,response to temperature stimulus,BP,CAMK2A;SLC12A5;VGF
6941,GO:0021884,0.166702748025375,0.985912853798389,1,27,forebrain neuron development,BP,SLC4A10
8190,GO:0032094,0.167535015954199,0.985700692194055,1,31,response to food,BP,CCK
4872,GO:0010665,0.167576315543227,0.985741506566383,1,28,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
11275,GO:0043484,0.167769502346968,0.962482887427949,2,111,regulation of RNA splicing,BP,RBFOX1;CELF4
8899,GO:0033198,0.168067730249303,0.985637738857718,1,29,response to ATP,BP,SELL
12470,GO:0046461,0.168528786360296,0.985524899557867,1,31,neutral lipid catabolic process,BP,FABP7
12473,GO:0046464,0.168528786360296,0.985524899557867,1,31,acylglycerol catabolic process,BP,FABP7
8682,GO:0032839,0.168739248327909,0.98555495877167,1,27,dendrite cytoplasm,CC,HPCA
13401,GO:0050684,0.168852943073363,0.962093034421718,2,111,regulation of mRNA processing,BP,RBFOX1;CELF4
21232,GO:2000171,0.168861303785954,0.985553494407488,1,26,negative regulation of dendrite development,BP,NGEF
16356,GO:0071495,0.168920817637465,0.90216798323817,11,1205,cellular response to endogenous stimulus,BP,GABRA1;CAMK2A;STMN2;NEURL1;GABRG2;IGFBP2;CHRM3;GABRB2;GNG3;ADCY1;ZCCHC12
4950,GO:0010800,0.16924020981542,0.985466184993993,1,27,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
6426,GO:0019098,0.169319083500584,0.985433383826083,1,28,reproductive behavior,BP,GRIN1
4684,GO:0010092,0.169903743642218,0.985311607875688,1,29,specification of animal organ identity,BP,TBR1
14411,GO:0055069,0.169920289149781,0.985248860203687,1,33,zinc ion homeostasis,BP,SLC30A3
14416,GO:0055075,0.169932676606218,0.985363391034456,1,26,potassium ion homeostasis,BP,SLC12A5
13071,GO:0048513,0.170235116441816,0.884489769875769,23,2884,animal organ development,BP,NNAT;PTPRN;SYT1;CELF4;SLC17A7;NEURL1;HPCA;VGF;SYT4;CHI3L1;TESPA1;TBR1;SLC4A10;CXCL14;GABRB2;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;GRIN1;SLC6A17;GRIN2B
12294,GO:0046006,0.170464390712117,0.985164696978436,1,32,regulation of activated T cell proliferation,BP,IGFBP2
19404,GO:1902803,0.17108287834877,0.985137151057959,1,27,regulation of synaptic vesicle transport,BP,RIMS1
12161,GO:0045761,0.171125813422628,0.985092362994958,1,29,regulation of adenylate cyclase activity,BP,HPCA
14851,GO:0060560,0.171147063065877,0.945332684579242,3,207,developmental growth involved in morphogenesis,BP,SYT1;RIMS1;SYT4
5770,GO:0016247,0.17163098714817,0.961049522386526,2,121,channel regulator activity,MF,CACNG3;KCNS1
12170,GO:0045777,0.171836756377393,0.984931468400502,1,31,positive regulation of blood pressure,BP,CNR1
12407,GO:0046320,0.172132684223639,0.98492850571724,1,28,regulation of fatty acid oxidation,BP,CNR1
2107,GO:0004629,0.172376891418163,0.98492471798619,1,26,phospholipase C activity,MF,CHRM3
12284,GO:0045987,0.174462081252934,0.984467636864494,1,30,positive regulation of smooth muscle contraction,BP,CHRM3
18902,GO:1901385,0.174746372617991,0.984398955282689,1,31,regulation of voltage-gated calcium channel activity,BP,HPCA
21287,GO:2000273,0.174804789848733,0.984421844994197,1,29,positive regulation of signaling receptor activity,BP,NEURL1
5471,GO:0015631,0.175066263856798,0.932107669816717,4,319,tubulin binding,MF,NEFH;STMN2;NEFM;DNM1
20690,GO:1905476,0.175473068367681,0.984298352163345,1,29,negative regulation of protein localization to membrane,BP,MRAP2
8842,GO:0033120,0.175718442150865,0.984252877915407,1,29,positive regulation of RNA splicing,BP,CELF4
5410,GO:0015301,0.177351771219373,0.983967580305084,1,28,anion:anion antiporter activity,MF,SLC4A10
7174,GO:0030140,0.177520533000912,0.983898795732265,1,30,trans-Golgi network transport vesicle,CC,NRGN
4510,GO:0009410,0.177873986009953,0.942133346284798,3,235,response to xenobiotic stimulus,BP,CNR1;HPCA;GRIN1
14172,GO:0051968,0.178455424862098,0.983760300906659,1,28,positive regulation of synaptic transmission, glutamatergic,BP,CACNG3
11585,GO:0044325,0.17908820091557,0.958313108437763,2,115,ion channel binding,MF,RIMS1;KCNC2
13543,GO:0050880,0.179193839715446,0.95825461928847,2,120,regulation of blood vessel size,BP,CHGA;CHRM3
4869,GO:0010662,0.179260089564274,0.983570362267678,1,30,regulation of striated muscle cell apoptotic process,BP,CAMK2A
11141,GO:0043243,0.179386316617471,0.983546391854509,1,30,positive regulation of protein complex disassembly,BP,STMN2
13403,GO:0050686,0.179689635366133,0.983507104294081,1,29,negative regulation of mRNA processing,BP,CELF4
10501,GO:0040019,0.179804665376334,0.983485226352701,1,29,positive regulation of embryonic development,BP,DMRT2
17824,GO:0097553,0.179867089097126,0.958020646138344,2,115,calcium ion transmembrane import into cytosol,BP,GRIN1;GRIN2B
472,GO:0001504,0.180006102928649,0.983428423006266,1,30,neurotransmitter uptake,BP,SNAP25
16233,GO:0071322,0.180026445567796,0.957945376861184,2,119,cellular response to carbohydrate stimulus,BP,PTPRN;VSNL1
4866,GO:0010659,0.18003592009804,0.98342273627205,1,30,cardiac muscle cell apoptotic process,BP,CAMK2A
14142,GO:0051930,0.180054093944018,0.983401999788375,1,31,regulation of sensory perception of pain,BP,CCK
14143,GO:0051931,0.180054093944018,0.983401999788375,1,31,regulation of sensory perception,BP,CCK
2789,GO:0005834,0.180474492391401,0.983290080367659,1,33,heterotrimeric G-protein complex,CC,GNG3
20636,GO:1905360,0.180474492391401,0.983290080367659,1,33,GTPase complex,CC,GNG3
3970,GO:0008227,0.180523252500967,0.983296011380054,1,32,G-protein coupled amine receptor activity,MF,CHRM3
3705,GO:0007271,0.180675421244157,0.983283129469731,1,31,synaptic transmission, cholinergic,BP,CHRM3
9615,GO:0035150,0.180800730167242,0.957646215020225,2,121,regulation of tube size,BP,CHGA;CHRM3
17974,GO:0098657,0.181211735179859,0.907851526399551,7,706,import into cell,BP,CACNG3;SYT1;DNM1;PACSIN1;CALY;SNAP25;SYT4
4376,GO:0009152,0.181615560313581,0.940353457809784,3,235,purine ribonucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
13516,GO:0050850,0.181863568827591,0.983022522569062,1,33,positive regulation of calcium-mediated signaling,BP,NEUROD2
6074,GO:0016831,0.182541630646214,0.982906716215919,1,32,carboxy-lyase activity,MF,GAD2
10697,GO:0042379,0.182683041648992,0.982765926868012,1,41,chemokine receptor binding,MF,CXCL14
1405,GO:0003091,0.183286044118035,0.98281572163694,1,29,renal water homeostasis,BP,ADCY1
3228,GO:0006536,0.183382343925683,0.982759933999214,1,31,glutamate metabolic process,BP,GAD2
8741,GO:0032941,0.183716429711622,0.982662079697922,1,33,secretion by tissue,BP,CHRM3
17379,GO:0090313,0.183770777726936,0.982684146758947,1,31,regulation of protein targeting to membrane,BP,HPCA
13369,GO:0050650,0.184166278465914,0.98262486385391,1,30,chondroitin sulfate proteoglycan biosynthetic process,BP,CHST9
12251,GO:0045927,0.184921757991786,0.938783805165454,3,224,positive regulation of growth,BP,SYT1;RIMS1;SYT4
576,GO:0001678,0.186171840602313,0.955598688773228,2,121,cellular glucose homeostasis,BP,PTPRN;VSNL1
8257,GO:0032228,0.186177172070528,0.982229114596883,1,30,regulation of synaptic transmission, GABAergic,BP,CNR1
16015,GO:0070888,0.186622029501462,0.982122366890427,1,31,E-box binding,MF,NEUROD2
3519,GO:0006953,0.187058415778427,0.981957907531614,1,36,acute-phase response,BP,CNR1
2988,GO:0006164,0.187627529374803,0.937447943394564,3,239,purine nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
3653,GO:0007190,0.187930416550982,0.981861345713424,1,31,activation of adenylate cyclase activity,BP,ADCY1
7078,GO:0023014,0.188800319234332,0.898290903016708,8,852,signal transduction by protein phosphorylation,BP,CAMK2A;EPHB6;RGS4;CHI3L1;SHC3;GNG3;GRIN1;GRIN2B
12152,GO:0045742,0.188908046409454,0.981647163485683,1,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1
6694,GO:0019900,0.188920999258164,0.902868578658454,7,695,kinase binding,MF,NEFH;EEF1A2;EPHB6;DNM1;HPCA;TBR1;SHC3
3939,GO:0008180,0.188965154888091,0.981618901829409,1,33,COP9 signalosome,CC,TESPA1
18691,GO:1900271,0.19041964954051,0.98135912006714,1,31,regulation of long-term synaptic potentiation,BP,NRGN
12192,GO:0045823,0.190753933454222,0.981239825859438,1,34,positive regulation of heart contraction,BP,CHGA
12969,GO:0048247,0.191086593459058,0.981103689153196,1,39,lymphocyte chemotaxis,BP,CXCL14
4865,GO:0010658,0.191546570470826,0.981111004949489,1,32,striated muscle cell apoptotic process,BP,CAMK2A
13482,GO:0050793,0.191935378971523,0.8727633351343,18,2200,regulation of developmental process,BP,NGEF;SYT1;RIMS1;CELF4;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;CHI3L1;TESPA1;TBR1;CXCL14;NEUROD2;ENC1;DMRT2;GRIN1
12879,GO:0048009,0.19202556250168,0.981031188265748,1,31,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
7693,GO:0031111,0.192395555426994,0.980936717803998,1,32,negative regulation of microtubule polymerization or depolymerization,BP,STMN2
3639,GO:0007173,0.192515847285156,0.953137141923896,2,119,epidermal growth factor receptor signaling pathway,BP,NEURL1;SHC3
8782,GO:0033003,0.193118683176006,0.980738127335506,1,35,regulation of mast cell activation,BP,CNR1
1355,GO:0002931,0.19340349793465,0.980728677364237,1,32,response to ischemia,BP,CAMK2A
13486,GO:0050798,0.193654210508821,0.980612274902206,1,36,activated T cell proliferation,BP,IGFBP2
18899,GO:1901381,0.193741201551943,0.980658702519543,1,32,positive regulation of potassium ion transmembrane transport,BP,KCNC2
6770,GO:0021537,0.193770055989553,0.934460957407277,3,225,telencephalon development,BP,TBR1;NRGN;GRIN1
3795,GO:0007548,0.194145409896269,0.934264389907694,3,231,sex differentiation,BP,PTPRN;VGF;DMRT2
7501,GO:0030808,0.194695595204743,0.952244868612652,2,127,regulation of nucleotide biosynthetic process,BP,HPCA;MRAP2
18705,GO:1900371,0.194695595204743,0.952244868612652,2,127,regulation of purine nucleotide biosynthetic process,BP,HPCA;MRAP2
2594,GO:0005484,0.19526342512157,0.980276046647148,1,36,SNAP receptor activity,MF,SNAP25
17306,GO:0090218,0.195642635937685,0.980262154216972,1,32,positive regulation of lipid kinase activity,BP,EEF1A2
10945,GO:0042887,0.19613195432043,0.980093279803592,1,36,amide transmembrane transporter activity,MF,SLC14A1
7902,GO:0031503,0.196211976252266,0.933235575304829,3,233,protein-containing complex localization,BP,CACNG3;DNM1;SNAP25
10879,GO:0042742,0.196710151389092,0.951378847145062,2,147,defense response to bacterium,BP,CHGA;VGF
13522,GO:0050856,0.197499195252887,0.979819044241732,1,35,regulation of T cell receptor signaling pathway,BP,TESPA1
11642,GO:0044431,0.197603111608459,0.892342733127866,8,849,Golgi apparatus part,CC,CAMK1G;RBFOX1;ST8SIA5;SNAP25;SYT4;GAD2;CHST9;TMEM130
13507,GO:0050829,0.197704013421117,0.979683410807958,1,42,defense response to Gram-negative bacterium,BP,CHGA
10716,GO:0042417,0.197847018064146,0.979761357031592,1,34,dopamine metabolic process,BP,SNCB
9592,GO:0035091,0.198022094568609,0.932349748958704,3,224,phosphatidylinositol binding,MF,SYT1;RPH3A;NRGN
5547,GO:0015804,0.198269992712734,0.979688623003327,1,33,neutral amino acid transport,BP,SLC6A17
19106,GO:1901998,0.198621463767239,0.979579852964081,1,35,toxin transport,BP,DNM1
9121,GO:0033865,0.198857865696119,0.979499049546056,1,37,nucleoside bisphosphate metabolic process,BP,SULT4A1
9127,GO:0033875,0.198857865696119,0.979499049546056,1,37,ribonucleoside bisphosphate metabolic process,BP,SULT4A1
9146,GO:0034032,0.198857865696119,0.979499049546056,1,37,purine nucleoside bisphosphate metabolic process,BP,SULT4A1
18815,GO:1901186,0.199039626854612,0.979506817948337,1,34,positive regulation of ERBB signaling pathway,BP,NEURL1
8698,GO:0032880,0.199053995001833,0.89134986994795,8,864,regulation of protein localization,BP,NNAT;CNR1;HPCA;SNAP25;SYT4;MRAP2;VSNL1;KCNC2
14420,GO:0055080,0.199312936531229,0.901922175614566,6,613,cation homeostasis,BP,SLC30A3;SLC12A5;SLC4A10;GNG3;GRIN1;GRIN2B
8421,GO:0032459,0.199522828461663,0.979371003112191,1,36,regulation of protein oligomerization,BP,CCK
12169,GO:0045776,0.201776135886409,0.978883329323296,1,36,negative regulation of blood pressure,BP,CNR1
10078,GO:0036002,0.201789800246053,0.978896346348196,1,35,pre-mRNA binding,MF,CELF4
12592,GO:0046676,0.201825201431079,0.978888640418964,1,35,negative regulation of insulin secretion,BP,VSNL1
4461,GO:0009260,0.202154394974887,0.930230279559024,3,248,ribonucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
13700,GO:0051129,0.202423915060405,0.899940878147416,6,599,negative regulation of cellular component organization,BP,NGEF;STMN2;PACSIN1;SYT4;NEUROD2;GRIN2B
7502,GO:0030809,0.202727090183962,0.978691808563988,1,35,negative regulation of nucleotide biosynthetic process,BP,HPCA
18706,GO:1900372,0.202727090183962,0.978691808563988,1,35,negative regulation of purine nucleotide biosynthetic process,BP,HPCA
13699,GO:0051128,0.202981311210943,0.864217762211314,18,2210,regulation of cellular component organization,BP,NGEF;SYT1;RIMS1;STMN2;NEURL1;IGFBP2;CNR1;PACSIN1;CALY;SNAP25;SYT4;TBR1;TENM2;NEUROD2;ENC1;GRIN1;CCK;GRIN2B
1060,GO:0002437,0.204139064530741,0.978321244311222,1,39,inflammatory response to antigenic stimulus,BP,CNR1
2914,GO:0006040,0.204465207541192,0.978293263376223,1,36,amino sugar metabolic process,BP,CHI3L1
15303,GO:0061462,0.204832546614895,0.978228451399263,1,35,protein localization to lysosome,BP,CACNG3
3887,GO:0008092,0.205264902605321,0.887104420546786,8,839,cytoskeletal protein binding,MF,PTPRN;NEFH;STMN2;NEFM;DNM1;HPCA;PACSIN1;ENC1
16917,GO:0072522,0.205300244301404,0.928630641420069,3,250,purine-containing compound biosynthetic process,BP,HPCA;MRAP2;ADCY1
15947,GO:0070741,0.205565946159448,0.978065779631313,1,35,response to interleukin-6,BP,CHI3L1
561,GO:0001659,0.205610684579565,0.978055835171415,1,35,temperature homeostasis,BP,CNR1
12444,GO:0046390,0.207003677741374,0.927759206131588,3,251,ribose phosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
11666,GO:0044464,0.208960673353304,0.885979535791354,92,13950,cell part,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;NPTX2;DNM1;NEURL1;GABRA4;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;SLC12A5;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;SLC13A5;STAC2;SLC4A10;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;SV2B;MYT1L;CCK;SELL;SLC6A17;GRIN2B
21387,GO:2000401,0.209191946739377,0.977174535235773,1,40,regulation of lymphocyte migration,BP,CXCL14
2629,GO:0005547,0.209597833362822,0.977197385503242,1,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,NRGN
11433,GO:0043954,0.2096951819492,0.977137615954781,1,35,cellular component maintenance,BP,GRIN2B
3858,GO:0008038,0.209807792895537,0.977170366973381,1,32,neuron recognition,BP,CNR1
130,GO:0000266,0.210376090077487,0.977000958974246,1,34,mitochondrial fission,BP,DNM1
11040,GO:0043085,0.210530494475111,0.872402378487463,11,1274,positive regulation of catalytic activity,BP,EEF1A2;EPHB6;NEURL1;RGS4;HPCA;CHI3L1;GNG3;ADCY1;GRIN1;CCK;GRIN2B
510,GO:0001558,0.210897744309202,0.912169778019106,4,365,regulation of cell growth,BP,SYT1;RIMS1;IGFBP2;SYT4
18018,GO:0098771,0.211162289273981,0.894285764855179,6,624,inorganic ion homeostasis,BP,SLC30A3;SLC12A5;SLC4A10;GNG3;GRIN1;GRIN2B
11556,GO:0044282,0.211590319569169,0.911745936221498,4,389,small molecule catabolic process,BP,BCAT1;CRYM;CNR1;GAD2
5822,GO:0016339,0.211851823715459,0.976682993127243,1,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,SELL
2758,GO:0005782,0.211911880005665,0.976537848269609,1,41,peroxisomal matrix,CC,CRYM
8087,GO:0031907,0.211911880005665,0.976537848269609,1,41,microbody lumen,CC,CRYM
3670,GO:0007212,0.212706399059306,0.976397079968478,1,38,dopamine receptor signaling pathway,BP,CALY
3763,GO:0007423,0.213532018608902,0.900553468831886,5,476,sensory organ development,BP,CELF4;SLC17A7;HPCA;CXCL14;GABRB2
4340,GO:0009112,0.215051943998423,0.975835284287354,1,39,nucleobase metabolic process,BP,GDA
3943,GO:0008188,0.215071609809144,0.975788783805715,1,42,neuropeptide receptor activity,MF,PRLHR
13253,GO:0048854,0.215387719501268,0.975823708272116,1,35,brain morphogenesis,BP,SLC4A10
740,GO:0001917,0.215555587759142,0.975766111905262,1,36,photoreceptor inner segment,CC,DNM1
14743,GO:0060402,0.215719853252459,0.943584443289892,2,131,calcium ion transport into cytosol,BP,GRIN1;GRIN2B
14539,GO:0060119,0.216118595191949,0.975633777269005,1,36,inner ear receptor cell development,BP,GABRB2
9804,GO:0035556,0.216643103604184,0.850943843750624,20,2545,intracellular signal transduction,BP,CAMK1G;NGEF;CAMK2A;CHGA;EPHB6;RGS4;IQSEC3;HPCA;CHI3L1;MRAP2;UNC13C;STAC2;SHC3;ZNF385D;GNG3;ADCY1;KCNC2;NEUROD2;GRIN1;GRIN2B
12693,GO:0046915,0.217170606324977,0.975367936033976,1,37,transition metal ion transmembrane transporter activity,MF,SLC30A3
15101,GO:0061001,0.217245274725203,0.975405923834769,1,34,regulation of dendritic spine morphogenesis,BP,NGEF
11109,GO:0043198,0.217716309638221,0.975274705322621,1,35,dendritic shaft,CC,SLC12A5
13480,GO:0050790,0.217965829866508,0.855574819119691,16,2006,regulation of catalytic activity,BP,NGEF;SNCB;RIMS1;EEF1A2;EPHB6;NEURL1;RGS4;CNR1;HPCA;CHI3L1;TMEM132D;GNG3;ADCY1;GRIN1;CCK;GRIN2B
14425,GO:0055086,0.218073609834258,0.889742100860939,6,670,nucleobase-containing small molecule metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
8197,GO:0032101,0.219124800319825,0.889062824783345,6,643,regulation of response to external stimulus,BP,CNR1;TBR1;CXCL14;FABP7;GRIN1;CCK
3633,GO:0007166,0.219289152242873,0.848830997433286,20,2588,cell surface receptor signaling pathway,BP,CACNG3;GABRA1;PTPRN;NGEF;CAMK2A;RIMS1;CELF4;SLC17A7;EPHB6;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;TESPA1;SHC3;GABRA2;ZCCHC12;GRIN1;GRIN2B
13842,GO:0051347,0.21930261781486,0.888961927209388,6,612,positive regulation of transferase activity,BP,EEF1A2;EPHB6;NEURL1;CHI3L1;GNG3;ADCY1
3664,GO:0007204,0.220750020963553,0.920596140117161,3,255,positive regulation of cytosolic calcium ion concentration,BP,GNG3;GRIN1;GRIN2B
12156,GO:0045746,0.221053002323865,0.974405476442955,1,39,negative regulation of Notch signaling pathway,BP,NEURL1
16987,GO:0072657,0.221320616283366,0.89563705233816,5,528,protein localization to membrane,BP,HPCA;PACSIN1;SNAP25;MRAP2;GRIN1
9657,GO:0035264,0.221883210680043,0.94093583815961,2,131,multicellular organism growth,BP,SLC12A5;SLC4A10
11430,GO:0043949,0.222007131077206,0.974158390794906,1,40,regulation of cAMP-mediated signaling,BP,MRAP2
13611,GO:0050999,0.222062628573304,0.974160512198289,1,39,regulation of nitric-oxide synthase activity,BP,CNR1
12689,GO:0046907,0.2230233433003,0.857733173444872,13,1614,intracellular transport,BP,CACNG3;SYT13;SYT1;RIMS1;RPH3A;NEFH;CHGA;DNM1;HPCA;CALY;SNAP25;SYT4;UNC13C
17347,GO:0090278,0.224107344032576,0.973644582067084,1,40,negative regulation of peptide hormone secretion,BP,VSNL1
11427,GO:0043933,0.225198249670779,0.851751876136308,15,1932,protein-containing complex subunit organization,BP,SYT1;LNX1;RIMS1;CELF4;STMN2;DNM1;KCNS1;CALY;SNAP25;TESPA1;UNC13C;KCNC2;GRIN1;CCK;GRIN2B
3486,GO:0006898,0.225798118271337,0.917910792246965,3,253,receptor-mediated endocytosis,BP,CACNG3;DNM1;SNAP25
13508,GO:0050830,0.226354935780625,0.972972340619918,1,49,defense response to Gram-positive bacterium,BP,CHGA
8198,GO:0032102,0.227395421405448,0.917044363785677,3,258,negative regulation of response to external stimulus,BP,FABP7;GRIN1;CCK
3560,GO:0007019,0.22745659316787,0.972847393732155,1,38,microtubule depolymerization,BP,STMN2
11713,GO:0044703,0.227635834523482,0.876842132679157,7,777,multi-organism reproductive process,BP,CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;GRIN1
13834,GO:0051339,0.227698969076874,0.972737444436463,1,41,regulation of lyase activity,BP,HPCA
1502,GO:0003254,0.228197113520086,0.972644636792558,1,39,regulation of membrane depolarization,BP,CCK
5501,GO:0015701,0.228322508227855,0.972580929299983,1,41,bicarbonate transport,BP,SLC4A10
13462,GO:0050768,0.228432390696819,0.916509853570034,3,245,negative regulation of neurogenesis,BP,NGEF;STMN2;SYT4
7767,GO:0031279,0.22895822470122,0.972420852129437,1,41,regulation of cyclase activity,BP,HPCA
3510,GO:0006937,0.229190557384752,0.937684933879396,2,142,regulation of muscle contraction,BP,CHGA;CHRM3
13763,GO:0051224,0.229750058509826,0.937432583506443,2,143,negative regulation of protein transport,BP,SYT4;VSNL1
4949,GO:0010799,0.229805267888029,0.972257028874963,1,38,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
5094,GO:0010977,0.230140848229424,0.937293841527381,2,134,negative regulation of neuron projection development,BP,NGEF;STMN2
15166,GO:0061098,0.230201873605931,0.972156650592924,1,38,positive regulation of protein tyrosine kinase activity,BP,NEURL1
3809,GO:0007595,0.230610953523793,0.972052906875874,1,38,lactation,BP,NEURL1
7030,GO:0022602,0.230753544220691,0.971998935937298,1,39,ovulation cycle process,BP,PTPRN
967,GO:0002279,0.231050713042589,0.971875022978574,1,42,mast cell activation involved in immune response,BP,CHGA
11181,GO:0043303,0.231050713042589,0.971875022978574,1,42,mast cell degranulation,BP,CHGA
4676,GO:0010043,0.232934766893791,0.971301206048254,1,49,response to zinc ion,BP,SLC30A3
6689,GO:0019894,0.232974104404351,0.971468542307424,1,37,kinesin binding,MF,NEFH
19361,GO:1902667,0.232989033337401,0.971484858152403,1,36,regulation of axon guidance,BP,TBR1
1694,GO:0003924,0.233745539416159,0.91358052556186,3,271,GTPase activity,MF,EEF1A2;DNM1;GNG3
11159,GO:0043268,0.233874016957798,0.971199557515252,1,39,positive regulation of potassium ion transport,BP,KCNC2
2828,GO:0005891,0.234331493800288,0.971081325776766,1,39,voltage-gated calcium channel complex,CC,CACNG3
6610,GO:0019730,0.234345129291956,0.970849997665972,1,58,antimicrobial humoral response,BP,CHGA
13606,GO:0050994,0.234881706250796,0.970888847590123,1,42,regulation of lipid catabolic process,BP,CNR1
1380,GO:0003018,0.236393161665989,0.934447594980297,2,143,vascular process in circulatory system,BP,CHGA;CHRM3
7199,GO:0030173,0.236939238061463,0.970367589098504,1,41,integral component of Golgi membrane,CC,SYT4
19705,GO:1903428,0.23694532240108,0.970349886020931,1,42,positive regulation of reactive oxygen species biosynthetic process,BP,GRIN1
13380,GO:0050661,0.237095524471459,0.970280394322596,1,44,NADP binding,MF,CRYM
9595,GO:0035094,0.237405221238678,0.970229031652428,1,42,response to nicotine,BP,CNR1
16959,GO:0072583,0.237737569351561,0.970211516933105,1,38,clathrin-dependent endocytosis,BP,DNM1
3967,GO:0008217,0.237767089288476,0.933807857722505,2,147,regulation of blood pressure,BP,CHGA;CNR1
3680,GO:0007223,0.237806787625455,0.970193315174248,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
16904,GO:0072503,0.238360442003065,0.895836045046956,4,392,cellular divalent inorganic cation homeostasis,BP,SLC30A3;GNG3;GRIN1;GRIN2B
18835,GO:1901224,0.238541226709195,0.969913784600761,1,43,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1
10799,GO:0042581,0.238873332140819,0.933288597914628,2,151,specific granule,CC,SNAP25;CHI3L1
4686,GO:0010107,0.238924576734863,0.969879497411088,1,39,potassium ion import,BP,SLC12A5
7695,GO:0031113,0.239318482275676,0.969739780570538,1,41,regulation of microtubule polymerization,BP,STMN2
20457,GO:1904950,0.239644609330729,0.932949769418441,2,147,negative regulation of establishment of protein localization,BP,SYT4;VSNL1
19746,GO:1903522,0.239663684554591,0.91034950848932,3,258,regulation of blood circulation,BP,CACNG3;CHGA;CHRM3
16994,GO:0072666,0.240234634093982,0.969479548306373,1,42,establishment of protein localization to vacuole,BP,CACNG3
10612,GO:0042220,0.240303492042581,0.9694777450921,1,41,response to cocaine,BP,CNR1
4509,GO:0009409,0.240649616693507,0.969352922616646,1,43,response to cold,BP,VGF
14410,GO:0055067,0.240705199109296,0.932482096262104,2,142,monovalent inorganic cation homeostasis,BP,SLC12A5;SLC4A10
1071,GO:0002448,0.240728510269289,0.969316698870317,1,44,mast cell mediated immunity,BP,CHGA
7221,GO:0030204,0.240990126034237,0.969311841873717,1,40,chondroitin sulfate metabolic process,BP,CHST9
3847,GO:0008017,0.241641497983266,0.909282366504631,3,243,microtubule binding,MF,NEFH;NEFM;DNM1
14742,GO:0060401,0.241791174412551,0.931986191505259,2,141,cytosolic calcium ion transport,BP,GRIN1;GRIN2B
6695,GO:0019901,0.242163744560734,0.873613121241469,6,620,protein kinase binding,MF,NEFH;EEF1A2;EPHB6;DNM1;TBR1;SHC3
18447,GO:0120032,0.242386028014149,0.931711692690311,2,141,regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
9649,GO:0035254,0.243221595100416,0.968711965209085,1,40,glutamate receptor binding,MF,CAMK2A
15099,GO:0060999,0.243825479579415,0.968567350036135,1,39,positive regulation of dendritic spine development,BP,NEURL1
7455,GO:0030666,0.244225212193336,0.930821621918167,2,151,endocytic vesicle membrane,CC,CACNG3;CAMK2A
13443,GO:0050731,0.244426554587264,0.93073902941379,2,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;CCK
2505,GO:0005245,0.244963628211284,0.968221133021755,1,41,voltage-gated calcium channel activity,MF,CACNG3
3008,GO:0006195,0.246093465622178,0.967862521991406,1,44,purine nucleotide catabolic process,BP,GDA
12183,GO:0045806,0.246572992273093,0.967715575975983,1,45,negative regulation of endocytosis,BP,PACSIN1
10944,GO:0042886,0.246708397335679,0.836999900189423,14,1805,amide transport,BP,CACNG3;NNAT;PTPRN;RIMS1;RPH3A;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;VSNL1;KCNC2
10401,GO:0038127,0.247486243109477,0.929338589632174,2,141,ERBB signaling pathway,BP,NEURL1;SHC3
18721,GO:1900449,0.247810720260794,0.967422010240835,1,42,regulation of glutamate receptor signaling pathway,BP,CACNG3
14811,GO:0060491,0.247940219342022,0.929117377363365,2,143,regulation of cell projection assembly,BP,NEURL1;TENM2
6072,GO:0016829,0.247999429175021,0.929027575553757,2,160,lyase activity,MF,GAD2;ADCY1
7196,GO:0030170,0.24880461637934,0.967098067677996,1,45,pyridoxal phosphate binding,MF,GAD2
15690,GO:0070279,0.24880461637934,0.967098067677996,1,45,vitamin B6 binding,MF,GAD2
13373,GO:0050654,0.249157348061563,0.967048518348995,1,42,chondroitin sulfate proteoglycan metabolic process,BP,CHST9
2604,GO:0005507,0.250136479640763,0.966670432931866,1,49,copper ion binding,MF,SNCB
18731,GO:1900543,0.250424154568856,0.966645874375348,1,45,negative regulation of purine nucleotide metabolic process,BP,HPCA
6073,GO:0016830,0.252686593200308,0.965978655515627,1,47,carbon-carbon lyase activity,MF,GAD2
12110,GO:0045661,0.252744435358565,0.96597683771548,1,46,regulation of myoblast differentiation,BP,CXCL14
12281,GO:0045980,0.253284443469221,0.965823600896439,1,46,negative regulation of nucleotide metabolic process,BP,HPCA
18271,GO:0099601,0.25437426243819,0.965544736107449,1,44,regulation of neurotransmitter receptor activity,BP,CACNG3
17227,GO:0090102,0.254832594462771,0.96543077594565,1,43,cochlea development,BP,GABRB2
5453,GO:0015459,0.255021285998773,0.965328151802834,1,46,potassium channel regulator activity,MF,KCNS1
14421,GO:0055081,0.25563924466904,0.96518278575469,1,44,anion homeostasis,BP,SLC12A5
8126,GO:0031984,0.256347079062542,0.834666786484747,12,1491,organelle subcompartment,CC,CAMK1G;RBFOX1;ST8SIA5;PTPN5;SNAP25;SYT4;MRAP2;TESPA1;GAD2;CHST9;TMEM130;DDN
5067,GO:0010941,0.256497634691502,0.834544982817117,12,1515,regulation of cell death,BP,NGEF;CAMK2A;SNCB;CHGA;EEF1A2;EPHB6;NEURL1;CNR1;GABRB2;GRIN1;CCK;GRIN2B
3624,GO:0007157,0.256894785810931,0.964838674559755,1,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM2
7738,GO:0031228,0.257294001505011,0.96468964023162,1,45,intrinsic component of Golgi membrane,CC,SYT4
14409,GO:0055065,0.257540588646027,0.872049783894502,5,536,metal ion homeostasis,BP,SLC30A3;SLC12A5;GNG3;GRIN1;GRIN2B
12503,GO:0046503,0.258122174721274,0.964403978145202,1,48,glycerolipid catabolic process,BP,FABP7
4782,GO:0010518,0.258573229301691,0.964318531579305,1,45,positive regulation of phospholipase activity,BP,HPCA
19287,GO:1902475,0.259119953500548,0.964175998948617,1,44,L-alpha-amino acid transmembrane transport,BP,SLC17A7
3275,GO:0006584,0.259209939216436,0.964101671490818,1,47,catecholamine metabolic process,BP,SNCB
4570,GO:0009712,0.259209939216436,0.964101671490818,1,47,catechol-containing compound metabolic process,BP,SNCB
7425,GO:0030595,0.259257409254003,0.923623197651271,2,169,leukocyte chemotaxis,BP,CHGA;CXCL14
4788,GO:0010524,0.260037852888029,0.96384466238384,1,48,positive regulation of calcium ion transport into cytosol,BP,GRIN1
6855,GO:0021695,0.260843375982082,0.963671594794675,1,44,cerebellar cortex development,BP,NEUROD2
684,GO:0001836,0.261497780072522,0.963337106715752,1,54,release of cytochrome c from mitochondria,BP,CCK
16907,GO:0072507,0.262674213358107,0.880640670655184,4,408,divalent inorganic cation homeostasis,BP,SLC30A3;GNG3;GRIN1;GRIN2B
20689,GO:1905475,0.262874921899284,0.92191540263734,2,153,regulation of protein localization to membrane,BP,HPCA;MRAP2
11870,GO:0045123,0.264948598209748,0.962388693775843,1,48,cellular extravasation,BP,SELL
5814,GO:0016324,0.265541002854829,0.89559358021342,3,265,apical plasma membrane,CC,IGFBP2;MAL2;KCNC2
15203,GO:0061178,0.265808067138458,0.962115767039379,1,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
4940,GO:0010769,0.266658675241243,0.894950339451593,3,259,regulation of cell morphogenesis involved in differentiation,BP,NGEF;TBR1;GRIN1
13911,GO:0051480,0.267068634990496,0.894666700391612,3,281,regulation of cytosolic calcium ion concentration,BP,GNG3;GRIN1;GRIN2B
4172,GO:0008542,0.268262665216128,0.961455199616127,1,44,visual learning,BP,GRIN1
8623,GO:0032768,0.268807516507326,0.961206918852694,1,49,regulation of monooxygenase activity,BP,CNR1
7098,GO:0030003,0.269162411679408,0.864172114602864,5,547,cellular cation homeostasis,BP,SLC30A3;SLC4A10;GNG3;GRIN1;GRIN2B
3626,GO:0007159,0.269231041647673,0.893376691682975,3,290,leukocyte cell-cell adhesion,BP,IGFBP2;TESPA1;SELL
4514,GO:0009416,0.269397244389743,0.893305406731636,3,275,response to light stimulus,BP,SLC4A10;KCNC2;GRIN1
18092,GO:0098900,0.269484423749252,0.961083188925451,1,44,regulation of action potential,BP,CNR1
2481,GO:0005198,0.269697838770251,0.863778417917082,5,587,structural molecule activity,MF,NEFH;NEFM;CHI3L1;MAL2;MAP7D2
3790,GO:0007528,0.270245233268894,0.960850522832711,1,44,neuromuscular junction development,BP,UNC13C
4646,GO:0009966,0.270513901918197,0.805713318588276,21,2820,regulation of signal transduction,BP,CACNG3;NGEF;RIMS1;CHGA;CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;IQSEC3;VGF;CHI3L1;MRAP2;TESPA1;CXCL14;GNG3;NEUROD2;GRIN1;CCK;NMB
4715,GO:0010256,0.270798923053322,0.875435878788436,4,391,endomembrane system organization,BP,PTPRN;DNM1;PACSIN1;SYT4
2773,GO:0005798,0.270820093518268,0.917947415533478,2,162,Golgi-associated vesicle,CC,PACSIN1;NRGN
13267,GO:0048871,0.270917591837412,0.892402029311489,3,277,multicellular organismal homeostasis,BP,CNR1;MRAP2;ADCY1
497,GO:0001541,0.271152425072496,0.960488013319543,1,49,ovarian follicle development,BP,VGF
16918,GO:0072523,0.272148418866998,0.960180426632072,1,49,purine-containing compound catabolic process,BP,GDA
9527,GO:0034765,0.272434748472099,0.874362980466937,4,401,regulation of ion transmembrane transport,BP,CACNG3;HPCA;KCNS1;KCNC2
11328,GO:0043549,0.27466936727884,0.84323180629151,7,801,regulation of kinase activity,BP,EEF1A2;EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1
19014,GO:1901701,0.274876884257877,0.836846549636554,8,950,cellular response to oxygen-containing compound,BP,PTPRN;CAMK2A;NEURL1;CHRM3;GNG3;VSNL1;ADCY1;KCNC2
8143,GO:0032011,0.276444226559046,0.958925818121019,1,44,ARF protein signal transduction,BP,IQSEC3
8144,GO:0032012,0.276444226559046,0.958925818121019,1,44,regulation of ARF protein signal transduction,BP,IQSEC3
15512,GO:0062012,0.277312171478755,0.871155383551771,4,424,regulation of small molecule metabolic process,BP,CHGA;CNR1;HPCA;MRAP2
14537,GO:0060113,0.277401781173816,0.958552059125242,1,48,inner ear receptor cell differentiation,BP,GABRB2
11329,GO:0043550,0.277668207900145,0.958484535986594,1,47,regulation of lipid kinase activity,BP,EEF1A2
20879,GO:1990090,0.279919126500537,0.957734680844981,1,49,cellular response to nerve growth factor stimulus,BP,STMN2
9820,GO:0035580,0.280197792183326,0.957523010835083,1,58,specific granule lumen,CC,CHI3L1
962,GO:0002274,0.282036893548136,0.855260637800723,5,581,myeloid leukocyte activation,BP,CHGA;CNR1;SNAP25;CHI3L1;SELL
6776,GO:0021543,0.28254809590365,0.912015520350313,2,154,pallium development,BP,TBR1;GRIN1
16269,GO:0071375,0.283180425117602,0.885033333469036,3,281,cellular response to peptide hormone stimulus,BP,CAMK2A;GNG3;ADCY1
4583,GO:0009749,0.283218751224138,0.911636580183585,2,162,response to glucose,BP,PTPRN;VSNL1
7031,GO:0022603,0.28464073093117,0.829445537784854,8,943,regulation of anatomical structure morphogenesis,BP,NGEF;SYT1;RIMS1;SYT4;CHI3L1;TBR1;DMRT2;GRIN1
10997,GO:0043010,0.284966627611002,0.883959502342888,3,274,camera-type eye development,BP,CELF4;SLC17A7;HPCA
6691,GO:0019897,0.285700863664558,0.910360176700666,2,159,extrinsic component of plasma membrane,CC,SNAP25;GNG3
13484,GO:0050795,0.286189020016671,0.955625269738951,1,54,regulation of behavior,BP,CNR1
9587,GO:0035082,0.286353670596971,0.95561504060013,1,51,axoneme assembly,BP,NEURL1
2906,GO:0006022,0.286572315180668,0.909914165848058,2,157,aminoglycan metabolic process,BP,CHI3L1;CHST9
4898,GO:0010721,0.286628830270707,0.882937705287031,3,277,negative regulation of cell development,BP,NGEF;STMN2;SYT4
13520,GO:0050854,0.287468207307076,0.955232140632456,1,52,regulation of antigen receptor-mediated signaling pathway,BP,TESPA1
4867,GO:0010660,0.287534364089217,0.955210262344541,1,52,regulation of muscle cell apoptotic process,BP,CAMK2A
9621,GO:0035176,0.28770342094435,0.955202311862804,1,49,social behavior,BP,GRIN1
14024,GO:0051703,0.28770342094435,0.955202311862804,1,49,intraspecies interaction between organisms,BP,GRIN1
4310,GO:0009066,0.288468759676375,0.954857646092321,1,55,aspartate family amino acid metabolic process,BP,CRYM
6981,GO:0021953,0.289111974998005,0.908568175813556,2,161,central nervous system neuron differentiation,BP,TBR1;SLC4A10
13133,GO:0048638,0.289881236643423,0.880938325628653,3,278,regulation of developmental growth,BP,SYT1;RIMS1;SYT4
14110,GO:0051881,0.291152054113364,0.953909521799614,1,59,regulation of mitochondrial membrane potential,BP,CCK
3839,GO:0007632,0.291642145655657,0.953889278679383,1,49,visual behavior,BP,GRIN1
4781,GO:0010517,0.292773669550593,0.953458430120564,1,52,regulation of phospholipase activity,BP,HPCA
4039,GO:0008333,0.292804464326702,0.953448021231524,1,52,endosome to lysosome transport,BP,CACNG3
4582,GO:0009746,0.292915696435576,0.906540454442444,2,166,response to hexose,BP,PTPRN;VSNL1
15097,GO:0060997,0.292945524375028,0.953468020580487,1,48,dendritic spine morphogenesis,BP,NGEF
14591,GO:0060193,0.2936511422747,0.953131099230328,1,54,positive regulation of lipase activity,BP,HPCA
6474,GO:0019229,0.294325720411985,0.9529321857847,1,52,regulation of vasoconstriction,BP,CHRM3
1368,GO:0003006,0.295009954648706,0.846147443085304,5,554,developmental process involved in reproduction,BP,PTPRN;CELF4;NEURL1;VGF;DMRT2
68,GO:0000139,0.295183368271548,0.835924874741252,6,681,Golgi membrane,CC,CAMK1G;ST8SIA5;SYT4;GAD2;CHST9;TMEM130
3512,GO:0006940,0.296379599085707,0.952185311149286,1,55,regulation of smooth muscle contraction,BP,CHRM3
9263,GO:0034248,0.29653345898874,0.858345121150819,4,429,regulation of cellular amide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1
18833,GO:1901222,0.297269785041423,0.95187915434522,1,55,regulation of NIK/NF-kappaB signaling,BP,CHI3L1
11654,GO:0044448,0.29748524935716,0.904139347333443,2,157,cell cortex part,CC,RIMS1;UNC13C
18986,GO:1901654,0.297504791835628,0.904068706038456,2,172,response to ketone,BP,HPCA;ADCY1
12679,GO:0046888,0.297587619157184,0.951755433214467,1,56,negative regulation of hormone secretion,BP,VSNL1
11869,GO:0045121,0.297618683534176,0.876119854539908,3,285,membrane raft,CC,CNR1;MAL2;ADCY1
7303,GO:0030317,0.297694356211159,0.951691754729894,1,58,flagellated sperm motility,BP,NEURL1
4388,GO:0009165,0.298203139494248,0.875714948817825,3,306,nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
16993,GO:0072665,0.298411329687479,0.951499676642494,1,54,protein localization to vacuole,BP,CACNG3
2665,GO:0005622,0.298701106775672,0.791158212708628,84,12743,intracellular,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;SV2B;MYT1L;SELL;SLC6A17;GRIN2B
5349,GO:0015179,0.299036438110048,0.951298457112896,1,53,L-amino acid transmembrane transporter activity,MF,SLC17A7
18071,GO:0098857,0.299670635696934,0.874831292597366,3,286,membrane microdomain,CC,CNR1;MAL2;ADCY1
13551,GO:0050891,0.300300034408986,0.950875197358782,1,52,multicellular organismal water homeostasis,BP,ADCY1
10755,GO:0042490,0.300305344605401,0.950857251100861,1,53,mechanoreceptor differentiation,BP,GABRB2
19148,GO:1902108,0.301498119263183,0.950354694419745,1,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A
13575,GO:0050920,0.302322500904291,0.901437861506701,2,180,regulation of chemotaxis,BP,TBR1;CXCL14
118,GO:0000245,0.30269968475121,0.949958917910232,1,57,spliceosomal complex assembly,BP,CELF4
4864,GO:0010657,0.303154483739681,0.949827349750107,1,55,muscle cell apoptotic process,BP,CAMK2A
13256,GO:0048857,0.3035688596848,0.949666326009385,1,56,neural nucleus development,BP,KCNC2
18859,GO:1901293,0.303954569922721,0.872083685169845,3,310,nucleoside phosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
21834,GO:2001259,0.303990322626229,0.949547270619533,1,54,positive regulation of cation channel activity,BP,KCNC2
1578,GO:0003407,0.304522187329325,0.949374786724107,1,53,neural retina development,BP,SLC17A7
9273,GO:0034284,0.304884388440794,0.900073682724401,2,171,response to monosaccharide,BP,PTPRN;VSNL1
14551,GO:0060135,0.305023900296555,0.94916535279367,1,55,maternal process involved in female pregnancy,BP,CNR1
17881,GO:0097722,0.306788109447283,0.948465997671342,1,60,sperm motility,BP,NEURL1
10920,GO:0042803,0.306828573401625,0.827251627705775,6,727,protein homodimerization activity,MF,CAMK2A;CRYM;SYT4;TENM2;KCNK9;DMRT2
7612,GO:0030971,0.307433285110787,0.948304857882162,1,55,receptor tyrosine kinase binding,MF,SHC3
15762,GO:0070405,0.307534922634499,0.948211082073862,1,59,ammonium ion binding,MF,CHRM3
13111,GO:0048589,0.307681640895952,0.837066021994987,5,542,developmental growth,BP,SYT1;RIMS1;SLC12A5;SYT4;SLC4A10
6468,GO:0019220,0.308572531724915,0.792752531695012,12,1549,regulation of phosphate metabolic process,BP,CHGA;EEF1A2;EPHB6;NEURL1;RGS4;HPCA;CHI3L1;MRAP2;TMEM132D;GNG3;ADCY1;CCK
7948,GO:0031594,0.308731346636021,0.94785362839716,1,54,neuromuscular junction,CC,UNC13C
18960,GO:1901607,0.309704006491161,0.947428253999544,1,59,alpha-amino acid biosynthetic process,BP,BCAT1
13140,GO:0048645,0.310269030751533,0.947237057676073,1,58,animal organ formation,BP,TBR1
13464,GO:0050770,0.310595214355247,0.896965858302067,2,162,regulation of axonogenesis,BP,TBR1;GRIN1
5283,GO:0015031,0.311463006601646,0.787171688546502,13,1750,protein transport,BP,CACNG3;NNAT;PTPRN;RIMS1;RPH3A;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
7027,GO:0022414,0.312322328517169,0.802283659023458,9,1144,reproductive process,BP,PTPRN;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;DMRT2;GRIN1
8539,GO:0032637,0.313318789661141,0.946081980719663,1,61,interleukin-8 production,BP,CHI3L1
2,GO:0000003,0.314404428383056,0.800616449711168,9,1147,reproduction,BP,PTPRN;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;DMRT2;GRIN1
19748,GO:1903524,0.315191228237976,0.94540416111881,1,60,positive regulation of blood circulation,BP,CHGA
17938,GO:0098589,0.315265166983713,0.864867517502101,3,294,membrane region,CC,CNR1;MAL2;ADCY1
3805,GO:0007585,0.315566209740713,0.945278990105705,1,59,respiratory gaseous exchange,BP,GRIN1
13536,GO:0050870,0.31600327965308,0.89385008036403,2,187,positive regulation of T cell activation,BP,IGFBP2;TESPA1
11536,GO:0044242,0.316128290204967,0.893786597649458,2,185,cellular lipid catabolic process,BP,CNR1;FABP7
618,GO:0001756,0.317304754340936,0.944661519032248,1,57,somitogenesis,BP,DMRT2
7148,GO:0030104,0.317810326533918,0.944488222795463,1,56,water homeostasis,BP,ADCY1
18003,GO:0098742,0.319015194725186,0.89224003279174,2,164,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM2;SELL
19064,GO:1901880,0.320211792097185,0.94358645101144,1,56,negative regulation of protein depolymerization,BP,STMN2
13733,GO:0051174,0.320432750552734,0.782941620927796,12,1563,regulation of phosphorus metabolic process,BP,CHGA;EEF1A2;EPHB6;NEURL1;RGS4;HPCA;CHI3L1;MRAP2;TMEM132D;GNG3;ADCY1;CCK
4452,GO:0009247,0.320825748410116,0.943241789007855,1,64,glycolipid biosynthetic process,BP,ST8SIA5
5673,GO:0016049,0.321727592046315,0.84091846745481,4,437,cell growth,BP,SYT1;RIMS1;IGFBP2;SYT4
10856,GO:0042698,0.323768660152692,0.942174236281182,1,60,ovulation cycle,BP,PTPRN
8386,GO:0032418,0.324337754999226,0.941928415449803,1,62,lysosome localization,BP,CHGA
13109,GO:0048585,0.325156490070118,0.782724837592069,11,1434,negative regulation of response to stimulus,BP,CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;CNR1;MRAP2;FABP7;GRIN1;CCK
2909,GO:0006026,0.325380526022342,0.941570043988196,1,59,aminoglycan catabolic process,BP,CHI3L1
8823,GO:0033077,0.325530080316524,0.941497755749824,1,60,T cell differentiation in thymus,BP,TESPA1
8219,GO:0032147,0.326853916433754,0.857262466099667,3,303,activation of protein kinase activity,BP,CHI3L1;GNG3;ADCY1
18226,GO:0099516,0.326932631658549,0.941018303685503,1,56,ion antiporter activity,MF,SLC4A10
9895,GO:0035690,0.327666430316545,0.856705168107457,3,313,cellular response to drug,BP,CHRM3;ADCY1;KCNC2
14261,GO:0052548,0.327800406593915,0.856578308009228,3,335,regulation of endopeptidase activity,BP,GRIN1;CCK;GRIN2B
12049,GO:0045582,0.330444137211622,0.939530752253456,1,64,positive regulation of T cell differentiation,BP,TESPA1
3993,GO:0008270,0.330444879461021,0.809313892782225,6,715,zinc ion binding,MF,RPH3A;GDA;ZNF385D;ZCCHC12;MYT1L;GRIN2B
12215,GO:0045862,0.330832414863336,0.854587325873635,3,320,positive regulation of proteolysis,BP,GRIN1;CCK;GRIN2B
6227,GO:0017137,0.331247570828483,0.885187394545,2,170,Rab GTPase binding,MF,RIMS1;RPH3A
17001,GO:0072676,0.331361200981688,0.939108906590717,1,69,lymphocyte migration,BP,CXCL14
7034,GO:0022607,0.332159649818535,0.75604044403287,19,2621,cellular component assembly,BP,SYT1;LNX1;RIMS1;NEFH;CELF4;STMN2;NEFM;DNM1;NEURL1;KCNS1;CALY;SNAP25;TESPA1;UNC13C;TENM2;KCNC2;GRIN1;CCK;GRIN2B
11651,GO:0044445,0.333426307774665,0.883726625917654,2,227,cytosolic part,CC,SNAP25;ADCY1
3213,GO:0006520,0.33366113418939,0.852661937974946,3,340,cellular amino acid metabolic process,BP,BCAT1;CRYM;GAD2
18072,GO:0098858,0.333966695993972,0.883580290272299,2,174,actin-based cell projection,CC,NPTX2;TENM2
10733,GO:0042446,0.334479294244661,0.937895126169047,1,67,hormone biosynthetic process,BP,CHST9
9492,GO:0034704,0.33451698584921,0.937991100940477,1,59,calcium channel complex,CC,CACNG3
5567,GO:0015833,0.335776386378906,0.766743582520774,13,1784,peptide transport,BP,CACNG3;NNAT;PTPRN;RIMS1;RPH3A;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
19645,GO:1903313,0.337460632457074,0.936766030689261,1,62,positive regulation of mRNA metabolic process,BP,CELF4
8282,GO:0032272,0.33766137321618,0.936670782075768,1,63,negative regulation of protein polymerization,BP,STMN2
19703,GO:1903426,0.337779003946824,0.936596006517063,1,65,regulation of reactive oxygen species biosynthetic process,BP,GRIN1
4574,GO:0009725,0.338223159109173,0.794458891730092,7,876,response to hormone,BP,PTPRN;CAMK2A;IGFBP2;VGF;CHRM3;GNG3;ADCY1
19525,GO:1903039,0.338409227956071,0.880876835966911,2,196,positive regulation of leukocyte cell-cell adhesion,BP,IGFBP2;TESPA1
6693,GO:0019899,0.338624614037376,0.756311643837419,16,2123,enzyme binding,MF,PTPRN;NGEF;CAMK2A;RIMS1;RPH3A;NEFH;EEF1A2;EPHB6;DNM1;IQSEC3;HPCA;TBR1;SHC3;GRIN1;SELL;GRIN2B
4537,GO:0009593,0.339071546407252,0.935957336835059,1,75,detection of chemical stimulus,BP,SYT1
4080,GO:0008406,0.339552458517107,0.88024514595687,2,183,gonad development,BP,PTPRN;VGF
7970,GO:0031644,0.342398802808695,0.934728481315404,1,64,regulation of neurological system process,BP,CCK
11088,GO:0043169,0.342543067364671,0.736999471134451,27,3736,cation binding,MF,SYT13;SYT1;CAMK2A;LNX1;SNCB;RIMS1;RPH3A;NPTX2;NEURL1;GDA;HPCA;SYT4;CHRM3;UNC13C;STAC2;TENM2;ZNF385D;VSNL1;ADCY1;NPTX1;DMRT2;ZCCHC12;GRIN1;NELL2;MYT1L;SELL;GRIN2B
2322,GO:0004930,0.342927705892963,0.846384492337994,3,347,G-protein coupled receptor activity,MF,CNR1;PRLHR;CHRM3
16180,GO:0071230,0.34365564817916,0.934255684838896,1,61,cellular response to amino acid stimulus,BP,NEURL1
3710,GO:0007281,0.344767179234667,0.877107002337111,2,188,germ cell development,BP,CELF4;NEURL1
12197,GO:0045833,0.34480829823636,0.9337072119132,1,66,negative regulation of lipid metabolic process,BP,CNR1
11140,GO:0043242,0.344991594981802,0.933688208405994,1,62,negative regulation of protein complex disassembly,BP,STMN2
3845,GO:0008015,0.345416935889856,0.823864121163338,4,458,blood circulation,BP,CACNG3;CHGA;CNR1;CHRM3
3208,GO:0006513,0.345659550060366,0.933396139698715,1,63,protein monoubiquitination,BP,NEURL1
7192,GO:0030166,0.345911696066871,0.933337856337025,1,60,proteoglycan biosynthetic process,BP,CHST9
1623,GO:0003729,0.346650502705348,0.875967480256686,2,189,mRNA binding,MF,RBFOX1;CELF4
12686,GO:0046902,0.348130363871546,0.932270952072709,1,70,regulation of mitochondrial membrane permeability,BP,CAMK2A
2775,GO:0005802,0.348931844444919,0.874585101481404,2,189,trans-Golgi network,CC,RBFOX1;SNAP25
2595,GO:0005488,0.35032743487941,0.745519717145973,83,12653,binding,MF,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;EPHB6;NPTX2;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;TMEM132D;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;NELL2;SV2B;C11ORF87;MYT1L;CCK;SELL;CPNE4;NMB;GRIN2B
11880,GO:0045137,0.350615940430435,0.873563836394268,2,188,development of primary sexual characteristics,BP,PTPRN;VGF
14026,GO:0051705,0.350810441023319,0.93123634472659,1,63,multi-organism behavior,BP,GRIN1
3969,GO:0008219,0.350927317560833,0.750762337670152,14,1940,cell death,BP,NGEF;CAMK2A;SNCB;CHGA;EEF1A2;EPHB6;NEURL1;CNR1;CHI3L1;GABRB2;ZNF385D;GRIN1;CCK;GRIN2B
3467,GO:0006875,0.35109279313958,0.819674106349255,4,472,cellular metal ion homeostasis,BP,SLC30A3;GNG3;GRIN1;GRIN2B
1375,GO:0003013,0.351115256365354,0.819668816527293,4,462,circulatory system process,BP,CACNG3;CHGA;CNR1;CHRM3
11471,GO:0044057,0.352079334311663,0.818956198293494,4,462,regulation of system process,BP,CACNG3;CHGA;CHRM3;CCK
11242,GO:0043407,0.352101293137731,0.930631295069925,1,67,negative regulation of MAP kinase activity,BP,RGS4
4308,GO:0009064,0.353488664215113,0.930013079868596,1,69,glutamine family amino acid metabolic process,BP,GAD2
3310,GO:0006635,0.353738123267547,0.929893655485897,1,70,fatty acid beta-oxidation,BP,CNR1
11022,GO:0043043,0.353769700417324,0.802484759893214,5,671,peptide biosynthetic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
1186,GO:0002673,0.353772801719265,0.929854514669074,1,72,regulation of acute inflammatory response,BP,CNR1
18985,GO:1901653,0.353786558110175,0.83895268150956,3,321,cellular response to peptide,BP,CAMK2A;GNG3;ADCY1
4580,GO:0009743,0.354585801851859,0.871116538313617,2,192,response to carbohydrate,BP,PTPRN;VSNL1
3527,GO:0006970,0.35498234626532,0.929413067323222,1,66,response to osmotic stress,BP,SLC12A5
150,GO:0000302,0.356516081345777,0.869876633765013,2,206,response to reactive oxygen species,BP,PTPRN;KCNC2
7692,GO:0031110,0.356778137785566,0.928638768426761,1,66,regulation of microtubule polymerization or depolymerization,BP,STMN2
12630,GO:0046785,0.35720820323282,0.928452602324971,1,66,microtubule polymerization,BP,STMN2
11096,GO:0043178,0.357511433205872,0.928279994844156,1,69,alcohol binding,MF,RPH3A
1202,GO:0002690,0.357726458364841,0.928071902287139,1,79,positive regulation of leukocyte chemotaxis,BP,CXCL14
11177,GO:0043299,0.359079928372327,0.81371180959863,4,497,leukocyte degranulation,BP,CHGA;SNAP25;CHI3L1;SELL
3352,GO:0006687,0.359104637305451,0.927600191808085,1,68,glycosphingolipid metabolic process,BP,ST8SIA5
6471,GO:0019226,0.36069044234299,0.92692036853329,1,67,transmission of nerve impulse,BP,CACNG3
6769,GO:0021536,0.361421965800616,0.926558236910165,1,70,diencephalon development,BP,KCNC2
13514,GO:0050848,0.361912751897908,0.926329228924793,1,71,regulation of calcium-mediated signaling,BP,NEUROD2
10660,GO:0042310,0.362126025494242,0.926289071214735,1,67,vasoconstriction,BP,CHRM3
18478,GO:0120111,0.362360276020849,0.926185757448785,1,67,neuron projection cytoplasm,CC,HPCA
15747,GO:0070374,0.362896963445244,0.865938396432456,2,196,positive regulation of ERK1 and ERK2 cascade,BP,EPHB6;CHI3L1
3569,GO:0007032,0.363564224859869,0.925625482866592,1,69,endosome organization,BP,DNM1
14589,GO:0060191,0.36391732192623,0.925455482868215,1,70,regulation of lipase activity,BP,HPCA
15165,GO:0061097,0.364443867652789,0.925263072890768,1,67,regulation of protein tyrosine kinase activity,BP,NEURL1
21076,GO:1990782,0.364666386411017,0.925164136357289,1,67,protein tyrosine kinase binding,MF,SHC3
7886,GO:0031463,0.365462001385016,0.924824519837321,1,66,Cul3-RING ubiquitin ligase complex,CC,ENC1
8701,GO:0032886,0.365992579162908,0.864017911872972,2,189,regulation of microtubule-based process,BP,NEFH;STMN2
18079,GO:0098876,0.366049758380904,0.924532964996717,1,68,vesicle-mediated transport to the plasma membrane,BP,SNAP25
15971,GO:0070821,0.366120341827925,0.924487451316623,1,69,tertiary granule membrane,CC,SNAP25
556,GO:0001654,0.366303975911817,0.830159366072516,3,318,eye development,BP,CELF4;SLC17A7;HPCA
14260,GO:0052547,0.366807039406854,0.829728989752769,3,358,regulation of peptidase activity,BP,GRIN1;CCK;GRIN2B
10670,GO:0042327,0.367016828193804,0.771144060682064,7,891,positive regulation of phosphorylation,BP,EEF1A2;EPHB6;NEURL1;CHI3L1;GNG3;ADCY1;CCK
4545,GO:0009612,0.36767948804676,0.862927285662104,2,195,response to mechanical stimulus,BP,IGFBP2;CHI3L1
17329,GO:0090257,0.368046988457035,0.862679260684279,2,199,regulation of muscle system process,BP,CHGA;CHRM3
6982,GO:0021954,0.368701805040333,0.923356540782237,1,67,central nervous system neuron development,BP,SLC4A10
13833,GO:0051338,0.369171060297376,0.769367482811102,7,896,regulation of transferase activity,BP,EEF1A2;EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1
832,GO:0002039,0.369743478635727,0.922871160775987,1,68,p53 binding,MF,ZNF385D
11898,GO:0045177,0.370362951425864,0.827256196179202,3,322,apical part of cell,CC,IGFBP2;MAL2;KCNC2
14445,GO:0055117,0.370567882359714,0.922483059026299,1,69,regulation of cardiac muscle contraction,BP,CHGA
963,GO:0002275,0.370941303364898,0.804755884851747,4,505,myeloid cell activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
13442,GO:0050730,0.371239530230688,0.860636041628032,2,202,regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;CCK
7334,GO:0030374,0.371459865351917,0.922106488173737,1,67,ligand-dependent nuclear receptor transcription coactivator activity,MF,ZCCHC12
3315,GO:0006641,0.372361356242203,0.921599748085212,1,74,triglyceride metabolic process,BP,FABP7
11481,GO:0044089,0.372664225634189,0.803488876219213,4,464,positive regulation of cellular component biogenesis,BP,CHGA;NEURL1;TENM2;CCK
17463,GO:0090559,0.37380606205362,0.920913170447185,1,76,regulation of membrane permeability,BP,CAMK2A
19644,GO:1903312,0.373854147491681,0.92099665769072,1,68,negative regulation of mRNA metabolic process,BP,CELF4
1067,GO:0002444,0.37444789485808,0.802077234455761,4,508,myeloid leukocyte mediated immunity,BP,CHGA;SNAP25;CHI3L1;SELL
3421,GO:0006796,0.375100241026279,0.716386002245314,20,2851,phosphate-containing compound metabolic process,BP,CAMK1G;CAMK2A;CHGA;EEF1A2;EPHB6;NEURL1;PTPN5;RGS4;GDA;HPCA;SULT4A1;CHI3L1;MRAP2;SHC3;TMEM132D;GNG3;ADCY1;GRIN1;CCK;GRIN2B
11636,GO:0044424,0.375187792283358,0.7216922558679,82,12539,intracellular part,CC,CACNG3;CAMK1G;SYT13;GABRA1;NNAT;PTPRN;BCAT1;NGEF;SYT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;EPHB6;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;STAC2;CXCL14;GABRB2;TENM2;MAL2;SHC3;ZNF385D;GABRA2;CHST9;NRGN;SYN2;GNG3;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;SV2B;MYT1L;SELL;SLC6A17
7029,GO:0022600,0.375237790369697,0.92027779088362,1,74,digestive system process,BP,CHRM3
592,GO:0001708,0.375581521530052,0.920118944804885,1,74,cell fate specification,BP,MYT1L
2171,GO:0004714,0.375672004448716,0.920222537734584,1,64,transmembrane receptor protein tyrosine kinase activity,MF,EPHB6
12076,GO:0045621,0.375819162803137,0.91999660037539,1,75,positive regulation of lymphocyte differentiation,BP,TESPA1
16876,GO:0072384,0.376216297708801,0.919892737857275,1,69,organelle transport along microtubule,BP,NEFH
13836,GO:0051341,0.376704345606208,0.919562314328387,1,77,regulation of oxidoreductase activity,BP,CNR1
2484,GO:0005201,0.377286798875997,0.91944190018246,1,66,extracellular matrix structural constituent,MF,CHI3L1
4222,GO:0008652,0.377695666244439,0.919125300090457,1,75,cellular amino acid biosynthetic process,BP,BCAT1
1024,GO:0002367,0.378259124993969,0.918850341750705,1,76,cytokine production involved in immune response,BP,CHGA
11478,GO:0044085,0.37868905048686,0.713153943598673,20,2879,cellular component biogenesis,BP,SYT1;LNX1;RIMS1;NEFH;CHGA;CELF4;STMN2;NEFM;DNM1;NEURL1;KCNS1;CALY;SNAP25;TESPA1;UNC13C;TENM2;KCNC2;GRIN1;CCK;GRIN2B
13557,GO:0050900,0.379122428131499,0.82087316194818,3,357,leukocyte migration,BP,CHGA;CXCL14;SELL
9524,GO:0034762,0.380264066055422,0.797649037909397,4,472,regulation of transmembrane transport,BP,CACNG3;HPCA;KCNS1;KCNC2
13428,GO:0050714,0.381236679200008,0.854160890558985,2,207,positive regulation of protein secretion,BP,NNAT;VSNL1
12114,GO:0045665,0.382098078878456,0.85363950524373,2,196,negative regulation of neuron differentiation,BP,NGEF;STMN2
6713,GO:0019953,0.382692795768404,0.779741817997477,5,634,sexual reproduction,BP,CELF4;NEURL1;CNR1;VGF;GRIN1
11904,GO:0045184,0.38355895514754,0.725353122691237,13,1843,establishment of protein localization,BP,CACNG3;NNAT;PTPRN;RIMS1;RPH3A;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
4564,GO:0009653,0.38419456295763,0.71392100185962,17,2334,anatomical structure morphogenesis,BP,NGEF;SYT1;CAMK2A;RIMS1;NEFH;PACSIN1;SYT4;CHI3L1;TBR1;SLC4A10;TENM2;SHC3;ADCY1;NPTX1;DMRT2;GRIN1;CCK
6465,GO:0019217,0.384699649105592,0.915850059340628,1,73,regulation of fatty acid metabolic process,BP,CNR1
3891,GO:0008104,0.384953231708029,0.713231140645232,17,2415,protein localization,BP,CACNG3;NNAT;PTPRN;RIMS1;RPH3A;CNR1;HPCA;PACSIN1;VGF;SNAP25;SYT4;CHI3L1;MRAP2;MAL2;VSNL1;KCNC2;GRIN1
12664,GO:0046872,0.385516414999807,0.699149016548592,26,3657,metal ion binding,MF,SYT13;SYT1;CAMK2A;LNX1;SNCB;RIMS1;RPH3A;NPTX2;NEURL1;GDA;HPCA;SYT4;UNC13C;STAC2;TENM2;ZNF385D;VSNL1;ADCY1;NPTX1;DMRT2;ZCCHC12;GRIN1;NELL2;MYT1L;SELL;GRIN2B
8689,GO:0032870,0.387442401324821,0.775930554514524,5,621,cellular response to hormone stimulus,BP,CAMK2A;IGFBP2;CHRM3;GNG3;ADCY1
12014,GO:0045445,0.387617118178874,0.914412426761878,1,76,myoblast differentiation,BP,CXCL14
16843,GO:0072332,0.387730944427669,0.914320989199126,1,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385D
12213,GO:0045860,0.388793988831123,0.791020433936905,4,478,positive regulation of protein kinase activity,BP,NEURL1;CHI3L1;GNG3;ADCY1
2051,GO:0004553,0.388905159407808,0.913803501429076,1,75,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,CHI3L1
15142,GO:0061053,0.389428584092048,0.91357705232979,1,73,somite development,BP,DMRT2
6233,GO:0017148,0.389620792043644,0.848643735372125,2,205,negative regulation of translation,BP,CELF4;ENC1
3762,GO:0007422,0.390253298795201,0.913176948474423,1,73,peripheral nervous system development,BP,NEFH
14680,GO:0060326,0.391060812269957,0.847616153761645,2,225,cell chemotaxis,BP,CHGA;CXCL14
9435,GO:0034622,0.391073716470939,0.751055879077748,7,968,cellular protein-containing complex assembly,BP,CELF4;STMN2;DNM1;CALY;SNAP25;TESPA1;UNC13C
18830,GO:1901216,0.391687685542214,0.912451148431628,1,75,positive regulation of neuron death,BP,GRIN2B
18765,GO:1901019,0.391761544625811,0.912389199241746,1,77,regulation of calcium ion transmembrane transporter activity,BP,HPCA
10559,GO:0042102,0.392273291455933,0.912057920922476,1,84,positive regulation of T cell proliferation,BP,IGFBP2
21371,GO:2000379,0.393256319584215,0.911644617946595,1,78,positive regulation of reactive oxygen species metabolic process,BP,GRIN1
18799,GO:1901135,0.394077977698088,0.740646092216687,8,1114,carbohydrate derivative metabolic process,BP,CHGA;ST8SIA5;HPCA;SULT4A1;CHI3L1;MRAP2;CHST9;ADCY1
19063,GO:1901879,0.394266225295366,0.911214354969908,1,73,regulation of protein depolymerization,BP,STMN2
12692,GO:0046914,0.39446346889365,0.748206421403826,7,926,transition metal ion binding,MF,SNCB;RPH3A;GDA;ZNF385D;ZCCHC12;MYT1L;GRIN2B
14685,GO:0060333,0.394526530368695,0.91096110876391,1,83,interferon-gamma-mediated signaling pathway,BP,CAMK2A
10974,GO:0042981,0.394594107877796,0.728117057722886,10,1390,regulation of apoptotic process,BP,NGEF;CAMK2A;SNCB;EEF1A2;EPHB6;NEURL1;CNR1;GABRB2;GRIN1;CCK
18558,GO:1900034,0.394904022594457,0.910872282294189,1,75,regulation of cellular response to heat,BP,CAMK2A
569,GO:0001669,0.39518970110474,0.910667890134349,1,80,acrosomal vesicle,CC,SV2B
7865,GO:0031434,0.395839682871305,0.910514507433418,1,68,mitogen-activated protein kinase kinase binding,MF,EPHB6
3918,GO:0008144,0.398300241364183,0.715937111990708,12,1585,drug binding,MF,CAMK1G;GABRA1;CAMK2A;EPHB6;CNR1;CHRM3;CHI3L1;GAD2;SYN2;ADCY1;GRIN1;GRIN2B
3553,GO:0007009,0.398713453632172,0.909008666286331,1,73,plasma membrane organization,BP,PACSIN1
4540,GO:0009605,0.400970077678916,0.709866282426462,13,1859,response to external stimulus,BP,CHGA;IGFBP2;CNR1;HPCA;VGF;CHI3L1;TBR1;CXCL14;SHC3;FABP7;GRIN1;CCK;SELL
10537,GO:0042058,0.402141736270076,0.907230202299376,1,77,regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1
3499,GO:0006919,0.403318108685176,0.906526895511951,1,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK
7023,GO:0022409,0.404148725378776,0.838765207252035,2,224,positive regulation of cell-cell adhesion,BP,IGFBP2;TESPA1
1615,GO:0003714,0.404287827169716,0.838722886662204,2,209,transcription corepressor activity,MF,CRYM;NEUROD2
523,GO:0001578,0.404995466421796,0.905780793263842,1,77,microtubule bundle formation,BP,NEURL1
11034,GO:0043067,0.405136215395441,0.718844871656068,10,1402,regulation of programmed cell death,BP,NGEF;CAMK2A;SNCB;EEF1A2;EPHB6;NEURL1;CNR1;GABRB2;GRIN1;CCK
3514,GO:0006942,0.406842205264486,0.904809180888175,1,79,regulation of striated muscle contraction,BP,CHGA
5407,GO:0015297,0.407656089542623,0.904431073450737,1,76,antiporter activity,MF,SLC4A10
13119,GO:0048609,0.407724766997452,0.759322471604586,5,651,multicellular organismal reproductive process,BP,PTPRN;CELF4;NEURL1;CNR1;GRIN1
3911,GO:0008135,0.408956911987215,0.903658408076808,1,84,translation factor activity, RNA binding,MF,EEF1A2
3466,GO:0006874,0.409143140129577,0.798479824724313,3,361,cellular calcium ion homeostasis,BP,GNG3;GRIN1;GRIN2B
4859,GO:0010648,0.410793672174247,0.719499118764976,9,1234,negative regulation of cell communication,BP,CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;SYT4;MRAP2;VSNL1
19694,GO:1903409,0.413005963991098,0.901561990225268,1,83,reactive oxygen species biosynthetic process,BP,GRIN1
19545,GO:1903076,0.413364673600928,0.90141137960107,1,80,regulation of protein localization to plasma membrane,BP,MRAP2
3425,GO:0006805,0.414042350456815,0.900919935430376,1,92,xenobiotic metabolic process,BP,GRIN1
7093,GO:0023057,0.414638196107783,0.716104423628543,9,1238,negative regulation of signaling,BP,CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;SYT4;MRAP2;VSNL1
10581,GO:0042136,0.414908270677515,0.900562056872775,1,83,neurotransmitter biosynthetic process,BP,GAD2
1276,GO:0002793,0.415799853083863,0.830672095935562,2,225,positive regulation of peptide secretion,BP,NNAT;VSNL1
8460,GO:0032504,0.416102033499371,0.752341191527535,5,659,multicellular organism reproduction,BP,PTPRN;CELF4;NEURL1;CNR1;GRIN1
111,GO:0000226,0.416995771062924,0.768530668797691,4,487,microtubule cytoskeleton organization,BP,NEFH;STMN2;NEURL1;MAP7D2
3846,GO:0008016,0.418400381100713,0.828864315247949,2,218,regulation of heart contraction,BP,CACNG3;CHGA
11646,GO:0044438,0.419156279689638,0.898237797231917,1,89,microbody part,CC,CRYM
11647,GO:0044439,0.419156279689638,0.898237797231917,1,89,peroxisomal part,CC,CRYM
18190,GO:0099106,0.420821465594333,0.89737856905001,1,86,ion channel regulator activity,MF,KCNS1
2968,GO:0006112,0.421217426317722,0.897240640257782,1,80,energy reserve metabolic process,BP,MRAP2
2103,GO:0004620,0.421379042013835,0.89711480209042,1,83,phospholipase activity,MF,CHRM3
11087,GO:0043168,0.421926851779882,0.677419868822998,18,2524,anion binding,MF,CAMK1G;SYT13;SYT1;CAMK2A;RPH3A;EEF1A2;EPHB6;DNM1;PACSIN1;SYT4;GAD2;UNC13C;NRGN;SYN2;ADCY1;GRIN1;SELL;GRIN2B
18987,GO:1901655,0.423913442822057,0.895745142598287,1,83,cellular response to ketone,BP,ADCY1
9669,GO:0035282,0.424351814678461,0.895507116155402,1,83,segmentation,BP,DMRT2
13898,GO:0051453,0.424648253428379,0.89532119684359,1,85,regulation of intracellular pH,BP,SLC4A10
9264,GO:0034249,0.425441506415162,0.82384244640299,2,221,negative regulation of cellular amide metabolic process,BP,CELF4;ENC1
14415,GO:0055074,0.426957714939876,0.784638935576544,3,371,calcium ion homeostasis,BP,GNG3;GRIN1;GRIN2B
11892,GO:0045165,0.427009899058973,0.822709105663309,2,223,cell fate commitment,BP,TBR1;MYT1L
14167,GO:0051963,0.427357222649768,0.893949405545054,1,77,regulation of synapse assembly,BP,GRIN1
8382,GO:0032414,0.427872247461082,0.893570872675992,1,84,positive regulation of ion transmembrane transporter activity,BP,KCNC2
3806,GO:0007586,0.42820087326605,0.893319733800232,1,90,digestion,BP,CHRM3
3420,GO:0006793,0.428972550843745,0.667073840132891,20,2937,phosphorus metabolic process,BP,CAMK1G;CAMK2A;CHGA;EEF1A2;EPHB6;NEURL1;PTPN5;RGS4;GDA;HPCA;SULT4A1;CHI3L1;MRAP2;SHC3;TMEM132D;GNG3;ADCY1;GRIN1;CCK;GRIN2B
4647,GO:0009967,0.429295162479823,0.697266919821157,10,1422,positive regulation of signal transduction,BP,RIMS1;CHGA;EPHB6;NEURL1;CHI3L1;MRAP2;TESPA1;GNG3;NEUROD2;GRIN1
3314,GO:0006639,0.429708940603508,0.892510334817963,1,88,acylglycerol metabolic process,BP,FABP7
13673,GO:0051091,0.431498595539896,0.819455346515236,2,226,positive regulation of DNA binding transcription factor activity,BP,CAMK2A;NEUROD2
11041,GO:0043086,0.431964093019209,0.738913560213765,5,684,negative regulation of catalytic activity,BP,SNCB;RGS4;CNR1;HPCA;TMEM132D
9819,GO:0035579,0.432078138338523,0.891219430887011,1,86,specific granule membrane,CC,SNAP25
18943,GO:1901565,0.43222470363723,0.707266581667198,8,1129,organonitrogen compound catabolic process,BP,BCAT1;LNX1;EEF1A2;CRYM;GDA;CHI3L1;GAD2;ENC1
4786,GO:0010522,0.432288128753631,0.89109035989159,1,87,regulation of calcium ion transport into cytosol,BP,GRIN1
16989,GO:0072659,0.43235424085227,0.818855644001981,2,220,protein localization to plasma membrane,BP,PACSIN1;MRAP2
8199,GO:0032103,0.433655364196902,0.817820994779664,2,246,positive regulation of response to external stimulus,BP,CNR1;CXCL14
3881,GO:0008081,0.433666738122215,0.89038415368045,1,82,phosphoric diester hydrolase activity,MF,CHRM3
3313,GO:0006638,0.4338926504761,0.890170344761541,1,89,neutral lipid metabolic process,BP,FABP7
1200,GO:0002688,0.434502408350463,0.889715562066043,1,100,regulation of leukocyte chemotaxis,BP,CXCL14
8359,GO:0032386,0.434814683558099,0.778413483726198,3,371,regulation of intracellular transport,BP,RIMS1;NEFH;HPCA
7191,GO:0030165,0.435273323156451,0.889483092900176,1,82,PDZ domain binding,MF,LNX1
3498,GO:0006915,0.436931494682562,0.681006618216574,12,1746,apoptotic process,BP,NGEF;CAMK2A;SNCB;EEF1A2;EPHB6;NEURL1;CNR1;CHI3L1;GABRB2;ZNF385D;GRIN1;CCK
2415,GO:0005089,0.436993085464157,0.888602495188832,1,76,Rho guanyl-nucleotide exchange factor activity,MF,NGEF
3508,GO:0006935,0.437194701802017,0.751826215964386,4,526,chemotaxis,BP,CHGA;TBR1;CXCL14;SHC3
10672,GO:0042330,0.438164257147932,0.751013639461439,4,527,taxis,BP,CHGA;TBR1;CXCL14;SHC3
2167,GO:0004709,0.438809016875607,0.887557874786778,1,77,MAP kinase kinase kinase activity,MF,EPHB6
13782,GO:0051251,0.439713568851828,0.813385325869118,2,243,positive regulation of lymphocyte activation,BP,IGFBP2;TESPA1
7443,GO:0030641,0.439797291527267,0.88683175280914,1,89,regulation of cellular pH,BP,SLC4A10
6449,GO:0019199,0.440975938159596,0.886291657396398,1,79,transmembrane receptor protein kinase activity,MF,EPHB6
16223,GO:0071310,0.441015093421989,0.664314984453148,16,2351,cellular response to organic substance,BP,GABRA1;PTPRN;CAMK2A;NEFH;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;CHRM3;CHI3L1;GABRB2;GNG3;VSNL1;ADCY1;ZCCHC12
730,GO:0001906,0.441588511055211,0.885645527893248,1,105,cell killing,BP,CHGA
2911,GO:0006029,0.442765555608692,0.885207131434725,1,83,proteoglycan metabolic process,BP,CHST9
6782,GO:0021549,0.443971514578813,0.88448474842172,1,85,cerebellum development,BP,NEUROD2
8505,GO:0032587,0.444190802310819,0.884357997853033,1,85,ruffle membrane,CC,PACSIN1
13761,GO:0051222,0.444574337823642,0.770549884027319,3,382,positive regulation of protein transport,BP,NNAT;HPCA;VSNL1
20162,GO:1904375,0.446654379035741,0.882889488451279,1,88,regulation of protein localization to cell periphery,BP,MRAP2
18801,GO:1901137,0.447000357731604,0.72595773299717,5,685,carbohydrate derivative biosynthetic process,BP,ST8SIA5;HPCA;MRAP2;CHST9;ADCY1
4192,GO:0008593,0.448021573641674,0.882066579609524,1,90,regulation of Notch signaling pathway,BP,NEURL1
12694,GO:0046916,0.448104636111974,0.88192007438931,1,99,cellular transition metal ion homeostasis,BP,SLC30A3
6532,GO:0019395,0.449289004341659,0.881266308003873,1,95,fatty acid oxidation,BP,CNR1
10887,GO:0042752,0.449736829116703,0.881048025142309,1,91,regulation of circadian rhythm,BP,ADCY1
3176,GO:0006468,0.450264280549373,0.66871375911401,12,1712,protein phosphorylation,BP,CAMK1G;CAMK2A;EPHB6;NEURL1;RGS4;CHI3L1;SHC3;GNG3;ADCY1;GRIN1;CCK;GRIN2B
4942,GO:0010771,0.45028042181089,0.880790379851506,1,86,negative regulation of cell morphogenesis involved in differentiation,BP,NGEF
5054,GO:0010923,0.450328891908497,0.880735957299035,1,88,negative regulation of phosphatase activity,BP,TMEM132D
11358,GO:0043604,0.450416172983653,0.722936091081199,5,749,amide biosynthetic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
18813,GO:1901184,0.4525149797136,0.879418267505146,1,90,regulation of ERBB signaling pathway,BP,NEURL1
13441,GO:0050729,0.452996781841657,0.879032192316314,1,99,positive regulation of inflammatory response,BP,CNR1
3142,GO:0006417,0.45311983689848,0.763573170063558,3,386,regulation of translation,BP,CELF4;NEURL1;ENC1
9361,GO:0034440,0.454301085358291,0.878275656161605,1,97,lipid oxidation,BP,CNR1
11479,GO:0044087,0.454647758257414,0.705971403754127,6,806,regulation of cellular component biogenesis,BP,CHGA;STMN2;NEURL1;TENM2;GRIN1;CCK
7178,GO:0030148,0.455080145162398,0.8778659258839,1,92,sphingolipid biosynthetic process,BP,ST8SIA5
3487,GO:0006900,0.456649421903067,0.876913206994837,1,93,vesicle budding from membrane,BP,DNM1
11382,GO:0043648,0.457717732404245,0.87621462808561,1,98,dicarboxylic acid metabolic process,BP,GAD2
40,GO:0000082,0.458465143711753,0.799289561266092,2,240,G1/S transition of mitotic cell cycle,BP,BCAT1;CAMK2A
8379,GO:0032411,0.458781827754754,0.875627257340452,1,93,positive regulation of transporter activity,BP,KCNC2
14125,GO:0051899,0.458914884596991,0.87559577497894,1,89,membrane depolarization,BP,CCK
3713,GO:0007286,0.460690772005453,0.874423682976483,1,97,spermatid development,BP,NEURL1
8470,GO:0032526,0.46114170900527,0.874160007141751,1,96,response to retinoic acid,BP,IGFBP2
3550,GO:0007006,0.462766788512479,0.873094159582507,1,103,mitochondrial membrane organization,BP,CAMK2A
3511,GO:0006939,0.462825457418736,0.873154035831671,1,94,smooth muscle contraction,BP,CHRM3
13840,GO:0051345,0.462951349506226,0.711956650132966,5,680,positive regulation of hydrolase activity,BP,RGS4;HPCA;GRIN1;CCK;GRIN2B
8687,GO:0032868,0.463341113487131,0.795541585032313,2,238,response to insulin,BP,PTPRN;VGF
3475,GO:0006885,0.464745456909751,0.871951613297732,1,96,regulation of pH,BP,SLC4A10
19910,GO:1903828,0.464868225089953,0.871887358533901,1,95,negative regulation of cellular protein localization,BP,MRAP2
21086,GO:1990823,0.465406161124184,0.871591324136067,1,92,response to leukemia inhibitory factor,BP,NEFH
21090,GO:1990830,0.465406161124184,0.871591324136067,1,92,cellular response to leukemia inhibitory factor,BP,NEFH
22,GO:0000041,0.465433877058634,0.871483591645797,1,100,transition metal ion transport,BP,SLC30A3
6054,GO:0016798,0.466206663193031,0.871005769823803,1,100,hydrolase activity, acting on glycosyl bonds,MF,CHI3L1
9693,GO:0035335,0.469587856871312,0.868981853311993,1,93,peptidyl-tyrosine dephosphorylation,BP,PTPN5
3575,GO:0007041,0.470772203345947,0.868240311869152,1,93,lysosomal transport,BP,CACNG3
5956,GO:0016605,0.47105974475624,0.868047679743498,1,94,PML body,CC,TENM2
4547,GO:0009617,0.472081831685517,0.747702986853743,3,424,response to bacterium,BP,CHGA;CNR1;VGF
16294,GO:0071407,0.472565524943602,0.72151118018681,4,530,cellular response to organic cyclic compound,BP,GABRA1;GABRG2;GABRB2;ADCY1
2179,GO:0004725,0.473111996474245,0.866755285204422,1,94,protein tyrosine phosphatase activity,MF,PTPN5
9678,GO:0035305,0.473476367541844,0.866524996087512,1,94,negative regulation of dephosphorylation,BP,TMEM132D
7153,GO:0030117,0.47353051453026,0.866466878485123,1,96,membrane coat,CC,DNM1
13052,GO:0048475,0.47353051453026,0.866466878485123,1,96,coated membrane,CC,DNM1
1376,GO:0003014,0.47475641855035,0.865690003077951,1,96,renal system process,BP,ADCY1
8806,GO:0033036,0.474794125727959,0.627687627266862,18,2693,macromolecule localization,BP,CACNG3;NNAT;PTPRN;RBFOX1;RIMS1;RPH3A;CNR1;HPCA;PACSIN1;VGF;SNAP25;SYT4;CHI3L1;MRAP2;MAL2;VSNL1;KCNC2;GRIN1
6873,GO:0021761,0.475678525638697,0.865103777607972,1,96,limbic system development,BP,TBR1
17253,GO:0090150,0.476267785016236,0.785268191398744,2,285,establishment of protein localization to membrane,BP,HPCA;SNAP25
3140,GO:0006414,0.477109013145839,0.863920293430502,1,126,translational elongation,BP,EEF1A2
4306,GO:0009062,0.477760216904492,0.863686655051916,1,104,fatty acid catabolic process,BP,CNR1
13073,GO:0048515,0.478011435313064,0.863546255252563,1,102,spermatid differentiation,BP,NEURL1
10877,GO:0042737,0.478291949618816,0.863261551198806,1,113,drug catabolic process,BP,CHI3L1
7691,GO:0031109,0.47853952700629,0.863262848749111,1,97,microtubule polymerization or depolymerization,BP,STMN2
1199,GO:0002687,0.479199729204625,0.862677732196476,1,113,positive regulation of leukocyte migration,BP,CXCL14
7451,GO:0030660,0.479685629734728,0.862438989355558,1,105,Golgi-associated vesicle membrane,CC,NRGN
19523,GO:1903037,0.480861692303835,0.781670986234181,2,261,regulation of leukocyte cell-cell adhesion,BP,IGFBP2;TESPA1
14492,GO:0060047,0.480887912706014,0.781691812133652,2,248,heart contraction,BP,CACNG3;CHGA
13789,GO:0051258,0.481119208620764,0.781499781780699,2,250,protein polymerization,BP,STMN2;DNM1
13381,GO:0050662,0.48315092513498,0.77984242194249,2,258,coenzyme binding,MF,CRYM;GAD2
13792,GO:0051261,0.483749797983105,0.859903471264723,1,96,protein depolymerization,BP,STMN2
11769,GO:0044843,0.484776646534698,0.778551700901228,2,252,cell cycle G1/S phase transition,BP,BCAT1;CAMK2A
751,GO:0001934,0.486331448696183,0.677179405643054,6,852,positive regulation of protein phosphorylation,BP,EPHB6;NEURL1;CHI3L1;GNG3;ADCY1;CCK
1377,GO:0003015,0.487380289941765,0.776448313616858,2,251,heart process,BP,CACNG3;CHGA
11142,GO:0043244,0.48777833383348,0.857248900151422,1,97,regulation of protein complex disassembly,BP,STMN2
13108,GO:0048584,0.488621817996503,0.628613692784123,13,1967,positive regulation of response to stimulus,BP,RIMS1;CHGA;EPHB6;NEURL1;CNR1;CHI3L1;MRAP2;TESPA1;CXCL14;GNG3;VSNL1;NEUROD2;GRIN1
4163,GO:0008528,0.488718942541957,0.856460462740669,1,113,G-protein coupled peptide receptor activity,MF,PRLHR
4484,GO:0009314,0.488810254998898,0.73339681132048,3,402,response to radiation,BP,SLC4A10;KCNC2;GRIN1
5112,GO:0012501,0.49180812074557,0.62952501858109,12,1816,programmed cell death,BP,NGEF;CAMK2A;SNCB;EEF1A2;EPHB6;NEURL1;CNR1;CHI3L1;GABRB2;ZNF385D;GRIN1;CCK
13069,GO:0048511,0.492176409749818,0.772529529787503,2,254,rhythmic process,BP,PTPRN;ADCY1
12534,GO:0046578,0.492507982160844,0.772338154237244,2,232,regulation of Ras protein signal transduction,BP,NGEF;IQSEC3
555,GO:0001653,0.492543666445316,0.85390401188821,1,114,peptide receptor activity,MF,PRLHR
3755,GO:0007411,0.49254789172995,0.772289762910654,2,236,axon guidance,BP,TBR1;SHC3
10489,GO:0040007,0.493711895828211,0.670333615859677,6,854,growth,BP,SYT1;RIMS1;IGFBP2;SLC12A5;SYT4;SLC4A10
12902,GO:0048037,0.494506960664107,0.728376127664536,3,433,cofactor binding,MF,CRYM;GAD2;CREG2
10365,GO:0038061,0.496160968542421,0.851441780381254,1,117,NIK/NF-kappaB signaling,BP,CHI3L1
17784,GO:0097485,0.497143954831904,0.768500133788608,2,238,neuron projection guidance,BP,TBR1;SHC3
5829,GO:0016363,0.49715408392764,0.850916884586209,1,102,nuclear matrix,CC,ENC1
5668,GO:0016042,0.499337813272495,0.766574193821479,2,270,lipid catabolic process,BP,CNR1;FABP7
5798,GO:0016298,0.499475248474132,0.849303436419125,1,105,lipase activity,MF,CHRM3
9981,GO:0035821,0.499769012754696,0.849003885672985,1,115,modification of morphology or physiology of other organism,BP,CHGA
11963,GO:0045321,0.499826982218467,0.653736028711245,7,1066,leukocyte activation,BP,CHGA;IGFBP2;CNR1;SNAP25;CHI3L1;TESPA1;SELL
20458,GO:1904951,0.500420957640255,0.723195522352124,3,417,positive regulation of establishment of protein localization,BP,NNAT;HPCA;VSNL1
363,GO:0000978,0.500794647087368,0.722892769588932,3,401,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,TBR1;NEUROD2;DDN
13389,GO:0050671,0.501418487310979,0.847854928052573,1,117,positive regulation of lymphocyte proliferation,BP,IGFBP2
1206,GO:0002694,0.502769382961184,0.72109230591758,3,431,regulation of leukocyte activation,BP,IGFBP2;CNR1;TESPA1
7099,GO:0030004,0.504139136707354,0.846084749417862,1,106,cellular monovalent inorganic cation homeostasis,BP,SLC4A10
8745,GO:0032946,0.504585229648458,0.84565911582471,1,118,positive regulation of mononuclear cell proliferation,BP,IGFBP2
1208,GO:0002696,0.505061623341916,0.761780520829315,2,275,positive regulation of leukocyte activation,BP,IGFBP2;TESPA1
15745,GO:0070372,0.505330769639721,0.761601021603104,2,260,regulation of ERK1 and ERK2 cascade,BP,EPHB6;CHI3L1
13079,GO:0048523,0.50566086939881,0.584221003960018,27,4114,negative regulation of cellular process,BP,NGEF;SNCB;CHGA;CELF4;CRYM;STMN2;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;CNR1;HPCA;PACSIN1;SYT4;MRAP2;CXCL14;GABRB2;TENM2;TMEM132D;VSNL1;FABP7;NEUROD2;ENC1;GRIN1;MYT1L;GRIN2B
815,GO:0002020,0.506591792312335,0.844338277282469,1,110,protease binding,MF,SELL
13576,GO:0050921,0.507245968149922,0.843788592062954,1,120,positive regulation of chemotaxis,BP,CXCL14
12212,GO:0045859,0.507330326590479,0.671519363246784,5,719,regulation of protein kinase activity,BP,NEURL1;RGS4;CHI3L1;GNG3;ADCY1
7026,GO:0022412,0.508599195874024,0.758844142763111,2,261,cellular process involved in reproduction in multicellular organism,BP,CELF4;NEURL1
2908,GO:0006024,0.509838047566429,0.842139646525165,1,103,glycosaminoglycan biosynthetic process,BP,CHST9
8082,GO:0031902,0.510841129210927,0.841316130260165,1,114,late endosome membrane,CC,SLC30A3
20691,GO:1905477,0.511393018852634,0.840965737202369,1,110,positive regulation of protein localization to membrane,BP,HPCA
8332,GO:0032355,0.511567412920557,0.840802600534521,1,114,response to estradiol,BP,IGFBP2
21270,GO:2000241,0.511632682692338,0.840746889691662,1,115,regulation of reproductive process,BP,CNR1
12198,GO:0045834,0.513053291627778,0.839788613461392,1,110,positive regulation of lipid metabolic process,BP,EEF1A2
3800,GO:0007568,0.513156028295512,0.754956729877067,2,267,aging,BP,IGFBP2;CNR1
12047,GO:0045580,0.513185001146338,0.839674636950122,1,112,regulation of T cell differentiation,BP,TESPA1
9533,GO:0034774,0.513536213099716,0.754554694187722,2,294,secretory granule lumen,CC,CHI3L1;PCSK1
3212,GO:0006518,0.513692300854047,0.665491513958543,5,803,peptide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
15910,GO:0070665,0.513859151060788,0.839111373831628,1,121,positive regulation of leukocyte proliferation,BP,IGFBP2
7546,GO:0030863,0.514014682119698,0.83920632503791,1,101,cortical cytoskeleton,CC,RIMS1
6284,GO:0018105,0.514308284346184,0.754016718102025,2,254,peptidyl-serine phosphorylation,BP,CAMK1G;CAMK2A
19755,GO:1903533,0.51514950967456,0.838254081946006,1,114,regulation of protein targeting,BP,HPCA
19643,GO:1903311,0.516460855895415,0.752117614931661,2,271,regulation of mRNA metabolic process,BP,RBFOX1;CELF4
7735,GO:0031225,0.517737493366263,0.836331790065944,1,121,anchored component of membrane,CC,GAD2
18944,GO:1901566,0.518341519062431,0.608399550516537,11,1757,organonitrogen compound biosynthetic process,BP,BCAT1;EEF1A2;CELF4;ST8SIA5;NEURL1;HPCA;MRAP2;CHST9;ADCY1;ENC1;PCSK1
13976,GO:0051604,0.518497037875644,0.750331364023268,2,283,protein maturation,BP,NNAT;PCSK1
7173,GO:0030139,0.520997859911679,0.748198682545123,2,274,endocytic vesicle,CC,CACNG3;CAMK2A
3857,GO:0008037,0.520998912586908,0.8340357847627,1,114,cell recognition,BP,CNR1
2907,GO:0006023,0.521733586120513,0.833575191173615,1,107,aminoglycan biosynthetic process,BP,CHST9
12292,GO:0045995,0.521949758381394,0.833406467410156,1,108,regulation of embryonic development,BP,DMRT2
13541,GO:0050878,0.522069930129464,0.703716946864051,3,424,regulation of body fluid levels,BP,NEURL1;CHRM3;ADCY1
3333,GO:0006664,0.522219931413537,0.833107793119248,1,118,glycolipid metabolic process,BP,ST8SIA5
19736,GO:1903509,0.522219931413537,0.833107793119248,1,118,liposaccharide metabolic process,BP,ST8SIA5
369,GO:0000987,0.52282354685177,0.703044847335462,3,414,proximal promoter sequence-specific DNA binding,MF,TBR1;NEUROD2;DDN
13529,GO:0050863,0.523335581370994,0.746144079027656,2,283,regulation of T cell activation,BP,IGFBP2;TESPA1
11190,GO:0043312,0.523388758323283,0.702462765249209,3,454,neutrophil degranulation,BP,SNAP25;CHI3L1;SELL
19737,GO:1903510,0.523461019700619,0.832302454019222,1,108,mucopolysaccharide metabolic process,BP,CHST9
12058,GO:0045596,0.523555860151517,0.675149345049018,4,575,negative regulation of cell differentiation,BP,NGEF;STMN2;SYT4;CXCL14
6662,GO:0019842,0.523630018309488,0.832067259491763,1,119,vitamin binding,MF,GAD2
11169,GO:0043280,0.525268861129728,0.830836366736514,1,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK
2755,GO:0005777,0.525451303499676,0.830701985402975,1,122,peroxisome,CC,CRYM
10798,GO:0042579,0.525451303499676,0.830701985402975,1,122,microbody,CC,CRYM
13533,GO:0050867,0.526363486859854,0.743498279041871,2,285,positive regulation of cell activation,BP,IGFBP2;TESPA1
13184,GO:0048706,0.527293034074304,0.829407312392999,1,115,embryonic skeletal system development,BP,DMRT2
970,GO:0002283,0.527469428905141,0.698708162398614,3,457,neutrophil activation involved in immune response,BP,SNAP25;CHI3L1;SELL
3138,GO:0006412,0.527621763928456,0.671246400052647,4,651,translation,BP,EEF1A2;CELF4;NEURL1;ENC1
14417,GO:0055076,0.527720132401594,0.829016195613245,1,123,transition metal ion homeostasis,BP,SLC30A3
20037,GO:1904064,0.528247396000193,0.828689825247697,1,116,positive regulation of cation transmembrane transport,BP,KCNC2
1116,GO:0002526,0.528477617895541,0.828436644437845,1,125,acute inflammatory response,BP,CNR1
10780,GO:0042552,0.528646467707141,0.82844483851737,1,111,myelination,BP,MAL2
19147,GO:1902107,0.529440238866065,0.827783286720077,1,118,positive regulation of leukocyte differentiation,BP,TESPA1
16840,GO:0072329,0.530107179992839,0.827248914904255,1,122,monocarboxylic acid catabolic process,BP,CNR1
10490,GO:0040008,0.531243648309444,0.66787655522906,4,589,regulation of growth,BP,SYT1;RIMS1;IGFBP2;SYT4
3882,GO:0008083,0.535258474667165,0.823298529307939,1,131,growth factor activity,MF,VGF
7799,GO:0031325,0.535329284957662,0.568570852351494,18,2752,positive regulation of cellular metabolic process,BP,PTPRN;CHGA;EEF1A2;CELF4;EPHB6;NEURL1;HPCA;CHI3L1;MRAP2;TBR1;GNG3;ADCY1;NEUROD2;DMRT2;GRIN1;DDN;CCK;GRIN2B
3706,GO:0007272,0.535422217767648,0.823339405841459,1,113,ensheathment of neurons,BP,MAL2
4056,GO:0008366,0.535422217767648,0.823339405841459,1,113,axon ensheathment,BP,MAL2
19445,GO:1902904,0.538801574323657,0.820735544360566,1,116,negative regulation of supramolecular fiber organization,BP,STMN2
14598,GO:0060205,0.538865045900474,0.732368302075919,2,310,cytoplasmic vesicle lumen,CC,CHI3L1;PCSK1
1023,GO:0002366,0.538971035567833,0.660473740327279,4,622,leukocyte activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
15744,GO:0070371,0.539230775894959,0.732136036893412,2,276,ERK1 and ERK2 cascade,BP,EPHB6;CHI3L1
10570,GO:0042119,0.539316984882816,0.687675098910895,3,465,neutrophil activation,BP,SNAP25;CHI3L1;SELL
8125,GO:0031983,0.540838626232278,0.730595128317988,2,311,vesicle lumen,CC,CHI3L1;PCSK1
11162,GO:0043271,0.542343406926737,0.817982378647811,1,119,negative regulation of ion transport,BP,CNR1
7807,GO:0031333,0.542732876473464,0.817691162844012,1,118,negative regulation of protein complex assembly,BP,STMN2
1069,GO:0002446,0.542812253495232,0.684382467935288,3,467,neutrophil mediated immunity,BP,SNAP25;CHI3L1;SELL
14493,GO:0060048,0.543625459871167,0.816999827524249,1,118,cardiac muscle contraction,BP,CHGA
958,GO:0002263,0.543823008613204,0.655804967637258,4,625,cell activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
10190,GO:0036230,0.546456369862587,0.680929633973258,3,470,granulocyte activation,BP,SNAP25;CHI3L1;SELL
12184,GO:0045807,0.548253249687483,0.813338655686573,1,123,positive regulation of endocytosis,BP,CALY
1872,GO:0004252,0.55038864741829,0.811576436929862,1,132,serine-type endopeptidase activity,MF,PCSK1
2434,GO:0005125,0.551064168635325,0.810924575706094,1,148,cytokine activity,MF,CXCL14
10574,GO:0042129,0.551494319747382,0.8106925461799,1,133,regulation of T cell proliferation,BP,IGFBP2
10578,GO:0042133,0.551553709263444,0.810742594463996,1,122,neurotransmitter metabolic process,BP,GAD2
16589,GO:0071901,0.552231133072742,0.810176559588814,1,125,negative regulation of protein serine/threonine kinase activity,BP,RGS4
19577,GO:1903169,0.553284775182242,0.809347299958776,1,124,regulation of calcium ion transmembrane transport,BP,HPCA
13860,GO:0051384,0.553426336887748,0.809189368181529,1,129,response to glucocorticoid,BP,IGFBP2
7108,GO:0030018,0.554148794406876,0.808706831082871,1,119,Z disc,CC,IGFN1
17757,GO:0097435,0.556604552066469,0.64340852697931,4,588,supramolecular fiber organization,BP,NEFH;STMN2;NEFM;PACSIN1
9427,GO:0034605,0.557016924921457,0.806386341006137,1,121,cellular response to heat,BP,CAMK2A
13531,GO:0050865,0.557024175087898,0.670829218308179,3,464,regulation of cell activation,BP,IGFBP2;CNR1;TESPA1
13771,GO:0051235,0.558520226321384,0.714504287609243,2,286,maintenance of location,BP,SLC17A7;SLC30A3
3953,GO:0008201,0.558885238706109,0.804793873496184,1,130,heparin binding,MF,SELL
3571,GO:0007034,0.559843181769714,0.804081621040491,1,123,vacuolar transport,BP,CACNG3
4623,GO:0009893,0.560064427690254,0.541612946609881,19,2947,positive regulation of metabolic process,BP,PTPRN;RIMS1;CHGA;EEF1A2;CELF4;EPHB6;NEURL1;HPCA;CHI3L1;MRAP2;TBR1;GNG3;ADCY1;NEUROD2;DMRT2;GRIN1;DDN;CCK;GRIN2B
16165,GO:0071214,0.562488583391705,0.710797187527043,2,288,cellular response to abiotic stimulus,BP,HPCA;NEUROD2
18381,GO:0104004,0.562488583391705,0.710797187527043,2,288,cellular response to environmental stimulus,BP,HPCA;NEUROD2
9529,GO:0034767,0.5645609014117,0.800188558492356,1,127,positive regulation of ion transmembrane transport,BP,KCNC2
16183,GO:0071236,0.565897446576408,0.799077848450557,1,128,cellular response to antibiotic,BP,ADCY1
3525,GO:0006959,0.567276360050167,0.797738150129858,1,154,humoral immune response,BP,CHGA
17197,GO:0090066,0.568110160325673,0.660073967297967,3,448,regulation of anatomical structure size,BP,CHGA;SLC12A5;CHRM3
13919,GO:0051494,0.568906388707444,0.79660182185442,1,126,negative regulation of cytoskeleton organization,BP,STMN2
17656,GO:0097223,0.569152695174009,0.796316365657907,1,135,sperm part,CC,SV2B
17810,GO:0097529,0.571728779163464,0.794098401277647,1,143,myeloid leukocyte migration,BP,CHGA
7556,GO:0030879,0.571912803277152,0.794107954381929,1,124,mammary gland development,BP,NEURL1
6061,GO:0016810,0.572140020118774,0.793816437309073,1,135,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,GDA
362,GO:0000977,0.573049666172468,0.627079557257126,4,608,RNA polymerase II regulatory region sequence-specific DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
13732,GO:0051173,0.57347612962784,0.532412869750816,17,2654,positive regulation of nitrogen compound metabolic process,BP,PTPRN;CHGA;CELF4;EPHB6;NEURL1;HPCA;CHI3L1;MRAP2;TBR1;GNG3;ADCY1;NEUROD2;DMRT2;GRIN1;DDN;CCK;GRIN2B
3699,GO:0007265,0.573662670073085,0.65462304667378,3,438,Ras protein signal transduction,BP,NGEF;IQSEC3;SHC3
12476,GO:0046467,0.574367306538171,0.791947547244512,1,134,membrane lipid biosynthetic process,BP,ST8SIA5
2160,GO:0004702,0.575779613370825,0.790919255477515,1,117,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EPHB6
6316,GO:0018209,0.576079112842514,0.697920801904122,2,285,peptidyl-serine modification,BP,CAMK1G;CAMK2A
16248,GO:0071347,0.577211145095274,0.789438096554319,1,146,cellular response to interleukin-1,BP,CHI3L1
14123,GO:0051897,0.577477996408116,0.789332741305383,1,131,positive regulation of protein kinase B signaling,BP,CHI3L1
383,GO:0001012,0.577539808042711,0.622562325975129,4,611,RNA polymerase II regulatory region DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
174,GO:0000377,0.577769973015583,0.696218236984893,2,311,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,RBFOX1;CELF4
186,GO:0000398,0.577769973015583,0.696218236984893,2,311,mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
2853,GO:0005938,0.578349716700608,0.695752105303672,2,280,cell cortex,CC,RIMS1;UNC13C
9342,GO:0034399,0.578557219213161,0.788448685529796,1,127,nuclear periphery,CC,ENC1
6659,GO:0019838,0.579907476657055,0.787282173328897,1,128,growth factor binding,MF,IGFBP2
1207,GO:0002695,0.580543576028476,0.786646583389237,1,138,negative regulation of leukocyte activation,BP,CNR1
13675,GO:0051093,0.580848231909995,0.599694576245751,5,775,negative regulation of developmental process,BP,NGEF;STMN2;SYT4;CXCL14;NEUROD2
15260,GO:0061351,0.58088237239763,0.786453891977275,1,127,neural precursor cell proliferation,BP,FABP7
13832,GO:0051336,0.580988314429308,0.573813620833689,7,1106,regulation of hydrolase activity,BP,NGEF;RGS4;HPCA;TMEM132D;GRIN1;CCK;GRIN2B
16247,GO:0071346,0.58141886181788,0.785837582202756,1,145,cellular response to interferon-gamma,BP,CAMK2A
18261,GO:0099568,0.58151820884957,0.646806851857829,3,439,cytoplasmic region,CC,RIMS1;HPCA;UNC13C
98,GO:0000187,0.582615664631889,0.784902235305445,1,133,activation of MAPK activity,BP,GNG3
173,GO:0000375,0.582722441174756,0.691416460116886,2,314,RNA splicing, via transesterification reactions,BP,RBFOX1;CELF4
13674,GO:0051092,0.584147280646828,0.783556871232033,1,135,positive regulation of NF-kappaB transcription factor activity,BP,CAMK2A
7992,GO:0031674,0.584411857128922,0.783372320200804,1,130,I band,CC,IGFN1
16333,GO:0071466,0.58506162030266,0.782680065975298,1,145,cellular response to xenobiotic stimulus,BP,GRIN1
12074,GO:0045619,0.58577625532135,0.782121280410091,1,137,regulation of lymphocyte differentiation,BP,TESPA1
9565,GO:0035023,0.585842945164039,0.782195990977159,1,123,regulation of Rho protein signal transduction,BP,NGEF
1367,GO:0003002,0.586674848385971,0.6875863856508,2,304,regionalization,BP,TBR1;DMRT2
16588,GO:0071900,0.587149435391521,0.641104625648359,3,465,regulation of protein serine/threonine kinase activity,BP,RGS4;CHI3L1;GNG3
3758,GO:0007416,0.589499871139955,0.77900019286731,1,122,synapse assembly,BP,GRIN1
4804,GO:0010565,0.591246943524225,0.777230171022248,1,147,regulation of cellular ketone metabolic process,BP,CNR1
9923,GO:0035725,0.592549050769173,0.776229132421338,1,129,sodium ion transmembrane transport,BP,SLC17A7
475,GO:0001508,0.593001304186173,0.775826868843039,1,129,action potential,BP,CNR1
405,GO:0001078,0.593916879153072,0.774963536834177,1,134,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYT1L
5805,GO:0016310,0.596645274923393,0.520742792118921,13,2076,phosphorylation,BP,CAMK1G;CAMK2A;EEF1A2;EPHB6;NEURL1;RGS4;CHI3L1;SHC3;GNG3;ADCY1;GRIN1;CCK;GRIN2B
9430,GO:0034614,0.597060429839103,0.772036825309611,1,147,cellular response to reactive oxygen species,BP,KCNC2
8114,GO:0031960,0.597750544491308,0.771422514392778,1,146,response to corticosteroid,BP,IGFBP2
623,GO:0001764,0.598207324020406,0.771150128847553,1,130,neuron migration,BP,CCK
21369,GO:2000377,0.600060803104125,0.769339486887872,1,145,regulation of reactive oxygen species metabolic process,BP,GRIN1
3549,GO:0007005,0.600215901212491,0.627715377608973,3,513,mitochondrion organization,BP,CAMK2A;DNM1;CCK
1066,GO:0002443,0.602846410547015,0.596550518804186,4,680,leukocyte mediated immunity,BP,CHGA;SNAP25;CHI3L1;SELL
5089,GO:0010970,0.602933810543925,0.766788528991088,1,137,transport along microtubule,BP,NEFH
18191,GO:0099111,0.602933810543925,0.766788528991088,1,137,microtubule-based transport,BP,NEFH
17917,GO:0098542,0.603150243386161,0.671107279518758,2,337,defense response to other organism,BP,CHGA;VGF
16485,GO:0071695,0.603898777946118,0.765904499124962,1,137,anatomical structure maturation,BP,GRIN1
12257,GO:0045935,0.604079901319298,0.527055189891062,10,1589,positive regulation of nucleobase-containing compound metabolic process,BP,PTPRN;CHGA;CELF4;HPCA;MRAP2;TBR1;NEUROD2;DMRT2;GRIN1;DDN
15251,GO:0061337,0.604710318678727,0.765159209984084,1,137,cardiac conduction,BP,CACNG3
3294,GO:0006612,0.604904724298541,0.764701199037838,1,177,protein targeting to membrane,BP,HPCA
1197,GO:0002685,0.605534580632226,0.764229221258989,1,159,regulation of leukocyte migration,BP,CXCL14
7476,GO:0030695,0.605793799524784,0.668554727502541,2,292,GTPase regulator activity,MF,RIMS1;RGS4
15970,GO:0070820,0.607062883469142,0.762866543280968,1,152,tertiary granule,CC,SNAP25
3419,GO:0006790,0.607741365733382,0.666462828536951,2,331,sulfur compound metabolic process,BP,SULT4A1;CHST9
3509,GO:0006936,0.608190961905274,0.666041128353396,2,317,muscle contraction,BP,CHGA;CHRM3
7382,GO:0030509,0.608230794586947,0.761888863834519,1,139,BMP signaling pathway,BP,ZCCHC12
4333,GO:0009101,0.608235218394039,0.666015592296769,2,310,glycoprotein biosynthetic process,BP,ST8SIA5;CHST9
11260,GO:0043436,0.60849022973261,0.556478253133187,6,1015,oxoacid metabolic process,BP,BCAT1;CRYM;CNR1;SULT4A1;GAD2;CHST9
11555,GO:0044281,0.611114940539192,0.514280114393633,11,1868,small molecule metabolic process,BP,BCAT1;CHGA;CRYM;CNR1;GDA;HPCA;SULT4A1;MRAP2;GAD2;CHST9;ADCY1
11244,GO:0043409,0.613494760430542,0.756931508800352,1,143,negative regulation of MAPK cascade,BP,RGS4
2747,GO:0005768,0.613531797857942,0.565708298334643,5,810,endosome,CC,PTPRN;STMN2;SLC30A3;PACSIN1;CALY
9810,GO:0035567,0.613952289724693,0.756443528652687,1,150,non-canonical Wnt signaling pathway,BP,CAMK2A
12166,GO:0045766,0.614053206928594,0.756396611591061,1,144,positive regulation of angiogenesis,BP,CHI3L1
11245,GO:0043410,0.615697658689081,0.611628923350159,3,482,positive regulation of MAPK cascade,BP,EPHB6;CHI3L1;GNG3
2633,GO:0005576,0.616969464038066,0.477644193901478,22,3750,extracellular region,CC,CHGA;CRYM;EPHB6;NPTX2;DNM1;IGFBP2;GDA;VGF;SYT4;CHI3L1;CXCL14;GABRB2;MAL2;CHST9;ADCY1;PCSK1;CREG2;GRIN1;NELL2;CCK;CPNE4;NMB
1063,GO:0002440,0.617161108245111,0.753380253683264,1,153,production of molecular mediator of immune response,BP,CHGA
3975,GO:0008236,0.617348893841169,0.753172266869576,1,157,serine-type peptidase activity,MF,PCSK1
17948,GO:0098609,0.617618117588368,0.581030765162264,4,647,cell-cell adhesion,BP,IGFBP2;TESPA1;TENM2;SELL
10556,GO:0042098,0.618925705457692,0.75166029460323,1,158,T cell proliferation,BP,IGFBP2
4648,GO:0009968,0.619041803609085,0.534037492618816,7,1142,negative regulation of signal transduction,BP,CELF4;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;MRAP2
2944,GO:0006082,0.619172119729473,0.545150255279051,6,1026,organic acid metabolic process,BP,BCAT1;CRYM;CNR1;SULT4A1;GAD2;CHST9
11240,GO:0043405,0.619315397989627,0.654580925694476,2,315,regulation of MAP kinase activity,BP,RGS4;GNG3
3266,GO:0006575,0.620226111476236,0.750407249455828,1,159,cellular modified amino acid metabolic process,BP,CRYM
9292,GO:0034341,0.621028673075169,0.749608667855449,1,163,response to interferon-gamma,BP,CAMK2A
19845,GO:1903708,0.621731874520096,0.749018081366452,1,151,positive regulation of hemopoiesis,BP,TESPA1
11243,GO:0043408,0.621747281317455,0.576624695628595,4,652,regulation of MAPK cascade,BP,EPHB6;RGS4;CHI3L1;GNG3
3785,GO:0007519,0.623159791267156,0.747663248959748,1,148,skeletal muscle tissue development,BP,NEURL1
4827,GO:0010608,0.62450732838359,0.602241877462863,3,508,posttranscriptional regulation of gene expression,BP,CELF4;NEURL1;ENC1
2616,GO:0005525,0.624962008723421,0.64861517997036,2,335,GTP binding,MF,EEF1A2;DNM1
3334,GO:0006665,0.62640658154599,0.744492026556812,1,150,sphingolipid metabolic process,BP,ST8SIA5
15852,GO:0070555,0.626810258700558,0.743982007930112,1,166,response to interleukin-1,BP,CHI3L1
7021,GO:0022407,0.627119856913382,0.646336544378699,2,336,regulation of cell-cell adhesion,BP,IGFBP2;TESPA1
17219,GO:0090090,0.62743706996772,0.743409532971406,1,160,negative regulation of canonical Wnt signaling pathway,BP,IGFBP2
13532,GO:0050866,0.627675455565891,0.743205000568233,1,156,negative regulation of cell activation,BP,CNR1
6248,GO:0017171,0.628382947012971,0.742475222307206,1,161,serine hydrolase activity,MF,PCSK1
6464,GO:0019216,0.629079347421427,0.644298512714632,2,322,regulation of lipid metabolic process,BP,EEF1A2;CNR1
8483,GO:0032550,0.630088507270459,0.643185020231201,2,338,purine ribonucleoside binding,MF,EEF1A2;DNM1
7220,GO:0030203,0.632370186605848,0.738656493475517,1,146,glycosaminoglycan metabolic process,BP,CHST9
13391,GO:0050673,0.632396886210008,0.640765515235743,2,323,epithelial cell proliferation,BP,PTPRN;FABP7
633,GO:0001775,0.632597834769393,0.519476648816835,7,1199,cell activation,BP,CHGA;IGFBP2;CNR1;SNAP25;CHI3L1;TESPA1;SELL
14622,GO:0060249,0.633020697710595,0.640072574343095,2,333,anatomical structure homeostasis,BP,SLC17A7;NELL2
4389,GO:0009166,0.634151716298296,0.736803979866981,1,156,nucleotide catabolic process,BP,GDA
715,GO:0001883,0.634816484647271,0.638129828764924,2,341,purine nucleoside binding,MF,EEF1A2;DNM1
16512,GO:0071772,0.6355227762343,0.735481530303248,1,150,response to BMP,BP,ZCCHC12
16513,GO:0071773,0.6355227762343,0.735481530303248,1,150,cellular response to BMP stimulus,BP,ZCCHC12
4850,GO:0010639,0.636822597544904,0.636010621924999,2,327,negative regulation of organelle organization,BP,STMN2;SYT4
16590,GO:0071902,0.637034970837711,0.635781976283474,2,327,positive regulation of protein serine/threonine kinase activity,BP,CHI3L1;GNG3
6592,GO:0019637,0.637114634139213,0.525824985738389,6,1039,organophosphate metabolic process,BP,CHGA;GDA;HPCA;SULT4A1;MRAP2;ADCY1
8482,GO:0032549,0.637786142976178,0.634933762600987,2,342,ribonucleoside binding,MF,EEF1A2;DNM1
14838,GO:0060538,0.637901108741728,0.733061338390472,1,154,skeletal muscle organ development,BP,NEURL1
10797,GO:0042578,0.637945933794227,0.634816696516534,2,321,phosphoric ester hydrolase activity,MF,PTPN5;CHRM3
13075,GO:0048519,0.639613699105068,0.44659469501002,28,4543,negative regulation of biological process,BP,NGEF;SNCB;CHGA;CELF4;CRYM;STMN2;EPHB6;DNM1;NEURL1;IGFBP2;RGS4;CNR1;HPCA;PACSIN1;SYT4;MRAP2;CXCL14;GABRB2;TENM2;TMEM132D;VSNL1;FABP7;NEUROD2;ENC1;GRIN1;MYT1L;CCK;GRIN2B
3513,GO:0006941,0.644111117059946,0.726728116705031,1,157,striated muscle contraction,BP,CHGA
2744,GO:0005765,0.646641959801064,0.625318410403817,2,336,lysosomal membrane,CC,EEF1A2;SLC30A3
18068,GO:0098852,0.646641959801064,0.625318410403817,2,336,lytic vacuole membrane,CC,EEF1A2;SLC30A3
13396,GO:0050679,0.64707052172947,0.723675279102133,1,158,positive regulation of epithelial cell proliferation,BP,PTPRN
18858,GO:1901292,0.647809144854996,0.72288158192117,1,162,nucleoside phosphate catabolic process,BP,GDA
714,GO:0001882,0.648699278413392,0.623025398654179,2,349,nucleoside binding,MF,EEF1A2;DNM1
2143,GO:0004674,0.648970285308023,0.57565793222613,3,474,protein serine/threonine kinase activity,MF,CAMK1G;CAMK2A;EPHB6
6287,GO:0018108,0.649682276038053,0.62198002570548,2,334,peptidyl-tyrosine phosphorylation,BP,NEURL1;CCK
18800,GO:1901136,0.650354697699155,0.720208257300573,1,166,carbohydrate derivative catabolic process,BP,CHI3L1
2725,GO:0005741,0.650609691809045,0.719963571815503,1,163,mitochondrial outer membrane,CC,CNR1
4508,GO:0009408,0.65146787295141,0.719096821504478,1,159,response to heat,BP,CAMK2A
328,GO:0000910,0.651566318244625,0.719009282172395,1,157,cytokinesis,BP,PACSIN1
8494,GO:0032561,0.65204730361768,0.619322925060338,2,351,guanyl ribonucleotide binding,MF,EEF1A2;DNM1
5052,GO:0010921,0.652864250636034,0.71766510788832,1,155,regulation of phosphatase activity,BP,TMEM132D
6389,GO:0019001,0.653837788689935,0.61733339709547,2,352,guanyl nucleotide binding,MF,EEF1A2;DNM1
6319,GO:0018212,0.65420762525182,0.616959529933206,2,337,peptidyl-tyrosine modification,BP,NEURL1;CCK
12174,GO:0045785,0.655085328933729,0.615944837191562,2,352,positive regulation of cell adhesion,BP,IGFBP2;TESPA1
3815,GO:0007601,0.655114052338954,0.715227426259758,1,164,visual perception,BP,RIMS1
20007,GO:1904018,0.655891191643458,0.714427716128911,1,161,positive regulation of vasculature development,BP,CHI3L1
10668,GO:0042325,0.656018116382683,0.484926062588037,8,1340,regulation of phosphorylation,BP,EEF1A2;EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1;CCK
11086,GO:0043167,0.656189980266096,0.424100022706312,35,5495,ion binding,MF,CAMK1G;SYT13;SYT1;CAMK2A;LNX1;SNCB;RIMS1;RPH3A;EEF1A2;EPHB6;NPTX2;DNM1;NEURL1;GDA;HPCA;PACSIN1;SYT4;CHRM3;GAD2;UNC13C;STAC2;TENM2;ZNF385D;NRGN;SYN2;VSNL1;ADCY1;NPTX1;DMRT2;ZCCHC12;GRIN1;NELL2;MYT1L;SELL;GRIN2B
7309,GO:0030324,0.65676117753502,0.713528678211712,1,158,lung development,BP,CHI3L1
13382,GO:0050663,0.65999149349788,0.710004872101557,1,169,cytokine secretion,BP,CHI3L1
11551,GO:0044272,0.660577186835547,0.709391209091111,1,167,sulfur compound biosynthetic process,BP,CHST9
3709,GO:0007276,0.660799446492588,0.562341298433624,3,523,gamete generation,BP,CELF4;NEURL1;CNR1
7480,GO:0030705,0.661827565270437,0.708107509973359,1,159,cytoskeleton-dependent intracellular transport,BP,NEFH
601,GO:0001726,0.662487766033288,0.707412375633558,1,157,ruffle,CC,PACSIN1
4055,GO:0008361,0.662579247093971,0.707313758210575,1,157,regulation of cell size,BP,SLC12A5
13590,GO:0050953,0.662744929476569,0.70705955326049,1,167,sensory perception of light stimulus,BP,RIMS1
361,GO:0000976,0.665505646722745,0.528435196475619,4,679,transcription regulatory region sequence-specific DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
13758,GO:0051216,0.666054434134499,0.703494730441817,1,164,cartilage development,BP,CHI3L1
3289,GO:0006605,0.666379344591986,0.603131895222465,2,394,protein targeting,BP,CACNG3;HPCA
7308,GO:0030323,0.666580154256256,0.702937043051776,1,162,respiratory tube development,BP,CHI3L1
7461,GO:0030674,0.666849336412156,0.702635898298168,1,163,protein binding, bridging,MF,NEFH
13388,GO:0050670,0.667219081064895,0.702104072851173,1,182,regulation of lymphocyte proliferation,BP,IGFBP2
8280,GO:0032270,0.667466964571448,0.472223215507413,8,1363,positive regulation of cellular protein metabolic process,BP,EPHB6;NEURL1;CHI3L1;GNG3;ADCY1;GRIN1;CCK;GRIN2B
13518,GO:0050852,0.667599760828921,0.701687983301959,1,182,T cell receptor signaling pathway,BP,TESPA1
14873,GO:0060589,0.667893819928411,0.601547783057319,2,332,nucleoside-triphosphatase regulator activity,MF,RIMS1;RGS4
8743,GO:0032944,0.669341451611306,0.699772667771522,1,183,regulation of mononuclear cell proliferation,BP,IGFBP2
15821,GO:0070507,0.66939986745844,0.699851050398478,1,162,regulation of microtubule cytoskeleton organization,BP,STMN2
13780,GO:0051249,0.669622166625668,0.599477509418893,2,370,regulation of lymphocyte activation,BP,IGFBP2;TESPA1
2622,GO:0005539,0.669835586283014,0.699292945319773,1,173,glycosaminoglycan binding,MF,SELL
3677,GO:0007219,0.669982235030862,0.699152129813199,1,170,Notch signaling pathway,BP,NEURL1
17618,GO:0097164,0.669991045632546,0.699082819358404,1,179,ammonium ion metabolic process,BP,SNCB
13657,GO:0051056,0.670039625399399,0.599115115446058,2,324,regulation of small GTPase mediated signal transduction,BP,NGEF;IQSEC3
1613,GO:0003712,0.674512432636666,0.546672979674472,3,527,transcription cofactor activity,MF,CRYM;NEUROD2;ZCCHC12
2176,GO:0004721,0.675533789669346,0.693023987970362,1,166,phosphoprotein phosphatase activity,MF,PTPN5
9526,GO:0034764,0.67676293679656,0.691626128709166,1,169,positive regulation of transmembrane transport,BP,KCNC2
14846,GO:0060548,0.676792264708716,0.496032371204443,5,891,negative regulation of cell death,BP,SNCB;CHGA;EPHB6;GABRB2;GRIN1
7842,GO:0031401,0.679171386825945,0.479007247932886,6,1036,positive regulation of protein modification process,BP,EPHB6;NEURL1;CHI3L1;GNG3;ADCY1;CCK
15908,GO:0070663,0.680708273869867,0.687048165614763,1,189,regulation of leukocyte proliferation,BP,IGFBP2
12264,GO:0045944,0.680736188614192,0.477225883909289,6,1028,positive regulation of transcription by RNA polymerase II,BP,PTPRN;TBR1;NEUROD2;DMRT2;GRIN1;DDN
8681,GO:0032838,0.680759614205429,0.687134110774674,1,167,plasma membrane bounded cell projection cytoplasm,CC,HPCA
11128,GO:0043226,0.682093988976798,0.406487209279118,74,11807,organelle,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;DNM1;NEURL1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;CXCL14;GABRB2;TENM2;MAL2;ZNF385D;GABRA2;CHST9;NRGN;SYN2;GNG3;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;SV2B;MYT1L;SELL;CPNE4;SLC6A17;GRIN2B
7115,GO:0030031,0.682374812500444,0.537548791890732,3,520,cell projection assembly,BP,NEFH;NEURL1;TENM2
14122,GO:0051896,0.684500657037709,0.682820113412515,1,174,regulation of protein kinase B signaling,BP,CHI3L1
2873,GO:0005975,0.684753042899301,0.534735692433632,3,541,carbohydrate metabolic process,BP,ST8SIA5;CHI3L1;CHST9
19446,GO:1902905,0.685138097080924,0.682062129641991,1,178,positive regulation of supramolecular fiber organization,BP,STMN2
11357,GO:0043603,0.685476835960092,0.486008657917873,5,963,cellular amide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
2405,GO:0005057,0.686339332111143,0.680797303867454,1,162,signal transducer activity, downstream of receptor,MF,EPHB6
12258,GO:0045936,0.686394778635748,0.532810709376827,3,538,negative regulation of phosphate metabolic process,BP,RGS4;HPCA;TMEM132D
3833,GO:0007623,0.686972683099633,0.679950946993011,1,178,circadian rhythm,BP,ADCY1
4802,GO:0010563,0.687483387850334,0.531527663239636,3,539,negative regulation of phosphorus metabolic process,BP,RGS4;HPCA;TMEM132D
19311,GO:1902533,0.687970069912911,0.483157904101376,5,897,positive regulation of intracellular signal transduction,BP,EPHB6;CHI3L1;MRAP2;GNG3;NEUROD2
8119,GO:0031968,0.689659832023287,0.676819525145164,1,181,organelle outer membrane,CC,CNR1
17382,GO:0090316,0.689704216428916,0.676780966359929,1,179,positive regulation of intracellular protein transport,BP,HPCA
11370,GO:0043624,0.690087619520273,0.676216370980062,1,199,cellular protein complex disassembly,BP,STMN2
8117,GO:0031966,0.690208805769483,0.528220018447222,3,618,mitochondrial membrane,CC,DNM1;CNR1;NRGN
2170,GO:0004713,0.690420188553272,0.67601775466553,1,169,protein tyrosine kinase activity,MF,EPHB6
3554,GO:0007010,0.690814799995309,0.45467343755193,7,1179,cytoskeleton organization,BP,NEFH;STMN2;NEFM;NEURL1;IQSEC3;PACSIN1;MAP7D2
13376,GO:0050657,0.693233117253246,0.672658415411216,1,179,nucleic acid transport,BP,RBFOX1
13377,GO:0050658,0.693233117253246,0.672658415411216,1,179,RNA transport,BP,RBFOX1
7107,GO:0030017,0.693458033776446,0.672381138783578,1,181,sarcomere,CC,IGFN1
6677,GO:0019867,0.69448810873538,0.671156444557688,1,183,outer membrane,CC,CNR1
6175,GO:0017048,0.694812379374179,0.670917516624863,1,163,Rho GTPase binding,MF,NGEF
4640,GO:0009952,0.695818258762917,0.669586432464192,1,183,anterior/posterior pattern specification,BP,DMRT2
2435,GO:0005126,0.696018375194781,0.669239644964326,1,202,cytokine receptor binding,MF,CXCL14
749,GO:0001932,0.696860361951874,0.447693719531797,7,1227,regulation of protein phosphorylation,BP,EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1;CCK
10606,GO:0042180,0.697031652682207,0.668054829503053,1,199,cellular ketone metabolic process,BP,CNR1
7042,GO:0022618,0.697468727889251,0.667557965943456,1,195,ribonucleoprotein complex assembly,BP,CELF4
3534,GO:0006979,0.69846524012152,0.565452167318014,2,390,response to oxidative stress,BP,PTPRN;KCNC2
7884,GO:0031461,0.698611651151445,0.666289919672839,1,180,cullin-RING ubiquitin ligase complex,CC,ENC1
18223,GO:0099513,0.699326163393862,0.517438994607995,3,539,polymeric cytoskeletal fiber,CC,NEFH;NEFM;DNM1
7204,GO:0030178,0.699485774904242,0.665166152071899,1,193,negative regulation of Wnt signaling pathway,BP,IGFBP2
3518,GO:0006952,0.699581485974182,0.444519183142301,7,1305,defense response,BP,CAMK2A;CHGA;CNR1;VGF;CHI3L1;NEUROD2;CCK
13772,GO:0051236,0.700308954909093,0.664249190649939,1,182,establishment of RNA localization,BP,RBFOX1
3558,GO:0007017,0.701411830249755,0.486696475249174,4,701,microtubule-based process,BP,NEFH;STMN2;NEURL1;MAP7D2
7112,GO:0030027,0.702497912585023,0.661660760192695,1,176,lamellipodium,CC,STMN2
4332,GO:0009100,0.70420024486287,0.55850647680311,2,371,glycoprotein metabolic process,BP,ST8SIA5;CHST9
13672,GO:0051090,0.705261703698287,0.557193388802924,2,376,regulation of DNA binding transcription factor activity,BP,CAMK2A;NEUROD2
21094,GO:1990837,0.706109259517919,0.481070781127505,4,715,sequence-specific double-stranded DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
5742,GO:0016197,0.707211189670307,0.655897356763991,1,183,endosomal transport,BP,CALY
14530,GO:0060090,0.708761746268888,0.654006903761115,1,182,molecular adaptor activity,MF,NEFH
16246,GO:0071345,0.708875806396286,0.458566067642431,5,951,cellular response to cytokine stimulus,BP,PTPRN;CAMK2A;NEFH;PTPN5;CHI3L1
14840,GO:0060541,0.710348970823424,0.6520497779202,1,183,respiratory system development,BP,CHI3L1
9344,GO:0034404,0.711944771271763,0.649988124082071,1,198,nucleobase-containing small molecule biosynthetic process,BP,GDA
17666,GO:0097237,0.712547069378176,0.649209253402957,1,204,cellular response to toxic substance,BP,KCNC2
8281,GO:0032271,0.714203608508008,0.6472133522732,1,193,regulation of protein polymerization,BP,STMN2
11170,GO:0043281,0.714292647186857,0.647040214670138,1,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK
9676,GO:0035303,0.714696400889086,0.646662453472307,1,183,regulation of dephosphorylation,BP,TMEM132D
13118,GO:0048608,0.715053502795123,0.545048373041484,2,379,reproductive structure development,BP,PTPRN;VGF
16179,GO:0071229,0.716529638297064,0.644338289575169,1,188,cellular response to acid chemical,BP,NEURL1
15301,GO:0061458,0.718835718504384,0.540289716353044,2,382,reproductive system development,BP,PTPRN;VGF
2752,GO:0005774,0.719212616813356,0.539801272828818,2,388,vacuolar membrane,CC,EEF1A2;SLC30A3
2723,GO:0005739,0.719357213446302,0.412765000359619,8,1555,mitochondrion,CC,BCAT1;CAMK2A;SNCB;NEFH;CRYM;DNM1;CNR1;NRGN
16544,GO:0071826,0.719736264534036,0.640190969080088,1,207,ribonucleoprotein complex subunit organization,BP,CELF4
3711,GO:0007283,0.72038441841822,0.538308035801951,2,394,spermatogenesis,BP,NEURL1;CNR1
11655,GO:0044449,0.721666275646507,0.637804160649328,1,196,contractile fiber part,CC,IGFN1
4063,GO:0008380,0.721759654517617,0.536543779538128,2,405,RNA splicing,BP,RBFOX1;CELF4
1374,GO:0003012,0.721873625105239,0.536429595908369,2,390,muscle system process,BP,CHGA;CHRM3
2724,GO:0005740,0.724918574346328,0.485932400117076,3,654,mitochondrial envelope,CC,DNM1;CNR1;NRGN
3746,GO:0007389,0.725451514422372,0.531873497673712,2,390,pattern specification process,BP,TBR1;DMRT2
9866,GO:0035637,0.725764536694115,0.632598262797434,1,190,multicellular organismal signaling,BP,CACNG3
13920,GO:0051495,0.725906539001089,0.632361199575059,1,199,positive regulation of cytoskeleton organization,BP,STMN2
19007,GO:1901681,0.726782709553458,0.631203778018246,1,204,sulfur compound binding,MF,SELL
10565,GO:0042110,0.727427980422858,0.529315975913413,2,403,T cell activation,BP,IGFBP2;TESPA1
3700,GO:0007266,0.727977620608341,0.62976119216152,1,187,Rho protein signal transduction,BP,NGEF
18222,GO:0099512,0.728380372437582,0.453916570320716,4,742,supramolecular fiber,CC,NEFH;NEFM;DNM1;IGFN1
3317,GO:0006643,0.728684768926642,0.628742438647689,1,204,membrane lipid metabolic process,BP,ST8SIA5
3698,GO:0007264,0.730940173050633,0.478465450777063,3,550,small GTPase mediated signal transduction,BP,NGEF;IQSEC3;SHC3
5675,GO:0016051,0.731235419458094,0.625426322341474,1,203,carbohydrate biosynthetic process,BP,CHST9
7106,GO:0030016,0.732714062672187,0.623500931724349,1,201,myofibril,CC,IGFN1
2759,GO:0005783,0.732768620421548,0.389977794027,9,1645,endoplasmic reticulum,CC,PTPN5;VGF;CHI3L1;MRAP2;TESPA1;TENM2;CREG2;GRIN1;DDN
367,GO:0000982,0.733704270692606,0.521244933927976,2,387,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,DDN;MYT1L
2951,GO:0006091,0.733861297889896,0.520952060280838,2,433,generation of precursor metabolites and energy,BP,VGF;MRAP2
13778,GO:0051247,0.735410487071316,0.39375538713782,8,1452,positive regulation of protein metabolic process,BP,EPHB6;NEURL1;CHI3L1;GNG3;ADCY1;GRIN1;CCK;GRIN2B
11129,GO:0043227,0.735634148510883,0.341396523338595,68,11041,membrane-bounded organelle,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;SYT1;CAMK2A;SNCB;RBFOX1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;SLC17A7;DNM1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;GDA;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;CXCL14;GABRB2;TENM2;MAL2;ZNF385D;GABRA2;CHST9;NRGN;SYN2;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;SV2B;MYT1L;SELL;CPNE4;SLC6A17
18178,GO:0099081,0.736200857143315,0.444174693868938,4,749,supramolecular polymer,CC,NEFH;NEFM;DNM1;IGFN1
1633,GO:0003779,0.736293437860629,0.517887064507538,2,380,actin binding,MF,HPCA;ENC1
18177,GO:0099080,0.73735005126645,0.442733764884804,4,750,supramolecular complex,CC,NEFH;NEFM;DNM1;IGFN1
5925,GO:0016567,0.737888837073356,0.442048702006744,4,762,protein ubiquitination,BP,LNX1;NEURL1;NEUROD2;ENC1
11484,GO:0044092,0.738575355597601,0.422512422224831,5,962,negative regulation of molecular function,BP,SNCB;RGS4;CNR1;HPCA;TMEM132D
16968,GO:0072593,0.740211931184606,0.613476922109538,1,215,reactive oxygen species metabolic process,BP,GRIN1
7233,GO:0030217,0.7406518767234,0.612945325496081,1,204,T cell differentiation,BP,TESPA1
13517,GO:0050851,0.740871961819488,0.612565966988151,1,220,antigen receptor-mediated signaling pathway,BP,TESPA1
12456,GO:0046434,0.741462197963367,0.611833721576075,1,208,organophosphate catabolic process,BP,GDA
18942,GO:1901564,0.741844337415827,0.330379092551577,35,5941,organonitrogen compound metabolic process,BP,CAMK1G;NNAT;BCAT1;CAMK2A;LNX1;SNCB;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;NEURL1;PTPN5;IGFBP2;RGS4;GDA;HPCA;VGF;SULT4A1;CHRM3;CHI3L1;MRAP2;GAD2;TENM2;SHC3;CHST9;GNG3;ADCY1;NEUROD2;ENC1;PCSK1;GRIN1;CCK;GRIN2B
11149,GO:0043254,0.741931558663352,0.510432752050202,2,402,regulation of protein complex assembly,BP,STMN2;CCK
13977,GO:0051606,0.742816294286672,0.60994564272029,1,220,detection of stimulus,BP,SYT1
12581,GO:0046651,0.743513713468898,0.608992493599333,1,222,lymphocyte proliferation,BP,IGFBP2
7804,GO:0031330,0.745822580273474,0.605932671941018,1,207,negative regulation of cellular catabolic process,BP,CNR1
12959,GO:0048232,0.745901957490147,0.505143076729265,2,413,male gamete generation,BP,NEURL1;CNR1
11282,GO:0043491,0.746370025570774,0.605185822953687,1,207,protein kinase B signaling,BP,CHI3L1
8742,GO:0032943,0.747065986066957,0.604147573080032,1,224,mononuclear cell proliferation,BP,IGFBP2
11172,GO:0043292,0.74850406747264,0.602235967906795,1,212,contractile fiber,CC,IGFN1
4627,GO:0009897,0.749400036644841,0.600992897686644,1,214,external side of plasma membrane,CC,SELL
17425,GO:0090407,0.752198421283485,0.451024914266436,3,610,organophosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
3476,GO:0006886,0.752816946469479,0.40469877253515,5,1001,intracellular protein transport,BP,CACNG3;RIMS1;RPH3A;HPCA;SNAP25
3131,GO:0006403,0.754281572058925,0.594215309325786,1,215,RNA localization,BP,RBFOX1
2749,GO:0005770,0.755807655361632,0.592057681018956,1,219,late endosome,CC,SLC30A3
5880,GO:0016485,0.756936393910584,0.590450986350536,1,223,protein processing,BP,PCSK1
7189,GO:0030162,0.757588627505816,0.443902430898736,3,633,regulation of proteolysis,BP,GRIN1;CCK;GRIN2B
371,GO:0000989,0.758046025420521,0.443331427701828,3,599,transcription factor activity, transcription factor binding,MF,CRYM;NEUROD2;ZCCHC12
370,GO:0000988,0.762116226714443,0.43791777456077,3,603,transcription factor activity, protein binding,MF,CRYM;NEUROD2;ZCCHC12
15299,GO:0061448,0.763305007387172,0.581433032022314,1,216,connective tissue development,BP,CHI3L1
11033,GO:0043066,0.763370960559033,0.409414570674161,4,807,negative regulation of apoptotic process,BP,SNCB;EPHB6;GABRB2;GRIN1
5642,GO:0015980,0.763447796943152,0.581098327966948,1,244,energy derivation by oxidation of organic compounds,BP,MRAP2
18950,GO:1901575,0.763693935876218,0.347196226037951,10,1889,organic substance catabolic process,BP,BCAT1;LNX1;EEF1A2;CRYM;CNR1;GDA;CHI3L1;GAD2;FABP7;ENC1
15378,GO:0061630,0.763873065717687,0.580638578263766,1,212,ubiquitin protein ligase activity,MF,NEURL1
5625,GO:0015931,0.764279833271569,0.580011605532981,1,220,nucleobase-containing compound transport,BP,RBFOX1
15906,GO:0070661,0.764325184748431,0.579875361482372,1,235,leukocyte proliferation,BP,IGFBP2
19145,GO:1902105,0.765454977703932,0.578302489717275,1,223,regulation of leukocyte differentiation,BP,TESPA1
5806,GO:0016311,0.76652214041059,0.47707534522903,2,412,dephosphorylation,BP,PTPN5;TMEM132D
162,GO:0000323,0.768484211161176,0.429353431975115,3,626,lytic vacuole,CC,CHGA;EEF1A2;SLC30A3
2743,GO:0005764,0.768484211161176,0.429353431975115,3,626,lysosome,CC,CHGA;EEF1A2;SLC30A3
16257,GO:0071356,0.769100703798947,0.572889380932516,1,250,cellular response to tumor necrosis factor,BP,CHI3L1
460,GO:0001227,0.770050842614368,0.571639851568284,1,219,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MYT1L
18965,GO:1901615,0.770809824725744,0.471044896769449,2,433,organic hydroxy compound metabolic process,BP,SNCB;CRYM
6303,GO:0018193,0.771152912640259,0.368204854235224,6,1143,peptidyl-amino acid modification,BP,CAMK1G;NNAT;CAMK2A;NEURL1;CHI3L1;CCK
8361,GO:0032388,0.771231129254266,0.569883565007652,1,224,positive regulation of intracellular transport,BP,HPCA
15391,GO:0061659,0.771281302868609,0.569845468556452,1,217,ubiquitin-like protein ligase activity,MF,NEURL1
11036,GO:0043069,0.772313597511104,0.397662773814177,4,818,negative regulation of programmed cell death,BP,SNCB;EPHB6;GABRB2;GRIN1
9174,GO:0034097,0.77543336975831,0.375702531490891,5,1030,response to cytokine,BP,PTPRN;CAMK2A;NEFH;PTPN5;CHI3L1
7808,GO:0031334,0.778050831866707,0.559721586586201,1,232,positive regulation of protein complex assembly,BP,CCK
1604,GO:0003690,0.77861088820381,0.3893097640078,4,793,double-stranded DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
2267,GO:0004842,0.780822085555033,0.456856916344049,2,422,ubiquitin-protein transferase activity,MF,LNX1;NEURL1
15991,GO:0070848,0.781723241568672,0.411289680061925,3,621,response to growth factor,BP,STMN2;KCNC2;ZCCHC12
3177,GO:0006469,0.782996744513419,0.552229261029962,1,236,negative regulation of protein kinase activity,BP,RGS4
6229,GO:0017144,0.785415475577586,0.406115438115308,3,685,drug metabolic process,BP,SNCB;CHI3L1;GAD2
3190,GO:0006486,0.78552508154545,0.548373977366739,1,234,protein glycosylation,BP,ST8SIA5
11247,GO:0043413,0.78552508154545,0.548373977366739,1,234,macromolecule glycosylation,BP,ST8SIA5
3125,GO:0006397,0.786402109980127,0.448746151844919,2,455,mRNA processing,BP,RBFOX1;CELF4
2141,GO:0004672,0.786958453476011,0.40405056066904,3,596,protein kinase activity,MF,CAMK1G;CAMK2A;EPHB6
14027,GO:0051707,0.788517904340687,0.401794414734605,3,679,response to other organism,BP,CHGA;CNR1;VGF
4652,GO:0009986,0.789181464213059,0.400907884655508,3,632,cell surface,CC,GRIN1;SELL;GRIN2B
15014,GO:0060828,0.789274498305304,0.542547635414989,1,243,regulation of canonical Wnt signaling pathway,BP,IGFBP2
6028,GO:0016757,0.789832139856093,0.541694400691896,1,240,transferase activity, transferring glycosyl groups,MF,ST8SIA5
11116,GO:0043207,0.789947274639843,0.399791358411211,3,681,response to external biotic stimulus,BP,CHGA;CNR1;VGF
8871,GO:0033157,0.793077902038489,0.536622375841022,1,240,regulation of intracellular protein transport,BP,HPCA
9428,GO:0034612,0.794635390683581,0.534059074124155,1,268,response to tumor necrosis factor,BP,CHI3L1
6050,GO:0016791,0.795363550039172,0.533038007682009,1,236,phosphatase activity,MF,PTPN5
15569,GO:0070085,0.795621295237981,0.532607656206838,1,241,glycosylation,BP,ST8SIA5
11519,GO:0044212,0.795655649462482,0.366218557017291,4,810,transcription regulatory region DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
399,GO:0001067,0.7965605150698,0.364974692888908,4,811,regulatory region nucleic acid binding,MF,TBR1;NEUROD2;DMRT2;DDN
4625,GO:0009895,0.797360591790897,0.529842459695984,1,242,negative regulation of catabolic process,BP,CNR1
366,GO:0000981,0.798563455613042,0.345089858543858,5,1002,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN;MYT1L
7259,GO:0030258,0.799916700684442,0.525753379879986,1,243,lipid modification,BP,CNR1
12626,GO:0046777,0.800380880922254,0.525092904903831,1,225,protein autophosphorylation,BP,CAMK2A
469,GO:0001501,0.801106524736482,0.427052253013507,2,447,skeletal system development,BP,CHI3L1;DMRT2
9070,GO:0033673,0.802437125791055,0.521663684420199,1,250,negative regulation of kinase activity,BP,RGS4
12165,GO:0045765,0.802973114353366,0.520817207885142,1,245,regulation of angiogenesis,BP,CHI3L1
9423,GO:0034599,0.803110336792257,0.520541722432223,1,258,cellular response to oxidative stress,BP,KCNC2
3954,GO:0008202,0.803856069445027,0.519327786091839,1,259,steroid metabolic process,BP,SULT4A1
6636,GO:0019787,0.804380790235242,0.422121557068284,2,446,ubiquitin-like protein transferase activity,MF,LNX1;NEURL1
11042,GO:0043087,0.804832196131527,0.421457521487237,2,435,regulation of GTPase activity,BP,NGEF;RGS4
1196,GO:0002684,0.805320472619564,0.352800700851285,4,882,positive regulation of immune system process,BP,IGFBP2;CNR1;TESPA1;CXCL14
19310,GO:1902532,0.806457696098494,0.418954129947367,2,458,negative regulation of intracellular signal transduction,BP,RGS4;MRAP2
8409,GO:0032446,0.807630649410623,0.349592581802951,4,844,protein modification by small protein conjugation,BP,LNX1;NEURL1;NEUROD2;ENC1
16842,GO:0072331,0.810336156141355,0.508691187346175,1,259,signal transduction by p53 class mediator,BP,ZNF385D
11241,GO:0043406,0.812382794384627,0.505326185221634,1,249,positive regulation of MAP kinase activity,BP,GNG3
13511,GO:0050839,0.814033698204015,0.407340808833281,2,459,cell adhesion molecule binding,MF,TENM2;SELL
17637,GO:0097193,0.814952963048128,0.50093957909431,1,269,intrinsic apoptotic signaling pathway,BP,ZNF385D
5679,GO:0016055,0.81626291759498,0.403866326707002,2,471,Wnt signaling pathway,BP,CAMK2A;IGFBP2
18540,GO:0198738,0.818080926609593,0.401031330953013,2,473,cell-cell signaling by wnt,BP,CAMK2A;IGFBP2
3447,GO:0006839,0.818081975298057,0.495617189603723,1,277,mitochondrial transport,BP,CAMK2A
4823,GO:0010604,0.819106548661701,0.261725337280654,15,2755,positive regulation of macromolecule metabolic process,BP,PTPRN;RIMS1;CELF4;EPHB6;NEURL1;CHI3L1;TBR1;GNG3;ADCY1;NEUROD2;DMRT2;GRIN1;DDN;CCK;GRIN2B
4541,GO:0009607,0.820096608632146,0.356264977772822,3,717,response to biotic stimulus,BP,CHGA;CNR1;VGF
7801,GO:0031327,0.822485398684524,0.291416601142739,7,1402,negative regulation of cellular biosynthetic process,BP,CELF4;CRYM;HPCA;TENM2;NEUROD2;ENC1;MYT1L
19909,GO:1903827,0.823996542742631,0.391726542691246,2,476,regulation of cellular protein localization,BP,HPCA;MRAP2
11131,GO:0043229,0.826658941941512,0.235507182837206,67,11050,intracellular organelle,CC,CACNG3;CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;SYT1;CAMK2A;SNCB;RBFOX1;RIMS1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;NEFM;SLC17A7;DNM1;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;UNC13C;SLC14A1;CXCL14;GABRB2;TENM2;ZNF385D;GABRA2;CHST9;NRGN;SYN2;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;CREG2;GRIN1;DDN;MAP7D2;SV2B;MYT1L;SELL;SLC6A17
13785,GO:0051254,0.828088324162012,0.283855099784279,7,1398,positive regulation of RNA metabolic process,BP,PTPRN;CELF4;TBR1;NEUROD2;DMRT2;GRIN1;DDN
13843,GO:0051348,0.829213788356008,0.476341756280721,1,275,negative regulation of transferase activity,BP,RGS4
3521,GO:0006955,0.829701862640086,0.274606892743798,8,1692,immune response,BP,CAMK2A;CHGA;CNR1;SNAP25;CHI3L1;TESPA1;CXCL14;SELL
2764,GO:0005788,0.830327449484503,0.474402024174738,1,267,endoplasmic reticulum lumen,CC,VGF
13439,GO:0050727,0.831200480861999,0.472797395705657,1,283,regulation of inflammatory response,BP,CNR1
18883,GO:1901342,0.831445972413433,0.472413668568641,1,268,regulation of vasculature development,BP,CHI3L1
6618,GO:0019752,0.831678695414824,0.315154410962981,4,928,carboxylic acid metabolic process,BP,BCAT1;CRYM;CNR1;GAD2
4620,GO:0009890,0.83190490487046,0.278663524552648,7,1422,negative regulation of biosynthetic process,BP,CELF4;CRYM;HPCA;TENM2;NEUROD2;ENC1;MYT1L
10133,GO:0036094,0.833118998307819,0.25212854912859,12,2242,small molecule binding,MF,CAMK1G;CAMK2A;RPH3A;EEF1A2;CRYM;EPHB6;DNM1;GAD2;SYN2;ADCY1;GRIN1;GRIN2B
8770,GO:0032984,0.834424327117263,0.467004513834042,1,294,protein-containing complex disassembly,BP,STMN2
3543,GO:0006996,0.835208145373111,0.234364667126143,19,3463,organelle organization,BP,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;NEFH;CHGA;STMN2;NEFM;SLC17A7;DNM1;NEURL1;IQSEC3;PACSIN1;SNAP25;SYT4;UNC13C;MAP7D2;CCK
9429,GO:0034613,0.83942844860698,0.261512990564151,8,1643,cellular protein localization,BP,CACNG3;RIMS1;RPH3A;HPCA;PACSIN1;SNAP25;MRAP2;GRIN1
8453,GO:0032496,0.840218139552422,0.456493329788074,1,295,response to lipopolysaccharide,BP,CNR1
13395,GO:0050678,0.841969963586974,0.453333474327255,1,277,regulation of epithelial cell proliferation,BP,PTPRN
2751,GO:0005773,0.842983014897479,0.321467336412688,3,715,vacuole,CC,CHGA;EEF1A2;SLC30A3
11736,GO:0044772,0.843363996931068,0.36026787536015,2,515,mitotic cell cycle phase transition,BP,BCAT1;CAMK2A
15939,GO:0070727,0.844127996221789,0.255116825858123,8,1653,cellular macromolecule localization,BP,CACNG3;RIMS1;RPH3A;HPCA;PACSIN1;SNAP25;MRAP2;GRIN1
2421,GO:0005096,0.844772029419034,0.44819956668307,1,262,GTPase activator activity,MF,RGS4
11539,GO:0044248,0.847975665643356,0.239902253929214,10,2055,cellular catabolic process,BP,BCAT1;LNX1;EEF1A2;CRYM;CNR1;GDA;CHI3L1;GAD2;FABP7;ENC1
7143,GO:0030098,0.84904986341654,0.440092437660569,1,286,lymphocyte differentiation,BP,TESPA1
2765,GO:0005789,0.849692845415769,0.288390322735962,4,930,endoplasmic reticulum membrane,CC,PTPN5;MRAP2;TESPA1;DDN
3178,GO:0006470,0.850085542485155,0.438148805582296,1,281,protein dephosphorylation,BP,PTPN5
14512,GO:0060070,0.850597649449985,0.437140851800946,1,292,canonical Wnt signaling pathway,BP,IGFBP2
18051,GO:0098827,0.852141250826887,0.28467965025006,4,934,endoplasmic reticulum subcompartment,CC,PTPN5;MRAP2;TESPA1;DDN
11645,GO:0044437,0.854167520024517,0.342055316305083,2,525,vacuolar part,CC,EEF1A2;SLC30A3
2277,GO:0004857,0.855026302582404,0.428595939281962,1,314,enzyme inhibitor activity,MF,SNCB
74,GO:0000151,0.85565301428065,0.427458883690963,1,289,ubiquitin ligase complex,CC,ENC1
12256,GO:0045934,0.85609758126362,0.253243266543449,6,1282,negative regulation of nucleobase-containing compound metabolic process,BP,CELF4;CRYM;HPCA;TENM2;NEUROD2;MYT1L
945,GO:0002237,0.856815009779145,0.425140350271959,1,311,response to molecule of bacterial origin,BP,CNR1
4773,GO:0010506,0.857291648302306,0.424269764749072,1,292,regulation of autophagy,BP,EEF1A2
7802,GO:0031328,0.858018000787688,0.235962919543975,8,1652,positive regulation of cellular biosynthetic process,BP,PTPRN;HPCA;MRAP2;TBR1;NEUROD2;DMRT2;GRIN1;DDN
18446,GO:0120031,0.858133700806058,0.335265589034492,2,506,plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
17634,GO:0097190,0.859712922935848,0.332479554711216,2,552,apoptotic signaling pathway,BP,ZNF385D;CCK
10602,GO:0042175,0.860309945366911,0.272169593173453,4,947,nuclear outer membrane-endoplasmic reticulum membrane network,CC,PTPN5;MRAP2;TESPA1;DDN
3174,GO:0006464,0.86103638992764,0.200544297947731,20,3680,cellular protein modification process,BP,CAMK1G;NNAT;CAMK2A;LNX1;ST8SIA5;EPHB6;NEURL1;PTPN5;RGS4;VGF;CHRM3;CHI3L1;SHC3;GNG3;ADCY1;NEUROD2;ENC1;GRIN1;CCK;GRIN2B
10182,GO:0036211,0.86103638992764,0.200544297947731,20,3680,protein modification process,BP,CAMK1G;NNAT;CAMK2A;LNX1;ST8SIA5;EPHB6;NEURL1;PTPN5;RGS4;VGF;CHRM3;CHI3L1;SHC3;GNG3;ADCY1;NEUROD2;ENC1;GRIN1;CCK;GRIN2B
288,GO:0000790,0.861294161804727,0.416386438147441,1,304,nuclear chromatin,CC,ENC1
3205,GO:0006508,0.861808164186936,0.236979521311848,7,1519,proteolysis,BP,LNX1;TENM2;ENC1;PCSK1;GRIN1;CCK;GRIN2B
3101,GO:0006357,0.861879780492298,0.221123784734964,10,2015,regulation of transcription by RNA polymerase II,BP,PTPRN;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
3559,GO:0007018,0.863251019199214,0.412556765818179,1,288,microtubule-based movement,BP,NEFH
11618,GO:0044389,0.863335357562301,0.412336895247188,1,305,ubiquitin-like protein ligase binding,MF,PTPRN
1053,GO:0002429,0.86374092017647,0.411493160728708,1,318,immune response-activating cell surface receptor signaling pathway,BP,TESPA1
3643,GO:0007178,0.863821183530041,0.411392973729008,1,297,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ZCCHC12
13776,GO:0051241,0.864062225430768,0.266356925632804,4,946,negative regulation of multicellular organismal process,BP,NGEF;STMN2;SYT4;NEUROD2
4005,GO:0008284,0.864346711098244,0.287381825203252,3,755,positive regulation of cell proliferation,BP,PTPRN;IGFBP2;CCK
4621,GO:0009891,0.866619576991914,0.223897204964756,8,1673,positive regulation of biosynthetic process,BP,PTPRN;HPCA;MRAP2;TBR1;NEUROD2;DMRT2;GRIN1;DDN
11734,GO:0044770,0.866633989239754,0.320369786640752,2,545,cell cycle phase transition,BP,BCAT1;CAMK2A
11635,GO:0044422,0.867084331852956,0.181377565110109,48,8301,organelle part,CC,CACNG3;CAMK1G;GABRA1;PTPRN;SYT1;CAMK2A;RBFOX1;RPH3A;NEFH;CHGA;EEF1A2;ST8SIA5;CRYM;NEFM;SLC17A7;DNM1;PTPN5;GABRG2;SLC30A3;CNR1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;SLC14A1;GABRB2;TENM2;GABRA2;CHST9;NRGN;SYN2;IGFN1;TMEM130;ENC1;ZCCHC12;PCSK1;GRIN1;DDN;SV2B;SELL;SLC6A17;GRIN2B
1614,GO:0003713,0.868362371035332,0.402243998564262,1,303,transcription coactivator activity,MF,ZCCHC12
19309,GO:1902531,0.868424515803397,0.221346758787767,8,1666,regulation of intracellular signal transduction,BP,NGEF;EPHB6;RGS4;IQSEC3;CHI3L1;MRAP2;GNG3;NEUROD2
3308,GO:0006631,0.871618337766446,0.3955371235578,1,326,fatty acid metabolic process,BP,CNR1
4840,GO:0010628,0.871763723943527,0.216605412230213,8,1676,positive regulation of gene expression,BP,PTPRN;RIMS1;CELF4;TBR1;NEUROD2;DMRT2;GRIN1;DDN
19444,GO:1902903,0.87183488301343,0.395140467138641,1,308,regulation of supramolecular fiber organization,BP,STMN2
953,GO:0002252,0.874023983608464,0.250683511703571,4,994,immune effector process,BP,CHGA;SNAP25;CHI3L1;SELL
7152,GO:0030111,0.875001734091655,0.388562145955086,1,319,regulation of Wnt signaling pathway,BP,IGFBP2
59,GO:0000122,0.875365783291572,0.269156846963183,3,746,negative regulation of transcription by RNA polymerase II,BP,CRYM;TENM2;MYT1L
1862,GO:0004175,0.876962095310758,0.384444885792893,1,328,endopeptidase activity,MF,PCSK1
11643,GO:0044432,0.878319469909632,0.230312709654602,5,1172,endoplasmic reticulum part,CC,PTPN5;VGF;MRAP2;TESPA1;DDN
12580,GO:0046649,0.879707976643606,0.296802270378665,2,568,lymphocyte activation,BP,IGFBP2;TESPA1
10493,GO:0040011,0.881248421878257,0.208808383969114,7,1518,locomotion,BP,CHGA;NEURL1;TBR1;CXCL14;SHC3;CCK;SELL
6035,GO:0016773,0.88151741288752,0.258781577675627,3,720,phosphotransferase activity, alcohol group as acceptor,MF,CAMK1G;CAMK2A;EPHB6
11414,GO:0043900,0.881599313665555,0.37460659705987,1,339,regulation of multi-organism process,BP,CNR1
4797,GO:0010558,0.881774227011741,0.215354585857038,6,1339,negative regulation of macromolecule biosynthetic process,BP,CELF4;CRYM;TENM2;NEUROD2;ENC1;MYT1L
4596,GO:0009792,0.882119148901432,0.292384547115879,2,545,embryo development ending in birth or egg hatching,BP,CELF4;DMRT2
3520,GO:0006954,0.882173451765363,0.292241579121852,2,589,inflammatory response,BP,CNR1;CHI3L1
12225,GO:0045893,0.882318169749419,0.214535182052323,6,1329,positive regulation of transcription, DNA-templated,BP,PTPRN;TBR1;NEUROD2;DMRT2;GRIN1;DDN
19735,GO:1903508,0.882318169749419,0.214535182052323,6,1329,positive regulation of nucleic acid-templated transcription,BP,PTPRN;TBR1;NEUROD2;DMRT2;GRIN1;DDN
19365,GO:1902680,0.882769729610998,0.213852216381828,6,1330,positive regulation of RNA biosynthetic process,BP,PTPRN;TBR1;NEUROD2;DMRT2;GRIN1;DDN
13777,GO:0051246,0.883386223504466,0.185191728104791,12,2450,regulation of protein metabolic process,BP,EEF1A2;CELF4;EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1;ENC1;GRIN1;CCK;GRIN2B
13784,GO:0051253,0.884465862743423,0.220768868116561,5,1156,negative regulation of RNA metabolic process,BP,CELF4;CRYM;TENM2;NEUROD2;MYT1L
19911,GO:1903829,0.885053752882202,0.367209467845934,1,326,positive regulation of cellular protein localization,BP,HPCA
15146,GO:0061061,0.886866809441483,0.283534384657324,2,556,muscle structure development,BP,NEURL1;CXCL14
1262,GO:0002768,0.888052536416804,0.360625820265587,1,347,immune response-regulating cell surface receptor signaling pathway,BP,TESPA1
10603,GO:0042176,0.888334644861415,0.360039272944371,1,333,regulation of protein catabolic process,BP,EEF1A2
8278,GO:0032268,0.88933248527272,0.179712856640104,11,2288,regulation of cellular protein metabolic process,BP,CELF4;EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1;ENC1;GRIN1;CCK;GRIN2B
6211,GO:0017111,0.891057855890583,0.242314093934553,3,764,nucleoside-triphosphatase activity,MF,EEF1A2;DNM1;GNG3
5177,GO:0014706,0.893015042552878,0.34967458019093,1,329,striated muscle tissue development,BP,NEURL1
13470,GO:0050776,0.893485959123204,0.238030716412051,3,828,regulation of immune response,BP,CNR1;TESPA1;SELL
8476,GO:0032535,0.89459210636606,0.346118043004833,1,335,regulation of cellular component size,BP,SLC12A5
7183,GO:0030155,0.896758612692923,0.264671252307587,2,582,regulation of cell adhesion,BP,IGFBP2;TESPA1
9142,GO:0033993,0.897043141548574,0.231760300626064,3,815,response to lipid,BP,IGFBP2;CNR1;ADCY1
14638,GO:0060271,0.898309865973983,0.33766538474914,1,338,cilium assembly,BP,NEURL1
7190,GO:0030163,0.89861726806265,0.228967551337466,3,806,protein catabolic process,BP,LNX1;EEF1A2;ENC1
4849,GO:0010638,0.899821682526765,0.258711411974385,2,587,positive regulation of organelle organization,BP,SYT1;STMN2
7840,GO:0031399,0.900282837887432,0.18025420446981,7,1575,regulation of protein modification process,BP,EPHB6;NEURL1;RGS4;CHI3L1;GNG3;ADCY1;CCK
3783,GO:0007517,0.900326268988725,0.333013632400655,1,344,muscle organ development,BP,NEURL1
14444,GO:0055114,0.90139157784899,0.223978586738974,3,870,oxidation-reduction process,BP,CRYM;CNR1;MRAP2
13841,GO:0051346,0.901758762928885,0.329651477627865,1,364,negative regulation of hydrolase activity,BP,TMEM132D
13091,GO:0048545,0.902591579184115,0.327729785278249,1,355,response to steroid hormone,BP,IGFBP2
3503,GO:0006928,0.902897918352981,0.171093766420521,8,1741,movement of cell or subcellular component,BP,NEFH;CHGA;NEURL1;TBR1;CXCL14;SHC3;CCK;SELL
3307,GO:0006629,0.903154373809736,0.190937479451305,5,1238,lipid metabolic process,BP,EEF1A2;ST8SIA5;CNR1;SULT4A1;FABP7
2635,GO:0005578,0.903258738540291,0.326209913996865,1,337,proteinaceous extracellular matrix,CC,CHI3L1
11640,GO:0044429,0.903651181922804,0.219894761104816,3,909,mitochondrial part,CC,DNM1;CNR1;NRGN
14837,GO:0060537,0.903697429729003,0.325168396294323,1,343,muscle tissue development,BP,NEURL1
1195,GO:0002683,0.904238462175185,0.323846035771288,1,368,negative regulation of immune system process,BP,CNR1
15901,GO:0070647,0.904812364596865,0.200029825076735,4,1010,protein modification by small protein conjugation or removal,BP,LNX1;NEURL1;NEUROD2;ENC1
11788,GO:0044877,0.905616005402952,0.216380986076398,3,804,protein-containing complex binding,MF,RPH3A;NEFH;GRIN1
11741,GO:0044782,0.905663704216658,0.320522972159931,1,349,cilium organization,BP,NEURL1
11246,GO:0043412,0.905766289135665,0.142068337374358,20,3845,macromolecule modification,BP,CAMK1G;NNAT;CAMK2A;LNX1;ST8SIA5;EPHB6;NEURL1;PTPN5;RGS4;VGF;CHRM3;CHI3L1;SHC3;GNG3;ADCY1;NEUROD2;ENC1;GRIN1;CCK;GRIN2B
4006,GO:0008285,0.906532431088165,0.245432432997358,2,608,negative regulation of cell proliferation,BP,NEURL1;FABP7
1194,GO:0002682,0.906974099169675,0.184680289512025,5,1276,regulation of immune system process,BP,IGFBP2;CNR1;TESPA1;CXCL14;SELL
665,GO:0001816,0.907374777078477,0.243738577816961,2,618,cytokine production,BP,CHGA;CHI3L1
16263,GO:0071363,0.908553564185517,0.241387231597852,2,597,cellular response to growth factor stimulus,BP,STMN2;ZCCHC12
12446,GO:0046394,0.908654385076866,0.31334725200404,1,374,carboxylic acid biosynthetic process,BP,BCAT1
13797,GO:0051270,0.908930250191103,0.210327568214834,3,811,regulation of cellular component movement,BP,NEFH;TBR1;CXCL14
5872,GO:0016462,0.908998922750532,0.21020395140803,3,806,pyrophosphatase activity,MF,EEF1A2;DNM1;GNG3
13472,GO:0050778,0.909165691304564,0.240127680864196,2,631,positive regulation of immune response,BP,CNR1;TESPA1
5957,GO:0016607,0.909189875201217,0.312085947570749,1,361,nuclear speck,CC,ZCCHC12
5677,GO:0016053,0.909289821234125,0.311818661622592,1,375,organic acid biosynthetic process,BP,BCAT1
6313,GO:0018205,0.909346676750737,0.311716736059257,1,357,peptidyl-lysine modification,BP,NNAT
6067,GO:0016817,0.909504299916337,0.209275035981947,3,808,hydrolase activity, acting on acid anhydrides,MF,EEF1A2;DNM1;GNG3
6068,GO:0016818,0.909504299916337,0.209275035981947,3,808,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,EEF1A2;DNM1;GNG3
5800,GO:0016301,0.910854128987476,0.20680125759197,3,784,kinase activity,MF,CAMK1G;CAMK2A;EPHB6
3556,GO:0007015,0.912269850305554,0.304628337044315,1,359,actin filament organization,BP,PACSIN1
11339,GO:0043565,0.912335552363428,0.187057668956516,4,1019,sequence-specific DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN
19843,GO:1903706,0.913152014141012,0.302419140721113,1,387,regulation of hemopoiesis,BP,TESPA1
7119,GO:0030036,0.914521070932064,0.229248845263223,2,595,actin cytoskeleton organization,BP,IQSEC3;PACSIN1
2664,GO:0005615,0.914879426251686,0.136954053090838,14,3093,extracellular space,CC,CHGA;CRYM;DNM1;IGFBP2;GDA;VGF;CHI3L1;CXCL14;GABRB2;MAL2;ADCY1;PCSK1;CCK;CPNE4
3108,GO:0006366,0.916445546417766,0.143457450489416,10,2184,transcription by RNA polymerase II,BP,PTPRN;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
7822,GO:0031349,0.916775825649229,0.293449195708029,1,394,positive regulation of defense response,BP,CNR1
11395,GO:0043687,0.916999127645018,0.292895307877345,1,392,post-translational protein modification,BP,VGF
13975,GO:0051603,0.917522802732588,0.223018220518606,2,627,proteolysis involved in cellular protein catabolic process,BP,LNX1;ENC1
11634,GO:0044421,0.920361753952763,0.127640748624206,15,3280,extracellular region part,CC,CHGA;CRYM;DNM1;IGFBP2;GDA;VGF;SYT4;CHI3L1;CXCL14;GABRB2;MAL2;ADCY1;PCSK1;CCK;CPNE4
11326,GO:0043547,0.920636359621306,0.283785556513224,1,362,positive regulation of GTPase activity,BP,RGS4
461,GO:0001228,0.921369093257877,0.281887848846208,1,379,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NEUROD2
750,GO:0001933,0.922131640197231,0.279924426514751,1,387,negative regulation of protein phosphorylation,BP,RGS4
6469,GO:0019221,0.924089219731548,0.209156771887706,2,686,cytokine-mediated signaling pathway,BP,PTPRN;CAMK2A
1618,GO:0003723,0.924428844927905,0.147987575893002,6,1531,RNA binding,MF,RBFOX1;RIMS1;EEF1A2;CELF4;DNM1;ZNF385D
2814,GO:0005874,0.924519818875168,0.27378246578023,1,379,microtubule,CC,DNM1
7037,GO:0022613,0.925553065291573,0.271001606643247,1,442,ribonucleoprotein complex biogenesis,BP,CELF4
11557,GO:0044283,0.927138415037237,0.20262387924065,2,673,small molecule biosynthetic process,BP,BCAT1;GDA
11652,GO:0044446,0.927634648130901,0.104620652277514,45,8105,intracellular organelle part,CC,CACNG3;CAMK1G;GABRA1;PTPRN;SYT1;CAMK2A;RBFOX1;RPH3A;NEFH;CHGA;EEF1A2;ST8SIA5;CRYM;NEFM;SLC17A7;DNM1;PTPN5;GABRG2;SLC30A3;CNR1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;GAD2;UNC13C;SLC14A1;GABRB2;TENM2;GABRA2;CHST9;NRGN;SYN2;TMEM130;ENC1;ZCCHC12;PCSK1;DDN;SV2B;SELL;SLC6A17
12489,GO:0046486,0.928181784767409,0.264164768681642,1,396,glycerolipid metabolic process,BP,FABP7
19734,GO:1903507,0.929856570410526,0.155756529095178,4,1081,negative regulation of nucleic acid-templated transcription,BP,CRYM;TENM2;NEUROD2;MYT1L
21207,GO:2000113,0.929921225387812,0.145849263339345,5,1278,negative regulation of cellular macromolecule biosynthetic process,BP,CELF4;CRYM;TENM2;ENC1;MYT1L
13196,GO:0048732,0.930102378039148,0.2590598322738,1,396,gland development,BP,NEURL1
19364,GO:1902679,0.930298687333013,0.154945130896922,4,1083,negative regulation of RNA biosynthetic process,BP,CRYM;TENM2;NEUROD2;MYT1L
17723,GO:0097367,0.930329285768649,0.1252728707599,9,1979,carbohydrate derivative binding,MF,CAMK1G;CAMK2A;EEF1A2;EPHB6;DNM1;CHI3L1;SYN2;ADCY1;SELL
4300,GO:0009056,0.931164263095042,0.121164074567037,10,2305,catabolic process,BP,BCAT1;LNX1;EEF1A2;CRYM;CNR1;GDA;CHI3L1;GAD2;FABP7;ENC1
6574,GO:0019538,0.93144506049754,0.103368905380786,26,5052,protein metabolic process,BP,CAMK1G;NNAT;CAMK2A;LNX1;EEF1A2;CELF4;ST8SIA5;EPHB6;NEURL1;PTPN5;IGFBP2;RGS4;VGF;CHRM3;CHI3L1;TENM2;SHC3;CHST9;GNG3;ADCY1;NEUROD2;ENC1;PCSK1;GRIN1;CCK;GRIN2B
6048,GO:0016788,0.931481789428263,0.193173713081101,2,660,hydrolase activity, acting on ester bonds,MF,PTPN5;CHRM3
7798,GO:0031324,0.931537117398448,0.120594585452895,10,2239,negative regulation of cellular metabolic process,BP,CELF4;CRYM;RGS4;CNR1;HPCA;TENM2;TMEM132D;NEUROD2;ENC1;MYT1L
7246,GO:0030234,0.931911990892821,0.166566915421536,3,895,enzyme regulator activity,MF,SNCB;RIMS1;RGS4
7319,GO:0030335,0.933617090655282,0.249557567928719,1,409,positive regulation of cell migration,BP,CXCL14
12992,GO:0048285,0.933823076536066,0.248998937738496,1,407,organelle fission,BP,DNM1
2839,GO:0005911,0.936475816883312,0.241719729760514,1,399,cell-cell junction,CC,FABP7
11542,GO:0044257,0.936887600378513,0.181147187007721,2,676,cellular protein catabolic process,BP,LNX1;ENC1
10669,GO:0042326,0.937004605046177,0.240222970219992,1,420,negative regulation of phosphorylation,BP,RGS4
21224,GO:2000147,0.937499499425815,0.238846157364079,1,420,positive regulation of cell motility,BP,CXCL14
13266,GO:0048870,0.938316500330174,0.131005468000318,5,1309,cell motility,BP,CHGA;NEURL1;CXCL14;CCK;SELL
14011,GO:0051674,0.938316500330174,0.131005468000318,5,1309,localization of cell,BP,CHGA;NEURL1;CXCL14;CCK;SELL
1111,GO:0002521,0.938332223638894,0.236517747658166,1,422,leukocyte differentiation,BP,TESPA1
19772,GO:1903561,0.939208119102984,0.108667919359922,10,2434,extracellular vesicle,CC,CRYM;DNM1;IGFBP2;GDA;SYT4;CHI3L1;GABRB2;MAL2;ADCY1;CPNE4
11132,GO:0043230,0.93949766600933,0.108213763182157,10,2436,extracellular organelle,CC,CRYM;DNM1;IGFBP2;GDA;SYT4;CHI3L1;GABRB2;MAL2;ADCY1;CPNE4
4661,GO:0010008,0.939513688729611,0.233194306636021,1,425,endosome membrane,CC,SLC30A3
11548,GO:0044267,0.940633844033542,0.0920812954842748,23,4601,cellular protein metabolic process,BP,CAMK1G;NNAT;CAMK2A;LNX1;EEF1A2;CELF4;ST8SIA5;EPHB6;NEURL1;PTPN5;IGFBP2;RGS4;VGF;CHRM3;CHI3L1;SHC3;GNG3;ADCY1;NEUROD2;ENC1;GRIN1;CCK;GRIN2B
4770,GO:0010498,0.941492678264915,0.227567076800556,1,436,proteasomal protein catabolic process,BP,ENC1
13799,GO:0051272,0.941957778187,0.226244231062984,1,431,positive regulation of cellular component movement,BP,CXCL14
1252,GO:0002757,0.942948997627038,0.223379644182198,1,447,immune response-activating signal transduction,BP,TESPA1
7629,GO:0031012,0.943530441985414,0.22172931912443,1,425,extracellular matrix,CC,CHI3L1
4004,GO:0008283,0.944935673707001,0.108489798928513,7,1764,cell proliferation,BP,PTPRN;BCAT1;NEURL1;IGFBP2;CHRM3;FABP7;CCK
7113,GO:0030029,0.945938138992122,0.160358043956271,2,674,actin filament-based process,BP,IQSEC3;PACSIN1
11849,GO:0045087,0.946116038842476,0.159908029408529,2,742,innate immune response,BP,CAMK2A;CHGA
11541,GO:0044255,0.946608868400546,0.136658144072902,3,951,cellular lipid metabolic process,BP,ST8SIA5;CNR1;FABP7
14025,GO:0051704,0.946806876953561,0.101806411022481,8,2025,multi-organism process,BP,CHGA;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;GRIN1
487,GO:0001525,0.946981744131121,0.211636610078792,1,432,angiogenesis,BP,CHI3L1
284,GO:0000785,0.947355061037264,0.210511346780869,1,450,chromatin,CC,ENC1
16969,GO:0072594,0.947886047157508,0.208892301072692,1,493,establishment of protein localization to organelle,BP,CACNG3
9868,GO:0035639,0.948263821224018,0.102805641735925,7,1677,purine ribonucleoside triphosphate binding,MF,CAMK1G;CAMK2A;EEF1A2;EPHB6;DNM1;SYN2;ADCY1
10499,GO:0040017,0.948492439016834,0.207131428356661,1,449,positive regulation of locomotion,BP,CXCL14
5955,GO:0016604,0.949788783182769,0.151217453149157,2,702,nuclear body,CC,TENM2;ZCCHC12
4796,GO:0010557,0.950366749671155,0.103395039059207,6,1558,positive regulation of macromolecule biosynthetic process,BP,PTPRN;TBR1;NEUROD2;DMRT2;GRIN1;DDN
3497,GO:0006914,0.950711850714874,0.200451635736265,1,456,autophagy,BP,EEF1A2
15495,GO:0061919,0.950711850714874,0.200451635736265,1,456,process utilizing autophagic mechanism,BP,EEF1A2
5685,GO:0016071,0.950998827655472,0.148282777253785,2,771,mRNA metabolic process,BP,RBFOX1;CELF4
10572,GO:0042127,0.951109724995186,0.107587684693626,5,1403,regulation of cell proliferation,BP,PTPRN;NEURL1;IGFBP2;FABP7;CCK
18515,GO:0140110,0.951259250640266,0.0976248566750007,7,1741,transcription regulator activity,MF,CRYM;TBR1;NEUROD2;DMRT2;ZCCHC12;DDN;MYT1L
11648,GO:0044440,0.951955196156039,0.19666411539151,1,461,endosomal part,CC,SLC30A3
1259,GO:0002764,0.953082658620186,0.193190972580728,1,476,immune response-regulating signaling pathway,BP,TESPA1
8279,GO:0032269,0.953825493477635,0.121289535334898,3,974,negative regulation of cellular protein metabolic process,BP,CELF4;RGS4;ENC1
3622,GO:0007155,0.95400731443857,0.109566183739495,4,1156,cell adhesion,BP,IGFBP2;TESPA1;TENM2;SELL
13141,GO:0048646,0.954162082424772,0.120569657690182,3,937,anatomical structure formation involved in morphogenesis,BP,CHI3L1;TBR1;DMRT2
7035,GO:0022610,0.955519587950118,0.106527406424031,4,1163,biological adhesion,BP,IGFBP2;TESPA1;TENM2;SELL
8488,GO:0032555,0.956046337534807,0.0892475244677974,7,1716,purine ribonucleotide binding,MF,CAMK1G;CAMK2A;EEF1A2;EPHB6;DNM1;SYN2;ADCY1
6034,GO:0016772,0.956143284728493,0.116254648921377,3,934,transferase activity, transferring phosphorus-containing groups,MF,CAMK1G;CAMK2A;EPHB6
8118,GO:0031967,0.956517255185653,0.115408589913608,3,1053,organelle envelope,CC,DNM1;CNR1;NRGN
8122,GO:0031975,0.956517255185653,0.115408589913608,3,1053,envelope,CC,DNM1;CNR1;NRGN
11660,GO:0044454,0.957256070321747,0.18014027971139,1,479,nuclear chromosome part,CC,ENC1
3862,GO:0008047,0.957415374592477,0.179647432046936,1,465,enzyme activator activity,MF,RGS4
4301,GO:0009057,0.957755604887243,0.101988451411108,4,1229,macromolecule catabolic process,BP,LNX1;EEF1A2;CHI3L1;ENC1
15530,GO:0070011,0.957862478090266,0.178204207071684,1,486,peptidase activity, acting on L-amino acid peptides,MF,PCSK1
8486,GO:0032553,0.958135982823295,0.0855438336399539,7,1728,ribonucleotide binding,MF,CAMK1G;CAMK2A;EEF1A2;EPHB6;DNM1;SYN2;ADCY1
6192,GO:0017076,0.95834340081136,0.0851745809387444,7,1730,purine nucleotide binding,MF,CAMK1G;CAMK2A;EEF1A2;EPHB6;DNM1;SYN2;ADCY1
13918,GO:0051493,0.95938736952834,0.173323459349881,1,473,regulation of cytoskeleton organization,BP,STMN2
5876,GO:0016477,0.959663876010836,0.098092396820433,4,1193,cell migration,BP,CHGA;CXCL14;CCK;SELL
6047,GO:0016787,0.959824517212187,0.0773436030389149,9,2218,hydrolase activity,MF,EEF1A2;DNM1;PTPN5;GDA;CHRM3;CHI3L1;GNG3;PCSK1;MPPED1
954,GO:0002253,0.960349568870213,0.170179432088014,1,504,activation of immune response,BP,TESPA1
83,GO:0000166,0.960682309309538,0.0781707514433733,8,1948,nucleotide binding,MF,CAMK1G;CAMK2A;EEF1A2;CRYM;EPHB6;DNM1;SYN2;ADCY1
18854,GO:1901265,0.960773735631778,0.0780111340006833,8,1949,nucleoside phosphate binding,MF,CAMK1G;CAMK2A;EEF1A2;CRYM;EPHB6;DNM1;SYN2;ADCY1
7803,GO:0031329,0.960893542838974,0.123779719661816,2,760,regulation of cellular catabolic process,BP,EEF1A2;CNR1
1609,GO:0003700,0.962227120809994,0.0863128653463164,5,1401,DNA binding transcription factor activity,MF,TBR1;NEUROD2;DMRT2;DDN;MYT1L
7797,GO:0031323,0.963318007201338,0.0579907327850873,28,5530,regulation of cellular metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;EEF1A2;CELF4;CRYM;EPHB6;NEURL1;RGS4;CNR1;HPCA;CHI3L1;MRAP2;TBR1;TENM2;TMEM132D;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
6017,GO:0016740,0.963992377922411,0.0702141879847787,9,2201,transferase activity,MF,CAMK1G;BCAT1;CAMK2A;LNX1;ST8SIA5;EPHB6;NEURL1;SULT4A1;CHST9
2786,GO:0005829,0.964123678199647,0.0586247591149203,22,4599,cytosol,CC,BCAT1;NGEF;SYT1;CAMK2A;SNCB;RIMS1;RPH3A;CRYM;EPHB6;RGS4;GDA;HPCA;PACSIN1;SULT4A1;SNAP25;GAD2;STAC2;GABRB2;SHC3;VSNL1;FABP7;ADCY1
3972,GO:0008233,0.964194183692536,0.157474293380573,1,510,peptidase activity,MF,PCSK1
13779,GO:0051248,0.964429488714204,0.0977000657056393,3,1027,negative regulation of protein metabolic process,BP,CELF4;RGS4;ENC1
7025,GO:0022411,0.965496679451891,0.153065896249412,1,526,cellular component disassembly,BP,STMN2
112,GO:0000228,0.965920910913605,0.151633830938479,1,511,nuclear chromosome,CC,ENC1
8639,GO:0032787,0.966683375643032,0.149013387078304,1,530,monocarboxylic acid metabolic process,BP,CNR1
15554,GO:0070062,0.967299285622487,0.0644670735175446,9,2418,extracellular exosome,CC,CRYM;DNM1;IGFBP2;GDA;CHI3L1;GABRB2;MAL2;ADCY1;CPNE4
2615,GO:0005524,0.967366171258032,0.0761213095028445,5,1372,ATP binding,MF,CAMK1G;CAMK2A;EPHB6;SYN2;ADCY1
16286,GO:0071396,0.967664906989564,0.145642098010254,1,514,cellular response to lipid,BP,ADCY1
17070,GO:0080090,0.96786635559634,0.0515804005232354,27,5408,regulation of primary metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;EEF1A2;CELF4;CRYM;EPHB6;NEURL1;RGS4;CNR1;HPCA;CHI3L1;MRAP2;TBR1;TENM2;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
19529,GO:1903047,0.968676330334516,0.103402771294872,2,802,mitotic cell cycle process,BP,BCAT1;CAMK2A
13072,GO:0048514,0.970142041819801,0.136967462552554,1,513,blood vessel morphogenesis,BP,CHI3L1
9459,GO:0034655,0.970223509330943,0.136639177874393,1,577,nucleobase-containing compound catabolic process,BP,GDA
2803,GO:0005856,0.970318320190981,0.0633210154921806,7,1846,cytoskeleton,CC,RIMS1;NEFH;NEFM;DNM1;SNAP25;ENC1;MAP7D2
13730,GO:0051171,0.970687805774554,0.0476308354739175,26,5276,regulation of nitrogen compound metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;EEF1A2;CELF4;CRYM;EPHB6;NEURL1;RGS4;HPCA;CHI3L1;MRAP2;TBR1;TENM2;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
12224,GO:0045892,0.970917287391952,0.0825575534000837,3,1044,negative regulation of transcription, DNA-templated,BP,CRYM;TENM2;MYT1L
8775,GO:0032991,0.970938358724843,0.0487112479540011,21,4539,protein-containing complex,CC,CACNG3;CAMK1G;GABRA1;SYT1;RPH3A;EEF1A2;EPHB6;DNM1;GABRA4;GABRG2;KCNS1;SNAP25;TESPA1;GABRB2;GABRA2;GNG3;ADCY1;KCNC2;ENC1;GRIN1;GRIN2B
13731,GO:0051172,0.971028929369309,0.0597279939359947,8,2098,negative regulation of nitrogen compound metabolic process,BP,CELF4;CRYM;RGS4;HPCA;TENM2;NEUROD2;ENC1;MYT1L
7841,GO:0031400,0.971199648981418,0.13318492861919,1,536,negative regulation of protein modification process,BP,RGS4
10494,GO:0040012,0.971408320264458,0.0959831658650721,2,802,regulation of locomotion,BP,TBR1;CXCL14
10996,GO:0043009,0.972007587621137,0.130285768952598,1,527,chordate embryonic development,BP,DMRT2
3207,GO:0006511,0.97204962702839,0.130126463395555,1,539,ubiquitin-dependent protein catabolic process,BP,LNX1
8492,GO:0032559,0.972387324272903,0.0658935496047764,5,1407,adenyl ribonucleotide binding,MF,CAMK1G;CAMK2A;EPHB6;SYN2;ADCY1
6711,GO:0019941,0.973762099225046,0.123880571274483,1,549,modification-dependent protein catabolic process,BP,LNX1
7412,GO:0030554,0.973772663134069,0.0630201211850852,5,1419,adenyl nucleotide binding,MF,CAMK1G;CAMK2A;EPHB6;SYN2;ADCY1
4622,GO:0009892,0.973970309021872,0.0512522827859811,10,2548,negative regulation of metabolic process,BP,CELF4;CRYM;RGS4;CNR1;HPCA;TENM2;TMEM132D;NEUROD2;ENC1;MYT1L
3124,GO:0006396,0.974761549991788,0.0866329591124042,2,891,RNA processing,BP,RBFOX1;CELF4
11378,GO:0043632,0.975164398994429,0.118680311102763,1,558,modification-dependent macromolecule catabolic process,BP,LNX1
13819,GO:0051301,0.976219718996642,0.114715321894892,1,561,cell division,BP,PACSIN1
2718,GO:0005730,0.976259152768579,0.0823827954597863,2,876,nucleolus,CC,SLC14A1;ENC1
12607,GO:0046700,0.976327435865629,0.114282324933568,1,615,heterocycle catabolic process,BP,GDA
11549,GO:0044270,0.97657222494189,0.113354261265934,1,617,cellular nitrogen compound catabolic process,BP,GDA
4624,GO:0009894,0.976933041244967,0.0804550854959063,2,852,regulation of catabolic process,BP,EEF1A2;CNR1
6470,GO:0019222,0.978307373362859,0.035632545225717,29,5893,regulation of metabolic process,BP,PTPRN;CAMK2A;RBFOX1;RIMS1;CHGA;EEF1A2;CELF4;CRYM;EPHB6;NEURL1;RGS4;CNR1;HPCA;CHI3L1;MRAP2;TBR1;TENM2;TMEM132D;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
6548,GO:0019439,0.978631100449665,0.105442322351168,1,632,aromatic compound catabolic process,BP,GDA
1031,GO:0002376,0.978677184032887,0.0440615499727558,9,2461,immune system process,BP,CAMK2A;CHGA;IGFBP2;CNR1;SNAP25;CHI3L1;TESPA1;CXCL14;SELL
5884,GO:0016491,0.978864412476718,0.104530026518137,1,642,oxidoreductase activity,MF,CRYM
7820,GO:0031347,0.98136997752166,0.094607247917711,1,622,regulation of defense response,BP,CNR1
3910,GO:0008134,0.98142248124638,0.0944070921354384,1,593,transcription factor binding,MF,PTPRN
18889,GO:1901361,0.981532055945942,0.0939411577703226,1,656,organic cyclic compound catabolic process,BP,GDA
515,GO:0001568,0.981960283406515,0.0922339859857968,1,583,blood vessel development,BP,CHI3L1
17079,GO:0080135,0.982213523844374,0.091195231853744,1,602,regulation of cellular response to stress,BP,CAMK2A
4841,GO:0010629,0.982748991744682,0.0437416366679582,5,1630,negative regulation of gene expression,BP,CELF4;CRYM;TENM2;ENC1;MYT1L
2708,GO:0005694,0.982850118092067,0.0629101189784939,2,898,chromosome,CC,ENC1;MYT1L
4200,GO:0008610,0.983215400584643,0.0870712775649415,1,624,lipid biosynthetic process,BP,ST8SIA5
4594,GO:0009790,0.98414426180059,0.0589219406811775,2,888,embryo development,BP,CELF4;DMRT2
4617,GO:0009887,0.984390508325408,0.0581529603108695,2,905,animal organ morphogenesis,BP,TBR1;SLC4A10
760,GO:0001944,0.984649646144169,0.0810765868184008,1,607,vasculature development,BP,CHI3L1
8811,GO:0033043,0.984808422932807,0.047585051982928,3,1156,regulation of organelle organization,BP,SYT1;STMN2;SYT4
16860,GO:0072358,0.985499176991128,0.077454509743628,1,615,cardiovascular system development,BP,CHI3L1
11550,GO:0044271,0.986878359728067,0.0236755046267535,20,4581,cellular nitrogen compound biosynthetic process,BP,PTPRN;CAMK2A;EEF1A2;CELF4;CRYM;NEURL1;GDA;HPCA;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
18508,GO:0140096,0.988025103148981,0.0283161232117676,7,2047,catalytic activity, acting on a protein,MF,CAMK1G;CAMK2A;LNX1;EPHB6;NEURL1;PTPN5;PCSK1
6698,GO:0019904,0.98854987145691,0.0639960080284658,1,653,protein domain specific binding,MF,LNX1
135,GO:0000278,0.988767072576108,0.0440875687926825,2,971,mitotic cell cycle,BP,BCAT1;CAMK2A
6467,GO:0019219,0.989623644774031,0.0199359248240446,16,3836,regulation of nucleobase-containing compound metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;CELF4;CRYM;HPCA;MRAP2;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
11547,GO:0044265,0.990076067486796,0.0396912380899355,2,1024,cellular macromolecule catabolic process,BP,LNX1;ENC1
7017,GO:0022402,0.990558747827922,0.0315812044053521,3,1257,cell cycle process,BP,BCAT1;CAMK2A;PACSIN1
7318,GO:0030334,0.9911221674881,0.05199355810351,1,697,regulation of cell migration,BP,CXCL14
7142,GO:0030097,0.992535207482652,0.0450784606399211,1,744,hemopoiesis,BP,TESPA1
11657,GO:0044451,0.992673879744131,0.030648580760283,2,1030,nucleoplasm part,CC,TENM2;ZCCHC12
20917,GO:1990234,0.992964506847231,0.0429270830471963,1,744,transferase complex,CC,ENC1
8966,GO:0033365,0.993019158996022,0.0426462567223743,1,778,protein localization to organelle,BP,CACNG3
7800,GO:0031326,0.993167359653541,0.0135683855531033,16,3955,regulation of cellular biosynthetic process,BP,PTPRN;CAMK2A;CELF4;CRYM;NEURL1;HPCA;MRAP2;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
21222,GO:2000145,0.993274294813876,0.0413584376147124,1,739,regulation of cell motility,BP,CXCL14
16038,GO:0070925,0.993583711346234,0.0397747969916962,1,747,organelle assembly,BP,NEURL1
11632,GO:0044419,0.993790491858715,0.0387004443915366,1,809,interspecies interaction between organisms,BP,CHGA
9636,GO:0035239,0.993798949608233,0.0386670187648423,1,732,tube morphogenesis,BP,CHI3L1
13084,GO:0048534,0.994221259130238,0.0364594524627442,1,782,hematopoietic or lymphoid organ development,BP,TESPA1
11533,GO:0044237,0.994238477290583,0.0100846593180437,48,9385,cellular metabolic process,BP,CACNG3;CAMK1G;NNAT;PTPRN;BCAT1;CAMK2A;LNX1;SNCB;RBFOX1;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;IGFBP2;RGS4;CNR1;GDA;HPCA;VGF;SULT4A1;SNAP25;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;TENM2;SHC3;TMEM132D;CHST9;GNG3;FABP7;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
4619,GO:0009889,0.994566602482724,0.0109798614740712,16,4015,regulation of biosynthetic process,BP,PTPRN;CAMK2A;CELF4;CRYM;NEURL1;HPCA;MRAP2;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
11638,GO:0044427,0.994590600927017,0.0345081267060773,1,784,chromosomal part,CC,ENC1
5470,GO:0015630,0.994784711290654,0.0228890604386525,2,1069,microtubule cytoskeleton,CC,DNM1;MAP7D2
14627,GO:0060255,0.994937266928412,0.00948579367163949,24,5463,regulation of macromolecule metabolic process,BP,PTPRN;CAMK2A;RBFOX1;RIMS1;EEF1A2;CELF4;CRYM;EPHB6;NEURL1;RGS4;CHI3L1;TBR1;TENM2;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
4824,GO:0010605,0.995434698636419,0.0118825845282335,7,2346,negative regulation of macromolecule metabolic process,BP,CELF4;CRYM;RGS4;TENM2;NEUROD2;ENC1;MYT1L
11544,GO:0044260,0.995559913857973,0.00798837679045213,35,7344,cellular macromolecule metabolic process,BP,CACNG3;CAMK1G;NNAT;PTPRN;CAMK2A;LNX1;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;IGFBP2;RGS4;VGF;SNAP25;CHRM3;CHI3L1;TBR1;TENM2;SHC3;CHST9;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L;CCK;GRIN2B
1110,GO:0002520,0.995602716395078,0.0290160837617716,1,821,immune system development,BP,TESPA1
11641,GO:0044430,0.995976147826782,0.0149823707050545,3,1378,cytoskeletal part,CC,NEFH;NEFM;DNM1
4760,GO:0010468,0.996389080956093,0.00752001192496923,16,4126,regulation of gene expression,BP,PTPRN;CAMK2A;RBFOX1;RIMS1;CELF4;CRYM;NEURL1;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
21206,GO:2000112,0.996465150712044,0.00762034265414121,14,3735,regulation of cellular macromolecule biosynthetic process,BP,PTPRN;CAMK2A;CELF4;CRYM;NEURL1;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
13783,GO:0051252,0.996544473093939,0.00760870342834571,13,3546,regulation of RNA metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CELF4;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
16492,GO:0071704,0.996564736963993,0.0062151995439952,48,9506,organic substance metabolic process,BP,CACNG3;CAMK1G;NNAT;PTPRN;BCAT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;IGFBP2;RGS4;CNR1;GDA;HPCA;VGF;SULT4A1;SNAP25;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;TENM2;SHC3;CHST9;GNG3;FABP7;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
9458,GO:0034654,0.9966925179827,0.00704135778688696,15,3968,nucleobase-containing compound biosynthetic process,BP,PTPRN;CAMK2A;CRYM;GDA;HPCA;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
11540,GO:0044249,0.996994869985345,0.00582818074818596,24,5674,cellular biosynthetic process,BP,PTPRN;BCAT1;CAMK2A;EEF1A2;CELF4;ST8SIA5;CRYM;NEURL1;GDA;HPCA;MRAP2;TBR1;GAD2;TENM2;CHST9;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
6293,GO:0018130,0.997347672031242,0.0057370059918143,15,4024,heterocycle biosynthetic process,BP,PTPRN;CAMK2A;CRYM;GDA;HPCA;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
6547,GO:0019438,0.997437680974377,0.00555593575734614,15,4031,aromatic compound biosynthetic process,BP,PTPRN;CAMK2A;CRYM;GDA;HPCA;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
4795,GO:0010556,0.997459849280301,0.00561042520872402,14,3815,regulation of macromolecule biosynthetic process,BP,PTPRN;CAMK2A;CELF4;CRYM;NEURL1;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
17078,GO:0080134,0.997500450776335,0.0120775888081878,2,1232,regulation of response to stress,BP,CAMK2A;CNR1
1638,GO:0003824,0.997844411913837,0.00437953002257774,21,5189,catalytic activity,MF,CAMK1G;BCAT1;CAMK2A;LNX1;EEF1A2;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;GDA;SULT4A1;CHRM3;CHI3L1;GAD2;CHST9;GNG3;ADCY1;PCSK1;MPPED1
3922,GO:0008152,0.997987674167594,0.00377080008611358,50,9943,metabolic process,BP,CACNG3;CAMK1G;NNAT;PTPRN;BCAT1;CAMK2A;LNX1;SNCB;RBFOX1;RIMS1;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;IGFBP2;RGS4;CNR1;GDA;PRLHR;HPCA;VGF;SULT4A1;SNAP25;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;TENM2;SHC3;TMEM132D;CHST9;GNG3;FABP7;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
9673,GO:0035295,0.998001798665358,0.0148658070164138,1,895,tube development,BP,CHI3L1
4302,GO:0009058,0.998262219491656,0.00348856899448062,24,5810,biosynthetic process,BP,PTPRN;BCAT1;CAMK2A;EEF1A2;CELF4;ST8SIA5;CRYM;NEURL1;GDA;HPCA;MRAP2;TBR1;GAD2;TENM2;CHST9;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
19293,GO:1902494,0.998288227302172,0.00866133648583874,2,1316,catalytic complex,CC,GNG3;ENC1
16861,GO:0072359,0.998293572323426,0.0129834688540253,1,916,circulatory system development,BP,CHI3L1
4759,GO:0010467,0.998321923066128,0.00353912672057166,19,4917,gene expression,BP,NNAT;PTPRN;CAMK2A;RBFOX1;RIMS1;EEF1A2;CELF4;CRYM;NEURL1;TBR1;TENM2;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
3099,GO:0006355,0.998361128859145,0.00400419145854731,11,3325,regulation of transcription, DNA-templated,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
18890,GO:1901362,0.99844796610384,0.00348433299435213,15,4153,organic cyclic compound biosynthetic process,BP,PTPRN;CAMK2A;CRYM;GDA;HPCA;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
19733,GO:1903506,0.998498766524897,0.0036916901354384,11,3344,regulation of nucleic acid-templated transcription,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
21755,GO:2001141,0.998529978793909,0.0036205073792871,11,3349,regulation of RNA biosynthetic process,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
3426,GO:0006807,0.998666121460774,0.00255178799514645,42,8813,nitrogen compound metabolic process,BP,CAMK1G;NNAT;PTPRN;BCAT1;CAMK2A;LNX1;SNCB;RBFOX1;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;NEURL1;PTPN5;IGFBP2;RGS4;GDA;HPCA;VGF;SULT4A1;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;TENM2;SHC3;CHST9;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
1596,GO:0003676,0.998738147293265,0.0030597081240291,12,3624,nucleic acid binding,MF,RBFOX1;RIMS1;EEF1A2;CELF4;DNM1;TBR1;ZNF385D;NEUROD2;DMRT2;ZCCHC12;DDN;MYT1L
4618,GO:0009888,0.998772844824347,0.0052097624722495,3,1600,tissue development,BP,NEURL1;CHI3L1;DMRT2
14763,GO:0060429,0.998811335201699,0.00950445947162117,1,996,epithelium development,BP,DMRT2
11089,GO:0043170,0.99881204721282,0.00229807764342722,38,8159,macromolecule metabolic process,BP,CACNG3;CAMK1G;NNAT;PTPRN;CAMK2A;LNX1;RBFOX1;RIMS1;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;DNM1;NEURL1;PTPN5;IGFBP2;RGS4;VGF;SNAP25;CHRM3;CHI3L1;TBR1;TENM2;SHC3;CHST9;GNG3;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
11133,GO:0043231,0.998871655299124,0.00218038262099108,47,9620,intracellular membrane-bounded organelle,CC,CAMK1G;SYT13;PTPRN;BCAT1;SYT1;CAMK2A;SNCB;RBFOX1;RPH3A;NEFH;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;STMN2;DNM1;PTPN5;SLC30A3;RGS4;CNR1;VGF;SNAP25;SYT4;CHI3L1;MRAP2;TESPA1;TBR1;GAD2;SLC14A1;CXCL14;TENM2;ZNF385D;CHST9;NRGN;IGFN1;FABP7;ADCY1;TMEM130;NEUROD2;ENC1;DMRT2;ZCCHC12;CREG2;GRIN1;DDN;MYT1L
3517,GO:0006950,0.9989147856581,0.00281739489953194,10,3316,response to stress,BP,PTPRN;CAMK2A;CHGA;CNR1;SLC12A5;VGF;CHI3L1;KCNC2;NEUROD2;CCK
18951,GO:1901576,0.998941691303244,0.00220676581905523,23,5750,organic substance biosynthetic process,BP,PTPRN;BCAT1;CAMK2A;EEF1A2;CELF4;ST8SIA5;CRYM;NEURL1;GDA;HPCA;MRAP2;TBR1;TENM2;CHST9;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
9451,GO:0034645,0.999034688028457,0.00216498995122608,17,4656,cellular macromolecule biosynthetic process,BP,PTPRN;CAMK2A;EEF1A2;CELF4;ST8SIA5;CRYM;NEURL1;TBR1;TENM2;CHST9;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
3095,GO:0006351,0.99917130921277,0.00212622489440764,11,3476,transcription, DNA-templated,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
17859,GO:0097659,0.999224979838937,0.00199778415407915,11,3490,nucleic acid-templated transcription,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
8628,GO:0032774,0.999270006939994,0.00188951025230209,11,3503,RNA biosynthetic process,BP,PTPRN;CAMK2A;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
3580,GO:0007049,0.999339979376124,0.00298125119570825,3,1708,cell cycle,BP,BCAT1;CAMK2A;PACSIN1
9448,GO:0034641,0.999397529720489,0.00129818136381536,23,5915,cellular nitrogen compound metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;EEF1A2;CELF4;CRYM;NEURL1;GDA;HPCA;SULT4A1;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L
4303,GO:0009059,0.999414964726152,0.00135339138984374,17,4765,macromolecule biosynthetic process,BP,PTPRN;CAMK2A;EEF1A2;CELF4;ST8SIA5;CRYM;NEURL1;TBR1;TENM2;CHST9;NEUROD2;ENC1;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
1597,GO:0003677,0.999491737091712,0.00183497052981155,5,2234,DNA binding,MF,TBR1;NEUROD2;DMRT2;DDN;MYT1L
11534,GO:0044238,0.999582607082707,0.000850962847941467,43,9218,primary metabolic process,BP,CAMK1G;NNAT;PTPRN;BCAT1;CAMK2A;LNX1;RBFOX1;CHGA;EEF1A2;CELF4;ST8SIA5;CRYM;EPHB6;NEURL1;PTPN5;IGFBP2;RGS4;CNR1;GDA;HPCA;VGF;SULT4A1;CHRM3;CHI3L1;MRAP2;TBR1;GAD2;TENM2;SHC3;CHST9;GNG3;FABP7;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;PCSK1;GRIN1;DDN;MYT1L;CCK;GRIN2B
3378,GO:0006725,0.999645072707972,0.000812357864526698,20,5463,cellular aromatic compound metabolic process,BP,PTPRN;CAMK2A;SNCB;RBFOX1;CHGA;CELF4;CRYM;GDA;HPCA;SULT4A1;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
2978,GO:0006139,0.999670502819485,0.000766670198021727,19,5285,nucleobase-containing compound metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;CELF4;CRYM;GDA;HPCA;SULT4A1;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
12487,GO:0046483,0.99982416350623,0.000423660511557691,19,5424,heterocycle metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CHGA;CELF4;CRYM;GDA;HPCA;SULT4A1;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
18888,GO:1901360,0.99984188929273,0.000378319304755869,20,5637,organic cyclic compound metabolic process,BP,PTPRN;CAMK2A;SNCB;RBFOX1;CHGA;CELF4;CRYM;GDA;HPCA;SULT4A1;MRAP2;TBR1;TENM2;ADCY1;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
18891,GO:1901363,0.999843283251262,0.000379965005077079,19,5338,heterocyclic compound binding,MF,CAMK1G;CAMK2A;RBFOX1;RIMS1;EEF1A2;CELF4;CRYM;EPHB6;DNM1;TBR1;GAD2;ZNF385D;SYN2;ADCY1;NEUROD2;DMRT2;ZCCHC12;DDN;MYT1L
11130,GO:0043228,0.999852842144103,0.000437180540817232,10,3648,non-membrane-bounded organelle,CC,RIMS1;NEFH;NEFM;DNM1;SNAP25;SLC14A1;IGFN1;ENC1;MAP7D2;MYT1L
11134,GO:0043232,0.999852842144103,0.000437180540817232,10,3648,intracellular non-membrane-bounded organelle,CC,RIMS1;NEFH;NEFM;DNM1;SNAP25;SLC14A1;IGFN1;ENC1;MAP7D2;MYT1L
5684,GO:0016070,0.999879093388496,0.000331939728886869,13,4304,RNA metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CELF4;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
17615,GO:0097159,0.999884539787874,0.000284548468272063,19,5402,organic cyclic compound binding,MF,CAMK1G;CAMK2A;RBFOX1;RIMS1;EEF1A2;CELF4;CRYM;EPHB6;DNM1;TBR1;GAD2;ZNF385D;SYN2;ADCY1;NEUROD2;DMRT2;ZCCHC12;DDN;MYT1L
9008,GO:0033554,0.999928650617502,0.000498246226570775,2,1782,cellular response to stress,BP,CAMK2A;KCNC2
2667,GO:0005634,0.999969865026494,7.58396776430723e-05,23,6455,nucleus,CC,PTPRN;CAMK2A;RBFOX1;CELF4;CRYM;DNM1;PTPN5;RGS4;TESPA1;TBR1;SLC14A1;TENM2;ZNF385D;NRGN;IGFN1;FABP7;ADCY1;NEUROD2;ENC1;DMRT2;ZCCHC12;DDN;MYT1L
17370,GO:0090304,0.999989673332504,3.23539698079131e-05,13,4746,nucleic acid metabolic process,BP,PTPRN;CAMK2A;RBFOX1;CELF4;CRYM;TBR1;TENM2;NEUROD2;DMRT2;ZCCHC12;GRIN1;DDN;MYT1L
2677,GO:0005654,0.999993032290743,3.10009858685949e-05,6,3238,nucleoplasm,CC,CAMK2A;DNM1;PTPN5;TENM2;ENC1;ZCCHC12
8123,GO:0031981,0.999998733233488,5.73773589368842e-06,7,3766,nuclear lumen,CC,CAMK2A;DNM1;PTPN5;SLC14A1;TENM2;ENC1;ZCCHC12
8121,GO:0031974,0.999998863061552,4.22587817874925e-06,11,4759,membrane-enclosed lumen,CC,CAMK2A;CRYM;DNM1;PTPN5;VGF;CHI3L1;SLC14A1;TENM2;ENC1;ZCCHC12;PCSK1
11135,GO:0043233,0.999998863061552,4.22587817874925e-06,11,4759,organelle lumen,CC,CAMK2A;CRYM;DNM1;PTPN5;VGF;CHI3L1;SLC14A1;TENM2;ENC1;ZCCHC12;PCSK1
15532,GO:0070013,0.999998863061552,4.22587817874925e-06,11,4759,intracellular organelle lumen,CC,CAMK2A;CRYM;DNM1;PTPN5;VGF;CHI3L1;SLC14A1;TENM2;ENC1;ZCCHC12;PCSK1
11639,GO:0044428,0.999999254233331,3.25504367596788e-06,8,4087,nuclear part,CC,CAMK2A;DNM1;PTPN5;TESPA1;SLC14A1;TENM2;ENC1;ZCCHC12
10336,GO:0038003,0.999999999999987,0.943855793164879,0,10,opioid receptor signaling pathway,BP,
5755,GO:0016229,0.99999999999999,0.880703877187346,0,25,steroid dehydrogenase activity,MF,
5998,GO:0016706,0.99999999999999,0.755407740630913,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
8471,GO:0032527,0.999999999999992,0.77192806719578,0,39,protein exit from endoplasmic reticulum,BP,
11090,GO:0043171,0.999999999999992,0.843898833296821,0,25,peptide catabolic process,BP,
7776,GO:0031293,0.999999999999995,0.848115841141013,0,24,membrane protein intracellular domain proteolysis,BP,
21630,GO:2000779,0.999999999999996,0.714017894231058,0,50,regulation of double-strand break repair,BP,
32,GO:0000060,0.999999999999999,0.762819122967454,0,43,protein import into nucleus, translocation,BP,
14566,GO:0060158,0.999999999999999,0.946218329457123,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
17061,GO:0080008,1,0.796803716453864,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
2507,GO:0005247,1,0.938506104097907,0,9,voltage-gated chloride channel activity,MF,
1,GO:0000002,1,0.839734401563377,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.993795565412523,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.987839189835125,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.9930956730518,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.945641799953361,0,8,single strand break repair,BP,
7,GO:0000014,1,0.95203667388984,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.977342644699093,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.640548166212938,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.973272361167012,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.935452437170213,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.977498123337686,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.979205229935164,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.875590966386744,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.932720915461719,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.873062475513537,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.994995753572652,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.983569556287853,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.985905116486077,0,3,acyl binding,MF,
20,GO:0000036,1,0.993046014416702,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.829388613734011,0,29,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.562324065643077,0,87,autophagosome assembly,BP,
24,GO:0000048,1,0.987415933017648,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.702230135735741,0,55,tRNA binding,MF,
26,GO:0000050,1,0.933167484375787,0,12,urea cycle,BP,
27,GO:0000052,1,0.94883850387338,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.994897017664268,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.930743378007976,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.956458036483382,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.962891437810256,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.897594603898994,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.962060674721891,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.392347239293713,0,143,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.249867307268587,0,211,cell cycle checkpoint,BP,
37,GO:0000076,1,0.903927132281238,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.378734279860104,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.597482399798289,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000083,1,0.83385424662259,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
42,GO:0000086,1,0.222158817969791,0,237,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994090826494099,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.79111430812972,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.905731880327857,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.938099983912676,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.958455141266832,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.966125652697791,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.981943940327642,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.97874865368541,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.986434172775785,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.937560117014057,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.980375575194651,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.992528647190764,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.985278322609125,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.661342272379437,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.970180682361362,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.99273069832021,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.611554659558827,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.936339084882535,0,11,SAGA complex,CC,
62,GO:0000125,1,0.980822522720696,0,3,PCAF complex,CC,
63,GO:0000126,1,0.984537691951766,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.960706559108931,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.875657272014492,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.897591846683815,0,16,Golgi cis cisterna,CC,
67,GO:0000138,1,0.960204779906603,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.879712582948129,0,18,exocyst,CC,
70,GO:0000146,1,0.876286651731835,0,17,microfilament motor activity,MF,
71,GO:0000147,1,0.965392058909172,0,5,actin cortical patch assembly,BP,
73,GO:0000150,1,0.951498422220736,0,8,recombinase activity,MF,
75,GO:0000152,1,0.790002575174989,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.931485305749491,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.836468395903018,0,31,rRNA modification,BP,
78,GO:0000155,1,0.955907888717821,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.878718697284046,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.9487504644702,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.929978595403735,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.995611997115238,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.986110008651431,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.965732754953664,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.995216412396374,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.82667582291259,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.939433803156513,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.916674243285848,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.879667050582449,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.977141825577383,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.932306426030476,0,10,rDNA binding,MF,
94,GO:0000183,1,0.905662362350596,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.571308024024637,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.887466256669049,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.686236462412817,0,53,activation of MAPKK activity,BP,
100,GO:0000209,1,0.150721715338371,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.992557269535793,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.934563481229786,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.977792828636643,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.978185911234951,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.989258614178421,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.849681082995755,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.963708422910419,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.979573447816673,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.993491565681315,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.995956484503298,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
113,GO:0000229,1,0.99134840477337,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.943873379437557,0,8,astral microtubule,CC,
115,GO:0000242,1,0.868678497717921,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.957198797364632,0,8,commitment complex,CC,
117,GO:0000244,1,0.919134474180365,0,12,spliceosomal tri-snRNP complex assembly,BP,
119,GO:0000246,1,0.992491891609527,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.995953922606191,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.98563331805918,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.992493074882697,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.995301999084177,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.987285330828155,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.981955209908468,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.973231940854655,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.995542866866675,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.995669135788894,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.995310331571433,0,1,mitochondrial chromosome,CC,
131,GO:0000268,1,0.9735077862986,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.992371422184906,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.621244101980779,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.832369286642091,0,26,polysaccharide catabolic process,BP,
136,GO:0000280,1,0.0871109969691112,0,367,nuclear division,BP,
137,GO:0000281,1,0.649229600387128,0,64,mitotic cytokinesis,BP,
138,GO:0000285,1,0.974048298461855,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
139,GO:0000287,1,0.29218317001456,0,185,magnesium ion binding,MF,
140,GO:0000288,1,0.628927965797664,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.780927115421435,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.952690730045072,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.827459077009253,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.978735507761384,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.985670001003467,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.932593079003248,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.993965764289673,0,1,spermine transport,BP,
148,GO:0000298,1,0.976709538622527,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.974158845862859,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.859921281425691,0,27,response to superoxide,BP,
152,GO:0000305,1,0.842882858970639,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.972029928499867,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.790526872943946,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.985010952375167,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.97989041353484,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.692115540077371,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.887246090782271,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.799086963128454,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.985039313604468,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.982363575715938,0,3,storage vacuole,CC,
163,GO:0000333,1,0.984909463621963,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.995776749802096,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.947104178064084,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.910637677920194,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.953519910824748,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.9226327403532,0,13,transcription export complex,CC,
169,GO:0000347,1,0.967268211558242,0,6,THO complex,CC,
170,GO:0000349,1,0.987158040165181,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.984494495795479,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.984956419932787,0,2,cis assembly of pre-catalytic spliceosome,BP,
175,GO:0000379,1,0.983057405608299,0,3,tRNA-type intron splice site recognition and cleavage,BP,
178,GO:0000384,1,0.990456432825589,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.980034863193106,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.800529175423018,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.961701397248352,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.988876393229446,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.971849652347167,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.908586845144802,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.961385896306531,0,6,mRNA 5'-splice site recognition,BP,
187,GO:0000400,1,0.898901950434479,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.956363178920297,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.977881131975862,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.949814017011931,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.985243344219007,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.794697409026464,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.973501960112497,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.992288596009447,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.992288596009447,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.992962628811745,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.84171412638065,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.969865261568316,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.992334473328975,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.992514062926265,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.99249955134373,0,1,HIR complex,CC,
202,GO:0000421,1,0.828668473685961,0,30,autophagosome membrane,CC,
203,GO:0000422,1,0.598999861290648,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.88300266676637,0,18,mitophagy,BP,
205,GO:0000428,1,0.436945950096273,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.976470816238953,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.984060544255987,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.992288596009447,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.984060544255987,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.992288596009447,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.976470816238953,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.985238474957526,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.95265734647228,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.975668828647232,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.967268211558242,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.948903291437287,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.992304884908068,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992438901033039,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992438901033039,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.987661553313843,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.989358925995286,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.963558773062536,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.830220663262033,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.992773258657246,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.808932748848919,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.952367395461559,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.882840215219085,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.963558773062536,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.863744625834483,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.885920363015434,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.979213537168472,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.914412361333317,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.920248975072331,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.960196806302075,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.99252916033396,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.955903791284634,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.967478287896474,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.988040441852388,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.995937198802247,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.993420146576655,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.723785256287472,0,62,proteasome complex,CC,
242,GO:0000506,1,0.953946642114066,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.821066843266888,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.977034223006111,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.990593516962261,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.97753281067351,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.991434097678326,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.978832373035934,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.950795242432898,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.970627692850346,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.995588915806326,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000712,1,0.917238047017908,0,13,resolution of meiotic recombination intermediates,BP,
253,GO:0000715,1,0.876308408046502,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.875128665634801,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.995081675552396,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.981006127163862,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.91184465657303,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.394318050347335,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.492731600947951,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.489305057214765,0,105,recombinational repair,BP,
261,GO:0000726,1,0.655477174848578,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.969900307750744,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.857886163257017,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.937851352421182,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.639684689858877,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.8375119337979,0,25,strand displacement,BP,
267,GO:0000733,1,0.93891821410974,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.852162648538635,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.975037196924209,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.995045410378932,0,1,karyogamy,BP,
272,GO:0000773,1,0.996152411222081,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.935344766016805,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.30077990104473,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.441715554683299,0,125,kinetochore,CC,
276,GO:0000777,1,0.538526431602156,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.928344529907029,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.502134746754246,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.882160517237087,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.412828317579769,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.929503712323762,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.929503712323762,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.500839568768502,0,105,nuclear chromosome, telomeric region,CC,
285,GO:0000786,1,0.80176592897526,0,47,nucleosome,CC,
286,GO:0000788,1,0.938653413061301,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.996019596666789,0,1,cytoplasmic chromatin,CC,
289,GO:0000791,1,0.835904616237586,0,29,euchromatin,CC,
290,GO:0000792,1,0.636573389421769,0,68,heterochromatin,CC,
291,GO:0000793,1,0.281143912553594,0,194,condensed chromosome,CC,
292,GO:0000794,1,0.585529603221981,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.822395706664186,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.948289508242573,0,7,condensin complex,CC,
295,GO:0000797,1,0.992462492145244,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.966816116559056,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.977512112892858,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.917299236317011,0,13,lateral element,CC,
299,GO:0000801,1,0.963859081021655,0,6,central element,CC,
300,GO:0000803,1,0.847982976360455,0,25,sex chromosome,CC,
301,GO:0000805,1,0.953155877291347,0,7,X chromosome,CC,
302,GO:0000806,1,0.986545576022676,0,2,Y chromosome,CC,
303,GO:0000808,1,0.939725881569472,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.981176424522905,0,3,GINS complex,CC,
305,GO:0000812,1,0.941754654545157,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.939735829568015,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.984461331408039,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.93149485228254,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.98764210362104,0,2,nuclear MIS12/MIND complex,CC,
310,GO:0000819,1,0.232786773889916,0,223,sister chromatid segregation,BP,
311,GO:0000820,1,0.969151366407472,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.986183660319328,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.97750530841975,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.994958464653527,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.994958464653527,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.994958464653527,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.966606418949935,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.966606418949935,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.966606418949935,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.993130369924021,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.966606418949935,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.95910427214694,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.966378630816147,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.980516316615322,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
329,GO:0000912,1,0.957272936343563,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.957272936343563,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994186446320444,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.99485390608053,0,1,division septum assembly,BP,
333,GO:0000920,1,0.90404732850384,0,17,cell separation after cytokinesis,BP,
334,GO:0000921,1,0.913071511198734,0,13,septin ring assembly,BP,
335,GO:0000922,1,0.387034378331328,0,141,spindle pole,CC,
336,GO:0000923,1,0.963937981912983,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.9930956730518,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.876896808567614,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.950134385495982,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.60008215575837,0,79,P-body,CC,
341,GO:0000938,1,0.971111945224913,0,4,GARP complex,CC,
342,GO:0000939,1,0.982865623344119,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.914771907138219,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.994038197782596,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.975526878001759,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.335853434522348,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.964483167781613,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.978718126656581,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.766628881320511,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.971773110941458,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.98545867388293,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.986114554210605,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.906026432284573,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.975363150739862,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.969723617316965,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.883311227299315,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.979213537168472,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.955149011801681,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.980386274164651,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.924164823990457,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.792968082743667,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.647753554142733,0,66,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.861909278286216,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.944828926122753,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.987943731563422,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.985999334182064,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.831636128194188,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.994988329335024,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.969985028486262,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.985999334182064,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.985999334182064,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.971653893776584,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.883119792730242,0,18,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.992168996315963,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.948138704704937,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.957198514635949,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.987457847439628,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.976578578084227,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.984537691951766,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.965852058022811,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.965852058022811,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.974284206019045,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.994938724401093,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.962883856879136,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.561902469488465,0,85,core promoter sequence-specific DNA binding,MF,
395,GO:0001047,1,0.388964920487788,0,138,core promoter binding,MF,
396,GO:0001054,1,0.9420262500863,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.943797921932932,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.919285182534739,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.984962397896689,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.993401986990587,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.949993178392133,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001076,1,0.292694670981539,0,183,transcription factor activity, RNA polymerase II transcription factor binding,MF,
404,GO:0001077,1,0.178132927153509,0,256,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,
406,GO:0001079,1,0.994251771467272,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994251771467272,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.95826259742514,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.993401986990587,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.406415396260868,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.992168996315963,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.901324228875754,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.979581386330201,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.945385752062634,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.992519956748011,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.980634621806843,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.757599850117953,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.757599850117953,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.9930956730518,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.736957432381797,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.81349255325875,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.509184015445975,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.746082159029482,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.828733427170549,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.99281320809659,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.99281320809659,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.99281320809659,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.995695063021694,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.972245400265889,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.972245400265889,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.889429949234376,0,17,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.82732821490813,0,27,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.949881305199031,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.984581259828401,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.976578578084227,0,3,TFIIIC-class transcription factor binding,MF,
437,GO:0001158,1,0.570791740459418,0,85,enhancer sequence-specific DNA binding,MF,
438,GO:0001160,1,0.984581259828401,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.926431785214742,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.938996188825392,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.948138704704937,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.948138704704937,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.992477802416981,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.984871751099239,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994830736114273,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.992511259427353,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.948138704704937,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
448,GO:0001190,1,0.648486891412123,0,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
449,GO:0001191,1,0.741324168963167,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.996289750890851,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.996289750890851,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.822057501556752,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.936762404475669,0,9,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.758065200416181,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.91224188175613,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.867826442810223,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.977351879913884,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.984605556019299,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.99263407243923,0,1,RNA polymerase II transcription corepressor binding,MF,
462,GO:0001300,1,0.98549071136876,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.962119059147455,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.996116978937686,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.996116978937686,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.902920929433798,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.987675926384744,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.970108942017169,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.902629799711414,0,16,cartilage condensation,BP,
471,GO:0001503,1,0.100757118420464,0,342,ossification,BP,
474,GO:0001507,1,0.986293030107427,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.694448234530076,0,57,RNA methylation,BP,
477,GO:0001512,1,0.995971794784606,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.949674997399018,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.97992193050083,0,4,opioid peptide activity,MF,
480,GO:0001516,1,0.884569807922601,0,22,prostaglandin biosynthetic process,BP,
481,GO:0001517,1,0.957914121224708,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.900199345244652,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.992513811625648,0,1,peptide amidation,BP,
484,GO:0001520,1,0.98096089535862,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.907719492808721,0,18,pseudouridine synthesis,BP,
486,GO:0001523,1,0.64679718419869,0,70,retinoid metabolic process,BP,
488,GO:0001527,1,0.934242009295327,0,10,microfibril,CC,
489,GO:0001530,1,0.874226926290506,0,23,lipopolysaccharide binding,MF,
490,GO:0001532,1,0.992646037009475,0,1,interleukin-21 receptor activity,MF,
491,GO:0001533,1,0.851413968225574,0,25,cornified envelope,CC,
492,GO:0001534,1,0.972107545643372,0,4,radial spoke,CC,
493,GO:0001536,1,0.978850824528458,0,3,radial spoke stalk,CC,
495,GO:0001539,1,0.819046552896959,0,31,cilium or flagellum-dependent cell motility,BP,
496,GO:0001540,1,0.699932071379489,0,55,amyloid-beta binding,MF,
498,GO:0001542,1,0.936447213961458,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.992234028582499,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.992253234819762,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.992499060204334,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.98372600654435,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.95968702486678,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.984937219097334,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994673546817048,0,1,ovarian follicle atresia,BP,
507,GO:0001554,1,0.962952059413096,0,5,luteolysis,BP,
508,GO:0001555,1,0.980675241468336,0,3,oocyte growth,BP,
509,GO:0001556,1,0.880747366709134,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.977269082377135,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.953397700849446,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.903224261318338,0,18,response to protozoan,BP,
514,GO:0001567,1,0.995657523143073,0,1,cholesterol 25-hydroxylase activity,MF,
516,GO:0001569,1,0.814732300178065,0,31,branching involved in blood vessel morphogenesis,BP,
517,GO:0001570,1,0.608138056779863,0,73,vasculogenesis,BP,
518,GO:0001572,1,0.992463567771584,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001573,1,0.896090122874259,0,17,ganglioside metabolic process,BP,
520,GO:0001574,1,0.937622384263608,0,10,ganglioside biosynthetic process,BP,
521,GO:0001575,1,0.989149419734072,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994374354536359,0,1,globoside biosynthetic process,BP,
524,GO:0001579,1,0.985481787863399,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.905183476443246,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.992786892016865,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.993454267129848,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.992467824338962,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.978182976943199,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.982345137580182,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.985866298120349,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.993893966305661,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.980657351121825,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.977252337423951,0,4,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.991435737484197,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.984612142082582,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.987111863029686,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.932609544919803,0,12,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.96463723540122,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.894585419449205,0,19,purinergic nucleotide receptor activity,MF,
541,GO:0001618,1,0.650281400519086,0,64,virus receptor activity,MF,
542,GO:0001621,1,0.995486638379835,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.992640226698019,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.966699478212167,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988048501966952,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.982027228258943,0,3,calcitonin gene-related peptide receptor activity,MF,
547,GO:0001637,1,0.864380491701422,0,24,G-protein coupled chemoattractant receptor activity,MF,
548,GO:0001640,1,0.956096067030167,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.985857086202169,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.977543574941682,0,3,group III metabotropic glutamate receptor activity,MF,
551,GO:0001649,1,0.28123744638639,0,191,osteoblast differentiation,BP,
552,GO:0001650,1,0.441620267517096,0,126,fibrillar center,CC,
553,GO:0001651,1,0.995937198802247,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.972707369064583,0,5,granular component,CC,
557,GO:0001655,1,0.130921143449865,0,294,urogenital system development,BP,
558,GO:0001656,1,0.582238939684032,0,81,metanephros development,BP,
559,GO:0001657,1,0.539124058359067,0,92,ureteric bud development,BP,
560,GO:0001658,1,0.698190147777893,0,54,branching involved in ureteric bud morphogenesis,BP,
566,GO:0001665,1,0.965910903633956,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
567,GO:0001666,1,0.128888717546954,0,323,response to hypoxia,BP,
568,GO:0001667,1,0.106715161056636,0,332,ameboidal-type cell migration,BP,
570,GO:0001671,1,0.859187116327719,0,25,ATPase activator activity,MF,
571,GO:0001672,1,0.936500612437176,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.932742516637259,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.994074608767601,0,1,female germ cell nucleus,CC,
574,GO:0001675,1,0.944829169612383,0,8,acrosome assembly,BP,
575,GO:0001676,1,0.585409235978411,0,86,long-chain fatty acid metabolic process,BP,
577,GO:0001680,1,0.993993865113311,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.993017721497802,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.936669628327369,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.984604375238769,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.993727778298395,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.996254262411469,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.906367605641946,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.993046861751883,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.989723807936601,0,2,gastrin-induced gastric acid secretion,BP,
586,GO:0001701,1,0.137231398039095,0,293,in utero embryonic development,BP,
587,GO:0001702,1,0.838128732479112,0,25,gastrulation with mouth forming second,BP,
588,GO:0001704,1,0.4696918896591,0,110,formation of primary germ layer,BP,
589,GO:0001705,1,0.985080959175212,0,2,ectoderm formation,BP,
590,GO:0001706,1,0.699496526598263,0,53,endoderm formation,BP,
591,GO:0001707,1,0.658802249997306,0,62,mesoderm formation,BP,
593,GO:0001709,1,0.786018841536264,0,37,cell fate determination,BP,
594,GO:0001710,1,0.900890660974577,0,17,mesodermal cell fate commitment,BP,
595,GO:0001711,1,0.909787877818248,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.985080959175212,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.955715200169368,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.992505247890261,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994442654280709,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.694585612592848,0,52,stress fiber,CC,
602,GO:0001727,1,0.965793369644316,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.98544597023716,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.975566595610246,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.946876904209809,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.987105224676537,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.976822271997471,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.985936400835878,0,2,prenylcysteine oxidase activity,MF,
609,GO:0001736,1,0.489558134166203,0,117,establishment of planar polarity,BP,
610,GO:0001738,1,0.440445566543817,0,132,morphogenesis of a polarized epithelium,BP,
611,GO:0001739,1,0.96931209999807,0,5,sex chromatin,CC,
612,GO:0001740,1,0.981150907203154,0,3,Barr body,CC,
613,GO:0001741,1,0.927227127763266,0,12,XY body,CC,
614,GO:0001743,1,0.977823768419329,0,3,optic placode formation,BP,
615,GO:0001750,1,0.643112129662169,0,66,photoreceptor outer segment,CC,
616,GO:0001754,1,0.769329959921923,0,38,eye photoreceptor cell differentiation,BP,
617,GO:0001755,1,0.736518312287272,0,46,neural crest cell migration,BP,
619,GO:0001757,1,0.969475228362155,0,5,somite specification,BP,
620,GO:0001758,1,0.960895846239903,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.89736452055833,0,18,organ induction,BP,
622,GO:0001763,1,0.281002137971346,0,185,morphogenesis of a branching structure,BP,
624,GO:0001765,1,0.946370898937622,0,9,membrane raft assembly,BP,
626,GO:0001767,1,0.936893377529393,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.944193434865633,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.992272981896782,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.921562110825666,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.817662062774836,0,32,immunological synapse,CC,
631,GO:0001773,1,0.875100183066346,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.848225314160679,0,25,microglial cell activation,BP,
634,GO:0001776,1,0.60146400777422,0,80,leukocyte homeostasis,BP,
635,GO:0001777,1,0.98489962786188,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.964253746434955,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.897047349301019,0,17,natural killer cell differentiation,BP,
638,GO:0001780,1,0.908015101918063,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.95601964452539,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.835959295791079,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.869488391693547,0,22,B cell apoptotic process,BP,
643,GO:0001785,1,0.986050393463012,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.958277810059276,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.995292804183984,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.995076263676782,0,1,IgM binding,MF,
648,GO:0001792,1,0.992492312224722,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.984389134135967,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.984389134135967,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.995292804183984,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.989045286922607,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.989942837854083,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.989942837854083,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.989942837854083,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.982976556077007,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.99012375634017,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994470114937692,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.995629720126796,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.985282502592497,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.995292804183984,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.989942837854083,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.995292804183984,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.995292804183984,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
666,GO:0001817,1,0.0264437109905307,0,561,regulation of cytokine production,BP,
667,GO:0001818,1,0.261560047745405,0,213,negative regulation of cytokine production,BP,
668,GO:0001819,1,0.0993830274603295,0,362,positive regulation of cytokine production,BP,
669,GO:0001820,1,0.943138734049986,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.950050016733181,0,9,histamine secretion,BP,
671,GO:0001822,1,0.183590735607354,0,246,kidney development,BP,
672,GO:0001823,1,0.526782144482844,0,96,mesonephros development,BP,
673,GO:0001824,1,0.707929236415542,0,54,blastocyst development,BP,
674,GO:0001825,1,0.852209396285191,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.957357388366195,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.984930681959076,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.978876762228941,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.925892557783521,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.986725593144897,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.893645078792174,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.925728175106061,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.985407246399704,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.992654781804303,0,1,blastocyst hatching,BP,
685,GO:0001837,1,0.440329112139906,0,123,epithelial to mesenchymal transition,BP,
686,GO:0001838,1,0.45107008638006,0,118,embryonic epithelial tube formation,BP,
687,GO:0001839,1,0.961946912509103,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.940101974400083,0,9,neural plate development,BP,
689,GO:0001841,1,0.506205343007036,0,100,neural tube formation,BP,
690,GO:0001842,1,0.95772593677429,0,7,neural fold formation,BP,
691,GO:0001843,1,0.558127069799706,0,85,neural tube closure,BP,
692,GO:0001844,1,0.824775522449966,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.928104686024483,0,12,phagolysosome assembly,BP,
694,GO:0001846,1,0.924929455313303,0,12,opsonin binding,MF,
695,GO:0001847,1,0.974615432940123,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.906118083491203,0,15,complement binding,MF,
697,GO:0001849,1,0.962870078729947,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.994894157560873,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.972627738221869,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.987453601182227,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.993870199242249,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.992089267287523,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.946221127009371,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.972596569430319,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.950536655768712,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.987280424115656,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.987280424115656,0,2,negative regulation of complement activation, lectin pathway,BP,
708,GO:0001871,1,0.886747564439637,0,19,pattern binding,MF,
709,GO:0001872,1,0.994685480976322,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.967721159514542,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.977704466212745,0,4,response to yeast,BP,
712,GO:0001880,1,0.979465437573345,0,3,Mullerian duct regression,BP,
713,GO:0001881,1,0.819593953249468,0,30,receptor recycling,BP,
716,GO:0001884,1,0.985927828502817,0,2,pyrimidine nucleoside binding,MF,
717,GO:0001885,1,0.696586894409316,0,53,endothelial cell development,BP,
718,GO:0001886,1,0.933769737264316,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.966568945962295,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.985390130000894,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
721,GO:0001889,1,0.426537186013356,0,131,liver development,BP,
722,GO:0001890,1,0.410804362472355,0,136,placenta development,BP,
723,GO:0001891,1,0.878304956420805,0,20,phagocytic cup,CC,
724,GO:0001892,1,0.582030695522944,0,81,embryonic placenta development,BP,
725,GO:0001893,1,0.820833989492033,0,30,maternal placenta development,BP,
726,GO:0001894,1,0.333350209692194,0,170,tissue homeostasis,BP,
727,GO:0001895,1,0.724030738424403,0,51,retina homeostasis,BP,
728,GO:0001897,1,0.987300920414236,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.977360201276709,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.971803444464201,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.639051182931979,0,76,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.733500606729874,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.919407211244338,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.82672387833289,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.857090624900884,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.893211255739432,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.961566170881182,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.937922060305126,0,12,positive regulation of T cell mediated cytotoxicity,BP,
741,GO:0001919,1,0.861436045949326,0,22,regulation of receptor recycling,BP,
742,GO:0001920,1,0.973458711853183,0,4,negative regulation of receptor recycling,BP,
743,GO:0001921,1,0.914756785879954,0,13,positive regulation of receptor recycling,BP,
744,GO:0001922,1,0.97755271415342,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980825715531987,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.979103029627831,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994030122618919,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.919569425442645,0,13,uropod,CC,
752,GO:0001935,1,0.45363936881355,0,119,endothelial cell proliferation,BP,
753,GO:0001936,1,0.497897863230703,0,105,regulation of endothelial cell proliferation,BP,
754,GO:0001937,1,0.811494242778043,0,31,negative regulation of endothelial cell proliferation,BP,
755,GO:0001938,1,0.598432841975971,0,78,positive regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.959815882766556,0,6,female pronucleus,CC,
757,GO:0001940,1,0.966481282269674,0,5,male pronucleus,CC,
758,GO:0001941,1,0.795524290896814,0,33,postsynaptic membrane organization,BP,
759,GO:0001942,1,0.586372880967249,0,81,hair follicle development,BP,
761,GO:0001945,1,0.847533083219842,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.901646449528332,0,15,lymphangiogenesis,BP,
763,GO:0001947,1,0.689946886808729,0,55,heart looping,BP,
764,GO:0001949,1,0.993697131329752,0,1,sebaceous gland cell differentiation,BP,
765,GO:0001951,1,0.971153424206906,0,4,intestinal D-glucose absorption,BP,
766,GO:0001952,1,0.510517731967715,0,98,regulation of cell-matrix adhesion,BP,
767,GO:0001953,1,0.803035424980154,0,31,negative regulation of cell-matrix adhesion,BP,
768,GO:0001954,1,0.742188873358595,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.947896743131366,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.91324471276751,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.960868114701274,0,6,intramembranous ossification,BP,
772,GO:0001958,1,0.843188144991895,0,25,endochondral ossification,BP,
773,GO:0001959,1,0.405025201193471,0,142,regulation of cytokine-mediated signaling pathway,BP,
774,GO:0001960,1,0.767576329700519,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.760421744629058,0,43,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.85346845209781,0,26,synaptic transmission, dopaminergic,BP,
779,GO:0001966,1,0.995674921403549,0,1,thigmotaxis,BP,
781,GO:0001968,1,0.838730977172054,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.977360201276709,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.985020348837556,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.992224552812038,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.926754462011631,0,12,retinoic acid binding,MF,
786,GO:0001973,1,0.929585161752274,0,12,adenosine receptor signaling pathway,BP,
787,GO:0001974,1,0.769534780820728,0,39,blood vessel remodeling,BP,
789,GO:0001976,1,0.933184591851582,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.927476460431476,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.99418338746981,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.995130829709671,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.996322506949816,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.99418338746981,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.99418338746981,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.830821520570724,0,29,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.916112371946361,0,13,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.974302365991107,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.944653277700709,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.975536642043059,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.974578249632544,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.987225056153524,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.99471720079266,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.971486186054983,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.971486186054983,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.943017256971218,0,9,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.943017256971218,0,9,angiotensin maturation,BP,
808,GO:0002007,1,0.995130829709671,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
809,GO:0002009,1,0.0356939259042873,0,496,morphogenesis of an epithelium,BP,
810,GO:0002011,1,0.706936112328919,0,50,morphogenesis of an epithelial sheet,BP,
811,GO:0002016,1,0.962196672582194,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.99479381427251,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.987353019354849,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.982599829355271,0,3,regulation of renal output by angiotensin,BP,
817,GO:0002023,1,0.994427380625081,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.94982319859735,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.980916865358752,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
821,GO:0002027,1,0.563445719777338,0,86,regulation of heart rate,BP,
822,GO:0002028,1,0.591411483579507,0,80,regulation of sodium ion transport,BP,
824,GO:0002030,1,0.992944041442165,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
826,GO:0002032,1,0.98925380947869,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.976254221177506,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.978771459198413,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.966098383410212,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994302857303437,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994016006353376,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
833,GO:0002040,1,0.524560974028197,0,94,sprouting angiogenesis,BP,
834,GO:0002041,1,0.993963760667476,0,1,intussusceptive angiogenesis,BP,
835,GO:0002042,1,0.736912644795465,0,45,cell migration involved in sprouting angiogenesis,BP,
836,GO:0002043,1,0.905048460366326,0,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.996173397837253,0,1,opsin binding,MF,
838,GO:0002051,1,0.970115188741375,0,4,osteoblast fate commitment,BP,
839,GO:0002052,1,0.869394378671571,0,20,positive regulation of neuroblast proliferation,BP,
840,GO:0002053,1,0.826071027399091,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.977697898380452,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.996432450088202,0,1,adenine binding,MF,
843,GO:0002058,1,0.994296726458758,0,1,uracil binding,MF,
844,GO:0002059,1,0.994296726458758,0,1,thymine binding,MF,
845,GO:0002060,1,0.983306928233483,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994296726458758,0,1,pyrimidine nucleobase binding,MF,
847,GO:0002062,1,0.543160849074765,0,89,chondrocyte differentiation,BP,
848,GO:0002063,1,0.848558947822898,0,23,chondrocyte development,BP,
849,GO:0002064,1,0.295030489617048,0,179,epithelial cell development,BP,
850,GO:0002065,1,0.520726960714922,0,98,columnar/cuboidal epithelial cell differentiation,BP,
851,GO:0002066,1,0.711906325466445,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.758132925517384,0,42,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.856308859974443,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.966885786086034,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.915390159814411,0,14,epithelial cell maturation,BP,
856,GO:0002071,1,0.988769713528015,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.941130653453751,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.964625530174303,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.894067505369862,0,17,osteoblast development,BP,
860,GO:0002077,1,0.995661884370703,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.978103355574828,0,3,inner acrosomal membrane,CC,
862,GO:0002080,1,0.894546461225392,0,17,acrosomal membrane,CC,
863,GO:0002081,1,0.985337521303893,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.910466468026673,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.995232713259837,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.945346356420953,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.974868971469764,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.989032351315372,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.922529356744783,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
870,GO:0002088,1,0.669748414441314,0,59,lens development in camera-type eye,BP,
871,GO:0002089,1,0.890897098339762,0,16,lens morphogenesis in camera-type eye,BP,
872,GO:0002090,1,0.791909940824865,0,35,regulation of receptor internalization,BP,
873,GO:0002091,1,0.942878256239799,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.859092849091163,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.922369436226336,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.987896829411232,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.90521787602129,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.929337032778981,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.992344799859512,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.981581695933717,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.799213970794717,0,32,podosome,CC,
882,GO:0002113,1,0.993973783651891,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.986525842112793,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.89995674005606,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.919637805284747,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.954651938521164,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.985336402227633,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987407808738394,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.995562597367028,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.984235506440195,0,2,polycystin complex,CC,
891,GO:0002134,1,0.985927828502817,0,2,UTP binding,MF,
892,GO:0002135,1,0.993479070722466,0,1,CTP binding,MF,
893,GO:0002138,1,0.952739501033822,0,8,retinoic acid biosynthetic process,BP,
894,GO:0002139,1,0.972012711438311,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.992248443248606,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.979607785983634,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.979607785983634,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.977918208698526,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994343722952723,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.992671539938845,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.992671539938845,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.957535470790949,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.992576979859984,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.993709554440484,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.965106508017798,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.98031894957328,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.968478521959686,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.970598494059447,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.927377796564514,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.943983575242311,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.986042883939944,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.992908399563964,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.970209781807505,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.968682899795352,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.959876506586392,0,7,manchette,CC,
916,GO:0002178,1,0.932837975812708,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.644691141018199,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.934365718250432,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.892791136637917,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.985342108253419,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.977441671037995,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.993492460514419,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.97420759943527,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981910545599024,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.991554008170324,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.978464636518585,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.992780976418393,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.994757603372113,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.95323398035597,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.679476594834665,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.771254174918489,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.771254174918489,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
934,GO:0002215,1,0.988890394842243,0,2,defense response to nematode,BP,
935,GO:0002218,1,0.189790742059689,0,262,activation of innate immune response,BP,
936,GO:0002220,1,0.529562473856118,0,108,innate immune response activating cell surface receptor signaling pathway,BP,
937,GO:0002221,1,0.348072448557102,0,160,pattern recognition receptor signaling pathway,BP,
938,GO:0002223,1,0.537463445721039,0,105,stimulatory C-type lectin receptor signaling pathway,BP,
939,GO:0002224,1,0.441851863644903,0,125,toll-like receptor signaling pathway,BP,
940,GO:0002225,1,0.990299232945564,0,2,positive regulation of antimicrobial peptide production,BP,
941,GO:0002227,1,0.947535218176807,0,12,innate immune response in mucosa,BP,
942,GO:0002228,1,0.729703132833523,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.876887922262951,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.989372610135501,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.985838786053353,0,2,response to molecule of fungal origin,BP,
947,GO:0002244,1,0.38481929409803,0,158,hematopoietic progenitor cell differentiation,BP,
948,GO:0002246,1,0.963706283794534,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.968176666319539,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.970856570845827,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.140038756550295,0,310,adaptive immune response,BP,
952,GO:0002251,1,0.904986677864198,0,20,organ or tissue specific immune response,BP,
955,GO:0002254,1,0.98276321972641,0,3,kinin cascade,BP,
956,GO:0002260,1,0.688829888891611,0,60,lymphocyte homeostasis,BP,
957,GO:0002262,1,0.425493795585955,0,133,myeloid cell homeostasis,BP,
959,GO:0002265,1,0.976773458058757,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.982990014656197,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.987639617120042,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.986868010209346,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.983260499468946,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.976606951924099,0,4,eosinophil activation involved in immune response,BP,
968,GO:0002281,1,0.943402397673292,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.986052523038101,0,2,microglial cell activation involved in immune response,BP,
971,GO:0002285,1,0.422443100163913,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.623646758907459,0,73,T cell activation involved in immune response,BP,
973,GO:0002287,1,0.720479275575339,0,50,alpha-beta T cell activation involved in immune response,BP,
974,GO:0002290,1,0.992991488566786,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.95275455068902,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.699260419969015,0,55,T cell differentiation involved in immune response,BP,
977,GO:0002293,1,0.720479275575339,0,50,alpha-beta T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.725452526326946,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.922076081780514,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.984848398424111,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.995179173051146,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.995365513822552,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.995365513822552,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.993166955740399,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.995365513822552,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.995365513822552,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.978424085162073,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.670329834850317,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.900935793246679,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.981838304428732,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.939210513462133,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.987820508660475,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.986617262706075,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.964890047306188,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.888879205302833,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.965105799944589,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.952540816451949,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.991433178258238,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.976947714713604,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.947477115015813,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.93241474043907,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.969468597060619,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.984329174145814,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.992398437741682,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.992398437741682,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.876991601475917,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.98828930050388,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.983943226043531,0,3,B cell selection,BP,
1009,GO:0002343,1,0.993340913152087,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.993340913152087,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.901789124342736,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.966914590118048,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.98211684291216,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.990539955921688,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.98276321972641,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.993700949794621,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.979881458022744,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.996356917639189,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.874839474268196,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.976342071149063,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.993876132633729,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.904740686151104,0,16,alpha-beta T cell lineage commitment,BP,
1025,GO:0002368,1,0.987294868804003,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.831123376240649,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.985854825369315,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.959444126090723,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.996215912706309,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.899506441401683,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.583427347574621,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.978185892401857,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992482469059609,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.749592351007087,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.988446463902443,0,2,hepatic immune response,BP,
1037,GO:0002385,1,0.915574280808551,0,18,mucosal immune response,BP,
1038,GO:0002386,1,0.987239933230605,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.97838492170549,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.994725105921154,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.983574047318512,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.873569249693336,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.979550030640207,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.98231987493985,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987239933230605,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.995017001984482,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.918003119856031,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.947387323245647,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.947387323245647,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.986536051063254,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.995869041004546,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.983910969782477,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.952590672369924,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.607333053676569,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992486526135919,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.625963229058308,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.98888323701337,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.98888323701337,0,2,immune complex clearance by monocytes and macrophages,BP,
1062,GO:0002439,1,0.980136373907418,0,4,chronic inflammatory response to antigenic stimulus,BP,
1064,GO:0002441,1,0.966914590118048,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.98211684291216,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.984389134135967,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.976606951924099,0,4,eosinophil mediated immunity,BP,
1072,GO:0002449,1,0.298148439530837,0,194,lymphocyte mediated immunity,BP,
1073,GO:0002450,1,0.995292804183984,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.802463239986689,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.633260592960419,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.967861947127571,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.988232819951723,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.283262558613088,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.98220575936537,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.988232819951723,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.908022075420856,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.949043479587388,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.619920578503996,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.955552221927012,0,7,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.987702484303565,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.996161763542896,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1087,GO:0002478,1,0.388217572574779,0,163,antigen processing and presentation of exogenous peptide antigen,BP,
1088,GO:0002479,1,0.700666361028648,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.961744225841389,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.996161763542896,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.94988176897148,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.99249965888042,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.99249965888042,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1094,GO:0002495,1,0.550953515312129,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1095,GO:0002501,1,0.982340212914498,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.994725105921154,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.987550100880473,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1098,GO:0002504,1,0.546731802182656,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1099,GO:0002505,1,0.991819732858453,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.991819732858453,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.865021790582656,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.987682431678384,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994322270557619,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.993322633427007,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.968013635837614,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.985845545303773,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.929265448997698,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.995894182048718,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.989110180285093,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.987994939099769,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.936686092431265,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.95561648808606,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.982453090503201,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002528,1,0.985115967473376,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1118,GO:0002532,1,0.741008052180271,0,47,production of molecular mediator involved in inflammatory response,BP,
1119,GO:0002534,1,0.820749184855299,0,30,cytokine production involved in inflammatory response,BP,
1120,GO:0002536,1,0.985333323115498,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.984688837635711,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.986211596932978,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.986211596932978,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.982417224334639,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.988504571484624,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.98635413013608,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.904135166342747,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.994789911630504,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1129,GO:0002548,1,0.803877036903494,0,40,monocyte chemotaxis,BP,
1131,GO:0002553,1,0.966914590118048,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.98211684291216,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.992495450415882,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.992495450415882,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.708152657542186,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.92194832041554,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.962631923248626,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.985336652860614,0,2,pro-T cell differentiation,BP,
1139,GO:0002573,1,0.333640616263774,0,169,myeloid leukocyte differentiation,BP,
1140,GO:0002576,1,0.473144534122217,0,119,platelet degranulation,BP,
1141,GO:0002577,1,0.909816544918011,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.959105439556195,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.953514473663283,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.973230080516017,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980721062490096,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.992363275409229,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.970503119625212,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.977973328112179,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.992363275409229,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.980700858159892,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.988248750773753,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.992363275409229,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.989603641282092,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.989603641282092,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.949043479587388,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.987712006842313,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.9608552471476,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.995292804183984,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.989571410188701,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994663586089518,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.944420016250767,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.985334217642284,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.987605298945444,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.726139837322082,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.936703722987831,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.815440036194237,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.9930956730518,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.9930956730518,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.90279752497199,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.99432942202529,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.944605793540556,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.993322633427007,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.993322633427007,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992473161339329,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992473161339329,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.987815005773995,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.993876132633729,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.993876132633729,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.993876132633729,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.985845545303773,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.985845545303773,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.940869563142078,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.958460657127361,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.970856570845827,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.981755558407684,0,3,positive regulation of T cell anergy,BP,
1187,GO:0002674,1,0.947047862865372,0,9,negative regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.955873025654666,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.97434469634655,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.981046939606584,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.957773283933423,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.962631923248626,0,5,somatic recombination of T cell receptor gene segments,BP,
1198,GO:0002686,1,0.823680063792712,0,33,negative regulation of leukocyte migration,BP,
1201,GO:0002689,1,0.921930071701891,0,14,negative regulation of leukocyte chemotaxis,BP,
1203,GO:0002691,1,0.872288836753103,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.954131556679254,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.92329978942415,0,12,positive regulation of cellular extravasation,BP,
1209,GO:0002697,1,0.150750418873992,0,300,regulation of immune effector process,BP,
1210,GO:0002698,1,0.557504400385485,0,93,negative regulation of immune effector process,BP,
1211,GO:0002699,1,0.374900572089916,0,158,positive regulation of immune effector process,BP,
1212,GO:0002700,1,0.522538743301132,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.831029746563853,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.657668032133291,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.388128288416465,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.77968520601336,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.573438882421947,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.508475377967469,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.829147504968649,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.645595859139489,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.752139988822185,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.916149248346905,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.840188392027628,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.772734712230332,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.943490237234141,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.841840822184394,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.81591486131216,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.935315455833353,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.878202771838432,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.687213349466151,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.881837907271074,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.801833284423843,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.993340913152087,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.878023728289823,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.966613184470931,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.914633005186427,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.985854825369315,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.992484154418602,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.993320980783552,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.966758689697704,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.988658825791806,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992482826476782,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.996215912706309,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.996215912706309,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.920014815405696,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.972486824697718,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.953059052802316,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.990268104634472,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.705620337681678,0,51,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.793759516202706,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.827200929261668,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1253,GO:0002758,1,0.212456067374449,0,245,innate immune response-activating signal transduction,BP,
1254,GO:0002759,1,0.977848381659574,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.990299232945564,0,2,positive regulation of antimicrobial humoral response,BP,
1256,GO:0002761,1,0.532212815855347,0,96,regulation of myeloid leukocyte differentiation,BP,
1257,GO:0002762,1,0.758124952109713,0,41,negative regulation of myeloid leukocyte differentiation,BP,
1258,GO:0002763,1,0.763371905506882,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.963300240310856,0,6,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.968658547622777,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.994241557580047,0,1,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.978839035339737,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.97919002640989,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.996234043686668,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.97919002640989,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.996234043686668,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.982892207787586,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.992521158735778,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.982892207787586,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.992521158735778,0,1,negative regulation of antibacterial peptide production,BP,
1277,GO:0002803,1,0.990299232945564,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.996234043686668,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.996296889663328,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.476202584945695,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.804671887658204,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.640757535913714,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.510065238381976,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.820284207574855,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.657860536696523,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.892228593636341,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.956609430158386,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.932518476621819,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.845607742501352,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.931627953025242,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.912630599765334,0,15,positive regulation of type 2 immune response,BP,
1292,GO:0002831,1,0.499152089585711,0,109,regulation of response to biotic stimulus,BP,
1293,GO:0002832,1,0.783158707924332,0,38,negative regulation of response to biotic stimulus,BP,
1294,GO:0002833,1,0.80964355552997,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.934624758967841,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.986508660614086,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.954501786072827,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.934624758967841,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.986508660614086,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.954501786072827,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.986536051063254,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.993913838322188,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.993876132633729,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.993876132633729,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.947387323245647,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.986508660614086,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.960349032928487,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.947387323245647,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.986508660614086,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.960349032928487,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1312,GO:0002862,1,0.952827061082191,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.977526446505762,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.970856570845827,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.986091483004964,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.995253170303175,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.990795062224225,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.982453090503201,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.992704304506391,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.989674214464981,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.994789911630504,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.994789911630504,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.962566762916659,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.989788684680856,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.972500083114237,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.766340164566597,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.942203150064116,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.879715230399409,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.772734712230332,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.943490237234141,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.841840822184394,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.984389134135967,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.995292804183984,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.989045286922607,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.993322633427007,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.993322633427007,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.98064713241184,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.900397201596931,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.934989064005058,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.984007120575377,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.98064713241184,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.98064713241184,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.970856570845827,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.981755558407684,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.737240149514128,0,51,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.935700988655046,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.938351717224039,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.951173494923651,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.969181702081993,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.981425049485889,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.987083070849205,0,2,trabecular meshwork development,BP,
1356,GO:0002933,1,0.983266625259946,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.936049699315327,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.987307677187994,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.977177644532811,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.986219008994379,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.986334649996209,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.995562597367028,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.992497314225378,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.984247740958277,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.980448938820001,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.987415933017648,0,2,leukotriene-C(4) hydrolase,MF,
1369,GO:0003007,1,0.218670131617357,0,223,heart morphogenesis,BP,
1371,GO:0003009,1,0.811551701932315,0,36,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.969654985761967,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.981562248148657,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.828077215884308,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.99210212686792,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.979389030676041,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.9930956730518,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.995130829709671,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.995130829709671,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.986771980258105,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.781776614932084,0,39,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992453808587364,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.978771459198413,0,3,angiotensin-mediated drinking behavior,BP,
1390,GO:0003057,1,0.970270988315494,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.995842275743558,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.960306054263147,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.987592106829149,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.994965955595125,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.996116978937686,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.996116978937686,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.996116978937686,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.892519789318441,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.976254221177506,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1400,GO:0003073,1,0.624071303190998,0,73,regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.890502695034058,0,18,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.996483460864596,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.946825577692792,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.924457121481263,0,13,negative regulation of systemic arterial blood pressure,BP,
1406,GO:0003093,1,0.936955294300957,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.899567798851694,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.995070841980215,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.96765130073676,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.967907300726716,0,5,renal water transport,BP,
1411,GO:0003099,1,0.983119908257079,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.964887795512514,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.97251548629284,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.977613281282949,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.996483460864596,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.98461604590045,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.94033241386439,0,10,heart field specification,BP,
1418,GO:0003129,1,0.97875858701231,0,4,heart induction,BP,
1419,GO:0003130,1,0.987735084509436,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.993036377919383,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.987735084509436,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.987735084509436,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.995951357786099,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.99234069128402,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.94511598479782,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.955260637126928,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.993854405045589,0,1,cardiogenic plate morphogenesis,BP,
1428,GO:0003143,1,0.661757318394283,0,61,embryonic heart tube morphogenesis,BP,
1429,GO:0003147,1,0.996089420284806,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.842596364844265,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.943783008493642,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.965582822049215,0,5,muscular septum morphogenesis,BP,
1433,GO:0003151,1,0.622568291755305,0,71,outflow tract morphogenesis,BP,
1434,GO:0003156,1,0.819497269848644,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.929565971525551,0,11,endocardium development,BP,
1436,GO:0003158,1,0.488470504005951,0,106,endothelium development,BP,
1437,GO:0003159,1,0.90843775406454,0,15,morphogenesis of an endothelium,BP,
1438,GO:0003160,1,0.963616768978619,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.923898501089088,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.979334548703916,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.980948610400965,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.968179632552392,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.987149339753763,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.975599658025103,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992467599886079,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.994713244419678,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.984696964784024,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.765495143997355,0,38,heart valve development,BP,
1449,GO:0003171,1,0.853405187063188,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.99234069128402,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.932197642235095,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.958819832048935,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.966242183000227,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.927288517136447,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.787090409393244,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.966242183000227,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.862555962762822,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.932197642235095,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.927288517136447,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.99234069128402,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.963346552924976,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.924177888357691,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.951597949086264,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.976902890696056,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.995302833467761,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.985972819152033,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.768188454577091,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.901926242584398,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.976534973752064,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.825110608559825,0,29,endocardial cushion morphogenesis,BP,
1471,GO:0003205,1,0.369555781884764,0,145,cardiac chamber development,BP,
1472,GO:0003206,1,0.472305878366445,0,112,cardiac chamber morphogenesis,BP,
1473,GO:0003207,1,0.931288940844114,0,11,cardiac chamber formation,BP,
1474,GO:0003208,1,0.636453793567842,0,67,cardiac ventricle morphogenesis,BP,
1475,GO:0003209,1,0.822203853575334,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.995951357786099,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.942672871199014,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.984530327081489,0,2,cardiac right atrium morphogenesis,BP,
1479,GO:0003214,1,0.914702654235192,0,13,cardiac left ventricle morphogenesis,BP,
1480,GO:0003215,1,0.883403548810487,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.992523571807978,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.981170228130222,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.983773417591794,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.979336335497381,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.892070254206824,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.941744778067395,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.991999282194596,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.960376046974283,0,6,atrial cardiac muscle tissue development,BP,
1489,GO:0003229,1,0.71156867995668,0,50,ventricular cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.799319947958243,0,32,cardiac atrium development,BP,
1491,GO:0003231,1,0.469256227971953,0,110,cardiac ventricle development,BP,
1492,GO:0003235,1,0.995951357786099,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.995951357786099,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.976285197061926,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.988071634917429,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.995237841458615,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.984075155755347,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.984075155755347,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.992133593536938,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.991878319710833,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.959793942229559,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1503,GO:0003256,1,0.956594979434806,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.977454347638242,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.995951357786099,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.995951357786099,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.944379885253083,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.936905180918953,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.94331621910176,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.992089665801698,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.872089592627839,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.971460414404493,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.97795337116072,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980307516048331,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.963241601013476,0,6,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003279,1,0.519096745588394,0,93,cardiac septum development,BP,
1517,GO:0003281,1,0.647838046189668,0,61,ventricular septum development,BP,
1518,GO:0003283,1,0.881360416027653,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.970684645082969,0,4,septum primum development,BP,
1520,GO:0003285,1,0.987334491552467,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.970684645082969,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.992582429968912,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.987144215692767,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.992735870788185,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.895030785993273,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.855578256853541,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.624053442891347,0,68,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.895030785993273,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.949798644907337,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.971618430300776,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.977652115772088,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.856757855744885,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.96178722952064,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.987783118242718,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.995951357786099,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956295534750619,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.992289616971345,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.881748476937521,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.987783118242718,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994406998783492,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.987783118242718,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.986559926535253,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.986559926535253,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1545,GO:0003334,1,0.942660199830304,0,9,keratinocyte development,BP,
1546,GO:0003335,1,0.995722131704521,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.920570656960125,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.814187821057587,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.951895704181725,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.981465456166929,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1551,GO:0003341,1,0.677272860106261,0,60,cilium movement,BP,
1552,GO:0003342,1,0.987575896851875,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.987575896851875,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.937554974606032,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.992504071281835,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.960530812021277,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981340945958982,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.890959842017946,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.913026958168913,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.992838734189371,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.930752978480343,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.965547712068237,0,5,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.98669737981628,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.993608490836106,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.958903912807824,0,6,brainstem development,BP,
1566,GO:0003365,1,0.977045921510156,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.985511076886249,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1570,GO:0003376,1,0.926866569364564,0,12,sphingosine-1-phosphate signaling pathway,BP,
1571,GO:0003382,1,0.835960297227988,0,26,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.977254992924158,0,3,apical constriction,BP,
1573,GO:0003400,1,0.9942129704155,0,1,regulation of COPII vesicle coating,BP,
1574,GO:0003401,1,0.822609547529218,0,29,axis elongation,BP,
1575,GO:0003402,1,0.959549283151994,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.986201621732757,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.964256485959893,0,5,retinal pigment epithelium development,BP,
1579,GO:0003408,1,0.977573183434335,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.992628597379342,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.934635500134639,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.992506090263331,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.970822972075884,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.869118200179258,0,21,endochondral bone growth,BP,
1585,GO:0003417,1,0.911406362197486,0,14,growth plate cartilage development,BP,
1586,GO:0003418,1,0.961935504535041,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.97923925301822,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.986454202976381,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.992503924341286,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.985065621100359,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.992506090263331,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.985554346648338,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.972334281882183,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.959391938040939,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.726735563102904,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.941149642491437,0,10,AT DNA binding,MF,
1600,GO:0003682,1,0.033828337068505,0,494,chromatin binding,MF,
1601,GO:0003684,1,0.647486471798583,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.908418871465474,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.952794215197279,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.941997346865723,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.99417930958253,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.954093393934598,0,7,satellite DNA binding,MF,
1608,GO:0003697,1,0.531999168214953,0,96,single-stranded DNA binding,MF,
1610,GO:0003705,1,0.548846296844715,0,91,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1611,GO:0003707,1,0.689387633031599,0,54,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.953193879014299,0,7,retinoic acid receptor activity,MF,
1616,GO:0003720,1,0.947639835453488,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.992500133858096,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.632898209078518,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.638530599695898,0,65,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.979098456460413,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.597474611353189,0,77,single-stranded RNA binding,MF,
1624,GO:0003730,1,0.651239175442093,0,62,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.530201742716838,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.738937961393485,0,50,translation initiation factor activity,MF,
1628,GO:0003747,1,0.960434839188947,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.84171412638065,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.892368973435796,0,17,protein disulfide isomerase activity,MF,
1631,GO:0003774,1,0.408653303262842,0,125,motor activity,MF,
1632,GO:0003777,1,0.450114270398847,0,109,microtubule motor activity,MF,
1634,GO:0003785,1,0.864362795606209,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.988086701468028,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.959342219805505,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1637,GO:0003823,1,0.777315128549325,0,45,antigen binding,MF,
1639,GO:0003826,1,0.988347876827618,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.985979578690735,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003829,1,0.985033251829589,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992448954349124,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.949085291168028,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.9930956730518,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.984848459695443,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.962782998182266,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994411076577941,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.980456816418084,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.889663423197988,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.992654781804303,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.992747990387103,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.990417339428131,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.986206257007343,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.974540726856667,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.982670715825285,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.949847479457635,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.985561418958626,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.994696402161051,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.988347876827618,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.987345198655197,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992456603639031,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.990163160395617,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.988400156472328,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.978856968380379,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.972801898496564,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.99622159485821,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.987576666168797,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.985057705462414,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994330443615449,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.992489054350594,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981282901888934,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.994805504076954,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.993651598794977,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.98564843853402,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.990592436944966,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.977579322539169,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.843034282581494,0,26,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.982677800706919,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.788593190505494,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.996040653319932,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.9315654771282,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.995808377488784,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.95419769328182,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.959647616417902,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003916,1,0.958043092637937,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.972753837271441,0,4,DNA topoisomerase type I activity,MF,
1688,GO:0003918,1,0.984881444594139,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.994610573360766,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.99025055154854,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.993625295286928,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.993625295286928,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.969187104979779,0,5,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.99464861929238,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.99464861929238,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994355978110344,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.98870657502479,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.993507719716997,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.994159949389673,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.984583659926154,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.986348728575555,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.994133486269735,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.975661892014724,0,4,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.992827893854145,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.994374354536359,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.880281982098883,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.890103383923418,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.993664822857648,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.990984099760303,0,2,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.847935958817716,0,40,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.982224501992617,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.986355470870562,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992472498259577,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.957779380384304,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.979530084639546,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003962,1,0.995049967525852,0,1,cystathionine gamma-synthase activity,MF,
1718,GO:0003963,1,0.987338059211124,0,2,RNA-3'-phosphate cyclase activity,MF,
1719,GO:0003964,1,0.947639835453488,0,8,RNA-directed DNA polymerase activity,MF,
1720,GO:0003968,1,0.984871751099239,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1721,GO:0003972,1,0.9930956730518,0,1,RNA ligase (ATP) activity,MF,
1722,GO:0003973,1,0.987437507524136,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1723,GO:0003974,1,0.995280216262359,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1724,GO:0003975,1,0.994259943745572,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003976,1,0.982585903192754,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003977,1,0.986527405967865,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1727,GO:0003978,1,0.995280216262359,0,1,UDP-glucose 4-epimerase activity,MF,
1728,GO:0003979,1,0.992687589924966,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1729,GO:0003980,1,0.9844809840496,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1730,GO:0003983,1,0.99426198695223,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1731,GO:0003985,1,0.982547703283048,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.981852153153114,0,4,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.978293973863049,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.966645499667046,0,6,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.992091978259893,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.987124506253476,0,2,acetylcholinesterase activity,MF,
1737,GO:0003991,1,0.994406998783492,0,1,acetylglutamate kinase activity,MF,
1738,GO:0003993,1,0.968099928966618,0,6,acid phosphatase activity,MF,
1739,GO:0003994,1,0.98573051257409,0,2,aconitate hydratase activity,MF,
1740,GO:0003995,1,0.907474118821267,0,15,acyl-CoA dehydrogenase activity,MF,
1741,GO:0003996,1,0.970245738496601,0,5,acyl-CoA ligase activity,MF,
1742,GO:0003997,1,0.968035426014674,0,5,acyl-CoA oxidase activity,MF,
1743,GO:0003998,1,0.992412995782499,0,2,acylphosphatase activity,MF,
1744,GO:0003999,1,0.996432450088202,0,1,adenine phosphoribosyltransferase activity,MF,
1745,GO:0004000,1,0.941559898690676,0,9,adenosine deaminase activity,MF,
1746,GO:0004001,1,0.994443672100244,0,1,adenosine kinase activity,MF,
1747,GO:0004003,1,0.796329033921386,0,32,ATP-dependent DNA helicase activity,MF,
1748,GO:0004004,1,0.637511107690801,0,64,ATP-dependent RNA helicase activity,MF,
1749,GO:0004008,1,0.984551994568206,0,2,copper-exporting ATPase activity,MF,
1750,GO:0004012,1,0.857206243684386,0,20,phospholipid-translocating ATPase activity,MF,
1751,GO:0004013,1,0.979053022684671,0,3,adenosylhomocysteinase activity,MF,
1752,GO:0004014,1,0.992647380323441,0,1,adenosylmethionine decarboxylase activity,MF,
1754,GO:0004017,1,0.946740189275337,0,8,adenylate kinase activity,MF,
1755,GO:0004018,1,0.995495190398897,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1756,GO:0004019,1,0.988125769772171,0,2,adenylosuccinate synthase activity,MF,
1757,GO:0004020,1,0.986026965220578,0,2,adenylylsulfate kinase activity,MF,
1758,GO:0004021,1,0.987313380288783,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1759,GO:0004022,1,0.971115942036128,0,5,alcohol dehydrogenase (NAD) activity,MF,
1760,GO:0004024,1,0.98787317305703,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1761,GO:0004027,1,0.995859708528055,0,1,alcohol sulfotransferase activity,MF,
1762,GO:0004028,1,0.954532011993039,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1763,GO:0004029,1,0.901268093730531,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1764,GO:0004030,1,0.96203223254742,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1765,GO:0004031,1,0.992453518757083,0,1,aldehyde oxidase activity,MF,
1766,GO:0004032,1,0.951200245873655,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1767,GO:0004033,1,0.880648550732811,0,25,aldo-keto reductase (NADP) activity,MF,
1768,GO:0004034,1,0.993589918707245,0,1,aldose 1-epimerase activity,MF,
1769,GO:0004035,1,0.986441051538771,0,2,alkaline phosphatase activity,MF,
1770,GO:0004037,1,0.995542866866675,0,1,allantoicase activity,MF,
1771,GO:0004040,1,0.982599343882163,0,3,amidase activity,MF,
1772,GO:0004042,1,0.994406998783492,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1773,GO:0004043,1,0.992538933289659,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1774,GO:0004044,1,0.992511962798839,0,1,amidophosphoribosyltransferase activity,MF,
1775,GO:0004045,1,0.981221143255467,0,4,aminoacyl-tRNA hydrolase activity,MF,
1776,GO:0004046,1,0.975036977191902,0,5,aminoacylase activity,MF,
1777,GO:0004047,1,0.989889488706247,0,2,aminomethyltransferase activity,MF,
1778,GO:0004051,1,0.993454267129848,0,1,arachidonate 5-lipoxygenase activity,MF,
1779,GO:0004052,1,0.980719446323232,0,3,arachidonate 12-lipoxygenase activity,MF,
1780,GO:0004053,1,0.990158699815872,0,2,arginase activity,MF,
1781,GO:0004055,1,0.994897017664268,0,1,argininosuccinate synthase activity,MF,
1782,GO:0004056,1,0.994569333881831,0,1,argininosuccinate lyase activity,MF,
1783,GO:0004057,1,0.994117220958021,0,1,arginyltransferase activity,MF,
1784,GO:0004058,1,0.99451374769836,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1785,GO:0004059,1,0.995512209712619,0,1,aralkylamine N-acetyltransferase activity,MF,
1786,GO:0004060,1,0.985839784461735,0,3,arylamine N-acetyltransferase activity,MF,
1787,GO:0004061,1,0.995135257868318,0,1,arylformamidase activity,MF,
1789,GO:0004063,1,0.990957434969283,0,2,aryldialkylphosphatase activity,MF,
1790,GO:0004064,1,0.970620778965828,0,6,arylesterase activity,MF,
1791,GO:0004065,1,0.926694969675658,0,11,arylsulfatase activity,MF,
1792,GO:0004066,1,0.987542704237149,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1793,GO:0004067,1,0.98866085188809,0,2,asparaginase activity,MF,
1794,GO:0004069,1,0.987976197576296,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1795,GO:0004070,1,0.984714936051485,0,2,aspartate carbamoyltransferase activity,MF,
1796,GO:0004074,1,0.992370987416194,0,2,biliverdin reductase activity,MF,
1797,GO:0004075,1,0.985618563720983,0,2,biotin carboxylase activity,MF,
1798,GO:0004077,1,0.992365376255917,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1799,GO:0004078,1,0.992365376255917,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004079,1,0.992365376255917,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1801,GO:0004080,1,0.992365376255917,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1802,GO:0004081,1,0.989316189358492,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1803,GO:0004082,1,0.981385831595401,0,4,bisphosphoglycerate mutase activity,MF,
1805,GO:0004085,1,0.994713244419678,0,1,butyryl-CoA dehydrogenase activity,MF,
1806,GO:0004087,1,0.984714936051485,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1807,GO:0004088,1,0.984714936051485,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1808,GO:0004089,1,0.93290404308714,0,13,carbonate dehydratase activity,MF,
1809,GO:0004090,1,0.979305538378094,0,5,carbonyl reductase (NADPH) activity,MF,
1810,GO:0004092,1,0.993043571103745,0,1,carnitine O-acetyltransferase activity,MF,
1811,GO:0004095,1,0.971894813566887,0,4,carnitine O-palmitoyltransferase activity,MF,
1812,GO:0004096,1,0.977497146126187,0,4,catalase activity,MF,
1813,GO:0004098,1,0.994746791237208,0,1,cerebroside-sulfatase activity,MF,
1814,GO:0004102,1,0.993619684523514,0,1,choline O-acetyltransferase activity,MF,
1815,GO:0004103,1,0.988503480985049,0,2,choline kinase activity,MF,
1816,GO:0004104,1,0.980439446220492,0,3,cholinesterase activity,MF,
1817,GO:0004105,1,0.987776139694397,0,2,choline-phosphate cytidylyltransferase activity,MF,
1818,GO:0004108,1,0.992860644241066,0,1,citrate (Si)-synthase activity,MF,
1819,GO:0004109,1,0.986804493286946,0,2,coproporphyrinogen oxidase activity,MF,
1820,GO:0004111,1,0.973554408984865,0,5,creatine kinase activity,MF,
1821,GO:0004112,1,0.850177016622713,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004113,1,0.992433569457904,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1823,GO:0004114,1,0.856669138136027,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1824,GO:0004115,1,0.893913546523345,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1825,GO:0004117,1,0.980072371504594,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1826,GO:0004118,1,0.977038376846562,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004119,1,0.984911977034771,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004122,1,0.993379716894051,0,1,cystathionine beta-synthase activity,MF,
1829,GO:0004123,1,0.995049967525852,0,1,cystathionine gamma-lyase activity,MF,
1830,GO:0004126,1,0.947779345848701,0,10,cytidine deaminase activity,MF,
1831,GO:0004127,1,0.972519351802988,0,4,cytidylate kinase activity,MF,
1832,GO:0004128,1,0.958228116662002,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1833,GO:0004129,1,0.917154745194999,0,22,cytochrome-c oxidase activity,MF,
1834,GO:0004132,1,0.994493470259061,0,1,dCMP deaminase activity,MF,
1835,GO:0004133,1,0.992263008596149,0,1,glycogen debranching enzyme activity,MF,
1836,GO:0004134,1,0.992263008596149,0,1,4-alpha-glucanotransferase activity,MF,
1837,GO:0004135,1,0.992263008596149,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1838,GO:0004137,1,0.985870885245177,0,2,deoxycytidine kinase activity,MF,
1839,GO:0004138,1,0.996131220855828,0,1,deoxyguanosine kinase activity,MF,
1840,GO:0004139,1,0.995081675552396,0,1,deoxyribose-phosphate aldolase activity,MF,
1841,GO:0004140,1,0.988450961345636,0,2,dephospho-CoA kinase activity,MF,
1842,GO:0004142,1,0.982012050008786,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1843,GO:0004143,1,0.927839069385659,0,10,diacylglycerol kinase activity,MF,
1844,GO:0004144,1,0.986206257007343,0,2,diacylglycerol O-acyltransferase activity,MF,
1845,GO:0004145,1,0.98649353513705,0,3,diamine N-acetyltransferase activity,MF,
1846,GO:0004146,1,0.988589495888212,0,2,dihydrofolate reductase activity,MF,
1847,GO:0004148,1,0.992534274512751,0,1,dihydrolipoyl dehydrogenase activity,MF,
1848,GO:0004149,1,0.993006365576562,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1849,GO:0004151,1,0.984714936051485,0,2,dihydroorotase activity,MF,
1850,GO:0004152,1,0.994415153683557,0,1,dihydroorotate dehydrogenase activity,MF,
1851,GO:0004155,1,0.995215551857106,0,1,6,7-dihydropteridine reductase activity,MF,
1852,GO:0004157,1,0.986819018366891,0,2,dihydropyrimidinase activity,MF,
1853,GO:0004161,1,0.988574809059083,0,2,dimethylallyltranstransferase activity,MF,
1854,GO:0004163,1,0.994947197944683,0,1,diphosphomevalonate decarboxylase activity,MF,
1855,GO:0004164,1,0.99496221216027,0,1,diphthine synthase activity,MF,
1856,GO:0004165,1,0.97884327304302,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1857,GO:0004167,1,0.987039522622855,0,3,dopachrome isomerase activity,MF,
1858,GO:0004168,1,0.994149766902327,0,1,dolichol kinase activity,MF,
1859,GO:0004169,1,0.973917302432844,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1860,GO:0004170,1,0.994807449703121,0,1,dUTP diphosphatase activity,MF,
1861,GO:0004174,1,0.986542145561582,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1863,GO:0004176,1,0.971855980834641,0,4,ATP-dependent peptidase activity,MF,
1864,GO:0004177,1,0.748898150120665,0,43,aminopeptidase activity,MF,
1865,GO:0004180,1,0.796311949149426,0,36,carboxypeptidase activity,MF,
1866,GO:0004181,1,0.864367954950919,0,23,metallocarboxypeptidase activity,MF,
1867,GO:0004185,1,0.944143076268407,0,9,serine-type carboxypeptidase activity,MF,
1868,GO:0004190,1,0.895474454561202,0,18,aspartic-type endopeptidase activity,MF,
1869,GO:0004197,1,0.589780731292908,0,81,cysteine-type endopeptidase activity,MF,
1870,GO:0004198,1,0.884117222866408,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1871,GO:0004222,1,0.517779741058947,0,94,metalloendopeptidase activity,MF,
1873,GO:0004298,1,0.929019818125167,0,18,threonine-type endopeptidase activity,MF,
1874,GO:0004300,1,0.954729093896448,0,8,enoyl-CoA hydratase activity,MF,
1875,GO:0004301,1,0.961598002824402,0,7,epoxide hydrolase activity,MF,
1876,GO:0004303,1,0.956909726402895,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1877,GO:0004304,1,0.994980888130085,0,1,estrone sulfotransferase activity,MF,
1878,GO:0004305,1,0.974576001268747,0,4,ethanolamine kinase activity,MF,
1879,GO:0004306,1,0.994836539727285,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1880,GO:0004307,1,0.990144603111765,0,2,ethanolaminephosphotransferase activity,MF,
1881,GO:0004308,1,0.969381515917572,0,5,exo-alpha-sialidase activity,MF,
1882,GO:0004309,1,0.972068372229805,0,4,exopolyphosphatase activity,MF,
1883,GO:0004310,1,0.994335551361362,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1884,GO:0004311,1,0.980366019712064,0,3,farnesyltranstransferase activity,MF,
1885,GO:0004312,1,0.938189575702836,0,10,fatty acid synthase activity,MF,
1886,GO:0004313,1,0.992156415186924,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1887,GO:0004314,1,0.986856486720343,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1888,GO:0004315,1,0.987982380197244,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1889,GO:0004316,1,0.992156415186924,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1890,GO:0004317,1,0.992156415186924,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1891,GO:0004319,1,0.992156415186924,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1892,GO:0004320,1,0.987220316088634,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1893,GO:0004321,1,0.976058351010925,0,4,fatty-acyl-CoA synthase activity,MF,
1894,GO:0004322,1,0.965919540053618,0,5,ferroxidase activity,MF,
1895,GO:0004324,1,0.994758585258665,0,1,ferredoxin-NADP+ reductase activity,MF,
1896,GO:0004325,1,0.9922576124332,0,1,ferrochelatase activity,MF,
1897,GO:0004326,1,0.993576982081585,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1898,GO:0004329,1,0.985145511458319,0,2,formate-tetrahydrofolate ligase activity,MF,
1899,GO:0004331,1,0.972801898496564,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1900,GO:0004332,1,0.98438721273831,0,3,fructose-bisphosphate aldolase activity,MF,
1901,GO:0004333,1,0.99496221216027,0,1,fumarate hydratase activity,MF,
1902,GO:0004334,1,0.995532178766511,0,1,fumarylacetoacetase activity,MF,
1903,GO:0004335,1,0.988406825925072,0,2,galactokinase activity,MF,
1904,GO:0004336,1,0.992937203934637,0,1,galactosylceramidase activity,MF,
1905,GO:0004337,1,0.988574809059083,0,2,geranyltranstransferase activity,MF,
1906,GO:0004339,1,0.992321256293606,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1907,GO:0004340,1,0.964034925878364,0,5,glucokinase activity,MF,
1908,GO:0004341,1,0.994700369020467,0,1,gluconolactonase activity,MF,
1909,GO:0004342,1,0.988704558226093,0,2,glucosamine-6-phosphate deaminase activity,MF,
1910,GO:0004343,1,0.992502085487007,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1911,GO:0004344,1,0.992106452708226,0,1,glucose dehydrogenase activity,MF,
1912,GO:0004345,1,0.986019646230557,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1913,GO:0004346,1,0.980940426366091,0,3,glucose-6-phosphatase activity,MF,
1914,GO:0004347,1,0.994376395813296,0,1,glucose-6-phosphate isomerase activity,MF,
1915,GO:0004348,1,0.981538418718262,0,3,glucosylceramidase activity,MF,
1916,GO:0004349,1,0.992562148440043,0,1,glutamate 5-kinase activity,MF,
1917,GO:0004350,1,0.992562148440043,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1919,GO:0004352,1,0.986491712023626,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1920,GO:0004353,1,0.986491712023626,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1921,GO:0004356,1,0.984962157232859,0,2,glutamate-ammonia ligase activity,MF,
1922,GO:0004357,1,0.985342744936483,0,2,glutamate-cysteine ligase activity,MF,
1923,GO:0004359,1,0.979616812944238,0,3,glutaminase activity,MF,
1924,GO:0004360,1,0.985018818966641,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1925,GO:0004361,1,0.995108588206697,0,1,glutaryl-CoA dehydrogenase activity,MF,
1926,GO:0004362,1,0.994005935689679,0,1,glutathione-disulfide reductase activity,MF,
1927,GO:0004363,1,0.994740885029255,0,1,glutathione synthase activity,MF,
1928,GO:0004364,1,0.898452114638554,0,24,glutathione transferase activity,MF,
1929,GO:0004365,1,0.995740477653328,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1930,GO:0004366,1,0.978741020426302,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1931,GO:0004367,1,0.98553039677948,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1932,GO:0004368,1,0.985401876654302,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1933,GO:0004370,1,0.984588296657745,0,2,glycerol kinase activity,MF,
1934,GO:0004372,1,0.987738414708503,0,2,glycine hydroxymethyltransferase activity,MF,
1935,GO:0004373,1,0.985348874451515,0,2,glycogen (starch) synthase activity,MF,
1936,GO:0004375,1,0.992506314483297,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1937,GO:0004376,1,0.974643146889885,0,4,glycolipid mannosyltransferase activity,MF,
1938,GO:0004377,1,0.993496939314332,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1939,GO:0004378,1,0.992941754270209,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1940,GO:0004379,1,0.984964855171422,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1941,GO:0004380,1,0.995333528883485,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1942,GO:0004381,1,0.995333528883485,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1943,GO:0004382,1,0.987040655227007,0,2,guanosine-diphosphatase activity,MF,
1945,GO:0004385,1,0.911478982016584,0,13,guanylate kinase activity,MF,
1946,GO:0004386,1,0.359638288891251,0,143,helicase activity,MF,
1947,GO:0004392,1,0.99046131354524,0,2,heme oxygenase (decyclizing) activity,MF,
1948,GO:0004394,1,0.992496102855771,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1949,GO:0004395,1,0.995807011225709,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1950,GO:0004396,1,0.964034925878364,0,5,hexokinase activity,MF,
1951,GO:0004397,1,0.992714948015017,0,1,histidine ammonia-lyase activity,MF,
1952,GO:0004398,1,0.993727778298395,0,1,histidine decarboxylase activity,MF,
1953,GO:0004402,1,0.709015830156827,0,50,histone acetyltransferase activity,MF,
1954,GO:0004407,1,0.748132083984295,0,43,histone deacetylase activity,MF,
1955,GO:0004408,1,0.993969773002142,0,1,holocytochrome-c synthase activity,MF,
1956,GO:0004411,1,0.994699377532294,0,1,homogentisate 1,2-dioxygenase activity,MF,
1957,GO:0004415,1,0.96930085291325,0,5,hyalurononglucosaminidase activity,MF,
1958,GO:0004416,1,0.988246186604704,0,2,hydroxyacylglutathione hydrolase activity,MF,
1959,GO:0004418,1,0.995512209712619,0,1,hydroxymethylbilane synthase activity,MF,
1960,GO:0004419,1,0.989014241144089,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1961,GO:0004420,1,0.992481641817201,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1962,GO:0004421,1,0.986340968802966,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1963,GO:0004422,1,0.990309718035064,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1964,GO:0004423,1,0.992383189934159,0,1,iduronate-2-sulfatase activity,MF,
1965,GO:0004427,1,0.986362903944763,0,3,inorganic diphosphatase activity,MF,
1966,GO:0004430,1,0.970375097659278,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1968,GO:0004438,1,0.89464907970132,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1969,GO:0004439,1,0.943656366051469,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1970,GO:0004441,1,0.994369250835666,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1971,GO:0004445,1,0.965176442472279,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1972,GO:0004446,1,0.993012653350283,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1973,GO:0004447,1,0.992884017536836,0,1,iodide peroxidase activity,MF,
1974,GO:0004448,1,0.973223720152706,0,5,isocitrate dehydrogenase activity,MF,
1975,GO:0004449,1,0.984072731567432,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1976,GO:0004450,1,0.988977194886493,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1977,GO:0004452,1,0.994282421202187,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1978,GO:0004454,1,0.993714342557595,0,1,ketohexokinase activity,MF,
1979,GO:0004457,1,0.973910707323969,0,5,lactate dehydrogenase activity,MF,
1980,GO:0004458,1,0.987913878787639,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1981,GO:0004459,1,0.98582726241627,0,3,L-lactate dehydrogenase activity,MF,
1982,GO:0004461,1,0.983373823908643,0,3,lactose synthase activity,MF,
1983,GO:0004462,1,0.994464016402695,0,1,lactoylglutathione lyase activity,MF,
1984,GO:0004463,1,0.994404959635515,0,1,leukotriene-A4 hydrolase activity,MF,
1985,GO:0004464,1,0.985751401219004,0,4,leukotriene-C4 synthase activity,MF,
1986,GO:0004465,1,0.962715319791374,0,6,lipoprotein lipase activity,MF,
1987,GO:0004466,1,0.969822382510985,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1988,GO:0004467,1,0.919020060705474,0,12,long-chain fatty acid-CoA ligase activity,MF,
1989,GO:0004468,1,0.970617623923864,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1990,GO:0004470,1,0.975159765525332,0,4,malic enzyme activity,MF,
1991,GO:0004471,1,0.979274776510104,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1992,GO:0004473,1,0.979274776510104,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1993,GO:0004474,1,0.992386603804784,0,1,malate synthase activity,MF,
1994,GO:0004475,1,0.995293641349122,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1995,GO:0004476,1,0.994995753572652,0,1,mannose-6-phosphate isomerase activity,MF,
1996,GO:0004477,1,0.973257595554063,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1997,GO:0004478,1,0.985680768315361,0,2,methionine adenosyltransferase activity,MF,
1998,GO:0004479,1,0.99314632348085,0,1,methionyl-tRNA formyltransferase activity,MF,
1999,GO:0004482,1,0.992348523628312,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2000,GO:0004483,1,0.986238532970005,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2001,GO:0004484,1,0.99248373283494,0,1,mRNA guanylyltransferase activity,MF,
2002,GO:0004485,1,0.986042883939944,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2003,GO:0004486,1,0.99256185361887,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2004,GO:0004487,1,0.980585354305703,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2005,GO:0004488,1,0.973257595554063,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2006,GO:0004489,1,0.992267484257496,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2007,GO:0004490,1,0.995316979435397,0,1,methylglutaconyl-CoA hydratase activity,MF,
2008,GO:0004491,1,0.994178290216842,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2009,GO:0004492,1,0.994319205483428,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2010,GO:0004493,1,0.996294146734027,0,1,methylmalonyl-CoA epimerase activity,MF,
2011,GO:0004494,1,0.992879880767985,0,1,methylmalonyl-CoA mutase activity,MF,
2012,GO:0004496,1,0.994405979230079,0,1,mevalonate kinase activity,MF,
2013,GO:0004497,1,0.622278991633532,0,75,monooxygenase activity,MF,
2014,GO:0004498,1,0.993576982081585,0,1,calcidiol 1-monooxygenase activity,MF,
2015,GO:0004499,1,0.969323579188828,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2016,GO:0004500,1,0.985969554365339,0,2,dopamine beta-monooxygenase activity,MF,
2017,GO:0004502,1,0.99244887965099,0,1,kynurenine 3-monooxygenase activity,MF,
2018,GO:0004504,1,0.992513811625648,0,1,peptidylglycine monooxygenase activity,MF,
2019,GO:0004505,1,0.983262048596187,0,3,phenylalanine 4-monooxygenase activity,MF,
2020,GO:0004506,1,0.992849815923972,0,1,squalene monooxygenase activity,MF,
2021,GO:0004509,1,0.994498542501618,0,1,steroid 21-monooxygenase activity,MF,
2022,GO:0004510,1,0.994909387568471,0,1,tryptophan 5-monooxygenase activity,MF,
2023,GO:0004511,1,0.994742854438429,0,1,tyrosine 3-monooxygenase activity,MF,
2024,GO:0004512,1,0.994020037543521,0,1,inositol-3-phosphate synthase activity,MF,
2025,GO:0004513,1,0.993925789035099,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2026,GO:0004514,1,0.981078013406038,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2027,GO:0004515,1,0.972440178223954,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2028,GO:0004516,1,0.9930956730518,0,1,nicotinate phosphoribosyltransferase activity,MF,
2029,GO:0004517,1,0.978540804026334,0,3,nitric-oxide synthase activity,MF,
2030,GO:0004518,1,0.293879533420124,0,193,nuclease activity,MF,
2031,GO:0004519,1,0.484103415495364,0,118,endonuclease activity,MF,
2032,GO:0004520,1,0.745346668246981,0,47,endodeoxyribonuclease activity,MF,
2033,GO:0004521,1,0.739594089079202,0,51,endoribonuclease activity,MF,
2034,GO:0004522,1,0.988119269839591,0,3,ribonuclease A activity,MF,
2035,GO:0004523,1,0.969170145836838,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2036,GO:0004525,1,0.972918707387016,0,4,ribonuclease III activity,MF,
2037,GO:0004526,1,0.941164040273659,0,11,ribonuclease P activity,MF,
2038,GO:0004527,1,0.617152995269466,0,73,exonuclease activity,MF,
2039,GO:0004528,1,0.961413164785055,0,6,phosphodiesterase I activity,MF,
2040,GO:0004529,1,0.886468620017892,0,19,exodeoxyribonuclease activity,MF,
2041,GO:0004530,1,0.984827296952926,0,2,deoxyribonuclease I activity,MF,
2042,GO:0004531,1,0.990539437987153,0,2,deoxyribonuclease II activity,MF,
2043,GO:0004532,1,0.804403715590109,0,34,exoribonuclease activity,MF,
2044,GO:0004534,1,0.976891393031411,0,3,5'-3' exoribonuclease activity,MF,
2045,GO:0004535,1,0.9186908230471,0,12,poly(A)-specific ribonuclease activity,MF,
2046,GO:0004536,1,0.666563313584596,0,65,deoxyribonuclease activity,MF,
2047,GO:0004540,1,0.567735268965004,0,94,ribonuclease activity,MF,
2048,GO:0004549,1,0.913349174940019,0,16,tRNA-specific ribonuclease activity,MF,
2049,GO:0004550,1,0.907417303295054,0,17,nucleoside diphosphate kinase activity,MF,
2050,GO:0004551,1,0.910946160343402,0,16,nucleotide diphosphatase activity,MF,
2052,GO:0004556,1,0.989459154183471,0,2,alpha-amylase activity,MF,
2053,GO:0004557,1,0.988133235698523,0,2,alpha-galactosidase activity,MF,
2054,GO:0004558,1,0.977498123337686,0,3,alpha-1,4-glucosidase activity,MF,
2055,GO:0004559,1,0.909193274523267,0,13,alpha-mannosidase activity,MF,
2056,GO:0004560,1,0.988706917849736,0,2,alpha-L-fucosidase activity,MF,
2057,GO:0004561,1,0.993100557913874,0,1,alpha-N-acetylglucosaminidase activity,MF,
2058,GO:0004563,1,0.967883299411471,0,5,beta-N-acetylhexosaminidase activity,MF,
2059,GO:0004565,1,0.961490307807483,0,6,beta-galactosidase activity,MF,
2060,GO:0004566,1,0.98151470497266,0,3,beta-glucuronidase activity,MF,
2061,GO:0004567,1,0.99261857801174,0,1,beta-mannosidase activity,MF,
2063,GO:0004569,1,0.992478470261189,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2064,GO:0004571,1,0.951179056239935,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2065,GO:0004572,1,0.984838950955472,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2066,GO:0004573,1,0.99317366425755,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2067,GO:0004574,1,0.992530918766145,0,1,oligo-1,6-glucosidase activity,MF,
2068,GO:0004576,1,0.946012007482065,0,10,oligosaccharyl transferase activity,MF,
2069,GO:0004577,1,0.988904266586918,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2070,GO:0004578,1,0.99250173731854,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2071,GO:0004579,1,0.94987626184207,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2072,GO:0004581,1,0.99593396841215,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2073,GO:0004582,1,0.98823798304289,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2074,GO:0004583,1,0.972744927289326,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2075,GO:0004584,1,0.993820984470009,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2076,GO:0004585,1,0.995215551857106,0,1,ornithine carbamoyltransferase activity,MF,
2077,GO:0004586,1,0.980133747944198,0,3,ornithine decarboxylase activity,MF,
2078,GO:0004587,1,0.99459047963083,0,1,ornithine-oxo-acid transaminase activity,MF,
2079,GO:0004588,1,0.993288254911896,0,1,orotate phosphoribosyltransferase activity,MF,
2080,GO:0004590,1,0.993288254911896,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2081,GO:0004591,1,0.973442030243485,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2082,GO:0004594,1,0.974365458904739,0,4,pantothenate kinase activity,MF,
2083,GO:0004595,1,0.993949749296195,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2084,GO:0004596,1,0.933513656796232,0,11,peptide alpha-N-acetyltransferase activity,MF,
2085,GO:0004597,1,0.99252625852527,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2086,GO:0004598,1,0.992513811625648,0,1,peptidylamidoglycolate lyase activity,MF,
2087,GO:0004601,1,0.818702347676732,0,38,peroxidase activity,MF,
2088,GO:0004602,1,0.931980317442259,0,16,glutathione peroxidase activity,MF,
2089,GO:0004603,1,0.995953922606191,0,1,phenylethanolamine N-methyltransferase activity,MF,
2090,GO:0004605,1,0.978928490421424,0,3,phosphatidate cytidylyltransferase activity,MF,
2091,GO:0004607,1,0.995682134087877,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2092,GO:0004608,1,0.996152411222081,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2093,GO:0004609,1,0.987575432686308,0,2,phosphatidylserine decarboxylase activity,MF,
2094,GO:0004610,1,0.994555211479909,0,1,phosphoacetylglucosamine mutase activity,MF,
2095,GO:0004611,1,0.987901664983935,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2096,GO:0004613,1,0.987901664983935,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2097,GO:0004614,1,0.966045419661895,0,5,phosphoglucomutase activity,MF,
2098,GO:0004615,1,0.989700967929331,0,2,phosphomannomutase activity,MF,
2099,GO:0004616,1,0.981885561719773,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2100,GO:0004617,1,0.994512734573476,0,1,phosphoglycerate dehydrogenase activity,MF,
2101,GO:0004618,1,0.993697131329752,0,1,phosphoglycerate kinase activity,MF,
2102,GO:0004619,1,0.981385831595401,0,4,phosphoglycerate mutase activity,MF,
2104,GO:0004621,1,0.993966766284853,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2105,GO:0004622,1,0.887342802002545,0,18,lysophospholipase activity,MF,
2106,GO:0004623,1,0.856712128398335,0,26,phospholipase A2 activity,MF,
2108,GO:0004630,1,0.963493470856888,0,6,phospholipase D activity,MF,
2109,GO:0004631,1,0.995762864722722,0,1,phosphomevalonate kinase activity,MF,
2110,GO:0004632,1,0.995810425383856,0,1,phosphopantothenate--cysteine ligase activity,MF,
2111,GO:0004633,1,0.994109094531449,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2112,GO:0004634,1,0.977342644699093,0,4,phosphopyruvate hydratase activity,MF,
2113,GO:0004637,1,0.992570005492899,0,1,phosphoribosylamine-glycine ligase activity,MF,
2114,GO:0004638,1,0.992608675887534,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2115,GO:0004639,1,0.992608675887534,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2116,GO:0004641,1,0.992570005492899,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2117,GO:0004642,1,0.99241822546087,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2118,GO:0004643,1,0.994355978110344,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2119,GO:0004644,1,0.992570005492899,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2120,GO:0004645,1,0.959554014048814,0,6,phosphorylase activity,MF,
2121,GO:0004647,1,0.984176651648627,0,3,phosphoserine phosphatase activity,MF,
2122,GO:0004648,1,0.99431000981612,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2123,GO:0004649,1,0.987674802063252,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2124,GO:0004651,1,0.98775021593665,0,2,polynucleotide 5'-phosphatase activity,MF,
2125,GO:0004652,1,0.936096341865091,0,9,polynucleotide adenylyltransferase activity,MF,
2126,GO:0004653,1,0.875581289664286,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2127,GO:0004654,1,0.992476900260023,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2128,GO:0004655,1,0.992692080994819,0,1,porphobilinogen synthase activity,MF,
2129,GO:0004656,1,0.974707382139835,0,4,procollagen-proline 4-dioxygenase activity,MF,
2130,GO:0004657,1,0.994109094531449,0,1,proline dehydrogenase activity,MF,
2131,GO:0004658,1,0.988549017402431,0,2,propionyl-CoA carboxylase activity,MF,
2132,GO:0004659,1,0.908556428986416,0,15,prenyltransferase activity,MF,
2133,GO:0004660,1,0.988370331693565,0,2,protein farnesyltransferase activity,MF,
2134,GO:0004661,1,0.971148752814075,0,5,protein geranylgeranyltransferase activity,MF,
2135,GO:0004662,1,0.988503174244844,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2136,GO:0004663,1,0.977824502679749,0,4,Rab geranylgeranyltransferase activity,MF,
2137,GO:0004666,1,0.984986189436677,0,2,prostaglandin-endoperoxide synthase activity,MF,
2138,GO:0004667,1,0.991645931795441,0,2,prostaglandin-D synthase activity,MF,
2139,GO:0004668,1,0.979311479796522,0,3,protein-arginine deiminase activity,MF,
2140,GO:0004671,1,0.992463834993875,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2142,GO:0004673,1,0.952503948367764,0,7,protein histidine kinase activity,MF,
2144,GO:0004675,1,0.895875641052897,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2145,GO:0004676,1,0.99227636978334,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2146,GO:0004677,1,0.976937084221588,0,3,DNA-dependent protein kinase activity,MF,
2147,GO:0004679,1,0.953110452664616,0,7,AMP-activated protein kinase activity,MF,
2149,GO:0004686,1,0.992245001182228,0,1,elongation factor-2 kinase activity,MF,
2150,GO:0004687,1,0.970223586945978,0,4,myosin light chain kinase activity,MF,
2151,GO:0004689,1,0.965716589119837,0,5,phosphorylase kinase activity,MF,
2152,GO:0004690,1,0.944101170079958,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2153,GO:0004691,1,0.958317740132374,0,6,cAMP-dependent protein kinase activity,MF,
2154,GO:0004692,1,0.985171467995989,0,2,cGMP-dependent protein kinase activity,MF,
2155,GO:0004693,1,0.810208285366588,0,34,cyclin-dependent protein serine/threonine kinase activity,MF,
2156,GO:0004694,1,0.970891339536458,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2157,GO:0004697,1,0.895446998209826,0,15,protein kinase C activity,MF,
2158,GO:0004698,1,0.977448945523785,0,3,calcium-dependent protein kinase C activity,MF,
2159,GO:0004699,1,0.978204815683451,0,3,calcium-independent protein kinase C activity,MF,
2161,GO:0004703,1,0.975001959703552,0,4,G-protein coupled receptor kinase activity,MF,
2162,GO:0004704,1,0.968215200272254,0,5,NF-kappaB-inducing kinase activity,MF,
2163,GO:0004705,1,0.980699455201944,0,3,JUN kinase activity,MF,
2164,GO:0004706,1,0.977676021782657,0,3,JUN kinase kinase kinase activity,MF,
2165,GO:0004707,1,0.912841977521725,0,14,MAP kinase activity,MF,
2166,GO:0004708,1,0.905504551454264,0,15,MAP kinase kinase activity,MF,
2168,GO:0004711,1,0.950685727338997,0,7,ribosomal protein S6 kinase activity,MF,
2169,GO:0004712,1,0.761305578990489,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2172,GO:0004715,1,0.713531842188582,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2173,GO:0004716,1,0.934421330978638,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2174,GO:0004719,1,0.980193753496394,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2175,GO:0004720,1,0.95792885866818,0,6,protein-lysine 6-oxidase activity,MF,
2177,GO:0004722,1,0.646034757192127,0,66,protein serine/threonine phosphatase activity,MF,
2178,GO:0004723,1,0.950399685985429,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2180,GO:0004726,1,0.948820194199634,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2181,GO:0004727,1,0.990235373415167,0,2,prenylated protein tyrosine phosphatase activity,MF,
2182,GO:0004728,1,0.99339854533039,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2183,GO:0004729,1,0.995048145492834,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2184,GO:0004730,1,0.995187876653141,0,1,pseudouridylate synthase activity,MF,
2185,GO:0004731,1,0.986225213882192,0,2,purine-nucleoside phosphorylase activity,MF,
2186,GO:0004733,1,0.992563938200111,0,1,pyridoxamine-phosphate oxidase activity,MF,
2187,GO:0004735,1,0.98993997016982,0,2,pyrroline-5-carboxylate reductase activity,MF,
2188,GO:0004736,1,0.992499809313605,0,1,pyruvate carboxylase activity,MF,
2189,GO:0004738,1,0.966750078633746,0,5,pyruvate dehydrogenase activity,MF,
2190,GO:0004739,1,0.988039616893544,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2191,GO:0004740,1,0.971511979974958,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2192,GO:0004741,1,0.977367495897343,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2193,GO:0004742,1,0.992489332642608,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2194,GO:0004743,1,0.9859526459111,0,2,pyruvate kinase activity,MF,
2195,GO:0004744,1,0.993354321866076,0,1,retinal isomerase activity,MF,
2196,GO:0004745,1,0.934834310418441,0,12,retinol dehydrogenase activity,MF,
2197,GO:0004747,1,0.995896812446831,0,1,ribokinase activity,MF,
2198,GO:0004748,1,0.977905378228213,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2199,GO:0004749,1,0.976514583277442,0,4,ribose phosphate diphosphokinase activity,MF,
2200,GO:0004750,1,0.993947749705736,0,1,ribulose-phosphate 3-epimerase activity,MF,
2201,GO:0004751,1,0.994876954360601,0,1,ribose-5-phosphate isomerase activity,MF,
2202,GO:0004753,1,0.992376542535849,0,1,saccharopine dehydrogenase activity,MF,
2203,GO:0004756,1,0.987442639479654,0,2,selenide, water dikinase activity,MF,
2204,GO:0004757,1,0.995530648221239,0,1,sepiapterin reductase activity,MF,
2205,GO:0004758,1,0.966211119615355,0,5,serine C-palmitoyltransferase activity,MF,
2206,GO:0004760,1,0.995296987477883,0,1,serine-pyruvate transaminase activity,MF,
2207,GO:0004766,1,0.995793304464424,0,1,spermidine synthase activity,MF,
2208,GO:0004767,1,0.969391291043976,0,5,sphingomyelin phosphodiesterase activity,MF,
2209,GO:0004768,1,0.978678246745685,0,3,stearoyl-CoA 9-desaturase activity,MF,
2210,GO:0004769,1,0.995953922606191,0,1,steroid delta-isomerase activity,MF,
2211,GO:0004771,1,0.946566937693705,0,8,sterol esterase activity,MF,
2212,GO:0004772,1,0.992584977524049,0,1,sterol O-acyltransferase activity,MF,
2213,GO:0004773,1,0.992333826302718,0,1,steryl-sulfatase activity,MF,
2214,GO:0004774,1,0.983658299637342,0,3,succinate-CoA ligase activity,MF,
2215,GO:0004775,1,0.989761091536139,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2216,GO:0004776,1,0.989386550794795,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2217,GO:0004777,1,0.99243882233873,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2218,GO:0004778,1,0.995254868359485,0,1,succinyl-CoA hydrolase activity,MF,
2219,GO:0004779,1,0.986026965220578,0,2,sulfate adenylyltransferase activity,MF,
2220,GO:0004781,1,0.986026965220578,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2221,GO:0004782,1,0.993210827817845,0,1,sulfinoalanine decarboxylase activity,MF,
2222,GO:0004784,1,0.977613666438524,0,5,superoxide dismutase activity,MF,
2223,GO:0004788,1,0.993826867711281,0,1,thiamine diphosphokinase activity,MF,
2224,GO:0004790,1,0.993457795060686,0,1,thioether S-methyltransferase activity,MF,
2225,GO:0004791,1,0.956762549373092,0,8,thioredoxin-disulfide reductase activity,MF,
2226,GO:0004792,1,0.985212920237156,0,3,thiosulfate sulfurtransferase activity,MF,
2227,GO:0004793,1,0.987738414708503,0,2,threonine aldolase activity,MF,
2228,GO:0004794,1,0.990928834325919,0,2,L-threonine ammonia-lyase activity,MF,
2229,GO:0004795,1,0.994321248875851,0,1,threonine synthase activity,MF,
2230,GO:0004796,1,0.994326357179665,0,1,thromboxane-A synthase activity,MF,
2231,GO:0004797,1,0.987788826222693,0,2,thymidine kinase activity,MF,
2232,GO:0004798,1,0.988861019818926,0,2,thymidylate kinase activity,MF,
2233,GO:0004799,1,0.995326921115523,0,1,thymidylate synthase activity,MF,
2234,GO:0004800,1,0.986732290818844,0,2,thyroxine 5'-deiodinase activity,MF,
2235,GO:0004801,1,0.995835535614641,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2236,GO:0004802,1,0.987683364011033,0,2,transketolase activity,MF,
2237,GO:0004803,1,0.992499443483694,0,1,transposase activity,MF,
2238,GO:0004806,1,0.888634508520209,0,18,triglyceride lipase activity,MF,
2239,GO:0004807,1,0.995526051060913,0,1,triose-phosphate isomerase activity,MF,
2240,GO:0004809,1,0.982016623773548,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2241,GO:0004810,1,0.993993865113311,0,1,tRNA adenylyltransferase activity,MF,
2242,GO:0004812,1,0.75214073347509,0,44,aminoacyl-tRNA ligase activity,MF,
2243,GO:0004813,1,0.979956605983599,0,3,alanine-tRNA ligase activity,MF,
2244,GO:0004814,1,0.983264938666197,0,3,arginine-tRNA ligase activity,MF,
2245,GO:0004815,1,0.986526754278052,0,2,aspartate-tRNA ligase activity,MF,
2246,GO:0004816,1,0.987011930298606,0,2,asparagine-tRNA ligase activity,MF,
2247,GO:0004817,1,0.98814183551778,0,2,cysteine-tRNA ligase activity,MF,
2248,GO:0004818,1,0.985005945104461,0,2,glutamate-tRNA ligase activity,MF,
2249,GO:0004819,1,0.986164152259627,0,2,glutamine-tRNA ligase activity,MF,
2250,GO:0004820,1,0.988474024779937,0,2,glycine-tRNA ligase activity,MF,
2251,GO:0004821,1,0.988213824529325,0,2,histidine-tRNA ligase activity,MF,
2252,GO:0004822,1,0.98507837789776,0,2,isoleucine-tRNA ligase activity,MF,
2253,GO:0004823,1,0.985010003280386,0,2,leucine-tRNA ligase activity,MF,
2254,GO:0004824,1,0.994330443615449,0,1,lysine-tRNA ligase activity,MF,
2255,GO:0004825,1,0.985931546118718,0,2,methionine-tRNA ligase activity,MF,
2256,GO:0004826,1,0.970217709294957,0,5,phenylalanine-tRNA ligase activity,MF,
2257,GO:0004827,1,0.982395666284347,0,3,proline-tRNA ligase activity,MF,
2258,GO:0004828,1,0.989187725872338,0,2,serine-tRNA ligase activity,MF,
2259,GO:0004829,1,0.979538979814084,0,3,threonine-tRNA ligase activity,MF,
2260,GO:0004830,1,0.986328065011254,0,2,tryptophan-tRNA ligase activity,MF,
2261,GO:0004831,1,0.987009436981041,0,2,tyrosine-tRNA ligase activity,MF,
2262,GO:0004832,1,0.97764408624057,0,3,valine-tRNA ligase activity,MF,
2263,GO:0004833,1,0.990500704603204,0,2,tryptophan 2,3-dioxygenase activity,MF,
2264,GO:0004835,1,0.992438349593765,0,1,tubulin-tyrosine ligase activity,MF,
2265,GO:0004838,1,0.99312462568774,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2266,GO:0004839,1,0.964076480572835,0,5,ubiquitin activating enzyme activity,MF,
2268,GO:0004843,1,0.610920132464182,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2269,GO:0004844,1,0.973786620201428,0,5,uracil DNA N-glycosylase activity,MF,
2270,GO:0004849,1,0.971800169813201,0,5,uridine kinase activity,MF,
2271,GO:0004850,1,0.988682859254664,0,2,uridine phosphorylase activity,MF,
2272,GO:0004852,1,0.995677809051378,0,1,uroporphyrinogen-III synthase activity,MF,
2273,GO:0004853,1,0.995634131061048,0,1,uroporphyrinogen decarboxylase activity,MF,
2274,GO:0004854,1,0.984899167110373,0,2,xanthine dehydrogenase activity,MF,
2275,GO:0004855,1,0.992388791626608,0,1,xanthine oxidase activity,MF,
2276,GO:0004856,1,0.992517346621251,0,1,xylulokinase activity,MF,
2279,GO:0004860,1,0.568081770324752,0,89,protein kinase inhibitor activity,MF,
2280,GO:0004861,1,0.93413630994033,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2281,GO:0004862,1,0.946406409321238,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2282,GO:0004864,1,0.821944495504555,0,31,protein phosphatase inhibitor activity,MF,
2283,GO:0004865,1,0.948418270368245,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2284,GO:0004866,1,0.490251716859785,0,120,endopeptidase inhibitor activity,MF,
2285,GO:0004867,1,0.69859892687517,0,60,serine-type endopeptidase inhibitor activity,MF,
2286,GO:0004869,1,0.793271644608007,0,41,cysteine-type endopeptidase inhibitor activity,MF,
2288,GO:0004873,1,0.991058055869364,0,2,asialoglycoprotein receptor activity,MF,
2289,GO:0004874,1,0.984866927052744,0,2,aryl hydrocarbon receptor activity,MF,
2290,GO:0004875,1,0.958375276781058,0,7,complement receptor activity,MF,
2291,GO:0004876,1,0.994651615069553,0,1,complement component C3a receptor activity,MF,
2292,GO:0004877,1,0.992089267287523,0,1,complement component C3b receptor activity,MF,
2293,GO:0004878,1,0.987007765421829,0,2,complement component C5a receptor activity,MF,
2294,GO:0004879,1,0.733950578120497,0,45,nuclear receptor activity,MF,
2295,GO:0004882,1,0.985496988751736,0,2,androgen receptor activity,MF,
2296,GO:0004883,1,0.992313446012772,0,1,glucocorticoid receptor activity,MF,
2297,GO:0004886,1,0.981345611802683,0,3,9-cis retinoic acid receptor activity,MF,
2298,GO:0004887,1,0.960877525287905,0,6,thyroid hormone receptor activity,MF,
2301,GO:0004896,1,0.589682001335694,0,82,cytokine receptor activity,MF,
2302,GO:0004897,1,0.972079194961849,0,4,ciliary neurotrophic factor receptor activity,MF,
2303,GO:0004900,1,0.994850052728369,0,1,erythropoietin receptor activity,MF,
2304,GO:0004904,1,0.969802790445892,0,5,interferon receptor activity,MF,
2305,GO:0004905,1,0.987987196786501,0,2,type I interferon receptor activity,MF,
2306,GO:0004906,1,0.988443178187768,0,2,interferon-gamma receptor activity,MF,
2307,GO:0004908,1,0.955386023860353,0,7,interleukin-1 receptor activity,MF,
2308,GO:0004909,1,0.987112820788874,0,2,interleukin-1, Type I, activating receptor activity,MF,
2309,GO:0004910,1,0.988451760105192,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2310,GO:0004911,1,0.980699329368499,0,3,interleukin-2 receptor activity,MF,
2311,GO:0004912,1,0.99246113266151,0,1,interleukin-3 receptor activity,MF,
2312,GO:0004913,1,0.989203776027062,0,2,interleukin-4 receptor activity,MF,
2313,GO:0004914,1,0.987012804226354,0,2,interleukin-5 receptor activity,MF,
2314,GO:0004915,1,0.985238375155118,0,2,interleukin-6 receptor activity,MF,
2315,GO:0004917,1,0.99036597424642,0,2,interleukin-7 receptor activity,MF,
2316,GO:0004918,1,0.986764403901618,0,2,interleukin-8 receptor activity,MF,
2317,GO:0004920,1,0.968524832654906,0,5,interleukin-10 receptor activity,MF,
2318,GO:0004921,1,0.992686954287854,0,1,interleukin-11 receptor activity,MF,
2319,GO:0004923,1,0.984766164957528,0,2,leukemia inhibitory factor receptor activity,MF,
2320,GO:0004924,1,0.977403070136923,0,3,oncostatin-M receptor activity,MF,
2321,GO:0004925,1,0.991899367334061,0,1,prolactin receptor activity,MF,
2323,GO:0004931,1,0.959256686254377,0,7,extracellularly ATP-gated cation channel activity,MF,
2324,GO:0004935,1,0.939847573732399,0,10,adrenergic receptor activity,MF,
2325,GO:0004936,1,0.969047201252079,0,5,alpha-adrenergic receptor activity,MF,
2326,GO:0004937,1,0.981618595891641,0,3,alpha1-adrenergic receptor activity,MF,
2327,GO:0004938,1,0.987195607370296,0,2,alpha2-adrenergic receptor activity,MF,
2328,GO:0004939,1,0.980916865358752,0,3,beta-adrenergic receptor activity,MF,
2329,GO:0004940,1,0.993001373146167,0,1,beta1-adrenergic receptor activity,MF,
2330,GO:0004941,1,0.994480273921555,0,1,beta2-adrenergic receptor activity,MF,
2331,GO:0004945,1,0.985866298120349,0,3,angiotensin type II receptor activity,MF,
2332,GO:0004947,1,0.988307499453615,0,2,bradykinin receptor activity,MF,
2333,GO:0004948,1,0.9850348496446,0,2,calcitonin receptor activity,MF,
2335,GO:0004950,1,0.864380491701422,0,24,chemokine receptor activity,MF,
2336,GO:0004951,1,0.98950199718318,0,2,cholecystokinin receptor activity,MF,
2337,GO:0004952,1,0.960909434742168,0,7,dopamine neurotransmitter receptor activity,MF,
2338,GO:0004953,1,0.902117728728471,0,17,icosanoid receptor activity,MF,
2339,GO:0004954,1,0.933215874687162,0,11,prostanoid receptor activity,MF,
2340,GO:0004955,1,0.938846047543835,0,10,prostaglandin receptor activity,MF,
2341,GO:0004956,1,0.986050393463012,0,2,prostaglandin D receptor activity,MF,
2342,GO:0004957,1,0.962954867271329,0,6,prostaglandin E receptor activity,MF,
2343,GO:0004958,1,0.985566886136547,0,2,prostaglandin F receptor activity,MF,
2344,GO:0004960,1,0.994006942278645,0,1,thromboxane receptor activity,MF,
2345,GO:0004961,1,0.994006942278645,0,1,thromboxane A2 receptor activity,MF,
2346,GO:0004962,1,0.985054261538942,0,2,endothelin receptor activity,MF,
2347,GO:0004965,1,0.977536939801919,0,3,G-protein coupled GABA receptor activity,MF,
2348,GO:0004966,1,0.949647091519082,0,10,galanin receptor activity,MF,
2349,GO:0004967,1,0.987950215907098,0,2,glucagon receptor activity,MF,
2350,GO:0004968,1,0.992493526234599,0,1,gonadotropin-releasing hormone receptor activity,MF,
2351,GO:0004969,1,0.966727439958748,0,5,histamine receptor activity,MF,
2353,GO:0004971,1,0.970038008765133,0,4,AMPA glutamate receptor activity,MF,
2355,GO:0004974,1,0.966699478212167,0,6,leukotriene receptor activity,MF,
2356,GO:0004977,1,0.979480872631139,0,4,melanocortin receptor activity,MF,
2357,GO:0004979,1,0.994822986656738,0,1,beta-endorphin receptor activity,MF,
2358,GO:0004980,1,0.988357924650192,0,2,melanocyte-stimulating hormone receptor activity,MF,
2359,GO:0004982,1,0.984002349633768,0,3,N-formyl peptide receptor activity,MF,
2361,GO:0004984,1,0.924638527489986,0,17,olfactory receptor activity,MF,
2362,GO:0004985,1,0.957042099424556,0,8,opioid receptor activity,MF,
2363,GO:0004990,1,0.992489161697064,0,1,oxytocin receptor activity,MF,
2364,GO:0004991,1,0.98751543026653,0,2,parathyroid hormone receptor activity,MF,
2365,GO:0004992,1,0.980470593340744,0,3,platelet activating factor receptor activity,MF,
2366,GO:0004993,1,0.926376280601961,0,13,G-protein coupled serotonin receptor activity,MF,
2367,GO:0004994,1,0.976199681481833,0,4,somatostatin receptor activity,MF,
2368,GO:0004995,1,0.981518186610675,0,3,tachykinin receptor activity,MF,
2369,GO:0004996,1,0.988369229713915,0,2,thyroid-stimulating hormone receptor activity,MF,
2370,GO:0004998,1,0.985438194493293,0,2,transferrin receptor activity,MF,
2371,GO:0004999,1,0.980908398660093,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2372,GO:0005000,1,0.966620756028089,0,5,vasopressin receptor activity,MF,
2373,GO:0005001,1,0.886236033729814,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2375,GO:0005004,1,0.949332811354104,0,7,GPI-linked ephrin receptor activity,MF,
2377,GO:0005006,1,0.986669145354255,0,2,epidermal growth factor-activated receptor activity,MF,
2378,GO:0005007,1,0.963493192379288,0,5,fibroblast growth factor-activated receptor activity,MF,
2379,GO:0005008,1,0.992309419475446,0,1,hepatocyte growth factor-activated receptor activity,MF,
2380,GO:0005009,1,0.992110905361166,0,1,insulin-activated receptor activity,MF,
2381,GO:0005010,1,0.969299003477138,0,4,insulin-like growth factor-activated receptor activity,MF,
2382,GO:0005011,1,0.985021841522673,0,2,macrophage colony-stimulating factor receptor activity,MF,
2383,GO:0005017,1,0.980291560630626,0,3,platelet-derived growth factor-activated receptor activity,MF,
2384,GO:0005018,1,0.992315675607404,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2385,GO:0005019,1,0.987883719968557,0,2,platelet-derived growth factor beta-receptor activity,MF,
2386,GO:0005020,1,0.992436528352499,0,1,stem cell factor receptor activity,MF,
2387,GO:0005021,1,0.949220917142821,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2388,GO:0005024,1,0.941349831021191,0,8,transforming growth factor beta-activated receptor activity,MF,
2389,GO:0005025,1,0.970448170670223,0,4,transforming growth factor beta receptor activity, type I,MF,
2390,GO:0005026,1,0.992473161339329,0,1,transforming growth factor beta receptor activity, type II,MF,
2391,GO:0005030,1,0.971144841202394,0,4,neurotrophin receptor activity,MF,
2392,GO:0005031,1,0.86623293009344,0,24,tumor necrosis factor-activated receptor activity,MF,
2393,GO:0005034,1,0.9927132062119,0,1,osmosensor activity,MF,
2394,GO:0005035,1,0.86623293009344,0,24,death receptor activity,MF,
2395,GO:0005041,1,0.910712348443885,0,13,low-density lipoprotein particle receptor activity,MF,
2396,GO:0005042,1,0.955452381313422,0,6,netrin receptor activity,MF,
2397,GO:0005044,1,0.713956603820562,0,49,scavenger receptor activity,MF,
2398,GO:0005046,1,0.988575541535446,0,2,KDEL sequence binding,MF,
2399,GO:0005047,1,0.96191571539703,0,6,signal recognition particle binding,MF,
2400,GO:0005048,1,0.770283062545186,0,39,signal sequence binding,MF,
2401,GO:0005049,1,0.943117190220196,0,8,nuclear export signal receptor activity,MF,
2402,GO:0005052,1,0.985285546045765,0,2,peroxisome matrix targeting signal-1 binding,MF,
2403,GO:0005053,1,0.995485859517824,0,1,peroxisome matrix targeting signal-2 binding,MF,
2404,GO:0005055,1,0.989693913861415,0,2,laminin receptor activity,MF,
2406,GO:0005068,1,0.93269323302725,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2407,GO:0005070,1,0.687412108055624,0,57,SH3/SH2 adaptor activity,MF,
2408,GO:0005072,1,0.928650038271287,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2409,GO:0005078,1,0.947897725927599,0,7,MAP-kinase scaffold activity,MF,
2410,GO:0005080,1,0.74758843712264,0,43,protein kinase C binding,MF,
2413,GO:0005087,1,0.978245341401405,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2416,GO:0005090,1,0.9942129704155,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005092,1,0.918955237880655,0,14,GDP-dissociation inhibitor activity,MF,
2418,GO:0005093,1,0.98747560342084,0,2,Rab GDP-dissociation inhibitor activity,MF,
2419,GO:0005094,1,0.986967969181994,0,3,Rho GDP-dissociation inhibitor activity,MF,
2420,GO:0005095,1,0.914271412860514,0,14,GTPase inhibitor activity,MF,
2423,GO:0005104,1,0.890718662199969,0,19,fibroblast growth factor receptor binding,MF,
2424,GO:0005105,1,0.98537396116604,0,3,type 1 fibroblast growth factor receptor binding,MF,
2425,GO:0005109,1,0.809710487563876,0,33,frizzled binding,MF,
2426,GO:0005111,1,0.987905375724376,0,3,type 2 fibroblast growth factor receptor binding,MF,
2427,GO:0005112,1,0.860545623739581,0,21,Notch binding,MF,
2428,GO:0005113,1,0.955838053473457,0,7,patched binding,MF,
2429,GO:0005114,1,0.952732743049802,0,7,type II transforming growth factor beta receptor binding,MF,
2430,GO:0005115,1,0.992381002025962,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2431,GO:0005119,1,0.977472376463793,0,3,smoothened binding,MF,
2432,GO:0005123,1,0.904506228598944,0,16,death receptor binding,MF,
2433,GO:0005124,1,0.978622847548511,0,4,scavenger receptor binding,MF,
2436,GO:0005127,1,0.969739664875899,0,5,ciliary neurotrophic factor receptor binding,MF,
2437,GO:0005128,1,0.988396307694885,0,2,erythropoietin receptor binding,MF,
2438,GO:0005130,1,0.995437108734149,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2439,GO:0005131,1,0.971795364852303,0,4,growth hormone receptor binding,MF,
2440,GO:0005134,1,0.980958893619381,0,3,interleukin-2 receptor binding,MF,
2441,GO:0005135,1,0.992644436213173,0,1,interleukin-3 receptor binding,MF,
2442,GO:0005136,1,0.987794754472039,0,2,interleukin-4 receptor binding,MF,
2443,GO:0005137,1,0.994215011665041,0,1,interleukin-5 receptor binding,MF,
2444,GO:0005138,1,0.957872716391729,0,7,interleukin-6 receptor binding,MF,
2445,GO:0005139,1,0.987972949189023,0,2,interleukin-7 receptor binding,MF,
2446,GO:0005141,1,0.995253170303175,0,1,interleukin-10 receptor binding,MF,
2447,GO:0005142,1,0.993838653063675,0,1,interleukin-11 receptor binding,MF,
2448,GO:0005143,1,0.98266634734533,0,3,interleukin-12 receptor binding,MF,
2449,GO:0005144,1,0.995786420869193,0,1,interleukin-13 receptor binding,MF,
2450,GO:0005146,1,0.987738926029448,0,2,leukemia inhibitory factor receptor binding,MF,
2451,GO:0005147,1,0.994832671464641,0,1,oncostatin-M receptor binding,MF,
2452,GO:0005149,1,0.930278959246865,0,11,interleukin-1 receptor binding,MF,
2453,GO:0005150,1,0.987549093788541,0,2,interleukin-1, Type I receptor binding,MF,
2454,GO:0005151,1,0.987441741340705,0,2,interleukin-1, Type II receptor binding,MF,
2455,GO:0005152,1,0.987313726543911,0,2,interleukin-1 receptor antagonist activity,MF,
2456,GO:0005153,1,0.98588193014679,0,2,interleukin-8 receptor binding,MF,
2457,GO:0005154,1,0.820486280364597,0,29,epidermal growth factor receptor binding,MF,
2458,GO:0005157,1,0.984202589118197,0,3,macrophage colony-stimulating factor receptor binding,MF,
2459,GO:0005158,1,0.858140589165838,0,21,insulin receptor binding,MF,
2460,GO:0005159,1,0.917546827016094,0,13,insulin-like growth factor receptor binding,MF,
2461,GO:0005160,1,0.747352597592842,0,45,transforming growth factor beta receptor binding,MF,
2462,GO:0005161,1,0.900996104722174,0,14,platelet-derived growth factor receptor binding,MF,
2463,GO:0005163,1,0.996088214191366,0,1,nerve growth factor receptor binding,MF,
2464,GO:0005164,1,0.849505090862643,0,29,tumor necrosis factor receptor binding,MF,
2465,GO:0005165,1,0.930917116050733,0,11,neurotrophin receptor binding,MF,
2466,GO:0005166,1,0.985357222657703,0,3,neurotrophin p75 receptor binding,MF,
2467,GO:0005167,1,0.944818791572797,0,8,neurotrophin TRK receptor binding,MF,
2468,GO:0005168,1,0.955641918659262,0,6,neurotrophin TRKA receptor binding,MF,
2469,GO:0005169,1,0.981188931525279,0,3,neurotrophin TRKB receptor binding,MF,
2470,GO:0005170,1,0.992424332023491,0,1,neurotrophin TRKC receptor binding,MF,
2471,GO:0005171,1,0.989029983451007,0,2,hepatocyte growth factor receptor binding,MF,
2472,GO:0005172,1,0.938176995957709,0,10,vascular endothelial growth factor receptor binding,MF,
2473,GO:0005173,1,0.977342743479807,0,3,stem cell factor receptor binding,MF,
2474,GO:0005174,1,0.988898792612791,0,2,CD40 receptor binding,MF,
2475,GO:0005175,1,0.996500551848469,0,1,CD27 receptor binding,MF,
2476,GO:0005176,1,0.982334180271886,0,3,ErbB-2 class receptor binding,MF,
2477,GO:0005178,1,0.472233273292647,0,111,integrin binding,MF,
2479,GO:0005183,1,0.991881837191876,0,2,gonadotropin hormone-releasing hormone activity,MF,
2482,GO:0005199,1,0.992598137900429,0,1,structural constituent of cell wall,MF,
2485,GO:0005212,1,0.944271691694467,0,13,structural constituent of eye lens,MF,
2488,GO:0005217,1,0.80231909019248,0,30,intracellular ligand-gated ion channel activity,MF,
2489,GO:0005219,1,0.971321692601366,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2490,GO:0005220,1,0.976162501133438,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2491,GO:0005221,1,0.944594700195018,0,8,intracellular cyclic nucleotide activated cation channel activity,MF,
2492,GO:0005222,1,0.951122251165423,0,7,intracellular cAMP activated cation channel activity,MF,
2493,GO:0005223,1,0.966408784855021,0,5,intracellular cGMP activated cation channel activity,MF,
2494,GO:0005225,1,0.931213044964548,0,10,volume-sensitive anion channel activity,MF,
2495,GO:0005227,1,0.849498060207595,0,25,calcium activated cation channel activity,MF,
2496,GO:0005228,1,0.984894749803172,0,2,intracellular sodium activated potassium channel activity,MF,
2497,GO:0005229,1,0.879273808102038,0,18,intracellular calcium activated chloride channel activity,MF,
2502,GO:0005242,1,0.872486451960334,0,20,inward rectifier potassium channel activity,MF,
2503,GO:0005243,1,0.939053418084838,0,10,gap junction channel activity,MF,
2506,GO:0005246,1,0.829700799799292,0,30,calcium channel regulator activity,MF,
2508,GO:0005248,1,0.841884940644695,0,23,voltage-gated sodium channel activity,MF,
2510,GO:0005250,1,0.972174050781753,0,4,A-type (transient outward) potassium channel activity,MF,
2512,GO:0005252,1,0.992500836531796,0,1,open rectifier potassium channel activity,MF,
2515,GO:0005260,1,0.992353639835833,0,1,intracellularly ATP-gated chloride channel activity,MF,
2519,GO:0005272,1,0.728442624450063,0,43,sodium channel activity,MF,
2520,GO:0005275,1,0.987470200994292,0,2,amine transmembrane transporter activity,MF,
2521,GO:0005277,1,0.987293338183422,0,2,acetylcholine transmembrane transporter activity,MF,
2522,GO:0005280,1,0.973579224925975,0,4,amino acid:proton symporter activity,MF,
2523,GO:0005283,1,0.888239608022589,0,17,amino acid:sodium symporter activity,MF,
2524,GO:0005287,1,0.986093492666007,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2525,GO:0005289,1,0.986093492666007,0,2,high-affinity arginine transmembrane transporter activity,MF,
2526,GO:0005290,1,0.979950315148189,0,3,L-histidine transmembrane transporter activity,MF,
2527,GO:0005292,1,0.986093492666007,0,2,high-affinity lysine transmembrane transporter activity,MF,
2528,GO:0005294,1,0.992063322733495,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2529,GO:0005295,1,0.985705380612776,0,2,neutral amino acid:sodium symporter activity,MF,
2530,GO:0005298,1,0.98505697625093,0,2,proline:sodium symporter activity,MF,
2531,GO:0005302,1,0.992714948015017,0,1,L-tyrosine transmembrane transporter activity,MF,
2532,GO:0005308,1,0.985074685344285,0,2,creatine transmembrane transporter activity,MF,
2533,GO:0005309,1,0.992543567417889,0,1,creatine:sodium symporter activity,MF,
2536,GO:0005314,1,0.9536893323289,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2538,GO:0005316,1,0.992635084921823,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2539,GO:0005319,1,0.460467055876497,0,117,lipid transporter activity,MF,
2540,GO:0005324,1,0.971902861807416,0,5,long-chain fatty acid transporter activity,MF,
2543,GO:0005329,1,0.964038822290927,0,5,dopamine transmembrane transporter activity,MF,
2544,GO:0005330,1,0.977749131958434,0,3,dopamine:sodium symporter activity,MF,
2545,GO:0005332,1,0.974097157826987,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2546,GO:0005333,1,0.986182247157862,0,2,norepinephrine transmembrane transporter activity,MF,
2547,GO:0005334,1,0.992601845650791,0,1,norepinephrine:sodium symporter activity,MF,
2548,GO:0005335,1,0.992480267403341,0,1,serotonin:sodium symporter activity,MF,
2549,GO:0005337,1,0.963589880970839,0,6,nucleoside transmembrane transporter activity,MF,
2550,GO:0005338,1,0.928279161865556,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2553,GO:0005344,1,0.948031741668618,0,13,oxygen carrier activity,MF,
2554,GO:0005345,1,0.969932191893168,0,5,purine nucleobase transmembrane transporter activity,MF,
2555,GO:0005346,1,0.932593079003248,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2556,GO:0005347,1,0.949239428687797,0,8,ATP transmembrane transporter activity,MF,
2557,GO:0005350,1,0.981505681100491,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2558,GO:0005351,1,0.933862020611849,0,10,carbohydrate:proton symporter activity,MF,
2559,GO:0005353,1,0.993903895013174,0,1,fructose transmembrane transporter activity,MF,
2560,GO:0005355,1,0.888463243021439,0,18,glucose transmembrane transporter activity,MF,
2561,GO:0005362,1,0.986681144892646,0,2,low-affinity glucose:sodium symporter activity,MF,
2562,GO:0005365,1,0.984257910122337,0,2,myo-inositol transmembrane transporter activity,MF,
2563,GO:0005366,1,0.992280270305388,0,1,myo-inositol:proton symporter activity,MF,
2564,GO:0005367,1,0.99191586352118,0,1,myo-inositol:sodium symporter activity,MF,
2565,GO:0005368,1,0.992322459540864,0,1,taurine transmembrane transporter activity,MF,
2566,GO:0005369,1,0.992322459540864,0,1,taurine:sodium symporter activity,MF,
2568,GO:0005375,1,0.961741767820269,0,6,copper ion transmembrane transporter activity,MF,
2569,GO:0005381,1,0.93694312725358,0,10,iron ion transmembrane transporter activity,MF,
2570,GO:0005384,1,0.95645209274945,0,6,manganese ion transmembrane transporter activity,MF,
2572,GO:0005388,1,0.898521691700704,0,14,calcium-transporting ATPase activity,MF,
2573,GO:0005391,1,0.929942792626063,0,11,sodium:potassium-exchanging ATPase activity,MF,
2574,GO:0005395,1,0.992249703482257,0,1,eye pigment precursor transporter activity,MF,
2575,GO:0005402,1,0.896822745960392,0,16,carbohydrate:cation symporter activity,MF,
2576,GO:0005412,1,0.967835191338974,0,5,glucose:sodium symporter activity,MF,
2577,GO:0005415,1,0.988602366842377,0,2,nucleoside:sodium symporter activity,MF,
2578,GO:0005416,1,0.875671163057722,0,19,amino acid:cation symporter activity,MF,
2579,GO:0005427,1,0.992515696500163,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2580,GO:0005432,1,0.959304392203585,0,6,calcium:sodium antiporter activity,MF,
2582,GO:0005451,1,0.910282145518282,0,13,monovalent cation:proton antiporter activity,MF,
2584,GO:0005456,1,0.9949207709724,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2585,GO:0005457,1,0.985030220946446,0,2,GDP-fucose transmembrane transporter activity,MF,
2586,GO:0005459,1,0.991015585319008,0,2,UDP-galactose transmembrane transporter activity,MF,
2587,GO:0005461,1,0.992326330131574,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2588,GO:0005462,1,0.98658570010375,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2589,GO:0005464,1,0.992296175874829,0,1,UDP-xylose transmembrane transporter activity,MF,
2590,GO:0005471,1,0.988210667294783,0,2,ATP:ADP antiporter activity,MF,
2591,GO:0005476,1,0.983003383783815,0,3,carnitine:acyl carnitine antiporter activity,MF,
2592,GO:0005477,1,0.992544260090184,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2593,GO:0005483,1,0.980006295271838,0,3,soluble NSF attachment protein activity,MF,
2596,GO:0005496,1,0.614095986483807,0,77,steroid binding,MF,
2597,GO:0005497,1,0.979607079533819,0,4,androgen binding,MF,
2598,GO:0005499,1,0.973122281032104,0,4,vitamin D binding,MF,
2599,GO:0005501,1,0.875865526288655,0,23,retinoid binding,MF,
2600,GO:0005502,1,0.974628146592684,0,4,11-cis retinal binding,MF,
2601,GO:0005503,1,0.987105614292286,0,2,all-trans retinal binding,MF,
2602,GO:0005504,1,0.883521100910406,0,24,fatty acid binding,MF,
2603,GO:0005506,1,0.449962210147858,0,129,iron ion binding,MF,
2609,GO:0005518,1,0.667473131159804,0,58,collagen binding,MF,
2610,GO:0005519,1,0.99250076557408,0,1,cytoskeletal regulatory protein binding,MF,
2612,GO:0005521,1,0.902218254356999,0,15,lamin binding,MF,
2613,GO:0005522,1,0.931846725119158,0,10,profilin binding,MF,
2614,GO:0005523,1,0.927780658878433,0,13,tropomyosin binding,MF,
2617,GO:0005527,1,0.92812187119212,0,13,macrolide binding,MF,
2618,GO:0005528,1,0.92812187119212,0,13,FK506 binding,MF,
2619,GO:0005534,1,0.969383561723127,0,5,galactose binding,MF,
2620,GO:0005536,1,0.926629425555755,0,11,glucose binding,MF,
2621,GO:0005537,1,0.919274716804568,0,14,mannose binding,MF,
2623,GO:0005540,1,0.880461820414827,0,19,hyaluronic acid binding,MF,
2624,GO:0005542,1,0.949826608117538,0,10,folic acid binding,MF,
2630,GO:0005548,1,0.694582297449404,0,52,phospholipid transporter activity,MF,
2631,GO:0005549,1,0.99245845070902,0,2,odorant binding,MF,
2634,GO:0005577,1,0.956081713526985,0,7,fibrinogen complex,CC,
2636,GO:0005579,1,0.970976924193617,0,4,membrane attack complex,CC,
2637,GO:0005581,1,0.585679206648984,0,78,collagen trimer,CC,
2638,GO:0005582,1,0.992426317320403,0,1,collagen type XV trimer,CC,
2639,GO:0005583,1,0.914033518119489,0,12,fibrillar collagen trimer,CC,
2640,GO:0005584,1,0.984840504532473,0,2,collagen type I trimer,CC,
2641,GO:0005585,1,0.992448355833603,0,1,collagen type II trimer,CC,
2642,GO:0005586,1,0.99240722683828,0,1,collagen type III trimer,CC,
2643,GO:0005587,1,0.954392322144124,0,6,collagen type IV trimer,CC,
2644,GO:0005588,1,0.976962537717358,0,3,collagen type V trimer,CC,
2645,GO:0005589,1,0.980224869654867,0,3,collagen type VI trimer,CC,
2646,GO:0005590,1,0.992092935676161,0,1,collagen type VII trimer,CC,
2647,GO:0005591,1,0.993338409672199,0,1,collagen type VIII trimer,CC,
2648,GO:0005592,1,0.984667319259722,0,2,collagen type XI trimer,CC,
2649,GO:0005593,1,0.956670773855489,0,6,FACIT collagen trimer,CC,
2650,GO:0005594,1,0.979253133200933,0,3,collagen type IX trimer,CC,
2651,GO:0005595,1,0.992045174231971,0,1,collagen type XII trimer,CC,
2652,GO:0005596,1,0.992323921224254,0,1,collagen type XIV trimer,CC,
2653,GO:0005597,1,0.992397349607375,0,1,collagen type XVI trimer,CC,
2654,GO:0005598,1,0.993338409672199,0,1,short-chain collagen trimer,CC,
2655,GO:0005600,1,0.992788597661988,0,1,collagen type XIII trimer,CC,
2656,GO:0005602,1,0.992140316191174,0,2,complement component C1 complex,CC,
2657,GO:0005604,1,0.529859374285695,0,88,basement membrane,CC,
2658,GO:0005605,1,0.862560159783915,0,20,basal lamina,CC,
2659,GO:0005606,1,0.976831516005057,0,3,laminin-1 complex,CC,
2660,GO:0005607,1,0.984878873896295,0,2,laminin-2 complex,CC,
2661,GO:0005608,1,0.984511114059971,0,2,laminin-3 complex,CC,
2662,GO:0005610,1,0.976794699809519,0,3,laminin-5 complex,CC,
2663,GO:0005614,1,0.916932297999497,0,12,interstitial matrix,CC,
2668,GO:0005635,1,0.0620817553434928,0,420,nuclear envelope,CC,
2669,GO:0005637,1,0.720068174696293,0,50,nuclear inner membrane,CC,
2670,GO:0005638,1,0.973563073618518,0,4,lamin filament,CC,
2671,GO:0005639,1,0.910865765901467,0,14,integral component of nuclear inner membrane,CC,
2672,GO:0005640,1,0.877264703314081,0,20,nuclear outer membrane,CC,
2673,GO:0005641,1,0.946475471826238,0,8,nuclear envelope lumen,CC,
2674,GO:0005642,1,0.965611737853449,0,5,annulate lamellae,CC,
2675,GO:0005643,1,0.599142447852054,0,76,nuclear pore,CC,
2676,GO:0005652,1,0.942090984823845,0,9,nuclear lamina,CC,
2678,GO:0005655,1,0.960400334598876,0,8,nucleolar ribonuclease P complex,CC,
2679,GO:0005656,1,0.983271255446626,0,3,nuclear pre-replicative complex,CC,
2680,GO:0005657,1,0.649052469830617,0,67,replication fork,CC,
2681,GO:0005658,1,0.961436252616274,0,6,alpha DNA polymerase:primase complex,CC,
2682,GO:0005662,1,0.915440271494562,0,14,DNA replication factor A complex,CC,
2683,GO:0005663,1,0.968228005989846,0,6,DNA replication factor C complex,CC,
2684,GO:0005664,1,0.939725881569472,0,9,nuclear origin of replication recognition complex,CC,
2685,GO:0005665,1,0.904715849006864,0,18,DNA-directed RNA polymerase II, core complex,CC,
2686,GO:0005666,1,0.908799054165006,0,17,DNA-directed RNA polymerase III complex,CC,
2687,GO:0005667,1,0.124924129133309,0,318,transcription factor complex,CC,
2688,GO:0005668,1,0.989757166098366,0,2,RNA polymerase transcription factor SL1 complex,CC,
2689,GO:0005669,1,0.804912500154905,0,36,transcription factor TFIID complex,CC,
2690,GO:0005671,1,0.9158299295501,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2691,GO:0005672,1,0.976802363586491,0,5,transcription factor TFIIA complex,CC,
2692,GO:0005673,1,0.988249468454752,0,2,transcription factor TFIIE complex,CC,
2693,GO:0005674,1,0.989018432406877,0,2,transcription factor TFIIF complex,CC,
2694,GO:0005675,1,0.933264592328115,0,12,holo TFIIH complex,CC,
2695,GO:0005677,1,0.945920653464713,0,8,chromatin silencing complex,CC,
2696,GO:0005680,1,0.882924237190101,0,21,anaphase-promoting complex,CC,
2697,GO:0005681,1,0.328461638986937,0,180,spliceosomal complex,CC,
2698,GO:0005682,1,0.874896929548706,0,22,U5 snRNP,CC,
2699,GO:0005683,1,0.970201697416316,0,7,U7 snRNP,CC,
2700,GO:0005684,1,0.717770175681248,0,57,U2-type spliceosomal complex,CC,
2701,GO:0005685,1,0.89784267167711,0,20,U1 snRNP,CC,
2702,GO:0005686,1,0.900173507645121,0,20,U2 snRNP,CC,
2703,GO:0005687,1,0.947362312586973,0,11,U4 snRNP,CC,
2704,GO:0005688,1,0.962461167417171,0,8,U6 snRNP,CC,
2705,GO:0005689,1,0.875651704907,0,26,U12-type spliceosomal complex,CC,
2706,GO:0005690,1,0.994164023806241,0,1,U4atac snRNP,CC,
2707,GO:0005691,1,0.992487981924976,0,1,U6atac snRNP,CC,
2709,GO:0005697,1,0.873112958785462,0,22,telomerase holoenzyme complex,CC,
2710,GO:0005712,1,0.985875050939747,0,2,chiasma,CC,
2711,GO:0005713,1,0.993617816321152,0,1,recombination nodule,CC,
2712,GO:0005715,1,0.993617816321152,0,1,late recombination nodule,CC,
2713,GO:0005719,1,0.869671652809678,0,23,nuclear euchromatin,CC,
2714,GO:0005720,1,0.817843189408019,0,31,nuclear heterochromatin,CC,
2715,GO:0005721,1,0.878281403016874,0,19,pericentric heterochromatin,CC,
2716,GO:0005724,1,0.995237841458615,0,1,nuclear telomeric heterochromatin,CC,
2717,GO:0005726,1,0.970182071917477,0,4,perichromatin fibrils,CC,
2719,GO:0005731,1,0.995097852422239,0,1,nucleolus organizer region,CC,
2720,GO:0005732,1,0.904850462797444,0,20,small nucleolar ribonucleoprotein complex,CC,
2721,GO:0005736,1,0.934944366709113,0,12,DNA-directed RNA polymerase I complex,CC,
2726,GO:0005742,1,0.959691424190286,0,8,mitochondrial outer membrane translocase complex,CC,
2727,GO:0005743,1,0.0917971330034337,0,435,mitochondrial inner membrane,CC,
2728,GO:0005744,1,0.938916997611703,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2729,GO:0005745,1,0.986136379078734,0,2,m-AAA complex,CC,
2730,GO:0005746,1,0.718118531793795,0,76,mitochondrial respiratory chain,CC,
2731,GO:0005747,1,0.835956224082939,0,43,mitochondrial respiratory chain complex I,CC,
2732,GO:0005749,1,0.97874865368541,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2733,GO:0005750,1,0.945197499181358,0,11,mitochondrial respiratory chain complex III,CC,
2734,GO:0005751,1,0.953337226756873,0,13,mitochondrial respiratory chain complex IV,CC,
2735,GO:0005753,1,0.994155875773371,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2736,GO:0005757,1,0.978827834057447,0,4,mitochondrial permeability transition pore complex,CC,
2737,GO:0005758,1,0.685807100158981,0,68,mitochondrial intermembrane space,CC,
2738,GO:0005759,1,0.0886634507279131,0,420,mitochondrial matrix,CC,
2739,GO:0005760,1,0.985026198209461,0,2,gamma DNA polymerase complex,CC,
2740,GO:0005761,1,0.692115540077371,0,82,mitochondrial ribosome,CC,
2741,GO:0005762,1,0.799086963128454,0,50,mitochondrial large ribosomal subunit,CC,
2742,GO:0005763,1,0.887246090782271,0,27,mitochondrial small ribosomal subunit,CC,
2745,GO:0005766,1,0.424094531552133,0,140,primary lysosome,CC,
2746,GO:0005767,1,0.927179427583031,0,13,secondary lysosome,CC,
2748,GO:0005769,1,0.125319219144647,0,307,early endosome,CC,
2750,GO:0005771,1,0.816247146462703,0,35,multivesicular body,CC,
2753,GO:0005775,1,0.379603680345788,0,154,vacuolar lumen,CC,
2754,GO:0005776,1,0.563005843074089,0,86,autophagosome,CC,
2756,GO:0005778,1,0.694958919391112,0,57,peroxisomal membrane,CC,
2757,GO:0005779,1,0.905589172400357,0,17,integral component of peroxisomal membrane,CC,
2760,GO:0005784,1,0.982684640203916,0,4,Sec61 translocon complex,CC,
2761,GO:0005785,1,0.953713413096387,0,8,signal recognition particle receptor complex,CC,
2762,GO:0005786,1,0.968141967210565,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2763,GO:0005787,1,0.974025627671872,0,5,signal peptidase complex,CC,
2766,GO:0005790,1,0.816181772235513,0,31,smooth endoplasmic reticulum,CC,
2767,GO:0005791,1,0.603967095277059,0,83,rough endoplasmic reticulum,CC,
2768,GO:0005793,1,0.482281130817973,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2770,GO:0005795,1,0.42051002580723,0,129,Golgi stack,CC,
2771,GO:0005796,1,0.624668804865719,0,72,Golgi lumen,CC,
2772,GO:0005797,1,0.953442782008377,0,8,Golgi medial cisterna,CC,
2774,GO:0005801,1,0.702776459547994,0,53,cis-Golgi network,CC,
2776,GO:0005811,1,0.632454131176614,0,71,lipid droplet,CC,
2777,GO:0005813,1,0.0426744429934989,0,464,centrosome,CC,
2778,GO:0005814,1,0.448871033499744,0,117,centriole,CC,
2779,GO:0005815,1,0.011208580347602,0,655,microtubule organizing center,CC,
2780,GO:0005816,1,0.957280154349034,0,6,spindle pole body,CC,
2781,GO:0005818,1,0.943873379437557,0,8,aster,CC,
2782,GO:0005819,1,0.128483125029296,0,304,spindle,CC,
2783,GO:0005826,1,0.965917582814428,0,5,actomyosin contractile ring,CC,
2784,GO:0005827,1,0.965834629278,0,5,polar microtubule,CC,
2785,GO:0005828,1,0.949287624877334,0,7,kinetochore microtubule,CC,
2787,GO:0005832,1,0.933901061208694,0,11,chaperonin-containing T-complex,CC,
2788,GO:0005833,1,0.959327987224314,0,11,hemoglobin complex,CC,
2790,GO:0005838,1,0.897764692473643,0,21,proteasome regulatory particle,CC,
2791,GO:0005839,1,0.917839176909897,0,19,proteasome core complex,CC,
2792,GO:0005840,1,0.338264206627269,0,228,ribosome,CC,
2793,GO:0005844,1,0.68213232518114,0,69,polysome,CC,
2794,GO:0005845,1,0.933633039818183,0,11,mRNA cap binding complex,CC,
2795,GO:0005846,1,0.986834708134303,0,2,nuclear cap binding complex,CC,
2796,GO:0005847,1,0.896594192607042,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2797,GO:0005849,1,0.885335285718809,0,18,mRNA cleavage factor complex,CC,
2798,GO:0005850,1,0.971267124620479,0,4,eukaryotic translation initiation factor 2 complex,CC,
2799,GO:0005851,1,0.96610451260584,0,6,eukaryotic translation initiation factor 2B complex,CC,
2800,GO:0005852,1,0.908686441125093,0,17,eukaryotic translation initiation factor 3 complex,CC,
2802,GO:0005854,1,0.988522560598635,0,2,nascent polypeptide-associated complex,CC,
2804,GO:0005858,1,0.884758977443858,0,17,axonemal dynein complex,CC,
2805,GO:0005859,1,0.872159740949748,0,21,muscle myosin complex,CC,
2806,GO:0005861,1,0.974028044610423,0,7,troponin complex,CC,
2807,GO:0005862,1,0.976872030714227,0,4,muscle thin filament tropomyosin,CC,
2808,GO:0005863,1,0.977567032413166,0,3,striated muscle myosin thick filament,CC,
2809,GO:0005865,1,0.839743325116124,0,29,striated muscle thin filament,CC,
2810,GO:0005868,1,0.87443665266083,0,22,cytoplasmic dynein complex,CC,
2811,GO:0005869,1,0.954051712222513,0,8,dynactin complex,CC,
2812,GO:0005871,1,0.695580267281461,0,50,kinesin complex,CC,
2813,GO:0005873,1,0.984875240221265,0,2,plus-end kinesin complex,CC,
2815,GO:0005875,1,0.378213335782747,0,141,microtubule associated complex,CC,
2816,GO:0005876,1,0.679437932939652,0,57,spindle microtubule,CC,
2817,GO:0005879,1,0.973483967052283,0,4,axonemal microtubule,CC,
2818,GO:0005880,1,0.995528350677512,0,1,nuclear microtubule,CC,
2819,GO:0005881,1,0.696204312548328,0,54,cytoplasmic microtubule,CC,
2822,GO:0005884,1,0.524990322194715,0,97,actin filament,CC,
2823,GO:0005885,1,0.945916767905648,0,11,Arp2/3 protein complex,CC,
2826,GO:0005889,1,0.985126054471451,0,2,potassium:proton exchanging ATPase complex,CC,
2827,GO:0005890,1,0.940813609231652,0,10,sodium:potassium-exchanging ATPase complex,CC,
2829,GO:0005892,1,0.902867674480714,0,16,acetylcholine-gated channel complex,CC,
2830,GO:0005895,1,0.994215011665041,0,1,interleukin-5 receptor complex,CC,
2831,GO:0005896,1,0.981217055705337,0,3,interleukin-6 receptor complex,CC,
2832,GO:0005898,1,0.992500025092142,0,1,interleukin-13 receptor complex,CC,
2833,GO:0005899,1,0.976796341476164,0,3,insulin receptor complex,CC,
2834,GO:0005900,1,0.985265239544527,0,2,oncostatin-M receptor complex,CC,
2835,GO:0005901,1,0.602600441101339,0,73,caveola,CC,
2836,GO:0005902,1,0.615281498452617,0,72,microvillus,CC,
2837,GO:0005903,1,0.57836211514905,0,80,brush border,CC,
2838,GO:0005905,1,0.629535263375219,0,66,clathrin-coated pit,CC,
2840,GO:0005912,1,0.0328930779278813,0,508,adherens junction,CC,
2841,GO:0005913,1,0.484079758506985,0,105,cell-cell adherens junction,CC,
2842,GO:0005914,1,0.992609113052937,0,1,spot adherens junction,CC,
2843,GO:0005915,1,0.949139820435686,0,7,zonula adherens,CC,
2844,GO:0005916,1,0.928940262200276,0,10,fascia adherens,CC,
2845,GO:0005921,1,0.868755799467738,0,23,gap junction,CC,
2846,GO:0005922,1,0.922255292982379,0,14,connexin complex,CC,
2847,GO:0005923,1,0.478905551815381,0,107,bicellular tight junction,CC,
2848,GO:0005924,1,0.0803828203606795,0,384,cell-substrate adherens junction,CC,
2849,GO:0005925,1,0.0817109251031347,0,381,focal adhesion,CC,
2850,GO:0005927,1,0.984153435585545,0,3,muscle tendon junction,CC,
2851,GO:0005929,1,0.0392202901389486,0,480,cilium,CC,
2852,GO:0005930,1,0.50447983526665,0,99,axoneme,CC,
2854,GO:0005940,1,0.920009142398826,0,12,septin ring,CC,
2855,GO:0005942,1,0.876608118459021,0,18,phosphatidylinositol 3-kinase complex,CC,
2856,GO:0005943,1,0.98495427462774,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2857,GO:0005944,1,0.984960738240851,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2858,GO:0005945,1,0.98543150710102,0,2,6-phosphofructokinase complex,CC,
2859,GO:0005947,1,0.970640711184048,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2860,GO:0005952,1,0.95898063002458,0,6,cAMP-dependent protein kinase complex,CC,
2861,GO:0005953,1,0.988503174244844,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2863,GO:0005955,1,0.970376225193446,0,4,calcineurin complex,CC,
2864,GO:0005956,1,0.989191748631619,0,2,protein kinase CK2 complex,CC,
2865,GO:0005958,1,0.979610518974473,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2866,GO:0005960,1,0.987995325430001,0,2,glycine cleavage complex,CC,
2867,GO:0005964,1,0.965716589119837,0,5,phosphorylase kinase complex,CC,
2868,GO:0005965,1,0.988370331693565,0,2,protein farnesyltransferase complex,CC,
2869,GO:0005967,1,0.979068752207784,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2870,GO:0005968,1,0.974855711977726,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2871,GO:0005969,1,0.992194893954347,0,1,serine-pyruvate aminotransferase complex,CC,
2872,GO:0005971,1,0.977905378228213,0,3,ribonucleoside-diphosphate reductase complex,CC,
2874,GO:0005976,1,0.504989879166175,0,99,polysaccharide metabolic process,BP,
2875,GO:0005977,1,0.624969001236947,0,68,glycogen metabolic process,BP,
2876,GO:0005978,1,0.737142207907091,0,44,glycogen biosynthetic process,BP,
2878,GO:0005980,1,0.85024860143924,0,23,glycogen catabolic process,BP,
2879,GO:0005981,1,0.973249243005808,0,4,regulation of glycogen catabolic process,BP,
2880,GO:0005982,1,0.992321256293606,0,1,starch metabolic process,BP,
2881,GO:0005983,1,0.992321256293606,0,1,starch catabolic process,BP,
2882,GO:0005984,1,0.942723397686933,0,9,disaccharide metabolic process,BP,
2883,GO:0005985,1,0.987965270188734,0,2,sucrose metabolic process,BP,
2884,GO:0005986,1,0.995400344957096,0,1,sucrose biosynthetic process,BP,
2885,GO:0005988,1,0.981568087444666,0,3,lactose metabolic process,BP,
2886,GO:0005989,1,0.981568087444666,0,3,lactose biosynthetic process,BP,
2887,GO:0005991,1,0.992886097355274,0,1,trehalose metabolic process,BP,
2888,GO:0005996,1,0.218804343964722,0,234,monosaccharide metabolic process,BP,
2889,GO:0005997,1,0.979177250241857,0,4,xylulose metabolic process,BP,
2890,GO:0005998,1,0.992517346621251,0,1,xylulose catabolic process,BP,
2891,GO:0005999,1,0.990190367012135,0,2,xylulose biosynthetic process,BP,
2892,GO:0006000,1,0.924781474766594,0,13,fructose metabolic process,BP,
2893,GO:0006001,1,0.974654948760416,0,4,fructose catabolic process,BP,
2894,GO:0006002,1,0.950969210310346,0,8,fructose 6-phosphate metabolic process,BP,
2895,GO:0006003,1,0.972801898496564,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2896,GO:0006004,1,0.906908457402631,0,14,fucose metabolic process,BP,
2897,GO:0006006,1,0.327394591395217,0,171,glucose metabolic process,BP,
2898,GO:0006007,1,0.842416912846337,0,28,glucose catabolic process,BP,
2899,GO:0006011,1,0.961864459807799,0,6,UDP-glucose metabolic process,BP,
2900,GO:0006012,1,0.914203615583766,0,14,galactose metabolic process,BP,
2901,GO:0006013,1,0.948432731915059,0,8,mannose metabolic process,BP,
2902,GO:0006014,1,0.986717020914917,0,3,D-ribose metabolic process,BP,
2903,GO:0006015,1,0.980911879545185,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2904,GO:0006020,1,0.926142565114868,0,11,inositol metabolic process,BP,
2905,GO:0006021,1,0.97456766783441,0,4,inositol biosynthetic process,BP,
2910,GO:0006027,1,0.699747928869485,0,53,glycosaminoglycan catabolic process,BP,
2915,GO:0006041,1,0.975946533113891,0,4,glucosamine metabolic process,BP,
2916,GO:0006043,1,0.988704558226093,0,2,glucosamine catabolic process,BP,
2917,GO:0006044,1,0.905754322275597,0,15,N-acetylglucosamine metabolic process,BP,
2918,GO:0006045,1,0.984991609743528,0,2,N-acetylglucosamine biosynthetic process,BP,
2919,GO:0006046,1,0.983641633390898,0,3,N-acetylglucosamine catabolic process,BP,
2920,GO:0006047,1,0.910658810829217,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2921,GO:0006048,1,0.934880378942199,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006049,1,0.99292485473066,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2923,GO:0006050,1,0.99086226246789,0,2,mannosamine metabolic process,BP,
2924,GO:0006051,1,0.99086226246789,0,2,N-acetylmannosamine metabolic process,BP,
2925,GO:0006054,1,0.936422089124844,0,11,N-acetylneuraminate metabolic process,BP,
2926,GO:0006055,1,0.995842275743558,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2927,GO:0006056,1,0.994995753572652,0,1,mannoprotein metabolic process,BP,
2928,GO:0006057,1,0.994995753572652,0,1,mannoprotein biosynthetic process,BP,
2929,GO:0006059,1,0.984865005344838,0,3,hexitol metabolic process,BP,
2930,GO:0006060,1,0.989147915449972,0,2,sorbitol metabolic process,BP,
2931,GO:0006061,1,0.995611997115238,0,1,sorbitol biosynthetic process,BP,
2932,GO:0006062,1,0.993507719716997,0,1,sorbitol catabolic process,BP,
2933,GO:0006063,1,0.954371554695209,0,8,uronic acid metabolic process,BP,
2934,GO:0006064,1,0.973600898871411,0,5,glucuronate catabolic process,BP,
2935,GO:0006065,1,0.97941625870397,0,3,UDP-glucuronate biosynthetic process,BP,
2936,GO:0006066,1,0.161550596647586,0,281,alcohol metabolic process,BP,
2937,GO:0006067,1,0.916899299417058,0,15,ethanol metabolic process,BP,
2938,GO:0006068,1,0.953680474597975,0,9,ethanol catabolic process,BP,
2939,GO:0006069,1,0.948568846854247,0,8,ethanol oxidation,BP,
2940,GO:0006071,1,0.927095712374869,0,12,glycerol metabolic process,BP,
2941,GO:0006072,1,0.942457695977155,0,8,glycerol-3-phosphate metabolic process,BP,
2942,GO:0006073,1,0.6201470571471,0,69,cellular glucan metabolic process,BP,
2943,GO:0006081,1,0.656945906769476,0,69,cellular aldehyde metabolic process,BP,
2945,GO:0006083,1,0.977935564577433,0,3,acetate metabolic process,BP,
2946,GO:0006084,1,0.799571301197186,0,34,acetyl-CoA metabolic process,BP,
2947,GO:0006085,1,0.875114203085273,0,19,acetyl-CoA biosynthetic process,BP,
2948,GO:0006086,1,0.905287001973992,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2949,GO:0006089,1,0.935409769549589,0,11,lactate metabolic process,BP,
2950,GO:0006090,1,0.437013935995986,0,126,pyruvate metabolic process,BP,
2952,GO:0006094,1,0.663294881193936,0,67,gluconeogenesis,BP,
2953,GO:0006096,1,0.54427453446962,0,92,glycolytic process,BP,
2954,GO:0006097,1,0.988977194886493,0,2,glyoxylate cycle,BP,
2955,GO:0006098,1,0.912434957900917,0,17,pentose-phosphate shunt,BP,
2956,GO:0006099,1,0.839597739366234,0,29,tricarboxylic acid cycle,BP,
2957,GO:0006101,1,0.814572317872862,0,33,citrate metabolic process,BP,
2958,GO:0006102,1,0.973099424981826,0,5,isocitrate metabolic process,BP,
2959,GO:0006103,1,0.889615550544519,0,18,2-oxoglutarate metabolic process,BP,
2960,GO:0006104,1,0.964840061151504,0,6,succinyl-CoA metabolic process,BP,
2962,GO:0006106,1,0.982998369608588,0,3,fumarate metabolic process,BP,
2963,GO:0006107,1,0.929300580390049,0,12,oxaloacetate metabolic process,BP,
2964,GO:0006108,1,0.960200945268771,0,7,malate metabolic process,BP,
2965,GO:0006109,1,0.349140249105454,0,155,regulation of carbohydrate metabolic process,BP,
2966,GO:0006110,1,0.660318598838083,0,61,regulation of glycolytic process,BP,
2967,GO:0006111,1,0.837917467064835,0,26,regulation of gluconeogenesis,BP,
2969,GO:0006114,1,0.967878973701774,0,5,glycerol biosynthetic process,BP,
2970,GO:0006116,1,0.973915900804193,0,4,NADH oxidation,BP,
2971,GO:0006117,1,0.993420146576655,0,1,acetaldehyde metabolic process,BP,
2972,GO:0006119,1,0.621836160574012,0,98,oxidative phosphorylation,BP,
2973,GO:0006120,1,0.829867171297792,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2974,GO:0006121,1,0.978672150168294,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2975,GO:0006122,1,0.931182362910451,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2976,GO:0006123,1,0.93467587963246,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2977,GO:0006127,1,0.985401876654302,0,2,glycerophosphate shuttle,BP,
2983,GO:0006148,1,0.993722014927607,0,1,inosine catabolic process,BP,
2984,GO:0006152,1,0.965095710696759,0,6,purine nucleoside catabolic process,BP,
2985,GO:0006154,1,0.98886838866853,0,2,adenosine catabolic process,BP,
2986,GO:0006157,1,0.995403562116892,0,1,deoxyadenosine catabolic process,BP,
2989,GO:0006165,1,0.493585227202763,0,109,nucleoside diphosphate phosphorylation,BP,
2990,GO:0006166,1,0.973888808357274,0,5,purine ribonucleoside salvage,BP,
2991,GO:0006167,1,0.968372126956809,0,6,AMP biosynthetic process,BP,
2992,GO:0006168,1,0.986776387024673,0,3,adenine salvage,BP,
2993,GO:0006169,1,0.994443672100244,0,1,adenosine salvage,BP,
2995,GO:0006172,1,0.986552607720995,0,2,ADP biosynthetic process,BP,
2996,GO:0006173,1,0.992532286807249,0,1,dADP biosynthetic process,BP,
2997,GO:0006174,1,0.9930956730518,0,1,dADP phosphorylation,BP,
2998,GO:0006175,1,0.994443672100244,0,1,dATP biosynthetic process,BP,
2999,GO:0006177,1,0.972881652137979,0,5,GMP biosynthetic process,BP,
3000,GO:0006178,1,0.990309718035064,0,2,guanine salvage,BP,
3002,GO:0006183,1,0.954728786121831,0,10,GTP biosynthetic process,BP,
3003,GO:0006185,1,0.996155923041539,0,1,dGDP biosynthetic process,BP,
3004,GO:0006186,1,0.9930956730518,0,1,dGDP phosphorylation,BP,
3005,GO:0006188,1,0.937077337821074,0,10,IMP biosynthetic process,BP,
3006,GO:0006189,1,0.960611515335206,0,6,'de novo' IMP biosynthetic process,BP,
3007,GO:0006193,1,0.99602270581164,0,1,ITP catabolic process,BP,
3009,GO:0006196,1,0.985044460288139,0,2,AMP catabolic process,BP,
3010,GO:0006198,1,0.880894678369557,0,17,cAMP catabolic process,BP,
3011,GO:0006203,1,0.983742368943048,0,3,dGTP catabolic process,BP,
3012,GO:0006206,1,0.894660580037543,0,18,pyrimidine nucleobase metabolic process,BP,
3013,GO:0006207,1,0.958231492553506,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3014,GO:0006208,1,0.981326389518617,0,3,pyrimidine nucleobase catabolic process,BP,
3015,GO:0006210,1,0.981326389518617,0,3,thymine catabolic process,BP,
3016,GO:0006211,1,0.976296289273891,0,3,5-methylcytosine catabolic process,BP,
3017,GO:0006212,1,0.987073606536277,0,2,uracil catabolic process,BP,
3018,GO:0006213,1,0.787353388275604,0,43,pyrimidine nucleoside metabolic process,BP,
3019,GO:0006214,1,0.992735870788185,0,1,thymidine catabolic process,BP,
3020,GO:0006216,1,0.958340610976605,0,8,cytidine catabolic process,BP,
3021,GO:0006218,1,0.994926449873857,0,1,uridine catabolic process,BP,
3022,GO:0006220,1,0.782009077772226,0,45,pyrimidine nucleotide metabolic process,BP,
3023,GO:0006221,1,0.844880481910271,0,31,pyrimidine nucleotide biosynthetic process,BP,
3024,GO:0006222,1,0.941673995289347,0,10,UMP biosynthetic process,BP,
3025,GO:0006226,1,0.984654293644344,0,3,dUMP biosynthetic process,BP,
3026,GO:0006227,1,0.988861019818926,0,2,dUDP biosynthetic process,BP,
3027,GO:0006228,1,0.958169453821018,0,9,UTP biosynthetic process,BP,
3028,GO:0006231,1,0.983546367319528,0,3,dTMP biosynthetic process,BP,
3029,GO:0006233,1,0.988861019818926,0,2,dTDP biosynthetic process,BP,
3030,GO:0006235,1,0.980039467083523,0,4,dTTP biosynthetic process,BP,
3031,GO:0006238,1,0.995834185229467,0,1,CMP salvage,BP,
3032,GO:0006241,1,0.937556893282743,0,13,CTP biosynthetic process,BP,
3033,GO:0006244,1,0.933290373626418,0,13,pyrimidine nucleotide catabolic process,BP,
3034,GO:0006253,1,0.996003358562593,0,1,dCTP catabolic process,BP,
3035,GO:0006256,1,0.992912744500514,0,1,UDP catabolic process,BP,
3036,GO:0006258,1,0.989909529042068,0,2,UDP-glucose catabolic process,BP,
3037,GO:0006259,1,0.00257112096383711,0,896,DNA metabolic process,BP,
3038,GO:0006260,1,0.161567252823748,0,274,DNA replication,BP,
3039,GO:0006261,1,0.397638925761552,0,141,DNA-dependent DNA replication,BP,
3040,GO:0006264,1,0.933020475523642,0,10,mitochondrial DNA replication,BP,
3041,GO:0006265,1,0.9401552482218,0,9,DNA topological change,BP,
3042,GO:0006266,1,0.869825576262924,0,23,DNA ligation,BP,
3043,GO:0006267,1,0.983271255446626,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3044,GO:0006268,1,0.953599521175362,0,7,DNA unwinding involved in DNA replication,BP,
3045,GO:0006269,1,0.967998608398093,0,5,DNA replication, synthesis of RNA primer,BP,
3046,GO:0006270,1,0.760149405548213,0,42,DNA replication initiation,BP,
3047,GO:0006271,1,0.884314798300746,0,20,DNA strand elongation involved in DNA replication,BP,
3048,GO:0006272,1,0.980450457814048,0,3,leading strand elongation,BP,
3049,GO:0006273,1,0.931338333312326,0,11,lagging strand elongation,BP,
3050,GO:0006275,1,0.492277554759506,0,107,regulation of DNA replication,BP,
3051,GO:0006278,1,0.644299401868883,0,67,RNA-dependent DNA biosynthetic process,BP,
3052,GO:0006281,1,0.0453500952534742,0,475,DNA repair,BP,
3053,GO:0006282,1,0.553079312576558,0,89,regulation of DNA repair,BP,
3054,GO:0006283,1,0.654467382363292,0,73,transcription-coupled nucleotide-excision repair,BP,
3055,GO:0006284,1,0.779458216128589,0,41,base-excision repair,BP,
3056,GO:0006285,1,0.948054746238761,0,10,base-excision repair, AP site formation,BP,
3057,GO:0006286,1,0.991301113765315,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3058,GO:0006287,1,0.966885612482308,0,5,base-excision repair, gap-filling,BP,
3059,GO:0006288,1,0.982811734801989,0,3,base-excision repair, DNA ligation,BP,
3060,GO:0006289,1,0.510694234041882,0,112,nucleotide-excision repair,BP,
3061,GO:0006290,1,0.956786944980492,0,7,pyrimidine dimer repair,BP,
3062,GO:0006293,1,0.875190696102296,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3063,GO:0006294,1,0.842451435269385,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3064,GO:0006295,1,0.875190696102296,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3065,GO:0006296,1,0.801113133384905,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3066,GO:0006297,1,0.871661275120163,0,23,nucleotide-excision repair, DNA gap filling,BP,
3067,GO:0006298,1,0.819875506644179,0,30,mismatch repair,BP,
3068,GO:0006301,1,0.739712727324759,0,48,postreplication repair,BP,
3069,GO:0006302,1,0.282819810992335,0,189,double-strand break repair,BP,
3070,GO:0006303,1,0.682786295324009,0,58,double-strand break repair via nonhomologous end joining,BP,
3071,GO:0006304,1,0.550294032884326,0,92,DNA modification,BP,
3072,GO:0006305,1,0.687241948644586,0,54,DNA alkylation,BP,
3073,GO:0006306,1,0.687241948644586,0,54,DNA methylation,BP,
3074,GO:0006307,1,0.943237118919226,0,10,DNA dealkylation involved in DNA repair,BP,
3075,GO:0006308,1,0.805038287459983,0,35,DNA catabolic process,BP,
3076,GO:0006309,1,0.885150433946821,0,20,apoptotic DNA fragmentation,BP,
3077,GO:0006310,1,0.214009226214111,0,232,DNA recombination,BP,
3078,GO:0006311,1,0.97167820576797,0,4,meiotic gene conversion,BP,
3079,GO:0006312,1,0.857666107186045,0,23,mitotic recombination,BP,
3080,GO:0006313,1,0.992499443483694,0,1,transposition, DNA-mediated,BP,
3081,GO:0006323,1,0.418339683142606,0,142,DNA packaging,BP,
3082,GO:0006325,1,0.0103688642361618,0,674,chromatin organization,BP,
3083,GO:0006333,1,0.4452783105816,0,133,chromatin assembly or disassembly,BP,
3084,GO:0006334,1,0.59264673624692,0,91,nucleosome assembly,BP,
3085,GO:0006335,1,0.930264949053464,0,14,DNA replication-dependent nucleosome assembly,BP,
3086,GO:0006336,1,0.791839891665407,0,40,DNA replication-independent nucleosome assembly,BP,
3087,GO:0006337,1,0.89463670945822,0,17,nucleosome disassembly,BP,
3088,GO:0006338,1,0.362827469818346,0,158,chromatin remodeling,BP,
3089,GO:0006342,1,0.63220682100243,0,75,chromatin silencing,BP,
3090,GO:0006343,1,0.992505424922139,0,1,establishment of chromatin silencing,BP,
3091,GO:0006344,1,0.970646146163616,0,4,maintenance of chromatin silencing,BP,
3092,GO:0006346,1,0.90525307610935,0,14,methylation-dependent chromatin silencing,BP,
3093,GO:0006348,1,0.956330652174075,0,8,chromatin silencing at telomere,BP,
3094,GO:0006349,1,0.892981350777153,0,16,regulation of gene expression by genetic imprinting,BP,
3096,GO:0006352,1,0.243365857910267,0,223,DNA-templated transcription, initiation,BP,
3097,GO:0006353,1,0.520339198249821,0,107,DNA-templated transcription, termination,BP,
3098,GO:0006354,1,0.467734838019076,0,122,DNA-templated transcription, elongation,BP,
3100,GO:0006356,1,0.817347212558671,0,30,regulation of transcription by RNA polymerase I,BP,
3102,GO:0006359,1,0.833860771643406,0,27,regulation of transcription by RNA polymerase III,BP,
3103,GO:0006360,1,0.687989095284863,0,59,transcription by RNA polymerase I,BP,
3104,GO:0006361,1,0.815680789126862,0,35,transcription initiation from RNA polymerase I promoter,BP,
3105,GO:0006362,1,0.84019706258356,0,30,transcription elongation from RNA polymerase I promoter,BP,
3106,GO:0006363,1,0.840570730656808,0,30,termination of RNA polymerase I transcription,BP,
3107,GO:0006364,1,0.261345046587689,0,249,rRNA processing,BP,
3109,GO:0006367,1,0.327968090803361,0,175,transcription initiation from RNA polymerase II promoter,BP,
3110,GO:0006368,1,0.546871321261481,0,97,transcription elongation from RNA polymerase II promoter,BP,
3111,GO:0006369,1,0.655327218281904,0,68,termination of RNA polymerase II transcription,BP,
3112,GO:0006370,1,0.836341428552337,0,31,7-methylguanosine mRNA capping,BP,
3114,GO:0006378,1,0.762189896468551,0,40,mRNA polyadenylation,BP,
3115,GO:0006379,1,0.843798883617763,0,27,mRNA cleavage,BP,
3116,GO:0006382,1,0.964623379866438,0,5,adenosine to inosine editing,BP,
3117,GO:0006383,1,0.717206535581628,0,53,transcription by RNA polymerase III,BP,
3118,GO:0006384,1,0.952330583252951,0,7,transcription initiation from RNA polymerase III promoter,BP,
3119,GO:0006386,1,0.996373924457365,0,1,termination of RNA polymerase III transcription,BP,
3120,GO:0006388,1,0.927971578718614,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3121,GO:0006390,1,0.919140507915097,0,13,mitochondrial transcription,BP,
3122,GO:0006391,1,0.982268577477821,0,3,transcription initiation from mitochondrial promoter,BP,
3123,GO:0006393,1,0.986238532970005,0,2,termination of mitochondrial transcription,BP,
3126,GO:0006398,1,0.968044591267348,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3127,GO:0006399,1,0.331424658355674,0,181,tRNA metabolic process,BP,
3128,GO:0006400,1,0.639428874444701,0,73,tRNA modification,BP,
3129,GO:0006401,1,0.121438821419719,0,361,RNA catabolic process,BP,
3130,GO:0006402,1,0.145926803437073,0,332,mRNA catabolic process,BP,
3132,GO:0006404,1,0.983332974577425,0,3,RNA import into nucleus,BP,
3133,GO:0006405,1,0.416883402860512,0,135,RNA export from nucleus,BP,
3134,GO:0006406,1,0.504658470379303,0,104,mRNA export from nucleus,BP,
3135,GO:0006407,1,0.98389176456966,0,3,rRNA export from nucleus,BP,
3136,GO:0006408,1,0.989439073630149,0,2,snRNA export from nucleus,BP,
3137,GO:0006409,1,0.810910139502331,0,31,tRNA export from nucleus,BP,
3139,GO:0006413,1,0.362283860657081,0,191,translational initiation,BP,
3141,GO:0006415,1,0.617670559686079,0,99,translational termination,BP,
3143,GO:0006418,1,0.734701359995478,0,49,tRNA aminoacylation for protein translation,BP,
3144,GO:0006419,1,0.979956605983599,0,3,alanyl-tRNA aminoacylation,BP,
3145,GO:0006420,1,0.983264938666197,0,3,arginyl-tRNA aminoacylation,BP,
3146,GO:0006421,1,0.97970889360535,0,3,asparaginyl-tRNA aminoacylation,BP,
3147,GO:0006422,1,0.993880091364926,0,1,aspartyl-tRNA aminoacylation,BP,
3148,GO:0006423,1,0.98814183551778,0,2,cysteinyl-tRNA aminoacylation,BP,
3149,GO:0006424,1,0.985005945104461,0,2,glutamyl-tRNA aminoacylation,BP,
3150,GO:0006425,1,0.986164152259627,0,2,glutaminyl-tRNA aminoacylation,BP,
3151,GO:0006426,1,0.988474024779937,0,2,glycyl-tRNA aminoacylation,BP,
3152,GO:0006427,1,0.988213824529325,0,2,histidyl-tRNA aminoacylation,BP,
3153,GO:0006428,1,0.98507837789776,0,2,isoleucyl-tRNA aminoacylation,BP,
3154,GO:0006429,1,0.985010003280386,0,2,leucyl-tRNA aminoacylation,BP,
3155,GO:0006430,1,0.994330443615449,0,1,lysyl-tRNA aminoacylation,BP,
3156,GO:0006431,1,0.985931546118718,0,2,methionyl-tRNA aminoacylation,BP,
3157,GO:0006432,1,0.970217709294957,0,5,phenylalanyl-tRNA aminoacylation,BP,
3158,GO:0006433,1,0.982395666284347,0,3,prolyl-tRNA aminoacylation,BP,
3159,GO:0006434,1,0.989187725872338,0,2,seryl-tRNA aminoacylation,BP,
3160,GO:0006435,1,0.979538979814084,0,3,threonyl-tRNA aminoacylation,BP,
3161,GO:0006436,1,0.986328065011254,0,2,tryptophanyl-tRNA aminoacylation,BP,
3162,GO:0006437,1,0.987009436981041,0,2,tyrosyl-tRNA aminoacylation,BP,
3163,GO:0006438,1,0.97764408624057,0,3,valyl-tRNA aminoacylation,BP,
3164,GO:0006446,1,0.623800492846778,0,74,regulation of translational initiation,BP,
3165,GO:0006447,1,0.980209630306342,0,3,regulation of translational initiation by iron,BP,
3166,GO:0006448,1,0.888221051964935,0,18,regulation of translational elongation,BP,
3167,GO:0006449,1,0.946928563476043,0,8,regulation of translational termination,BP,
3168,GO:0006450,1,0.899699449643126,0,18,regulation of translational fidelity,BP,
3169,GO:0006451,1,0.949674997399018,0,8,translational readthrough,BP,
3170,GO:0006452,1,0.98077769890233,0,3,translational frameshifting,BP,
3171,GO:0006457,1,0.253788556804042,0,225,protein folding,BP,
3172,GO:0006458,1,0.738065346240688,0,48,'de novo' protein folding,BP,
3173,GO:0006463,1,0.992512418411382,0,1,steroid hormone receptor complex assembly,BP,
3175,GO:0006465,1,0.890284614579159,0,20,signal peptide processing,BP,
3179,GO:0006471,1,0.847745254822638,0,26,protein ADP-ribosylation,BP,
3180,GO:0006473,1,0.3190677629558,0,174,protein acetylation,BP,
3181,GO:0006474,1,0.900892466547067,0,16,N-terminal protein amino acid acetylation,BP,
3182,GO:0006475,1,0.377562842333639,0,146,internal protein amino acid acetylation,BP,
3183,GO:0006476,1,0.527020725945616,0,95,protein deacetylation,BP,
3184,GO:0006477,1,0.960274256442656,0,6,protein sulfation,BP,
3185,GO:0006478,1,0.989140739072603,0,2,peptidyl-tyrosine sulfation,BP,
3186,GO:0006479,1,0.33157345648149,0,163,protein methylation,BP,
3187,GO:0006480,1,0.98933857647837,0,2,N-terminal protein amino acid methylation,BP,
3188,GO:0006481,1,0.981282901888934,0,3,C-terminal protein methylation,BP,
3189,GO:0006482,1,0.806764504083567,0,29,protein demethylation,BP,
3191,GO:0006487,1,0.573703568999046,0,89,protein N-linked glycosylation,BP,
3192,GO:0006488,1,0.881774960647156,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3193,GO:0006489,1,0.956867542100522,0,7,dolichyl diphosphate biosynthetic process,BP,
3194,GO:0006490,1,0.876033381734586,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3195,GO:0006491,1,0.879651107319621,0,18,N-glycan processing,BP,
3196,GO:0006493,1,0.515403723338719,0,99,protein O-linked glycosylation,BP,
3197,GO:0006497,1,0.432630167712317,0,134,protein lipidation,BP,
3198,GO:0006498,1,0.960307755242897,0,6,N-terminal protein lipidation,BP,
3199,GO:0006499,1,0.970768144197602,0,4,N-terminal protein myristoylation,BP,
3200,GO:0006500,1,0.989227871424976,0,2,N-terminal protein palmitoylation,BP,
3201,GO:0006501,1,0.712891730157334,0,55,C-terminal protein lipidation,BP,
3202,GO:0006505,1,0.823688476226672,0,33,GPI anchor metabolic process,BP,
3203,GO:0006506,1,0.832332321133946,0,31,GPI anchor biosynthetic process,BP,
3204,GO:0006507,1,0.993966766284853,0,1,GPI anchor release,BP,
3206,GO:0006509,1,0.768465464445967,0,40,membrane protein ectodomain proteolysis,BP,
3209,GO:0006515,1,0.847540713039145,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3210,GO:0006516,1,0.896410060606837,0,17,glycoprotein catabolic process,BP,
3211,GO:0006517,1,0.7942708058379,0,34,protein deglycosylation,BP,
3214,GO:0006521,1,0.757802944276147,0,55,regulation of cellular amino acid metabolic process,BP,
3215,GO:0006522,1,0.978050383175467,0,4,alanine metabolic process,BP,
3216,GO:0006524,1,0.978050383175467,0,4,alanine catabolic process,BP,
3217,GO:0006525,1,0.887015565084048,0,20,arginine metabolic process,BP,
3218,GO:0006526,1,0.964279385132304,0,6,arginine biosynthetic process,BP,
3219,GO:0006527,1,0.93495909891003,0,11,arginine catabolic process,BP,
3220,GO:0006528,1,0.972236545726718,0,5,asparagine metabolic process,BP,
3221,GO:0006529,1,0.987542704237149,0,2,asparagine biosynthetic process,BP,
3222,GO:0006530,1,0.98866085188809,0,2,asparagine catabolic process,BP,
3223,GO:0006531,1,0.943085559171128,0,10,aspartate metabolic process,BP,
3224,GO:0006532,1,0.987976197576296,0,2,aspartate biosynthetic process,BP,
3225,GO:0006533,1,0.983666641441279,0,3,aspartate catabolic process,BP,
3226,GO:0006534,1,0.920734692539384,0,13,cysteine metabolic process,BP,
3227,GO:0006535,1,0.993379716894051,0,1,cysteine biosynthetic process from serine,BP,
3229,GO:0006537,1,0.965270166943814,0,5,glutamate biosynthetic process,BP,
3231,GO:0006539,1,0.994750725323016,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3233,GO:0006541,1,0.855615861992116,0,23,glutamine metabolic process,BP,
3234,GO:0006542,1,0.984962157232859,0,2,glutamine biosynthetic process,BP,
3235,GO:0006543,1,0.978480087055475,0,3,glutamine catabolic process,BP,
3236,GO:0006544,1,0.940306702587009,0,10,glycine metabolic process,BP,
3237,GO:0006545,1,0.983092484368015,0,3,glycine biosynthetic process,BP,
3238,GO:0006546,1,0.982470801548671,0,3,glycine catabolic process,BP,
3239,GO:0006547,1,0.944605613460755,0,9,histidine metabolic process,BP,
3240,GO:0006548,1,0.957601981260154,0,7,histidine catabolic process,BP,
3241,GO:0006549,1,0.967388265451039,0,5,isoleucine metabolic process,BP,
3242,GO:0006550,1,0.989566605557399,0,2,isoleucine catabolic process,BP,
3244,GO:0006552,1,0.96333501133443,0,6,leucine catabolic process,BP,
3247,GO:0006555,1,0.882392334553576,0,20,methionine metabolic process,BP,
3248,GO:0006556,1,0.980141906527894,0,3,S-adenosylmethionine biosynthetic process,BP,
3249,GO:0006557,1,0.992647380323441,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3250,GO:0006558,1,0.948293878314087,0,10,L-phenylalanine metabolic process,BP,
3251,GO:0006559,1,0.948293878314087,0,10,L-phenylalanine catabolic process,BP,
3252,GO:0006560,1,0.959829816701204,0,7,proline metabolic process,BP,
3253,GO:0006561,1,0.977259968839625,0,4,proline biosynthetic process,BP,
3254,GO:0006562,1,0.982168413725058,0,3,proline catabolic process,BP,
3255,GO:0006563,1,0.939334012023973,0,11,L-serine metabolic process,BP,
3256,GO:0006564,1,0.966562574963261,0,6,L-serine biosynthetic process,BP,
3257,GO:0006565,1,0.97810300932421,0,4,L-serine catabolic process,BP,
3258,GO:0006566,1,0.980697617543536,0,4,threonine metabolic process,BP,
3259,GO:0006567,1,0.986299353656924,0,3,threonine catabolic process,BP,
3260,GO:0006568,1,0.951736062696684,0,9,tryptophan metabolic process,BP,
3261,GO:0006569,1,0.963981088407882,0,7,tryptophan catabolic process,BP,
3262,GO:0006570,1,0.958553214171808,0,8,tyrosine metabolic process,BP,
3263,GO:0006572,1,0.969588283698021,0,6,tyrosine catabolic process,BP,
3265,GO:0006574,1,0.97779505239041,0,4,valine catabolic process,BP,
3267,GO:0006576,1,0.76502295539079,0,46,cellular biogenic amine metabolic process,BP,
3268,GO:0006577,1,0.890881775800834,0,17,amino-acid betaine metabolic process,BP,
3269,GO:0006578,1,0.954292041443612,0,7,amino-acid betaine biosynthetic process,BP,
3270,GO:0006579,1,0.980022483635739,0,3,amino-acid betaine catabolic process,BP,
3271,GO:0006580,1,0.993228636089122,0,1,ethanolamine metabolic process,BP,
3272,GO:0006581,1,0.986293030107427,0,2,acetylcholine catabolic process,BP,
3273,GO:0006582,1,0.899674383119816,0,16,melanin metabolic process,BP,
3274,GO:0006583,1,0.99384750826789,0,1,melanin biosynthetic process from tyrosine,BP,
3276,GO:0006585,1,0.994742854438429,0,1,dopamine biosynthetic process from tyrosine,BP,
3277,GO:0006586,1,0.937462238744909,0,12,indolalkylamine metabolic process,BP,
3278,GO:0006589,1,0.985969554365339,0,2,octopamine biosynthetic process,BP,
3279,GO:0006590,1,0.912829895153819,0,13,thyroid hormone generation,BP,
3280,GO:0006591,1,0.949137576172912,0,9,ornithine metabolic process,BP,
3281,GO:0006592,1,0.992562148440043,0,1,ornithine biosynthetic process,BP,
3282,GO:0006593,1,0.995215551857106,0,1,ornithine catabolic process,BP,
3283,GO:0006595,1,0.919749295379483,0,16,polyamine metabolic process,BP,
3284,GO:0006596,1,0.932433171431882,0,13,polyamine biosynthetic process,BP,
3285,GO:0006597,1,0.98782506348269,0,2,spermine biosynthetic process,BP,
3286,GO:0006598,1,0.972210009282926,0,6,polyamine catabolic process,BP,
3287,GO:0006600,1,0.942058464352719,0,10,creatine metabolic process,BP,
3288,GO:0006601,1,0.989566059091583,0,2,creatine biosynthetic process,BP,
3290,GO:0006606,1,0.427085698934049,0,128,protein import into nucleus,BP,
3291,GO:0006607,1,0.865198829816451,0,20,NLS-bearing protein import into nucleus,BP,
3292,GO:0006610,1,0.944958414811246,0,8,ribosomal protein import into nucleus,BP,
3293,GO:0006611,1,0.324758285793224,0,173,protein export from nucleus,BP,
3295,GO:0006613,1,0.671939143654227,0,95,cotranslational protein targeting to membrane,BP,
3296,GO:0006614,1,0.694560510795711,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3297,GO:0006616,1,0.970947022386419,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3298,GO:0006617,1,0.990356727748478,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3299,GO:0006620,1,0.957704585523872,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3300,GO:0006621,1,0.939084771837799,0,10,protein retention in ER lumen,BP,
3301,GO:0006622,1,0.877385860116105,0,19,protein targeting to lysosome,BP,
3302,GO:0006623,1,0.805820921618902,0,31,protein targeting to vacuole,BP,
3303,GO:0006624,1,0.990774535284821,0,2,vacuolar protein processing,BP,
3304,GO:0006625,1,0.892850280238689,0,17,protein targeting to peroxisome,BP,
3305,GO:0006626,1,0.445365154017306,0,135,protein targeting to mitochondrion,BP,
3306,GO:0006627,1,0.95643534486117,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3309,GO:0006633,1,0.481583540944554,0,119,fatty acid biosynthetic process,BP,
3311,GO:0006636,1,0.789969719604758,0,40,unsaturated fatty acid biosynthetic process,BP,
3312,GO:0006637,1,0.564590966128198,0,91,acyl-CoA metabolic process,BP,
3316,GO:0006642,1,0.970785476641433,0,4,triglyceride mobilization,BP,
3318,GO:0006644,1,0.0641582805504711,0,414,phospholipid metabolic process,BP,
3319,GO:0006646,1,0.910834074900737,0,14,phosphatidylethanolamine biosynthetic process,BP,
3320,GO:0006649,1,0.985028972831936,0,2,phospholipid transfer to membrane,BP,
3321,GO:0006650,1,0.109924983301366,0,331,glycerophospholipid metabolic process,BP,
3322,GO:0006651,1,0.988460172941539,0,2,diacylglycerol biosynthetic process,BP,
3323,GO:0006654,1,0.797631490038057,0,33,phosphatidic acid biosynthetic process,BP,
3324,GO:0006655,1,0.935421212848038,0,10,phosphatidylglycerol biosynthetic process,BP,
3325,GO:0006656,1,0.816070652953026,0,33,phosphatidylcholine biosynthetic process,BP,
3326,GO:0006657,1,0.958850722515824,0,7,CDP-choline pathway,BP,
3327,GO:0006658,1,0.860017902352527,0,24,phosphatidylserine metabolic process,BP,
3328,GO:0006659,1,0.974104534116445,0,4,phosphatidylserine biosynthetic process,BP,
3329,GO:0006660,1,0.994980888130085,0,1,phosphatidylserine catabolic process,BP,
3330,GO:0006661,1,0.396128553401972,0,136,phosphatidylinositol biosynthetic process,BP,
3331,GO:0006662,1,0.934639005944934,0,12,glycerol ether metabolic process,BP,
3332,GO:0006663,1,0.975670683722877,0,4,platelet activating factor biosynthetic process,BP,
3335,GO:0006666,1,0.992435093267707,0,1,3-keto-sphinganine metabolic process,BP,
3336,GO:0006667,1,0.982763278317844,0,3,sphinganine metabolic process,BP,
3337,GO:0006668,1,0.985557954595594,0,2,sphinganine-1-phosphate metabolic process,BP,
3338,GO:0006669,1,0.992878851329483,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3339,GO:0006670,1,0.93483030253194,0,11,sphingosine metabolic process,BP,
3340,GO:0006671,1,0.99248757873928,0,1,phytosphingosine metabolic process,BP,
3341,GO:0006672,1,0.580804333610026,0,84,ceramide metabolic process,BP,
3342,GO:0006677,1,0.893346630763372,0,18,glycosylceramide metabolic process,BP,
3343,GO:0006678,1,0.955105292284939,0,7,glucosylceramide metabolic process,BP,
3344,GO:0006679,1,0.987724188058949,0,2,glucosylceramide biosynthetic process,BP,
3345,GO:0006680,1,0.979496517475881,0,3,glucosylceramide catabolic process,BP,
3346,GO:0006681,1,0.95053692526745,0,8,galactosylceramide metabolic process,BP,
3347,GO:0006682,1,0.969693867721839,0,5,galactosylceramide biosynthetic process,BP,
3348,GO:0006683,1,0.992937203934637,0,1,galactosylceramide catabolic process,BP,
3349,GO:0006684,1,0.923204558988617,0,13,sphingomyelin metabolic process,BP,
3350,GO:0006685,1,0.967373550447212,0,5,sphingomyelin catabolic process,BP,
3351,GO:0006686,1,0.9640690194724,0,6,sphingomyelin biosynthetic process,BP,
3354,GO:0006689,1,0.969072031246204,0,5,ganglioside catabolic process,BP,
3355,GO:0006690,1,0.60310598571411,0,86,icosanoid metabolic process,BP,
3356,GO:0006691,1,0.890905913175098,0,20,leukotriene metabolic process,BP,
3357,GO:0006692,1,0.821400488187038,0,34,prostanoid metabolic process,BP,
3358,GO:0006693,1,0.821400488187038,0,34,prostaglandin metabolic process,BP,
3359,GO:0006694,1,0.362164534133514,0,161,steroid biosynthetic process,BP,
3360,GO:0006695,1,0.666922705695068,0,62,cholesterol biosynthetic process,BP,
3361,GO:0006696,1,0.988639870376095,0,2,ergosterol biosynthetic process,BP,
3362,GO:0006699,1,0.813128548893055,0,32,bile acid biosynthetic process,BP,
3363,GO:0006700,1,0.882131138573292,0,20,C21-steroid hormone biosynthetic process,BP,
3364,GO:0006701,1,0.966552557363337,0,5,progesterone biosynthetic process,BP,
3365,GO:0006702,1,0.957438631450735,0,7,androgen biosynthetic process,BP,
3366,GO:0006703,1,0.947635166065173,0,10,estrogen biosynthetic process,BP,
3367,GO:0006704,1,0.920600238281867,0,13,glucocorticoid biosynthetic process,BP,
3368,GO:0006705,1,0.94585240112083,0,8,mineralocorticoid biosynthetic process,BP,
3369,GO:0006706,1,0.891198349256974,0,20,steroid catabolic process,BP,
3370,GO:0006707,1,0.948361606372265,0,9,cholesterol catabolic process,BP,
3371,GO:0006710,1,0.978238224491143,0,4,androgen catabolic process,BP,
3372,GO:0006711,1,0.994980888130085,0,1,estrogen catabolic process,BP,
3373,GO:0006713,1,0.994967825778002,0,1,glucocorticoid catabolic process,BP,
3374,GO:0006714,1,0.991182289855314,0,2,sesquiterpenoid metabolic process,BP,
3375,GO:0006720,1,0.532612302199635,0,103,isoprenoid metabolic process,BP,
3376,GO:0006721,1,0.590556215112154,0,85,terpenoid metabolic process,BP,
3377,GO:0006722,1,0.993736437773384,0,1,triterpenoid metabolic process,BP,
3379,GO:0006726,1,0.980435080166352,0,3,eye pigment biosynthetic process,BP,
3380,GO:0006729,1,0.96459106714992,0,7,tetrahydrobiopterin biosynthetic process,BP,
3381,GO:0006730,1,0.818913312334104,0,33,one-carbon metabolic process,BP,
3382,GO:0006732,1,0.111731619295142,0,348,coenzyme metabolic process,BP,
3383,GO:0006733,1,0.334980851772784,0,172,oxidoreduction coenzyme metabolic process,BP,
3384,GO:0006734,1,0.806999624096971,0,35,NADH metabolic process,BP,
3385,GO:0006735,1,0.864536250501398,0,24,NADH regeneration,BP,
3386,GO:0006738,1,0.993722014927607,0,1,nicotinamide riboside catabolic process,BP,
3387,GO:0006739,1,0.826743330497271,0,33,NADP metabolic process,BP,
3388,GO:0006740,1,0.980346050141984,0,3,NADPH regeneration,BP,
3389,GO:0006741,1,0.973685560973198,0,4,NADP biosynthetic process,BP,
3390,GO:0006742,1,0.984868033700114,0,3,NADP catabolic process,BP,
3391,GO:0006743,1,0.922187227929531,0,15,ubiquinone metabolic process,BP,
3392,GO:0006744,1,0.929178343218956,0,14,ubiquinone biosynthetic process,BP,
3393,GO:0006747,1,0.994610573360766,0,1,FAD biosynthetic process,BP,
3394,GO:0006749,1,0.786093730340533,0,46,glutathione metabolic process,BP,
3395,GO:0006750,1,0.920793641185458,0,14,glutathione biosynthetic process,BP,
3396,GO:0006751,1,0.972260400985638,0,5,glutathione catabolic process,BP,
3398,GO:0006754,1,0.475138786505852,0,115,ATP biosynthetic process,BP,
3399,GO:0006756,1,0.9930956730518,0,1,AMP phosphorylation,BP,
3400,GO:0006757,1,0.540493375605879,0,93,ATP generation from ADP,BP,
3401,GO:0006760,1,0.839631579876535,0,28,folic acid-containing compound metabolic process,BP,
3402,GO:0006766,1,0.469779630089486,0,122,vitamin metabolic process,BP,
3403,GO:0006767,1,0.590856112211705,0,83,water-soluble vitamin metabolic process,BP,
3404,GO:0006768,1,0.936234598227061,0,10,biotin metabolic process,BP,
3405,GO:0006771,1,0.955541131525378,0,7,riboflavin metabolic process,BP,
3406,GO:0006772,1,0.975827441219255,0,4,thiamine metabolic process,BP,
3407,GO:0006775,1,0.802159956315572,0,37,fat-soluble vitamin metabolic process,BP,
3408,GO:0006776,1,0.956222837483909,0,7,vitamin A metabolic process,BP,
3409,GO:0006777,1,0.96178420319594,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3410,GO:0006778,1,0.830809937306316,0,31,porphyrin-containing compound metabolic process,BP,
3411,GO:0006779,1,0.86763699735768,0,23,porphyrin-containing compound biosynthetic process,BP,
3412,GO:0006780,1,0.989913505301675,0,2,uroporphyrinogen III biosynthetic process,BP,
3413,GO:0006781,1,0.99421092928736,0,1,succinyl-CoA pathway,BP,
3414,GO:0006782,1,0.956957164104878,0,8,protoporphyrinogen IX biosynthetic process,BP,
3415,GO:0006783,1,0.89166264794236,0,19,heme biosynthetic process,BP,
3416,GO:0006784,1,0.98517248936743,0,2,heme a biosynthetic process,BP,
3417,GO:0006787,1,0.982904333140756,0,4,porphyrin-containing compound catabolic process,BP,
3418,GO:0006788,1,0.99046131354524,0,2,heme oxidation,BP,
3422,GO:0006797,1,0.96527423778124,0,5,polyphosphate metabolic process,BP,
3423,GO:0006798,1,0.972068372229805,0,4,polyphosphate catabolic process,BP,
3424,GO:0006801,1,0.720058698767793,0,55,superoxide metabolic process,BP,
3427,GO:0006808,1,0.983204208892666,0,3,regulation of nitrogen utilization,BP,
3428,GO:0006809,1,0.689366585176098,0,58,nitric oxide biosynthetic process,BP,
3438,GO:0006824,1,0.976921206766591,0,4,cobalt ion transport,BP,
3439,GO:0006825,1,0.883638874791222,0,20,copper ion transport,BP,
3440,GO:0006826,1,0.716496289579727,0,54,iron ion transport,BP,
3441,GO:0006828,1,0.928694162822502,0,10,manganese ion transport,BP,
3446,GO:0006837,1,0.913148997600728,0,15,serotonin transport,BP,
3449,GO:0006843,1,0.995296987477883,0,1,mitochondrial citrate transmembrane transport,BP,
3450,GO:0006844,1,0.988656264232898,0,2,acyl carnitine transport,BP,
3451,GO:0006848,1,0.973933490883112,0,4,pyruvate transport,BP,
3452,GO:0006850,1,0.986238532970005,0,2,mitochondrial pyruvate transmembrane transport,BP,
3453,GO:0006851,1,0.86907620762175,0,22,mitochondrial calcium ion transmembrane transport,BP,
3454,GO:0006853,1,0.938873365469476,0,9,carnitine shuttle,BP,
3456,GO:0006857,1,0.94715883890867,0,8,oligopeptide transport,BP,
3457,GO:0006858,1,0.983317270316296,0,3,extracellular transport,BP,
3458,GO:0006862,1,0.879849652734273,0,20,nucleotide transport,BP,
3459,GO:0006863,1,0.965629071369044,0,6,purine nucleobase transport,BP,
3460,GO:0006864,1,0.988029767073713,0,2,pyrimidine nucleotide transport,BP,
3462,GO:0006867,1,0.98677450068437,0,2,asparagine transport,BP,
3463,GO:0006868,1,0.959645791246866,0,6,glutamine transport,BP,
3464,GO:0006869,1,0.149117776920734,0,286,lipid transport,BP,
3468,GO:0006876,1,0.992504578103526,0,1,cellular cadmium ion homeostasis,BP,
3469,GO:0006878,1,0.925190689833763,0,13,cellular copper ion homeostasis,BP,
3470,GO:0006879,1,0.700834315683413,0,57,cellular iron ion homeostasis,BP,
3471,GO:0006880,1,0.986758677891076,0,3,intracellular sequestering of iron ion,BP,
3473,GO:0006883,1,0.893854570496456,0,16,cellular sodium ion homeostasis,BP,
3478,GO:0006888,1,0.297202700330346,0,186,ER to Golgi vesicle-mediated transport,BP,
3479,GO:0006890,1,0.591201746016608,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3480,GO:0006891,1,0.803724332219256,0,33,intra-Golgi vesicle-mediated transport,BP,
3481,GO:0006892,1,0.534067047083918,0,92,post-Golgi vesicle-mediated transport,BP,
3482,GO:0006893,1,0.729235555744403,0,47,Golgi to plasma membrane transport,BP,
3483,GO:0006895,1,0.869609967863495,0,19,Golgi to endosome transport,BP,
3484,GO:0006896,1,0.909151439752458,0,14,Golgi to vacuole transport,BP,
3488,GO:0006901,1,0.652407296912736,0,66,vesicle coating,BP,
3489,GO:0006903,1,0.571853662140827,0,85,vesicle targeting,BP,
3492,GO:0006907,1,0.888199052084765,0,18,pinocytosis,BP,
3493,GO:0006909,1,0.245072856320789,0,218,phagocytosis,BP,
3494,GO:0006910,1,0.917349414380822,0,14,phagocytosis, recognition,BP,
3495,GO:0006911,1,0.759253740415764,0,44,phagocytosis, engulfment,BP,
3496,GO:0006913,1,0.119576631362665,0,324,nucleocytoplasmic transport,BP,
3500,GO:0006921,1,0.831207294726363,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3501,GO:0006924,1,0.946912869465961,0,9,activation-induced cell death of T cells,BP,
3502,GO:0006925,1,0.897743253684554,0,17,inflammatory cell apoptotic process,BP,
3504,GO:0006929,1,0.843236282087977,0,25,substrate-dependent cell migration,BP,
3505,GO:0006930,1,0.948878969154858,0,8,substrate-dependent cell migration, cell extension,BP,
3506,GO:0006931,1,0.974814396470419,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3507,GO:0006933,1,0.981775361384859,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3515,GO:0006948,1,0.992749534641708,0,1,induction by virus of host cell-cell fusion,BP,
3516,GO:0006949,1,0.776453791553778,0,38,syncytium formation,BP,
3522,GO:0006956,1,0.748749367608728,0,48,complement activation,BP,
3523,GO:0006957,1,0.936935719674027,0,10,complement activation, alternative pathway,BP,
3524,GO:0006958,1,0.849807677168689,0,26,complement activation, classical pathway,BP,
3526,GO:0006968,1,0.74985450522629,0,49,cellular defense response,BP,
3529,GO:0006972,1,0.87519184111892,0,20,hyperosmotic response,BP,
3530,GO:0006974,1,0.00741168607930217,0,745,cellular response to DNA damage stimulus,BP,
3531,GO:0006975,1,0.950767076542561,0,8,DNA damage induced protein phosphorylation,BP,
3532,GO:0006977,1,0.687261597322014,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3533,GO:0006978,1,0.888403056768068,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3535,GO:0006982,1,0.991282049299025,0,2,response to lipid hydroperoxide,BP,
3536,GO:0006983,1,0.932839625368564,0,10,ER overload response,BP,
3537,GO:0006984,1,0.759090162249514,0,42,ER-nucleus signaling pathway,BP,
3538,GO:0006986,1,0.335503333054129,0,170,response to unfolded protein,BP,
3539,GO:0006987,1,0.947852539015291,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3540,GO:0006990,1,0.982017245977798,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3541,GO:0006991,1,0.931666799897244,0,10,response to sterol depletion,BP,
3542,GO:0006995,1,0.943592005524054,0,11,cellular response to nitrogen starvation,BP,
3544,GO:0006997,1,0.415112368423135,0,132,nucleus organization,BP,
3545,GO:0006998,1,0.586079822566767,0,81,nuclear envelope organization,BP,
3546,GO:0006999,1,0.901825786107095,0,15,nuclear pore organization,BP,
3547,GO:0007000,1,0.954558983463248,0,7,nucleolus organization,BP,
3548,GO:0007004,1,0.653472955677377,0,65,telomere maintenance via telomerase,BP,
3551,GO:0007007,1,0.884910885658967,0,22,inner mitochondrial membrane organization,BP,
3552,GO:0007008,1,0.992592558685411,0,1,outer mitochondrial membrane organization,BP,
3555,GO:0007014,1,0.992515370007935,0,1,actin ubiquitination,BP,
3557,GO:0007016,1,0.925677405769015,0,10,cytoskeletal anchoring at plasma membrane,BP,
3561,GO:0007020,1,0.840578688770106,0,25,microtubule nucleation,BP,
3562,GO:0007021,1,0.966315809756598,0,7,tubulin complex assembly,BP,
3563,GO:0007023,1,0.979026599258285,0,4,post-chaperonin tubulin folding pathway,BP,
3565,GO:0007028,1,0.936744473592361,0,9,cytoplasm organization,BP,
3566,GO:0007029,1,0.733612435639674,0,46,endoplasmic reticulum organization,BP,
3567,GO:0007030,1,0.413676983872802,0,127,Golgi organization,BP,
3568,GO:0007031,1,0.824809910258673,0,31,peroxisome organization,BP,
3570,GO:0007033,1,0.368506066099221,0,152,vacuole organization,BP,
3572,GO:0007035,1,0.875536191884821,0,22,vacuolar acidification,BP,
3573,GO:0007039,1,0.913299309364106,0,14,protein catabolic process in the vacuole,BP,
3574,GO:0007040,1,0.689447839437673,0,58,lysosome organization,BP,
3576,GO:0007042,1,0.959366505461519,0,8,lysosomal lumen acidification,BP,
3577,GO:0007043,1,0.473147596412798,0,108,cell-cell junction assembly,BP,
3578,GO:0007044,1,0.536518741732395,0,87,cell-substrate junction assembly,BP,
3579,GO:0007045,1,0.60311164312098,0,71,cell-substrate adherens junction assembly,BP,
3581,GO:0007050,1,0.218622734822363,0,234,cell cycle arrest,BP,
3582,GO:0007051,1,0.333330227100332,0,162,spindle organization,BP,
3583,GO:0007052,1,0.490606446140422,0,106,mitotic spindle organization,BP,
3584,GO:0007056,1,0.988315434436656,0,2,spindle assembly involved in female meiosis,BP,
3585,GO:0007057,1,0.988315434436656,0,2,spindle assembly involved in female meiosis I,BP,
3586,GO:0007059,1,0.114730512330851,0,328,chromosome segregation,BP,
3587,GO:0007060,1,0.972840211734203,0,4,male meiosis chromosome segregation,BP,
3588,GO:0007062,1,0.448904835057547,0,123,sister chromatid cohesion,BP,
3589,GO:0007063,1,0.877824348975921,0,19,regulation of sister chromatid cohesion,BP,
3590,GO:0007064,1,0.880033229570485,0,19,mitotic sister chromatid cohesion,BP,
3591,GO:0007066,1,0.996218187345399,0,1,female meiosis sister chromatid cohesion,BP,
3592,GO:0007072,1,0.995097852422239,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3593,GO:0007076,1,0.890152953449949,0,16,mitotic chromosome condensation,BP,
3594,GO:0007077,1,0.756765209972069,0,42,mitotic nuclear envelope disassembly,BP,
3595,GO:0007079,1,0.977601679638521,0,3,mitotic chromosome movement towards spindle pole,BP,
3596,GO:0007080,1,0.757914667329052,0,44,mitotic metaphase plate congression,BP,
3597,GO:0007084,1,0.943502336491207,0,10,mitotic nuclear envelope reassembly,BP,
3598,GO:0007088,1,0.37250036887683,0,151,regulation of mitotic nuclear division,BP,
3599,GO:0007089,1,0.973141197779147,0,4,traversing start control point of mitotic cell cycle,BP,
3600,GO:0007091,1,0.717541431351863,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3601,GO:0007093,1,0.365669988048421,0,157,mitotic cell cycle checkpoint,BP,
3602,GO:0007094,1,0.819520675494568,0,31,mitotic spindle assembly checkpoint,BP,
3603,GO:0007095,1,0.875919024723009,0,19,mitotic G2 DNA damage checkpoint,BP,
3604,GO:0007096,1,0.905795330252792,0,16,regulation of exit from mitosis,BP,
3605,GO:0007097,1,0.869503492719097,0,19,nuclear migration,BP,
3606,GO:0007098,1,0.460873108516081,0,114,centrosome cycle,BP,
3607,GO:0007099,1,0.816529036899327,0,29,centriole replication,BP,
3608,GO:0007100,1,0.904859106160542,0,15,mitotic centrosome separation,BP,
3609,GO:0007113,1,0.984395069979788,0,3,endomitotic cell cycle,BP,
3610,GO:0007127,1,0.537107034012654,0,96,meiosis I,BP,
3611,GO:0007129,1,0.804625403914991,0,34,synapsis,BP,
3612,GO:0007130,1,0.903633250833497,0,16,synaptonemal complex assembly,BP,
3613,GO:0007131,1,0.748424216835554,0,44,reciprocal meiotic recombination,BP,
3614,GO:0007135,1,0.950582277888408,0,8,meiosis II,BP,
3615,GO:0007140,1,0.775411528771408,0,39,male meiotic nuclear division,BP,
3616,GO:0007141,1,0.895370445786008,0,18,male meiosis I,BP,
3617,GO:0007143,1,0.857584505616483,0,23,female meiotic nuclear division,BP,
3618,GO:0007144,1,0.95773670433527,0,7,female meiosis I,BP,
3619,GO:0007146,1,0.9930956730518,0,1,meiotic recombination nodule assembly,BP,
3620,GO:0007147,1,0.992526659677222,0,1,female meiosis II,BP,
3623,GO:0007156,1,0.50433139565,0,93,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3625,GO:0007158,1,0.890102179001543,0,16,neuron cell-cell adhesion,BP,
3627,GO:0007160,1,0.256972580849069,0,194,cell-matrix adhesion,BP,
3628,GO:0007161,1,0.969641046118435,0,4,calcium-independent cell-matrix adhesion,BP,
3629,GO:0007162,1,0.229089526690993,0,222,negative regulation of cell adhesion,BP,
3630,GO:0007163,1,0.259522528524725,0,196,establishment or maintenance of cell polarity,BP,
3631,GO:0007164,1,0.489558134166203,0,117,establishment of tissue polarity,BP,
3635,GO:0007168,1,0.972464461443609,0,5,receptor guanylyl cyclase signaling pathway,BP,
3637,GO:0007171,1,0.912418111391847,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3638,GO:0007172,1,0.947947827774867,0,8,signal complex assembly,BP,
3640,GO:0007174,1,0.994080688044968,0,1,epidermal growth factor catabolic process,BP,
3641,GO:0007175,1,0.913461969482196,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3644,GO:0007179,1,0.336329817246747,0,162,transforming growth factor beta receptor signaling pathway,BP,
3645,GO:0007181,1,0.980944350639386,0,3,transforming growth factor beta receptor complex assembly,BP,
3646,GO:0007182,1,0.959273740020248,0,6,common-partner SMAD protein phosphorylation,BP,
3647,GO:0007183,1,0.90994283639126,0,14,SMAD protein complex assembly,BP,
3648,GO:0007185,1,0.957262607555008,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3654,GO:0007191,1,0.942304341898863,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3656,GO:0007194,1,0.877342864886541,0,20,negative regulation of adenylate cyclase activity,BP,
3657,GO:0007195,1,0.961205905977764,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3658,GO:0007196,1,0.934261149037415,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3660,GO:0007198,1,0.978329021303608,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3661,GO:0007199,1,0.99341927840292,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3663,GO:0007202,1,0.867142526921694,0,22,activation of phospholipase C activity,BP,
3666,GO:0007206,1,0.984758251934212,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3668,GO:0007208,1,0.98521215496828,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3669,GO:0007210,1,0.926376280601961,0,13,serotonin receptor signaling pathway,BP,
3674,GO:0007216,1,0.898012499796987,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3675,GO:0007217,1,0.96426577810357,0,7,tachykinin receptor signaling pathway,BP,
3678,GO:0007220,1,0.889579244851021,0,17,Notch receptor processing,BP,
3679,GO:0007221,1,0.873800912037504,0,18,positive regulation of transcription of Notch receptor target,BP,
3681,GO:0007224,1,0.434453677550801,0,123,smoothened signaling pathway,BP,
3682,GO:0007225,1,0.992468207829124,0,1,patched ligand maturation,BP,
3683,GO:0007227,1,0.973084088413336,0,4,signal transduction downstream of smoothened,BP,
3684,GO:0007228,1,0.980437409374394,0,3,positive regulation of hh target transcription factor activity,BP,
3685,GO:0007229,1,0.521589202254254,0,94,integrin-mediated signaling pathway,BP,
3686,GO:0007231,1,0.982798717753185,0,3,osmosensory signaling pathway,BP,
3687,GO:0007249,1,0.209372285030565,0,241,I-kappaB kinase/NF-kappaB signaling,BP,
3689,GO:0007252,1,0.908459799305789,0,14,I-kappaB phosphorylation,BP,
3690,GO:0007253,1,0.962278058603521,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3691,GO:0007254,1,0.284970693214789,0,186,JNK cascade,BP,
3692,GO:0007256,1,0.955224806578538,0,6,activation of JNKK activity,BP,
3693,GO:0007257,1,0.797276700541392,0,32,activation of JUN kinase activity,BP,
3694,GO:0007258,1,0.973629202324759,0,4,JUN phosphorylation,BP,
3695,GO:0007259,1,0.448155664413896,0,125,JAK-STAT cascade,BP,
3696,GO:0007260,1,0.70194910801464,0,58,tyrosine phosphorylation of STAT protein,BP,
3704,GO:0007270,1,0.945915648188477,0,8,neuron-neuron synaptic transmission,BP,
3707,GO:0007274,1,0.848269907242644,0,25,neuromuscular synaptic transmission,BP,
3712,GO:0007284,1,0.98503310256961,0,2,spermatogonial cell division,BP,
3715,GO:0007289,1,0.913541837110379,0,14,spermatid nucleus differentiation,BP,
3716,GO:0007290,1,0.992466306792551,0,1,spermatid nucleus elongation,BP,
3717,GO:0007291,1,0.996168751565161,0,1,sperm individualization,BP,
3718,GO:0007292,1,0.501398351424666,0,105,female gamete generation,BP,
3719,GO:0007296,1,0.972245804517044,0,4,vitellogenesis,BP,
3720,GO:0007308,1,0.986027031806539,0,2,oocyte construction,BP,
3721,GO:0007309,1,0.986027031806539,0,2,oocyte axis specification,BP,
3722,GO:0007314,1,0.986027031806539,0,2,oocyte anterior/posterior axis specification,BP,
3723,GO:0007315,1,0.986027031806539,0,2,pole plasm assembly,BP,
3724,GO:0007320,1,0.938528250463216,0,10,insemination,BP,
3725,GO:0007338,1,0.545871401040996,0,101,single fertilization,BP,
3726,GO:0007339,1,0.865272068951418,0,25,binding of sperm to zona pellucida,BP,
3727,GO:0007340,1,0.857846509157053,0,26,acrosome reaction,BP,
3728,GO:0007341,1,0.970451607357547,0,6,penetration of zona pellucida,BP,
3729,GO:0007342,1,0.956450579197397,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3730,GO:0007343,1,0.9862609023551,0,2,egg activation,BP,
3731,GO:0007344,1,0.995045410378932,0,1,pronuclear fusion,BP,
3732,GO:0007346,1,0.0178969663657961,0,612,regulation of mitotic cell cycle,BP,
3733,GO:0007349,1,0.996168751565161,0,1,cellularization,BP,
3734,GO:0007350,1,0.904155215645416,0,15,blastoderm segmentation,BP,
3735,GO:0007351,1,0.92386565868184,0,12,tripartite regional subdivision,BP,
3736,GO:0007352,1,0.981515288758675,0,3,zygotic specification of dorsal/ventral axis,BP,
3737,GO:0007354,1,0.976450038813485,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3738,GO:0007356,1,0.983703487587683,0,3,thorax and anterior abdomen determination,BP,
3739,GO:0007368,1,0.488861905447631,0,108,determination of left/right symmetry,BP,
3740,GO:0007369,1,0.327203064654338,0,164,gastrulation,BP,
3741,GO:0007371,1,0.992512604166219,0,1,ventral midline determination,BP,
3742,GO:0007379,1,0.90876570468168,0,15,segment specification,BP,
3743,GO:0007386,1,0.966689138950461,0,5,compartment pattern specification,BP,
3744,GO:0007387,1,0.993202392167601,0,1,anterior compartment pattern formation,BP,
3745,GO:0007388,1,0.993202392167601,0,1,posterior compartment specification,BP,
3747,GO:0007398,1,0.880619999896049,0,18,ectoderm development,BP,
3749,GO:0007400,1,0.993608490836106,0,1,neuroblast fate determination,BP,
3750,GO:0007402,1,0.990167985385949,0,2,ganglion mother cell fate determination,BP,
3751,GO:0007403,1,0.992576808374421,0,1,glial cell fate determination,BP,
3752,GO:0007405,1,0.684656544660303,0,53,neuroblast proliferation,BP,
3753,GO:0007406,1,0.9644836614208,0,5,negative regulation of neuroblast proliferation,BP,
3756,GO:0007412,1,0.988521667775006,0,2,axon target recognition,BP,
3760,GO:0007418,1,0.972988481811754,0,4,ventral midline development,BP,
3764,GO:0007431,1,0.777476742430689,0,38,salivary gland development,BP,
3765,GO:0007435,1,0.79637742475701,0,34,salivary gland morphogenesis,BP,
3766,GO:0007439,1,0.986379989368734,0,2,ectodermal digestive tract development,BP,
3767,GO:0007440,1,0.930757950098862,0,10,foregut morphogenesis,BP,
3768,GO:0007442,1,0.952608234840621,0,7,hindgut morphogenesis,BP,
3769,GO:0007468,1,0.988003338435559,0,2,regulation of rhodopsin gene expression,BP,
3770,GO:0007492,1,0.599091630714643,0,76,endoderm development,BP,
3771,GO:0007493,1,0.986455034949907,0,2,endodermal cell fate determination,BP,
3772,GO:0007494,1,0.925690104412683,0,11,midgut development,BP,
3773,GO:0007495,1,0.992694680171535,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3774,GO:0007497,1,0.985005975978166,0,2,posterior midgut development,BP,
3775,GO:0007498,1,0.478328271105985,0,112,mesoderm development,BP,
3776,GO:0007499,1,0.992474793069835,0,1,ectoderm and mesoderm interaction,BP,
3777,GO:0007500,1,0.987928079199701,0,2,mesodermal cell fate determination,BP,
3778,GO:0007501,1,0.922914216332546,0,13,mesodermal cell fate specification,BP,
3779,GO:0007506,1,0.987042976920317,0,2,gonadal mesoderm development,BP,
3780,GO:0007507,1,0.0337696473199859,0,490,heart development,BP,
3781,GO:0007509,1,0.992318421825767,0,1,mesoderm migration involved in gastrulation,BP,
3782,GO:0007512,1,0.924555938353717,0,12,adult heart development,BP,
3784,GO:0007518,1,0.988780813135318,0,2,myoblast fate determination,BP,
3786,GO:0007520,1,0.827905202038891,0,29,myoblast fusion,BP,
3787,GO:0007521,1,0.984990579306166,0,2,muscle cell fate determination,BP,
3788,GO:0007522,1,0.992368948881377,0,1,visceral muscle development,BP,
3789,GO:0007525,1,0.984479967093424,0,2,somatic muscle development,BP,
3791,GO:0007529,1,0.985055990828548,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3792,GO:0007530,1,0.872923035960077,0,21,sex determination,BP,
3793,GO:0007538,1,0.984974817025799,0,2,primary sex determination,BP,
3794,GO:0007542,1,0.984974817025799,0,2,primary sex determination, germ-line,BP,
3796,GO:0007549,1,0.919210065402436,0,12,dosage compensation,BP,
3798,GO:0007566,1,0.766700360716416,0,42,embryo implantation,BP,
3799,GO:0007567,1,0.900455435845935,0,16,parturition,BP,
3801,GO:0007569,1,0.533141308405107,0,96,cell aging,BP,
3802,GO:0007571,1,0.996116978937686,0,1,age-dependent general metabolic decline,BP,
3803,GO:0007576,1,0.993477290746117,0,1,nucleolar fragmentation,BP,
3807,GO:0007588,1,0.72914000324635,0,50,excretion,BP,
3810,GO:0007596,1,0.148412116806472,0,292,blood coagulation,BP,
3811,GO:0007597,1,0.917812925006661,0,15,blood coagulation, intrinsic pathway,BP,
3812,GO:0007598,1,0.975727480122967,0,4,blood coagulation, extrinsic pathway,BP,
3813,GO:0007599,1,0.143956441410724,0,297,hemostasis,BP,
3816,GO:0007602,1,0.77333289240087,0,41,phototransduction,BP,
3817,GO:0007603,1,0.842377029178403,0,26,phototransduction, visible light,BP,
3819,GO:0007606,1,0.629177692178989,0,81,sensory perception of chemical stimulus,BP,
3820,GO:0007608,1,0.815984623139464,0,35,sensory perception of smell,BP,
3825,GO:0007614,1,0.945236452766178,0,9,short-term memory,BP,
3829,GO:0007619,1,0.980810924092389,0,3,courtship behavior,BP,
3831,GO:0007621,1,0.980049769216713,0,3,negative regulation of female receptivity,BP,
3832,GO:0007622,1,0.788355346472523,0,39,rhythmic behavior,BP,
3834,GO:0007624,1,0.992496753068908,0,1,ultradian rhythm,BP,
3835,GO:0007625,1,0.912691766794645,0,15,grooming behavior,BP,
3837,GO:0007628,1,0.837150141296209,0,26,adult walking behavior,BP,
3840,GO:0007634,1,0.993670504707627,0,1,optokinetic behavior,BP,
3842,GO:0007638,1,0.908846954921926,0,13,mechanosensory behavior,BP,
3844,GO:0008013,1,0.565562538612245,0,79,beta-catenin binding,MF,
3848,GO:0008020,1,0.956435807994128,0,8,G-protein coupled photoreceptor activity,MF,
3851,GO:0008023,1,0.721455330085075,0,48,transcription elongation factor complex,CC,
3852,GO:0008024,1,0.946005319468266,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3853,GO:0008026,1,0.526438098840757,0,91,ATP-dependent helicase activity,MF,
3854,GO:0008028,1,0.724996364856151,0,49,monocarboxylic acid transmembrane transporter activity,MF,
3855,GO:0008033,1,0.490753345673241,0,118,tRNA processing,BP,
3856,GO:0008035,1,0.959939904707687,0,7,high-density lipoprotein particle binding,MF,
3859,GO:0008043,1,0.992169278996121,0,2,intracellular ferritin complex,CC,
3860,GO:0008045,1,0.865230956700863,0,21,motor neuron axon guidance,BP,
3861,GO:0008046,1,0.950132861706506,0,7,axon guidance receptor activity,MF,
3863,GO:0008048,1,0.984765744449373,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3864,GO:0008049,1,0.994738914950931,0,1,male courtship behavior,BP,
3865,GO:0008050,1,0.985999093916227,0,2,female courtship behavior,BP,
3866,GO:0008052,1,0.996151239358703,0,1,sensory organ boundary specification,BP,
3867,GO:0008053,1,0.883237550081401,0,21,mitochondrial fusion,BP,
3868,GO:0008057,1,0.992242820359331,0,1,eye pigment granule organization,BP,
3870,GO:0008063,1,0.959066661895347,0,6,Toll signaling pathway,BP,
3871,GO:0008064,1,0.340024263068453,0,166,regulation of actin polymerization or depolymerization,BP,
3872,GO:0008065,1,0.98020410340628,0,3,establishment of blood-nerve barrier,BP,
3875,GO:0008073,1,0.987038576646368,0,3,ornithine decarboxylase inhibitor activity,MF,
3878,GO:0008078,1,0.984437058199882,0,3,mesodermal cell migration,BP,
3879,GO:0008079,1,0.960434839188947,0,6,translation termination factor activity,MF,
3880,GO:0008080,1,0.604110256793038,0,77,N-acetyltransferase activity,MF,
3883,GO:0008088,1,0.694225579405013,0,54,axo-dendritic transport,BP,
3884,GO:0008089,1,0.783691210400072,0,37,anterograde axonal transport,BP,
3885,GO:0008090,1,0.949211244010921,0,8,retrograde axonal transport,BP,
3886,GO:0008091,1,0.939348054797822,0,8,spectrin,CC,
3888,GO:0008093,1,0.921199183195208,0,12,cytoskeletal adaptor activity,MF,
3889,GO:0008094,1,0.583551745054184,0,78,DNA-dependent ATPase activity,MF,
3890,GO:0008097,1,0.953508146236968,0,10,5S rRNA binding,MF,
3892,GO:0008106,1,0.910274625810831,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3893,GO:0008107,1,0.99249363300448,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3894,GO:0008108,1,0.99570649754465,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3895,GO:0008109,1,0.985111748638362,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008111,1,0.994606558282605,0,1,alpha-methylacyl-CoA racemase activity,MF,
3897,GO:0008112,1,0.995341766142714,0,1,nicotinamide N-methyltransferase activity,MF,
3898,GO:0008113,1,0.991220445774434,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3899,GO:0008115,1,0.993720095530032,0,1,sarcosine oxidase activity,MF,
3900,GO:0008116,1,0.992401174963689,0,1,prostaglandin-I synthase activity,MF,
3901,GO:0008117,1,0.992386253683635,0,1,sphinganine-1-phosphate aldolase activity,MF,
3902,GO:0008118,1,0.994097927936679,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3903,GO:0008119,1,0.992655340042976,0,1,thiopurine S-methyltransferase activity,MF,
3904,GO:0008120,1,0.995246367791094,0,1,ceramide glucosyltransferase activity,MF,
3905,GO:0008121,1,0.967952468197725,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3906,GO:0008124,1,0.989957588420262,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3907,GO:0008126,1,0.993017721497802,0,1,acetylesterase activity,MF,
3908,GO:0008127,1,0.995761471711935,0,1,quercetin 2,3-dioxygenase activity,MF,
3909,GO:0008131,1,0.965091059428315,0,5,primary amine oxidase activity,MF,
3912,GO:0008137,1,0.85692298916998,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3913,GO:0008138,1,0.779627370329524,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3914,GO:0008139,1,0.855187017597039,0,22,nuclear localization sequence binding,MF,
3915,GO:0008140,1,0.9511348351159,0,8,cAMP response element binding protein binding,MF,
3916,GO:0008142,1,0.96518955191671,0,5,oxysterol binding,MF,
3917,GO:0008143,1,0.896223988707837,0,16,poly(A) binding,MF,
3920,GO:0008147,1,0.9931581694697,0,2,structural constituent of bone,MF,
3923,GO:0008154,1,0.294514407163982,0,187,actin polymerization or depolymerization,BP,
3924,GO:0008156,1,0.80439384600737,0,32,negative regulation of DNA replication,BP,
3925,GO:0008157,1,0.884014086709248,0,18,protein phosphatase 1 binding,MF,
3926,GO:0008158,1,0.981050770421145,0,3,hedgehog receptor activity,MF,
3927,GO:0008160,1,0.99335600463666,0,1,protein tyrosine phosphatase activator activity,MF,
3928,GO:0008168,1,0.306149675937431,0,181,methyltransferase activity,MF,
3929,GO:0008169,1,0.981613035170857,0,3,C-methyltransferase activity,MF,
3930,GO:0008170,1,0.585125128004308,0,81,N-methyltransferase activity,MF,
3931,GO:0008171,1,0.890719936711862,0,18,O-methyltransferase activity,MF,
3932,GO:0008172,1,0.962621448487092,0,6,S-methyltransferase activity,MF,
3933,GO:0008173,1,0.71955567665278,0,51,RNA methyltransferase activity,MF,
3934,GO:0008174,1,0.942718128332505,0,9,mRNA methyltransferase activity,MF,
3935,GO:0008175,1,0.837981890331809,0,27,tRNA methyltransferase activity,MF,
3936,GO:0008176,1,0.990793903881549,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3937,GO:0008177,1,0.97874865368541,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3938,GO:0008179,1,0.915306444867951,0,13,adenylate cyclase binding,MF,
3940,GO:0008184,1,0.978272257515747,0,3,glycogen phosphorylase activity,MF,
3941,GO:0008186,1,0.632708900298129,0,65,RNA-dependent ATPase activity,MF,
3942,GO:0008187,1,0.855257230111956,0,23,poly-pyrimidine tract binding,MF,
3944,GO:0008190,1,0.938826706491976,0,10,eukaryotic initiation factor 4E binding,MF,
3945,GO:0008191,1,0.913753253271442,0,15,metalloendopeptidase inhibitor activity,MF,
3946,GO:0008192,1,0.980853188140869,0,3,RNA guanylyltransferase activity,MF,
3947,GO:0008193,1,0.988282271684689,0,2,tRNA guanylyltransferase activity,MF,
3948,GO:0008194,1,0.457263338820566,0,118,UDP-glycosyltransferase activity,MF,
3949,GO:0008195,1,0.977425641070164,0,3,phosphatidate phosphatase activity,MF,
3950,GO:0008198,1,0.882120040232491,0,21,ferrous iron binding,MF,
3951,GO:0008199,1,0.967991582290724,0,6,ferric iron binding,MF,
3952,GO:0008200,1,0.825495211910859,0,31,ion channel inhibitor activity,MF,
3955,GO:0008203,1,0.461884785464113,0,118,cholesterol metabolic process,BP,
3956,GO:0008204,1,0.988639870376095,0,2,ergosterol metabolic process,BP,
3957,GO:0008206,1,0.762401204277308,0,42,bile acid metabolic process,BP,
3958,GO:0008207,1,0.842189881305166,0,29,C21-steroid hormone metabolic process,BP,
3959,GO:0008209,1,0.879789061260041,0,21,androgen metabolic process,BP,
3960,GO:0008210,1,0.89932092127973,0,18,estrogen metabolic process,BP,
3961,GO:0008211,1,0.891995256005682,0,19,glucocorticoid metabolic process,BP,
3962,GO:0008212,1,0.94585240112083,0,8,mineralocorticoid metabolic process,BP,
3963,GO:0008213,1,0.33157345648149,0,163,protein alkylation,BP,
3964,GO:0008214,1,0.806764504083567,0,29,protein dealkylation,BP,
3965,GO:0008215,1,0.964313087979874,0,7,spermine metabolic process,BP,
3966,GO:0008216,1,0.960752759947266,0,8,spermidine metabolic process,BP,
3968,GO:0008218,1,0.99255839226198,0,1,bioluminescence,BP,
3971,GO:0008228,1,0.956440031595437,0,7,opsonization,BP,
3973,GO:0008234,1,0.349583146248588,0,157,cysteine-type peptidase activity,MF,
3974,GO:0008235,1,0.698920453865692,0,54,metalloexopeptidase activity,MF,
3976,GO:0008237,1,0.336355470041499,0,160,metallopeptidase activity,MF,
3977,GO:0008238,1,0.538023015694228,0,94,exopeptidase activity,MF,
3978,GO:0008239,1,0.93377172751671,0,11,dipeptidyl-peptidase activity,MF,
3979,GO:0008240,1,0.977778470822434,0,3,tripeptidyl-peptidase activity,MF,
3980,GO:0008241,1,0.992600392373194,0,1,peptidyl-dipeptidase activity,MF,
3981,GO:0008242,1,0.945073273006933,0,9,omega peptidase activity,MF,
3982,GO:0008250,1,0.937007245567947,0,12,oligosaccharyltransferase complex,CC,
3983,GO:0008251,1,0.985566488822031,0,2,tRNA-specific adenosine deaminase activity,MF,
3984,GO:0008252,1,0.914360329278219,0,14,nucleotidase activity,MF,
3985,GO:0008253,1,0.92740997931869,0,12,5'-nucleotidase activity,MF,
3986,GO:0008254,1,0.992261827399625,0,1,3'-nucleotidase activity,MF,
3987,GO:0008260,1,0.987484873119311,0,2,3-oxoacid CoA-transferase activity,MF,
3988,GO:0008263,1,0.986313261807271,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3989,GO:0008265,1,0.993165469991438,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3990,GO:0008266,1,0.880877776227258,0,19,poly(U) RNA binding,MF,
3991,GO:0008267,1,0.99219497651956,0,1,poly-glutamine tract binding,MF,
3992,GO:0008269,1,0.988926337989612,0,2,JAK pathway signal transduction adaptor activity,MF,
3994,GO:0008271,1,0.930035367744933,0,10,secondary active sulfate transmembrane transporter activity,MF,
3995,GO:0008272,1,0.918334207111745,0,12,sulfate transport,BP,
3996,GO:0008273,1,0.971770285643533,0,4,calcium, potassium:sodium antiporter activity,MF,
3997,GO:0008274,1,0.950134385495982,0,7,gamma-tubulin ring complex,CC,
3998,GO:0008275,1,0.971029986727732,0,4,gamma-tubulin small complex,CC,
3999,GO:0008276,1,0.595889356410238,0,77,protein methyltransferase activity,MF,
4001,GO:0008278,1,0.931328745055795,0,10,cohesin complex,CC,
4002,GO:0008281,1,0.984977026570501,0,2,sulfonylurea receptor activity,MF,
4003,GO:0008282,1,0.971785737667597,0,4,inward rectifying potassium channel,CC,
4007,GO:0008286,1,0.455765437839817,0,118,insulin receptor signaling pathway,BP,
4008,GO:0008287,1,0.741578407248493,0,44,protein serine/threonine phosphatase complex,CC,
4010,GO:0008290,1,0.955983734333002,0,7,F-actin capping protein complex,CC,
4011,GO:0008291,1,0.979688417375389,0,3,acetylcholine metabolic process,BP,
4012,GO:0008292,1,0.993304539438279,0,1,acetylcholine biosynthetic process,BP,
4014,GO:0008295,1,0.977908459841901,0,4,spermidine biosynthetic process,BP,
4015,GO:0008296,1,0.94281167128797,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4016,GO:0008297,1,0.954311343794965,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4017,GO:0008298,1,0.928610020126468,0,12,intracellular mRNA localization,BP,
4018,GO:0008299,1,0.845697915992458,0,27,isoprenoid biosynthetic process,BP,
4019,GO:0008300,1,0.961153707531427,0,7,isoprenoid catabolic process,BP,
4020,GO:0008301,1,0.891624836615724,0,18,DNA binding, bending,MF,
4021,GO:0008305,1,0.791340443761761,0,32,integrin complex,CC,
4023,GO:0008307,1,0.76638601235976,0,41,structural constituent of muscle,MF,
4024,GO:0008308,1,0.915117600632921,0,14,voltage-gated anion channel activity,MF,
4025,GO:0008309,1,0.977021061305368,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4026,GO:0008310,1,0.968032788738519,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4027,GO:0008311,1,0.990103758005212,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4028,GO:0008312,1,0.962478215206927,0,7,7S RNA binding,MF,
4029,GO:0008318,1,0.956701443530534,0,7,protein prenyltransferase activity,MF,
4030,GO:0008320,1,0.936211206398094,0,13,protein transmembrane transporter activity,MF,
4031,GO:0008321,1,0.978375261447209,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4033,GO:0008327,1,0.906540452245821,0,15,methyl-CpG binding,MF,
4035,GO:0008329,1,0.918337323465975,0,14,signaling pattern recognition receptor activity,MF,
4036,GO:0008330,1,0.976845557608081,0,4,protein tyrosine/threonine phosphatase activity,MF,
4037,GO:0008331,1,0.914556957869622,0,12,high voltage-gated calcium channel activity,MF,
4038,GO:0008332,1,0.971448975056196,0,4,low voltage-gated calcium channel activity,MF,
4040,GO:0008334,1,0.86658883720728,0,24,histone mRNA metabolic process,BP,
4041,GO:0008336,1,0.994774271506862,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4042,GO:0008340,1,0.923362472609806,0,11,determination of adult lifespan,BP,
4043,GO:0008343,1,0.964197238645374,0,7,adult feeding behavior,BP,
4045,GO:0008347,1,0.780532499053909,0,38,glial cell migration,BP,
4046,GO:0008348,1,0.992521158735778,0,1,negative regulation of antimicrobial humoral response,BP,
4047,GO:0008349,1,0.922925912071219,0,11,MAP kinase kinase kinase kinase activity,MF,
4048,GO:0008352,1,0.993281785686216,0,1,katanin complex,CC,
4049,GO:0008353,1,0.910391690515578,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4050,GO:0008354,1,0.952694706037225,0,7,germ cell migration,BP,
4052,GO:0008356,1,0.885506128396557,0,18,asymmetric cell division,BP,
4053,GO:0008358,1,0.986027031806539,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4054,GO:0008360,1,0.350532061042388,0,154,regulation of cell shape,BP,
4058,GO:0008374,1,0.774475900809545,0,37,O-acyltransferase activity,MF,
4059,GO:0008375,1,0.705658906893732,0,53,acetylglucosaminyltransferase activity,MF,
4060,GO:0008376,1,0.738917841833314,0,44,acetylgalactosaminyltransferase activity,MF,
4061,GO:0008378,1,0.820610165071259,0,31,galactosyltransferase activity,MF,
4062,GO:0008379,1,0.980357101382973,0,5,thioredoxin peroxidase activity,MF,
4064,GO:0008381,1,0.940585891580329,0,9,mechanosensitive ion channel activity,MF,
4065,GO:0008384,1,0.985101766438393,0,2,IkappaB kinase activity,MF,
4066,GO:0008385,1,0.944798588920329,0,9,IkappaB kinase complex,CC,
4067,GO:0008386,1,0.994612580195461,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4068,GO:0008387,1,0.993987835832886,0,1,steroid 7-alpha-hydroxylase activity,MF,
4069,GO:0008389,1,0.990073142622504,0,2,coumarin 7-hydroxylase activity,MF,
4070,GO:0008391,1,0.958090174189681,0,8,arachidonic acid monooxygenase activity,MF,
4071,GO:0008392,1,0.958090174189681,0,8,arachidonic acid epoxygenase activity,MF,
4072,GO:0008395,1,0.880075189838711,0,22,steroid hydroxylase activity,MF,
4073,GO:0008396,1,0.987781699808102,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4074,GO:0008397,1,0.99250159893432,0,1,sterol 12-alpha-hydroxylase activity,MF,
4075,GO:0008398,1,0.992775972610841,0,1,sterol 14-demethylase activity,MF,
4076,GO:0008401,1,0.980134753841702,0,3,retinoic acid 4-hydroxylase activity,MF,
4077,GO:0008403,1,0.992702287084678,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4078,GO:0008404,1,0.994832671464641,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4079,GO:0008405,1,0.994832671464641,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4081,GO:0008408,1,0.735035046126931,0,48,3'-5' exonuclease activity,MF,
4082,GO:0008409,1,0.892550348669385,0,16,5'-3' exonuclease activity,MF,
4083,GO:0008410,1,0.975663568035823,0,4,CoA-transferase activity,MF,
4084,GO:0008413,1,0.990992087852615,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4085,GO:0008417,1,0.919960099692532,0,12,fucosyltransferase activity,MF,
4086,GO:0008418,1,0.996005864466437,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4087,GO:0008419,1,0.993296377384215,0,1,RNA lariat debranching enzyme activity,MF,
4088,GO:0008420,1,0.949977788492905,0,8,CTD phosphatase activity,MF,
4089,GO:0008422,1,0.97465928298252,0,4,beta-glucosidase activity,MF,
4090,GO:0008424,1,0.99263407243923,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4091,GO:0008425,1,0.995807011225709,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4092,GO:0008426,1,0.984597355799977,0,3,protein kinase C inhibitor activity,MF,
4093,GO:0008427,1,0.985767478868869,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4094,GO:0008428,1,0.980162071582913,0,3,ribonuclease inhibitor activity,MF,
4095,GO:0008429,1,0.951284978670763,0,9,phosphatidylethanolamine binding,MF,
4097,GO:0008431,1,0.986172752933747,0,2,vitamin E binding,MF,
4098,GO:0008432,1,0.949579491309779,0,8,JUN kinase binding,MF,
4099,GO:0008434,1,0.992470006950484,0,1,calcitriol receptor activity,MF,
4100,GO:0008437,1,0.994545112371257,0,1,thyrotropin-releasing hormone activity,MF,
4101,GO:0008440,1,0.967808615189736,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4102,GO:0008441,1,0.985939668613353,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4103,GO:0008442,1,0.994597517599788,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4104,GO:0008443,1,0.9522281932321,0,7,phosphofructokinase activity,MF,
4105,GO:0008444,1,0.994159949389673,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4106,GO:0008445,1,0.995270104706776,0,1,D-aspartate oxidase activity,MF,
4107,GO:0008446,1,0.995170443075178,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4108,GO:0008448,1,0.994879826578492,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4109,GO:0008449,1,0.977500516554188,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4110,GO:0008452,1,0.9930956730518,0,1,RNA ligase activity,MF,
4111,GO:0008453,1,0.981599585858734,0,3,alanine-glyoxylate transaminase activity,MF,
4112,GO:0008454,1,0.980411042667421,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4113,GO:0008455,1,0.993210827817845,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4114,GO:0008456,1,0.992513861620335,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4115,GO:0008457,1,0.99249750382539,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4116,GO:0008458,1,0.992654224949752,0,1,carnitine O-octanoyltransferase activity,MF,
4117,GO:0008459,1,0.986261450243759,0,2,chondroitin 6-sulfotransferase activity,MF,
4118,GO:0008460,1,0.994738914950931,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4119,GO:0008465,1,0.995843621414349,0,1,glycerate dehydrogenase activity,MF,
4120,GO:0008466,1,0.987575043563871,0,2,glycogenin glucosyltransferase activity,MF,
4121,GO:0008467,1,0.963707420089018,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4122,GO:0008469,1,0.945045058524624,0,9,histone-arginine N-methyltransferase activity,MF,
4123,GO:0008470,1,0.992475493298774,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4124,GO:0008474,1,0.940640826307706,0,10,palmitoyl-(protein) hydrolase activity,MF,
4125,GO:0008475,1,0.978335765916307,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4126,GO:0008476,1,0.989140739072603,0,2,protein-tyrosine sulfotransferase activity,MF,
4127,GO:0008478,1,0.992248191262378,0,1,pyridoxal kinase activity,MF,
4128,GO:0008479,1,0.980476172237732,0,4,queuine tRNA-ribosyltransferase activity,MF,
4129,GO:0008480,1,0.992623517359629,0,1,sarcosine dehydrogenase activity,MF,
4130,GO:0008481,1,0.987738330223016,0,2,sphinganine kinase activity,MF,
4131,GO:0008482,1,0.993878111687654,0,1,sulfite oxidase activity,MF,
4133,GO:0008484,1,0.893852622570558,0,16,sulfuric ester hydrolase activity,MF,
4134,GO:0008486,1,0.976709538622527,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4135,GO:0008488,1,0.992703967315673,0,1,gamma-glutamyl carboxylase activity,MF,
4136,GO:0008489,1,0.992945762084722,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4137,GO:0008493,1,0.994825894207195,0,1,tetracycline transmembrane transporter activity,MF,
4138,GO:0008494,1,0.931823792059156,0,11,translation activator activity,MF,
4139,GO:0008495,1,0.992843041620907,0,1,protoheme IX farnesyltransferase activity,MF,
4140,GO:0008496,1,0.992493165986531,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4141,GO:0008499,1,0.924469212359179,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4142,GO:0008502,1,0.978445309624837,0,4,melatonin receptor activity,MF,
4144,GO:0008504,1,0.945550300939514,0,8,monoamine transmembrane transporter activity,MF,
4145,GO:0008506,1,0.979401557966769,0,3,sucrose:proton symporter activity,MF,
4146,GO:0008507,1,0.992534662855244,0,1,sodium:iodide symporter activity,MF,
4147,GO:0008508,1,0.980440418062591,0,4,bile acid:sodium symporter activity,MF,
4150,GO:0008511,1,0.984817646877803,0,2,sodium:potassium:chloride symporter activity,MF,
4151,GO:0008513,1,0.987728352322778,0,2,secondary active organic cation transmembrane transporter activity,MF,
4153,GO:0008515,1,0.979401557966769,0,3,sucrose transmembrane transporter activity,MF,
4154,GO:0008517,1,0.96333861663593,0,6,folic acid transmembrane transporter activity,MF,
4155,GO:0008518,1,0.993022823484038,0,1,reduced folate carrier activity,MF,
4156,GO:0008519,1,0.839988387484771,0,27,ammonium transmembrane transporter activity,MF,
4157,GO:0008520,1,0.992283750874609,0,1,L-ascorbate:sodium symporter activity,MF,
4158,GO:0008521,1,0.993283400584553,0,1,acetyl-CoA transmembrane transporter activity,MF,
4159,GO:0008523,1,0.992626888281478,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4160,GO:0008525,1,0.945425425252905,0,8,phosphatidylcholine transporter activity,MF,
4161,GO:0008526,1,0.944956278982223,0,8,phosphatidylinositol transporter activity,MF,
4162,GO:0008527,1,0.93466411802898,0,14,taste receptor activity,MF,
4164,GO:0008531,1,0.993210827817845,0,1,riboflavin kinase activity,MF,
4165,GO:0008532,1,0.950996751617003,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4166,GO:0008534,1,0.982097205905123,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4167,GO:0008535,1,0.866886831683076,0,24,respiratory chain complex IV assembly,BP,
4168,GO:0008536,1,0.794610185199426,0,33,Ran GTPase binding,MF,
4169,GO:0008537,1,0.985127356291315,0,3,proteasome activator complex,CC,
4170,GO:0008540,1,0.937709448013475,0,12,proteasome regulatory particle, base subcomplex,CC,
4171,GO:0008541,1,0.966164936524926,0,7,proteasome regulatory particle, lid subcomplex,CC,
4173,GO:0008543,1,0.525136919586596,0,98,fibroblast growth factor receptor signaling pathway,BP,
4174,GO:0008544,1,0.167041992512144,0,272,epidermis development,BP,
4175,GO:0008545,1,0.985161862576419,0,2,JUN kinase kinase activity,MF,
4176,GO:0008553,1,0.920473130701404,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4177,GO:0008554,1,0.992464831005232,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4178,GO:0008555,1,0.992420746762804,0,1,chloride-transporting ATPase activity,MF,
4179,GO:0008556,1,0.929942792626063,0,11,potassium-transporting ATPase activity,MF,
4180,GO:0008559,1,0.955545764575267,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4181,GO:0008565,1,0.620410282634747,0,77,protein transporter activity,MF,
4182,GO:0008568,1,0.933092031247505,0,10,microtubule-severing ATPase activity,MF,
4183,GO:0008569,1,0.87205257155268,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4184,GO:0008574,1,0.810124438350349,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4185,GO:0008579,1,0.992428372504378,0,1,JUN kinase phosphatase activity,MF,
4186,GO:0008582,1,0.970991448361767,0,4,regulation of synaptic growth at neuromuscular junction,BP,
4187,GO:0008584,1,0.462840127982102,0,116,male gonad development,BP,
4189,GO:0008589,1,0.605398563082042,0,72,regulation of smoothened signaling pathway,BP,
4190,GO:0008591,1,0.994941551134375,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4191,GO:0008592,1,0.992661572531617,0,1,regulation of Toll signaling pathway,BP,
4193,GO:0008594,1,0.985054320379573,0,2,photoreceptor cell morphogenesis,BP,
4194,GO:0008595,1,0.92386565868184,0,12,anterior/posterior axis specification, embryo,BP,
4195,GO:0008597,1,0.981610500946274,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4196,GO:0008603,1,0.956909314484173,0,7,cAMP-dependent protein kinase regulator activity,MF,
4197,GO:0008607,1,0.980860586057904,0,3,phosphorylase kinase regulator activity,MF,
4198,GO:0008608,1,0.823474309448268,0,30,attachment of spindle microtubules to kinetochore,BP,
4199,GO:0008609,1,0.992223594317153,0,1,alkylglycerone-phosphate synthase activity,MF,
4201,GO:0008611,1,0.969397850828601,0,5,ether lipid biosynthetic process,BP,
4202,GO:0008612,1,0.979007271466019,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4203,GO:0008614,1,0.986915830226218,0,2,pyridoxine metabolic process,BP,
4204,GO:0008615,1,0.986915830226218,0,2,pyridoxine biosynthetic process,BP,
4205,GO:0008616,1,0.984704669278013,0,3,queuosine biosynthetic process,BP,
4206,GO:0008617,1,0.996131220855828,0,1,guanosine metabolic process,BP,
4207,GO:0008622,1,0.971704388890454,0,5,epsilon DNA polymerase complex,CC,
4208,GO:0008623,1,0.986112607733974,0,2,CHRAC,CC,
4209,GO:0008625,1,0.618635848116319,0,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,
4210,GO:0008626,1,0.969966760396197,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4211,GO:0008627,1,0.949005394133459,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4212,GO:0008628,1,0.985499858643243,0,3,hormone-mediated apoptotic signaling pathway,BP,
4213,GO:0008630,1,0.546284270666585,0,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
4214,GO:0008631,1,0.765723674577344,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4215,GO:0008635,1,0.945889100126454,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4217,GO:0008641,1,0.934568805969461,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4218,GO:0008643,1,0.423248781973242,0,127,carbohydrate transport,BP,
4219,GO:0008645,1,0.519423742314,0,96,hexose transmembrane transport,BP,
4220,GO:0008649,1,0.913726723814981,0,15,rRNA methyltransferase activity,MF,
4221,GO:0008650,1,0.99253705953421,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4223,GO:0008654,1,0.174743236926563,0,263,phospholipid biosynthetic process,BP,
4224,GO:0008655,1,0.936810372551704,0,12,pyrimidine-containing compound salvage,BP,
4225,GO:0008656,1,0.916479208433457,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4226,GO:0008670,1,0.991165242968912,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4227,GO:0008689,1,0.995807011225709,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4228,GO:0008700,1,0.9930956730518,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4229,GO:0008705,1,0.991990801598826,0,1,methionine synthase activity,MF,
4230,GO:0008709,1,0.996201642158946,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4231,GO:0008721,1,0.993597334811366,0,1,D-serine ammonia-lyase activity,MF,
4232,GO:0008725,1,0.996040653319932,0,1,DNA-3-methyladenine glycosylase activity,MF,
4233,GO:0008732,1,0.987738414708503,0,2,L-allo-threonine aldolase activity,MF,
4234,GO:0008745,1,0.996202214779005,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4235,GO:0008746,1,0.988546320375375,0,2,NAD(P)+ transhydrogenase activity,MF,
4236,GO:0008747,1,0.995369587248448,0,1,N-acetylneuraminate lyase activity,MF,
4237,GO:0008750,1,0.992472498259577,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4238,GO:0008753,1,0.992567940002861,0,1,NADPH dehydrogenase (quinone) activity,MF,
4239,GO:0008757,1,0.421630858404966,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
4240,GO:0008761,1,0.992427058729524,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4241,GO:0008768,1,0.996298533774494,0,1,UDP-sugar diphosphatase activity,MF,
4242,GO:0008775,1,0.994899875712745,0,1,acetate CoA-transferase activity,MF,
4243,GO:0008781,1,0.990915334281001,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4244,GO:0008783,1,0.994151802981525,0,1,agmatinase activity,MF,
4245,GO:0008785,1,0.995359800673115,0,1,alkyl hydroperoxide reductase activity,MF,
4246,GO:0008792,1,0.9930956730518,0,1,arginine decarboxylase activity,MF,
4247,GO:0008794,1,0.996247543640063,0,1,arsenate reductase (glutaredoxin) activity,MF,
4248,GO:0008796,1,0.989316189358492,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4249,GO:0008798,1,0.986223745822892,0,2,beta-aspartyl-peptidase activity,MF,
4250,GO:0008802,1,0.992538933289659,0,1,betaine-aldehyde dehydrogenase activity,MF,
4251,GO:0008803,1,0.9961582611186,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4252,GO:0008808,1,0.992507882206926,0,1,cardiolipin synthase activity,MF,
4253,GO:0008812,1,0.992524318051586,0,1,choline dehydrogenase activity,MF,
4254,GO:0008817,1,0.992496924427464,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4255,GO:0008821,1,0.952434906043602,0,8,crossover junction endodeoxyribonuclease activity,MF,
4256,GO:0008823,1,0.966579644020943,0,5,cupric reductase activity,MF,
4257,GO:0008829,1,0.994907487051213,0,1,dCTP deaminase activity,MF,
4258,GO:0008832,1,0.992685056253613,0,1,dGTPase activity,MF,
4259,GO:0008841,1,0.993576982081585,0,1,dihydrofolate synthase activity,MF,
4260,GO:0008843,1,0.993919811159171,0,1,endochitinase activity,MF,
4261,GO:0008852,1,0.993030540161847,0,1,exodeoxyribonuclease I activity,MF,
4262,GO:0008853,1,0.977994594956918,0,4,exodeoxyribonuclease III activity,MF,
4263,GO:0008859,1,0.996196481795283,0,1,exoribonuclease II activity,MF,
4264,GO:0008865,1,0.964034925878364,0,5,fructokinase activity,MF,
4265,GO:0008887,1,0.992662147519201,0,1,glycerate kinase activity,MF,
4266,GO:0008889,1,0.965079289032421,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4267,GO:0008890,1,0.995328574556727,0,1,glycine C-acetyltransferase activity,MF,
4268,GO:0008891,1,0.995041759703579,0,1,glycolate oxidase activity,MF,
4270,GO:0008893,1,0.99609423804275,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4271,GO:0008894,1,0.993163986079041,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4272,GO:0008897,1,0.992993947212347,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4273,GO:0008900,1,0.985126850594624,0,2,potassium:proton exchanging ATPase activity,MF,
4274,GO:0008903,1,0.996012116899999,0,1,hydroxypyruvate isomerase activity,MF,
4275,GO:0008905,1,0.995293641349122,0,1,mannose-phosphate guanylyltransferase activity,MF,
4276,GO:0008934,1,0.973294089222002,0,4,inositol monophosphate 1-phosphatase activity,MF,
4277,GO:0008940,1,0.978833526665864,0,3,nitrate reductase activity,MF,
4278,GO:0008941,1,0.988233726834153,0,2,nitric oxide dioxygenase activity,MF,
4279,GO:0008948,1,0.974539161138458,0,4,oxaloacetate decarboxylase activity,MF,
4280,GO:0008955,1,0.992501332759201,0,1,peptidoglycan glycosyltransferase activity,MF,
4281,GO:0008962,1,0.987993033241719,0,2,phosphatidylglycerophosphatase activity,MF,
4282,GO:0008963,1,0.994259943745572,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4283,GO:0008967,1,0.987282916977313,0,2,phosphoglycolate phosphatase activity,MF,
4284,GO:0008970,1,0.946698049261254,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4285,GO:0008973,1,0.992657023081578,0,1,phosphopentomutase activity,MF,
4286,GO:0008988,1,0.986238532970005,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4287,GO:0008995,1,0.99339854533039,0,1,ribonuclease E activity,MF,
4288,GO:0009000,1,0.99362342400942,0,1,selenocysteine lyase activity,MF,
4289,GO:0009007,1,0.992519826340834,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4290,GO:0009008,1,0.966196938026738,0,5,DNA-methyltransferase activity,MF,
4291,GO:0009013,1,0.99243882233873,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4292,GO:0009019,1,0.972011309801253,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4293,GO:0009020,1,0.994637624686316,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4294,GO:0009032,1,0.995198286271971,0,1,thymidine phosphorylase activity,MF,
4295,GO:0009041,1,0.981939562064391,0,3,uridylate kinase activity,MF,
4296,GO:0009048,1,0.929511000175282,0,10,dosage compensation by inactivation of X chromosome,BP,
4297,GO:0009051,1,0.984715520837191,0,3,pentose-phosphate shunt, oxidative branch,BP,
4298,GO:0009052,1,0.971814243247033,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4299,GO:0009055,1,0.592478863370842,0,101,electron transfer activity,MF,
4304,GO:0009060,1,0.664776124450028,0,74,aerobic respiration,BP,
4305,GO:0009061,1,0.993754774569947,0,1,anaerobic respiration,BP,
4311,GO:0009067,1,0.86732377856787,0,22,aspartate family amino acid biosynthetic process,BP,
4313,GO:0009069,1,0.803218391289054,0,36,serine family amino acid metabolic process,BP,
4314,GO:0009070,1,0.914412312901463,0,15,serine family amino acid biosynthetic process,BP,
4315,GO:0009071,1,0.9420587981598,0,11,serine family amino acid catabolic process,BP,
4316,GO:0009072,1,0.883190976519933,0,23,aromatic amino acid family metabolic process,BP,
4317,GO:0009074,1,0.909502948671243,0,18,aromatic amino acid family catabolic process,BP,
4318,GO:0009078,1,0.978050383175467,0,4,pyruvate family amino acid metabolic process,BP,
4319,GO:0009080,1,0.978050383175467,0,4,pyruvate family amino acid catabolic process,BP,
4323,GO:0009084,1,0.895905164243542,0,17,glutamine family amino acid biosynthetic process,BP,
4324,GO:0009085,1,0.98542335947449,0,2,lysine biosynthetic process,BP,
4325,GO:0009086,1,0.927409172172205,0,12,methionine biosynthetic process,BP,
4326,GO:0009087,1,0.992583515143324,0,1,methionine catabolic process,BP,
4327,GO:0009088,1,0.994321248875851,0,1,threonine biosynthetic process,BP,
4328,GO:0009092,1,0.97669672495134,0,4,homoserine metabolic process,BP,
4329,GO:0009093,1,0.984042160250489,0,3,cysteine catabolic process,BP,
4334,GO:0009106,1,0.987743010244403,0,2,lipoate metabolic process,BP,
4335,GO:0009107,1,0.995173064841884,0,1,lipoate biosynthetic process,BP,
4336,GO:0009108,1,0.24056092898079,0,221,coenzyme biosynthetic process,BP,
4337,GO:0009109,1,0.922936302250917,0,14,coenzyme catabolic process,BP,
4338,GO:0009110,1,0.876249387399815,0,21,vitamin biosynthetic process,BP,
4339,GO:0009111,1,0.942841201232266,0,10,vitamin catabolic process,BP,
4341,GO:0009113,1,0.922697769262617,0,13,purine nucleobase biosynthetic process,BP,
4342,GO:0009115,1,0.984899167110373,0,2,xanthine catabolic process,BP,
4343,GO:0009116,1,0.503448117579766,0,113,nucleoside metabolic process,BP,
4345,GO:0009119,1,0.561723678475604,0,94,ribonucleoside metabolic process,BP,
4346,GO:0009120,1,0.967543428224344,0,6,deoxyribonucleoside metabolic process,BP,
4347,GO:0009123,1,0.161677931773518,0,304,nucleoside monophosphate metabolic process,BP,
4348,GO:0009124,1,0.365104967167473,0,159,nucleoside monophosphate biosynthetic process,BP,
4349,GO:0009125,1,0.938681716449439,0,11,nucleoside monophosphate catabolic process,BP,
4350,GO:0009126,1,0.188425374719071,0,278,purine nucleoside monophosphate metabolic process,BP,
4351,GO:0009127,1,0.415399130649896,0,137,purine nucleoside monophosphate biosynthetic process,BP,
4352,GO:0009128,1,0.949653221278274,0,9,purine nucleoside monophosphate catabolic process,BP,
4353,GO:0009129,1,0.912710235682148,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4354,GO:0009130,1,0.917000758342913,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009131,1,0.995325266673793,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4356,GO:0009132,1,0.42007793445209,0,134,nucleoside diphosphate metabolic process,BP,
4357,GO:0009133,1,0.966181321502681,0,6,nucleoside diphosphate biosynthetic process,BP,
4358,GO:0009134,1,0.964585931585495,0,6,nucleoside diphosphate catabolic process,BP,
4359,GO:0009135,1,0.471523952071572,0,113,purine nucleoside diphosphate metabolic process,BP,
4360,GO:0009136,1,0.982759699621465,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009137,1,0.982289802380317,0,3,purine nucleoside diphosphate catabolic process,BP,
4362,GO:0009138,1,0.981851910730671,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4363,GO:0009139,1,0.988861019818926,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009140,1,0.992912744500514,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4365,GO:0009141,1,0.181296405731453,0,289,nucleoside triphosphate metabolic process,BP,
4366,GO:0009142,1,0.40642106115001,0,143,nucleoside triphosphate biosynthetic process,BP,
4367,GO:0009143,1,0.932573871477661,0,12,nucleoside triphosphate catabolic process,BP,
4368,GO:0009144,1,0.204726357946856,0,269,purine nucleoside triphosphate metabolic process,BP,
4369,GO:0009145,1,0.450928303011174,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009146,1,0.967875317465884,0,6,purine nucleoside triphosphate catabolic process,BP,
4371,GO:0009147,1,0.897306084853869,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4372,GO:0009148,1,0.911720407219231,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009149,1,0.990831349678872,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4375,GO:0009151,1,0.945160608207858,0,10,purine deoxyribonucleotide metabolic process,BP,
4377,GO:0009153,1,0.983222355845678,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4378,GO:0009154,1,0.813339261737062,0,31,purine ribonucleotide catabolic process,BP,
4379,GO:0009155,1,0.971741349698792,0,5,purine deoxyribonucleotide catabolic process,BP,
4380,GO:0009156,1,0.386019151839526,0,149,ribonucleoside monophosphate biosynthetic process,BP,
4381,GO:0009157,1,0.951845666357533,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4382,GO:0009158,1,0.953456152043272,0,8,ribonucleoside monophosphate catabolic process,BP,
4383,GO:0009159,1,0.988452887858344,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4384,GO:0009161,1,0.175707509894734,0,289,ribonucleoside monophosphate metabolic process,BP,
4385,GO:0009162,1,0.937230139696527,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4386,GO:0009163,1,0.797012640062199,0,41,nucleoside biosynthetic process,BP,
4387,GO:0009164,1,0.859019396396162,0,27,nucleoside catabolic process,BP,
4390,GO:0009167,1,0.189192542131659,0,277,purine ribonucleoside monophosphate metabolic process,BP,
4391,GO:0009168,1,0.415399130649896,0,137,purine ribonucleoside monophosphate biosynthetic process,BP,
4392,GO:0009169,1,0.953456152043272,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4393,GO:0009170,1,0.996155923041539,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4394,GO:0009173,1,0.941673995289347,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4395,GO:0009174,1,0.941673995289347,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4396,GO:0009176,1,0.969260847571235,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009177,1,0.973814402324104,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4398,GO:0009178,1,0.995325266673793,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4399,GO:0009179,1,0.471523952071572,0,113,purine ribonucleoside diphosphate metabolic process,BP,
4400,GO:0009180,1,0.982759699621465,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4401,GO:0009181,1,0.982289802380317,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4402,GO:0009182,1,0.981889413823604,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4403,GO:0009183,1,0.98871662455909,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009185,1,0.466215051355611,0,115,ribonucleoside diphosphate metabolic process,BP,
4405,GO:0009186,1,0.97095013722607,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4407,GO:0009188,1,0.982759699621465,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4408,GO:0009189,1,0.977702060340793,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4410,GO:0009191,1,0.971312258725803,0,5,ribonucleoside diphosphate catabolic process,BP,
4411,GO:0009193,1,0.992912744500514,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4412,GO:0009195,1,0.992912744500514,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4413,GO:0009196,1,0.988861019818926,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4414,GO:0009197,1,0.988861019818926,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4415,GO:0009199,1,0.20490363113042,0,268,ribonucleoside triphosphate metabolic process,BP,
4416,GO:0009200,1,0.917714565315106,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4417,GO:0009201,1,0.436748837124327,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4418,GO:0009202,1,0.967862257252507,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4419,GO:0009203,1,0.99602270581164,0,1,ribonucleoside triphosphate catabolic process,BP,
4420,GO:0009204,1,0.962829194315703,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4421,GO:0009205,1,0.212809672192621,0,262,purine ribonucleoside triphosphate metabolic process,BP,
4422,GO:0009206,1,0.453468290161994,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4423,GO:0009207,1,0.99602270581164,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4424,GO:0009208,1,0.924077582197836,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009209,1,0.930303337279038,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009211,1,0.971051983617837,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4427,GO:0009212,1,0.980039467083523,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4428,GO:0009213,1,0.990831349678872,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4429,GO:0009214,1,0.863059089804631,0,20,cyclic nucleotide catabolic process,BP,
4430,GO:0009215,1,0.95227546479584,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4431,GO:0009216,1,0.987577318729289,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4432,GO:0009217,1,0.971741349698792,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4433,GO:0009218,1,0.87730832352663,0,23,pyrimidine ribonucleotide metabolic process,BP,
4434,GO:0009219,1,0.905965923933348,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4435,GO:0009220,1,0.889533988972351,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4436,GO:0009221,1,0.958854049934143,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4437,GO:0009222,1,0.992912744500514,0,1,pyrimidine ribonucleotide catabolic process,BP,
4438,GO:0009223,1,0.939956281550281,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4439,GO:0009224,1,0.995834185229467,0,1,CMP biosynthetic process,BP,
4440,GO:0009225,1,0.802261294239134,0,36,nucleotide-sugar metabolic process,BP,
4441,GO:0009226,1,0.873880598127251,0,23,nucleotide-sugar biosynthetic process,BP,
4442,GO:0009227,1,0.982905052661555,0,3,nucleotide-sugar catabolic process,BP,
4443,GO:0009229,1,0.993826867711281,0,1,thiamine diphosphate biosynthetic process,BP,
4444,GO:0009231,1,0.993210827817845,0,1,riboflavin biosynthetic process,BP,
4445,GO:0009233,1,0.985268136579741,0,2,menaquinone metabolic process,BP,
4446,GO:0009234,1,0.992523571807978,0,1,menaquinone biosynthetic process,BP,
4447,GO:0009235,1,0.893612077555603,0,18,cobalamin metabolic process,BP,
4448,GO:0009236,1,0.978042157817966,0,3,cobalamin biosynthetic process,BP,
4449,GO:0009237,1,0.992921528341152,0,1,siderophore metabolic process,BP,
4450,GO:0009240,1,0.979554807214161,0,4,isopentenyl diphosphate biosynthetic process,BP,
4451,GO:0009245,1,0.993046014416702,0,2,lipid A biosynthetic process,BP,
4454,GO:0009250,1,0.737142207907091,0,44,glucan biosynthetic process,BP,
4455,GO:0009251,1,0.843708993983832,0,24,glucan catabolic process,BP,
4456,GO:0009253,1,0.992371422184906,0,2,peptidoglycan catabolic process,BP,
4457,GO:0009256,1,0.964389144390552,0,5,10-formyltetrahydrofolate metabolic process,BP,
4458,GO:0009257,1,0.985145511458319,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4459,GO:0009258,1,0.98501540375951,0,2,10-formyltetrahydrofolate catabolic process,BP,
4462,GO:0009261,1,0.80756280143605,0,32,ribonucleotide catabolic process,BP,
4463,GO:0009262,1,0.833161196193752,0,33,deoxyribonucleotide metabolic process,BP,
4464,GO:0009263,1,0.921917569859004,0,14,deoxyribonucleotide biosynthetic process,BP,
4465,GO:0009264,1,0.90888137564164,0,18,deoxyribonucleotide catabolic process,BP,
4466,GO:0009265,1,0.942759889186988,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009267,1,0.425846081463318,0,130,cellular response to starvation,BP,
4469,GO:0009268,1,0.792869191926468,0,36,response to pH,BP,
4470,GO:0009295,1,0.768548732527601,0,41,nucleoid,CC,
4471,GO:0009298,1,0.980112434998286,0,4,GDP-mannose biosynthetic process,BP,
4472,GO:0009299,1,0.848457513804199,0,25,mRNA transcription,BP,
4473,GO:0009301,1,0.662688293385592,0,66,snRNA transcription,BP,
4474,GO:0009303,1,0.842721783360174,0,27,rRNA transcription,BP,
4475,GO:0009304,1,0.953524651992301,0,7,tRNA transcription,BP,
4476,GO:0009305,1,0.992365376255917,0,1,protein biotinylation,BP,
4478,GO:0009308,1,0.507765031684117,0,120,amine metabolic process,BP,
4479,GO:0009309,1,0.896179186077085,0,20,amine biosynthetic process,BP,
4480,GO:0009310,1,0.886692458302552,0,21,amine catabolic process,BP,
4481,GO:0009311,1,0.61844181295925,0,73,oligosaccharide metabolic process,BP,
4482,GO:0009312,1,0.781500938495052,0,38,oligosaccharide biosynthetic process,BP,
4483,GO:0009313,1,0.929359343353211,0,11,oligosaccharide catabolic process,BP,
4485,GO:0009328,1,0.975226341564614,0,4,phenylalanine-tRNA ligase complex,CC,
4486,GO:0009330,1,0.984959346988803,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4487,GO:0009331,1,0.978012778062705,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4488,GO:0009346,1,0.992489054350594,0,1,citrate lyase complex,CC,
4489,GO:0009353,1,0.995723547946495,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4490,GO:0009360,1,0.993220090569116,0,1,DNA polymerase III complex,CC,
4491,GO:0009368,1,0.989811286133534,0,2,endopeptidase Clp complex,CC,
4492,GO:0009372,1,0.992638670220271,0,1,quorum sensing,BP,
4493,GO:0009374,1,0.964554971209642,0,5,biotin binding,MF,
4494,GO:0009378,1,0.962963416780215,0,5,four-way junction helicase activity,MF,
4495,GO:0009383,1,0.98574686574859,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4496,GO:0009384,1,0.992427058729524,0,1,N-acylmannosamine kinase activity,MF,
4497,GO:0009386,1,0.98928148650223,0,2,translational attenuation,BP,
4498,GO:0009394,1,0.856234544152225,0,29,2'-deoxyribonucleotide metabolic process,BP,
4499,GO:0009395,1,0.816587553152288,0,31,phospholipid catabolic process,BP,
4500,GO:0009396,1,0.946380777120808,0,9,folic acid-containing compound biosynthetic process,BP,
4501,GO:0009397,1,0.973958875496865,0,4,folic acid-containing compound catabolic process,BP,
4502,GO:0009398,1,0.993210827817845,0,1,FMN biosynthetic process,BP,
4503,GO:0009400,1,0.993013917221064,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4504,GO:0009403,1,0.976368373080543,0,4,toxin biosynthetic process,BP,
4505,GO:0009404,1,0.888357232602636,0,20,toxin metabolic process,BP,
4506,GO:0009405,1,0.984845184385805,0,2,pathogenesis,BP,
4507,GO:0009407,1,0.976051262591702,0,5,toxin catabolic process,BP,
4511,GO:0009411,1,0.432548079441448,0,129,response to UV,BP,
4512,GO:0009414,1,0.958813390133846,0,7,response to water deprivation,BP,
4513,GO:0009415,1,0.92588664758867,0,12,response to water,BP,
4515,GO:0009435,1,0.745812757866398,0,47,NAD biosynthetic process,BP,
4516,GO:0009436,1,0.988424801941742,0,2,glyoxylate catabolic process,BP,
4517,GO:0009437,1,0.916866809052731,0,13,carnitine metabolic process,BP,
4518,GO:0009438,1,0.973553597180159,0,5,methylglyoxal metabolic process,BP,
4519,GO:0009439,1,0.991513598311312,0,2,cyanate metabolic process,BP,
4520,GO:0009440,1,0.991513598311312,0,2,cyanate catabolic process,BP,
4521,GO:0009441,1,0.983607369601643,0,3,glycolate metabolic process,BP,
4522,GO:0009443,1,0.992248191262378,0,1,pyridoxal 5'-phosphate salvage,BP,
4523,GO:0009444,1,0.992426276080992,0,1,pyruvate oxidation,BP,
4524,GO:0009445,1,0.962094788949047,0,7,putrescine metabolic process,BP,
4525,GO:0009446,1,0.969659101982705,0,5,putrescine biosynthetic process,BP,
4526,GO:0009447,1,0.987374255429854,0,3,putrescine catabolic process,BP,
4527,GO:0009448,1,0.971530800249762,0,4,gamma-aminobutyric acid metabolic process,BP,
4528,GO:0009449,1,0.978934297312933,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4529,GO:0009450,1,0.98495188585302,0,2,gamma-aminobutyric acid catabolic process,BP,
4530,GO:0009451,1,0.449372609983041,0,130,RNA modification,BP,
4531,GO:0009452,1,0.83007189783656,0,32,7-methylguanosine RNA capping,BP,
4532,GO:0009566,1,0.45144694345419,0,129,fertilization,BP,
4533,GO:0009581,1,0.5047065436605,0,103,detection of external stimulus,BP,
4534,GO:0009582,1,0.495641808654683,0,106,detection of abiotic stimulus,BP,
4535,GO:0009583,1,0.711137523272633,0,53,detection of light stimulus,BP,
4536,GO:0009584,1,0.756157528373169,0,43,detection of visible light,BP,
4538,GO:0009595,1,0.880484908479238,0,19,detection of biotic stimulus,BP,
4539,GO:0009597,1,0.967173620611598,0,5,detection of virus,BP,
4542,GO:0009608,1,0.988624898964948,0,2,response to symbiont,BP,
4543,GO:0009609,1,0.988624898964948,0,2,response to symbiotic bacterium,BP,
4544,GO:0009611,1,0.0243198217986118,0,562,response to wounding,BP,
4546,GO:0009615,1,0.189309309585056,0,264,response to virus,BP,
4549,GO:0009624,1,0.993367825152927,0,1,response to nematode,BP,
4551,GO:0009629,1,0.948052490004249,0,9,response to gravity,BP,
4552,GO:0009631,1,0.992442258119062,0,1,cold acclimation,BP,
4553,GO:0009635,1,0.935740983019,0,11,response to herbicide,BP,
4555,GO:0009637,1,0.985198632304915,0,2,response to blue light,BP,
4557,GO:0009644,1,0.986852106695633,0,2,response to high light intensity,BP,
4558,GO:0009645,1,0.99255839226198,0,1,response to low light intensity stimulus,BP,
4559,GO:0009646,1,0.992632563568689,0,1,response to absence of light,BP,
4560,GO:0009648,1,0.856752836800152,0,24,photoperiodism,BP,
4561,GO:0009649,1,0.846317771988846,0,26,entrainment of circadian clock,BP,
4562,GO:0009650,1,0.922418026369251,0,13,UV protection,BP,
4563,GO:0009651,1,0.880435493714255,0,20,response to salt stress,BP,
4565,GO:0009669,1,0.979401557966769,0,3,sucrose:cation symporter activity,MF,
4566,GO:0009673,1,0.992521432846201,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4567,GO:0009674,1,0.984817646877803,0,2,potassium:sodium symporter activity,MF,
4568,GO:0009692,1,0.993367825152927,0,1,ethylene metabolic process,BP,
4569,GO:0009698,1,0.969178799633532,0,6,phenylpropanoid metabolic process,BP,
4571,GO:0009713,1,0.886171092047304,0,19,catechol-containing compound biosynthetic process,BP,
4573,GO:0009720,1,0.99285717449457,0,1,detection of hormone stimulus,BP,
4575,GO:0009726,1,0.977581997536651,0,3,detection of endogenous stimulus,BP,
4576,GO:0009730,1,0.976810260662373,0,4,detection of carbohydrate stimulus,BP,
4577,GO:0009732,1,0.976810260662373,0,4,detection of hexose stimulus,BP,
4578,GO:0009737,1,0.992489247294393,0,1,response to abscisic acid,BP,
4579,GO:0009738,1,0.992489247294393,0,1,abscisic acid-activated signaling pathway,BP,
4581,GO:0009744,1,0.971573696063924,0,4,response to sucrose,BP,
4584,GO:0009750,1,0.949209036129481,0,8,response to fructose,BP,
4585,GO:0009753,1,0.982986543424467,0,4,response to jasmonic acid,BP,
4586,GO:0009755,1,0.265009522366362,0,198,hormone-mediated signaling pathway,BP,
4587,GO:0009756,1,0.958906132458065,0,7,carbohydrate mediated signaling,BP,
4588,GO:0009757,1,0.972056737793876,0,5,hexose mediated signaling,BP,
4589,GO:0009758,1,0.992133512631521,0,1,carbohydrate utilization,BP,
4590,GO:0009785,1,0.985198632304915,0,2,blue light signaling pathway,BP,
4591,GO:0009786,1,0.975611432933607,0,4,regulation of asymmetric cell division,BP,
4592,GO:0009787,1,0.992489247294393,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4593,GO:0009789,1,0.992489247294393,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009794,1,0.974279756961907,0,4,regulation of mitotic cell cycle, embryonic,BP,
4598,GO:0009798,1,0.600063120992624,0,80,axis specification,BP,
4599,GO:0009799,1,0.461760274731359,0,117,specification of symmetry,BP,
4600,GO:0009804,1,0.969178799633532,0,6,coumarin metabolic process,BP,
4601,GO:0009810,1,0.994131452236153,0,1,stilbene metabolic process,BP,
4602,GO:0009812,1,0.966731280744499,0,6,flavonoid metabolic process,BP,
4603,GO:0009814,1,0.994145695392548,0,1,defense response, incompatible interaction,BP,
4604,GO:0009817,1,0.994145695392548,0,1,defense response to fungus, incompatible interaction,BP,
4605,GO:0009820,1,0.973632217662593,0,5,alkaloid metabolic process,BP,
4606,GO:0009822,1,0.990454576910656,0,2,alkaloid catabolic process,BP,
4607,GO:0009826,1,0.987211457136394,0,2,unidimensional cell growth,BP,
4608,GO:0009838,1,0.972286147880561,0,5,abscission,BP,
4609,GO:0009841,1,0.993828830199542,0,1,mitochondrial endopeptidase Clp complex,CC,
4610,GO:0009850,1,0.990825235085361,0,2,auxin metabolic process,BP,
4611,GO:0009852,1,0.990825235085361,0,2,auxin catabolic process,BP,
4612,GO:0009855,1,0.464108846340868,0,116,determination of bilateral symmetry,BP,
4613,GO:0009880,1,0.693519797651906,0,56,embryonic pattern specification,BP,
4614,GO:0009881,1,0.942272861491775,0,10,photoreceptor activity,MF,
4615,GO:0009882,1,0.985198632304915,0,2,blue light photoreceptor activity,MF,
4616,GO:0009886,1,0.933165403277181,0,11,post-embryonic animal morphogenesis,BP,
4626,GO:0009896,1,0.0839799666805552,0,365,positive regulation of catabolic process,BP,
4629,GO:0009912,1,0.97001805865511,0,5,auditory receptor cell fate commitment,BP,
4630,GO:0009913,1,0.323496969366565,0,173,epidermal cell differentiation,BP,
4632,GO:0009918,1,0.993290687475071,0,1,sterol delta7 reductase activity,MF,
4633,GO:0009922,1,0.959484659774481,0,6,fatty acid elongase activity,MF,
4634,GO:0009925,1,0.792641409764199,0,33,basal plasma membrane,CC,
4636,GO:0009946,1,0.984533727965992,0,3,proximal/distal axis specification,BP,
4637,GO:0009948,1,0.765659624813519,0,43,anterior/posterior axis specification,BP,
4638,GO:0009949,1,0.995345054077821,0,1,polarity specification of anterior/posterior axis,BP,
4639,GO:0009950,1,0.897345223587433,0,16,dorsal/ventral axis specification,BP,
4641,GO:0009953,1,0.575452064455116,0,86,dorsal/ventral pattern formation,BP,
4642,GO:0009954,1,0.81208497302269,0,32,proximal/distal pattern formation,BP,
4643,GO:0009955,1,0.994139589794725,0,1,adaxial/abaxial pattern specification,BP,
4644,GO:0009956,1,0.992502605896741,0,1,radial pattern formation,BP,
4645,GO:0009957,1,0.978690587084747,0,3,epidermal cell fate specification,BP,
4649,GO:0009972,1,0.958340610976605,0,8,cytidine deamination,BP,
4651,GO:0009982,1,0.926436078927246,0,13,pseudouridine synthase activity,MF,
4654,GO:0009988,1,0.741177495327898,0,51,cell-cell recognition,BP,
4656,GO:0009992,1,0.994189505532725,0,1,cellular water homeostasis,BP,
4657,GO:0009994,1,0.759576009840206,0,43,oocyte differentiation,BP,
4658,GO:0009996,1,0.972141173749633,0,5,negative regulation of cell fate specification,BP,
4659,GO:0010001,1,0.283686760019546,0,190,glial cell differentiation,BP,
4660,GO:0010002,1,0.891634587735231,0,16,cardioblast differentiation,BP,
4662,GO:0010009,1,0.966954221262268,0,5,cytoplasmic side of endosome membrane,CC,
4663,GO:0010015,1,0.996390802365142,0,1,root morphogenesis,BP,
4664,GO:0010021,1,0.992715647457439,0,1,amylopectin biosynthetic process,BP,
4665,GO:0010025,1,0.986820977704296,0,2,wax biosynthetic process,BP,
4666,GO:0010032,1,0.962707059072051,0,5,meiotic chromosome condensation,BP,
4668,GO:0010034,1,0.992544492713728,0,1,response to acetate,BP,
4670,GO:0010037,1,0.992760130660534,0,1,response to carbon dioxide,BP,
4672,GO:0010039,1,0.812042073688955,0,32,response to iron ion,BP,
4673,GO:0010040,1,0.975915004667647,0,4,response to iron(II) ion,BP,
4674,GO:0010041,1,0.970272653562351,0,5,response to iron(III) ion,BP,
4675,GO:0010042,1,0.898338582805553,0,16,response to manganese ion,BP,
4677,GO:0010044,1,0.968665653138297,0,5,response to aluminum ion,BP,
4678,GO:0010045,1,0.992232189620402,0,1,response to nickel cation,BP,
4679,GO:0010046,1,0.961032296719431,0,6,response to mycotoxin,BP,
4680,GO:0010053,1,0.996390802365142,0,1,root epidermal cell differentiation,BP,
4681,GO:0010054,1,0.996390802365142,0,1,trichoblast differentiation,BP,
4682,GO:0010070,1,0.993720095530032,0,1,zygote asymmetric cell division,BP,
4683,GO:0010085,1,0.994384559683417,0,1,polarity specification of proximal/distal axis,BP,
4685,GO:0010106,1,0.994663586089518,0,1,cellular response to iron ion starvation,BP,
4687,GO:0010121,1,0.99459047963083,0,1,arginine catabolic process to proline via ornithine,BP,
4688,GO:0010124,1,0.990825235085361,0,2,phenylacetate catabolic process,BP,
4689,GO:0010133,1,0.986806707755451,0,2,proline catabolic process to glutamate,BP,
4690,GO:0010138,1,0.97391941737398,0,5,pyrimidine ribonucleotide salvage,BP,
4691,GO:0010139,1,0.995275165074226,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4692,GO:0010142,1,0.986340968802966,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4693,GO:0010155,1,0.923429596383697,0,15,regulation of proton transport,BP,
4694,GO:0010157,1,0.992210787244755,0,1,response to chlorate,BP,
4695,GO:0010159,1,0.980228201243916,0,3,specification of animal organ position,BP,
4696,GO:0010160,1,0.996151239358703,0,1,formation of animal organ boundary,BP,
4697,GO:0010164,1,0.995275165074226,0,1,response to cesium ion,BP,
4698,GO:0010165,1,0.788553803584582,0,35,response to X-ray,BP,
4699,GO:0010166,1,0.986820977704296,0,2,wax metabolic process,BP,
4700,GO:0010171,1,0.724913790962524,0,47,body morphogenesis,BP,
4701,GO:0010172,1,0.922528752181737,0,11,embryonic body morphogenesis,BP,
4702,GO:0010181,1,0.929272416316831,0,11,FMN binding,MF,
4703,GO:0010182,1,0.972056737793876,0,5,sugar mediated signaling pathway,BP,
4704,GO:0010189,1,0.995169568624002,0,1,vitamin E biosynthetic process,BP,
4705,GO:0010193,1,0.976331971519438,0,4,response to ozone,BP,
4706,GO:0010212,1,0.391013607266689,0,142,response to ionizing radiation,BP,
4707,GO:0010216,1,0.963162201994437,0,5,maintenance of DNA methylation,BP,
4708,GO:0010224,1,0.901453092565634,0,17,response to UV-B,BP,
4709,GO:0010225,1,0.917042823173027,0,13,response to UV-C,BP,
4711,GO:0010232,1,0.992735870788185,0,1,vascular transport,BP,
4713,GO:0010248,1,0.928136257475071,0,12,establishment or maintenance of transmembrane electrochemical gradient,BP,
4714,GO:0010255,1,0.972056737793876,0,5,glucose mediated signaling pathway,BP,
4716,GO:0010257,1,0.77821698366724,0,55,NADH dehydrogenase complex assembly,BP,
4717,GO:0010259,1,0.842826923925548,0,25,multicellular organism aging,BP,
4718,GO:0010265,1,0.961126294936697,0,6,SCF complex assembly,BP,
4719,GO:0010266,1,0.981462775780363,0,3,response to vitamin B1,BP,
4720,GO:0010269,1,0.969799773140303,0,5,response to selenium ion,BP,
4721,GO:0010273,1,0.959619327697067,0,11,detoxification of copper ion,BP,
4722,GO:0010286,1,0.97322409503892,0,5,heat acclimation,BP,
4723,GO:0010288,1,0.8727853834332,0,21,response to lead ion,BP,
4724,GO:0010309,1,0.995175684230004,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4725,GO:0010310,1,0.922511129910303,0,14,regulation of hydrogen peroxide metabolic process,BP,
4726,GO:0010314,1,0.936345143636135,0,10,phosphatidylinositol-5-phosphate binding,MF,
4727,GO:0010324,1,0.681220308371078,0,61,membrane invagination,BP,
4728,GO:0010332,1,0.711484818560298,0,52,response to gamma radiation,BP,
4729,GO:0010335,1,0.99248257145969,0,1,response to non-ionic osmotic stress,BP,
4730,GO:0010340,1,0.961843660587266,0,6,carboxyl-O-methyltransferase activity,MF,
4731,GO:0010348,1,0.9930956730518,0,1,lithium:proton antiporter activity,MF,
4732,GO:0010359,1,0.936179362028836,0,9,regulation of anion channel activity,BP,
4733,GO:0010360,1,0.978681516015614,0,3,negative regulation of anion channel activity,BP,
4734,GO:0010369,1,0.909956190420751,0,14,chromocenter,CC,
4735,GO:0010370,1,0.987073409450181,0,2,perinucleolar chromocenter,CC,
4736,GO:0010385,1,0.965874621438704,0,5,double-stranded methylated DNA binding,MF,
4738,GO:0010389,1,0.313656928186811,0,186,regulation of G2/M transition of mitotic cell cycle,BP,
4739,GO:0010390,1,0.831578909796998,0,27,histone monoubiquitination,BP,
4740,GO:0010412,1,0.99261857801174,0,1,mannan metabolic process,BP,
4741,GO:0010420,1,0.995807011225709,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4742,GO:0010421,1,0.930486154889149,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4743,GO:0010428,1,0.992375319400732,0,1,methyl-CpNpG binding,MF,
4744,GO:0010430,1,0.992470536249967,0,1,fatty acid omega-oxidation,BP,
4745,GO:0010446,1,0.987460387960992,0,2,response to alkaline pH,BP,
4746,GO:0010447,1,0.883333411938944,0,19,response to acidic pH,BP,
4747,GO:0010452,1,0.938889566417699,0,9,histone H3-K36 methylation,BP,
4748,GO:0010453,1,0.87013227652621,0,23,regulation of cell fate commitment,BP,
4749,GO:0010454,1,0.945092566563701,0,10,negative regulation of cell fate commitment,BP,
4750,GO:0010455,1,0.968119914410539,0,6,positive regulation of cell fate commitment,BP,
4751,GO:0010457,1,0.921442518501147,0,11,centriole-centriole cohesion,BP,
4752,GO:0010458,1,0.845846462965148,0,27,exit from mitosis,BP,
4753,GO:0010459,1,0.953018132664071,0,9,negative regulation of heart rate,BP,
4754,GO:0010460,1,0.872933259101106,0,22,positive regulation of heart rate,BP,
4755,GO:0010463,1,0.726952335488262,0,46,mesenchymal cell proliferation,BP,
4756,GO:0010464,1,0.783764543751342,0,35,regulation of mesenchymal cell proliferation,BP,
4757,GO:0010465,1,0.985632075711448,0,2,nerve growth factor receptor activity,MF,
4758,GO:0010466,1,0.30775740258457,0,194,negative regulation of peptidase activity,BP,
4762,GO:0010470,1,0.812278372900848,0,32,regulation of gastrulation,BP,
4763,GO:0010477,1,0.992656460679826,0,1,response to sulfur dioxide,BP,
4764,GO:0010481,1,0.98825118129238,0,2,epidermal cell division,BP,
4765,GO:0010482,1,0.98825118129238,0,2,regulation of epidermal cell division,BP,
4766,GO:0010484,1,0.970139456618076,0,4,H3 histone acetyltransferase activity,MF,
4767,GO:0010485,1,0.880495915431786,0,18,H4 histone acetyltransferase activity,MF,
4768,GO:0010494,1,0.755476222889632,0,40,cytoplasmic stress granule,CC,
4769,GO:0010496,1,0.994551172977047,0,1,intercellular transport,BP,
4772,GO:0010501,1,0.741146075260363,0,44,RNA secondary structure unwinding,BP,
4774,GO:0010507,1,0.638988545122187,0,67,negative regulation of autophagy,BP,
4775,GO:0010508,1,0.515304225083628,0,97,positive regulation of autophagy,BP,
4776,GO:0010509,1,0.99240722683828,0,1,polyamine homeostasis,BP,
4777,GO:0010510,1,0.917930026823589,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4778,GO:0010511,1,0.956428532382811,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4779,GO:0010512,1,0.986135037575416,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4780,GO:0010513,1,0.969880050559877,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010519,1,0.969094094917073,0,5,negative regulation of phospholipase activity,BP,
4784,GO:0010520,1,0.978713856868773,0,3,regulation of reciprocal meiotic recombination,BP,
4785,GO:0010521,1,0.981965724036025,0,3,telomerase inhibitor activity,MF,
4787,GO:0010523,1,0.901227315536008,0,17,negative regulation of calcium ion transport into cytosol,BP,
4789,GO:0010528,1,0.896904424697668,0,17,regulation of transposition,BP,
4790,GO:0010529,1,0.896904424697668,0,17,negative regulation of transposition,BP,
4791,GO:0010533,1,0.980313753825458,0,4,regulation of activation of Janus kinase activity,BP,
4792,GO:0010536,1,0.989541347022746,0,2,positive regulation of activation of Janus kinase activity,BP,
4793,GO:0010543,1,0.815883045435157,0,30,regulation of platelet activation,BP,
4794,GO:0010544,1,0.893393623005283,0,17,negative regulation of platelet activation,BP,
4798,GO:0010559,1,0.798277439834161,0,36,regulation of glycoprotein biosynthetic process,BP,
4799,GO:0010560,1,0.883397027380189,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4800,GO:0010561,1,0.941616924030187,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4803,GO:0010564,1,0.0116651178605135,0,670,regulation of cell cycle process,BP,
4805,GO:0010566,1,0.919039170065824,0,13,regulation of ketone biosynthetic process,BP,
4806,GO:0010569,1,0.832486598365762,0,27,regulation of double-strand break repair via homologous recombination,BP,
4807,GO:0010571,1,0.955744538729505,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4808,GO:0010572,1,0.964881266820651,0,5,positive regulation of platelet activation,BP,
4809,GO:0010573,1,0.815736447750859,0,31,vascular endothelial growth factor production,BP,
4810,GO:0010574,1,0.822011910489495,0,30,regulation of vascular endothelial growth factor production,BP,
4811,GO:0010575,1,0.842975636231114,0,25,positive regulation of vascular endothelial growth factor production,BP,
4812,GO:0010578,1,0.993447226924968,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4813,GO:0010585,1,0.994701360356908,0,1,glutamine secretion,BP,
4814,GO:0010586,1,0.861214857089751,0,22,miRNA metabolic process,BP,
4815,GO:0010587,1,0.96355098000415,0,5,miRNA catabolic process,BP,
4816,GO:0010591,1,0.833895132497436,0,27,regulation of lamellipodium assembly,BP,
4817,GO:0010592,1,0.904031655214067,0,15,positive regulation of lamellipodium assembly,BP,
4818,GO:0010593,1,0.984847762504294,0,2,negative regulation of lamellipodium assembly,BP,
4819,GO:0010594,1,0.417214508091009,0,130,regulation of endothelial cell migration,BP,
4820,GO:0010595,1,0.574550301791287,0,83,positive regulation of endothelial cell migration,BP,
4821,GO:0010596,1,0.756020879355622,0,42,negative regulation of endothelial cell migration,BP,
4822,GO:0010603,1,0.942890171575991,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4825,GO:0010606,1,0.962389489122766,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4826,GO:0010607,1,0.994633622784871,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4828,GO:0010609,1,0.987050352990239,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4829,GO:0010611,1,0.742812957666933,0,44,regulation of cardiac muscle hypertrophy,BP,
4830,GO:0010612,1,0.942004756674737,0,8,regulation of cardiac muscle adaptation,BP,
4831,GO:0010613,1,0.837289711403588,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4832,GO:0010614,1,0.899150106481992,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4833,GO:0010615,1,0.985099555891363,0,2,positive regulation of cardiac muscle adaptation,BP,
4834,GO:0010616,1,0.956259904127914,0,6,negative regulation of cardiac muscle adaptation,BP,
4835,GO:0010621,1,0.98439831024684,0,3,negative regulation of transcription by transcription factor localization,BP,
4836,GO:0010623,1,0.927306618435396,0,12,programmed cell death involved in cell development,BP,
4837,GO:0010624,1,0.957418593032472,0,6,regulation of Schwann cell proliferation,BP,
4838,GO:0010625,1,0.993648771258722,0,1,positive regulation of Schwann cell proliferation,BP,
4839,GO:0010626,1,0.963540571011324,0,5,negative regulation of Schwann cell proliferation,BP,
4842,GO:0010631,1,0.200650333633196,0,238,epithelial cell migration,BP,
4843,GO:0010632,1,0.288499349269476,0,184,regulation of epithelial cell migration,BP,
4844,GO:0010633,1,0.685863484953615,0,57,negative regulation of epithelial cell migration,BP,
4845,GO:0010634,1,0.445893554884636,0,120,positive regulation of epithelial cell migration,BP,
4846,GO:0010635,1,0.949495726975366,0,8,regulation of mitochondrial fusion,BP,
4847,GO:0010636,1,0.985815135627328,0,2,positive regulation of mitochondrial fusion,BP,
4848,GO:0010637,1,0.969761079066855,0,5,negative regulation of mitochondrial fusion,BP,
4851,GO:0010640,1,0.85757355339374,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4852,GO:0010641,1,0.964355802262441,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4853,GO:0010642,1,0.89603763143946,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4854,GO:0010643,1,0.985621390112528,0,2,cell communication by chemical coupling,BP,
4855,GO:0010644,1,0.828767588157484,0,27,cell communication by electrical coupling,BP,
4856,GO:0010645,1,0.992735870788185,0,1,regulation of cell communication by chemical coupling,BP,
4860,GO:0010649,1,0.921584558993636,0,12,regulation of cell communication by electrical coupling,BP,
4861,GO:0010650,1,0.98458136021587,0,2,positive regulation of cell communication by electrical coupling,BP,
4862,GO:0010652,1,0.992735870788185,0,1,positive regulation of cell communication by chemical coupling,BP,
4863,GO:0010656,1,0.814370968720944,0,32,negative regulation of muscle cell apoptotic process,BP,
4871,GO:0010664,1,0.867715704851858,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4874,GO:0010667,1,0.886736099538147,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4875,GO:0010668,1,0.956169627076494,0,6,ectodermal cell differentiation,BP,
4876,GO:0010669,1,0.883782430553828,0,19,epithelial structure maintenance,BP,
4877,GO:0010675,1,0.498799144691129,0,104,regulation of cellular carbohydrate metabolic process,BP,
4878,GO:0010676,1,0.739131477439072,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4879,GO:0010677,1,0.825972597854572,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4880,GO:0010692,1,0.937263864481679,0,9,regulation of alkaline phosphatase activity,BP,
4881,GO:0010693,1,0.980233859100007,0,3,negative regulation of alkaline phosphatase activity,BP,
4882,GO:0010694,1,0.956172255093373,0,6,positive regulation of alkaline phosphatase activity,BP,
4883,GO:0010698,1,0.989166197582049,0,2,acetyltransferase activator activity,MF,
4884,GO:0010700,1,0.97151230463482,0,5,negative regulation of norepinephrine secretion,BP,
4885,GO:0010701,1,0.979477800197273,0,3,positive regulation of norepinephrine secretion,BP,
4886,GO:0010705,1,0.985638544318667,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4887,GO:0010710,1,0.982083556924136,0,3,regulation of collagen catabolic process,BP,
4888,GO:0010711,1,0.996396050682575,0,1,negative regulation of collagen catabolic process,BP,
4889,GO:0010712,1,0.824366041757586,0,31,regulation of collagen metabolic process,BP,
4890,GO:0010713,1,0.955278954314844,0,8,negative regulation of collagen metabolic process,BP,
4891,GO:0010714,1,0.880084502783132,0,20,positive regulation of collagen metabolic process,BP,
4892,GO:0010715,1,0.912665299544661,0,13,regulation of extracellular matrix disassembly,BP,
4893,GO:0010716,1,0.976324991329563,0,4,negative regulation of extracellular matrix disassembly,BP,
4894,GO:0010717,1,0.59742663390963,0,77,regulation of epithelial to mesenchymal transition,BP,
4895,GO:0010718,1,0.739142138174094,0,44,positive regulation of epithelial to mesenchymal transition,BP,
4896,GO:0010719,1,0.858002881871506,0,25,negative regulation of epithelial to mesenchymal transition,BP,
4899,GO:0010722,1,0.992266554827563,0,1,regulation of ferrochelatase activity,BP,
4900,GO:0010724,1,0.973973200136956,0,4,regulation of definitive erythrocyte differentiation,BP,
4901,GO:0010725,1,0.988127005636861,0,2,regulation of primitive erythrocyte differentiation,BP,
4902,GO:0010726,1,0.987247949323674,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4903,GO:0010727,1,0.959328630919661,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4904,GO:0010728,1,0.973710120951355,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4905,GO:0010729,1,0.99450259893695,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4906,GO:0010730,1,0.97909374959067,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4907,GO:0010731,1,0.990521641135454,0,2,protein glutathionylation,BP,
4908,GO:0010732,1,0.990521641135454,0,2,regulation of protein glutathionylation,BP,
4909,GO:0010734,1,0.990521641135454,0,2,negative regulation of protein glutathionylation,BP,
4910,GO:0010735,1,0.972472561812872,0,4,positive regulation of transcription via serum response element binding,BP,
4911,GO:0010736,1,0.987243286524877,0,2,serum response element binding,MF,
4912,GO:0010737,1,0.838286123599529,0,26,protein kinase A signaling,BP,
4913,GO:0010738,1,0.883985617982747,0,18,regulation of protein kinase A signaling,BP,
4914,GO:0010739,1,0.964765254969202,0,6,positive regulation of protein kinase A signaling,BP,
4915,GO:0010742,1,0.828071992701119,0,29,macrophage derived foam cell differentiation,BP,
4916,GO:0010743,1,0.852227329458505,0,25,regulation of macrophage derived foam cell differentiation,BP,
4917,GO:0010744,1,0.915397188232764,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4918,GO:0010745,1,0.93105190204195,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4919,GO:0010746,1,0.970415297256094,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4920,GO:0010748,1,0.970415297256094,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4921,GO:0010749,1,0.967584623141771,0,5,regulation of nitric oxide mediated signal transduction,BP,
4922,GO:0010750,1,0.985981705248652,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4923,GO:0010751,1,0.98134401760231,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4924,GO:0010752,1,0.984929798990838,0,2,regulation of cGMP-mediated signaling,BP,
4925,GO:0010754,1,0.992383715131089,0,1,negative regulation of cGMP-mediated signaling,BP,
4926,GO:0010755,1,0.943223059944276,0,10,regulation of plasminogen activation,BP,
4927,GO:0010756,1,0.97343043919667,0,5,positive regulation of plasminogen activation,BP,
4928,GO:0010757,1,0.968976516234189,0,5,negative regulation of plasminogen activation,BP,
4929,GO:0010758,1,0.895554223791807,0,18,regulation of macrophage chemotaxis,BP,
4930,GO:0010759,1,0.939470693851928,0,10,positive regulation of macrophage chemotaxis,BP,
4931,GO:0010760,1,0.973740632758457,0,5,negative regulation of macrophage chemotaxis,BP,
4932,GO:0010761,1,0.764989227697813,0,38,fibroblast migration,BP,
4933,GO:0010762,1,0.82316706745997,0,28,regulation of fibroblast migration,BP,
4934,GO:0010763,1,0.9256033368212,0,11,positive regulation of fibroblast migration,BP,
4935,GO:0010764,1,0.949783755496189,0,8,negative regulation of fibroblast migration,BP,
4936,GO:0010765,1,0.818724935172407,0,30,positive regulation of sodium ion transport,BP,
4937,GO:0010766,1,0.907976294415629,0,14,negative regulation of sodium ion transport,BP,
4938,GO:0010767,1,0.977960199929141,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4939,GO:0010768,1,0.984613773348352,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4941,GO:0010770,1,0.399028792002073,0,133,positive regulation of cell morphogenesis involved in differentiation,BP,
4943,GO:0010789,1,0.9930956730518,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4944,GO:0010792,1,0.965248158100124,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4945,GO:0010793,1,0.964811021627553,0,5,regulation of mRNA export from nucleus,BP,
4946,GO:0010795,1,0.995807011225709,0,1,regulation of ubiquinone biosynthetic process,BP,
4947,GO:0010796,1,0.984680653067076,0,3,regulation of multivesicular body size,BP,
4948,GO:0010797,1,0.995877010169695,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4951,GO:0010801,1,0.910877720547165,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4952,GO:0010803,1,0.719328704941461,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4953,GO:0010804,1,0.912511617735849,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4954,GO:0010807,1,0.95969517055624,0,6,regulation of synaptic vesicle priming,BP,
4955,GO:0010808,1,0.992331842885463,0,1,positive regulation of synaptic vesicle priming,BP,
4956,GO:0010810,1,0.302946924743316,0,174,regulation of cell-substrate adhesion,BP,
4957,GO:0010811,1,0.507608828760786,0,101,positive regulation of cell-substrate adhesion,BP,
4958,GO:0010812,1,0.698051796431501,0,51,negative regulation of cell-substrate adhesion,BP,
4959,GO:0010813,1,0.987978138805085,0,2,neuropeptide catabolic process,BP,
4960,GO:0010814,1,0.992440781289541,0,1,substance P catabolic process,BP,
4961,GO:0010815,1,0.974220449164624,0,4,bradykinin catabolic process,BP,
4962,GO:0010816,1,0.992440781289541,0,1,calcitonin catabolic process,BP,
4964,GO:0010818,1,0.902848996675442,0,18,T cell chemotaxis,BP,
4965,GO:0010819,1,0.944339685909156,0,10,regulation of T cell chemotaxis,BP,
4966,GO:0010820,1,0.948199027259305,0,9,positive regulation of T cell chemotaxis,BP,
4967,GO:0010821,1,0.266962082241202,0,209,regulation of mitochondrion organization,BP,
4968,GO:0010822,1,0.374282477905763,0,156,positive regulation of mitochondrion organization,BP,
4969,GO:0010823,1,0.754637766234336,0,45,negative regulation of mitochondrion organization,BP,
4970,GO:0010824,1,0.766037067802919,0,39,regulation of centrosome duplication,BP,
4971,GO:0010825,1,0.957433114172052,0,6,positive regulation of centrosome duplication,BP,
4972,GO:0010826,1,0.923575339202653,0,12,negative regulation of centrosome duplication,BP,
4973,GO:0010827,1,0.635650335587455,0,66,regulation of glucose transmembrane transport,BP,
4974,GO:0010828,1,0.758833031926238,0,39,positive regulation of glucose transmembrane transport,BP,
4975,GO:0010829,1,0.904801634037377,0,16,negative regulation of glucose transmembrane transport,BP,
4976,GO:0010830,1,0.743836832005987,0,46,regulation of myotube differentiation,BP,
4977,GO:0010831,1,0.850976164103752,0,25,positive regulation of myotube differentiation,BP,
4978,GO:0010832,1,0.91716998432057,0,14,negative regulation of myotube differentiation,BP,
4979,GO:0010833,1,0.609247781416487,0,75,telomere maintenance via telomere lengthening,BP,
4980,GO:0010835,1,0.96268760048414,0,6,regulation of protein ADP-ribosylation,BP,
4981,GO:0010836,1,0.984016764824599,0,3,negative regulation of protein ADP-ribosylation,BP,
4982,GO:0010837,1,0.841070717702485,0,25,regulation of keratinocyte proliferation,BP,
4983,GO:0010838,1,0.953069275482645,0,7,positive regulation of keratinocyte proliferation,BP,
4984,GO:0010839,1,0.924720183445507,0,11,negative regulation of keratinocyte proliferation,BP,
4985,GO:0010840,1,0.984269329722112,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4986,GO:0010841,1,0.984269329722112,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4987,GO:0010842,1,0.871416273565303,0,19,retina layer formation,BP,
4988,GO:0010845,1,0.985897898918095,0,2,positive regulation of reciprocal meiotic recombination,BP,
4989,GO:0010847,1,0.972513792538972,0,4,regulation of chromatin assembly,BP,
4990,GO:0010848,1,0.985183418409295,0,2,regulation of chromatin disassembly,BP,
4991,GO:0010849,1,0.994155875773371,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4992,GO:0010851,1,0.972316797543052,0,5,cyclase regulator activity,MF,
4993,GO:0010853,1,0.979670619087255,0,4,cyclase activator activity,MF,
4994,GO:0010854,1,0.992495145176256,0,1,adenylate cyclase regulator activity,MF,
4995,GO:0010855,1,0.992495145176256,0,1,adenylate cyclase inhibitor activity,MF,
4996,GO:0010856,1,0.992636613534815,0,1,adenylate cyclase activator activity,MF,
4998,GO:0010858,1,0.985767478868869,0,3,calcium-dependent protein kinase regulator activity,MF,
4999,GO:0010859,1,0.992488247971201,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5000,GO:0010862,1,0.75060103684003,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5001,GO:0010863,1,0.809041344481402,0,31,positive regulation of phospholipase C activity,BP,
5002,GO:0010866,1,0.907858195506944,0,15,regulation of triglyceride biosynthetic process,BP,
5003,GO:0010867,1,0.932232719765062,0,11,positive regulation of triglyceride biosynthetic process,BP,
5004,GO:0010868,1,0.985038947389126,0,2,negative regulation of triglyceride biosynthetic process,BP,
5005,GO:0010869,1,0.886778241850911,0,18,regulation of receptor biosynthetic process,BP,
5006,GO:0010870,1,0.940024099040708,0,10,positive regulation of receptor biosynthetic process,BP,
5007,GO:0010871,1,0.965219992158451,0,5,negative regulation of receptor biosynthetic process,BP,
5008,GO:0010872,1,0.956988030512206,0,8,regulation of cholesterol esterification,BP,
5009,GO:0010873,1,0.970578630204501,0,6,positive regulation of cholesterol esterification,BP,
5010,GO:0010874,1,0.891337419139991,0,18,regulation of cholesterol efflux,BP,
5011,GO:0010875,1,0.92001345385835,0,13,positive regulation of cholesterol efflux,BP,
5012,GO:0010876,1,0.12362642858054,0,316,lipid localization,BP,
5013,GO:0010877,1,0.989964396929235,0,2,lipid transport involved in lipid storage,BP,
5014,GO:0010878,1,0.902298918196075,0,15,cholesterol storage,BP,
5015,GO:0010879,1,0.994016006353376,0,1,cholesterol transport involved in cholesterol storage,BP,
5016,GO:0010880,1,0.847566093652401,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5017,GO:0010881,1,0.890396719358726,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5018,GO:0010882,1,0.862126589727887,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5020,GO:0010884,1,0.881170368659493,0,20,positive regulation of lipid storage,BP,
5021,GO:0010885,1,0.914523528877333,0,13,regulation of cholesterol storage,BP,
5022,GO:0010886,1,0.950557866132087,0,7,positive regulation of cholesterol storage,BP,
5023,GO:0010887,1,0.962110608907525,0,6,negative regulation of cholesterol storage,BP,
5024,GO:0010888,1,0.90404231247351,0,16,negative regulation of lipid storage,BP,
5025,GO:0010889,1,0.931658363039378,0,12,regulation of sequestering of triglyceride,BP,
5026,GO:0010890,1,0.964053147932467,0,7,positive regulation of sequestering of triglyceride,BP,
5027,GO:0010891,1,0.966409649384392,0,5,negative regulation of sequestering of triglyceride,BP,
5028,GO:0010893,1,0.915861962480377,0,13,positive regulation of steroid biosynthetic process,BP,
5029,GO:0010894,1,0.87020783582968,0,22,negative regulation of steroid biosynthetic process,BP,
5030,GO:0010896,1,0.960273124739292,0,7,regulation of triglyceride catabolic process,BP,
5031,GO:0010897,1,0.980186335845711,0,3,negative regulation of triglyceride catabolic process,BP,
5032,GO:0010898,1,0.979688368564595,0,4,positive regulation of triglyceride catabolic process,BP,
5033,GO:0010899,1,0.982474902612863,0,3,regulation of phosphatidylcholine catabolic process,BP,
5034,GO:0010900,1,0.996703414100925,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5035,GO:0010901,1,0.992728279421261,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5036,GO:0010902,1,0.996451967819362,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5037,GO:0010903,1,0.996263188717863,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5038,GO:0010904,1,0.994178290216842,0,1,regulation of UDP-glucose catabolic process,BP,
5039,GO:0010905,1,0.994178290216842,0,1,negative regulation of UDP-glucose catabolic process,BP,
5040,GO:0010906,1,0.57650051704448,0,81,regulation of glucose metabolic process,BP,
5041,GO:0010907,1,0.818412937325197,0,28,positive regulation of glucose metabolic process,BP,
5042,GO:0010908,1,0.9783298276895,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5043,GO:0010909,1,0.9783298276895,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5044,GO:0010911,1,0.951587408267338,0,7,regulation of isomerase activity,BP,
5045,GO:0010912,1,0.951587408267338,0,7,positive regulation of isomerase activity,BP,
5046,GO:0010915,1,0.988545127618809,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5047,GO:0010916,1,0.988545127618809,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5048,GO:0010917,1,0.954820921372943,0,8,negative regulation of mitochondrial membrane potential,BP,
5049,GO:0010918,1,0.952993841643466,0,8,positive regulation of mitochondrial membrane potential,BP,
5050,GO:0010919,1,0.923340367614341,0,12,regulation of inositol phosphate biosynthetic process,BP,
5051,GO:0010920,1,0.993002618111896,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5053,GO:0010922,1,0.823197126258728,0,28,positive regulation of phosphatase activity,BP,
5055,GO:0010924,1,0.993002618111896,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5056,GO:0010925,1,0.993002618111896,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5057,GO:0010927,1,0.517434932233357,0,95,cellular component assembly involved in morphogenesis,BP,
5058,GO:0010931,1,0.992176537338435,0,1,macrophage tolerance induction,BP,
5059,GO:0010932,1,0.992176537338435,0,1,regulation of macrophage tolerance induction,BP,
5060,GO:0010933,1,0.992176537338435,0,1,positive regulation of macrophage tolerance induction,BP,
5061,GO:0010934,1,0.912583286220603,0,14,macrophage cytokine production,BP,
5062,GO:0010935,1,0.92545638723977,0,12,regulation of macrophage cytokine production,BP,
5063,GO:0010936,1,0.967762615596457,0,5,negative regulation of macrophage cytokine production,BP,
5064,GO:0010938,1,0.992522555202321,0,1,cytoplasmic microtubule depolymerization,BP,
5065,GO:0010939,1,0.856637713221389,0,27,regulation of necrotic cell death,BP,
5066,GO:0010940,1,0.971736741150903,0,6,positive regulation of necrotic cell death,BP,
5069,GO:0010944,1,0.952992175904067,0,8,negative regulation of transcription by competitive promoter binding,BP,
5070,GO:0010948,1,0.146672858682254,0,304,negative regulation of cell cycle process,BP,
5071,GO:0010949,1,0.993264128755224,0,1,negative regulation of intestinal phytosterol absorption,BP,
5073,GO:0010951,1,0.322175008490226,0,187,negative regulation of endopeptidase activity,BP,
5075,GO:0010954,1,0.890810974282577,0,18,positive regulation of protein processing,BP,
5076,GO:0010955,1,0.800425663944583,0,35,negative regulation of protein processing,BP,
5077,GO:0010956,1,0.979432817977431,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5078,GO:0010957,1,0.969184099049332,0,5,negative regulation of vitamin D biosynthetic process,BP,
5079,GO:0010958,1,0.959738529094292,0,6,regulation of amino acid import across plasma membrane,BP,
5081,GO:0010960,1,0.928070354641452,0,10,magnesium ion homeostasis,BP,
5082,GO:0010961,1,0.970935048782493,0,4,cellular magnesium ion homeostasis,BP,
5084,GO:0010963,1,0.988989664192653,0,2,regulation of L-arginine import,BP,
5085,GO:0010965,1,0.714992074682683,0,52,regulation of mitotic sister chromatid separation,BP,
5086,GO:0010966,1,0.970343241852367,0,4,regulation of phosphate transport,BP,
5087,GO:0010967,1,0.995135257868318,0,1,regulation of polyamine biosynthetic process,BP,
5088,GO:0010968,1,0.963030270656984,0,6,regulation of microtubule nucleation,BP,
5090,GO:0010971,1,0.871107181416718,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5091,GO:0010972,1,0.615982295706501,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5095,GO:0010979,1,0.98609486444974,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5096,GO:0010980,1,0.98609486444974,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5097,GO:0010982,1,0.986508386565073,0,2,regulation of high-density lipoprotein particle clearance,BP,
5098,GO:0010983,1,0.986508386565073,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5099,GO:0010984,1,0.920070592625481,0,14,regulation of lipoprotein particle clearance,BP,
5100,GO:0010985,1,0.96050440891841,0,7,negative regulation of lipoprotein particle clearance,BP,
5101,GO:0010986,1,0.974376181359917,0,4,positive regulation of lipoprotein particle clearance,BP,
5102,GO:0010988,1,0.950677506246943,0,8,regulation of low-density lipoprotein particle clearance,BP,
5103,GO:0010989,1,0.97163764946745,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5104,GO:0010990,1,0.959247544980006,0,6,regulation of SMAD protein complex assembly,BP,
5105,GO:0010991,1,0.966498580000891,0,5,negative regulation of SMAD protein complex assembly,BP,
5106,GO:0010992,1,0.95634947351008,0,7,ubiquitin recycling,BP,
5107,GO:0010994,1,0.970971843089718,0,5,free ubiquitin chain polymerization,BP,
5108,GO:0010996,1,0.868669406000917,0,21,response to auditory stimulus,BP,
5109,GO:0010997,1,0.967260224001453,0,5,anaphase-promoting complex binding,MF,
5110,GO:0010998,1,0.934258581532931,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5111,GO:0010999,1,0.992483857259806,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5115,GO:0012507,1,0.707192943008333,0,57,ER to Golgi transport vesicle membrane,CC,
5117,GO:0014002,1,0.810675831195168,0,31,astrocyte development,BP,
5118,GO:0014003,1,0.788033409773908,0,38,oligodendrocyte development,BP,
5119,GO:0014004,1,0.977986648959462,0,3,microglia differentiation,BP,
5120,GO:0014005,1,0.977986648959462,0,3,microglia development,BP,
5121,GO:0014009,1,0.793634160021822,0,34,glial cell proliferation,BP,
5122,GO:0014010,1,0.950111090879233,0,7,Schwann cell proliferation,BP,
5123,GO:0014011,1,0.9930956730518,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5124,GO:0014012,1,0.974243801062188,0,5,peripheral nervous system axon regeneration,BP,
5125,GO:0014013,1,0.528617634449137,0,98,regulation of gliogenesis,BP,
5126,GO:0014014,1,0.796598819142309,0,36,negative regulation of gliogenesis,BP,
5127,GO:0014015,1,0.70808686414438,0,54,positive regulation of gliogenesis,BP,
5128,GO:0014016,1,0.980920483871155,0,3,neuroblast differentiation,BP,
5129,GO:0014017,1,0.993608490836106,0,1,neuroblast fate commitment,BP,
5130,GO:0014020,1,0.534394968999216,0,92,primary neural tube formation,BP,
5131,GO:0014022,1,0.978310524546135,0,3,neural plate elongation,BP,
5132,GO:0014028,1,0.987847528104782,0,2,notochord formation,BP,
5133,GO:0014029,1,0.931611038894346,0,11,neural crest formation,BP,
5134,GO:0014031,1,0.617130442224304,0,72,mesenchymal cell development,BP,
5135,GO:0014032,1,0.635857161128197,0,68,neural crest cell development,BP,
5136,GO:0014033,1,0.606536816943345,0,75,neural crest cell differentiation,BP,
5137,GO:0014034,1,0.981016505819774,0,3,neural crest cell fate commitment,BP,
5138,GO:0014036,1,0.988446369267472,0,2,neural crest cell fate specification,BP,
5139,GO:0014037,1,0.7756600782155,0,36,Schwann cell differentiation,BP,
5140,GO:0014038,1,0.980603782774911,0,3,regulation of Schwann cell differentiation,BP,
5141,GO:0014040,1,0.985487194411332,0,2,positive regulation of Schwann cell differentiation,BP,
5142,GO:0014041,1,0.939212271408405,0,9,regulation of neuron maturation,BP,
5143,GO:0014042,1,0.969775573825415,0,4,positive regulation of neuron maturation,BP,
5144,GO:0014043,1,0.980063653800416,0,3,negative regulation of neuron maturation,BP,
5145,GO:0014044,1,0.820309677766338,0,28,Schwann cell development,BP,
5146,GO:0014045,1,0.973183187763291,0,4,establishment of endothelial blood-brain barrier,BP,
5151,GO:0014050,1,0.968583776348435,0,5,negative regulation of glutamate secretion,BP,
5152,GO:0014051,1,0.935989748942218,0,9,gamma-aminobutyric acid secretion,BP,
5153,GO:0014052,1,0.957938206388916,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5154,GO:0014053,1,0.992456603639031,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5155,GO:0014054,1,0.972531121483773,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5156,GO:0014055,1,0.980553223591558,0,3,acetylcholine secretion, neurotransmission,BP,
5157,GO:0014056,1,0.980553223591558,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5158,GO:0014057,1,0.987206149938186,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5160,GO:0014060,1,0.979349452126878,0,4,regulation of epinephrine secretion,BP,
5161,GO:0014061,1,0.928275349988994,0,12,regulation of norepinephrine secretion,BP,
5162,GO:0014062,1,0.960319312547465,0,7,regulation of serotonin secretion,BP,
5163,GO:0014063,1,0.975776391017549,0,4,negative regulation of serotonin secretion,BP,
5164,GO:0014064,1,0.992480267403341,0,1,positive regulation of serotonin secretion,BP,
5165,GO:0014065,1,0.445726229251357,0,116,phosphatidylinositol 3-kinase signaling,BP,
5166,GO:0014066,1,0.545832546213513,0,88,regulation of phosphatidylinositol 3-kinase signaling,BP,
5167,GO:0014067,1,0.936236509694963,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5168,GO:0014068,1,0.661456177209828,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5174,GO:0014701,1,0.932987474724748,0,9,junctional sarcoplasmic reticulum membrane,CC,
5175,GO:0014704,1,0.720205755396304,0,47,intercalated disc,CC,
5176,GO:0014705,1,0.992493561891618,0,1,C zone,CC,
5178,GO:0014707,1,0.988265608299071,0,2,branchiomeric skeletal muscle development,BP,
5179,GO:0014717,1,0.988319632272777,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5180,GO:0014718,1,0.988319632272777,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5181,GO:0014719,1,0.96848396799753,0,5,skeletal muscle satellite cell activation,BP,
5182,GO:0014721,1,0.969654985761967,0,5,twitch skeletal muscle contraction,BP,
5183,GO:0014722,1,0.965658239045063,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5184,GO:0014724,1,0.984963587905135,0,2,regulation of twitch skeletal muscle contraction,BP,
5185,GO:0014728,1,0.992361198544908,0,1,regulation of the force of skeletal muscle contraction,BP,
5186,GO:0014731,1,0.947348376314603,0,7,spectrin-associated cytoskeleton,CC,
5187,GO:0014732,1,0.95838026376386,0,7,skeletal muscle atrophy,BP,
5188,GO:0014733,1,0.933788118243666,0,10,regulation of skeletal muscle adaptation,BP,
5189,GO:0014734,1,0.979096046083551,0,3,skeletal muscle hypertrophy,BP,
5190,GO:0014735,1,0.982929595872767,0,3,regulation of muscle atrophy,BP,
5191,GO:0014736,1,0.987811820724928,0,2,negative regulation of muscle atrophy,BP,
5192,GO:0014737,1,0.995058153067491,0,1,positive regulation of muscle atrophy,BP,
5193,GO:0014738,1,0.983163262084638,0,3,regulation of muscle hyperplasia,BP,
5194,GO:0014739,1,0.996533379757721,0,1,positive regulation of muscle hyperplasia,BP,
5195,GO:0014740,1,0.986583845388633,0,2,negative regulation of muscle hyperplasia,BP,
5196,GO:0014741,1,0.886054857051627,0,18,negative regulation of muscle hypertrophy,BP,
5197,GO:0014742,1,0.837289711403588,0,26,positive regulation of muscle hypertrophy,BP,
5198,GO:0014743,1,0.731973666948796,0,46,regulation of muscle hypertrophy,BP,
5199,GO:0014744,1,0.969145754470374,0,5,positive regulation of muscle adaptation,BP,
5200,GO:0014745,1,0.924781489086514,0,11,negative regulation of muscle adaptation,BP,
5201,GO:0014802,1,0.976696450304001,0,4,terminal cisterna,CC,
5202,GO:0014804,1,0.994631621074449,0,1,terminal cisterna lumen,CC,
5203,GO:0014805,1,0.981089028315302,0,4,smooth muscle adaptation,BP,
5204,GO:0014806,1,0.989038621387066,0,2,smooth muscle hyperplasia,BP,
5206,GO:0014808,1,0.830551162775996,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5207,GO:0014809,1,0.972479976676023,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5208,GO:0014810,1,0.996386594832414,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5209,GO:0014812,1,0.598035031331891,0,74,muscle cell migration,BP,
5210,GO:0014813,1,0.994022053753213,0,1,skeletal muscle satellite cell commitment,BP,
5211,GO:0014816,1,0.950454827085089,0,7,skeletal muscle satellite cell differentiation,BP,
5212,GO:0014819,1,0.933610659696732,0,11,regulation of skeletal muscle contraction,BP,
5213,GO:0014820,1,0.945184619147958,0,9,tonic smooth muscle contraction,BP,
5214,GO:0014821,1,0.899717339039819,0,18,phasic smooth muscle contraction,BP,
5215,GO:0014822,1,0.99345603044542,0,1,detection of wounding,BP,
5216,GO:0014823,1,0.701760955984429,0,54,response to activity,BP,
5217,GO:0014824,1,0.956076623495351,0,7,artery smooth muscle contraction,BP,
5218,GO:0014825,1,0.996352645489994,0,1,stomach fundus smooth muscle contraction,BP,
5219,GO:0014826,1,0.976289001359726,0,4,vein smooth muscle contraction,BP,
5220,GO:0014827,1,0.964812257340598,0,6,intestine smooth muscle contraction,BP,
5221,GO:0014828,1,0.992436528352499,0,1,distal stomach smooth muscle contraction,BP,
5223,GO:0014831,1,0.933216128337984,0,11,gastro-intestinal system smooth muscle contraction,BP,
5224,GO:0014832,1,0.954605534646957,0,7,urinary bladder smooth muscle contraction,BP,
5225,GO:0014834,1,0.973460550916137,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5226,GO:0014835,1,0.986541235659496,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5227,GO:0014839,1,0.990482348691361,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5228,GO:0014841,1,0.912334412344227,0,13,skeletal muscle satellite cell proliferation,BP,
5229,GO:0014842,1,0.919492698384806,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5230,GO:0014843,1,0.992300185940321,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5231,GO:0014846,1,0.984947481461669,0,2,esophagus smooth muscle contraction,BP,
5232,GO:0014847,1,0.996352645489994,0,1,proximal stomach smooth muscle contraction,BP,
5233,GO:0014848,1,0.954605534646957,0,7,urinary tract smooth muscle contraction,BP,
5234,GO:0014850,1,0.870240637595548,0,21,response to muscle activity,BP,
5235,GO:0014852,1,0.99298720592179,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5236,GO:0014853,1,0.99298720592179,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5237,GO:0014854,1,0.920675015087147,0,13,response to inactivity,BP,
5238,GO:0014855,1,0.664258077439113,0,59,striated muscle cell proliferation,BP,
5239,GO:0014856,1,0.908083572882638,0,14,skeletal muscle cell proliferation,BP,
5240,GO:0014857,1,0.915208847388419,0,13,regulation of skeletal muscle cell proliferation,BP,
5241,GO:0014858,1,0.980350935680996,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5242,GO:0014859,1,0.978297907826884,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5243,GO:0014861,1,0.992420411501682,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5244,GO:0014862,1,0.992361198544908,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5245,GO:0014866,1,0.919337245659574,0,12,skeletal myofibril assembly,BP,
5246,GO:0014870,1,0.937014773750027,0,10,response to muscle inactivity,BP,
5247,GO:0014873,1,0.988509622166653,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5248,GO:0014874,1,0.91446657919639,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5249,GO:0014876,1,0.995644392572973,0,1,response to injury involved in regulation of muscle adaptation,BP,
5250,GO:0014877,1,0.943533085232074,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5251,GO:0014878,1,0.975059368325147,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5252,GO:0014883,1,0.969976069111568,0,5,transition between fast and slow fiber,BP,
5253,GO:0014886,1,0.992647650005318,0,1,transition between slow and fast fiber,BP,
5254,GO:0014887,1,0.855578256853541,0,22,cardiac muscle adaptation,BP,
5255,GO:0014888,1,0.766341776526072,0,40,striated muscle adaptation,BP,
5256,GO:0014889,1,0.929027581964567,0,12,muscle atrophy,BP,
5257,GO:0014891,1,0.951828064979707,0,8,striated muscle atrophy,BP,
5258,GO:0014894,1,0.943533085232074,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5259,GO:0014895,1,0.996483460864596,0,1,smooth muscle hypertrophy,BP,
5260,GO:0014896,1,0.609353690033494,0,72,muscle hypertrophy,BP,
5261,GO:0014897,1,0.615814238051546,0,70,striated muscle hypertrophy,BP,
5262,GO:0014898,1,0.855578256853541,0,22,cardiac muscle hypertrophy in response to stress,BP,
5263,GO:0014900,1,0.978624391971067,0,4,muscle hyperplasia,BP,
5264,GO:0014901,1,0.988319632272777,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5265,GO:0014902,1,0.556969307428531,0,88,myotube differentiation,BP,
5266,GO:0014904,1,0.819042178905981,0,30,myotube cell development,BP,
5267,GO:0014908,1,0.987322443392452,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5268,GO:0014909,1,0.642727287578937,0,63,smooth muscle cell migration,BP,
5269,GO:0014910,1,0.678851397077953,0,55,regulation of smooth muscle cell migration,BP,
5270,GO:0014911,1,0.807472310495243,0,30,positive regulation of smooth muscle cell migration,BP,
5271,GO:0014912,1,0.869361156823918,0,21,negative regulation of smooth muscle cell migration,BP,
5272,GO:0014916,1,0.979046086407574,0,3,regulation of lung blood pressure,BP,
5273,GO:0015002,1,0.917154745194999,0,22,heme-copper terminal oxidase activity,MF,
5274,GO:0015012,1,0.833569339857569,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5275,GO:0015014,1,0.955514050839714,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5276,GO:0015015,1,0.958091288457476,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5277,GO:0015016,1,0.970011463505153,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5278,GO:0015018,1,0.982893164575833,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5279,GO:0015019,1,0.992433166955736,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5280,GO:0015020,1,0.909246397928964,0,14,glucuronosyltransferase activity,MF,
5281,GO:0015026,1,0.788056474349101,0,36,coreceptor activity,MF,
5282,GO:0015030,1,0.718623128113817,0,53,Cajal body,CC,
5284,GO:0015035,1,0.902678886819208,0,20,protein disulfide oxidoreductase activity,MF,
5285,GO:0015036,1,0.823153132296974,0,36,disulfide oxidoreductase activity,MF,
5286,GO:0015037,1,0.93476061585298,0,13,peptide disulfide oxidoreductase activity,MF,
5287,GO:0015038,1,0.977979551446129,0,5,glutathione disulfide oxidoreductase activity,MF,
5288,GO:0015039,1,0.994758585258665,0,1,NADPH-adrenodoxin reductase activity,MF,
5289,GO:0015052,1,0.993314385620213,0,1,beta3-adrenergic receptor activity,MF,
5290,GO:0015054,1,0.994313075102455,0,1,gastrin receptor activity,MF,
5291,GO:0015056,1,0.988608758492499,0,2,corticotrophin-releasing factor receptor activity,MF,
5292,GO:0015057,1,0.965297673511535,0,5,thrombin-activated receptor activity,MF,
5293,GO:0015065,1,0.983769836563306,0,3,uridine nucleotide receptor activity,MF,
5294,GO:0015067,1,0.993403709912039,0,1,amidinotransferase activity,MF,
5295,GO:0015068,1,0.993403709912039,0,1,glycine amidinotransferase activity,MF,
5296,GO:0015074,1,0.934217127621921,0,10,DNA integration,BP,
5299,GO:0015078,1,0.561947020041916,0,97,proton transmembrane transporter activity,MF,
5303,GO:0015086,1,0.992495950313024,0,1,cadmium ion transmembrane transporter activity,MF,
5304,GO:0015087,1,0.992495950313024,0,1,cobalt ion transmembrane transporter activity,MF,
5305,GO:0015091,1,0.978609682097444,0,3,ferric iron transmembrane transporter activity,MF,
5306,GO:0015093,1,0.977736517352205,0,3,ferrous iron transmembrane transporter activity,MF,
5307,GO:0015094,1,0.992495950313024,0,1,lead ion transmembrane transporter activity,MF,
5308,GO:0015095,1,0.894190547854805,0,16,magnesium ion transmembrane transporter activity,MF,
5309,GO:0015098,1,0.994757603372113,0,1,molybdate ion transmembrane transporter activity,MF,
5310,GO:0015101,1,0.858476662871089,0,24,organic cation transmembrane transporter activity,MF,
5312,GO:0015105,1,0.995783661766125,0,1,arsenite transmembrane transporter activity,MF,
5315,GO:0015111,1,0.977650886724416,0,3,iodide transmembrane transporter activity,MF,
5316,GO:0015112,1,0.993294749711147,0,1,nitrate transmembrane transporter activity,MF,
5318,GO:0015116,1,0.925171665152929,0,11,sulfate transmembrane transporter activity,MF,
5319,GO:0015117,1,0.994774271506862,0,1,thiosulfate transmembrane transporter activity,MF,
5320,GO:0015119,1,0.979718360158011,0,3,hexose phosphate transmembrane transporter activity,MF,
5321,GO:0015125,1,0.920462496179999,0,13,bile acid transmembrane transporter activity,MF,
5322,GO:0015126,1,0.992464831005232,0,1,canalicular bile acid transmembrane transporter activity,MF,
5323,GO:0015127,1,0.992444797609066,0,1,bilirubin transmembrane transporter activity,MF,
5324,GO:0015129,1,0.967071041273206,0,5,lactate transmembrane transporter activity,MF,
5325,GO:0015130,1,0.992496881829069,0,1,mevalonate transmembrane transporter activity,MF,
5326,GO:0015131,1,0.994774271506862,0,1,oxaloacetate transmembrane transporter activity,MF,
5327,GO:0015132,1,0.992494088677384,0,1,prostaglandin transmembrane transporter activity,MF,
5328,GO:0015136,1,0.992619975020415,0,1,sialic acid transmembrane transporter activity,MF,
5330,GO:0015139,1,0.992991488566786,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5331,GO:0015140,1,0.989784824913428,0,2,malate transmembrane transporter activity,MF,
5334,GO:0015143,1,0.983157507936904,0,3,urate transmembrane transporter activity,MF,
5335,GO:0015144,1,0.810846619071495,0,32,carbohydrate transmembrane transporter activity,MF,
5336,GO:0015145,1,0.875988822045493,0,20,monosaccharide transmembrane transporter activity,MF,
5337,GO:0015149,1,0.882809430509718,0,19,hexose transmembrane transporter activity,MF,
5338,GO:0015152,1,0.994337594357053,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5339,GO:0015154,1,0.979401557966769,0,3,disaccharide transmembrane transporter activity,MF,
5340,GO:0015157,1,0.979401557966769,0,3,oligosaccharide transmembrane transporter activity,MF,
5341,GO:0015165,1,0.941636001029873,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5342,GO:0015166,1,0.950752072077756,0,8,polyol transmembrane transporter activity,MF,
5343,GO:0015168,1,0.97196549827243,0,5,glycerol transmembrane transporter activity,MF,
5346,GO:0015173,1,0.979433986517093,0,3,aromatic amino acid transmembrane transporter activity,MF,
5347,GO:0015174,1,0.930937772853112,0,11,basic amino acid transmembrane transporter activity,MF,
5348,GO:0015175,1,0.825255898938763,0,29,neutral amino acid transmembrane transporter activity,MF,
5350,GO:0015180,1,0.965701154999832,0,5,L-alanine transmembrane transporter activity,MF,
5351,GO:0015181,1,0.961571075677521,0,6,arginine transmembrane transporter activity,MF,
5352,GO:0015182,1,0.98677450068437,0,2,L-asparagine transmembrane transporter activity,MF,
5353,GO:0015183,1,0.973634650861572,0,4,L-aspartate transmembrane transporter activity,MF,
5354,GO:0015184,1,0.980177446906647,0,3,L-cystine transmembrane transporter activity,MF,
5355,GO:0015185,1,0.967697057434459,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5356,GO:0015186,1,0.966824845954422,0,5,L-glutamine transmembrane transporter activity,MF,
5357,GO:0015187,1,0.960967834295255,0,6,glycine transmembrane transporter activity,MF,
5358,GO:0015189,1,0.961571075677521,0,6,L-lysine transmembrane transporter activity,MF,
5359,GO:0015190,1,0.993101958031973,0,1,L-leucine transmembrane transporter activity,MF,
5360,GO:0015191,1,0.993101958031973,0,1,L-methionine transmembrane transporter activity,MF,
5361,GO:0015193,1,0.963953143094828,0,5,L-proline transmembrane transporter activity,MF,
5362,GO:0015194,1,0.947825991187702,0,9,L-serine transmembrane transporter activity,MF,
5363,GO:0015195,1,0.992491325136976,0,1,L-threonine transmembrane transporter activity,MF,
5364,GO:0015196,1,0.993617816321152,0,1,L-tryptophan transmembrane transporter activity,MF,
5365,GO:0015203,1,0.989414600719383,0,2,polyamine transmembrane transporter activity,MF,
5367,GO:0015205,1,0.962445631465071,0,6,nucleobase transmembrane transporter activity,MF,
5368,GO:0015207,1,0.988210667294783,0,2,adenine transmembrane transporter activity,MF,
5369,GO:0015215,1,0.903574592527425,0,16,nucleotide transmembrane transporter activity,MF,
5370,GO:0015216,1,0.925572164285446,0,12,purine nucleotide transmembrane transporter activity,MF,
5371,GO:0015217,1,0.94304453478832,0,9,ADP transmembrane transporter activity,MF,
5372,GO:0015218,1,0.988029767073713,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5373,GO:0015220,1,0.959079132033838,0,6,choline transmembrane transporter activity,MF,
5374,GO:0015222,1,0.98035874266614,0,3,serotonin transmembrane transporter activity,MF,
5375,GO:0015226,1,0.964833295939738,0,6,carnitine transmembrane transporter activity,MF,
5376,GO:0015227,1,0.988656264232898,0,2,acyl carnitine transmembrane transporter activity,MF,
5377,GO:0015228,1,0.980350904648416,0,3,coenzyme A transmembrane transporter activity,MF,
5378,GO:0015229,1,0.992283750874609,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5379,GO:0015230,1,0.986878115176111,0,2,FAD transmembrane transporter activity,MF,
5380,GO:0015232,1,0.94589655718523,0,8,heme transporter activity,MF,
5381,GO:0015234,1,0.980389701900696,0,3,thiamine transmembrane transporter activity,MF,
5383,GO:0015245,1,0.948114860559957,0,8,fatty acid transmembrane transporter activity,MF,
5384,GO:0015247,1,0.977518303845783,0,3,aminophospholipid transmembrane transporter activity,MF,
5385,GO:0015248,1,0.853521357347486,0,25,sterol transporter activity,MF,
5386,GO:0015250,1,0.943850687992416,0,10,water channel activity,MF,
5387,GO:0015252,1,0.981334073322581,0,3,proton channel activity,MF,
5388,GO:0015254,1,0.978680231443472,0,4,glycerol channel activity,MF,
5391,GO:0015269,1,0.905721594027863,0,16,calcium-activated potassium channel activity,MF,
5392,GO:0015271,1,0.903791755929414,0,14,outward rectifier potassium channel activity,MF,
5393,GO:0015272,1,0.965406437485917,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5394,GO:0015275,1,0.977881364969864,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5396,GO:0015277,1,0.963225651757105,0,5,kainate selective glutamate receptor activity,MF,
5397,GO:0015278,1,0.856015580300238,0,21,calcium-release channel activity,MF,
5398,GO:0015279,1,0.936269473605657,0,9,store-operated calcium channel activity,MF,
5399,GO:0015280,1,0.944814589478818,0,8,ligand-gated sodium channel activity,MF,
5400,GO:0015288,1,0.967581425892645,0,6,porin activity,MF,
5402,GO:0015292,1,0.9930956730518,0,1,uniporter activity,MF,
5405,GO:0015295,1,0.870277029594197,0,21,solute:proton symporter activity,MF,
5408,GO:0015298,1,0.803882888229103,0,31,solute:cation antiporter activity,MF,
5409,GO:0015299,1,0.880595737732679,0,18,solute:proton antiporter activity,MF,
5411,GO:0015307,1,0.98205230043165,0,3,drug:proton antiporter activity,MF,
5412,GO:0015315,1,0.979718360158011,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5413,GO:0015317,1,0.995159932180312,0,1,phosphate:proton symporter activity,MF,
5417,GO:0015322,1,0.992515696500163,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5418,GO:0015327,1,0.992063322733495,0,1,cystine:glutamate antiporter activity,MF,
5419,GO:0015328,1,0.992063322733495,0,1,cystine secondary active transmembrane transporter activity,MF,
5420,GO:0015333,1,0.980113393921072,0,3,peptide:proton symporter activity,MF,
5421,GO:0015343,1,0.9930956730518,0,1,siderophore transmembrane transporter activity,MF,
5422,GO:0015347,1,0.861384897539608,0,22,sodium-independent organic anion transmembrane transporter activity,MF,
5423,GO:0015349,1,0.97148584557244,0,4,thyroid hormone transmembrane transporter activity,MF,
5424,GO:0015350,1,0.985400357869193,0,2,methotrexate transmembrane transporter activity,MF,
5425,GO:0015355,1,0.934471498591324,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5426,GO:0015362,1,0.992498868762855,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5427,GO:0015367,1,0.994984610841332,0,1,oxoglutarate:malate antiporter activity,MF,
5428,GO:0015368,1,0.925134420389439,0,11,calcium:cation antiporter activity,MF,
5429,GO:0015369,1,0.992412968345535,0,1,calcium:proton antiporter activity,MF,
5431,GO:0015373,1,0.970571586915991,0,4,anion:sodium symporter activity,MF,
5432,GO:0015375,1,0.985705380612776,0,2,glycine:sodium symporter activity,MF,
5434,GO:0015378,1,0.984817646877803,0,2,sodium:chloride symporter activity,MF,
5436,GO:0015382,1,0.992949794499282,0,1,sodium:sulfate symporter activity,MF,
5437,GO:0015385,1,0.91704342907867,0,12,sodium:proton antiporter activity,MF,
5438,GO:0015386,1,0.929848944173895,0,10,potassium:proton antiporter activity,MF,
5439,GO:0015389,1,0.988602366842377,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5440,GO:0015390,1,0.994100972515824,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5441,GO:0015391,1,0.988602366842377,0,2,nucleobase:cation symporter activity,MF,
5442,GO:0015399,1,0.494770372333461,0,102,primary active transmembrane transporter activity,MF,
5443,GO:0015405,1,0.494770372333461,0,102,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5444,GO:0015410,1,0.977806320783943,0,3,manganese-transporting ATPase activity,MF,
5445,GO:0015420,1,0.99233132566982,0,1,cobalamin-transporting ATPase activity,MF,
5446,GO:0015421,1,0.992545195807672,0,1,oligopeptide-transporting ATPase activity,MF,
5447,GO:0015431,1,0.99233132566982,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5448,GO:0015432,1,0.98506458776214,0,2,bile acid-exporting ATPase activity,MF,
5449,GO:0015433,1,0.985108142263487,0,2,peptide antigen-transporting ATPase activity,MF,
5450,GO:0015439,1,0.992856680677661,0,1,heme-transporting ATPase activity,MF,
5451,GO:0015440,1,0.970805932876284,0,4,peptide-transporting ATPase activity,MF,
5452,GO:0015450,1,0.970668568444898,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5455,GO:0015467,1,0.931913280426709,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5456,GO:0015485,1,0.792890670062358,0,37,cholesterol binding,MF,
5457,GO:0015489,1,0.989414600719383,0,2,putrescine transmembrane transporter activity,MF,
5458,GO:0015491,1,0.818498510734715,0,28,cation:cation antiporter activity,MF,
5459,GO:0015495,1,0.993431463673407,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5460,GO:0015499,1,0.993290687475071,0,1,formate transmembrane transporter activity,MF,
5461,GO:0015501,1,0.9536893323289,0,7,glutamate:sodium symporter activity,MF,
5462,GO:0015526,1,0.979718360158011,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5463,GO:0015538,1,0.992619975020415,0,1,sialic acid:proton symporter activity,MF,
5465,GO:0015562,1,0.978465579931877,0,3,efflux transmembrane transporter activity,MF,
5466,GO:0015578,1,0.993644063609721,0,1,mannose transmembrane transporter activity,MF,
5467,GO:0015605,1,0.859501755488122,0,23,organophosphate ester transmembrane transporter activity,MF,
5468,GO:0015616,1,0.969817607673151,0,4,DNA translocase activity,MF,
5469,GO:0015629,1,0.0446624771604742,0,454,actin cytoskeleton,CC,
5473,GO:0015636,1,0.993923795854944,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5474,GO:0015643,1,0.948320126189296,0,9,toxic substance binding,MF,
5475,GO:0015645,1,0.891581576135753,0,17,fatty acid ligase activity,MF,
5476,GO:0015651,1,0.945413716443227,0,9,quaternary ammonium group transmembrane transporter activity,MF,
5477,GO:0015658,1,0.993101958031973,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5478,GO:0015660,1,0.993290687475071,0,1,formate efflux transmembrane transporter activity,MF,
5479,GO:0015662,1,0.774470256571348,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5480,GO:0015665,1,0.989263627424997,0,2,alcohol transmembrane transporter activity,MF,
5481,GO:0015669,1,0.926454521645686,0,17,gas transport,BP,
5482,GO:0015670,1,0.983327364642848,0,3,carbon dioxide transport,BP,
5483,GO:0015671,1,0.942172511294634,0,14,oxygen transport,BP,
5485,GO:0015677,1,0.944469691788692,0,8,copper ion import,BP,
5486,GO:0015679,1,0.984680309405014,0,2,plasma membrane copper ion transport,BP,
5487,GO:0015680,1,0.985186501712407,0,3,intracellular copper ion transport,BP,
5488,GO:0015682,1,0.793495262033487,0,38,ferric iron transport,BP,
5489,GO:0015684,1,0.977736517352205,0,3,ferrous iron transport,BP,
5490,GO:0015688,1,0.983716751219203,0,3,iron chelate transport,BP,
5491,GO:0015689,1,0.994757603372113,0,1,molybdate ion transport,BP,
5492,GO:0015691,1,0.972473950418166,0,4,cadmium ion transport,BP,
5493,GO:0015692,1,0.992495950313024,0,1,lead ion transport,BP,
5494,GO:0015693,1,0.887405247633481,0,17,magnesium ion transport,BP,
5495,GO:0015694,1,0.992444797609066,0,1,mercury ion transport,BP,
5496,GO:0015695,1,0.782256171083116,0,38,organic cation transport,BP,
5498,GO:0015697,1,0.925877266316511,0,12,quaternary ammonium group transport,BP,
5500,GO:0015700,1,0.995783661766125,0,1,arsenite transport,BP,
5502,GO:0015705,1,0.962348214533219,0,5,iodide transport,BP,
5503,GO:0015706,1,0.993294749711147,0,1,nitrate transport,BP,
5504,GO:0015707,1,0.992504578103526,0,1,nitrite transport,BP,
5505,GO:0015709,1,0.994774271506862,0,1,thiosulfate transport,BP,
5507,GO:0015712,1,0.967991249444046,0,5,hexose phosphate transport,BP,
5508,GO:0015718,1,0.417876799592884,0,133,monocarboxylic acid transport,BP,
5509,GO:0015721,1,0.853395751420022,0,25,bile acid and bile salt transport,BP,
5510,GO:0015722,1,0.970602435624157,0,4,canalicular bile acid transport,BP,
5511,GO:0015723,1,0.992444797609066,0,1,bilirubin transport,BP,
5512,GO:0015724,1,0.993290687475071,0,1,formate transport,BP,
5513,GO:0015727,1,0.959806898708564,0,6,lactate transport,BP,
5514,GO:0015728,1,0.992496881829069,0,1,mevalonate transport,BP,
5515,GO:0015729,1,0.994774271506862,0,1,oxaloacetate transport,BP,
5516,GO:0015732,1,0.919313263226533,0,13,prostaglandin transport,BP,
5517,GO:0015734,1,0.992322459540864,0,1,taurine transport,BP,
5518,GO:0015739,1,0.992619975020415,0,1,sialic acid transport,BP,
5520,GO:0015742,1,0.982400545620456,0,3,alpha-ketoglutarate transport,BP,
5521,GO:0015743,1,0.994774271506862,0,1,malate transport,BP,
5524,GO:0015747,1,0.976710532764861,0,4,urate transport,BP,
5525,GO:0015748,1,0.575928748616336,0,83,organophosphate ester transport,BP,
5526,GO:0015749,1,0.515388983529956,0,97,monosaccharide transmembrane transport,BP,
5527,GO:0015755,1,0.993903895013174,0,1,fructose transmembrane transport,BP,
5528,GO:0015760,1,0.967991249444046,0,5,glucose-6-phosphate transport,BP,
5529,GO:0015761,1,0.993644063609721,0,1,mannose transmembrane transport,BP,
5530,GO:0015766,1,0.979401557966769,0,3,disaccharide transport,BP,
5531,GO:0015770,1,0.979401557966769,0,3,sucrose transport,BP,
5532,GO:0015772,1,0.979401557966769,0,3,oligosaccharide transport,BP,
5533,GO:0015780,1,0.922710781060813,0,13,nucleotide-sugar transmembrane transport,BP,
5534,GO:0015782,1,0.9949207709724,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5535,GO:0015783,1,0.985030220946446,0,2,GDP-fucose transmembrane transport,BP,
5536,GO:0015786,1,0.994005935689679,0,1,UDP-glucose transmembrane transport,BP,
5537,GO:0015787,1,0.992326330131574,0,1,UDP-glucuronic acid transmembrane transport,BP,
5538,GO:0015790,1,0.992296175874829,0,1,UDP-xylose transmembrane transport,BP,
5539,GO:0015791,1,0.936762229488051,0,10,polyol transport,BP,
5540,GO:0015793,1,0.97196549827243,0,5,glycerol transport,BP,
5541,GO:0015797,1,0.993290687475071,0,1,mannitol transport,BP,
5542,GO:0015798,1,0.970303742195234,0,4,myo-inositol transport,BP,
5544,GO:0015801,1,0.966317557193429,0,5,aromatic amino acid transport,BP,
5545,GO:0015802,1,0.927953738388132,0,12,basic amino acid transport,BP,
5548,GO:0015805,1,0.994090826494099,0,1,S-adenosyl-L-methionine transport,BP,
5550,GO:0015808,1,0.965701154999832,0,5,L-alanine transport,BP,
5551,GO:0015809,1,0.951875314338224,0,8,arginine transport,BP,
5552,GO:0015810,1,0.980398844314959,0,3,aspartate transmembrane transport,BP,
5553,GO:0015811,1,0.980177446906647,0,3,L-cystine transport,BP,
5554,GO:0015812,1,0.912601571908966,0,13,gamma-aminobutyric acid transport,BP,
5557,GO:0015817,1,0.986757935237228,0,2,histidine transport,BP,
5558,GO:0015819,1,0.994778185922604,0,1,lysine transport,BP,
5560,GO:0015821,1,0.993101958031973,0,1,methionine transport,BP,
5561,GO:0015822,1,0.961095019499724,0,6,ornithine transport,BP,
5563,GO:0015825,1,0.947825991187702,0,9,L-serine transport,BP,
5564,GO:0015826,1,0.992491325136976,0,1,threonine transport,BP,
5565,GO:0015827,1,0.980313377410674,0,3,tryptophan transport,BP,
5566,GO:0015828,1,0.992714948015017,0,1,tyrosine transport,BP,
5569,GO:0015838,1,0.944899642800419,0,9,amino-acid betaine transport,BP,
5571,GO:0015842,1,0.977202253038882,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5573,GO:0015846,1,0.959735166695642,0,7,polyamine transport,BP,
5574,GO:0015847,1,0.989414600719383,0,2,putrescine transport,BP,
5577,GO:0015851,1,0.958175388031217,0,7,nucleobase transport,BP,
5578,GO:0015853,1,0.983827288543224,0,3,adenine transport,BP,
5579,GO:0015855,1,0.981505681100491,0,3,pyrimidine nucleobase transport,BP,
5580,GO:0015858,1,0.956862975982919,0,7,nucleoside transport,BP,
5581,GO:0015860,1,0.994100972515824,0,1,purine nucleoside transmembrane transport,BP,
5582,GO:0015862,1,0.993884052577415,0,1,uridine transport,BP,
5583,GO:0015864,1,0.988020737139021,0,2,pyrimidine nucleoside transport,BP,
5584,GO:0015865,1,0.907888316918394,0,15,purine nucleotide transport,BP,
5585,GO:0015866,1,0.94304453478832,0,9,ADP transport,BP,
5586,GO:0015867,1,0.935546361166938,0,10,ATP transport,BP,
5587,GO:0015868,1,0.914776451211878,0,14,purine ribonucleotide transport,BP,
5588,GO:0015870,1,0.973986657068316,0,4,acetylcholine transport,BP,
5589,GO:0015871,1,0.950671581248225,0,7,choline transport,BP,
5591,GO:0015874,1,0.901870319601876,0,16,norepinephrine transport,BP,
5592,GO:0015876,1,0.993283400584553,0,1,acetyl-CoA transport,BP,
5593,GO:0015878,1,0.992626888281478,0,1,biotin transport,BP,
5594,GO:0015879,1,0.959358166799417,0,7,carnitine transport,BP,
5595,GO:0015880,1,0.980350904648416,0,3,coenzyme A transport,BP,
5596,GO:0015881,1,0.985074685344285,0,2,creatine transmembrane transport,BP,
5597,GO:0015882,1,0.992283750874609,0,1,L-ascorbic acid transmembrane transport,BP,
5598,GO:0015884,1,0.951742434868036,0,8,folic acid transport,BP,
5599,GO:0015886,1,0.94589655718523,0,8,heme transport,BP,
5600,GO:0015887,1,0.992626888281478,0,1,pantothenate transmembrane transport,BP,
5601,GO:0015888,1,0.978151255605481,0,3,thiamine transport,BP,
5602,GO:0015889,1,0.965908396363968,0,6,cobalamin transport,BP,
5603,GO:0015891,1,0.983716751219203,0,3,siderophore transport,BP,
5605,GO:0015904,1,0.994825894207195,0,1,tetracycline transport,BP,
5606,GO:0015908,1,0.628992568679357,0,71,fatty acid transport,BP,
5607,GO:0015909,1,0.726306854060575,0,50,long-chain fatty acid transport,BP,
5608,GO:0015910,1,0.986508483986553,0,2,peroxisomal long-chain fatty acid import,BP,
5609,GO:0015911,1,0.964403953421378,0,5,plasma membrane long-chain fatty acid transport,BP,
5610,GO:0015912,1,0.993923795854944,0,1,short-chain fatty acid transport,BP,
5611,GO:0015913,1,0.993923795854944,0,1,short-chain fatty acid import,BP,
5612,GO:0015914,1,0.676286708725517,0,58,phospholipid transport,BP,
5613,GO:0015916,1,0.993283400584553,0,1,fatty-acyl-CoA transport,BP,
5614,GO:0015917,1,0.969942552464261,0,4,aminophospholipid transport,BP,
5615,GO:0015918,1,0.619557396193377,0,74,sterol transport,BP,
5616,GO:0015919,1,0.897221347421834,0,16,peroxisomal membrane transport,BP,
5617,GO:0015920,1,0.988163906032368,0,2,lipopolysaccharide transport,BP,
5618,GO:0015922,1,0.995270104706776,0,1,aspartate oxidase activity,MF,
5619,GO:0015923,1,0.902475642222309,0,14,mannosidase activity,MF,
5620,GO:0015924,1,0.936750878450944,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5621,GO:0015925,1,0.95007598215769,0,8,galactosidase activity,MF,
5622,GO:0015926,1,0.931846603720675,0,10,glucosidase activity,MF,
5623,GO:0015928,1,0.988706917849736,0,2,fucosidase activity,MF,
5624,GO:0015929,1,0.926282174540841,0,12,hexosaminidase activity,MF,
5626,GO:0015932,1,0.795971306319222,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5627,GO:0015934,1,0.610449520093223,0,113,large ribosomal subunit,CC,
5628,GO:0015935,1,0.743157128001492,0,69,small ribosomal subunit,CC,
5629,GO:0015936,1,0.912184971665397,0,15,coenzyme A metabolic process,BP,
5630,GO:0015937,1,0.943608886882717,0,10,coenzyme A biosynthetic process,BP,
5631,GO:0015938,1,0.996131220855828,0,1,coenzyme A catabolic process,BP,
5632,GO:0015939,1,0.951820179446011,0,8,pantothenate metabolic process,BP,
5633,GO:0015942,1,0.963698747248408,0,6,formate metabolic process,BP,
5634,GO:0015949,1,0.83372873702987,0,32,nucleobase-containing small molecule interconversion,BP,
5635,GO:0015950,1,0.99025055154854,0,2,purine nucleotide interconversion,BP,
5636,GO:0015951,1,0.99025055154854,0,2,purine ribonucleotide interconversion,BP,
5637,GO:0015959,1,0.957277652611448,0,7,diadenosine polyphosphate metabolic process,BP,
5638,GO:0015960,1,0.98010948111784,0,3,diadenosine polyphosphate biosynthetic process,BP,
5639,GO:0015961,1,0.976709538622527,0,4,diadenosine polyphosphate catabolic process,BP,
5640,GO:0015965,1,0.98010948111784,0,3,diadenosine tetraphosphate metabolic process,BP,
5641,GO:0015966,1,0.98010948111784,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5643,GO:0015985,1,0.949196524915022,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5644,GO:0015986,1,0.949196524915022,0,9,ATP synthesis coupled proton transport,BP,
5645,GO:0015988,1,0.844240125240199,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5646,GO:0015990,1,0.996380268640864,0,1,electron transport coupled proton transport,BP,
5647,GO:0015991,1,0.847312362006201,0,27,ATP hydrolysis coupled proton transport,BP,
5648,GO:0016004,1,0.946988115166649,0,9,phospholipase activator activity,MF,
5649,GO:0016005,1,0.985903012570205,0,2,phospholipase A2 activator activity,MF,
5650,GO:0016010,1,0.877527738558899,0,20,dystrophin-associated glycoprotein complex,CC,
5651,GO:0016011,1,0.958027293128634,0,7,dystroglycan complex,CC,
5652,GO:0016012,1,0.965373531583602,0,6,sarcoglycan complex,CC,
5653,GO:0016013,1,0.975835400694843,0,4,syntrophin complex,CC,
5654,GO:0016015,1,0.96810603712315,0,6,morphogen activity,MF,
5655,GO:0016018,1,0.943250332183599,0,10,cyclosporin A binding,MF,
5656,GO:0016019,1,0.991540103437705,0,2,peptidoglycan receptor activity,MF,
5659,GO:0016024,1,0.925903870597327,0,11,CDP-diacylglycerol biosynthetic process,BP,
5660,GO:0016028,1,0.992525081295466,0,1,rhabdomere,CC,
5661,GO:0016031,1,0.992592558685411,0,1,tRNA import into mitochondrion,BP,
5662,GO:0016032,1,0.0095889817660188,0,736,viral process,BP,
5663,GO:0016034,1,0.99570649754465,0,1,maleylacetoacetate isomerase activity,MF,
5664,GO:0016035,1,0.987986816920182,0,2,zeta DNA polymerase complex,CC,
5665,GO:0016036,1,0.994006942278645,0,1,cellular response to phosphate starvation,BP,
5666,GO:0016037,1,0.993120337670458,0,1,light absorption,BP,
5667,GO:0016038,1,0.993120337670458,0,1,absorption of visible light,BP,
5670,GO:0016045,1,0.931132295270116,0,10,detection of bacterium,BP,
5671,GO:0016046,1,0.992397610851452,0,1,detection of fungus,BP,
5672,GO:0016048,1,0.888298349742644,0,18,detection of temperature stimulus,BP,
5676,GO:0016052,1,0.341615713675363,0,163,carbohydrate catabolic process,BP,
5680,GO:0016056,1,0.85794226843133,0,23,rhodopsin mediated signaling pathway,BP,
5681,GO:0016062,1,0.993441960566051,0,1,adaptation of rhodopsin mediated signaling,BP,
5682,GO:0016064,1,0.570212890654217,0,90,immunoglobulin mediated immune response,BP,
5683,GO:0016068,1,0.985282502592497,0,3,type I hypersensitivity,BP,
5686,GO:0016072,1,0.213635566871662,0,279,rRNA metabolic process,BP,
5687,GO:0016073,1,0.60251943411089,0,84,snRNA metabolic process,BP,
5688,GO:0016074,1,0.944238128676302,0,12,snoRNA metabolic process,BP,
5689,GO:0016075,1,0.911938906595291,0,16,rRNA catabolic process,BP,
5690,GO:0016077,1,0.992364374867111,0,1,snoRNA catabolic process,BP,
5691,GO:0016078,1,0.969793249880182,0,6,tRNA catabolic process,BP,
5693,GO:0016080,1,0.970132809429427,0,4,synaptic vesicle targeting,BP,
5696,GO:0016093,1,0.956125416139954,0,8,polyprenol metabolic process,BP,
5697,GO:0016094,1,0.978530827246305,0,3,polyprenol biosynthetic process,BP,
5698,GO:0016095,1,0.98452431503574,0,3,polyprenol catabolic process,BP,
5699,GO:0016098,1,0.990530127741724,0,2,monoterpenoid metabolic process,BP,
5700,GO:0016101,1,0.618950882315935,0,77,diterpenoid metabolic process,BP,
5701,GO:0016102,1,0.946158236902607,0,9,diterpenoid biosynthetic process,BP,
5702,GO:0016103,1,0.983150099665392,0,3,diterpenoid catabolic process,BP,
5703,GO:0016107,1,0.991182289855314,0,2,sesquiterpenoid catabolic process,BP,
5704,GO:0016108,1,0.979587896041475,0,3,tetraterpenoid metabolic process,BP,
5705,GO:0016109,1,0.993354321866076,0,1,tetraterpenoid biosynthetic process,BP,
5706,GO:0016114,1,0.916421549966072,0,14,terpenoid biosynthetic process,BP,
5707,GO:0016115,1,0.974479467548476,0,5,terpenoid catabolic process,BP,
5708,GO:0016116,1,0.979587896041475,0,3,carotenoid metabolic process,BP,
5709,GO:0016117,1,0.993354321866076,0,1,carotenoid biosynthetic process,BP,
5710,GO:0016119,1,0.986142410906011,0,2,carotene metabolic process,BP,
5711,GO:0016121,1,0.992998889487678,0,1,carotene catabolic process,BP,
5712,GO:0016122,1,0.986399267117778,0,2,xanthophyll metabolic process,BP,
5713,GO:0016123,1,0.993354321866076,0,1,xanthophyll biosynthetic process,BP,
5714,GO:0016125,1,0.421051936802283,0,133,sterol metabolic process,BP,
5715,GO:0016126,1,0.644896517267875,0,68,sterol biosynthetic process,BP,
5716,GO:0016127,1,0.948361606372265,0,9,sterol catabolic process,BP,
5717,GO:0016128,1,0.982006005564709,0,3,phytosteroid metabolic process,BP,
5718,GO:0016129,1,0.982006005564709,0,3,phytosteroid biosynthetic process,BP,
5719,GO:0016131,1,0.993290687475071,0,1,brassinosteroid metabolic process,BP,
5720,GO:0016132,1,0.993290687475071,0,1,brassinosteroid biosynthetic process,BP,
5721,GO:0016137,1,0.912092204922607,0,17,glycoside metabolic process,BP,
5722,GO:0016139,1,0.952516736591894,0,8,glycoside catabolic process,BP,
5723,GO:0016149,1,0.992518065227422,0,1,translation release factor activity, codon specific,MF,
5724,GO:0016150,1,0.995270104706776,0,1,translation release factor activity, codon nonspecific,MF,
5725,GO:0016151,1,0.98916199147947,0,2,nickel cation binding,MF,
5726,GO:0016153,1,0.992597529215744,0,1,urocanate hydratase activity,MF,
5727,GO:0016154,1,0.995198286271971,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5728,GO:0016155,1,0.98501540375951,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5729,GO:0016160,1,0.981860532368261,0,3,amylase activity,MF,
5730,GO:0016165,1,0.987193472153629,0,2,linoleate 13S-lipoxygenase activity,MF,
5731,GO:0016167,1,0.984979956896265,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5732,GO:0016174,1,0.95855629869592,0,6,NAD(P)H oxidase activity,MF,
5733,GO:0016175,1,0.957615707223448,0,7,superoxide-generating NADPH oxidase activity,MF,
5734,GO:0016176,1,0.95416323683125,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5735,GO:0016180,1,0.868050841341328,0,23,snRNA processing,BP,
5736,GO:0016182,1,0.992462896762271,0,1,synaptic vesicle budding from endosome,BP,
5739,GO:0016189,1,0.992194893954347,0,1,synaptic vesicle to endosome fusion,BP,
5740,GO:0016191,1,0.964482989711676,0,5,synaptic vesicle uncoating,BP,
5743,GO:0016198,1,0.957829401454801,0,6,axon choice point recognition,BP,
5744,GO:0016199,1,0.969998435730114,0,4,axon midline choice point recognition,BP,
5745,GO:0016202,1,0.457697536329165,0,115,regulation of striated muscle tissue development,BP,
5746,GO:0016206,1,0.986842589114962,0,2,catechol O-methyltransferase activity,MF,
5747,GO:0016208,1,0.9423048078486,0,10,AMP binding,MF,
5748,GO:0016209,1,0.685188976049467,0,71,antioxidant activity,MF,
5749,GO:0016211,1,0.984962157232859,0,2,ammonia ligase activity,MF,
5750,GO:0016212,1,0.987784741083347,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5751,GO:0016213,1,0.99271425012845,0,1,linoleoyl-CoA desaturase activity,MF,
5752,GO:0016215,1,0.978678246745685,0,3,acyl-CoA desaturase activity,MF,
5753,GO:0016222,1,0.986460113798056,0,2,procollagen-proline 4-dioxygenase complex,CC,
5754,GO:0016226,1,0.898531293689968,0,20,iron-sulfur cluster assembly,BP,
5756,GO:0016230,1,0.988201140640558,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5757,GO:0016231,1,0.992440547150207,0,1,beta-N-acetylglucosaminidase activity,MF,
5758,GO:0016232,1,0.993052817825418,0,1,HNK-1 sulfotransferase activity,MF,
5759,GO:0016233,1,0.761563332879713,0,42,telomere capping,BP,
5761,GO:0016235,1,0.754402840345431,0,41,aggresome,CC,
5762,GO:0016236,1,0.164017266521042,0,278,macroautophagy,BP,
5763,GO:0016237,1,0.992452426779513,0,1,lysosomal microautophagy,BP,
5764,GO:0016239,1,0.676533629309001,0,57,positive regulation of macroautophagy,BP,
5765,GO:0016240,1,0.974547082446538,0,4,autophagosome membrane docking,BP,
5766,GO:0016241,1,0.360127989280261,0,155,regulation of macroautophagy,BP,
5767,GO:0016242,1,0.833081938478152,0,27,negative regulation of macroautophagy,BP,
5768,GO:0016243,1,0.992500155709995,0,1,regulation of autophagosome size,BP,
5769,GO:0016246,1,0.904396422930383,0,15,RNA interference,BP,
5771,GO:0016248,1,0.819296281523387,0,32,channel inhibitor activity,MF,
5772,GO:0016250,1,0.993117488637468,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5773,GO:0016254,1,0.911403807963027,0,16,preassembly of GPI anchor in ER membrane,BP,
5774,GO:0016255,1,0.957109449355947,0,7,attachment of GPI anchor to protein,BP,
5775,GO:0016256,1,0.988259249014411,0,2,N-glycan processing to lysosome,BP,
5776,GO:0016259,1,0.974791414146229,0,4,selenocysteine metabolic process,BP,
5777,GO:0016260,1,0.987442639479654,0,2,selenocysteine biosynthetic process,BP,
5778,GO:0016262,1,0.980444732363182,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5779,GO:0016263,1,0.989643321168773,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5780,GO:0016264,1,0.933038852821274,0,10,gap junction assembly,BP,
5781,GO:0016266,1,0.722303013268253,0,48,O-glycan processing,BP,
5782,GO:0016267,1,0.989643321168773,0,2,O-glycan processing, core 1,BP,
5783,GO:0016272,1,0.972330754372569,0,7,prefoldin complex,CC,
5784,GO:0016273,1,0.92648414366598,0,12,arginine N-methyltransferase activity,MF,
5785,GO:0016274,1,0.92648414366598,0,12,protein-arginine N-methyltransferase activity,MF,
5786,GO:0016277,1,0.993741255981152,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5787,GO:0016278,1,0.699932911249317,0,51,lysine N-methyltransferase activity,MF,
5788,GO:0016279,1,0.704816527866223,0,50,protein-lysine N-methyltransferase activity,MF,
5789,GO:0016281,1,0.943336299387504,0,9,eukaryotic translation initiation factor 4F complex,CC,
5790,GO:0016282,1,0.99248272463869,0,1,eukaryotic 43S preinitiation complex,CC,
5791,GO:0016286,1,0.975690927439636,0,4,small conductance calcium-activated potassium channel activity,MF,
5792,GO:0016287,1,0.993235666408232,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5793,GO:0016289,1,0.910230075463407,0,17,CoA hydrolase activity,MF,
5794,GO:0016290,1,0.951775635738818,0,9,palmitoyl-CoA hydrolase activity,MF,
5795,GO:0016295,1,0.987220316088634,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5796,GO:0016296,1,0.987220316088634,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5797,GO:0016297,1,0.987220316088634,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5799,GO:0016300,1,0.978458944353432,0,3,tRNA (uracil) methyltransferase activity,MF,
5801,GO:0016303,1,0.773760741219435,0,37,1-phosphatidylinositol-3-kinase activity,MF,
5802,GO:0016307,1,0.899108560030566,0,15,phosphatidylinositol phosphate kinase activity,MF,
5803,GO:0016308,1,0.959519942815339,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5804,GO:0016309,1,0.985297375774833,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5807,GO:0016312,1,0.972137595500911,0,4,inositol bisphosphate phosphatase activity,MF,
5808,GO:0016314,1,0.979882991644287,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5809,GO:0016316,1,0.984861181183125,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5810,GO:0016320,1,0.98801620837769,0,2,endoplasmic reticulum membrane fusion,BP,
5811,GO:0016321,1,0.97398244082837,0,4,female meiosis chromosome segregation,BP,
5812,GO:0016322,1,0.934489507516041,0,10,neuron remodeling,BP,
5815,GO:0016327,1,0.906369698566941,0,16,apicolateral plasma membrane,CC,
5816,GO:0016328,1,0.682703275391159,0,56,lateral plasma membrane,CC,
5817,GO:0016331,1,0.380713195937414,0,143,morphogenesis of embryonic epithelium,BP,
5818,GO:0016332,1,0.992502622493449,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5819,GO:0016333,1,0.992903548761955,0,1,morphogenesis of follicular epithelium,BP,
5820,GO:0016334,1,0.992903548761955,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5821,GO:0016338,1,0.898110530816565,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5823,GO:0016340,1,0.984708399673331,0,2,calcium-dependent cell-matrix adhesion,BP,
5824,GO:0016342,1,0.814834322824597,0,28,catenin complex,CC,
5825,GO:0016344,1,0.978180824859167,0,3,meiotic chromosome movement towards spindle pole,BP,
5827,GO:0016361,1,0.972769834516371,0,4,activin receptor activity, type I,MF,
5828,GO:0016362,1,0.983873699802741,0,2,activin receptor activity, type II,MF,
5830,GO:0016401,1,0.974854355515544,0,4,palmitoyl-CoA oxidase activity,MF,
5831,GO:0016402,1,0.986959007960127,0,2,pristanoyl-CoA oxidase activity,MF,
5832,GO:0016403,1,0.988247058363933,0,2,dimethylargininase activity,MF,
5833,GO:0016404,1,0.985666668844309,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5834,GO:0016405,1,0.860592194099096,0,22,CoA-ligase activity,MF,
5835,GO:0016406,1,0.958039738514511,0,6,carnitine O-acyltransferase activity,MF,
5836,GO:0016407,1,0.542628394753389,0,94,acetyltransferase activity,MF,
5837,GO:0016408,1,0.903324090530035,0,17,C-acyltransferase activity,MF,
5838,GO:0016409,1,0.777218047020388,0,38,palmitoyltransferase activity,MF,
5839,GO:0016410,1,0.547220867426503,0,92,N-acyltransferase activity,MF,
5840,GO:0016411,1,0.86639664043881,0,21,acylglycerol O-acyltransferase activity,MF,
5841,GO:0016413,1,0.953008717771384,0,7,O-acetyltransferase activity,MF,
5842,GO:0016414,1,0.992654224949752,0,1,O-octanoyltransferase activity,MF,
5843,GO:0016415,1,0.988877222462377,0,2,octanoyltransferase activity,MF,
5844,GO:0016416,1,0.964563490320813,0,5,O-palmitoyltransferase activity,MF,
5845,GO:0016417,1,0.817275028052506,0,31,S-acyltransferase activity,MF,
5846,GO:0016418,1,0.984704062469324,0,2,S-acetyltransferase activity,MF,
5847,GO:0016419,1,0.986856486720343,0,2,S-malonyltransferase activity,MF,
5848,GO:0016420,1,0.986856486720343,0,2,malonyltransferase activity,MF,
5849,GO:0016421,1,0.967039765823145,0,5,CoA carboxylase activity,MF,
5850,GO:0016422,1,0.982166041583218,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5851,GO:0016423,1,0.920945228159683,0,13,tRNA (guanine) methyltransferase activity,MF,
5852,GO:0016426,1,0.980745549264334,0,3,tRNA (adenine) methyltransferase activity,MF,
5853,GO:0016427,1,0.949931613864001,0,8,tRNA (cytosine) methyltransferase activity,MF,
5854,GO:0016428,1,0.974536756997577,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5855,GO:0016429,1,0.980745549264334,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5856,GO:0016433,1,0.965409667144224,0,6,rRNA (adenine) methyltransferase activity,MF,
5857,GO:0016434,1,0.978939954050349,0,3,rRNA (cytosine) methyltransferase activity,MF,
5858,GO:0016435,1,0.981675215391797,0,3,rRNA (guanine) methyltransferase activity,MF,
5859,GO:0016436,1,0.98539978584268,0,2,rRNA (uridine) methyltransferase activity,MF,
5860,GO:0016441,1,0.456767383505715,0,121,posttranscriptional gene silencing,BP,
5861,GO:0016442,1,0.924456659378916,0,11,RISC complex,CC,
5862,GO:0016444,1,0.708152657542186,0,51,somatic cell DNA recombination,BP,
5863,GO:0016445,1,0.725462314269414,0,48,somatic diversification of immunoglobulins,BP,
5864,GO:0016446,1,0.929089329373958,0,11,somatic hypermutation of immunoglobulin genes,BP,
5865,GO:0016447,1,0.750234993862926,0,43,somatic recombination of immunoglobulin gene segments,BP,
5866,GO:0016453,1,0.977956980988447,0,4,C-acetyltransferase activity,MF,
5867,GO:0016454,1,0.966211119615355,0,5,C-palmitoyltransferase activity,MF,
5868,GO:0016458,1,0.250204913207613,0,212,gene silencing,BP,
5869,GO:0016459,1,0.657574371766345,0,61,myosin complex,CC,
5870,GO:0016460,1,0.835815255683317,0,27,myosin II complex,CC,
5871,GO:0016461,1,0.935587395258128,0,10,unconventional myosin complex,CC,
5873,GO:0016469,1,0.856019385525604,0,28,proton-transporting two-sector ATPase complex,CC,
5874,GO:0016471,1,0.91551466447547,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5875,GO:0016476,1,0.979149295030979,0,3,regulation of embryonic cell shape,BP,
5877,GO:0016479,1,0.973811945946122,0,4,negative regulation of transcription by RNA polymerase I,BP,
5878,GO:0016480,1,0.984684424121776,0,3,negative regulation of transcription by RNA polymerase III,BP,
5879,GO:0016482,1,0.39281410022187,0,136,cytosolic transport,BP,
5882,GO:0016487,1,0.991182289855314,0,2,farnesol metabolic process,BP,
5883,GO:0016488,1,0.991182289855314,0,2,farnesol catabolic process,BP,
5885,GO:0016492,1,0.987824135976439,0,2,G-protein coupled neurotensin receptor activity,MF,
5886,GO:0016493,1,0.941244187955903,0,10,C-C chemokine receptor activity,MF,
5887,GO:0016494,1,0.953307323810373,0,8,C-X-C chemokine receptor activity,MF,
5888,GO:0016495,1,0.992697962954806,0,1,C-X3-C chemokine receptor activity,MF,
5889,GO:0016496,1,0.992653115385843,0,1,substance P receptor activity,MF,
5890,GO:0016497,1,0.993718177000479,0,1,substance K receptor activity,MF,
5891,GO:0016499,1,0.994545112371257,0,1,orexin receptor activity,MF,
5892,GO:0016500,1,0.933487000178891,0,10,protein-hormone receptor activity,MF,
5893,GO:0016501,1,0.987332255420518,0,2,prostacyclin receptor activity,MF,
5894,GO:0016502,1,0.894585419449205,0,19,nucleotide receptor activity,MF,
5895,GO:0016503,1,0.99574749633392,0,1,pheromone receptor activity,MF,
5896,GO:0016504,1,0.808952689078112,0,35,peptidase activator activity,MF,
5897,GO:0016505,1,0.901855354599359,0,17,peptidase activator activity involved in apoptotic process,MF,
5898,GO:0016507,1,0.992796358704659,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5899,GO:0016508,1,0.978684631715203,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5900,GO:0016509,1,0.980558193254702,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5901,GO:0016514,1,0.90669227298289,0,15,SWI/SNF complex,CC,
5902,GO:0016517,1,0.994582429640857,0,1,interleukin-12 receptor activity,MF,
5903,GO:0016519,1,0.994488396173548,0,1,gastric inhibitory peptide receptor activity,MF,
5904,GO:0016520,1,0.988168486471442,0,2,growth hormone-releasing hormone receptor activity,MF,
5905,GO:0016521,1,0.992704304506391,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5906,GO:0016525,1,0.564868484782158,0,85,negative regulation of angiogenesis,BP,
5907,GO:0016528,1,0.633518300021164,0,68,sarcoplasm,CC,
5908,GO:0016529,1,0.673683132738697,0,59,sarcoplasmic reticulum,CC,
5909,GO:0016530,1,0.963792055634407,0,7,metallochaperone activity,MF,
5910,GO:0016531,1,0.978083890306388,0,5,copper chaperone activity,MF,
5911,GO:0016532,1,0.984555086518548,0,3,superoxide dismutase copper chaperone activity,MF,
5912,GO:0016533,1,0.982175458677837,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5913,GO:0016534,1,0.98615916045369,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5914,GO:0016538,1,0.845887097462663,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5915,GO:0016539,1,0.995345054077821,0,1,intein-mediated protein splicing,BP,
5916,GO:0016540,1,0.918111370629189,0,13,protein autoprocessing,BP,
5917,GO:0016553,1,0.917614970190805,0,14,base conversion or substitution editing,BP,
5918,GO:0016554,1,0.95128507318851,0,9,cytidine to uridine editing,BP,
5919,GO:0016556,1,0.911904965610428,0,15,mRNA modification,BP,
5920,GO:0016557,1,0.984002590486394,0,3,peroxisome membrane biogenesis,BP,
5921,GO:0016558,1,0.924102292823076,0,12,protein import into peroxisome matrix,BP,
5922,GO:0016559,1,0.952727973480927,0,9,peroxisome fission,BP,
5923,GO:0016560,1,0.972692267396527,0,4,protein import into peroxisome matrix, docking,BP,
5924,GO:0016561,1,0.987290599544134,0,2,protein import into peroxisome matrix, translocation,BP,
5926,GO:0016569,1,0.0529062900242302,0,426,covalent chromatin modification,BP,
5927,GO:0016570,1,0.0560931500608213,0,418,histone modification,BP,
5928,GO:0016571,1,0.429930812970315,0,122,histone methylation,BP,
5929,GO:0016572,1,0.802524729977248,0,34,histone phosphorylation,BP,
5930,GO:0016573,1,0.399056095728579,0,137,histone acetylation,BP,
5931,GO:0016574,1,0.744377452991102,0,43,histone ubiquitination,BP,
5932,GO:0016575,1,0.571129429730393,0,83,histone deacetylation,BP,
5933,GO:0016576,1,0.960251211515534,0,6,histone dephosphorylation,BP,
5934,GO:0016577,1,0.816493029139629,0,27,histone demethylation,BP,
5935,GO:0016578,1,0.860372032363712,0,22,histone deubiquitination,BP,
5936,GO:0016579,1,0.198357210924095,0,249,protein deubiquitination,BP,
5937,GO:0016580,1,0.920996613829623,0,12,Sin3 complex,CC,
5938,GO:0016581,1,0.885006886998793,0,17,NuRD complex,CC,
5939,GO:0016584,1,0.961583893556703,0,7,nucleosome positioning,BP,
5940,GO:0016586,1,0.98477484408713,0,2,RSC-type complex,CC,
5941,GO:0016589,1,0.953842808309748,0,7,NURF complex,CC,
5942,GO:0016590,1,0.99236785925964,0,1,ACF complex,CC,
5943,GO:0016591,1,0.512216360408857,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5944,GO:0016592,1,0.800065160238831,0,36,mediator complex,CC,
5945,GO:0016593,1,0.947730961856692,0,8,Cdc73/Paf1 complex,CC,
5948,GO:0016596,1,0.9930956730518,0,1,thienylcyclohexylpiperidine binding,MF,
5950,GO:0016598,1,0.989029715896362,0,2,protein arginylation,BP,
5951,GO:0016600,1,0.936726587716095,0,9,flotillin complex,CC,
5952,GO:0016601,1,0.778871891240636,0,37,Rac protein signal transduction,BP,
5953,GO:0016602,1,0.97550645799311,0,4,CCAAT-binding factor complex,CC,
5954,GO:0016603,1,0.989372892134738,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5958,GO:0016608,1,0.993182279278975,0,2,growth hormone-releasing hormone activity,MF,
5959,GO:0016614,1,0.508934839218555,0,117,oxidoreductase activity, acting on CH-OH group of donors,MF,
5960,GO:0016615,1,0.959767014260294,0,7,malate dehydrogenase activity,MF,
5961,GO:0016616,1,0.558895594217734,0,103,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5962,GO:0016618,1,0.982283970450839,0,3,hydroxypyruvate reductase activity,MF,
5963,GO:0016620,1,0.811665663944906,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5964,GO:0016623,1,0.98753231612747,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5965,GO:0016624,1,0.95058471381946,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5966,GO:0016627,1,0.728512657953461,0,53,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5967,GO:0016628,1,0.873995494970864,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5968,GO:0016634,1,0.950524998854027,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5969,GO:0016635,1,0.973281296688662,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5972,GO:0016641,1,0.898421837322174,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5973,GO:0016642,1,0.992506314483297,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5976,GO:0016647,1,0.983353116889759,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5977,GO:0016649,1,0.986542145561582,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5978,GO:0016651,1,0.608280860103803,0,97,oxidoreductase activity, acting on NAD(P)H,MF,
5979,GO:0016652,1,0.988546320375375,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5980,GO:0016653,1,0.916580517301062,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5981,GO:0016655,1,0.800617017592178,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5982,GO:0016657,1,0.99025055154854,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5983,GO:0016661,1,0.968434008574674,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5984,GO:0016662,1,0.993379716894051,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5985,GO:0016667,1,0.739466489478918,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5986,GO:0016668,1,0.928387889387937,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5987,GO:0016670,1,0.947674429275408,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5988,GO:0016671,1,0.942743822715123,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5989,GO:0016672,1,0.991874589953119,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5990,GO:0016675,1,0.911228342112999,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5991,GO:0016676,1,0.917154745194999,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5992,GO:0016679,1,0.961530708904652,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5993,GO:0016681,1,0.967952468197725,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5994,GO:0016684,1,0.799570276246055,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
5995,GO:0016701,1,0.861948928543847,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5996,GO:0016702,1,0.861948928543847,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5997,GO:0016705,1,0.432155374180414,0,129,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5999,GO:0016708,1,0.988233726834153,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6000,GO:0016709,1,0.795520150970844,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6001,GO:0016711,1,0.993367825152927,0,1,flavonoid 3'-monooxygenase activity,MF,
6002,GO:0016712,1,0.894695665209751,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6003,GO:0016713,1,0.989709707622791,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6004,GO:0016714,1,0.966391251228666,0,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6005,GO:0016715,1,0.971245713805227,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016717,1,0.964614819425098,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6007,GO:0016721,1,0.977613666438524,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6008,GO:0016722,1,0.895122569893852,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6009,GO:0016723,1,0.932479474893477,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6010,GO:0016724,1,0.965919540053618,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6011,GO:0016725,1,0.952192517690871,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6012,GO:0016726,1,0.984899167110373,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6013,GO:0016727,1,0.992388791626608,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6014,GO:0016728,1,0.977905378228213,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6015,GO:0016730,1,0.994758585258665,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6016,GO:0016731,1,0.994758585258665,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6018,GO:0016741,1,0.282470683263673,0,193,transferase activity, transferring one-carbon groups,MF,
6019,GO:0016742,1,0.94866555323888,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6020,GO:0016743,1,0.980002879323205,0,3,carboxyl- or carbamoyltransferase activity,MF,
6021,GO:0016744,1,0.983569671780367,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6022,GO:0016746,1,0.238775033428632,0,220,transferase activity, transferring acyl groups,MF,
6023,GO:0016747,1,0.284057836237488,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6024,GO:0016748,1,0.981486826915215,0,3,succinyltransferase activity,MF,
6025,GO:0016749,1,0.988400156472328,0,2,N-succinyltransferase activity,MF,
6026,GO:0016751,1,0.993006365576562,0,1,S-succinyltransferase activity,MF,
6027,GO:0016755,1,0.92543001498179,0,12,transferase activity, transferring amino-acyl groups,MF,
6029,GO:0016758,1,0.317457901783991,0,175,transferase activity, transferring hexosyl groups,MF,
6030,GO:0016763,1,0.75787945640808,0,44,transferase activity, transferring pentosyl groups,MF,
6031,GO:0016765,1,0.748631255909604,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6032,GO:0016768,1,0.995142329008537,0,1,spermine synthase activity,MF,
6036,GO:0016774,1,0.980788501520649,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6037,GO:0016775,1,0.927302068656865,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6038,GO:0016776,1,0.771317377996828,0,41,phosphotransferase activity, phosphate group as acceptor,MF,
6039,GO:0016778,1,0.970484971507558,0,5,diphosphotransferase activity,MF,
6040,GO:0016779,1,0.437867434031604,0,131,nucleotidyltransferase activity,MF,
6041,GO:0016780,1,0.892452029469605,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6042,GO:0016781,1,0.987442639479654,0,2,phosphotransferase activity, paired acceptors,MF,
6044,GO:0016783,1,0.941401043355252,0,12,sulfurtransferase activity,MF,
6045,GO:0016784,1,0.99550371414173,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6046,GO:0016785,1,0.992397349607375,0,1,transferase activity, transferring selenium-containing groups,MF,
6049,GO:0016790,1,0.831773974875134,0,32,thiolester hydrolase activity,MF,
6051,GO:0016793,1,0.992685056253613,0,1,triphosphoric monoester hydrolase activity,MF,
6052,GO:0016794,1,0.99609423804275,0,1,diphosphoric monoester hydrolase activity,MF,
6053,GO:0016796,1,0.723807053939302,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6055,GO:0016799,1,0.88656719837143,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6056,GO:0016801,1,0.917776802017766,0,14,hydrolase activity, acting on ether bonds,MF,
6057,GO:0016802,1,0.979053022684671,0,3,trialkylsulfonium hydrolase activity,MF,
6058,GO:0016803,1,0.937425856338713,0,11,ether hydrolase activity,MF,
6059,GO:0016805,1,0.90439108105426,0,16,dipeptidase activity,MF,
6060,GO:0016807,1,0.9930956730518,0,1,cysteine-type carboxypeptidase activity,MF,
6062,GO:0016811,1,0.591264545293071,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6063,GO:0016812,1,0.951761792751836,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6064,GO:0016813,1,0.948416827492699,0,9,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6066,GO:0016815,1,0.995669135788894,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6069,GO:0016822,1,0.986245311084573,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6070,GO:0016823,1,0.986245311084573,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6071,GO:0016826,1,0.993117488637468,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6075,GO:0016832,1,0.953530576746204,0,8,aldehyde-lyase activity,MF,
6076,GO:0016833,1,0.963020325400714,0,6,oxo-acid-lyase activity,MF,
6077,GO:0016835,1,0.680522815000554,0,66,carbon-oxygen lyase activity,MF,
6078,GO:0016836,1,0.756431561721481,0,48,hydro-lyase activity,MF,
6079,GO:0016838,1,0.983724243625874,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6080,GO:0016840,1,0.930282208782461,0,13,carbon-nitrogen lyase activity,MF,
6081,GO:0016841,1,0.972283660449274,0,5,ammonia-lyase activity,MF,
6082,GO:0016842,1,0.963467984548054,0,7,amidine-lyase activity,MF,
6083,GO:0016843,1,0.9930956730518,0,1,amine-lyase activity,MF,
6084,GO:0016844,1,0.9930956730518,0,1,strictosidine synthase activity,MF,
6085,GO:0016846,1,0.959462746475619,0,9,carbon-sulfur lyase activity,MF,
6087,GO:0016853,1,0.458434704284014,0,132,isomerase activity,MF,
6088,GO:0016854,1,0.911912149534369,0,16,racemase and epimerase activity,MF,
6089,GO:0016855,1,0.993597334811366,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6090,GO:0016857,1,0.934563040402854,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6091,GO:0016859,1,0.832514145526076,0,33,cis-trans isomerase activity,MF,
6092,GO:0016860,1,0.778978023569806,0,43,intramolecular oxidoreductase activity,MF,
6093,GO:0016861,1,0.957992206570101,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6094,GO:0016862,1,0.993150300101914,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6095,GO:0016863,1,0.949077847845928,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6096,GO:0016864,1,0.892368973435796,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6097,GO:0016866,1,0.851709749285175,0,27,intramolecular transferase activity,MF,
6098,GO:0016868,1,0.938287637454499,0,11,intramolecular transferase activity, phosphotransferases,MF,
6099,GO:0016872,1,0.994020037543521,0,1,intramolecular lyase activity,MF,
6100,GO:0016874,1,0.370641625527203,0,149,ligase activity,MF,
6101,GO:0016875,1,0.75214073347509,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6102,GO:0016877,1,0.785111355125167,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6103,GO:0016878,1,0.840179822399693,0,26,acid-thiol ligase activity,MF,
6104,GO:0016879,1,0.728237026201913,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6105,GO:0016880,1,0.978160609315176,0,3,acid-ammonia (or amide) ligase activity,MF,
6106,GO:0016881,1,0.885360086263529,0,18,acid-amino acid ligase activity,MF,
6107,GO:0016882,1,0.988876095988605,0,2,cyclo-ligase activity,MF,
6108,GO:0016884,1,0.936100146059211,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6109,GO:0016885,1,0.954284567092534,0,7,ligase activity, forming carbon-carbon bonds,MF,
6110,GO:0016886,1,0.935601374712069,0,10,ligase activity, forming phosphoric ester bonds,MF,
6111,GO:0016887,1,0.0555080472797996,0,407,ATPase activity,MF,
6112,GO:0016888,1,0.934252590125503,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6113,GO:0016889,1,0.893552480011624,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6114,GO:0016890,1,0.987997514343941,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6115,GO:0016891,1,0.851231346330909,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6116,GO:0016892,1,0.962141741421679,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6117,GO:0016893,1,0.812009541335625,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6118,GO:0016894,1,0.859685948762376,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6119,GO:0016895,1,0.886468620017892,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6120,GO:0016896,1,0.813596969296951,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016898,1,0.987913878787639,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6122,GO:0016899,1,0.980041028379639,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6123,GO:0016900,1,0.992198559349443,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6124,GO:0016901,1,0.985401876654302,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6125,GO:0016903,1,0.767604603309748,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6127,GO:0016909,1,0.980699455201944,0,3,SAP kinase activity,MF,
6129,GO:0016918,1,0.934476502217864,0,13,retinal binding,MF,
6130,GO:0016920,1,0.992273659186067,0,1,pyroglutamyl-peptidase activity,MF,
6131,GO:0016922,1,0.864288075365133,0,21,ligand-dependent nuclear receptor binding,MF,
6132,GO:0016925,1,0.554927231060331,0,88,protein sumoylation,BP,
6133,GO:0016926,1,0.952058942718415,0,7,protein desumoylation,BP,
6134,GO:0016929,1,0.956679693279547,0,6,SUMO-specific protease activity,MF,
6135,GO:0016933,1,0.968301091747149,0,5,extracellularly glycine-gated ion channel activity,MF,
6136,GO:0016934,1,0.968301091747149,0,5,extracellularly glycine-gated chloride channel activity,MF,
6137,GO:0016935,1,0.985382453949032,0,2,glycine-gated chloride channel complex,CC,
6138,GO:0016936,1,0.981675689797549,0,4,galactoside binding,MF,
6139,GO:0016938,1,0.992890804908913,0,1,kinesin I complex,CC,
6140,GO:0016939,1,0.977701042513931,0,3,kinesin II complex,CC,
6141,GO:0016941,1,0.978526813682591,0,3,natriuretic peptide receptor activity,MF,
6142,GO:0016942,1,0.96892087749538,0,5,insulin-like growth factor binding protein complex,CC,
6143,GO:0016964,1,0.991673441697979,0,1,alpha-2 macroglobulin receptor activity,MF,
6144,GO:0016971,1,0.979251437165844,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6145,GO:0016972,1,0.971873846633169,0,4,thiol oxidase activity,MF,
6146,GO:0016973,1,0.925803359943001,0,12,poly(A)+ mRNA export from nucleus,BP,
6147,GO:0016979,1,0.995597130472838,0,1,lipoate-protein ligase activity,MF,
6148,GO:0016990,1,0.993993865113311,0,1,arginine deiminase activity,MF,
6149,GO:0016992,1,0.995173064841884,0,1,lipoate synthase activity,MF,
6150,GO:0016997,1,0.969381515917572,0,5,alpha-sialidase activity,MF,
6151,GO:0016998,1,0.980792326523619,0,4,cell wall macromolecule catabolic process,BP,
6152,GO:0016999,1,0.486890693074907,0,123,antibiotic metabolic process,BP,
6153,GO:0017000,1,0.904844341200354,0,15,antibiotic biosynthetic process,BP,
6154,GO:0017001,1,0.799909844946851,0,42,antibiotic catabolic process,BP,
6155,GO:0017002,1,0.949831216274602,0,7,activin-activated receptor activity,MF,
6156,GO:0017003,1,0.993969773002142,0,1,protein-heme linkage,BP,
6157,GO:0017004,1,0.815666769705849,0,34,cytochrome complex assembly,BP,
6158,GO:0017005,1,0.992524318051586,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6159,GO:0017006,1,0.993969773002142,0,1,protein-tetrapyrrole linkage,BP,
6160,GO:0017014,1,0.918558504912988,0,13,protein nitrosylation,BP,
6161,GO:0017015,1,0.517485226525926,0,98,regulation of transforming growth factor beta receptor signaling pathway,BP,
6163,GO:0017017,1,0.930925501311626,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6164,GO:0017018,1,0.977361293031078,0,3,myosin phosphatase activity,MF,
6165,GO:0017020,1,0.99298720592179,0,1,myosin phosphatase regulator activity,MF,
6166,GO:0017022,1,0.692774098787761,0,57,myosin binding,MF,
6167,GO:0017024,1,0.99626541460386,0,1,myosin I binding,MF,
6168,GO:0017025,1,0.862369065099379,0,25,TBP-class protein binding,MF,
6169,GO:0017034,1,0.964658895674373,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6170,GO:0017038,1,0.313838879247725,0,179,protein import,BP,
6171,GO:0017040,1,0.969643794532655,0,5,N-acylsphingosine amidohydrolase activity,MF,
6172,GO:0017042,1,0.995157298489048,0,1,glycosylceramidase activity,MF,
6173,GO:0017045,1,0.995793304464424,0,1,corticotropin-releasing hormone activity,MF,
6174,GO:0017046,1,0.799586197838339,0,35,peptide hormone binding,MF,
6176,GO:0017049,1,0.87355236686644,0,20,GTP-Rho binding,MF,
6177,GO:0017050,1,0.987738330223016,0,2,D-erythro-sphingosine kinase activity,MF,
6178,GO:0017053,1,0.565522913816635,0,82,transcriptional repressor complex,CC,
6179,GO:0017055,1,0.986333268214324,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6180,GO:0017056,1,0.852531470978719,0,23,structural constituent of nuclear pore,MF,
6181,GO:0017057,1,0.988243112426768,0,2,6-phosphogluconolactonase activity,MF,
6182,GO:0017059,1,0.951161010709911,0,8,serine C-palmitoyltransferase complex,CC,
6183,GO:0017060,1,0.981600439396353,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6184,GO:0017061,1,0.992456319577188,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6185,GO:0017062,1,0.945648644365321,0,9,respiratory chain complex III assembly,BP,
6186,GO:0017064,1,0.988895218888353,0,2,fatty acid amide hydrolase activity,MF,
6187,GO:0017065,1,0.995353256537892,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6188,GO:0017069,1,0.80029805167565,0,38,snRNA binding,MF,
6189,GO:0017070,1,0.937512169730463,0,11,U6 snRNA binding,MF,
6190,GO:0017071,1,0.992522626739562,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6193,GO:0017077,1,0.989131002459761,0,2,oxidative phosphorylation uncoupler activity,MF,
6194,GO:0017080,1,0.822019880758729,0,32,sodium channel regulator activity,MF,
6195,GO:0017081,1,0.910007513858244,0,15,chloride channel regulator activity,MF,
6196,GO:0017082,1,0.9930956730518,0,1,mineralocorticoid receptor activity,MF,
6197,GO:0017084,1,0.992562148440043,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6198,GO:0017085,1,0.904147682235246,0,16,response to insecticide,BP,
6199,GO:0017087,1,0.99250214587588,0,1,mitochondrial processing peptidase complex,CC,
6200,GO:0017089,1,0.988461168441918,0,2,glycolipid transporter activity,MF,
6201,GO:0017090,1,0.992906238791437,0,1,meprin A complex,CC,
6202,GO:0017091,1,0.855823278455319,0,24,AU-rich element binding,MF,
6203,GO:0017095,1,0.977368630430259,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6204,GO:0017098,1,0.987310810201572,0,2,sulfonylurea receptor binding,MF,
6205,GO:0017099,1,0.976098822940349,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6206,GO:0017101,1,0.927413304217464,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6207,GO:0017102,1,0.986194608037143,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6208,GO:0017108,1,0.966291788970183,0,5,5'-flap endonuclease activity,MF,
6209,GO:0017109,1,0.985342744936483,0,2,glutamate-cysteine ligase complex,CC,
6210,GO:0017110,1,0.920549354686061,0,13,nucleoside-diphosphatase activity,MF,
6212,GO:0017112,1,0.707190461210052,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6213,GO:0017113,1,0.992735870788185,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6214,GO:0017116,1,0.978502723311199,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6215,GO:0017119,1,0.91622243340661,0,13,Golgi transport complex,CC,
6216,GO:0017121,1,0.934532187435897,0,10,phospholipid scrambling,BP,
6217,GO:0017124,1,0.437241979008199,0,121,SH3 domain binding,MF,
6218,GO:0017125,1,0.992467984324353,0,1,deoxycytidyl transferase activity,MF,
6219,GO:0017126,1,0.992424290539175,0,1,nucleologenesis,BP,
6220,GO:0017127,1,0.91440101267349,0,15,cholesterol transporter activity,MF,
6221,GO:0017128,1,0.946845701728513,0,8,phospholipid scramblase activity,MF,
6222,GO:0017129,1,0.987628125874238,0,2,triglyceride binding,MF,
6223,GO:0017130,1,0.992295536432322,0,1,poly(C) RNA binding,MF,
6224,GO:0017133,1,0.993838653063675,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6225,GO:0017134,1,0.869643033779299,0,21,fibroblast growth factor binding,MF,
6226,GO:0017136,1,0.899847142326887,0,16,NAD-dependent histone deacetylase activity,MF,
6228,GO:0017143,1,0.986678555093668,0,2,insecticide metabolic process,BP,
6230,GO:0017145,1,0.774479034480508,0,37,stem cell division,BP,
6232,GO:0017147,1,0.808911490404248,0,31,Wnt-protein binding,MF,
6234,GO:0017150,1,0.977177644532811,0,4,tRNA dihydrouridine synthase activity,MF,
6235,GO:0017151,1,0.946687393217523,0,8,DEAD/H-box RNA helicase binding,MF,
6237,GO:0017154,1,0.919637805284747,0,11,semaphorin receptor activity,MF,
6241,GO:0017159,1,0.9822707477695,0,3,pantetheine hydrolase activity,MF,
6242,GO:0017160,1,0.89621274660475,0,16,Ral GTPase binding,MF,
6243,GO:0017161,1,0.984861181183125,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6244,GO:0017162,1,0.940775812527267,0,9,aryl hydrocarbon receptor binding,MF,
6245,GO:0017166,1,0.927421213977408,0,10,vinculin binding,MF,
6246,GO:0017168,1,0.99249955134373,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6247,GO:0017169,1,0.961219706842808,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6249,GO:0017172,1,0.995281897954798,0,1,cysteine dioxygenase activity,MF,
6250,GO:0017174,1,0.996062732145202,0,1,glycine N-methyltransferase activity,MF,
6251,GO:0017176,1,0.965029722480753,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6252,GO:0017177,1,0.992502791315339,0,1,glucosidase II complex,CC,
6253,GO:0017178,1,0.9930956730518,0,1,diphthine-ammonia ligase activity,MF,
6254,GO:0017182,1,0.948756156842066,0,8,peptidyl-diphthamide metabolic process,BP,
6255,GO:0017183,1,0.948756156842066,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6256,GO:0017185,1,0.944655836029446,0,8,peptidyl-lysine hydroxylation,BP,
6257,GO:0017186,1,0.989372892134738,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6258,GO:0017187,1,0.957975743738616,0,8,peptidyl-glutamic acid carboxylation,BP,
6259,GO:0017188,1,0.992378290649057,0,1,aspartate N-acetyltransferase activity,MF,
6260,GO:0017196,1,0.961925570037588,0,6,N-terminal peptidyl-methionine acetylation,BP,
6261,GO:0017198,1,0.991737229061066,0,2,N-terminal peptidyl-serine acetylation,BP,
6262,GO:0018002,1,0.991737229061066,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6263,GO:0018008,1,0.984964855171422,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6264,GO:0018009,1,0.994278334107238,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6265,GO:0018011,1,0.9930956730518,0,1,N-terminal peptidyl-alanine methylation,BP,
6266,GO:0018012,1,0.9930956730518,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6267,GO:0018013,1,0.9930956730518,0,1,N-terminal peptidyl-glycine methylation,BP,
6268,GO:0018016,1,0.9930956730518,0,1,N-terminal peptidyl-proline dimethylation,BP,
6269,GO:0018022,1,0.484852415898006,0,104,peptidyl-lysine methylation,BP,
6270,GO:0018023,1,0.791224189817133,0,35,peptidyl-lysine trimethylation,BP,
6271,GO:0018024,1,0.749947625587186,0,41,histone-lysine N-methyltransferase activity,MF,
6272,GO:0018025,1,0.9930956730518,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6273,GO:0018026,1,0.947957029499907,0,8,peptidyl-lysine monomethylation,BP,
6274,GO:0018027,1,0.905404253504506,0,15,peptidyl-lysine dimethylation,BP,
6275,GO:0018032,1,0.992513811625648,0,1,protein amidation,BP,
6276,GO:0018057,1,0.971170188739646,0,4,peptidyl-lysine oxidation,BP,
6277,GO:0018063,1,0.993969773002142,0,1,cytochrome c-heme linkage,BP,
6279,GO:0018076,1,0.969431547014232,0,4,N-terminal peptidyl-lysine acetylation,BP,
6280,GO:0018094,1,0.992582790591473,0,1,protein polyglycylation,BP,
6281,GO:0018095,1,0.939456525582513,0,9,protein polyglutamylation,BP,
6282,GO:0018101,1,0.979311479796522,0,3,protein citrullination,BP,
6283,GO:0018103,1,0.966821615586552,0,5,protein C-linked glycosylation,BP,
6285,GO:0018106,1,0.99644068843454,0,1,peptidyl-histidine phosphorylation,BP,
6288,GO:0018114,1,0.993597334811366,0,1,threonine racemase activity,MF,
6289,GO:0018117,1,0.995218992452226,0,1,protein adenylylation,BP,
6290,GO:0018119,1,0.918558504912988,0,13,peptidyl-cysteine S-nitrosylation,BP,
6291,GO:0018125,1,0.982866979893407,0,3,peptidyl-cysteine methylation,BP,
6292,GO:0018126,1,0.859069625377329,0,22,protein hydroxylation,BP,
6294,GO:0018146,1,0.840688914284869,0,26,keratan sulfate biosynthetic process,BP,
6295,GO:0018149,1,0.84464760907995,0,27,peptide cross-linking,BP,
6296,GO:0018153,1,0.987271915204491,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6297,GO:0018158,1,0.931133329808474,0,12,protein oxidation,BP,
6298,GO:0018160,1,0.995512209712619,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6299,GO:0018166,1,0.992438349593765,0,1,C-terminal protein-tyrosinylation,BP,
6300,GO:0018171,1,0.979638659135914,0,4,peptidyl-cysteine oxidation,BP,
6301,GO:0018175,1,0.995218992452226,0,1,protein nucleotidylation,BP,
6302,GO:0018192,1,0.993645945930351,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6304,GO:0018194,1,0.9930956730518,0,1,peptidyl-alanine modification,BP,
6305,GO:0018195,1,0.876654619497595,0,21,peptidyl-arginine modification,BP,
6306,GO:0018196,1,0.770326478802612,0,43,peptidyl-asparagine modification,BP,
6307,GO:0018197,1,0.977483872124107,0,3,peptidyl-aspartic acid modification,BP,
6309,GO:0018199,1,0.976778704967408,0,4,peptidyl-glutamine modification,BP,
6310,GO:0018200,1,0.843695001581379,0,27,peptidyl-glutamic acid modification,BP,
6311,GO:0018201,1,0.978163288812235,0,3,peptidyl-glycine modification,BP,
6312,GO:0018202,1,0.93808259201399,0,10,peptidyl-histidine modification,BP,
6314,GO:0018206,1,0.934307090331184,0,11,peptidyl-methionine modification,BP,
6315,GO:0018208,1,0.766433909048733,0,45,peptidyl-proline modification,BP,
6318,GO:0018211,1,0.966821615586552,0,5,peptidyl-tryptophan modification,BP,
6320,GO:0018214,1,0.957975743738616,0,8,protein carboxylation,BP,
6321,GO:0018216,1,0.90791768385661,0,15,peptidyl-arginine methylation,BP,
6322,GO:0018217,1,0.992500155709995,0,1,peptidyl-aspartic acid phosphorylation,BP,
6323,GO:0018230,1,0.868796256450368,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6324,GO:0018231,1,0.868796256450368,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6325,GO:0018242,1,0.869527820785743,0,20,protein O-linked glycosylation via serine,BP,
6326,GO:0018243,1,0.875581289664286,0,19,protein O-linked glycosylation via threonine,BP,
6327,GO:0018262,1,0.987271915204491,0,2,isopeptide cross-linking,BP,
6328,GO:0018271,1,0.992365376255917,0,1,biotin-protein ligase activity,MF,
6329,GO:0018272,1,0.995049967525852,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6330,GO:0018277,1,0.993820984470009,0,1,protein deamination,BP,
6331,GO:0018279,1,0.776328882894033,0,42,protein N-linked glycosylation via asparagine,BP,
6332,GO:0018282,1,0.986103812493659,0,2,metal incorporation into metallo-sulfur cluster,BP,
6333,GO:0018283,1,0.986103812493659,0,2,iron incorporation into metallo-sulfur cluster,BP,
6334,GO:0018293,1,0.995887592748429,0,1,protein-FAD linkage,BP,
6335,GO:0018298,1,0.953250618373804,0,8,protein-chromophore linkage,BP,
6336,GO:0018307,1,0.989891304694055,0,2,enzyme active site formation,BP,
6337,GO:0018312,1,0.987337522889975,0,2,peptidyl-serine ADP-ribosylation,BP,
6338,GO:0018315,1,0.99249272490571,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6339,GO:0018317,1,0.966821615586552,0,5,protein C-linked glycosylation via tryptophan,BP,
6340,GO:0018322,1,0.992438349593765,0,1,protein tyrosinylation,BP,
6341,GO:0018323,1,0.99622159485821,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6342,GO:0018335,1,0.971084077202036,0,4,protein succinylation,BP,
6343,GO:0018342,1,0.94930826281426,0,8,protein prenylation,BP,
6344,GO:0018343,1,0.988370331693565,0,2,protein farnesylation,BP,
6345,GO:0018344,1,0.963645068583292,0,6,protein geranylgeranylation,BP,
6346,GO:0018345,1,0.812685811052642,0,32,protein palmitoylation,BP,
6347,GO:0018350,1,0.993768333028796,0,1,protein esterification,BP,
6348,GO:0018352,1,0.988887592229463,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6349,GO:0018364,1,0.992543816463995,0,2,peptidyl-glutamine methylation,BP,
6350,GO:0018377,1,0.970768144197602,0,4,protein myristoylation,BP,
6351,GO:0018393,1,0.390948410301053,0,140,internal peptidyl-lysine acetylation,BP,
6352,GO:0018394,1,0.374754708497921,0,147,peptidyl-lysine acetylation,BP,
6353,GO:0018395,1,0.992527806493065,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6354,GO:0018400,1,0.992310447052227,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6355,GO:0018401,1,0.966642130318521,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6356,GO:0018406,1,0.966821615586552,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6357,GO:0018410,1,0.675776500015418,0,63,C-terminal protein amino acid modification,BP,
6358,GO:0018423,1,0.988735030357699,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6359,GO:0018444,1,0.977968737065919,0,3,translation release factor complex,CC,
6360,GO:0018455,1,0.995789176732612,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6361,GO:0018467,1,0.993307815258335,0,1,formaldehyde dehydrogenase activity,MF,
6362,GO:0018478,1,0.994178290216842,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6363,GO:0018479,1,0.989354744626049,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6364,GO:0018549,1,0.995110373720574,0,1,methanethiol oxidase activity,MF,
6365,GO:0018585,1,0.994224198709231,0,1,fluorene oxygenase activity,MF,
6366,GO:0018636,1,0.987033176388619,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6367,GO:0018685,1,0.995070841980215,0,1,alkane 1-monooxygenase activity,MF,
6368,GO:0018733,1,0.995904685459632,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6369,GO:0018738,1,0.995900752357557,0,1,S-formylglutathione hydrolase activity,MF,
6370,GO:0018773,1,0.995165192397572,0,1,acetylpyruvate hydrolase activity,MF,
6371,GO:0018812,1,0.972664538770891,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6372,GO:0018872,1,0.993615949149888,0,1,arsonoacetate metabolic process,BP,
6373,GO:0018874,1,0.994435528031066,0,1,benzoate metabolic process,BP,
6374,GO:0018879,1,0.987529220367555,0,2,biphenyl metabolic process,BP,
6375,GO:0018885,1,0.995180915878961,0,1,carbon tetrachloride metabolic process,BP,
6376,GO:0018894,1,0.986678555093668,0,2,dibenzo-p-dioxin metabolic process,BP,
6377,GO:0018904,1,0.914184283187286,0,16,ether metabolic process,BP,
6378,GO:0018910,1,0.995180915878961,0,1,benzene metabolic process,BP,
6379,GO:0018916,1,0.97998302578581,0,4,nitrobenzene metabolic process,BP,
6380,GO:0018917,1,0.994224198709231,0,1,fluorene metabolic process,BP,
6381,GO:0018931,1,0.995611997115238,0,1,naphthalene metabolic process,BP,
6383,GO:0018963,1,0.988044418945836,0,2,phthalate metabolic process,BP,
6385,GO:0018969,1,0.992952109810685,0,1,thiocyanate metabolic process,BP,
6386,GO:0018992,1,0.984974817025799,0,2,germ-line sex determination,BP,
6387,GO:0018993,1,0.985789085533407,0,2,somatic sex determination,BP,
6388,GO:0018995,1,0.652472285264703,0,65,host,CC,
6390,GO:0019002,1,0.987714355481024,0,2,GMP binding,MF,
6391,GO:0019003,1,0.694853795813784,0,58,GDP binding,MF,
6392,GO:0019005,1,0.706181801355285,0,55,SCF ubiquitin ligase complex,CC,
6393,GO:0019008,1,0.988109722590666,0,2,molybdopterin synthase complex,CC,
6394,GO:0019034,1,0.985001495400202,0,2,viral replication complex,CC,
6395,GO:0019035,1,0.99239080334567,0,1,viral integration complex,CC,
6396,GO:0019042,1,0.932925281541983,0,11,viral latency,BP,
6397,GO:0019043,1,0.947575775498265,0,9,establishment of viral latency,BP,
6398,GO:0019045,1,0.984547398601798,0,2,latent virus replication,BP,
6399,GO:0019046,1,0.984547398601798,0,2,release from viral latency,BP,
6400,GO:0019048,1,0.803371194746332,0,32,modulation by virus of host morphology or physiology,BP,
6401,GO:0019049,1,0.972447837117768,0,4,evasion or tolerance of host defenses by virus,BP,
6402,GO:0019050,1,0.982887956856832,0,3,suppression by virus of host apoptotic process,BP,
6403,GO:0019054,1,0.867291959733956,0,21,modulation by virus of host process,BP,
6404,GO:0019056,1,0.992979319685909,0,1,modulation by virus of host transcription,BP,
6405,GO:0019058,1,0.146098440628867,0,291,viral life cycle,BP,
6406,GO:0019060,1,0.991336711223962,0,2,intracellular transport of viral protein in host cell,BP,
6407,GO:0019061,1,0.993995875773563,0,1,uncoating of virus,BP,
6408,GO:0019062,1,0.953505611534678,0,7,virion attachment to host cell,BP,
6409,GO:0019064,1,0.962543707123116,0,6,fusion of virus membrane with host plasma membrane,BP,
6410,GO:0019065,1,0.978565755165828,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6411,GO:0019068,1,0.799220473474379,0,37,virion assembly,BP,
6412,GO:0019072,1,0.984902990449422,0,2,viral genome packaging,BP,
6413,GO:0019074,1,0.984902990449422,0,2,viral RNA genome packaging,BP,
6414,GO:0019075,1,0.986238532970005,0,2,virus maturation,BP,
6415,GO:0019076,1,0.800603540498938,0,33,viral release from host cell,BP,
6416,GO:0019079,1,0.503038740076958,0,106,viral genome replication,BP,
6417,GO:0019080,1,0.37311774337845,0,184,viral gene expression,BP,
6418,GO:0019081,1,0.91336453368943,0,14,viral translation,BP,
6419,GO:0019082,1,0.992495386674681,0,1,viral protein processing,BP,
6420,GO:0019083,1,0.408840799974026,0,170,viral transcription,BP,
6421,GO:0019085,1,0.985158716386246,0,2,early viral transcription,BP,
6422,GO:0019086,1,0.975577774934609,0,4,late viral transcription,BP,
6423,GO:0019087,1,0.981677530791165,0,3,transformation of host cell by virus,BP,
6424,GO:0019088,1,0.995326921115523,0,1,immortalization of host cell by virus,BP,
6425,GO:0019089,1,0.992332187741306,0,1,transmission of virus,BP,
6427,GO:0019100,1,0.984974817025799,0,2,male germ-line sex determination,BP,
6428,GO:0019101,1,0.992934940742317,0,1,female somatic sex determination,BP,
6429,GO:0019102,1,0.992803818119721,0,1,male somatic sex determination,BP,
6430,GO:0019103,1,0.967601458952333,0,6,pyrimidine nucleotide binding,MF,
6431,GO:0019104,1,0.926266204590691,0,15,DNA N-glycosylase activity,MF,
6432,GO:0019107,1,0.984964855171422,0,2,myristoyltransferase activity,MF,
6433,GO:0019115,1,0.994593496571265,0,1,benzaldehyde dehydrogenase activity,MF,
6434,GO:0019118,1,0.995669135788894,0,1,phenanthrene-epoxide hydrolase activity,MF,
6435,GO:0019119,1,0.995669135788894,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6436,GO:0019135,1,0.994781119827985,0,1,deoxyhypusine monooxygenase activity,MF,
6437,GO:0019136,1,0.977446575773664,0,4,deoxynucleoside kinase activity,MF,
6438,GO:0019144,1,0.99131283342162,0,2,ADP-sugar diphosphatase activity,MF,
6439,GO:0019145,1,0.993549443156936,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6440,GO:0019150,1,0.994434509783822,0,1,D-ribulokinase activity,MF,
6441,GO:0019153,1,0.995305335104429,0,1,protein-disulfide reductase (glutathione) activity,MF,
6442,GO:0019158,1,0.964034925878364,0,5,mannokinase activity,MF,
6443,GO:0019166,1,0.984006024001614,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6444,GO:0019171,1,0.992156415186924,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6445,GO:0019184,1,0.907441749315458,0,16,nonribosomal peptide biosynthetic process,BP,
6446,GO:0019185,1,0.985806545151912,0,2,snRNA-activating protein complex,CC,
6447,GO:0019187,1,0.99250173731854,0,1,beta-1,4-mannosyltransferase activity,MF,
6448,GO:0019198,1,0.886236033729814,0,16,transmembrane receptor protein phosphatase activity,MF,
6450,GO:0019200,1,0.864496863352494,0,22,carbohydrate kinase activity,MF,
6451,GO:0019201,1,0.84310745046853,0,25,nucleotide kinase activity,MF,
6452,GO:0019202,1,0.985708654921437,0,2,amino acid kinase activity,MF,
6453,GO:0019203,1,0.949864200635158,0,8,carbohydrate phosphatase activity,MF,
6454,GO:0019205,1,0.737493653879147,0,49,nucleobase-containing compound kinase activity,MF,
6455,GO:0019206,1,0.918410638913968,0,14,nucleoside kinase activity,MF,
6456,GO:0019207,1,0.272899610825032,0,202,kinase regulator activity,MF,
6457,GO:0019208,1,0.579048544238741,0,83,phosphatase regulator activity,MF,
6458,GO:0019209,1,0.614760500952971,0,74,kinase activator activity,MF,
6459,GO:0019210,1,0.554023954465917,0,93,kinase inhibitor activity,MF,
6460,GO:0019211,1,0.937590749127347,0,10,phosphatase activator activity,MF,
6461,GO:0019212,1,0.812690572788139,0,33,phosphatase inhibitor activity,MF,
6462,GO:0019213,1,0.693843427757774,0,55,deacetylase activity,MF,
6463,GO:0019215,1,0.921180601864516,0,12,intermediate filament binding,MF,
6466,GO:0019218,1,0.533384619851816,0,97,regulation of steroid metabolic process,BP,
6472,GO:0019227,1,0.96216929616404,0,6,neuronal action potential propagation,BP,
6473,GO:0019228,1,0.787833250730115,0,34,neuronal action potential,BP,
6475,GO:0019230,1,0.972205365309071,0,4,proprioception,BP,
6477,GO:0019236,1,0.98028645496456,0,4,response to pheromone,BP,
6478,GO:0019237,1,0.957716211600455,0,6,centromeric DNA binding,MF,
6479,GO:0019238,1,0.962582396239743,0,6,cyclohydrolase activity,MF,
6481,GO:0019240,1,0.965053922607527,0,5,citrulline biosynthetic process,BP,
6482,GO:0019242,1,0.994376395813296,0,1,methylglyoxal biosynthetic process,BP,
6483,GO:0019243,1,0.988246186604704,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6484,GO:0019244,1,0.995816558292115,0,1,lactate biosynthetic process from pyruvate,BP,
6485,GO:0019249,1,0.984449721978869,0,3,lactate biosynthetic process,BP,
6486,GO:0019254,1,0.98010636233522,0,3,carnitine metabolic process, CoA-linked,BP,
6487,GO:0019255,1,0.988848123383697,0,2,glucose 1-phosphate metabolic process,BP,
6488,GO:0019262,1,0.970137643106641,0,6,N-acetylneuraminate catabolic process,BP,
6489,GO:0019264,1,0.987738414708503,0,2,glycine biosynthetic process from serine,BP,
6490,GO:0019265,1,0.995296987477883,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6491,GO:0019276,1,0.985538778873923,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6492,GO:0019285,1,0.985118463489298,0,2,glycine betaine biosynthetic process from choline,BP,
6493,GO:0019287,1,0.985188556841566,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6494,GO:0019290,1,0.992921528341152,0,1,siderophore biosynthetic process,BP,
6495,GO:0019303,1,0.991798476762685,0,2,D-ribose catabolic process,BP,
6496,GO:0019317,1,0.944341973182581,0,8,fucose catabolic process,BP,
6497,GO:0019318,1,0.253938253999485,0,209,hexose metabolic process,BP,
6498,GO:0019319,1,0.651106812496164,0,70,hexose biosynthetic process,BP,
6499,GO:0019320,1,0.7438966115011,0,47,hexose catabolic process,BP,
6500,GO:0019321,1,0.927362037580781,0,14,pentose metabolic process,BP,
6501,GO:0019322,1,0.978866616139838,0,4,pentose biosynthetic process,BP,
6502,GO:0019323,1,0.974546779160783,0,5,pentose catabolic process,BP,
6503,GO:0019336,1,0.942416152615598,0,9,phenol-containing compound catabolic process,BP,
6504,GO:0019341,1,0.993367825152927,0,1,dibenzo-p-dioxin catabolic process,BP,
6505,GO:0019343,1,0.988462122294462,0,2,cysteine biosynthetic process via cystathionine,BP,
6506,GO:0019344,1,0.982348836221463,0,3,cysteine biosynthetic process,BP,
6507,GO:0019346,1,0.97669672495134,0,4,transsulfuration,BP,
6508,GO:0019348,1,0.971799290358953,0,5,dolichol metabolic process,BP,
6509,GO:0019353,1,0.993206219974093,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6510,GO:0019355,1,0.97989041353484,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6511,GO:0019357,1,0.9930956730518,0,1,nicotinate nucleotide biosynthetic process,BP,
6512,GO:0019358,1,0.9930956730518,0,1,nicotinate nucleotide salvage,BP,
6513,GO:0019359,1,0.456761791872622,0,119,nicotinamide nucleotide biosynthetic process,BP,
6514,GO:0019362,1,0.363551852932033,0,157,pyridine nucleotide metabolic process,BP,
6515,GO:0019363,1,0.456761791872622,0,119,pyridine nucleotide biosynthetic process,BP,
6516,GO:0019364,1,0.984868033700114,0,3,pyridine nucleotide catabolic process,BP,
6517,GO:0019365,1,0.9930956730518,0,1,pyridine nucleotide salvage,BP,
6518,GO:0019367,1,0.959484659774481,0,6,fatty acid elongation, saturated fatty acid,BP,
6519,GO:0019368,1,0.959484659774481,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6520,GO:0019369,1,0.781348813644283,0,41,arachidonic acid metabolic process,BP,
6521,GO:0019370,1,0.942937866275357,0,11,leukotriene biosynthetic process,BP,
6522,GO:0019371,1,0.941589620151094,0,11,cyclooxygenase pathway,BP,
6523,GO:0019372,1,0.913946780513414,0,16,lipoxygenase pathway,BP,
6524,GO:0019373,1,0.938987377642058,0,11,epoxygenase P450 pathway,BP,
6525,GO:0019374,1,0.95053692526745,0,8,galactolipid metabolic process,BP,
6526,GO:0019375,1,0.969693867721839,0,5,galactolipid biosynthetic process,BP,
6527,GO:0019376,1,0.992937203934637,0,1,galactolipid catabolic process,BP,
6528,GO:0019377,1,0.921511816106685,0,13,glycolipid catabolic process,BP,
6529,GO:0019388,1,0.946127810531565,0,9,galactose catabolic process,BP,
6530,GO:0019389,1,0.993312740697061,0,1,glucuronoside metabolic process,BP,
6531,GO:0019391,1,0.993312740697061,0,1,glucuronoside catabolic process,BP,
6533,GO:0019400,1,0.913053353516063,0,15,alditol metabolic process,BP,
6534,GO:0019401,1,0.963630503996999,0,6,alditol biosynthetic process,BP,
6535,GO:0019402,1,0.995670583484006,0,1,galactitol metabolic process,BP,
6536,GO:0019405,1,0.966388509223933,0,5,alditol catabolic process,BP,
6537,GO:0019406,1,0.995611997115238,0,1,hexitol biosynthetic process,BP,
6538,GO:0019407,1,0.993507719716997,0,1,hexitol catabolic process,BP,
6539,GO:0019408,1,0.98579786931925,0,2,dolichol biosynthetic process,BP,
6540,GO:0019413,1,0.985387367554096,0,2,acetate biosynthetic process,BP,
6541,GO:0019417,1,0.985103495180423,0,2,sulfur oxidation,BP,
6542,GO:0019418,1,0.981550984807045,0,4,sulfide oxidation,BP,
6543,GO:0019427,1,0.985387367554096,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6544,GO:0019430,1,0.883757744322942,0,22,removal of superoxide radicals,BP,
6545,GO:0019432,1,0.82719594725256,0,28,triglyceride biosynthetic process,BP,
6549,GO:0019441,1,0.968070847919706,0,6,tryptophan catabolic process to kynurenine,BP,
6550,GO:0019442,1,0.990636787776111,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6551,GO:0019448,1,0.984042160250489,0,3,L-cysteine catabolic process,BP,
6552,GO:0019464,1,0.982470801548671,0,3,glycine decarboxylation via glycine cleavage system,BP,
6553,GO:0019470,1,0.973768038956458,0,4,4-hydroxyproline catabolic process,BP,
6554,GO:0019471,1,0.937729552903662,0,10,4-hydroxyproline metabolic process,BP,
6555,GO:0019474,1,0.973465503181179,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6556,GO:0019477,1,0.973465503181179,0,4,L-lysine catabolic process,BP,
6557,GO:0019478,1,0.990592436944966,0,2,D-amino acid catabolic process,BP,
6558,GO:0019482,1,0.97423032514731,0,4,beta-alanine metabolic process,BP,
6559,GO:0019483,1,0.987187134369641,0,2,beta-alanine biosynthetic process,BP,
6560,GO:0019493,1,0.99459047963083,0,1,arginine catabolic process to proline,BP,
6561,GO:0019509,1,0.971057924839752,0,5,L-methionine salvage from methylthioadenosine,BP,
6562,GO:0019510,1,0.993961757538668,0,1,S-adenosylhomocysteine catabolic process,BP,
6563,GO:0019511,1,0.917050402354761,0,13,peptidyl-proline hydroxylation,BP,
6564,GO:0019516,1,0.989242439690028,0,2,lactate oxidation,BP,
6565,GO:0019518,1,0.995328574556727,0,1,L-threonine catabolic process to glycine,BP,
6566,GO:0019519,1,0.993507719716997,0,1,pentitol metabolic process,BP,
6567,GO:0019520,1,0.987799688386837,0,2,aldonic acid metabolic process,BP,
6568,GO:0019521,1,0.987799688386837,0,2,D-gluconate metabolic process,BP,
6569,GO:0019527,1,0.993507719716997,0,1,pentitol catabolic process,BP,
6570,GO:0019530,1,0.959193343283276,0,6,taurine metabolic process,BP,
6571,GO:0019531,1,0.936643288831356,0,9,oxalate transmembrane transporter activity,MF,
6572,GO:0019532,1,0.932235305345761,0,10,oxalate transport,BP,
6573,GO:0019534,1,0.970141707255105,0,4,toxin transmembrane transporter activity,MF,
6575,GO:0019541,1,0.973464041428192,0,4,propionate metabolic process,BP,
6576,GO:0019542,1,0.985387367554096,0,2,propionate biosynthetic process,BP,
6577,GO:0019543,1,0.987901664983935,0,2,propionate catabolic process,BP,
6578,GO:0019544,1,0.99459047963083,0,1,arginine catabolic process to glutamate,BP,
6579,GO:0019546,1,0.993993865113311,0,1,arginine deiminase pathway,BP,
6580,GO:0019547,1,0.990158699815872,0,2,arginine catabolic process to ornithine,BP,
6581,GO:0019550,1,0.987976197576296,0,2,glutamate catabolic process to aspartate,BP,
6582,GO:0019551,1,0.987976197576296,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6583,GO:0019556,1,0.974582917032379,0,4,histidine catabolic process to glutamate and formamide,BP,
6584,GO:0019557,1,0.974582917032379,0,4,histidine catabolic process to glutamate and formate,BP,
6585,GO:0019563,1,0.972705362351703,0,4,glycerol catabolic process,BP,
6586,GO:0019566,1,0.986238532970005,0,2,arabinose metabolic process,BP,
6587,GO:0019585,1,0.954371554695209,0,8,glucuronate metabolic process,BP,
6588,GO:0019605,1,0.989177891551102,0,2,butyrate metabolic process,BP,
6589,GO:0019614,1,0.947768299179402,0,8,catechol-containing compound catabolic process,BP,
6590,GO:0019626,1,0.953595998903652,0,8,short-chain fatty acid catabolic process,BP,
6591,GO:0019627,1,0.92779964519739,0,13,urea metabolic process,BP,
6593,GO:0019640,1,0.973600898871411,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6594,GO:0019646,1,0.93467587963246,0,16,aerobic electron transport chain,BP,
6595,GO:0019673,1,0.967418349807116,0,7,GDP-mannose metabolic process,BP,
6596,GO:0019674,1,0.67309319189385,0,64,NAD metabolic process,BP,
6597,GO:0019676,1,0.986783326668916,0,2,ammonia assimilation cycle,BP,
6598,GO:0019677,1,0.988618509314143,0,2,NAD catabolic process,BP,
6599,GO:0019682,1,0.889287874078359,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6600,GO:0019692,1,0.845750100179786,0,31,deoxyribose phosphate metabolic process,BP,
6602,GO:0019694,1,0.959193343283276,0,6,alkanesulfonate metabolic process,BP,
6603,GO:0019695,1,0.937658711865877,0,9,choline metabolic process,BP,
6604,GO:0019706,1,0.840347426316094,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6605,GO:0019707,1,0.840347426316094,0,27,protein-cysteine S-acyltransferase activity,MF,
6606,GO:0019720,1,0.96178420319594,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6608,GO:0019724,1,0.566550691047426,0,91,B cell mediated immunity,BP,
6611,GO:0019731,1,0.903316673858503,0,22,antibacterial humoral response,BP,
6612,GO:0019732,1,0.979924365303464,0,4,antifungal humoral response,BP,
6613,GO:0019740,1,0.968416402174747,0,5,nitrogen utilization,BP,
6614,GO:0019742,1,0.993736437773384,0,1,pentacyclic triterpenoid metabolic process,BP,
6615,GO:0019747,1,0.992139541450628,0,2,regulation of isoprenoid metabolic process,BP,
6616,GO:0019748,1,0.719216206583794,0,56,secondary metabolic process,BP,
6617,GO:0019751,1,0.515341568679791,0,101,polyol metabolic process,BP,
6620,GO:0019763,1,0.975777412539669,0,5,immunoglobulin receptor activity,MF,
6621,GO:0019767,1,0.996579378356977,0,1,IgE receptor activity,MF,
6622,GO:0019770,1,0.990333023440015,0,2,IgG receptor activity,MF,
6623,GO:0019772,1,0.995292804183984,0,1,low-affinity IgG receptor activity,MF,
6624,GO:0019773,1,0.972331704952884,0,7,proteasome core complex, alpha-subunit complex,CC,
6625,GO:0019774,1,0.965564475824514,0,9,proteasome core complex, beta-subunit complex,CC,
6626,GO:0019776,1,0.981090528570005,0,3,Atg8 ligase activity,MF,
6627,GO:0019777,1,0.989689686174499,0,2,Atg12 transferase activity,MF,
6628,GO:0019778,1,0.992452426779513,0,1,Atg12 activating enzyme activity,MF,
6629,GO:0019779,1,0.992452426779513,0,1,Atg8 activating enzyme activity,MF,
6630,GO:0019780,1,0.992325727738016,0,1,FAT10 activating enzyme activity,MF,
6631,GO:0019781,1,0.989257183959483,0,2,NEDD8 activating enzyme activity,MF,
6632,GO:0019782,1,0.992614454679435,0,1,ISG15 activating enzyme activity,MF,
6633,GO:0019783,1,0.505057860171752,0,98,ubiquitin-like protein-specific protease activity,MF,
6634,GO:0019784,1,0.962821963572764,0,7,NEDD8-specific protease activity,MF,
6635,GO:0019785,1,0.987015817258369,0,2,ISG15-specific protease activity,MF,
6637,GO:0019788,1,0.970030331383198,0,6,NEDD8 transferase activity,MF,
6638,GO:0019789,1,0.903060581581194,0,16,SUMO transferase activity,MF,
6639,GO:0019797,1,0.979428260561731,0,3,procollagen-proline 3-dioxygenase activity,MF,
6640,GO:0019798,1,0.954650768607475,0,7,procollagen-proline dioxygenase activity,MF,
6641,GO:0019799,1,0.9930956730518,0,1,tubulin N-acetyltransferase activity,MF,
6642,GO:0019800,1,0.960875253691027,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6643,GO:0019805,1,0.983794756607954,0,3,quinolinate biosynthetic process,BP,
6644,GO:0019807,1,0.995638534101709,0,1,aspartoacylase activity,MF,
6645,GO:0019808,1,0.979239219612789,0,4,polyamine binding,MF,
6646,GO:0019809,1,0.98649353513705,0,3,spermidine binding,MF,
6647,GO:0019810,1,0.992647380323441,0,1,putrescine binding,MF,
6648,GO:0019811,1,0.992480267403341,0,1,cocaine binding,MF,
6649,GO:0019814,1,0.973847757333794,0,5,immunoglobulin complex,CC,
6650,GO:0019815,1,0.984234933612911,0,3,B cell receptor complex,CC,
6651,GO:0019825,1,0.839008246619056,0,33,oxygen binding,MF,
6652,GO:0019826,1,0.979235762489415,0,3,oxygen sensor activity,MF,
6653,GO:0019827,1,0.368678511922509,0,147,stem cell population maintenance,BP,
6654,GO:0019828,1,0.984815142491436,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6655,GO:0019829,1,0.714070053430736,0,51,cation-transporting ATPase activity,MF,
6656,GO:0019834,1,0.986171635134223,0,3,phospholipase A2 inhibitor activity,MF,
6657,GO:0019835,1,0.849592359009101,0,30,cytolysis,BP,
6658,GO:0019836,1,0.987300920414236,0,2,hemolysis by symbiont of host erythrocytes,BP,
6660,GO:0019840,1,0.869879164331892,0,24,isoprenoid binding,MF,
6661,GO:0019841,1,0.946686850491765,0,11,retinol binding,MF,
6663,GO:0019843,1,0.758677658811215,0,55,rRNA binding,MF,
6664,GO:0019852,1,0.942594360212336,0,10,L-ascorbic acid metabolic process,BP,
6665,GO:0019853,1,0.990227669372356,0,2,L-ascorbic acid biosynthetic process,BP,
6666,GO:0019855,1,0.953354264645693,0,9,calcium channel inhibitor activity,MF,
6667,GO:0019856,1,0.958231492553506,0,6,pyrimidine nucleobase biosynthetic process,BP,
6668,GO:0019857,1,0.976296289273891,0,3,5-methylcytosine metabolic process,BP,
6669,GO:0019858,1,0.98873960158086,0,2,cytosine metabolic process,BP,
6670,GO:0019859,1,0.981326389518617,0,3,thymine metabolic process,BP,
6671,GO:0019860,1,0.982460322027477,0,3,uracil metabolic process,BP,
6672,GO:0019862,1,0.995354894055887,0,1,IgA binding,MF,
6673,GO:0019863,1,0.983496328206273,0,4,IgE binding,MF,
6674,GO:0019864,1,0.955458487050147,0,9,IgG binding,MF,
6675,GO:0019865,1,0.919820788481338,0,16,immunoglobulin binding,MF,
6676,GO:0019866,1,0.0655596823423827,0,485,organelle inner membrane,CC,
6678,GO:0019869,1,0.945578198299003,0,9,chloride channel inhibitor activity,MF,
6679,GO:0019870,1,0.959442984251662,0,6,potassium channel inhibitor activity,MF,
6680,GO:0019871,1,0.960803012782054,0,6,sodium channel inhibitor activity,MF,
6681,GO:0019878,1,0.98542335947449,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6682,GO:0019882,1,0.296493715253076,0,206,antigen processing and presentation,BP,
6683,GO:0019883,1,0.931849292352293,0,11,antigen processing and presentation of endogenous antigen,BP,
6684,GO:0019884,1,0.376923052558752,0,167,antigen processing and presentation of exogenous antigen,BP,
6685,GO:0019885,1,0.954497096615817,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6686,GO:0019886,1,0.559487961176674,0,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6687,GO:0019887,1,0.312687888524135,0,182,protein kinase regulator activity,MF,
6688,GO:0019888,1,0.636511014166658,0,70,protein phosphatase regulator activity,MF,
6690,GO:0019896,1,0.926771997013863,0,11,axonal transport of mitochondrion,BP,
6696,GO:0019902,1,0.317711242660468,0,164,phosphatase binding,MF,
6697,GO:0019903,1,0.447010677405602,0,116,protein phosphatase binding,MF,
6700,GO:0019907,1,0.961333414798785,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6701,GO:0019908,1,0.905353084730912,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6703,GO:0019912,1,0.988064124721706,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6704,GO:0019915,1,0.68620438911467,0,59,lipid storage,BP,
6705,GO:0019918,1,0.97386324876721,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6706,GO:0019919,1,0.951065188116351,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6712,GO:0019948,1,0.986927456398949,0,2,SUMO activating enzyme activity,MF,
6714,GO:0019955,1,0.537829125435438,0,96,cytokine binding,MF,
6715,GO:0019956,1,0.848729591684774,0,25,chemokine binding,MF,
6716,GO:0019957,1,0.939119015005585,0,10,C-C chemokine binding,MF,
6717,GO:0019958,1,0.960189996002007,0,6,C-X-C chemokine binding,MF,
6718,GO:0019959,1,0.979335108129211,0,3,interleukin-8 binding,MF,
6719,GO:0019960,1,0.962868188383889,0,5,C-X3-C chemokine binding,MF,
6720,GO:0019961,1,0.9849775377926,0,2,interferon binding,MF,
6721,GO:0019962,1,0.992358242512686,0,1,type I interferon binding,MF,
6722,GO:0019964,1,0.992563038845129,0,1,interferon-gamma binding,MF,
6723,GO:0019966,1,0.957515194571733,0,7,interleukin-1 binding,MF,
6724,GO:0019969,1,0.992514627565054,0,1,interleukin-10 binding,MF,
6725,GO:0019970,1,0.992686954287854,0,1,interleukin-11 binding,MF,
6726,GO:0019972,1,0.995559571918776,0,1,interleukin-12 binding,MF,
6727,GO:0019975,1,0.995559571918776,0,1,interleukin-17 binding,MF,
6728,GO:0019976,1,0.980699329368499,0,3,interleukin-2 binding,MF,
6729,GO:0019981,1,0.985238375155118,0,2,interleukin-6 binding,MF,
6730,GO:0019985,1,0.788052879956957,0,38,translesion synthesis,BP,
6731,GO:0019988,1,0.99314632348085,0,1,charged-tRNA amino acid modification,BP,
6733,GO:0020003,1,0.98301840929082,0,3,symbiont-containing vacuole,CC,
6734,GO:0020005,1,0.989853389935651,0,2,symbiont-containing vacuole membrane,CC,
6735,GO:0020012,1,0.985692914434426,0,2,evasion or tolerance of host immune response,BP,
6736,GO:0020016,1,0.97772824617607,0,3,ciliary pocket,CC,
6737,GO:0020018,1,0.97772824617607,0,3,ciliary pocket membrane,CC,
6738,GO:0020021,1,0.995326921115523,0,1,immortalization of host cell,BP,
6739,GO:0020027,1,0.922434424561975,0,14,hemoglobin metabolic process,BP,
6740,GO:0020037,1,0.546149467083877,0,99,heme binding,MF,
6741,GO:0021501,1,0.99438047800194,0,1,prechordal plate formation,BP,
6742,GO:0021502,1,0.97934995034273,0,3,neural fold elevation formation,BP,
6743,GO:0021503,1,0.992159800398871,0,1,neural fold bending,BP,
6744,GO:0021508,1,0.992299844463885,0,1,floor plate formation,BP,
6745,GO:0021509,1,0.99457336522293,0,1,roof plate formation,BP,
6746,GO:0021510,1,0.557886757668384,0,89,spinal cord development,BP,
6747,GO:0021511,1,0.852378687636966,0,24,spinal cord patterning,BP,
6748,GO:0021512,1,0.992493129594882,0,1,spinal cord anterior/posterior patterning,BP,
6749,GO:0021513,1,0.865849193816321,0,22,spinal cord dorsal/ventral patterning,BP,
6750,GO:0021514,1,0.899848959966775,0,16,ventral spinal cord interneuron differentiation,BP,
6751,GO:0021515,1,0.758162445568608,0,44,cell differentiation in spinal cord,BP,
6752,GO:0021516,1,0.896044591924565,0,18,dorsal spinal cord development,BP,
6753,GO:0021517,1,0.778238039358091,0,39,ventral spinal cord development,BP,
6754,GO:0021519,1,0.995786420869193,0,1,spinal cord association neuron specification,BP,
6755,GO:0021520,1,0.929962743425369,0,12,spinal cord motor neuron cell fate specification,BP,
6756,GO:0021521,1,0.938408819506699,0,10,ventral spinal cord interneuron specification,BP,
6757,GO:0021522,1,0.840171824127727,0,28,spinal cord motor neuron differentiation,BP,
6758,GO:0021523,1,0.975662255801709,0,4,somatic motor neuron differentiation,BP,
6759,GO:0021524,1,0.983542465126351,0,3,visceral motor neuron differentiation,BP,
6760,GO:0021526,1,0.988624237287107,0,2,medial motor column neuron differentiation,BP,
6761,GO:0021527,1,0.937189573265141,0,11,spinal cord association neuron differentiation,BP,
6762,GO:0021528,1,0.9930956730518,0,1,commissural neuron differentiation in spinal cord,BP,
6763,GO:0021529,1,0.9817147840912,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6764,GO:0021530,1,0.9817147840912,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6765,GO:0021532,1,0.795987871138593,0,35,neural tube patterning,BP,
6766,GO:0021533,1,0.889983904173329,0,17,cell differentiation in hindbrain,BP,
6767,GO:0021534,1,0.934942172760836,0,11,cell proliferation in hindbrain,BP,
6768,GO:0021535,1,0.909571890245292,0,13,cell migration in hindbrain,BP,
6771,GO:0021538,1,0.977512100912746,0,3,epithalamus development,BP,
6772,GO:0021539,1,0.989434241474475,0,2,subthalamus development,BP,
6773,GO:0021540,1,0.967847175689498,0,5,corpus callosum morphogenesis,BP,
6774,GO:0021541,1,0.992494243749718,0,1,ammon gyrus development,BP,
6775,GO:0021542,1,0.900776985859037,0,15,dentate gyrus development,BP,
6777,GO:0021544,1,0.8563142620747,0,23,subpallium development,BP,
6778,GO:0021545,1,0.757987491505961,0,41,cranial nerve development,BP,
6779,GO:0021546,1,0.969522253839792,0,5,rhombomere development,BP,
6780,GO:0021547,1,0.99438047800194,0,1,midbrain-hindbrain boundary initiation,BP,
6783,GO:0021550,1,0.993608490836106,0,1,medulla oblongata development,BP,
6784,GO:0021551,1,0.991889823009446,0,1,central nervous system morphogenesis,BP,
6785,GO:0021553,1,0.977900460283266,0,3,olfactory nerve development,BP,
6786,GO:0021554,1,0.929609401000231,0,11,optic nerve development,BP,
6787,GO:0021555,1,0.983766364087841,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6788,GO:0021557,1,0.988199444238387,0,2,oculomotor nerve development,BP,
6789,GO:0021558,1,0.995538291756773,0,1,trochlear nerve development,BP,
6790,GO:0021559,1,0.935819431553033,0,10,trigeminal nerve development,BP,
6791,GO:0021560,1,0.986321212011166,0,2,abducens nerve development,BP,
6792,GO:0021561,1,0.939112379342356,0,9,facial nerve development,BP,
6793,GO:0021562,1,0.959835773838433,0,6,vestibulocochlear nerve development,BP,
6794,GO:0021563,1,0.964204159557549,0,5,glossopharyngeal nerve development,BP,
6795,GO:0021564,1,0.980087039697006,0,3,vagus nerve development,BP,
6796,GO:0021566,1,0.992454674590059,0,1,hypoglossal nerve development,BP,
6797,GO:0021568,1,0.995715037900245,0,1,rhombomere 2 development,BP,
6798,GO:0021569,1,0.988336565046211,0,2,rhombomere 3 development,BP,
6799,GO:0021570,1,0.995307001601259,0,1,rhombomere 4 development,BP,
6800,GO:0021571,1,0.985652670161466,0,2,rhombomere 5 development,BP,
6801,GO:0021572,1,0.992604370919357,0,1,rhombomere 6 development,BP,
6802,GO:0021575,1,0.776667506437731,0,37,hindbrain morphogenesis,BP,
6803,GO:0021577,1,0.985946847660833,0,2,hindbrain structural organization,BP,
6806,GO:0021587,1,0.789425028535343,0,34,cerebellum morphogenesis,BP,
6807,GO:0021589,1,0.985946847660833,0,2,cerebellum structural organization,BP,
6808,GO:0021590,1,0.98005771328107,0,3,cerebellum maturation,BP,
6809,GO:0021591,1,0.853270517797644,0,24,ventricular system development,BP,
6810,GO:0021592,1,0.992428700074193,0,1,fourth ventricle development,BP,
6811,GO:0021593,1,0.992997032225599,0,1,rhombomere morphogenesis,BP,
6812,GO:0021594,1,0.992997032225599,0,1,rhombomere formation,BP,
6813,GO:0021598,1,0.986321212011166,0,2,abducens nerve morphogenesis,BP,
6814,GO:0021599,1,0.986321212011166,0,2,abducens nerve formation,BP,
6815,GO:0021602,1,0.847590267009839,0,24,cranial nerve morphogenesis,BP,
6816,GO:0021603,1,0.960249923368078,0,6,cranial nerve formation,BP,
6817,GO:0021604,1,0.940158140097921,0,9,cranial nerve structural organization,BP,
6818,GO:0021610,1,0.939112379342356,0,9,facial nerve morphogenesis,BP,
6819,GO:0021612,1,0.952693219539118,0,7,facial nerve structural organization,BP,
6820,GO:0021615,1,0.972012243509175,0,4,glossopharyngeal nerve morphogenesis,BP,
6821,GO:0021618,1,0.992454674590059,0,1,hypoglossal nerve morphogenesis,BP,
6822,GO:0021622,1,0.992628597379342,0,1,oculomotor nerve morphogenesis,BP,
6823,GO:0021623,1,0.992628597379342,0,1,oculomotor nerve formation,BP,
6825,GO:0021631,1,0.957086856279242,0,6,optic nerve morphogenesis,BP,
6826,GO:0021633,1,0.9868489408696,0,2,optic nerve structural organization,BP,
6827,GO:0021634,1,0.992497689872966,0,1,optic nerve formation,BP,
6828,GO:0021636,1,0.963940263249628,0,5,trigeminal nerve morphogenesis,BP,
6829,GO:0021637,1,0.963940263249628,0,5,trigeminal nerve structural organization,BP,
6830,GO:0021644,1,0.988022415945018,0,2,vagus nerve morphogenesis,BP,
6831,GO:0021648,1,0.97451204069477,0,4,vestibulocochlear nerve morphogenesis,BP,
6832,GO:0021649,1,0.993588067364596,0,1,vestibulocochlear nerve structural organization,BP,
6833,GO:0021650,1,0.980802117846842,0,3,vestibulocochlear nerve formation,BP,
6834,GO:0021658,1,0.992997032225599,0,1,rhombomere 3 morphogenesis,BP,
6835,GO:0021660,1,0.992997032225599,0,1,rhombomere 3 formation,BP,
6836,GO:0021664,1,0.992997032225599,0,1,rhombomere 5 morphogenesis,BP,
6837,GO:0021666,1,0.992997032225599,0,1,rhombomere 5 formation,BP,
6838,GO:0021670,1,0.934141848530919,0,10,lateral ventricle development,BP,
6840,GO:0021678,1,0.985490190540681,0,3,third ventricle development,BP,
6841,GO:0021679,1,0.98546614375907,0,2,cerebellar molecular layer development,BP,
6842,GO:0021680,1,0.861630011760165,0,21,cerebellar Purkinje cell layer development,BP,
6843,GO:0021681,1,0.917941418726482,0,13,cerebellar granular layer development,BP,
6844,GO:0021682,1,0.992392988194256,0,1,nerve maturation,BP,
6845,GO:0021683,1,0.939986007053783,0,9,cerebellar granular layer morphogenesis,BP,
6846,GO:0021684,1,0.953025811093994,0,7,cerebellar granular layer formation,BP,
6847,GO:0021685,1,0.992255254502941,0,1,cerebellar granular layer structural organization,BP,
6848,GO:0021686,1,0.99522928928386,0,1,cerebellar granular layer maturation,BP,
6849,GO:0021687,1,0.98546614375907,0,2,cerebellar molecular layer morphogenesis,BP,
6850,GO:0021688,1,0.992622328642548,0,1,cerebellar molecular layer formation,BP,
6851,GO:0021691,1,0.984756436457531,0,2,cerebellar Purkinje cell layer maturation,BP,
6852,GO:0021692,1,0.924271019349134,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6853,GO:0021693,1,0.984934143230523,0,2,cerebellar Purkinje cell layer structural organization,BP,
6854,GO:0021694,1,0.94579437639897,0,8,cerebellar Purkinje cell layer formation,BP,
6856,GO:0021696,1,0.823581756035916,0,28,cerebellar cortex morphogenesis,BP,
6857,GO:0021697,1,0.878390269566048,0,19,cerebellar cortex formation,BP,
6858,GO:0021698,1,0.984934143230523,0,2,cerebellar cortex structural organization,BP,
6859,GO:0021699,1,0.98005771328107,0,3,cerebellar cortex maturation,BP,
6861,GO:0021702,1,0.94579437639897,0,8,cerebellar Purkinje cell differentiation,BP,
6862,GO:0021707,1,0.953025811093994,0,7,cerebellar granule cell differentiation,BP,
6863,GO:0021718,1,0.98615916045369,0,2,superior olivary nucleus development,BP,
6864,GO:0021722,1,0.98615916045369,0,2,superior olivary nucleus maturation,BP,
6865,GO:0021730,1,0.984947805455905,0,2,trigeminal sensory nucleus development,BP,
6866,GO:0021740,1,0.984947805455905,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6867,GO:0021747,1,0.977583830159781,0,3,cochlear nucleus development,BP,
6868,GO:0021750,1,0.993608490836106,0,1,vestibular nucleus development,BP,
6869,GO:0021756,1,0.886332423275764,0,17,striatum development,BP,
6870,GO:0021757,1,0.992524318051586,0,1,caudate nucleus development,BP,
6871,GO:0021758,1,0.992524318051586,0,1,putamen development,BP,
6874,GO:0021762,1,0.785086803376485,0,39,substantia nigra development,BP,
6875,GO:0021763,1,0.994076634870323,0,1,subthalamic nucleus development,BP,
6877,GO:0021766,1,0.613289349845243,0,72,hippocampus development,BP,
6878,GO:0021767,1,0.992101486545164,0,1,mammillary body development,BP,
6879,GO:0021768,1,0.992553992934665,0,1,nucleus accumbens development,BP,
6880,GO:0021769,1,0.973052166429565,0,4,orbitofrontal cortex development,BP,
6881,GO:0021771,1,0.992391502731925,0,1,lateral geniculate nucleus development,BP,
6882,GO:0021772,1,0.812998437238914,0,30,olfactory bulb development,BP,
6883,GO:0021773,1,0.978843491197104,0,3,striatal medium spiny neuron differentiation,BP,
6884,GO:0021775,1,0.977111181793573,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6885,GO:0021776,1,0.977111181793573,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6886,GO:0021778,1,0.966465427130953,0,5,oligodendrocyte cell fate specification,BP,
6887,GO:0021779,1,0.966465427130953,0,5,oligodendrocyte cell fate commitment,BP,
6888,GO:0021780,1,0.966465427130953,0,5,glial cell fate specification,BP,
6889,GO:0021781,1,0.922326946797595,0,12,glial cell fate commitment,BP,
6890,GO:0021782,1,0.544823046022497,0,92,glial cell development,BP,
6891,GO:0021783,1,0.916331625649741,0,13,preganglionic parasympathetic fiber development,BP,
6892,GO:0021784,1,0.989102785806742,0,2,postganglionic parasympathetic fiber development,BP,
6893,GO:0021785,1,0.948602993869502,0,7,branchiomotor neuron axon guidance,BP,
6894,GO:0021793,1,0.992583515143324,0,1,chemorepulsion of branchiomotor axon,BP,
6895,GO:0021794,1,0.922675768417889,0,13,thalamus development,BP,
6896,GO:0021795,1,0.767551890319845,0,38,cerebral cortex cell migration,BP,
6897,GO:0021796,1,0.958678519175586,0,6,cerebral cortex regionalization,BP,
6898,GO:0021797,1,0.980732482277518,0,3,forebrain anterior/posterior pattern specification,BP,
6899,GO:0021798,1,0.95725182063281,0,7,forebrain dorsal/ventral pattern formation,BP,
6900,GO:0021799,1,0.84493006052132,0,24,cerebral cortex radially oriented cell migration,BP,
6901,GO:0021800,1,0.942093914324363,0,8,cerebral cortex tangential migration,BP,
6902,GO:0021801,1,0.886962181316329,0,17,cerebral cortex radial glia guided migration,BP,
6903,GO:0021812,1,0.985824327164567,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6904,GO:0021813,1,0.993396826597678,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6905,GO:0021814,1,0.96414837591203,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6906,GO:0021815,1,0.977053464097901,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6907,GO:0021817,1,0.977053464097901,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6908,GO:0021819,1,0.926752582426363,0,11,layer formation in cerebral cortex,BP,
6909,GO:0021822,1,0.99426913853978,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6910,GO:0021823,1,0.984753974045561,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6911,GO:0021824,1,0.986032372202934,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6912,GO:0021825,1,0.970997157305112,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6913,GO:0021826,1,0.944031269746453,0,8,substrate-independent telencephalic tangential migration,BP,
6914,GO:0021827,1,0.984753974045561,0,2,postnatal olfactory bulb interneuron migration,BP,
6915,GO:0021828,1,0.986032372202934,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6916,GO:0021830,1,0.944031269746453,0,8,interneuron migration from the subpallium to the cortex,BP,
6917,GO:0021831,1,0.99298173693035,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6918,GO:0021836,1,0.984753974045561,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6919,GO:0021840,1,0.98634967010217,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6920,GO:0021842,1,0.98634967010217,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6921,GO:0021843,1,0.944031269746453,0,8,substrate-independent telencephalic tangential interneuron migration,BP,
6923,GO:0021847,1,0.978891703022567,0,3,ventricular zone neuroblast division,BP,
6924,GO:0021849,1,0.985133709450053,0,2,neuroblast division in subventricular zone,BP,
6925,GO:0021853,1,0.96423518320477,0,5,cerebral cortex GABAergic interneuron migration,BP,
6926,GO:0021854,1,0.897458095906471,0,18,hypothalamus development,BP,
6927,GO:0021855,1,0.980190906559194,0,3,hypothalamus cell migration,BP,
6928,GO:0021856,1,0.986032372202934,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6931,GO:0021861,1,0.960385364768364,0,7,forebrain radial glial cell differentiation,BP,
6932,GO:0021869,1,0.959784403305616,0,6,forebrain ventricular zone progenitor cell division,BP,
6933,GO:0021870,1,0.992358937812529,0,1,Cajal-Retzius cell differentiation,BP,
6934,GO:0021871,1,0.872795173215715,0,21,forebrain regionalization,BP,
6936,GO:0021873,1,0.949459174014166,0,7,forebrain neuroblast division,BP,
6939,GO:0021881,1,0.99258627170319,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6940,GO:0021882,1,0.987970625677167,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6942,GO:0021885,1,0.693525450197589,0,52,forebrain cell migration,BP,
6943,GO:0021886,1,0.982267811894661,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6944,GO:0021888,1,0.982267811894661,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6945,GO:0021889,1,0.927216197746448,0,11,olfactory bulb interneuron differentiation,BP,
6946,GO:0021891,1,0.950022861183107,0,7,olfactory bulb interneuron development,BP,
6947,GO:0021892,1,0.937196071052169,0,10,cerebral cortex GABAergic interneuron differentiation,BP,
6948,GO:0021893,1,0.987970625677167,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6949,GO:0021894,1,0.960446717718611,0,6,cerebral cortex GABAergic interneuron development,BP,
6950,GO:0021895,1,0.86143553036814,0,22,cerebral cortex neuron differentiation,BP,
6951,GO:0021896,1,0.984336954154379,0,2,forebrain astrocyte differentiation,BP,
6952,GO:0021897,1,0.984336954154379,0,2,forebrain astrocyte development,BP,
6953,GO:0021898,1,0.980645178874173,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6955,GO:0021903,1,0.941274741652907,0,10,rostrocaudal neural tube patterning,BP,
6956,GO:0021904,1,0.869520197900645,0,21,dorsal/ventral neural tube patterning,BP,
6957,GO:0021905,1,0.992289616971345,0,1,forebrain-midbrain boundary formation,BP,
6958,GO:0021910,1,0.944445624029713,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6959,GO:0021912,1,0.984494864443619,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6960,GO:0021913,1,0.979414460243998,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6961,GO:0021914,1,0.966607623257166,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6962,GO:0021915,1,0.361210865416844,0,149,neural tube development,BP,
6963,GO:0021917,1,0.992289616971345,0,1,somatic motor neuron fate commitment,BP,
6964,GO:0021918,1,0.992289616971345,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6965,GO:0021919,1,0.99254402833422,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6966,GO:0021920,1,0.995786420869193,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6967,GO:0021924,1,0.940712138121514,0,10,cell proliferation in external granule layer,BP,
6968,GO:0021930,1,0.940712138121514,0,10,cerebellar granule cell precursor proliferation,BP,
6969,GO:0021932,1,0.937996719453065,0,9,hindbrain radial glia guided cell migration,BP,
6970,GO:0021933,1,0.99522928928386,0,1,radial glia guided migration of cerebellar granule cell,BP,
6971,GO:0021934,1,0.984383087576563,0,2,hindbrain tangential cell migration,BP,
6972,GO:0021935,1,0.984383087576563,0,2,cerebellar granule cell precursor tangential migration,BP,
6973,GO:0021936,1,0.94242004172391,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6974,GO:0021937,1,0.967523200091627,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6975,GO:0021938,1,0.972988481811754,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6976,GO:0021940,1,0.954118267930641,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6977,GO:0021941,1,0.987745067106744,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6978,GO:0021942,1,0.971495703181041,0,4,radial glia guided migration of Purkinje cell,BP,
6979,GO:0021943,1,0.970157897687803,0,4,formation of radial glial scaffolds,BP,
6980,GO:0021952,1,0.846472074830836,0,23,central nervous system projection neuron axonogenesis,BP,
6983,GO:0021955,1,0.818291208757226,0,28,central nervous system neuron axonogenesis,BP,
6984,GO:0021956,1,0.99455924843368,0,1,central nervous system interneuron axonogenesis,BP,
6985,GO:0021957,1,0.958321929448069,0,6,corticospinal tract morphogenesis,BP,
6986,GO:0021960,1,0.963555098039299,0,5,anterior commissure morphogenesis,BP,
6987,GO:0021965,1,0.97694999440188,0,3,spinal cord ventral commissure morphogenesis,BP,
6988,GO:0021966,1,0.98827262503183,0,2,corticospinal neuron axon guidance,BP,
6989,GO:0021972,1,0.99245198775029,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6990,GO:0021978,1,0.926680047474142,0,12,telencephalon regionalization,BP,
6991,GO:0021979,1,0.96106331567795,0,6,hypothalamus cell differentiation,BP,
6992,GO:0021983,1,0.77196619921308,0,41,pituitary gland development,BP,
6993,GO:0021984,1,0.933399354991511,0,12,adenohypophysis development,BP,
6994,GO:0021985,1,0.985807847568185,0,2,neurohypophysis development,BP,
6995,GO:0021986,1,0.977512100912746,0,3,habenula development,BP,
6997,GO:0021988,1,0.806977721102852,0,31,olfactory lobe development,BP,
6998,GO:0021993,1,0.992428700074193,0,1,initiation of neural tube closure,BP,
6999,GO:0021997,1,0.984609891810672,0,2,neural plate axis specification,BP,
7000,GO:0021998,1,0.992527806493065,0,1,neural plate mediolateral regionalization,BP,
7001,GO:0021999,1,0.962034433472677,0,6,neural plate anterior/posterior regionalization,BP,
7002,GO:0022007,1,0.978310524546135,0,3,convergent extension involved in neural plate elongation,BP,
7004,GO:0022009,1,0.973183187763291,0,4,central nervous system vasculogenesis,BP,
7005,GO:0022010,1,0.895605565282087,0,17,central nervous system myelination,BP,
7006,GO:0022011,1,0.836447371215036,0,25,myelination in peripheral nervous system,BP,
7007,GO:0022012,1,0.992178754021501,0,1,subpallium cell proliferation in forebrain,BP,
7008,GO:0022018,1,0.992178754021501,0,1,lateral ganglionic eminence cell proliferation,BP,
7009,GO:0022027,1,0.956536512911451,0,6,interkinetic nuclear migration,BP,
7010,GO:0022028,1,0.955589671894349,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7011,GO:0022029,1,0.709034095549551,0,49,telencephalon cell migration,BP,
7012,GO:0022030,1,0.886962181316329,0,17,telencephalon glial cell migration,BP,
7014,GO:0022038,1,0.906218338951096,0,15,corpus callosum development,BP,
7015,GO:0022400,1,0.875413923406397,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7018,GO:0022404,1,0.577542678027936,0,83,molting cycle process,BP,
7019,GO:0022405,1,0.577542678027936,0,83,hair cycle process,BP,
7022,GO:0022408,1,0.422845479143217,0,135,negative regulation of cell-cell adhesion,BP,
7024,GO:0022410,1,0.889062130320017,0,21,circadian sleep/wake cycle process,BP,
7028,GO:0022417,1,0.967223567144588,0,7,protein maturation by protein folding,BP,
7033,GO:0022605,1,0.965354168455507,0,6,mammalian oogenesis stage,BP,
7036,GO:0022612,1,0.470657180690015,0,110,gland morphogenesis,BP,
7038,GO:0022614,1,0.963605138791005,0,5,membrane to membrane docking,BP,
7039,GO:0022615,1,0.978259979184996,0,4,protein to membrane docking,BP,
7040,GO:0022616,1,0.844952046300502,0,26,DNA strand elongation,BP,
7041,GO:0022617,1,0.590793314028942,0,78,extracellular matrix disassembly,BP,
7043,GO:0022622,1,0.996390802365142,0,1,root system development,BP,
7044,GO:0022624,1,0.88439794077793,0,24,proteasome accessory complex,CC,
7045,GO:0022625,1,0.768011247210751,0,62,cytosolic large ribosomal subunit,CC,
7046,GO:0022626,1,0.609957298113737,0,114,cytosolic ribosome,CC,
7047,GO:0022627,1,0.826859042511974,0,45,cytosolic small ribosomal subunit,CC,
7050,GO:0022821,1,0.903580374147284,0,14,potassium ion antiporter activity,MF,
7052,GO:0022829,1,0.902704903466219,0,17,wide pore channel activity,MF,
7063,GO:0022848,1,0.916239505737788,0,14,acetylcholine-gated cation-selective channel activity,MF,
7065,GO:0022850,1,0.977921363204497,0,4,serotonin-gated cation-selective channel activity,MF,
7067,GO:0022852,1,0.985203732195101,0,2,glycine-gated chloride ion channel activity,MF,
7068,GO:0022853,1,0.708684534019556,0,52,active ion transmembrane transporter activity,MF,
7070,GO:0022858,1,0.965701154999832,0,5,alanine transmembrane transporter activity,MF,
7071,GO:0022884,1,0.922165108788231,0,15,macromolecule transmembrane transporter activity,MF,
7072,GO:0022889,1,0.947825991187702,0,9,serine transmembrane transporter activity,MF,
7074,GO:0022894,1,0.994062459126175,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7076,GO:0022900,1,0.44611888634044,0,158,electron transport chain,BP,
7077,GO:0022904,1,0.625383134306349,0,97,respiratory electron transport chain,BP,
7079,GO:0023016,1,0.979555693609076,0,3,signal transduction by trans-phosphorylation,BP,
7080,GO:0023019,1,0.899815974057098,0,18,signal transduction involved in regulation of gene expression,BP,
7081,GO:0023021,1,0.980844757051136,0,3,termination of signal transduction,BP,
7082,GO:0023023,1,0.895830373559818,0,20,MHC protein complex binding,MF,
7083,GO:0023024,1,0.984126641210627,0,3,MHC class I protein complex binding,MF,
7084,GO:0023025,1,0.986869599068229,0,2,MHC class Ib protein complex binding,MF,
7085,GO:0023026,1,0.915664546413713,0,16,MHC class II protein complex binding,MF,
7086,GO:0023029,1,0.965603685050312,0,5,MHC class Ib protein binding,MF,
7087,GO:0023030,1,0.986869599068229,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7088,GO:0023035,1,0.951473114705376,0,8,CD40 signaling pathway,BP,
7089,GO:0023041,1,0.962115106010464,0,6,neuronal signal transduction,BP,
7100,GO:0030007,1,0.912046611959037,0,13,cellular potassium ion homeostasis,BP,
7101,GO:0030008,1,0.923069451354663,0,14,TRAPP complex,CC,
7102,GO:0030010,1,0.435860778537495,0,119,establishment of cell polarity,BP,
7103,GO:0030011,1,0.893610545175897,0,17,maintenance of cell polarity,BP,
7104,GO:0030014,1,0.901018028654612,0,15,CCR4-NOT complex,CC,
7105,GO:0030015,1,0.965935620764356,0,5,CCR4-NOT core complex,CC,
7109,GO:0030020,1,0.956747704584633,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7110,GO:0030021,1,0.992771849511622,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7111,GO:0030023,1,0.961788090434571,0,5,extracellular matrix constituent conferring elasticity,MF,
7116,GO:0030032,1,0.694064274258754,0,53,lamellipodium assembly,BP,
7117,GO:0030033,1,0.892259123380646,0,16,microvillus assembly,BP,
7118,GO:0030035,1,0.97075832473292,0,4,microspike assembly,BP,
7120,GO:0030037,1,0.992452499827418,0,1,actin filament reorganization involved in cell cycle,BP,
7121,GO:0030038,1,0.555419693925666,0,86,contractile actin filament bundle assembly,BP,
7122,GO:0030041,1,0.352479180936031,0,161,actin filament polymerization,BP,
7123,GO:0030042,1,0.7202683592216,0,47,actin filament depolymerization,BP,
7124,GO:0030043,1,0.976831129720578,0,4,actin filament fragmentation,BP,
7125,GO:0030046,1,0.963611493360871,0,5,parallel actin filament bundle assembly,BP,
7126,GO:0030047,1,0.977945802983702,0,3,actin modification,BP,
7127,GO:0030048,1,0.441881755972185,0,118,actin filament-based movement,BP,
7128,GO:0030049,1,0.82992851283195,0,32,muscle filament sliding,BP,
7129,GO:0030050,1,0.941312460420803,0,8,vesicle transport along actin filament,BP,
7131,GO:0030055,1,0.0785035382625366,0,387,cell-substrate junction,CC,
7132,GO:0030056,1,0.960971735167154,0,5,hemidesmosome,CC,
7133,GO:0030057,1,0.860128304300417,0,20,desmosome,CC,
7134,GO:0030060,1,0.980083595335043,0,4,L-malate dehydrogenase activity,MF,
7135,GO:0030061,1,0.971781061061178,0,4,mitochondrial crista,CC,
7136,GO:0030062,1,0.964654626248826,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7137,GO:0030070,1,0.972711476195609,0,4,insulin processing,BP,
7138,GO:0030071,1,0.733743172062655,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7141,GO:0030091,1,0.964492080049086,0,7,protein repair,BP,
7144,GO:0030099,1,0.105825645432435,0,344,myeloid cell differentiation,BP,
7146,GO:0030101,1,0.740873777542887,0,49,natural killer cell activation,BP,
7147,GO:0030103,1,0.98931821880491,0,2,vasopressin secretion,BP,
7149,GO:0030107,1,0.992991488566786,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7150,GO:0030108,1,0.99550371414173,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7151,GO:0030109,1,0.987774723428312,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7154,GO:0030118,1,0.719297761097298,0,48,clathrin coat,CC,
7155,GO:0030119,1,0.734203428734535,0,45,AP-type membrane coat adaptor complex,CC,
7156,GO:0030120,1,0.698959354808083,0,54,vesicle coat,CC,
7157,GO:0030121,1,0.960788180812657,0,6,AP-1 adaptor complex,CC,
7158,GO:0030122,1,0.907199239984772,0,14,AP-2 adaptor complex,CC,
7159,GO:0030123,1,0.931857977573882,0,10,AP-3 adaptor complex,CC,
7160,GO:0030124,1,0.976361836492325,0,4,AP-4 adaptor complex,CC,
7161,GO:0030125,1,0.839639819244272,0,26,clathrin vesicle coat,CC,
7162,GO:0030126,1,0.909659862034824,0,15,COPI vesicle coat,CC,
7163,GO:0030127,1,0.908627874143592,0,14,COPII vesicle coat,CC,
7164,GO:0030128,1,0.900364029543658,0,15,clathrin coat of endocytic vesicle,CC,
7165,GO:0030130,1,0.92439572015596,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7166,GO:0030131,1,0.819015411991779,0,29,clathrin adaptor complex,CC,
7167,GO:0030132,1,0.879745738236793,0,19,clathrin coat of coated pit,CC,
7169,GO:0030134,1,0.60024485533424,0,83,COPII-coated ER to Golgi transport vesicle,CC,
7176,GO:0030144,1,0.979931969007181,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7177,GO:0030145,1,0.728365183913218,0,48,manganese ion binding,MF,
7179,GO:0030149,1,0.87294463118864,0,22,sphingolipid catabolic process,BP,
7180,GO:0030150,1,0.908835393941789,0,17,protein import into mitochondrial matrix,BP,
7181,GO:0030151,1,0.973499471025402,0,4,molybdenum ion binding,MF,
7184,GO:0030156,1,0.996433481513825,0,1,benzodiazepine receptor binding,MF,
7185,GO:0030157,1,0.922732439977955,0,13,pancreatic juice secretion,BP,
7186,GO:0030158,1,0.97788429586072,0,3,protein xylosyltransferase activity,MF,
7187,GO:0030159,1,0.84964060862383,0,24,receptor signaling complex scaffold activity,MF,
7188,GO:0030160,1,0.971722837974536,0,4,GKAP/Homer scaffold activity,MF,
7193,GO:0030167,1,0.973366153770035,0,4,proteoglycan catabolic process,BP,
7194,GO:0030168,1,0.375122347653961,0,149,platelet activation,BP,
7195,GO:0030169,1,0.913947651038557,0,13,low-density lipoprotein particle binding,MF,
7197,GO:0030171,1,0.995082576578034,0,1,voltage-gated proton channel activity,MF,
7198,GO:0030172,1,0.988244010098452,0,3,troponin C binding,MF,
7200,GO:0030174,1,0.962216752800814,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7202,GO:0030176,1,0.422163737861086,0,137,integral component of endoplasmic reticulum membrane,CC,
7203,GO:0030177,1,0.361747090531351,0,160,positive regulation of Wnt signaling pathway,BP,
7206,GO:0030183,1,0.530194008856586,0,96,B cell differentiation,BP,
7207,GO:0030184,1,0.993140495715573,0,1,nitric oxide transmembrane transporter activity,MF,
7208,GO:0030185,1,0.984125582468014,0,3,nitric oxide transport,BP,
7209,GO:0030186,1,0.995512209712619,0,1,melatonin metabolic process,BP,
7210,GO:0030187,1,0.995512209712619,0,1,melatonin biosynthetic process,BP,
7211,GO:0030193,1,0.642808937760196,0,69,regulation of blood coagulation,BP,
7212,GO:0030194,1,0.862194678937938,0,23,positive regulation of blood coagulation,BP,
7213,GO:0030195,1,0.765219125072434,0,43,negative regulation of blood coagulation,BP,
7214,GO:0030197,1,0.985633503319235,0,2,extracellular matrix constituent, lubricant activity,MF,
7215,GO:0030198,1,0.117030440524193,0,306,extracellular matrix organization,BP,
7216,GO:0030199,1,0.738135835871244,0,43,collagen fibril organization,BP,
7217,GO:0030200,1,0.980769831593687,0,3,heparan sulfate proteoglycan catabolic process,BP,
7218,GO:0030201,1,0.799277140670577,0,31,heparan sulfate proteoglycan metabolic process,BP,
7219,GO:0030202,1,0.941201922475233,0,8,heparin metabolic process,BP,
7222,GO:0030205,1,0.91598097627964,0,13,dermatan sulfate metabolic process,BP,
7224,GO:0030207,1,0.918008609008177,0,13,chondroitin sulfate catabolic process,BP,
7225,GO:0030208,1,0.921366287984239,0,12,dermatan sulfate biosynthetic process,BP,
7226,GO:0030209,1,0.994159949389673,0,1,dermatan sulfate catabolic process,BP,
7227,GO:0030210,1,0.941201922475233,0,8,heparin biosynthetic process,BP,
7228,GO:0030212,1,0.796308334391183,0,34,hyaluronan metabolic process,BP,
7229,GO:0030213,1,0.916083174743052,0,13,hyaluronan biosynthetic process,BP,
7230,GO:0030214,1,0.913248208963608,0,14,hyaluronan catabolic process,BP,
7231,GO:0030215,1,0.863325980327544,0,20,semaphorin receptor binding,MF,
7232,GO:0030216,1,0.444472857655165,0,126,keratinocyte differentiation,BP,
7234,GO:0030218,1,0.519337145618453,0,101,erythrocyte differentiation,BP,
7235,GO:0030219,1,0.63907867528241,0,70,megakaryocyte differentiation,BP,
7236,GO:0030220,1,0.888078812302511,0,18,platelet formation,BP,
7237,GO:0030221,1,0.98798252263011,0,2,basophil differentiation,BP,
7238,GO:0030222,1,0.980741820012593,0,3,eosinophil differentiation,BP,
7239,GO:0030223,1,0.963324597128283,0,6,neutrophil differentiation,BP,
7240,GO:0030224,1,0.820327424611513,0,30,monocyte differentiation,BP,
7241,GO:0030225,1,0.794221118476145,0,36,macrophage differentiation,BP,
7242,GO:0030226,1,0.976157107834735,0,3,apolipoprotein receptor activity,MF,
7243,GO:0030228,1,0.892262886145223,0,16,lipoprotein particle receptor activity,MF,
7244,GO:0030229,1,0.970869850952225,0,4,very-low-density lipoprotein particle receptor activity,MF,
7245,GO:0030233,1,0.995227575740951,0,1,deoxynucleotide transmembrane transporter activity,MF,
7247,GO:0030235,1,0.954255824841872,0,7,nitric-oxide synthase regulator activity,MF,
7248,GO:0030237,1,0.985490267227261,0,2,female sex determination,BP,
7249,GO:0030238,1,0.912180777801311,0,14,male sex determination,BP,
7250,GO:0030239,1,0.657502631411428,0,62,myofibril assembly,BP,
7251,GO:0030240,1,0.931490883323765,0,10,skeletal muscle thin filament assembly,BP,
7252,GO:0030241,1,0.949440449601282,0,7,skeletal muscle myosin thick filament assembly,BP,
7253,GO:0030242,1,0.963656867167558,0,5,autophagy of peroxisome,BP,
7255,GO:0030247,1,0.886747564439637,0,19,polysaccharide binding,MF,
7256,GO:0030249,1,0.979670619087255,0,4,guanylate cyclase regulator activity,MF,
7257,GO:0030250,1,0.979670619087255,0,4,guanylate cyclase activator activity,MF,
7258,GO:0030252,1,0.915239281022103,0,14,growth hormone secretion,BP,
7260,GO:0030259,1,0.958010116848528,0,7,lipid glycosylation,BP,
7261,GO:0030260,1,0.449801461632732,0,121,entry into host cell,BP,
7262,GO:0030261,1,0.827538692478402,0,27,chromosome condensation,BP,
7263,GO:0030262,1,0.84090716996583,0,28,apoptotic nuclear changes,BP,
7264,GO:0030263,1,0.971080821690852,0,4,apoptotic chromosome condensation,BP,
7265,GO:0030264,1,0.9930956730518,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7266,GO:0030267,1,0.982283970450839,0,3,glyoxylate reductase (NADP) activity,MF,
7267,GO:0030272,1,0.996278722506559,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7268,GO:0030273,1,0.993712426650281,0,1,melanin-concentrating hormone receptor activity,MF,
7269,GO:0030274,1,0.959630390169134,0,6,LIM domain binding,MF,
7270,GO:0030275,1,0.910869380424589,0,15,LRR domain binding,MF,
7272,GO:0030277,1,0.920336896420893,0,13,maintenance of gastrointestinal epithelium,BP,
7273,GO:0030278,1,0.33272231972968,0,167,regulation of ossification,BP,
7274,GO:0030279,1,0.683065072376155,0,59,negative regulation of ossification,BP,
7275,GO:0030280,1,0.973094537154051,0,5,structural constituent of epidermis,MF,
7276,GO:0030282,1,0.540091421632552,0,93,bone mineralization,BP,
7277,GO:0030283,1,0.996201642158946,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7278,GO:0030284,1,0.964766804820331,0,5,estrogen receptor activity,MF,
7280,GO:0030286,1,0.721694795044513,0,48,dynein complex,CC,
7281,GO:0030289,1,0.983822755682846,0,3,protein phosphatase 4 complex,CC,
7282,GO:0030290,1,0.992535647518547,0,1,sphingolipid activator protein activity,MF,
7283,GO:0030291,1,0.81986474694751,0,33,protein serine/threonine kinase inhibitor activity,MF,
7284,GO:0030292,1,0.981457569103404,0,3,protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030294,1,0.994130435310069,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7286,GO:0030295,1,0.641921496636032,0,68,protein kinase activator activity,MF,
7287,GO:0030296,1,0.900281440873525,0,15,protein tyrosine kinase activator activity,MF,
7288,GO:0030297,1,0.951876724456702,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7289,GO:0030299,1,0.951831457787917,0,8,intestinal cholesterol absorption,BP,
7290,GO:0030300,1,0.982206151393067,0,3,regulation of intestinal cholesterol absorption,BP,
7291,GO:0030301,1,0.653027135569931,0,67,cholesterol transport,BP,
7292,GO:0030302,1,0.995227575740951,0,1,deoxynucleotide transport,BP,
7293,GO:0030305,1,0.987542201906654,0,2,heparanase activity,MF,
7294,GO:0030306,1,0.945429321932265,0,8,ADP-ribosylation factor binding,MF,
7296,GO:0030308,1,0.368341148656533,0,154,negative regulation of cell growth,BP,
7297,GO:0030309,1,0.950541916756515,0,8,poly-N-acetyllactosamine metabolic process,BP,
7298,GO:0030311,1,0.957611325701535,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7299,GO:0030312,1,0.994052343891405,0,1,external encapsulating structure,CC,
7300,GO:0030314,1,0.948507314680218,0,7,junctional membrane complex,CC,
7301,GO:0030315,1,0.729339037705725,0,44,T-tubule,CC,
7302,GO:0030316,1,0.601240302107498,0,76,osteoclast differentiation,BP,
7304,GO:0030318,1,0.85468424286421,0,22,melanocyte differentiation,BP,
7306,GO:0030321,1,0.969351272372974,0,5,transepithelial chloride transport,BP,
7310,GO:0030325,1,0.888627388869175,0,19,adrenal gland development,BP,
7311,GO:0030326,1,0.440763304131063,0,122,embryonic limb morphogenesis,BP,
7312,GO:0030327,1,0.978750709328305,0,3,prenylated protein catabolic process,BP,
7313,GO:0030328,1,0.985936400835878,0,2,prenylcysteine catabolic process,BP,
7314,GO:0030329,1,0.985936400835878,0,2,prenylcysteine metabolic process,BP,
7315,GO:0030330,1,0.505764977282921,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7316,GO:0030331,1,0.778367486326315,0,37,estrogen receptor binding,MF,
7317,GO:0030332,1,0.829866999136635,0,30,cyclin binding,MF,
7320,GO:0030336,1,0.237790785096236,0,216,negative regulation of cell migration,BP,
7321,GO:0030337,1,0.988832221128089,0,2,DNA polymerase processivity factor activity,MF,
7322,GO:0030342,1,0.992702287084678,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7323,GO:0030343,1,0.995275165074226,0,1,vitamin D3 25-hydroxylase activity,MF,
7324,GO:0030345,1,0.992771849511622,0,1,structural constituent of tooth enamel,MF,
7325,GO:0030346,1,0.956097847602664,0,7,protein phosphatase 2B binding,MF,
7327,GO:0030350,1,0.98492945843117,0,2,iron-responsive element binding,MF,
7328,GO:0030351,1,0.993012653350283,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7329,GO:0030366,1,0.990818011398455,0,2,molybdopterin synthase activity,MF,
7330,GO:0030368,1,0.945239896816411,0,8,interleukin-17 receptor activity,MF,
7331,GO:0030369,1,0.985392845832359,0,2,ICAM-3 receptor activity,MF,
7333,GO:0030372,1,0.992464632574136,0,1,high molecular weight B cell growth factor receptor binding,MF,
7335,GO:0030375,1,0.970259129245377,0,4,thyroid hormone receptor coactivator activity,MF,
7336,GO:0030377,1,0.99555805783233,0,1,urokinase plasminogen activator receptor activity,MF,
7337,GO:0030378,1,0.993597334811366,0,1,serine racemase activity,MF,
7338,GO:0030379,1,0.992277980291002,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7339,GO:0030382,1,0.995052698512545,0,1,sperm mitochondrion organization,BP,
7340,GO:0030387,1,0.995565619186604,0,1,fructosamine-3-kinase activity,MF,
7341,GO:0030388,1,0.972705781107141,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7342,GO:0030389,1,0.992070534429531,0,2,fructosamine metabolic process,BP,
7343,GO:0030393,1,0.995565619186604,0,1,fructoselysine metabolic process,BP,
7344,GO:0030395,1,0.991688761996071,0,2,lactose binding,MF,
7345,GO:0030397,1,0.736456398696569,0,46,membrane disassembly,BP,
7346,GO:0030407,1,0.99475662131183,0,1,formimidoyltransferase activity,MF,
7347,GO:0030409,1,0.99475662131183,0,1,glutamate formimidoyltransferase activity,MF,
7348,GO:0030412,1,0.99475662131183,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7349,GO:0030414,1,0.472964774211398,0,125,peptidase inhibitor activity,MF,
7350,GO:0030421,1,0.996263188717863,0,1,defecation,BP,
7351,GO:0030422,1,0.943527678843708,0,9,production of siRNA involved in RNA interference,BP,
7352,GO:0030423,1,0.975303782945587,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7357,GO:0030429,1,0.995485080421186,0,1,kynureninase activity,MF,
7358,GO:0030430,1,0.963548454935687,0,6,host cell cytoplasm,CC,
7359,GO:0030431,1,0.842060927702354,0,29,sleep,BP,
7360,GO:0030432,1,0.955214387322663,0,8,peristalsis,BP,
7361,GO:0030433,1,0.636077389186709,0,70,ubiquitin-dependent ERAD pathway,BP,
7362,GO:0030449,1,0.799126220785547,0,36,regulation of complement activation,BP,
7363,GO:0030450,1,0.9862002291371,0,2,regulation of complement activation, classical pathway,BP,
7364,GO:0030451,1,0.992089267287523,0,1,regulation of complement activation, alternative pathway,BP,
7365,GO:0030473,1,0.962392841692393,0,5,nuclear migration along microtubule,BP,
7366,GO:0030474,1,0.9930956730518,0,1,spindle pole body duplication,BP,
7367,GO:0030478,1,0.970956428207395,0,4,actin cap,CC,
7368,GO:0030479,1,0.950711321988714,0,7,actin cortical patch,CC,
7369,GO:0030485,1,0.987860552777189,0,2,smooth muscle contractile fiber,CC,
7370,GO:0030488,1,0.821661633731696,0,31,tRNA methylation,BP,
7371,GO:0030490,1,0.740477030859367,0,51,maturation of SSU-rRNA,BP,
7372,GO:0030492,1,0.984832989149332,0,4,hemoglobin binding,MF,
7373,GO:0030496,1,0.340558178760809,0,160,midbody,CC,
7374,GO:0030497,1,0.929449111190605,0,11,fatty acid elongation,BP,
7375,GO:0030500,1,0.669747401979685,0,60,regulation of bone mineralization,BP,
7376,GO:0030501,1,0.792738227929862,0,34,positive regulation of bone mineralization,BP,
7377,GO:0030502,1,0.931585719974095,0,11,negative regulation of bone mineralization,BP,
7378,GO:0030504,1,0.992179493274743,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7379,GO:0030505,1,0.984481533276871,0,2,inorganic diphosphate transport,BP,
7380,GO:0030506,1,0.88063030839389,0,17,ankyrin binding,MF,
7383,GO:0030510,1,0.586137458351681,0,79,regulation of BMP signaling pathway,BP,
7384,GO:0030511,1,0.848574049540028,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7385,GO:0030512,1,0.641220591131296,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7386,GO:0030513,1,0.810729539710055,0,31,positive regulation of BMP signaling pathway,BP,
7387,GO:0030514,1,0.749327885876605,0,43,negative regulation of BMP signaling pathway,BP,
7388,GO:0030515,1,0.847528181911919,0,29,snoRNA binding,MF,
7389,GO:0030516,1,0.563866181613687,0,82,regulation of axon extension,BP,
7390,GO:0030517,1,0.789195628726966,0,34,negative regulation of axon extension,BP,
7391,GO:0030518,1,0.430116156848922,0,125,intracellular steroid hormone receptor signaling pathway,BP,
7392,GO:0030520,1,0.704610039679878,0,51,intracellular estrogen receptor signaling pathway,BP,
7393,GO:0030521,1,0.662729607296245,0,61,androgen receptor signaling pathway,BP,
7394,GO:0030522,1,0.175923381868282,0,256,intracellular receptor signaling pathway,BP,
7395,GO:0030523,1,0.992489332642608,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7396,GO:0030526,1,0.99246113266151,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7397,GO:0030532,1,0.667356834059484,0,68,small nuclear ribonucleoprotein complex,CC,
7399,GO:0030538,1,0.982165748126509,0,3,embryonic genitalia morphogenesis,BP,
7400,GO:0030539,1,0.885785411263758,0,19,male genitalia development,BP,
7401,GO:0030540,1,0.898661055916773,0,16,female genitalia development,BP,
7402,GO:0030544,1,0.799113464198786,0,36,Hsp70 protein binding,MF,
7404,GO:0030546,1,0.926478475222981,0,11,receptor activator activity,MF,
7405,GO:0030547,1,0.892105734208471,0,19,receptor inhibitor activity,MF,
7406,GO:0030548,1,0.962081666726947,0,7,acetylcholine receptor regulator activity,MF,
7407,GO:0030549,1,0.995960960804899,0,1,acetylcholine receptor activator activity,MF,
7408,GO:0030550,1,0.975092370073554,0,4,acetylcholine receptor inhibitor activity,MF,
7409,GO:0030551,1,0.790624174045859,0,34,cyclic nucleotide binding,MF,
7410,GO:0030552,1,0.848907272415753,0,23,cAMP binding,MF,
7411,GO:0030553,1,0.920451533350249,0,12,cGMP binding,MF,
7413,GO:0030572,1,0.992507882206926,0,1,phosphatidyltransferase activity,MF,
7414,GO:0030573,1,0.993987835832886,0,1,bile acid catabolic process,BP,
7415,GO:0030574,1,0.657019089643063,0,60,collagen catabolic process,BP,
7416,GO:0030575,1,0.924749168025836,0,11,nuclear body organization,BP,
7417,GO:0030576,1,0.980093841668131,0,3,Cajal body organization,BP,
7418,GO:0030578,1,0.972826697834792,0,4,PML body organization,BP,
7419,GO:0030579,1,0.967940093066985,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7420,GO:0030580,1,0.995807011225709,0,1,quinone cofactor methyltransferase activity,MF,
7421,GO:0030581,1,0.991336711223962,0,2,symbiont intracellular protein transport in host,BP,
7422,GO:0030586,1,0.992632563568689,0,1,[methionine synthase] reductase activity,MF,
7423,GO:0030593,1,0.682902773600334,0,69,neutrophil chemotaxis,BP,
7426,GO:0030611,1,0.996247543640063,0,1,arsenate reductase activity,MF,
7427,GO:0030613,1,0.988152313306632,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7428,GO:0030614,1,0.988152313306632,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7429,GO:0030616,1,0.992133593536938,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7430,GO:0030617,1,0.985796152520314,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7431,GO:0030618,1,0.962509762786726,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7432,GO:0030619,1,0.96023892276222,0,7,U1 snRNA binding,MF,
7433,GO:0030620,1,0.970372573079397,0,6,U2 snRNA binding,MF,
7434,GO:0030621,1,0.965792814952352,0,5,U4 snRNA binding,MF,
7435,GO:0030622,1,0.986624368367605,0,2,U4atac snRNA binding,MF,
7436,GO:0030623,1,0.992252730100824,0,1,U5 snRNA binding,MF,
7437,GO:0030624,1,0.992487981924976,0,1,U6atac snRNA binding,MF,
7438,GO:0030626,1,0.987313347551441,0,2,U12 snRNA binding,MF,
7439,GO:0030627,1,0.988908661102389,0,2,pre-mRNA 5'-splice site binding,MF,
7440,GO:0030628,1,0.966726345365912,0,6,pre-mRNA 3'-splice site binding,MF,
7441,GO:0030629,1,0.9930956730518,0,1,U6 snRNA 3'-end binding,MF,
7442,GO:0030638,1,0.962643653228649,0,8,polyketide metabolic process,BP,
7444,GO:0030643,1,0.958861390280448,0,6,cellular phosphate ion homeostasis,BP,
7446,GO:0030647,1,0.962643653228649,0,8,aminoglycoside antibiotic metabolic process,BP,
7447,GO:0030653,1,0.992444797609066,0,1,beta-lactam antibiotic metabolic process,BP,
7448,GO:0030656,1,0.937883896425951,0,11,regulation of vitamin metabolic process,BP,
7453,GO:0030663,1,0.896277062498545,0,18,COPI-coated vesicle membrane,CC,
7457,GO:0030669,1,0.777950173884314,0,41,clathrin-coated endocytic vesicle membrane,CC,
7458,GO:0030670,1,0.662128339781653,0,67,phagocytic vesicle membrane,CC,
7462,GO:0030676,1,0.887427681564027,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7463,GO:0030677,1,0.931109295966501,0,13,ribonuclease P complex,CC,
7464,GO:0030678,1,0.982757843163735,0,3,mitochondrial ribonuclease P complex,CC,
7465,GO:0030681,1,0.947454383995286,0,10,multimeric ribonuclease P complex,CC,
7466,GO:0030682,1,0.985692914434426,0,2,evasion or tolerance of host defense response,BP,
7467,GO:0030683,1,0.985692914434426,0,2,evasion or tolerance by virus of host immune response,BP,
7468,GO:0030684,1,0.642353088894867,0,72,preribosome,CC,
7469,GO:0030686,1,0.824682030182941,0,30,90S preribosome,CC,
7470,GO:0030687,1,0.867579722234024,0,24,preribosome, large subunit precursor,CC,
7471,GO:0030688,1,0.926736825131377,0,12,preribosome, small subunit precursor,CC,
7472,GO:0030689,1,0.981316350798312,0,3,Noc complex,CC,
7473,GO:0030690,1,0.993056811932997,0,1,Noc1p-Noc2p complex,CC,
7474,GO:0030691,1,0.993056811932997,0,1,Noc2p-Noc3p complex,CC,
7475,GO:0030692,1,0.988178288246096,0,2,Noc4p-Nop14p complex,CC,
7477,GO:0030696,1,0.992709751666111,0,1,tRNA (m5U54) methyltransferase activity,MF,
7478,GO:0030697,1,0.992709751666111,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7479,GO:0030702,1,0.99249955134373,0,1,chromatin silencing at centromere,BP,
7481,GO:0030718,1,0.987911450026964,0,2,germ-line stem cell population maintenance,BP,
7482,GO:0030719,1,0.986027031806539,0,2,P granule organization,BP,
7483,GO:0030728,1,0.878830132871195,0,19,ovulation,BP,
7484,GO:0030729,1,0.992612654432657,0,1,acetoacetate-CoA ligase activity,MF,
7485,GO:0030730,1,0.91579833645601,0,15,sequestering of triglyceride,BP,
7486,GO:0030731,1,0.996137127717995,0,1,guanidinoacetate N-methyltransferase activity,MF,
7487,GO:0030742,1,0.869835128317577,0,23,GTP-dependent protein binding,MF,
7488,GO:0030748,1,0.993457795060686,0,1,amine N-methyltransferase activity,MF,
7489,GO:0030760,1,0.995341766142714,0,1,pyridine N-methyltransferase activity,MF,
7490,GO:0030791,1,0.993615949149888,0,1,arsenite methyltransferase activity,MF,
7491,GO:0030792,1,0.993615949149888,0,1,methylarsonite methyltransferase activity,MF,
7498,GO:0030805,1,0.977757474097958,0,3,regulation of cyclic nucleotide catabolic process,BP,
7499,GO:0030806,1,0.985279731239398,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7500,GO:0030807,1,0.992366508624123,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7504,GO:0030811,1,0.645569847326553,0,64,regulation of nucleotide catabolic process,BP,
7505,GO:0030812,1,0.925116434957794,0,12,negative regulation of nucleotide catabolic process,BP,
7506,GO:0030813,1,0.883853883627134,0,17,positive regulation of nucleotide catabolic process,BP,
7508,GO:0030815,1,0.850080796423266,0,25,negative regulation of cAMP metabolic process,BP,
7511,GO:0030818,1,0.871242028328447,0,21,negative regulation of cAMP biosynthetic process,BP,
7513,GO:0030820,1,0.977757474097958,0,3,regulation of cAMP catabolic process,BP,
7514,GO:0030821,1,0.985279731239398,0,2,negative regulation of cAMP catabolic process,BP,
7515,GO:0030822,1,0.992366508624123,0,1,positive regulation of cAMP catabolic process,BP,
7518,GO:0030825,1,0.907255516081087,0,17,positive regulation of cGMP metabolic process,BP,
7521,GO:0030828,1,0.919197577538232,0,15,positive regulation of cGMP biosynthetic process,BP,
7522,GO:0030832,1,0.336938181822752,0,167,regulation of actin filament length,BP,
7523,GO:0030833,1,0.387589799540007,0,147,regulation of actin filament polymerization,BP,
7524,GO:0030834,1,0.736969123931067,0,44,regulation of actin filament depolymerization,BP,
7525,GO:0030835,1,0.786824009918794,0,34,negative regulation of actin filament depolymerization,BP,
7526,GO:0030836,1,0.936542021360459,0,10,positive regulation of actin filament depolymerization,BP,
7527,GO:0030837,1,0.714695177329299,0,51,negative regulation of actin filament polymerization,BP,
7528,GO:0030838,1,0.574919810548357,0,88,positive regulation of actin filament polymerization,BP,
7529,GO:0030842,1,0.992405588969486,0,1,regulation of intermediate filament depolymerization,BP,
7530,GO:0030844,1,0.992405588969486,0,1,positive regulation of intermediate filament depolymerization,BP,
7531,GO:0030845,1,0.993002618111896,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7532,GO:0030846,1,0.991956301967642,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7533,GO:0030849,1,0.98753842609075,0,2,autosome,CC,
7534,GO:0030850,1,0.730560093772882,0,46,prostate gland development,BP,
7535,GO:0030851,1,0.853927159325958,0,25,granulocyte differentiation,BP,
7536,GO:0030852,1,0.920249219221819,0,13,regulation of granulocyte differentiation,BP,
7537,GO:0030853,1,0.952092951345378,0,7,negative regulation of granulocyte differentiation,BP,
7538,GO:0030854,1,0.959344745736817,0,7,positive regulation of granulocyte differentiation,BP,
7539,GO:0030855,1,0.0306178746332437,0,525,epithelial cell differentiation,BP,
7540,GO:0030856,1,0.451935822526733,0,120,regulation of epithelial cell differentiation,BP,
7541,GO:0030857,1,0.804987389735713,0,33,negative regulation of epithelial cell differentiation,BP,
7542,GO:0030858,1,0.721815267135167,0,50,positive regulation of epithelial cell differentiation,BP,
7543,GO:0030859,1,0.884121483069497,0,18,polarized epithelial cell differentiation,BP,
7544,GO:0030860,1,0.986020107686586,0,2,regulation of polarized epithelial cell differentiation,BP,
7545,GO:0030862,1,0.992405804698064,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7547,GO:0030864,1,0.598733029822956,0,72,cortical actin cytoskeleton,CC,
7548,GO:0030865,1,0.710641225822311,0,49,cortical cytoskeleton organization,BP,
7549,GO:0030866,1,0.759205386560608,0,39,cortical actin cytoskeleton organization,BP,
7550,GO:0030867,1,0.849221866870909,0,28,rough endoplasmic reticulum membrane,CC,
7551,GO:0030868,1,0.972248088367112,0,5,smooth endoplasmic reticulum membrane,CC,
7552,GO:0030870,1,0.965097382425266,0,5,Mre11 complex,CC,
7553,GO:0030874,1,0.995097852422239,0,1,nucleolar chromatin,CC,
7554,GO:0030877,1,0.916593310941544,0,12,beta-catenin destruction complex,CC,
7555,GO:0030878,1,0.853195831658884,0,25,thyroid gland development,BP,
7557,GO:0030880,1,0.430419157701973,0,134,RNA polymerase complex,CC,
7558,GO:0030881,1,0.966602429434057,0,6,beta-2-microglobulin binding,MF,
7559,GO:0030882,1,0.98595496974464,0,2,lipid antigen binding,MF,
7560,GO:0030883,1,0.98595496974464,0,2,endogenous lipid antigen binding,MF,
7561,GO:0030884,1,0.98595496974464,0,2,exogenous lipid antigen binding,MF,
7562,GO:0030885,1,0.976533483467501,0,5,regulation of myeloid dendritic cell activation,BP,
7563,GO:0030886,1,0.98487475676591,0,3,negative regulation of myeloid dendritic cell activation,BP,
7564,GO:0030887,1,0.995416391962496,0,1,positive regulation of myeloid dendritic cell activation,BP,
7565,GO:0030888,1,0.710640034881551,0,55,regulation of B cell proliferation,BP,
7566,GO:0030889,1,0.903811969041715,0,16,negative regulation of B cell proliferation,BP,
7567,GO:0030890,1,0.802930866942337,0,36,positive regulation of B cell proliferation,BP,
7568,GO:0030891,1,0.975281984161706,0,4,VCB complex,CC,
7569,GO:0030893,1,0.959116813966563,0,6,meiotic cohesin complex,CC,
7570,GO:0030894,1,0.85131749059551,0,26,replisome,CC,
7571,GO:0030895,1,0.988092727121276,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7572,GO:0030896,1,0.96968957217464,0,5,checkpoint clamp complex,CC,
7573,GO:0030897,1,0.904132729513325,0,14,HOPS complex,CC,
7574,GO:0030898,1,0.91527011353024,0,12,actin-dependent ATPase activity,MF,
7575,GO:0030899,1,0.988057776844553,0,3,calcium-dependent ATPase activity,MF,
7577,GO:0030901,1,0.591516475335189,0,82,midbrain development,BP,
7579,GO:0030903,1,0.899986820657532,0,16,notochord development,BP,
7580,GO:0030904,1,0.869360304762985,0,21,retromer complex,CC,
7581,GO:0030905,1,0.973982295723734,0,4,retromer, tubulation complex,CC,
7582,GO:0030906,1,0.974751035756623,0,4,retromer, cargo-selective complex,CC,
7583,GO:0030908,1,0.995345054077821,0,1,protein splicing,BP,
7584,GO:0030910,1,0.971273485794653,0,4,olfactory placode formation,BP,
7585,GO:0030911,1,0.944898907071671,0,8,TPR domain binding,MF,
7586,GO:0030913,1,0.952143768785866,0,7,paranodal junction assembly,BP,
7587,GO:0030914,1,0.933670727615361,0,11,STAGA complex,CC,
7588,GO:0030915,1,0.968342149439826,0,6,Smc5-Smc6 complex,CC,
7589,GO:0030916,1,0.955607191745241,0,8,otic vesicle formation,BP,
7590,GO:0030917,1,0.959762988554465,0,7,midbrain-hindbrain boundary development,BP,
7591,GO:0030920,1,0.991737229061066,0,2,peptidyl-serine acetylation,BP,
7592,GO:0030934,1,0.976644351917384,0,3,anchoring collagen complex,CC,
7593,GO:0030935,1,0.993338409672199,0,1,sheet-forming collagen trimer,CC,
7594,GO:0030936,1,0.992788597661988,0,1,transmembrane collagen trimer,CC,
7595,GO:0030942,1,0.983650649081601,0,3,endoplasmic reticulum signal peptide binding,MF,
7596,GO:0030943,1,0.981141817558427,0,3,mitochondrion targeting sequence binding,MF,
7597,GO:0030947,1,0.833059646506029,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7598,GO:0030948,1,0.940449938476191,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7599,GO:0030949,1,0.908272320281349,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7600,GO:0030950,1,0.914382779376837,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7601,GO:0030951,1,0.97139574732991,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7602,GO:0030952,1,0.888203994866915,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7603,GO:0030953,1,0.949487465163081,0,7,astral microtubule organization,BP,
7604,GO:0030955,1,0.903858449582677,0,14,potassium ion binding,MF,
7605,GO:0030956,1,0.98244081586836,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7606,GO:0030957,1,0.940119491854816,0,10,Tat protein binding,MF,
7607,GO:0030961,1,0.9930956730518,0,1,peptidyl-arginine hydroxylation,BP,
7608,GO:0030964,1,0.835956224082939,0,43,NADH dehydrogenase complex,CC,
7609,GO:0030968,1,0.451044975154679,0,123,endoplasmic reticulum unfolded protein response,BP,
7610,GO:0030969,1,0.979126406627516,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7611,GO:0030970,1,0.84421086509847,0,26,retrograde protein transport, ER to cytosol,BP,
7613,GO:0030974,1,0.988563744257134,0,2,thiamine pyrophosphate transmembrane transport,BP,
7614,GO:0030975,1,0.993826867711281,0,1,thiamine binding,MF,
7615,GO:0030976,1,0.966320967234282,0,5,thiamine pyrophosphate binding,MF,
7616,GO:0030977,1,0.994924557862983,0,1,taurine binding,MF,
7617,GO:0030981,1,0.977969232533,0,3,cortical microtubule cytoskeleton,CC,
7618,GO:0030983,1,0.916113424390471,0,13,mismatched DNA binding,MF,
7619,GO:0030984,1,0.989065761401342,0,2,kininogen binding,MF,
7620,GO:0030990,1,0.811632733183189,0,31,intraciliary transport particle,CC,
7621,GO:0030991,1,0.942669420326477,0,8,intraciliary transport particle A,CC,
7622,GO:0030992,1,0.877838818390068,0,20,intraciliary transport particle B,CC,
7623,GO:0030997,1,0.97917282296847,0,3,regulation of centriole-centriole cohesion,BP,
7624,GO:0031000,1,0.883441329881431,0,18,response to caffeine,BP,
7625,GO:0031001,1,0.9930956730518,0,1,response to brefeldin A,BP,
7626,GO:0031005,1,0.924300559767007,0,11,filamin binding,MF,
7627,GO:0031010,1,0.926372731576918,0,11,ISWI-type complex,CC,
7628,GO:0031011,1,0.919740831667874,0,15,Ino80 complex,CC,
7630,GO:0031013,1,0.976419412964683,0,5,troponin I binding,MF,
7631,GO:0031014,1,0.985449468068286,0,4,troponin T binding,MF,
7632,GO:0031016,1,0.643344754381186,0,67,pancreas development,BP,
7633,GO:0031017,1,0.970916103090368,0,5,exocrine pancreas development,BP,
7634,GO:0031018,1,0.771148192304753,0,40,endocrine pancreas development,BP,
7635,GO:0031021,1,0.98220373936782,0,3,interphase microtubule organizing center,CC,
7636,GO:0031022,1,0.984424174669689,0,2,nuclear migration along microfilament,BP,
7637,GO:0031023,1,0.435654763525399,0,122,microtubule organizing center organization,BP,
7638,GO:0031032,1,0.292682754778001,0,178,actomyosin structure organization,BP,
7639,GO:0031033,1,0.900536495378225,0,15,myosin filament organization,BP,
7640,GO:0031034,1,0.905671801875799,0,14,myosin filament assembly,BP,
7641,GO:0031038,1,0.994335551361362,0,1,myosin II filament organization,BP,
7643,GO:0031047,1,0.399226506775286,0,140,gene silencing by RNA,BP,
7644,GO:0031048,1,0.985628698551379,0,2,chromatin silencing by small RNA,BP,
7645,GO:0031049,1,0.993036377919383,0,1,programmed DNA elimination,BP,
7646,GO:0031050,1,0.741845288345554,0,43,dsRNA fragmentation,BP,
7647,GO:0031052,1,0.993036377919383,0,1,chromosome breakage,BP,
7648,GO:0031053,1,0.932402382307569,0,10,primary miRNA processing,BP,
7649,GO:0031054,1,0.916135501312848,0,13,pre-miRNA processing,BP,
7650,GO:0031055,1,0.835970078455388,0,32,chromatin remodeling at centromere,BP,
7651,GO:0031056,1,0.404391362680454,0,132,regulation of histone modification,BP,
7652,GO:0031057,1,0.777725205349909,0,37,negative regulation of histone modification,BP,
7653,GO:0031058,1,0.577005676167713,0,81,positive regulation of histone modification,BP,
7654,GO:0031060,1,0.668911901918794,0,57,regulation of histone methylation,BP,
7655,GO:0031061,1,0.887597895286158,0,17,negative regulation of histone methylation,BP,
7656,GO:0031062,1,0.794520991356496,0,33,positive regulation of histone methylation,BP,
7657,GO:0031063,1,0.846821441028556,0,25,regulation of histone deacetylation,BP,
7658,GO:0031064,1,0.975022046867623,0,4,negative regulation of histone deacetylation,BP,
7659,GO:0031065,1,0.88817139301328,0,17,positive regulation of histone deacetylation,BP,
7660,GO:0031069,1,0.853570637004727,0,24,hair follicle morphogenesis,BP,
7661,GO:0031071,1,0.993789717240295,0,1,cysteine desulfurase activity,MF,
7662,GO:0031072,1,0.483975111936976,0,110,heat shock protein binding,MF,
7663,GO:0031074,1,0.981082895586513,0,3,nucleocytoplasmic transport complex,CC,
7664,GO:0031076,1,0.76663714546696,0,37,embryonic camera-type eye development,BP,
7665,GO:0031077,1,0.957077235745663,0,7,post-embryonic camera-type eye development,BP,
7666,GO:0031078,1,0.926861874789689,0,11,histone deacetylase activity (H3-K14 specific),MF,
7667,GO:0031080,1,0.935186728009653,0,10,nuclear pore outer ring,CC,
7668,GO:0031081,1,0.985642381151682,0,2,nuclear pore distribution,BP,
7671,GO:0031084,1,0.978420877331147,0,3,BLOC-2 complex,CC,
7672,GO:0031085,1,0.985799727468382,0,2,BLOC-3 complex,CC,
7673,GO:0031086,1,0.956073076456439,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7674,GO:0031087,1,0.96298504217462,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7675,GO:0031088,1,0.962141295515681,0,6,platelet dense granule membrane,CC,
7676,GO:0031089,1,0.941167291221042,0,11,platelet dense granule lumen,CC,
7678,GO:0031091,1,0.585516847051099,0,84,platelet alpha granule,CC,
7679,GO:0031092,1,0.896663640421415,0,16,platelet alpha granule membrane,CC,
7680,GO:0031093,1,0.675437737616509,0,63,platelet alpha granule lumen,CC,
7681,GO:0031094,1,0.920591560710275,0,11,platelet dense tubular network,CC,
7682,GO:0031095,1,0.933224603064819,0,9,platelet dense tubular network membrane,CC,
7683,GO:0031098,1,0.163745998340249,0,268,stress-activated protein kinase signaling cascade,BP,
7684,GO:0031099,1,0.362569823979648,0,160,regeneration,BP,
7685,GO:0031100,1,0.647843201713592,0,70,animal organ regeneration,BP,
7686,GO:0031102,1,0.723107770447415,0,49,neuron projection regeneration,BP,
7687,GO:0031103,1,0.765712992535935,0,40,axon regeneration,BP,
7688,GO:0031104,1,0.992498214150706,0,1,dendrite regeneration,BP,
7689,GO:0031105,1,0.920009142398826,0,12,septin complex,CC,
7690,GO:0031106,1,0.900736717702408,0,15,septin ring organization,BP,
7698,GO:0031116,1,0.851076786281918,0,24,positive regulation of microtubule polymerization,BP,
7700,GO:0031118,1,0.963003985818906,0,8,rRNA pseudouridine synthesis,BP,
7701,GO:0031119,1,0.962953552334927,0,7,tRNA pseudouridine synthesis,BP,
7702,GO:0031120,1,0.982210289108346,0,4,snRNA pseudouridine synthesis,BP,
7703,GO:0031122,1,0.692992367947676,0,52,cytoplasmic microtubule organization,BP,
7704,GO:0031123,1,0.462084555905843,0,120,RNA 3'-end processing,BP,
7705,GO:0031124,1,0.559589908745667,0,88,mRNA 3'-end processing,BP,
7706,GO:0031125,1,0.944734131082841,0,12,rRNA 3'-end processing,BP,
7707,GO:0031126,1,0.967489859721592,0,7,snoRNA 3'-end processing,BP,
7708,GO:0031127,1,0.99249363300448,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7709,GO:0031128,1,0.836015505455194,0,28,developmental induction,BP,
7710,GO:0031129,1,0.992435572563869,0,1,inductive cell-cell signaling,BP,
7711,GO:0031133,1,0.973493705168843,0,4,regulation of axon diameter,BP,
7712,GO:0031134,1,0.98056797385132,0,3,sister chromatid biorientation,BP,
7713,GO:0031143,1,0.907344551446732,0,14,pseudopodium,CC,
7714,GO:0031145,1,0.669185948565887,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7715,GO:0031146,1,0.682919652425246,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7716,GO:0031151,1,0.992242149641407,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7717,GO:0031161,1,0.992721299222384,0,1,phosphatidylinositol catabolic process,BP,
7718,GO:0031163,1,0.898531293689968,0,20,metallo-sulfur cluster assembly,BP,
7719,GO:0031166,1,0.978072011836986,0,3,integral component of vacuolar membrane,CC,
7720,GO:0031167,1,0.897766541567458,0,18,rRNA methylation,BP,
7722,GO:0031177,1,0.985256420160166,0,3,phosphopantetheine binding,MF,
7723,GO:0031179,1,0.992513811625648,0,1,peptide modification,BP,
7725,GO:0031204,1,0.981518711178284,0,3,posttranslational protein targeting to membrane, translocation,BP,
7726,GO:0031205,1,0.981474194929193,0,3,endoplasmic reticulum Sec complex,CC,
7727,GO:0031208,1,0.985788441194235,0,2,POZ domain binding,MF,
7728,GO:0031209,1,0.942000653085057,0,8,SCAR complex,CC,
7729,GO:0031210,1,0.901301081887011,0,17,phosphatidylcholine binding,MF,
7730,GO:0031211,1,0.951161010709911,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7731,GO:0031213,1,0.985000005056151,0,2,RSF complex,CC,
7732,GO:0031214,1,0.477174414793619,0,112,biomineral tissue development,BP,
7733,GO:0031223,1,0.922951032829969,0,11,auditory behavior,BP,
7737,GO:0031227,1,0.410892888250283,0,141,intrinsic component of endoplasmic reticulum membrane,CC,
7739,GO:0031229,1,0.910865765901467,0,14,intrinsic component of nuclear inner membrane,CC,
7740,GO:0031231,1,0.905589172400357,0,17,intrinsic component of peroxisomal membrane,CC,
7741,GO:0031232,1,0.957477522861779,0,7,extrinsic component of external side of plasma membrane,CC,
7742,GO:0031233,1,0.903780934593905,0,18,intrinsic component of external side of plasma membrane,CC,
7744,GO:0031235,1,0.900257672617567,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7745,GO:0031247,1,0.987672386450864,0,2,actin rod assembly,BP,
7746,GO:0031248,1,0.574241449221691,0,85,protein acetyltransferase complex,CC,
7747,GO:0031249,1,0.993704771852438,0,1,denatured protein binding,MF,
7748,GO:0031251,1,0.984880272633915,0,2,PAN complex,CC,
7751,GO:0031254,1,0.919569425442645,0,13,cell trailing edge,CC,
7753,GO:0031257,1,0.9930956730518,0,1,cell trailing edge membrane,CC,
7754,GO:0031258,1,0.858879341543935,0,22,lamellipodium membrane,CC,
7755,GO:0031259,1,0.9930956730518,0,1,uropod membrane,CC,
7756,GO:0031261,1,0.969244114984239,0,5,DNA replication preinitiation complex,CC,
7757,GO:0031262,1,0.981229452175214,0,4,Ndc80 complex,CC,
7758,GO:0031264,1,0.944596153949582,0,9,death-inducing signaling complex,CC,
7759,GO:0031265,1,0.962399447370718,0,6,CD95 death-inducing signaling complex,CC,
7761,GO:0031268,1,0.922070024300847,0,13,pseudopodium organization,BP,
7762,GO:0031269,1,0.922070024300847,0,13,pseudopodium assembly,BP,
7763,GO:0031271,1,0.9930956730518,0,1,lateral pseudopodium assembly,BP,
7764,GO:0031272,1,0.922070024300847,0,13,regulation of pseudopodium assembly,BP,
7765,GO:0031274,1,0.928485429570061,0,12,positive regulation of pseudopodium assembly,BP,
7766,GO:0031275,1,0.9930956730518,0,1,regulation of lateral pseudopodium assembly,BP,
7772,GO:0031284,1,0.953646548391897,0,8,positive regulation of guanylate cyclase activity,BP,
7773,GO:0031289,1,0.99279985327218,0,1,actin phosphorylation,BP,
7774,GO:0031290,1,0.869530403700858,0,19,retinal ganglion cell axon guidance,BP,
7775,GO:0031291,1,0.981742950812616,0,3,Ran protein signal transduction,BP,
7777,GO:0031294,1,0.665705646226665,0,68,lymphocyte costimulation,BP,
7778,GO:0031295,1,0.668449603773768,0,67,T cell costimulation,BP,
7779,GO:0031296,1,0.988109673498681,0,3,B cell costimulation,BP,
7780,GO:0031297,1,0.833210336559294,0,27,replication fork processing,BP,
7781,GO:0031298,1,0.944921418262341,0,9,replication fork protection complex,CC,
7784,GO:0031302,1,0.992440781289541,0,1,intrinsic component of endosome membrane,CC,
7785,GO:0031304,1,0.813086562482251,0,35,intrinsic component of mitochondrial inner membrane,CC,
7786,GO:0031305,1,0.813086562482251,0,35,integral component of mitochondrial inner membrane,CC,
7787,GO:0031306,1,0.863784280274432,0,23,intrinsic component of mitochondrial outer membrane,CC,
7788,GO:0031307,1,0.870341943162876,0,22,integral component of mitochondrial outer membrane,CC,
7789,GO:0031308,1,0.9930956730518,0,1,intrinsic component of nuclear outer membrane,CC,
7790,GO:0031309,1,0.9930956730518,0,1,integral component of nuclear outer membrane,CC,
7791,GO:0031310,1,0.978072011836986,0,3,intrinsic component of vacuolar membrane,CC,
7792,GO:0031312,1,0.807386035466157,0,32,extrinsic component of organelle membrane,CC,
7793,GO:0031313,1,0.947195078107339,0,8,extrinsic component of endosome membrane,CC,
7794,GO:0031314,1,0.965205823974207,0,5,extrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031315,1,0.985329146493547,0,2,extrinsic component of mitochondrial outer membrane,CC,
7796,GO:0031320,1,0.993507719716997,0,1,hexitol dehydrogenase activity,MF,
7805,GO:0031331,1,0.120284672042937,0,312,positive regulation of cellular catabolic process,BP,
7806,GO:0031332,1,0.924456659378916,0,11,RNAi effector complex,CC,
7809,GO:0031335,1,0.98760192745823,0,2,regulation of sulfur amino acid metabolic process,BP,
7810,GO:0031337,1,0.994006942278645,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7814,GO:0031341,1,0.703496255169368,0,60,regulation of cell killing,BP,
7815,GO:0031342,1,0.909554425970627,0,16,negative regulation of cell killing,BP,
7816,GO:0031343,1,0.801548353906122,0,38,positive regulation of cell killing,BP,
7821,GO:0031348,1,0.383694840525876,0,151,negative regulation of defense response,BP,
7823,GO:0031362,1,0.924105423677266,0,14,anchored component of external side of plasma membrane,CC,
7824,GO:0031365,1,0.834381578226279,0,28,N-terminal protein amino acid modification,BP,
7825,GO:0031369,1,0.834675502089102,0,29,translation initiation factor binding,MF,
7826,GO:0031370,1,0.99246788836698,0,1,eukaryotic initiation factor 4G binding,MF,
7827,GO:0031371,1,0.952398403881182,0,8,ubiquitin conjugating enzyme complex,CC,
7828,GO:0031372,1,0.988932235249747,0,2,UBC13-MMS2 complex,CC,
7829,GO:0031379,1,0.985187393046343,0,2,RNA-directed RNA polymerase complex,CC,
7830,GO:0031380,1,0.992632563568689,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7831,GO:0031386,1,0.922927297057594,0,16,protein tag,MF,
7832,GO:0031389,1,0.992950951146867,0,1,Rad17 RFC-like complex,CC,
7833,GO:0031390,1,0.952848780985064,0,8,Ctf18 RFC-like complex,CC,
7834,GO:0031392,1,0.966283673015295,0,5,regulation of prostaglandin biosynthetic process,BP,
7835,GO:0031393,1,0.98529666750118,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7836,GO:0031394,1,0.98070616643753,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7837,GO:0031396,1,0.332802571700525,0,170,regulation of protein ubiquitination,BP,
7838,GO:0031397,1,0.679112358345112,0,61,negative regulation of protein ubiquitination,BP,
7839,GO:0031398,1,0.534412018093906,0,97,positive regulation of protein ubiquitination,BP,
7843,GO:0031402,1,0.916629956151965,0,12,sodium ion binding,MF,
7844,GO:0031403,1,0.984891167039125,0,2,lithium ion binding,MF,
7845,GO:0031404,1,0.949976300534357,0,8,chloride ion binding,MF,
7846,GO:0031405,1,0.9919727708295,0,1,lipoic acid binding,MF,
7848,GO:0031407,1,0.99381510762746,0,1,oxylipin metabolic process,BP,
7850,GO:0031414,1,0.939282323229054,0,10,N-terminal protein acetyltransferase complex,CC,
7851,GO:0031415,1,0.971862427322271,0,5,NatA complex,CC,
7852,GO:0031416,1,0.988477058235182,0,2,NatB complex,CC,
7853,GO:0031417,1,0.977755419512711,0,3,NatC complex,CC,
7854,GO:0031418,1,0.876701255772232,0,20,L-ascorbic acid binding,MF,
7855,GO:0031419,1,0.943471064116525,0,9,cobalamin binding,MF,
7856,GO:0031420,1,0.870386403049199,0,19,alkali metal ion binding,MF,
7857,GO:0031424,1,0.685098873418768,0,63,keratinization,BP,
7858,GO:0031427,1,0.973424361608191,0,4,response to methotrexate,BP,
7859,GO:0031428,1,0.98055574878921,0,4,box C/D snoRNP complex,CC,
7860,GO:0031429,1,0.978257386458527,0,5,box H/ACA snoRNP complex,CC,
7861,GO:0031430,1,0.827245985355274,0,29,M band,CC,
7862,GO:0031431,1,0.985612854160475,0,2,Dbf4-dependent protein kinase complex,CC,
7863,GO:0031432,1,0.914496949671193,0,14,titin binding,MF,
7864,GO:0031433,1,0.964626404325556,0,5,telethonin binding,MF,
7866,GO:0031435,1,0.899110940502729,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7867,GO:0031436,1,0.985703568303737,0,2,BRCA1-BARD1 complex,CC,
7868,GO:0031437,1,0.979113686636681,0,3,regulation of mRNA cleavage,BP,
7869,GO:0031438,1,0.992776802320677,0,1,negative regulation of mRNA cleavage,BP,
7870,GO:0031439,1,0.986238485313485,0,2,positive regulation of mRNA cleavage,BP,
7871,GO:0031440,1,0.860397030107766,0,22,regulation of mRNA 3'-end processing,BP,
7872,GO:0031441,1,0.937790207065924,0,9,negative regulation of mRNA 3'-end processing,BP,
7873,GO:0031442,1,0.942647692493288,0,9,positive regulation of mRNA 3'-end processing,BP,
7874,GO:0031443,1,0.984893506039827,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7875,GO:0031444,1,0.984530133308331,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7876,GO:0031445,1,0.987331117998594,0,2,regulation of heterochromatin assembly,BP,
7877,GO:0031446,1,0.99254602603732,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7878,GO:0031448,1,0.99254602603732,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7879,GO:0031449,1,0.992361198544908,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7880,GO:0031453,1,0.987331117998594,0,2,positive regulation of heterochromatin assembly,BP,
7881,GO:0031455,1,0.985118463489298,0,2,glycine betaine metabolic process,BP,
7882,GO:0031456,1,0.985118463489298,0,2,glycine betaine biosynthetic process,BP,
7883,GO:0031460,1,0.992458295176073,0,1,glycine betaine transport,BP,
7885,GO:0031462,1,0.914967971756363,0,14,Cul2-RING ubiquitin ligase complex,CC,
7887,GO:0031464,1,0.926181692411614,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7888,GO:0031465,1,0.969272258242557,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7889,GO:0031466,1,0.966074050447446,0,6,Cul5-RING ubiquitin ligase complex,CC,
7890,GO:0031467,1,0.971007826529276,0,5,Cul7-RING ubiquitin ligase complex,CC,
7891,GO:0031468,1,0.897696541334705,0,18,nuclear envelope reassembly,BP,
7892,GO:0031475,1,0.995432342359858,0,1,myosin V complex,CC,
7893,GO:0031477,1,0.992248443248606,0,1,myosin VII complex,CC,
7894,GO:0031489,1,0.905611636960446,0,16,myosin V binding,MF,
7895,GO:0031490,1,0.562502928428724,0,90,chromatin DNA binding,MF,
7896,GO:0031491,1,0.708088646770519,0,55,nucleosome binding,MF,
7897,GO:0031492,1,0.828834230319425,0,32,nucleosomal DNA binding,MF,
7898,GO:0031493,1,0.988241235869925,0,2,nucleosomal histone binding,MF,
7899,GO:0031497,1,0.529242077133155,0,108,chromatin assembly,BP,
7900,GO:0031498,1,0.881366302651859,0,19,chromatin disassembly,BP,
7901,GO:0031501,1,0.982130908667022,0,4,mannosyltransferase complex,CC,
7903,GO:0031506,1,0.994995753572652,0,1,cell wall glycoprotein biosynthetic process,BP,
7904,GO:0031507,1,0.945391184620937,0,9,heterochromatin assembly,BP,
7905,GO:0031508,1,0.988716937285847,0,2,pericentric heterochromatin assembly,BP,
7906,GO:0031509,1,0.995237841458615,0,1,telomeric heterochromatin assembly,BP,
7907,GO:0031510,1,0.982524989501479,0,3,SUMO activating enzyme complex,CC,
7908,GO:0031514,1,0.467720547547979,0,120,motile cilium,CC,
7909,GO:0031515,1,0.981551677430994,0,3,tRNA (m1A) methyltransferase complex,CC,
7910,GO:0031519,1,0.731394023494595,0,46,PcG protein complex,CC,
7911,GO:0031523,1,0.985392071118161,0,2,Myb complex,CC,
7912,GO:0031526,1,0.757746930965094,0,41,brush border membrane,CC,
7913,GO:0031527,1,0.888491364716188,0,17,filopodium membrane,CC,
7914,GO:0031528,1,0.868194550254428,0,21,microvillus membrane,CC,
7915,GO:0031529,1,0.75414753128266,0,44,ruffle organization,BP,
7916,GO:0031530,1,0.991881837191876,0,2,gonadotropin-releasing hormone receptor binding,MF,
7917,GO:0031531,1,0.995723547946495,0,1,thyrotropin-releasing hormone receptor binding,MF,
7918,GO:0031532,1,0.519227184340899,0,100,actin cytoskeleton reorganization,BP,
7919,GO:0031533,1,0.992348523628312,0,1,mRNA cap methyltransferase complex,CC,
7920,GO:0031536,1,0.979675400911421,0,4,positive regulation of exit from mitosis,BP,
7921,GO:0031543,1,0.924162494677926,0,12,peptidyl-proline dioxygenase activity,MF,
7922,GO:0031544,1,0.972392274183483,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7923,GO:0031545,1,0.950414712199472,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7924,GO:0031547,1,0.96252525749828,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7925,GO:0031548,1,0.984975579441842,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7926,GO:0031549,1,0.992419404014377,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7927,GO:0031550,1,0.992499895423057,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7928,GO:0031554,1,0.991956301967642,0,1,regulation of DNA-templated transcription, termination,BP,
7929,GO:0031559,1,0.992493074882697,0,1,oxidosqualene cyclase activity,MF,
7930,GO:0031570,1,0.353768114184267,0,157,DNA integrity checkpoint,BP,
7931,GO:0031571,1,0.645757952017255,0,69,mitotic G1 DNA damage checkpoint,BP,
7932,GO:0031572,1,0.797822051593817,0,32,G2 DNA damage checkpoint,BP,
7933,GO:0031573,1,0.918831365429118,0,14,intra-S DNA damage checkpoint,BP,
7934,GO:0031577,1,0.804478422022654,0,34,spindle checkpoint,BP,
7937,GO:0031581,1,0.925431288713093,0,11,hemidesmosome assembly,BP,
7938,GO:0031583,1,0.994356999235507,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7940,GO:0031585,1,0.968954010818417,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7941,GO:0031587,1,0.976900257611685,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7942,GO:0031588,1,0.93905233268713,0,9,nucleotide-activated protein kinase complex,CC,
7943,GO:0031589,1,0.128310158991517,0,295,cell-substrate adhesion,BP,
7944,GO:0031590,1,0.986078899240412,0,2,wybutosine metabolic process,BP,
7945,GO:0031591,1,0.986078899240412,0,2,wybutosine biosynthetic process,BP,
7946,GO:0031592,1,0.992201423453386,0,1,centrosomal corona,CC,
7947,GO:0031593,1,0.785857505028914,0,35,polyubiquitin modification-dependent protein binding,MF,
7949,GO:0031595,1,0.960930569495228,0,8,nuclear proteasome complex,CC,
7950,GO:0031597,1,0.935424191825147,0,12,cytosolic proteasome complex,CC,
7951,GO:0031616,1,0.944884439397617,0,10,spindle pole centrosome,CC,
7952,GO:0031618,1,0.939531329954933,0,9,nuclear pericentric heterochromatin,CC,
7956,GO:0031624,1,0.788884231469485,0,33,ubiquitin conjugating enzyme binding,MF,
7957,GO:0031625,1,0.149079413366745,0,292,ubiquitin protein ligase binding,MF,
7958,GO:0031626,1,0.99243501329512,0,1,beta-endorphin binding,MF,
7959,GO:0031627,1,0.978537448959566,0,3,telomeric loop formation,BP,
7960,GO:0031628,1,0.953665525997711,0,8,opioid receptor binding,MF,
7962,GO:0031630,1,0.980630818401563,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7963,GO:0031635,1,0.987315393722161,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7964,GO:0031638,1,0.782078038220749,0,40,zymogen activation,BP,
7965,GO:0031639,1,0.891227960861799,0,19,plasminogen activation,BP,
7967,GO:0031641,1,0.792533836970331,0,34,regulation of myelination,BP,
7968,GO:0031642,1,0.956242099848152,0,6,negative regulation of myelination,BP,
7969,GO:0031643,1,0.915623948658246,0,13,positive regulation of myelination,BP,
7971,GO:0031645,1,0.921744264759205,0,12,negative regulation of neurological system process,BP,
7972,GO:0031646,1,0.859980160515017,0,23,positive regulation of neurological system process,BP,
7973,GO:0031647,1,0.222822583116019,0,234,regulation of protein stability,BP,
7974,GO:0031648,1,0.762336863675393,0,41,protein destabilization,BP,
7977,GO:0031651,1,0.992496223623435,0,1,negative regulation of heat generation,BP,
7979,GO:0031657,1,0.915537224930587,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7980,GO:0031658,1,0.959981733619433,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7981,GO:0031659,1,0.953721599574783,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7982,GO:0031663,1,0.735614117845736,0,49,lipopolysaccharide-mediated signaling pathway,BP,
7983,GO:0031664,1,0.877997647504999,0,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7984,GO:0031665,1,0.94068324689136,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7985,GO:0031666,1,0.954203986185016,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7987,GO:0031668,1,0.235562980384682,0,223,cellular response to extracellular stimulus,BP,
7988,GO:0031669,1,0.27970797327007,0,195,cellular response to nutrient levels,BP,
7989,GO:0031670,1,0.690897433819788,0,58,cellular response to nutrient,BP,
7990,GO:0031672,1,0.776689813462287,0,39,A band,CC,
7991,GO:0031673,1,0.991493876006158,0,1,H zone,CC,
7993,GO:0031681,1,0.943325248828497,0,9,G-protein beta-subunit binding,MF,
7994,GO:0031682,1,0.992807372296908,0,1,G-protein gamma-subunit binding,MF,
7995,GO:0031683,1,0.89003000492464,0,18,G-protein beta/gamma-subunit complex binding,MF,
7996,GO:0031685,1,0.980657352520704,0,3,adenosine receptor binding,MF,
7997,GO:0031686,1,0.992754206822178,0,1,A1 adenosine receptor binding,MF,
7998,GO:0031687,1,0.995281897954798,0,1,A2A adenosine receptor binding,MF,
7999,GO:0031690,1,0.890971902456957,0,18,adrenergic receptor binding,MF,
8000,GO:0031691,1,0.988917934299303,0,2,alpha-1A adrenergic receptor binding,MF,
8001,GO:0031692,1,0.981504471209835,0,3,alpha-1B adrenergic receptor binding,MF,
8002,GO:0031694,1,0.977466552096292,0,4,alpha-2A adrenergic receptor binding,MF,
8003,GO:0031695,1,0.993635605447189,0,1,alpha-2B adrenergic receptor binding,MF,
8004,GO:0031696,1,0.986187136751274,0,2,alpha-2C adrenergic receptor binding,MF,
8005,GO:0031697,1,0.971062019049152,0,4,beta-1 adrenergic receptor binding,MF,
8006,GO:0031698,1,0.974085226485963,0,4,beta-2 adrenergic receptor binding,MF,
8007,GO:0031699,1,0.985860268602053,0,2,beta-3 adrenergic receptor binding,MF,
8008,GO:0031700,1,0.995544390071837,0,1,adrenomedullin receptor binding,MF,
8011,GO:0031703,1,0.99341927840292,0,1,type 2 angiotensin receptor binding,MF,
8012,GO:0031704,1,0.992672739688804,0,1,apelin receptor binding,MF,
8013,GO:0031705,1,0.983675591196645,0,3,bombesin receptor binding,MF,
8014,GO:0031707,1,0.994356999235507,0,1,endothelin A receptor binding,MF,
8015,GO:0031708,1,0.983675591196645,0,3,endothelin B receptor binding,MF,
8016,GO:0031711,1,0.986539083110176,0,2,bradykinin receptor binding,MF,
8017,GO:0031714,1,0.992440312753478,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8018,GO:0031715,1,0.992440312753478,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8019,GO:0031717,1,0.99522928928386,0,1,cannabinoid receptor binding,MF,
8020,GO:0031718,1,0.99522928928386,0,1,type 1 cannabinoid receptor binding,MF,
8021,GO:0031720,1,0.989746552809402,0,3,haptoglobin binding,MF,
8022,GO:0031724,1,0.995894182048718,0,1,CXCR5 chemokine receptor binding,MF,
8023,GO:0031726,1,0.996365437323365,0,1,CCR1 chemokine receptor binding,MF,
8024,GO:0031727,1,0.986411862597092,0,3,CCR2 chemokine receptor binding,MF,
8025,GO:0031728,1,0.993337508829517,0,2,CCR3 chemokine receptor binding,MF,
8026,GO:0031730,1,0.974231635026132,0,4,CCR5 chemokine receptor binding,MF,
8027,GO:0031731,1,0.996325214701462,0,1,CCR6 chemokine receptor binding,MF,
8028,GO:0031732,1,0.992789861151807,0,2,CCR7 chemokine receptor binding,MF,
8029,GO:0031735,1,0.988696881270701,0,3,CCR10 chemokine receptor binding,MF,
8030,GO:0031737,1,0.992644968459419,0,1,CX3C chemokine receptor binding,MF,
8031,GO:0031739,1,0.994313075102455,0,1,cholecystokinin receptor binding,MF,
8032,GO:0031741,1,0.994313075102455,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8033,GO:0031748,1,0.955566510152282,0,7,D1 dopamine receptor binding,MF,
8035,GO:0031750,1,0.988273707436988,0,2,D3 dopamine receptor binding,MF,
8036,GO:0031751,1,0.995181786897452,0,1,D4 dopamine receptor binding,MF,
8037,GO:0031752,1,0.980138994284416,0,3,D5 dopamine receptor binding,MF,
8038,GO:0031753,1,0.993085287446715,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8039,GO:0031755,1,0.993085287446715,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8040,GO:0031762,1,0.988917934299303,0,2,follicle-stimulating hormone receptor binding,MF,
8041,GO:0031763,1,0.996390802365142,0,1,galanin receptor binding,MF,
8042,GO:0031764,1,0.996390802365142,0,1,type 1 galanin receptor binding,MF,
8043,GO:0031765,1,0.996390802365142,0,1,type 2 galanin receptor binding,MF,
8044,GO:0031766,1,0.996390802365142,0,1,type 3 galanin receptor binding,MF,
8045,GO:0031768,1,0.996458096886506,0,1,ghrelin receptor binding,MF,
8046,GO:0031770,1,0.99671265800679,0,1,growth hormone-releasing hormone receptor binding,MF,
8047,GO:0031773,1,0.996460136282059,0,1,kisspeptin receptor binding,MF,
8048,GO:0031775,1,0.992176865634032,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8054,GO:0031798,1,0.992225886861261,0,1,type 1 metabotropic glutamate receptor binding,MF,
8055,GO:0031802,1,0.968913892060953,0,5,type 5 metabotropic glutamate receptor binding,MF,
8056,GO:0031811,1,0.992503090702835,0,1,G-protein coupled nucleotide receptor binding,MF,
8057,GO:0031812,1,0.992503090702835,0,1,P2Y1 nucleotide receptor binding,MF,
8058,GO:0031821,1,0.955373794911744,0,7,G-protein coupled serotonin receptor binding,MF,
8059,GO:0031826,1,0.984354884995139,0,3,type 2A serotonin receptor binding,MF,
8060,GO:0031834,1,0.995976240652135,0,1,neurokinin receptor binding,MF,
8061,GO:0031835,1,0.995976240652135,0,1,substance P receptor binding,MF,
8062,GO:0031838,1,0.985486016194195,0,4,haptoglobin-hemoglobin complex,CC,
8063,GO:0031839,1,0.996352645489994,0,1,type 1 neuromedin U receptor binding,MF,
8064,GO:0031840,1,0.996352645489994,0,1,type 2 neuromedin U receptor binding,MF,
8065,GO:0031841,1,0.996610217817555,0,1,neuropeptide Y receptor binding,MF,
8066,GO:0031848,1,0.93347215222183,0,10,protection from non-homologous end joining at telomere,BP,
8067,GO:0031849,1,0.976078900823078,0,4,olfactory receptor binding,MF,
8068,GO:0031852,1,0.973359640626437,0,4,mu-type opioid receptor binding,MF,
8069,GO:0031858,1,0.992704304506391,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8070,GO:0031859,1,0.994744823175433,0,1,platelet activating factor receptor binding,MF,
8071,GO:0031860,1,0.977547287579404,0,3,telomeric 3' overhang formation,BP,
8072,GO:0031862,1,0.984922369453116,0,2,prostanoid receptor binding,MF,
8073,GO:0031867,1,0.992505711200361,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8074,GO:0031870,1,0.992359981035912,0,1,thromboxane A2 receptor binding,MF,
8075,GO:0031871,1,0.979997580341107,0,3,proteinase activated receptor binding,MF,
8076,GO:0031877,1,0.992309676339087,0,1,somatostatin receptor binding,MF,
8077,GO:0031883,1,0.994349850897736,0,1,taste receptor binding,MF,
8078,GO:0031893,1,0.986682755282235,0,2,vasopressin receptor binding,MF,
8079,GO:0031894,1,0.992496608308158,0,1,V1A vasopressin receptor binding,MF,
8080,GO:0031896,1,0.994142642339631,0,1,V2 vasopressin receptor binding,MF,
8081,GO:0031901,1,0.425799658536461,0,127,early endosome membrane,CC,
8083,GO:0031903,1,0.694958919391112,0,57,microbody membrane,CC,
8084,GO:0031904,1,0.856630927583786,0,26,endosome lumen,CC,
8085,GO:0031905,1,0.982820521948014,0,3,early endosome lumen,CC,
8086,GO:0031906,1,0.974419249735674,0,6,late endosome lumen,CC,
8090,GO:0031929,1,0.51156316093882,0,99,TOR signaling,BP,
8091,GO:0031930,1,0.995522981677329,0,1,mitochondria-nucleus signaling pathway,BP,
8092,GO:0031931,1,0.953169705064559,0,7,TORC1 complex,CC,
8093,GO:0031932,1,0.918099016921785,0,13,TORC2 complex,CC,
8094,GO:0031933,1,0.98143287747699,0,3,telomeric heterochromatin,CC,
8095,GO:0031935,1,0.873388265158669,0,19,regulation of chromatin silencing,BP,
8096,GO:0031936,1,0.944081831517423,0,8,negative regulation of chromatin silencing,BP,
8097,GO:0031937,1,0.944179694996412,0,8,positive regulation of chromatin silencing,BP,
8098,GO:0031938,1,0.989972065964993,0,2,regulation of chromatin silencing at telomere,BP,
8099,GO:0031940,1,0.995237841458615,0,1,positive regulation of chromatin silencing at telomere,BP,
8100,GO:0031941,1,0.793533524264547,0,36,filamentous actin,CC,
8101,GO:0031943,1,0.943237508992689,0,9,regulation of glucocorticoid metabolic process,BP,
8102,GO:0031944,1,0.965588954493094,0,5,negative regulation of glucocorticoid metabolic process,BP,
8103,GO:0031945,1,0.992502895160612,0,1,positive regulation of glucocorticoid metabolic process,BP,
8104,GO:0031946,1,0.951131558093712,0,7,regulation of glucocorticoid biosynthetic process,BP,
8105,GO:0031947,1,0.965588954493094,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8106,GO:0031948,1,0.992502895160612,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8107,GO:0031952,1,0.756205400191118,0,39,regulation of protein autophosphorylation,BP,
8108,GO:0031953,1,0.930664158031614,0,10,negative regulation of protein autophosphorylation,BP,
8109,GO:0031954,1,0.836846402366985,0,25,positive regulation of protein autophosphorylation,BP,
8110,GO:0031956,1,0.950816440053053,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8111,GO:0031957,1,0.941055997241233,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8112,GO:0031958,1,0.887935933350595,0,17,corticosteroid receptor signaling pathway,BP,
8113,GO:0031959,1,0.985574243274477,0,2,mineralocorticoid receptor signaling pathway,BP,
8115,GO:0031962,1,0.992374751668866,0,1,mineralocorticoid receptor binding,MF,
8116,GO:0031965,1,0.155788871059508,0,278,nuclear membrane,CC,
8120,GO:0031970,1,0.648961851353693,0,76,organelle envelope lumen,CC,
8127,GO:0031985,1,0.519156302249619,0,98,Golgi cisterna,CC,
8128,GO:0031987,1,0.943623388024991,0,8,locomotion involved in locomotory behavior,BP,
8129,GO:0031990,1,0.986003719922804,0,2,mRNA export from nucleus in response to heat stress,BP,
8132,GO:0031996,1,0.929160243674605,0,11,thioesterase binding,MF,
8133,GO:0031997,1,0.982378439632361,0,3,N-terminal myristoylation domain binding,MF,
8136,GO:0032000,1,0.940935765405054,0,9,positive regulation of fatty acid beta-oxidation,BP,
8137,GO:0032002,1,0.987813526330858,0,2,interleukin-28 receptor complex,CC,
8138,GO:0032006,1,0.572516483288659,0,82,regulation of TOR signaling,BP,
8139,GO:0032007,1,0.772090787943158,0,38,negative regulation of TOR signaling,BP,
8140,GO:0032008,1,0.803262563569704,0,33,positive regulation of TOR signaling,BP,
8141,GO:0032009,1,0.945476292781924,0,8,early phagosome,CC,
8142,GO:0032010,1,0.97143886653339,0,5,phagolysosome,CC,
8145,GO:0032020,1,0.968479027108117,0,6,ISG15-protein conjugation,BP,
8146,GO:0032021,1,0.972664538770891,0,4,NELF complex,CC,
8147,GO:0032023,1,0.993987835832886,0,1,trypsinogen activation,BP,
8149,GO:0032025,1,0.945606447557397,0,9,response to cobalt ion,BP,
8151,GO:0032027,1,0.977057262924655,0,4,myosin light chain binding,MF,
8152,GO:0032028,1,0.994337594357053,0,1,myosin head/neck binding,MF,
8153,GO:0032029,1,0.991899962683398,0,1,myosin tail binding,MF,
8154,GO:0032036,1,0.951145569815726,0,9,myosin heavy chain binding,MF,
8155,GO:0032038,1,0.992515392876157,0,2,myosin II heavy chain binding,MF,
8156,GO:0032039,1,0.89691006613111,0,15,integrator complex,CC,
8157,GO:0032040,1,0.821050530671599,0,32,small-subunit processome,CC,
8158,GO:0032041,1,0.926861874789689,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8159,GO:0032042,1,0.894650336723589,0,16,mitochondrial DNA metabolic process,BP,
8160,GO:0032044,1,0.98802857801933,0,2,DSIF complex,CC,
8161,GO:0032045,1,0.914868291051789,0,13,guanyl-nucleotide exchange factor complex,CC,
8162,GO:0032048,1,0.912039064775472,0,14,cardiolipin metabolic process,BP,
8163,GO:0032049,1,0.948965076144496,0,8,cardiolipin biosynthetic process,BP,
8164,GO:0032050,1,0.954770727470219,0,7,clathrin heavy chain binding,MF,
8166,GO:0032052,1,0.952615614546211,0,10,bile acid binding,MF,
8167,GO:0032053,1,0.985455613193431,0,2,ciliary basal body organization,BP,
8168,GO:0032055,1,0.960902523416581,0,6,negative regulation of translation in response to stress,BP,
8169,GO:0032056,1,0.960441490577227,0,6,positive regulation of translation in response to stress,BP,
8170,GO:0032057,1,0.97275230680109,0,4,negative regulation of translational initiation in response to stress,BP,
8171,GO:0032058,1,0.971415530729346,0,4,positive regulation of translational initiation in response to stress,BP,
8172,GO:0032059,1,0.946270967206087,0,8,bleb,CC,
8173,GO:0032060,1,0.929175049469274,0,11,bleb assembly,BP,
8174,GO:0032069,1,0.827182195589861,0,30,regulation of nuclease activity,BP,
8175,GO:0032070,1,0.94234727697913,0,10,regulation of deoxyribonuclease activity,BP,
8176,GO:0032071,1,0.952896543662518,0,8,regulation of endodeoxyribonuclease activity,BP,
8177,GO:0032072,1,0.992577495925823,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8178,GO:0032074,1,0.956190114784764,0,7,negative regulation of nuclease activity,BP,
8179,GO:0032075,1,0.904149084752286,0,16,positive regulation of nuclease activity,BP,
8180,GO:0032076,1,0.989488026952587,0,2,negative regulation of deoxyribonuclease activity,BP,
8181,GO:0032077,1,0.970945140057902,0,5,positive regulation of deoxyribonuclease activity,BP,
8182,GO:0032078,1,0.996264301944444,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8183,GO:0032079,1,0.975132252849132,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8184,GO:0032088,1,0.599633349329251,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8185,GO:0032089,1,0.985429177771409,0,2,NACHT domain binding,MF,
8186,GO:0032090,1,0.988839114200601,0,2,Pyrin domain binding,MF,
8187,GO:0032091,1,0.56055973278444,0,91,negative regulation of protein binding,BP,
8188,GO:0032092,1,0.574460934247603,0,84,positive regulation of protein binding,BP,
8189,GO:0032093,1,0.9930956730518,0,1,SAM domain binding,MF,
8193,GO:0032097,1,0.987938644212139,0,3,positive regulation of response to food,BP,
8196,GO:0032100,1,0.987938644212139,0,3,positive regulation of appetite,BP,
8202,GO:0032106,1,0.975982930466429,0,5,positive regulation of response to extracellular stimulus,BP,
8205,GO:0032109,1,0.975982930466429,0,5,positive regulation of response to nutrient levels,BP,
8206,GO:0032116,1,0.985174246202604,0,2,SMC loading complex,CC,
8209,GO:0032129,1,0.987778594542397,0,2,histone deacetylase activity (H3-K9 specific),MF,
8210,GO:0032133,1,0.973469137548959,0,5,chromosome passenger complex,CC,
8211,GO:0032135,1,0.959619303175203,0,6,DNA insertion or deletion binding,MF,
8212,GO:0032137,1,0.978969857049205,0,3,guanine/thymine mispair binding,MF,
8213,GO:0032138,1,0.971015034603458,0,4,single base insertion or deletion binding,MF,
8214,GO:0032139,1,0.981013260848152,0,3,dinucleotide insertion or deletion binding,MF,
8215,GO:0032142,1,0.977843543219179,0,3,single guanine insertion binding,MF,
8216,GO:0032143,1,0.985258909910829,0,2,single thymine insertion binding,MF,
8217,GO:0032144,1,0.992456603639031,0,1,4-aminobutyrate transaminase complex,CC,
8218,GO:0032145,1,0.992456603639031,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8220,GO:0032148,1,0.833468095520923,0,29,activation of protein kinase B activity,BP,
8221,GO:0032153,1,0.593997115015615,0,76,cell division site,CC,
8222,GO:0032154,1,0.704869630995536,0,51,cleavage furrow,CC,
8223,GO:0032155,1,0.661273459225003,0,60,cell division site part,CC,
8224,GO:0032156,1,0.913097942879571,0,13,septin cytoskeleton,CC,
8225,GO:0032160,1,0.920009142398826,0,12,septin filament array,CC,
8226,GO:0032173,1,0.992842561187002,0,1,septin collar,CC,
8227,GO:0032181,1,0.985243344219007,0,2,dinucleotide repeat insertion binding,MF,
8228,GO:0032182,1,0.578156216937451,0,83,ubiquitin-like protein binding,MF,
8229,GO:0032183,1,0.902270514301139,0,14,SUMO binding,MF,
8230,GO:0032184,1,0.963586095639205,0,5,SUMO polymer binding,MF,
8231,GO:0032185,1,0.894511125310796,0,16,septin cytoskeleton organization,BP,
8232,GO:0032190,1,0.985182720666088,0,3,acrosin binding,MF,
8233,GO:0032194,1,0.992523571807978,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8234,GO:0032196,1,0.883547777785786,0,19,transposition,BP,
8235,GO:0032200,1,0.384283148673782,0,149,telomere organization,BP,
8236,GO:0032201,1,0.849592466959488,0,27,telomere maintenance via semi-conservative replication,BP,
8237,GO:0032202,1,0.976496128691066,0,4,telomere assembly,BP,
8238,GO:0032203,1,0.994837506282806,0,1,telomere formation via telomerase,BP,
8239,GO:0032204,1,0.598630839449755,0,76,regulation of telomere maintenance,BP,
8240,GO:0032205,1,0.785950185397645,0,34,negative regulation of telomere maintenance,BP,
8241,GO:0032206,1,0.724270050870337,0,49,positive regulation of telomere maintenance,BP,
8242,GO:0032207,1,0.992949794499282,0,1,regulation of telomere maintenance via recombination,BP,
8243,GO:0032208,1,0.992949794499282,0,1,negative regulation of telomere maintenance via recombination,BP,
8244,GO:0032210,1,0.707617250398544,0,52,regulation of telomere maintenance via telomerase,BP,
8245,GO:0032211,1,0.877102536769635,0,19,negative regulation of telomere maintenance via telomerase,BP,
8246,GO:0032212,1,0.804532755017587,0,34,positive regulation of telomere maintenance via telomerase,BP,
8247,GO:0032213,1,0.985909299363446,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8248,GO:0032214,1,0.985909299363446,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8249,GO:0032217,1,0.975424668714109,0,4,riboflavin transmembrane transporter activity,MF,
8250,GO:0032218,1,0.979428260561731,0,3,riboflavin transport,BP,
8251,GO:0032222,1,0.955394721728464,0,7,regulation of synaptic transmission, cholinergic,BP,
8252,GO:0032223,1,0.993418410569946,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8253,GO:0032224,1,0.968253413303819,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8254,GO:0032225,1,0.910036010821053,0,15,regulation of synaptic transmission, dopaminergic,BP,
8255,GO:0032226,1,0.96032882331247,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8256,GO:0032227,1,0.977832629274399,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8258,GO:0032229,1,0.964345044642536,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8259,GO:0032230,1,0.924144367390741,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8260,GO:0032231,1,0.55589471044045,0,86,regulation of actin filament bundle assembly,BP,
8261,GO:0032232,1,0.859320518785891,0,22,negative regulation of actin filament bundle assembly,BP,
8262,GO:0032233,1,0.691184268243254,0,56,positive regulation of actin filament bundle assembly,BP,
8263,GO:0032237,1,0.970844881822529,0,4,activation of store-operated calcium channel activity,BP,
8264,GO:0032239,1,0.88358048259757,0,17,regulation of nucleobase-containing compound transport,BP,
8265,GO:0032240,1,0.984508290636492,0,2,negative regulation of nucleobase-containing compound transport,BP,
8266,GO:0032241,1,0.944409435008463,0,8,positive regulation of nucleobase-containing compound transport,BP,
8267,GO:0032242,1,0.993021544808823,0,1,regulation of nucleoside transport,BP,
8268,GO:0032244,1,0.993021544808823,0,1,positive regulation of nucleoside transport,BP,
8269,GO:0032252,1,0.970171754060941,0,4,secretory granule localization,BP,
8270,GO:0032253,1,0.9930956730518,0,1,dense core granule localization,BP,
8271,GO:0032258,1,0.9873847007344,0,2,protein localization by the Cvt pathway,BP,
8272,GO:0032259,1,0.132114154824424,0,305,methylation,BP,
8273,GO:0032261,1,0.962182637177818,0,7,purine nucleotide salvage,BP,
8274,GO:0032262,1,0.969316568574081,0,6,pyrimidine nucleotide salvage,BP,
8275,GO:0032263,1,0.990309718035064,0,2,GMP salvage,BP,
8276,GO:0032264,1,0.975510758332465,0,4,IMP salvage,BP,
8277,GO:0032266,1,0.79682972245609,0,33,phosphatidylinositol-3-phosphate binding,MF,
8283,GO:0032273,1,0.477390918868392,0,116,positive regulation of protein polymerization,BP,
8284,GO:0032274,1,0.913465041851978,0,14,gonadotropin secretion,BP,
8285,GO:0032275,1,0.936699839441521,0,10,luteinizing hormone secretion,BP,
8286,GO:0032276,1,0.940194338126004,0,10,regulation of gonadotropin secretion,BP,
8287,GO:0032277,1,0.96495638886621,0,6,negative regulation of gonadotropin secretion,BP,
8288,GO:0032278,1,0.957367964857558,0,7,positive regulation of gonadotropin secretion,BP,
8290,GO:0032280,1,0.945122246413366,0,8,symmetric synapse,CC,
8292,GO:0032286,1,0.972497651803217,0,4,central nervous system myelin maintenance,BP,
8293,GO:0032287,1,0.937071642830905,0,9,peripheral nervous system myelin maintenance,BP,
8294,GO:0032288,1,0.866662932413408,0,20,myelin assembly,BP,
8295,GO:0032289,1,0.980037930477055,0,3,central nervous system myelin formation,BP,
8296,GO:0032290,1,0.969358775121953,0,4,peripheral nervous system myelin formation,BP,
8297,GO:0032291,1,0.895605565282087,0,17,axon ensheathment in central nervous system,BP,
8298,GO:0032292,1,0.836447371215036,0,25,peripheral nervous system axon ensheathment,BP,
8299,GO:0032296,1,0.972918707387016,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8300,GO:0032298,1,0.994061447208065,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8301,GO:0032299,1,0.984487095936217,0,3,ribonuclease H2 complex,CC,
8302,GO:0032300,1,0.936675917110242,0,9,mismatch repair complex,CC,
8303,GO:0032301,1,0.985258909910829,0,2,MutSalpha complex,CC,
8304,GO:0032302,1,0.985243344219007,0,2,MutSbeta complex,CC,
8305,GO:0032303,1,0.933377645321963,0,11,regulation of icosanoid secretion,BP,
8306,GO:0032304,1,0.992447604720358,0,1,negative regulation of icosanoid secretion,BP,
8307,GO:0032305,1,0.940484526830785,0,10,positive regulation of icosanoid secretion,BP,
8308,GO:0032306,1,0.961821245322935,0,7,regulation of prostaglandin secretion,BP,
8309,GO:0032308,1,0.961821245322935,0,7,positive regulation of prostaglandin secretion,BP,
8310,GO:0032309,1,0.838360325234744,0,28,icosanoid secretion,BP,
8311,GO:0032310,1,0.940384332293958,0,10,prostaglandin secretion,BP,
8312,GO:0032311,1,0.990951481551204,0,2,angiogenin-PRI complex,CC,
8313,GO:0032324,1,0.957181597058405,0,7,molybdopterin cofactor biosynthetic process,BP,
8315,GO:0032329,1,0.941580278357277,0,10,serine transport,BP,
8316,GO:0032330,1,0.748164110335826,0,42,regulation of chondrocyte differentiation,BP,
8317,GO:0032331,1,0.893714084063609,0,17,negative regulation of chondrocyte differentiation,BP,
8318,GO:0032332,1,0.874612941425878,0,19,positive regulation of chondrocyte differentiation,BP,
8319,GO:0032341,1,0.951087439604421,0,7,aldosterone metabolic process,BP,
8320,GO:0032342,1,0.951087439604421,0,7,aldosterone biosynthetic process,BP,
8321,GO:0032344,1,0.958578910607081,0,6,regulation of aldosterone metabolic process,BP,
8322,GO:0032345,1,0.972876610603811,0,4,negative regulation of aldosterone metabolic process,BP,
8323,GO:0032346,1,0.98530777646116,0,2,positive regulation of aldosterone metabolic process,BP,
8324,GO:0032347,1,0.958578910607081,0,6,regulation of aldosterone biosynthetic process,BP,
8325,GO:0032348,1,0.972876610603811,0,4,negative regulation of aldosterone biosynthetic process,BP,
8326,GO:0032349,1,0.98530777646116,0,2,positive regulation of aldosterone biosynthetic process,BP,
8327,GO:0032350,1,0.817437488763721,0,31,regulation of hormone metabolic process,BP,
8328,GO:0032351,1,0.931102025305894,0,11,negative regulation of hormone metabolic process,BP,
8329,GO:0032352,1,0.922056058148252,0,12,positive regulation of hormone metabolic process,BP,
8330,GO:0032353,1,0.934974498156716,0,10,negative regulation of hormone biosynthetic process,BP,
8331,GO:0032354,1,0.904918828894941,0,14,response to follicle-stimulating hormone,BP,
8333,GO:0032356,1,0.937138254195014,0,10,oxidized DNA binding,MF,
8334,GO:0032357,1,0.942491730686105,0,9,oxidized purine DNA binding,MF,
8335,GO:0032358,1,0.996324673417562,0,1,oxidized pyrimidine DNA binding,MF,
8336,GO:0032361,1,0.994551172977047,0,1,pyridoxal phosphate catabolic process,BP,
8337,GO:0032364,1,0.962830110116088,0,6,oxygen homeostasis,BP,
8338,GO:0032365,1,0.823937185250683,0,29,intracellular lipid transport,BP,
8339,GO:0032366,1,0.88918287309786,0,18,intracellular sterol transport,BP,
8340,GO:0032367,1,0.88918287309786,0,18,intracellular cholesterol transport,BP,
8341,GO:0032368,1,0.595827061447164,0,82,regulation of lipid transport,BP,
8342,GO:0032369,1,0.880962909462871,0,19,negative regulation of lipid transport,BP,
8343,GO:0032370,1,0.748931722517433,0,47,positive regulation of lipid transport,BP,
8344,GO:0032371,1,0.806501063849587,0,35,regulation of sterol transport,BP,
8345,GO:0032372,1,0.95272128238611,0,8,negative regulation of sterol transport,BP,
8346,GO:0032373,1,0.89156926350742,0,18,positive regulation of sterol transport,BP,
8347,GO:0032374,1,0.806501063849587,0,35,regulation of cholesterol transport,BP,
8348,GO:0032375,1,0.95272128238611,0,8,negative regulation of cholesterol transport,BP,
8349,GO:0032376,1,0.89156926350742,0,18,positive regulation of cholesterol transport,BP,
8350,GO:0032377,1,0.957249269627116,0,7,regulation of intracellular lipid transport,BP,
8351,GO:0032378,1,0.992524621296595,0,1,negative regulation of intracellular lipid transport,BP,
8352,GO:0032379,1,0.983816270592261,0,3,positive regulation of intracellular lipid transport,BP,
8353,GO:0032380,1,0.957249269627116,0,7,regulation of intracellular sterol transport,BP,
8354,GO:0032381,1,0.992524621296595,0,1,negative regulation of intracellular sterol transport,BP,
8355,GO:0032382,1,0.983816270592261,0,3,positive regulation of intracellular sterol transport,BP,
8356,GO:0032383,1,0.957249269627116,0,7,regulation of intracellular cholesterol transport,BP,
8357,GO:0032384,1,0.992524621296595,0,1,negative regulation of intracellular cholesterol transport,BP,
8358,GO:0032385,1,0.983816270592261,0,3,positive regulation of intracellular cholesterol transport,BP,
8360,GO:0032387,1,0.70969827187698,0,56,negative regulation of intracellular transport,BP,
8362,GO:0032389,1,0.971902502198349,0,4,MutLalpha complex,CC,
8363,GO:0032391,1,0.804270852952383,0,32,photoreceptor connecting cilium,CC,
8364,GO:0032392,1,0.581017625801442,0,80,DNA geometric change,BP,
8365,GO:0032393,1,0.963740911827511,0,7,MHC class I receptor activity,MF,
8366,GO:0032394,1,0.995338474228066,0,1,MHC class Ib receptor activity,MF,
8367,GO:0032395,1,0.95848616108302,0,9,MHC class II receptor activity,MF,
8368,GO:0032396,1,0.980773774814081,0,3,inhibitory MHC class I receptor activity,MF,
8369,GO:0032397,1,0.99550371414173,0,1,activating MHC class I receptor activity,MF,
8370,GO:0032398,1,0.995166943682569,0,1,MHC class Ib protein complex,CC,
8371,GO:0032400,1,0.846810273159804,0,26,melanosome localization,BP,
8372,GO:0032401,1,0.85824247476447,0,24,establishment of melanosome localization,BP,
8373,GO:0032402,1,0.864962036893493,0,23,melanosome transport,BP,
8374,GO:0032404,1,0.950872173122964,0,8,mismatch repair complex binding,MF,
8375,GO:0032405,1,0.968689707639231,0,5,MutLalpha complex binding,MF,
8376,GO:0032407,1,0.969266156870252,0,5,MutSalpha complex binding,MF,
8378,GO:0032410,1,0.647299345998548,0,67,negative regulation of transporter activity,BP,
8381,GO:0032413,1,0.679403611362847,0,60,negative regulation of ion transmembrane transporter activity,BP,
8383,GO:0032415,1,0.97224756864402,0,5,regulation of sodium:proton antiporter activity,BP,
8384,GO:0032416,1,0.994547132949344,0,1,negative regulation of sodium:proton antiporter activity,BP,
8385,GO:0032417,1,0.97757941058872,0,4,positive regulation of sodium:proton antiporter activity,BP,
8387,GO:0032419,1,0.994080688044968,0,1,extrinsic component of lysosome membrane,CC,
8388,GO:0032420,1,0.768930646679638,0,39,stereocilium,CC,
8389,GO:0032421,1,0.744902468515834,0,44,stereocilium bundle,CC,
8390,GO:0032422,1,0.973884623868004,0,4,purine-rich negative regulatory element binding,MF,
8391,GO:0032423,1,0.977958523917608,0,3,regulation of mismatch repair,BP,
8392,GO:0032425,1,0.985355831574557,0,2,positive regulation of mismatch repair,BP,
8393,GO:0032426,1,0.902444030693768,0,15,stereocilium tip,CC,
8394,GO:0032427,1,0.9867363669194,0,2,GBD domain binding,MF,
8395,GO:0032428,1,0.992535647518547,0,1,beta-N-acetylgalactosaminidase activity,MF,
8396,GO:0032429,1,0.951177905713573,0,8,regulation of phospholipase A2 activity,BP,
8397,GO:0032430,1,0.970736193851376,0,5,positive regulation of phospholipase A2 activity,BP,
8398,GO:0032431,1,0.984129389986315,0,3,activation of phospholipase A2 activity,BP,
8399,GO:0032432,1,0.677145365966188,0,56,actin filament bundle,CC,
8400,GO:0032433,1,0.891745471864736,0,16,filopodium tip,CC,
8401,GO:0032434,1,0.477600730282908,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8402,GO:0032435,1,0.843366159952119,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8403,GO:0032436,1,0.59794918406711,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8404,GO:0032437,1,0.966331472847954,0,5,cuticular plate,CC,
8405,GO:0032438,1,0.851207204231464,0,26,melanosome organization,BP,
8406,GO:0032440,1,0.995826066349948,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8407,GO:0032444,1,0.978478650179425,0,3,activin responsive factor complex,CC,
8408,GO:0032445,1,0.993903895013174,0,1,fructose import,BP,
8410,GO:0032447,1,0.993645945930351,0,1,protein urmylation,BP,
8411,GO:0032448,1,0.995333528883485,0,1,DNA hairpin binding,MF,
8412,GO:0032449,1,0.966557806173399,0,5,CBM complex,CC,
8413,GO:0032450,1,0.977498123337686,0,3,maltose alpha-glucosidase activity,MF,
8414,GO:0032451,1,0.781832369083102,0,34,demethylase activity,MF,
8415,GO:0032452,1,0.82742696582404,0,25,histone demethylase activity,MF,
8416,GO:0032453,1,0.955154234835339,0,6,histone demethylase activity (H3-K4 specific),MF,
8417,GO:0032454,1,0.91378894897448,0,12,histone demethylase activity (H3-K9 specific),MF,
8418,GO:0032455,1,0.974059571446431,0,4,nerve growth factor processing,BP,
8419,GO:0032456,1,0.786495965037546,0,34,endocytic recycling,BP,
8420,GO:0032458,1,0.992503965986649,0,1,slow endocytic recycling,BP,
8422,GO:0032460,1,0.9123681257764,0,14,negative regulation of protein oligomerization,BP,
8424,GO:0032462,1,0.902117992319105,0,17,regulation of protein homooligomerization,BP,
8425,GO:0032463,1,0.938788178216537,0,10,negative regulation of protein homooligomerization,BP,
8426,GO:0032464,1,0.958154305747041,0,7,positive regulation of protein homooligomerization,BP,
8427,GO:0032465,1,0.611210314185986,0,73,regulation of cytokinesis,BP,
8428,GO:0032466,1,0.957043777339267,0,7,negative regulation of cytokinesis,BP,
8429,GO:0032467,1,0.824239407312939,0,29,positive regulation of cytokinesis,BP,
8430,GO:0032468,1,0.992554260787264,0,1,Golgi calcium ion homeostasis,BP,
8431,GO:0032469,1,0.870261968793934,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8432,GO:0032470,1,0.984780615196025,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8433,GO:0032471,1,0.953665959220196,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8434,GO:0032472,1,0.987217495288499,0,2,Golgi calcium ion transport,BP,
8435,GO:0032473,1,0.992094053059202,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8436,GO:0032474,1,0.97843087028145,0,3,otolith morphogenesis,BP,
8437,GO:0032475,1,0.993304539438279,0,1,otolith formation,BP,
8438,GO:0032479,1,0.471360191535057,0,115,regulation of type I interferon production,BP,
8439,GO:0032480,1,0.748104294039101,0,45,negative regulation of type I interferon production,BP,
8440,GO:0032481,1,0.634034311757991,0,69,positive regulation of type I interferon production,BP,
8441,GO:0032482,1,0.664053707548525,0,67,Rab protein signal transduction,BP,
8442,GO:0032483,1,0.970470320279134,0,4,regulation of Rab protein signal transduction,BP,
8443,GO:0032484,1,0.97753157447483,0,3,Ral protein signal transduction,BP,
8444,GO:0032485,1,0.97753157447483,0,3,regulation of Ral protein signal transduction,BP,
8445,GO:0032486,1,0.910573792717703,0,13,Rap protein signal transduction,BP,
8446,GO:0032487,1,0.977431414240294,0,3,regulation of Rap protein signal transduction,BP,
8447,GO:0032488,1,0.918154687138589,0,14,Cdc42 protein signal transduction,BP,
8448,GO:0032489,1,0.966666383998506,0,6,regulation of Cdc42 protein signal transduction,BP,
8449,GO:0032490,1,0.923518691060438,0,12,detection of molecule of bacterial origin,BP,
8450,GO:0032493,1,0.948539839745634,0,8,response to bacterial lipoprotein,BP,
8451,GO:0032494,1,0.93917878604153,0,10,response to peptidoglycan,BP,
8452,GO:0032495,1,0.906240164903837,0,14,response to muramyl dipeptide,BP,
8454,GO:0032497,1,0.978474232311721,0,4,detection of lipopolysaccharide,BP,
8455,GO:0032498,1,0.992482826476782,0,1,detection of muramyl dipeptide,BP,
8456,GO:0032499,1,0.988595352372268,0,2,detection of peptidoglycan,BP,
8457,GO:0032500,1,0.992482826476782,0,1,muramyl dipeptide binding,MF,
8461,GO:0032506,1,0.854501766605708,0,23,cytokinetic process,BP,
8462,GO:0032507,1,0.624240841983383,0,72,maintenance of protein location in cell,BP,
8463,GO:0032508,1,0.623305278030131,0,70,DNA duplex unwinding,BP,
8464,GO:0032509,1,0.877176502732453,0,21,endosome transport via multivesicular body sorting pathway,BP,
8465,GO:0032510,1,0.958831945990195,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8466,GO:0032511,1,0.956699817159813,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8467,GO:0032515,1,0.751598943327585,0,45,negative regulation of phosphoprotein phosphatase activity,BP,
8468,GO:0032516,1,0.895224837875855,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8469,GO:0032525,1,0.949004767256522,0,9,somite rostral/caudal axis specification,BP,
8472,GO:0032528,1,0.849661962111831,0,23,microvillus organization,BP,
8473,GO:0032530,1,0.917960530381869,0,12,regulation of microvillus organization,BP,
8474,GO:0032532,1,0.959938740892769,0,6,regulation of microvillus length,BP,
8475,GO:0032534,1,0.956287735397487,0,6,regulation of microvillus assembly,BP,
8477,GO:0032536,1,0.927472845138777,0,11,regulation of cell projection size,BP,
8478,GO:0032541,1,0.969271981224395,0,5,cortical endoplasmic reticulum,CC,
8479,GO:0032542,1,0.986058012346355,0,2,sulfiredoxin activity,MF,
8480,GO:0032543,1,0.522921561394633,0,127,mitochondrial translation,BP,
8481,GO:0032545,1,0.988418553512764,0,2,CURI complex,CC,
8484,GO:0032551,1,0.985927828502817,0,2,pyrimidine ribonucleoside binding,MF,
8485,GO:0032552,1,0.966514732438611,0,6,deoxyribonucleotide binding,MF,
8487,GO:0032554,1,0.975460650429277,0,4,purine deoxyribonucleotide binding,MF,
8489,GO:0032556,1,0.990831349678872,0,2,pyrimidine deoxyribonucleotide binding,MF,
8490,GO:0032557,1,0.980269745875835,0,3,pyrimidine ribonucleotide binding,MF,
8491,GO:0032558,1,0.982649958666983,0,3,adenyl deoxyribonucleotide binding,MF,
8493,GO:0032560,1,0.992685056253613,0,1,guanyl deoxyribonucleotide binding,MF,
8495,GO:0032564,1,0.982649958666983,0,3,dATP binding,MF,
8496,GO:0032567,1,0.992685056253613,0,1,dGTP binding,MF,
8497,GO:0032570,1,0.780365432764599,0,40,response to progesterone,BP,
8498,GO:0032571,1,0.975826140599633,0,4,response to vitamin K,BP,
8499,GO:0032574,1,0.992501104056474,0,1,5'-3' RNA helicase activity,MF,
8500,GO:0032575,1,0.992501104056474,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8501,GO:0032580,1,0.593951902281831,0,77,Golgi cisterna membrane,CC,
8502,GO:0032581,1,0.994860641298683,0,1,ER-dependent peroxisome organization,BP,
8503,GO:0032584,1,0.960008365440465,0,6,growth cone membrane,CC,
8504,GO:0032585,1,0.946936061948679,0,9,multivesicular body membrane,CC,
8506,GO:0032588,1,0.602657663121216,0,79,trans-Golgi network membrane,CC,
8510,GO:0032592,1,0.672252948555757,0,65,integral component of mitochondrial membrane,CC,
8511,GO:0032593,1,0.956950959655817,0,7,insulin-responsive compartment,CC,
8513,GO:0032596,1,0.967528903169104,0,5,protein transport into membrane raft,BP,
8514,GO:0032601,1,0.995786420869193,0,1,connective tissue growth factor production,BP,
8515,GO:0032602,1,0.636399614045298,0,74,chemokine production,BP,
8516,GO:0032603,1,0.996245299443384,0,1,fractalkine production,BP,
8517,GO:0032604,1,0.928697424329115,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8518,GO:0032605,1,0.992685056253613,0,1,hepatocyte growth factor production,BP,
8519,GO:0032606,1,0.469244551554996,0,116,type I interferon production,BP,
8520,GO:0032607,1,0.838696729810642,0,26,interferon-alpha production,BP,
8521,GO:0032608,1,0.73080892086568,0,47,interferon-beta production,BP,
8522,GO:0032609,1,0.573209832386944,0,91,interferon-gamma production,BP,
8523,GO:0032610,1,0.964114602885396,0,7,interleukin-1 alpha production,BP,
8524,GO:0032611,1,0.696300036251891,0,59,interleukin-1 beta production,BP,
8525,GO:0032612,1,0.648484644771474,0,72,interleukin-1 production,BP,
8526,GO:0032613,1,0.772893285493204,0,42,interleukin-10 production,BP,
8527,GO:0032615,1,0.733273358011898,0,49,interleukin-12 production,BP,
8528,GO:0032616,1,0.895059351474118,0,17,interleukin-13 production,BP,
8529,GO:0032618,1,0.99016639103229,0,2,interleukin-15 production,BP,
8530,GO:0032620,1,0.886729324067775,0,20,interleukin-17 production,BP,
8531,GO:0032621,1,0.944499023549764,0,8,interleukin-18 production,BP,
8532,GO:0032623,1,0.694978681938011,0,56,interleukin-2 production,BP,
8533,GO:0032625,1,0.992538827451657,0,1,interleukin-21 production,BP,
8534,GO:0032627,1,0.966583006289642,0,5,interleukin-23 production,BP,
8535,GO:0032632,1,0.979001107035422,0,3,interleukin-3 production,BP,
8536,GO:0032633,1,0.821314922767752,0,31,interleukin-4 production,BP,
8537,GO:0032634,1,0.902869886721132,0,15,interleukin-5 production,BP,
8538,GO:0032635,1,0.509732837870284,0,105,interleukin-6 production,BP,
8540,GO:0032639,1,0.988019506068691,0,2,TRAIL production,BP,
8541,GO:0032640,1,0.507277335400658,0,110,tumor necrosis factor production,BP,
8542,GO:0032641,1,0.986000075632408,0,2,lymphotoxin A production,BP,
8543,GO:0032642,1,0.659967707166549,0,67,regulation of chemokine production,BP,
8544,GO:0032643,1,0.995786420869193,0,1,regulation of connective tissue growth factor production,BP,
8545,GO:0032644,1,0.996245299443384,0,1,regulation of fractalkine production,BP,
8546,GO:0032645,1,0.933295961007539,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8547,GO:0032646,1,0.992685056253613,0,1,regulation of hepatocyte growth factor production,BP,
8548,GO:0032647,1,0.842455664093799,0,25,regulation of interferon-alpha production,BP,
8549,GO:0032648,1,0.739914147672128,0,45,regulation of interferon-beta production,BP,
8550,GO:0032649,1,0.617459873653805,0,80,regulation of interferon-gamma production,BP,
8551,GO:0032650,1,0.967439082569036,0,6,regulation of interleukin-1 alpha production,BP,
8552,GO:0032651,1,0.733626936659638,0,51,regulation of interleukin-1 beta production,BP,
8553,GO:0032652,1,0.685638609616699,0,63,regulation of interleukin-1 production,BP,
8554,GO:0032653,1,0.78380826947404,0,40,regulation of interleukin-10 production,BP,
8555,GO:0032655,1,0.743932091788882,0,47,regulation of interleukin-12 production,BP,
8556,GO:0032656,1,0.898689130352644,0,16,regulation of interleukin-13 production,BP,
8557,GO:0032658,1,0.994977161225563,0,1,regulation of interleukin-15 production,BP,
8558,GO:0032660,1,0.902087169391669,0,17,regulation of interleukin-17 production,BP,
8559,GO:0032661,1,0.958841745898542,0,6,regulation of interleukin-18 production,BP,
8560,GO:0032663,1,0.72537560454214,0,49,regulation of interleukin-2 production,BP,
8561,GO:0032667,1,0.966583006289642,0,5,regulation of interleukin-23 production,BP,
8562,GO:0032672,1,0.986395587049743,0,2,regulation of interleukin-3 production,BP,
8563,GO:0032673,1,0.854299249714765,0,25,regulation of interleukin-4 production,BP,
8564,GO:0032674,1,0.902869886721132,0,15,regulation of interleukin-5 production,BP,
8565,GO:0032675,1,0.536363480205527,0,97,regulation of interleukin-6 production,BP,
8566,GO:0032677,1,0.714180355408624,0,55,regulation of interleukin-8 production,BP,
8567,GO:0032679,1,0.988019506068691,0,2,regulation of TRAIL production,BP,
8568,GO:0032680,1,0.517273117732121,0,107,regulation of tumor necrosis factor production,BP,
8569,GO:0032681,1,0.993196290611937,0,1,regulation of lymphotoxin A production,BP,
8570,GO:0032682,1,0.913365741803589,0,16,negative regulation of chemokine production,BP,
8571,GO:0032685,1,0.992646573316868,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8572,GO:0032686,1,0.992685056253613,0,1,negative regulation of hepatocyte growth factor production,BP,
8573,GO:0032687,1,0.964914413944338,0,6,negative regulation of interferon-alpha production,BP,
8574,GO:0032688,1,0.914970224534402,0,14,negative regulation of interferon-beta production,BP,
8575,GO:0032689,1,0.853255205768099,0,26,negative regulation of interferon-gamma production,BP,
8576,GO:0032690,1,0.995568637382513,0,1,negative regulation of interleukin-1 alpha production,BP,
8577,GO:0032691,1,0.917351905024084,0,15,negative regulation of interleukin-1 beta production,BP,
8578,GO:0032692,1,0.884643513867585,0,21,negative regulation of interleukin-1 production,BP,
8579,GO:0032693,1,0.922492224309177,0,14,negative regulation of interleukin-10 production,BP,
8580,GO:0032695,1,0.90100127033003,0,16,negative regulation of interleukin-12 production,BP,
8581,GO:0032696,1,0.979807626696227,0,3,negative regulation of interleukin-13 production,BP,
8582,GO:0032700,1,0.94532628937457,0,9,negative regulation of interleukin-17 production,BP,
8583,GO:0032701,1,0.987934294805523,0,2,negative regulation of interleukin-18 production,BP,
8584,GO:0032703,1,0.886401246279791,0,19,negative regulation of interleukin-2 production,BP,
8585,GO:0032707,1,0.986251495315651,0,2,negative regulation of interleukin-23 production,BP,
8586,GO:0032712,1,0.993901908091466,0,1,negative regulation of interleukin-3 production,BP,
8587,GO:0032713,1,0.965704005139589,0,5,negative regulation of interleukin-4 production,BP,
8588,GO:0032714,1,0.979100819678817,0,3,negative regulation of interleukin-5 production,BP,
8589,GO:0032715,1,0.808895217921746,0,33,negative regulation of interleukin-6 production,BP,
8590,GO:0032717,1,0.9081074895208,0,16,negative regulation of interleukin-8 production,BP,
8591,GO:0032720,1,0.774824811599802,0,43,negative regulation of tumor necrosis factor production,BP,
8592,GO:0032722,1,0.730827549938205,0,50,positive regulation of chemokine production,BP,
8593,GO:0032723,1,0.995786420869193,0,1,positive regulation of connective tissue growth factor production,BP,
8594,GO:0032724,1,0.996245299443384,0,1,positive regulation of fractalkine production,BP,
8595,GO:0032725,1,0.940214089729714,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8596,GO:0032727,1,0.873131689230664,0,19,positive regulation of interferon-alpha production,BP,
8597,GO:0032728,1,0.820580931211522,0,29,positive regulation of interferon-beta production,BP,
8598,GO:0032729,1,0.715766405556854,0,55,positive regulation of interferon-gamma production,BP,
8599,GO:0032730,1,0.971746502662501,0,5,positive regulation of interleukin-1 alpha production,BP,
8600,GO:0032731,1,0.819209769918387,0,32,positive regulation of interleukin-1 beta production,BP,
8601,GO:0032732,1,0.791680331808781,0,38,positive regulation of interleukin-1 production,BP,
8602,GO:0032733,1,0.842555352692997,0,28,positive regulation of interleukin-10 production,BP,
8603,GO:0032735,1,0.838454937182339,0,29,positive regulation of interleukin-12 production,BP,
8604,GO:0032736,1,0.917226272265937,0,13,positive regulation of interleukin-13 production,BP,
8605,GO:0032738,1,0.994977161225563,0,1,positive regulation of interleukin-15 production,BP,
8606,GO:0032740,1,0.948696410405584,0,9,positive regulation of interleukin-17 production,BP,
8607,GO:0032741,1,0.977732394360633,0,3,positive regulation of interleukin-18 production,BP,
8608,GO:0032743,1,0.822990586654399,0,29,positive regulation of interleukin-2 production,BP,
8609,GO:0032747,1,0.985832317561249,0,2,positive regulation of interleukin-23 production,BP,
8610,GO:0032752,1,0.992448093317305,0,1,positive regulation of interleukin-3 production,BP,
8611,GO:0032753,1,0.879253038685442,0,21,positive regulation of interleukin-4 production,BP,
8612,GO:0032754,1,0.927251874174597,0,11,positive regulation of interleukin-5 production,BP,
8613,GO:0032755,1,0.663731478748599,0,64,positive regulation of interleukin-6 production,BP,
8614,GO:0032757,1,0.783197777911042,0,40,positive regulation of interleukin-8 production,BP,
8615,GO:0032759,1,0.988019506068691,0,2,positive regulation of TRAIL production,BP,
8616,GO:0032760,1,0.674409205294625,0,64,positive regulation of tumor necrosis factor production,BP,
8617,GO:0032761,1,0.993196290611937,0,1,positive regulation of lymphotoxin A production,BP,
8619,GO:0032763,1,0.970044961807793,0,5,regulation of mast cell cytokine production,BP,
8620,GO:0032764,1,0.987963928060192,0,2,negative regulation of mast cell cytokine production,BP,
8621,GO:0032765,1,0.98186495372544,0,3,positive regulation of mast cell cytokine production,BP,
8622,GO:0032767,1,0.981454688176545,0,3,copper-dependent protein binding,MF,
8625,GO:0032770,1,0.867349365492544,0,23,positive regulation of monooxygenase activity,BP,
8626,GO:0032771,1,0.992492007106331,0,1,regulation of monophenol monooxygenase activity,BP,
8627,GO:0032773,1,0.992492007106331,0,1,positive regulation of monophenol monooxygenase activity,BP,
8629,GO:0032775,1,0.992519826340834,0,1,DNA methylation on adenine,BP,
8630,GO:0032776,1,0.977579322539169,0,3,DNA methylation on cytosine,BP,
8631,GO:0032777,1,0.97489134177703,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8632,GO:0032780,1,0.927596705472057,0,13,negative regulation of ATPase activity,BP,
8633,GO:0032781,1,0.753232766745671,0,50,positive regulation of ATPase activity,BP,
8634,GO:0032782,1,0.974955315143206,0,4,bile acid secretion,BP,
8635,GO:0032783,1,0.95746814582302,0,6,ELL-EAF complex,CC,
8636,GO:0032784,1,0.766011805277678,0,41,regulation of DNA-templated transcription, elongation,BP,
8637,GO:0032785,1,0.918009524079547,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8638,GO:0032786,1,0.863720583978265,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8640,GO:0032788,1,0.995254868359485,0,1,saturated monocarboxylic acid metabolic process,BP,
8641,GO:0032789,1,0.995254868359485,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8642,GO:0032790,1,0.949001701749341,0,8,ribosome disassembly,BP,
8643,GO:0032792,1,0.969512194348242,0,5,negative regulation of CREB transcription factor activity,BP,
8644,GO:0032793,1,0.907513468557568,0,14,positive regulation of CREB transcription factor activity,BP,
8645,GO:0032794,1,0.904905839880534,0,14,GTPase activating protein binding,MF,
8646,GO:0032795,1,0.981684510410827,0,3,heterotrimeric G-protein binding,MF,
8647,GO:0032796,1,0.987531671072345,0,2,uropod organization,BP,
8648,GO:0032797,1,0.928593253281064,0,12,SMN complex,CC,
8649,GO:0032798,1,0.986238532970005,0,2,Swi5-Sfr1 complex,CC,
8650,GO:0032799,1,0.878685939287595,0,20,low-density lipoprotein receptor particle metabolic process,BP,
8651,GO:0032800,1,0.866014150356944,0,22,receptor biosynthetic process,BP,
8652,GO:0032801,1,0.804614756966657,0,32,receptor catabolic process,BP,
8653,GO:0032802,1,0.921003555223322,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8654,GO:0032803,1,0.96933605049338,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8655,GO:0032804,1,0.987769451068714,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8656,GO:0032805,1,0.988479028984946,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8657,GO:0032806,1,0.861283033196927,0,24,carboxy-terminal domain protein kinase complex,CC,
8658,GO:0032807,1,0.974875842874249,0,4,DNA ligase IV complex,CC,
8659,GO:0032808,1,0.952637010095965,0,7,lacrimal gland development,BP,
8661,GO:0032810,1,0.987855535715928,0,2,sterol response element binding,MF,
8662,GO:0032811,1,0.983042230141989,0,3,negative regulation of epinephrine secretion,BP,
8663,GO:0032812,1,0.996244176478543,0,1,positive regulation of epinephrine secretion,BP,
8664,GO:0032813,1,0.778837702468232,0,43,tumor necrosis factor receptor superfamily binding,MF,
8665,GO:0032814,1,0.875793726481964,0,22,regulation of natural killer cell activation,BP,
8666,GO:0032815,1,0.973831626676529,0,5,negative regulation of natural killer cell activation,BP,
8667,GO:0032816,1,0.923999701293969,0,13,positive regulation of natural killer cell activation,BP,
8668,GO:0032817,1,0.965524799392528,0,6,regulation of natural killer cell proliferation,BP,
8669,GO:0032819,1,0.979768016597724,0,4,positive regulation of natural killer cell proliferation,BP,
8670,GO:0032823,1,0.940142280676785,0,10,regulation of natural killer cell differentiation,BP,
8671,GO:0032824,1,0.996202214779005,0,1,negative regulation of natural killer cell differentiation,BP,
8672,GO:0032825,1,0.955481278937849,0,7,positive regulation of natural killer cell differentiation,BP,
8673,GO:0032826,1,0.991433178258238,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8674,GO:0032827,1,0.996202214779005,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8675,GO:0032829,1,0.989084527831858,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8676,GO:0032831,1,0.989084527831858,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8677,GO:0032832,1,0.995179173051146,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8678,GO:0032834,1,0.995179173051146,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8679,GO:0032835,1,0.683574694896333,0,54,glomerulus development,BP,
8680,GO:0032836,1,0.930033315672506,0,10,glomerular basement membrane development,BP,
8683,GO:0032841,1,0.992528647190764,0,1,calcitonin binding,MF,
8684,GO:0032847,1,0.975665551041437,0,4,regulation of cellular pH reduction,BP,
8685,GO:0032848,1,0.99250527293932,0,1,negative regulation of cellular pH reduction,BP,
8686,GO:0032849,1,0.983034407230594,0,3,positive regulation of cellular pH reduction,BP,
8688,GO:0032869,1,0.284912313738501,0,187,cellular response to insulin stimulus,BP,
8690,GO:0032872,1,0.272230216403362,0,193,regulation of stress-activated MAPK cascade,BP,
8691,GO:0032873,1,0.768208835773164,0,39,negative regulation of stress-activated MAPK cascade,BP,
8692,GO:0032874,1,0.400414693333981,0,136,positive regulation of stress-activated MAPK cascade,BP,
8693,GO:0032875,1,0.948182686471988,0,7,regulation of DNA endoreduplication,BP,
8694,GO:0032876,1,0.969765325385331,0,4,negative regulation of DNA endoreduplication,BP,
8695,GO:0032877,1,0.984959867230478,0,2,positive regulation of DNA endoreduplication,BP,
8696,GO:0032878,1,0.856089648230084,0,21,regulation of establishment or maintenance of cell polarity,BP,
8699,GO:0032881,1,0.791276067784695,0,33,regulation of polysaccharide metabolic process,BP,
8700,GO:0032885,1,0.80366402897861,0,30,regulation of polysaccharide biosynthetic process,BP,
8702,GO:0032887,1,0.992263514958006,0,1,regulation of spindle elongation,BP,
8703,GO:0032888,1,0.992263514958006,0,1,regulation of mitotic spindle elongation,BP,
8704,GO:0032889,1,0.993513126323671,0,1,regulation of vacuole fusion, non-autophagic,BP,
8706,GO:0032891,1,0.902177677159937,0,15,negative regulation of organic acid transport,BP,
8708,GO:0032897,1,0.874030111835467,0,20,negative regulation of viral transcription,BP,
8709,GO:0032898,1,0.970966183262889,0,4,neurotrophin production,BP,
8710,GO:0032899,1,0.985576774533017,0,2,regulation of neurotrophin production,BP,
8711,GO:0032900,1,0.993021544808823,0,1,negative regulation of neurotrophin production,BP,
8712,GO:0032901,1,0.992503444947022,0,1,positive regulation of neurotrophin production,BP,
8713,GO:0032902,1,0.985177772467352,0,2,nerve growth factor production,BP,
8714,GO:0032905,1,0.935510997582771,0,10,transforming growth factor beta1 production,BP,
8715,GO:0032906,1,0.944869584362324,0,8,transforming growth factor beta2 production,BP,
8716,GO:0032907,1,0.984489801548312,0,2,transforming growth factor beta3 production,BP,
8717,GO:0032908,1,0.935510997582771,0,10,regulation of transforming growth factor beta1 production,BP,
8718,GO:0032909,1,0.944869584362324,0,8,regulation of transforming growth factor beta2 production,BP,
8719,GO:0032910,1,0.984489801548312,0,2,regulation of transforming growth factor beta3 production,BP,
8720,GO:0032911,1,0.971834816576206,0,4,negative regulation of transforming growth factor beta1 production,BP,
8721,GO:0032912,1,0.98510267755581,0,2,negative regulation of transforming growth factor beta2 production,BP,
8722,GO:0032914,1,0.962634151284615,0,6,positive regulation of transforming growth factor beta1 production,BP,
8723,GO:0032915,1,0.989048266138793,0,2,positive regulation of transforming growth factor beta2 production,BP,
8724,GO:0032916,1,0.984489801548312,0,2,positive regulation of transforming growth factor beta3 production,BP,
8725,GO:0032917,1,0.98649353513705,0,3,polyamine acetylation,BP,
8726,GO:0032918,1,0.98649353513705,0,3,spermidine acetylation,BP,
8727,GO:0032919,1,0.996186124260156,0,1,spermine acetylation,BP,
8728,GO:0032920,1,0.996186124260156,0,1,putrescine acetylation,BP,
8729,GO:0032922,1,0.702914915227722,0,50,circadian regulation of gene expression,BP,
8730,GO:0032924,1,0.793218282196537,0,36,activin receptor signaling pathway,BP,
8731,GO:0032925,1,0.866968587423628,0,23,regulation of activin receptor signaling pathway,BP,
8732,GO:0032926,1,0.944684065096817,0,9,negative regulation of activin receptor signaling pathway,BP,
8733,GO:0032927,1,0.948027591760734,0,8,positive regulation of activin receptor signaling pathway,BP,
8734,GO:0032928,1,0.909819142155192,0,16,regulation of superoxide anion generation,BP,
8735,GO:0032929,1,0.991255486529241,0,2,negative regulation of superoxide anion generation,BP,
8736,GO:0032930,1,0.924842188072489,0,13,positive regulation of superoxide anion generation,BP,
8737,GO:0032933,1,0.945586261839567,0,8,SREBP signaling pathway,BP,
8738,GO:0032934,1,0.771010160724472,0,41,sterol binding,MF,
8739,GO:0032937,1,0.979245254737599,0,3,SREBP-SCAP-Insig complex,CC,
8744,GO:0032945,1,0.669963514377072,0,64,negative regulation of mononuclear cell proliferation,BP,
8746,GO:0032947,1,0.570163468661271,0,80,protein-containing complex scaffold activity,MF,
8747,GO:0032954,1,0.985013636093323,0,2,regulation of cytokinetic process,BP,
8748,GO:0032956,1,0.130024626151979,0,305,regulation of actin cytoskeleton organization,BP,
8749,GO:0032957,1,0.942316980625573,0,8,inositol trisphosphate metabolic process,BP,
8750,GO:0032958,1,0.850608525623153,0,24,inositol phosphate biosynthetic process,BP,
8751,GO:0032959,1,0.95661508407409,0,6,inositol trisphosphate biosynthetic process,BP,
8752,GO:0032960,1,0.971142469508595,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8753,GO:0032962,1,0.978493104029888,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8754,GO:0032963,1,0.498494114110011,0,103,collagen metabolic process,BP,
8755,GO:0032964,1,0.798374536271277,0,35,collagen biosynthetic process,BP,
8756,GO:0032965,1,0.843722017174597,0,27,regulation of collagen biosynthetic process,BP,
8757,GO:0032966,1,0.958735676418012,0,7,negative regulation of collagen biosynthetic process,BP,
8758,GO:0032967,1,0.880084502783132,0,20,positive regulation of collagen biosynthetic process,BP,
8759,GO:0032968,1,0.913454724601962,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8760,GO:0032970,1,0.0967882169063025,0,346,regulation of actin filament-based process,BP,
8761,GO:0032971,1,0.978191545611589,0,4,regulation of muscle filament sliding,BP,
8762,GO:0032972,1,0.992466284837289,0,2,regulation of muscle filament sliding speed,BP,
8763,GO:0032976,1,0.996356917639189,0,1,release of matrix enzymes from mitochondria,BP,
8764,GO:0032977,1,0.992481170254558,0,1,membrane insertase activity,MF,
8765,GO:0032978,1,0.992481170254558,0,1,protein insertion into membrane from inner side,BP,
8766,GO:0032979,1,0.992481170254558,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8767,GO:0032981,1,0.77821698366724,0,55,mitochondrial respiratory chain complex I assembly,BP,
8768,GO:0032982,1,0.883116845971645,0,17,myosin filament,CC,
8769,GO:0032983,1,0.963225651757105,0,5,kainate selective glutamate receptor complex,CC,
8771,GO:0032986,1,0.886071335123201,0,19,protein-DNA complex disassembly,BP,
8772,GO:0032988,1,0.919798239667011,0,13,ribonucleoprotein complex disassembly,BP,
8776,GO:0032993,1,0.450590339411185,0,137,protein-DNA complex,CC,
8777,GO:0032994,1,0.826036658346427,0,34,protein-lipid complex,CC,
8778,GO:0032996,1,0.994819107136748,0,1,Bcl3-Bcl10 complex,CC,
8779,GO:0032997,1,0.991708085436449,0,2,Fc receptor complex,CC,
8780,GO:0032998,1,0.991708085436449,0,2,Fc-epsilon receptor I complex,CC,
8781,GO:0033002,1,0.328083071564076,0,167,muscle cell proliferation,BP,
8784,GO:0033005,1,0.913653679615024,0,15,positive regulation of mast cell activation,BP,
8785,GO:0033006,1,0.849400525724689,0,27,regulation of mast cell activation involved in immune response,BP,
8786,GO:0033007,1,0.960639162167152,0,7,negative regulation of mast cell activation involved in immune response,BP,
8787,GO:0033008,1,0.932857462771223,0,12,positive regulation of mast cell activation involved in immune response,BP,
8788,GO:0033010,1,0.954489305568601,0,7,paranodal junction,CC,
8789,GO:0033011,1,0.988629363982435,0,2,perinuclear theca,CC,
8790,GO:0033013,1,0.742263574655744,0,49,tetrapyrrole metabolic process,BP,
8791,GO:0033014,1,0.848558250912046,0,26,tetrapyrrole biosynthetic process,BP,
8792,GO:0033015,1,0.982904333140756,0,4,tetrapyrrole catabolic process,BP,
8793,GO:0033017,1,0.781965541066559,0,36,sarcoplasmic reticulum membrane,CC,
8794,GO:0033018,1,0.954799893773789,0,7,sarcoplasmic reticulum lumen,CC,
8795,GO:0033023,1,0.98164410965383,0,3,mast cell homeostasis,BP,
8796,GO:0033024,1,0.98164410965383,0,3,mast cell apoptotic process,BP,
8797,GO:0033025,1,0.98164410965383,0,3,regulation of mast cell apoptotic process,BP,
8798,GO:0033026,1,0.989024323295571,0,2,negative regulation of mast cell apoptotic process,BP,
8799,GO:0033028,1,0.83920105068701,0,28,myeloid cell apoptotic process,BP,
8800,GO:0033029,1,0.959938741625872,0,6,regulation of neutrophil apoptotic process,BP,
8801,GO:0033030,1,0.985529895554808,0,2,negative regulation of neutrophil apoptotic process,BP,
8802,GO:0033031,1,0.974036912322969,0,4,positive regulation of neutrophil apoptotic process,BP,
8803,GO:0033032,1,0.858999614193986,0,24,regulation of myeloid cell apoptotic process,BP,
8804,GO:0033033,1,0.924402224826175,0,13,negative regulation of myeloid cell apoptotic process,BP,
8805,GO:0033034,1,0.955442280803085,0,7,positive regulation of myeloid cell apoptotic process,BP,
8807,GO:0033037,1,0.992388660385464,0,1,polysaccharide localization,BP,
8808,GO:0033038,1,0.959777656190202,0,10,bitter taste receptor activity,MF,
8809,GO:0033040,1,0.992786892016865,0,1,sour taste receptor activity,MF,
8810,GO:0033041,1,0.993454267129848,0,1,sweet taste receptor activity,MF,
8812,GO:0033044,1,0.132953212150662,0,295,regulation of chromosome organization,BP,
8813,GO:0033045,1,0.631286526110599,0,70,regulation of sister chromatid segregation,BP,
8815,GO:0033047,1,0.671839470945046,0,61,regulation of mitotic sister chromatid segregation,BP,
8816,GO:0033048,1,0.794574399043136,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8817,GO:0033058,1,0.977466221212224,0,3,directional locomotion,BP,
8818,GO:0033059,1,0.718852945441825,0,52,cellular pigmentation,BP,
8819,GO:0033061,1,0.944227272735768,0,9,DNA recombinase mediator complex,CC,
8820,GO:0033063,1,0.957408429238679,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8821,GO:0033065,1,0.989615907757326,0,2,Rad51C-XRCC3 complex,CC,
8822,GO:0033076,1,0.984661635605856,0,3,isoquinoline alkaloid metabolic process,BP,
8824,GO:0033078,1,0.982878686864771,0,3,extrathymic T cell differentiation,BP,
8825,GO:0033079,1,0.958428400585334,0,7,immature T cell proliferation,BP,
8826,GO:0033080,1,0.969542058128038,0,5,immature T cell proliferation in thymus,BP,
8828,GO:0033082,1,0.987705281054826,0,2,regulation of extrathymic T cell differentiation,BP,
8829,GO:0033083,1,0.965670706168466,0,6,regulation of immature T cell proliferation,BP,
8830,GO:0033084,1,0.976867478447298,0,4,regulation of immature T cell proliferation in thymus,BP,
8831,GO:0033085,1,0.966519420109376,0,6,negative regulation of T cell differentiation in thymus,BP,
8832,GO:0033087,1,0.982654073060093,0,3,negative regulation of immature T cell proliferation,BP,
8833,GO:0033088,1,0.987484888180709,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8835,GO:0033091,1,0.982719901721744,0,3,positive regulation of immature T cell proliferation,BP,
8836,GO:0033092,1,0.989249403279346,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8837,GO:0033093,1,0.964974998122068,0,5,Weibel-Palade body,CC,
8838,GO:0033106,1,0.982396731302172,0,3,cis-Golgi network membrane,CC,
8839,GO:0033108,1,0.647106456478612,0,87,mitochondrial respiratory chain complex assembly,BP,
8840,GO:0033116,1,0.676304060432593,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8843,GO:0033121,1,0.977757474097958,0,3,regulation of purine nucleotide catabolic process,BP,
8844,GO:0033122,1,0.985279731239398,0,2,negative regulation of purine nucleotide catabolic process,BP,
8845,GO:0033123,1,0.992366508624123,0,1,positive regulation of purine nucleotide catabolic process,BP,
8846,GO:0033127,1,0.921232300062294,0,13,regulation of histone phosphorylation,BP,
8847,GO:0033128,1,0.983332054506812,0,3,negative regulation of histone phosphorylation,BP,
8848,GO:0033129,1,0.949307638873817,0,8,positive regulation of histone phosphorylation,BP,
8849,GO:0033130,1,0.940933060323783,0,9,acetylcholine receptor binding,MF,
8850,GO:0033131,1,0.948811257690463,0,9,regulation of glucokinase activity,BP,
8851,GO:0033132,1,0.976589095260543,0,4,negative regulation of glucokinase activity,BP,
8852,GO:0033133,1,0.971563050088075,0,5,positive regulation of glucokinase activity,BP,
8853,GO:0033135,1,0.502943142767675,0,105,regulation of peptidyl-serine phosphorylation,BP,
8854,GO:0033137,1,0.859522264972594,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8855,GO:0033138,1,0.613398624501344,0,76,positive regulation of peptidyl-serine phosphorylation,BP,
8856,GO:0033139,1,0.972888472584041,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8857,GO:0033140,1,0.994826862990665,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8858,GO:0033141,1,0.977948683724337,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8859,GO:0033142,1,0.994166061307062,0,1,progesterone receptor binding,MF,
8860,GO:0033143,1,0.629780252288489,0,69,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8861,GO:0033144,1,0.816381646070058,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8862,GO:0033145,1,0.916452079028248,0,14,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8863,GO:0033146,1,0.791590146816498,0,34,regulation of intracellular estrogen receptor signaling pathway,BP,
8864,GO:0033147,1,0.920388766631121,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8865,GO:0033148,1,0.946924578291136,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8866,GO:0033149,1,0.984864307618527,0,2,FFAT motif binding,MF,
8867,GO:0033150,1,0.994681505227936,0,1,cytoskeletal calyx,CC,
8868,GO:0033151,1,0.918413167999768,0,12,V(D)J recombination,BP,
8869,GO:0033152,1,0.972841657391329,0,4,immunoglobulin V(D)J recombination,BP,
8870,GO:0033153,1,0.962631923248626,0,5,T cell receptor V(D)J recombination,BP,
8872,GO:0033158,1,0.884806062101254,0,18,regulation of protein import into nucleus, translocation,BP,
8873,GO:0033159,1,0.978741421623411,0,3,negative regulation of protein import into nucleus, translocation,BP,
8874,GO:0033160,1,0.924201537727475,0,11,positive regulation of protein import into nucleus, translocation,BP,
8875,GO:0033162,1,0.939403975745039,0,11,melanosome membrane,CC,
8876,GO:0033165,1,0.98842761910774,0,2,interphotoreceptor matrix,CC,
8877,GO:0033167,1,0.992015039827887,0,1,ARC complex,CC,
8878,GO:0033168,1,0.992015039827887,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8879,GO:0033169,1,0.907785984694886,0,13,histone H3-K9 demethylation,BP,
8880,GO:0033170,1,0.952794215197279,0,8,protein-DNA loading ATPase activity,MF,
8881,GO:0033173,1,0.847049323700447,0,24,calcineurin-NFAT signaling cascade,BP,
8882,GO:0033176,1,0.873303606510971,0,24,proton-transporting V-type ATPase complex,CC,
8883,GO:0033177,1,0.93907914760414,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8884,GO:0033178,1,0.938671448825859,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8885,GO:0033179,1,0.94320785929455,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8886,GO:0033180,1,0.947840833599955,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8887,GO:0033181,1,0.989008438891641,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8888,GO:0033182,1,0.931928032649234,0,10,regulation of histone ubiquitination,BP,
8889,GO:0033183,1,0.978312516441483,0,3,negative regulation of histone ubiquitination,BP,
8890,GO:0033184,1,0.964373697555295,0,5,positive regulation of histone ubiquitination,BP,
8891,GO:0033185,1,0.98823798304289,0,3,dolichol-phosphate-mannose synthase complex,CC,
8892,GO:0033186,1,0.978925996188239,0,3,CAF-1 complex,CC,
8893,GO:0033188,1,0.980448938820001,0,3,sphingomyelin synthase activity,MF,
8894,GO:0033189,1,0.91127204030817,0,15,response to vitamin A,BP,
8895,GO:0033192,1,0.964486069187014,0,5,calmodulin-dependent protein phosphatase activity,MF,
8896,GO:0033193,1,0.992450589190541,0,1,Lsd1/2 complex,CC,
8897,GO:0033194,1,0.908278223343552,0,16,response to hydroperoxide,BP,
8898,GO:0033197,1,0.928357047253356,0,12,response to vitamin E,BP,
8900,GO:0033202,1,0.919740831667874,0,15,DNA helicase complex,CC,
8901,GO:0033204,1,0.993590844782397,0,1,ribonuclease P RNA binding,MF,
8902,GO:0033206,1,0.963628174402088,0,5,meiotic cytokinesis,BP,
8903,GO:0033209,1,0.40357059256997,0,161,tumor necrosis factor-mediated signaling pathway,BP,
8904,GO:0033210,1,0.942393997679717,0,9,leptin-mediated signaling pathway,BP,
8905,GO:0033211,1,0.96822275687972,0,5,adiponectin-activated signaling pathway,BP,
8906,GO:0033212,1,0.993803373464768,0,1,iron assimilation,BP,
8907,GO:0033214,1,0.993803373464768,0,1,iron assimilation by chelation and transport,BP,
8908,GO:0033216,1,0.959690456265887,0,6,ferric iron import,BP,
8909,GO:0033218,1,0.183379811943864,0,271,amide binding,MF,
8910,GO:0033220,1,0.970805932876284,0,4,amide-transporting ATPase activity,MF,
8911,GO:0033227,1,0.965878936097658,0,5,dsRNA transport,BP,
8912,GO:0033229,1,0.992513861620335,0,1,cysteine transmembrane transporter activity,MF,
8913,GO:0033231,1,0.992500488936931,0,1,carbohydrate export,BP,
8914,GO:0033233,1,0.8756896489041,0,21,regulation of protein sumoylation,BP,
8915,GO:0033234,1,0.937893897604079,0,10,negative regulation of protein sumoylation,BP,
8916,GO:0033235,1,0.933911879348205,0,11,positive regulation of protein sumoylation,BP,
8917,GO:0033238,1,0.677870456305959,0,72,regulation of cellular amine metabolic process,BP,
8918,GO:0033239,1,0.964271459423849,0,5,negative regulation of cellular amine metabolic process,BP,
8919,GO:0033240,1,0.947793926862301,0,9,positive regulation of cellular amine metabolic process,BP,
8920,GO:0033241,1,0.992129025827869,0,1,regulation of cellular amine catabolic process,BP,
8921,GO:0033242,1,0.992129025827869,0,1,negative regulation of cellular amine catabolic process,BP,
8922,GO:0033256,1,0.957065751667578,0,7,I-kappaB/NF-kappaB complex,CC,
8923,GO:0033257,1,0.987639617120042,0,2,Bcl3/NF-kappaB2 complex,CC,
8924,GO:0033260,1,0.739626939392197,0,49,nuclear DNA replication,BP,
8925,GO:0033262,1,0.920211029445478,0,12,regulation of nuclear cell cycle DNA replication,BP,
8926,GO:0033263,1,0.970605202572309,0,4,CORVET complex,CC,
8927,GO:0033265,1,0.986935921917724,0,2,choline binding,MF,
8929,GO:0033268,1,0.897402835608255,0,15,node of Ranvier,CC,
8930,GO:0033269,1,0.972413227216566,0,4,internode region of axon,CC,
8931,GO:0033270,1,0.917151097540906,0,12,paranode region of axon,CC,
8932,GO:0033273,1,0.592257957645142,0,83,response to vitamin,BP,
8933,GO:0033274,1,0.992267484257496,0,1,response to vitamin B2,BP,
8934,GO:0033275,1,0.82992851283195,0,32,actin-myosin filament sliding,BP,
8935,GO:0033276,1,0.919379188751157,0,13,transcription factor TFTC complex,CC,
8936,GO:0033277,1,0.986418723206713,0,2,abortive mitotic cell cycle,BP,
8937,GO:0033278,1,0.963803938406235,0,5,cell proliferation in midbrain,BP,
8938,GO:0033280,1,0.81202634621806,0,32,response to vitamin D,BP,
8939,GO:0033283,1,0.98506458776214,0,2,organic acid-transporting ATPase activity,MF,
8940,GO:0033284,1,0.98506458776214,0,2,carboxylic acid-transporting ATPase activity,MF,
8941,GO:0033285,1,0.98506458776214,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8942,GO:0033290,1,0.992496133153366,0,1,eukaryotic 48S preinitiation complex,CC,
8943,GO:0033291,1,0.996783374530608,0,1,eukaryotic 80S initiation complex,CC,
8944,GO:0033292,1,0.984424347844148,0,2,T-tubule organization,BP,
8945,GO:0033293,1,0.749381962770639,0,51,monocarboxylic acid binding,MF,
8946,GO:0033299,1,0.970308669594131,0,5,secretion of lysosomal enzymes,BP,
8947,GO:0033300,1,0.977757527580791,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8948,GO:0033301,1,0.992514679706444,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8949,GO:0033306,1,0.987348598824887,0,2,phytol metabolic process,BP,
8950,GO:0033313,1,0.966303812662632,0,5,meiotic cell cycle checkpoint,BP,
8951,GO:0033314,1,0.949955530269305,0,8,mitotic DNA replication checkpoint,BP,
8952,GO:0033316,1,0.992813660106105,0,1,meiotic spindle assembly checkpoint,BP,
8953,GO:0033319,1,0.994366188281796,0,1,UDP-D-xylose metabolic process,BP,
8954,GO:0033320,1,0.994366188281796,0,1,UDP-D-xylose biosynthetic process,BP,
8955,GO:0033326,1,0.985648072622581,0,2,cerebrospinal fluid secretion,BP,
8956,GO:0033327,1,0.937459930721895,0,10,Leydig cell differentiation,BP,
8957,GO:0033328,1,0.992528902940077,0,1,peroxisome membrane targeting sequence binding,MF,
8958,GO:0033341,1,0.985770859090483,0,2,regulation of collagen binding,BP,
8959,GO:0033342,1,0.993514930936206,0,1,negative regulation of collagen binding,BP,
8960,GO:0033343,1,0.992205894640246,0,1,positive regulation of collagen binding,BP,
8961,GO:0033344,1,0.818594773839642,0,32,cholesterol efflux,BP,
8962,GO:0033345,1,0.993786795711739,0,1,asparagine catabolic process via L-aspartate,BP,
8963,GO:0033353,1,0.971838360289026,0,4,S-adenosylmethionine cycle,BP,
8965,GO:0033364,1,0.987636436089259,0,2,mast cell secretory granule organization,BP,
8967,GO:0033366,1,0.995828775803207,0,1,protein localization to secretory granule,BP,
8968,GO:0033367,1,0.995828775803207,0,1,protein localization to mast cell secretory granule,BP,
8969,GO:0033368,1,0.995828775803207,0,1,protease localization to mast cell secretory granule,BP,
8970,GO:0033370,1,0.995828775803207,0,1,maintenance of protein location in mast cell secretory granule,BP,
8971,GO:0033371,1,0.995828775803207,0,1,T cell secretory granule organization,BP,
8972,GO:0033373,1,0.995828775803207,0,1,maintenance of protease location in mast cell secretory granule,BP,
8973,GO:0033374,1,0.995828775803207,0,1,protein localization to T cell secretory granule,BP,
8974,GO:0033375,1,0.995828775803207,0,1,protease localization to T cell secretory granule,BP,
8975,GO:0033377,1,0.995828775803207,0,1,maintenance of protein location in T cell secretory granule,BP,
8976,GO:0033379,1,0.995828775803207,0,1,maintenance of protease location in T cell secretory granule,BP,
8977,GO:0033380,1,0.995828775803207,0,1,granzyme B localization to T cell secretory granule,BP,
8978,GO:0033382,1,0.995828775803207,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8979,GO:0033383,1,0.988574809059083,0,2,geranyl diphosphate metabolic process,BP,
8980,GO:0033384,1,0.988574809059083,0,2,geranyl diphosphate biosynthetic process,BP,
8981,GO:0033385,1,0.993059485020038,0,1,geranylgeranyl diphosphate metabolic process,BP,
8982,GO:0033386,1,0.993059485020038,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8983,GO:0033387,1,0.980133747944198,0,3,putrescine biosynthetic process from ornithine,BP,
8984,GO:0033388,1,0.994151802981525,0,1,putrescine biosynthetic process from arginine,BP,
8985,GO:0033391,1,0.925440508773496,0,11,chromatoid body,CC,
8986,GO:0033396,1,0.994411076577941,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8987,GO:0033477,1,0.994567317597039,0,1,S-methylmethionine metabolic process,BP,
8988,GO:0033483,1,0.945527316298365,0,9,gas homeostasis,BP,
8989,GO:0033484,1,0.982036118849336,0,3,nitric oxide homeostasis,BP,
8990,GO:0033488,1,0.992775972610841,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8991,GO:0033489,1,0.975062879380475,0,4,cholesterol biosynthetic process via desmosterol,BP,
8992,GO:0033490,1,0.975062879380475,0,4,cholesterol biosynthetic process via lathosterol,BP,
8993,GO:0033499,1,0.989323658182771,0,2,galactose catabolic process via UDP-galactose,BP,
8995,GO:0033503,1,0.973544280438988,0,4,HULC complex,CC,
8996,GO:0033504,1,0.964607798320605,0,5,floor plate development,BP,
8997,GO:0033505,1,0.98672720565049,0,2,floor plate morphogenesis,BP,
8998,GO:0033512,1,0.97961870359394,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8999,GO:0033514,1,0.993720095530032,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9000,GO:0033522,1,0.848395063062504,0,24,histone H2A ubiquitination,BP,
9001,GO:0033523,1,0.92209399586808,0,12,histone H2B ubiquitination,BP,
9002,GO:0033526,1,0.993206219974093,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9003,GO:0033539,1,0.916439077772256,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9004,GO:0033540,1,0.915990292372845,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9005,GO:0033549,1,0.923936155062652,0,12,MAP kinase phosphatase activity,MF,
9006,GO:0033552,1,0.993401986990587,0,1,response to vitamin B3,BP,
9007,GO:0033553,1,0.973244577763465,0,4,rDNA heterochromatin,CC,
9010,GO:0033557,1,0.986238532970005,0,2,Slx1-Slx4 complex,CC,
9011,GO:0033558,1,0.742667914944113,0,44,protein deacetylase activity,MF,
9012,GO:0033559,1,0.601287846156504,0,86,unsaturated fatty acid metabolic process,BP,
9013,GO:0033560,1,0.992502394700296,0,1,folate reductase activity,MF,
9014,GO:0033561,1,0.888924021139754,0,18,regulation of water loss via skin,BP,
9015,GO:0033563,1,0.980431736350003,0,3,dorsal/ventral axon guidance,BP,
9016,GO:0033564,1,0.956621638347065,0,6,anterior/posterior axon guidance,BP,
9017,GO:0033565,1,0.978336915050302,0,3,ESCRT-0 complex,CC,
9018,GO:0033566,1,0.986851071172013,0,2,gamma-tubulin complex localization,BP,
9019,GO:0033567,1,0.970843279097525,0,5,DNA replication, Okazaki fragment processing,BP,
9020,GO:0033570,1,0.985438194493293,0,2,transferrin transmembrane transporter activity,MF,
9021,GO:0033572,1,0.808840915127517,0,35,transferrin transport,BP,
9022,GO:0033574,1,0.780027442706834,0,41,response to testosterone,BP,
9023,GO:0033577,1,0.986484128733234,0,2,protein glycosylation in endoplasmic reticulum,BP,
9024,GO:0033578,1,0.966840546582738,0,5,protein glycosylation in Golgi,BP,
9025,GO:0033588,1,0.96815886416711,0,5,Elongator holoenzyme complex,CC,
9026,GO:0033590,1,0.982293543604574,0,3,response to cobalamin,BP,
9027,GO:0033591,1,0.96804292448022,0,5,response to L-ascorbic acid,BP,
9028,GO:0033592,1,0.964561137737,0,5,RNA strand annealing activity,MF,
9029,GO:0033593,1,0.991928171767674,0,1,BRCA2-MAGE-D1 complex,CC,
9030,GO:0033594,1,0.977020312337342,0,4,response to hydroxyisoflavone,BP,
9031,GO:0033595,1,0.986785070634269,0,2,response to genistein,BP,
9032,GO:0033596,1,0.984606294030165,0,2,TSC1-TSC2 complex,CC,
9033,GO:0033597,1,0.994242578886084,0,1,mitotic checkpoint complex,CC,
9034,GO:0033598,1,0.843762490083033,0,26,mammary gland epithelial cell proliferation,BP,
9035,GO:0033599,1,0.895295984018117,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9036,GO:0033600,1,0.972797292728187,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9037,GO:0033601,1,0.944625511941871,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9039,GO:0033603,1,0.962431487345585,0,6,positive regulation of dopamine secretion,BP,
9041,GO:0033605,1,0.939129991615104,0,10,positive regulation of catecholamine secretion,BP,
9042,GO:0033608,1,0.9930956730518,0,1,formyl-CoA transferase activity,MF,
9043,GO:0033609,1,0.9930956730518,0,1,oxalate metabolic process,BP,
9044,GO:0033612,1,0.88947321900139,0,18,receptor serine/threonine kinase binding,MF,
9045,GO:0033613,1,0.627793457770596,0,70,activating transcription factor binding,MF,
9046,GO:0033615,1,0.982064472308383,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9047,GO:0033617,1,0.889634082503732,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9048,GO:0033619,1,0.667794727197377,0,61,membrane protein proteolysis,BP,
9049,GO:0033622,1,0.876055122732778,0,19,integrin activation,BP,
9050,GO:0033623,1,0.932274508749297,0,10,regulation of integrin activation,BP,
9051,GO:0033624,1,0.98489383801284,0,2,negative regulation of integrin activation,BP,
9052,GO:0033625,1,0.967431539010038,0,5,positive regulation of integrin activation,BP,
9053,GO:0033626,1,0.992515696500163,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9054,GO:0033627,1,0.709388379503569,0,52,cell adhesion mediated by integrin,BP,
9055,GO:0033628,1,0.791616957465813,0,37,regulation of cell adhesion mediated by integrin,BP,
9056,GO:0033629,1,0.947080021310124,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9057,GO:0033630,1,0.906960436339869,0,16,positive regulation of cell adhesion mediated by integrin,BP,
9058,GO:0033631,1,0.927632340945753,0,11,cell-cell adhesion mediated by integrin,BP,
9059,GO:0033632,1,0.956025645868444,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9060,GO:0033633,1,0.992461201025428,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9061,GO:0033634,1,0.981473056821882,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9062,GO:0033643,1,0.923260702189877,0,12,host cell part,CC,
9063,GO:0033644,1,0.992495450415882,0,1,host cell membrane,CC,
9064,GO:0033646,1,0.943350690780288,0,9,host intracellular part,CC,
9065,GO:0033647,1,0.966945239100027,0,5,host intracellular organelle,CC,
9066,GO:0033648,1,0.966945239100027,0,5,host intracellular membrane-bounded organelle,CC,
9067,GO:0033650,1,0.995034445110811,0,1,host cell mitochondrion,CC,
9068,GO:0033655,1,0.963548454935687,0,6,host cell cytoplasm part,CC,
9069,GO:0033668,1,0.975511840058801,0,4,negative regulation by symbiont of host apoptotic process,BP,
9072,GO:0033676,1,0.995606061131081,0,1,double-stranded DNA-dependent ATPase activity,MF,
9073,GO:0033677,1,0.979078801485397,0,3,DNA/RNA helicase activity,MF,
9074,GO:0033678,1,0.993276950665733,0,1,5'-3' DNA/RNA helicase activity,MF,
9075,GO:0033679,1,0.992475522317594,0,1,3'-5' DNA/RNA helicase activity,MF,
9076,GO:0033680,1,0.985802548194706,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9077,GO:0033681,1,0.992475522317594,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9078,GO:0033682,1,0.993276950665733,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9079,GO:0033683,1,0.791363954893844,0,39,nucleotide-excision repair, DNA incision,BP,
9080,GO:0033684,1,0.956872794752986,0,7,regulation of luteinizing hormone secretion,BP,
9081,GO:0033685,1,0.982069527811795,0,3,negative regulation of luteinizing hormone secretion,BP,
9082,GO:0033686,1,0.974347905346491,0,4,positive regulation of luteinizing hormone secretion,BP,
9083,GO:0033687,1,0.8400728667163,0,26,osteoblast proliferation,BP,
9084,GO:0033688,1,0.855085417550258,0,23,regulation of osteoblast proliferation,BP,
9085,GO:0033689,1,0.935473702526423,0,9,negative regulation of osteoblast proliferation,BP,
9086,GO:0033690,1,0.932176109863291,0,11,positive regulation of osteoblast proliferation,BP,
9087,GO:0033691,1,0.945231018421557,0,8,sialic acid binding,MF,
9088,GO:0033692,1,0.656047982462461,0,61,cellular polysaccharide biosynthetic process,BP,
9090,GO:0033695,1,0.994701360356908,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9091,GO:0033699,1,0.994512734573476,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9092,GO:0033700,1,0.95550414584244,0,8,phospholipid efflux,BP,
9093,GO:0033735,1,0.996206790329829,0,1,aspartate dehydrogenase activity,MF,
9094,GO:0033737,1,0.993549443156936,0,1,1-pyrroline dehydrogenase activity,MF,
9095,GO:0033743,1,0.976432557081246,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9096,GO:0033745,1,0.980639582952395,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9097,GO:0033746,1,0.992527806493065,0,1,histone demethylase activity (H3-R2 specific),MF,
9098,GO:0033749,1,0.992527806493065,0,1,histone demethylase activity (H4-R3 specific),MF,
9099,GO:0033750,1,0.930743378007976,0,13,ribosome localization,BP,
9100,GO:0033754,1,0.995348338038366,0,1,indoleamine 2,3-dioxygenase activity,MF,
9102,GO:0033764,1,0.897520797303089,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9103,GO:0033765,1,0.987345198655197,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9104,GO:0033768,1,0.992896611361181,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9105,GO:0033778,1,0.99250159893432,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9106,GO:0033781,1,0.99438047800194,0,1,cholesterol 24-hydroxylase activity,MF,
9107,GO:0033787,1,0.993012653350283,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9108,GO:0033791,1,0.993909859270583,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9109,GO:0033798,1,0.994355978110344,0,1,thyroxine 5-deiodinase activity,MF,
9110,GO:0033814,1,0.995585172911336,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9111,GO:0033819,1,0.996195333386217,0,1,lipoyl(octanoyl) transferase activity,MF,
9112,GO:0033823,1,0.992852746849844,0,1,procollagen glucosyltransferase activity,MF,
9113,GO:0033829,1,0.98358562409692,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9114,GO:0033842,1,0.985185988039373,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9115,GO:0033857,1,0.984881837114031,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9116,GO:0033858,1,0.992704980034153,0,1,N-acetylgalactosamine kinase activity,MF,
9117,GO:0033860,1,0.963396429680704,0,7,regulation of NAD(P)H oxidase activity,BP,
9118,GO:0033861,1,0.989617584517263,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9119,GO:0033862,1,0.992855694437468,0,1,UMP kinase activity,MF,
9120,GO:0033864,1,0.973506538034678,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9122,GO:0033866,1,0.906137764873626,0,16,nucleoside bisphosphate biosynthetic process,BP,
9123,GO:0033867,1,0.995225861160605,0,1,Fas-activated serine/threonine kinase activity,MF,
9124,GO:0033869,1,0.996131220855828,0,1,nucleoside bisphosphate catabolic process,BP,
9125,GO:0033871,1,0.994661592279131,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9126,GO:0033872,1,0.988048569039227,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9128,GO:0033878,1,0.992507332158947,0,1,hormone-sensitive lipase activity,MF,
9129,GO:0033882,1,0.995950074278353,0,1,choloyl-CoA hydrolase activity,MF,
9130,GO:0033883,1,0.990568592795625,0,2,pyridoxal phosphatase activity,MF,
9131,GO:0033885,1,0.994131452236153,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9132,GO:0033897,1,0.995828775803207,0,1,ribonuclease T2 activity,MF,
9133,GO:0033906,1,0.98883492855328,0,2,hyaluronoglucuronidase activity,MF,
9134,GO:0033919,1,0.992502791315339,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9135,GO:0033925,1,0.99248257145969,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9136,GO:0033961,1,0.995042672785874,0,1,cis-stilbene-oxide hydrolase activity,MF,
9137,GO:0033962,1,0.880872540696151,0,18,cytoplasmic mRNA processing body assembly,BP,
9138,GO:0033967,1,0.995937198802247,0,1,box C/D snoRNA metabolic process,BP,
9139,GO:0033979,1,0.993420146576655,0,1,box H/ACA snoRNA metabolic process,BP,
9140,GO:0033981,1,0.996528434757302,0,1,D-dopachrome decarboxylase activity,MF,
9141,GO:0033989,1,0.993234101134144,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9143,GO:0034014,1,0.993966766284853,0,1,response to triglyceride,BP,
9144,GO:0034030,1,0.906137764873626,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9145,GO:0034031,1,0.996131220855828,0,1,ribonucleoside bisphosphate catabolic process,BP,
9147,GO:0034033,1,0.906137764873626,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9148,GO:0034034,1,0.996131220855828,0,1,purine nucleoside bisphosphate catabolic process,BP,
9150,GO:0034036,1,0.960312610445776,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9151,GO:0034038,1,0.995912531305709,0,1,deoxyhypusine synthase activity,MF,
9152,GO:0034039,1,0.989617387525999,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9153,GO:0034040,1,0.956587032409102,0,6,lipid-transporting ATPase activity,MF,
9154,GO:0034041,1,0.9787850909305,0,3,sterol-transporting ATPase activity,MF,
9155,GO:0034045,1,0.895288341245732,0,16,phagophore assembly site membrane,CC,
9156,GO:0034046,1,0.951687492765032,0,7,poly(G) binding,MF,
9157,GO:0034056,1,0.971519092077626,0,4,estrogen response element binding,MF,
9158,GO:0034057,1,0.986076016734773,0,2,RNA strand-exchange activity,MF,
9159,GO:0034058,1,0.929519260452357,0,10,endosomal vesicle fusion,BP,
9160,GO:0034059,1,0.97874846328939,0,3,response to anoxia,BP,
9161,GO:0034061,1,0.798817945066747,0,34,DNA polymerase activity,MF,
9162,GO:0034062,1,0.777952023059988,0,43,5'-3' RNA polymerase activity,MF,
9163,GO:0034063,1,0.908825538210324,0,13,stress granule assembly,BP,
9164,GO:0034066,1,0.988884727275306,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9165,GO:0034067,1,0.858279027583525,0,21,protein localization to Golgi apparatus,BP,
9166,GO:0034080,1,0.845526477514217,0,30,CENP-A containing nucleosome assembly,BP,
9167,GO:0034085,1,0.959042259165114,0,6,establishment of sister chromatid cohesion,BP,
9168,GO:0034086,1,0.93667933169548,0,10,maintenance of sister chromatid cohesion,BP,
9169,GO:0034087,1,0.984619438213088,0,2,establishment of mitotic sister chromatid cohesion,BP,
9170,GO:0034088,1,0.93667933169548,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9171,GO:0034091,1,0.963787148945773,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9172,GO:0034092,1,0.980410827018371,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9173,GO:0034093,1,0.983047565951533,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9175,GO:0034098,1,0.939162696111295,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9176,GO:0034101,1,0.498258460589292,0,109,erythrocyte homeostasis,BP,
9177,GO:0034103,1,0.682681989725832,0,58,regulation of tissue remodeling,BP,
9178,GO:0034104,1,0.90472243579255,0,16,negative regulation of tissue remodeling,BP,
9179,GO:0034105,1,0.870345353541908,0,22,positive regulation of tissue remodeling,BP,
9180,GO:0034109,1,0.643696664794963,0,67,homotypic cell-cell adhesion,BP,
9181,GO:0034110,1,0.856098721741512,0,23,regulation of homotypic cell-cell adhesion,BP,
9182,GO:0034111,1,0.910911874645618,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9183,GO:0034112,1,0.975165828624912,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9184,GO:0034113,1,0.73832203914682,0,46,heterotypic cell-cell adhesion,BP,
9185,GO:0034114,1,0.902714437224648,0,17,regulation of heterotypic cell-cell adhesion,BP,
9186,GO:0034115,1,0.953893391408477,0,8,negative regulation of heterotypic cell-cell adhesion,BP,
9187,GO:0034116,1,0.941877656791405,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9188,GO:0034117,1,0.996614046736757,0,1,erythrocyte aggregation,BP,
9189,GO:0034118,1,0.996614046736757,0,1,regulation of erythrocyte aggregation,BP,
9190,GO:0034120,1,0.996614046736757,0,1,positive regulation of erythrocyte aggregation,BP,
9191,GO:0034121,1,0.685482859479209,0,57,regulation of toll-like receptor signaling pathway,BP,
9192,GO:0034122,1,0.801969715052072,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9193,GO:0034123,1,0.877865271500237,0,20,positive regulation of toll-like receptor signaling pathway,BP,
9194,GO:0034124,1,0.977134107219323,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9195,GO:0034125,1,0.989823572626094,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9196,GO:0034127,1,0.951124020611336,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9197,GO:0034128,1,0.956288860877022,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9198,GO:0034130,1,0.993011391587234,0,1,toll-like receptor 1 signaling pathway,BP,
9199,GO:0034134,1,0.923750883966118,0,12,toll-like receptor 2 signaling pathway,BP,
9200,GO:0034135,1,0.955933177811264,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9201,GO:0034136,1,0.977812541377251,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9202,GO:0034137,1,0.977629238744489,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9203,GO:0034138,1,0.880877293409149,0,19,toll-like receptor 3 signaling pathway,BP,
9204,GO:0034139,1,0.940513125761011,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9205,GO:0034140,1,0.978116153288654,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9206,GO:0034141,1,0.954804866982535,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9207,GO:0034142,1,0.836014795599244,0,28,toll-like receptor 4 signaling pathway,BP,
9208,GO:0034143,1,0.90606073087361,0,15,regulation of toll-like receptor 4 signaling pathway,BP,
9209,GO:0034144,1,0.959726573650212,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9210,GO:0034145,1,0.944104938226901,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9211,GO:0034146,1,0.985034340713044,0,2,toll-like receptor 5 signaling pathway,BP,
9212,GO:0034147,1,0.992485775250643,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9213,GO:0034148,1,0.992485775250643,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9214,GO:0034150,1,0.992377591294024,0,1,toll-like receptor 6 signaling pathway,BP,
9215,GO:0034154,1,0.955651187922704,0,7,toll-like receptor 7 signaling pathway,BP,
9216,GO:0034155,1,0.982180194041075,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9217,GO:0034156,1,0.995112158155111,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9218,GO:0034157,1,0.987005162129868,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9219,GO:0034158,1,0.992494734055781,0,1,toll-like receptor 8 signaling pathway,BP,
9220,GO:0034162,1,0.87038612886125,0,20,toll-like receptor 9 signaling pathway,BP,
9221,GO:0034163,1,0.958594891659952,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9222,GO:0034164,1,0.987459894462744,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9223,GO:0034165,1,0.985183079025697,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9224,GO:0034166,1,0.992624234415905,0,1,toll-like receptor 10 signaling pathway,BP,
9225,GO:0034182,1,0.963787148945773,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9226,GO:0034183,1,0.980410827018371,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9227,GO:0034184,1,0.983047565951533,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9228,GO:0034185,1,0.892779849171647,0,16,apolipoprotein binding,MF,
9229,GO:0034186,1,0.975072416848164,0,4,apolipoprotein A-I binding,MF,
9230,GO:0034188,1,0.984354706429422,0,2,apolipoprotein A-I receptor activity,MF,
9231,GO:0034189,1,0.985110366001864,0,2,very-low-density lipoprotein particle binding,MF,
9232,GO:0034190,1,0.969916306747784,0,5,apolipoprotein receptor binding,MF,
9233,GO:0034191,1,0.977223130821575,0,4,apolipoprotein A-I receptor binding,MF,
9234,GO:0034196,1,0.97805629717008,0,4,acylglycerol transport,BP,
9235,GO:0034197,1,0.97805629717008,0,4,triglyceride transport,BP,
9236,GO:0034198,1,0.763508949751997,0,42,cellular response to amino acid starvation,BP,
9238,GO:0034201,1,0.967600946104349,0,5,response to oleic acid,BP,
9239,GO:0034203,1,0.99244279954059,0,1,glycolipid translocation,BP,
9240,GO:0034204,1,0.83317273741718,0,24,lipid translocation,BP,
9241,GO:0034205,1,0.856144720230194,0,23,amyloid-beta formation,BP,
9242,GO:0034211,1,0.992094053059202,0,1,GTP-dependent protein kinase activity,MF,
9243,GO:0034212,1,0.666625021147909,0,60,peptide N-acetyltransferase activity,MF,
9244,GO:0034213,1,0.995387437374092,0,1,quinolinate catabolic process,BP,
9245,GO:0034214,1,0.944805647776599,0,8,protein hexamerization,BP,
9246,GO:0034219,1,0.50460803823522,0,100,carbohydrate transmembrane transport,BP,
9248,GO:0034224,1,0.994049311060551,0,1,cellular response to zinc ion starvation,BP,
9249,GO:0034227,1,0.973407263354307,0,5,tRNA thio-modification,BP,
9250,GO:0034230,1,0.992468016287556,0,1,enkephalin processing,BP,
9251,GO:0034231,1,0.992468016287556,0,1,islet amyloid polypeptide processing,BP,
9252,GO:0034235,1,0.964250908532767,0,6,GPI anchor binding,MF,
9253,GO:0034236,1,0.908713149329699,0,14,protein kinase A catalytic subunit binding,MF,
9254,GO:0034237,1,0.881880573953523,0,17,protein kinase A regulatory subunit binding,MF,
9255,GO:0034238,1,0.992500534321205,0,1,macrophage fusion,BP,
9256,GO:0034239,1,0.992500534321205,0,1,regulation of macrophage fusion,BP,
9257,GO:0034241,1,0.992500534321205,0,1,positive regulation of macrophage fusion,BP,
9258,GO:0034242,1,0.98302687013235,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9259,GO:0034243,1,0.848477775109597,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9260,GO:0034244,1,0.931926754971427,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9261,GO:0034245,1,0.992506960715736,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9262,GO:0034247,1,0.995772592857048,0,1,snoRNA splicing,BP,
9265,GO:0034250,1,0.432534163640515,0,131,positive regulation of cellular amide metabolic process,BP,
9266,GO:0034255,1,0.994251771467272,0,1,regulation of urea metabolic process,BP,
9267,GO:0034260,1,0.745559646120523,0,44,negative regulation of GTPase activity,BP,
9268,GO:0034271,1,0.979602125020023,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9269,GO:0034272,1,0.979602125020023,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9270,GO:0034274,1,0.977781949257654,0,3,Atg12-Atg5-Atg16 complex,CC,
9271,GO:0034275,1,0.995348338038366,0,1,kynurenic acid metabolic process,BP,
9272,GO:0034276,1,0.995348338038366,0,1,kynurenic acid biosynthetic process,BP,
9274,GO:0034285,1,0.971573696063924,0,4,response to disaccharide,BP,
9275,GO:0034287,1,0.976810260662373,0,4,detection of monosaccharide stimulus,BP,
9276,GO:0034308,1,0.739414442665423,0,50,primary alcohol metabolic process,BP,
9277,GO:0034309,1,0.99622159485821,0,1,primary alcohol biosynthetic process,BP,
9278,GO:0034310,1,0.940577583119867,0,12,primary alcohol catabolic process,BP,
9279,GO:0034311,1,0.897745703883381,0,19,diol metabolic process,BP,
9280,GO:0034312,1,0.912156974117033,0,16,diol biosynthetic process,BP,
9281,GO:0034314,1,0.825736928130803,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9282,GO:0034315,1,0.90668466920854,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9283,GO:0034316,1,0.970877554591627,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9284,GO:0034329,1,0.221298807244696,0,215,cell junction assembly,BP,
9285,GO:0034330,1,0.164671176149707,0,256,cell junction organization,BP,
9286,GO:0034331,1,0.929142801187307,0,11,cell junction maintenance,BP,
9287,GO:0034332,1,0.419480294235611,0,121,adherens junction organization,BP,
9288,GO:0034333,1,0.562212707806389,0,81,adherens junction assembly,BP,
9289,GO:0034334,1,0.970877498085453,0,4,adherens junction maintenance,BP,
9290,GO:0034338,1,0.975325366333868,0,4,short-chain carboxylesterase activity,MF,
9291,GO:0034340,1,0.630444562626358,0,75,response to type I interferon,BP,
9293,GO:0034342,1,0.987433407078069,0,2,response to type III interferon,BP,
9294,GO:0034343,1,0.978010311211619,0,3,type III interferon production,BP,
9295,GO:0034344,1,0.978010311211619,0,3,regulation of type III interferon production,BP,
9296,GO:0034346,1,0.992806926483247,0,1,positive regulation of type III interferon production,BP,
9297,GO:0034349,1,0.909847194339997,0,14,glial cell apoptotic process,BP,
9298,GO:0034350,1,0.948011767064852,0,8,regulation of glial cell apoptotic process,BP,
9299,GO:0034351,1,0.948011767064852,0,8,negative regulation of glial cell apoptotic process,BP,
9300,GO:0034353,1,0.9930956730518,0,1,RNA pyrophosphohydrolase activity,MF,
9301,GO:0034354,1,0.995776749802096,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9302,GO:0034355,1,0.9930956730518,0,1,NAD salvage,BP,
9303,GO:0034356,1,0.921143942164014,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9304,GO:0034358,1,0.836892612466627,0,32,plasma lipoprotein particle,CC,
9305,GO:0034359,1,0.991730188379944,0,1,mature chylomicron,CC,
9306,GO:0034360,1,0.991730188379944,0,1,chylomicron remnant,CC,
9307,GO:0034361,1,0.92253563953814,0,15,very-low-density lipoprotein particle,CC,
9308,GO:0034362,1,0.933976523380356,0,12,low-density lipoprotein particle,CC,
9309,GO:0034363,1,0.980504704642687,0,4,intermediate-density lipoprotein particle,CC,
9310,GO:0034364,1,0.906427413340268,0,21,high-density lipoprotein particle,CC,
9311,GO:0034365,1,0.988638828322598,0,3,discoidal high-density lipoprotein particle,CC,
9312,GO:0034366,1,0.973305563566622,0,6,spherical high-density lipoprotein particle,CC,
9313,GO:0034367,1,0.876137001251714,0,23,protein-containing complex remodeling,BP,
9314,GO:0034368,1,0.882487320877978,0,22,protein-lipid complex remodeling,BP,
9315,GO:0034369,1,0.882487320877978,0,22,plasma lipoprotein particle remodeling,BP,
9316,GO:0034370,1,0.95964619050474,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9317,GO:0034371,1,0.973161003261773,0,5,chylomicron remodeling,BP,
9318,GO:0034372,1,0.96765115898545,0,7,very-low-density lipoprotein particle remodeling,BP,
9319,GO:0034373,1,0.995290291168204,0,1,intermediate-density lipoprotein particle remodeling,BP,
9320,GO:0034374,1,0.936238381315642,0,11,low-density lipoprotein particle remodeling,BP,
9321,GO:0034375,1,0.930080737208282,0,14,high-density lipoprotein particle remodeling,BP,
9322,GO:0034377,1,0.874268590650338,0,22,plasma lipoprotein particle assembly,BP,
9323,GO:0034378,1,0.959380592373459,0,7,chylomicron assembly,BP,
9324,GO:0034379,1,0.944483738279856,0,9,very-low-density lipoprotein particle assembly,BP,
9325,GO:0034380,1,0.936120025932174,0,11,high-density lipoprotein particle assembly,BP,
9326,GO:0034381,1,0.753703050876531,0,46,plasma lipoprotein particle clearance,BP,
9327,GO:0034382,1,0.962492466064319,0,7,chylomicron remnant clearance,BP,
9328,GO:0034383,1,0.82798261098745,0,29,low-density lipoprotein particle clearance,BP,
9329,GO:0034384,1,0.945676507294481,0,10,high-density lipoprotein particle clearance,BP,
9330,GO:0034385,1,0.92253563953814,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9331,GO:0034386,1,0.992456603639031,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9332,GO:0034388,1,0.960644181633947,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9333,GO:0034389,1,0.900064039278896,0,17,lipid particle organization,BP,
9334,GO:0034390,1,0.897061334542501,0,17,smooth muscle cell apoptotic process,BP,
9335,GO:0034391,1,0.897061334542501,0,17,regulation of smooth muscle cell apoptotic process,BP,
9336,GO:0034392,1,0.969646523935294,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9337,GO:0034393,1,0.937682848578686,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9338,GO:0034394,1,0.711154992353234,0,51,protein localization to cell surface,BP,
9339,GO:0034395,1,0.988021519179096,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9340,GO:0034397,1,0.925240480083377,0,11,telomere localization,BP,
9341,GO:0034398,1,0.959002657171841,0,6,telomere tethering at nuclear periphery,BP,
9343,GO:0034402,1,0.986317202919574,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9345,GO:0034405,1,0.798680189342482,0,33,response to fluid shear stress,BP,
9346,GO:0034414,1,0.986635397709178,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9347,GO:0034416,1,0.993012653350283,0,1,bisphosphoglycerate phosphatase activity,MF,
9348,GO:0034417,1,0.993012653350283,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9349,GO:0034418,1,0.987993267759916,0,2,urate biosynthetic process,BP,
9350,GO:0034421,1,0.979228337155284,0,3,post-translational protein acetylation,BP,
9351,GO:0034423,1,0.993325943315911,0,1,autophagosome lumen,CC,
9352,GO:0034427,1,0.950656892943828,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9353,GO:0034431,1,0.976709538622527,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9354,GO:0034432,1,0.976709538622527,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9355,GO:0034433,1,0.945785126135717,0,10,steroid esterification,BP,
9356,GO:0034434,1,0.945785126135717,0,10,sterol esterification,BP,
9357,GO:0034435,1,0.945785126135717,0,10,cholesterol esterification,BP,
9358,GO:0034436,1,0.981651784358685,0,3,glycoprotein transport,BP,
9359,GO:0034437,1,0.985440460162907,0,2,glycoprotein transporter activity,MF,
9360,GO:0034439,1,0.988592383970141,0,2,lipoprotein lipid oxidation,BP,
9362,GO:0034441,1,0.991374693317988,0,2,plasma lipoprotein particle oxidation,BP,
9363,GO:0034442,1,0.988592383970141,0,2,regulation of lipoprotein oxidation,BP,
9364,GO:0034443,1,0.995985737856088,0,1,negative regulation of lipoprotein oxidation,BP,
9365,GO:0034444,1,0.996408596781254,0,1,regulation of plasma lipoprotein oxidation,BP,
9366,GO:0034445,1,0.996408596781254,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9367,GO:0034446,1,0.584964462940626,0,79,substrate adhesion-dependent cell spreading,BP,
9368,GO:0034447,1,0.959072766468891,0,8,very-low-density lipoprotein particle clearance,BP,
9369,GO:0034448,1,0.97266993748804,0,5,EGO complex,CC,
9370,GO:0034450,1,0.917533798619651,0,13,ubiquitin-ubiquitin ligase activity,MF,
9371,GO:0034451,1,0.828939317370068,0,27,centriolar satellite,CC,
9372,GO:0034452,1,0.928771253673853,0,10,dynactin binding,MF,
9373,GO:0034453,1,0.853689479161124,0,22,microtubule anchoring,BP,
9374,GO:0034454,1,0.934603211260235,0,9,microtubule anchoring at centrosome,BP,
9375,GO:0034455,1,0.985965353827561,0,2,t-UTP complex,CC,
9376,GO:0034456,1,0.988418553512764,0,2,UTP-C complex,CC,
9377,GO:0034457,1,0.985577910900524,0,3,Mpp10 complex,CC,
9378,GO:0034458,1,0.98611318501201,0,2,3'-5' RNA helicase activity,MF,
9379,GO:0034459,1,0.992475522317594,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9380,GO:0034462,1,0.994046279050695,0,1,small-subunit processome assembly,BP,
9381,GO:0034463,1,0.996783374530608,0,1,90S preribosome assembly,BP,
9382,GO:0034464,1,0.94159767894195,0,9,BBSome,CC,
9383,GO:0034465,1,0.976510214876832,0,4,response to carbon monoxide,BP,
9384,GO:0034466,1,0.99311891218743,0,1,chromaffin granule lumen,CC,
9385,GO:0034470,1,0.106547088132637,0,389,ncRNA processing,BP,
9386,GO:0034471,1,0.896742560877968,0,19,ncRNA 5'-end processing,BP,
9387,GO:0034472,1,0.916978267759248,0,15,snRNA 3'-end processing,BP,
9388,GO:0034473,1,0.986879801064186,0,3,U1 snRNA 3'-end processing,BP,
9389,GO:0034474,1,0.992279337138393,0,1,U2 snRNA 3'-end processing,BP,
9390,GO:0034475,1,0.965040703461078,0,8,U4 snRNA 3'-end processing,BP,
9391,GO:0034476,1,0.986879801064186,0,3,U5 snRNA 3'-end processing,BP,
9392,GO:0034477,1,0.9930956730518,0,1,U6 snRNA 3'-end processing,BP,
9394,GO:0034483,1,0.906764344379971,0,14,heparan sulfate sulfotransferase activity,MF,
9395,GO:0034485,1,0.971961054909288,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9396,GO:0034497,1,0.912616136804812,0,13,protein localization to phagophore assembly site,BP,
9397,GO:0034498,1,0.948647751978113,0,8,early endosome to Golgi transport,BP,
9398,GO:0034499,1,0.984806130171533,0,2,late endosome to Golgi transport,BP,
9399,GO:0034501,1,0.902961212120835,0,16,protein localization to kinetochore,BP,
9400,GO:0034502,1,0.635620250469842,0,70,protein localization to chromosome,BP,
9401,GO:0034504,1,0.222683914213023,0,226,protein localization to nucleus,BP,
9402,GO:0034505,1,0.901130817357091,0,15,tooth mineralization,BP,
9403,GO:0034506,1,0.99249965888042,0,1,chromosome, centromeric core domain,CC,
9404,GO:0034508,1,0.787657128172642,0,40,centromere complex assembly,BP,
9405,GO:0034511,1,0.969686551680579,0,5,U3 snoRNA binding,MF,
9406,GO:0034513,1,0.978257386458527,0,5,box H/ACA snoRNA binding,MF,
9407,GO:0034515,1,0.985614823864729,0,2,proteasome storage granule,CC,
9408,GO:0034516,1,0.995485080421186,0,1,response to vitamin B6,BP,
9409,GO:0034518,1,0.933633039818183,0,11,RNA cap binding complex,CC,
9410,GO:0034545,1,0.995165192397572,0,1,fumarylpyruvate hydrolase activity,MF,
9411,GO:0034551,1,0.945648644365321,0,9,mitochondrial respiratory chain complex III assembly,BP,
9412,GO:0034552,1,0.99189218600855,0,2,respiratory chain complex II assembly,BP,
9413,GO:0034553,1,0.99189218600855,0,2,mitochondrial respiratory chain complex II assembly,BP,
9414,GO:0034584,1,0.985237206922713,0,2,piRNA binding,MF,
9415,GO:0034587,1,0.908401435841493,0,14,piRNA metabolic process,BP,
9416,GO:0034589,1,0.992491325136976,0,1,hydroxyproline transport,BP,
9417,GO:0034590,1,0.992491325136976,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9418,GO:0034593,1,0.833630454719567,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9419,GO:0034594,1,0.959640019600369,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9420,GO:0034595,1,0.909006344604166,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9421,GO:0034596,1,0.941337512782174,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9422,GO:0034597,1,0.984861181183125,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9424,GO:0034602,1,0.992491226095675,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9425,GO:0034603,1,0.966750078633746,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9426,GO:0034604,1,0.966750078633746,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9431,GO:0034616,1,0.909021902608052,0,14,response to laminar fluid shear stress,BP,
9432,GO:0034617,1,0.973395336351553,0,4,tetrahydrobiopterin binding,MF,
9433,GO:0034618,1,0.961664861698335,0,6,arginine binding,MF,
9434,GO:0034620,1,0.402148198038094,0,140,cellular response to unfolded protein,BP,
9436,GO:0034625,1,0.959484659774481,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9437,GO:0034626,1,0.959484659774481,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9438,GO:0034627,1,0.975751233790597,0,4,'de novo' NAD biosynthetic process,BP,
9439,GO:0034628,1,0.97989041353484,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9440,GO:0034629,1,0.856467979981742,0,23,cellular protein-containing complex localization,BP,
9441,GO:0034632,1,0.989263627424997,0,2,retinol transmembrane transporter activity,MF,
9442,GO:0034633,1,0.989263627424997,0,2,retinol transport,BP,
9443,GO:0034634,1,0.99233132566982,0,1,glutathione transmembrane transporter activity,MF,
9444,GO:0034635,1,0.986919850957124,0,2,glutathione transport,BP,
9445,GO:0034637,1,0.601733431015325,0,75,cellular carbohydrate biosynthetic process,BP,
9446,GO:0034638,1,0.953068355134028,0,8,phosphatidylcholine catabolic process,BP,
9447,GO:0034640,1,0.992668565662403,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9449,GO:0034643,1,0.879495027309607,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9450,GO:0034644,1,0.618710361000968,0,74,cellular response to UV,BP,
9452,GO:0034647,1,0.984358864945239,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9453,GO:0034648,1,0.969910184874755,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9454,GO:0034649,1,0.992503444947022,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9455,GO:0034650,1,0.94569670068662,0,8,cortisol metabolic process,BP,
9456,GO:0034651,1,0.950821807057168,0,7,cortisol biosynthetic process,BP,
9457,GO:0034653,1,0.983150099665392,0,3,retinoic acid catabolic process,BP,
9460,GO:0034656,1,0.779867432430119,0,43,nucleobase-containing small molecule catabolic process,BP,
9461,GO:0034657,1,0.974477249851784,0,4,GID complex,CC,
9462,GO:0034660,1,0.0385055791801331,0,546,ncRNA metabolic process,BP,
9463,GO:0034661,1,0.858611367016423,0,24,ncRNA catabolic process,BP,
9464,GO:0034663,1,0.944729760677195,0,9,endoplasmic reticulum chaperone complex,CC,
9465,GO:0034665,1,0.985029894009926,0,2,integrin alpha1-beta1 complex,CC,
9466,GO:0034666,1,0.977667783485657,0,3,integrin alpha2-beta1 complex,CC,
9467,GO:0034667,1,0.985019004748589,0,2,integrin alpha3-beta1 complex,CC,
9468,GO:0034668,1,0.992501937538747,0,1,integrin alpha4-beta1 complex,CC,
9469,GO:0034669,1,0.985511076886249,0,2,integrin alpha4-beta7 complex,CC,
9470,GO:0034670,1,0.992055080609252,0,1,chemotaxis to arachidonic acid,BP,
9471,GO:0034673,1,0.980471457119583,0,3,inhibin-betaglycan-ActRII complex,CC,
9472,GO:0034676,1,0.992387260241028,0,1,integrin alpha6-beta4 complex,CC,
9473,GO:0034677,1,0.992510586774016,0,1,integrin alpha7-beta1 complex,CC,
9474,GO:0034678,1,0.977789060592527,0,3,integrin alpha8-beta1 complex,CC,
9475,GO:0034679,1,0.992500648993162,0,1,integrin alpha9-beta1 complex,CC,
9476,GO:0034680,1,0.985002397610466,0,2,integrin alpha10-beta1 complex,CC,
9477,GO:0034681,1,0.985015299273571,0,2,integrin alpha11-beta1 complex,CC,
9478,GO:0034683,1,0.98480062628659,0,2,integrin alphav-beta3 complex,CC,
9479,GO:0034684,1,0.984935268476686,0,2,integrin alphav-beta5 complex,CC,
9480,GO:0034685,1,0.986068678901414,0,2,integrin alphav-beta6 complex,CC,
9481,GO:0034686,1,0.984478549640918,0,2,integrin alphav-beta8 complex,CC,
9482,GO:0034687,1,0.985392845832359,0,2,integrin alphaL-beta2 complex,CC,
9483,GO:0034688,1,0.985416998011591,0,2,integrin alphaM-beta2 complex,CC,
9484,GO:0034693,1,0.993629040895979,0,1,U11/U12 snRNP,CC,
9485,GO:0034694,1,0.830197393476103,0,29,response to prostaglandin,BP,
9486,GO:0034695,1,0.868198768688106,0,22,response to prostaglandin E,BP,
9487,GO:0034696,1,0.98779070951652,0,2,response to prostaglandin F,BP,
9488,GO:0034698,1,0.838962517188108,0,25,response to gonadotropin,BP,
9489,GO:0034699,1,0.978820070813592,0,3,response to luteinizing hormone,BP,
9494,GO:0034706,1,0.842183024359138,0,23,sodium channel complex,CC,
9496,GO:0034708,1,0.568198240706884,0,88,methyltransferase complex,CC,
9497,GO:0034709,1,0.947979082671202,0,12,methylosome,CC,
9498,GO:0034711,1,0.970036764633508,0,5,inhibin binding,MF,
9499,GO:0034713,1,0.939919170902871,0,9,type I transforming growth factor beta receptor binding,MF,
9500,GO:0034714,1,0.979416387277575,0,3,type III transforming growth factor beta receptor binding,MF,
9501,GO:0034715,1,0.974989193939026,0,6,pICln-Sm protein complex,CC,
9502,GO:0034718,1,0.992416536150941,0,1,SMN-Gemin2 complex,CC,
9503,GO:0034719,1,0.915787201885958,0,17,SMN-Sm protein complex,CC,
9504,GO:0034720,1,0.955154234835339,0,6,histone H3-K4 demethylation,BP,
9505,GO:0034721,1,0.984358864945239,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9506,GO:0034722,1,0.99547649485031,0,1,gamma-glutamyl-peptidase activity,MF,
9507,GO:0034723,1,0.930264949053464,0,14,DNA replication-dependent nucleosome organization,BP,
9508,GO:0034724,1,0.785863798166168,0,41,DNA replication-independent nucleosome organization,BP,
9509,GO:0034727,1,0.992452426779513,0,1,piecemeal microautophagy of the nucleus,BP,
9510,GO:0034728,1,0.501234439911652,0,117,nucleosome organization,BP,
9511,GO:0034729,1,0.980755169434766,0,3,histone H3-K79 methylation,BP,
9512,GO:0034736,1,0.992584977524049,0,1,cholesterol O-acyltransferase activity,MF,
9513,GO:0034739,1,0.989785348264561,0,2,histone deacetylase activity (H4-K16 specific),MF,
9514,GO:0034750,1,0.985066694182384,0,2,Scrib-APC-beta-catenin complex,CC,
9515,GO:0034751,1,0.981782971885191,0,3,aryl hydrocarbon receptor complex,CC,
9516,GO:0034752,1,0.992344799859512,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9517,GO:0034753,1,0.992344799859512,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9518,GO:0034754,1,0.58133283551513,0,91,cellular hormone metabolic process,BP,
9519,GO:0034755,1,0.900077754376485,0,16,iron ion transmembrane transport,BP,
9520,GO:0034756,1,0.973075060490187,0,5,regulation of iron ion transport,BP,
9521,GO:0034757,1,0.98891931560652,0,2,negative regulation of iron ion transport,BP,
9522,GO:0034759,1,0.98891931560652,0,2,regulation of iron ion transmembrane transport,BP,
9523,GO:0034760,1,0.98891931560652,0,2,negative regulation of iron ion transmembrane transport,BP,
9525,GO:0034763,1,0.528496574789376,0,100,negative regulation of transmembrane transport,BP,
9528,GO:0034766,1,0.596713054768027,0,80,negative regulation of ion transmembrane transport,BP,
9530,GO:0034769,1,0.986929323630505,0,2,basement membrane disassembly,BP,
9531,GO:0034770,1,0.956803481553671,0,6,histone H4-K20 methylation,BP,
9532,GO:0034773,1,0.972196107600744,0,4,histone H4-K20 trimethylation,BP,
9534,GO:0034775,1,0.99233132566982,0,1,glutathione transmembrane transport,BP,
9536,GO:0034777,1,0.994075621778268,0,1,recycling endosome lumen,CC,
9537,GO:0034875,1,0.994701360356908,0,1,caffeine oxidase activity,MF,
9538,GO:0034899,1,0.994391701332776,0,1,trimethylamine monooxygenase activity,MF,
9539,GO:0034959,1,0.992440781289541,0,1,endothelin maturation,BP,
9540,GO:0034963,1,0.995937198802247,0,1,box C/D snoRNA processing,BP,
9541,GO:0034964,1,0.993420146576655,0,1,box H/ACA snoRNA processing,BP,
9542,GO:0034968,1,0.512331666392229,0,96,histone lysine methylation,BP,
9543,GO:0034969,1,0.926110437208516,0,12,histone arginine methylation,BP,
9544,GO:0034970,1,0.986232792922503,0,2,histone H3-R2 methylation,BP,
9545,GO:0034971,1,0.987157008955551,0,2,histone H3-R17 methylation,BP,
9546,GO:0034975,1,0.915168306807737,0,13,protein folding in endoplasmic reticulum,BP,
9547,GO:0034976,1,0.183584024779936,0,260,response to endoplasmic reticulum stress,BP,
9548,GO:0034979,1,0.893287203848889,0,17,NAD-dependent protein deacetylase activity,MF,
9549,GO:0034982,1,0.933568134926273,0,12,mitochondrial protein processing,BP,
9550,GO:0034983,1,0.954155604213228,0,7,peptidyl-lysine deacetylation,BP,
9551,GO:0034986,1,0.985391208447418,0,2,iron chaperone activity,MF,
9552,GO:0034987,1,0.964014632775354,0,6,immunoglobulin receptor binding,MF,
9553,GO:0034988,1,0.985859237807887,0,2,Fc-gamma receptor I complex binding,MF,
9554,GO:0034991,1,0.974113024108282,0,4,nuclear meiotic cohesin complex,CC,
9555,GO:0034992,1,0.951041881901564,0,7,microtubule organizing center attachment site,CC,
9556,GO:0034993,1,0.951041881901564,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9557,GO:0034998,1,0.9930956730518,0,1,oligosaccharyltransferase I complex,CC,
9558,GO:0035004,1,0.620964292767956,0,69,phosphatidylinositol 3-kinase activity,MF,
9559,GO:0035005,1,0.948060515628116,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9560,GO:0035014,1,0.943457301481091,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9561,GO:0035019,1,0.645128587782921,0,67,somatic stem cell population maintenance,BP,
9562,GO:0035020,1,0.892929759702253,0,16,regulation of Rac protein signal transduction,BP,
9563,GO:0035021,1,0.9717141742992,0,4,negative regulation of Rac protein signal transduction,BP,
9564,GO:0035022,1,0.973975732244994,0,4,positive regulation of Rac protein signal transduction,BP,
9566,GO:0035024,1,0.8817542832195,0,18,negative regulation of Rho protein signal transduction,BP,
9567,GO:0035025,1,0.867094516927752,0,22,positive regulation of Rho protein signal transduction,BP,
9568,GO:0035026,1,0.985152016247709,0,2,leading edge cell differentiation,BP,
9569,GO:0035032,1,0.960725443679332,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9570,GO:0035033,1,0.984612699069325,0,3,histone deacetylase regulator activity,MF,
9571,GO:0035034,1,0.987119009319124,0,2,histone acetyltransferase regulator activity,MF,
9572,GO:0035035,1,0.820530194746386,0,29,histone acetyltransferase binding,MF,
9573,GO:0035036,1,0.820446659356836,0,35,sperm-egg recognition,BP,
9574,GO:0035037,1,0.992481327938349,0,1,sperm entry,BP,
9575,GO:0035038,1,0.986741116649597,0,2,female pronucleus assembly,BP,
9576,GO:0035039,1,0.993915828702927,0,1,male pronucleus assembly,BP,
9577,GO:0035050,1,0.627652818029003,0,69,embryonic heart tube development,BP,
9578,GO:0035051,1,0.443387648891855,0,118,cardiocyte differentiation,BP,
9579,GO:0035054,1,0.979630502589313,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9580,GO:0035061,1,0.970536864351883,0,4,interchromatin granule,CC,
9581,GO:0035063,1,0.9843433166368,0,2,nuclear speck organization,BP,
9582,GO:0035064,1,0.682523269851389,0,56,methylated histone binding,MF,
9583,GO:0035065,1,0.708130371684192,0,52,regulation of histone acetylation,BP,
9584,GO:0035066,1,0.834933457909535,0,28,positive regulation of histone acetylation,BP,
9585,GO:0035067,1,0.894655644730109,0,17,negative regulation of histone acetylation,BP,
9586,GO:0035068,1,0.93871119565144,0,9,micro-ribonucleoprotein complex,CC,
9588,GO:0035087,1,0.975913312146241,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9589,GO:0035088,1,0.738872699600451,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9590,GO:0035089,1,0.891375592068669,0,17,establishment of apical/basal cell polarity,BP,
9591,GO:0035090,1,0.92716696277164,0,12,maintenance of apical/basal cell polarity,BP,
9593,GO:0035092,1,0.961400599242308,0,6,sperm chromatin condensation,BP,
9594,GO:0035093,1,0.972999398651309,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9596,GO:0035095,1,0.952121680124897,0,7,behavioral response to nicotine,BP,
9597,GO:0035097,1,0.62740625030306,0,68,histone methyltransferase complex,CC,
9598,GO:0035098,1,0.895364815179723,0,16,ESC/E(Z) complex,CC,
9599,GO:0035101,1,0.97881188483014,0,3,FACT complex,CC,
9600,GO:0035102,1,0.928308095150565,0,11,PRC1 complex,CC,
9601,GO:0035106,1,0.979114639608254,0,3,operant conditioning,BP,
9602,GO:0035107,1,0.382164998586489,0,142,appendage morphogenesis,BP,
9603,GO:0035108,1,0.382164998586489,0,142,limb morphogenesis,BP,
9604,GO:0035112,1,0.930659493506678,0,11,genitalia morphogenesis,BP,
9605,GO:0035113,1,0.440763304131063,0,122,embryonic appendage morphogenesis,BP,
9606,GO:0035115,1,0.815143691550812,0,32,embryonic forelimb morphogenesis,BP,
9607,GO:0035116,1,0.839783780696278,0,28,embryonic hindlimb morphogenesis,BP,
9608,GO:0035120,1,0.991947384974868,0,1,post-embryonic appendage morphogenesis,BP,
9609,GO:0035127,1,0.991947384974868,0,1,post-embryonic limb morphogenesis,BP,
9610,GO:0035128,1,0.991947384974868,0,1,post-embryonic forelimb morphogenesis,BP,
9611,GO:0035136,1,0.770270368602201,0,40,forelimb morphogenesis,BP,
9612,GO:0035137,1,0.794579406698539,0,36,hindlimb morphogenesis,BP,
9613,GO:0035145,1,0.882937297781258,0,19,exon-exon junction complex,CC,
9614,GO:0035148,1,0.391416797300966,0,140,tube formation,BP,
9616,GO:0035162,1,0.867542106886598,0,20,embryonic hemopoiesis,BP,
9617,GO:0035166,1,0.978164140431545,0,3,post-embryonic hemopoiesis,BP,
9618,GO:0035173,1,0.9027578320084,0,16,histone kinase activity,MF,
9619,GO:0035174,1,0.959907872548342,0,7,histone serine kinase activity,MF,
9620,GO:0035175,1,0.995112158155111,0,1,histone kinase activity (H3-S10 specific),MF,
9622,GO:0035184,1,0.966184724039807,0,5,histone threonine kinase activity,MF,
9623,GO:0035188,1,0.992654781804303,0,1,hatching,BP,
9624,GO:0035189,1,0.97998279405899,0,3,Rb-E2F complex,CC,
9625,GO:0035194,1,0.460384458639497,0,120,posttranscriptional gene silencing by RNA,BP,
9626,GO:0035195,1,0.479873823499187,0,114,gene silencing by miRNA,BP,
9627,GO:0035196,1,0.758160545871135,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9628,GO:0035197,1,0.932174673290873,0,10,siRNA binding,MF,
9629,GO:0035198,1,0.859673736813543,0,22,miRNA binding,MF,
9630,GO:0035226,1,0.992775144600045,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9631,GO:0035227,1,0.992775144600045,0,1,regulation of glutamate-cysteine ligase activity,BP,
9632,GO:0035229,1,0.992775144600045,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9633,GO:0035234,1,0.954749365509358,0,7,ectopic germ cell programmed cell death,BP,
9635,GO:0035238,1,0.9930956730518,0,1,vitamin A biosynthetic process,BP,
9637,GO:0035240,1,0.952044610295684,0,8,dopamine binding,MF,
9638,GO:0035241,1,0.974263693480211,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9639,GO:0035242,1,0.951065188116351,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9640,GO:0035243,1,0.97386324876721,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9641,GO:0035246,1,0.92648414366598,0,12,peptidyl-arginine N-methylation,BP,
9642,GO:0035247,1,0.938516407656395,0,10,peptidyl-arginine omega-N-methylation,BP,
9643,GO:0035248,1,0.992985378273077,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9645,GO:0035250,1,0.841232687759428,0,27,UDP-galactosyltransferase activity,MF,
9646,GO:0035251,1,0.943004216486383,0,9,UDP-glucosyltransferase activity,MF,
9647,GO:0035252,1,0.959156200962317,0,6,UDP-xylosyltransferase activity,MF,
9648,GO:0035253,1,0.925709674788227,0,11,ciliary rootlet,CC,
9650,GO:0035255,1,0.831784840376857,0,26,ionotropic glutamate receptor binding,MF,
9651,GO:0035256,1,0.952153902488544,0,8,G-protein coupled glutamate receptor binding,MF,
9652,GO:0035257,1,0.382044158843914,0,143,nuclear hormone receptor binding,MF,
9653,GO:0035258,1,0.568212968903079,0,84,steroid hormone receptor binding,MF,
9654,GO:0035259,1,0.907423302999227,0,14,glucocorticoid receptor binding,MF,
9655,GO:0035261,1,0.984115466441914,0,2,external genitalia morphogenesis,BP,
9656,GO:0035262,1,0.986132438999343,0,2,gonad morphogenesis,BP,
9658,GO:0035265,1,0.379058842522461,0,141,organ growth,BP,
9659,GO:0035267,1,0.898047190923987,0,18,NuA4 histone acetyltransferase complex,CC,
9660,GO:0035268,1,0.89662662639905,0,17,protein mannosylation,BP,
9661,GO:0035269,1,0.931396693085523,0,12,protein O-linked mannosylation,BP,
9662,GO:0035270,1,0.470308613505665,0,117,endocrine system development,BP,
9663,GO:0035272,1,0.732832363819278,0,47,exocrine system development,BP,
9664,GO:0035276,1,0.987041956756791,0,2,ethanol binding,MF,
9665,GO:0035278,1,0.915459967760038,0,13,miRNA mediated inhibition of translation,BP,
9666,GO:0035279,1,0.9856797394481,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9667,GO:0035280,1,0.953212780002399,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9668,GO:0035281,1,0.988508293863638,0,2,pre-miRNA export from nucleus,BP,
9670,GO:0035283,1,0.985652670161466,0,2,central nervous system segmentation,BP,
9671,GO:0035284,1,0.985652670161466,0,2,brain segmentation,BP,
9672,GO:0035290,1,0.978682291640386,0,3,trunk segmentation,BP,
9675,GO:0035299,1,0.992486849857591,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9677,GO:0035304,1,0.458566854562159,0,118,regulation of protein dephosphorylation,BP,
9679,GO:0035306,1,0.720779151587823,0,48,positive regulation of dephosphorylation,BP,
9680,GO:0035307,1,0.783934675472703,0,36,positive regulation of protein dephosphorylation,BP,
9681,GO:0035308,1,0.731055329990139,0,49,negative regulation of protein dephosphorylation,BP,
9682,GO:0035312,1,0.95853826832214,0,6,5'-3' exodeoxyribonuclease activity,MF,
9683,GO:0035313,1,0.903892934447826,0,14,wound healing, spreading of epidermal cells,BP,
9684,GO:0035315,1,0.781201290583289,0,36,hair cell differentiation,BP,
9685,GO:0035325,1,0.94118265020534,0,10,Toll-like receptor binding,MF,
9686,GO:0035326,1,0.517887405655706,0,99,enhancer binding,MF,
9687,GO:0035327,1,0.875744150457081,0,21,transcriptionally active chromatin,CC,
9688,GO:0035329,1,0.757429576934617,0,38,hippo signaling,BP,
9689,GO:0035330,1,0.921544699560451,0,11,regulation of hippo signaling,BP,
9690,GO:0035331,1,0.942610466208309,0,8,negative regulation of hippo signaling,BP,
9691,GO:0035332,1,0.98443731042206,0,2,positive regulation of hippo signaling,BP,
9692,GO:0035333,1,0.916197375989297,0,13,Notch receptor processing, ligand-dependent,BP,
9694,GO:0035336,1,0.863556286171239,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9695,GO:0035337,1,0.795896982914868,0,35,fatty-acyl-CoA metabolic process,BP,
9696,GO:0035338,1,0.896717768089059,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9697,GO:0035339,1,0.979304024123268,0,4,SPOTS complex,CC,
9698,GO:0035349,1,0.980350904648416,0,3,coenzyme A transmembrane transport,BP,
9699,GO:0035350,1,0.986878115176111,0,2,FAD transmembrane transport,BP,
9700,GO:0035352,1,0.994016006353376,0,1,NAD transmembrane transport,BP,
9701,GO:0035354,1,0.98564950536708,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9702,GO:0035355,1,0.992377591294024,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9703,GO:0035356,1,0.957709805786405,0,7,cellular triglyceride homeostasis,BP,
9704,GO:0035357,1,0.873397923866714,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9705,GO:0035358,1,0.922625523333605,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9706,GO:0035359,1,0.981478478988073,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9707,GO:0035360,1,0.953597499404296,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9708,GO:0035363,1,0.974227582507223,0,4,histone locus body,CC,
9709,GO:0035368,1,0.974276765373333,0,4,selenocysteine insertion sequence binding,MF,
9710,GO:0035370,1,0.987421171197723,0,2,UBC13-UEV1A complex,CC,
9711,GO:0035371,1,0.875188952961807,0,18,microtubule plus-end,CC,
9712,GO:0035372,1,0.911200768090332,0,13,protein localization to microtubule,BP,
9713,GO:0035373,1,0.979641803821764,0,3,chondroitin sulfate proteoglycan binding,MF,
9714,GO:0035374,1,0.960494345205473,0,6,chondroitin sulfate binding,MF,
9715,GO:0035375,1,0.992221678212835,0,1,zymogen binding,MF,
9716,GO:0035376,1,0.959897868818872,0,7,sterol import,BP,
9717,GO:0035377,1,0.985546054829513,0,2,transepithelial water transport,BP,
9718,GO:0035378,1,0.993140495715573,0,1,carbon dioxide transmembrane transport,BP,
9719,GO:0035379,1,0.993140495715573,0,1,carbon dioxide transmembrane transporter activity,MF,
9720,GO:0035381,1,0.951918762888072,0,8,ATP-gated ion channel activity,MF,
9721,GO:0035383,1,0.564590966128198,0,91,thioester metabolic process,BP,
9722,GO:0035384,1,0.731815135383911,0,46,thioester biosynthetic process,BP,
9723,GO:0035385,1,0.950002525486623,0,7,Roundabout signaling pathway,BP,
9724,GO:0035397,1,0.992749534641708,0,1,helper T cell enhancement of adaptive immune response,BP,
9725,GO:0035400,1,0.99242681178355,0,1,histone tyrosine kinase activity,MF,
9726,GO:0035401,1,0.99242681178355,0,1,histone kinase activity (H3-Y41 specific),MF,
9727,GO:0035402,1,0.986107041259996,0,2,histone kinase activity (H3-T11 specific),MF,
9728,GO:0035403,1,0.984613250856512,0,2,histone kinase activity (H3-T6 specific),MF,
9729,GO:0035404,1,0.928646322806145,0,12,histone-serine phosphorylation,BP,
9730,GO:0035405,1,0.966184724039807,0,5,histone-threonine phosphorylation,BP,
9731,GO:0035406,1,0.99242681178355,0,1,histone-tyrosine phosphorylation,BP,
9732,GO:0035407,1,0.986107041259996,0,2,histone H3-T11 phosphorylation,BP,
9733,GO:0035408,1,0.984613250856512,0,2,histone H3-T6 phosphorylation,BP,
9734,GO:0035409,1,0.99242681178355,0,1,histone H3-Y41 phosphorylation,BP,
9735,GO:0035410,1,0.995861044061941,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9737,GO:0035425,1,0.985636673389243,0,2,autocrine signaling,BP,
9738,GO:0035426,1,0.965139803724656,0,5,extracellular matrix-cell signaling,BP,
9739,GO:0035434,1,0.961741767820269,0,6,copper ion transmembrane transport,BP,
9740,GO:0035435,1,0.938127095345721,0,9,phosphate ion transmembrane transport,BP,
9741,GO:0035437,1,0.918725062167613,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9742,GO:0035438,1,0.995147621146568,0,1,cyclic-di-GMP binding,MF,
9743,GO:0035441,1,0.977247140827121,0,3,cell migration involved in vasculogenesis,BP,
9744,GO:0035442,1,0.988508795246109,0,2,dipeptide transmembrane transport,BP,
9745,GO:0035443,1,0.99233132566982,0,1,tripeptide transmembrane transport,BP,
9746,GO:0035445,1,0.992743396839482,0,1,borate transmembrane transport,BP,
9747,GO:0035455,1,0.881566317629616,0,20,response to interferon-alpha,BP,
9748,GO:0035456,1,0.892825558637576,0,20,response to interferon-beta,BP,
9749,GO:0035457,1,0.931810179861318,0,10,cellular response to interferon-alpha,BP,
9750,GO:0035458,1,0.922076676902517,0,13,cellular response to interferon-beta,BP,
9751,GO:0035459,1,0.872979647858673,0,20,cargo loading into vesicle,BP,
9752,GO:0035461,1,0.923946190277476,0,11,vitamin transmembrane transport,BP,
9753,GO:0035469,1,0.963550161324096,0,5,determination of pancreatic left/right asymmetry,BP,
9754,GO:0035470,1,0.990133085800177,0,2,positive regulation of vascular wound healing,BP,
9755,GO:0035473,1,0.97348814813532,0,4,lipase binding,MF,
9756,GO:0035480,1,0.995951357786099,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9757,GO:0035481,1,0.995951357786099,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9758,GO:0035482,1,0.984655538334694,0,4,gastric motility,BP,
9759,GO:0035483,1,0.989406903957037,0,3,gastric emptying,BP,
9760,GO:0035485,1,0.994864485296992,0,1,adenine/guanine mispair binding,MF,
9761,GO:0035490,1,0.992710095381765,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9762,GO:0035491,1,0.992710095381765,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9763,GO:0035493,1,0.905119639277297,0,15,SNARE complex assembly,BP,
9764,GO:0035494,1,0.980570833625648,0,3,SNARE complex disassembly,BP,
9765,GO:0035497,1,0.916930555844464,0,13,cAMP response element binding,MF,
9766,GO:0035498,1,0.992501255451989,0,1,carnosine metabolic process,BP,
9767,GO:0035499,1,0.992501255451989,0,1,carnosine biosynthetic process,BP,
9768,GO:0035500,1,0.985598427815215,0,2,MH2 domain binding,MF,
9769,GO:0035501,1,0.993036377919383,0,1,MH1 domain binding,MF,
9770,GO:0035502,1,0.967499564327272,0,5,metanephric part of ureteric bud development,BP,
9771,GO:0035504,1,0.995463955836341,0,1,regulation of myosin light chain kinase activity,BP,
9772,GO:0035505,1,0.995463955836341,0,1,positive regulation of myosin light chain kinase activity,BP,
9773,GO:0035507,1,0.950594246450817,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9774,GO:0035508,1,0.99240152199866,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9775,GO:0035509,1,0.965315443568903,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9776,GO:0035510,1,0.839646452309793,0,28,DNA dealkylation,BP,
9777,GO:0035511,1,0.970456840659871,0,5,oxidative DNA demethylation,BP,
9778,GO:0035513,1,0.974070125281458,0,4,oxidative RNA demethylation,BP,
9779,GO:0035514,1,0.984127062165284,0,3,DNA demethylase activity,MF,
9780,GO:0035515,1,0.974070125281458,0,4,oxidative RNA demethylase activity,MF,
9781,GO:0035516,1,0.9924916978135,0,1,oxidative DNA demethylase activity,MF,
9782,GO:0035517,1,0.96986665548162,0,4,PR-DUB complex,CC,
9783,GO:0035518,1,0.897811672657298,0,16,histone H2A monoubiquitination,BP,
9784,GO:0035519,1,0.980247486326375,0,4,protein K29-linked ubiquitination,BP,
9785,GO:0035520,1,0.935156345467731,0,9,monoubiquitinated protein deubiquitination,BP,
9786,GO:0035521,1,0.971571743152787,0,4,monoubiquitinated histone deubiquitination,BP,
9787,GO:0035522,1,0.971571743152787,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9788,GO:0035523,1,0.977174213946011,0,3,protein K29-linked deubiquitination,BP,
9789,GO:0035524,1,0.963953143094828,0,5,proline transmembrane transport,BP,
9790,GO:0035525,1,0.993420146576655,0,1,NF-kappaB p50/p65 complex,CC,
9791,GO:0035526,1,0.985016129135717,0,2,retrograde transport, plasma membrane to Golgi,BP,
9792,GO:0035529,1,0.960735834523943,0,7,NADH pyrophosphatase activity,MF,
9793,GO:0035538,1,0.992650639009511,0,1,carbohydrate response element binding,MF,
9794,GO:0035539,1,0.990992087852615,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9795,GO:0035542,1,0.938422983779917,0,9,regulation of SNARE complex assembly,BP,
9796,GO:0035544,1,0.97855519516148,0,3,negative regulation of SNARE complex assembly,BP,
9797,GO:0035545,1,0.992501879531504,0,1,determination of left/right asymmetry in nervous system,BP,
9798,GO:0035546,1,0.96296572823161,0,5,interferon-beta secretion,BP,
9799,GO:0035547,1,0.96296572823161,0,5,regulation of interferon-beta secretion,BP,
9800,GO:0035548,1,0.992991488566786,0,1,negative regulation of interferon-beta secretion,BP,
9801,GO:0035549,1,0.969764453978119,0,4,positive regulation of interferon-beta secretion,BP,
9802,GO:0035552,1,0.981357661672857,0,3,oxidative single-stranded DNA demethylation,BP,
9803,GO:0035553,1,0.980535934136261,0,3,oxidative single-stranded RNA demethylation,BP,
9805,GO:0035561,1,0.863097147028011,0,21,regulation of chromatin binding,BP,
9806,GO:0035562,1,0.949280002095604,0,7,negative regulation of chromatin binding,BP,
9807,GO:0035563,1,0.916064525038428,0,13,positive regulation of chromatin binding,BP,
9808,GO:0035564,1,0.984650455838321,0,2,regulation of kidney size,BP,
9809,GO:0035566,1,0.992497689872966,0,1,regulation of metanephros size,BP,
9811,GO:0035568,1,0.9930956730518,0,1,N-terminal peptidyl-proline methylation,BP,
9812,GO:0035570,1,0.9930956730518,0,1,N-terminal peptidyl-serine methylation,BP,
9813,GO:0035572,1,0.9930956730518,0,1,N-terminal peptidyl-serine dimethylation,BP,
9814,GO:0035573,1,0.9930956730518,0,1,N-terminal peptidyl-serine trimethylation,BP,
9815,GO:0035574,1,0.985508214744165,0,2,histone H4-K20 demethylation,BP,
9816,GO:0035575,1,0.985508214744165,0,2,histone demethylase activity (H4-K20 specific),MF,
9817,GO:0035577,1,0.712822001404414,0,53,azurophil granule membrane,CC,
9818,GO:0035578,1,0.61945160394011,0,81,azurophil granule lumen,CC,
9821,GO:0035581,1,0.948120216437257,0,8,sequestering of extracellular ligand from receptor,BP,
9822,GO:0035582,1,0.977542288266113,0,4,sequestering of BMP in extracellular matrix,BP,
9823,GO:0035583,1,0.976498566591655,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9824,GO:0035584,1,0.90151782953342,0,17,calcium-mediated signaling using intracellular calcium source,BP,
9825,GO:0035585,1,0.984922146951661,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9826,GO:0035586,1,0.87790364278275,0,22,purinergic receptor activity,MF,
9827,GO:0035587,1,0.839588349800527,0,29,purinergic receptor signaling pathway,BP,
9828,GO:0035588,1,0.881951885866517,0,21,G-protein coupled purinergic receptor signaling pathway,BP,
9829,GO:0035589,1,0.932609544919803,0,12,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9830,GO:0035590,1,0.887837638162196,0,20,purinergic nucleotide receptor signaling pathway,BP,
9831,GO:0035591,1,0.580370073229614,0,80,signaling adaptor activity,MF,
9832,GO:0035594,1,0.974334977023415,0,4,ganglioside binding,MF,
9833,GO:0035596,1,0.987183854653326,0,2,methylthiotransferase activity,MF,
9834,GO:0035597,1,0.994504626693371,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9835,GO:0035598,1,0.992639187713331,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9836,GO:0035600,1,0.987183854653326,0,2,tRNA methylthiolation,BP,
9837,GO:0035601,1,0.495075694959497,0,105,protein deacylation,BP,
9838,GO:0035602,1,0.99249805125143,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9839,GO:0035603,1,0.99249805125143,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9840,GO:0035604,1,0.99249805125143,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9841,GO:0035605,1,0.995740477653328,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9842,GO:0035606,1,0.992350638239317,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9843,GO:0035607,1,0.984952549840936,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9844,GO:0035608,1,0.952437833178244,0,7,protein deglutamylation,BP,
9845,GO:0035609,1,0.973566430215791,0,4,C-terminal protein deglutamylation,BP,
9846,GO:0035610,1,0.970783054557651,0,4,protein side chain deglutamylation,BP,
9847,GO:0035611,1,0.99301708613116,0,1,protein branching point deglutamylation,BP,
9848,GO:0035612,1,0.94225113492115,0,8,AP-2 adaptor complex binding,MF,
9849,GO:0035613,1,0.905915081173437,0,15,RNA stem-loop binding,MF,
9850,GO:0035614,1,0.984074586578323,0,3,snRNA stem-loop binding,MF,
9851,GO:0035615,1,0.927660916146443,0,11,clathrin adaptor activity,MF,
9852,GO:0035616,1,0.977755632460586,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9853,GO:0035617,1,0.980148360156163,0,3,stress granule disassembly,BP,
9854,GO:0035620,1,0.973405772111436,0,4,ceramide transporter activity,MF,
9855,GO:0035621,1,0.987050301224284,0,2,ER to Golgi ceramide transport,BP,
9856,GO:0035622,1,0.992502206977349,0,1,intrahepatic bile duct development,BP,
9857,GO:0035623,1,0.992660426771397,0,1,renal glucose absorption,BP,
9858,GO:0035624,1,0.972181309469635,0,4,receptor transactivation,BP,
9859,GO:0035625,1,0.979828901716342,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9860,GO:0035627,1,0.953831543200955,0,7,ceramide transport,BP,
9861,GO:0035630,1,0.951677664056939,0,7,bone mineralization involved in bone maturation,BP,
9862,GO:0035631,1,0.929279838123186,0,11,CD40 receptor complex,CC,
9863,GO:0035633,1,0.971753173587896,0,4,maintenance of permeability of blood-brain barrier,BP,
9864,GO:0035634,1,0.98278987407185,0,3,response to stilbenoid,BP,
9865,GO:0035635,1,0.883295197749135,0,18,entry of bacterium into host cell,BP,
9867,GO:0035638,1,0.992468207829124,0,1,signal maturation,BP,
9871,GO:0035642,1,0.992864637654743,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9872,GO:0035643,1,0.995131715877176,0,1,L-DOPA receptor activity,MF,
9873,GO:0035644,1,0.99283588311333,0,1,phosphoanandamide dephosphorylation,BP,
9874,GO:0035645,1,0.992492083778143,0,1,enteric smooth muscle cell differentiation,BP,
9875,GO:0035646,1,0.939897072920571,0,10,endosome to melanosome transport,BP,
9876,GO:0035650,1,0.977189802074451,0,4,AP-1 adaptor complex binding,MF,
9877,GO:0035651,1,0.984078026463824,0,3,AP-3 adaptor complex binding,MF,
9878,GO:0035655,1,0.950720029397275,0,8,interleukin-18-mediated signaling pathway,BP,
9879,GO:0035658,1,0.980428584818829,0,3,Mon1-Ccz1 complex,CC,
9880,GO:0035659,1,0.99510680161285,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9881,GO:0035662,1,0.988370825629262,0,3,Toll-like receptor 4 binding,MF,
9882,GO:0035663,1,0.980491259607291,0,3,Toll-like receptor 2 binding,MF,
9883,GO:0035664,1,0.994977161225563,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9884,GO:0035665,1,0.994977161225563,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9885,GO:0035666,1,0.845358345651364,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9886,GO:0035668,1,0.985318194346167,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9887,GO:0035669,1,0.985318194346167,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9888,GO:0035671,1,0.98325808945383,0,3,enone reductase activity,MF,
9889,GO:0035672,1,0.958988434862992,0,6,oligopeptide transmembrane transport,BP,
9890,GO:0035673,1,0.970139940358783,0,4,oligopeptide transmembrane transporter activity,MF,
9892,GO:0035675,1,0.993304539438279,0,1,neuromast hair cell development,BP,
9893,GO:0035684,1,0.996427285923482,0,1,helper T cell extravasation,BP,
9894,GO:0035686,1,0.977446282871513,0,4,sperm fibrous sheath,CC,
9896,GO:0035691,1,0.988263376899949,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9897,GO:0035692,1,0.988225173087174,0,2,macrophage migration inhibitory factor receptor complex,CC,
9898,GO:0035693,1,0.995741883048187,0,1,NOS2-CD74 complex,CC,
9899,GO:0035694,1,0.973222206753802,0,4,mitochondrial protein catabolic process,BP,
9900,GO:0035695,1,0.992491226095675,0,1,mitophagy by induced vacuole formation,BP,
9901,GO:0035696,1,0.978513428435148,0,3,monocyte extravasation,BP,
9902,GO:0035697,1,0.983211106055537,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9903,GO:0035698,1,0.989584284018052,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9904,GO:0035700,1,0.988575159311115,0,2,astrocyte chemotaxis,BP,
9905,GO:0035701,1,0.958893794994596,0,6,hematopoietic stem cell migration,BP,
9906,GO:0035704,1,0.993560428442244,0,1,helper T cell chemotaxis,BP,
9907,GO:0035705,1,0.993560428442244,0,1,T-helper 17 cell chemotaxis,BP,
9908,GO:0035708,1,0.992556991255456,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9909,GO:0035709,1,0.986739758052889,0,2,memory T cell activation,BP,
9910,GO:0035710,1,0.649327942642965,0,66,CD4-positive, alpha-beta T cell activation,BP,
9911,GO:0035711,1,0.988476887506793,0,2,T-helper 1 cell activation,BP,
9912,GO:0035712,1,0.985254043987591,0,2,T-helper 2 cell activation,BP,
9913,GO:0035713,1,0.992556991255456,0,1,response to nitrogen dioxide,BP,
9914,GO:0035715,1,0.993560428442244,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9915,GO:0035716,1,0.993560428442244,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9916,GO:0035717,1,0.986865908481586,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9917,GO:0035718,1,0.991242110069824,0,2,macrophage migration inhibitory factor binding,MF,
9918,GO:0035720,1,0.980140569158276,0,3,intraciliary anterograde transport,BP,
9919,GO:0035721,1,0.923196527833688,0,12,intraciliary retrograde transport,BP,
9920,GO:0035722,1,0.772887987695236,0,44,interleukin-12-mediated signaling pathway,BP,
9921,GO:0035723,1,0.914218212837505,0,13,interleukin-15-mediated signaling pathway,BP,
9922,GO:0035724,1,0.992298692247779,0,1,CD24 biosynthetic process,BP,
9924,GO:0035726,1,0.961919804040035,0,6,common myeloid progenitor cell proliferation,BP,
9925,GO:0035727,1,0.967475570538617,0,5,lysophosphatidic acid binding,MF,
9926,GO:0035728,1,0.904475133787909,0,15,response to hepatocyte growth factor,BP,
9927,GO:0035729,1,0.917157279668971,0,13,cellular response to hepatocyte growth factor stimulus,BP,
9928,GO:0035730,1,0.996191884523064,0,1,S-nitrosoglutathione binding,MF,
9929,GO:0035731,1,0.996191884523064,0,1,dinitrosyl-iron complex binding,MF,
9930,GO:0035732,1,0.996191884523064,0,1,nitric oxide storage,BP,
9931,GO:0035733,1,0.951271563726215,0,7,hepatic stellate cell activation,BP,
9932,GO:0035735,1,0.769584420031469,0,40,intraciliary transport involved in cilium assembly,BP,
9933,GO:0035739,1,0.9641607994104,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9934,GO:0035740,1,0.983661797701465,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9935,GO:0035743,1,0.920944146087019,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9936,GO:0035744,1,0.980794187528261,0,4,T-helper 1 cell cytokine production,BP,
9937,GO:0035745,1,0.941705873941686,0,10,T-helper 2 cell cytokine production,BP,
9938,GO:0035746,1,0.995869041004546,0,1,granzyme A production,BP,
9940,GO:0035748,1,0.957828327695239,0,6,myelin sheath abaxonal region,CC,
9941,GO:0035749,1,0.962450960452824,0,6,myelin sheath adaxonal region,CC,
9942,GO:0035750,1,0.992421667234375,0,1,protein localization to myelin sheath abaxonal region,BP,
9943,GO:0035751,1,0.935664666276763,0,12,regulation of lysosomal lumen pH,BP,
9944,GO:0035752,1,0.99474580729091,0,1,lysosomal lumen pH elevation,BP,
9945,GO:0035754,1,0.954711924768151,0,8,B cell chemotaxis,BP,
9946,GO:0035755,1,0.993431463673407,0,1,cardiolipin hydrolase activity,MF,
9947,GO:0035757,1,0.99421092928736,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9948,GO:0035758,1,0.99421092928736,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9949,GO:0035759,1,0.989506232374757,0,2,mesangial cell-matrix adhesion,BP,
9950,GO:0035766,1,0.96892431530047,0,5,cell chemotaxis to fibroblast growth factor,BP,
9951,GO:0035767,1,0.860683458675274,0,23,endothelial cell chemotaxis,BP,
9952,GO:0035768,1,0.96892431530047,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9953,GO:0035770,1,0.293422798583445,0,187,ribonucleoprotein granule,CC,
9954,GO:0035771,1,0.957245728789134,0,7,interleukin-4-mediated signaling pathway,BP,
9955,GO:0035772,1,0.995021601984253,0,1,interleukin-13-mediated signaling pathway,BP,
9958,GO:0035782,1,0.995869041004546,0,1,mature natural killer cell chemotaxis,BP,
9959,GO:0035783,1,0.992556991255456,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9960,GO:0035787,1,0.971213220644341,0,4,cell migration involved in kidney development,BP,
9961,GO:0035788,1,0.978629760428758,0,3,cell migration involved in metanephros development,BP,
9962,GO:0035789,1,0.978629760428758,0,3,metanephric mesenchymal cell migration,BP,
9963,GO:0035790,1,0.984878032850449,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9964,GO:0035791,1,0.911620779676667,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9965,GO:0035793,1,0.978629760428758,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9966,GO:0035794,1,0.699078915813573,0,59,positive regulation of mitochondrial membrane permeability,BP,
9967,GO:0035795,1,0.974732616137096,0,5,negative regulation of mitochondrial membrane permeability,BP,
9968,GO:0035799,1,0.970703641058442,0,4,ureter maturation,BP,
9969,GO:0035800,1,0.988180845368279,0,2,deubiquitinase activator activity,MF,
9970,GO:0035801,1,0.987843180276574,0,2,adrenal cortex development,BP,
9971,GO:0035802,1,0.987843180276574,0,2,adrenal cortex formation,BP,
9972,GO:0035803,1,0.991210006876943,0,2,egg coat formation,BP,
9973,GO:0035805,1,0.994052343891405,0,1,egg coat,CC,
9974,GO:0035809,1,0.893540409525445,0,18,regulation of urine volume,BP,
9975,GO:0035810,1,0.922451623675498,0,12,positive regulation of urine volume,BP,
9976,GO:0035811,1,0.983637793246736,0,3,negative regulation of urine volume,BP,
9977,GO:0035812,1,0.902955354500345,0,16,renal sodium excretion,BP,
9978,GO:0035813,1,0.902955354500345,0,16,regulation of renal sodium excretion,BP,
9979,GO:0035814,1,0.971650581772515,0,5,negative regulation of renal sodium excretion,BP,
9980,GO:0035815,1,0.942147670772425,0,9,positive regulation of renal sodium excretion,BP,
9982,GO:0035822,1,0.964220695929253,0,5,gene conversion,BP,
9983,GO:0035825,1,0.748424216835554,0,44,homologous recombination,BP,
9984,GO:0035838,1,0.977435754808864,0,3,growing cell tip,CC,
9985,GO:0035841,1,0.98482758994255,0,2,new growing cell tip,CC,
9986,GO:0035844,1,0.974799313168742,0,4,cloaca development,BP,
9987,GO:0035845,1,0.938530779134174,0,9,photoreceptor cell outer segment organization,BP,
9988,GO:0035850,1,0.754491011873741,0,41,epithelial cell differentiation involved in kidney development,BP,
9989,GO:0035851,1,0.992871698300894,0,1,Krueppel-associated box domain binding,MF,
9990,GO:0035853,1,0.992483181132787,0,1,chromosome passenger complex localization to spindle midzone,BP,
9991,GO:0035854,1,0.988127005636861,0,2,eosinophil fate commitment,BP,
9992,GO:0035855,1,0.895968194402205,0,15,megakaryocyte development,BP,
9993,GO:0035859,1,0.917119042482574,0,13,Seh1-associated complex,CC,
9994,GO:0035860,1,0.963146779591604,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9995,GO:0035861,1,0.814007977274769,0,30,site of double-strand break,CC,
9996,GO:0035862,1,0.992364374867111,0,1,dITP metabolic process,BP,
9997,GO:0035863,1,0.992364374867111,0,1,dITP catabolic process,BP,
9998,GO:0035864,1,0.93782422147872,0,10,response to potassium ion,BP,
9999,GO:0035865,1,0.963470937192812,0,6,cellular response to potassium ion,BP,
10000,GO:0035866,1,0.977052101439761,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10001,GO:0035867,1,0.969297451607747,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10002,GO:0035868,1,0.977489802442712,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10003,GO:0035869,1,0.683334483769002,0,58,ciliary transition zone,CC,
10004,GO:0035870,1,0.98841714127293,0,2,dITP diphosphatase activity,MF,
10005,GO:0035871,1,0.940913535211313,0,8,protein K11-linked deubiquitination,BP,
10006,GO:0035872,1,0.794162588191683,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10007,GO:0035873,1,0.959806898708564,0,6,lactate transmembrane transport,BP,
10008,GO:0035877,1,0.976220743220164,0,4,death effector domain binding,MF,
10009,GO:0035878,1,0.948186583603996,0,8,nail development,BP,
10010,GO:0035879,1,0.979611715512345,0,3,plasma membrane lactate transport,BP,
10011,GO:0035880,1,0.981454744382868,0,3,embryonic nail plate morphogenesis,BP,
10012,GO:0035881,1,0.952617004315598,0,7,amacrine cell differentiation,BP,
10013,GO:0035883,1,0.847238872898388,0,25,enteroendocrine cell differentiation,BP,
10014,GO:0035886,1,0.88380392742302,0,19,vascular smooth muscle cell differentiation,BP,
10015,GO:0035887,1,0.995049967525852,0,1,aortic smooth muscle cell differentiation,BP,
10016,GO:0035890,1,0.800603540498938,0,33,exit from host,BP,
10017,GO:0035891,1,0.800603540498938,0,33,exit from host cell,BP,
10018,GO:0035897,1,0.963129458120891,0,6,proteolysis in other organism,BP,
10019,GO:0035898,1,0.980080423184357,0,3,parathyroid hormone secretion,BP,
10020,GO:0035900,1,0.965797338274459,0,6,response to isolation stress,BP,
10021,GO:0035902,1,0.886746528067882,0,19,response to immobilization stress,BP,
10022,GO:0035904,1,0.713803052494102,0,47,aorta development,BP,
10023,GO:0035905,1,0.973951838689678,0,4,ascending aorta development,BP,
10024,GO:0035907,1,0.938261486850433,0,9,dorsal aorta development,BP,
10025,GO:0035909,1,0.808962034520955,0,30,aorta morphogenesis,BP,
10026,GO:0035910,1,0.973951838689678,0,4,ascending aorta morphogenesis,BP,
10027,GO:0035912,1,0.945221593025187,0,8,dorsal aorta morphogenesis,BP,
10028,GO:0035914,1,0.66096102075133,0,61,skeletal muscle cell differentiation,BP,
10029,GO:0035915,1,0.994467065957617,0,1,pore formation in membrane of other organism,BP,
10030,GO:0035921,1,0.994360062471495,0,1,desmosome disassembly,BP,
10031,GO:0035922,1,0.995302833467761,0,1,foramen ovale closure,BP,
10032,GO:0035924,1,0.757257936799283,0,41,cellular response to vascular endothelial growth factor stimulus,BP,
10033,GO:0035925,1,0.919080785768708,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10034,GO:0035926,1,0.96547737726147,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
10035,GO:0035927,1,0.977420387905638,0,4,RNA import into mitochondrion,BP,
10036,GO:0035928,1,0.984715754729863,0,3,rRNA import into mitochondrion,BP,
10037,GO:0035929,1,0.900457392756627,0,18,steroid hormone secretion,BP,
10038,GO:0035930,1,0.927710034791463,0,13,corticosteroid hormone secretion,BP,
10039,GO:0035931,1,0.973526778431485,0,4,mineralocorticoid secretion,BP,
10040,GO:0035932,1,0.973526778431485,0,4,aldosterone secretion,BP,
10041,GO:0035933,1,0.952949940411683,0,9,glucocorticoid secretion,BP,
10042,GO:0035934,1,0.981151511500507,0,4,corticosterone secretion,BP,
10043,GO:0035935,1,0.992640748193215,0,1,androgen secretion,BP,
10044,GO:0035936,1,0.984965815854361,0,2,testosterone secretion,BP,
10045,GO:0035938,1,0.980273187052757,0,3,estradiol secretion,BP,
10046,GO:0035939,1,0.97984811537135,0,3,microsatellite binding,MF,
10047,GO:0035945,1,0.993589918707245,0,1,mitochondrial ncRNA surveillance,BP,
10048,GO:0035946,1,0.993589918707245,0,1,mitochondrial mRNA surveillance,BP,
10049,GO:0035947,1,0.9639719531874,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10050,GO:0035948,1,0.978099511782443,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10051,GO:0035962,1,0.980889276849118,0,3,response to interleukin-13,BP,
10052,GO:0035963,1,0.980889276849118,0,3,cellular response to interleukin-13,BP,
10053,GO:0035964,1,0.961611368978511,0,6,COPI-coated vesicle budding,BP,
10054,GO:0035965,1,0.967561358436601,0,5,cardiolipin acyl-chain remodeling,BP,
10055,GO:0035966,1,0.298334889075861,0,188,response to topologically incorrect protein,BP,
10056,GO:0035967,1,0.362252894484462,0,156,cellular response to topologically incorrect protein,BP,
10057,GO:0035970,1,0.901135175452785,0,16,peptidyl-threonine dephosphorylation,BP,
10058,GO:0035971,1,0.995869041004546,0,1,peptidyl-histidine dephosphorylation,BP,
10059,GO:0035973,1,0.951801247660728,0,7,aggrephagy,BP,
10060,GO:0035976,1,0.973144019359376,0,5,transcription factor AP-1 complex,CC,
10061,GO:0035977,1,0.972818972056336,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10062,GO:0035978,1,0.993036377919383,0,1,histone H2A-S139 phosphorylation,BP,
10063,GO:0035981,1,0.9879202738662,0,2,tongue muscle cell differentiation,BP,
10064,GO:0035983,1,0.973228770821392,0,4,response to trichostatin A,BP,
10065,GO:0035984,1,0.973228770821392,0,4,cellular response to trichostatin A,BP,
10066,GO:0035985,1,0.978649774025185,0,4,senescence-associated heterochromatin focus,CC,
10067,GO:0035986,1,0.983676870614213,0,3,senescence-associated heterochromatin focus assembly,BP,
10068,GO:0035987,1,0.734967502112164,0,45,endodermal cell differentiation,BP,
10069,GO:0035988,1,0.910902401569435,0,14,chondrocyte proliferation,BP,
10070,GO:0035989,1,0.970014097552726,0,5,tendon development,BP,
10071,GO:0035990,1,0.985315990682319,0,3,tendon cell differentiation,BP,
10072,GO:0035992,1,0.985315990682319,0,3,tendon formation,BP,
10073,GO:0035993,1,0.989085098971849,0,2,deltoid tuberosity development,BP,
10074,GO:0035994,1,0.893557541957186,0,17,response to muscle stretch,BP,
10075,GO:0035995,1,0.986374005050286,0,2,detection of muscle stretch,BP,
10076,GO:0035998,1,0.99464861929238,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10077,GO:0035999,1,0.946541738391227,0,9,tetrahydrofolate interconversion,BP,
10079,GO:0036003,1,0.854325191042793,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10080,GO:0036004,1,0.995851679006923,0,1,GAF domain binding,MF,
10081,GO:0036005,1,0.948399233191244,0,8,response to macrophage colony-stimulating factor,BP,
10082,GO:0036006,1,0.948399233191244,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10083,GO:0036009,1,0.995937198802247,0,1,protein-glutamine N-methyltransferase activity,MF,
10084,GO:0036010,1,0.876966903318142,0,18,protein localization to endosome,BP,
10085,GO:0036015,1,0.975868174654528,0,4,response to interleukin-3,BP,
10086,GO:0036016,1,0.975868174654528,0,4,cellular response to interleukin-3,BP,
10087,GO:0036017,1,0.968977226951394,0,7,response to erythropoietin,BP,
10088,GO:0036018,1,0.972148913467826,0,6,cellular response to erythropoietin,BP,
10089,GO:0036019,1,0.879054758851452,0,19,endolysosome,CC,
10090,GO:0036020,1,0.908133561661661,0,14,endolysosome membrane,CC,
10091,GO:0036021,1,0.968010554904071,0,5,endolysosome lumen,CC,
10092,GO:0036022,1,0.982347320222272,0,3,limb joint morphogenesis,BP,
10093,GO:0036023,1,0.982347320222272,0,3,embryonic skeletal limb joint morphogenesis,BP,
10094,GO:0036024,1,0.993919811159171,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10095,GO:0036025,1,0.993919811159171,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10096,GO:0036026,1,0.993919811159171,0,1,protein C inhibitor-PLAT complex,CC,
10097,GO:0036027,1,0.993919811159171,0,1,protein C inhibitor-PLAU complex,CC,
10098,GO:0036028,1,0.993919811159171,0,1,protein C inhibitor-thrombin complex,CC,
10099,GO:0036029,1,0.993919811159171,0,1,protein C inhibitor-KLK3 complex,CC,
10100,GO:0036030,1,0.993919811159171,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10101,GO:0036033,1,0.969121877407459,0,4,mediator complex binding,MF,
10102,GO:0036034,1,0.987148444839421,0,2,mediator complex assembly,BP,
10103,GO:0036035,1,0.896126634209803,0,16,osteoclast development,BP,
10104,GO:0036037,1,0.92043511451854,0,13,CD8-positive, alpha-beta T cell activation,BP,
10105,GO:0036038,1,0.926761022691112,0,13,MKS complex,CC,
10106,GO:0036041,1,0.957377098377968,0,9,long-chain fatty acid binding,MF,
10107,GO:0036042,1,0.980634086016907,0,4,long-chain fatty acyl-CoA binding,MF,
10108,GO:0036046,1,0.992717755137753,0,1,protein demalonylation,BP,
10109,GO:0036047,1,0.992717755137753,0,1,peptidyl-lysine demalonylation,BP,
10110,GO:0036048,1,0.992717755137753,0,1,protein desuccinylation,BP,
10111,GO:0036049,1,0.992717755137753,0,1,peptidyl-lysine desuccinylation,BP,
10112,GO:0036053,1,0.993194769652385,0,1,glomerular endothelium fenestra,CC,
10113,GO:0036054,1,0.992717755137753,0,1,protein-malonyllysine demalonylase activity,MF,
10114,GO:0036055,1,0.992717755137753,0,1,protein-succinyllysine desuccinylase activity,MF,
10115,GO:0036056,1,0.948631795980549,0,7,filtration diaphragm,CC,
10116,GO:0036057,1,0.948631795980549,0,7,slit diaphragm,CC,
10117,GO:0036058,1,0.992499605138544,0,1,filtration diaphragm assembly,BP,
10118,GO:0036060,1,0.992499605138544,0,1,slit diaphragm assembly,BP,
10119,GO:0036064,1,0.5033706483677,0,101,ciliary basal body,CC,
10120,GO:0036065,1,0.842793205674476,0,25,fucosylation,BP,
10121,GO:0036066,1,0.909106285058353,0,14,protein O-linked fucosylation,BP,
10122,GO:0036071,1,0.99263407243923,0,1,N-glycan fucosylation,BP,
10123,GO:0036072,1,0.960868114701274,0,6,direct ossification,BP,
10124,GO:0036075,1,0.843188144991895,0,25,replacement ossification,BP,
10125,GO:0036080,1,0.985030220946446,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10126,GO:0036085,1,0.992678210028626,0,1,GDP-fucose import into Golgi lumen,BP,
10127,GO:0036088,1,0.995300329559495,0,1,D-serine catabolic process,BP,
10128,GO:0036089,1,0.954140921850671,0,7,cleavage furrow formation,BP,
10129,GO:0036090,1,0.989070876678273,0,2,cleavage furrow ingression,BP,
10130,GO:0036091,1,0.969772633147367,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10131,GO:0036092,1,0.733502399821572,0,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10132,GO:0036093,1,0.968682899795352,0,6,germ cell proliferation,BP,
10134,GO:0036100,1,0.987953609368482,0,2,leukotriene catabolic process,BP,
10135,GO:0036101,1,0.987953609368482,0,2,leukotriene B4 catabolic process,BP,
10136,GO:0036102,1,0.987953609368482,0,2,leukotriene B4 metabolic process,BP,
10137,GO:0036105,1,0.992528902940077,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10138,GO:0036109,1,0.925618982416701,0,12,alpha-linolenic acid metabolic process,BP,
10139,GO:0036111,1,0.993234101134144,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10140,GO:0036112,1,0.981630964664114,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10141,GO:0036114,1,0.995415591911866,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10142,GO:0036115,1,0.995415591911866,0,1,fatty-acyl-CoA catabolic process,BP,
10143,GO:0036116,1,0.995415591911866,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10144,GO:0036117,1,0.987859832834794,0,2,hyaluranon cable,CC,
10145,GO:0036118,1,0.980449521073103,0,3,hyaluranon cable assembly,BP,
10146,GO:0036119,1,0.863297099549947,0,21,response to platelet-derived growth factor,BP,
10147,GO:0036120,1,0.86949862825155,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10148,GO:0036122,1,0.946094184402728,0,9,BMP binding,MF,
10149,GO:0036123,1,0.963523483924117,0,6,histone H3-K9 dimethylation,BP,
10150,GO:0036124,1,0.905779048310176,0,14,histone H3-K9 trimethylation,BP,
10151,GO:0036125,1,0.992796358704659,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10152,GO:0036126,1,0.684952940238407,0,61,sperm flagellum,CC,
10153,GO:0036128,1,0.962485170667271,0,6,CatSper complex,CC,
10154,GO:0036130,1,0.995861044061941,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10155,GO:0036131,1,0.995861044061941,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10156,GO:0036132,1,0.981805770393807,0,3,13-prostaglandin reductase activity,MF,
10157,GO:0036134,1,0.994326357179665,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10158,GO:0036135,1,0.985410554102684,0,2,Schwann cell migration,BP,
10159,GO:0036137,1,0.987784741083347,0,2,kynurenine aminotransferase activity,MF,
10160,GO:0036138,1,0.992288085650284,0,1,peptidyl-histidine hydroxylation,BP,
10161,GO:0036139,1,0.992288085650284,0,1,peptidyl-histidine dioxygenase activity,MF,
10162,GO:0036140,1,0.992288085650284,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10163,GO:0036143,1,0.996314907465142,0,1,kringle domain binding,MF,
10164,GO:0036145,1,0.994982750011379,0,1,dendritic cell homeostasis,BP,
10165,GO:0036146,1,0.966677720820828,0,5,cellular response to mycotoxin,BP,
10166,GO:0036148,1,0.916571719648506,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10167,GO:0036149,1,0.941478834853017,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10168,GO:0036150,1,0.908853136096246,0,15,phosphatidylserine acyl-chain remodeling,BP,
10169,GO:0036151,1,0.875930619791437,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10170,GO:0036152,1,0.884955556744505,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10171,GO:0036153,1,0.993062166357861,0,1,triglyceride acyl-chain remodeling,BP,
10172,GO:0036155,1,0.966559848661856,0,5,acylglycerol acyl-chain remodeling,BP,
10173,GO:0036156,1,0.968000836229273,0,4,inner dynein arm,CC,
10174,GO:0036157,1,0.943505255205213,0,9,outer dynein arm,CC,
10175,GO:0036158,1,0.902106185430155,0,16,outer dynein arm assembly,BP,
10176,GO:0036159,1,0.910651676441261,0,14,inner dynein arm assembly,BP,
10177,GO:0036164,1,0.996024569208464,0,1,cell-abiotic substrate adhesion,BP,
10178,GO:0036166,1,0.972610249319539,0,4,phenotypic switching,BP,
10179,GO:0036179,1,0.993136144703322,0,1,osteoclast maturation,BP,
10180,GO:0036194,1,0.986225061595587,0,3,muscle cell projection,CC,
10181,GO:0036195,1,0.986225061595587,0,3,muscle cell projection membrane,CC,
10183,GO:0036213,1,0.994186446320444,0,1,contractile ring contraction,BP,
10184,GO:0036215,1,0.985367675293364,0,2,response to stem cell factor,BP,
10185,GO:0036216,1,0.985367675293364,0,2,cellular response to stem cell factor stimulus,BP,
10186,GO:0036219,1,0.996458096886506,0,1,GTP diphosphatase activity,MF,
10187,GO:0036220,1,0.99602270581164,0,1,ITP diphosphatase activity,MF,
10188,GO:0036222,1,0.99602270581164,0,1,XTP diphosphatase activity,MF,
10189,GO:0036228,1,0.986363957121616,0,2,protein localization to nuclear inner membrane,BP,
10191,GO:0036245,1,0.987991853575749,0,2,cellular response to menadione,BP,
10192,GO:0036250,1,0.994699377532294,0,1,peroxisome transport along microtubule,BP,
10193,GO:0036255,1,0.992506314483297,0,1,response to methylamine,BP,
10194,GO:0036257,1,0.827321005962464,0,31,multivesicular body organization,BP,
10195,GO:0036258,1,0.833104365974444,0,30,multivesicular body assembly,BP,
10196,GO:0036260,1,0.83007189783656,0,32,RNA capping,BP,
10197,GO:0036261,1,0.992517228918941,0,1,7-methylguanosine cap hypermethylation,BP,
10198,GO:0036265,1,0.979861689159021,0,4,RNA (guanine-N7)-methylation,BP,
10199,GO:0036266,1,0.993469296531821,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10200,GO:0036269,1,0.98772924755407,0,2,swimming behavior,BP,
10201,GO:0036270,1,0.883441329881431,0,18,response to diuretic,BP,
10202,GO:0036284,1,0.9877200670867,0,2,tubulobulbar complex,CC,
10203,GO:0036289,1,0.951385803967455,0,7,peptidyl-serine autophosphorylation,BP,
10204,GO:0036290,1,0.992499787811949,0,1,protein trans-autophosphorylation,BP,
10205,GO:0036292,1,0.988154584024193,0,2,DNA rewinding,BP,
10206,GO:0036293,1,0.121616609835407,0,331,response to decreased oxygen levels,BP,
10207,GO:0036294,1,0.306357321487486,0,189,cellular response to decreased oxygen levels,BP,
10208,GO:0036295,1,0.922135116811163,0,13,cellular response to increased oxygen levels,BP,
10209,GO:0036296,1,0.846018302943184,0,27,response to increased oxygen levels,BP,
10210,GO:0036297,1,0.745808419026263,0,44,interstrand cross-link repair,BP,
10211,GO:0036301,1,0.966821628729009,0,5,macrophage colony-stimulating factor production,BP,
10212,GO:0036302,1,0.949269678326598,0,7,atrioventricular canal development,BP,
10213,GO:0036303,1,0.881266086937087,0,18,lymph vessel morphogenesis,BP,
10214,GO:0036304,1,0.987255805993375,0,2,umbilical cord morphogenesis,BP,
10215,GO:0036306,1,0.995302833467761,0,1,embryonic heart tube elongation,BP,
10216,GO:0036309,1,0.983482693174826,0,2,protein localization to M-band,BP,
10217,GO:0036310,1,0.945157955618591,0,8,annealing helicase activity,MF,
10218,GO:0036312,1,0.940795535607492,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10219,GO:0036313,1,0.993685697734458,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10220,GO:0036314,1,0.846564379190329,0,23,response to sterol,BP,
10221,GO:0036315,1,0.895390243960359,0,15,cellular response to sterol,BP,
10222,GO:0036316,1,0.993198575377995,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10223,GO:0036317,1,0.9930956730518,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10224,GO:0036323,1,0.992468430778302,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10225,GO:0036324,1,0.988491223741306,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10226,GO:0036326,1,0.992468430778302,0,1,VEGF-A-activated receptor activity,MF,
10227,GO:0036327,1,0.992468430778302,0,1,VEGF-B-activated receptor activity,MF,
10228,GO:0036328,1,0.992434893288302,0,1,VEGF-C-activated receptor activity,MF,
10229,GO:0036332,1,0.992468430778302,0,1,placental growth factor-activated receptor activity,MF,
10230,GO:0036333,1,0.993326771744696,0,1,hepatocyte homeostasis,BP,
10231,GO:0036335,1,0.992430576624328,0,1,intestinal stem cell homeostasis,BP,
10232,GO:0036336,1,0.848995794850895,0,26,dendritic cell migration,BP,
10233,GO:0036337,1,0.972319007578327,0,4,Fas signaling pathway,BP,
10234,GO:0036342,1,0.906796033303983,0,15,post-anal tail morphogenesis,BP,
10235,GO:0036343,1,0.978888090148233,0,4,psychomotor behavior,BP,
10236,GO:0036344,1,0.883571851218027,0,19,platelet morphogenesis,BP,
10237,GO:0036345,1,0.988109107998674,0,2,platelet maturation,BP,
10238,GO:0036351,1,0.993913838322188,0,1,histone H2A-K13 ubiquitination,BP,
10239,GO:0036352,1,0.993913838322188,0,1,histone H2A-K15 ubiquitination,BP,
10240,GO:0036353,1,0.953738022633888,0,7,histone H2A-K119 monoubiquitination,BP,
10241,GO:0036361,1,0.993597334811366,0,1,racemase activity, acting on amino acids and derivatives,MF,
10242,GO:0036363,1,0.986005650099638,0,2,transforming growth factor beta activation,BP,
10243,GO:0036367,1,0.993441960566051,0,1,light adaption,BP,
10244,GO:0036369,1,0.984531840775389,0,2,transcription factor catabolic process,BP,
10245,GO:0036371,1,0.992186978032181,0,1,protein localization to T-tubule,BP,
10246,GO:0036372,1,0.996173397837253,0,1,opsin transport,BP,
10247,GO:0036374,1,0.980800648325782,0,3,glutathione hydrolase activity,MF,
10248,GO:0036376,1,0.912805179176736,0,14,sodium ion export across plasma membrane,BP,
10249,GO:0036378,1,0.9888821865613,0,2,calcitriol biosynthetic process from calciol,BP,
10250,GO:0036379,1,0.833446990163399,0,30,myofilament,CC,
10251,GO:0036387,1,0.983271255446626,0,3,pre-replicative complex,CC,
10252,GO:0036388,1,0.983271255446626,0,3,pre-replicative complex assembly,BP,
10253,GO:0036392,1,0.992515370007935,0,1,chemokine (C-C motif) ligand 20 production,BP,
10254,GO:0036393,1,0.992952109810685,0,1,thiocyanate peroxidase activity,MF,
10255,GO:0036396,1,0.984132190490174,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10256,GO:0036398,1,0.986360945301976,0,2,TCR signalosome,CC,
10257,GO:0036399,1,0.992638670220271,0,1,TCR signalosome assembly,BP,
10258,GO:0036402,1,0.973010585534951,0,6,proteasome-activating ATPase activity,MF,
10259,GO:0036403,1,0.993337575931577,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10260,GO:0036404,1,0.992015039827887,0,1,conversion of ds siRNA to ss siRNA,BP,
10261,GO:0036413,1,0.986526991231919,0,2,histone H3-R26 citrullination,BP,
10262,GO:0036414,1,0.979311479796522,0,3,histone citrullination,BP,
10263,GO:0036435,1,0.988308094372616,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10264,GO:0036438,1,0.973179641720146,0,4,maintenance of lens transparency,BP,
10265,GO:0036440,1,0.992860644241066,0,1,citrate synthase activity,MF,
10266,GO:0036442,1,0.849072911019255,0,27,proton-exporting ATPase activity,MF,
10267,GO:0036444,1,0.944619579513055,0,8,calcium import into the mitochondrion,BP,
10268,GO:0036445,1,0.909057824725373,0,13,neuronal stem cell division,BP,
10269,GO:0036446,1,0.977595276254827,0,3,myofibroblast differentiation,BP,
10270,GO:0036449,1,0.948359647052451,0,7,microtubule minus-end,CC,
10271,GO:0036451,1,0.986238532970005,0,2,cap mRNA methylation,BP,
10272,GO:0036452,1,0.843004836339985,0,28,ESCRT complex,CC,
10273,GO:0036454,1,0.96892087749538,0,5,growth factor complex,CC,
10274,GO:0036455,1,0.995993936222627,0,1,iron-sulfur transferase activity,MF,
10275,GO:0036458,1,0.994159949389673,0,1,hepatocyte growth factor binding,MF,
10276,GO:0036459,1,0.538755809250627,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10277,GO:0036461,1,0.991519579287373,0,2,BLOC-2 complex binding,MF,
10278,GO:0036462,1,0.959233644640778,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10279,GO:0036464,1,0.311760501472279,0,178,cytoplasmic ribonucleoprotein granule,CC,
10281,GO:0036466,1,0.984998894178571,0,2,synaptic vesicle recycling via endosome,BP,
10282,GO:0036468,1,0.99451374769836,0,1,L-dopa decarboxylase activity,MF,
10283,GO:0036470,1,0.99622159485821,0,1,tyrosine 3-monooxygenase activator activity,MF,
10284,GO:0036471,1,0.99622159485821,0,1,cellular response to glyoxal,BP,
10285,GO:0036473,1,0.62267880632916,0,73,cell death in response to oxidative stress,BP,
10286,GO:0036474,1,0.848835099859685,0,26,cell death in response to hydrogen peroxide,BP,
10287,GO:0036475,1,0.867198554149461,0,21,neuron death in response to oxidative stress,BP,
10288,GO:0036476,1,0.977369294577486,0,4,neuron death in response to hydrogen peroxide,BP,
10290,GO:0036478,1,0.99622159485821,0,1,L-dopa decarboxylase activator activity,MF,
10291,GO:0036479,1,0.992094053059202,0,1,peroxidase inhibitor activity,MF,
10292,GO:0036480,1,0.953240502489927,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10293,GO:0036481,1,0.9664512694224,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10294,GO:0036482,1,0.989526899231931,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10295,GO:0036483,1,0.992479185176651,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10296,GO:0036484,1,0.978682291640386,0,3,trunk neural crest cell migration,BP,
10297,GO:0036486,1,0.978682291640386,0,3,ventral trunk neural crest cell migration,BP,
10298,GO:0036487,1,0.992129025827869,0,1,nitric-oxide synthase inhibitor activity,MF,
10299,GO:0036488,1,0.991153383038512,0,2,CHOP-C/EBP complex,CC,
10300,GO:0036490,1,0.946034481709779,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10301,GO:0036491,1,0.95313184554233,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10302,GO:0036492,1,0.959092480859537,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10303,GO:0036493,1,0.981194120933553,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10304,GO:0036494,1,0.992402822174554,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10305,GO:0036496,1,0.989322972904273,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10306,GO:0036497,1,0.993787769364138,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10307,GO:0036498,1,0.644658883540776,0,67,IRE1-mediated unfolded protein response,BP,
10308,GO:0036499,1,0.884307042460016,0,20,PERK-mediated unfolded protein response,BP,
10309,GO:0036500,1,0.937691629068759,0,10,ATF6-mediated unfolded protein response,BP,
10310,GO:0036501,1,0.992487668761665,0,1,UFD1-NPL4 complex,CC,
10311,GO:0036502,1,0.992729965791436,0,1,Derlin-1-VIMP complex,CC,
10312,GO:0036503,1,0.56190949901492,0,89,ERAD pathway,BP,
10313,GO:0036505,1,0.986579074579665,0,2,prosaposin receptor activity,MF,
10314,GO:0036506,1,0.979800295265595,0,3,maintenance of unfolded protein,BP,
10315,GO:0036507,1,0.850830656877178,0,24,protein demannosylation,BP,
10316,GO:0036508,1,0.850830656877178,0,24,protein alpha-1,2-demannosylation,BP,
10317,GO:0036509,1,0.987913986896509,0,2,trimming of terminal mannose on B branch,BP,
10318,GO:0036510,1,0.980358421419555,0,3,trimming of terminal mannose on C branch,BP,
10319,GO:0036511,1,0.987913986896509,0,2,trimming of first mannose on A branch,BP,
10320,GO:0036512,1,0.987913986896509,0,2,trimming of second mannose on A branch,BP,
10321,GO:0036513,1,0.929589221575613,0,11,Derlin-1 retrotranslocation complex,CC,
10322,GO:0036514,1,0.962654564413664,0,5,dopaminergic neuron axon guidance,BP,
10323,GO:0036515,1,0.969542218472631,0,4,serotonergic neuron axon guidance,BP,
10324,GO:0036517,1,0.992381002025962,0,1,chemoattraction of serotonergic neuron axon,BP,
10325,GO:0036518,1,0.985332767996722,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10326,GO:0036524,1,0.99622159485821,0,1,protein deglycase activity,MF,
10327,GO:0036525,1,0.99622159485821,0,1,protein deglycation,BP,
10328,GO:0036526,1,0.99622159485821,0,1,peptidyl-cysteine deglycation,BP,
10329,GO:0036527,1,0.99622159485821,0,1,peptidyl-arginine deglycation,BP,
10330,GO:0036528,1,0.99622159485821,0,1,peptidyl-lysine deglycation,BP,
10331,GO:0036529,1,0.99622159485821,0,1,protein deglycation, glyoxal removal,BP,
10332,GO:0036530,1,0.99622159485821,0,1,protein deglycation, methylglyoxal removal,BP,
10333,GO:0036531,1,0.99622159485821,0,1,glutathione deglycation,BP,
10334,GO:0038001,1,0.978135994257235,0,3,paracrine signaling,BP,
10335,GO:0038002,1,0.992422210100083,0,1,endocrine signaling,BP,
10337,GO:0038007,1,0.948267645323377,0,7,netrin-activated signaling pathway,BP,
10338,GO:0038016,1,0.986516553246626,0,2,insulin receptor internalization,BP,
10339,GO:0038018,1,0.984856041714099,0,2,Wnt receptor catabolic process,BP,
10340,GO:0038021,1,0.99249290984952,0,1,leptin receptor activity,MF,
10342,GO:0038024,1,0.579396213021523,0,80,cargo receptor activity,MF,
10343,GO:0038025,1,0.985080213079643,0,2,reelin receptor activity,MF,
10344,GO:0038026,1,0.969765008738151,0,4,reelin-mediated signaling pathway,BP,
10345,GO:0038027,1,0.964268027306951,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10346,GO:0038028,1,0.97124023079958,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10347,GO:0038030,1,0.951392660865823,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10348,GO:0038031,1,0.958582341882796,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10349,GO:0038033,1,0.966778961982952,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10350,GO:0038034,1,0.65811798493479,0,67,signal transduction in absence of ligand,BP,
10351,GO:0038036,1,0.950994644881321,0,8,sphingosine-1-phosphate receptor activity,MF,
10352,GO:0038037,1,0.951518531988809,0,8,G-protein coupled receptor dimeric complex,CC,
10353,GO:0038038,1,0.992289191531084,0,1,G-protein coupled receptor homodimeric complex,CC,
10354,GO:0038039,1,0.984929595595675,0,2,G-protein coupled receptor heterodimeric complex,CC,
10355,GO:0038042,1,0.961776876092734,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10356,GO:0038043,1,0.987012804226354,0,2,interleukin-5-mediated signaling pathway,BP,
10357,GO:0038044,1,0.964134815799983,0,5,transforming growth factor-beta secretion,BP,
10358,GO:0038046,1,0.994999459268022,0,1,enkephalin receptor activity,MF,
10359,GO:0038047,1,0.994822986656738,0,1,morphine receptor activity,MF,
10360,GO:0038048,1,0.99245373618402,0,1,dynorphin receptor activity,MF,
10361,GO:0038049,1,0.98429975228441,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10362,GO:0038051,1,0.992313446012772,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10363,GO:0038052,1,0.98602361125435,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10366,GO:0038062,1,0.985240486457758,0,2,protein tyrosine kinase collagen receptor activity,MF,
10367,GO:0038063,1,0.933515859954211,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10368,GO:0038064,1,0.970176735819955,0,4,collagen receptor activity,MF,
10369,GO:0038065,1,0.919235160438212,0,11,collagen-activated signaling pathway,BP,
10370,GO:0038066,1,0.785404247403617,0,37,p38MAPK cascade,BP,
10371,GO:0038083,1,0.694203258612247,0,52,peptidyl-tyrosine autophosphorylation,BP,
10372,GO:0038084,1,0.839644075354961,0,25,vascular endothelial growth factor signaling pathway,BP,
10373,GO:0038085,1,0.966496204953818,0,5,vascular endothelial growth factor binding,MF,
10374,GO:0038086,1,0.97742517431527,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10375,GO:0038089,1,0.952014285353302,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10376,GO:0038091,1,0.97742517431527,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10377,GO:0038092,1,0.918761566568355,0,14,nodal signaling pathway,BP,
10378,GO:0038093,1,0.327637822486572,0,178,Fc receptor signaling pathway,BP,
10379,GO:0038094,1,0.613797152071029,0,74,Fc-gamma receptor signaling pathway,BP,
10380,GO:0038095,1,0.483974358338454,0,118,Fc-epsilon receptor signaling pathway,BP,
10381,GO:0038096,1,0.625963229058308,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10382,GO:0038097,1,0.992426276080992,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10383,GO:0038098,1,0.987018079126572,0,2,sequestering of BMP from receptor via BMP binding,BP,
10384,GO:0038100,1,0.986803120176043,0,2,nodal binding,MF,
10385,GO:0038101,1,0.995078068725704,0,1,sequestering of nodal from receptor via nodal binding,BP,
10386,GO:0038107,1,0.962469832911325,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10387,GO:0038108,1,0.972836394231455,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10388,GO:0038109,1,0.985367675293364,0,2,Kit signaling pathway,BP,
10389,GO:0038110,1,0.925650880251533,0,11,interleukin-2-mediated signaling pathway,BP,
10390,GO:0038111,1,0.892476985244975,0,18,interleukin-7-mediated signaling pathway,BP,
10391,GO:0038112,1,0.986764403901618,0,2,interleukin-8-mediated signaling pathway,BP,
10392,GO:0038113,1,0.980390182371828,0,3,interleukin-9-mediated signaling pathway,BP,
10393,GO:0038114,1,0.952006693583428,0,7,interleukin-21-mediated signaling pathway,BP,
10394,GO:0038115,1,0.99421092928736,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10395,GO:0038116,1,0.99421092928736,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10396,GO:0038117,1,0.99421092928736,0,1,C-C motif chemokine 19 receptor activity,MF,
10397,GO:0038118,1,0.996083383182969,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10398,GO:0038121,1,0.99421092928736,0,1,C-C motif chemokine 21 receptor activity,MF,
10399,GO:0038123,1,0.981036279425905,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10400,GO:0038124,1,0.974927505545415,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10402,GO:0038128,1,0.775801411193274,0,38,ERBB2 signaling pathway,BP,
10403,GO:0038129,1,0.98203208793165,0,3,ERBB3 signaling pathway,BP,
10404,GO:0038131,1,0.9873995990426,0,2,neuregulin receptor activity,MF,
10405,GO:0038132,1,0.962716595873158,0,5,neuregulin binding,MF,
10406,GO:0038133,1,0.994472147266652,0,1,ERBB2-ERBB3 signaling pathway,BP,
10407,GO:0038145,1,0.969589764841123,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10408,GO:0038154,1,0.992686954287854,0,1,interleukin-11-mediated signaling pathway,BP,
10409,GO:0038155,1,0.955425422869989,0,7,interleukin-23-mediated signaling pathway,BP,
10410,GO:0038156,1,0.99246113266151,0,1,interleukin-3-mediated signaling pathway,BP,
10411,GO:0038158,1,0.987809212348582,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10412,GO:0038161,1,0.985050403855671,0,2,prolactin signaling pathway,BP,
10413,GO:0038162,1,0.983099541811517,0,3,erythropoietin-mediated signaling pathway,BP,
10414,GO:0038163,1,0.983714114773923,0,3,thrombopoietin-mediated signaling pathway,BP,
10415,GO:0038164,1,0.992523424579651,0,1,thrombopoietin receptor activity,MF,
10416,GO:0038165,1,0.972351332047733,0,4,oncostatin-M-mediated signaling pathway,BP,
10418,GO:0038167,1,0.992422126633666,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10419,GO:0038168,1,0.992422126633666,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10420,GO:0038169,1,0.976199681481833,0,4,somatostatin receptor signaling pathway,BP,
10421,GO:0038170,1,0.976199681481833,0,4,somatostatin signaling pathway,BP,
10423,GO:0038172,1,0.979921301473,0,3,interleukin-33-mediated signaling pathway,BP,
10424,GO:0038178,1,0.987007765421829,0,2,complement component C5a signaling pathway,BP,
10425,GO:0038179,1,0.792423456383865,0,35,neurotrophin signaling pathway,BP,
10426,GO:0038180,1,0.927888186444228,0,12,nerve growth factor signaling pathway,BP,
10427,GO:0038181,1,0.9823003827244,0,3,bile acid receptor activity,MF,
10428,GO:0038182,1,0.99547649485031,0,1,G-protein coupled bile acid receptor activity,MF,
10429,GO:0038183,1,0.9823003827244,0,3,bile acid signaling pathway,BP,
10430,GO:0038184,1,0.99547649485031,0,1,cell surface bile acid receptor signaling pathway,BP,
10431,GO:0038185,1,0.994251771467272,0,1,intracellular bile acid receptor signaling pathway,BP,
10432,GO:0038186,1,0.992470006950484,0,1,lithocholic acid receptor activity,MF,
10433,GO:0038187,1,0.918337323465975,0,14,pattern recognition receptor activity,MF,
10434,GO:0038188,1,0.98950199718318,0,2,cholecystokinin signaling pathway,BP,
10435,GO:0038189,1,0.973021782499881,0,4,neuropilin signaling pathway,BP,
10436,GO:0038190,1,0.986184313975938,0,2,VEGF-activated neuropilin signaling pathway,BP,
10437,GO:0038191,1,0.866151582779693,0,19,neuropilin binding,MF,
10438,GO:0038192,1,0.994488396173548,0,1,gastric inhibitory peptide signaling pathway,BP,
10439,GO:0038193,1,0.994006942278645,0,1,thromboxane A2 signaling pathway,BP,
10440,GO:0038194,1,0.988369229713915,0,2,thyroid-stimulating hormone signaling pathway,BP,
10441,GO:0038195,1,0.99555805783233,0,1,urokinase plasminogen activator signaling pathway,BP,
10442,GO:0038201,1,0.899068781645346,0,16,TOR complex,CC,
10443,GO:0038202,1,0.810980879146555,0,32,TORC1 signaling,BP,
10444,GO:0038203,1,0.953955320812368,0,7,TORC2 signaling,BP,
10445,GO:0039003,1,0.985057492417239,0,2,pronephric field specification,BP,
10446,GO:0039007,1,0.992405804698064,0,1,pronephric nephron morphogenesis,BP,
10447,GO:0039008,1,0.992405804698064,0,1,pronephric nephron tubule morphogenesis,BP,
10448,GO:0039017,1,0.985057492417239,0,2,pattern specification involved in pronephros development,BP,
10449,GO:0039019,1,0.984986772583971,0,2,pronephric nephron development,BP,
10450,GO:0039020,1,0.992405804698064,0,1,pronephric nephron tubule development,BP,
10451,GO:0039022,1,0.992405804698064,0,1,pronephric duct development,BP,
10452,GO:0039023,1,0.992405804698064,0,1,pronephric duct morphogenesis,BP,
10453,GO:0039502,1,0.992434292396331,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10454,GO:0039503,1,0.992434292396331,0,1,suppression by virus of host innate immune response,BP,
10455,GO:0039506,1,0.985614681611557,0,2,modulation by virus of host molecular function,BP,
10456,GO:0039507,1,0.985614681611557,0,2,suppression by virus of host molecular function,BP,
10457,GO:0039513,1,0.993128930994008,0,1,suppression by virus of host catalytic activity,BP,
10458,GO:0039514,1,0.992434292396331,0,1,suppression by virus of host JAK-STAT cascade,BP,
10459,GO:0039516,1,0.993128930994008,0,1,modulation by virus of host catalytic activity,BP,
10460,GO:0039519,1,0.984915525713995,0,2,modulation by virus of host autophagy,BP,
10461,GO:0039520,1,0.992406365285257,0,1,induction by virus of host autophagy,BP,
10462,GO:0039521,1,0.992452426779513,0,1,suppression by virus of host autophagy,BP,
10463,GO:0039526,1,0.982887956856832,0,3,modulation by virus of host apoptotic process,BP,
10464,GO:0039528,1,0.870619796244753,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10465,GO:0039529,1,0.897829540432305,0,15,RIG-I signaling pathway,BP,
10466,GO:0039530,1,0.949821892241852,0,8,MDA-5 signaling pathway,BP,
10467,GO:0039531,1,0.899576913746679,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10468,GO:0039532,1,0.941879071197879,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10469,GO:0039533,1,0.966695272401471,0,5,regulation of MDA-5 signaling pathway,BP,
10470,GO:0039534,1,0.981887158154047,0,3,negative regulation of MDA-5 signaling pathway,BP,
10471,GO:0039535,1,0.911482971033798,0,13,regulation of RIG-I signaling pathway,BP,
10472,GO:0039536,1,0.954339126448865,0,7,negative regulation of RIG-I signaling pathway,BP,
10473,GO:0039552,1,0.992410233204546,0,1,RIG-I binding,MF,
10474,GO:0039562,1,0.992434292396331,0,1,suppression by virus of host STAT activity,BP,
10475,GO:0039563,1,0.992434292396331,0,1,suppression by virus of host STAT1 activity,BP,
10476,GO:0039564,1,0.992434292396331,0,1,suppression by virus of host STAT2 activity,BP,
10477,GO:0039650,1,0.993128930994008,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10478,GO:0039656,1,0.980841472588662,0,3,modulation by virus of host gene expression,BP,
10479,GO:0039663,1,0.962543707123116,0,6,membrane fusion involved in viral entry into host cell,BP,
10480,GO:0039689,1,0.97962393216922,0,3,negative stranded viral RNA replication,BP,
10481,GO:0039692,1,0.928435557984,0,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10482,GO:0039694,1,0.84216597146546,0,26,viral RNA genome replication,BP,
10483,GO:0039695,1,0.992475522317594,0,1,DNA-templated viral transcription,BP,
10484,GO:0039702,1,0.883425411342711,0,21,viral budding via host ESCRT complex,BP,
10485,GO:0039706,1,0.933963881791546,0,11,co-receptor binding,MF,
10486,GO:0039713,1,0.99257195088681,0,1,viral factory,CC,
10487,GO:0039714,1,0.99257195088681,0,1,cytoplasmic viral factory,CC,
10488,GO:0040001,1,0.850255136417364,0,24,establishment of mitotic spindle localization,BP,
10491,GO:0040009,1,0.96724875056836,0,5,regulation of growth rate,BP,
10492,GO:0040010,1,0.996458096886506,0,1,positive regulation of growth rate,BP,
10495,GO:0040013,1,0.16688186928296,0,267,negative regulation of locomotion,BP,
10496,GO:0040014,1,0.672119762185955,0,60,regulation of multicellular organism growth,BP,
10497,GO:0040015,1,0.929443532506951,0,11,negative regulation of multicellular organism growth,BP,
10498,GO:0040016,1,0.959654541028626,0,6,embryonic cleavage,BP,
10500,GO:0040018,1,0.827213751062957,0,29,positive regulation of multicellular organism growth,BP,
10502,GO:0040020,1,0.842654586472804,0,26,regulation of meiotic nuclear division,BP,
10503,GO:0040029,1,0.173480246384565,0,266,regulation of gene expression, epigenetic,BP,
10504,GO:0040030,1,0.989121851581357,0,2,regulation of molecular function, epigenetic,BP,
10505,GO:0040031,1,0.968746306408793,0,6,snRNA modification,BP,
10506,GO:0040032,1,0.994769374436115,0,1,post-embryonic body morphogenesis,BP,
10507,GO:0040033,1,0.915459967760038,0,13,negative regulation of translation, ncRNA-mediated,BP,
10508,GO:0040034,1,0.924668660987622,0,12,regulation of development, heterochronic,BP,
10509,GO:0040036,1,0.833984427991335,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10510,GO:0040037,1,0.91251209939582,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10511,GO:0040038,1,0.97756800806172,0,3,polar body extrusion after meiotic divisions,BP,
10513,GO:0042000,1,0.993719136156557,0,1,translocation of peptides or proteins into host,BP,
10514,GO:0042007,1,0.995588167675736,0,1,interleukin-18 binding,MF,
10515,GO:0042008,1,0.992548087391005,0,1,interleukin-18 receptor activity,MF,
10516,GO:0042011,1,0.992749534641708,0,1,interleukin-16 binding,MF,
10517,GO:0042012,1,0.992749534641708,0,1,interleukin-16 receptor activity,MF,
10518,GO:0042015,1,0.980193372821549,0,3,interleukin-20 binding,MF,
10519,GO:0042019,1,0.994582429640857,0,1,interleukin-23 binding,MF,
10520,GO:0042020,1,0.994582429640857,0,1,interleukin-23 receptor activity,MF,
10521,GO:0042022,1,0.994582429640857,0,1,interleukin-12 receptor complex,CC,
10522,GO:0042023,1,0.941632582666748,0,8,DNA endoreduplication,BP,
10523,GO:0042025,1,0.979046000361112,0,3,host cell nucleus,CC,
10524,GO:0042026,1,0.844295675534562,0,26,protein refolding,BP,
10525,GO:0042030,1,0.979944735365609,0,3,ATPase inhibitor activity,MF,
10526,GO:0042033,1,0.938490331876563,0,12,chemokine biosynthetic process,BP,
10527,GO:0042035,1,0.576205329679978,0,87,regulation of cytokine biosynthetic process,BP,
10528,GO:0042036,1,0.845532294718527,0,28,negative regulation of cytokine biosynthetic process,BP,
10529,GO:0042040,1,0.99249272490571,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10530,GO:0042043,1,0.9117683420019,0,13,neurexin family protein binding,MF,
10532,GO:0042045,1,0.951197891015265,0,7,epithelial fluid transport,BP,
10534,GO:0042053,1,0.890406330258076,0,18,regulation of dopamine metabolic process,BP,
10535,GO:0042054,1,0.695691073573872,0,53,histone methyltransferase activity,MF,
10536,GO:0042056,1,0.886199945503461,0,22,chemoattractant activity,MF,
10538,GO:0042059,1,0.763878839625923,0,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10539,GO:0042060,1,0.0479235971418987,0,459,wound healing,BP,
10540,GO:0042063,1,0.19827134216501,0,244,gliogenesis,BP,
10541,GO:0042069,1,0.890406330258076,0,18,regulation of catecholamine metabolic process,BP,
10542,GO:0042073,1,0.720389038449679,0,50,intraciliary transport,BP,
10543,GO:0042074,1,0.921379611154624,0,13,cell migration involved in gastrulation,BP,
10544,GO:0042078,1,0.982494886252243,0,3,germ-line stem cell division,BP,
10545,GO:0042083,1,0.995326921115523,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10546,GO:0042084,1,0.991990801598826,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10547,GO:0042088,1,0.802518552519601,0,36,T-helper 1 type immune response,BP,
10548,GO:0042089,1,0.554982108202671,0,93,cytokine biosynthetic process,BP,
10549,GO:0042090,1,0.953962801424557,0,7,interleukin-12 biosynthetic process,BP,
10550,GO:0042091,1,0.979906302169959,0,3,interleukin-10 biosynthetic process,BP,
10551,GO:0042092,1,0.817283318622648,0,33,type 2 immune response,BP,
10552,GO:0042093,1,0.728978141230498,0,48,T-helper cell differentiation,BP,
10553,GO:0042094,1,0.883744671161253,0,20,interleukin-2 biosynthetic process,BP,
10554,GO:0042095,1,0.912832900938736,0,15,interferon-gamma biosynthetic process,BP,
10555,GO:0042097,1,0.978435318874044,0,3,interleukin-4 biosynthetic process,BP,
10557,GO:0042100,1,0.655304822404513,0,68,B cell proliferation,BP,
10558,GO:0042101,1,0.893880929017028,0,19,T cell receptor complex,CC,
10561,GO:0042105,1,0.977081561073408,0,5,alpha-beta T cell receptor complex,CC,
10562,GO:0042107,1,0.551953436539861,0,94,cytokine metabolic process,BP,
10563,GO:0042108,1,0.716114994384872,0,52,positive regulation of cytokine biosynthetic process,BP,
10564,GO:0042109,1,0.986000075632408,0,2,lymphotoxin A biosynthetic process,BP,
10566,GO:0042113,1,0.27659410921502,0,197,B cell activation,BP,
10567,GO:0042116,1,0.678554756882538,0,60,macrophage activation,BP,
10568,GO:0042117,1,0.959092761574372,0,7,monocyte activation,BP,
10569,GO:0042118,1,0.942126919172841,0,9,endothelial cell activation,BP,
10571,GO:0042126,1,0.973870547699526,0,4,nitrate metabolic process,BP,
10573,GO:0042128,1,0.993878111687654,0,1,nitrate assimilation,BP,
10575,GO:0042130,1,0.724851959745836,0,51,negative regulation of T cell proliferation,BP,
10576,GO:0042131,1,0.993510421661706,0,1,thiamine phosphate phosphatase activity,MF,
10577,GO:0042132,1,0.995400344957096,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10579,GO:0042134,1,0.990701440257913,0,2,rRNA primary transcript binding,MF,
10580,GO:0042135,1,0.866826258611131,0,21,neurotransmitter catabolic process,BP,
10583,GO:0042138,1,0.980113646241682,0,3,meiotic DNA double-strand break formation,BP,
10584,GO:0042140,1,0.9930956730518,0,1,late meiotic recombination nodule assembly,BP,
10585,GO:0042144,1,0.986020887260754,0,2,vacuole fusion, non-autophagic,BP,
10586,GO:0042147,1,0.613858850686534,0,72,retrograde transport, endosome to Golgi,BP,
10587,GO:0042148,1,0.950115907406899,0,8,strand invasion,BP,
10588,GO:0042149,1,0.78349172437781,0,37,cellular response to glucose starvation,BP,
10589,GO:0042157,1,0.350773992139579,0,167,lipoprotein metabolic process,BP,
10590,GO:0042158,1,0.423793603847169,0,138,lipoprotein biosynthetic process,BP,
10591,GO:0042159,1,0.913737404284267,0,14,lipoprotein catabolic process,BP,
10592,GO:0042160,1,0.988592383970141,0,2,lipoprotein modification,BP,
10593,GO:0042161,1,0.988592383970141,0,2,lipoprotein oxidation,BP,
10594,GO:0042162,1,0.780885959877843,0,36,telomeric DNA binding,MF,
10595,GO:0042163,1,0.995559571918776,0,1,interleukin-12 beta subunit binding,MF,
10598,GO:0042167,1,0.982904333140756,0,4,heme catabolic process,BP,
10599,GO:0042168,1,0.86605442447064,0,25,heme metabolic process,BP,
10600,GO:0042169,1,0.80023051416243,0,32,SH2 domain binding,MF,
10601,GO:0042171,1,0.88348374740159,0,18,lysophosphatidic acid acyltransferase activity,MF,
10604,GO:0042177,1,0.51095287154913,0,105,negative regulation of protein catabolic process,BP,
10605,GO:0042178,1,0.948246172137992,0,10,xenobiotic catabolic process,BP,
10607,GO:0042181,1,0.8211058189464,0,33,ketone biosynthetic process,BP,
10608,GO:0042182,1,0.965436923886473,0,6,ketone catabolic process,BP,
10609,GO:0042197,1,0.995180915878961,0,1,halogenated hydrocarbon metabolic process,BP,
10610,GO:0042214,1,0.980957380071586,0,3,terpene metabolic process,BP,
10611,GO:0042219,1,0.881251632662957,0,20,cellular modified amino acid catabolic process,BP,
10614,GO:0042222,1,0.985368230065074,0,3,interleukin-1 biosynthetic process,BP,
10615,GO:0042223,1,0.992448093317305,0,1,interleukin-3 biosynthetic process,BP,
10616,GO:0042226,1,0.914958695184945,0,14,interleukin-6 biosynthetic process,BP,
10617,GO:0042228,1,0.937366618434584,0,10,interleukin-8 biosynthetic process,BP,
10618,GO:0042231,1,0.988421416143508,0,2,interleukin-13 biosynthetic process,BP,
10619,GO:0042241,1,0.992661572531617,0,1,interleukin-18 biosynthetic process,BP,
10620,GO:0042245,1,0.985947857479443,0,2,RNA repair,BP,
10621,GO:0042246,1,0.735324506102218,0,50,tissue regeneration,BP,
10622,GO:0042247,1,0.992903548761955,0,1,establishment of planar polarity of follicular epithelium,BP,
10623,GO:0042249,1,0.888362163643715,0,17,establishment of planar polarity of embryonic epithelium,BP,
10624,GO:0042253,1,0.981656914214473,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10625,GO:0042254,1,0.181323921658464,0,309,ribosome biogenesis,BP,
10626,GO:0042255,1,0.7685032486059,0,53,ribosome assembly,BP,
10627,GO:0042256,1,0.972478706826464,0,5,mature ribosome assembly,BP,
10628,GO:0042262,1,0.976815779501434,0,5,DNA protection,BP,
10629,GO:0042264,1,0.984871397914835,0,2,peptidyl-aspartic acid hydroxylation,BP,
10630,GO:0042265,1,0.992288085650284,0,1,peptidyl-asparagine hydroxylation,BP,
10631,GO:0042267,1,0.748636341878693,0,48,natural killer cell mediated cytotoxicity,BP,
10632,GO:0042268,1,0.948206017050895,0,10,regulation of cytolysis,BP,
10633,GO:0042269,1,0.827496140728515,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10634,GO:0042270,1,0.987699620995255,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10635,GO:0042271,1,0.981076718482595,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10636,GO:0042272,1,0.979288144494168,0,3,nuclear RNA export factor complex,CC,
10637,GO:0042273,1,0.706105686575818,0,66,ribosomal large subunit biogenesis,BP,
10638,GO:0042274,1,0.691489563931822,0,67,ribosomal small subunit biogenesis,BP,
10639,GO:0042275,1,0.99543075164963,0,1,error-free postreplication DNA repair,BP,
10640,GO:0042276,1,0.895682700968405,0,19,error-prone translesion synthesis,BP,
10641,GO:0042277,1,0.221568219655383,0,239,peptide binding,MF,
10642,GO:0042278,1,0.634330272058432,0,73,purine nucleoside metabolic process,BP,
10643,GO:0042281,1,0.987734634752096,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10644,GO:0042282,1,0.992481641817201,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10645,GO:0042284,1,0.990480577866614,0,2,sphingolipid delta-4 desaturase activity,MF,
10646,GO:0042285,1,0.959156200962317,0,6,xylosyltransferase activity,MF,
10647,GO:0042287,1,0.844436365309586,0,27,MHC protein binding,MF,
10648,GO:0042288,1,0.905087931934372,0,16,MHC class I protein binding,MF,
10649,GO:0042289,1,0.965993302444674,0,6,MHC class II protein binding,MF,
10650,GO:0042292,1,0.993645945930351,0,1,URM1 activating enzyme activity,MF,
10651,GO:0042296,1,0.979102125484239,0,4,ISG15 transferase activity,MF,
10652,GO:0042297,1,0.947256357747162,0,7,vocal learning,BP,
10654,GO:0042303,1,0.523731900948408,0,98,molting cycle,BP,
10655,GO:0042304,1,0.803720731689836,0,34,regulation of fatty acid biosynthetic process,BP,
10656,GO:0042306,1,0.733689087537544,0,47,regulation of protein import into nucleus,BP,
10657,GO:0042307,1,0.812946738505213,0,30,positive regulation of protein import into nucleus,BP,
10658,GO:0042308,1,0.940197284213677,0,10,negative regulation of protein import into nucleus,BP,
10659,GO:0042309,1,0.99311891218743,0,1,homoiothermy,BP,
10661,GO:0042311,1,0.843887603665627,0,27,vasodilation,BP,
10662,GO:0042313,1,0.994356999235507,0,1,protein kinase C deactivation,BP,
10663,GO:0042316,1,0.992444797609066,0,1,penicillin metabolic process,BP,
10664,GO:0042320,1,0.977493776847235,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10665,GO:0042321,1,0.974227120448883,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10666,GO:0042322,1,0.992266148973531,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10667,GO:0042323,1,0.988456857221963,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10671,GO:0042328,1,0.970017233521322,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10673,GO:0042335,1,0.979001573107609,0,3,cuticle development,BP,
10674,GO:0042339,1,0.814232430306301,0,31,keratan sulfate metabolic process,BP,
10675,GO:0042340,1,0.928697711589004,0,11,keratan sulfate catabolic process,BP,
10676,GO:0042350,1,0.983430292321044,0,3,GDP-L-fucose biosynthetic process,BP,
10677,GO:0042351,1,0.990860282024419,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10678,GO:0042352,1,0.992502176336645,0,1,GDP-L-fucose salvage,BP,
10679,GO:0042354,1,0.944341973182581,0,8,L-fucose metabolic process,BP,
10680,GO:0042355,1,0.944341973182581,0,8,L-fucose catabolic process,BP,
10681,GO:0042356,1,0.995669135788894,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10682,GO:0042357,1,0.988814274510764,0,2,thiamine diphosphate metabolic process,BP,
10683,GO:0042359,1,0.891185667115098,0,19,vitamin D metabolic process,BP,
10684,GO:0042360,1,0.983657526228578,0,3,vitamin E metabolic process,BP,
10685,GO:0042361,1,0.992690468663689,0,1,menaquinone catabolic process,BP,
10686,GO:0042362,1,0.930290051294965,0,12,fat-soluble vitamin biosynthetic process,BP,
10687,GO:0042363,1,0.962613564937644,0,6,fat-soluble vitamin catabolic process,BP,
10688,GO:0042364,1,0.941951441142785,0,9,water-soluble vitamin biosynthetic process,BP,
10689,GO:0042365,1,0.983388698920057,0,3,water-soluble vitamin catabolic process,BP,
10690,GO:0042368,1,0.948406317084079,0,9,vitamin D biosynthetic process,BP,
10691,GO:0042369,1,0.986325667659808,0,2,vitamin D catabolic process,BP,
10692,GO:0042371,1,0.992523571807978,0,1,vitamin K biosynthetic process,BP,
10693,GO:0042373,1,0.973511061642325,0,5,vitamin K metabolic process,BP,
10694,GO:0042374,1,0.988732678245184,0,2,phylloquinone metabolic process,BP,
10695,GO:0042376,1,0.988732678245184,0,2,phylloquinone catabolic process,BP,
10696,GO:0042377,1,0.992690468663689,0,1,vitamin K catabolic process,BP,
10698,GO:0042382,1,0.959445397902056,0,6,paraspeckles,CC,
10699,GO:0042383,1,0.431152920829795,0,124,sarcolemma,CC,
10701,GO:0042392,1,0.988553888831199,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10702,GO:0042393,1,0.312868719508745,0,170,histone binding,MF,
10703,GO:0042398,1,0.800308448299538,0,36,cellular modified amino acid biosynthetic process,BP,
10704,GO:0042401,1,0.899863076023308,0,19,cellular biogenic amine biosynthetic process,BP,
10705,GO:0042402,1,0.89373505996521,0,20,cellular biogenic amine catabolic process,BP,
10707,GO:0042404,1,0.994355978110344,0,1,thyroid hormone catabolic process,BP,
10708,GO:0042405,1,0.921571013973492,0,11,nuclear inclusion body,CC,
10709,GO:0042406,1,0.975898219347387,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10710,GO:0042407,1,0.917245933385897,0,15,cristae formation,BP,
10711,GO:0042412,1,0.988524432486938,0,2,taurine biosynthetic process,BP,
10712,GO:0042413,1,0.993571454215617,0,1,carnitine catabolic process,BP,
10713,GO:0042414,1,0.982945507245749,0,3,epinephrine metabolic process,BP,
10714,GO:0042415,1,0.935146677775954,0,10,norepinephrine metabolic process,BP,
10715,GO:0042416,1,0.933223927710713,0,11,dopamine biosynthetic process,BP,
10717,GO:0042418,1,0.990717831273928,0,2,epinephrine biosynthetic process,BP,
10718,GO:0042420,1,0.954651823731057,0,7,dopamine catabolic process,BP,
10719,GO:0042421,1,0.960950371218789,0,6,norepinephrine biosynthetic process,BP,
10720,GO:0042423,1,0.886171092047304,0,19,catecholamine biosynthetic process,BP,
10721,GO:0042424,1,0.947768299179402,0,8,catecholamine catabolic process,BP,
10722,GO:0042426,1,0.95725793789217,0,6,choline catabolic process,BP,
10723,GO:0042427,1,0.989450779788295,0,2,serotonin biosynthetic process,BP,
10724,GO:0042428,1,0.942088287992703,0,9,serotonin metabolic process,BP,
10725,GO:0042430,1,0.899628810190671,0,18,indole-containing compound metabolic process,BP,
10726,GO:0042435,1,0.985009851750184,0,3,indole-containing compound biosynthetic process,BP,
10727,GO:0042436,1,0.963981088407882,0,7,indole-containing compound catabolic process,BP,
10728,GO:0042438,1,0.906474946872385,0,15,melanin biosynthetic process,BP,
10729,GO:0042439,1,0.960138615546985,0,6,ethanolamine-containing compound metabolic process,BP,
10730,GO:0042440,1,0.699603127886715,0,58,pigment metabolic process,BP,
10731,GO:0042441,1,0.980435080166352,0,3,eye pigment metabolic process,BP,
10734,GO:0042447,1,0.919986110898381,0,14,hormone catabolic process,BP,
10735,GO:0042448,1,0.927321325810182,0,13,progesterone metabolic process,BP,
10736,GO:0042450,1,0.989810604267621,0,2,arginine biosynthetic process via ornithine,BP,
10737,GO:0042451,1,0.896568430838361,0,21,purine nucleoside biosynthetic process,BP,
10738,GO:0042454,1,0.913652915239067,0,16,ribonucleoside catabolic process,BP,
10739,GO:0042455,1,0.819331177478418,0,36,ribonucleoside biosynthetic process,BP,
10740,GO:0042461,1,0.767952484514379,0,38,photoreceptor cell development,BP,
10741,GO:0042462,1,0.824964867782089,0,28,eye photoreceptor cell development,BP,
10742,GO:0042470,1,0.523713810018829,0,101,melanosome,CC,
10743,GO:0042471,1,0.497814574971633,0,106,ear morphogenesis,BP,
10744,GO:0042472,1,0.556925326636959,0,87,inner ear morphogenesis,BP,
10745,GO:0042473,1,0.945178134496861,0,9,outer ear morphogenesis,BP,
10746,GO:0042474,1,0.89334139351523,0,19,middle ear morphogenesis,BP,
10747,GO:0042475,1,0.628365669537325,0,70,odontogenesis of dentin-containing tooth,BP,
10748,GO:0042476,1,0.502134027537022,0,104,odontogenesis,BP,
10749,GO:0042481,1,0.882210580185384,0,20,regulation of odontogenesis,BP,
10750,GO:0042482,1,0.956686223570964,0,7,positive regulation of odontogenesis,BP,
10751,GO:0042483,1,0.97280231192395,0,4,negative regulation of odontogenesis,BP,
10752,GO:0042487,1,0.945783711760087,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10753,GO:0042488,1,0.993693316481998,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10754,GO:0042489,1,0.986619822523569,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10756,GO:0042491,1,0.820112439667668,0,29,inner ear auditory receptor cell differentiation,BP,
10757,GO:0042492,1,0.95843247815685,0,6,gamma-delta T cell differentiation,BP,
10759,GO:0042494,1,0.963202136288881,0,5,detection of bacterial lipoprotein,BP,
10760,GO:0042495,1,0.98564950536708,0,2,detection of triacyl bacterial lipopeptide,BP,
10761,GO:0042496,1,0.985020356294115,0,2,detection of diacyl bacterial lipopeptide,BP,
10762,GO:0042497,1,0.992586830541788,0,1,triacyl lipopeptide binding,MF,
10763,GO:0042500,1,0.961532269574674,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10764,GO:0042501,1,0.954519839501183,0,7,serine phosphorylation of STAT protein,BP,
10765,GO:0042509,1,0.712425036756865,0,56,regulation of tyrosine phosphorylation of STAT protein,BP,
10766,GO:0042531,1,0.748874976692942,0,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10767,GO:0042532,1,0.936463176908837,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10768,GO:0042533,1,0.893942557041776,0,18,tumor necrosis factor biosynthetic process,BP,
10769,GO:0042534,1,0.893942557041776,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10770,GO:0042535,1,0.931181670802985,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10771,GO:0042536,1,0.972555269727867,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10772,GO:0042537,1,0.907985492740859,0,18,benzene-containing compound metabolic process,BP,
10773,GO:0042538,1,0.95611320225698,0,7,hyperosmotic salinity response,BP,
10774,GO:0042539,1,0.98500798645775,0,2,hypotonic salinity response,BP,
10775,GO:0042541,1,0.948811858396426,0,9,hemoglobin biosynthetic process,BP,
10776,GO:0042542,1,0.468364129697072,0,123,response to hydrogen peroxide,BP,
10777,GO:0042543,1,0.996622641222573,0,1,protein N-linked glycosylation via arginine,BP,
10778,GO:0042546,1,0.994995753572652,0,1,cell wall biogenesis,BP,
10779,GO:0042551,1,0.765703586527974,0,39,neuron maturation,BP,
10781,GO:0042554,1,0.863889946270451,0,24,superoxide anion generation,BP,
10782,GO:0042555,1,0.924911328625602,0,11,MCM complex,CC,
10783,GO:0042558,1,0.813794712941495,0,34,pteridine-containing compound metabolic process,BP,
10784,GO:0042559,1,0.924706131247895,0,14,pteridine-containing compound biosynthetic process,BP,
10785,GO:0042560,1,0.973958875496865,0,4,pteridine-containing compound catabolic process,BP,
10787,GO:0042564,1,0.992489161697064,0,1,NLS-dependent protein nuclear import complex,CC,
10788,GO:0042565,1,0.988508293863638,0,2,RNA nuclear export complex,CC,
10789,GO:0042567,1,0.97263255028807,0,4,insulin-like growth factor ternary complex,CC,
10790,GO:0042568,1,0.996184970378253,0,1,insulin-like growth factor binary complex,CC,
10791,GO:0042571,1,0.989448150612376,0,2,immunoglobulin complex, circulating,CC,
10792,GO:0042572,1,0.847524271876155,0,27,retinol metabolic process,BP,
10793,GO:0042573,1,0.90141355676448,0,17,retinoic acid metabolic process,BP,
10794,GO:0042574,1,0.916818781912401,0,13,retinal metabolic process,BP,
10795,GO:0042575,1,0.90345956247921,0,16,DNA polymerase complex,CC,
10796,GO:0042577,1,0.986846756450982,0,2,lipid phosphatase activity,MF,
10800,GO:0042582,1,0.424094531552133,0,140,azurophil granule,CC,
10803,GO:0042585,1,0.994074608767601,0,1,germinal vesicle,CC,
10804,GO:0042586,1,0.995953922606191,0,1,peptide deformylase activity,MF,
10805,GO:0042587,1,0.968365841896246,0,5,glycogen granule,CC,
10806,GO:0042588,1,0.9256079702205,0,12,zymogen granule,CC,
10807,GO:0042589,1,0.937517102248586,0,10,zymogen granule membrane,CC,
10808,GO:0042590,1,0.690286373732872,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10811,GO:0042594,1,0.346428833109176,0,162,response to starvation,BP,
10812,GO:0042595,1,0.988776348371902,0,2,behavioral response to starvation,BP,
10814,GO:0042599,1,0.914879977089853,0,15,lamellar body,CC,
10815,GO:0042602,1,0.996307281608513,0,1,riboflavin reductase (NADPH) activity,MF,
10816,GO:0042605,1,0.891684577022345,0,21,peptide antigen binding,MF,
10817,GO:0042608,1,0.961790623642262,0,7,T cell receptor binding,MF,
10818,GO:0042609,1,0.959194435187697,0,7,CD4 receptor binding,MF,
10819,GO:0042610,1,0.988750558640311,0,2,CD8 receptor binding,MF,
10820,GO:0042611,1,0.906026748630853,0,22,MHC protein complex,CC,
10821,GO:0042612,1,0.96496390824947,0,8,MHC class I protein complex,CC,
10822,GO:0042613,1,0.938944534798233,0,14,MHC class II protein complex,CC,
10823,GO:0042622,1,0.915058339881103,0,13,photoreceptor outer segment membrane,CC,
10824,GO:0042623,1,0.0859453989781658,0,348,ATPase activity, coupled,MF,
10825,GO:0042624,1,0.996483460864596,0,1,ATPase activity, uncoupled,MF,
10826,GO:0042625,1,0.708684534019556,0,52,ATPase coupled ion transmembrane transporter activity,MF,
10827,GO:0042626,1,0.509825993845609,0,96,ATPase activity, coupled to transmembrane movement of substances,MF,
10828,GO:0042627,1,0.953632768467509,0,9,chylomicron,CC,
10829,GO:0042628,1,0.994023062010398,0,1,mating plug formation,BP,
10831,GO:0042631,1,0.985088392932586,0,2,cellular response to water deprivation,BP,
10832,GO:0042632,1,0.723253446093306,0,52,cholesterol homeostasis,BP,
10833,GO:0042633,1,0.523731900948408,0,98,hair cycle,BP,
10834,GO:0042634,1,0.847522277197694,0,25,regulation of hair cycle,BP,
10835,GO:0042635,1,0.933109053756939,0,12,positive regulation of hair cycle,BP,
10836,GO:0042636,1,0.970349535740457,0,4,negative regulation of hair cycle,BP,
10837,GO:0042637,1,0.975675461161165,0,4,catagen,BP,
10838,GO:0042640,1,0.964434129250183,0,5,anagen,BP,
10839,GO:0042641,1,0.63503762299713,0,64,actomyosin,CC,
10840,GO:0042643,1,0.985473693668428,0,2,actomyosin, actin portion,CC,
10841,GO:0042645,1,0.768548732527601,0,41,mitochondrial nucleoid,CC,
10842,GO:0042658,1,0.995741883048187,0,1,MHC class II protein binding, via antigen binding groove,MF,
10843,GO:0042659,1,0.929971341475444,0,11,regulation of cell fate specification,BP,
10844,GO:0042660,1,0.992300185940321,0,1,positive regulation of cell fate specification,BP,
10845,GO:0042661,1,0.964770812738465,0,6,regulation of mesodermal cell fate specification,BP,
10846,GO:0042662,1,0.979483708961049,0,4,negative regulation of mesodermal cell fate specification,BP,
10847,GO:0042663,1,0.984361752936568,0,3,regulation of endodermal cell fate specification,BP,
10848,GO:0042664,1,0.995951357786099,0,1,negative regulation of endodermal cell fate specification,BP,
10849,GO:0042665,1,0.992505247890261,0,1,regulation of ectodermal cell fate specification,BP,
10850,GO:0042666,1,0.992505247890261,0,1,negative regulation of ectodermal cell fate specification,BP,
10851,GO:0042668,1,0.991312926222843,0,2,auditory receptor cell fate determination,BP,
10852,GO:0042670,1,0.948061571436859,0,8,retinal cone cell differentiation,BP,
10853,GO:0042692,1,0.126418878075626,0,306,muscle cell differentiation,BP,
10854,GO:0042693,1,0.930820819128253,0,12,muscle cell fate commitment,BP,
10855,GO:0042695,1,0.9704717983738,0,5,thelarche,BP,
10857,GO:0042699,1,0.988917934299303,0,2,follicle-stimulating hormone signaling pathway,BP,
10858,GO:0042700,1,0.992475406166524,0,1,luteinizing hormone signaling pathway,BP,
10859,GO:0042701,1,0.977843754553522,0,4,progesterone secretion,BP,
10860,GO:0042704,1,0.985184835200569,0,2,uterine wall breakdown,BP,
10861,GO:0042709,1,0.993834721845543,0,1,succinate-CoA ligase complex,CC,
10862,GO:0042710,1,0.993803373464768,0,1,biofilm formation,BP,
10863,GO:0042711,1,0.920427825773761,0,12,maternal behavior,BP,
10864,GO:0042713,1,0.963101697185701,0,5,sperm ejaculation,BP,
10865,GO:0042719,1,0.976687881792975,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10866,GO:0042720,1,0.991819496044457,0,2,mitochondrial inner membrane peptidase complex,CC,
10867,GO:0042721,1,0.97400307622956,0,5,mitochondrial inner membrane protein insertion complex,CC,
10868,GO:0042723,1,0.956686441984055,0,7,thiamine-containing compound metabolic process,BP,
10869,GO:0042726,1,0.948375213952082,0,8,flavin-containing compound metabolic process,BP,
10870,GO:0042727,1,0.98785761966824,0,2,flavin-containing compound biosynthetic process,BP,
10871,GO:0042728,1,0.992504135278238,0,1,flavin-containing compound catabolic process,BP,
10872,GO:0042730,1,0.885614666111676,0,20,fibrinolysis,BP,
10873,GO:0042731,1,0.974008386731729,0,4,PH domain binding,MF,
10874,GO:0042732,1,0.984966785557949,0,3,D-xylose metabolic process,BP,
10875,GO:0042733,1,0.671043921200233,0,60,embryonic digit morphogenesis,BP,
10878,GO:0042738,1,0.922324175388662,0,14,exogenous drug catabolic process,BP,
10880,GO:0042743,1,0.800102997495077,0,40,hydrogen peroxide metabolic process,BP,
10881,GO:0042744,1,0.892713084747324,0,21,hydrogen peroxide catabolic process,BP,
10882,GO:0042745,1,0.879035798128838,0,23,circadian sleep/wake cycle,BP,
10883,GO:0042746,1,0.984269329722112,0,3,circadian sleep/wake cycle, wakefulness,BP,
10884,GO:0042747,1,0.961625075535461,0,8,circadian sleep/wake cycle, REM sleep,BP,
10885,GO:0042748,1,0.952891560947417,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10886,GO:0042749,1,0.910911300936641,0,17,regulation of circadian sleep/wake cycle,BP,
10888,GO:0042753,1,0.907094382129325,0,16,positive regulation of circadian rhythm,BP,
10889,GO:0042754,1,0.918745945348644,0,13,negative regulation of circadian rhythm,BP,
10891,GO:0042756,1,0.951442193908036,0,8,drinking behavior,BP,
10892,GO:0042758,1,0.95192940970977,0,8,long-chain fatty acid catabolic process,BP,
10893,GO:0042759,1,0.924046865844649,0,12,long-chain fatty acid biosynthetic process,BP,
10894,GO:0042760,1,0.954026797713872,0,7,very long-chain fatty acid catabolic process,BP,
10895,GO:0042761,1,0.929449111190605,0,11,very long-chain fatty acid biosynthetic process,BP,
10896,GO:0042762,1,0.886805212707049,0,17,regulation of sulfur metabolic process,BP,
10897,GO:0042765,1,0.969187104979779,0,5,GPI-anchor transamidase complex,CC,
10898,GO:0042766,1,0.992174445286917,0,1,nucleosome mobilization,BP,
10899,GO:0042769,1,0.803416114078202,0,37,DNA damage response, detection of DNA damage,BP,
10900,GO:0042770,1,0.441525132654905,0,127,signal transduction in response to DNA damage,BP,
10901,GO:0042771,1,0.774788801303071,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10902,GO:0042772,1,0.884822888994865,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10903,GO:0042773,1,0.68983290953069,0,81,ATP synthesis coupled electron transport,BP,
10904,GO:0042774,1,0.9930956730518,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10905,GO:0042775,1,0.694646799805666,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10906,GO:0042776,1,0.984055094056642,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10907,GO:0042779,1,0.986635397709178,0,2,tRNA 3'-trailer cleavage,BP,
10908,GO:0042780,1,0.958625254402881,0,7,tRNA 3'-end processing,BP,
10909,GO:0042781,1,0.986635397709178,0,2,3'-tRNA processing endoribonuclease activity,MF,
10910,GO:0042788,1,0.871470161750332,0,30,polysomal ribosome,CC,
10911,GO:0042789,1,0.885359004380815,0,19,mRNA transcription by RNA polymerase II,BP,
10912,GO:0042790,1,0.925821809278717,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10913,GO:0042791,1,0.960706559108931,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10914,GO:0042795,1,0.662688293385592,0,66,snRNA transcription by RNA polymerase II,BP,
10915,GO:0042796,1,0.960396270148069,0,6,snRNA transcription by RNA polymerase III,BP,
10916,GO:0042797,1,0.960706559108931,0,6,tRNA transcription by RNA polymerase III,BP,
10917,GO:0042799,1,0.991839420260484,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10918,GO:0042800,1,0.897645936984939,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10921,GO:0042805,1,0.748595425250557,0,40,actinin binding,MF,
10922,GO:0042806,1,0.976214186625511,0,4,fucose binding,MF,
10923,GO:0042809,1,0.903079011849325,0,15,vitamin D receptor binding,MF,
10924,GO:0042813,1,0.855984894687698,0,22,Wnt-activated receptor activity,MF,
10925,GO:0042816,1,0.966575745030722,0,5,vitamin B6 metabolic process,BP,
10926,GO:0042819,1,0.979264423868928,0,3,vitamin B6 biosynthetic process,BP,
10927,GO:0042820,1,0.994551172977047,0,1,vitamin B6 catabolic process,BP,
10928,GO:0042822,1,0.979501974650236,0,3,pyridoxal phosphate metabolic process,BP,
10929,GO:0042823,1,0.984869189215541,0,2,pyridoxal phosphate biosynthetic process,BP,
10930,GO:0042824,1,0.972938578092227,0,4,MHC class I peptide loading complex,CC,
10931,GO:0042825,1,0.978099110478133,0,3,TAP complex,CC,
10932,GO:0042826,1,0.496649467391838,0,104,histone deacetylase binding,MF,
10933,GO:0042827,1,0.898707963407768,0,18,platelet dense granule,CC,
10934,GO:0042832,1,0.909254257068464,0,17,defense response to protozoan,BP,
10935,GO:0042834,1,0.95135634141724,0,8,peptidoglycan binding,MF,
10937,GO:0042839,1,0.99550371414173,0,1,D-glucuronate metabolic process,BP,
10938,GO:0042840,1,0.99550371414173,0,1,D-glucuronate catabolic process,BP,
10939,GO:0042843,1,0.996044348490844,0,1,D-xylose catabolic process,BP,
10940,GO:0042851,1,0.982669428835228,0,3,L-alanine metabolic process,BP,
10941,GO:0042853,1,0.982669428835228,0,3,L-alanine catabolic process,BP,
10942,GO:0042866,1,0.531937016099889,0,96,pyruvate biosynthetic process,BP,
10943,GO:0042883,1,0.992513861620335,0,1,cysteine transport,BP,
10948,GO:0042903,1,0.987198634004988,0,2,tubulin deacetylase activity,MF,
10949,GO:0042904,1,0.974765616473374,0,4,9-cis-retinoic acid biosynthetic process,BP,
10950,GO:0042905,1,0.974765616473374,0,4,9-cis-retinoic acid metabolic process,BP,
10951,GO:0042908,1,0.941109804233522,0,8,xenobiotic transport,BP,
10952,GO:0042910,1,0.941109804233522,0,8,xenobiotic transmembrane transporter activity,MF,
10953,GO:0042921,1,0.900946501265039,0,15,glucocorticoid receptor signaling pathway,BP,
10954,GO:0042922,1,0.996352645489994,0,1,neuromedin U receptor binding,MF,
10955,GO:0042923,1,0.896256218299274,0,19,neuropeptide binding,MF,
10956,GO:0042924,1,0.987111863029686,0,2,neuromedin U binding,MF,
10957,GO:0042930,1,0.9930956730518,0,1,enterobactin transport,BP,
10958,GO:0042931,1,0.9930956730518,0,1,enterobactin transmembrane transporter activity,MF,
10959,GO:0042937,1,0.99233132566982,0,1,tripeptide transmembrane transporter activity,MF,
10960,GO:0042938,1,0.988508795246109,0,2,dipeptide transport,BP,
10961,GO:0042939,1,0.986919850957124,0,2,tripeptide transport,BP,
10962,GO:0042940,1,0.958219198413804,0,6,D-amino acid transport,BP,
10963,GO:0042941,1,0.994651615069553,0,1,D-alanine transport,BP,
10964,GO:0042942,1,0.988100558167663,0,2,D-serine transport,BP,
10965,GO:0042946,1,0.9930956730518,0,1,glucoside transport,BP,
10966,GO:0042947,1,0.9930956730518,0,1,glucoside transmembrane transporter activity,MF,
10967,GO:0042953,1,0.913700359318128,0,13,lipoprotein transport,BP,
10968,GO:0042954,1,0.962120200298434,0,6,lipoprotein transporter activity,MF,
10969,GO:0042974,1,0.854691985021802,0,23,retinoic acid receptor binding,MF,
10970,GO:0042975,1,0.931918308237752,0,10,peroxisome proliferator activated receptor binding,MF,
10971,GO:0042976,1,0.943650509715981,0,9,activation of Janus kinase activity,BP,
10972,GO:0042978,1,0.977653728044286,0,3,ornithine decarboxylase activator activity,MF,
10973,GO:0042979,1,0.964979037516337,0,6,ornithine decarboxylase regulator activity,MF,
10975,GO:0042982,1,0.741222996032088,0,46,amyloid precursor protein metabolic process,BP,
10976,GO:0042983,1,0.940850821538562,0,10,amyloid precursor protein biosynthetic process,BP,
10977,GO:0042984,1,0.940850821538562,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10978,GO:0042985,1,0.970070058027587,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10979,GO:0042986,1,0.987277830667667,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10980,GO:0042987,1,0.808464060969432,0,32,amyloid precursor protein catabolic process,BP,
10981,GO:0042988,1,0.992436090749969,0,1,X11-like protein binding,MF,
10982,GO:0042989,1,0.952997085596425,0,10,sequestering of actin monomers,BP,
10983,GO:0042994,1,0.895439404075963,0,18,cytoplasmic sequestering of transcription factor,BP,
10985,GO:0042996,1,0.958752518656388,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10986,GO:0042997,1,0.973307681087697,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10987,GO:0042998,1,0.985049766413671,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10988,GO:0042999,1,0.992477437519875,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10989,GO:0043000,1,0.988058780594435,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10990,GO:0043001,1,0.81411118838981,0,31,Golgi to plasma membrane protein transport,BP,
10991,GO:0043002,1,0.992477437519875,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10992,GO:0043004,1,0.992477437519875,0,1,cytoplasmic sequestering of CFTR protein,BP,
10994,GO:0043006,1,0.987912501535788,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10995,GO:0043008,1,0.947411984686182,0,8,ATP-dependent protein binding,MF,
10998,GO:0043011,1,0.91824579026853,0,15,myeloid dendritic cell differentiation,BP,
10999,GO:0043012,1,0.993393393342137,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11000,GO:0043014,1,0.832955684711932,0,27,alpha-tubulin binding,MF,
11001,GO:0043015,1,0.837070371203109,0,26,gamma-tubulin binding,MF,
11002,GO:0043016,1,0.993196290611937,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11003,GO:0043017,1,0.993196290611937,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11004,GO:0043020,1,0.958332433265387,0,8,NADPH oxidase complex,CC,
11005,GO:0043021,1,0.493362312899009,0,109,ribonucleoprotein complex binding,MF,
11006,GO:0043022,1,0.735328321527513,0,47,ribosome binding,MF,
11007,GO:0043023,1,0.934749922186621,0,11,ribosomal large subunit binding,MF,
11008,GO:0043024,1,0.91528190899098,0,14,ribosomal small subunit binding,MF,
11010,GO:0043027,1,0.865631367065331,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11011,GO:0043028,1,0.787613705645657,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11012,GO:0043029,1,0.795110635344772,0,37,T cell homeostasis,BP,
11013,GO:0043030,1,0.797695310546769,0,36,regulation of macrophage activation,BP,
11014,GO:0043031,1,0.955808237420588,0,8,negative regulation of macrophage activation,BP,
11015,GO:0043032,1,0.877745658088921,0,21,positive regulation of macrophage activation,BP,
11016,GO:0043033,1,0.992263008596149,0,1,isoamylase complex,CC,
11017,GO:0043034,1,0.874406643864808,0,19,costamere,CC,
11018,GO:0043035,1,0.992508461190713,0,1,chromatin insulator sequence binding,MF,
11019,GO:0043038,1,0.716356564941077,0,53,amino acid activation,BP,
11020,GO:0043039,1,0.721760299646753,0,52,tRNA aminoacylation,BP,
11021,GO:0043041,1,0.992537884150759,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11023,GO:0043044,1,0.683238566190273,0,62,ATP-dependent chromatin remodeling,BP,
11024,GO:0043045,1,0.959577107377601,0,6,DNA methylation involved in embryo development,BP,
11025,GO:0043046,1,0.889633660818103,0,17,DNA methylation involved in gamete generation,BP,
11026,GO:0043047,1,0.92859636479269,0,11,single-stranded telomeric DNA binding,MF,
11027,GO:0043048,1,0.994149766902327,0,1,dolichyl monophosphate biosynthetic process,BP,
11028,GO:0043049,1,0.992780976418393,0,1,otic placode formation,BP,
11029,GO:0043060,1,0.993617816321152,0,1,meiotic metaphase I plate congression,BP,
11030,GO:0043062,1,0.087273031922539,0,352,extracellular structure organization,BP,
11031,GO:0043063,1,0.992458260162457,0,1,intercellular bridge organization,BP,
11037,GO:0043073,1,0.927211734719525,0,12,germ cell nucleus,CC,
11044,GO:0043094,1,0.823611191177775,0,34,cellular metabolic compound salvage,BP,
11045,GO:0043095,1,0.996460136282059,0,1,regulation of GTP cyclohydrolase I activity,BP,
11046,GO:0043096,1,0.975790489162232,0,5,purine nucleobase salvage,BP,
11047,GO:0043097,1,0.941260418635291,0,11,pyrimidine nucleoside salvage,BP,
11048,GO:0043101,1,0.923714921879422,0,14,purine-containing compound salvage,BP,
11049,GO:0043102,1,0.959555936414615,0,7,amino acid salvage,BP,
11050,GO:0043103,1,0.984508127170177,0,3,hypoxanthine salvage,BP,
11051,GO:0043105,1,0.996460136282059,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11052,GO:0043111,1,0.98825349148114,0,2,replication fork arrest,BP,
11054,GO:0043113,1,0.722420033230919,0,47,receptor clustering,BP,
11055,GO:0043114,1,0.817137829991501,0,30,regulation of vascular permeability,BP,
11056,GO:0043116,1,0.928292905018041,0,11,negative regulation of vascular permeability,BP,
11057,GO:0043117,1,0.938851105815995,0,10,positive regulation of vascular permeability,BP,
11058,GO:0043120,1,0.971863854757124,0,5,tumor necrosis factor binding,MF,
11059,GO:0043121,1,0.928653944425705,0,10,neurotrophin binding,MF,
11060,GO:0043122,1,0.257231920002273,0,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11061,GO:0043123,1,0.358830898147723,0,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11062,GO:0043124,1,0.763486321702826,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11063,GO:0043125,1,0.974833012571232,0,4,ErbB-3 class receptor binding,MF,
11064,GO:0043126,1,0.995463955836341,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11065,GO:0043128,1,0.995463955836341,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11066,GO:0043129,1,0.951719726703209,0,8,surfactant homeostasis,BP,
11067,GO:0043130,1,0.66054968675461,0,65,ubiquitin binding,MF,
11068,GO:0043131,1,0.99243882233873,0,1,erythrocyte enucleation,BP,
11069,GO:0043132,1,0.986782552422839,0,2,NAD transport,BP,
11070,GO:0043136,1,0.99273069832021,0,1,glycerol-3-phosphatase activity,MF,
11071,GO:0043137,1,0.977933846544474,0,4,DNA replication, removal of RNA primer,BP,
11072,GO:0043138,1,0.919300081647262,0,12,3'-5' DNA helicase activity,MF,
11073,GO:0043139,1,0.956373011757027,0,7,5'-3' DNA helicase activity,MF,
11074,GO:0043140,1,0.94845398880838,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11075,GO:0043141,1,0.969217303104417,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11076,GO:0043142,1,0.918972366089402,0,13,single-stranded DNA-dependent ATPase activity,MF,
11077,GO:0043144,1,0.963398505742167,0,8,snoRNA processing,BP,
11078,GO:0043149,1,0.555419693925666,0,86,stress fiber assembly,BP,
11079,GO:0043152,1,0.979528526284477,0,4,induction of bacterial agglutination,BP,
11080,GO:0043153,1,0.870415930640355,0,21,entrainment of circadian clock by photoperiod,BP,
11081,GO:0043154,1,0.588462682475304,0,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11082,GO:0043159,1,0.9882282171784,0,2,acrosomal matrix,CC,
11083,GO:0043161,1,0.081313467281598,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11084,GO:0043162,1,0.892156318049032,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11085,GO:0043163,1,0.986386241051932,0,2,cell envelope organization,BP,
11091,GO:0043173,1,0.919254312969729,0,15,nucleotide salvage,BP,
11092,GO:0043174,1,0.916667981625003,0,16,nucleoside salvage,BP,
11093,GO:0043175,1,0.791176664581336,0,35,RNA polymerase core enzyme binding,MF,
11094,GO:0043176,1,0.933740018951891,0,11,amine binding,MF,
11097,GO:0043179,1,0.994356999235507,0,1,rhythmic excitation,BP,
11098,GO:0043181,1,0.992530918766145,0,1,vacuolar sequestering,BP,
11099,GO:0043183,1,0.9885780536916,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11100,GO:0043184,1,0.955391279145424,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11101,GO:0043185,1,0.994390681201705,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11102,GO:0043186,1,0.908697523500126,0,14,P granule,CC,
11103,GO:0043189,1,0.898047190923987,0,18,H4/H2A histone acetyltransferase complex,CC,
11104,GO:0043190,1,0.949855962681192,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11110,GO:0043199,1,0.974590252237927,0,4,sulfate binding,MF,
11112,GO:0043201,1,0.915233760993907,0,12,response to leucine,BP,
11113,GO:0043202,1,0.564737005163438,0,87,lysosomal lumen,CC,
11119,GO:0043210,1,0.994924557862983,0,1,alkanesulfonate binding,MF,
11120,GO:0043215,1,0.992500488936931,0,1,daunorubicin transport,BP,
11121,GO:0043217,1,0.905600598508831,0,14,myelin maintenance,BP,
11122,GO:0043218,1,0.921764092689574,0,13,compact myelin,CC,
11123,GO:0043219,1,0.975386335299737,0,4,lateral loop,CC,
11124,GO:0043220,1,0.936265296310356,0,10,Schmidt-Lanterman incisure,CC,
11125,GO:0043221,1,0.992504353124575,0,1,SMC family protein binding,MF,
11126,GO:0043224,1,0.991978290522482,0,2,nuclear SCF ubiquitin ligase complex,CC,
11127,GO:0043225,1,0.913437450069003,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11137,GO:0043236,1,0.837335228809051,0,26,laminin binding,MF,
11138,GO:0043237,1,0.965570971708598,0,5,laminin-1 binding,MF,
11139,GO:0043240,1,0.942374860537323,0,9,Fanconi anaemia nuclear complex,CC,
11143,GO:0043247,1,0.915019727270531,0,13,telomere maintenance in response to DNA damage,BP,
11144,GO:0043248,1,0.944537730787108,0,12,proteasome assembly,BP,
11145,GO:0043249,1,0.922494647338442,0,13,erythrocyte maturation,BP,
11146,GO:0043250,1,0.995459238093135,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11147,GO:0043251,1,0.995459238093135,0,1,sodium-dependent organic anion transport,BP,
11148,GO:0043252,1,0.845393884529747,0,25,sodium-independent organic anion transport,BP,
11150,GO:0043255,1,0.625454256534536,0,67,regulation of carbohydrate biosynthetic process,BP,
11151,GO:0043256,1,0.939727089520499,0,8,laminin complex,CC,
11152,GO:0043257,1,0.992377678705397,0,1,laminin-8 complex,CC,
11153,GO:0043259,1,0.976685067999599,0,3,laminin-10 complex,CC,
11154,GO:0043260,1,0.976688597689477,0,3,laminin-11 complex,CC,
11155,GO:0043262,1,0.980818676778041,0,3,adenosine-diphosphatase activity,MF,
11156,GO:0043265,1,0.992724882606032,0,1,ectoplasm,CC,
11158,GO:0043267,1,0.842618450895193,0,25,negative regulation of potassium ion transport,BP,
11163,GO:0043273,1,0.992418309753475,0,1,CTPase activity,MF,
11164,GO:0043274,1,0.914844114672279,0,13,phospholipase binding,MF,
11165,GO:0043276,1,0.816863783297828,0,29,anoikis,BP,
11166,GO:0043277,1,0.76664178469486,0,41,apoptotic cell clearance,BP,
11171,GO:0043291,1,0.983993971824447,0,2,RAVE complex,CC,
11173,GO:0043293,1,0.987326702895827,0,2,apoptosome,CC,
11174,GO:0043295,1,0.944244193910808,0,11,glutathione binding,MF,
11175,GO:0043296,1,0.428111155198716,0,122,apical junction complex,CC,
11176,GO:0043297,1,0.68682908239648,0,56,apical junction assembly,BP,
11178,GO:0043300,1,0.773102727309892,0,41,regulation of leukocyte degranulation,BP,
11179,GO:0043301,1,0.935190663010211,0,11,negative regulation of leukocyte degranulation,BP,
11180,GO:0043302,1,0.883653152587978,0,20,positive regulation of leukocyte degranulation,BP,
11182,GO:0043304,1,0.849400525724689,0,27,regulation of mast cell degranulation,BP,
11183,GO:0043305,1,0.967532411963092,0,6,negative regulation of mast cell degranulation,BP,
11184,GO:0043306,1,0.932857462771223,0,12,positive regulation of mast cell degranulation,BP,
11185,GO:0043307,1,0.971504150560088,0,5,eosinophil activation,BP,
11186,GO:0043308,1,0.976606951924099,0,4,eosinophil degranulation,BP,
11187,GO:0043309,1,0.9822663130807,0,3,regulation of eosinophil degranulation,BP,
11188,GO:0043310,1,0.993560428442244,0,1,negative regulation of eosinophil degranulation,BP,
11189,GO:0043311,1,0.988633429353361,0,2,positive regulation of eosinophil degranulation,BP,
11191,GO:0043313,1,0.944441126593148,0,8,regulation of neutrophil degranulation,BP,
11192,GO:0043314,1,0.984778720954217,0,2,negative regulation of neutrophil degranulation,BP,
11193,GO:0043315,1,0.971969950412431,0,4,positive regulation of neutrophil degranulation,BP,
11194,GO:0043316,1,0.981043320220807,0,3,cytotoxic T cell degranulation,BP,
11195,GO:0043317,1,0.987889315252564,0,2,regulation of cytotoxic T cell degranulation,BP,
11196,GO:0043318,1,0.987889315252564,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11197,GO:0043320,1,0.96702729536991,0,5,natural killer cell degranulation,BP,
11198,GO:0043321,1,0.985823270135573,0,2,regulation of natural killer cell degranulation,BP,
11199,GO:0043323,1,0.985823270135573,0,2,positive regulation of natural killer cell degranulation,BP,
11200,GO:0043324,1,0.980435080166352,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11201,GO:0043325,1,0.873366238167846,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11202,GO:0043328,1,0.980656131597393,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11203,GO:0043330,1,0.834528771483852,0,28,response to exogenous dsRNA,BP,
11204,GO:0043331,1,0.590154106263864,0,78,response to dsRNA,BP,
11205,GO:0043335,1,0.988175687658139,0,2,protein unfolding,BP,
11206,GO:0043337,1,0.992507882206926,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11207,GO:0043353,1,0.94901641055322,0,8,enucleate erythrocyte differentiation,BP,
11208,GO:0043354,1,0.99243882233873,0,1,enucleate erythrocyte maturation,BP,
11209,GO:0043363,1,0.9930956730518,0,1,nucleate erythrocyte differentiation,BP,
11210,GO:0043366,1,0.981941862903517,0,3,beta selection,BP,
11211,GO:0043367,1,0.681096251318102,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11212,GO:0043368,1,0.836751888911448,0,28,positive T cell selection,BP,
11213,GO:0043369,1,0.891799526260868,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11214,GO:0043370,1,0.813074205469616,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11215,GO:0043371,1,0.907428040657878,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11216,GO:0043372,1,0.879170278903265,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11217,GO:0043373,1,0.916424746965279,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11218,GO:0043374,1,0.94032902532628,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11219,GO:0043375,1,0.99250527293932,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11220,GO:0043376,1,0.985087172878575,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11221,GO:0043378,1,0.992502394700296,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11222,GO:0043379,1,0.961215708649487,0,6,memory T cell differentiation,BP,
11223,GO:0043380,1,0.968827963534761,0,5,regulation of memory T cell differentiation,BP,
11224,GO:0043382,1,0.976105969294678,0,4,positive regulation of memory T cell differentiation,BP,
11225,GO:0043383,1,0.933969853999638,0,11,negative T cell selection,BP,
11226,GO:0043385,1,0.993161023776059,0,1,mycotoxin metabolic process,BP,
11227,GO:0043387,1,0.993161023776059,0,1,mycotoxin catabolic process,BP,
11228,GO:0043388,1,0.725539461787396,0,51,positive regulation of DNA binding,BP,
11229,GO:0043392,1,0.728915737490297,0,51,negative regulation of DNA binding,BP,
11230,GO:0043393,1,0.279510490350445,0,196,regulation of protein binding,BP,
11231,GO:0043394,1,0.791451554320106,0,34,proteoglycan binding,MF,
11232,GO:0043395,1,0.884280224765808,0,18,heparan sulfate proteoglycan binding,MF,
11233,GO:0043396,1,0.985195195721416,0,2,corticotropin-releasing hormone secretion,BP,
11234,GO:0043397,1,0.985195195721416,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11235,GO:0043398,1,0.980962373065354,0,3,HLH domain binding,MF,
11236,GO:0043400,1,0.974341265816734,0,5,cortisol secretion,BP,
11237,GO:0043401,1,0.30583635101854,0,174,steroid hormone mediated signaling pathway,BP,
11238,GO:0043402,1,0.977367877342581,0,3,glucocorticoid mediated signaling pathway,BP,
11239,GO:0043403,1,0.844644946135666,0,27,skeletal muscle tissue regeneration,BP,
11248,GO:0043414,1,0.182103758028023,0,253,macromolecule methylation,BP,
11249,GO:0043415,1,0.968644815678933,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11250,GO:0043416,1,0.968644815678933,0,5,regulation of skeletal muscle tissue regeneration,BP,
11251,GO:0043418,1,0.979850313467083,0,3,homocysteine catabolic process,BP,
11252,GO:0043420,1,0.995485080421186,0,1,anthranilate metabolic process,BP,
11253,GO:0043422,1,0.924236922754457,0,12,protein kinase B binding,MF,
11254,GO:0043423,1,0.992489460197031,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11255,GO:0043425,1,0.849372429310765,0,24,bHLH transcription factor binding,MF,
11256,GO:0043426,1,0.965270468850978,0,5,MRF binding,MF,
11257,GO:0043433,1,0.377250285429205,0,149,negative regulation of DNA binding transcription factor activity,BP,
11259,GO:0043435,1,0.967368097475711,0,5,response to corticotropin-releasing hormone,BP,
11261,GO:0043438,1,0.992974509894189,0,1,acetoacetic acid metabolic process,BP,
11263,GO:0043455,1,0.934326605039486,0,11,regulation of secondary metabolic process,BP,
11264,GO:0043456,1,0.981385831595401,0,4,regulation of pentose-phosphate shunt,BP,
11265,GO:0043457,1,0.870229044861479,0,21,regulation of cellular respiration,BP,
11266,GO:0043461,1,0.977522658548998,0,4,proton-transporting ATP synthase complex assembly,BP,
11267,GO:0043462,1,0.670031056345234,0,70,regulation of ATPase activity,BP,
11268,GO:0043467,1,0.482947712096166,0,108,regulation of generation of precursor metabolites and energy,BP,
11269,GO:0043470,1,0.629980480063743,0,69,regulation of carbohydrate catabolic process,BP,
11270,GO:0043471,1,0.949564968229808,0,9,regulation of cellular carbohydrate catabolic process,BP,
11271,GO:0043473,1,0.543371368846055,0,93,pigmentation,BP,
11272,GO:0043474,1,0.980435080166352,0,3,pigment metabolic process involved in pigmentation,BP,
11273,GO:0043476,1,0.925095568315371,0,12,pigment accumulation,BP,
11274,GO:0043482,1,0.925095568315371,0,12,cellular pigment accumulation,BP,
11276,GO:0043485,1,0.939897072920571,0,10,endosome to pigment granule transport,BP,
11277,GO:0043486,1,0.796467784804941,0,40,histone exchange,BP,
11278,GO:0043487,1,0.378844422332763,0,156,regulation of RNA stability,BP,
11279,GO:0043488,1,0.401054064795028,0,148,regulation of mRNA stability,BP,
11280,GO:0043489,1,0.786647507977163,0,35,RNA stabilization,BP,
11281,GO:0043490,1,0.985238204081078,0,2,malate-aspartate shuttle,BP,
11283,GO:0043492,1,0.461081267445039,0,109,ATPase activity, coupled to movement of substances,MF,
11284,GO:0043495,1,0.943235663079398,0,9,protein membrane anchor,MF,
11285,GO:0043496,1,0.875058847498927,0,21,regulation of protein homodimerization activity,BP,
11286,GO:0043497,1,0.940762894203129,0,10,regulation of protein heterodimerization activity,BP,
11287,GO:0043500,1,0.584221159380272,0,83,muscle adaptation,BP,
11288,GO:0043501,1,0.881427692725166,0,20,skeletal muscle adaptation,BP,
11289,GO:0043502,1,0.640409943165882,0,67,regulation of muscle adaptation,BP,
11290,GO:0043503,1,0.990440695030371,0,2,skeletal muscle fiber adaptation,BP,
11291,GO:0043504,1,0.978239736056966,0,3,mitochondrial DNA repair,BP,
11292,GO:0043506,1,0.586227424937723,0,77,regulation of JUN kinase activity,BP,
11293,GO:0043507,1,0.636138892080494,0,64,positive regulation of JUN kinase activity,BP,
11294,GO:0043508,1,0.918990717506644,0,13,negative regulation of JUN kinase activity,BP,
11295,GO:0043509,1,0.994206847407389,0,1,activin A complex,CC,
11296,GO:0043511,1,0.989818825221431,0,2,inhibin complex,CC,
11297,GO:0043512,1,0.989818825221431,0,2,inhibin A complex,CC,
11298,GO:0043513,1,0.995586670742104,0,1,inhibin B complex,CC,
11299,GO:0043514,1,0.995559571918776,0,1,interleukin-12 complex,CC,
11300,GO:0043515,1,0.966709453604195,0,5,kinetochore binding,MF,
11301,GO:0043516,1,0.836260494999841,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11302,GO:0043517,1,0.915352228560347,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11303,GO:0043518,1,0.918130982378472,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11304,GO:0043519,1,0.994335551361362,0,1,regulation of myosin II filament organization,BP,
11305,GO:0043522,1,0.949553304896082,0,9,leucine zipper domain binding,MF,
11308,GO:0043525,1,0.747077782840843,0,45,positive regulation of neuron apoptotic process,BP,
11309,GO:0043527,1,0.972513706853659,0,5,tRNA methyltransferase complex,CC,
11310,GO:0043531,1,0.796217778414176,0,33,ADP binding,MF,
11311,GO:0043532,1,0.99230334631138,0,1,angiostatin binding,MF,
11312,GO:0043533,1,0.96435652184044,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11313,GO:0043534,1,0.520406939693234,0,98,blood vessel endothelial cell migration,BP,
11314,GO:0043535,1,0.594659791719617,0,78,regulation of blood vessel endothelial cell migration,BP,
11315,GO:0043536,1,0.726636135170332,0,48,positive regulation of blood vessel endothelial cell migration,BP,
11316,GO:0043537,1,0.823945259321587,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11317,GO:0043538,1,0.99279985327218,0,1,regulation of actin phosphorylation,BP,
11318,GO:0043539,1,0.822090483310403,0,31,protein serine/threonine kinase activator activity,MF,
11319,GO:0043540,1,0.995054517796043,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11320,GO:0043541,1,0.985367169237607,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11321,GO:0043542,1,0.323912561117822,0,169,endothelial cell migration,BP,
11322,GO:0043543,1,0.242370551569416,0,215,protein acylation,BP,
11323,GO:0043544,1,0.992534274512751,0,1,lipoamide binding,MF,
11324,GO:0043545,1,0.957181597058405,0,7,molybdopterin cofactor metabolic process,BP,
11325,GO:0043546,1,0.95814512580823,0,6,molybdopterin cofactor binding,MF,
11327,GO:0043548,1,0.826104835478518,0,27,phosphatidylinositol 3-kinase binding,MF,
11330,GO:0043551,1,0.755605086097718,0,40,regulation of phosphatidylinositol 3-kinase activity,BP,
11331,GO:0043552,1,0.812214492727952,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11332,GO:0043553,1,0.986215836464529,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11333,GO:0043555,1,0.88814975179724,0,18,regulation of translation in response to stress,BP,
11334,GO:0043558,1,0.912835342134765,0,14,regulation of translational initiation in response to stress,BP,
11335,GO:0043559,1,0.962057197081482,0,5,insulin binding,MF,
11336,GO:0043560,1,0.921826951603101,0,11,insulin receptor substrate binding,MF,
11337,GO:0043562,1,0.943592005524054,0,11,cellular response to nitrogen levels,BP,
11338,GO:0043564,1,0.98688107996845,0,2,Ku70:Ku80 complex,CC,
11341,GO:0043568,1,0.943059279813999,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11342,GO:0043569,1,0.951908459484019,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11343,GO:0043570,1,0.963221689876963,0,5,maintenance of DNA repeat elements,BP,
11344,GO:0043574,1,0.886164858351651,0,18,peroxisomal transport,BP,
11346,GO:0043578,1,0.976600804323629,0,3,nuclear matrix organization,BP,
11348,GO:0043584,1,0.897416191576396,0,16,nose development,BP,
11349,GO:0043585,1,0.977747667098303,0,3,nose morphogenesis,BP,
11350,GO:0043586,1,0.882227856873813,0,19,tongue development,BP,
11351,GO:0043587,1,0.947704464774935,0,8,tongue morphogenesis,BP,
11352,GO:0043588,1,0.212459185204655,0,234,skin development,BP,
11353,GO:0043589,1,0.942285630488745,0,8,skin morphogenesis,BP,
11354,GO:0043596,1,0.767810579545637,0,41,nuclear replication fork,CC,
11355,GO:0043601,1,0.859988640346772,0,24,nuclear replisome,CC,
11356,GO:0043602,1,0.993543965901044,0,1,nitrate catabolic process,BP,
11359,GO:0043605,1,0.984919355833873,0,3,cellular amide catabolic process,BP,
11360,GO:0043606,1,0.974582917032379,0,4,formamide metabolic process,BP,
11361,GO:0043610,1,0.992133512631521,0,1,regulation of carbohydrate utilization,BP,
11362,GO:0043614,1,0.984977805638401,0,2,multi-eIF complex,CC,
11363,GO:0043615,1,0.958868419423198,0,7,astrocyte cell migration,BP,
11364,GO:0043616,1,0.793444531295165,0,33,keratinocyte proliferation,BP,
11365,GO:0043618,1,0.533488918338694,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11366,GO:0043619,1,0.932260561832894,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11367,GO:0043620,1,0.514609416988814,0,113,regulation of DNA-templated transcription in response to stress,BP,
11368,GO:0043621,1,0.704759484144376,0,51,protein self-association,MF,
11369,GO:0043622,1,0.970614385116463,0,4,cortical microtubule organization,BP,
11371,GO:0043625,1,0.976679666386465,0,4,delta DNA polymerase complex,CC,
11372,GO:0043626,1,0.995707210401901,0,1,PCNA complex,CC,
11374,GO:0043628,1,0.851342868987111,0,28,ncRNA 3'-end processing,BP,
11375,GO:0043629,1,0.992193119339442,0,1,ncRNA polyadenylation,BP,
11376,GO:0043630,1,0.992193119339442,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11377,GO:0043631,1,0.750635870569596,0,42,RNA polyadenylation,BP,
11379,GO:0043633,1,0.955575697903861,0,8,polyadenylation-dependent RNA catabolic process,BP,
11380,GO:0043634,1,0.962821893677391,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11381,GO:0043647,1,0.651699913311579,0,62,inositol phosphate metabolic process,BP,
11384,GO:0043650,1,0.924252615742371,0,12,dicarboxylic acid biosynthetic process,BP,
11385,GO:0043651,1,0.907828418070376,0,15,linoleic acid metabolic process,BP,
11386,GO:0043652,1,0.936217966891621,0,11,engulfment of apoptotic cell,BP,
11387,GO:0043653,1,0.949784766886813,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11388,GO:0043654,1,0.96293578433708,0,6,recognition of apoptotic cell,BP,
11389,GO:0043656,1,0.943350690780288,0,9,intracellular region of host,CC,
11390,GO:0043657,1,0.652472285264703,0,65,host cell,CC,
11391,GO:0043666,1,0.516792668064506,0,100,regulation of phosphoprotein phosphatase activity,BP,
11393,GO:0043682,1,0.984551994568206,0,2,copper-transporting ATPase activity,MF,
11394,GO:0043686,1,0.982683088795176,0,3,co-translational protein modification,BP,
11396,GO:0043691,1,0.929228672735962,0,13,reverse cholesterol transport,BP,
11397,GO:0043696,1,0.954371850652319,0,7,dedifferentiation,BP,
11398,GO:0043697,1,0.954371850652319,0,7,cell dedifferentiation,BP,
11399,GO:0043733,1,0.996040653319932,0,1,DNA-3-methylbase glycosylase activity,MF,
11400,GO:0043734,1,0.97763781334056,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11401,GO:0043739,1,0.992656460679826,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11402,GO:0043754,1,0.9919727708295,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11403,GO:0043783,1,0.993838653063675,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11404,GO:0043795,1,0.995611997115238,0,1,glyceraldehyde oxidoreductase activity,MF,
11405,GO:0043812,1,0.977691702863997,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11406,GO:0043813,1,0.96268238087427,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11407,GO:0043843,1,0.993454267129848,0,1,ADP-specific glucokinase activity,MF,
11408,GO:0043849,1,0.992927640297914,0,1,Ras palmitoyltransferase activity,MF,
11409,GO:0043855,1,0.944594700195018,0,8,cyclic nucleotide-gated ion channel activity,MF,
11410,GO:0043865,1,0.993101958031973,0,1,methionine transmembrane transporter activity,MF,
11411,GO:0043874,1,0.994526910786547,0,1,acireductone synthase activity,MF,
11412,GO:0043890,1,0.993805327330778,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11413,GO:0043891,1,0.995740477653328,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11415,GO:0043901,1,0.409548613219951,0,143,negative regulation of multi-organism process,BP,
11416,GO:0043902,1,0.366762844128599,0,158,positive regulation of multi-organism process,BP,
11417,GO:0043903,1,0.282785081495314,0,201,regulation of symbiosis, encompassing mutualism through parasitism,BP,
11418,GO:0043914,1,0.99250214587588,0,1,NADPH:sulfur oxidoreductase activity,MF,
11419,GO:0043916,1,0.996040653319932,0,1,DNA-7-methylguanine glycosylase activity,MF,
11420,GO:0043921,1,0.851419509508121,0,24,modulation by host of viral transcription,BP,
11421,GO:0043922,1,0.939345315886624,0,9,negative regulation by host of viral transcription,BP,
11422,GO:0043923,1,0.892350088832722,0,17,positive regulation by host of viral transcription,BP,
11423,GO:0043924,1,0.991574213347054,0,1,suramin binding,MF,
11424,GO:0043928,1,0.836760799438049,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11425,GO:0043931,1,0.902676376826686,0,14,ossification involved in bone maturation,BP,
11426,GO:0043932,1,0.976702809080364,0,4,ossification involved in bone remodeling,BP,
11428,GO:0043946,1,0.995046322358917,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11429,GO:0043947,1,0.995046322358917,0,1,positive regulation by host of symbiont catalytic activity,BP,
11434,GO:0043966,1,0.693262276760984,0,56,histone H3 acetylation,BP,
11435,GO:0043967,1,0.664997508670417,0,62,histone H4 acetylation,BP,
11436,GO:0043968,1,0.914389213211328,0,15,histone H2A acetylation,BP,
11437,GO:0043969,1,0.992132784581788,0,1,histone H2B acetylation,BP,
11438,GO:0043970,1,0.916925234279683,0,13,histone H3-K9 acetylation,BP,
11439,GO:0043972,1,0.992469474285025,0,1,histone H3-K23 acetylation,BP,
11440,GO:0043973,1,0.994138572394411,0,1,histone H3-K4 acetylation,BP,
11441,GO:0043974,1,0.978065397462886,0,3,histone H3-K27 acetylation,BP,
11442,GO:0043981,1,0.903670784294697,0,15,histone H4-K5 acetylation,BP,
11443,GO:0043982,1,0.903670784294697,0,15,histone H4-K8 acetylation,BP,
11444,GO:0043983,1,0.955776328561329,0,7,histone H4-K12 acetylation,BP,
11445,GO:0043984,1,0.881633370129098,0,18,histone H4-K16 acetylation,BP,
11446,GO:0043985,1,0.962495967193321,0,6,histone H4-R3 methylation,BP,
11447,GO:0043987,1,0.963312442432447,0,6,histone H3-S10 phosphorylation,BP,
11448,GO:0043988,1,0.981441311766153,0,3,histone H3-S28 phosphorylation,BP,
11449,GO:0043990,1,0.992759732834092,0,1,histone H2A-S1 phosphorylation,BP,
11450,GO:0043994,1,0.992469474285025,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11451,GO:0043995,1,0.932151670535879,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11452,GO:0043996,1,0.932151670535879,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11453,GO:0043997,1,0.992736616128885,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11454,GO:0043998,1,0.992611761719951,0,1,H2A histone acetyltransferase activity,MF,
11455,GO:0044003,1,0.772019033765339,0,38,modification by symbiont of host morphology or physiology,BP,
11456,GO:0044004,1,0.971803444464201,0,5,disruption by symbiont of host cell,BP,
11457,GO:0044007,1,0.992332187741306,0,1,dissemination or transmission of symbiont from host,BP,
11458,GO:0044010,1,0.993803373464768,0,1,single-species biofilm formation,BP,
11459,GO:0044020,1,0.976519936276632,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11460,GO:0044026,1,0.988148195714687,0,2,DNA hypermethylation,BP,
11461,GO:0044027,1,0.995606803906147,0,1,hypermethylation of CpG island,BP,
11462,GO:0044028,1,0.985074521761518,0,2,DNA hypomethylation,BP,
11463,GO:0044029,1,0.985074521761518,0,2,hypomethylation of CpG island,BP,
11464,GO:0044030,1,0.900435067435305,0,15,regulation of DNA methylation,BP,
11465,GO:0044033,1,0.958541949165312,0,7,multi-organism metabolic process,BP,
11466,GO:0044035,1,0.995238695253471,0,1,multi-organism catabolic process,BP,
11467,GO:0044036,1,0.975883229190281,0,5,cell wall macromolecule metabolic process,BP,
11468,GO:0044038,1,0.994995753572652,0,1,cell wall macromolecule biosynthetic process,BP,
11469,GO:0044042,1,0.6201470571471,0,69,glucan metabolic process,BP,
11470,GO:0044053,1,0.993719136156557,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11472,GO:0044058,1,0.827073659408362,0,32,regulation of digestive system process,BP,
11473,GO:0044060,1,0.77988499620944,0,40,regulation of endocrine process,BP,
11474,GO:0044062,1,0.884547799802516,0,19,regulation of excretion,BP,
11475,GO:0044065,1,0.904964879535046,0,15,regulation of respiratory system process,BP,
11476,GO:0044068,1,0.844210263365352,0,25,modulation by symbiont of host cellular process,BP,
11480,GO:0044088,1,0.774470637336007,0,39,regulation of vacuole organization,BP,
11482,GO:0044090,1,0.925829849940609,0,11,positive regulation of vacuole organization,BP,
11483,GO:0044091,1,0.803133376703608,0,32,membrane biogenesis,BP,
11486,GO:0044094,1,0.979046000361112,0,3,host cell nuclear part,CC,
11487,GO:0044105,1,0.996334396234701,0,1,L-xylulose reductase (NAD+) activity,MF,
11488,GO:0044106,1,0.533882094879619,0,112,cellular amine metabolic process,BP,
11489,GO:0044107,1,0.977647081258061,0,4,cellular alcohol metabolic process,BP,
11490,GO:0044108,1,0.977647081258061,0,4,cellular alcohol biosynthetic process,BP,
11491,GO:0044110,1,0.932683327661936,0,13,growth involved in symbiotic interaction,BP,
11492,GO:0044111,1,0.987607021341091,0,2,development involved in symbiotic interaction,BP,
11493,GO:0044115,1,0.995238695253471,0,1,development of symbiont involved in interaction with host,BP,
11494,GO:0044116,1,0.932683327661936,0,13,growth of symbiont involved in interaction with host,BP,
11495,GO:0044117,1,0.936000792809419,0,12,growth of symbiont in host,BP,
11496,GO:0044126,1,0.939571354817404,0,11,regulation of growth of symbiont in host,BP,
11497,GO:0044128,1,0.992443724279991,0,1,positive regulation of growth of symbiont in host,BP,
11498,GO:0044130,1,0.946729083113254,0,10,negative regulation of growth of symbiont in host,BP,
11499,GO:0044133,1,0.996458096886506,0,1,growth of symbiont on or near host,BP,
11500,GO:0044139,1,0.996458096886506,0,1,modulation of growth of symbiont on or near host,BP,
11501,GO:0044140,1,0.996458096886506,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11502,GO:0044144,1,0.936241364292187,0,12,modulation of growth of symbiont involved in interaction with host,BP,
11503,GO:0044145,1,0.995238695253471,0,1,modulation of development of symbiont involved in interaction with host,BP,
11504,GO:0044146,1,0.943373984363387,0,11,negative regulation of growth of symbiont involved in interaction with host,BP,
11505,GO:0044147,1,0.995238695253471,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11506,GO:0044148,1,0.992443724279991,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11507,GO:0044154,1,0.947293926306721,0,8,histone H3-K14 acetylation,BP,
11508,GO:0044179,1,0.987300920414236,0,2,hemolysis in other organism,BP,
11509,GO:0044183,1,0.790416936986573,0,38,protein binding involved in protein folding,MF,
11510,GO:0044190,1,0.995034445110811,0,1,host cell mitochondrial envelope,CC,
11511,GO:0044194,1,0.971795151261935,0,5,cytolytic granule,CC,
11512,GO:0044205,1,0.98010275443804,0,3,'de novo' UMP biosynthetic process,BP,
11513,GO:0044206,1,0.97391941737398,0,5,UMP salvage,BP,
11514,GO:0044207,1,0.992496133153366,0,1,translation initiation ternary complex,CC,
11515,GO:0044208,1,0.983673909089161,0,3,'de novo' AMP biosynthetic process,BP,
11516,GO:0044209,1,0.990895742713576,0,2,AMP salvage,BP,
11517,GO:0044210,1,0.98564843853402,0,2,'de novo' CTP biosynthetic process,BP,
11518,GO:0044211,1,0.98506928909188,0,3,CTP salvage,BP,
11520,GO:0044213,1,0.926431785214742,0,12,intronic transcription regulatory region DNA binding,MF,
11521,GO:0044214,1,0.963426669081932,0,5,spanning component of plasma membrane,CC,
11522,GO:0044215,1,0.63132474956252,0,70,other organism,CC,
11523,GO:0044216,1,0.63132474956252,0,70,other organism cell,CC,
11524,GO:0044217,1,0.63132474956252,0,70,other organism part,CC,
11525,GO:0044218,1,0.967355772640437,0,5,other organism cell membrane,CC,
11526,GO:0044220,1,0.992462018200445,0,1,host cell perinuclear region of cytoplasm,CC,
11527,GO:0044221,1,0.992495450415882,0,1,host cell synapse,CC,
11528,GO:0044224,1,0.930157762374427,0,10,juxtaparanode region of axon,CC,
11529,GO:0044228,1,0.992468780000021,0,1,host cell surface,CC,
11530,GO:0044231,1,0.992495450415882,0,1,host cell presynaptic membrane,CC,
11531,GO:0044232,1,0.88088869530063,0,19,organelle membrane contact site,CC,
11532,GO:0044233,1,0.918778876070392,0,13,ER-mitochondrion membrane contact site,CC,
11535,GO:0044241,1,0.945147900548004,0,9,lipid digestion,BP,
11537,GO:0044245,1,0.981603210216691,0,3,polysaccharide digestion,BP,
11538,GO:0044247,1,0.837470460147337,0,25,cellular polysaccharide catabolic process,BP,
11543,GO:0044258,1,0.993768333028796,0,1,intestinal lipid catabolic process,BP,
11545,GO:0044262,1,0.217052063634735,0,227,cellular carbohydrate metabolic process,BP,
11546,GO:0044264,1,0.543645881463117,0,88,cellular polysaccharide metabolic process,BP,
11552,GO:0044273,1,0.766196284239685,0,42,sulfur compound catabolic process,BP,
11553,GO:0044275,1,0.771021019290441,0,39,cellular carbohydrate catabolic process,BP,
11554,GO:0044279,1,0.967355772640437,0,5,other organism membrane,CC,
11558,GO:0044284,1,0.996259845628799,0,1,mitochondrial crista junction,CC,
11559,GO:0044291,1,0.646885430798238,0,62,cell-cell contact zone,CC,
11560,GO:0044292,1,0.935501356787867,0,10,dendrite terminus,CC,
11561,GO:0044294,1,0.956917820233759,0,6,dendritic growth cone,CC,
11562,GO:0044295,1,0.861614254365906,0,21,axonal growth cone,CC,
11565,GO:0044299,1,0.99232168597376,0,1,C-fiber,CC,
11567,GO:0044301,1,0.987987092696398,0,2,climbing fiber,CC,
11568,GO:0044302,1,0.970012089297177,0,4,dentate gyrus mossy fiber,CC,
11572,GO:0044307,1,0.991847648948235,0,1,dendritic branch,CC,
11573,GO:0044308,1,0.977229458399624,0,3,axonal spine,CC,
11575,GO:0044313,1,0.977209470582053,0,3,protein K6-linked deubiquitination,BP,
11576,GO:0044314,1,0.980496865966873,0,4,protein K27-linked ubiquitination,BP,
11577,GO:0044316,1,0.985994917051537,0,2,cone cell pedicle,CC,
11578,GO:0044317,1,0.995657523143073,0,1,rod spherule,CC,
11579,GO:0044319,1,0.834791165997699,0,27,wound healing, spreading of cells,BP,
11580,GO:0044320,1,0.902773566163997,0,15,cellular response to leptin stimulus,BP,
11581,GO:0044321,1,0.87882261769076,0,19,response to leptin,BP,
11582,GO:0044322,1,0.832404804316587,0,28,endoplasmic reticulum quality control compartment,CC,
11583,GO:0044323,1,0.970505045894427,0,4,retinoic acid-responsive element binding,MF,
11584,GO:0044324,1,0.996249785530288,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11586,GO:0044326,1,0.97189832833175,0,4,dendritic spine neck,CC,
11588,GO:0044331,1,0.80079133444332,0,32,cell-cell adhesion mediated by cadherin,BP,
11589,GO:0044332,1,0.954791963539203,0,6,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11590,GO:0044333,1,0.994795764468499,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11591,GO:0044334,1,0.985132540243401,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11592,GO:0044335,1,0.992028466866788,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11593,GO:0044336,1,0.978232646037207,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11594,GO:0044338,1,0.987993579124844,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11595,GO:0044339,1,0.973146179088537,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11596,GO:0044340,1,0.965846116666581,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11599,GO:0044343,1,0.992484179088526,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11600,GO:0044344,1,0.442685999104826,0,124,cellular response to fibroblast growth factor stimulus,BP,
11601,GO:0044345,1,0.992484179088526,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11602,GO:0044346,1,0.883389045354774,0,18,fibroblast apoptotic process,BP,
11603,GO:0044349,1,0.995081675552396,0,1,DNA excision,BP,
11604,GO:0044351,1,0.95340136482492,0,7,macropinocytosis,BP,
11605,GO:0044352,1,0.972891550786576,0,4,pinosome,CC,
11606,GO:0044354,1,0.972891550786576,0,4,macropinosome,CC,
11607,GO:0044355,1,0.995550473751808,0,1,clearance of foreign intracellular DNA,BP,
11608,GO:0044356,1,0.995550473751808,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11609,GO:0044359,1,0.955566695490707,0,8,modulation of molecular function in other organism,BP,
11610,GO:0044362,1,0.96295795785317,0,7,negative regulation of molecular function in other organism,BP,
11612,GO:0044375,1,0.987362505821919,0,3,regulation of peroxisome size,BP,
11613,GO:0044378,1,0.987902011621676,0,2,non-sequence-specific DNA binding, bending,MF,
11614,GO:0044380,1,0.704161883144891,0,49,protein localization to cytoskeleton,BP,
11615,GO:0044381,1,0.862445540028752,0,21,glucose import in response to insulin stimulus,BP,
11616,GO:0044387,1,0.950534953364103,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11617,GO:0044388,1,0.974792241496979,0,5,small protein activating enzyme binding,MF,
11619,GO:0044390,1,0.76362512732257,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11620,GO:0044391,1,0.455497845854498,0,181,ribosomal subunit,CC,
11621,GO:0044393,1,0.978493507385233,0,3,microspike,CC,
11622,GO:0044396,1,0.965392058909172,0,5,actin cortical patch organization,BP,
11623,GO:0044403,1,0.00700488702764271,0,786,symbiont process,BP,
11624,GO:0044406,1,0.930357475021528,0,11,adhesion of symbiont to host,BP,
11625,GO:0044407,1,0.993803373464768,0,1,single-species biofilm formation in or on host organism,BP,
11626,GO:0044409,1,0.449801461632732,0,121,entry into host,BP,
11627,GO:0044413,1,0.972447837117768,0,4,avoidance of host defenses,BP,
11628,GO:0044414,1,0.992434292396331,0,1,suppression of host defenses,BP,
11629,GO:0044415,1,0.972447837117768,0,4,evasion or tolerance of host defenses,BP,
11630,GO:0044416,1,0.994145695392548,0,1,induction by symbiont of host defense response,BP,
11631,GO:0044417,1,0.947958169052401,0,9,translocation of molecules into host,BP,
11633,GO:0044420,1,0.438841700147319,0,114,extracellular matrix component,CC,
11649,GO:0044441,1,0.081127014576975,0,369,ciliary part,CC,
11653,GO:0044447,1,0.814396246845599,0,29,axoneme part,CC,
11656,GO:0044450,1,0.336070850424761,0,159,microtubule organizing center part,CC,
11658,GO:0044452,1,0.346307206048974,0,169,nucleolar part,CC,
11659,GO:0044453,1,0.904570879629602,0,15,nuclear membrane part,CC,
11661,GO:0044455,1,0.402839464117717,0,170,mitochondrial membrane part,CC,
11663,GO:0044458,1,0.888751070330615,0,19,motile cilium assembly,BP,
11667,GO:0044467,1,0.986528236751183,0,2,glial cell-derived neurotrophic factor secretion,BP,
11668,GO:0044495,1,0.996352645489994,0,1,modulation of blood pressure in other organism,BP,
11669,GO:0044497,1,0.996352645489994,0,1,positive regulation of blood pressure in other organism,BP,
11670,GO:0044501,1,0.985129121261887,0,2,modulation of signal transduction in other organism,BP,
11671,GO:0044508,1,0.992732905485045,0,1,glucagon-like peptide 1 receptor activity,MF,
11672,GO:0044524,1,0.995049967525852,0,1,protein sulfhydration,BP,
11673,GO:0044528,1,0.974042983174116,0,4,regulation of mitochondrial mRNA stability,BP,
11674,GO:0044530,1,0.979298431192396,0,3,supraspliceosomal complex,CC,
11675,GO:0044531,1,0.964026020846371,0,6,modulation of programmed cell death in other organism,BP,
11676,GO:0044532,1,0.964026020846371,0,6,modulation of apoptotic process in other organism,BP,
11677,GO:0044533,1,0.984305221305541,0,3,positive regulation of apoptotic process in other organism,BP,
11678,GO:0044537,1,0.99497902520046,0,1,regulation of circulating fibrinogen levels,BP,
11679,GO:0044539,1,0.95616732156115,0,7,long-chain fatty acid import,BP,
11680,GO:0044540,1,0.995049967525852,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11681,GO:0044545,1,0.967649262778392,0,5,NSL complex,CC,
11682,GO:0044546,1,0.918774297562209,0,12,NLRP3 inflammasome complex assembly,BP,
11683,GO:0044547,1,0.965964100567394,0,5,DNA topoisomerase binding,MF,
11684,GO:0044548,1,0.92019777037991,0,14,S100 protein binding,MF,
11685,GO:0044549,1,0.996460136282059,0,1,GTP cyclohydrolase binding,MF,
11686,GO:0044550,1,0.867410444328199,0,22,secondary metabolite biosynthetic process,BP,
11687,GO:0044557,1,0.957777868189038,0,7,relaxation of smooth muscle,BP,
11688,GO:0044558,1,0.992449848111986,0,1,uterine smooth muscle relaxation,BP,
11689,GO:0044565,1,0.988422425789195,0,2,dendritic cell proliferation,BP,
11690,GO:0044571,1,0.982005218088225,0,4,[2Fe-2S] cluster assembly,BP,
11691,GO:0044594,1,0.993234101134144,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11692,GO:0044595,1,0.995807011225709,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11693,GO:0044596,1,0.995807011225709,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11694,GO:0044597,1,0.962643653228649,0,8,daunorubicin metabolic process,BP,
11695,GO:0044598,1,0.962643653228649,0,8,doxorubicin metabolic process,BP,
11696,GO:0044599,1,0.9930956730518,0,1,AP-5 adaptor complex,CC,
11697,GO:0044601,1,0.995218992452226,0,1,protein denucleotidylation,BP,
11698,GO:0044602,1,0.995218992452226,0,1,protein deadenylylation,BP,
11699,GO:0044603,1,0.995218992452226,0,1,protein adenylylhydrolase activity,MF,
11700,GO:0044609,1,0.987413110779779,0,2,DBIRD complex,CC,
11701,GO:0044610,1,0.994016006353376,0,1,FMN transmembrane transporter activity,MF,
11702,GO:0044611,1,0.977393836470221,0,3,nuclear pore inner ring,CC,
11703,GO:0044613,1,0.93439107921763,0,11,nuclear pore central transport channel,CC,
11704,GO:0044614,1,0.970540757051713,0,4,nuclear pore cytoplasmic filaments,CC,
11705,GO:0044615,1,0.943242024668622,0,8,nuclear pore nuclear basket,CC,
11706,GO:0044620,1,0.993046014416702,0,2,ACP phosphopantetheine attachment site binding,MF,
11707,GO:0044648,1,0.9930956730518,0,1,histone H3-K4 dimethylation,BP,
11708,GO:0044650,1,0.942532972274216,0,9,adhesion of symbiont to host cell,BP,
11709,GO:0044651,1,0.995782280998159,0,1,adhesion of symbiont to host epithelial cell,BP,
11710,GO:0044665,1,0.831393140603806,0,28,MLL1/2 complex,CC,
11711,GO:0044666,1,0.932903675584171,0,10,MLL3/4 complex,CC,
11712,GO:0044691,1,0.977107329838693,0,3,tooth eruption,BP,
11715,GO:0044713,1,0.996458096886506,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11716,GO:0044714,1,0.996458096886506,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11717,GO:0044715,1,0.99588495169311,0,1,8-oxo-dGDP phosphatase activity,MF,
11718,GO:0044721,1,0.994699377532294,0,1,protein import into peroxisome matrix, substrate release,BP,
11719,GO:0044722,1,0.992503924341286,0,1,renal phosphate excretion,BP,
11720,GO:0044725,1,0.991960257597572,0,1,chromatin reprogramming in the zygote,BP,
11721,GO:0044727,1,0.991960257597572,0,1,DNA demethylation of male pronucleus,BP,
11722,GO:0044728,1,0.607011416902888,0,74,DNA methylation or demethylation,BP,
11723,GO:0044729,1,0.985621910040795,0,2,hemi-methylated DNA-binding,MF,
11724,GO:0044730,1,0.995238695253471,0,1,bone sialoprotein binding,MF,
11725,GO:0044732,1,0.9930956730518,0,1,mitotic spindle pole body,CC,
11726,GO:0044736,1,0.979428260561731,0,3,acid-sensing ion channel activity,MF,
11727,GO:0044743,1,0.807744089590636,0,37,protein transmembrane import into intracellular organelle,BP,
11728,GO:0044752,1,0.97932335018505,0,3,response to human chorionic gonadotropin,BP,
11729,GO:0044753,1,0.985094451668017,0,2,amphisome,CC,
11730,GO:0044754,1,0.953116198564777,0,8,autolysosome,CC,
11731,GO:0044764,1,0.804187850373256,0,33,multi-organism cellular process,BP,
11732,GO:0044766,1,0.641534529450149,0,69,multi-organism transport,BP,
11733,GO:0044769,1,0.890086096488304,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11735,GO:0044771,1,0.985717249523591,0,2,meiotic cell cycle phase transition,BP,
11737,GO:0044773,1,0.525564644456624,0,100,mitotic DNA damage checkpoint,BP,
11738,GO:0044774,1,0.504755031835957,0,106,mitotic DNA integrity checkpoint,BP,
11739,GO:0044778,1,0.987809691649112,0,2,meiotic DNA integrity checkpoint,BP,
11740,GO:0044779,1,0.992813660106105,0,1,meiotic spindle checkpoint,BP,
11742,GO:0044783,1,0.640943461678583,0,70,G1 DNA damage checkpoint,BP,
11743,GO:0044784,1,0.717541431351863,0,51,metaphase/anaphase transition of cell cycle,BP,
11744,GO:0044785,1,0.992813660106105,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11745,GO:0044786,1,0.696327736137554,0,57,cell cycle DNA replication,BP,
11746,GO:0044788,1,0.876488148756257,0,20,modulation by host of viral process,BP,
11747,GO:0044789,1,0.963188949515701,0,5,modulation by host of viral release from host cell,BP,
11748,GO:0044791,1,0.963188949515701,0,5,positive regulation by host of viral release from host cell,BP,
11749,GO:0044793,1,0.961017936118367,0,6,negative regulation by host of viral process,BP,
11750,GO:0044794,1,0.918376929455248,0,13,positive regulation by host of viral process,BP,
11751,GO:0044795,1,0.995952640561838,0,1,trans-Golgi network to recycling endosome transport,BP,
11752,GO:0044796,1,0.995707210401901,0,1,DNA polymerase processivity factor complex,CC,
11753,GO:0044798,1,0.320234862484403,0,175,nuclear transcription factor complex,CC,
11754,GO:0044800,1,0.962543707123116,0,6,multi-organism membrane fusion,BP,
11755,GO:0044803,1,0.955280450545205,0,7,multi-organism membrane organization,BP,
11756,GO:0044804,1,0.882305567061613,0,19,autophagy of nucleus,BP,
11757,GO:0044805,1,0.977609330280744,0,3,late nucleophagy,BP,
11758,GO:0044806,1,0.949252406048635,0,7,G-quadruplex DNA unwinding,BP,
11759,GO:0044815,1,0.76021502680259,0,54,DNA packaging complex,CC,
11760,GO:0044818,1,0.838207351169259,0,26,mitotic G2/M transition checkpoint,BP,
11761,GO:0044819,1,0.645757952017255,0,69,mitotic G1/S transition checkpoint,BP,
11762,GO:0044821,1,0.966318303500514,0,5,meiotic telomere tethering at nuclear periphery,BP,
11763,GO:0044827,1,0.921079901643942,0,12,modulation by host of viral genome replication,BP,
11764,GO:0044828,1,0.972180349756862,0,4,negative regulation by host of viral genome replication,BP,
11765,GO:0044829,1,0.953995313223254,0,7,positive regulation by host of viral genome replication,BP,
11766,GO:0044830,1,0.985483750701946,0,2,modulation by host of viral RNA genome replication,BP,
11767,GO:0044837,1,0.951705305818905,0,7,actomyosin contractile ring organization,BP,
11768,GO:0044839,1,0.200802282673792,0,252,cell cycle G2/M phase transition,BP,
11770,GO:0044848,1,0.940966150704753,0,9,biological phase,BP,
11771,GO:0044849,1,0.918124586118822,0,14,estrous cycle,BP,
11772,GO:0044851,1,0.940966150704753,0,9,hair cycle phase,BP,
11773,GO:0044853,1,0.524568202338036,0,93,plasma membrane raft,CC,
11774,GO:0044854,1,0.975378793754535,0,4,plasma membrane raft assembly,BP,
11775,GO:0044855,1,0.993166212636534,0,1,plasma membrane raft distribution,BP,
11776,GO:0044856,1,0.993166212636534,0,1,plasma membrane raft localization,BP,
11777,GO:0044857,1,0.975378793754535,0,4,plasma membrane raft organization,BP,
11778,GO:0044858,1,0.993166212636534,0,1,plasma membrane raft polarization,BP,
11779,GO:0044860,1,0.974013832620988,0,4,protein localization to plasma membrane raft,BP,
11780,GO:0044861,1,0.987214177427577,0,2,protein transport into plasma membrane raft,BP,
11781,GO:0044866,1,0.994685480976322,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11782,GO:0044867,1,0.994685480976322,0,1,modulation by host of viral catalytic activity,BP,
11783,GO:0044868,1,0.987053206967686,0,2,modulation by host of viral molecular function,BP,
11784,GO:0044869,1,0.994685480976322,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11785,GO:0044870,1,0.994685480976322,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11786,GO:0044871,1,0.994685480976322,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11787,GO:0044872,1,0.913700359318128,0,13,lipoprotein localization,BP,
11789,GO:0044878,1,0.979047266657369,0,4,mitotic cytokinesis checkpoint,BP,
11790,GO:0045002,1,0.96015569592686,0,6,double-strand break repair via single-strand annealing,BP,
11791,GO:0045003,1,0.937851352421182,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11792,GO:0045004,1,0.984827348357289,0,2,DNA replication proofreading,BP,
11793,GO:0045005,1,0.802308886536316,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11794,GO:0045006,1,0.940141257989451,0,12,DNA deamination,BP,
11795,GO:0045007,1,0.985698731615808,0,3,depurination,BP,
11796,GO:0045008,1,0.956740823850092,0,8,depyrimidination,BP,
11797,GO:0045009,1,0.939403975745039,0,11,chitosome,CC,
11798,GO:0045010,1,0.748151214110742,0,45,actin nucleation,BP,
11799,GO:0045016,1,0.99260737169117,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11800,GO:0045017,1,0.192250561884654,0,246,glycerolipid biosynthetic process,BP,
11801,GO:0045019,1,0.928801432271282,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11802,GO:0045022,1,0.779381875335491,0,37,early endosome to late endosome transport,BP,
11803,GO:0045023,1,0.752588376228912,0,42,G0 to G1 transition,BP,
11804,GO:0045025,1,0.986114554210605,0,2,mitochondrial degradosome,CC,
11806,GO:0045027,1,0.994349850897736,0,1,DNA end binding,MF,
11807,GO:0045028,1,0.932609544919803,0,12,G-protein coupled purinergic nucleotide receptor activity,MF,
11808,GO:0045029,1,0.988472595705705,0,2,UDP-activated nucleotide receptor activity,MF,
11809,GO:0045030,1,0.995242960354168,0,1,UTP-activated nucleotide receptor activity,MF,
11810,GO:0045031,1,0.987406423276806,0,2,ATP-activated adenosine receptor activity,MF,
11811,GO:0045032,1,0.992754206822178,0,1,ADP-activated adenosine receptor activity,MF,
11812,GO:0045039,1,0.972233671977733,0,6,protein import into mitochondrial inner membrane,BP,
11813,GO:0045040,1,0.969225940619312,0,6,protein import into mitochondrial outer membrane,BP,
11814,GO:0045041,1,0.989379224051687,0,2,protein import into mitochondrial intermembrane space,BP,
11815,GO:0045046,1,0.959692692034362,0,6,protein import into peroxisome membrane,BP,
11816,GO:0045047,1,0.656202198623199,0,100,protein targeting to ER,BP,
11817,GO:0045048,1,0.969490857583923,0,5,protein insertion into ER membrane,BP,
11818,GO:0045053,1,0.961253570435583,0,5,protein retention in Golgi apparatus,BP,
11819,GO:0045054,1,0.976500682970124,0,4,constitutive secretory pathway,BP,
11822,GO:0045058,1,0.761709544161118,0,42,T cell selection,BP,
11823,GO:0045059,1,0.948411771853122,0,9,positive thymic T cell selection,BP,
11824,GO:0045060,1,0.94102782486205,0,10,negative thymic T cell selection,BP,
11825,GO:0045061,1,0.892083830674222,0,18,thymic T cell selection,BP,
11826,GO:0045062,1,0.995113941510925,0,1,extrathymic T cell selection,BP,
11827,GO:0045063,1,0.894618764244376,0,17,T-helper 1 cell differentiation,BP,
11828,GO:0045064,1,0.916720686302737,0,14,T-helper 2 cell differentiation,BP,
11829,GO:0045065,1,0.980845689419425,0,3,cytotoxic T cell differentiation,BP,
11830,GO:0045066,1,0.842781193609258,0,26,regulatory T cell differentiation,BP,
11831,GO:0045069,1,0.595850491703094,0,81,regulation of viral genome replication,BP,
11832,GO:0045070,1,0.806413639011815,0,32,positive regulation of viral genome replication,BP,
11833,GO:0045071,1,0.740061172409372,0,49,negative regulation of viral genome replication,BP,
11834,GO:0045072,1,0.916534013075994,0,14,regulation of interferon-gamma biosynthetic process,BP,
11835,GO:0045073,1,0.94229439370532,0,11,regulation of chemokine biosynthetic process,BP,
11836,GO:0045074,1,0.979906302169959,0,3,regulation of interleukin-10 biosynthetic process,BP,
11837,GO:0045075,1,0.953962801424557,0,7,regulation of interleukin-12 biosynthetic process,BP,
11838,GO:0045076,1,0.898846146265027,0,17,regulation of interleukin-2 biosynthetic process,BP,
11839,GO:0045077,1,0.976860855929641,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11840,GO:0045078,1,0.938258475263986,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11841,GO:0045079,1,0.987379654468168,0,3,negative regulation of chemokine biosynthetic process,BP,
11842,GO:0045080,1,0.954344267552154,0,8,positive regulation of chemokine biosynthetic process,BP,
11843,GO:0045081,1,0.992528562305407,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11844,GO:0045082,1,0.987283690079989,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11845,GO:0045083,1,0.992497962251046,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11846,GO:0045084,1,0.968552001826515,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11847,GO:0045085,1,0.979440102050175,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11848,GO:0045086,1,0.922715377092282,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11850,GO:0045088,1,0.0989800256407275,0,361,regulation of innate immune response,BP,
11851,GO:0045089,1,0.141904573577372,0,306,positive regulation of innate immune response,BP,
11852,GO:0045091,1,0.932970000519146,0,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11853,GO:0045092,1,0.992531098712922,0,1,interleukin-18 receptor complex,CC,
11854,GO:0045095,1,0.887146153441544,0,20,keratin filament,CC,
11855,GO:0045098,1,0.98388101866243,0,3,type III intermediate filament,CC,
11858,GO:0045105,1,0.992405588969486,0,1,intermediate filament polymerization or depolymerization,BP,
11859,GO:0045106,1,0.992405588969486,0,1,intermediate filament depolymerization,BP,
11860,GO:0045108,1,0.992405588969486,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11864,GO:0045112,1,0.969289028794694,0,5,integrin biosynthetic process,BP,
11865,GO:0045113,1,0.976953824012422,0,4,regulation of integrin biosynthetic process,BP,
11866,GO:0045116,1,0.926928393456474,0,14,protein neddylation,BP,
11867,GO:0045117,1,0.887828981488887,0,19,azole transport,BP,
11868,GO:0045120,1,0.921795928669072,0,12,pronucleus,CC,
11871,GO:0045124,1,0.820677029785094,0,30,regulation of bone resorption,BP,
11872,GO:0045125,1,0.915178261882481,0,15,bioactive lipid receptor activity,MF,
11873,GO:0045127,1,0.995340120683152,0,1,N-acetylglucosamine kinase activity,MF,
11874,GO:0045128,1,0.99271425012845,0,1,negative regulation of reciprocal meiotic recombination,BP,
11875,GO:0045130,1,0.993194009839091,0,1,keratan sulfotransferase activity,MF,
11876,GO:0045131,1,0.992859650556228,0,1,pre-mRNA branch point binding,MF,
11877,GO:0045132,1,0.631399839810362,0,70,meiotic chromosome segregation,BP,
11878,GO:0045134,1,0.97334334877614,0,4,uridine-diphosphatase activity,MF,
11879,GO:0045136,1,0.945841168963172,0,9,development of secondary sexual characteristics,BP,
11881,GO:0045141,1,0.932301164634903,0,10,meiotic telomere clustering,BP,
11882,GO:0045142,1,0.985032999082517,0,2,triplex DNA binding,MF,
11883,GO:0045143,1,0.74037008447983,0,46,homologous chromosome segregation,BP,
11884,GO:0045144,1,0.957742958248244,0,7,meiotic sister chromatid segregation,BP,
11885,GO:0045145,1,0.985830097255265,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11886,GO:0045153,1,0.995880984378134,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11887,GO:0045155,1,0.988321906349692,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11888,GO:0045159,1,0.966251404771802,0,6,myosin II binding,MF,
11889,GO:0045161,1,0.918944957087709,0,12,neuronal ion channel clustering,BP,
11890,GO:0045162,1,0.949824352892125,0,7,clustering of voltage-gated sodium channels,BP,
11891,GO:0045163,1,0.978144136211719,0,3,clustering of voltage-gated potassium channels,BP,
11893,GO:0045167,1,0.99510680161285,0,1,asymmetric protein localization involved in cell fate determination,BP,
11894,GO:0045168,1,0.9881932031887,0,2,cell-cell signaling involved in cell fate commitment,BP,
11895,GO:0045171,1,0.703814257803649,0,54,intercellular bridge,CC,
11896,GO:0045174,1,0.991874589953119,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11897,GO:0045176,1,0.926850814579013,0,11,apical protein localization,BP,
11899,GO:0045178,1,0.710360926265654,0,49,basal part of cell,CC,
11900,GO:0045179,1,0.958880110253433,0,7,apical cortex,CC,
11901,GO:0045180,1,0.962260168990096,0,5,basal cortex,CC,
11905,GO:0045185,1,0.514036326323641,0,102,maintenance of protein location,BP,
11906,GO:0045186,1,0.992238295793342,0,1,zonula adherens assembly,BP,
11907,GO:0045187,1,0.917841108141895,0,16,regulation of circadian sleep/wake cycle, sleep,BP,
11908,GO:0045188,1,0.960443203556611,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11909,GO:0045190,1,0.771254174918489,0,39,isotype switching,BP,
11910,GO:0045191,1,0.836054262356788,0,27,regulation of isotype switching,BP,
11911,GO:0045196,1,0.9790195703954,0,3,establishment or maintenance of neuroblast polarity,BP,
11912,GO:0045197,1,0.754719971577438,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11913,GO:0045198,1,0.917429167237927,0,13,establishment of epithelial cell apical/basal polarity,BP,
11914,GO:0045199,1,0.92716696277164,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11915,GO:0045200,1,0.9790195703954,0,3,establishment of neuroblast polarity,BP,
11917,GO:0045204,1,0.977634568667733,0,3,MAPK export from nucleus,BP,
11918,GO:0045208,1,0.992538092339853,0,1,MAPK phosphatase export from nucleus,BP,
11919,GO:0045209,1,0.992538092339853,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11920,GO:0045210,1,0.984846465103416,0,2,FasL biosynthetic process,BP,
11922,GO:0045212,1,0.993418410569946,0,1,neurotransmitter receptor biosynthetic process,BP,
11923,GO:0045213,1,0.982601085530911,0,3,neurotransmitter receptor metabolic process,BP,
11924,GO:0045214,1,0.749009460038666,0,43,sarcomere organization,BP,
11925,GO:0045216,1,0.206024205603897,0,224,cell-cell junction organization,BP,
11926,GO:0045217,1,0.93625947834826,0,10,cell-cell junction maintenance,BP,
11927,GO:0045218,1,0.978310493623887,0,3,zonula adherens maintenance,BP,
11928,GO:0045219,1,0.992414500628079,0,1,regulation of FasL biosynthetic process,BP,
11929,GO:0045221,1,0.992414500628079,0,1,negative regulation of FasL biosynthetic process,BP,
11930,GO:0045222,1,0.995950074278353,0,1,CD4 biosynthetic process,BP,
11931,GO:0045223,1,0.995950074278353,0,1,regulation of CD4 biosynthetic process,BP,
11932,GO:0045225,1,0.995950074278353,0,1,negative regulation of CD4 biosynthetic process,BP,
11933,GO:0045226,1,0.980389422730769,0,3,extracellular polysaccharide biosynthetic process,BP,
11934,GO:0045229,1,0.986386241051932,0,2,external encapsulating structure organization,BP,
11935,GO:0045234,1,0.994973430152043,0,1,protein palmitoleylation,BP,
11936,GO:0045236,1,0.922880808711012,0,16,CXCR chemokine receptor binding,MF,
11937,GO:0045239,1,0.918057733805548,0,13,tricarboxylic acid cycle enzyme complex,CC,
11938,GO:0045240,1,0.928438366851746,0,11,dihydrolipoyl dehydrogenase complex,CC,
11939,GO:0045244,1,0.993834721845543,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11940,GO:0045251,1,0.993838653063675,0,1,electron transfer flavoprotein complex,CC,
11941,GO:0045252,1,0.952441649324405,0,7,oxoglutarate dehydrogenase complex,CC,
11942,GO:0045254,1,0.953674067002642,0,7,pyruvate dehydrogenase complex,CC,
11943,GO:0045257,1,0.97874865368541,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11944,GO:0045259,1,0.989806483327499,0,2,proton-transporting ATP synthase complex,CC,
11945,GO:0045263,1,0.995625301282031,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11946,GO:0045271,1,0.835956224082939,0,43,respiratory chain complex I,CC,
11947,GO:0045272,1,0.985246239989749,0,3,plasma membrane respiratory chain complex I,CC,
11948,GO:0045273,1,0.97874865368541,0,4,respiratory chain complex II,CC,
11949,GO:0045274,1,0.993754774569947,0,1,plasma membrane respiratory chain complex II,CC,
11950,GO:0045275,1,0.945197499181358,0,11,respiratory chain complex III,CC,
11951,GO:0045277,1,0.950198223670773,0,14,respiratory chain complex IV,CC,
11952,GO:0045281,1,0.97874865368541,0,4,succinate dehydrogenase complex,CC,
11953,GO:0045282,1,0.993754774569947,0,1,plasma membrane succinate dehydrogenase complex,CC,
11954,GO:0045283,1,0.97874865368541,0,4,fumarate reductase complex,CC,
11955,GO:0045292,1,0.897768270258085,0,17,mRNA cis splicing, via spliceosome,BP,
11956,GO:0045293,1,0.984132190490174,0,3,mRNA editing complex,CC,
11957,GO:0045294,1,0.92270556495593,0,11,alpha-catenin binding,MF,
11958,GO:0045295,1,0.918659106133598,0,11,gamma-catenin binding,MF,
11959,GO:0045296,1,0.126162747051253,0,309,cadherin binding,MF,
11960,GO:0045297,1,0.994023062010398,0,1,post-mating behavior,BP,
11961,GO:0045298,1,0.96651562042022,0,5,tubulin complex,CC,
11964,GO:0045322,1,0.978627257909098,0,3,unmethylated CpG binding,MF,
11965,GO:0045323,1,0.980255997472491,0,3,interleukin-1 receptor complex,CC,
11966,GO:0045324,1,0.936999359568162,0,11,late endosome to vacuole transport,BP,
11967,GO:0045329,1,0.968712613584262,0,5,carnitine biosynthetic process,BP,
11968,GO:0045332,1,0.839528502787861,0,23,phospholipid translocation,BP,
11969,GO:0045333,1,0.415588050524318,0,162,cellular respiration,BP,
11970,GO:0045334,1,0.705094911184612,0,57,clathrin-coated endocytic vesicle,CC,
11971,GO:0045335,1,0.475131633987815,0,118,phagocytic vesicle,CC,
11972,GO:0045337,1,0.975070262063297,0,4,farnesyl diphosphate biosynthetic process,BP,
11973,GO:0045338,1,0.969545606998354,0,5,farnesyl diphosphate metabolic process,BP,
11974,GO:0045340,1,0.99622159485821,0,1,mercury ion binding,MF,
11975,GO:0045341,1,0.963403471637566,0,5,MHC class I biosynthetic process,BP,
11976,GO:0045342,1,0.935404671461954,0,11,MHC class II biosynthetic process,BP,
11977,GO:0045343,1,0.963403471637566,0,5,regulation of MHC class I biosynthetic process,BP,
11978,GO:0045345,1,0.963403471637566,0,5,positive regulation of MHC class I biosynthetic process,BP,
11979,GO:0045346,1,0.942473160694378,0,10,regulation of MHC class II biosynthetic process,BP,
11980,GO:0045347,1,0.972694166916972,0,5,negative regulation of MHC class II biosynthetic process,BP,
11981,GO:0045348,1,0.964338393759832,0,6,positive regulation of MHC class II biosynthetic process,BP,
11982,GO:0045349,1,0.961619600749069,0,6,interferon-alpha biosynthetic process,BP,
11983,GO:0045350,1,0.941069710398356,0,9,interferon-beta biosynthetic process,BP,
11984,GO:0045351,1,0.931540274371346,0,11,type I interferon biosynthetic process,BP,
11985,GO:0045352,1,0.994980888130085,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11986,GO:0045353,1,0.994980888130085,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11987,GO:0045354,1,0.961619600749069,0,6,regulation of interferon-alpha biosynthetic process,BP,
11988,GO:0045355,1,0.9907664345937,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11989,GO:0045356,1,0.970584274425955,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
11990,GO:0045357,1,0.941069710398356,0,9,regulation of interferon-beta biosynthetic process,BP,
11991,GO:0045358,1,0.99078833121703,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11992,GO:0045359,1,0.949823752055182,0,7,positive regulation of interferon-beta biosynthetic process,BP,
11993,GO:0045360,1,0.985368230065074,0,3,regulation of interleukin-1 biosynthetic process,BP,
11994,GO:0045362,1,0.985368230065074,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
11995,GO:0045366,1,0.992425739494694,0,1,regulation of interleukin-13 biosynthetic process,BP,
11996,GO:0045368,1,0.992425739494694,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
11997,GO:0045381,1,0.992661572531617,0,1,regulation of interleukin-18 biosynthetic process,BP,
11998,GO:0045399,1,0.992448093317305,0,1,regulation of interleukin-3 biosynthetic process,BP,
11999,GO:0045401,1,0.992448093317305,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12000,GO:0045402,1,0.978435318874044,0,3,regulation of interleukin-4 biosynthetic process,BP,
12001,GO:0045403,1,0.992658152060687,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12002,GO:0045404,1,0.985673041437394,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12003,GO:0045408,1,0.921641536476875,0,13,regulation of interleukin-6 biosynthetic process,BP,
12004,GO:0045409,1,0.975131314682205,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12005,GO:0045410,1,0.955180007640631,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12006,GO:0045414,1,0.94447107475442,0,9,regulation of interleukin-8 biosynthetic process,BP,
12007,GO:0045415,1,0.977964577825461,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12008,GO:0045416,1,0.962121176657708,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12009,GO:0045423,1,0.98563411270596,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12010,GO:0045425,1,0.98563411270596,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12011,GO:0045428,1,0.739820880339082,0,47,regulation of nitric oxide biosynthetic process,BP,
12012,GO:0045429,1,0.79666957682225,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12013,GO:0045444,1,0.278853143988065,0,193,fat cell differentiation,BP,
12015,GO:0045446,1,0.542080634696771,0,90,endothelial cell differentiation,BP,
12016,GO:0045448,1,0.974279756961907,0,4,mitotic cell cycle, embryonic,BP,
12017,GO:0045453,1,0.732396194968608,0,48,bone resorption,BP,
12018,GO:0045454,1,0.692675921942142,0,63,cell redox homeostasis,BP,
12020,GO:0045472,1,0.937169564333909,0,10,response to ether,BP,
12021,GO:0045475,1,0.931212573446618,0,10,locomotor rhythm,BP,
12022,GO:0045485,1,0.992486293116064,0,1,omega-6 fatty acid desaturase activity,MF,
12023,GO:0045494,1,0.806533663515825,0,31,photoreceptor cell maintenance,BP,
12024,GO:0045495,1,0.908697523500126,0,14,pole plasm,CC,
12025,GO:0045499,1,0.857784359711626,0,21,chemorepellent activity,MF,
12026,GO:0045503,1,0.834091100180437,0,24,dynein light chain binding,MF,
12027,GO:0045504,1,0.910623107482456,0,14,dynein heavy chain binding,MF,
12028,GO:0045505,1,0.823905207545843,0,28,dynein intermediate chain binding,MF,
12029,GO:0045509,1,0.985386759253413,0,2,interleukin-27 receptor activity,MF,
12030,GO:0045513,1,0.995559571918776,0,1,interleukin-27 binding,MF,
12031,GO:0045519,1,0.996096642961063,0,1,interleukin-23 receptor binding,MF,
12032,GO:0045523,1,0.992094296009109,0,2,interleukin-27 receptor binding,MF,
12033,GO:0045540,1,0.759995706477554,0,41,regulation of cholesterol biosynthetic process,BP,
12034,GO:0045541,1,0.972555545302471,0,5,negative regulation of cholesterol biosynthetic process,BP,
12035,GO:0045542,1,0.964317924538212,0,5,positive regulation of cholesterol biosynthetic process,BP,
12036,GO:0045545,1,0.95971971842348,0,6,syndecan binding,MF,
12037,GO:0045550,1,0.991182289855314,0,2,geranylgeranyl reductase activity,MF,
12038,GO:0045553,1,0.992818204671279,0,1,TRAIL biosynthetic process,BP,
12039,GO:0045554,1,0.992818204671279,0,1,regulation of TRAIL biosynthetic process,BP,
12040,GO:0045556,1,0.992818204671279,0,1,positive regulation of TRAIL biosynthetic process,BP,
12041,GO:0045569,1,0.975929161386109,0,4,TRAIL binding,MF,
12042,GO:0045575,1,0.986868010209346,0,2,basophil activation,BP,
12044,GO:0045577,1,0.837492398767437,0,27,regulation of B cell differentiation,BP,
12045,GO:0045578,1,0.97083170022781,0,5,negative regulation of B cell differentiation,BP,
12046,GO:0045579,1,0.920275683028549,0,13,positive regulation of B cell differentiation,BP,
12048,GO:0045581,1,0.832911578001095,0,28,negative regulation of T cell differentiation,BP,
12050,GO:0045583,1,0.987759515363388,0,2,regulation of cytotoxic T cell differentiation,BP,
12051,GO:0045585,1,0.987759515363388,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12052,GO:0045586,1,0.970226402424824,0,4,regulation of gamma-delta T cell differentiation,BP,
12053,GO:0045588,1,0.977561273898774,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12054,GO:0045589,1,0.853797144376708,0,24,regulation of regulatory T cell differentiation,BP,
12055,GO:0045590,1,0.979943881268278,0,3,negative regulation of regulatory T cell differentiation,BP,
12056,GO:0045591,1,0.942491819911561,0,10,positive regulation of regulatory T cell differentiation,BP,
12060,GO:0045598,1,0.478444664379838,0,111,regulation of fat cell differentiation,BP,
12061,GO:0045599,1,0.749564357881471,0,43,negative regulation of fat cell differentiation,BP,
12062,GO:0045600,1,0.70260048317427,0,54,positive regulation of fat cell differentiation,BP,
12063,GO:0045601,1,0.815221224763346,0,30,regulation of endothelial cell differentiation,BP,
12064,GO:0045602,1,0.94423848492543,0,8,negative regulation of endothelial cell differentiation,BP,
12065,GO:0045603,1,0.90385527570346,0,15,positive regulation of endothelial cell differentiation,BP,
12066,GO:0045604,1,0.731567099971988,0,48,regulation of epidermal cell differentiation,BP,
12067,GO:0045605,1,0.945059318056929,0,9,negative regulation of epidermal cell differentiation,BP,
12068,GO:0045606,1,0.878572402814049,0,20,positive regulation of epidermal cell differentiation,BP,
12069,GO:0045607,1,0.956563772248635,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12070,GO:0045608,1,0.980375321343953,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12071,GO:0045616,1,0.811724077928599,0,31,regulation of keratinocyte differentiation,BP,
12072,GO:0045617,1,0.974488938373438,0,4,negative regulation of keratinocyte differentiation,BP,
12073,GO:0045618,1,0.910769364166603,0,14,positive regulation of keratinocyte differentiation,BP,
12075,GO:0045620,1,0.801166718277183,0,35,negative regulation of lymphocyte differentiation,BP,
12077,GO:0045622,1,0.84653784746939,0,26,regulation of T-helper cell differentiation,BP,
12078,GO:0045623,1,0.914220028264983,0,13,negative regulation of T-helper cell differentiation,BP,
12079,GO:0045624,1,0.907523838216729,0,16,positive regulation of T-helper cell differentiation,BP,
12080,GO:0045625,1,0.94151800531913,0,10,regulation of T-helper 1 cell differentiation,BP,
12081,GO:0045626,1,0.978889986631785,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12082,GO:0045627,1,0.965604165737209,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12083,GO:0045628,1,0.931724337466727,0,11,regulation of T-helper 2 cell differentiation,BP,
12084,GO:0045629,1,0.974866637363749,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12085,GO:0045630,1,0.955756671575502,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12086,GO:0045631,1,0.956563772248635,0,7,regulation of mechanoreceptor differentiation,BP,
12087,GO:0045632,1,0.976213661000238,0,4,negative regulation of mechanoreceptor differentiation,BP,
12088,GO:0045634,1,0.952188527852008,0,7,regulation of melanocyte differentiation,BP,
12089,GO:0045636,1,0.962242373200325,0,5,positive regulation of melanocyte differentiation,BP,
12090,GO:0045637,1,0.271520366772013,0,200,regulation of myeloid cell differentiation,BP,
12091,GO:0045638,1,0.628724111222924,0,73,negative regulation of myeloid cell differentiation,BP,
12092,GO:0045639,1,0.616721374266014,0,74,positive regulation of myeloid cell differentiation,BP,
12093,GO:0045643,1,0.992526983778079,0,1,regulation of eosinophil differentiation,BP,
12094,GO:0045645,1,0.992526983778079,0,1,positive regulation of eosinophil differentiation,BP,
12095,GO:0045646,1,0.757368926000933,0,42,regulation of erythrocyte differentiation,BP,
12096,GO:0045647,1,0.949224898140585,0,8,negative regulation of erythrocyte differentiation,BP,
12097,GO:0045648,1,0.833729148695499,0,27,positive regulation of erythrocyte differentiation,BP,
12098,GO:0045649,1,0.89013384445946,0,19,regulation of macrophage differentiation,BP,
12099,GO:0045650,1,0.966396503751896,0,6,negative regulation of macrophage differentiation,BP,
12100,GO:0045651,1,0.921111965499108,0,13,positive regulation of macrophage differentiation,BP,
12101,GO:0045652,1,0.71795715482992,0,54,regulation of megakaryocyte differentiation,BP,
12102,GO:0045653,1,0.968420458704754,0,8,negative regulation of megakaryocyte differentiation,BP,
12103,GO:0045654,1,0.966015370830271,0,6,positive regulation of megakaryocyte differentiation,BP,
12104,GO:0045655,1,0.898473807037495,0,16,regulation of monocyte differentiation,BP,
12105,GO:0045656,1,0.958986415823604,0,6,negative regulation of monocyte differentiation,BP,
12106,GO:0045657,1,0.949099175013657,0,8,positive regulation of monocyte differentiation,BP,
12107,GO:0045658,1,0.979695706793841,0,3,regulation of neutrophil differentiation,BP,
12108,GO:0045659,1,0.98504398623061,0,2,negative regulation of neutrophil differentiation,BP,
12109,GO:0045660,1,0.994571349758133,0,1,positive regulation of neutrophil differentiation,BP,
12112,GO:0045663,1,0.891667603259832,0,17,positive regulation of myoblast differentiation,BP,
12116,GO:0045667,1,0.500173726387204,0,105,regulation of osteoblast differentiation,BP,
12117,GO:0045668,1,0.783175144236376,0,38,negative regulation of osteoblast differentiation,BP,
12118,GO:0045669,1,0.689304095634157,0,56,positive regulation of osteoblast differentiation,BP,
12119,GO:0045670,1,0.707273593851538,0,52,regulation of osteoclast differentiation,BP,
12120,GO:0045671,1,0.84582080818191,0,24,negative regulation of osteoclast differentiation,BP,
12121,GO:0045672,1,0.896316406945402,0,17,positive regulation of osteoclast differentiation,BP,
12122,GO:0045682,1,0.64340714359427,0,68,regulation of epidermis development,BP,
12123,GO:0045683,1,0.923887864253238,0,12,negative regulation of epidermis development,BP,
12124,GO:0045684,1,0.821307094189423,0,32,positive regulation of epidermis development,BP,
12125,GO:0045685,1,0.677087740635972,0,61,regulation of glial cell differentiation,BP,
12127,GO:0045687,1,0.795040179719109,0,37,positive regulation of glial cell differentiation,BP,
12128,GO:0045703,1,0.995861044061941,0,1,ketoreductase activity,MF,
12129,GO:0045713,1,0.946926884259159,0,8,low-density lipoprotein particle receptor biosynthetic process,BP,
12130,GO:0045714,1,0.951843239135107,0,7,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12131,GO:0045715,1,0.98480062628659,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12132,GO:0045716,1,0.981376289429626,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12133,GO:0045717,1,0.917978303889765,0,13,negative regulation of fatty acid biosynthetic process,BP,
12134,GO:0045719,1,0.964357882583613,0,5,negative regulation of glycogen biosynthetic process,BP,
12135,GO:0045720,1,0.987764529194498,0,2,negative regulation of integrin biosynthetic process,BP,
12136,GO:0045721,1,0.940770664503285,0,9,negative regulation of gluconeogenesis,BP,
12137,GO:0045722,1,0.937683266356917,0,9,positive regulation of gluconeogenesis,BP,
12138,GO:0045723,1,0.925321699707645,0,13,positive regulation of fatty acid biosynthetic process,BP,
12139,GO:0045724,1,0.885216260595856,0,18,positive regulation of cilium assembly,BP,
12140,GO:0045725,1,0.907800517740632,0,13,positive regulation of glycogen biosynthetic process,BP,
12141,GO:0045726,1,0.985293155871156,0,2,positive regulation of integrin biosynthetic process,BP,
12142,GO:0045727,1,0.491780855131079,0,112,positive regulation of translation,BP,
12143,GO:0045728,1,0.994231345668807,0,1,respiratory burst after phagocytosis,BP,
12144,GO:0045730,1,0.875610238283832,0,23,respiratory burst,BP,
12145,GO:0045732,1,0.266615221543954,0,198,positive regulation of protein catabolic process,BP,
12146,GO:0045736,1,0.8243941740727,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12147,GO:0045737,1,0.820150064349567,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12148,GO:0045738,1,0.863187865254,0,22,negative regulation of DNA repair,BP,
12149,GO:0045739,1,0.759581447395761,0,42,positive regulation of DNA repair,BP,
12150,GO:0045740,1,0.720123947800128,0,51,positive regulation of DNA replication,BP,
12153,GO:0045743,1,0.96536188983898,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12157,GO:0045747,1,0.748174267834307,0,44,positive regulation of Notch signaling pathway,BP,
12158,GO:0045751,1,0.992661572531617,0,1,negative regulation of Toll signaling pathway,BP,
12160,GO:0045760,1,0.932806104053177,0,10,positive regulation of action potential,BP,
12163,GO:0045763,1,0.984635399267018,0,2,negative regulation of cellular amino acid metabolic process,BP,
12164,GO:0045764,1,0.98455819388789,0,3,positive regulation of cellular amino acid metabolic process,BP,
12167,GO:0045769,1,0.991965896704122,0,1,negative regulation of asymmetric cell division,BP,
12168,GO:0045773,1,0.768371174475184,0,37,positive regulation of axon extension,BP,
12171,GO:0045778,1,0.596702969300461,0,78,positive regulation of ossification,BP,
12172,GO:0045779,1,0.946333698570931,0,9,negative regulation of bone resorption,BP,
12173,GO:0045780,1,0.917688994885268,0,13,positive regulation of bone resorption,BP,
12175,GO:0045786,1,0.0241566570570829,0,570,negative regulation of cell cycle,BP,
12176,GO:0045787,1,0.109464626151815,0,336,positive regulation of cell cycle,BP,
12177,GO:0045792,1,0.942549813378626,0,9,negative regulation of cell size,BP,
12178,GO:0045793,1,0.935831017194012,0,10,positive regulation of cell size,BP,
12179,GO:0045794,1,0.962857484132484,0,5,negative regulation of cell volume,BP,
12180,GO:0045795,1,0.992290893630497,0,1,positive regulation of cell volume,BP,
12181,GO:0045796,1,0.993264128755224,0,1,negative regulation of intestinal cholesterol absorption,BP,
12182,GO:0045799,1,0.979876384084841,0,3,positive regulation of chromatin assembly or disassembly,BP,
12185,GO:0045813,1,0.994941551134375,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12186,GO:0045814,1,0.569167271495818,0,90,negative regulation of gene expression, epigenetic,BP,
12187,GO:0045815,1,0.7049175512683,0,57,positive regulation of gene expression, epigenetic,BP,
12188,GO:0045819,1,0.992501908453202,0,1,positive regulation of glycogen catabolic process,BP,
12189,GO:0045820,1,0.938946803370002,0,10,negative regulation of glycolytic process,BP,
12190,GO:0045821,1,0.890660734972382,0,16,positive regulation of glycolytic process,BP,
12191,GO:0045822,1,0.884235125607081,0,19,negative regulation of heart contraction,BP,
12193,GO:0045824,1,0.779100168489046,0,39,negative regulation of innate immune response,BP,
12194,GO:0045827,1,0.995861044061941,0,1,negative regulation of isoprenoid metabolic process,BP,
12195,GO:0045829,1,0.973499944351575,0,4,negative regulation of isotype switching,BP,
12196,GO:0045830,1,0.882665954868825,0,19,positive regulation of isotype switching,BP,
12199,GO:0045835,1,0.940969407967757,0,9,negative regulation of meiotic nuclear division,BP,
12200,GO:0045836,1,0.931364965686338,0,11,positive regulation of meiotic nuclear division,BP,
12201,GO:0045837,1,0.950419304276608,0,9,negative regulation of membrane potential,BP,
12202,GO:0045838,1,0.934659809078884,0,11,positive regulation of membrane potential,BP,
12203,GO:0045839,1,0.748476695548201,0,46,negative regulation of mitotic nuclear division,BP,
12204,GO:0045840,1,0.743594788724153,0,45,positive regulation of mitotic nuclear division,BP,
12205,GO:0045841,1,0.813371002678313,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12206,GO:0045842,1,0.949955124480932,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12207,GO:0045843,1,0.759309721309275,0,42,negative regulation of striated muscle tissue development,BP,
12208,GO:0045844,1,0.662389445470844,0,60,positive regulation of striated muscle tissue development,BP,
12209,GO:0045848,1,0.994251771467272,0,1,positive regulation of nitrogen utilization,BP,
12210,GO:0045851,1,0.753675504872406,0,48,pH reduction,BP,
12211,GO:0045852,1,0.973165153866899,0,4,pH elevation,BP,
12214,GO:0045861,1,0.185088551134149,0,273,negative regulation of proteolysis,BP,
12216,GO:0045869,1,0.946667857419604,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12217,GO:0045870,1,0.99239080334567,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12218,GO:0045872,1,0.994613583435388,0,1,positive regulation of rhodopsin gene expression,BP,
12219,GO:0045875,1,0.972870642730991,0,4,negative regulation of sister chromatid cohesion,BP,
12220,GO:0045876,1,0.948029784419966,0,8,positive regulation of sister chromatid cohesion,BP,
12221,GO:0045879,1,0.814930128244727,0,29,negative regulation of smoothened signaling pathway,BP,
12222,GO:0045880,1,0.815717415492683,0,29,positive regulation of smoothened signaling pathway,BP,
12223,GO:0045887,1,0.992251216428342,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12226,GO:0045898,1,0.918821402165043,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12227,GO:0045899,1,0.938631664882303,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12228,GO:0045900,1,0.975442845235851,0,4,negative regulation of translational elongation,BP,
12229,GO:0045901,1,0.973772248754772,0,4,positive regulation of translational elongation,BP,
12230,GO:0045903,1,0.986870058743368,0,3,positive regulation of translational fidelity,BP,
12231,GO:0045905,1,0.98077769890233,0,3,positive regulation of translational termination,BP,
12232,GO:0045906,1,0.951201167946082,0,7,negative regulation of vasoconstriction,BP,
12233,GO:0045907,1,0.843682623662433,0,26,positive regulation of vasoconstriction,BP,
12234,GO:0045910,1,0.850012137311006,0,23,negative regulation of DNA recombination,BP,
12235,GO:0045911,1,0.857095348312929,0,23,positive regulation of DNA recombination,BP,
12236,GO:0045912,1,0.808592535641435,0,32,negative regulation of carbohydrate metabolic process,BP,
12237,GO:0045913,1,0.662000832489216,0,59,positive regulation of carbohydrate metabolic process,BP,
12238,GO:0045914,1,0.979321525135522,0,3,negative regulation of catecholamine metabolic process,BP,
12239,GO:0045915,1,0.963716190736463,0,6,positive regulation of catecholamine metabolic process,BP,
12240,GO:0045916,1,0.959315145074523,0,6,negative regulation of complement activation,BP,
12241,GO:0045917,1,0.979990217231711,0,3,positive regulation of complement activation,BP,
12242,GO:0045918,1,0.985285229154754,0,3,negative regulation of cytolysis,BP,
12243,GO:0045919,1,0.962372620273986,0,7,positive regulation of cytolysis,BP,
12247,GO:0045923,1,0.835932625173826,0,28,positive regulation of fatty acid metabolic process,BP,
12248,GO:0045924,1,0.967849041618334,0,5,regulation of female receptivity,BP,
12249,GO:0045925,1,0.993709554440484,0,1,positive regulation of female receptivity,BP,
12250,GO:0045926,1,0.246916301283293,0,218,negative regulation of growth,BP,
12252,GO:0045930,1,0.171630572805015,0,281,negative regulation of mitotic cell cycle,BP,
12253,GO:0045931,1,0.42506149953057,0,129,positive regulation of mitotic cell cycle,BP,
12254,GO:0045932,1,0.88431327101698,0,19,negative regulation of muscle contraction,BP,
12260,GO:0045938,1,0.971089685795253,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12261,GO:0045939,1,0.87020783582968,0,22,negative regulation of steroid metabolic process,BP,
12262,GO:0045940,1,0.887899646282711,0,19,positive regulation of steroid metabolic process,BP,
12263,GO:0045943,1,0.865342904181707,0,21,positive regulation of transcription by RNA polymerase I,BP,
12265,GO:0045945,1,0.924527616129982,0,11,positive regulation of transcription by RNA polymerase III,BP,
12266,GO:0045947,1,0.886935405894007,0,19,negative regulation of translational initiation,BP,
12267,GO:0045948,1,0.839964488315042,0,26,positive regulation of translational initiation,BP,
12268,GO:0045950,1,0.980747307443693,0,3,negative regulation of mitotic recombination,BP,
12269,GO:0045953,1,0.942402680693349,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12270,GO:0045954,1,0.888254999635521,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12273,GO:0045957,1,0.992089267287523,0,1,negative regulation of complement activation, alternative pathway,BP,
12274,GO:0045959,1,0.9862002291371,0,2,negative regulation of complement activation, classical pathway,BP,
12275,GO:0045963,1,0.979321525135522,0,3,negative regulation of dopamine metabolic process,BP,
12276,GO:0045964,1,0.963716190736463,0,6,positive regulation of dopamine metabolic process,BP,
12277,GO:0045967,1,0.984077760975947,0,2,negative regulation of growth rate,BP,
12278,GO:0045974,1,0.915459967760038,0,13,regulation of translation, ncRNA-mediated,BP,
12279,GO:0045976,1,0.985134456555599,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12280,GO:0045977,1,0.995538291756773,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12283,GO:0045986,1,0.926325581774354,0,12,negative regulation of smooth muscle contraction,BP,
12285,GO:0045988,1,0.951695919870286,0,7,negative regulation of striated muscle contraction,BP,
12287,GO:0045990,1,0.969136473299121,0,5,carbon catabolite regulation of transcription,BP,
12288,GO:0045991,1,0.969136473299121,0,5,carbon catabolite activation of transcription,BP,
12289,GO:0045992,1,0.845788844008566,0,25,negative regulation of embryonic development,BP,
12290,GO:0045993,1,0.992483857259806,0,1,negative regulation of translational initiation by iron,BP,
12291,GO:0045994,1,0.987633765380144,0,2,positive regulation of translational initiation by iron,BP,
12293,GO:0046005,1,0.992666933968205,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12295,GO:0046007,1,0.932013653782953,0,11,negative regulation of activated T cell proliferation,BP,
12296,GO:0046010,1,0.984718624020383,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12297,GO:0046013,1,0.988501244708347,0,2,regulation of T cell homeostatic proliferation,BP,
12298,GO:0046015,1,0.971956878217784,0,5,regulation of transcription by glucose,BP,
12299,GO:0046016,1,0.976669775481402,0,4,positive regulation of transcription by glucose,BP,
12300,GO:0046030,1,0.923798817660085,0,11,inositol trisphosphate phosphatase activity,MF,
12301,GO:0046031,1,0.524599993777391,0,98,ADP metabolic process,BP,
12302,GO:0046032,1,0.99540918280277,0,1,ADP catabolic process,BP,
12303,GO:0046033,1,0.9344567860814,0,11,AMP metabolic process,BP,
12304,GO:0046034,1,0.250745648445971,0,234,ATP metabolic process,BP,
12305,GO:0046035,1,0.995834185229467,0,1,CMP metabolic process,BP,
12306,GO:0046036,1,0.937556893282743,0,13,CTP metabolic process,BP,
12307,GO:0046037,1,0.868892918949606,0,21,GMP metabolic process,BP,
12308,GO:0046038,1,0.995591158854113,0,1,GMP catabolic process,BP,
12309,GO:0046039,1,0.837324590973393,0,30,GTP metabolic process,BP,
12310,GO:0046040,1,0.918923457225537,0,13,IMP metabolic process,BP,
12311,GO:0046041,1,0.989361773264479,0,2,ITP metabolic process,BP,
12312,GO:0046048,1,0.992912744500514,0,1,UDP metabolic process,BP,
12313,GO:0046049,1,0.941673995289347,0,10,UMP metabolic process,BP,
12314,GO:0046051,1,0.951759138396106,0,10,UTP metabolic process,BP,
12315,GO:0046054,1,0.996155923041539,0,1,dGMP metabolic process,BP,
12316,GO:0046056,1,0.985678997389146,0,2,dADP metabolic process,BP,
12318,GO:0046060,1,0.975385158298761,0,5,dATP metabolic process,BP,
12319,GO:0046061,1,0.984621640490902,0,3,dATP catabolic process,BP,
12320,GO:0046065,1,0.996003358562593,0,1,dCTP metabolic process,BP,
12321,GO:0046066,1,0.989277866979028,0,2,dGDP metabolic process,BP,
12323,GO:0046069,1,0.959307473605297,0,6,cGMP catabolic process,BP,
12324,GO:0046070,1,0.979935849942406,0,4,dGTP metabolic process,BP,
12325,GO:0046072,1,0.988861019818926,0,2,dTDP metabolic process,BP,
12326,GO:0046073,1,0.983546367319528,0,3,dTMP metabolic process,BP,
12327,GO:0046075,1,0.980039467083523,0,4,dTTP metabolic process,BP,
12328,GO:0046077,1,0.988861019818926,0,2,dUDP metabolic process,BP,
12329,GO:0046078,1,0.975469776124595,0,5,dUMP metabolic process,BP,
12330,GO:0046079,1,0.995325266673793,0,1,dUMP catabolic process,BP,
12331,GO:0046080,1,0.994807449703121,0,1,dUTP metabolic process,BP,
12332,GO:0046081,1,0.994807449703121,0,1,dUTP catabolic process,BP,
12333,GO:0046083,1,0.986776387024673,0,3,adenine metabolic process,BP,
12334,GO:0046084,1,0.986776387024673,0,3,adenine biosynthetic process,BP,
12335,GO:0046085,1,0.945098928409707,0,9,adenosine metabolic process,BP,
12336,GO:0046086,1,0.986983909586657,0,2,adenosine biosynthetic process,BP,
12337,GO:0046087,1,0.958340610976605,0,8,cytidine metabolic process,BP,
12338,GO:0046090,1,0.995403562116892,0,1,deoxyadenosine metabolic process,BP,
12339,GO:0046092,1,0.992446736914712,0,1,deoxycytidine metabolic process,BP,
12341,GO:0046099,1,0.990309718035064,0,2,guanine biosynthetic process,BP,
12342,GO:0046100,1,0.97363852442102,0,5,hypoxanthine metabolic process,BP,
12343,GO:0046101,1,0.978831958714945,0,4,hypoxanthine biosynthetic process,BP,
12344,GO:0046102,1,0.9826595803823,0,3,inosine metabolic process,BP,
12345,GO:0046103,1,0.98886838866853,0,2,inosine biosynthetic process,BP,
12346,GO:0046104,1,0.980612504384472,0,3,thymidine metabolic process,BP,
12347,GO:0046108,1,0.988682859254664,0,2,uridine metabolic process,BP,
12348,GO:0046110,1,0.980371437418136,0,3,xanthine metabolic process,BP,
12349,GO:0046111,1,0.995403562116892,0,1,xanthine biosynthetic process,BP,
12350,GO:0046112,1,0.88412707908023,0,19,nucleobase biosynthetic process,BP,
12352,GO:0046116,1,0.984704669278013,0,3,queuosine metabolic process,BP,
12353,GO:0046121,1,0.983311740803513,0,3,deoxyribonucleoside catabolic process,BP,
12354,GO:0046122,1,0.991552384289076,0,2,purine deoxyribonucleoside metabolic process,BP,
12355,GO:0046124,1,0.995403562116892,0,1,purine deoxyribonucleoside catabolic process,BP,
12356,GO:0046125,1,0.980612504384472,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12357,GO:0046127,1,0.992735870788185,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12358,GO:0046128,1,0.646344945819753,0,70,purine ribonucleoside metabolic process,BP,
12359,GO:0046129,1,0.896568430838361,0,21,purine ribonucleoside biosynthetic process,BP,
12360,GO:0046130,1,0.965095710696759,0,6,purine ribonucleoside catabolic process,BP,
12361,GO:0046131,1,0.847048518439504,0,30,pyrimidine ribonucleoside metabolic process,BP,
12362,GO:0046132,1,0.896234268206542,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12363,GO:0046133,1,0.946715506837828,0,10,pyrimidine ribonucleoside catabolic process,BP,
12364,GO:0046134,1,0.871842950991699,0,25,pyrimidine nucleoside biosynthetic process,BP,
12365,GO:0046135,1,0.894529463257771,0,20,pyrimidine nucleoside catabolic process,BP,
12366,GO:0046136,1,0.990675168037627,0,2,positive regulation of vitamin metabolic process,BP,
12367,GO:0046137,1,0.965171407693253,0,6,negative regulation of vitamin metabolic process,BP,
12368,GO:0046144,1,0.995300329559495,0,1,D-alanine family amino acid metabolic process,BP,
12369,GO:0046146,1,0.96459106714992,0,7,tetrahydrobiopterin metabolic process,BP,
12370,GO:0046148,1,0.731414257751109,0,50,pigment biosynthetic process,BP,
12371,GO:0046149,1,0.982904333140756,0,4,pigment catabolic process,BP,
12372,GO:0046160,1,0.98517248936743,0,2,heme a metabolic process,BP,
12373,GO:0046164,1,0.784401007314333,0,40,alcohol catabolic process,BP,
12374,GO:0046165,1,0.444072838951416,0,126,alcohol biosynthetic process,BP,
12375,GO:0046166,1,0.989882619057397,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12376,GO:0046167,1,0.984588296657745,0,2,glycerol-3-phosphate biosynthetic process,BP,
12377,GO:0046168,1,0.98553039677948,0,2,glycerol-3-phosphate catabolic process,BP,
12378,GO:0046173,1,0.720293695769305,0,52,polyol biosynthetic process,BP,
12379,GO:0046174,1,0.890300762215271,0,17,polyol catabolic process,BP,
12380,GO:0046176,1,0.9930956730518,0,1,aldonic acid catabolic process,BP,
12381,GO:0046177,1,0.9930956730518,0,1,D-gluconate catabolic process,BP,
12382,GO:0046184,1,0.915036307572294,0,13,aldehyde biosynthetic process,BP,
12383,GO:0046185,1,0.944701425213614,0,10,aldehyde catabolic process,BP,
12384,GO:0046189,1,0.799096641816309,0,35,phenol-containing compound biosynthetic process,BP,
12385,GO:0046203,1,0.991067471095187,0,2,spermidine catabolic process,BP,
12386,GO:0046204,1,0.996186124260156,0,1,nor-spermidine metabolic process,BP,
12387,GO:0046208,1,0.979939323182448,0,4,spermine catabolic process,BP,
12388,GO:0046209,1,0.674607497594685,0,61,nitric oxide metabolic process,BP,
12389,GO:0046210,1,0.993543965901044,0,1,nitric oxide catabolic process,BP,
12390,GO:0046218,1,0.963981088407882,0,7,indolalkylamine catabolic process,BP,
12391,GO:0046219,1,0.985009851750184,0,3,indolalkylamine biosynthetic process,BP,
12392,GO:0046222,1,0.993161023776059,0,1,aflatoxin metabolic process,BP,
12393,GO:0046223,1,0.993161023776059,0,1,aflatoxin catabolic process,BP,
12394,GO:0046226,1,0.99093362277038,0,2,coumarin catabolic process,BP,
12395,GO:0046247,1,0.992998889487678,0,1,terpene catabolic process,BP,
12396,GO:0046271,1,0.99093362277038,0,2,phenylpropanoid catabolic process,BP,
12397,GO:0046272,1,0.994131452236153,0,1,stilbene catabolic process,BP,
12398,GO:0046292,1,0.981782303155565,0,3,formaldehyde metabolic process,BP,
12399,GO:0046293,1,0.992466306792551,0,1,formaldehyde biosynthetic process,BP,
12400,GO:0046294,1,0.989235721659205,0,2,formaldehyde catabolic process,BP,
12401,GO:0046295,1,0.99622159485821,0,1,glycolate biosynthetic process,BP,
12402,GO:0046296,1,0.995041759703579,0,1,glycolate catabolic process,BP,
12403,GO:0046305,1,0.988524432486938,0,2,alkanesulfonate biosynthetic process,BP,
12404,GO:0046316,1,0.9930956730518,0,1,gluconokinase activity,MF,
12405,GO:0046317,1,0.992442258119062,0,1,regulation of glucosylceramide biosynthetic process,BP,
12406,GO:0046318,1,0.992442258119062,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12408,GO:0046321,1,0.903469462366392,0,15,positive regulation of fatty acid oxidation,BP,
12410,GO:0046323,1,0.629916530300869,0,67,glucose import,BP,
12411,GO:0046324,1,0.685527930237442,0,55,regulation of glucose import,BP,
12412,GO:0046325,1,0.927418321732465,0,12,negative regulation of glucose import,BP,
12413,GO:0046326,1,0.781812579683651,0,35,positive regulation of glucose import,BP,
12414,GO:0046327,1,0.987901664983935,0,2,glycerol biosynthetic process from pyruvate,BP,
12415,GO:0046328,1,0.345885335527195,0,157,regulation of JNK cascade,BP,
12416,GO:0046329,1,0.81586565661156,0,30,negative regulation of JNK cascade,BP,
12417,GO:0046330,1,0.459231667941054,0,116,positive regulation of JNK cascade,BP,
12418,GO:0046331,1,0.9881932031887,0,2,lateral inhibition,BP,
12419,GO:0046332,1,0.59211289417656,0,74,SMAD binding,MF,
12420,GO:0046333,1,0.985969554365339,0,2,octopamine metabolic process,BP,
12421,GO:0046337,1,0.884619483885996,0,18,phosphatidylethanolamine metabolic process,BP,
12422,GO:0046338,1,0.985781677874902,0,2,phosphatidylethanolamine catabolic process,BP,
12423,GO:0046339,1,0.920341719500834,0,12,diacylglycerol metabolic process,BP,
12424,GO:0046340,1,0.978235236987526,0,3,diacylglycerol catabolic process,BP,
12425,GO:0046341,1,0.921090495054824,0,12,CDP-diacylglycerol metabolic process,BP,
12427,GO:0046349,1,0.920839760555223,0,13,amino sugar biosynthetic process,BP,
12428,GO:0046351,1,0.977052356500916,0,4,disaccharide biosynthetic process,BP,
12429,GO:0046355,1,0.99261857801174,0,1,mannan catabolic process,BP,
12430,GO:0046356,1,0.990425358505801,0,2,acetyl-CoA catabolic process,BP,
12431,GO:0046359,1,0.994713244419678,0,1,butyrate catabolic process,BP,
12432,GO:0046360,1,0.994321248875851,0,1,2-oxobutyrate biosynthetic process,BP,
12433,GO:0046361,1,0.994321248875851,0,1,2-oxobutyrate metabolic process,BP,
12434,GO:0046364,1,0.631030568163739,0,76,monosaccharide biosynthetic process,BP,
12435,GO:0046365,1,0.71104546872531,0,56,monosaccharide catabolic process,BP,
12436,GO:0046368,1,0.976185185340068,0,4,GDP-L-fucose metabolic process,BP,
12437,GO:0046370,1,0.989147915449972,0,2,fructose biosynthetic process,BP,
12438,GO:0046373,1,0.986238532970005,0,2,L-arabinose metabolic process,BP,
12439,GO:0046379,1,0.980389422730769,0,3,extracellular polysaccharide metabolic process,BP,
12440,GO:0046380,1,0.992508391537397,0,1,N-acetylneuraminate biosynthetic process,BP,
12441,GO:0046381,1,0.995842275743558,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12442,GO:0046385,1,0.942759889186988,0,11,deoxyribose phosphate biosynthetic process,BP,
12443,GO:0046386,1,0.90220099333443,0,19,deoxyribose phosphate catabolic process,BP,
12445,GO:0046391,1,0.980911879545185,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12448,GO:0046398,1,0.972070390160222,0,4,UDP-glucuronate metabolic process,BP,
12449,GO:0046403,1,0.995081675552396,0,1,polynucleotide 3'-phosphatase activity,MF,
12450,GO:0046404,1,0.982522065635506,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12451,GO:0046415,1,0.955527264907268,0,7,urate metabolic process,BP,
12452,GO:0046416,1,0.984249394747893,0,3,D-amino acid metabolic process,BP,
12453,GO:0046425,1,0.499255681662853,0,109,regulation of JAK-STAT cascade,BP,
12454,GO:0046426,1,0.739675884785528,0,45,negative regulation of JAK-STAT cascade,BP,
12455,GO:0046427,1,0.702001488712064,0,58,positive regulation of JAK-STAT cascade,BP,
12457,GO:0046436,1,0.995300329559495,0,1,D-alanine metabolic process,BP,
12458,GO:0046437,1,0.993597334811366,0,1,D-amino acid biosynthetic process,BP,
12459,GO:0046439,1,0.956325432959855,0,7,L-cysteine metabolic process,BP,
12460,GO:0046440,1,0.973465503181179,0,4,L-lysine metabolic process,BP,
12461,GO:0046443,1,0.994610573360766,0,1,FAD metabolic process,BP,
12462,GO:0046444,1,0.993210827817845,0,1,FMN metabolic process,BP,
12463,GO:0046448,1,0.993664822857648,0,1,tropane alkaloid metabolic process,BP,
12464,GO:0046449,1,0.970154334730247,0,4,creatinine metabolic process,BP,
12465,GO:0046452,1,0.983009223030982,0,3,dihydrofolate metabolic process,BP,
12466,GO:0046456,1,0.805667650586743,0,38,icosanoid biosynthetic process,BP,
12467,GO:0046457,1,0.884569807922601,0,22,prostanoid biosynthetic process,BP,
12468,GO:0046459,1,0.907413333164659,0,16,short-chain fatty acid metabolic process,BP,
12469,GO:0046460,1,0.817631855665188,0,30,neutral lipid biosynthetic process,BP,
12471,GO:0046462,1,0.988110863036157,0,2,monoacylglycerol metabolic process,BP,
12472,GO:0046463,1,0.817631855665188,0,30,acylglycerol biosynthetic process,BP,
12474,GO:0046465,1,0.956867542100522,0,7,dolichyl diphosphate metabolic process,BP,
12475,GO:0046466,1,0.858271151673769,0,25,membrane lipid catabolic process,BP,
12477,GO:0046469,1,0.963360683510016,0,6,platelet activating factor metabolic process,BP,
12478,GO:0046470,1,0.653076681810867,0,70,phosphatidylcholine metabolic process,BP,
12479,GO:0046471,1,0.836104386379235,0,27,phosphatidylglycerol metabolic process,BP,
12480,GO:0046473,1,0.791631392732997,0,34,phosphatidic acid metabolic process,BP,
12481,GO:0046474,1,0.223873690377053,0,223,glycerophospholipid biosynthetic process,BP,
12482,GO:0046475,1,0.883767184771085,0,19,glycerophospholipid catabolic process,BP,
12483,GO:0046476,1,0.957786371382932,0,7,glycosylceramide biosynthetic process,BP,
12484,GO:0046477,1,0.956376599464197,0,7,glycosylceramide catabolic process,BP,
12485,GO:0046478,1,0.992463567771584,0,1,lactosylceramide metabolic process,BP,
12486,GO:0046479,1,0.926784555870893,0,12,glycosphingolipid catabolic process,BP,
12488,GO:0046485,1,0.946817544766938,0,9,ether lipid metabolic process,BP,
12490,GO:0046487,1,0.960173616539416,0,7,glyoxylate metabolic process,BP,
12491,GO:0046488,1,0.257195593092228,0,201,phosphatidylinositol metabolic process,BP,
12492,GO:0046490,1,0.979554807214161,0,4,isopentenyl diphosphate metabolic process,BP,
12493,GO:0046491,1,0.996294146734027,0,1,L-methylmalonyl-CoA metabolic process,BP,
12494,GO:0046493,1,0.993046014416702,0,2,lipid A metabolic process,BP,
12495,GO:0046495,1,0.993722014927607,0,1,nicotinamide riboside metabolic process,BP,
12496,GO:0046496,1,0.363551852932033,0,157,nicotinamide nucleotide metabolic process,BP,
12497,GO:0046497,1,0.9930956730518,0,1,nicotinate nucleotide metabolic process,BP,
12498,GO:0046498,1,0.964357159393827,0,6,S-adenosylhomocysteine metabolic process,BP,
12499,GO:0046499,1,0.992647380323441,0,1,S-adenosylmethioninamine metabolic process,BP,
12500,GO:0046500,1,0.929113066885402,0,12,S-adenosylmethionine metabolic process,BP,
12501,GO:0046501,1,0.942404046302536,0,10,protoporphyrinogen IX metabolic process,BP,
12502,GO:0046502,1,0.989913505301675,0,2,uroporphyrinogen III metabolic process,BP,
12504,GO:0046504,1,0.969397850828601,0,5,glycerol ether biosynthetic process,BP,
12505,GO:0046511,1,0.987095228685278,0,2,sphinganine biosynthetic process,BP,
12506,GO:0046512,1,0.94566057905799,0,9,sphingosine biosynthetic process,BP,
12507,GO:0046513,1,0.70580142868947,0,54,ceramide biosynthetic process,BP,
12508,GO:0046514,1,0.91783714854478,0,14,ceramide catabolic process,BP,
12509,GO:0046519,1,0.916750890520757,0,14,sphingoid metabolic process,BP,
12510,GO:0046520,1,0.938568829247507,0,10,sphingoid biosynthetic process,BP,
12511,GO:0046521,1,0.994822986656738,0,1,sphingoid catabolic process,BP,
12512,GO:0046523,1,0.992750697136801,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12513,GO:0046525,1,0.995083477331418,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12514,GO:0046526,1,0.993507719716997,0,1,D-xylulose reductase activity,MF,
12515,GO:0046527,1,0.898749560926901,0,16,glucosyltransferase activity,MF,
12516,GO:0046530,1,0.698187759471463,0,52,photoreceptor cell differentiation,BP,
12517,GO:0046532,1,0.960753546874006,0,6,regulation of photoreceptor cell differentiation,BP,
12518,GO:0046533,1,0.960753546874006,0,6,negative regulation of photoreceptor cell differentiation,BP,
12519,GO:0046538,1,0.981385831595401,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12520,GO:0046539,1,0.996254262411469,0,1,histamine N-methyltransferase activity,MF,
12521,GO:0046540,1,0.878025315577918,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12523,GO:0046543,1,0.956482948018135,0,7,development of secondary female sexual characteristics,BP,
12524,GO:0046544,1,0.992442567681061,0,1,development of secondary male sexual characteristics,BP,
12526,GO:0046546,1,0.459317040292135,0,117,development of primary male sexual characteristics,BP,
12527,GO:0046548,1,0.951990479155506,0,7,retinal rod cell development,BP,
12528,GO:0046549,1,0.948061571436859,0,8,retinal cone cell development,BP,
12529,GO:0046554,1,0.995750298009353,0,1,malate dehydrogenase (NADP+) activity,MF,
12530,GO:0046556,1,0.986238532970005,0,2,alpha-L-arabinofuranosidase activity,MF,
12531,GO:0046570,1,0.995815196818794,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12532,GO:0046573,1,0.98623620804879,0,3,lactonohydrolase activity,MF,
12533,GO:0046577,1,0.992510382724911,0,1,long-chain-alcohol oxidase activity,MF,
12535,GO:0046579,1,0.744844886542462,0,45,positive regulation of Ras protein signal transduction,BP,
12536,GO:0046580,1,0.723165540407145,0,46,negative regulation of Ras protein signal transduction,BP,
12537,GO:0046581,1,0.957477724725981,0,6,intercellular canaliculus,CC,
12538,GO:0046586,1,0.989112131530665,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12539,GO:0046587,1,0.992833519730857,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12540,GO:0046588,1,0.996252025119076,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12541,GO:0046592,1,0.989568173923053,0,2,polyamine oxidase activity,MF,
12542,GO:0046596,1,0.856277341828864,0,26,regulation of viral entry into host cell,BP,
12543,GO:0046597,1,0.910051009448586,0,16,negative regulation of viral entry into host cell,BP,
12544,GO:0046598,1,0.948148306938743,0,9,positive regulation of viral entry into host cell,BP,
12545,GO:0046599,1,0.888044153640175,0,17,regulation of centriole replication,BP,
12546,GO:0046600,1,0.945645475745146,0,8,negative regulation of centriole replication,BP,
12547,GO:0046601,1,0.977883098273048,0,3,positive regulation of centriole replication,BP,
12548,GO:0046602,1,0.936890560627583,0,10,regulation of mitotic centrosome separation,BP,
12549,GO:0046603,1,0.995563353161914,0,1,negative regulation of mitotic centrosome separation,BP,
12550,GO:0046604,1,0.97441032871425,0,4,positive regulation of mitotic centrosome separation,BP,
12551,GO:0046605,1,0.692976133101402,0,54,regulation of centrosome cycle,BP,
12552,GO:0046606,1,0.914214657942111,0,14,negative regulation of centrosome cycle,BP,
12553,GO:0046607,1,0.932921981528131,0,10,positive regulation of centrosome cycle,BP,
12554,GO:0046618,1,0.974686032612144,0,4,drug export,BP,
12555,GO:0046619,1,0.985128353977951,0,2,optic placode formation involved in camera-type eye formation,BP,
12556,GO:0046620,1,0.570915218351062,0,82,regulation of organ growth,BP,
12557,GO:0046621,1,0.84385152404878,0,24,negative regulation of organ growth,BP,
12558,GO:0046622,1,0.739949841079033,0,44,positive regulation of organ growth,BP,
12559,GO:0046623,1,0.99233132566982,0,1,sphingolipid-translocating ATPase activity,MF,
12560,GO:0046624,1,0.944012586429304,0,9,sphingolipid transporter activity,MF,
12562,GO:0046626,1,0.726295162229234,0,48,regulation of insulin receptor signaling pathway,BP,
12563,GO:0046627,1,0.81720529495217,0,31,negative regulation of insulin receptor signaling pathway,BP,
12564,GO:0046628,1,0.92453759231039,0,11,positive regulation of insulin receptor signaling pathway,BP,
12565,GO:0046629,1,0.928455056506734,0,11,gamma-delta T cell activation,BP,
12566,GO:0046631,1,0.502519834340425,0,106,alpha-beta T cell activation,BP,
12567,GO:0046632,1,0.577840710934775,0,83,alpha-beta T cell differentiation,BP,
12568,GO:0046633,1,0.867907713493334,0,23,alpha-beta T cell proliferation,BP,
12569,GO:0046634,1,0.653951345558304,0,67,regulation of alpha-beta T cell activation,BP,
12570,GO:0046635,1,0.757919425272346,0,45,positive regulation of alpha-beta T cell activation,BP,
12571,GO:0046636,1,0.84912580567178,0,25,negative regulation of alpha-beta T cell activation,BP,
12572,GO:0046637,1,0.739102550412397,0,47,regulation of alpha-beta T cell differentiation,BP,
12573,GO:0046638,1,0.809216615079845,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12574,GO:0046639,1,0.896128372351632,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12575,GO:0046640,1,0.885556310838273,0,20,regulation of alpha-beta T cell proliferation,BP,
12576,GO:0046641,1,0.910841699271735,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12577,GO:0046642,1,0.970823296725133,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12578,GO:0046643,1,0.95617950069152,0,6,regulation of gamma-delta T cell activation,BP,
12579,GO:0046645,1,0.963409257061035,0,5,positive regulation of gamma-delta T cell activation,BP,
12582,GO:0046653,1,0.893785297486479,0,18,tetrahydrofolate metabolic process,BP,
12583,GO:0046654,1,0.956061143409099,0,7,tetrahydrofolate biosynthetic process,BP,
12584,GO:0046655,1,0.879129094819862,0,20,folic acid metabolic process,BP,
12585,GO:0046657,1,0.988776993159692,0,2,folic acid catabolic process,BP,
12586,GO:0046658,1,0.805671849086791,0,37,anchored component of plasma membrane,CC,
12588,GO:0046661,1,0.397828104952344,0,139,male sex differentiation,BP,
12589,GO:0046666,1,0.978648362491597,0,4,retinal cell programmed cell death,BP,
12590,GO:0046668,1,0.987322198011319,0,2,regulation of retinal cell programmed cell death,BP,
12591,GO:0046671,1,0.99250527293932,0,1,negative regulation of retinal cell programmed cell death,BP,
12594,GO:0046680,1,0.99437027163239,0,1,response to DDT,BP,
12596,GO:0046684,1,0.977686502150679,0,4,response to pyrethroid,BP,
12597,GO:0046685,1,0.838452668206493,0,29,response to arsenic-containing substance,BP,
12598,GO:0046686,1,0.732183583771649,0,56,response to cadmium ion,BP,
12599,GO:0046687,1,0.996030150017592,0,1,response to chromate,BP,
12600,GO:0046688,1,0.855530726932688,0,30,response to copper ion,BP,
12601,GO:0046689,1,0.952936074839445,0,8,response to mercury ion,BP,
12602,GO:0046690,1,0.99255839226198,0,1,response to tellurium ion,BP,
12603,GO:0046691,1,0.992996414181188,0,1,intracellular canaliculus,CC,
12604,GO:0046695,1,0.983817665920707,0,3,SLIK (SAGA-like) complex,CC,
12605,GO:0046696,1,0.97129293289035,0,5,lipopolysaccharide receptor complex,CC,
12606,GO:0046697,1,0.881977074311551,0,19,decidualization,BP,
12608,GO:0046703,1,0.966055750069715,0,7,natural killer cell lectin-like receptor binding,MF,
12609,GO:0046707,1,0.987808255652435,0,2,IDP metabolic process,BP,
12610,GO:0046709,1,0.987808255652435,0,2,IDP catabolic process,BP,
12611,GO:0046710,1,0.911478982016584,0,13,GDP metabolic process,BP,
12612,GO:0046711,1,0.996155923041539,0,1,GDP biosynthetic process,BP,
12613,GO:0046713,1,0.992743396839482,0,1,borate transport,BP,
12614,GO:0046715,1,0.992743396839482,0,1,active borate transmembrane transporter activity,MF,
12615,GO:0046716,1,0.903361470961785,0,15,muscle cell cellular homeostasis,BP,
12617,GO:0046718,1,0.502279044976487,0,105,viral entry into host cell,BP,
12618,GO:0046719,1,0.955336121236256,0,7,regulation by virus of viral protein levels in host cell,BP,
12619,GO:0046724,1,0.988618908464486,0,2,oxalic acid secretion,BP,
12620,GO:0046725,1,0.992537264470943,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12621,GO:0046726,1,0.970935979295444,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12622,GO:0046730,1,0.994145695392548,0,1,induction of host immune response by virus,BP,
12623,GO:0046732,1,0.994145695392548,0,1,active induction of host immune response by virus,BP,
12624,GO:0046745,1,0.9930956730518,0,1,viral capsid secondary envelopment,BP,
12625,GO:0046755,1,0.866562887547987,0,24,viral budding,BP,
12627,GO:0046778,1,0.987777207727359,0,2,modification by virus of host mRNA processing,BP,
12628,GO:0046782,1,0.684246045579094,0,60,regulation of viral transcription,BP,
12629,GO:0046784,1,0.953952690812889,0,8,viral mRNA export from host cell nucleus,BP,
12631,GO:0046786,1,0.992457028593699,0,1,viral replication complex formation and maintenance,BP,
12632,GO:0046789,1,0.992685056253613,0,1,host cell surface receptor binding,MF,
12633,GO:0046790,1,0.968631408169191,0,5,virion binding,MF,
12634,GO:0046794,1,0.692726248906539,0,56,transport of virus,BP,
12635,GO:0046811,1,0.988977133917179,0,2,histone deacetylase inhibitor activity,MF,
12636,GO:0046812,1,0.992685056253613,0,1,host cell surface binding,MF,
12637,GO:0046813,1,0.967027509289267,0,5,receptor-mediated virion attachment to host cell,BP,
12638,GO:0046822,1,0.523914683427479,0,97,regulation of nucleocytoplasmic transport,BP,
12639,GO:0046823,1,0.889161319883786,0,19,negative regulation of nucleocytoplasmic transport,BP,
12640,GO:0046824,1,0.687934987830426,0,55,positive regulation of nucleocytoplasmic transport,BP,
12641,GO:0046825,1,0.775037282977918,0,39,regulation of protein export from nucleus,BP,
12642,GO:0046826,1,0.960639024160245,0,7,negative regulation of protein export from nucleus,BP,
12643,GO:0046827,1,0.877999208922386,0,20,positive regulation of protein export from nucleus,BP,
12644,GO:0046831,1,0.896524797776033,0,15,regulation of RNA export from nucleus,BP,
12645,GO:0046832,1,0.984508290636492,0,2,negative regulation of RNA export from nucleus,BP,
12646,GO:0046833,1,0.951049678532644,0,7,positive regulation of RNA export from nucleus,BP,
12647,GO:0046834,1,0.49058933481557,0,103,lipid phosphorylation,BP,
12648,GO:0046835,1,0.84129458296046,0,26,carbohydrate phosphorylation,BP,
12649,GO:0046836,1,0.970507005101264,0,5,glycolipid transport,BP,
12650,GO:0046838,1,0.925526839997937,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12651,GO:0046839,1,0.838205346278181,0,24,phospholipid dephosphorylation,BP,
12653,GO:0046848,1,0.996635005949123,0,1,hydroxyapatite binding,MF,
12654,GO:0046849,1,0.623627790206945,0,72,bone remodeling,BP,
12655,GO:0046850,1,0.773230486516671,0,38,regulation of bone remodeling,BP,
12656,GO:0046851,1,0.932165962929301,0,11,negative regulation of bone remodeling,BP,
12657,GO:0046852,1,0.917688994885268,0,13,positive regulation of bone remodeling,BP,
12658,GO:0046854,1,0.535616795120367,0,91,phosphatidylinositol phosphorylation,BP,
12659,GO:0046855,1,0.932282365373864,0,10,inositol phosphate dephosphorylation,BP,
12660,GO:0046856,1,0.84316207778353,0,23,phosphatidylinositol dephosphorylation,BP,
12661,GO:0046864,1,0.989263627424997,0,2,isoprenoid transport,BP,
12662,GO:0046865,1,0.989263627424997,0,2,terpenoid transport,BP,
12663,GO:0046870,1,0.969445758796021,0,5,cadmium ion binding,MF,
12666,GO:0046874,1,0.979256185502646,0,4,quinolinate metabolic process,BP,
12667,GO:0046875,1,0.834588144355223,0,27,ephrin receptor binding,MF,
12668,GO:0046877,1,0.96702306046173,0,6,regulation of saliva secretion,BP,
12669,GO:0046878,1,0.981876122920131,0,3,positive regulation of saliva secretion,BP,
12671,GO:0046880,1,0.960770350999242,0,6,regulation of follicle-stimulating hormone secretion,BP,
12672,GO:0046881,1,0.960770350999242,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12673,GO:0046882,1,0.982577602549282,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12675,GO:0046884,1,0.953530501258557,0,7,follicle-stimulating hormone secretion,BP,
12676,GO:0046885,1,0.852119711466854,0,24,regulation of hormone biosynthetic process,BP,
12677,GO:0046886,1,0.941066908905904,0,9,positive regulation of hormone biosynthetic process,BP,
12680,GO:0046889,1,0.688902049603073,0,58,positive regulation of lipid biosynthetic process,BP,
12681,GO:0046890,1,0.373424677731229,0,151,regulation of lipid biosynthetic process,BP,
12682,GO:0046898,1,0.974052276036084,0,4,response to cycloheximide,BP,
12683,GO:0046899,1,0.986454116995142,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12684,GO:0046900,1,0.989082236243662,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12685,GO:0046901,1,0.993576982081585,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12688,GO:0046906,1,0.515090539949001,0,108,tetrapyrrole binding,MF,
12690,GO:0046911,1,0.995924249434127,0,1,metal chelating activity,MF,
12691,GO:0046912,1,0.964539214833167,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12695,GO:0046920,1,0.947624437400555,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12696,GO:0046921,1,0.99263407243923,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12697,GO:0046922,1,0.985426206446601,0,2,peptide-O-fucosyltransferase activity,MF,
12698,GO:0046923,1,0.971421846013034,0,5,ER retention sequence binding,MF,
12701,GO:0046930,1,0.91232720254788,0,15,pore complex,CC,
12702,GO:0046931,1,0.899971910927389,0,16,pore complex assembly,BP,
12703,GO:0046933,1,0.98684950978907,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12704,GO:0046934,1,0.660396226060781,0,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12705,GO:0046935,1,0.964603328328796,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12706,GO:0046939,1,0.47723816983271,0,115,nucleotide phosphorylation,BP,
12707,GO:0046940,1,0.968658269968721,0,5,nucleoside monophosphate phosphorylation,BP,
12710,GO:0046946,1,0.978335765916307,0,3,hydroxylysine metabolic process,BP,
12711,GO:0046947,1,0.978335765916307,0,3,hydroxylysine biosynthetic process,BP,
12712,GO:0046949,1,0.838112733184376,0,27,fatty-acyl-CoA biosynthetic process,BP,
12713,GO:0046950,1,0.9313832550122,0,11,cellular ketone body metabolic process,BP,
12714,GO:0046951,1,0.943194455854007,0,9,ketone body biosynthetic process,BP,
12715,GO:0046952,1,0.974549326369272,0,4,ketone body catabolic process,BP,
12716,GO:0046958,1,0.956959443156246,0,6,nonassociative learning,BP,
12717,GO:0046959,1,0.970063803989683,0,4,habituation,BP,
12718,GO:0046960,1,0.986448852777769,0,2,sensitization,BP,
12719,GO:0046961,1,0.890086096488304,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12720,GO:0046963,1,0.988923921275082,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12721,GO:0046964,1,0.988923921275082,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12722,GO:0046965,1,0.909820575485277,0,14,retinoid X receptor binding,MF,
12723,GO:0046966,1,0.841772229145854,0,26,thyroid hormone receptor binding,MF,
12724,GO:0046967,1,0.985438572852119,0,2,cytosol to ER transport,BP,
12725,GO:0046968,1,0.985049662748603,0,2,peptide antigen transport,BP,
12726,GO:0046969,1,0.987778594542397,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12727,GO:0046970,1,0.994661592279131,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12728,GO:0046972,1,0.932151670535879,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12729,GO:0046974,1,0.963860556680724,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12730,GO:0046975,1,0.960169033110078,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12731,GO:0046976,1,0.965437066014023,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12732,GO:0046977,1,0.973971480207595,0,4,TAP binding,MF,
12733,GO:0046978,1,0.973971480207595,0,4,TAP1 binding,MF,
12734,GO:0046979,1,0.981333223641103,0,3,TAP2 binding,MF,
12735,GO:0046980,1,0.99249965888042,0,1,tapasin binding,MF,
12738,GO:0046984,1,0.975340797105933,0,4,regulation of hemoglobin biosynthetic process,BP,
12739,GO:0046985,1,0.982728432427765,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12740,GO:0046986,1,0.992483857259806,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12741,GO:0046996,1,0.9930956730518,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12742,GO:0046997,1,0.985437699469873,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12743,GO:0047006,1,0.991229175549291,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12744,GO:0047012,1,0.995301999084177,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12745,GO:0047015,1,0.996201642158946,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12746,GO:0047016,1,0.994174213189959,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12747,GO:0047017,1,0.988985003389092,0,2,prostaglandin-F synthase activity,MF,
12748,GO:0047020,1,0.995861044061941,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12749,GO:0047021,1,0.995838234023709,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12750,GO:0047023,1,0.982986543424467,0,4,androsterone dehydrogenase activity,MF,
12751,GO:0047025,1,0.988748656102302,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12752,GO:0047035,1,0.974163435447047,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12753,GO:0047042,1,0.995642929265729,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12754,GO:0047045,1,0.987725085559507,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12755,GO:0047057,1,0.992198559349443,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12756,GO:0047066,1,0.99621363569025,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12757,GO:0047086,1,0.982986543424467,0,4,ketosteroid monooxygenase activity,MF,
12758,GO:0047105,1,0.993549443156936,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12759,GO:0047115,1,0.983128296342143,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12760,GO:0047117,1,0.992156415186924,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12762,GO:0047130,1,0.992376542535849,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12763,GO:0047131,1,0.992376542535849,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12764,GO:0047134,1,0.968385676328437,0,6,protein-disulfide reductase activity,MF,
12765,GO:0047144,1,0.938843088382868,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12766,GO:0047150,1,0.988158728545005,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12767,GO:0047159,1,0.992501384926178,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12768,GO:0047166,1,0.99472313059879,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12769,GO:0047173,1,0.992458854066094,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12770,GO:0047179,1,0.991974935990256,0,2,platelet-activating factor acetyltransferase activity,MF,
12771,GO:0047184,1,0.968796482771015,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12772,GO:0047186,1,0.992503368575524,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12773,GO:0047191,1,0.992501384926178,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12774,GO:0047192,1,0.979778412477019,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12775,GO:0047220,1,0.993093586967458,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12776,GO:0047223,1,0.993005739688697,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12777,GO:0047237,1,0.978160307479527,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12778,GO:0047238,1,0.963447448715038,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12779,GO:0047256,1,0.99249750382539,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12780,GO:0047263,1,0.992945762084722,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12781,GO:0047273,1,0.992621383391815,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12782,GO:0047275,1,0.986805102109918,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12783,GO:0047277,1,0.994657603017739,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12784,GO:0047280,1,0.992477858359252,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12785,GO:0047288,1,0.98756708271792,0,2,monosialoganglioside sialyltransferase activity,MF,
12786,GO:0047290,1,0.995222428885051,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12787,GO:0047291,1,0.993925789035099,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12788,GO:0047293,1,0.995232713259837,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12789,GO:0047298,1,0.992456603639031,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12790,GO:0047322,1,0.984588573014814,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12791,GO:0047323,1,0.994286508371181,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12792,GO:0047325,1,0.992652011336942,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12793,GO:0047326,1,0.994958464653527,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12794,GO:0047341,1,0.992577151613587,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12795,GO:0047349,1,0.992414288092751,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12796,GO:0047369,1,0.9930956730518,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12797,GO:0047372,1,0.93223710311808,0,11,acylglycerol lipase activity,MF,
12798,GO:0047374,1,0.983019109467884,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12799,GO:0047389,1,0.985162174656604,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12800,GO:0047390,1,0.992501793731769,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12801,GO:0047391,1,0.980507901280165,0,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12802,GO:0047394,1,0.994069544948467,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12803,GO:0047395,1,0.992908399563964,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12804,GO:0047408,1,0.987615854176758,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12805,GO:0047409,1,0.987615854176758,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12806,GO:0047429,1,0.948764653594821,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12807,GO:0047444,1,0.995842275743558,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12808,GO:0047451,1,0.992156415186924,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12809,GO:0047464,1,0.992447454105328,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12810,GO:0047484,1,0.9415517484497,0,9,regulation of response to osmotic stress,BP,
12811,GO:0047485,1,0.512467197013929,0,106,protein N-terminus binding,MF,
12812,GO:0047493,1,0.980448938820001,0,3,ceramide cholinephosphotransferase activity,MF,
12813,GO:0047496,1,0.771600123832087,0,38,vesicle transport along microtubule,BP,
12814,GO:0047497,1,0.879495027309607,0,19,mitochondrion transport along microtubule,BP,
12815,GO:0047498,1,0.956251846811626,0,7,calcium-dependent phospholipase A2 activity,MF,
12816,GO:0047499,1,0.96266039746467,0,6,calcium-independent phospholipase A2 activity,MF,
12817,GO:0047522,1,0.981805770393807,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12818,GO:0047536,1,0.994097927936679,0,1,2-aminoadipate transaminase activity,MF,
12819,GO:0047545,1,0.992358242512686,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12820,GO:0047555,1,0.919928920645636,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12821,GO:0047560,1,0.992435093267707,0,1,3-dehydrosphinganine reductase activity,MF,
12822,GO:0047578,1,0.993649713525989,0,1,4-hydroxyglutamate transaminase activity,MF,
12823,GO:0047598,1,0.993290687475071,0,1,7-dehydrocholesterol reductase activity,MF,
12824,GO:0047617,1,0.918644836867775,0,15,acyl-CoA hydrolase activity,MF,
12825,GO:0047620,1,0.992908399563964,0,1,acylglycerol kinase activity,MF,
12826,GO:0047621,1,0.995165192397572,0,1,acylpyruvate hydrolase activity,MF,
12827,GO:0047623,1,0.985057705462414,0,2,adenosine-phosphate deaminase activity,MF,
12828,GO:0047631,1,0.976909912348395,0,5,ADP-ribose diphosphatase activity,MF,
12829,GO:0047635,1,0.987313380288783,0,2,alanine-oxo-acid transaminase activity,MF,
12830,GO:0047658,1,0.995135257868318,0,1,alpha-amino-acid esterase activity,MF,
12831,GO:0047661,1,0.993597334811366,0,1,amino-acid racemase activity,MF,
12832,GO:0047676,1,0.992436011100654,0,1,arachidonate-CoA ligase activity,MF,
12833,GO:0047685,1,0.995453723261454,0,1,amine sulfotransferase activity,MF,
12834,GO:0047693,1,0.996458096886506,0,1,ATP diphosphatase activity,MF,
12835,GO:0047696,1,0.986368692620454,0,2,beta-adrenergic receptor kinase activity,MF,
12836,GO:0047708,1,0.990385704953775,0,2,biotinidase activity,MF,
12837,GO:0047710,1,0.988540756286265,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12838,GO:0047718,1,0.986863247914872,0,3,indanol dehydrogenase activity,MF,
12839,GO:0047726,1,0.993543965901044,0,1,iron-cytochrome-c reductase activity,MF,
12840,GO:0047730,1,0.992501255451989,0,1,carnosine synthase activity,MF,
12841,GO:0047734,1,0.9930956730518,0,1,CDP-glycerol diphosphatase activity,MF,
12842,GO:0047743,1,0.995900752357557,0,1,chlordecone reductase activity,MF,
12843,GO:0047747,1,0.99380728193192,0,1,cholate-CoA ligase activity,MF,
12844,GO:0047750,1,0.992141489190307,0,2,cholestenol delta-isomerase activity,MF,
12845,GO:0047751,1,0.987345198655197,0,2,cholestenone 5-alpha-reductase activity,MF,
12847,GO:0047757,1,0.984651766443059,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12848,GO:0047760,1,0.968846094487231,0,5,butyrate-CoA ligase activity,MF,
12849,GO:0047777,1,0.992386603804784,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12850,GO:0047787,1,0.995861044061941,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12851,GO:0047800,1,0.992514889634931,0,1,cysteamine dioxygenase activity,MF,
12852,GO:0047801,1,0.994290595590016,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12853,GO:0047837,1,0.996044348490844,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12854,GO:0047840,1,0.996003358562593,0,1,dCTP diphosphatase activity,MF,
12855,GO:0047844,1,0.962275706033192,0,7,deoxycytidine deaminase activity,MF,
12856,GO:0047856,1,0.995904685459632,0,1,dihydrocoumarin hydrolase activity,MF,
12857,GO:0047860,1,0.995798796815009,0,1,diiodophenylpyruvate reductase activity,MF,
12858,GO:0047865,1,0.992761326637004,0,1,dimethylglycine dehydrogenase activity,MF,
12859,GO:0047874,1,0.994325335540673,0,1,dolichyldiphosphatase activity,MF,
12860,GO:0047888,1,0.994655607572797,0,1,fatty acid peroxidase activity,MF,
12861,GO:0047894,1,0.986770011515912,0,3,flavonol 3-sulfotransferase activity,MF,
12862,GO:0047915,1,0.995161686647073,0,1,ganglioside galactosyltransferase activity,MF,
12863,GO:0047933,1,0.992155192551791,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12864,GO:0047936,1,0.992106452708226,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12865,GO:0047939,1,0.99550371414173,0,1,L-glucuronate reductase activity,MF,
12866,GO:0047946,1,0.994413115218373,0,1,glutamine N-acyltransferase activity,MF,
12867,GO:0047961,1,0.990087406694529,0,2,glycine N-acyltransferase activity,MF,
12868,GO:0047963,1,0.992576979859984,0,1,glycine N-choloyltransferase activity,MF,
12869,GO:0047969,1,0.995041759703579,0,1,glyoxylate oxidase activity,MF,
12870,GO:0047977,1,0.987098426187172,0,2,hepoxilin-epoxide hydrolase activity,MF,
12871,GO:0047982,1,0.995049967525852,0,1,homocysteine desulfhydrase activity,MF,
12872,GO:0047988,1,0.994750725323016,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12873,GO:0047992,1,0.9930956730518,0,1,hydroxylysine kinase activity,MF,
12874,GO:0048002,1,0.360902430912762,0,175,antigen processing and presentation of peptide antigen,BP,
12875,GO:0048003,1,0.971182228630512,0,4,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12876,GO:0048006,1,0.992509180880764,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12877,GO:0048007,1,0.971182228630512,0,4,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12878,GO:0048008,1,0.707826007061895,0,48,platelet-derived growth factor receptor signaling pathway,BP,
12880,GO:0048010,1,0.546415131310789,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12881,GO:0048011,1,0.851047907133119,0,24,neurotrophin TRK receptor signaling pathway,BP,
12882,GO:0048012,1,0.901927703374085,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12884,GO:0048014,1,0.977554361690722,0,3,Tie signaling pathway,BP,
12885,GO:0048015,1,0.374261079111571,0,141,phosphatidylinositol-mediated signaling,BP,
12886,GO:0048016,1,0.780359377760019,0,36,inositol phosphate-mediated signaling,BP,
12887,GO:0048017,1,0.366378063049399,0,144,inositol lipid-mediated signaling,BP,
12889,GO:0048019,1,0.931997107180293,0,12,receptor antagonist activity,MF,
12890,GO:0048020,1,0.90823927125075,0,20,CCR chemokine receptor binding,MF,
12891,GO:0048021,1,0.959517455766935,0,6,regulation of melanin biosynthetic process,BP,
12892,GO:0048022,1,0.984733756691248,0,2,negative regulation of melanin biosynthetic process,BP,
12893,GO:0048023,1,0.974396738742411,0,4,positive regulation of melanin biosynthetic process,BP,
12897,GO:0048027,1,0.880104883003507,0,22,mRNA 5'-UTR binding,MF,
12898,GO:0048029,1,0.665708899566992,0,64,monosaccharide binding,MF,
12899,GO:0048030,1,0.986907594802013,0,3,disaccharide binding,MF,
12900,GO:0048033,1,0.992843041620907,0,1,heme o metabolic process,BP,
12901,GO:0048034,1,0.992843041620907,0,1,heme O biosynthetic process,BP,
12903,GO:0048038,1,0.9292793534823,0,14,quinone binding,MF,
12904,GO:0048039,1,0.97028300991549,0,6,ubiquinone binding,MF,
12905,GO:0048040,1,0.994366188281796,0,1,UDP-glucuronate decarboxylase activity,MF,
12906,GO:0048041,1,0.60311164312098,0,71,focal adhesion assembly,BP,
12907,GO:0048048,1,0.784652036804671,0,34,embryonic eye morphogenesis,BP,
12908,GO:0048050,1,0.967818217449956,0,6,post-embryonic eye morphogenesis,BP,
12909,GO:0048066,1,0.754563684837138,0,42,developmental pigmentation,BP,
12910,GO:0048069,1,0.953271593011087,0,7,eye pigmentation,BP,
12911,GO:0048070,1,0.901735656793253,0,15,regulation of developmental pigmentation,BP,
12912,GO:0048073,1,0.98503605620815,0,2,regulation of eye pigmentation,BP,
12913,GO:0048075,1,0.992491066793184,0,1,positive regulation of eye pigmentation,BP,
12914,GO:0048087,1,0.938432219968118,0,9,positive regulation of developmental pigmentation,BP,
12915,GO:0048096,1,0.940375890028259,0,9,chromatin-mediated maintenance of transcription,BP,
12916,GO:0048101,1,0.986772647889584,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12917,GO:0048102,1,0.957047765831333,0,7,autophagic cell death,BP,
12918,GO:0048103,1,0.853224252909956,0,22,somatic stem cell division,BP,
12919,GO:0048104,1,0.969680479883735,0,4,establishment of body hair or bristle planar orientation,BP,
12920,GO:0048105,1,0.969680479883735,0,4,establishment of body hair planar orientation,BP,
12921,GO:0048133,1,0.982494886252243,0,3,male germ-line stem cell asymmetric division,BP,
12922,GO:0048143,1,0.921170184819246,0,12,astrocyte activation,BP,
12923,GO:0048144,1,0.61473297318617,0,77,fibroblast proliferation,BP,
12924,GO:0048145,1,0.61939950434949,0,76,regulation of fibroblast proliferation,BP,
12925,GO:0048146,1,0.736199019392448,0,48,positive regulation of fibroblast proliferation,BP,
12926,GO:0048147,1,0.849621969037003,0,27,negative regulation of fibroblast proliferation,BP,
12927,GO:0048148,1,0.907284756443594,0,15,behavioral response to cocaine,BP,
12928,GO:0048149,1,0.936994288781736,0,10,behavioral response to ethanol,BP,
12929,GO:0048156,1,0.932627681273956,0,11,tau protein binding,MF,
12930,GO:0048160,1,0.992475406166524,0,1,primary follicle stage,BP,
12931,GO:0048162,1,0.98372600654435,0,3,multi-layer follicle stage,BP,
12932,GO:0048165,1,0.984937219097334,0,2,fused antrum stage,BP,
12939,GO:0048175,1,0.992685056253613,0,1,hepatocyte growth factor biosynthetic process,BP,
12940,GO:0048176,1,0.992685056253613,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12941,GO:0048178,1,0.992685056253613,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12942,GO:0048179,1,0.980127029950277,0,3,activin receptor complex,CC,
12943,GO:0048180,1,0.994206847407389,0,1,activin complex,CC,
12944,GO:0048185,1,0.922956024617069,0,12,activin binding,MF,
12945,GO:0048188,1,0.921721257084773,0,12,Set1C/COMPASS complex,CC,
12946,GO:0048193,1,0.105269222915481,0,335,Golgi vesicle transport,BP,
12947,GO:0048194,1,0.596337714744353,0,78,Golgi vesicle budding,BP,
12948,GO:0048199,1,0.635032085466209,0,70,vesicle targeting, to, from or within Golgi,BP,
12949,GO:0048200,1,0.961611368978511,0,6,Golgi transport vesicle coating,BP,
12950,GO:0048203,1,0.987725399572544,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12951,GO:0048205,1,0.961611368978511,0,6,COPI coating of Golgi vesicle,BP,
12952,GO:0048207,1,0.669602119609359,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12953,GO:0048208,1,0.669602119609359,0,62,COPII vesicle coating,BP,
12954,GO:0048209,1,0.986690123079393,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12955,GO:0048210,1,0.977729575462668,0,4,Golgi vesicle fusion to target membrane,BP,
12956,GO:0048211,1,0.985643252595723,0,2,Golgi vesicle docking,BP,
12957,GO:0048213,1,0.98809030268238,0,2,Golgi vesicle prefusion complex stabilization,BP,
12958,GO:0048227,1,0.949651821418218,0,8,plasma membrane to endosome transport,BP,
12960,GO:0048237,1,0.984947496901732,0,3,rough endoplasmic reticulum lumen,CC,
12961,GO:0048239,1,0.987312702837011,0,2,negative regulation of DNA recombination at telomere,BP,
12962,GO:0048240,1,0.904110934301742,0,17,sperm capacitation,BP,
12963,GO:0048241,1,0.979349452126878,0,4,epinephrine transport,BP,
12964,GO:0048242,1,0.979349452126878,0,4,epinephrine secretion,BP,
12965,GO:0048243,1,0.921243826719656,0,13,norepinephrine secretion,BP,
12966,GO:0048244,1,0.995191350726741,0,1,phytanoyl-CoA dioxygenase activity,MF,
12967,GO:0048245,1,0.946703145505048,0,11,eosinophil chemotaxis,BP,
12968,GO:0048246,1,0.847239695607803,0,29,macrophage chemotaxis,BP,
12970,GO:0048248,1,0.97768798354929,0,5,CXCR3 chemokine receptor binding,MF,
12971,GO:0048250,1,0.990230175174579,0,2,iron import into the mitochondrion,BP,
12972,GO:0048251,1,0.94002149777505,0,9,elastic fiber assembly,BP,
12973,GO:0048254,1,0.978893153811195,0,4,snoRNA localization,BP,
12974,GO:0048255,1,0.807694504681908,0,31,mRNA stabilization,BP,
12975,GO:0048256,1,0.953205047519627,0,7,flap endonuclease activity,MF,
12976,GO:0048257,1,0.986870138136567,0,2,3'-flap endonuclease activity,MF,
12977,GO:0048259,1,0.619570969793444,0,72,regulation of receptor-mediated endocytosis,BP,
12978,GO:0048260,1,0.744419383843765,0,44,positive regulation of receptor-mediated endocytosis,BP,
12979,GO:0048261,1,0.89884378384883,0,17,negative regulation of receptor-mediated endocytosis,BP,
12980,GO:0048262,1,0.946054229240465,0,9,determination of dorsal/ventral asymmetry,BP,
12981,GO:0048263,1,0.95288551574903,0,8,determination of dorsal identity,BP,
12982,GO:0048264,1,0.992834463720673,0,1,determination of ventral identity,BP,
12983,GO:0048265,1,0.846646268613796,0,26,response to pain,BP,
12984,GO:0048266,1,0.922999213346849,0,12,behavioral response to pain,BP,
12986,GO:0048269,1,0.987466374712797,0,2,methionine adenosyltransferase complex,CC,
12987,GO:0048270,1,0.994381498470811,0,1,methionine adenosyltransferase regulator activity,MF,
12988,GO:0048273,1,0.960801869109052,0,6,mitogen-activated protein kinase p38 binding,MF,
12990,GO:0048280,1,0.951728261412109,0,8,vesicle fusion with Golgi apparatus,BP,
12993,GO:0048286,1,0.784612613830738,0,35,lung alveolus development,BP,
12994,GO:0048289,1,0.959649166382338,0,6,isotype switching to IgE isotypes,BP,
12995,GO:0048290,1,0.962066068038979,0,6,isotype switching to IgA isotypes,BP,
12996,GO:0048291,1,0.927867250503616,0,11,isotype switching to IgG isotypes,BP,
12997,GO:0048293,1,0.959649166382338,0,6,regulation of isotype switching to IgE isotypes,BP,
12998,GO:0048294,1,0.979099224689879,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12999,GO:0048295,1,0.980138979396053,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13000,GO:0048296,1,0.969232040066306,0,5,regulation of isotype switching to IgA isotypes,BP,
13001,GO:0048297,1,0.994282421202187,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13002,GO:0048298,1,0.974807023800974,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13003,GO:0048302,1,0.933552980312465,0,10,regulation of isotype switching to IgG isotypes,BP,
13004,GO:0048304,1,0.953394304739028,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13005,GO:0048305,1,0.905917274624719,0,18,immunoglobulin secretion,BP,
13007,GO:0048308,1,0.911497944048443,0,15,organelle inheritance,BP,
13008,GO:0048311,1,0.890663178585788,0,16,mitochondrion distribution,BP,
13009,GO:0048312,1,0.945211194584465,0,8,intracellular distribution of mitochondria,BP,
13010,GO:0048313,1,0.917840541829529,0,14,Golgi inheritance,BP,
13011,GO:0048318,1,0.958866439668221,0,7,axial mesoderm development,BP,
13012,GO:0048319,1,0.97942922352446,0,3,axial mesoderm morphogenesis,BP,
13013,GO:0048320,1,0.987012040673845,0,2,axial mesoderm formation,BP,
13014,GO:0048321,1,0.994384559683417,0,1,axial mesodermal cell differentiation,BP,
13015,GO:0048322,1,0.994384559683417,0,1,axial mesodermal cell fate commitment,BP,
13016,GO:0048327,1,0.994384559683417,0,1,axial mesodermal cell fate specification,BP,
13017,GO:0048332,1,0.648670911146982,0,64,mesoderm morphogenesis,BP,
13018,GO:0048333,1,0.81883122976814,0,30,mesodermal cell differentiation,BP,
13019,GO:0048338,1,0.992527806493065,0,1,mesoderm structural organization,BP,
13020,GO:0048339,1,0.890196015763525,0,17,paraxial mesoderm development,BP,
13021,GO:0048340,1,0.938930513126266,0,9,paraxial mesoderm morphogenesis,BP,
13022,GO:0048341,1,0.960965234083829,0,6,paraxial mesoderm formation,BP,
13023,GO:0048342,1,0.995173938235442,0,1,paraxial mesodermal cell differentiation,BP,
13024,GO:0048343,1,0.995173938235442,0,1,paraxial mesodermal cell fate commitment,BP,
13025,GO:0048352,1,0.992527806493065,0,1,paraxial mesoderm structural organization,BP,
13026,GO:0048364,1,0.996390802365142,0,1,root development,BP,
13027,GO:0048365,1,0.651364219827986,0,60,Rac GTPase binding,MF,
13028,GO:0048368,1,0.914239403124274,0,15,lateral mesoderm development,BP,
13029,GO:0048369,1,0.973938036953776,0,4,lateral mesoderm morphogenesis,BP,
13030,GO:0048370,1,0.973938036953776,0,4,lateral mesoderm formation,BP,
13031,GO:0048371,1,0.978535396872541,0,3,lateral mesodermal cell differentiation,BP,
13032,GO:0048372,1,0.984982081158489,0,2,lateral mesodermal cell fate commitment,BP,
13033,GO:0048377,1,0.984982081158489,0,2,lateral mesodermal cell fate specification,BP,
13034,GO:0048378,1,0.984982081158489,0,2,regulation of lateral mesodermal cell fate specification,BP,
13035,GO:0048382,1,0.97604077557046,0,4,mesendoderm development,BP,
13036,GO:0048384,1,0.836281917283105,0,28,retinoic acid receptor signaling pathway,BP,
13037,GO:0048385,1,0.911113132188641,0,15,regulation of retinoic acid receptor signaling pathway,BP,
13038,GO:0048386,1,0.972606285497782,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13039,GO:0048387,1,0.9497174077158,0,8,negative regulation of retinoic acid receptor signaling pathway,BP,
13040,GO:0048388,1,0.982989090779755,0,3,endosomal lumen acidification,BP,
13041,GO:0048389,1,0.989777319609514,0,2,intermediate mesoderm development,BP,
13042,GO:0048390,1,0.99497902520046,0,1,intermediate mesoderm morphogenesis,BP,
13043,GO:0048391,1,0.99497902520046,0,1,intermediate mesoderm formation,BP,
13044,GO:0048392,1,0.99497902520046,0,1,intermediate mesodermal cell differentiation,BP,
13045,GO:0048403,1,0.977364730386775,0,3,brain-derived neurotrophic factor binding,MF,
13046,GO:0048406,1,0.956893488971316,0,6,nerve growth factor binding,MF,
13047,GO:0048407,1,0.920400970243166,0,11,platelet-derived growth factor binding,MF,
13048,GO:0048408,1,0.982767656126391,0,3,epidermal growth factor binding,MF,
13050,GO:0048469,1,0.402568329579296,0,142,cell maturation,BP,
13053,GO:0048476,1,0.972914206774215,0,5,Holliday junction resolvase complex,CC,
13054,GO:0048477,1,0.64781990359028,0,67,oogenesis,BP,
13055,GO:0048478,1,0.955422304599017,0,7,replication fork protection,BP,
13056,GO:0048483,1,0.771768692445685,0,38,autonomic nervous system development,BP,
13057,GO:0048484,1,0.935362469905222,0,10,enteric nervous system development,BP,
13058,GO:0048485,1,0.875561236808133,0,19,sympathetic nervous system development,BP,
13059,GO:0048486,1,0.913115667741238,0,14,parasympathetic nervous system development,BP,
13060,GO:0048487,1,0.794839611694801,0,36,beta-tubulin binding,MF,
13063,GO:0048490,1,0.899537585248205,0,17,anterograde synaptic vesicle transport,BP,
13064,GO:0048495,1,0.964726829026138,0,5,Roundabout binding,MF,
13065,GO:0048496,1,0.970808756848112,0,4,maintenance of animal organ identity,BP,
13066,GO:0048499,1,0.977190396249881,0,4,synaptic vesicle membrane organization,BP,
13067,GO:0048500,1,0.950308815626904,0,9,signal recognition particle,CC,
13068,GO:0048505,1,0.92860756436005,0,11,regulation of timing of cell differentiation,BP,
13070,GO:0048512,1,0.793928260674646,0,38,circadian behavior,BP,
13076,GO:0048520,1,0.897445861455722,0,18,positive regulation of behavior,BP,
13077,GO:0048521,1,0.933242780658012,0,13,negative regulation of behavior,BP,
13080,GO:0048524,1,0.529798139238678,0,100,positive regulation of viral process,BP,
13081,GO:0048525,1,0.600603178188324,0,80,negative regulation of viral process,BP,
13082,GO:0048531,1,0.914887140322723,0,14,beta-1,3-galactosyltransferase activity,MF,
13083,GO:0048532,1,0.899447548060338,0,15,anatomical structure arrangement,BP,
13085,GO:0048535,1,0.914367513509655,0,15,lymph node development,BP,
13086,GO:0048536,1,0.808362397370472,0,33,spleen development,BP,
13087,GO:0048537,1,0.964169171310694,0,6,mucosal-associated lymphoid tissue development,BP,
13088,GO:0048538,1,0.747104708082582,0,43,thymus development,BP,
13089,GO:0048539,1,0.955208109598809,0,7,bone marrow development,BP,
13090,GO:0048541,1,0.964169171310694,0,6,Peyer's patch development,BP,
13092,GO:0048546,1,0.73706976657301,0,45,digestive tract morphogenesis,BP,
13093,GO:0048548,1,0.940890133000561,0,9,regulation of pinocytosis,BP,
13094,GO:0048549,1,0.971573034683301,0,4,positive regulation of pinocytosis,BP,
13095,GO:0048550,1,0.968428498333974,0,5,negative regulation of pinocytosis,BP,
13096,GO:0048557,1,0.904662875864481,0,16,embryonic digestive tract morphogenesis,BP,
13097,GO:0048560,1,0.988325402118729,0,2,establishment of anatomical structure orientation,BP,
13098,GO:0048561,1,0.99410503296017,0,1,establishment of animal organ orientation,BP,
13099,GO:0048562,1,0.171620998331037,0,266,embryonic organ morphogenesis,BP,
13100,GO:0048563,1,0.95306654800834,0,8,post-embryonic animal organ morphogenesis,BP,
13101,GO:0048565,1,0.4385314049476,0,122,digestive tract development,BP,
13102,GO:0048566,1,0.816718974442755,0,32,embryonic digestive tract development,BP,
13103,GO:0048567,1,0.99345603044542,0,1,ectodermal digestive tract morphogenesis,BP,
13104,GO:0048568,1,0.0709061961605101,0,396,embryonic organ development,BP,
13105,GO:0048569,1,0.90590267248814,0,15,post-embryonic animal organ development,BP,
13106,GO:0048570,1,0.948117744791388,0,8,notochord morphogenesis,BP,
13112,GO:0048592,1,0.402609072354944,0,132,eye morphogenesis,BP,
13113,GO:0048593,1,0.510617586172189,0,98,camera-type eye morphogenesis,BP,
13114,GO:0048596,1,0.833000937086405,0,25,embryonic camera-type eye morphogenesis,BP,
13115,GO:0048597,1,0.986341116833586,0,3,post-embryonic camera-type eye morphogenesis,BP,
13116,GO:0048598,1,0.0257862668625029,0,539,embryonic morphogenesis,BP,
13117,GO:0048599,1,0.781770832807142,0,38,oocyte development,BP,
13120,GO:0048611,1,0.986379989368734,0,2,embryonic ectodermal digestive tract development,BP,
13121,GO:0048613,1,0.99345603044542,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13122,GO:0048617,1,0.938184110219984,0,9,embryonic foregut morphogenesis,BP,
13123,GO:0048619,1,0.979564888480717,0,3,embryonic hindgut morphogenesis,BP,
13124,GO:0048625,1,0.967889354263678,0,5,myoblast fate commitment,BP,
13125,GO:0048627,1,0.988318228020446,0,2,myoblast development,BP,
13126,GO:0048630,1,0.953467627458699,0,7,skeletal muscle tissue growth,BP,
13127,GO:0048631,1,0.963510208611787,0,5,regulation of skeletal muscle tissue growth,BP,
13128,GO:0048632,1,0.98540620870628,0,2,negative regulation of skeletal muscle tissue growth,BP,
13129,GO:0048633,1,0.977783015094429,0,3,positive regulation of skeletal muscle tissue growth,BP,
13130,GO:0048634,1,0.452328433890573,0,117,regulation of muscle organ development,BP,
13131,GO:0048635,1,0.753619243339567,0,43,negative regulation of muscle organ development,BP,
13132,GO:0048636,1,0.662389445470844,0,60,positive regulation of muscle organ development,BP,
13135,GO:0048640,1,0.5587447363953,0,85,negative regulation of developmental growth,BP,
13136,GO:0048641,1,0.730578529301592,0,46,regulation of skeletal muscle tissue development,BP,
13137,GO:0048642,1,0.918815943501636,0,13,negative regulation of skeletal muscle tissue development,BP,
13138,GO:0048643,1,0.866602301729979,0,21,positive regulation of skeletal muscle tissue development,BP,
13139,GO:0048644,1,0.589675152848504,0,78,muscle organ morphogenesis,BP,
13142,GO:0048659,1,0.46253150452203,0,117,smooth muscle cell proliferation,BP,
13143,GO:0048660,1,0.472461651459253,0,114,regulation of smooth muscle cell proliferation,BP,
13144,GO:0048661,1,0.620449206763484,0,72,positive regulation of smooth muscle cell proliferation,BP,
13145,GO:0048662,1,0.78173141035127,0,39,negative regulation of smooth muscle cell proliferation,BP,
13147,GO:0048664,1,0.968610343512725,0,6,neuron fate determination,BP,
13151,GO:0048668,1,0.847435239716665,0,25,collateral sprouting,BP,
13152,GO:0048669,1,0.980579791251319,0,3,collateral sprouting in absence of injury,BP,
13153,GO:0048670,1,0.886741553391925,0,19,regulation of collateral sprouting,BP,
13154,GO:0048671,1,0.94591485980334,0,8,negative regulation of collateral sprouting,BP,
13155,GO:0048672,1,0.937477668319467,0,11,positive regulation of collateral sprouting,BP,
13156,GO:0048673,1,0.995330226998045,0,1,collateral sprouting of intact axon in response to injury,BP,
13157,GO:0048674,1,0.99366671585606,0,1,collateral sprouting of injured axon,BP,
13158,GO:0048675,1,0.467556817385649,0,107,axon extension,BP,
13159,GO:0048677,1,0.977957384173146,0,3,axon extension involved in regeneration,BP,
13160,GO:0048678,1,0.676962229219601,0,62,response to axon injury,BP,
13161,GO:0048679,1,0.861169690989527,0,22,regulation of axon regeneration,BP,
13162,GO:0048680,1,0.95762234299549,0,7,positive regulation of axon regeneration,BP,
13163,GO:0048681,1,0.920029582283593,0,12,negative regulation of axon regeneration,BP,
13164,GO:0048682,1,0.971762298339258,0,4,sprouting of injured axon,BP,
13165,GO:0048683,1,0.995330226998045,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13166,GO:0048685,1,0.995330226998045,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13167,GO:0048686,1,0.979224340679337,0,3,regulation of sprouting of injured axon,BP,
13168,GO:0048687,1,0.986690048914319,0,2,positive regulation of sprouting of injured axon,BP,
13169,GO:0048688,1,0.986148757332791,0,2,negative regulation of sprouting of injured axon,BP,
13170,GO:0048689,1,0.99366671585606,0,1,formation of growth cone in injured axon,BP,
13171,GO:0048690,1,0.985466509258083,0,2,regulation of axon extension involved in regeneration,BP,
13172,GO:0048691,1,0.992979319685909,0,1,positive regulation of axon extension involved in regeneration,BP,
13173,GO:0048692,1,0.992434613049477,0,1,negative regulation of axon extension involved in regeneration,BP,
13174,GO:0048693,1,0.99366671585606,0,1,regulation of collateral sprouting of injured axon,BP,
13175,GO:0048694,1,0.99366671585606,0,1,positive regulation of collateral sprouting of injured axon,BP,
13176,GO:0048696,1,0.995470232901551,0,1,regulation of collateral sprouting in absence of injury,BP,
13177,GO:0048697,1,0.995470232901551,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13179,GO:0048701,1,0.746787457354885,0,43,embryonic cranial skeleton morphogenesis,BP,
13180,GO:0048702,1,0.950455390378321,0,7,embryonic neurocranium morphogenesis,BP,
13181,GO:0048703,1,0.938866730425323,0,9,embryonic viscerocranium morphogenesis,BP,
13182,GO:0048704,1,0.566731656690044,0,88,embryonic skeletal system morphogenesis,BP,
13183,GO:0048705,1,0.2804298184769,0,192,skeletal system morphogenesis,BP,
13185,GO:0048708,1,0.63985962243988,0,67,astrocyte differentiation,BP,
13186,GO:0048709,1,0.570156119642162,0,87,oligodendrocyte differentiation,BP,
13187,GO:0048710,1,0.837968470407844,0,27,regulation of astrocyte differentiation,BP,
13188,GO:0048711,1,0.915648210898009,0,14,positive regulation of astrocyte differentiation,BP,
13189,GO:0048712,1,0.929543678626078,0,11,negative regulation of astrocyte differentiation,BP,
13190,GO:0048713,1,0.813057549873159,0,33,regulation of oligodendrocyte differentiation,BP,
13191,GO:0048714,1,0.900441181038156,0,17,positive regulation of oligodendrocyte differentiation,BP,
13192,GO:0048715,1,0.933748478900806,0,11,negative regulation of oligodendrocyte differentiation,BP,
13193,GO:0048729,1,0.0183572649135609,0,590,tissue morphogenesis,BP,
13194,GO:0048730,1,0.838055707258997,0,27,epidermis morphogenesis,BP,
13197,GO:0048733,1,0.958761157839004,0,6,sebaceous gland development,BP,
13198,GO:0048736,1,0.327261019848276,0,164,appendage development,BP,
13199,GO:0048738,1,0.28226159907755,0,184,cardiac muscle tissue development,BP,
13200,GO:0048739,1,0.910708300200076,0,13,cardiac muscle fiber development,BP,
13201,GO:0048741,1,0.835393553165763,0,27,skeletal muscle fiber development,BP,
13202,GO:0048742,1,0.940360917125607,0,9,regulation of skeletal muscle fiber development,BP,
13203,GO:0048743,1,0.960869019662687,0,6,positive regulation of skeletal muscle fiber development,BP,
13204,GO:0048745,1,0.87389335543459,0,19,smooth muscle tissue development,BP,
13205,GO:0048747,1,0.705965825485031,0,51,muscle fiber development,BP,
13206,GO:0048749,1,0.992499691111753,0,1,compound eye development,BP,
13207,GO:0048752,1,0.955761314106313,0,7,semicircular canal morphogenesis,BP,
13208,GO:0048753,1,0.844817185705737,0,27,pigment granule organization,BP,
13209,GO:0048754,1,0.380396275043374,0,142,branching morphogenesis of an epithelial tube,BP,
13210,GO:0048755,1,0.937030669471789,0,9,branching morphogenesis of a nerve,BP,
13211,GO:0048757,1,0.939897072920571,0,10,pigment granule maturation,BP,
13212,GO:0048762,1,0.289586160135619,0,185,mesenchymal cell differentiation,BP,
13213,GO:0048763,1,0.967681077620458,0,4,calcium-induced calcium release activity,MF,
13214,GO:0048764,1,0.996390802365142,0,1,trichoblast maturation,BP,
13215,GO:0048765,1,0.996390802365142,0,1,root hair cell differentiation,BP,
13216,GO:0048767,1,0.996390802365142,0,1,root hair elongation,BP,
13217,GO:0048769,1,0.971895171549508,0,4,sarcomerogenesis,BP,
13218,GO:0048770,1,0.523713810018829,0,101,pigment granule,CC,
13219,GO:0048771,1,0.408867258439955,0,135,tissue remodeling,BP,
13221,GO:0048787,1,0.964740914397053,0,5,presynaptic active zone membrane,CC,
13223,GO:0048789,1,0.992456461683755,0,1,cytoskeletal matrix organization at active zone,BP,
13224,GO:0048790,1,0.995462384203392,0,1,maintenance of presynaptic active zone structure,BP,
13226,GO:0048792,1,0.992574100876686,0,1,spontaneous exocytosis of neurotransmitter,BP,
13227,GO:0048793,1,0.957658232977323,0,6,pronephros development,BP,
13228,GO:0048799,1,0.869616216386821,0,19,animal organ maturation,BP,
13229,GO:0048806,1,0.767356259831231,0,40,genitalia development,BP,
13230,GO:0048807,1,0.985313755291975,0,3,female genitalia morphogenesis,BP,
13231,GO:0048808,1,0.981863227854858,0,3,male genitalia morphogenesis,BP,
13235,GO:0048817,1,0.984986633361584,0,2,negative regulation of hair follicle maturation,BP,
13236,GO:0048818,1,0.969717238396351,0,5,positive regulation of hair follicle maturation,BP,
13237,GO:0048819,1,0.940966150704753,0,9,regulation of hair follicle maturation,BP,
13238,GO:0048820,1,0.894536181813824,0,16,hair follicle maturation,BP,
13239,GO:0048821,1,0.835742981707998,0,28,erythrocyte development,BP,
13240,GO:0048822,1,0.97905851046216,0,3,enucleate erythrocyte development,BP,
13241,GO:0048823,1,0.9930956730518,0,1,nucleate erythrocyte development,BP,
13243,GO:0048840,1,0.971245788191988,0,4,otolith development,BP,
13244,GO:0048841,1,0.818620221744677,0,27,regulation of axon extension involved in axon guidance,BP,
13245,GO:0048842,1,0.949929924067675,0,7,positive regulation of axon extension involved in axon guidance,BP,
13246,GO:0048843,1,0.869558610063682,0,19,negative regulation of axon extension involved in axon guidance,BP,
13247,GO:0048844,1,0.667592110881849,0,58,artery morphogenesis,BP,
13248,GO:0048845,1,0.933403045826116,0,10,venous blood vessel morphogenesis,BP,
13249,GO:0048846,1,0.787882802658653,0,32,axon extension involved in axon guidance,BP,
13250,GO:0048850,1,0.984773159725635,0,2,hypophysis morphogenesis,BP,
13251,GO:0048852,1,0.979079390490929,0,3,diencephalon morphogenesis,BP,
13252,GO:0048853,1,0.92334314826462,0,13,forebrain morphogenesis,BP,
13254,GO:0048855,1,0.992334343913499,0,1,adenohypophysis morphogenesis,BP,
13258,GO:0048859,1,0.974147021066836,0,5,formation of anatomical boundary,BP,
13259,GO:0048861,1,0.972689994959098,0,4,leukemia inhibitory factor signaling pathway,BP,
13260,GO:0048863,1,0.231494082091274,0,233,stem cell differentiation,BP,
13261,GO:0048864,1,0.619739298816663,0,72,stem cell development,BP,
13262,GO:0048865,1,0.95455182655806,0,8,stem cell fate commitment,BP,
13263,GO:0048866,1,0.977585989636,0,4,stem cell fate specification,BP,
13264,GO:0048867,1,0.983838680962571,0,3,stem cell fate determination,BP,
13268,GO:0048872,1,0.23406089006581,0,225,homeostasis of number of cells,BP,
13269,GO:0048873,1,0.839731145504141,0,27,homeostasis of number of cells within a tissue,BP,
13270,GO:0048874,1,0.992638670220271,0,1,homeostasis of number of cells in a free-living population,BP,
13271,GO:0048875,1,0.93964332661736,0,10,chemical homeostasis within a tissue,BP,
13273,GO:0048880,1,0.971711297672803,0,4,sensory system development,BP,
13274,GO:0048882,1,0.993304539438279,0,1,lateral line development,BP,
13275,GO:0048884,1,0.993304539438279,0,1,neuromast development,BP,
13276,GO:0048886,1,0.993304539438279,0,1,neuromast hair cell differentiation,BP,
13277,GO:0048925,1,0.993304539438279,0,1,lateral line system development,BP,
13281,GO:0050000,1,0.625843150377611,0,71,chromosome localization,BP,
13282,GO:0050011,1,0.995316979435397,0,1,itaconyl-CoA hydratase activity,MF,
13283,GO:0050023,1,0.994828799955282,0,1,L-fuconate dehydratase activity,MF,
13284,GO:0050031,1,0.993720095530032,0,1,L-pipecolate oxidase activity,MF,
13285,GO:0050038,1,0.996334396234701,0,1,L-xylulose reductase (NADP+) activity,MF,
13286,GO:0050046,1,0.9930956730518,0,1,lathosterol oxidase activity,MF,
13287,GO:0050051,1,0.987953609368482,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13288,GO:0050072,1,0.957277154819294,0,7,m7G(5')pppN diphosphatase activity,MF,
13289,GO:0050080,1,0.99416198649944,0,1,malonyl-CoA decarboxylase activity,MF,
13290,GO:0050104,1,0.995462384203392,0,1,L-gulonate 3-dehydrogenase activity,MF,
13291,GO:0050115,1,0.992458854066094,0,1,myosin-light-chain-phosphatase activity,MF,
13292,GO:0050119,1,0.984751907720089,0,2,N-acetylglucosamine deacetylase activity,MF,
13293,GO:0050121,1,0.995501392282905,0,1,N-acylglucosamine 2-epimerase activity,MF,
13294,GO:0050124,1,0.992508391537397,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13295,GO:0050129,1,0.992684426528594,0,1,N-formylglutamate deformylase activity,MF,
13296,GO:0050135,1,0.990984099760303,0,2,NAD(P)+ nucleosidase activity,MF,
13297,GO:0050136,1,0.85692298916998,0,38,NADH dehydrogenase (quinone) activity,MF,
13298,GO:0050144,1,0.9930956730518,0,1,nucleoside deoxyribosyltransferase activity,MF,
13299,GO:0050145,1,0.968658269968721,0,5,nucleoside phosphate kinase activity,MF,
13300,GO:0050146,1,0.992425036491263,0,1,nucleoside phosphotransferase activity,MF,
13301,GO:0050152,1,0.995794678760663,0,1,omega-amidase activity,MF,
13302,GO:0050178,1,0.993150300101914,0,2,phenylpyruvate tautomerase activity,MF,
13303,GO:0050185,1,0.987625062872102,0,2,phosphatidylinositol deacylase activity,MF,
13304,GO:0050197,1,0.993915828702927,0,1,phytanate-CoA ligase activity,MF,
13305,GO:0050201,1,0.992502176336645,0,1,fucokinase activity,MF,
13306,GO:0050211,1,0.979188643853238,0,3,procollagen galactosyltransferase activity,MF,
13307,GO:0050220,1,0.981391475228066,0,4,prostaglandin-E synthase activity,MF,
13308,GO:0050221,1,0.995838234023709,0,1,prostaglandin-E2 9-reductase activity,MF,
13309,GO:0050252,1,0.986206257007343,0,2,retinol O-fatty-acyltransferase activity,MF,
13310,GO:0050253,1,0.985627175872346,0,2,retinyl-palmitate esterase activity,MF,
13311,GO:0050254,1,0.988477787140503,0,2,rhodopsin kinase activity,MF,
13312,GO:0050262,1,0.986238532970005,0,2,ribosylnicotinamide kinase activity,MF,
13313,GO:0050265,1,0.977971840690337,0,3,RNA uridylyltransferase activity,MF,
13314,GO:0050277,1,0.992505605941238,0,1,sedoheptulokinase activity,MF,
13315,GO:0050290,1,0.992468080180021,0,1,sphingomyelin phosphodiesterase D activity,MF,
13316,GO:0050291,1,0.954207581454321,0,7,sphingosine N-acyltransferase activity,MF,
13317,GO:0050294,1,0.986719609760971,0,3,steroid sulfotransferase activity,MF,
13318,GO:0050308,1,0.949864200635158,0,8,sugar-phosphatase activity,MF,
13319,GO:0050309,1,0.980940426366091,0,3,sugar-terminal-phosphatase activity,MF,
13320,GO:0050313,1,0.996186124260156,0,1,sulfur dioxygenase activity,MF,
13321,GO:0050321,1,0.915920663787657,0,13,tau-protein kinase activity,MF,
13322,GO:0050333,1,0.994956589380781,0,1,thiamin-triphosphatase activity,MF,
13323,GO:0050337,1,0.996587123471756,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13324,GO:0050346,1,0.9930956730518,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13325,GO:0050347,1,0.987839189835125,0,2,trans-octaprenyltranstransferase activity,MF,
13326,GO:0050353,1,0.992998889487678,0,1,trimethyllysine dioxygenase activity,MF,
13327,GO:0050355,1,0.99248373283494,0,1,triphosphatase activity,MF,
13328,GO:0050379,1,0.992447454105328,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13329,GO:0050405,1,0.984588573014814,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13330,GO:0050421,1,0.993379716894051,0,1,nitrite reductase (NO-forming) activity,MF,
13332,GO:0050428,1,0.960312610445776,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13333,GO:0050429,1,0.992326674406367,0,1,calcium-dependent phospholipase C activity,MF,
13334,GO:0050431,1,0.871759609005966,0,19,transforming growth factor beta binding,MF,
13337,GO:0050434,1,0.774384563613839,0,41,positive regulation of viral transcription,BP,
13338,GO:0050435,1,0.802930964741024,0,32,amyloid-beta metabolic process,BP,
13339,GO:0050436,1,0.984995000569934,0,2,microfibril binding,MF,
13340,GO:0050444,1,0.992632563568689,0,1,aquacobalamin reductase (NADPH) activity,MF,
13341,GO:0050459,1,0.9930956730518,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13342,GO:0050462,1,0.995842275743558,0,1,N-acetylneuraminate synthase activity,MF,
13343,GO:0050473,1,0.979206198319721,0,3,arachidonate 15-lipoxygenase activity,MF,
13344,GO:0050479,1,0.9930956730518,0,1,glyceryl-ether monooxygenase activity,MF,
13345,GO:0050480,1,0.994272203656633,0,1,imidazolonepropionase activity,MF,
13346,GO:0050482,1,0.888546642371126,0,19,arachidonic acid secretion,BP,
13347,GO:0050497,1,0.987183854653326,0,2,transferase activity, transferring alkylthio groups,MF,
13348,GO:0050501,1,0.975077022938127,0,4,hyaluronan synthase activity,MF,
13349,GO:0050508,1,0.977777813912052,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13350,GO:0050509,1,0.985167818323813,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13351,GO:0050510,1,0.970715720810218,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13352,GO:0050512,1,0.994374354536359,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13353,GO:0050528,1,0.993764455175452,0,1,acyloxyacyl hydrolase activity,MF,
13354,GO:0050542,1,0.97270873800712,0,6,icosanoid binding,MF,
13355,GO:0050543,1,0.973687686411617,0,6,icosatetraenoic acid binding,MF,
13356,GO:0050544,1,0.9775712144293,0,5,arachidonic acid binding,MF,
13357,GO:0050560,1,0.992601845650791,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13358,GO:0050561,1,0.99250236294245,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13359,GO:0050567,1,0.98244081586836,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13360,GO:0050571,1,0.995285258288038,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13361,GO:0050577,1,0.995669135788894,0,1,GDP-L-fucose synthase activity,MF,
13362,GO:0050610,1,0.991874589953119,0,2,methylarsonate reductase activity,MF,
13363,GO:0050613,1,0.987861919505479,0,2,delta14-sterol reductase activity,MF,
13364,GO:0050614,1,0.992491891609527,0,1,delta24-sterol reductase activity,MF,
13365,GO:0050632,1,0.995585172911336,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13366,GO:0050646,1,0.995027112828618,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13367,GO:0050647,1,0.995027112828618,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13368,GO:0050648,1,0.995027112828618,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13370,GO:0050651,1,0.903561802671093,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13371,GO:0050652,1,0.992514368891271,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13372,GO:0050653,1,0.985071265917484,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13374,GO:0050655,1,0.898279507873236,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13375,GO:0050656,1,0.959117028818025,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13378,GO:0050659,1,0.984917692857608,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13379,GO:0050660,1,0.600989591973274,0,77,flavin adenine dinucleotide binding,MF,
13383,GO:0050664,1,0.924864633278819,0,12,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13384,GO:0050665,1,0.932239345451076,0,11,hydrogen peroxide biosynthetic process,BP,
13385,GO:0050666,1,0.98760192745823,0,2,regulation of homocysteine metabolic process,BP,
13386,GO:0050667,1,0.913176965285199,0,14,homocysteine metabolic process,BP,
13387,GO:0050668,1,0.994006942278645,0,1,positive regulation of homocysteine metabolic process,BP,
13390,GO:0050672,1,0.669963514377072,0,64,negative regulation of lymphocyte proliferation,BP,
13392,GO:0050674,1,0.996546189543489,0,1,urothelial cell proliferation,BP,
13393,GO:0050675,1,0.996546189543489,0,1,regulation of urothelial cell proliferation,BP,
13394,GO:0050677,1,0.996546189543489,0,1,positive regulation of urothelial cell proliferation,BP,
13397,GO:0050680,1,0.479392138082156,0,109,negative regulation of epithelial cell proliferation,BP,
13398,GO:0050681,1,0.759653142710287,0,41,androgen receptor binding,MF,
13399,GO:0050682,1,0.978631425134199,0,3,AF-2 domain binding,MF,
13400,GO:0050683,1,0.99249766351281,0,1,AF-1 domain binding,MF,
13404,GO:0050687,1,0.872547103374006,0,21,negative regulation of defense response to virus,BP,
13405,GO:0050688,1,0.686735327027024,0,58,regulation of defense response to virus,BP,
13406,GO:0050689,1,0.973189350461255,0,5,negative regulation of defense response to virus by host,BP,
13407,GO:0050690,1,0.834375697560456,0,29,regulation of defense response to virus by virus,BP,
13408,GO:0050691,1,0.820563957238084,0,32,regulation of defense response to virus by host,BP,
13409,GO:0050692,1,0.980156147956589,0,3,DBD domain binding,MF,
13410,GO:0050693,1,0.963960483005427,0,6,LBD domain binding,MF,
13411,GO:0050694,1,0.976822271997471,0,4,galactose 3-O-sulfotransferase activity,MF,
13412,GO:0050698,1,0.986160018203839,0,2,proteoglycan sulfotransferase activity,MF,
13413,GO:0050699,1,0.831180322172087,0,30,WW domain binding,MF,
13414,GO:0050700,1,0.933188261552703,0,11,CARD domain binding,MF,
13415,GO:0050701,1,0.765626329759286,0,44,interleukin-1 secretion,BP,
13416,GO:0050702,1,0.785280682321471,0,39,interleukin-1 beta secretion,BP,
13417,GO:0050703,1,0.974297172606664,0,5,interleukin-1 alpha secretion,BP,
13418,GO:0050704,1,0.802352240471987,0,37,regulation of interleukin-1 secretion,BP,
13419,GO:0050705,1,0.977656402046312,0,4,regulation of interleukin-1 alpha secretion,BP,
13420,GO:0050706,1,0.820106803636126,0,33,regulation of interleukin-1 beta secretion,BP,
13421,GO:0050707,1,0.395349060939085,0,146,regulation of cytokine secretion,BP,
13424,GO:0050710,1,0.734226546478439,0,49,negative regulation of cytokine secretion,BP,
13425,GO:0050711,1,0.93715371862169,0,11,negative regulation of interleukin-1 secretion,BP,
13426,GO:0050712,1,0.995568637382513,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13427,GO:0050713,1,0.954451783532329,0,8,negative regulation of interleukin-1 beta secretion,BP,
13429,GO:0050715,1,0.528563755884092,0,100,positive regulation of cytokine secretion,BP,
13430,GO:0050716,1,0.853009541725845,0,26,positive regulation of interleukin-1 secretion,BP,
13431,GO:0050717,1,0.982008845058582,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13432,GO:0050718,1,0.862395370422816,0,24,positive regulation of interleukin-1 beta secretion,BP,
13433,GO:0050719,1,0.996325214701462,0,1,interleukin-1 alpha biosynthetic process,BP,
13434,GO:0050720,1,0.989003014320716,0,2,interleukin-1 beta biosynthetic process,BP,
13435,GO:0050721,1,0.996325214701462,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13436,GO:0050722,1,0.989003014320716,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13437,GO:0050725,1,0.989003014320716,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13438,GO:0050726,1,0.996325214701462,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13440,GO:0050728,1,0.534697036833468,0,100,negative regulation of inflammatory response,BP,
13444,GO:0050732,1,0.755047627730616,0,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13445,GO:0050733,1,0.966929429026899,0,5,RS domain binding,MF,
13446,GO:0050746,1,0.927118005849794,0,12,regulation of lipoprotein metabolic process,BP,
13447,GO:0050747,1,0.970578362809121,0,5,positive regulation of lipoprotein metabolic process,BP,
13448,GO:0050748,1,0.975863834078078,0,4,negative regulation of lipoprotein metabolic process,BP,
13450,GO:0050751,1,0.996245299443384,0,1,fractalkine biosynthetic process,BP,
13451,GO:0050752,1,0.996245299443384,0,1,regulation of fractalkine biosynthetic process,BP,
13452,GO:0050754,1,0.996245299443384,0,1,positive regulation of fractalkine biosynthetic process,BP,
13453,GO:0050755,1,0.938490331876563,0,12,chemokine metabolic process,BP,
13454,GO:0050756,1,0.996245299443384,0,1,fractalkine metabolic process,BP,
13455,GO:0050757,1,0.989340417419475,0,2,thymidylate synthase biosynthetic process,BP,
13456,GO:0050758,1,0.989340417419475,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13457,GO:0050760,1,0.993316855910407,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13458,GO:0050764,1,0.656001020361397,0,68,regulation of phagocytosis,BP,
13459,GO:0050765,1,0.925684914616248,0,13,negative regulation of phagocytosis,BP,
13460,GO:0050766,1,0.741133663863508,0,49,positive regulation of phagocytosis,BP,
13465,GO:0050771,1,0.657224623138163,0,60,negative regulation of axonogenesis,BP,
13466,GO:0050772,1,0.585142761892011,0,77,positive regulation of axonogenesis,BP,
13469,GO:0050775,1,0.792802776637471,0,32,positive regulation of dendrite morphogenesis,BP,
13471,GO:0050777,1,0.47245216602755,0,118,negative regulation of immune response,BP,
13473,GO:0050779,1,0.84340761056979,0,24,RNA destabilization,BP,
13475,GO:0050783,1,0.993664822857648,0,1,cocaine metabolic process,BP,
13476,GO:0050785,1,0.995702215958487,0,1,advanced glycation end-product receptor activity,MF,
13477,GO:0050786,1,0.960431488030101,0,10,RAGE receptor binding,MF,
13478,GO:0050787,1,0.988694648939359,0,2,detoxification of mercury ion,BP,
13481,GO:0050792,1,0.323421873999823,0,178,regulation of viral process,BP,
13488,GO:0050802,1,0.89582740034329,0,20,circadian sleep/wake cycle, sleep,BP,
13495,GO:0050810,1,0.60244455007873,0,77,regulation of steroid biosynthetic process,BP,
13496,GO:0050811,1,0.913388808566113,0,14,GABA receptor binding,MF,
13497,GO:0050812,1,0.911228502515012,0,13,regulation of acyl-CoA biosynthetic process,BP,
13498,GO:0050815,1,0.963390184645415,0,6,phosphoserine residue binding,MF,
13499,GO:0050816,1,0.981108259177143,0,3,phosphothreonine residue binding,MF,
13500,GO:0050817,1,0.146228790783899,0,294,coagulation,BP,
13501,GO:0050818,1,0.627672853303728,0,73,regulation of coagulation,BP,
13502,GO:0050819,1,0.753002673455201,0,46,negative regulation of coagulation,BP,
13503,GO:0050820,1,0.855596663792413,0,24,positive regulation of coagulation,BP,
13504,GO:0050821,1,0.399073577198651,0,145,protein stabilization,BP,
13505,GO:0050822,1,0.992553194993226,0,1,peptide stabilization,BP,
13506,GO:0050823,1,0.992553194993226,0,1,peptide antigen stabilization,BP,
13510,GO:0050833,1,0.973933490883112,0,4,pyruvate transmembrane transporter activity,MF,
13512,GO:0050840,1,0.719860525014221,0,48,extracellular matrix binding,MF,
13513,GO:0050847,1,0.944559657780324,0,8,progesterone receptor signaling pathway,BP,
13515,GO:0050849,1,0.898622684440209,0,17,negative regulation of calcium-mediated signaling,BP,
13519,GO:0050853,1,0.709034997227745,0,52,B cell receptor signaling pathway,BP,
13521,GO:0050855,1,0.871971343133521,0,20,regulation of B cell receptor signaling pathway,BP,
13524,GO:0050858,1,0.872668007935623,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13525,GO:0050859,1,0.969284657855372,0,5,negative regulation of B cell receptor signaling pathway,BP,
13526,GO:0050860,1,0.894972892931132,0,18,negative regulation of T cell receptor signaling pathway,BP,
13527,GO:0050861,1,0.953436707098072,0,7,positive regulation of B cell receptor signaling pathway,BP,
13530,GO:0050864,1,0.511745098458795,0,106,regulation of B cell activation,BP,
13534,GO:0050868,1,0.574260200618136,0,87,negative regulation of T cell activation,BP,
13535,GO:0050869,1,0.822117065673938,0,31,negative regulation of B cell activation,BP,
13537,GO:0050871,1,0.65524621596295,0,68,positive regulation of B cell activation,BP,
13538,GO:0050872,1,0.926303102238003,0,12,white fat cell differentiation,BP,
13539,GO:0050873,1,0.815189221378224,0,33,brown fat cell differentiation,BP,
13542,GO:0050879,1,0.759081557653132,0,45,multicellular organismal movement,BP,
13544,GO:0050881,1,0.759081557653132,0,45,musculoskeletal movement,BP,
13545,GO:0050882,1,0.956074327725486,0,6,voluntary musculoskeletal movement,BP,
13546,GO:0050883,1,0.993608490836106,0,1,musculoskeletal movement, spinal reflex action,BP,
13547,GO:0050884,1,0.909658340257017,0,14,neuromuscular process controlling posture,BP,
13548,GO:0050885,1,0.735883203673205,0,43,neuromuscular process controlling balance,BP,
13549,GO:0050886,1,0.636528737516718,0,71,endocrine process,BP,
13552,GO:0050892,1,0.841420922952832,0,26,intestinal absorption,BP,
13553,GO:0050893,1,0.974525496603479,0,4,sensory processing,BP,
13554,GO:0050894,1,0.992309676339087,0,1,determination of affect,BP,
13556,GO:0050897,1,0.992364374867111,0,1,cobalt ion binding,MF,
13559,GO:0050902,1,0.986198168744637,0,2,leukocyte adhesive activation,BP,
13560,GO:0050904,1,0.985290027704119,0,2,diapedesis,BP,
13562,GO:0050906,1,0.605671055400413,0,86,detection of stimulus involved in sensory perception,BP,
13563,GO:0050907,1,0.813531607787265,0,42,detection of chemical stimulus involved in sensory perception,BP,
13564,GO:0050908,1,0.908946839819791,0,14,detection of light stimulus involved in visual perception,BP,
13565,GO:0050909,1,0.789624448040734,0,42,sensory perception of taste,BP,
13566,GO:0050910,1,0.930696171299869,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13567,GO:0050911,1,0.924638527489986,0,17,detection of chemical stimulus involved in sensory perception of smell,BP,
13568,GO:0050912,1,0.892758958398228,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13569,GO:0050913,1,0.879829849290953,0,25,sensory perception of bitter taste,BP,
13570,GO:0050915,1,0.972362046413429,0,4,sensory perception of sour taste,BP,
13571,GO:0050916,1,0.972982001392159,0,4,sensory perception of sweet taste,BP,
13572,GO:0050917,1,0.965887629699262,0,5,sensory perception of umami taste,BP,
13573,GO:0050918,1,0.736117726995753,0,50,positive chemotaxis,BP,
13574,GO:0050919,1,0.767004855661092,0,36,negative chemotaxis,BP,
13577,GO:0050922,1,0.74612559700968,0,45,negative regulation of chemotaxis,BP,
13578,GO:0050923,1,0.969994741818646,0,4,regulation of negative chemotaxis,BP,
13579,GO:0050924,1,0.99245198775029,0,1,positive regulation of negative chemotaxis,BP,
13580,GO:0050925,1,0.984677677663379,0,2,negative regulation of negative chemotaxis,BP,
13581,GO:0050926,1,0.863087218824099,0,24,regulation of positive chemotaxis,BP,
13582,GO:0050927,1,0.869680110729058,0,23,positive regulation of positive chemotaxis,BP,
13583,GO:0050928,1,0.992429925275757,0,1,negative regulation of positive chemotaxis,BP,
13584,GO:0050929,1,0.99245198775029,0,1,induction of negative chemotaxis,BP,
13585,GO:0050930,1,0.933028278292232,0,13,induction of positive chemotaxis,BP,
13586,GO:0050931,1,0.8032353681282,0,32,pigment cell differentiation,BP,
13587,GO:0050932,1,0.939078512679787,0,9,regulation of pigment cell differentiation,BP,
13588,GO:0050942,1,0.948995344448181,0,7,positive regulation of pigment cell differentiation,BP,
13589,GO:0050951,1,0.880112604830978,0,19,sensory perception of temperature stimulus,BP,
13592,GO:0050955,1,0.984951587994441,0,2,thermoception,BP,
13593,GO:0050957,1,0.956026692230682,0,6,equilibrioception,BP,
13594,GO:0050960,1,0.992496995066751,0,1,detection of temperature stimulus involved in thermoception,BP,
13595,GO:0050961,1,0.912263857172007,0,14,detection of temperature stimulus involved in sensory perception,BP,
13596,GO:0050962,1,0.908946839819791,0,14,detection of light stimulus involved in sensory perception,BP,
13597,GO:0050965,1,0.912263857172007,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13598,GO:0050966,1,0.946074358187519,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13599,GO:0050968,1,0.985643946863346,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13600,GO:0050974,1,0.858756539659657,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13601,GO:0050975,1,0.98268452445017,0,3,sensory perception of touch,BP,
13602,GO:0050976,1,0.987164487551904,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13603,GO:0050982,1,0.773069108788196,0,37,detection of mechanical stimulus,BP,
13604,GO:0050992,1,0.994282421202187,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13605,GO:0050993,1,0.994282421202187,0,1,dimethylallyl diphosphate metabolic process,BP,
13608,GO:0050996,1,0.90435331562392,0,16,positive regulation of lipid catabolic process,BP,
13609,GO:0050997,1,0.901301081887011,0,17,quaternary ammonium group binding,MF,
13612,GO:0051000,1,0.894406728503156,0,17,positive regulation of nitric-oxide synthase activity,BP,
13614,GO:0051004,1,0.916887515770766,0,15,regulation of lipoprotein lipase activity,BP,
13615,GO:0051005,1,0.983919353918109,0,3,negative regulation of lipoprotein lipase activity,BP,
13616,GO:0051006,1,0.964705979998483,0,7,positive regulation of lipoprotein lipase activity,BP,
13617,GO:0051010,1,0.905395339168582,0,13,microtubule plus-end binding,MF,
13618,GO:0051011,1,0.934409870930571,0,9,microtubule minus-end binding,MF,
13619,GO:0051012,1,0.987576528838944,0,2,microtubule sliding,BP,
13620,GO:0051013,1,0.953506267359362,0,7,microtubule severing,BP,
13621,GO:0051014,1,0.949295341091612,0,8,actin filament severing,BP,
13622,GO:0051015,1,0.322303649441779,0,164,actin filament binding,MF,
13623,GO:0051016,1,0.910826124405777,0,14,barbed-end actin filament capping,BP,
13624,GO:0051017,1,0.387092110667184,0,139,actin filament bundle assembly,BP,
13625,GO:0051018,1,0.718070234572026,0,46,protein kinase A binding,MF,
13626,GO:0051019,1,0.836902028202667,0,26,mitogen-activated protein kinase binding,MF,
13628,GO:0051021,1,0.970877415506363,0,5,GDP-dissociation inhibitor binding,MF,
13629,GO:0051022,1,0.975304099160317,0,4,Rho GDP-dissociation inhibitor binding,MF,
13630,GO:0051023,1,0.922732424897181,0,15,regulation of immunoglobulin secretion,BP,
13631,GO:0051024,1,0.955084654115246,0,9,positive regulation of immunoglobulin secretion,BP,
13632,GO:0051025,1,0.986130839977899,0,2,negative regulation of immunoglobulin secretion,BP,
13633,GO:0051026,1,0.961300256871857,0,6,chiasma assembly,BP,
13634,GO:0051028,1,0.399562958721174,0,137,mRNA transport,BP,
13635,GO:0051029,1,0.968851245007324,0,6,rRNA transport,BP,
13636,GO:0051030,1,0.980738992823677,0,4,snRNA transport,BP,
13637,GO:0051031,1,0.804890564682259,0,32,tRNA transport,BP,
13638,GO:0051032,1,0.985006886688964,0,2,nucleic acid transmembrane transporter activity,MF,
13639,GO:0051033,1,0.985006886688964,0,2,RNA transmembrane transporter activity,MF,
13640,GO:0051036,1,0.970909130038187,0,5,regulation of endosome size,BP,
13641,GO:0051040,1,0.985417848900125,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13642,GO:0051041,1,0.992644968459419,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13643,GO:0051042,1,0.992719876885176,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13644,GO:0051043,1,0.873136549953602,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13645,GO:0051044,1,0.918909595006933,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13646,GO:0051045,1,0.950229539221826,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13653,GO:0051052,1,0.0902685453090121,0,358,regulation of DNA metabolic process,BP,
13654,GO:0051053,1,0.450148674089689,0,117,negative regulation of DNA metabolic process,BP,
13655,GO:0051054,1,0.265816889282024,0,201,positive regulation of DNA metabolic process,BP,
13656,GO:0051055,1,0.752124625481665,0,44,negative regulation of lipid biosynthetic process,BP,
13658,GO:0051057,1,0.707621392738726,0,52,positive regulation of small GTPase mediated signal transduction,BP,
13659,GO:0051058,1,0.691781336068611,0,52,negative regulation of small GTPase mediated signal transduction,BP,
13660,GO:0051059,1,0.844922461446744,0,28,NF-kappaB binding,MF,
13661,GO:0051066,1,0.989889514174018,0,2,dihydrobiopterin metabolic process,BP,
13662,GO:0051068,1,0.992534274512751,0,1,dihydrolipoamide metabolic process,BP,
13663,GO:0051081,1,0.736456398696569,0,46,nuclear envelope disassembly,BP,
13664,GO:0051082,1,0.519579448291236,0,108,unfolded protein binding,MF,
13665,GO:0051083,1,0.989216539123445,0,2,'de novo' cotranslational protein folding,BP,
13666,GO:0051084,1,0.813574860012999,0,32,'de novo' posttranslational protein folding,BP,
13667,GO:0051085,1,0.839389667519653,0,27,chaperone cofactor-dependent protein refolding,BP,
13668,GO:0051086,1,0.994625612940782,0,1,chaperone mediated protein folding independent of cofactor,BP,
13669,GO:0051087,1,0.573839604242162,0,89,chaperone binding,MF,
13670,GO:0051088,1,0.977707075969513,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13671,GO:0051089,1,0.992501793731769,0,1,constitutive protein ectodomain proteolysis,BP,
13677,GO:0051095,1,0.94208781861443,0,9,regulation of helicase activity,BP,
13678,GO:0051096,1,0.960468694078237,0,6,positive regulation of helicase activity,BP,
13679,GO:0051097,1,0.980870396406914,0,3,negative regulation of helicase activity,BP,
13680,GO:0051098,1,0.116578223507251,0,333,regulation of binding,BP,
13681,GO:0051099,1,0.345692173672662,0,163,positive regulation of binding,BP,
13682,GO:0051100,1,0.395722500923775,0,147,negative regulation of binding,BP,
13683,GO:0051101,1,0.504512197734386,0,110,regulation of DNA binding,BP,
13684,GO:0051102,1,0.992499071335374,0,1,DNA ligation involved in DNA recombination,BP,
13685,GO:0051103,1,0.934397179977784,0,11,DNA ligation involved in DNA repair,BP,
13686,GO:0051105,1,0.960890794797468,0,6,regulation of DNA ligation,BP,
13687,GO:0051106,1,0.967714537729516,0,5,positive regulation of DNA ligation,BP,
13688,GO:0051107,1,0.992950951146867,0,1,negative regulation of DNA ligation,BP,
13689,GO:0051117,1,0.632450910173181,0,73,ATPase binding,MF,
13690,GO:0051119,1,0.858175512599747,0,23,sugar transmembrane transporter activity,MF,
13691,GO:0051120,1,0.979809906639268,0,3,hepoxilin A3 synthase activity,MF,
13692,GO:0051121,1,0.966990057586275,0,5,hepoxilin metabolic process,BP,
13693,GO:0051122,1,0.966990057586275,0,5,hepoxilin biosynthetic process,BP,
13694,GO:0051123,1,0.828666312808249,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13695,GO:0051124,1,0.934065502557002,0,9,synaptic growth at neuromuscular junction,BP,
13696,GO:0051125,1,0.832322916055887,0,27,regulation of actin nucleation,BP,
13697,GO:0051126,1,0.959600364916272,0,7,negative regulation of actin nucleation,BP,
13698,GO:0051127,1,0.896652753714639,0,15,positive regulation of actin nucleation,BP,
13702,GO:0051131,1,0.893534378355902,0,18,chaperone-mediated protein complex assembly,BP,
13703,GO:0051132,1,0.956008982317706,0,8,NK T cell activation,BP,
13704,GO:0051133,1,0.967970118548606,0,6,regulation of NK T cell activation,BP,
13705,GO:0051134,1,0.994776229076601,0,1,negative regulation of NK T cell activation,BP,
13706,GO:0051135,1,0.973054547643509,0,5,positive regulation of NK T cell activation,BP,
13707,GO:0051136,1,0.959680775996404,0,6,regulation of NK T cell differentiation,BP,
13708,GO:0051138,1,0.971630182427038,0,4,positive regulation of NK T cell differentiation,BP,
13709,GO:0051139,1,0.984973839065939,0,2,metal ion:proton antiporter activity,MF,
13710,GO:0051140,1,0.984763091833007,0,3,regulation of NK T cell proliferation,BP,
13711,GO:0051142,1,0.984763091833007,0,3,positive regulation of NK T cell proliferation,BP,
13712,GO:0051145,1,0.715132798802229,0,51,smooth muscle cell differentiation,BP,
13713,GO:0051146,1,0.211061398113707,0,231,striated muscle cell differentiation,BP,
13714,GO:0051147,1,0.43198091185688,0,127,regulation of muscle cell differentiation,BP,
13715,GO:0051148,1,0.769548748758943,0,40,negative regulation of muscle cell differentiation,BP,
13716,GO:0051149,1,0.623192445937056,0,73,positive regulation of muscle cell differentiation,BP,
13717,GO:0051150,1,0.84211626382886,0,26,regulation of smooth muscle cell differentiation,BP,
13718,GO:0051151,1,0.929241368363471,0,11,negative regulation of smooth muscle cell differentiation,BP,
13719,GO:0051152,1,0.933616314073674,0,11,positive regulation of smooth muscle cell differentiation,BP,
13720,GO:0051153,1,0.588446660008498,0,82,regulation of striated muscle cell differentiation,BP,
13721,GO:0051154,1,0.834399730343067,0,28,negative regulation of striated muscle cell differentiation,BP,
13722,GO:0051155,1,0.740756511568017,0,47,positive regulation of striated muscle cell differentiation,BP,
13723,GO:0051156,1,0.857943306291807,0,26,glucose 6-phosphate metabolic process,BP,
13724,GO:0051160,1,0.993507719716997,0,1,L-xylitol catabolic process,BP,
13725,GO:0051164,1,0.993507719716997,0,1,L-xylitol metabolic process,BP,
13726,GO:0051167,1,0.973600898871411,0,5,xylulose 5-phosphate metabolic process,BP,
13727,GO:0051168,1,0.286190822258748,0,191,nuclear export,BP,
13728,GO:0051169,1,0.11753422558633,0,327,nuclear transport,BP,
13729,GO:0051170,1,0.3814284080188,0,149,import into nucleus,BP,
13734,GO:0051176,1,0.979535168611507,0,3,positive regulation of sulfur metabolic process,BP,
13735,GO:0051177,1,0.963489265415629,0,6,meiotic sister chromatid cohesion,BP,
13737,GO:0051180,1,0.824552605973353,0,30,vitamin transport,BP,
13738,GO:0051181,1,0.774107044795106,0,41,cofactor transport,BP,
13739,GO:0051182,1,0.946511123422752,0,8,coenzyme transport,BP,
13740,GO:0051184,1,0.869478458428658,0,20,cofactor transmembrane transporter activity,MF,
13741,GO:0051185,1,0.960537380680329,0,6,coenzyme transmembrane transporter activity,MF,
13742,GO:0051186,1,0.0435263169593562,0,512,cofactor metabolic process,BP,
13743,GO:0051187,1,0.78245448033693,0,45,cofactor catabolic process,BP,
13744,GO:0051188,1,0.172585441788401,0,274,cofactor biosynthetic process,BP,
13745,GO:0051189,1,0.957181597058405,0,7,prosthetic group metabolic process,BP,
13746,GO:0051192,1,0.993046014416702,0,2,prosthetic group binding,MF,
13747,GO:0051193,1,0.536694362500006,0,94,regulation of cofactor metabolic process,BP,
13748,GO:0051194,1,0.87326833809336,0,19,positive regulation of cofactor metabolic process,BP,
13749,GO:0051195,1,0.907590754571375,0,16,negative regulation of cofactor metabolic process,BP,
13750,GO:0051196,1,0.581806428223215,0,80,regulation of coenzyme metabolic process,BP,
13751,GO:0051197,1,0.890660734972382,0,16,positive regulation of coenzyme metabolic process,BP,
13752,GO:0051198,1,0.938946803370002,0,10,negative regulation of coenzyme metabolic process,BP,
13753,GO:0051204,1,0.814996586715425,0,34,protein insertion into mitochondrial membrane,BP,
13754,GO:0051205,1,0.756679356119404,0,46,protein insertion into membrane,BP,
13755,GO:0051208,1,0.502643646250053,0,103,sequestering of calcium ion,BP,
13756,GO:0051209,1,0.51669593680581,0,99,release of sequestered calcium ion into cytosol,BP,
13757,GO:0051213,1,0.570523637907406,0,85,dioxygenase activity,MF,
13760,GO:0051220,1,0.857133596936379,0,24,cytoplasmic sequestering of protein,BP,
13764,GO:0051225,1,0.489740838292447,0,105,spindle assembly,BP,
13765,GO:0051228,1,0.99243720307439,0,1,mitotic spindle disassembly,BP,
13766,GO:0051230,1,0.99243720307439,0,1,spindle disassembly,BP,
13767,GO:0051231,1,0.929646369195807,0,11,spindle elongation,BP,
13768,GO:0051232,1,0.993797516307772,0,1,meiotic spindle elongation,BP,
13769,GO:0051233,1,0.81062653108407,0,31,spindle midzone,CC,
13781,GO:0051250,1,0.477340489466423,0,117,negative regulation of lymphocyte activation,BP,
13786,GO:0051255,1,0.936549211093389,0,10,spindle midzone assembly,BP,
13787,GO:0051256,1,0.949613229898478,0,8,mitotic spindle midzone assembly,BP,
13788,GO:0051257,1,0.993617816321152,0,1,meiotic spindle midzone assembly,BP,
13794,GO:0051264,1,0.993062166357861,0,1,mono-olein transacylation activity,MF,
13795,GO:0051265,1,0.993062166357861,0,1,diolein transacylation activity,MF,
13796,GO:0051267,1,0.992658152060687,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13798,GO:0051271,1,0.181297935456026,0,255,negative regulation of cellular component movement,BP,
13800,GO:0051276,1,0.000598922373506525,0,1085,chromosome organization,BP,
13801,GO:0051279,1,0.63912484913873,0,68,regulation of release of sequestered calcium ion into cytosol,BP,
13802,GO:0051280,1,0.925749949964252,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13803,GO:0051281,1,0.801149866562904,0,35,positive regulation of release of sequestered calcium ion into cytosol,BP,
13804,GO:0051282,1,0.512828047156725,0,100,regulation of sequestering of calcium ion,BP,
13805,GO:0051283,1,0.51669593680581,0,99,negative regulation of sequestering of calcium ion,BP,
13806,GO:0051284,1,0.917943664169076,0,14,positive regulation of sequestering of calcium ion,BP,
13807,GO:0051286,1,0.949482335064696,0,7,cell tip,CC,
13808,GO:0051287,1,0.711424134908276,0,56,NAD binding,MF,
13809,GO:0051289,1,0.629855003755471,0,75,protein homotetramerization,BP,
13812,GO:0051292,1,0.9323586117581,0,10,nuclear pore complex assembly,BP,
13813,GO:0051293,1,0.78998467705026,0,34,establishment of spindle localization,BP,
13814,GO:0051294,1,0.839249077040845,0,26,establishment of spindle orientation,BP,
13815,GO:0051295,1,0.969975720345857,0,4,establishment of meiotic spindle localization,BP,
13816,GO:0051298,1,0.647869776389692,0,62,centrosome duplication,BP,
13817,GO:0051299,1,0.898076439665531,0,16,centrosome separation,BP,
13818,GO:0051300,1,0.9930956730518,0,1,spindle pole body organization,BP,
13820,GO:0051302,1,0.404606569176814,0,138,regulation of cell division,BP,
13821,GO:0051303,1,0.630638229835589,0,70,establishment of chromosome localization,BP,
13822,GO:0051304,1,0.610888324696276,0,75,chromosome separation,BP,
13823,GO:0051305,1,0.956266344232698,0,6,chromosome movement towards spindle pole,BP,
13824,GO:0051306,1,0.705230115142385,0,54,mitotic sister chromatid separation,BP,
13825,GO:0051307,1,0.897386426630583,0,16,meiotic chromosome separation,BP,
13826,GO:0051308,1,0.9930956730518,0,1,male meiosis chromosome separation,BP,
13827,GO:0051310,1,0.701957878758458,0,55,metaphase plate congression,BP,
13828,GO:0051311,1,0.993617816321152,0,1,meiotic metaphase plate congression,BP,
13829,GO:0051315,1,0.91808017383791,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13830,GO:0051316,1,0.98717461572975,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13831,GO:0051321,1,0.262441845471012,0,202,meiotic cell cycle,BP,
13835,GO:0051340,1,0.950535648597075,0,9,regulation of ligase activity,BP,
13837,GO:0051342,1,0.95189117091178,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13838,GO:0051343,1,0.975313476684138,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13839,GO:0051344,1,0.96897140514944,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13846,GO:0051351,1,0.962388903998729,0,7,positive regulation of ligase activity,BP,
13847,GO:0051352,1,0.987688298530387,0,2,negative regulation of ligase activity,BP,
13848,GO:0051353,1,0.776084885285988,0,41,positive regulation of oxidoreductase activity,BP,
13850,GO:0051355,1,0.992507395404326,0,1,proprioception involved in equilibrioception,BP,
13851,GO:0051365,1,0.979632750758872,0,3,cellular response to potassium ion starvation,BP,
13852,GO:0051371,1,0.875495171022454,0,18,muscle alpha-actinin binding,MF,
13853,GO:0051373,1,0.970346855252658,0,5,FATZ binding,MF,
13854,GO:0051377,1,0.977931564011193,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13855,GO:0051378,1,0.933740018951891,0,11,serotonin binding,MF,
13856,GO:0051379,1,0.958328640952084,0,7,epinephrine binding,MF,
13857,GO:0051380,1,0.969352296455752,0,5,norepinephrine binding,MF,
13858,GO:0051382,1,0.912451021335036,0,14,kinetochore assembly,BP,
13859,GO:0051383,1,0.882649603838915,0,19,kinetochore organization,BP,
13861,GO:0051385,1,0.841779942807251,0,28,response to mineralocorticoid,BP,
13862,GO:0051386,1,0.941183091379726,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13863,GO:0051387,1,0.981598507925381,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13864,GO:0051388,1,0.971082836256454,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13865,GO:0051389,1,0.984459165415528,0,2,inactivation of MAPKK activity,BP,
13866,GO:0051391,1,0.992501319796993,0,1,tRNA acetylation,BP,
13867,GO:0051392,1,0.992501319796993,0,1,tRNA N-acetyltransferase activity,MF,
13868,GO:0051393,1,0.788481643780121,0,33,alpha-actinin binding,MF,
13869,GO:0051400,1,0.948735844336874,0,8,BH domain binding,MF,
13871,GO:0051403,1,0.19679186393823,0,242,stress-activated MAPK cascade,BP,
13872,GO:0051409,1,0.938928300630117,0,10,response to nitrosative stress,BP,
13873,GO:0051410,1,0.970715084522283,0,5,detoxification of nitrogen compound,BP,
13874,GO:0051412,1,0.903098483392903,0,16,response to corticosterone,BP,
13875,GO:0051413,1,0.993540320151259,0,1,response to cortisone,BP,
13876,GO:0051414,1,0.966047424737489,0,5,response to cortisol,BP,
13877,GO:0051415,1,0.963937981912983,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13878,GO:0051417,1,0.9930956730518,0,1,microtubule nucleation by spindle pole body,BP,
13879,GO:0051418,1,0.949053099610377,0,7,microtubule nucleation by microtubule organizing center,BP,
13880,GO:0051424,1,0.994873121653457,0,1,corticotropin-releasing hormone binding,MF,
13881,GO:0051425,1,0.970091176280281,0,4,PTB domain binding,MF,
13882,GO:0051427,1,0.341542618559574,0,163,hormone receptor binding,MF,
13883,GO:0051428,1,0.913984073220727,0,17,peptide hormone receptor binding,MF,
13884,GO:0051429,1,0.975320005859328,0,5,corticotropin-releasing hormone receptor binding,MF,
13885,GO:0051430,1,0.979737502888245,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13886,GO:0051431,1,0.987892708955036,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13887,GO:0051433,1,0.992479891073703,0,1,BH2 domain binding,MF,
13888,GO:0051434,1,0.975226286308563,0,4,BH3 domain binding,MF,
13889,GO:0051438,1,0.72598767047541,0,51,regulation of ubiquitin-protein transferase activity,BP,
13890,GO:0051443,1,0.815708550250786,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13891,GO:0051444,1,0.923813381919644,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13892,GO:0051445,1,0.78067025018194,0,38,regulation of meiotic cell cycle,BP,
13893,GO:0051446,1,0.912092628940765,0,14,positive regulation of meiotic cell cycle,BP,
13894,GO:0051447,1,0.912312584414992,0,14,negative regulation of meiotic cell cycle,BP,
13895,GO:0051450,1,0.891771781667766,0,18,myoblast proliferation,BP,
13896,GO:0051451,1,0.930766520036492,0,11,myoblast migration,BP,
13897,GO:0051452,1,0.757974935121527,0,47,intracellular pH reduction,BP,
13899,GO:0051454,1,0.973165153866899,0,4,intracellular pH elevation,BP,
13900,GO:0051455,1,0.9930956730518,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13901,GO:0051456,1,0.994038197782596,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13902,GO:0051457,1,0.866590495225514,0,22,maintenance of protein location in nucleus,BP,
13903,GO:0051458,1,0.962852926841998,0,7,corticotropin secretion,BP,
13904,GO:0051459,1,0.969205935417126,0,6,regulation of corticotropin secretion,BP,
13905,GO:0051460,1,0.994873121653457,0,1,negative regulation of corticotropin secretion,BP,
13906,GO:0051461,1,0.974201880767497,0,5,positive regulation of corticotropin secretion,BP,
13907,GO:0051462,1,0.974341265816734,0,5,regulation of cortisol secretion,BP,
13908,GO:0051463,1,0.992341339665332,0,1,negative regulation of cortisol secretion,BP,
13909,GO:0051464,1,0.981862416879963,0,4,positive regulation of cortisol secretion,BP,
13910,GO:0051466,1,0.992672739688804,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13912,GO:0051481,1,0.936471990540619,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13913,GO:0051482,1,0.849195511227025,0,26,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
13915,GO:0051490,1,0.988225863317252,0,2,negative regulation of filopodium assembly,BP,
13917,GO:0051492,1,0.599293206920143,0,75,regulation of stress fiber assembly,BP,
13921,GO:0051496,1,0.730672789200576,0,47,positive regulation of stress fiber assembly,BP,
13922,GO:0051497,1,0.872748321851532,0,20,negative regulation of stress fiber assembly,BP,
13923,GO:0051499,1,0.988791528571765,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13924,GO:0051500,1,0.988791528571765,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13925,GO:0051503,1,0.919137728931757,0,13,adenine nucleotide transport,BP,
13926,GO:0051525,1,0.967026452843213,0,5,NFAT protein binding,MF,
13927,GO:0051536,1,0.692042079599591,0,61,iron-sulfur cluster binding,MF,
13928,GO:0051537,1,0.89408502768467,0,20,2 iron, 2 sulfur cluster binding,MF,
13929,GO:0051538,1,0.981752929049313,0,3,3 iron, 4 sulfur cluster binding,MF,
13930,GO:0051539,1,0.781084743853484,0,40,4 iron, 4 sulfur cluster binding,MF,
13931,GO:0051540,1,0.692042079599591,0,61,metal cluster binding,MF,
13932,GO:0051541,1,0.975110397020976,0,4,elastin metabolic process,BP,
13933,GO:0051542,1,0.986034297005959,0,2,elastin biosynthetic process,BP,
13934,GO:0051543,1,0.993830793386691,0,1,regulation of elastin biosynthetic process,BP,
13935,GO:0051545,1,0.993830793386691,0,1,negative regulation of elastin biosynthetic process,BP,
13936,GO:0051546,1,0.917696875631905,0,13,keratinocyte migration,BP,
13937,GO:0051547,1,0.9405031632243,0,9,regulation of keratinocyte migration,BP,
13938,GO:0051548,1,0.992406020361384,0,1,negative regulation of keratinocyte migration,BP,
13939,GO:0051549,1,0.947703935771884,0,8,positive regulation of keratinocyte migration,BP,
13940,GO:0051552,1,0.992338574129646,0,1,flavone metabolic process,BP,
13941,GO:0051560,1,0.869937228183717,0,21,mitochondrial calcium ion homeostasis,BP,
13942,GO:0051561,1,0.939342023157223,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13943,GO:0051562,1,0.982144662451391,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13944,GO:0051563,1,0.984976179811191,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13945,GO:0051567,1,0.813032030355755,0,29,histone H3-K9 methylation,BP,
13946,GO:0051568,1,0.721247271234436,0,48,histone H3-K4 methylation,BP,
13947,GO:0051569,1,0.846029895549146,0,24,regulation of histone H3-K4 methylation,BP,
13948,GO:0051570,1,0.86882235615907,0,20,regulation of histone H3-K9 methylation,BP,
13949,GO:0051571,1,0.898860003793739,0,15,positive regulation of histone H3-K4 methylation,BP,
13950,GO:0051572,1,0.979454498579571,0,3,negative regulation of histone H3-K4 methylation,BP,
13951,GO:0051573,1,0.932720280709469,0,10,negative regulation of histone H3-K9 methylation,BP,
13952,GO:0051574,1,0.938484433038855,0,9,positive regulation of histone H3-K9 methylation,BP,
13953,GO:0051575,1,0.96586454530671,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13954,GO:0051580,1,0.911005408669873,0,15,regulation of neurotransmitter uptake,BP,
13955,GO:0051581,1,0.974608430544657,0,4,negative regulation of neurotransmitter uptake,BP,
13956,GO:0051582,1,0.978540855510292,0,4,positive regulation of neurotransmitter uptake,BP,
13957,GO:0051583,1,0.936194053260376,0,11,dopamine uptake involved in synaptic transmission,BP,
13958,GO:0051584,1,0.96114184625676,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13959,GO:0051585,1,0.992705657091814,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13960,GO:0051586,1,0.984432635401505,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13963,GO:0051590,1,0.844438756808497,0,26,positive regulation of neurotransmitter transport,BP,
13966,GO:0051593,1,0.938594860001217,0,11,response to folic acid,BP,
13967,GO:0051594,1,0.976810260662373,0,4,detection of glucose,BP,
13968,GO:0051595,1,0.984218833208937,0,3,response to methylglyoxal,BP,
13969,GO:0051596,1,0.988246186604704,0,2,methylglyoxal catabolic process,BP,
13970,GO:0051597,1,0.955230415294539,0,7,response to methylmercury,BP,
13971,GO:0051598,1,0.99247687185389,0,1,meiotic recombination checkpoint,BP,
13972,GO:0051599,1,0.965673343303675,0,5,response to hydrostatic pressure,BP,
13973,GO:0051601,1,0.946763016648222,0,8,exocyst localization,BP,
13978,GO:0051607,1,0.305565476471739,0,186,defense response to virus,BP,
13979,GO:0051608,1,0.942825092823958,0,10,histamine transport,BP,
13980,GO:0051610,1,0.972821577969695,0,4,serotonin uptake,BP,
13981,GO:0051611,1,0.980193872012332,0,3,regulation of serotonin uptake,BP,
13982,GO:0051612,1,0.980193872012332,0,3,negative regulation of serotonin uptake,BP,
13983,GO:0051615,1,0.992399177074601,0,1,histamine uptake,BP,
13984,GO:0051620,1,0.992705657091814,0,1,norepinephrine uptake,BP,
13985,GO:0051621,1,0.992705657091814,0,1,regulation of norepinephrine uptake,BP,
13986,GO:0051622,1,0.992705657091814,0,1,negative regulation of norepinephrine uptake,BP,
13987,GO:0051639,1,0.9435088803588,0,8,actin filament network formation,BP,
13990,GO:0051642,1,0.853545521246479,0,22,centrosome localization,BP,
13991,GO:0051643,1,0.962869816814413,0,5,endoplasmic reticulum localization,BP,
13992,GO:0051645,1,0.916026482186703,0,13,Golgi localization,BP,
13993,GO:0051646,1,0.763759080019683,0,39,mitochondrion localization,BP,
13994,GO:0051647,1,0.85542003809049,0,22,nucleus localization,BP,
13998,GO:0051651,1,0.562832903715541,0,88,maintenance of location in cell,BP,
13999,GO:0051653,1,0.766604252710021,0,38,spindle localization,BP,
14000,GO:0051654,1,0.879495027309607,0,19,establishment of mitochondrion localization,BP,
14002,GO:0051657,1,0.928726782224244,0,10,maintenance of organelle location,BP,
14003,GO:0051659,1,0.986626208129045,0,2,maintenance of mitochondrion location,BP,
14004,GO:0051660,1,0.970410005923985,0,4,establishment of centrosome localization,BP,
14005,GO:0051661,1,0.962546395180433,0,5,maintenance of centrosome location,BP,
14006,GO:0051664,1,0.985642381151682,0,2,nuclear pore localization,BP,
14008,GO:0051666,1,0.965392058909172,0,5,actin cortical patch localization,BP,
14010,GO:0051673,1,0.977258220685814,0,5,membrane disruption in other organism,BP,
14012,GO:0051683,1,0.957756078585962,0,7,establishment of Golgi localization,BP,
14013,GO:0051684,1,0.977827074409933,0,3,maintenance of Golgi location,BP,
14014,GO:0051685,1,0.9930956730518,0,1,maintenance of ER location,BP,
14015,GO:0051686,1,0.991867785918404,0,1,establishment of ER localization,BP,
14016,GO:0051691,1,0.995157298489048,0,1,cellular oligosaccharide metabolic process,BP,
14017,GO:0051692,1,0.995157298489048,0,1,cellular oligosaccharide catabolic process,BP,
14018,GO:0051693,1,0.805036110349039,0,31,actin filament capping,BP,
14019,GO:0051694,1,0.960423487979461,0,6,pointed-end actin filament capping,BP,
14020,GO:0051695,1,0.992480106443716,0,1,actin filament uncapping,BP,
14021,GO:0051697,1,0.977056990434318,0,4,protein delipidation,BP,
14022,GO:0051701,1,0.289082939365772,0,188,interaction with host,BP,
14023,GO:0051702,1,0.68594594063335,0,61,interaction with symbiont,BP,
14028,GO:0051708,1,0.991336711223962,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14029,GO:0051709,1,0.94437331610375,0,10,regulation of killing of cells of other organism,BP,
14030,GO:0051710,1,0.996202214779005,0,1,regulation of cytolysis in other organism,BP,
14031,GO:0051712,1,0.951299011165684,0,9,positive regulation of killing of cells of other organism,BP,
14032,GO:0051714,1,0.996202214779005,0,1,positive regulation of cytolysis in other organism,BP,
14033,GO:0051715,1,0.980309785647012,0,4,cytolysis in other organism,BP,
14035,GO:0051717,1,0.985471198366429,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14036,GO:0051721,1,0.827515942850526,0,27,protein phosphatase 2A binding,MF,
14037,GO:0051722,1,0.993632790556943,0,1,protein C-terminal methylesterase activity,MF,
14038,GO:0051723,1,0.993632790556943,0,1,protein methylesterase activity,MF,
14039,GO:0051724,1,0.994016006353376,0,1,NAD transmembrane transporter activity,MF,
14040,GO:0051725,1,0.976038028574311,0,4,protein de-ADP-ribosylation,BP,
14041,GO:0051726,1,0.000636367644955929,0,1088,regulation of cell cycle,BP,
14042,GO:0051728,1,0.992852746849844,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14043,GO:0051729,1,0.992852746849844,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14044,GO:0051731,1,0.974960090362785,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14045,GO:0051732,1,0.995045410378932,0,1,polyribonucleotide kinase activity,MF,
14046,GO:0051733,1,0.982522065635506,0,3,polydeoxyribonucleotide kinase activity,MF,
14047,GO:0051734,1,0.982522065635506,0,3,ATP-dependent polynucleotide kinase activity,MF,
14048,GO:0051736,1,0.995045410378932,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14049,GO:0051747,1,0.991572731160136,0,2,cytosine C-5 DNA demethylase activity,MF,
14050,GO:0051748,1,0.99426198695223,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14051,GO:0051750,1,0.995807011225709,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14052,GO:0051754,1,0.972243568569644,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14053,GO:0051758,1,0.992328999210828,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14054,GO:0051764,1,0.925269004316652,0,11,actin crosslink formation,BP,
14055,GO:0051765,1,0.987647145286125,0,2,inositol tetrakisphosphate kinase activity,MF,
14056,GO:0051766,1,0.960694803466684,0,6,inositol trisphosphate kinase activity,MF,
14057,GO:0051767,1,0.896291092782337,0,17,nitric-oxide synthase biosynthetic process,BP,
14058,GO:0051769,1,0.896291092782337,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14059,GO:0051770,1,0.911056588663172,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14060,GO:0051771,1,0.983808278249385,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14061,GO:0051775,1,0.936075853386021,0,11,response to redox state,BP,
14062,GO:0051780,1,0.992496881829069,0,1,behavioral response to nutrient,BP,
14063,GO:0051781,1,0.634148031604844,0,71,positive regulation of cell division,BP,
14064,GO:0051782,1,0.909183672604245,0,14,negative regulation of cell division,BP,
14065,GO:0051783,1,0.324847766171927,0,171,regulation of nuclear division,BP,
14066,GO:0051784,1,0.709281755843812,0,54,negative regulation of nuclear division,BP,
14067,GO:0051785,1,0.696528756013724,0,55,positive regulation of nuclear division,BP,
14068,GO:0051786,1,0.992621383391815,0,1,all-trans-retinol 13,14-reductase activity,MF,
14069,GO:0051787,1,0.842708221359328,0,26,misfolded protein binding,MF,
14070,GO:0051788,1,0.859559814607944,0,23,response to misfolded protein,BP,
14071,GO:0051790,1,0.975668220111968,0,4,short-chain fatty acid biosynthetic process,BP,
14072,GO:0051791,1,0.94430689595447,0,10,medium-chain fatty acid metabolic process,BP,
14073,GO:0051792,1,0.973567192361526,0,5,medium-chain fatty acid biosynthetic process,BP,
14074,GO:0051793,1,0.971416033093636,0,5,medium-chain fatty acid catabolic process,BP,
14075,GO:0051794,1,0.975675461161165,0,4,regulation of timing of catagen,BP,
14076,GO:0051795,1,0.983057532268308,0,3,positive regulation of timing of catagen,BP,
14077,GO:0051796,1,0.992492007106331,0,1,negative regulation of timing of catagen,BP,
14078,GO:0051797,1,0.892357613918877,0,18,regulation of hair follicle development,BP,
14079,GO:0051798,1,0.940164586368881,0,11,positive regulation of hair follicle development,BP,
14080,GO:0051799,1,0.977610515379941,0,3,negative regulation of hair follicle development,BP,
14081,GO:0051800,1,0.987327183713331,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14082,GO:0051801,1,0.987300920414236,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14083,GO:0051805,1,0.985692914434426,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14084,GO:0051806,1,0.449801461632732,0,121,entry into cell of other organism involved in symbiotic interaction,BP,
14085,GO:0051807,1,0.985692914434426,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14086,GO:0051808,1,0.993719136156557,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14087,GO:0051817,1,0.560770069108869,0,90,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14088,GO:0051818,1,0.942349030671274,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14089,GO:0051821,1,0.992332187741306,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14090,GO:0051823,1,0.939114747188522,0,9,regulation of synapse structural plasticity,BP,
14091,GO:0051828,1,0.449801461632732,0,121,entry into other organism involved in symbiotic interaction,BP,
14092,GO:0051832,1,0.972447837117768,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14093,GO:0051833,1,0.992434292396331,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14094,GO:0051834,1,0.972447837117768,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14095,GO:0051835,1,0.974364822737587,0,4,positive regulation of synapse structural plasticity,BP,
14096,GO:0051836,1,0.947958169052401,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14097,GO:0051851,1,0.703671520524465,0,57,modification by host of symbiont morphology or physiology,BP,
14098,GO:0051852,1,0.965567946678081,0,8,disruption by host of symbiont cells,BP,
14100,GO:0051864,1,0.942127336535815,0,8,histone demethylase activity (H3-K36 specific),MF,
14101,GO:0051865,1,0.690832667326563,0,54,protein autoubiquitination,BP,
14102,GO:0051866,1,0.988382057456993,0,2,general adaptation syndrome,BP,
14103,GO:0051867,1,0.995804960329983,0,1,general adaptation syndrome, behavioral process,BP,
14104,GO:0051870,1,0.984663006032039,0,3,methotrexate binding,MF,
14105,GO:0051873,1,0.965567946678081,0,8,killing by host of symbiont cells,BP,
14106,GO:0051875,1,0.840235077565264,0,27,pigment granule localization,BP,
14107,GO:0051877,1,0.986140283548259,0,2,pigment granule aggregation in cell center,BP,
14108,GO:0051879,1,0.80833234375268,0,32,Hsp90 protein binding,MF,
14109,GO:0051880,1,0.948219165338603,0,7,G-quadruplex DNA binding,MF,
14112,GO:0051883,1,0.942349030671274,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14113,GO:0051884,1,0.964434129250183,0,5,regulation of timing of anagen,BP,
14114,GO:0051885,1,0.986432143760232,0,2,positive regulation of timing of anagen,BP,
14115,GO:0051886,1,0.992438428453313,0,1,negative regulation of timing of anagen,BP,
14116,GO:0051890,1,0.958046232741351,0,6,regulation of cardioblast differentiation,BP,
14117,GO:0051891,1,0.965295125925547,0,5,positive regulation of cardioblast differentiation,BP,
14118,GO:0051892,1,0.992493184157392,0,1,negative regulation of cardioblast differentiation,BP,
14119,GO:0051893,1,0.689522048780533,0,53,regulation of focal adhesion assembly,BP,
14120,GO:0051894,1,0.852074214610499,0,23,positive regulation of focal adhesion assembly,BP,
14121,GO:0051895,1,0.898400827121323,0,15,negative regulation of focal adhesion assembly,BP,
14124,GO:0051898,1,0.768574438058133,0,39,negative regulation of protein kinase B signaling,BP,
14128,GO:0051902,1,0.962970065261722,0,6,negative regulation of mitochondrial depolarization,BP,
14129,GO:0051903,1,0.993307815258335,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14130,GO:0051904,1,0.858247345477117,0,24,pigment granule transport,BP,
14131,GO:0051905,1,0.85157941964639,0,25,establishment of pigment granule localization,BP,
14132,GO:0051908,1,0.992684426528594,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14133,GO:0051916,1,0.99287526322897,0,1,granulocyte colony-stimulating factor binding,MF,
14134,GO:0051917,1,0.939506187939701,0,10,regulation of fibrinolysis,BP,
14135,GO:0051918,1,0.957068809538778,0,7,negative regulation of fibrinolysis,BP,
14136,GO:0051919,1,0.982376526124998,0,3,positive regulation of fibrinolysis,BP,
14137,GO:0051920,1,0.965264518577023,0,8,peroxiredoxin activity,MF,
14138,GO:0051923,1,0.92123725000768,0,14,sulfation,BP,
14140,GO:0051926,1,0.72989812140979,0,50,negative regulation of calcium ion transport,BP,
14145,GO:0051933,1,0.977404392311258,0,3,amino acid neurotransmitter reuptake,BP,
14146,GO:0051934,1,0.936194053260376,0,11,catecholamine uptake involved in synaptic transmission,BP,
14147,GO:0051935,1,0.977404392311258,0,3,glutamate reuptake,BP,
14150,GO:0051939,1,0.992482212079326,0,1,gamma-aminobutyric acid import,BP,
14151,GO:0051940,1,0.96114184625676,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14152,GO:0051941,1,0.984805829581958,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14153,GO:0051944,1,0.984432635401505,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14154,GO:0051945,1,0.992705657091814,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14155,GO:0051946,1,0.984805829581958,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14160,GO:0051956,1,0.936782456263697,0,10,negative regulation of amino acid transport,BP,
14162,GO:0051958,1,0.985400357869193,0,2,methotrexate transport,BP,
14163,GO:0051959,1,0.809979390917045,0,29,dynein light intermediate chain binding,MF,
14168,GO:0051964,1,0.955188689413722,0,6,negative regulation of synapse assembly,BP,
14169,GO:0051965,1,0.65493710995369,0,59,positive regulation of synapse assembly,BP,
14171,GO:0051967,1,0.932922071063923,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14173,GO:0051969,1,0.923509964695322,0,13,regulation of transmission of nerve impulse,BP,
14174,GO:0051970,1,0.982334614575816,0,3,negative regulation of transmission of nerve impulse,BP,
14175,GO:0051971,1,0.968672194684166,0,5,positive regulation of transmission of nerve impulse,BP,
14176,GO:0051972,1,0.745628963189349,0,45,regulation of telomerase activity,BP,
14177,GO:0051973,1,0.796832781047837,0,35,positive regulation of telomerase activity,BP,
14178,GO:0051974,1,0.943184168261166,0,9,negative regulation of telomerase activity,BP,
14179,GO:0051977,1,0.994169117915443,0,1,lysophospholipid transport,BP,
14180,GO:0051978,1,0.994169117915443,0,1,lysophospholipid transporter activity,MF,
14181,GO:0051983,1,0.549343656554118,0,90,regulation of chromosome segregation,BP,
14182,GO:0051984,1,0.849632778755873,0,24,positive regulation of chromosome segregation,BP,
14184,GO:0051987,1,0.968475320153651,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14185,GO:0051988,1,0.922152484186439,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14186,GO:0051990,1,0.987318627334748,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14187,GO:0051996,1,0.994335551361362,0,1,squalene synthase activity,MF,
14188,GO:0051998,1,0.961843660587266,0,6,protein carboxyl O-methyltransferase activity,MF,
14189,GO:0052026,1,0.992979319685909,0,1,modulation by symbiont of host transcription,BP,
14190,GO:0052027,1,0.985129121261887,0,2,modulation by symbiont of host signal transduction pathway,BP,
14191,GO:0052029,1,0.992434292396331,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14192,GO:0052031,1,0.986623830888731,0,2,modulation by symbiont of host defense response,BP,
14193,GO:0052037,1,0.992434292396331,0,1,negative regulation by symbiont of host defense response,BP,
14194,GO:0052040,1,0.964026020846371,0,6,modulation by symbiont of host programmed cell death,BP,
14195,GO:0052041,1,0.975511840058801,0,4,negative regulation by symbiont of host programmed cell death,BP,
14196,GO:0052042,1,0.984305221305541,0,3,positive regulation by symbiont of host programmed cell death,BP,
14197,GO:0052047,1,0.986013913213579,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14198,GO:0052053,1,0.993128930994008,0,1,negative regulation by symbiont of host catalytic activity,BP,
14199,GO:0052055,1,0.985614681611557,0,2,modulation by symbiont of host molecular function,BP,
14200,GO:0052056,1,0.985614681611557,0,2,negative regulation by symbiont of host molecular function,BP,
14201,GO:0052066,1,0.992285365105733,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14202,GO:0052097,1,0.992638670220271,0,1,interspecies quorum sensing,BP,
14203,GO:0052106,1,0.992638670220271,0,1,quorum sensing involved in interaction with host,BP,
14204,GO:0052126,1,0.800603540498938,0,33,movement in host environment,BP,
14205,GO:0052148,1,0.993128930994008,0,1,modulation by symbiont of host catalytic activity,BP,
14206,GO:0052150,1,0.968151244149016,0,5,modulation by symbiont of host apoptotic process,BP,
14207,GO:0052151,1,0.988516324864737,0,2,positive regulation by symbiont of host apoptotic process,BP,
14208,GO:0052167,1,0.992434292396331,0,1,modulation by symbiont of host innate immune response,BP,
14209,GO:0052170,1,0.992434292396331,0,1,negative regulation by symbiont of host innate immune response,BP,
14210,GO:0052173,1,0.967744900572909,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14211,GO:0052182,1,0.993801420336924,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14212,GO:0052190,1,0.992285365105733,0,1,modulation by symbiont of host phagocytosis,BP,
14213,GO:0052191,1,0.992285365105733,0,1,positive regulation by symbiont of host phagocytosis,BP,
14214,GO:0052192,1,0.800603540498938,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14215,GO:0052199,1,0.987850557880284,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14216,GO:0052200,1,0.967744900572909,0,5,response to host defenses,BP,
14217,GO:0052203,1,0.982956455097288,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14218,GO:0052204,1,0.96295795785317,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14219,GO:0052205,1,0.955566695490707,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14220,GO:0052212,1,0.993801420336924,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14221,GO:0052213,1,0.993801420336924,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14222,GO:0052214,1,0.995238695253471,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14223,GO:0052227,1,0.995238695253471,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14224,GO:0052229,1,0.995238695253471,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14225,GO:0052231,1,0.992285365105733,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14226,GO:0052248,1,0.964026020846371,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14227,GO:0052250,1,0.985129121261887,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14228,GO:0052251,1,0.994145695392548,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14229,GO:0052255,1,0.986623830888731,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14230,GO:0052261,1,0.992434292396331,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14231,GO:0052306,1,0.992434292396331,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14232,GO:0052309,1,0.992434292396331,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14233,GO:0052312,1,0.845432184658192,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14234,GO:0052314,1,0.989285151075903,0,2,phytoalexin metabolic process,BP,
14235,GO:0052330,1,0.984305221305541,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14236,GO:0052331,1,0.987300920414236,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14237,GO:0052360,1,0.995238695253471,0,1,catabolism by host of symbiont macromolecule,BP,
14238,GO:0052361,1,0.995238695253471,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14239,GO:0052362,1,0.995238695253471,0,1,catabolism by host of symbiont protein,BP,
14240,GO:0052363,1,0.995238695253471,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14241,GO:0052364,1,0.995238695253471,0,1,catabolism by host of substance in symbiont,BP,
14242,GO:0052370,1,0.992285365105733,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14243,GO:0052381,1,0.994286508371181,0,1,tRNA dimethylallyltransferase activity,MF,
14244,GO:0052403,1,0.994685480976322,0,1,negative regulation by host of symbiont catalytic activity,BP,
14245,GO:0052405,1,0.977015957429144,0,5,negative regulation by host of symbiont molecular function,BP,
14246,GO:0052416,1,0.995238695253471,0,1,metabolism by host of symbiont macromolecule,BP,
14247,GO:0052417,1,0.995238695253471,0,1,metabolism by host of symbiont protein,BP,
14248,GO:0052418,1,0.995238695253471,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14249,GO:0052419,1,0.995238695253471,0,1,metabolism by host of substance in symbiont,BP,
14250,GO:0052422,1,0.989757862066727,0,2,modulation by host of symbiont catalytic activity,BP,
14251,GO:0052428,1,0.969517895489798,0,6,modulation by host of symbiont molecular function,BP,
14252,GO:0052433,1,0.964026020846371,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14253,GO:0052472,1,0.851419509508121,0,24,modulation by host of symbiont transcription,BP,
14254,GO:0052490,1,0.975511840058801,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052493,1,0.992434292396331,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14256,GO:0052501,1,0.984305221305541,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14257,GO:0052509,1,0.994145695392548,0,1,positive regulation by symbiont of host defense response,BP,
14258,GO:0052510,1,0.994145695392548,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14259,GO:0052522,1,0.992285365105733,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14262,GO:0052550,1,0.995165192397572,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14263,GO:0052552,1,0.986623830888731,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14264,GO:0052553,1,0.986623830888731,0,2,modulation by symbiont of host immune response,BP,
14265,GO:0052561,1,0.992434292396331,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14266,GO:0052562,1,0.992434292396331,0,1,negative regulation by symbiont of host immune response,BP,
14267,GO:0052564,1,0.975182810649154,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14268,GO:0052567,1,0.995165192397572,0,1,response to defense-related host reactive oxygen species production,BP,
14269,GO:0052572,1,0.975182810649154,0,4,response to host immune response,BP,
14270,GO:0052590,1,0.992373136345145,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14271,GO:0052591,1,0.992373136345145,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14272,GO:0052593,1,0.985895950880965,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14273,GO:0052594,1,0.985895950880965,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14274,GO:0052595,1,0.985895950880965,0,2,aliphatic-amine oxidase activity,MF,
14275,GO:0052596,1,0.985895950880965,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14276,GO:0052629,1,0.914958325723237,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14277,GO:0052642,1,0.988465701772687,0,2,lysophosphatidic acid phosphatase activity,MF,
14278,GO:0052646,1,0.937669633985813,0,9,alditol phosphate metabolic process,BP,
14279,GO:0052650,1,0.957843173172858,0,8,NADP-retinol dehydrogenase activity,MF,
14280,GO:0052651,1,0.988110863036157,0,2,monoacylglycerol catabolic process,BP,
14285,GO:0052657,1,0.995591158854113,0,1,guanine phosphoribosyltransferase activity,MF,
14286,GO:0052658,1,0.957586485366309,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14287,GO:0052659,1,0.936268478355231,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14288,GO:0052666,1,0.994637624686316,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14289,GO:0052689,1,0.471182686480648,0,121,carboxylic ester hydrolase activity,MF,
14290,GO:0052692,1,0.995586670742104,0,1,raffinose alpha-galactosidase activity,MF,
14291,GO:0052695,1,0.980254594671945,0,3,cellular glucuronidation,BP,
14292,GO:0052717,1,0.992344799859512,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14293,GO:0052718,1,0.992344799859512,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14294,GO:0052723,1,0.966606418949935,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14295,GO:0052724,1,0.966606418949935,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14296,GO:0052725,1,0.992652011336942,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14297,GO:0052726,1,0.992652011336942,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14298,GO:0052731,1,0.994336572866918,0,1,phosphocholine phosphatase activity,MF,
14299,GO:0052732,1,0.994336572866918,0,1,phosphoethanolamine phosphatase activity,MF,
14300,GO:0052735,1,0.980014807747066,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14301,GO:0052739,1,0.985354057472465,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14302,GO:0052740,1,0.990279094275741,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14303,GO:0052742,1,0.740117044308018,0,43,phosphatidylinositol kinase activity,MF,
14304,GO:0052743,1,0.922656548926847,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14305,GO:0052744,1,0.89464907970132,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14306,GO:0052745,1,0.872880260519572,0,19,inositol phosphate phosphatase activity,MF,
14307,GO:0052746,1,0.985193509054244,0,2,inositol phosphorylation,BP,
14308,GO:0052794,1,0.981526587055406,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14309,GO:0052795,1,0.981526587055406,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14310,GO:0052796,1,0.981526587055406,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14311,GO:0052798,1,0.994355978110344,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14312,GO:0052803,1,0.939449905188124,0,10,imidazole-containing compound metabolic process,BP,
14313,GO:0052805,1,0.957601981260154,0,7,imidazole-containing compound catabolic process,BP,
14314,GO:0052810,1,0.985839948942102,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14315,GO:0052811,1,0.971058074064094,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14316,GO:0052812,1,0.978392001422873,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14317,GO:0052813,1,0.646066530346391,0,64,phosphatidylinositol bisphosphate kinase activity,MF,
14318,GO:0052815,1,0.988556811381841,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14319,GO:0052816,1,0.992576979859984,0,1,long-chain acyl-CoA hydrolase activity,MF,
14320,GO:0052817,1,0.992576979859984,0,1,very long chain acyl-CoA hydrolase activity,MF,
14321,GO:0052821,1,0.996040653319932,0,1,DNA-7-methyladenine glycosylase activity,MF,
14322,GO:0052822,1,0.996040653319932,0,1,DNA-3-methylguanine glycosylase activity,MF,
14323,GO:0052825,1,0.992652011336942,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14324,GO:0052826,1,0.993012653350283,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14325,GO:0052827,1,0.985715487806291,0,2,inositol pentakisphosphate phosphatase activity,MF,
14326,GO:0052828,1,0.984861181183125,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14327,GO:0052829,1,0.994369250835666,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14328,GO:0052830,1,0.992652011336942,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14329,GO:0052831,1,0.992652011336942,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14330,GO:0052832,1,0.973294089222002,0,4,inositol monophosphate 3-phosphatase activity,MF,
14331,GO:0052833,1,0.973294089222002,0,4,inositol monophosphate 4-phosphatase activity,MF,
14332,GO:0052834,1,0.973294089222002,0,4,inositol monophosphate phosphatase activity,MF,
14333,GO:0052835,1,0.992652011336942,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14334,GO:0052836,1,0.981446906287379,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14335,GO:0052839,1,0.981446906287379,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14336,GO:0052840,1,0.976709538622527,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14337,GO:0052841,1,0.976709538622527,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14338,GO:0052842,1,0.976709538622527,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14339,GO:0052843,1,0.976709538622527,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14340,GO:0052844,1,0.976709538622527,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14341,GO:0052845,1,0.976709538622527,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14342,GO:0052846,1,0.976709538622527,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14343,GO:0052847,1,0.976709538622527,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14344,GO:0052848,1,0.976709538622527,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14345,GO:0052851,1,0.966579644020943,0,5,ferric-chelate reductase (NADPH) activity,MF,
14346,GO:0052852,1,0.995041759703579,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14347,GO:0052853,1,0.995041759703579,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14348,GO:0052854,1,0.995041759703579,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14349,GO:0052856,1,0.996162929769167,0,1,NADHX epimerase activity,MF,
14350,GO:0052857,1,0.996162929769167,0,1,NADPHX epimerase activity,MF,
14351,GO:0052858,1,0.992536449568623,0,1,peptidyl-lysine acetyltransferase activity,MF,
14352,GO:0052866,1,0.815103033728889,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14353,GO:0052870,1,0.992847871206029,0,1,tocopherol omega-hydroxylase activity,MF,
14354,GO:0052871,1,0.992847871206029,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14355,GO:0052884,1,0.993354321866076,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14356,GO:0052885,1,0.993354321866076,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14357,GO:0052890,1,0.994713244419678,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14358,GO:0052894,1,0.994405979230079,0,1,norspermine:oxygen oxidoreductase activity,MF,
14359,GO:0052895,1,0.994405979230079,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14360,GO:0052899,1,0.995135257868318,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14361,GO:0052901,1,0.989568173923053,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14362,GO:0052902,1,0.995135257868318,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14363,GO:0052903,1,0.995135257868318,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14364,GO:0052904,1,0.995135257868318,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14365,GO:0052905,1,0.979428260561731,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14366,GO:0052906,1,0.992428863726114,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14367,GO:0052907,1,0.9930956730518,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14368,GO:0052909,1,0.9930956730518,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14369,GO:0052917,1,0.993795565412523,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14370,GO:0052918,1,0.992341123524015,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14371,GO:0052925,1,0.995434726625734,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14372,GO:0052926,1,0.992341123524015,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14373,GO:0052927,1,0.993993865113311,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14374,GO:0052928,1,0.993993865113311,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14375,GO:0052929,1,0.993993865113311,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14376,GO:0055001,1,0.37004210836399,0,148,muscle cell development,BP,
14377,GO:0055002,1,0.408156251940953,0,133,striated muscle cell development,BP,
14378,GO:0055003,1,0.868983637532741,0,19,cardiac myofibril assembly,BP,
14379,GO:0055005,1,0.980038607140634,0,3,ventricular cardiac myofibril assembly,BP,
14380,GO:0055006,1,0.643134808137208,0,63,cardiac cell development,BP,
14381,GO:0055007,1,0.520720872285545,0,94,cardiac muscle cell differentiation,BP,
14382,GO:0055008,1,0.65042339246457,0,63,cardiac muscle tissue morphogenesis,BP,
14383,GO:0055009,1,0.960376046974283,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14384,GO:0055010,1,0.742268457861045,0,44,ventricular cardiac muscle tissue morphogenesis,BP,
14385,GO:0055011,1,0.989870435992592,0,2,atrial cardiac muscle cell differentiation,BP,
14386,GO:0055012,1,0.904282132149357,0,15,ventricular cardiac muscle cell differentiation,BP,
14387,GO:0055013,1,0.66754889260927,0,58,cardiac muscle cell development,BP,
14388,GO:0055014,1,0.989870435992592,0,2,atrial cardiac muscle cell development,BP,
14389,GO:0055015,1,0.938904484535861,0,10,ventricular cardiac muscle cell development,BP,
14390,GO:0055017,1,0.632325722815333,0,67,cardiac muscle tissue growth,BP,
14391,GO:0055018,1,0.99497902520046,0,1,regulation of cardiac muscle fiber development,BP,
14392,GO:0055020,1,0.99497902520046,0,1,positive regulation of cardiac muscle fiber development,BP,
14393,GO:0055021,1,0.727202611431113,0,47,regulation of cardiac muscle tissue growth,BP,
14394,GO:0055022,1,0.896889691700199,0,16,negative regulation of cardiac muscle tissue growth,BP,
14395,GO:0055023,1,0.818644501308524,0,29,positive regulation of cardiac muscle tissue growth,BP,
14396,GO:0055024,1,0.63985993088795,0,66,regulation of cardiac muscle tissue development,BP,
14397,GO:0055025,1,0.77041557244731,0,38,positive regulation of cardiac muscle tissue development,BP,
14398,GO:0055026,1,0.845107314225656,0,25,negative regulation of cardiac muscle tissue development,BP,
14399,GO:0055028,1,0.992263514958006,0,1,cortical microtubule,CC,
14400,GO:0055029,1,0.440272546452424,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14401,GO:0055037,1,0.358780574351722,0,152,recycling endosome,CC,
14402,GO:0055038,1,0.643943257930024,0,67,recycling endosome membrane,CC,
14403,GO:0055048,1,0.992263514958006,0,1,anastral spindle assembly,BP,
14404,GO:0055056,1,0.939007362875453,0,9,D-glucose transmembrane transporter activity,MF,
14405,GO:0055057,1,0.909057824725373,0,13,neuroblast division,BP,
14406,GO:0055059,1,0.957470054050267,0,6,asymmetric neuroblast division,BP,
14407,GO:0055062,1,0.937972715076852,0,9,phosphate ion homeostasis,BP,
14412,GO:0055070,1,0.910708722267851,0,16,copper ion homeostasis,BP,
14413,GO:0055072,1,0.614180456501356,0,77,iron ion homeostasis,BP,
14414,GO:0055073,1,0.989120857291459,0,2,cadmium ion homeostasis,BP,
14418,GO:0055077,1,0.985997565803958,0,2,gap junction hemi-channel activity,MF,
14419,GO:0055078,1,0.76436764431778,0,40,sodium ion homeostasis,BP,
14426,GO:0055087,1,0.980951738584556,0,3,Ski complex,CC,
14427,GO:0055088,1,0.547230074441909,0,95,lipid homeostasis,BP,
14428,GO:0055089,1,0.922966110007579,0,12,fatty acid homeostasis,BP,
14429,GO:0055090,1,0.865523421474495,0,25,acylglycerol homeostasis,BP,
14430,GO:0055091,1,0.953495206444235,0,8,phospholipid homeostasis,BP,
14431,GO:0055092,1,0.723253446093306,0,52,sterol homeostasis,BP,
14432,GO:0055093,1,0.880367510920527,0,20,response to hyperoxia,BP,
14433,GO:0055094,1,0.870220245668548,0,21,response to lipoprotein particle,BP,
14434,GO:0055095,1,0.979564962697998,0,3,lipoprotein particle mediated signaling,BP,
14435,GO:0055096,1,0.979564962697998,0,3,low-density lipoprotein particle mediated signaling,BP,
14436,GO:0055100,1,0.979432623226182,0,3,adiponectin binding,MF,
14438,GO:0055103,1,0.992658152060687,0,1,ligase regulator activity,MF,
14439,GO:0055105,1,0.974641783463022,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14440,GO:0055106,1,0.91553838674322,0,16,ubiquitin-protein transferase regulator activity,MF,
14441,GO:0055108,1,0.994599527439214,0,1,Golgi to transport vesicle transport,BP,
14442,GO:0055111,1,0.992397436695006,0,1,ingression involved in gastrulation with mouth forming second,BP,
14443,GO:0055113,1,0.991958963776774,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14446,GO:0055118,1,0.958975118316588,0,6,negative regulation of cardiac muscle contraction,BP,
14448,GO:0055120,1,0.996089420284806,0,1,striated muscle dense body,CC,
14449,GO:0055123,1,0.41718977692209,0,130,digestive system development,BP,
14450,GO:0055129,1,0.977259968839625,0,4,L-proline biosynthetic process,BP,
14451,GO:0055130,1,0.995300329559495,0,1,D-alanine catabolic process,BP,
14452,GO:0055131,1,0.963642603909974,0,6,C3HC4-type RING finger domain binding,MF,
14453,GO:0060001,1,0.992140397443933,0,1,minus-end directed microfilament motor activity,MF,
14454,GO:0060002,1,0.98436779585537,0,2,plus-end directed microfilament motor activity,MF,
14455,GO:0060003,1,0.984551994568206,0,2,copper ion export,BP,
14456,GO:0060004,1,0.880003536796294,0,18,reflex,BP,
14457,GO:0060005,1,0.970616186797929,0,4,vestibular reflex,BP,
14458,GO:0060007,1,0.992495796016266,0,1,linear vestibuloocular reflex,BP,
14459,GO:0060008,1,0.892157590058659,0,17,Sertoli cell differentiation,BP,
14460,GO:0060009,1,0.916073166595359,0,13,Sertoli cell development,BP,
14461,GO:0060010,1,0.992619741397859,0,1,Sertoli cell fate commitment,BP,
14462,GO:0060011,1,0.98143768842131,0,3,Sertoli cell proliferation,BP,
14463,GO:0060012,1,0.954455079856769,0,7,synaptic transmission, glycinergic,BP,
14464,GO:0060013,1,0.943955833696363,0,8,righting reflex,BP,
14465,GO:0060014,1,0.992934940742317,0,1,granulosa cell differentiation,BP,
14466,GO:0060017,1,0.959321937437344,0,6,parathyroid gland development,BP,
14467,GO:0060018,1,0.977916395878371,0,3,astrocyte fate commitment,BP,
14468,GO:0060019,1,0.933417889009787,0,12,radial glial cell differentiation,BP,
14469,GO:0060020,1,0.949832700429635,0,8,Bergmann glial cell differentiation,BP,
14470,GO:0060021,1,0.567918394518239,0,83,roof of mouth development,BP,
14471,GO:0060022,1,0.957547252433129,0,6,hard palate development,BP,
14472,GO:0060023,1,0.965400331320982,0,5,soft palate development,BP,
14473,GO:0060024,1,0.971981142530885,0,4,rhythmic synaptic transmission,BP,
14474,GO:0060025,1,0.978076575334985,0,3,regulation of synaptic activity,BP,
14475,GO:0060026,1,0.903877650110006,0,15,convergent extension,BP,
14476,GO:0060027,1,0.944886490441576,0,8,convergent extension involved in gastrulation,BP,
14477,GO:0060028,1,0.953771589108808,0,7,convergent extension involved in axis elongation,BP,
14478,GO:0060029,1,0.96158627268772,0,6,convergent extension involved in organogenesis,BP,
14479,GO:0060031,1,0.987124290615527,0,2,mediolateral intercalation,BP,
14480,GO:0060032,1,0.984915521346406,0,2,notochord regression,BP,
14481,GO:0060033,1,0.935934330701244,0,10,anatomical structure regression,BP,
14482,GO:0060037,1,0.853930077304897,0,24,pharyngeal system development,BP,
14483,GO:0060038,1,0.726067623516187,0,46,cardiac muscle cell proliferation,BP,
14484,GO:0060039,1,0.871938851402628,0,19,pericardium development,BP,
14485,GO:0060040,1,0.978079058466657,0,4,retinal bipolar neuron differentiation,BP,
14487,GO:0060042,1,0.754262963482563,0,41,retina morphogenesis in camera-type eye,BP,
14488,GO:0060043,1,0.780378104632079,0,36,regulation of cardiac muscle cell proliferation,BP,
14489,GO:0060044,1,0.921425499740762,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14490,GO:0060045,1,0.855029468469473,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14491,GO:0060046,1,0.938697320905012,0,12,regulation of acrosome reaction,BP,
14494,GO:0060049,1,0.919633583999045,0,13,regulation of protein glycosylation,BP,
14495,GO:0060050,1,0.941135324527331,0,9,positive regulation of protein glycosylation,BP,
14496,GO:0060051,1,0.988174055078223,0,2,negative regulation of protein glycosylation,BP,
14498,GO:0060053,1,0.986112262833292,0,2,neurofilament cytoskeleton,CC,
14499,GO:0060054,1,0.976848971925254,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14500,GO:0060055,1,0.879748582625854,0,19,angiogenesis involved in wound healing,BP,
14501,GO:0060056,1,0.949138280679077,0,8,mammary gland involution,BP,
14502,GO:0060057,1,0.981431977907833,0,3,apoptotic process involved in mammary gland involution,BP,
14503,GO:0060058,1,0.981431977907833,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14504,GO:0060059,1,0.950689770354511,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14505,GO:0060060,1,0.992269174826927,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14506,GO:0060061,1,0.987823097311367,0,2,Spemann organizer formation,BP,
14507,GO:0060064,1,0.995470232901551,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14508,GO:0060065,1,0.877568181251876,0,19,uterus development,BP,
14509,GO:0060066,1,0.987719564564937,0,2,oviduct development,BP,
14510,GO:0060067,1,0.992381002025962,0,1,cervix development,BP,
14511,GO:0060068,1,0.94209371544651,0,9,vagina development,BP,
14513,GO:0060071,1,0.527470976850227,0,106,Wnt signaling pathway, planar cell polarity pathway,BP,
14514,GO:0060072,1,0.992343026055372,0,1,large conductance calcium-activated potassium channel activity,MF,
14515,GO:0060073,1,0.951991288712898,0,7,micturition,BP,
14517,GO:0060075,1,0.950685678701907,0,7,regulation of resting membrane potential,BP,
14523,GO:0060081,1,0.931911982598321,0,11,membrane hyperpolarization,BP,
14524,GO:0060083,1,0.977659847770978,0,3,smooth muscle contraction involved in micturition,BP,
14525,GO:0060084,1,0.979449147410614,0,3,synaptic transmission involved in micturition,BP,
14526,GO:0060086,1,0.985900637395518,0,2,circadian temperature homeostasis,BP,
14527,GO:0060087,1,0.972495466653925,0,5,relaxation of vascular smooth muscle,BP,
14528,GO:0060088,1,0.935814177380199,0,10,auditory receptor cell stereocilium organization,BP,
14531,GO:0060091,1,0.956044097998301,0,7,kinocilium,CC,
14532,GO:0060092,1,0.992672739688804,0,1,regulation of synaptic transmission, glycinergic,BP,
14533,GO:0060099,1,0.930037149686516,0,11,regulation of phagocytosis, engulfment,BP,
14534,GO:0060100,1,0.941289528919912,0,9,positive regulation of phagocytosis, engulfment,BP,
14535,GO:0060101,1,0.994776229076601,0,1,negative regulation of phagocytosis, engulfment,BP,
14536,GO:0060112,1,0.991349310434213,0,2,generation of ovulation cycle rhythm,BP,
14538,GO:0060117,1,0.888244212846169,0,17,auditory receptor cell development,BP,
14540,GO:0060120,1,0.97001805865511,0,5,inner ear receptor cell fate commitment,BP,
14541,GO:0060122,1,0.861758269063359,0,23,inner ear receptor cell stereocilium organization,BP,
14542,GO:0060123,1,0.93506177095264,0,11,regulation of growth hormone secretion,BP,
14543,GO:0060124,1,0.957209254441343,0,8,positive regulation of growth hormone secretion,BP,
14544,GO:0060125,1,0.984752603493561,0,2,negative regulation of growth hormone secretion,BP,
14545,GO:0060126,1,0.982339945482197,0,3,somatotropin secreting cell differentiation,BP,
14546,GO:0060127,1,0.994076634870323,0,1,prolactin secreting cell differentiation,BP,
14547,GO:0060128,1,0.988839272184124,0,2,corticotropin hormone secreting cell differentiation,BP,
14548,GO:0060129,1,0.981424994605145,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14549,GO:0060133,1,0.995658977751808,0,1,somatotropin secreting cell development,BP,
14552,GO:0060136,1,0.963468935162301,0,6,embryonic process involved in female pregnancy,BP,
14553,GO:0060137,1,0.949320777862116,0,8,maternal process involved in parturition,BP,
14554,GO:0060139,1,0.988516324864737,0,2,positive regulation of apoptotic process by virus,BP,
14555,GO:0060142,1,0.898818672912339,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14556,GO:0060143,1,0.907366112294659,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14557,GO:0060147,1,0.58183446262899,0,86,regulation of posttranscriptional gene silencing,BP,
14558,GO:0060148,1,0.866719224582379,0,21,positive regulation of posttranscriptional gene silencing,BP,
14559,GO:0060149,1,0.910317558850973,0,14,negative regulation of posttranscriptional gene silencing,BP,
14560,GO:0060151,1,0.985024918915952,0,2,peroxisome localization,BP,
14561,GO:0060152,1,0.985024918915952,0,2,microtubule-based peroxisome localization,BP,
14562,GO:0060154,1,0.982222422003139,0,3,cellular process regulating host cell cycle in response to virus,BP,
14563,GO:0060155,1,0.954333028946694,0,8,platelet dense granule organization,BP,
14564,GO:0060156,1,0.992735870788185,0,1,milk ejection reflex,BP,
14565,GO:0060157,1,0.970030720584778,0,5,urinary bladder development,BP,
14567,GO:0060159,1,0.943111107843197,0,9,regulation of dopamine receptor signaling pathway,BP,
14568,GO:0060160,1,0.986393186373083,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14569,GO:0060161,1,0.971390150619641,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14570,GO:0060163,1,0.989518163140086,0,2,subpallium neuron fate commitment,BP,
14571,GO:0060164,1,0.981903051848612,0,3,regulation of timing of neuron differentiation,BP,
14572,GO:0060165,1,0.993608490836106,0,1,regulation of timing of subpallium neuron differentiation,BP,
14573,GO:0060166,1,0.981856509128157,0,3,olfactory pit development,BP,
14574,GO:0060167,1,0.976623889287684,0,4,regulation of adenosine receptor signaling pathway,BP,
14575,GO:0060168,1,0.981134488637763,0,3,positive regulation of adenosine receptor signaling pathway,BP,
14576,GO:0060169,1,0.995403562116892,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14577,GO:0060170,1,0.616017586478826,0,71,ciliary membrane,CC,
14578,GO:0060171,1,0.984365208238987,0,2,stereocilium membrane,CC,
14579,GO:0060173,1,0.327261019848276,0,164,limb development,BP,
14580,GO:0060174,1,0.929026889653182,0,11,limb bud formation,BP,
14581,GO:0060175,1,0.992270697108362,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14582,GO:0060177,1,0.992600392373194,0,1,regulation of angiotensin metabolic process,BP,
14583,GO:0060178,1,0.994030122618919,0,1,regulation of exocyst localization,BP,
14585,GO:0060180,1,0.961164475054644,0,6,female mating behavior,BP,
14586,GO:0060183,1,0.992672739688804,0,1,apelin receptor signaling pathway,BP,
14587,GO:0060184,1,0.992852746849844,0,1,cell cycle switching,BP,
14588,GO:0060187,1,0.98495200413083,0,2,cell pole,CC,
14590,GO:0060192,1,0.93782550912331,0,11,negative regulation of lipase activity,BP,
14592,GO:0060197,1,0.982260145584251,0,3,cloacal septation,BP,
14599,GO:0060211,1,0.930046480573569,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14600,GO:0060212,1,0.994907487051213,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14601,GO:0060213,1,0.930046480573569,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14602,GO:0060214,1,0.977334111624861,0,4,endocardium formation,BP,
14603,GO:0060215,1,0.94587057786939,0,8,primitive hemopoiesis,BP,
14604,GO:0060216,1,0.863416542959152,0,21,definitive hemopoiesis,BP,
14605,GO:0060217,1,0.992450589190541,0,1,hemangioblast cell differentiation,BP,
14606,GO:0060218,1,0.612327327548139,0,89,hematopoietic stem cell differentiation,BP,
14607,GO:0060219,1,0.903669320947504,0,15,camera-type eye photoreceptor cell differentiation,BP,
14608,GO:0060221,1,0.980815446780572,0,3,retinal rod cell differentiation,BP,
14609,GO:0060228,1,0.988931370067579,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14610,GO:0060229,1,0.943095297736468,0,10,lipase activator activity,MF,
14611,GO:0060230,1,0.992357944536091,0,2,lipoprotein lipase activator activity,MF,
14612,GO:0060231,1,0.879357517819076,0,20,mesenchymal to epithelial transition,BP,
14613,GO:0060232,1,0.980514063002369,0,3,delamination,BP,
14614,GO:0060235,1,0.972729190551766,0,4,lens induction in camera-type eye,BP,
14615,GO:0060236,1,0.783737423363429,0,36,regulation of mitotic spindle organization,BP,
14616,GO:0060242,1,0.948013669287063,0,8,contact inhibition,BP,
14617,GO:0060243,1,0.99249384473055,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14618,GO:0060244,1,0.980680703326407,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14619,GO:0060245,1,0.992512604166219,0,1,detection of cell density,BP,
14620,GO:0060246,1,0.992512604166219,0,1,detection of cell density by contact stimulus,BP,
14621,GO:0060248,1,0.992512604166219,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14623,GO:0060251,1,0.842174490608963,0,25,regulation of glial cell proliferation,BP,
14624,GO:0060252,1,0.928449781753067,0,11,positive regulation of glial cell proliferation,BP,
14625,GO:0060253,1,0.91113035562955,0,14,negative regulation of glial cell proliferation,BP,
14626,GO:0060254,1,0.9949207709724,0,1,regulation of N-terminal protein palmitoylation,BP,
14629,GO:0060260,1,0.842530820859372,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14630,GO:0060261,1,0.884799112099075,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14631,GO:0060262,1,0.9949207709724,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14632,GO:0060263,1,0.946096463110667,0,10,regulation of respiratory burst,BP,
14633,GO:0060264,1,0.985333323115498,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14634,GO:0060265,1,0.991219256964014,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14635,GO:0060266,1,0.990400105068044,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14636,GO:0060267,1,0.978074152081339,0,4,positive regulation of respiratory burst,BP,
14637,GO:0060268,1,0.982764551384032,0,3,negative regulation of respiratory burst,BP,
14639,GO:0060272,1,0.927148057198763,0,12,embryonic skeletal joint morphogenesis,BP,
14640,GO:0060278,1,0.98091659320213,0,3,regulation of ovulation,BP,
14641,GO:0060279,1,0.986933850677965,0,2,positive regulation of ovulation,BP,
14642,GO:0060280,1,0.993903895013174,0,1,negative regulation of ovulation,BP,
14643,GO:0060281,1,0.93661013742744,0,10,regulation of oocyte development,BP,
14644,GO:0060282,1,0.973785167980879,0,4,positive regulation of oocyte development,BP,
14645,GO:0060283,1,0.974624861742654,0,4,negative regulation of oocyte development,BP,
14647,GO:0060285,1,0.825814189711103,0,30,cilium-dependent cell motility,BP,
14648,GO:0060287,1,0.941562165612814,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14649,GO:0060290,1,0.9642148497858,0,5,transdifferentiation,BP,
14651,GO:0060292,1,0.823142272572887,0,28,long term synaptic depression,BP,
14652,GO:0060293,1,0.908697523500126,0,14,germ plasm,CC,
14653,GO:0060294,1,0.911899794829724,0,16,cilium movement involved in cell motility,BP,
14654,GO:0060295,1,0.966622571074625,0,5,regulation of cilium movement involved in cell motility,BP,
14655,GO:0060296,1,0.966622571074625,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14656,GO:0060297,1,0.96398629122815,0,5,regulation of sarcomere organization,BP,
14657,GO:0060298,1,0.979474052012537,0,3,positive regulation of sarcomere organization,BP,
14658,GO:0060300,1,0.976323902082505,0,4,regulation of cytokine activity,BP,
14659,GO:0060301,1,0.993588067364596,0,1,positive regulation of cytokine activity,BP,
14660,GO:0060302,1,0.990055891157934,0,2,negative regulation of cytokine activity,BP,
14661,GO:0060304,1,0.956002836050874,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14662,GO:0060305,1,0.993002618111896,0,1,regulation of cell diameter,BP,
14663,GO:0060306,1,0.817197953182919,0,29,regulation of membrane repolarization,BP,
14664,GO:0060307,1,0.881343343637544,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14665,GO:0060309,1,0.996396050682575,0,1,elastin catabolic process,BP,
14666,GO:0060310,1,0.996396050682575,0,1,regulation of elastin catabolic process,BP,
14667,GO:0060311,1,0.996396050682575,0,1,negative regulation of elastin catabolic process,BP,
14668,GO:0060312,1,0.947760034229239,0,8,regulation of blood vessel remodeling,BP,
14669,GO:0060313,1,0.98122907276413,0,3,negative regulation of blood vessel remodeling,BP,
14670,GO:0060314,1,0.853108015809818,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14671,GO:0060315,1,0.938249524080086,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14672,GO:0060316,1,0.952385827596987,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14673,GO:0060317,1,0.816650162530427,0,31,cardiac epithelial to mesenchymal transition,BP,
14674,GO:0060318,1,0.96650052047334,0,5,definitive erythrocyte differentiation,BP,
14675,GO:0060319,1,0.973561494731713,0,4,primitive erythrocyte differentiation,BP,
14677,GO:0060323,1,0.794904255707169,0,34,head morphogenesis,BP,
14678,GO:0060324,1,0.726380111963447,0,46,face development,BP,
14679,GO:0060325,1,0.819417036556458,0,29,face morphogenesis,BP,
14681,GO:0060327,1,0.993143405834604,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14682,GO:0060330,1,0.874009609959442,0,22,regulation of response to interferon-gamma,BP,
14683,GO:0060331,1,0.967929967932304,0,6,negative regulation of response to interferon-gamma,BP,
14684,GO:0060332,1,0.965784982722316,0,5,positive regulation of response to interferon-gamma,BP,
14686,GO:0060334,1,0.874009609959442,0,22,regulation of interferon-gamma-mediated signaling pathway,BP,
14687,GO:0060335,1,0.965784982722316,0,5,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14688,GO:0060336,1,0.967929967932304,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14689,GO:0060337,1,0.64779149906753,0,71,type I interferon signaling pathway,BP,
14690,GO:0060338,1,0.816895409964826,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14691,GO:0060339,1,0.953792606332253,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14692,GO:0060340,1,0.935013713873159,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14694,GO:0060342,1,0.98794766761873,0,2,photoreceptor inner segment membrane,CC,
14695,GO:0060343,1,0.859302306471684,0,23,trabecula formation,BP,
14696,GO:0060345,1,0.992603524382402,0,1,spleen trabecula formation,BP,
14697,GO:0060346,1,0.932029094475234,0,10,bone trabecula formation,BP,
14698,GO:0060347,1,0.928898926878335,0,12,heart trabecula formation,BP,
14699,GO:0060348,1,0.31759509690795,0,167,bone development,BP,
14700,GO:0060349,1,0.586156235769721,0,79,bone morphogenesis,BP,
14701,GO:0060350,1,0.724167032762358,0,47,endochondral bone morphogenesis,BP,
14702,GO:0060351,1,0.853672963919422,0,23,cartilage development involved in endochondral bone morphogenesis,BP,
14703,GO:0060352,1,0.958985208139501,0,7,cell adhesion molecule production,BP,
14704,GO:0060353,1,0.972889388159909,0,5,regulation of cell adhesion molecule production,BP,
14705,GO:0060354,1,0.996263188717863,0,1,negative regulation of cell adhesion molecule production,BP,
14706,GO:0060355,1,0.976539416319645,0,4,positive regulation of cell adhesion molecule production,BP,
14708,GO:0060363,1,0.95101493161961,0,8,cranial suture morphogenesis,BP,
14709,GO:0060364,1,0.973423495411633,0,4,frontal suture morphogenesis,BP,
14710,GO:0060366,1,0.992178754021501,0,1,lambdoid suture morphogenesis,BP,
14711,GO:0060367,1,0.992178754021501,0,1,sagittal suture morphogenesis,BP,
14712,GO:0060368,1,0.961611779680634,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14713,GO:0060369,1,0.973551434206668,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14714,GO:0060370,1,0.988498539968937,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14715,GO:0060371,1,0.951162405674341,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14716,GO:0060372,1,0.952632644497028,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14717,GO:0060373,1,0.963092148427313,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14718,GO:0060374,1,0.963289413432096,0,5,mast cell differentiation,BP,
14719,GO:0060375,1,0.985163606982228,0,2,regulation of mast cell differentiation,BP,
14720,GO:0060377,1,0.992658152060687,0,1,negative regulation of mast cell differentiation,BP,
14721,GO:0060378,1,0.987227187698147,0,2,regulation of brood size,BP,
14722,GO:0060379,1,0.930077533577143,0,10,cardiac muscle cell myoblast differentiation,BP,
14723,GO:0060380,1,0.994427380625081,0,1,regulation of single-stranded telomeric DNA binding,BP,
14724,GO:0060381,1,0.994427380625081,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14725,GO:0060382,1,0.984882466702072,0,2,regulation of DNA strand elongation,BP,
14726,GO:0060383,1,0.992498126821826,0,1,positive regulation of DNA strand elongation,BP,
14729,GO:0060386,1,0.992390453579753,0,1,synapse assembly involved in innervation,BP,
14730,GO:0060389,1,0.679876196139091,0,59,pathway-restricted SMAD protein phosphorylation,BP,
14731,GO:0060390,1,0.891316451354148,0,17,regulation of SMAD protein signal transduction,BP,
14732,GO:0060391,1,0.912953480607853,0,13,positive regulation of SMAD protein signal transduction,BP,
14733,GO:0060392,1,0.98375204804597,0,3,negative regulation of SMAD protein signal transduction,BP,
14734,GO:0060393,1,0.695621200333792,0,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14735,GO:0060394,1,0.937502553137121,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14736,GO:0060395,1,0.670442615876139,0,60,SMAD protein signal transduction,BP,
14737,GO:0060396,1,0.879494272234591,0,18,growth hormone receptor signaling pathway,BP,
14738,GO:0060397,1,0.922195911602678,0,11,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14739,GO:0060398,1,0.973973454811876,0,4,regulation of growth hormone receptor signaling pathway,BP,
14740,GO:0060399,1,0.981359947720671,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14741,GO:0060400,1,0.992474646279923,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14744,GO:0060404,1,0.992522555202321,0,1,axonemal microtubule depolymerization,BP,
14746,GO:0060406,1,0.97789859759541,0,3,positive regulation of penile erection,BP,
14747,GO:0060407,1,0.995403562116892,0,1,negative regulation of penile erection,BP,
14748,GO:0060411,1,0.647551788428177,0,63,cardiac septum morphogenesis,BP,
14749,GO:0060412,1,0.785946823960373,0,35,ventricular septum morphogenesis,BP,
14750,GO:0060413,1,0.906567593431682,0,14,atrial septum morphogenesis,BP,
14751,GO:0060414,1,0.977588046487303,0,3,aorta smooth muscle tissue morphogenesis,BP,
14752,GO:0060415,1,0.611473218121071,0,72,muscle tissue morphogenesis,BP,
14753,GO:0060416,1,0.812549608342529,0,29,response to growth hormone,BP,
14754,GO:0060419,1,0.603907474813315,0,74,heart growth,BP,
14755,GO:0060420,1,0.697399810886883,0,53,regulation of heart growth,BP,
14756,GO:0060421,1,0.796463324617686,0,33,positive regulation of heart growth,BP,
14757,GO:0060422,1,0.993955751142775,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14758,GO:0060423,1,0.97975615501212,0,3,foregut regionalization,BP,
14759,GO:0060424,1,0.97975615501212,0,3,lung field specification,BP,
14760,GO:0060425,1,0.725606402520452,0,49,lung morphogenesis,BP,
14761,GO:0060426,1,0.968135306554844,0,5,lung vasculature development,BP,
14762,GO:0060428,1,0.80662151780768,0,33,lung epithelium development,BP,
14764,GO:0060430,1,0.961330037174017,0,6,lung saccule development,BP,
14765,GO:0060431,1,0.9676166619235,0,5,primary lung bud formation,BP,
14766,GO:0060432,1,0.996546189543489,0,1,lung pattern specification process,BP,
14767,GO:0060433,1,0.938894072144347,0,10,bronchus development,BP,
14768,GO:0060434,1,0.98597444930656,0,2,bronchus morphogenesis,BP,
14769,GO:0060435,1,0.99228012006254,0,2,bronchiole development,BP,
14770,GO:0060436,1,0.996546189543489,0,1,bronchiole morphogenesis,BP,
14771,GO:0060437,1,0.968883574623549,0,5,lung growth,BP,
14772,GO:0060438,1,0.880880049718923,0,19,trachea development,BP,
14773,GO:0060439,1,0.931267492467004,0,11,trachea morphogenesis,BP,
14774,GO:0060440,1,0.961366468919676,0,6,trachea formation,BP,
14775,GO:0060441,1,0.83490344993196,0,28,epithelial tube branching involved in lung morphogenesis,BP,
14776,GO:0060442,1,0.920659734520134,0,12,branching involved in prostate gland morphogenesis,BP,
14777,GO:0060443,1,0.741831500690679,0,43,mammary gland morphogenesis,BP,
14778,GO:0060444,1,0.855340250902264,0,22,branching involved in mammary gland duct morphogenesis,BP,
14779,GO:0060445,1,0.862397548999983,0,22,branching involved in salivary gland morphogenesis,BP,
14780,GO:0060447,1,0.984197927730295,0,3,bud outgrowth involved in lung branching,BP,
14781,GO:0060448,1,0.97998415746696,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14782,GO:0060449,1,0.957831324477112,0,7,bud elongation involved in lung branching,BP,
14784,GO:0060453,1,0.941976064508728,0,10,regulation of gastric acid secretion,BP,
14785,GO:0060454,1,0.985191883358292,0,2,positive regulation of gastric acid secretion,BP,
14786,GO:0060455,1,0.976823113816388,0,5,negative regulation of gastric acid secretion,BP,
14787,GO:0060456,1,0.944281580284779,0,10,positive regulation of digestive system process,BP,
14788,GO:0060457,1,0.929509632385781,0,13,negative regulation of digestive system process,BP,
14789,GO:0060458,1,0.988831236900382,0,2,right lung development,BP,
14790,GO:0060459,1,0.983892189531312,0,3,left lung development,BP,
14791,GO:0060460,1,0.988494119159462,0,2,left lung morphogenesis,BP,
14792,GO:0060461,1,0.99345603044542,0,1,right lung morphogenesis,BP,
14793,GO:0060462,1,0.959443397878517,0,6,lung lobe development,BP,
14794,GO:0060463,1,0.959443397878517,0,6,lung lobe morphogenesis,BP,
14795,GO:0060465,1,0.985218371738409,0,2,pharynx development,BP,
14796,GO:0060466,1,0.992298692247779,0,1,activation of meiosis involved in egg activation,BP,
14797,GO:0060467,1,0.989707792618082,0,2,negative regulation of fertilization,BP,
14798,GO:0060474,1,0.992608894317891,0,1,positive regulation of flagellated sperm motility involved in capacitation,BP,
14799,GO:0060478,1,0.976099385356029,0,4,acrosomal vesicle exocytosis,BP,
14800,GO:0060479,1,0.881720969815928,0,20,lung cell differentiation,BP,
14801,GO:0060480,1,0.986331971488224,0,3,lung goblet cell differentiation,BP,
14802,GO:0060481,1,0.978936065764219,0,4,lobar bronchus epithelium development,BP,
14803,GO:0060482,1,0.971595023647619,0,5,lobar bronchus development,BP,
14804,GO:0060484,1,0.949358527092293,0,8,lung-associated mesenchyme development,BP,
14805,GO:0060485,1,0.214772360933851,0,231,mesenchyme development,BP,
14806,GO:0060486,1,0.972883093354642,0,4,Clara cell differentiation,BP,
14807,GO:0060487,1,0.888323103146216,0,19,lung epithelial cell differentiation,BP,
14808,GO:0060488,1,0.984411059612575,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14809,GO:0060489,1,0.984411059612575,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14810,GO:0060490,1,0.984411059612575,0,2,lateral sprouting involved in lung morphogenesis,BP,
14812,GO:0060492,1,0.97975615501212,0,3,lung induction,BP,
14813,GO:0060495,1,0.996546189543489,0,1,cell-cell signaling involved in lung development,BP,
14814,GO:0060496,1,0.996546189543489,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14815,GO:0060501,1,0.958540884103088,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14816,GO:0060502,1,0.932965048341551,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14817,GO:0060503,1,0.99497902520046,0,1,bud dilation involved in lung branching,BP,
14818,GO:0060509,1,0.96588214002232,0,5,Type I pneumocyte differentiation,BP,
14819,GO:0060510,1,0.971515741651446,0,5,Type II pneumocyte differentiation,BP,
14820,GO:0060512,1,0.839235147642092,0,26,prostate gland morphogenesis,BP,
14821,GO:0060513,1,0.93826053681929,0,10,prostatic bud formation,BP,
14822,GO:0060514,1,0.992803818119721,0,1,prostate induction,BP,
14823,GO:0060515,1,0.992803818119721,0,1,prostate field specification,BP,
14824,GO:0060516,1,0.987881808632845,0,2,primary prostatic bud elongation,BP,
14825,GO:0060517,1,0.992502206977349,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14826,GO:0060520,1,0.992803818119721,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14827,GO:0060523,1,0.980306561208956,0,3,prostate epithelial cord elongation,BP,
14828,GO:0060525,1,0.929347921768329,0,10,prostate glandular acinus development,BP,
14829,GO:0060526,1,0.957101990566399,0,6,prostate glandular acinus morphogenesis,BP,
14830,GO:0060527,1,0.957101990566399,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14831,GO:0060528,1,0.978378884574941,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14832,GO:0060529,1,0.98502872681645,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14833,GO:0060532,1,0.985048685221598,0,2,bronchus cartilage development,BP,
14834,GO:0060534,1,0.944965247979905,0,8,trachea cartilage development,BP,
14835,GO:0060535,1,0.973235462201491,0,4,trachea cartilage morphogenesis,BP,
14836,GO:0060536,1,0.930598852389383,0,11,cartilage morphogenesis,BP,
14839,GO:0060539,1,0.95392245195684,0,7,diaphragm development,BP,
14841,GO:0060542,1,0.992386428745838,0,1,regulation of strand invasion,BP,
14842,GO:0060544,1,0.882328393981358,0,20,regulation of necroptotic process,BP,
14843,GO:0060545,1,0.98724891794767,0,2,positive regulation of necroptotic process,BP,
14844,GO:0060546,1,0.933734011012998,0,10,negative regulation of necroptotic process,BP,
14845,GO:0060547,1,0.923301978511127,0,13,negative regulation of necrotic cell death,BP,
14847,GO:0060556,1,0.952910877880203,0,8,regulation of vitamin D biosynthetic process,BP,
14848,GO:0060557,1,0.990675168037627,0,2,positive regulation of vitamin D biosynthetic process,BP,
14849,GO:0060558,1,0.962989266542753,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14850,GO:0060559,1,0.990675168037627,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14852,GO:0060561,1,0.85756777295587,0,23,apoptotic process involved in morphogenesis,BP,
14853,GO:0060562,1,0.129785808552843,0,299,epithelial tube morphogenesis,BP,
14854,GO:0060563,1,0.715635577124214,0,50,neuroepithelial cell differentiation,BP,
14855,GO:0060566,1,0.991956301967642,0,1,positive regulation of DNA-templated transcription, termination,BP,
14856,GO:0060571,1,0.84936629224889,0,26,morphogenesis of an epithelial fold,BP,
14857,GO:0060572,1,0.896371796384524,0,17,morphogenesis of an epithelial bud,BP,
14858,GO:0060573,1,0.938408819506699,0,10,cell fate specification involved in pattern specification,BP,
14859,GO:0060574,1,0.977870042968917,0,4,intestinal epithelial cell maturation,BP,
14860,GO:0060575,1,0.903861425198004,0,16,intestinal epithelial cell differentiation,BP,
14861,GO:0060576,1,0.943634880725962,0,10,intestinal epithelial cell development,BP,
14862,GO:0060577,1,0.989407008567703,0,2,pulmonary vein morphogenesis,BP,
14863,GO:0060578,1,0.994076634870323,0,1,superior vena cava morphogenesis,BP,
14864,GO:0060579,1,0.913500074844638,0,14,ventral spinal cord interneuron fate commitment,BP,
14865,GO:0060580,1,0.994406998783492,0,1,ventral spinal cord interneuron fate determination,BP,
14866,GO:0060581,1,0.913500074844638,0,14,cell fate commitment involved in pattern specification,BP,
14867,GO:0060582,1,0.994406998783492,0,1,cell fate determination involved in pattern specification,BP,
14868,GO:0060584,1,0.982778080010971,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14869,GO:0060585,1,0.982778080010971,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14870,GO:0060586,1,0.949174778572176,0,8,multicellular organismal iron ion homeostasis,BP,
14871,GO:0060587,1,0.988592383970141,0,2,regulation of lipoprotein lipid oxidation,BP,
14872,GO:0060588,1,0.995985737856088,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14874,GO:0060590,1,0.781521616993001,0,40,ATPase regulator activity,MF,
14875,GO:0060591,1,0.972946442160329,0,4,chondroblast differentiation,BP,
14876,GO:0060592,1,0.954669566572894,0,7,mammary gland formation,BP,
14877,GO:0060594,1,0.981333264534719,0,3,mammary gland specification,BP,
14878,GO:0060595,1,0.989069887568945,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14879,GO:0060596,1,0.97774461862312,0,3,mammary placode formation,BP,
14880,GO:0060598,1,0.995847653728046,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14881,GO:0060599,1,0.985239092968177,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14882,GO:0060600,1,0.934516171495903,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14883,GO:0060601,1,0.916690034106967,0,13,lateral sprouting from an epithelium,BP,
14884,GO:0060602,1,0.882970630429766,0,19,branch elongation of an epithelium,BP,
14885,GO:0060603,1,0.809883050805385,0,30,mammary gland duct morphogenesis,BP,
14886,GO:0060605,1,0.969259077197297,0,5,tube lumen cavitation,BP,
14887,GO:0060606,1,0.556187890816413,0,86,tube closure,BP,
14888,GO:0060611,1,0.993693316481998,0,1,mammary gland fat development,BP,
14889,GO:0060612,1,0.79266485643887,0,35,adipose tissue development,BP,
14890,GO:0060613,1,0.961070372791387,0,6,fat pad development,BP,
14891,GO:0060615,1,0.989069887568945,0,2,mammary gland bud formation,BP,
14892,GO:0060620,1,0.9930956730518,0,1,regulation of cholesterol import,BP,
14893,GO:0060623,1,0.986938577676749,0,2,regulation of chromosome condensation,BP,
14895,GO:0060628,1,0.921515233015045,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14896,GO:0060629,1,0.993010131930128,0,1,regulation of homologous chromosome segregation,BP,
14897,GO:0060631,1,0.951975073221852,0,7,regulation of meiosis I,BP,
14899,GO:0060633,1,0.965339092205734,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14900,GO:0060638,1,0.951417588512174,0,8,mesenchymal-epithelial cell signaling,BP,
14901,GO:0060644,1,0.900640564384235,0,16,mammary gland epithelial cell differentiation,BP,
14902,GO:0060648,1,0.983950803646916,0,3,mammary gland bud morphogenesis,BP,
14903,GO:0060661,1,0.990778943634512,0,2,submandibular salivary gland formation,BP,
14904,GO:0060662,1,0.969259077197297,0,5,salivary gland cavitation,BP,
14905,GO:0060664,1,0.972517317123444,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14906,GO:0060665,1,0.976190778607813,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14907,GO:0060666,1,0.96335174872054,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14908,GO:0060667,1,0.989069887568945,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14909,GO:0060668,1,0.992528477601884,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14910,GO:0060669,1,0.859037232892576,0,23,embryonic placenta morphogenesis,BP,
14911,GO:0060670,1,0.938856638576385,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14912,GO:0060671,1,0.987758231652299,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14913,GO:0060672,1,0.987758231652299,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14914,GO:0060674,1,0.822572957654023,0,29,placenta blood vessel development,BP,
14915,GO:0060675,1,0.675456534116925,0,59,ureteric bud morphogenesis,BP,
14916,GO:0060676,1,0.96272580247365,0,6,ureteric bud formation,BP,
14917,GO:0060677,1,0.950689767304216,0,7,ureteric bud elongation,BP,
14918,GO:0060678,1,0.994022053753213,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14919,GO:0060681,1,0.973346511460074,0,4,branch elongation involved in ureteric bud branching,BP,
14920,GO:0060683,1,0.993113229616071,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14921,GO:0060684,1,0.965784330235753,0,6,epithelial-mesenchymal cell signaling,BP,
14922,GO:0060685,1,0.961042312361604,0,6,regulation of prostatic bud formation,BP,
14923,GO:0060686,1,0.972538995980765,0,4,negative regulation of prostatic bud formation,BP,
14924,GO:0060687,1,0.952103459136522,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14925,GO:0060688,1,0.715503515385681,0,51,regulation of morphogenesis of a branching structure,BP,
14926,GO:0060689,1,0.979943768689702,0,3,cell differentiation involved in salivary gland development,BP,
14927,GO:0060690,1,0.994934951994993,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14928,GO:0060691,1,0.994934951994993,0,1,epithelial cell maturation involved in salivary gland development,BP,
14929,GO:0060693,1,0.9449559662461,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14930,GO:0060694,1,0.994837506282806,0,1,regulation of cholesterol transporter activity,BP,
14931,GO:0060696,1,0.966267958086401,0,6,regulation of phospholipid catabolic process,BP,
14932,GO:0060697,1,0.989563600150038,0,2,positive regulation of phospholipid catabolic process,BP,
14933,GO:0060698,1,0.985325413299915,0,2,endoribonuclease inhibitor activity,MF,
14934,GO:0060699,1,0.974877439414061,0,4,regulation of endoribonuclease activity,BP,
14935,GO:0060700,1,0.944530226275123,0,9,regulation of ribonuclease activity,BP,
14936,GO:0060701,1,0.985325413299915,0,2,negative regulation of ribonuclease activity,BP,
14937,GO:0060702,1,0.985325413299915,0,2,negative regulation of endoribonuclease activity,BP,
14938,GO:0060703,1,0.993198575377995,0,1,deoxyribonuclease inhibitor activity,MF,
14939,GO:0060706,1,0.865910397659863,0,22,cell differentiation involved in embryonic placenta development,BP,
14940,GO:0060707,1,0.929289421041951,0,11,trophoblast giant cell differentiation,BP,
14941,GO:0060708,1,0.981574685498823,0,3,spongiotrophoblast differentiation,BP,
14942,GO:0060709,1,0.992990262360756,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14943,GO:0060710,1,0.953989120427196,0,7,chorio-allantoic fusion,BP,
14944,GO:0060711,1,0.755005797013105,0,43,labyrinthine layer development,BP,
14945,GO:0060712,1,0.915090187929091,0,14,spongiotrophoblast layer development,BP,
14946,GO:0060713,1,0.884970791267262,0,19,labyrinthine layer morphogenesis,BP,
14947,GO:0060715,1,0.980092095930523,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14948,GO:0060716,1,0.883419371495503,0,19,labyrinthine layer blood vessel development,BP,
14949,GO:0060717,1,0.951974478181493,0,7,chorion development,BP,
14950,GO:0060718,1,0.964450885328741,0,5,chorionic trophoblast cell differentiation,BP,
14951,GO:0060720,1,0.988459185594375,0,2,spongiotrophoblast cell proliferation,BP,
14952,GO:0060721,1,0.988459185594375,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14953,GO:0060722,1,0.988459185594375,0,2,cell proliferation involved in embryonic placenta development,BP,
14954,GO:0060723,1,0.988459185594375,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14955,GO:0060729,1,0.966542798013093,0,5,intestinal epithelial structure maintenance,BP,
14956,GO:0060730,1,0.986026449459359,0,2,regulation of intestinal epithelial structure maintenance,BP,
14957,GO:0060731,1,0.992638670220271,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14958,GO:0060732,1,0.936892940840212,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14959,GO:0060733,1,0.984973495336058,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14960,GO:0060734,1,0.992473639872292,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14961,GO:0060735,1,0.995666237812036,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14962,GO:0060736,1,0.922856874334779,0,11,prostate gland growth,BP,
14963,GO:0060737,1,0.972954940014009,0,4,prostate gland morphogenetic growth,BP,
14964,GO:0060738,1,0.995345054077821,0,1,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14965,GO:0060739,1,0.992228514941185,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14966,GO:0060740,1,0.842029161171102,0,25,prostate gland epithelium morphogenesis,BP,
14967,GO:0060741,1,0.990572020206493,0,2,prostate gland stromal morphogenesis,BP,
14968,GO:0060742,1,0.930151872512703,0,10,epithelial cell differentiation involved in prostate gland development,BP,
14969,GO:0060743,1,0.986321950914519,0,2,epithelial cell maturation involved in prostate gland development,BP,
14970,GO:0060744,1,0.9704717983738,0,5,mammary gland branching involved in thelarche,BP,
14971,GO:0060745,1,0.954965705982339,0,6,mammary gland branching involved in pregnancy,BP,
14972,GO:0060746,1,0.913473486811744,0,13,parental behavior,BP,
14973,GO:0060748,1,0.977287042872124,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14974,GO:0060749,1,0.894972887826437,0,17,mammary gland alveolus development,BP,
14975,GO:0060750,1,0.973019414437228,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14976,GO:0060751,1,0.967321476850804,0,5,branch elongation involved in mammary gland duct branching,BP,
14977,GO:0060752,1,0.993264128755224,0,1,intestinal phytosterol absorption,BP,
14978,GO:0060753,1,0.966458446978397,0,6,regulation of mast cell chemotaxis,BP,
14979,GO:0060754,1,0.970815080521616,0,5,positive regulation of mast cell chemotaxis,BP,
14980,GO:0060759,1,0.385947717749089,0,149,regulation of response to cytokine stimulus,BP,
14981,GO:0060760,1,0.743405077767439,0,46,positive regulation of response to cytokine stimulus,BP,
14982,GO:0060761,1,0.748401852320482,0,48,negative regulation of response to cytokine stimulus,BP,
14983,GO:0060762,1,0.974827655509692,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14984,GO:0060763,1,0.986072944522514,0,2,mammary duct terminal end bud growth,BP,
14985,GO:0060764,1,0.988191174043138,0,2,cell-cell signaling involved in mammary gland development,BP,
14986,GO:0060765,1,0.84870413903583,0,25,regulation of androgen receptor signaling pathway,BP,
14987,GO:0060766,1,0.929364578123579,0,11,negative regulation of androgen receptor signaling pathway,BP,
14988,GO:0060767,1,0.931746550862087,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14989,GO:0060768,1,0.938789922718253,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14990,GO:0060769,1,0.980845678928411,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14991,GO:0060770,1,0.964765642776326,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14992,GO:0060775,1,0.987124290615527,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14993,GO:0060781,1,0.995345054077821,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14994,GO:0060782,1,0.995345054077821,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14995,GO:0060783,1,0.995345054077821,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14996,GO:0060784,1,0.992502206977349,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14997,GO:0060788,1,0.9090061922513,0,14,ectodermal placode formation,BP,
14998,GO:0060789,1,0.964660293484847,0,6,hair follicle placode formation,BP,
14999,GO:0060795,1,0.819751992272452,0,31,cell fate commitment involved in formation of primary germ layer,BP,
15000,GO:0060796,1,0.989363075011034,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15001,GO:0060800,1,0.980644874690656,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15002,GO:0060802,1,0.994384559683417,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15003,GO:0060803,1,0.995481181415834,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15004,GO:0060804,1,0.992719876885176,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15005,GO:0060806,1,0.995151143906478,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15006,GO:0060807,1,0.993854405045589,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15007,GO:0060809,1,0.98559949167021,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15008,GO:0060816,1,0.984648443696907,0,2,random inactivation of X chromosome,BP,
15009,GO:0060819,1,0.984723565044282,0,2,inactivation of X chromosome by genetic imprinting,BP,
15010,GO:0060821,1,0.992138613967713,0,1,inactivation of X chromosome by DNA methylation,BP,
15011,GO:0060823,1,0.98513998253297,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15012,GO:0060825,1,0.989997843065386,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15013,GO:0060827,1,0.992498660706466,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15015,GO:0060829,1,0.992498660706466,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15016,GO:0060830,1,0.981307852809439,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15017,GO:0060831,1,0.909991543245476,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15018,GO:0060836,1,0.946187321653425,0,8,lymphatic endothelial cell differentiation,BP,
15019,GO:0060837,1,0.942690049503115,0,9,blood vessel endothelial cell differentiation,BP,
15020,GO:0060838,1,0.978625473045933,0,3,lymphatic endothelial cell fate commitment,BP,
15021,GO:0060839,1,0.952385901754117,0,7,endothelial cell fate commitment,BP,
15022,GO:0060840,1,0.586013097395775,0,76,artery development,BP,
15023,GO:0060841,1,0.893860668093283,0,16,venous blood vessel development,BP,
15024,GO:0060842,1,0.960954539940338,0,6,arterial endothelial cell differentiation,BP,
15025,GO:0060843,1,0.992089665801698,0,1,venous endothelial cell differentiation,BP,
15026,GO:0060844,1,0.986497200730842,0,2,arterial endothelial cell fate commitment,BP,
15027,GO:0060846,1,0.980170972577337,0,3,blood vessel endothelial cell fate commitment,BP,
15028,GO:0060847,1,0.980170972577337,0,3,endothelial cell fate specification,BP,
15029,GO:0060849,1,0.985337158384558,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15030,GO:0060850,1,0.90827641869721,0,16,regulation of transcription involved in cell fate commitment,BP,
15031,GO:0060853,1,0.992622328642548,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15032,GO:0060856,1,0.935435189626048,0,10,establishment of blood-brain barrier,BP,
15033,GO:0060857,1,0.993991854901091,0,1,establishment of glial blood-brain barrier,BP,
15034,GO:0060872,1,0.941257492462763,0,9,semicircular canal development,BP,
15035,GO:0060873,1,0.992178754021501,0,1,anterior semicircular canal development,BP,
15036,GO:0060875,1,0.992178754021501,0,1,lateral semicircular canal development,BP,
15037,GO:0060876,1,0.990238332539292,0,2,semicircular canal formation,BP,
15038,GO:0060879,1,0.996546189543489,0,1,semicircular canal fusion,BP,
15039,GO:0060896,1,0.940141086708454,0,9,neural plate pattern specification,BP,
15040,GO:0060897,1,0.954843098295517,0,7,neural plate regionalization,BP,
15041,GO:0060900,1,0.916217210769195,0,12,embryonic camera-type eye formation,BP,
15042,GO:0060901,1,0.992492007106331,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15043,GO:0060903,1,0.972740851671813,0,4,positive regulation of meiosis I,BP,
15044,GO:0060904,1,0.992501005355722,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15045,GO:0060907,1,0.956298791151258,0,7,positive regulation of macrophage cytokine production,BP,
15046,GO:0060911,1,0.939468998286745,0,10,cardiac cell fate commitment,BP,
15047,GO:0060912,1,0.986992079175063,0,2,cardiac cell fate specification,BP,
15048,GO:0060913,1,0.983100455796863,0,3,cardiac cell fate determination,BP,
15049,GO:0060914,1,0.872585662964137,0,22,heart formation,BP,
15050,GO:0060915,1,0.989069887568945,0,2,mesenchymal cell differentiation involved in lung development,BP,
15051,GO:0060916,1,0.965584374354177,0,5,mesenchymal cell proliferation involved in lung development,BP,
15052,GO:0060920,1,0.968335287108792,0,5,cardiac pacemaker cell differentiation,BP,
15053,GO:0060921,1,0.980948610400965,0,3,sinoatrial node cell differentiation,BP,
15054,GO:0060922,1,0.987144215692767,0,2,atrioventricular node cell differentiation,BP,
15055,GO:0060923,1,0.962272506416067,0,6,cardiac muscle cell fate commitment,BP,
15056,GO:0060926,1,0.972272800894036,0,4,cardiac pacemaker cell development,BP,
15057,GO:0060927,1,0.994713244419678,0,1,cardiac pacemaker cell fate commitment,BP,
15058,GO:0060928,1,0.987144215692767,0,2,atrioventricular node cell development,BP,
15059,GO:0060929,1,0.994713244419678,0,1,atrioventricular node cell fate commitment,BP,
15060,GO:0060931,1,0.984936884660744,0,2,sinoatrial node cell development,BP,
15061,GO:0060932,1,0.987220262431166,0,2,His-Purkinje system cell differentiation,BP,
15062,GO:0060935,1,0.978733412680813,0,3,cardiac fibroblast cell differentiation,BP,
15063,GO:0060936,1,0.978733412680813,0,3,cardiac fibroblast cell development,BP,
15064,GO:0060938,1,0.978733412680813,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15065,GO:0060939,1,0.978733412680813,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15066,GO:0060940,1,0.986299698873118,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15067,GO:0060947,1,0.945614658465625,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15068,GO:0060948,1,0.978064706042091,0,3,cardiac vascular smooth muscle cell development,BP,
15069,GO:0060956,1,0.960530812021277,0,6,endocardial cell differentiation,BP,
15070,GO:0060957,1,0.9928824626793,0,1,endocardial cell fate commitment,BP,
15071,GO:0060964,1,0.595354029749781,0,83,regulation of gene silencing by miRNA,BP,
15072,GO:0060965,1,0.92430712337154,0,12,negative regulation of gene silencing by miRNA,BP,
15073,GO:0060966,1,0.58183446262899,0,86,regulation of gene silencing by RNA,BP,
15074,GO:0060967,1,0.910317558850973,0,14,negative regulation of gene silencing by RNA,BP,
15075,GO:0060968,1,0.504749770718693,0,106,regulation of gene silencing,BP,
15076,GO:0060969,1,0.859366841512205,0,22,negative regulation of gene silencing,BP,
15077,GO:0060971,1,0.974385240584945,0,4,embryonic heart tube left/right pattern formation,BP,
15078,GO:0060972,1,0.870043379917505,0,21,left/right pattern formation,BP,
15079,GO:0060973,1,0.894201614222331,0,17,cell migration involved in heart development,BP,
15080,GO:0060974,1,0.992056449075187,0,2,cell migration involved in heart formation,BP,
15081,GO:0060975,1,0.995951357786099,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15082,GO:0060976,1,0.747681707309893,0,41,coronary vasculature development,BP,
15083,GO:0060977,1,0.896284703498439,0,15,coronary vasculature morphogenesis,BP,
15084,GO:0060978,1,0.978468214713784,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15085,GO:0060979,1,0.969552335165681,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15086,GO:0060980,1,0.992523571807978,0,1,cell migration involved in coronary vasculogenesis,BP,
15087,GO:0060981,1,0.992390278679806,0,1,cell migration involved in coronary angiogenesis,BP,
15088,GO:0060982,1,0.937801463786465,0,9,coronary artery morphogenesis,BP,
15089,GO:0060986,1,0.762604356746173,0,43,endocrine hormone secretion,BP,
15090,GO:0060987,1,0.993903895013174,0,1,lipid tube,CC,
15091,GO:0060988,1,0.986443852019299,0,2,lipid tube assembly,BP,
15092,GO:0060992,1,0.926081735295341,0,11,response to fungicide,BP,
15093,GO:0060993,1,0.559559218445515,0,86,kidney morphogenesis,BP,
15094,GO:0060994,1,0.987532527656835,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15095,GO:0060995,1,0.985266894973113,0,2,cell-cell signaling involved in kidney development,BP,
15103,GO:0061003,1,0.881701346510965,0,17,positive regulation of dendritic spine morphogenesis,BP,
15104,GO:0061004,1,0.947793269734336,0,9,pattern specification involved in kidney development,BP,
15105,GO:0061005,1,0.711191672149184,0,50,cell differentiation involved in kidney development,BP,
15106,GO:0061008,1,0.417826279656409,0,134,hepaticobiliary system development,BP,
15107,GO:0061009,1,0.970998291702382,0,5,common bile duct development,BP,
15108,GO:0061010,1,0.981025185189625,0,3,gall bladder development,BP,
15109,GO:0061011,1,0.99502894755974,0,1,hepatic duct development,BP,
15110,GO:0061013,1,0.347157182835242,0,169,regulation of mRNA catabolic process,BP,
15111,GO:0061014,1,0.764421361303698,0,39,positive regulation of mRNA catabolic process,BP,
15112,GO:0061015,1,0.991208007929095,0,2,snRNA import into nucleus,BP,
15113,GO:0061017,1,0.99502894755974,0,1,hepatoblast differentiation,BP,
15116,GO:0061026,1,0.991889823009446,0,1,cardiac muscle tissue regeneration,BP,
15117,GO:0061027,1,0.987255805993375,0,2,umbilical cord development,BP,
15118,GO:0061028,1,0.768270887279769,0,38,establishment of endothelial barrier,BP,
15119,GO:0061029,1,0.916071382258646,0,13,eyelid development in camera-type eye,BP,
15120,GO:0061030,1,0.981739606963632,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15121,GO:0061031,1,0.983693510277207,0,3,endodermal digestive tract morphogenesis,BP,
15122,GO:0061032,1,0.986700577136632,0,2,visceral serous pericardium development,BP,
15123,GO:0061033,1,0.989073731583288,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15124,GO:0061034,1,0.984983023536429,0,2,olfactory bulb mitral cell layer development,BP,
15125,GO:0061035,1,0.68007251286818,0,56,regulation of cartilage development,BP,
15126,GO:0061036,1,0.826771811176888,0,27,positive regulation of cartilage development,BP,
15127,GO:0061037,1,0.866454116961923,0,22,negative regulation of cartilage development,BP,
15128,GO:0061038,1,0.960546059873867,0,6,uterus morphogenesis,BP,
15129,GO:0061040,1,0.992133593536938,0,1,female gonad morphogenesis,BP,
15130,GO:0061041,1,0.495639770257504,0,108,regulation of wound healing,BP,
15131,GO:0061042,1,0.943185507529971,0,9,vascular wound healing,BP,
15132,GO:0061043,1,0.975527248455953,0,4,regulation of vascular wound healing,BP,
15133,GO:0061044,1,0.992710095381765,0,1,negative regulation of vascular wound healing,BP,
15134,GO:0061045,1,0.678977296634761,0,60,negative regulation of wound healing,BP,
15135,GO:0061046,1,0.962869055661345,0,6,regulation of branching involved in lung morphogenesis,BP,
15136,GO:0061047,1,0.974835799211253,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15137,GO:0061048,1,0.99518961421555,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15138,GO:0061049,1,0.895030785993273,0,17,cell growth involved in cardiac muscle cell development,BP,
15139,GO:0061050,1,0.932025557470354,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15140,GO:0061051,1,0.957512438726314,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15141,GO:0061052,1,0.973393825415982,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15143,GO:0061054,1,0.987122530954719,0,2,dermatome development,BP,
15145,GO:0061056,1,0.977373130644958,0,4,sclerotome development,BP,
15147,GO:0061072,1,0.941841100501159,0,9,iris morphogenesis,BP,
15148,GO:0061073,1,0.9803085229052,0,3,ciliary body morphogenesis,BP,
15149,GO:0061074,1,0.967211707283515,0,5,regulation of neural retina development,BP,
15150,GO:0061075,1,0.987970625677167,0,2,positive regulation of neural retina development,BP,
15151,GO:0061076,1,0.992727777758575,0,1,negative regulation of neural retina development,BP,
15152,GO:0061077,1,0.642559494978818,0,71,chaperone-mediated protein folding,BP,
15153,GO:0061078,1,0.996610217817555,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15154,GO:0061081,1,0.935763549491429,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15156,GO:0061083,1,0.97327320396755,0,4,regulation of protein refolding,BP,
15157,GO:0061084,1,0.97327320396755,0,4,negative regulation of protein refolding,BP,
15158,GO:0061085,1,0.940304671775573,0,9,regulation of histone H3-K27 methylation,BP,
15159,GO:0061086,1,0.973802603160247,0,4,negative regulation of histone H3-K27 methylation,BP,
15160,GO:0061087,1,0.959502544044668,0,6,positive regulation of histone H3-K27 methylation,BP,
15162,GO:0061090,1,0.993745114306319,0,1,positive regulation of sequestering of zinc ion,BP,
15163,GO:0061091,1,0.977294867568196,0,3,regulation of phospholipid translocation,BP,
15164,GO:0061092,1,0.977294867568196,0,3,positive regulation of phospholipid translocation,BP,
15167,GO:0061099,1,0.856508251760872,0,24,negative regulation of protein tyrosine kinase activity,BP,
15168,GO:0061100,1,0.993608490836106,0,1,lung neuroendocrine cell differentiation,BP,
15169,GO:0061101,1,0.954665325191142,0,8,neuroendocrine cell differentiation,BP,
15170,GO:0061102,1,0.989175009825242,0,2,stomach neuroendocrine cell differentiation,BP,
15171,GO:0061103,1,0.993608490836106,0,1,carotid body glomus cell differentiation,BP,
15172,GO:0061104,1,0.98669737981628,0,2,adrenal chromaffin cell differentiation,BP,
15173,GO:0061105,1,0.995538291756773,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15174,GO:0061106,1,0.995538291756773,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15175,GO:0061107,1,0.981916129353317,0,3,seminal vesicle development,BP,
15176,GO:0061108,1,0.994023062010398,0,1,seminal vesicle epithelium development,BP,
15178,GO:0061113,1,0.977909026859115,0,3,pancreas morphogenesis,BP,
15179,GO:0061114,1,0.992780976418393,0,1,branching involved in pancreas morphogenesis,BP,
15180,GO:0061115,1,0.996546189543489,0,1,lung proximal/distal axis specification,BP,
15181,GO:0061117,1,0.896889691700199,0,16,negative regulation of heart growth,BP,
15182,GO:0061133,1,0.970691832424365,0,6,endopeptidase activator activity,MF,
15183,GO:0061134,1,0.384874582628197,0,159,peptidase regulator activity,MF,
15184,GO:0061135,1,0.475779868800163,0,126,endopeptidase regulator activity,MF,
15185,GO:0061136,1,0.343645731387125,0,165,regulation of proteasomal protein catabolic process,BP,
15186,GO:0061138,1,0.308772411968044,0,172,morphogenesis of a branching epithelium,BP,
15187,GO:0061140,1,0.952105925129831,0,9,lung secretory cell differentiation,BP,
15188,GO:0061141,1,0.981404640710514,0,3,lung ciliated cell differentiation,BP,
15189,GO:0061143,1,0.993011391587234,0,1,alveolar primary septum development,BP,
15190,GO:0061145,1,0.985048685221598,0,2,lung smooth muscle development,BP,
15191,GO:0061146,1,0.980241196500945,0,3,Peyer's patch morphogenesis,BP,
15192,GO:0061149,1,0.99497902520046,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15193,GO:0061150,1,0.99497902520046,0,1,renal system segmentation,BP,
15194,GO:0061151,1,0.99497902520046,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15195,GO:0061152,1,0.988500650232241,0,2,trachea submucosa development,BP,
15196,GO:0061153,1,0.988500650232241,0,2,trachea gland development,BP,
15197,GO:0061154,1,0.90843775406454,0,15,endothelial tube morphogenesis,BP,
15198,GO:0061155,1,0.99497902520046,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15199,GO:0061156,1,0.958443399134682,0,6,pulmonary artery morphogenesis,BP,
15200,GO:0061157,1,0.855692157637192,0,22,mRNA destabilization,BP,
15201,GO:0061158,1,0.917375142726883,0,12,3'-UTR-mediated mRNA destabilization,BP,
15202,GO:0061162,1,0.877345289563769,0,19,establishment of monopolar cell polarity,BP,
15204,GO:0061179,1,0.951751608958788,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15205,GO:0061180,1,0.646679102898236,0,64,mammary gland epithelium development,BP,
15206,GO:0061181,1,0.992493879782616,0,1,regulation of chondrocyte development,BP,
15207,GO:0061183,1,0.987122530954719,0,2,regulation of dermatome development,BP,
15208,GO:0061184,1,0.992502895160612,0,1,positive regulation of dermatome development,BP,
15209,GO:0061185,1,0.994579409117975,0,1,negative regulation of dermatome development,BP,
15210,GO:0061187,1,0.984839472190621,0,2,regulation of chromatin silencing at rDNA,BP,
15211,GO:0061188,1,0.984839472190621,0,2,negative regulation of chromatin silencing at rDNA,BP,
15212,GO:0061189,1,0.995345054077821,0,1,positive regulation of sclerotome development,BP,
15213,GO:0061190,1,0.995345054077821,0,1,regulation of sclerotome development,BP,
15214,GO:0061193,1,0.996151239358703,0,1,taste bud development,BP,
15215,GO:0061196,1,0.959530588243976,0,6,fungiform papilla development,BP,
15216,GO:0061197,1,0.965318849503237,0,5,fungiform papilla morphogenesis,BP,
15217,GO:0061198,1,0.979379748267303,0,3,fungiform papilla formation,BP,
15220,GO:0061205,1,0.985566150677189,0,2,paramesonephric duct development,BP,
15221,GO:0061209,1,0.974676750776898,0,4,cell proliferation involved in mesonephros development,BP,
15222,GO:0061213,1,0.876055770924259,0,20,positive regulation of mesonephros development,BP,
15223,GO:0061216,1,0.99497902520046,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15224,GO:0061217,1,0.861790183275084,0,23,regulation of mesonephros development,BP,
15225,GO:0061218,1,0.968328914603378,0,5,negative regulation of mesonephros development,BP,
15226,GO:0061227,1,0.989777319609514,0,2,pattern specification involved in mesonephros development,BP,
15227,GO:0061245,1,0.738872699600451,0,45,establishment or maintenance of bipolar cell polarity,BP,
15228,GO:0061289,1,0.985266894973113,0,2,Wnt signaling pathway involved in kidney development,BP,
15229,GO:0061290,1,0.985266894973113,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15230,GO:0061298,1,0.891498676027346,0,16,retina vasculature development in camera-type eye,BP,
15231,GO:0061299,1,0.939011927217752,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15232,GO:0061300,1,0.987716167226108,0,2,cerebellum vasculature development,BP,
15233,GO:0061301,1,0.992248779261604,0,1,cerebellum vasculature morphogenesis,BP,
15234,GO:0061302,1,0.970241183068608,0,5,smooth muscle cell-matrix adhesion,BP,
15235,GO:0061303,1,0.953080053289228,0,8,cornea development in camera-type eye,BP,
15236,GO:0061304,1,0.969789382737118,0,4,retinal blood vessel morphogenesis,BP,
15237,GO:0061307,1,0.936211187598798,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15238,GO:0061308,1,0.936211187598798,0,11,cardiac neural crest cell development involved in heart development,BP,
15239,GO:0061309,1,0.948212162011791,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15240,GO:0061311,1,0.856002572474588,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15241,GO:0061312,1,0.964526254871373,0,6,BMP signaling pathway involved in heart development,BP,
15242,GO:0061314,1,0.939985621320608,0,9,Notch signaling involved in heart development,BP,
15243,GO:0061316,1,0.981461348424767,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15244,GO:0061317,1,0.988802257413596,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15245,GO:0061318,1,0.901037484403521,0,15,renal filtration cell differentiation,BP,
15246,GO:0061323,1,0.906649003827462,0,15,cell proliferation involved in heart morphogenesis,BP,
15247,GO:0061324,1,0.992576808374421,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15248,GO:0061325,1,0.975670926414364,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15249,GO:0061326,1,0.556107130191952,0,87,renal tubule development,BP,
15250,GO:0061333,1,0.61784186427834,0,72,renal tubule morphogenesis,BP,
15252,GO:0061339,1,0.877345289563769,0,19,establishment or maintenance of monopolar cell polarity,BP,
15253,GO:0061341,1,0.984861314461197,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15254,GO:0061343,1,0.970388131656122,0,4,cell adhesion involved in heart morphogenesis,BP,
15255,GO:0061346,1,0.984861314461197,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15256,GO:0061347,1,0.992381002025962,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15257,GO:0061348,1,0.992381002025962,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15258,GO:0061349,1,0.992381002025962,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15259,GO:0061350,1,0.992381002025962,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15261,GO:0061354,1,0.992381002025962,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15262,GO:0061355,1,0.973844846767586,0,4,Wnt protein secretion,BP,
15263,GO:0061356,1,0.973844846767586,0,4,regulation of Wnt protein secretion,BP,
15264,GO:0061357,1,0.97891379638846,0,3,positive regulation of Wnt protein secretion,BP,
15265,GO:0061358,1,0.994822986656738,0,1,negative regulation of Wnt protein secretion,BP,
15266,GO:0061360,1,0.992497689872966,0,1,optic chiasma development,BP,
15267,GO:0061364,1,0.977415486148333,0,3,apoptotic process involved in luteolysis,BP,
15268,GO:0061365,1,0.964705979998483,0,7,positive regulation of triglyceride lipase activity,BP,
15269,GO:0061366,1,0.981450114009345,0,3,behavioral response to chemical pain,BP,
15270,GO:0061368,1,0.981450114009345,0,3,behavioral response to formalin induced pain,BP,
15271,GO:0061369,1,0.992502895160612,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15272,GO:0061370,1,0.96665759431732,0,6,testosterone biosynthetic process,BP,
15273,GO:0061371,1,0.678190422854747,0,58,determination of heart left/right asymmetry,BP,
15274,GO:0061373,1,0.992101486545164,0,1,mammillary axonal complex development,BP,
15275,GO:0061377,1,0.894972887826437,0,17,mammary gland lobule development,BP,
15276,GO:0061383,1,0.729097404030633,0,46,trabecula morphogenesis,BP,
15277,GO:0061384,1,0.810830234962422,0,31,heart trabecula morphogenesis,BP,
15278,GO:0061386,1,0.984546680420789,0,2,closure of optic fissure,BP,
15279,GO:0061387,1,0.516205387048257,0,96,regulation of extent of cell growth,BP,
15280,GO:0061394,1,0.989589622376218,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15281,GO:0061395,1,0.995098748559185,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15282,GO:0061400,1,0.9930956730518,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15283,GO:0061402,1,0.986916733527604,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15284,GO:0061408,1,0.981042987209093,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15285,GO:0061418,1,0.660685923460533,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15286,GO:0061419,1,0.964634612886927,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15287,GO:0061428,1,0.975113241858881,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15288,GO:0061430,1,0.910928417209471,0,13,bone trabecula morphogenesis,BP,
15289,GO:0061433,1,0.994661592279131,0,1,cellular response to caloric restriction,BP,
15290,GO:0061436,1,0.901304273569352,0,16,establishment of skin barrier,BP,
15291,GO:0061437,1,0.857336151215103,0,23,renal system vasculature development,BP,
15292,GO:0061438,1,0.958628964905518,0,6,renal system vasculature morphogenesis,BP,
15293,GO:0061439,1,0.958628964905518,0,6,kidney vasculature morphogenesis,BP,
15294,GO:0061440,1,0.857336151215103,0,23,kidney vasculature development,BP,
15295,GO:0061441,1,0.98608180270956,0,2,renal artery morphogenesis,BP,
15296,GO:0061443,1,0.98530232057578,0,2,endocardial cushion cell differentiation,BP,
15297,GO:0061444,1,0.992366073052242,0,1,endocardial cushion cell development,BP,
15298,GO:0061445,1,0.9928824626793,0,1,endocardial cushion cell fate commitment,BP,
15300,GO:0061450,1,0.943970700138862,0,10,trophoblast cell migration,BP,
15302,GO:0061459,1,0.992232774627354,0,1,L-arginine transmembrane transporter activity,MF,
15305,GO:0061470,1,0.97227580263599,0,4,T follicular helper cell differentiation,BP,
15306,GO:0061474,1,0.993480851959303,0,1,phagolysosome membrane,CC,
15307,GO:0061476,1,0.963469357002953,0,5,response to anticoagulant,BP,
15309,GO:0061481,1,0.996324673417562,0,1,response to TNF agonist,BP,
15310,GO:0061484,1,0.97181660903105,0,4,hematopoietic stem cell homeostasis,BP,
15311,GO:0061485,1,0.992239049434494,0,1,memory T cell proliferation,BP,
15312,GO:0061495,1,0.9930956730518,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15313,GO:0061502,1,0.972175925626593,0,4,early endosome to recycling endosome transport,BP,
15314,GO:0061505,1,0.984881444594139,0,2,DNA topoisomerase II activity,MF,
15315,GO:0061507,1,0.995147621146568,0,1,cyclic-GMP-AMP binding,MF,
15316,GO:0061508,1,0.9930956730518,0,1,CDP phosphorylation,BP,
15317,GO:0061511,1,0.973875702436829,0,4,centriole elongation,BP,
15318,GO:0061512,1,0.807012511903174,0,33,protein localization to cilium,BP,
15319,GO:0061513,1,0.979718360158011,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15320,GO:0061515,1,0.659558316002938,0,62,myeloid cell development,BP,
15321,GO:0061517,1,0.986366383647895,0,2,macrophage proliferation,BP,
15322,GO:0061518,1,0.986366383647895,0,2,microglial cell proliferation,BP,
15323,GO:0061519,1,0.992532939904111,0,1,macrophage homeostasis,BP,
15324,GO:0061523,1,0.992522555202321,0,1,cilium disassembly,BP,
15325,GO:0061525,1,0.945382612588476,0,8,hindgut development,BP,
15326,GO:0061526,1,0.973986657068316,0,4,acetylcholine secretion,BP,
15327,GO:0061528,1,0.992456603639031,0,1,aspartate secretion,BP,
15328,GO:0061534,1,0.991853636887597,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15329,GO:0061535,1,0.97698754889295,0,3,glutamate secretion, neurotransmission,BP,
15330,GO:0061536,1,0.992672739688804,0,1,glycine secretion,BP,
15331,GO:0061537,1,0.992672739688804,0,1,glycine secretion, neurotransmission,BP,
15332,GO:0061542,1,0.995807011225709,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15333,GO:0061547,1,0.985348874451515,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15334,GO:0061548,1,0.917701961160853,0,12,ganglion development,BP,
15335,GO:0061549,1,0.944086303270752,0,8,sympathetic ganglion development,BP,
15336,GO:0061550,1,0.964660412819915,0,5,cranial ganglion development,BP,
15337,GO:0061551,1,0.971876932468399,0,4,trigeminal ganglion development,BP,
15338,GO:0061552,1,0.993588067364596,0,1,ganglion morphogenesis,BP,
15340,GO:0061565,1,0.9930956730518,0,1,dAMP phosphorylation,BP,
15341,GO:0061566,1,0.9930956730518,0,1,CMP phosphorylation,BP,
15342,GO:0061567,1,0.9930956730518,0,1,dCMP phosphorylation,BP,
15343,GO:0061568,1,0.9930956730518,0,1,GDP phosphorylation,BP,
15344,GO:0061569,1,0.9930956730518,0,1,UDP phosphorylation,BP,
15345,GO:0061570,1,0.9930956730518,0,1,dCDP phosphorylation,BP,
15346,GO:0061571,1,0.9930956730518,0,1,TDP phosphorylation,BP,
15347,GO:0061572,1,0.387092110667184,0,139,actin filament bundle organization,BP,
15348,GO:0061574,1,0.9811266756219,0,3,ASAP complex,CC,
15349,GO:0061575,1,0.982989519482569,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15350,GO:0061577,1,0.926798333112188,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15351,GO:0061578,1,0.933650667630328,0,10,Lys63-specific deubiquitinase activity,MF,
15352,GO:0061580,1,0.992497395916573,0,1,colon epithelial cell migration,BP,
15353,GO:0061582,1,0.984895614142017,0,2,intestinal epithelial cell migration,BP,
15354,GO:0061588,1,0.964328984871758,0,5,calcium activated phospholipid scrambling,BP,
15355,GO:0061589,1,0.971745054295367,0,4,calcium activated phosphatidylserine scrambling,BP,
15356,GO:0061590,1,0.964328984871758,0,5,calcium activated phosphatidylcholine scrambling,BP,
15357,GO:0061591,1,0.964328984871758,0,5,calcium activated galactosylceramide scrambling,BP,
15358,GO:0061598,1,0.99249272490571,0,1,molybdopterin adenylyltransferase activity,MF,
15359,GO:0061599,1,0.99249272490571,0,1,molybdopterin molybdotransferase activity,MF,
15360,GO:0061604,1,0.993645945930351,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15361,GO:0061605,1,0.993645945930351,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15362,GO:0061608,1,0.945823467842085,0,9,nuclear import signal receptor activity,MF,
15363,GO:0061609,1,0.993691410422094,0,1,fructose-1-phosphate aldolase activity,MF,
15364,GO:0061611,1,0.994995753572652,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15365,GO:0061614,1,0.770531756293985,0,37,pri-miRNA transcription by RNA polymerase II,BP,
15366,GO:0061615,1,0.860787752033326,0,25,glycolytic process through fructose-6-phosphate,BP,
15367,GO:0061617,1,0.956015621989339,0,8,MICOS complex,CC,
15368,GO:0061618,1,0.991923324231181,0,1,sublamina densa,CC,
15369,GO:0061620,1,0.860787752033326,0,25,glycolytic process through glucose-6-phosphate,BP,
15370,GO:0061621,1,0.864536250501398,0,24,canonical glycolysis,BP,
15371,GO:0061622,1,0.988378950127028,0,2,glycolytic process through glucose-1-phosphate,BP,
15372,GO:0061623,1,0.995670583484006,0,1,glycolytic process from galactose,BP,
15373,GO:0061624,1,0.974654948760416,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15374,GO:0061626,1,0.958951244039489,0,7,pharyngeal arch artery morphogenesis,BP,
15375,GO:0061627,1,0.994567317597039,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15376,GO:0061628,1,0.97840406306156,0,3,H3K27me3 modified histone binding,MF,
15377,GO:0061629,1,0.970903677886508,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15379,GO:0061631,1,0.848849528361748,0,27,ubiquitin conjugating enzyme activity,MF,
15380,GO:0061635,1,0.957522249185781,0,7,regulation of protein complex stability,BP,
15381,GO:0061640,1,0.598249709630078,0,77,cytoskeleton-dependent cytokinesis,BP,
15382,GO:0061641,1,0.845526477514217,0,30,CENP-A containing chromatin organization,BP,
15383,GO:0061642,1,0.992381002025962,0,1,chemoattraction of axon,BP,
15384,GO:0061643,1,0.97802396555911,0,3,chemorepulsion of axon,BP,
15385,GO:0061645,1,0.950711321988714,0,7,endocytic patch,CC,
15386,GO:0061646,1,0.992454674590059,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15387,GO:0061647,1,0.754404012622463,0,40,histone H3-K9 modification,BP,
15388,GO:0061649,1,0.979229468873129,0,3,ubiquitin modification-dependent histone binding,MF,
15389,GO:0061650,1,0.845358474628689,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15390,GO:0061656,1,0.995894182048718,0,1,SUMO conjugating enzyme activity,MF,
15392,GO:0061663,1,0.992249619450988,0,1,NEDD8 ligase activity,MF,
15393,GO:0061665,1,0.969077595107046,0,5,SUMO ligase activity,MF,
15394,GO:0061668,1,0.960708422768892,0,6,mitochondrial ribosome assembly,BP,
15395,GO:0061669,1,0.977100413650987,0,3,spontaneous neurotransmitter secretion,BP,
15396,GO:0061670,1,0.995462384203392,0,1,evoked neurotransmitter secretion,BP,
15397,GO:0061673,1,0.96576346383072,0,5,mitotic spindle astral microtubule,CC,
15398,GO:0061676,1,0.959292415003868,0,6,importin-alpha family protein binding,MF,
15399,GO:0061682,1,0.99386427156966,0,1,seminal vesicle morphogenesis,BP,
15401,GO:0061685,1,0.9930956730518,0,1,diphthine methylesterase activity,MF,
15402,GO:0061687,1,0.947149256408112,0,13,detoxification of inorganic compound,BP,
15403,GO:0061689,1,0.974063105907226,0,4,tricellular tight junction,CC,
15404,GO:0061690,1,0.995935907200946,0,1,lipoamidase activity,MF,
15405,GO:0061695,1,0.194986499703548,0,251,transferase complex, transferring phosphorus-containing groups,CC,
15406,GO:0061697,1,0.992717755137753,0,1,protein-glutaryllysine deglutarylase activity,MF,
15407,GO:0061698,1,0.992717755137753,0,1,protein deglutarylation,BP,
15408,GO:0061699,1,0.992717755137753,0,1,peptidyl-lysine deglutarylation,BP,
15409,GO:0061700,1,0.941499550619897,0,9,GATOR2 complex,CC,
15410,GO:0061702,1,0.931736335565632,0,12,inflammasome complex,CC,
15411,GO:0061709,1,0.992308007089362,0,1,reticulophagy,BP,
15412,GO:0061711,1,0.989314705540533,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15413,GO:0061712,1,0.992639187713331,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15414,GO:0061713,1,0.996089420284806,0,1,anterior neural tube closure,BP,
15415,GO:0061714,1,0.992101995727654,0,2,folic acid receptor activity,MF,
15416,GO:0061718,1,0.864536250501398,0,24,glucose catabolic process to pyruvate,BP,
15417,GO:0061723,1,0.986011687916189,0,2,glycophagy,BP,
15418,GO:0061724,1,0.960598414714058,0,6,lipophagy,BP,
15419,GO:0061726,1,0.598999861290648,0,80,mitochondrion disassembly,BP,
15420,GO:0061727,1,0.988246186604704,0,2,methylglyoxal catabolic process to lactate,BP,
15421,GO:0061731,1,0.977905378228213,0,3,ribonucleoside-diphosphate reductase activity,MF,
15422,GO:0061732,1,0.960659759850321,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15423,GO:0061733,1,0.698791140530364,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15424,GO:0061734,1,0.962341474349727,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15425,GO:0061736,1,0.992391983437997,0,1,engulfment of target by autophagosome,BP,
15426,GO:0061737,1,0.972847314759375,0,5,leukotriene signaling pathway,BP,
15427,GO:0061738,1,0.981380310585589,0,3,late endosomal microautophagy,BP,
15428,GO:0061739,1,0.977897299315417,0,3,protein lipidation involved in autophagosome assembly,BP,
15429,GO:0061740,1,0.980129513296738,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15430,GO:0061741,1,0.987538411258731,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15431,GO:0061743,1,0.976074612680837,0,4,motor learning,BP,
15432,GO:0061744,1,0.971500458406818,0,5,motor behavior,BP,
15433,GO:0061749,1,0.984923262478586,0,2,forked DNA-dependent helicase activity,MF,
15434,GO:0061750,1,0.993893966305661,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15435,GO:0061752,1,0.98765483890448,0,2,telomeric repeat-containing RNA binding,MF,
15436,GO:0061753,1,0.992391983437997,0,1,substrate localization to autophagosome,BP,
15438,GO:0061757,1,0.988137190993277,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15439,GO:0061760,1,0.989371506921023,0,2,antifungal innate immune response,BP,
15440,GO:0061762,1,0.977126551979217,0,3,CAMKK-AMPK signaling cascade,BP,
15441,GO:0061763,1,0.986477127524537,0,2,multivesicular body-lysosome fusion,BP,
15442,GO:0061767,1,0.992374751668866,0,1,negative regulation of lung blood pressure,BP,
15443,GO:0061768,1,0.992460652976252,0,1,magnesium:sodium antiporter activity,MF,
15444,GO:0061769,1,0.986238532970005,0,2,ribosylnicotinate kinase activity,MF,
15445,GO:0061770,1,0.994231345668807,0,1,translation elongation factor binding,MF,
15446,GO:0061771,1,0.983106958765949,0,3,response to caloric restriction,BP,
15447,GO:0061772,1,0.992579584433495,0,1,drug transport across blood-nerve barrier,BP,
15448,GO:0061778,1,0.879273808102038,0,18,intracellular chloride channel activity,MF,
15449,GO:0061780,1,0.992024061958175,0,1,mitotic cohesin loading,BP,
15451,GO:0061783,1,0.984333700464232,0,4,peptidoglycan muralytic activity,MF,
15454,GO:0061798,1,0.992496223623435,0,1,GTP 3',8'-cyclase activity,MF,
15455,GO:0061799,1,0.992496223623435,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15456,GO:0061809,1,0.990984099760303,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15457,GO:0061811,1,0.995490529173201,0,1,ADP-ribosyl cyclase activity,MF,
15458,GO:0061812,1,0.995490529173201,0,1,cyclic ADP-ribose hydrolase,MF,
15459,GO:0061817,1,0.977517336293807,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15460,GO:0061819,1,0.979386870307773,0,3,telomeric DNA-containing double minutes formation,BP,
15461,GO:0061820,1,0.943361743505271,0,8,telomeric D-loop disassembly,BP,
15462,GO:0061821,1,0.970206007915799,0,4,telomeric D-loop binding,MF,
15463,GO:0061825,1,0.992502055555348,0,1,podosome core,CC,
15464,GO:0061827,1,0.969543452820834,0,5,sperm head,CC,
15465,GO:0061828,1,0.992225886861261,0,1,apical tubulobulbar complex,CC,
15466,GO:0061829,1,0.992225886861261,0,1,basal tubulobulbar complex,CC,
15467,GO:0061832,1,0.992210953231584,0,1,basal ectoplasmic specialization,CC,
15468,GO:0061833,1,0.986634707259529,0,2,protein localization to tricellular tight junction,BP,
15469,GO:0061842,1,0.843054077856077,0,24,microtubule organizing center localization,BP,
15470,GO:0061844,1,0.879297469099023,0,30,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15471,GO:0061845,1,0.992652011336942,0,1,neuron projection branch point,CC,
15472,GO:0061846,1,0.992652011336942,0,1,dendritic spine cytoplasm,CC,
15473,GO:0061847,1,0.993929777044837,0,1,response to cholecystokinin,BP,
15474,GO:0061849,1,0.984923262478586,0,2,telomeric G-quadruplex DNA binding,MF,
15475,GO:0061850,1,0.996275403119693,0,1,growth cone leading edge,CC,
15476,GO:0061851,1,0.99318946031378,0,1,leading edge of lamellipodium,CC,
15477,GO:0061853,1,0.992449848111986,0,1,regulation of neuroblast migration,BP,
15478,GO:0061855,1,0.992449848111986,0,1,negative regulation of neuroblast migration,BP,
15479,GO:0061857,1,0.98565103827236,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15480,GO:0061880,1,0.995126394850076,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15481,GO:0061881,1,0.995126394850076,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15482,GO:0061884,1,0.994480273921555,0,1,regulation of mini excitatory postsynaptic potential,BP,
15483,GO:0061885,1,0.994480273921555,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15484,GO:0061888,1,0.973227690855328,0,4,regulation of astrocyte activation,BP,
15485,GO:0061889,1,0.99242919076223,0,1,negative regulation of astrocyte activation,BP,
15486,GO:0061890,1,0.980653505261611,0,3,positive regulation of astrocyte activation,BP,
15487,GO:0061896,1,0.992471829330535,0,1,all-trans retinol 3,4-desaturase activity,MF,
15488,GO:0061897,1,0.992471829330535,0,1,all-trans retinal 3,4-desaturase activity,MF,
15489,GO:0061898,1,0.992471829330535,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15490,GO:0061899,1,0.992471829330535,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15491,GO:0061900,1,0.813331340918201,0,31,glial cell activation,BP,
15492,GO:0061901,1,0.994641624541702,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15493,GO:0061903,1,0.994641624541702,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15494,GO:0061912,1,0.758549014580569,0,40,selective autophagy,BP,
15496,GO:0061920,1,0.992132784581788,0,1,protein propionyltransferase activity,MF,
15497,GO:0061921,1,0.992132784581788,0,1,peptidyl-lysine propionylation,BP,
15498,GO:0061930,1,0.99243882233873,0,1,regulation of erythrocyte enucleation,BP,
15499,GO:0061931,1,0.99243882233873,0,1,positive regulation of erythrocyte enucleation,BP,
15500,GO:0061944,1,0.992490006418094,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15501,GO:0061945,1,0.980617216122819,0,3,regulation of protein K48-linked ubiquitination,BP,
15502,GO:0061951,1,0.77356621280635,0,39,establishment of protein localization to plasma membrane,BP,
15503,GO:0061953,1,0.980745549264334,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15504,GO:0061971,1,0.724167032762358,0,47,replacement bone morphogenesis,BP,
15505,GO:0061980,1,0.812981869422281,0,30,regulatory RNA binding,MF,
15506,GO:0061981,1,0.995485080421186,0,1,3-hydroxykynureninase activity,MF,
15507,GO:0061982,1,0.529090199235301,0,98,meiosis I cell cycle process,BP,
15508,GO:0061983,1,0.950582277888408,0,8,meiosis II cell cycle process,BP,
15509,GO:0061986,1,0.993723935190214,0,1,negative regulation of transcription by glucose,BP,
15510,GO:0061987,1,0.993723935190214,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15511,GO:0062009,1,0.931616978894563,0,10,secondary palate development,BP,
15515,GO:0065001,1,0.974707558731427,0,4,specification of axis polarity,BP,
15516,GO:0065002,1,0.75104020619275,0,49,intracellular protein transmembrane transport,BP,
15518,GO:0065004,1,0.313525398654217,0,192,protein-DNA complex assembly,BP,
15519,GO:0065005,1,0.862400725780255,0,24,protein-lipid complex assembly,BP,
15520,GO:0065006,1,0.991819732858453,0,2,protein-carbohydrate complex assembly,BP,
15524,GO:0065010,1,0.971009586477587,0,5,extracellular membrane-bounded organelle,CC,
15525,GO:0070001,1,0.895474454561202,0,18,aspartic-type peptidase activity,MF,
15526,GO:0070003,1,0.929019818125167,0,18,threonine-type peptidase activity,MF,
15527,GO:0070004,1,0.9930956730518,0,1,cysteine-type exopeptidase activity,MF,
15528,GO:0070006,1,0.873636950170278,0,19,metalloaminopeptidase activity,MF,
15529,GO:0070008,1,0.92513986793164,0,12,serine-type exopeptidase activity,MF,
15531,GO:0070012,1,0.986816191288453,0,2,oligopeptidase activity,MF,
15533,GO:0070016,1,0.928054424023764,0,10,armadillo repeat domain binding,MF,
15534,GO:0070022,1,0.970345584769647,0,4,transforming growth factor beta receptor complex,CC,
15535,GO:0070025,1,0.993379716894051,0,1,carbon monoxide binding,MF,
15536,GO:0070026,1,0.989596555779161,0,2,nitric oxide binding,MF,
15538,GO:0070033,1,0.981165350903789,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15539,GO:0070034,1,0.870105292130377,0,22,telomerase RNA binding,MF,
15540,GO:0070035,1,0.526438098840757,0,91,purine NTP-dependent helicase activity,MF,
15541,GO:0070037,1,0.996084591931523,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15542,GO:0070039,1,0.992438901033039,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15543,GO:0070042,1,0.992809607986288,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15544,GO:0070044,1,0.976149419495262,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15546,GO:0070051,1,0.978550790450114,0,3,fibrinogen binding,MF,
15547,GO:0070052,1,0.985144702369065,0,2,collagen V binding,MF,
15548,GO:0070053,1,0.980328924697972,0,3,thrombospondin receptor activity,MF,
15549,GO:0070054,1,0.979126406627516,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15550,GO:0070055,1,0.979126406627516,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15551,GO:0070059,1,0.710539366820563,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15552,GO:0070060,1,0.992104849801275,0,1,'de novo' actin filament nucleation,BP,
15553,GO:0070061,1,0.968770105948977,0,5,fructose binding,MF,
15555,GO:0070063,1,0.697643930222442,0,54,RNA polymerase binding,MF,
15556,GO:0070064,1,0.881663655565746,0,18,proline-rich region binding,MF,
15557,GO:0070069,1,0.892766074940759,0,25,cytochrome complex,CC,
15558,GO:0070070,1,0.931305897404917,0,10,proton-transporting V-type ATPase complex assembly,BP,
15559,GO:0070071,1,0.910357578959346,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15560,GO:0070072,1,0.931305897404917,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15561,GO:0070075,1,0.996546189543489,0,1,tear secretion,BP,
15562,GO:0070076,1,0.829100292219565,0,25,histone lysine demethylation,BP,
15563,GO:0070077,1,0.992527806493065,0,1,histone arginine demethylation,BP,
15564,GO:0070078,1,0.992527806493065,0,1,histone H3-R2 demethylation,BP,
15565,GO:0070079,1,0.992527806493065,0,1,histone H4-R3 demethylation,BP,
15566,GO:0070080,1,0.988700336539151,0,2,titin Z domain binding,MF,
15570,GO:0070086,1,0.976796429738789,0,4,ubiquitin-dependent endocytosis,BP,
15571,GO:0070087,1,0.955282502730381,0,6,chromo shadow domain binding,MF,
15572,GO:0070091,1,0.959605702398062,0,7,glucagon secretion,BP,
15573,GO:0070092,1,0.963539349765939,0,6,regulation of glucagon secretion,BP,
15574,GO:0070093,1,0.984688661239851,0,3,negative regulation of glucagon secretion,BP,
15575,GO:0070094,1,0.993410615469886,0,1,positive regulation of glucagon secretion,BP,
15576,GO:0070095,1,0.982010316746475,0,3,fructose-6-phosphate binding,MF,
15577,GO:0070096,1,0.992592558685411,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15578,GO:0070097,1,0.955971101948625,0,6,delta-catenin binding,MF,
15579,GO:0070098,1,0.705474360191649,0,63,chemokine-mediated signaling pathway,BP,
15580,GO:0070099,1,0.953481844603394,0,7,regulation of chemokine-mediated signaling pathway,BP,
15581,GO:0070100,1,0.969943746314358,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15582,GO:0070101,1,0.983033222003239,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15583,GO:0070102,1,0.888437836486025,0,17,interleukin-6-mediated signaling pathway,BP,
15584,GO:0070103,1,0.984023335559533,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15585,GO:0070104,1,0.99512284213113,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15586,GO:0070105,1,0.988846648208002,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15587,GO:0070106,1,0.929489836449334,0,11,interleukin-27-mediated signaling pathway,BP,
15588,GO:0070110,1,0.979898976945659,0,3,ciliary neurotrophic factor receptor complex,CC,
15589,GO:0070119,1,0.992497107157267,0,1,ciliary neurotrophic factor binding,MF,
15590,GO:0070120,1,0.967001714386757,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15591,GO:0070121,1,0.992405804698064,0,1,Kupffer's vesicle development,BP,
15592,GO:0070122,1,0.965510606468781,0,5,isopeptidase activity,MF,
15593,GO:0070123,1,0.992329688359495,0,1,transforming growth factor beta receptor activity, type III,MF,
15594,GO:0070124,1,0.989255329847268,0,2,mitochondrial translational initiation,BP,
15595,GO:0070125,1,0.683434213150242,0,84,mitochondrial translational elongation,BP,
15596,GO:0070126,1,0.675352477862916,0,86,mitochondrial translational termination,BP,
15597,GO:0070127,1,0.948264940910148,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15598,GO:0070129,1,0.895342052653975,0,18,regulation of mitochondrial translation,BP,
15599,GO:0070130,1,0.9930956730518,0,1,negative regulation of mitochondrial translation,BP,
15600,GO:0070131,1,0.934557193991271,0,11,positive regulation of mitochondrial translation,BP,
15601,GO:0070137,1,0.970138642235649,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15602,GO:0070138,1,0.97781833590734,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15603,GO:0070139,1,0.970138642235649,0,4,SUMO-specific endopeptidase activity,MF,
15604,GO:0070140,1,0.97781833590734,0,3,SUMO-specific isopeptidase activity,MF,
15605,GO:0070141,1,0.959972674605533,0,6,response to UV-A,BP,
15607,GO:0070143,1,0.992464764904577,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15608,GO:0070145,1,0.992601845650791,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15609,GO:0070150,1,0.988474024779937,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15610,GO:0070159,1,0.993779985512948,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15611,GO:0070160,1,0.469119888916502,0,110,occluding junction,CC,
15612,GO:0070161,1,0.0294922293033487,0,522,anchoring junction,CC,
15613,GO:0070162,1,0.959078044165891,0,6,adiponectin secretion,BP,
15614,GO:0070163,1,0.959078044165891,0,6,regulation of adiponectin secretion,BP,
15615,GO:0070164,1,0.97302677907737,0,4,negative regulation of adiponectin secretion,BP,
15616,GO:0070165,1,0.985668561510728,0,2,positive regulation of adiponectin secretion,BP,
15617,GO:0070166,1,0.938547522729606,0,9,enamel mineralization,BP,
15618,GO:0070167,1,0.657909177636136,0,63,regulation of biomineral tissue development,BP,
15619,GO:0070168,1,0.919655169569169,0,13,negative regulation of biomineral tissue development,BP,
15620,GO:0070169,1,0.788869810592274,0,35,positive regulation of biomineral tissue development,BP,
15621,GO:0070170,1,0.973962021048127,0,4,regulation of tooth mineralization,BP,
15622,GO:0070171,1,0.9859970119983,0,2,negative regulation of tooth mineralization,BP,
15623,GO:0070172,1,0.987795835173588,0,2,positive regulation of tooth mineralization,BP,
15624,GO:0070176,1,0.994949078231444,0,1,DRM complex,CC,
15625,GO:0070178,1,0.988927449089971,0,2,D-serine metabolic process,BP,
15626,GO:0070179,1,0.993597334811366,0,1,D-serine biosynthetic process,BP,
15627,GO:0070180,1,0.996592916727176,0,1,large ribosomal subunit rRNA binding,MF,
15628,GO:0070181,1,0.960016256388405,0,8,small ribosomal subunit rRNA binding,MF,
15629,GO:0070182,1,0.898403801928884,0,16,DNA polymerase binding,MF,
15630,GO:0070183,1,0.993048181673611,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15631,GO:0070184,1,0.994231345668807,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15632,GO:0070187,1,0.962235511933655,0,6,shelterin complex,CC,
15633,GO:0070189,1,0.961921290007237,0,7,kynurenine metabolic process,BP,
15634,GO:0070191,1,0.987808587384501,0,2,methionine-R-sulfoxide reductase activity,MF,
15635,GO:0070192,1,0.694171405422275,0,55,chromosome organization involved in meiotic cell cycle,BP,
15636,GO:0070193,1,0.886248138048647,0,19,synaptonemal complex organization,BP,
15637,GO:0070194,1,0.987366244062449,0,2,synaptonemal complex disassembly,BP,
15638,GO:0070195,1,0.992488860149545,0,1,growth hormone receptor complex,CC,
15639,GO:0070197,1,0.966318303500514,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15640,GO:0070198,1,0.837863499806597,0,27,protein localization to chromosome, telomeric region,BP,
15641,GO:0070199,1,0.868218353330049,0,23,establishment of protein localization to chromosome,BP,
15642,GO:0070200,1,0.907592398005304,0,15,establishment of protein localization to telomere,BP,
15644,GO:0070202,1,0.934087019699272,0,11,regulation of establishment of protein localization to chromosome,BP,
15645,GO:0070203,1,0.940585173211744,0,10,regulation of establishment of protein localization to telomere,BP,
15646,GO:0070206,1,0.732934414901706,0,48,protein trimerization,BP,
15647,GO:0070207,1,0.841313136406743,0,28,protein homotrimerization,BP,
15648,GO:0070208,1,0.925104339258374,0,11,protein heterotrimerization,BP,
15649,GO:0070209,1,0.992609113052937,0,1,ASTRA complex,CC,
15650,GO:0070212,1,0.971312400305671,0,4,protein poly-ADP-ribosylation,BP,
15651,GO:0070213,1,0.970776237507886,0,4,protein auto-ADP-ribosylation,BP,
15652,GO:0070221,1,0.981550984807045,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15653,GO:0070227,1,0.682941209794866,0,63,lymphocyte apoptotic process,BP,
15654,GO:0070228,1,0.751360070212885,0,48,regulation of lymphocyte apoptotic process,BP,
15655,GO:0070229,1,0.848568220679317,0,27,negative regulation of lymphocyte apoptotic process,BP,
15656,GO:0070230,1,0.924235665207742,0,14,positive regulation of lymphocyte apoptotic process,BP,
15657,GO:0070231,1,0.775439174913032,0,43,T cell apoptotic process,BP,
15658,GO:0070232,1,0.844060809215885,0,29,regulation of T cell apoptotic process,BP,
15659,GO:0070233,1,0.903454623325998,0,17,negative regulation of T cell apoptotic process,BP,
15660,GO:0070234,1,0.946155413771828,0,10,positive regulation of T cell apoptotic process,BP,
15661,GO:0070235,1,0.970691755539791,0,5,regulation of activation-induced cell death of T cells,BP,
15662,GO:0070236,1,0.975859903528372,0,4,negative regulation of activation-induced cell death of T cells,BP,
15663,GO:0070238,1,0.995179173051146,0,1,activated T cell autonomous cell death,BP,
15664,GO:0070239,1,0.995179173051146,0,1,regulation of activated T cell autonomous cell death,BP,
15665,GO:0070241,1,0.995179173051146,0,1,positive regulation of activated T cell autonomous cell death,BP,
15666,GO:0070242,1,0.900957136801402,0,17,thymocyte apoptotic process,BP,
15667,GO:0070243,1,0.930050447769521,0,12,regulation of thymocyte apoptotic process,BP,
15668,GO:0070244,1,0.959774808364134,0,7,negative regulation of thymocyte apoptotic process,BP,
15669,GO:0070245,1,0.969042635113035,0,5,positive regulation of thymocyte apoptotic process,BP,
15670,GO:0070246,1,0.995765648283165,0,1,natural killer cell apoptotic process,BP,
15671,GO:0070247,1,0.995765648283165,0,1,regulation of natural killer cell apoptotic process,BP,
15672,GO:0070251,1,0.993915828702927,0,1,pristanate-CoA ligase activity,MF,
15673,GO:0070252,1,0.526182421941433,0,95,actin-mediated cell contraction,BP,
15674,GO:0070253,1,0.982294901868649,0,4,somatostatin secretion,BP,
15675,GO:0070254,1,0.940715634208165,0,10,mucus secretion,BP,
15676,GO:0070255,1,0.944086664728569,0,9,regulation of mucus secretion,BP,
15677,GO:0070256,1,0.988456857221963,0,2,negative regulation of mucus secretion,BP,
15678,GO:0070257,1,0.961610472225224,0,6,positive regulation of mucus secretion,BP,
15679,GO:0070259,1,0.985671083098941,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15680,GO:0070260,1,0.9930956730518,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15681,GO:0070262,1,0.907430708947164,0,16,peptidyl-serine dephosphorylation,BP,
15682,GO:0070265,1,0.753502746139618,0,48,necrotic cell death,BP,
15683,GO:0070266,1,0.796271995775231,0,36,necroptotic process,BP,
15684,GO:0070267,1,0.992534081517813,0,1,oncosis,BP,
15685,GO:0070268,1,0.722692993744738,0,53,cornification,BP,
15686,GO:0070269,1,0.950719237672879,0,9,pyroptosis,BP,
15687,GO:0070273,1,0.863638902045462,0,22,phosphatidylinositol-4-phosphate binding,MF,
15688,GO:0070274,1,0.989983397146286,0,2,RES complex,CC,
15689,GO:0070278,1,0.966809776408759,0,5,extracellular matrix constituent secretion,BP,
15691,GO:0070280,1,0.992506314483297,0,1,pyridoxal binding,MF,
15692,GO:0070283,1,0.995173064841884,0,1,radical SAM enzyme activity,MF,
15693,GO:0070286,1,0.822479628700262,0,29,axonemal dynein complex assembly,BP,
15694,GO:0070287,1,0.992526659677222,0,1,ferritin receptor activity,MF,
15695,GO:0070288,1,0.992169278996121,0,2,ferritin complex,CC,
15696,GO:0070290,1,0.96647001427225,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15697,GO:0070291,1,0.980445496813354,0,3,N-acylethanolamine metabolic process,BP,
15698,GO:0070292,1,0.985256951309931,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15699,GO:0070293,1,0.912104712456349,0,15,renal absorption,BP,
15700,GO:0070294,1,0.97295819319927,0,4,renal sodium ion absorption,BP,
15701,GO:0070295,1,0.981789454557801,0,3,renal water absorption,BP,
15702,GO:0070296,1,0.817667649115116,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15704,GO:0070301,1,0.594879830673572,0,82,cellular response to hydrogen peroxide,BP,
15705,GO:0070302,1,0.270239869685527,0,194,regulation of stress-activated protein kinase signaling cascade,BP,
15706,GO:0070303,1,0.768208835773164,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15707,GO:0070304,1,0.397498612536255,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15708,GO:0070305,1,0.955452343589816,0,6,response to cGMP,BP,
15709,GO:0070306,1,0.838655642034584,0,26,lens fiber cell differentiation,BP,
15710,GO:0070307,1,0.930256056482656,0,11,lens fiber cell development,BP,
15711,GO:0070309,1,0.973027311391214,0,4,lens fiber cell morphogenesis,BP,
15712,GO:0070314,1,0.961426287063235,0,6,G1 to G0 transition,BP,
15713,GO:0070315,1,0.985411816959748,0,2,G1 to G0 transition involved in cell differentiation,BP,
15714,GO:0070316,1,0.76220753470295,0,40,regulation of G0 to G1 transition,BP,
15715,GO:0070317,1,0.78179643904355,0,36,negative regulation of G0 to G1 transition,BP,
15716,GO:0070318,1,0.975005791733571,0,4,positive regulation of G0 to G1 transition,BP,
15717,GO:0070320,1,0.993264927058927,0,1,inward rectifier potassium channel inhibitor activity,MF,
15720,GO:0070326,1,0.975919729440511,0,4,very-low-density lipoprotein particle receptor binding,MF,
15722,GO:0070328,1,0.865523421474495,0,25,triglyceride homeostasis,BP,
15723,GO:0070329,1,0.987442639479654,0,2,tRNA seleno-modification,BP,
15724,GO:0070330,1,0.907841047332564,0,16,aromatase activity,MF,
15725,GO:0070335,1,0.992268413959408,0,1,aspartate binding,MF,
15726,GO:0070336,1,0.985534136250151,0,2,flap-structured DNA binding,MF,
15727,GO:0070337,1,0.992386428745838,0,1,3'-flap-structured DNA binding,MF,
15728,GO:0070339,1,0.963248082076513,0,6,response to bacterial lipopeptide,BP,
15729,GO:0070340,1,0.978135378952014,0,3,detection of bacterial lipopeptide,BP,
15730,GO:0070341,1,0.943556074461853,0,9,fat cell proliferation,BP,
15731,GO:0070343,1,0.984890128933232,0,3,white fat cell proliferation,BP,
15732,GO:0070344,1,0.943556074461853,0,9,regulation of fat cell proliferation,BP,
15733,GO:0070345,1,0.964601263519663,0,5,negative regulation of fat cell proliferation,BP,
15734,GO:0070346,1,0.985591647465144,0,3,positive regulation of fat cell proliferation,BP,
15735,GO:0070350,1,0.984890128933232,0,3,regulation of white fat cell proliferation,BP,
15736,GO:0070352,1,0.992341512170403,0,2,positive regulation of white fat cell proliferation,BP,
15737,GO:0070358,1,0.962716846476663,0,6,actin polymerization-dependent cell motility,BP,
15738,GO:0070365,1,0.923766637311316,0,13,hepatocyte differentiation,BP,
15739,GO:0070366,1,0.990455774468999,0,2,regulation of hepatocyte differentiation,BP,
15740,GO:0070367,1,0.994482304904902,0,1,negative regulation of hepatocyte differentiation,BP,
15741,GO:0070368,1,0.995951357786099,0,1,positive regulation of hepatocyte differentiation,BP,
15742,GO:0070369,1,0.977416790263265,0,3,beta-catenin-TCF7L2 complex,CC,
15743,GO:0070370,1,0.97322409503892,0,5,cellular heat acclimation,BP,
15746,GO:0070373,1,0.680942851664143,0,58,negative regulation of ERK1 and ERK2 cascade,BP,
15748,GO:0070375,1,0.979326434745314,0,3,ERK5 cascade,BP,
15749,GO:0070376,1,0.992953270492542,0,1,regulation of ERK5 cascade,BP,
15750,GO:0070377,1,0.992953270492542,0,1,negative regulation of ERK5 cascade,BP,
15751,GO:0070381,1,0.985147586544588,0,2,endosome to plasma membrane transport vesicle,CC,
15753,GO:0070383,1,0.955797779963524,0,8,DNA cytosine deamination,BP,
15754,GO:0070384,1,0.974864023505063,0,4,Harderian gland development,BP,
15755,GO:0070390,1,0.99510680161285,0,1,transcription export complex 2,CC,
15756,GO:0070391,1,0.938080904960352,0,11,response to lipoteichoic acid,BP,
15757,GO:0070392,1,0.996083383182969,0,1,detection of lipoteichoic acid,BP,
15758,GO:0070401,1,0.989297595658655,0,2,NADP+ binding,MF,
15759,GO:0070402,1,0.924185835195451,0,13,NADPH binding,MF,
15760,GO:0070403,1,0.919046726149104,0,14,NAD+ binding,MF,
15761,GO:0070404,1,0.985385537726862,0,3,NADH binding,MF,
15763,GO:0070407,1,0.9927381116407,0,1,oxidation-dependent protein catabolic process,BP,
15764,GO:0070408,1,0.992388266636735,0,1,carbamoyl phosphate metabolic process,BP,
15765,GO:0070409,1,0.992388266636735,0,1,carbamoyl phosphate biosynthetic process,BP,
15766,GO:0070410,1,0.920134626910502,0,12,co-SMAD binding,MF,
15767,GO:0070411,1,0.922884360905393,0,11,I-SMAD binding,MF,
15768,GO:0070412,1,0.846155601506307,0,23,R-SMAD binding,MF,
15769,GO:0070413,1,0.992886097355274,0,1,trehalose metabolism in response to stress,BP,
15770,GO:0070417,1,0.952937859056146,0,7,cellular response to cold,BP,
15771,GO:0070418,1,0.992437242703964,0,1,DNA-dependent protein kinase complex,CC,
15772,GO:0070419,1,0.954091040119139,0,7,nonhomologous end joining complex,CC,
15773,GO:0070423,1,0.798591268066384,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15774,GO:0070424,1,0.943559550544658,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15775,GO:0070425,1,0.985374946280296,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15776,GO:0070426,1,0.979767881746954,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15777,GO:0070427,1,0.973894230577584,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15778,GO:0070428,1,0.98493993418233,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15779,GO:0070429,1,0.992485775250643,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15780,GO:0070430,1,0.992397610851452,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15781,GO:0070431,1,0.934687612633695,0,10,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15782,GO:0070432,1,0.965435758497164,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15783,GO:0070433,1,0.985374946280296,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15784,GO:0070434,1,0.979767881746954,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15785,GO:0070435,1,0.986111782690297,0,2,Shc-EGFR complex,CC,
15786,GO:0070436,1,0.985203788277841,0,2,Grb2-EGFR complex,CC,
15787,GO:0070442,1,0.995644392572973,0,1,integrin alphaIIb-beta3 complex,CC,
15788,GO:0070444,1,0.945988415468227,0,8,oligodendrocyte progenitor proliferation,BP,
15789,GO:0070445,1,0.945988415468227,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15790,GO:0070446,1,0.994661592279131,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15791,GO:0070447,1,0.978623674470889,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15792,GO:0070458,1,0.984262154264451,0,3,cellular detoxification of nitrogen compound,BP,
15793,GO:0070459,1,0.960259561203463,0,7,prolactin secretion,BP,
15794,GO:0070460,1,0.992504135278238,0,1,thyroid-stimulating hormone secretion,BP,
15795,GO:0070461,1,0.859386933871407,0,23,SAGA-type complex,CC,
15796,GO:0070462,1,0.992522555202321,0,1,plus-end specific microtubule depolymerization,BP,
15797,GO:0070463,1,0.992561266936587,0,1,tubulin-dependent ATPase activity,MF,
15798,GO:0070469,1,0.697364136920988,0,81,respiratory chain,CC,
15799,GO:0070470,1,0.979092223782918,0,4,plasma membrane respiratory chain,CC,
15800,GO:0070471,1,0.948692486429133,0,8,uterine smooth muscle contraction,BP,
15801,GO:0070472,1,0.954979887705901,0,7,regulation of uterine smooth muscle contraction,BP,
15802,GO:0070473,1,0.994651615069553,0,1,negative regulation of uterine smooth muscle contraction,BP,
15803,GO:0070474,1,0.960117091813383,0,6,positive regulation of uterine smooth muscle contraction,BP,
15804,GO:0070475,1,0.95939026267233,0,7,rRNA base methylation,BP,
15805,GO:0070476,1,0.996592916727176,0,1,rRNA (guanine-N7)-methylation,BP,
15806,GO:0070478,1,0.992495322655948,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15807,GO:0070481,1,0.992930438236879,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15808,GO:0070482,1,0.105845186870085,0,353,response to oxygen levels,BP,
15809,GO:0070483,1,0.992694680171535,0,1,detection of hypoxia,BP,
15810,GO:0070486,1,0.928757319583535,0,12,leukocyte aggregation,BP,
15811,GO:0070487,1,0.965948718211948,0,5,monocyte aggregation,BP,
15812,GO:0070488,1,0.993360655642704,0,2,neutrophil aggregation,BP,
15813,GO:0070489,1,0.987209922038614,0,2,T cell aggregation,BP,
15814,GO:0070491,1,0.663914662497315,0,62,repressing transcription factor binding,MF,
15816,GO:0070493,1,0.919209957256092,0,12,thrombin-activated receptor signaling pathway,BP,
15817,GO:0070494,1,0.980412274719919,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15818,GO:0070495,1,0.980412274719919,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15819,GO:0070498,1,0.57058017305587,0,96,interleukin-1-mediated signaling pathway,BP,
15820,GO:0070506,1,0.986573404473302,0,2,high-density lipoprotein particle receptor activity,MF,
15822,GO:0070508,1,0.959897868818872,0,7,cholesterol import,BP,
15823,GO:0070509,1,0.644456317935427,0,64,calcium ion import,BP,
15824,GO:0070510,1,0.992269809022325,0,1,regulation of histone H4-K20 methylation,BP,
15825,GO:0070512,1,0.992269809022325,0,1,positive regulation of histone H4-K20 methylation,BP,
15826,GO:0070513,1,0.950507818437931,0,9,death domain binding,MF,
15827,GO:0070522,1,0.972623431452458,0,4,ERCC4-ERCC1 complex,CC,
15828,GO:0070524,1,0.995600855478426,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15829,GO:0070525,1,0.927313936388645,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15830,GO:0070527,1,0.716424513870986,0,52,platelet aggregation,BP,
15831,GO:0070528,1,0.836127294988911,0,27,protein kinase C signaling,BP,
15832,GO:0070530,1,0.885715564770152,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15833,GO:0070531,1,0.965556912941127,0,5,BRCA1-A complex,CC,
15834,GO:0070534,1,0.758807777017466,0,42,protein K63-linked ubiquitination,BP,
15835,GO:0070535,1,0.964972533796893,0,5,histone H2A K63-linked ubiquitination,BP,
15836,GO:0070536,1,0.843048379932154,0,24,protein K63-linked deubiquitination,BP,
15837,GO:0070537,1,0.979330295097245,0,3,histone H2A K63-linked deubiquitination,BP,
15838,GO:0070538,1,0.991630819856259,0,2,oleic acid binding,MF,
15839,GO:0070539,1,0.992550086615673,0,1,linoleic acid binding,MF,
15840,GO:0070541,1,0.980747663305991,0,3,response to platinum ion,BP,
15841,GO:0070542,1,0.618990178002479,0,75,response to fatty acid,BP,
15842,GO:0070543,1,0.994409037765303,0,1,response to linoleic acid,BP,
15843,GO:0070544,1,0.942127336535815,0,8,histone H3-K36 demethylation,BP,
15844,GO:0070545,1,0.980570699601478,0,3,PeBoW complex,CC,
15845,GO:0070547,1,0.99312462568774,0,1,L-tyrosine aminotransferase activity,MF,
15846,GO:0070548,1,0.985018818966641,0,2,L-glutamine aminotransferase activity,MF,
15847,GO:0070550,1,0.992024061958175,0,1,rDNA condensation,BP,
15848,GO:0070551,1,0.9930956730518,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15849,GO:0070552,1,0.980259527921714,0,3,BRISC complex,CC,
15850,GO:0070553,1,0.9930956730518,0,1,nicotinic acid receptor activity,MF,
15851,GO:0070554,1,0.986787981162267,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15853,GO:0070557,1,0.989874741396216,0,2,PCNA-p21 complex,CC,
15854,GO:0070560,1,0.986146114045661,0,2,protein secretion by platelet,BP,
15855,GO:0070561,1,0.939409433721928,0,9,vitamin D receptor signaling pathway,BP,
15856,GO:0070562,1,0.960026052392454,0,6,regulation of vitamin D receptor signaling pathway,BP,
15857,GO:0070563,1,0.986846506101807,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15858,GO:0070564,1,0.987899815967216,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15859,GO:0070566,1,0.833831288824009,0,27,adenylyltransferase activity,MF,
15860,GO:0070567,1,0.945988083982579,0,9,cytidylyltransferase activity,MF,
15861,GO:0070568,1,0.968987807958227,0,5,guanylyltransferase activity,MF,
15862,GO:0070569,1,0.955134724554176,0,7,uridylyltransferase activity,MF,
15863,GO:0070570,1,0.838166799467199,0,26,regulation of neuron projection regeneration,BP,
15864,GO:0070571,1,0.907206107062501,0,14,negative regulation of neuron projection regeneration,BP,
15865,GO:0070572,1,0.952388570126395,0,8,positive regulation of neuron projection regeneration,BP,
15866,GO:0070573,1,0.980950532986048,0,3,metallodipeptidase activity,MF,
15867,GO:0070574,1,0.972473950418166,0,4,cadmium ion transmembrane transport,BP,
15868,GO:0070576,1,0.986118021735383,0,2,vitamin D 24-hydroxylase activity,MF,
15870,GO:0070578,1,0.943799146007042,0,9,RISC-loading complex,CC,
15871,GO:0070579,1,0.969858154501245,0,4,methylcytosine dioxygenase activity,MF,
15872,GO:0070584,1,0.87982341016124,0,21,mitochondrion morphogenesis,BP,
15873,GO:0070585,1,0.341937649481403,0,177,protein localization to mitochondrion,BP,
15874,GO:0070586,1,0.947420021759498,0,9,cell-cell adhesion involved in gastrulation,BP,
15875,GO:0070587,1,0.953893391408477,0,8,regulation of cell-cell adhesion involved in gastrulation,BP,
15877,GO:0070589,1,0.994995753572652,0,1,cellular component macromolecule biosynthetic process,BP,
15878,GO:0070593,1,0.984775988540781,0,2,dendrite self-avoidance,BP,
15879,GO:0070601,1,0.935171797703896,0,10,centromeric sister chromatid cohesion,BP,
15880,GO:0070602,1,0.974102070881023,0,4,regulation of centromeric sister chromatid cohesion,BP,
15881,GO:0070603,1,0.61839306871884,0,73,SWI/SNF superfamily-type complex,CC,
15882,GO:0070611,1,0.993320980783552,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15883,GO:0070612,1,0.993320980783552,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15884,GO:0070613,1,0.580661208111086,0,86,regulation of protein processing,BP,
15885,GO:0070615,1,0.9924983617562,0,1,nucleosome-dependent ATPase activity,MF,
15886,GO:0070618,1,0.993238802046988,0,1,Grb2-Sos complex,CC,
15887,GO:0070625,1,0.994390681201705,0,1,zymogen granule exocytosis,BP,
15888,GO:0070626,1,0.995495190398897,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15889,GO:0070627,1,0.992495950313024,0,1,ferrous iron import,BP,
15890,GO:0070628,1,0.886401105896394,0,21,proteasome binding,MF,
15891,GO:0070631,1,0.9930956730518,0,1,spindle pole body localization,BP,
15892,GO:0070632,1,0.9930956730518,0,1,establishment of spindle pole body localization,BP,
15893,GO:0070633,1,0.904825856078387,0,15,transepithelial transport,BP,
15894,GO:0070634,1,0.987001134093098,0,2,transepithelial ammonium transport,BP,
15895,GO:0070637,1,0.993722014927607,0,1,pyridine nucleoside metabolic process,BP,
15896,GO:0070638,1,0.993722014927607,0,1,pyridine nucleoside catabolic process,BP,
15897,GO:0070640,1,0.981363895424956,0,3,vitamin D3 metabolic process,BP,
15898,GO:0070643,1,0.995275165074226,0,1,vitamin D 25-hydroxylase activity,MF,
15899,GO:0070644,1,0.977539080223129,0,3,vitamin D response element binding,MF,
15900,GO:0070646,1,0.180256005835168,0,264,protein modification by small protein removal,BP,
15902,GO:0070649,1,0.97756800806172,0,3,formin-nucleated actin cable assembly,BP,
15903,GO:0070651,1,0.992930438236879,0,1,nonfunctional rRNA decay,BP,
15904,GO:0070652,1,0.952267161551781,0,8,HAUS complex,CC,
15905,GO:0070653,1,0.996263188717863,0,1,high-density lipoprotein particle receptor binding,MF,
15907,GO:0070662,1,0.977805094146921,0,3,mast cell proliferation,BP,
15909,GO:0070664,1,0.65462539537748,0,68,negative regulation of leukocyte proliferation,BP,
15911,GO:0070666,1,0.985258190649248,0,2,regulation of mast cell proliferation,BP,
15912,GO:0070667,1,0.992784769646895,0,1,negative regulation of mast cell proliferation,BP,
15913,GO:0070668,1,0.985258190649248,0,2,positive regulation of mast cell proliferation,BP,
15914,GO:0070669,1,0.915554804123714,0,13,response to interleukin-2,BP,
15915,GO:0070670,1,0.831081155531414,0,30,response to interleukin-4,BP,
15916,GO:0070671,1,0.762274538435774,0,46,response to interleukin-12,BP,
15917,GO:0070672,1,0.907296773431817,0,14,response to interleukin-15,BP,
15918,GO:0070673,1,0.931158662517206,0,11,response to interleukin-18,BP,
15919,GO:0070676,1,0.984716434907947,0,3,intralumenal vesicle formation,BP,
15920,GO:0070678,1,0.993249829917213,0,1,preprotein binding,MF,
15922,GO:0070681,1,0.98244081586836,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15923,GO:0070682,1,0.982010088861153,0,3,proteasome regulatory particle assembly,BP,
15924,GO:0070684,1,0.995979410872123,0,1,seminal clot liquefaction,BP,
15925,GO:0070685,1,0.994328400422354,0,1,macropinocytic cup,CC,
15926,GO:0070694,1,0.9930956730518,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15927,GO:0070695,1,0.964617886693219,0,5,FHF complex,CC,
15928,GO:0070696,1,0.894081218543429,0,17,transmembrane receptor protein serine/threonine kinase binding,MF,
15929,GO:0070697,1,0.968869691856516,0,5,activin receptor binding,MF,
15930,GO:0070698,1,0.987401704924808,0,2,type I activin receptor binding,MF,
15931,GO:0070699,1,0.986540679167227,0,2,type II activin receptor binding,MF,
15932,GO:0070700,1,0.922832459220506,0,12,BMP receptor binding,MF,
15933,GO:0070704,1,0.98563331805918,0,2,sterol desaturase activity,MF,
15934,GO:0070715,1,0.992638670220271,0,1,sodium-dependent organic cation transport,BP,
15935,GO:0070717,1,0.853046955415814,0,23,poly-purine tract binding,MF,
15936,GO:0070722,1,0.992554799311397,0,1,Tle3-Aes complex,CC,
15937,GO:0070723,1,0.865532551064078,0,20,response to cholesterol,BP,
15938,GO:0070724,1,0.992719876885176,0,1,BMP receptor complex,CC,
15940,GO:0070728,1,0.952335185471307,0,7,leucine binding,MF,
15941,GO:0070733,1,0.995218992452226,0,1,protein adenylyltransferase activity,MF,
15942,GO:0070734,1,0.882553011750649,0,19,histone H3-K27 methylation,BP,
15943,GO:0070735,1,0.992582790591473,0,1,protein-glycine ligase activity,MF,
15944,GO:0070736,1,0.992582790591473,0,1,protein-glycine ligase activity, initiating,MF,
15945,GO:0070739,1,0.952571763961616,0,7,protein-glutamic acid ligase activity,MF,
15946,GO:0070740,1,0.952571763961616,0,7,tubulin-glutamic acid ligase activity,MF,
15948,GO:0070742,1,0.908094108430011,0,14,C2H2 zinc finger domain binding,MF,
15949,GO:0070743,1,0.996096642961063,0,1,interleukin-23 complex,CC,
15950,GO:0070757,1,0.927284117424642,0,11,interleukin-35-mediated signaling pathway,BP,
15951,GO:0070761,1,0.970191358910298,0,5,pre-snoRNP complex,CC,
15952,GO:0070762,1,0.9930956730518,0,1,nuclear pore transmembrane ring,CC,
15953,GO:0070765,1,0.961876735506069,0,6,gamma-secretase complex,CC,
15954,GO:0070772,1,0.992749534641708,0,1,PAS complex,CC,
15955,GO:0070773,1,0.995690761056092,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15956,GO:0070774,1,0.99248757873928,0,1,phytoceramidase activity,MF,
15957,GO:0070775,1,0.951225784884057,0,7,H3 histone acetyltransferase complex,CC,
15958,GO:0070776,1,0.951225784884057,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15959,GO:0070777,1,0.969762423478412,0,4,D-aspartate transport,BP,
15960,GO:0070778,1,0.959115888910375,0,6,L-aspartate transmembrane transport,BP,
15961,GO:0070779,1,0.969762423478412,0,4,D-aspartate import across plasma membrane,BP,
15962,GO:0070780,1,0.988553888831199,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15963,GO:0070781,1,0.987617084941876,0,2,response to biotin,BP,
15964,GO:0070782,1,0.994237472557249,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15965,GO:0070813,1,0.97264371618669,0,5,hydrogen sulfide metabolic process,BP,
15966,GO:0070814,1,0.976368373080543,0,4,hydrogen sulfide biosynthetic process,BP,
15967,GO:0070815,1,0.971023825225178,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15968,GO:0070816,1,0.908591047049112,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15969,GO:0070818,1,0.995048145492834,0,1,protoporphyrinogen oxidase activity,MF,
15972,GO:0070822,1,0.904059846016267,0,15,Sin3-type complex,CC,
15973,GO:0070826,1,0.992495950313024,0,1,paraferritin complex,CC,
15974,GO:0070827,1,0.971019335968929,0,4,chromatin maintenance,BP,
15975,GO:0070828,1,0.905590515642934,0,15,heterochromatin organization,BP,
15976,GO:0070829,1,0.984795714784094,0,2,heterochromatin maintenance,BP,
15977,GO:0070830,1,0.731053947773063,0,47,bicellular tight junction assembly,BP,
15978,GO:0070831,1,0.944679714366791,0,8,basement membrane assembly,BP,
15979,GO:0070836,1,0.980400565402625,0,3,caveola assembly,BP,
15980,GO:0070837,1,0.977757527580791,0,3,dehydroascorbic acid transport,BP,
15982,GO:0070839,1,0.985162981164439,0,2,divalent metal ion export,BP,
15984,GO:0070841,1,0.876202086250961,0,20,inclusion body assembly,BP,
15985,GO:0070842,1,0.973912018725568,0,4,aggresome assembly,BP,
15986,GO:0070843,1,0.992497395916573,0,1,misfolded protein transport,BP,
15987,GO:0070844,1,0.992497395916573,0,1,polyubiquitinated protein transport,BP,
15988,GO:0070845,1,0.992497395916573,0,1,polyubiquitinated misfolded protein transport,BP,
15989,GO:0070846,1,0.992497395916573,0,1,Hsp90 deacetylation,BP,
15990,GO:0070847,1,0.957755379143282,0,8,core mediator complex,CC,
15992,GO:0070849,1,0.74184477760373,0,43,response to epidermal growth factor,BP,
15993,GO:0070851,1,0.498685423289882,0,107,growth factor receptor binding,MF,
15994,GO:0070852,1,0.959993916888676,0,6,cell body fiber,CC,
15995,GO:0070853,1,0.984538450541163,0,2,myosin VI binding,MF,
15996,GO:0070856,1,0.992359459383177,0,1,myosin VI light chain binding,MF,
15997,GO:0070857,1,0.947095684335342,0,8,regulation of bile acid biosynthetic process,BP,
15998,GO:0070858,1,0.980257841916935,0,3,negative regulation of bile acid biosynthetic process,BP,
15999,GO:0070859,1,0.980526276486694,0,3,positive regulation of bile acid biosynthetic process,BP,
16000,GO:0070860,1,0.993931771868374,0,1,RNA polymerase I core factor complex,CC,
16001,GO:0070861,1,0.853916912229012,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16002,GO:0070862,1,0.936332867624899,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16003,GO:0070863,1,0.926037760257773,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16004,GO:0070873,1,0.832566511343512,0,26,regulation of glycogen metabolic process,BP,
16005,GO:0070874,1,0.964357882583613,0,5,negative regulation of glycogen metabolic process,BP,
16006,GO:0070875,1,0.900987055618838,0,14,positive regulation of glycogen metabolic process,BP,
16007,GO:0070876,1,0.972063318535237,0,4,SOSS complex,CC,
16008,GO:0070877,1,0.985632042992662,0,2,microprocessor complex,CC,
16009,GO:0070878,1,0.942639773606865,0,8,primary miRNA binding,MF,
16010,GO:0070883,1,0.971256805276564,0,5,pre-miRNA binding,MF,
16011,GO:0070884,1,0.897618579274686,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16012,GO:0070885,1,0.978550900699084,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16013,GO:0070886,1,0.942307042072455,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16016,GO:0070889,1,0.987197215287052,0,2,platelet alpha granule organization,BP,
16017,GO:0070890,1,0.992283750874609,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16018,GO:0070891,1,0.979081486613162,0,4,lipoteichoic acid binding,MF,
16019,GO:0070892,1,0.994409037765303,0,1,lipoteichoic acid receptor activity,MF,
16020,GO:0070893,1,0.985555129048952,0,2,transposon integration,BP,
16021,GO:0070894,1,0.985555129048952,0,2,regulation of transposon integration,BP,
16022,GO:0070895,1,0.985555129048952,0,2,negative regulation of transposon integration,BP,
16023,GO:0070897,1,0.769250041857317,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16024,GO:0070898,1,0.991950758591335,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16025,GO:0070899,1,0.992838257870506,0,1,mitochondrial tRNA wobble uridine modification,BP,
16026,GO:0070900,1,0.949193637130854,0,9,mitochondrial tRNA modification,BP,
16027,GO:0070901,1,0.976789942651658,0,4,mitochondrial tRNA methylation,BP,
16028,GO:0070902,1,0.995187876653141,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16029,GO:0070903,1,0.994617595203431,0,1,mitochondrial tRNA thio-modification,BP,
16030,GO:0070904,1,0.992283750874609,0,1,transepithelial L-ascorbic acid transport,BP,
16031,GO:0070905,1,0.980577904362188,0,3,serine binding,MF,
16032,GO:0070911,1,0.824794125715553,0,32,global genome nucleotide-excision repair,BP,
16033,GO:0070914,1,0.93038935352622,0,11,UV-damage excision repair,BP,
16034,GO:0070915,1,0.970045626101387,0,5,lysophosphatidic acid receptor activity,MF,
16035,GO:0070918,1,0.741845288345554,0,43,production of small RNA involved in gene silencing by RNA,BP,
16036,GO:0070920,1,0.903357134352697,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16037,GO:0070922,1,0.941346985785638,0,9,small RNA loading onto RISC,BP,
16039,GO:0070926,1,0.992504308991839,0,1,regulation of ATP:ADP antiporter activity,BP,
16040,GO:0070931,1,0.992390147497698,0,1,Golgi-associated vesicle lumen,CC,
16041,GO:0070932,1,0.872970058109048,0,20,histone H3 deacetylation,BP,
16042,GO:0070933,1,0.940041519114904,0,9,histone H4 deacetylation,BP,
16043,GO:0070934,1,0.972737936538922,0,4,CRD-mediated mRNA stabilization,BP,
16044,GO:0070935,1,0.899525559249531,0,15,3'-UTR-mediated mRNA stabilization,BP,
16045,GO:0070936,1,0.723052071324696,0,49,protein K48-linked ubiquitination,BP,
16046,GO:0070937,1,0.965437632914074,0,5,CRD-mediated mRNA stability complex,CC,
16047,GO:0070938,1,0.926352830099775,0,11,contractile ring,CC,
16048,GO:0070939,1,0.978224643654375,0,3,Dsl1/NZR complex,CC,
16049,GO:0070940,1,0.96646478519116,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16050,GO:0070942,1,0.964954127318698,0,7,neutrophil mediated cytotoxicity,BP,
16051,GO:0070943,1,0.976379649395595,0,5,neutrophil mediated killing of symbiont cell,BP,
16052,GO:0070944,1,0.980753359862469,0,4,neutrophil mediated killing of bacterium,BP,
16053,GO:0070945,1,0.984450267604197,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16054,GO:0070947,1,0.991792006294566,0,2,neutrophil mediated killing of fungus,BP,
16055,GO:0070948,1,0.976979234856855,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16056,GO:0070949,1,0.988545666707828,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16057,GO:0070950,1,0.992973312581029,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16058,GO:0070951,1,0.992973312581029,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16059,GO:0070953,1,0.995541342746191,0,1,regulation of neutrophil mediated killing of fungus,BP,
16060,GO:0070960,1,0.988545666707828,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16061,GO:0070961,1,0.988545666707828,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16062,GO:0070962,1,0.992973312581029,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16063,GO:0070963,1,0.992973312581029,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16064,GO:0070965,1,0.995541342746191,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16065,GO:0070966,1,0.977941041034674,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16066,GO:0070970,1,0.930229526258444,0,10,interleukin-2 secretion,BP,
16067,GO:0070971,1,0.893053146986571,0,17,endoplasmic reticulum exit site,CC,
16068,GO:0070972,1,0.538503538403022,0,129,protein localization to endoplasmic reticulum,BP,
16069,GO:0070973,1,0.9594078678126,0,6,protein localization to endoplasmic reticulum exit site,BP,
16070,GO:0070974,1,0.992803818119721,0,1,POU domain binding,MF,
16071,GO:0070975,1,0.992248947281547,0,1,FHA domain binding,MF,
16072,GO:0070976,1,0.993203156849052,0,1,TIR domain binding,MF,
16073,GO:0070977,1,0.895891580876465,0,15,bone maturation,BP,
16074,GO:0070979,1,0.854682061735378,0,27,protein K11-linked ubiquitination,BP,
16075,GO:0070981,1,0.993889998995704,0,1,L-asparagine biosynthetic process,BP,
16076,GO:0070982,1,0.993889998995704,0,1,L-asparagine metabolic process,BP,
16077,GO:0070984,1,0.9924960420495,0,1,SET domain binding,MF,
16078,GO:0070985,1,0.991091672768932,0,2,TFIIK complex,CC,
16079,GO:0070986,1,0.915046272150136,0,13,left/right axis specification,BP,
16080,GO:0070987,1,0.897793835547795,0,18,error-free translesion synthesis,BP,
16081,GO:0070988,1,0.667724944066363,0,59,demethylation,BP,
16082,GO:0070989,1,0.926487167112554,0,12,oxidative demethylation,BP,
16083,GO:0070990,1,0.971299176236342,0,6,snRNP binding,MF,
16084,GO:0070991,1,0.979443486627224,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16085,GO:0070992,1,0.98959238470729,0,2,translation initiation complex,CC,
16086,GO:0070993,1,0.98503469565712,0,2,translation preinitiation complex,CC,
16087,GO:0070995,1,0.979580327617875,0,3,NADPH oxidation,BP,
16090,GO:0071000,1,0.98869790897632,0,2,response to magnetism,BP,
16091,GO:0071001,1,0.982110267863043,0,3,U4/U6 snRNP,CC,
16092,GO:0071004,1,0.902013731611903,0,17,U2-type prespliceosome,CC,
16093,GO:0071005,1,0.994164023806241,0,1,U2-type precatalytic spliceosome,CC,
16094,GO:0071006,1,0.980450136845032,0,3,U2-type catalytic step 1 spliceosome,CC,
16095,GO:0071007,1,0.849803762158508,0,29,U2-type catalytic step 2 spliceosome,CC,
16096,GO:0071008,1,0.974997073849279,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16097,GO:0071010,1,0.87753817039065,0,22,prespliceosome,CC,
16098,GO:0071011,1,0.837911982189791,0,31,precatalytic spliceosome,CC,
16099,GO:0071012,1,0.961711402135304,0,6,catalytic step 1 spliceosome,CC,
16100,GO:0071013,1,0.551151456162593,0,97,catalytic step 2 spliceosome,CC,
16101,GO:0071014,1,0.946235304582857,0,9,post-mRNA release spliceosomal complex,CC,
16102,GO:0071020,1,0.99015229307198,0,2,post-spliceosomal complex,CC,
16103,GO:0071021,1,0.995113941510925,0,1,U2-type post-spliceosomal complex,CC,
16104,GO:0071025,1,0.922375281486876,0,15,RNA surveillance,BP,
16105,GO:0071026,1,0.993589918707245,0,1,cytoplasmic RNA surveillance,BP,
16106,GO:0071027,1,0.934944634405438,0,13,nuclear RNA surveillance,BP,
16107,GO:0071028,1,0.934944634405438,0,13,nuclear mRNA surveillance,BP,
16108,GO:0071029,1,0.970400005494566,0,6,nuclear ncRNA surveillance,BP,
16109,GO:0071030,1,0.98823954951786,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16110,GO:0071031,1,0.990143753167617,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16111,GO:0071033,1,0.973708998901097,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16112,GO:0071034,1,0.975660969118421,0,4,CUT catabolic process,BP,
16113,GO:0071035,1,0.970400005494566,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16114,GO:0071038,1,0.977151562559265,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16115,GO:0071042,1,0.979454408062134,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16116,GO:0071043,1,0.975660969118421,0,4,CUT metabolic process,BP,
16117,GO:0071044,1,0.92893884605891,0,11,histone mRNA catabolic process,BP,
16118,GO:0071045,1,0.995227575740951,0,1,nuclear histone mRNA catabolic process,BP,
16119,GO:0071046,1,0.970400005494566,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16120,GO:0071047,1,0.979454408062134,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16121,GO:0071048,1,0.98823954951786,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16122,GO:0071049,1,0.990143753167617,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16123,GO:0071051,1,0.977873517137657,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16124,GO:0071062,1,0.980246653627034,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16125,GO:0071065,1,0.985647110624155,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16126,GO:0071071,1,0.920344382155475,0,13,regulation of phospholipid biosynthetic process,BP,
16127,GO:0071072,1,0.971437422710515,0,4,negative regulation of phospholipid biosynthetic process,BP,
16128,GO:0071073,1,0.953256523340668,0,8,positive regulation of phospholipid biosynthetic process,BP,
16129,GO:0071074,1,0.994731028006767,0,1,eukaryotic initiation factor eIF2 binding,MF,
16130,GO:0071077,1,0.980350904648416,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16131,GO:0071103,1,0.242995586257873,0,221,DNA conformation change,BP,
16132,GO:0071104,1,0.976704510089464,0,4,response to interleukin-9,BP,
16133,GO:0071105,1,0.988735181647828,0,2,response to interleukin-11,BP,
16134,GO:0071106,1,0.980350904648416,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16135,GO:0071107,1,0.953557977731954,0,7,response to parathyroid hormone,BP,
16136,GO:0071108,1,0.839734509810949,0,24,protein K48-linked deubiquitination,BP,
16137,GO:0071109,1,0.984376248192268,0,2,superior temporal gyrus development,BP,
16138,GO:0071110,1,0.992365376255917,0,1,histone biotinylation,BP,
16139,GO:0071133,1,0.992718460821496,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16140,GO:0071139,1,0.985763419846491,0,2,resolution of recombination intermediates,BP,
16141,GO:0071140,1,0.985763419846491,0,2,resolution of mitotic recombination intermediates,BP,
16142,GO:0071141,1,0.941176341414926,0,8,SMAD protein complex,CC,
16143,GO:0071144,1,0.984436494163148,0,2,heteromeric SMAD protein complex,CC,
16144,GO:0071148,1,0.984567347628791,0,2,TEAD-1-YAP complex,CC,
16145,GO:0071149,1,0.986687870634214,0,2,TEAD-2-YAP complex,CC,
16146,GO:0071156,1,0.510495598254481,0,107,regulation of cell cycle arrest,BP,
16147,GO:0071157,1,0.883588015771661,0,21,negative regulation of cell cycle arrest,BP,
16148,GO:0071158,1,0.585184548933829,0,84,positive regulation of cell cycle arrest,BP,
16149,GO:0071159,1,0.989768757044597,0,2,NF-kappaB complex,CC,
16150,GO:0071163,1,0.983922299068784,0,3,DNA replication preinitiation complex assembly,BP,
16151,GO:0071164,1,0.992517228918941,0,1,RNA trimethylguanosine synthase activity,MF,
16152,GO:0071166,1,0.452569604126779,0,123,ribonucleoprotein complex localization,BP,
16153,GO:0071168,1,0.87975060578035,0,20,protein localization to chromatin,BP,
16154,GO:0071169,1,0.963312581004762,0,7,establishment of protein localization to chromatin,BP,
16155,GO:0071173,1,0.819520675494568,0,31,spindle assembly checkpoint,BP,
16156,GO:0071174,1,0.819520675494568,0,31,mitotic spindle checkpoint,BP,
16157,GO:0071203,1,0.965739552666926,0,5,WASH complex,CC,
16158,GO:0071204,1,0.965246592660156,0,6,histone pre-mRNA 3'end processing complex,CC,
16159,GO:0071205,1,0.961789717657072,0,5,protein localization to juxtaparanode region of axon,BP,
16160,GO:0071206,1,0.99222584516358,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16161,GO:0071207,1,0.987592558418536,0,2,histone pre-mRNA stem-loop binding,MF,
16162,GO:0071208,1,0.983188044771222,0,4,histone pre-mRNA DCP binding,MF,
16163,GO:0071209,1,0.98547750382242,0,3,U7 snRNA binding,MF,
16164,GO:0071211,1,0.972671151158302,0,4,protein targeting to vacuole involved in autophagy,BP,
16166,GO:0071215,1,0.992489247294393,0,1,cellular response to abscisic acid stimulus,BP,
16167,GO:0071216,1,0.322073572169943,0,178,cellular response to biotic stimulus,BP,
16168,GO:0071217,1,0.992500488936931,0,1,cellular response to external biotic stimulus,BP,
16169,GO:0071218,1,0.870464703394632,0,21,cellular response to misfolded protein,BP,
16170,GO:0071219,1,0.367441260463647,0,159,cellular response to molecule of bacterial origin,BP,
16171,GO:0071220,1,0.963248082076513,0,6,cellular response to bacterial lipoprotein,BP,
16172,GO:0071221,1,0.963248082076513,0,6,cellular response to bacterial lipopeptide,BP,
16173,GO:0071222,1,0.386064524679441,0,151,cellular response to lipopolysaccharide,BP,
16174,GO:0071223,1,0.938080904960352,0,11,cellular response to lipoteichoic acid,BP,
16175,GO:0071224,1,0.968280367980569,0,5,cellular response to peptidoglycan,BP,
16176,GO:0071225,1,0.964214248863848,0,5,cellular response to muramyl dipeptide,BP,
16177,GO:0071226,1,0.985838786053353,0,2,cellular response to molecule of fungal origin,BP,
16178,GO:0071228,1,0.996033244402212,0,1,cellular response to tumor cell,BP,
16181,GO:0071231,1,0.992101995727654,0,2,cellular response to folic acid,BP,
16182,GO:0071233,1,0.936125640965835,0,9,cellular response to leucine,BP,
16186,GO:0071243,1,0.914830997778601,0,16,cellular response to arsenic-containing substance,BP,
16187,GO:0071245,1,0.99252469753454,0,1,cellular response to carbon monoxide,BP,
16188,GO:0071247,1,0.996030150017592,0,1,cellular response to chromate,BP,
16190,GO:0071250,1,0.992338574129646,0,1,cellular response to nitrite,BP,
16191,GO:0071253,1,0.971653257018991,0,4,connexin binding,MF,
16192,GO:0071256,1,0.982684640203916,0,4,translocon complex,CC,
16194,GO:0071258,1,0.992496881829069,0,1,cellular response to gravity,BP,
16195,GO:0071259,1,0.98869790897632,0,2,cellular response to magnetism,BP,
16196,GO:0071260,1,0.610439830249181,0,76,cellular response to mechanical stimulus,BP,
16197,GO:0071262,1,0.984973495336058,0,2,regulation of translational initiation in response to starvation,BP,
16198,GO:0071264,1,0.984973495336058,0,2,positive regulation of translational initiation in response to starvation,BP,
16199,GO:0071265,1,0.954804104535839,0,8,L-methionine biosynthetic process,BP,
16200,GO:0071266,1,0.995049967525852,0,1,'de novo' L-methionine biosynthetic process,BP,
16201,GO:0071267,1,0.959555936414615,0,7,L-methionine salvage,BP,
16202,GO:0071268,1,0.993961757538668,0,1,homocysteine biosynthetic process,BP,
16203,GO:0071275,1,0.994249728549904,0,1,cellular response to aluminum ion,BP,
16204,GO:0071276,1,0.844862921467665,0,32,cellular response to cadmium ion,BP,
16206,GO:0071279,1,0.983050071253014,0,3,cellular response to cobalt ion,BP,
16207,GO:0071280,1,0.916557360774479,0,18,cellular response to copper ion,BP,
16208,GO:0071281,1,0.938483337497027,0,10,cellular response to iron ion,BP,
16209,GO:0071283,1,0.990553423394344,0,2,cellular response to iron(III) ion,BP,
16210,GO:0071284,1,0.970244206691307,0,4,cellular response to lead ion,BP,
16211,GO:0071285,1,0.938614609750211,0,11,cellular response to lithium ion,BP,
16212,GO:0071286,1,0.957460018680081,0,6,cellular response to magnesium ion,BP,
16213,GO:0071287,1,0.939550503592272,0,9,cellular response to manganese ion,BP,
16214,GO:0071288,1,0.993140495715573,0,1,cellular response to mercury ion,BP,
16215,GO:0071294,1,0.922045380643087,0,17,cellular response to zinc ion,BP,
16216,GO:0071295,1,0.839660754922519,0,27,cellular response to vitamin,BP,
16217,GO:0071298,1,0.992577151613587,0,1,cellular response to L-ascorbic acid,BP,
16218,GO:0071300,1,0.654659661642966,0,64,cellular response to retinoic acid,BP,
16219,GO:0071301,1,0.992249619450988,0,1,cellular response to vitamin B1,BP,
16220,GO:0071305,1,0.889322183133653,0,18,cellular response to vitamin D,BP,
16221,GO:0071306,1,0.987245797856001,0,2,cellular response to vitamin E,BP,
16222,GO:0071307,1,0.986263007953875,0,2,cellular response to vitamin K,BP,
16224,GO:0071312,1,0.815680199784735,0,31,cellular response to alkaloid,BP,
16225,GO:0071313,1,0.94229549024443,0,8,cellular response to caffeine,BP,
16226,GO:0071314,1,0.983825947562264,0,3,cellular response to cocaine,BP,
16227,GO:0071315,1,0.9765097522542,0,4,cellular response to morphine,BP,
16228,GO:0071316,1,0.953603071735516,0,8,cellular response to nicotine,BP,
16229,GO:0071317,1,0.9765097522542,0,4,cellular response to isoquinoline alkaloid,BP,
16230,GO:0071318,1,0.921722273460408,0,13,cellular response to ATP,BP,
16231,GO:0071320,1,0.711540318910978,0,48,cellular response to cAMP,BP,
16232,GO:0071321,1,0.955452343589816,0,6,cellular response to cGMP,BP,
16234,GO:0071324,1,0.992450367225308,0,1,cellular response to disaccharide stimulus,BP,
16236,GO:0071329,1,0.992450367225308,0,1,cellular response to sucrose stimulus,BP,
16238,GO:0071332,1,0.968121564815079,0,5,cellular response to fructose stimulus,BP,
16240,GO:0071335,1,0.990778943634512,0,2,hair follicle cell proliferation,BP,
16241,GO:0071336,1,0.990778943634512,0,2,regulation of hair follicle cell proliferation,BP,
16242,GO:0071338,1,0.990778943634512,0,2,positive regulation of hair follicle cell proliferation,BP,
16243,GO:0071339,1,0.831393140603806,0,28,MLL1 complex,CC,
16244,GO:0071340,1,0.94254043507564,0,9,skeletal muscle acetylcholine-gated channel clustering,BP,
16245,GO:0071344,1,0.991085582224937,0,2,diphosphate metabolic process,BP,
16249,GO:0071348,1,0.992465784599113,0,1,cellular response to interleukin-11,BP,
16250,GO:0071349,1,0.772887987695236,0,44,cellular response to interleukin-12,BP,
16251,GO:0071350,1,0.914218212837505,0,13,cellular response to interleukin-15,BP,
16252,GO:0071351,1,0.950720029397275,0,8,cellular response to interleukin-18,BP,
16253,GO:0071352,1,0.919012011701475,0,12,cellular response to interleukin-2,BP,
16254,GO:0071353,1,0.840586394113294,0,28,cellular response to interleukin-4,BP,
16255,GO:0071354,1,0.812132735984563,0,31,cellular response to interleukin-6,BP,
16256,GO:0071355,1,0.980390182371828,0,3,cellular response to interleukin-9,BP,
16258,GO:0071357,1,0.64779149906753,0,71,cellular response to type I interferon,BP,
16259,GO:0071359,1,0.656143643792349,0,62,cellular response to dsRNA,BP,
16260,GO:0071360,1,0.920002895004034,0,13,cellular response to exogenous dsRNA,BP,
16261,GO:0071361,1,0.917096457880751,0,13,cellular response to ethanol,BP,
16262,GO:0071362,1,0.966283179742844,0,5,cellular response to ether,BP,
16265,GO:0071371,1,0.890845926582881,0,16,cellular response to gonadotropin stimulus,BP,
16266,GO:0071372,1,0.930540498031803,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16267,GO:0071373,1,0.986387020096171,0,2,cellular response to luteinizing hormone stimulus,BP,
16268,GO:0071374,1,0.964678742492536,0,5,cellular response to parathyroid hormone stimulus,BP,
16270,GO:0071376,1,0.967368097475711,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16272,GO:0071378,1,0.873564484574717,0,19,cellular response to growth hormone stimulus,BP,
16273,GO:0071379,1,0.866239119748059,0,21,cellular response to prostaglandin stimulus,BP,
16274,GO:0071380,1,0.894801524253053,0,16,cellular response to prostaglandin E stimulus,BP,
16275,GO:0071383,1,0.201668463364089,0,238,cellular response to steroid hormone stimulus,BP,
16276,GO:0071384,1,0.678833723012814,0,61,cellular response to corticosteroid stimulus,BP,
16277,GO:0071385,1,0.69323758737748,0,57,cellular response to glucocorticoid stimulus,BP,
16278,GO:0071386,1,0.977343236473454,0,3,cellular response to corticosterone stimulus,BP,
16279,GO:0071387,1,0.99243501329512,0,1,cellular response to cortisol stimulus,BP,
16280,GO:0071389,1,0.955660584084182,0,7,cellular response to mineralocorticoid stimulus,BP,
16281,GO:0071391,1,0.91959150523523,0,12,cellular response to estrogen stimulus,BP,
16282,GO:0071392,1,0.80873100882434,0,33,cellular response to estradiol stimulus,BP,
16283,GO:0071393,1,0.985546250702132,0,2,cellular response to progesterone stimulus,BP,
16284,GO:0071394,1,0.942518144063155,0,9,cellular response to testosterone stimulus,BP,
16285,GO:0071395,1,0.982986543424467,0,4,cellular response to jasmonic acid stimulus,BP,
16287,GO:0071397,1,0.91544081705463,0,12,cellular response to cholesterol,BP,
16288,GO:0071398,1,0.719584571232566,0,49,cellular response to fatty acid,BP,
16289,GO:0071400,1,0.986080219932414,0,2,cellular response to oleic acid,BP,
16290,GO:0071401,1,0.993966766284853,0,1,cellular response to triglyceride,BP,
16291,GO:0071402,1,0.857539532409827,0,23,cellular response to lipoprotein particle stimulus,BP,
16292,GO:0071403,1,0.985448651466492,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16293,GO:0071404,1,0.899442418912164,0,16,cellular response to low-density lipoprotein particle stimulus,BP,
16295,GO:0071409,1,0.980294359384044,0,3,cellular response to cycloheximide,BP,
16296,GO:0071412,1,0.993981810666468,0,1,cellular response to genistein,BP,
16297,GO:0071413,1,0.993981810666468,0,1,cellular response to hydroxyisoflavone,BP,
16298,GO:0071415,1,0.935106367613611,0,9,cellular response to purine-containing compound,BP,
16300,GO:0071418,1,0.995677809051378,0,1,cellular response to amine stimulus,BP,
16302,GO:0071421,1,0.970831699422622,0,4,manganese ion transmembrane transport,BP,
16304,GO:0071423,1,0.994774271506862,0,1,malate transmembrane transport,BP,
16305,GO:0071424,1,0.9930956730518,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16306,GO:0071425,1,0.880232560814047,0,19,hematopoietic stem cell proliferation,BP,
16307,GO:0071426,1,0.455247782207368,0,122,ribonucleoprotein complex export from nucleus,BP,
16308,GO:0071427,1,0.504658470379303,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16309,GO:0071428,1,0.919729128260966,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16310,GO:0071431,1,0.810910139502331,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16311,GO:0071435,1,0.924256536536983,0,12,potassium ion export,BP,
16312,GO:0071437,1,0.904385861550473,0,14,invadopodium,CC,
16313,GO:0071438,1,0.96654643920442,0,5,invadopodium membrane,CC,
16314,GO:0071439,1,0.940632822583638,0,9,clathrin complex,CC,
16315,GO:0071440,1,0.959749279009509,0,6,regulation of histone H3-K14 acetylation,BP,
16316,GO:0071441,1,0.992505424922139,0,1,negative regulation of histone H3-K14 acetylation,BP,
16317,GO:0071442,1,0.973723723847671,0,4,positive regulation of histone H3-K14 acetylation,BP,
16318,GO:0071444,1,0.996928236536806,0,1,cellular response to pheromone,BP,
16319,GO:0071447,1,0.95109890774301,0,8,cellular response to hydroperoxide,BP,
16320,GO:0071449,1,0.996241928812713,0,1,cellular response to lipid hydroperoxide,BP,
16321,GO:0071450,1,0.876157975304052,0,24,cellular response to oxygen radical,BP,
16322,GO:0071451,1,0.876157975304052,0,24,cellular response to superoxide,BP,
16323,GO:0071453,1,0.278712339726498,0,204,cellular response to oxygen levels,BP,
16324,GO:0071454,1,0.992245001182228,0,1,cellular response to anoxia,BP,
16325,GO:0071455,1,0.959541177659456,0,6,cellular response to hyperoxia,BP,
16326,GO:0071456,1,0.322488371563762,0,182,cellular response to hypoxia,BP,
16327,GO:0071458,1,0.967484512378515,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16328,GO:0071459,1,0.88100583957645,0,20,protein localization to chromosome, centromeric region,BP,
16329,GO:0071460,1,0.991637480117311,0,2,cellular response to cell-matrix adhesion,BP,
16330,GO:0071461,1,0.988971596869225,0,2,cellular response to redox state,BP,
16331,GO:0071462,1,0.977645691654485,0,3,cellular response to water stimulus,BP,
16332,GO:0071464,1,0.992445788837059,0,1,cellular response to hydrostatic pressure,BP,
16334,GO:0071467,1,0.884353966425132,0,19,cellular response to pH,BP,
16335,GO:0071468,1,0.939653060311296,0,9,cellular response to acidic pH,BP,
16336,GO:0071469,1,0.987460387960992,0,2,cellular response to alkaline pH,BP,
16337,GO:0071470,1,0.807819748488397,0,32,cellular response to osmotic stress,BP,
16338,GO:0071471,1,0.99248257145969,0,1,cellular response to non-ionic osmotic stress,BP,
16339,GO:0071472,1,0.94015952085653,0,9,cellular response to salt stress,BP,
16340,GO:0071474,1,0.929821676405156,0,11,cellular hyperosmotic response,BP,
16341,GO:0071475,1,0.975180096228302,0,4,cellular hyperosmotic salinity response,BP,
16342,GO:0071476,1,0.952210202713368,0,7,cellular hypotonic response,BP,
16343,GO:0071477,1,0.98500798645775,0,2,cellular hypotonic salinity response,BP,
16344,GO:0071478,1,0.342692368368841,0,164,cellular response to radiation,BP,
16345,GO:0071479,1,0.650056772077968,0,66,cellular response to ionizing radiation,BP,
16346,GO:0071480,1,0.840992107850544,0,27,cellular response to gamma radiation,BP,
16347,GO:0071481,1,0.91355790622553,0,13,cellular response to X-ray,BP,
16348,GO:0071482,1,0.500677940956118,0,106,cellular response to light stimulus,BP,
16349,GO:0071483,1,0.985198632304915,0,2,cellular response to blue light,BP,
16350,GO:0071484,1,0.985117291658483,0,2,cellular response to light intensity,BP,
16351,GO:0071485,1,0.992632563568689,0,1,cellular response to absence of light,BP,
16352,GO:0071486,1,0.992429517439099,0,1,cellular response to high light intensity,BP,
16353,GO:0071492,1,0.980491458784465,0,3,cellular response to UV-A,BP,
16354,GO:0071493,1,0.955068492756829,0,8,cellular response to UV-B,BP,
16355,GO:0071494,1,0.973624876047422,0,4,cellular response to UV-C,BP,
16357,GO:0071496,1,0.150218788159393,0,291,cellular response to external stimulus,BP,
16358,GO:0071498,1,0.88743852250737,0,18,cellular response to fluid shear stress,BP,
16359,GO:0071499,1,0.956289539154796,0,7,cellular response to laminar fluid shear stress,BP,
16360,GO:0071500,1,0.965711222509391,0,6,cellular response to nitrosative stress,BP,
16361,GO:0071501,1,0.938442249404886,0,9,cellular response to sterol depletion,BP,
16362,GO:0071502,1,0.970177190966686,0,5,cellular response to temperature stimulus,BP,
16363,GO:0071503,1,0.970497771923612,0,4,response to heparin,BP,
16364,GO:0071504,1,0.970497771923612,0,4,cellular response to heparin,BP,
16365,GO:0071505,1,0.985755166934994,0,2,response to mycophenolic acid,BP,
16366,GO:0071506,1,0.985755166934994,0,2,cellular response to mycophenolic acid,BP,
16367,GO:0071514,1,0.861281368492173,0,22,genetic imprinting,BP,
16368,GO:0071526,1,0.78934526554449,0,32,semaphorin-plexin signaling pathway,BP,
16369,GO:0071527,1,0.993817065858972,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16370,GO:0071528,1,0.992503561353837,0,1,tRNA re-export from nucleus,BP,
16371,GO:0071529,1,0.993412345312262,0,1,cementum mineralization,BP,
16372,GO:0071532,1,0.963838621478231,0,5,ankyrin repeat binding,MF,
16373,GO:0071535,1,0.973834253903938,0,4,RING-like zinc finger domain binding,MF,
16374,GO:0071538,1,0.993929777044837,0,1,SH2 domain-mediated complex assembly,BP,
16375,GO:0071539,1,0.824973896865931,0,27,protein localization to centrosome,BP,
16376,GO:0071540,1,0.992425408853645,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16377,GO:0071541,1,0.963405702968768,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16378,GO:0071542,1,0.825656730614379,0,30,dopaminergic neuron differentiation,BP,
16379,GO:0071543,1,0.976709538622527,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16380,GO:0071544,1,0.995690761056092,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16381,GO:0071545,1,0.921292235155528,0,12,inositol phosphate catabolic process,BP,
16382,GO:0071546,1,0.95726478973904,0,6,pi-body,CC,
16383,GO:0071547,1,0.96709410939099,0,5,piP-body,CC,
16384,GO:0071548,1,0.772485530606366,0,41,response to dexamethasone,BP,
16385,GO:0071549,1,0.818811681381658,0,32,cellular response to dexamethasone stimulus,BP,
16386,GO:0071550,1,0.949299686856003,0,9,death-inducing signaling complex assembly,BP,
16387,GO:0071553,1,0.983769836563306,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16388,GO:0071554,1,0.975883229190281,0,5,cell wall organization or biogenesis,BP,
16389,GO:0071556,1,0.879421793074708,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16390,GO:0071557,1,0.963150026602856,0,5,histone H3-K27 demethylation,BP,
16391,GO:0071558,1,0.963150026602856,0,5,histone demethylase activity (H3-K27 specific),MF,
16392,GO:0071559,1,0.240603147319457,0,212,response to transforming growth factor beta,BP,
16393,GO:0071560,1,0.247704228775731,0,208,cellular response to transforming growth factor beta stimulus,BP,
16394,GO:0071561,1,0.992446699087294,0,1,nucleus-vacuole junction,CC,
16395,GO:0071564,1,0.92372937048076,0,12,npBAF complex,CC,
16396,GO:0071565,1,0.910283036443165,0,14,nBAF complex,CC,
16397,GO:0071566,1,0.992895551312478,0,1,UFM1 activating enzyme activity,MF,
16398,GO:0071567,1,0.989979956166667,0,2,UFM1 hydrolase activity,MF,
16399,GO:0071568,1,0.989118862037169,0,2,UFM1 transferase activity,MF,
16400,GO:0071569,1,0.966434437844874,0,6,protein ufmylation,BP,
16401,GO:0071573,1,0.992910025256332,0,1,shelterin complex assembly,BP,
16403,GO:0071578,1,0.953510565084892,0,7,zinc ion import across plasma membrane,BP,
16404,GO:0071579,1,0.987569154737394,0,2,regulation of zinc ion transport,BP,
16405,GO:0071580,1,0.994524886623575,0,1,regulation of zinc ion transmembrane transport,BP,
16406,GO:0071581,1,0.994524886623575,0,1,regulation of zinc ion transmembrane import,BP,
16407,GO:0071582,1,0.994524886623575,0,1,negative regulation of zinc ion transport,BP,
16408,GO:0071583,1,0.994524886623575,0,1,negative regulation of zinc ion transmembrane transport,BP,
16409,GO:0071584,1,0.994524886623575,0,1,negative regulation of zinc ion transmembrane import,BP,
16410,GO:0071585,1,0.994524886623575,0,1,detoxification of cadmium ion,BP,
16411,GO:0071586,1,0.98825284276018,0,2,CAAX-box protein processing,BP,
16412,GO:0071593,1,0.975274532822151,0,4,lymphocyte aggregation,BP,
16413,GO:0071595,1,0.986238532970005,0,2,Nem1-Spo7 phosphatase complex,CC,
16414,GO:0071596,1,0.977016395561839,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16415,GO:0071598,1,0.967975888969255,0,5,neuronal ribonucleoprotein granule,CC,
16416,GO:0071599,1,0.907559393926874,0,15,otic vesicle development,BP,
16417,GO:0071600,1,0.941556975845156,0,10,otic vesicle morphogenesis,BP,
16418,GO:0071602,1,0.99248757873928,0,1,phytosphingosine biosynthetic process,BP,
16419,GO:0071603,1,0.971391265416894,0,4,endothelial cell-cell adhesion,BP,
16420,GO:0071604,1,0.829896462592379,0,28,transforming growth factor beta production,BP,
16421,GO:0071605,1,0.933487803121115,0,12,monocyte chemotactic protein-1 production,BP,
16422,GO:0071606,1,0.994593496571265,0,1,chemokine (C-C motif) ligand 4 production,BP,
16423,GO:0071608,1,0.972930362593299,0,4,macrophage inflammatory protein-1 alpha production,BP,
16424,GO:0071609,1,0.935944257509126,0,10,chemokine (C-C motif) ligand 5 production,BP,
16425,GO:0071610,1,0.993540320151259,0,1,chemokine (C-C motif) ligand 1 production,BP,
16426,GO:0071611,1,0.969293979549245,0,5,granulocyte colony-stimulating factor production,BP,
16427,GO:0071612,1,0.991901749540898,0,1,IP-10 production,BP,
16428,GO:0071613,1,0.989432148280444,0,2,granzyme B production,BP,
16429,GO:0071614,1,0.994832671464641,0,1,linoleic acid epoxygenase activity,MF,
16430,GO:0071616,1,0.731815135383911,0,46,acyl-CoA biosynthetic process,BP,
16431,GO:0071617,1,0.88348374740159,0,18,lysophospholipid acyltransferase activity,MF,
16432,GO:0071619,1,0.99399889259741,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16433,GO:0071621,1,0.625777631523764,0,83,granulocyte chemotaxis,BP,
16434,GO:0071622,1,0.789364830278878,0,43,regulation of granulocyte chemotaxis,BP,
16435,GO:0071623,1,0.985599247166474,0,2,negative regulation of granulocyte chemotaxis,BP,
16436,GO:0071624,1,0.857782010996788,0,30,positive regulation of granulocyte chemotaxis,BP,
16437,GO:0071625,1,0.882591327822987,0,17,vocalization behavior,BP,
16438,GO:0071626,1,0.995804276297472,0,1,mastication,BP,
16439,GO:0071629,1,0.995227575740951,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16440,GO:0071630,1,0.978267963494789,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16441,GO:0071633,1,0.993005114325294,0,1,dihydroceramidase activity,MF,
16442,GO:0071634,1,0.836197762831761,0,27,regulation of transforming growth factor beta production,BP,
16443,GO:0071635,1,0.954204794373973,0,7,negative regulation of transforming growth factor beta production,BP,
16444,GO:0071636,1,0.89681677125136,0,17,positive regulation of transforming growth factor beta production,BP,
16445,GO:0071637,1,0.933487803121115,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16446,GO:0071638,1,0.97175048707686,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16447,GO:0071639,1,0.960636284121596,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16448,GO:0071640,1,0.972930362593299,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16449,GO:0071641,1,0.987186544483117,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16450,GO:0071642,1,0.985560661975433,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16451,GO:0071643,1,0.994593496571265,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16452,GO:0071644,1,0.994593496571265,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16453,GO:0071649,1,0.940494209007921,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16454,GO:0071650,1,0.983579853696143,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16455,GO:0071651,1,0.956202309448705,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16456,GO:0071652,1,0.993540320151259,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16457,GO:0071654,1,0.993540320151259,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16458,GO:0071655,1,0.974091431734942,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16459,GO:0071656,1,0.993901908091466,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16460,GO:0071657,1,0.980069208007254,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16461,GO:0071658,1,0.991901749540898,0,1,regulation of IP-10 production,BP,
16462,GO:0071660,1,0.991901749540898,0,1,positive regulation of IP-10 production,BP,
16463,GO:0071661,1,0.989432148280444,0,2,regulation of granzyme B production,BP,
16464,GO:0071663,1,0.989432148280444,0,2,positive regulation of granzyme B production,BP,
16465,GO:0071664,1,0.970180407270678,0,4,catenin-TCF7L2 complex,CC,
16466,GO:0071665,1,0.992598137900429,0,1,gamma-catenin-TCF7L2 complex,CC,
16467,GO:0071670,1,0.951324948433888,0,8,smooth muscle cell chemotaxis,BP,
16468,GO:0071671,1,0.96563115635037,0,6,regulation of smooth muscle cell chemotaxis,BP,
16469,GO:0071672,1,0.980050616074293,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16470,GO:0071673,1,0.981873886478406,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16471,GO:0071674,1,0.731438210917817,0,55,mononuclear cell migration,BP,
16472,GO:0071675,1,0.811732508292759,0,34,regulation of mononuclear cell migration,BP,
16473,GO:0071676,1,0.959993803737065,0,6,negative regulation of mononuclear cell migration,BP,
16474,GO:0071677,1,0.906710871542984,0,17,positive regulation of mononuclear cell migration,BP,
16475,GO:0071678,1,0.992221511650861,0,1,olfactory bulb axon guidance,BP,
16476,GO:0071679,1,0.942280715712654,0,8,commissural neuron axon guidance,BP,
16477,GO:0071680,1,0.962972782702172,0,5,response to indole-3-methanol,BP,
16478,GO:0071681,1,0.962972782702172,0,5,cellular response to indole-3-methanol,BP,
16479,GO:0071682,1,0.906466543461929,0,19,endocytic vesicle lumen,CC,
16480,GO:0071684,1,0.992654781804303,0,1,organism emergence from protective structure,BP,
16481,GO:0071688,1,0.912505739296758,0,13,striated muscle myosin thick filament assembly,BP,
16482,GO:0071691,1,0.992285875031985,0,1,cardiac muscle thin filament assembly,BP,
16483,GO:0071692,1,0.962359416322409,0,6,protein localization to extracellular region,BP,
16484,GO:0071694,1,0.962359416322409,0,6,maintenance of protein location in extracellular region,BP,
16486,GO:0071696,1,0.903172048239523,0,15,ectodermal placode development,BP,
16487,GO:0071697,1,0.9090061922513,0,14,ectodermal placode morphogenesis,BP,
16488,GO:0071698,1,0.971273485794653,0,4,olfactory placode development,BP,
16489,GO:0071699,1,0.971273485794653,0,4,olfactory placode morphogenesis,BP,
16490,GO:0071701,1,0.992460995811538,0,1,regulation of MAPK export from nucleus,BP,
16494,GO:0071706,1,0.494159161968959,0,114,tumor necrosis factor superfamily cytokine production,BP,
16495,GO:0071707,1,0.995804276297472,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16496,GO:0071709,1,0.828345659525874,0,27,membrane assembly,BP,
16497,GO:0071711,1,0.874875154019814,0,19,basement membrane organization,BP,
16498,GO:0071712,1,0.92599058458809,0,12,ER-associated misfolded protein catabolic process,BP,
16499,GO:0071713,1,0.992470536249967,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16500,GO:0071714,1,0.992494088677384,0,1,icosanoid transmembrane transporter activity,MF,
16501,GO:0071715,1,0.819553525470474,0,31,icosanoid transport,BP,
16502,GO:0071723,1,0.954967408820587,0,7,lipopeptide binding,MF,
16503,GO:0071724,1,0.974927505545415,0,4,response to diacyl bacterial lipopeptide,BP,
16504,GO:0071725,1,0.981036279425905,0,3,response to triacyl bacterial lipopeptide,BP,
16505,GO:0071726,1,0.974927505545415,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16506,GO:0071727,1,0.981036279425905,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16509,GO:0071733,1,0.975861937691377,0,4,transcriptional activation by promoter-enhancer looping,BP,
16510,GO:0071763,1,0.958877214435452,0,6,nuclear membrane organization,BP,
16511,GO:0071765,1,0.992494532910122,0,1,nuclear inner membrane organization,BP,
16514,GO:0071774,1,0.430380839560175,0,128,response to fibroblast growth factor,BP,
16515,GO:0071782,1,0.884501381199784,0,18,endoplasmic reticulum tubular network,CC,
16516,GO:0071786,1,0.90428682900058,0,15,endoplasmic reticulum tubular network organization,BP,
16517,GO:0071787,1,0.974297106574576,0,4,endoplasmic reticulum tubular network formation,BP,
16518,GO:0071789,1,0.9930956730518,0,1,spindle pole body localization to nuclear envelope,BP,
16519,GO:0071790,1,0.9930956730518,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16520,GO:0071791,1,0.9858577992226,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16521,GO:0071796,1,0.995772592857048,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16522,GO:0071797,1,0.974028192048542,0,4,LUBAC complex,CC,
16523,GO:0071798,1,0.969263544840527,0,5,response to prostaglandin D,BP,
16524,GO:0071799,1,0.969263544840527,0,5,cellular response to prostaglandin D stimulus,BP,
16525,GO:0071800,1,0.87477540353485,0,20,podosome assembly,BP,
16526,GO:0071801,1,0.913856660859912,0,13,regulation of podosome assembly,BP,
16527,GO:0071802,1,0.992495226108232,0,1,negative regulation of podosome assembly,BP,
16528,GO:0071803,1,0.939455570589595,0,9,positive regulation of podosome assembly,BP,
16531,GO:0071806,1,0.730560202844084,0,54,protein transmembrane transport,BP,
16532,GO:0071812,1,0.992733644405457,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16533,GO:0071813,1,0.87131435038451,0,21,lipoprotein particle binding,MF,
16534,GO:0071814,1,0.87131435038451,0,21,protein-lipid complex binding,MF,
16535,GO:0071816,1,0.977039677578698,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16536,GO:0071817,1,0.971647967918299,0,5,MMXD complex,CC,
16537,GO:0071818,1,0.981519094252176,0,3,BAT3 complex,CC,
16538,GO:0071819,1,0.989156827718035,0,2,DUBm complex,CC,
16539,GO:0071820,1,0.995538291756773,0,1,N-box binding,MF,
16540,GO:0071821,1,0.988522385379066,0,2,FANCM-MHF complex,CC,
16541,GO:0071823,1,0.991819732858453,0,2,protein-carbohydrate complex subunit organization,BP,
16542,GO:0071824,1,0.26371155784771,0,219,protein-DNA complex subunit organization,BP,
16543,GO:0071825,1,0.784866996799753,0,39,protein-lipid complex subunit organization,BP,
16545,GO:0071827,1,0.795678343676229,0,37,plasma lipoprotein particle organization,BP,
16546,GO:0071830,1,0.962492466064319,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16547,GO:0071837,1,0.892411333615831,0,17,HMG box domain binding,MF,
16548,GO:0071838,1,0.95977310924006,0,6,cell proliferation in bone marrow,BP,
16549,GO:0071839,1,0.97559099333971,0,4,apoptotic process in bone marrow,BP,
16551,GO:0071846,1,0.996513538183237,0,1,actin filament debranching,BP,
16552,GO:0071847,1,0.985270287346246,0,2,TNFSF11-mediated signaling pathway,BP,
16553,GO:0071848,1,0.992733644405457,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16554,GO:0071850,1,0.913530845801125,0,14,mitotic cell cycle arrest,BP,
16556,GO:0071863,1,0.959674118893163,0,6,regulation of cell proliferation in bone marrow,BP,
16557,GO:0071864,1,0.959674118893163,0,6,positive regulation of cell proliferation in bone marrow,BP,
16558,GO:0071865,1,0.974475730219229,0,4,regulation of apoptotic process in bone marrow,BP,
16559,GO:0071866,1,0.974475730219229,0,4,negative regulation of apoptotic process in bone marrow,BP,
16560,GO:0071867,1,0.785453693320633,0,35,response to monoamine,BP,
16561,GO:0071868,1,0.799725881209053,0,32,cellular response to monoamine stimulus,BP,
16562,GO:0071869,1,0.785453693320633,0,35,response to catecholamine,BP,
16563,GO:0071870,1,0.799725881209053,0,32,cellular response to catecholamine stimulus,BP,
16564,GO:0071871,1,0.901357447989396,0,15,response to epinephrine,BP,
16565,GO:0071872,1,0.917712488023719,0,12,cellular response to epinephrine stimulus,BP,
16566,GO:0071873,1,0.978686351549702,0,3,response to norepinephrine,BP,
16567,GO:0071874,1,0.986243445815717,0,2,cellular response to norepinephrine stimulus,BP,
16569,GO:0071877,1,0.995690761056092,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16570,GO:0071878,1,0.984691736410775,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16571,GO:0071879,1,0.97908749276574,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16573,GO:0071881,1,0.988227042757534,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16574,GO:0071882,1,0.992504308991839,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16575,GO:0071885,1,0.98933857647837,0,2,N-terminal protein N-methyltransferase activity,MF,
16576,GO:0071886,1,0.98521215496828,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16577,GO:0071887,1,0.56482483329187,0,93,leukocyte apoptotic process,BP,
16578,GO:0071888,1,0.943943020960179,0,9,macrophage apoptotic process,BP,
16579,GO:0071889,1,0.843830529144585,0,25,14-3-3 protein binding,MF,
16580,GO:0071890,1,0.992433649884134,0,1,bicarbonate binding,MF,
16581,GO:0071893,1,0.99497902520046,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16582,GO:0071894,1,0.986903954246761,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16583,GO:0071895,1,0.95984931914512,0,6,odontoblast differentiation,BP,
16584,GO:0071896,1,0.969583383374354,0,4,protein localization to adherens junction,BP,
16585,GO:0071897,1,0.285862313928696,0,190,DNA biosynthetic process,BP,
16586,GO:0071898,1,0.980781741824023,0,3,regulation of estrogen receptor binding,BP,
16587,GO:0071899,1,0.980781741824023,0,3,negative regulation of estrogen receptor binding,BP,
16591,GO:0071907,1,0.951806719802992,0,7,determination of digestive tract left/right asymmetry,BP,
16592,GO:0071908,1,0.992419488068084,0,1,determination of intestine left/right asymmetry,BP,
16593,GO:0071909,1,0.992419488068084,0,1,determination of stomach left/right asymmetry,BP,
16594,GO:0071910,1,0.956268554474655,0,6,determination of liver left/right asymmetry,BP,
16595,GO:0071914,1,0.985063285450952,0,2,prominosome,CC,
16597,GO:0071920,1,0.987726159529454,0,2,cleavage body,CC,
16598,GO:0071921,1,0.966256478503934,0,5,cohesin loading,BP,
16599,GO:0071922,1,0.972976094489505,0,4,regulation of cohesin loading,BP,
16600,GO:0071926,1,0.972108582551897,0,4,endocannabinoid signaling pathway,BP,
16601,GO:0071929,1,0.98588193014679,0,2,alpha-tubulin acetylation,BP,
16602,GO:0071930,1,0.978230624025396,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16603,GO:0071931,1,0.981705720699101,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16604,GO:0071933,1,0.94870439824784,0,8,Arp2/3 complex binding,MF,
16605,GO:0071934,1,0.980389701900696,0,3,thiamine transmembrane transport,BP,
16606,GO:0071936,1,0.941705031319093,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16607,GO:0071938,1,0.993011391587234,0,1,vitamin A transport,BP,
16608,GO:0071939,1,0.993011391587234,0,1,vitamin A import,BP,
16609,GO:0071941,1,0.92211542552393,0,14,nitrogen cycle metabolic process,BP,
16610,GO:0071942,1,0.98119004872918,0,3,XPC complex,CC,
16612,GO:0071947,1,0.977903364333566,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16613,GO:0071949,1,0.849935961576381,0,25,FAD binding,MF,
16614,GO:0071951,1,0.99314632348085,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16615,GO:0071953,1,0.974471579347056,0,4,elastic fiber,CC,
16616,GO:0071954,1,0.992556991255456,0,1,chemokine (C-C motif) ligand 11 production,BP,
16617,GO:0071955,1,0.9848007619851,0,2,recycling endosome to Golgi transport,BP,
16618,GO:0071960,1,0.996275403119693,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16619,GO:0071962,1,0.983778599166301,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16620,GO:0071963,1,0.995047234063531,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16621,GO:0071971,1,0.954986307016395,0,7,extracellular exosome assembly,BP,
16622,GO:0071976,1,0.992631066479273,0,1,cell gliding,BP,
16623,GO:0071985,1,0.837415178407262,0,28,multivesicular body sorting pathway,BP,
16624,GO:0071986,1,0.959647682082217,0,6,Ragulator complex,CC,
16625,GO:0071987,1,0.97122331149757,0,4,WD40-repeat domain binding,MF,
16626,GO:0071988,1,0.992263514958006,0,1,protein localization to spindle pole body,BP,
16627,GO:0071997,1,0.99233132566982,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16628,GO:0072001,1,0.163501025304209,0,262,renal system development,BP,
16629,GO:0072003,1,0.98064518198041,0,3,kidney rudiment formation,BP,
16630,GO:0072004,1,0.985057492417239,0,2,kidney field specification,BP,
16631,GO:0072006,1,0.417630254438803,0,127,nephron development,BP,
16632,GO:0072007,1,0.957137110183155,0,7,mesangial cell differentiation,BP,
16633,GO:0072008,1,0.962169004351513,0,6,glomerular mesangial cell differentiation,BP,
16634,GO:0072009,1,0.511565349775311,0,99,nephron epithelium development,BP,
16635,GO:0072010,1,0.882305350725381,0,18,glomerular epithelium development,BP,
16636,GO:0072011,1,0.988401216881403,0,2,glomerular endothelium development,BP,
16637,GO:0072012,1,0.869454550625634,0,21,glomerulus vasculature development,BP,
16638,GO:0072014,1,0.967107283579048,0,5,proximal tubule development,BP,
16639,GO:0072015,1,0.936546785910957,0,9,glomerular visceral epithelial cell development,BP,
16640,GO:0072016,1,0.993322633427007,0,1,glomerular parietal epithelial cell development,BP,
16641,GO:0072017,1,0.92260074229388,0,11,distal tubule development,BP,
16642,GO:0072019,1,0.994272203656633,0,1,proximal convoluted tubule development,BP,
16643,GO:0072021,1,0.979773339321524,0,3,ascending thin limb development,BP,
16644,GO:0072023,1,0.995467096261008,0,1,thick ascending limb development,BP,
16645,GO:0072024,1,0.995467096261008,0,1,macula densa development,BP,
16646,GO:0072025,1,0.974210003712972,0,4,distal convoluted tubule development,BP,
16647,GO:0072027,1,0.993493355656994,0,1,connecting tubule development,BP,
16648,GO:0072028,1,0.617755808256707,0,72,nephron morphogenesis,BP,
16649,GO:0072033,1,0.94100802156039,0,8,renal vesicle formation,BP,
16650,GO:0072034,1,0.977967943572358,0,3,renal vesicle induction,BP,
16651,GO:0072036,1,0.992512604166219,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16652,GO:0072038,1,0.967690227324107,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16653,GO:0072039,1,0.977667989445244,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16654,GO:0072040,1,0.977667989445244,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16655,GO:0072044,1,0.921398991333168,0,12,collecting duct development,BP,
16656,GO:0072046,1,0.995521445600653,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16657,GO:0072047,1,0.972850598673175,0,5,proximal/distal pattern formation involved in nephron development,BP,
16658,GO:0072048,1,0.947793269734336,0,9,renal system pattern specification,BP,
16659,GO:0072049,1,0.971489578438638,0,5,comma-shaped body morphogenesis,BP,
16660,GO:0072050,1,0.957242415838573,0,7,S-shaped body morphogenesis,BP,
16661,GO:0072051,1,0.995467096261008,0,1,juxtaglomerular apparatus development,BP,
16662,GO:0072053,1,0.985134522151675,0,2,renal inner medulla development,BP,
16663,GO:0072054,1,0.985134522151675,0,2,renal outer medulla development,BP,
16664,GO:0072055,1,0.992445788837059,0,1,renal cortex development,BP,
16665,GO:0072059,1,0.992445788837059,0,1,cortical collecting duct development,BP,
16666,GO:0072060,1,0.992502622493449,0,1,outer medullary collecting duct development,BP,
16667,GO:0072061,1,0.981135589254937,0,3,inner medullary collecting duct development,BP,
16668,GO:0072069,1,0.980591636597574,0,3,DCT cell differentiation,BP,
16669,GO:0072070,1,0.936761769958404,0,10,loop of Henle development,BP,
16670,GO:0072071,1,0.990333692037942,0,2,kidney interstitial fibroblast differentiation,BP,
16671,GO:0072073,1,0.410509823463517,0,130,kidney epithelium development,BP,
16672,GO:0072074,1,0.887120573541149,0,18,kidney mesenchyme development,BP,
16673,GO:0072075,1,0.908441927461198,0,14,metanephric mesenchyme development,BP,
16674,GO:0072076,1,0.978804192830978,0,3,nephrogenic mesenchyme development,BP,
16675,GO:0072077,1,0.88600979535287,0,18,renal vesicle morphogenesis,BP,
16676,GO:0072078,1,0.636777373012725,0,68,nephron tubule morphogenesis,BP,
16677,GO:0072079,1,0.893875800827284,0,18,nephron tubule formation,BP,
16678,GO:0072080,1,0.564435129835795,0,85,nephron tubule development,BP,
16679,GO:0072081,1,0.972850598673175,0,5,specification of nephron tubule identity,BP,
16680,GO:0072086,1,0.977964250347437,0,4,specification of loop of Henle identity,BP,
16681,GO:0072087,1,0.881372301759904,0,19,renal vesicle development,BP,
16682,GO:0072088,1,0.627242795283221,0,70,nephron epithelium morphogenesis,BP,
16683,GO:0072089,1,0.484025530723494,0,104,stem cell proliferation,BP,
16684,GO:0072091,1,0.676172141013969,0,57,regulation of stem cell proliferation,BP,
16685,GO:0072092,1,0.976729174836,0,3,ureteric bud invasion,BP,
16686,GO:0072093,1,0.969414267961913,0,4,metanephric renal vesicle formation,BP,
16687,GO:0072095,1,0.980696453064245,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16688,GO:0072096,1,0.99497902520046,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16689,GO:0072097,1,0.99497902520046,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16690,GO:0072098,1,0.989777319609514,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16691,GO:0072099,1,0.99497902520046,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16692,GO:0072100,1,0.99497902520046,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16693,GO:0072101,1,0.99497902520046,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16694,GO:0072102,1,0.950443652424719,0,7,glomerulus morphogenesis,BP,
16695,GO:0072103,1,0.972163598878698,0,4,glomerulus vasculature morphogenesis,BP,
16696,GO:0072104,1,0.972163598878698,0,4,glomerular capillary formation,BP,
16697,GO:0072106,1,0.975098930937505,0,4,regulation of ureteric bud formation,BP,
16698,GO:0072107,1,0.975098930937505,0,4,positive regulation of ureteric bud formation,BP,
16699,GO:0072108,1,0.974241857949872,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16700,GO:0072109,1,0.912227568363229,0,14,glomerular mesangium development,BP,
16701,GO:0072110,1,0.941449681518945,0,9,glomerular mesangial cell proliferation,BP,
16702,GO:0072111,1,0.887591004623109,0,18,cell proliferation involved in kidney development,BP,
16703,GO:0072112,1,0.901037484403521,0,15,glomerular visceral epithelial cell differentiation,BP,
16704,GO:0072114,1,0.992405804698064,0,1,pronephros morphogenesis,BP,
16705,GO:0072124,1,0.948672681778622,0,8,regulation of glomerular mesangial cell proliferation,BP,
16706,GO:0072125,1,0.980444029635599,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16707,GO:0072126,1,0.96760136257059,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16708,GO:0072127,1,0.994022053753213,0,1,renal capsule development,BP,
16709,GO:0072128,1,0.994022053753213,0,1,renal capsule morphogenesis,BP,
16710,GO:0072129,1,0.994022053753213,0,1,renal capsule formation,BP,
16711,GO:0072130,1,0.994022053753213,0,1,renal capsule specification,BP,
16712,GO:0072131,1,0.973491118357604,0,4,kidney mesenchyme morphogenesis,BP,
16713,GO:0072132,1,0.744801419310791,0,45,mesenchyme morphogenesis,BP,
16714,GO:0072133,1,0.973491118357604,0,4,metanephric mesenchyme morphogenesis,BP,
16715,GO:0072134,1,0.984691549627128,0,2,nephrogenic mesenchyme morphogenesis,BP,
16716,GO:0072135,1,0.980505970524558,0,3,kidney mesenchymal cell proliferation,BP,
16717,GO:0072136,1,0.980505970524558,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16718,GO:0072137,1,0.970593437368206,0,4,condensed mesenchymal cell proliferation,BP,
16719,GO:0072138,1,0.981764218051753,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16720,GO:0072139,1,0.985874248523617,0,2,glomerular parietal epithelial cell differentiation,BP,
16721,GO:0072141,1,0.990333692037942,0,2,renal interstitial fibroblast development,BP,
16722,GO:0072143,1,0.963697761892929,0,6,mesangial cell development,BP,
16723,GO:0072144,1,0.968763792714478,0,5,glomerular mesangial cell development,BP,
16724,GO:0072148,1,0.905007689606983,0,15,epithelial cell fate commitment,BP,
16725,GO:0072156,1,0.976701183267686,0,3,distal tubule morphogenesis,BP,
16726,GO:0072160,1,0.908040758211659,0,13,nephron tubule epithelial cell differentiation,BP,
16727,GO:0072161,1,0.95549490339521,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16728,GO:0072162,1,0.972591619653432,0,4,metanephric mesenchymal cell differentiation,BP,
16729,GO:0072163,1,0.534636286129964,0,93,mesonephric epithelium development,BP,
16730,GO:0072164,1,0.534636286129964,0,93,mesonephric tubule development,BP,
16731,GO:0072165,1,0.994772313216438,0,1,anterior mesonephric tubule development,BP,
16732,GO:0072166,1,0.987649053534059,0,2,posterior mesonephric tubule development,BP,
16733,GO:0072167,1,0.994772313216438,0,1,specification of mesonephric tubule identity,BP,
16734,GO:0072168,1,0.994772313216438,0,1,specification of anterior mesonephric tubule identity,BP,
16735,GO:0072169,1,0.994772313216438,0,1,specification of posterior mesonephric tubule identity,BP,
16736,GO:0072170,1,0.86134625319066,0,22,metanephric tubule development,BP,
16737,GO:0072171,1,0.671911321735871,0,60,mesonephric tubule morphogenesis,BP,
16738,GO:0072172,1,0.953400063641511,0,8,mesonephric tubule formation,BP,
16739,GO:0072173,1,0.92925429915428,0,11,metanephric tubule morphogenesis,BP,
16740,GO:0072174,1,0.959035292127709,0,6,metanephric tubule formation,BP,
16741,GO:0072175,1,0.430829202181628,0,126,epithelial tube formation,BP,
16742,GO:0072176,1,0.9163007614472,0,13,nephric duct development,BP,
16743,GO:0072177,1,0.963677548282414,0,6,mesonephric duct development,BP,
16744,GO:0072178,1,0.935948678884975,0,10,nephric duct morphogenesis,BP,
16745,GO:0072179,1,0.975993853146717,0,4,nephric duct formation,BP,
16746,GO:0072180,1,0.984330617816651,0,3,mesonephric duct morphogenesis,BP,
16747,GO:0072181,1,0.995521445600653,0,1,mesonephric duct formation,BP,
16748,GO:0072182,1,0.922023275450731,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16749,GO:0072183,1,0.987348194851167,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16750,GO:0072184,1,0.994772313216438,0,1,renal vesicle progenitor cell differentiation,BP,
16751,GO:0072185,1,0.988627221862532,0,2,metanephric cap development,BP,
16752,GO:0072186,1,0.988627221862532,0,2,metanephric cap morphogenesis,BP,
16753,GO:0072189,1,0.915435286307007,0,13,ureter development,BP,
16754,GO:0072190,1,0.982355398645799,0,3,ureter urothelium development,BP,
16755,GO:0072191,1,0.976281909907698,0,4,ureter smooth muscle development,BP,
16756,GO:0072192,1,0.99497902520046,0,1,ureter epithelial cell differentiation,BP,
16757,GO:0072193,1,0.976281909907698,0,4,ureter smooth muscle cell differentiation,BP,
16758,GO:0072194,1,0.982660963010223,0,3,kidney smooth muscle tissue development,BP,
16759,GO:0072195,1,0.995345054077821,0,1,kidney smooth muscle cell differentiation,BP,
16760,GO:0072197,1,0.980408177785117,0,3,ureter morphogenesis,BP,
16761,GO:0072198,1,0.983658412626891,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16762,GO:0072199,1,0.983658412626891,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16763,GO:0072200,1,0.99497902520046,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16764,GO:0072201,1,0.948895916656765,0,8,negative regulation of mesenchymal cell proliferation,BP,
16765,GO:0072202,1,0.858216125142986,0,23,cell differentiation involved in metanephros development,BP,
16766,GO:0072203,1,0.935058165076879,0,10,cell proliferation involved in metanephros development,BP,
16767,GO:0072204,1,0.985266894973113,0,2,cell-cell signaling involved in metanephros development,BP,
16768,GO:0072205,1,0.95099034339324,0,7,metanephric collecting duct development,BP,
16769,GO:0072206,1,0.995467096261008,0,1,metanephric juxtaglomerular apparatus development,BP,
16770,GO:0072207,1,0.848643710784206,0,24,metanephric epithelium development,BP,
16771,GO:0072208,1,0.987257192604552,0,2,metanephric smooth muscle tissue development,BP,
16772,GO:0072209,1,0.986216010470093,0,2,metanephric mesangial cell differentiation,BP,
16773,GO:0072210,1,0.784102894122906,0,36,metanephric nephron development,BP,
16774,GO:0072213,1,0.994022053753213,0,1,metanephric capsule development,BP,
16775,GO:0072214,1,0.992445788837059,0,1,metanephric cortex development,BP,
16776,GO:0072215,1,0.875537618144497,0,20,regulation of metanephros development,BP,
16777,GO:0072216,1,0.9221824716462,0,12,positive regulation of metanephros development,BP,
16778,GO:0072217,1,0.95505067346698,0,7,negative regulation of metanephros development,BP,
16779,GO:0072218,1,0.979773339321524,0,3,metanephric ascending thin limb development,BP,
16780,GO:0072219,1,0.992445788837059,0,1,metanephric cortical collecting duct development,BP,
16781,GO:0072221,1,0.974210003712972,0,4,metanephric distal convoluted tubule development,BP,
16782,GO:0072223,1,0.964635074989038,0,5,metanephric glomerular mesangium development,BP,
16783,GO:0072224,1,0.923733077585316,0,11,metanephric glomerulus development,BP,
16784,GO:0072227,1,0.995467096261008,0,1,metanephric macula densa development,BP,
16785,GO:0072229,1,0.994272203656633,0,1,metanephric proximal convoluted tubule development,BP,
16786,GO:0072233,1,0.995467096261008,0,1,metanephric thick ascending limb development,BP,
16787,GO:0072234,1,0.877814497344164,0,19,metanephric nephron tubule development,BP,
16788,GO:0072235,1,0.958848016070262,0,6,metanephric distal tubule development,BP,
16789,GO:0072236,1,0.972426083623901,0,4,metanephric loop of Henle development,BP,
16790,GO:0072237,1,0.986046964826288,0,2,metanephric proximal tubule development,BP,
16791,GO:0072239,1,0.952213521877309,0,7,metanephric glomerulus vasculature development,BP,
16792,GO:0072240,1,0.980591636597574,0,3,metanephric DCT cell differentiation,BP,
16793,GO:0072243,1,0.871117801688933,0,20,metanephric nephron epithelium development,BP,
16794,GO:0072244,1,0.9923812645265,0,1,metanephric glomerular epithelium development,BP,
16795,GO:0072248,1,0.9923812645265,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16796,GO:0072249,1,0.9923812645265,0,1,metanephric glomerular visceral epithelial cell development,BP,
16797,GO:0072254,1,0.986216010470093,0,2,metanephric glomerular mesangial cell differentiation,BP,
16798,GO:0072255,1,0.992973910981209,0,1,metanephric glomerular mesangial cell development,BP,
16799,GO:0072257,1,0.947712127342994,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16800,GO:0072258,1,0.994772313216438,0,1,metanephric interstitial fibroblast differentiation,BP,
16801,GO:0072259,1,0.994772313216438,0,1,metanephric interstitial fibroblast development,BP,
16802,GO:0072262,1,0.978120498661851,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16803,GO:0072265,1,0.994022053753213,0,1,metanephric capsule morphogenesis,BP,
16804,GO:0072266,1,0.994022053753213,0,1,metanephric capsule formation,BP,
16805,GO:0072267,1,0.994022053753213,0,1,metanephric capsule specification,BP,
16806,GO:0072268,1,0.97708682831481,0,4,pattern specification involved in metanephros development,BP,
16807,GO:0072272,1,0.988130225667209,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16808,GO:0072273,1,0.845241939293845,0,25,metanephric nephron morphogenesis,BP,
16809,GO:0072274,1,0.9923812645265,0,1,metanephric glomerular basement membrane development,BP,
16810,GO:0072275,1,0.984763838309262,0,2,metanephric glomerulus morphogenesis,BP,
16811,GO:0072276,1,0.984763838309262,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16812,GO:0072277,1,0.984763838309262,0,2,metanephric glomerular capillary formation,BP,
16813,GO:0072278,1,0.980004701100913,0,3,metanephric comma-shaped body morphogenesis,BP,
16814,GO:0072282,1,0.947007011452562,0,8,metanephric nephron tubule morphogenesis,BP,
16815,GO:0072283,1,0.90599051672729,0,15,metanephric renal vesicle morphogenesis,BP,
16816,GO:0072284,1,0.965633933637885,0,5,metanephric S-shaped body morphogenesis,BP,
16817,GO:0072285,1,0.992512604166219,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16818,GO:0072286,1,0.993493355656994,0,1,metanephric connecting tubule development,BP,
16819,GO:0072287,1,0.991727859987194,0,1,metanephric distal tubule morphogenesis,BP,
16820,GO:0072289,1,0.970630477441615,0,4,metanephric nephron tubule formation,BP,
16821,GO:0072298,1,0.97084679049812,0,4,regulation of metanephric glomerulus development,BP,
16822,GO:0072299,1,0.992839688196313,0,1,negative regulation of metanephric glomerulus development,BP,
16823,GO:0072300,1,0.977850095610331,0,3,positive regulation of metanephric glomerulus development,BP,
16824,GO:0072301,1,0.985621910040795,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16825,GO:0072302,1,0.992839688196313,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16826,GO:0072303,1,0.99273069832021,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16827,GO:0072304,1,0.985057492417239,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16828,GO:0072305,1,0.985057492417239,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16829,GO:0072307,1,0.947712127342994,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16830,GO:0072308,1,0.992537264470943,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16831,GO:0072309,1,0.985057492417239,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16832,GO:0072310,1,0.930288951080357,0,10,glomerular epithelial cell development,BP,
16833,GO:0072311,1,0.895014549449324,0,16,glomerular epithelial cell differentiation,BP,
16834,GO:0072312,1,0.9923812645265,0,1,metanephric glomerular epithelial cell differentiation,BP,
16835,GO:0072313,1,0.9923812645265,0,1,metanephric glomerular epithelial cell development,BP,
16836,GO:0072318,1,0.959163225964822,0,6,clathrin coat disassembly,BP,
16837,GO:0072319,1,0.953584712908457,0,7,vesicle uncoating,BP,
16838,GO:0072320,1,0.97238357776927,0,4,volume-sensitive chloride channel activity,MF,
16839,GO:0072321,1,0.947750307476938,0,10,chaperone-mediated protein transport,BP,
16841,GO:0072330,1,0.180444553073631,0,268,monocarboxylic acid biosynthetic process,BP,
16844,GO:0072334,1,0.991015585319008,0,2,UDP-galactose transmembrane transport,BP,
16845,GO:0072337,1,0.893414086846233,0,17,modified amino acid transport,BP,
16846,GO:0072338,1,0.958136676359681,0,6,cellular lactam metabolic process,BP,
16847,GO:0072340,1,0.995135257868318,0,1,cellular lactam catabolic process,BP,
16849,GO:0072343,1,0.99064545827008,0,2,pancreatic stellate cell proliferation,BP,
16850,GO:0072344,1,0.974389095813336,0,4,rescue of stalled ribosome,BP,
16851,GO:0072345,1,0.959124152198505,0,6,NAADP-sensitive calcium-release channel activity,MF,
16853,GO:0072348,1,0.814246004958496,0,30,sulfur compound transport,BP,
16854,GO:0072349,1,0.915664741776031,0,13,modified amino acid transmembrane transporter activity,MF,
16855,GO:0072350,1,0.8010872007162,0,36,tricarboxylic acid metabolic process,BP,
16856,GO:0072354,1,0.995112158155111,0,1,histone kinase activity (H3-T3 specific),MF,
16857,GO:0072355,1,0.995112158155111,0,1,histone H3-T3 phosphorylation,BP,
16858,GO:0072356,1,0.99249965888042,0,1,chromosome passenger complex localization to kinetochore,BP,
16859,GO:0072357,1,0.952395940947867,0,7,PTW/PP1 phosphatase complex,CC,
16862,GO:0072361,1,0.984297631872215,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16863,GO:0072362,1,0.992200761606969,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16864,GO:0072363,1,0.992035380444475,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16865,GO:0072364,1,0.984240520548658,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16866,GO:0072365,1,0.992143196404521,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16867,GO:0072366,1,0.992035380444475,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16868,GO:0072367,1,0.969956946312222,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16869,GO:0072368,1,0.984749520849655,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16870,GO:0072369,1,0.984980673389167,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16871,GO:0072376,1,0.671935358465113,0,66,protein activation cascade,BP,
16872,GO:0072378,1,0.882665541474321,0,21,blood coagulation, fibrin clot formation,BP,
16873,GO:0072379,1,0.981519094252176,0,3,ER membrane insertion complex,CC,
16874,GO:0072382,1,0.991711556153745,0,1,minus-end-directed vesicle transport along microtubule,BP,
16875,GO:0072383,1,0.94817994382872,0,7,plus-end-directed vesicle transport along microtubule,BP,
16877,GO:0072385,1,0.969624853685473,0,4,minus-end-directed organelle transport along microtubule,BP,
16878,GO:0072386,1,0.940957629048911,0,8,plus-end-directed organelle transport along microtubule,BP,
16879,GO:0072387,1,0.987154697411217,0,2,flavin adenine dinucleotide metabolic process,BP,
16880,GO:0072388,1,0.994610573360766,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16881,GO:0072389,1,0.992504135278238,0,1,flavin adenine dinucleotide catabolic process,BP,
16882,GO:0072393,1,0.920608343791421,0,11,microtubule anchoring at microtubule organizing center,BP,
16883,GO:0072395,1,0.62139930955381,0,74,signal transduction involved in cell cycle checkpoint,BP,
16884,GO:0072396,1,0.965506884400878,0,5,response to cell cycle checkpoint signaling,BP,
16885,GO:0072401,1,0.626346719526263,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16886,GO:0072402,1,0.965506884400878,0,5,response to DNA integrity checkpoint signaling,BP,
16887,GO:0072413,1,0.676697776554954,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16888,GO:0072414,1,0.992274336619346,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16889,GO:0072422,1,0.626346719526263,0,73,signal transduction involved in DNA damage checkpoint,BP,
16890,GO:0072423,1,0.965506884400878,0,5,response to DNA damage checkpoint signaling,BP,
16891,GO:0072425,1,0.924132043399906,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16892,GO:0072428,1,0.994817166189577,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16893,GO:0072429,1,0.980819031879719,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16894,GO:0072431,1,0.681585568554868,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16895,GO:0072432,1,0.992274336619346,0,1,response to G1 DNA damage checkpoint signaling,BP,
16896,GO:0072434,1,0.984864506500024,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16897,GO:0072487,1,0.972284253340236,0,4,MSL complex,CC,
16898,GO:0072488,1,0.934495673054247,0,11,ammonium transmembrane transport,BP,
16899,GO:0072492,1,0.995034445110811,0,1,host cell mitochondrial intermembrane space,CC,
16900,GO:0072497,1,0.943801441853242,0,8,mesenchymal stem cell differentiation,BP,
16901,GO:0072498,1,0.916451882186356,0,14,embryonic skeletal joint development,BP,
16902,GO:0072501,1,0.958861390280448,0,6,cellular divalent inorganic anion homeostasis,BP,
16903,GO:0072502,1,0.958861390280448,0,6,cellular trivalent inorganic anion homeostasis,BP,
16905,GO:0072505,1,0.937972715076852,0,9,divalent inorganic anion homeostasis,BP,
16906,GO:0072506,1,0.937972715076852,0,9,trivalent inorganic anion homeostasis,BP,
16909,GO:0072510,1,0.978609682097444,0,3,trivalent inorganic cation transmembrane transporter activity,MF,
16911,GO:0072512,1,0.793495262033487,0,38,trivalent inorganic cation transport,BP,
16912,GO:0072513,1,0.974868465956738,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16913,GO:0072517,1,0.99257195088681,0,1,host cell viral assembly compartment,CC,
16914,GO:0072518,1,0.992329602207964,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16915,GO:0072520,1,0.930265703201114,0,11,seminiferous tubule development,BP,
16919,GO:0072524,1,0.351276447782362,0,162,pyridine-containing compound metabolic process,BP,
16920,GO:0072525,1,0.4472153572686,0,122,pyridine-containing compound biosynthetic process,BP,
16921,GO:0072526,1,0.968859360020486,0,6,pyridine-containing compound catabolic process,BP,
16922,GO:0072527,1,0.639033818505264,0,77,pyrimidine-containing compound metabolic process,BP,
16923,GO:0072528,1,0.80416955886861,0,39,pyrimidine-containing compound biosynthetic process,BP,
16924,GO:0072529,1,0.822969810825814,0,34,pyrimidine-containing compound catabolic process,BP,
16925,GO:0072530,1,0.951554592156102,0,8,purine-containing compound transmembrane transport,BP,
16926,GO:0072531,1,0.944362667701085,0,9,pyrimidine-containing compound transmembrane transport,BP,
16927,GO:0072534,1,0.984675201618317,0,2,perineuronal net,CC,
16928,GO:0072535,1,0.986566498059432,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16929,GO:0072536,1,0.994582429640857,0,1,interleukin-23 receptor complex,CC,
16930,GO:0072537,1,0.93768588536963,0,9,fibroblast activation,BP,
16931,GO:0072538,1,0.896157839929358,0,17,T-helper 17 type immune response,BP,
16932,GO:0072539,1,0.902806832701756,0,16,T-helper 17 cell differentiation,BP,
16933,GO:0072540,1,0.943200508343586,0,10,T-helper 17 cell lineage commitment,BP,
16934,GO:0072542,1,0.958084657335698,0,7,protein phosphatase activator activity,MF,
16935,GO:0072544,1,0.995131715877176,0,1,L-DOPA binding,MF,
16936,GO:0072545,1,0.989390859563802,0,2,tyrosine binding,MF,
16937,GO:0072546,1,0.932504853845395,0,10,ER membrane protein complex,CC,
16938,GO:0072553,1,0.959189510234469,0,6,terminal button organization,BP,
16939,GO:0072554,1,0.986465304874304,0,2,blood vessel lumenization,BP,
16940,GO:0072556,1,0.992495450415882,0,1,other organism presynaptic membrane,CC,
16941,GO:0072557,1,0.980377251897614,0,4,IPAF inflammasome complex,CC,
16942,GO:0072558,1,0.980734260305321,0,4,NLRP1 inflammasome complex,CC,
16943,GO:0072559,1,0.956620443763292,0,8,NLRP3 inflammasome complex,CC,
16944,GO:0072560,1,0.988769713528015,0,2,type B pancreatic cell maturation,BP,
16945,GO:0072562,1,0.581235523749146,0,92,blood microparticle,CC,
16946,GO:0072563,1,0.988053996825043,0,2,endothelial microparticle,CC,
16947,GO:0072564,1,0.989625273241723,0,2,blood microparticle formation,BP,
16948,GO:0072566,1,0.987726596462374,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16949,GO:0072567,1,0.930858145586557,0,12,chemokine (C-X-C motif) ligand 2 production,BP,
16950,GO:0072570,1,0.992660141208156,0,1,ADP-D-ribose binding,MF,
16951,GO:0072572,1,0.994270160236356,0,1,poly-ADP-D-ribose binding,MF,
16952,GO:0072573,1,0.992485775250643,0,1,tolerance induction to lipopolysaccharide,BP,
16953,GO:0072574,1,0.912539810468063,0,14,hepatocyte proliferation,BP,
16954,GO:0072575,1,0.912539810468063,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16955,GO:0072576,1,0.905505094654419,0,15,liver morphogenesis,BP,
16956,GO:0072577,1,0.735763031457571,0,46,endothelial cell apoptotic process,BP,
16957,GO:0072578,1,0.930852943999497,0,10,neurotransmitter-gated ion channel clustering,BP,
16958,GO:0072579,1,0.99249272490571,0,1,glycine receptor clustering,BP,
16960,GO:0072584,1,0.94156939691052,0,9,caveolin-mediated endocytosis,BP,
16961,GO:0072586,1,0.992482005489878,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16962,GO:0072587,1,0.992482005489878,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16963,GO:0072588,1,0.978257386458527,0,5,box H/ACA RNP complex,CC,
16964,GO:0072589,1,0.982511855960707,0,4,box H/ACA scaRNP complex,CC,
16965,GO:0072590,1,0.984433865233719,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16966,GO:0072591,1,0.99238143953564,0,1,citrate-L-glutamate ligase activity,MF,
16967,GO:0072592,1,0.974008131324459,0,5,oxygen metabolic process,BP,
16970,GO:0072595,1,0.770425098960342,0,40,maintenance of protein localization in organelle,BP,
16971,GO:0072599,1,0.635871016104271,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16972,GO:0072602,1,0.961735874411579,0,6,interleukin-4 secretion,BP,
16973,GO:0072603,1,0.960844679900478,0,6,interleukin-5 secretion,BP,
16974,GO:0072604,1,0.830446596217859,0,28,interleukin-6 secretion,BP,
16976,GO:0072608,1,0.955308252000062,0,8,interleukin-10 secretion,BP,
16977,GO:0072610,1,0.946246827713195,0,9,interleukin-12 secretion,BP,
16978,GO:0072611,1,0.957224729787481,0,7,interleukin-13 secretion,BP,
16979,GO:0072615,1,0.988876030199322,0,2,interleukin-17 secretion,BP,
16980,GO:0072616,1,0.992500232495284,0,1,interleukin-18 secretion,BP,
16981,GO:0072619,1,0.992538827451657,0,1,interleukin-21 secretion,BP,
16982,GO:0072641,1,0.948640791839458,0,7,type I interferon secretion,BP,
16983,GO:0072642,1,0.955339407915872,0,6,interferon-alpha secretion,BP,
16984,GO:0072643,1,0.903849873678109,0,15,interferon-gamma secretion,BP,
16985,GO:0072655,1,0.349546836504465,0,174,establishment of protein localization to mitochondrion,BP,
16986,GO:0072656,1,0.967871787967394,0,5,maintenance of protein location in mitochondrion,BP,
16988,GO:0072658,1,0.992040273112879,0,1,maintenance of protein location in membrane,BP,
16990,GO:0072660,1,0.992040273112879,0,1,maintenance of protein location in plasma membrane,BP,
16991,GO:0072662,1,0.892850280238689,0,17,protein localization to peroxisome,BP,
16992,GO:0072663,1,0.892850280238689,0,17,establishment of protein localization to peroxisome,BP,
16995,GO:0072669,1,0.964221112778761,0,7,tRNA-splicing ligase complex,CC,
16996,GO:0072671,1,0.993469296531821,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16997,GO:0072672,1,0.953810852021551,0,7,neutrophil extravasation,BP,
16998,GO:0072673,1,0.887335906826212,0,17,lamellipodium morphogenesis,BP,
16999,GO:0072674,1,0.971063050206807,0,4,multinuclear osteoclast differentiation,BP,
17000,GO:0072675,1,0.971063050206807,0,4,osteoclast fusion,BP,
17002,GO:0072677,1,0.927953351556451,0,14,eosinophil migration,BP,
17003,GO:0072678,1,0.783289543577746,0,42,T cell migration,BP,
17004,GO:0072679,1,0.972150248457336,0,5,thymocyte migration,BP,
17005,GO:0072680,1,0.992718460821496,0,1,extracellular matrix-dependent thymocyte migration,BP,
17006,GO:0072681,1,0.992718460821496,0,1,fibronectin-dependent thymocyte migration,BP,
17007,GO:0072682,1,0.992581712021613,0,1,eosinophil extravasation,BP,
17008,GO:0072683,1,0.979697766265767,0,4,T cell extravasation,BP,
17009,GO:0072684,1,0.99250678007534,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17010,GO:0072686,1,0.55543446480076,0,85,mitotic spindle,CC,
17011,GO:0072687,1,0.969853909033403,0,5,meiotic spindle,CC,
17012,GO:0072695,1,0.987312702837011,0,2,regulation of DNA recombination at telomere,BP,
17013,GO:0072697,1,0.925816953029518,0,11,protein localization to cell cortex,BP,
17014,GO:0072698,1,0.73569349812069,0,43,protein localization to microtubule cytoskeleton,BP,
17015,GO:0072702,1,0.992398959676028,0,1,response to methyl methanesulfonate,BP,
17016,GO:0072703,1,0.992398959676028,0,1,cellular response to methyl methanesulfonate,BP,
17017,GO:0072706,1,0.993435831545065,0,1,response to sodium dodecyl sulfate,BP,
17018,GO:0072707,1,0.993435831545065,0,1,cellular response to sodium dodecyl sulfate,BP,
17019,GO:0072708,1,0.968834038788919,0,5,response to sorbitol,BP,
17020,GO:0072709,1,0.982199511532628,0,3,cellular response to sorbitol,BP,
17021,GO:0072710,1,0.943542083691288,0,8,response to hydroxyurea,BP,
17022,GO:0072711,1,0.950105334527292,0,7,cellular response to hydroxyurea,BP,
17023,GO:0072714,1,0.995058153067491,0,1,response to selenite ion,BP,
17024,GO:0072715,1,0.995058153067491,0,1,cellular response to selenite ion,BP,
17025,GO:0072716,1,0.975559713799656,0,4,response to actinomycin D,BP,
17026,GO:0072717,1,0.982343362339813,0,3,cellular response to actinomycin D,BP,
17027,GO:0072718,1,0.940425305059035,0,9,response to cisplatin,BP,
17028,GO:0072719,1,0.960603855756521,0,6,cellular response to cisplatin,BP,
17029,GO:0072720,1,0.986238532970005,0,2,response to dithiothreitol,BP,
17030,GO:0072721,1,0.9930956730518,0,1,cellular response to dithiothreitol,BP,
17031,GO:0072733,1,0.982261714004516,0,3,response to staurosporine,BP,
17032,GO:0072734,1,0.982261714004516,0,3,cellular response to staurosporine,BP,
17033,GO:0072737,1,0.987683889902456,0,2,response to diamide,BP,
17034,GO:0072738,1,0.987683889902456,0,2,cellular response to diamide,BP,
17035,GO:0072739,1,0.987897874689268,0,2,response to anisomycin,BP,
17036,GO:0072740,1,0.994766434051296,0,1,cellular response to anisomycin,BP,
17037,GO:0072741,1,0.979069538627123,0,3,protein localization to cell division site,BP,
17038,GO:0072749,1,0.994930231011602,0,1,cellular response to cytochalasin B,BP,
17039,GO:0072750,1,0.995780899418405,0,1,cellular response to leptomycin B,BP,
17040,GO:0072752,1,0.992314646373509,0,1,cellular response to rapamycin,BP,
17041,GO:0072755,1,0.992510835477284,0,1,cellular response to benomyl,BP,
17042,GO:0072757,1,0.972444186179663,0,4,cellular response to camptothecin,BP,
17043,GO:0075044,1,0.97019781804595,0,4,autophagy of host cells involved in interaction with symbiont,BP,
17044,GO:0075071,1,0.97019781804595,0,4,autophagy involved in symbiotic interaction,BP,
17045,GO:0075109,1,0.992434292396331,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17046,GO:0075111,1,0.992434292396331,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17047,GO:0075112,1,0.992434292396331,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17048,GO:0075114,1,0.992434292396331,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17049,GO:0075136,1,0.967744900572909,0,5,response to host,BP,
17050,GO:0075341,1,0.993954750516888,0,1,host cell PML body,CC,
17051,GO:0075509,1,0.978565755165828,0,3,endocytosis involved in viral entry into host cell,BP,
17052,GO:0075519,1,0.996476386889832,0,1,microtubule-dependent intracellular transport of viral material,BP,
17053,GO:0075521,1,0.996476386889832,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17054,GO:0075522,1,0.936102609439671,0,10,IRES-dependent viral translational initiation,BP,
17055,GO:0075525,1,0.970823065973558,0,5,viral translational termination-reinitiation,BP,
17056,GO:0075528,1,0.986623830888731,0,2,modulation by virus of host immune response,BP,
17057,GO:0075606,1,0.996476386889832,0,1,transport of viral material towards nucleus,BP,
17058,GO:0075713,1,0.952721545238398,0,8,establishment of integrated proviral latency,BP,
17059,GO:0075732,1,0.984932374390871,0,2,viral penetration into host nucleus,BP,
17060,GO:0075733,1,0.707953677715917,0,53,intracellular transport of virus,BP,
17062,GO:0080009,1,0.939559125483214,0,10,mRNA methylation,BP,
17063,GO:0080019,1,0.986820977704296,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17064,GO:0080023,1,0.986238532970005,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17065,GO:0080025,1,0.863784595956423,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17066,GO:0080033,1,0.992338574129646,0,1,response to nitrite,BP,
17067,GO:0080048,1,0.9930956730518,0,1,GDP-D-glucose phosphorylase activity,MF,
17068,GO:0080058,1,0.995674921403549,0,1,protein deglutathionylation,BP,
17069,GO:0080084,1,0.965852058022811,0,5,5S rDNA binding,MF,
17071,GO:0080101,1,0.996152411222081,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17072,GO:0080111,1,0.870306133914576,0,22,DNA demethylation,BP,
17073,GO:0080120,1,0.98825284276018,0,2,CAAX-box protein maturation,BP,
17074,GO:0080121,1,0.986788308456172,0,2,AMP transport,BP,
17075,GO:0080122,1,0.980350904648416,0,3,AMP transmembrane transporter activity,MF,
17076,GO:0080129,1,0.996033244402212,0,1,proteasome core complex assembly,BP,
17077,GO:0080132,1,0.993697131329752,0,1,fatty acid alpha-hydroxylase activity,MF,
17080,GO:0080144,1,0.987308885852227,0,2,amino acid homeostasis,BP,
17081,GO:0080146,1,0.995049967525852,0,1,L-cysteine desulfhydrase activity,MF,
17082,GO:0080147,1,0.996390802365142,0,1,root hair cell development,BP,
17083,GO:0080154,1,0.916736386875474,0,16,regulation of fertilization,BP,
17084,GO:0080163,1,0.993761548880371,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17085,GO:0080171,1,0.689447839437673,0,58,lytic vacuole organization,BP,
17086,GO:0080182,1,0.900394075162417,0,16,histone H3-K4 trimethylation,BP,
17087,GO:0080184,1,0.971090127149602,0,5,response to phenylpropanoid,BP,
17088,GO:0085018,1,0.993140495715573,0,1,maintenance of symbiont-containing vacuole by host,BP,
17089,GO:0085020,1,0.959608821584837,0,7,protein K6-linked ubiquitination,BP,
17090,GO:0085029,1,0.815585848823392,0,30,extracellular matrix assembly,BP,
17091,GO:0085032,1,0.992639706538651,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17092,GO:0086001,1,0.635688445074577,0,63,cardiac muscle cell action potential,BP,
17093,GO:0086002,1,0.71543297769513,0,46,cardiac muscle cell action potential involved in contraction,BP,
17094,GO:0086003,1,0.668308005038917,0,56,cardiac muscle cell contraction,BP,
17095,GO:0086004,1,0.787329834456274,0,33,regulation of cardiac muscle cell contraction,BP,
17096,GO:0086005,1,0.809617465020121,0,29,ventricular cardiac muscle cell action potential,BP,
17097,GO:0086006,1,0.96573559303715,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17098,GO:0086007,1,0.961811004230788,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17099,GO:0086008,1,0.922509271679735,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17100,GO:0086009,1,0.760460470512915,0,40,membrane repolarization,BP,
17101,GO:0086010,1,0.717754672359861,0,45,membrane depolarization during action potential,BP,
17102,GO:0086011,1,0.849642324843526,0,24,membrane repolarization during action potential,BP,
17103,GO:0086012,1,0.86365986431095,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17104,GO:0086013,1,0.867782506247339,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17105,GO:0086014,1,0.874499301933342,0,18,atrial cardiac muscle cell action potential,BP,
17106,GO:0086015,1,0.939642446993715,0,8,SA node cell action potential,BP,
17107,GO:0086016,1,0.933245710675668,0,9,AV node cell action potential,BP,
17108,GO:0086017,1,0.980566052004217,0,3,Purkinje myocyte action potential,BP,
17109,GO:0086018,1,0.939642446993715,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17110,GO:0086019,1,0.811413488735942,0,29,cell-cell signaling involved in cardiac conduction,BP,
17111,GO:0086020,1,0.992227012909899,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17112,GO:0086021,1,0.992227012909899,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17114,GO:0086024,1,0.992186319295289,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17115,GO:0086026,1,0.874499301933342,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17116,GO:0086027,1,0.933245710675668,0,9,AV node cell to bundle of His cell signaling,BP,
17117,GO:0086028,1,0.959555149453078,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17118,GO:0086029,1,0.965702348247826,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17120,GO:0086036,1,0.948213014868214,0,8,regulation of cardiac muscle cell membrane potential,BP,
17121,GO:0086037,1,0.992538301346493,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17122,GO:0086038,1,0.9930956730518,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17123,GO:0086039,1,0.992176865634032,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17124,GO:0086040,1,0.992478248487567,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17125,GO:0086041,1,0.992261321307288,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17126,GO:0086042,1,0.949444102757842,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17127,GO:0086043,1,0.959555149453078,0,6,bundle of His cell action potential,BP,
17128,GO:0086045,1,0.961745395169218,0,5,membrane depolarization during AV node cell action potential,BP,
17129,GO:0086046,1,0.961650502898754,0,5,membrane depolarization during SA node cell action potential,BP,
17130,GO:0086047,1,0.980566052004217,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17131,GO:0086048,1,0.97733138971057,0,3,membrane depolarization during bundle of His cell action potential,BP,
17132,GO:0086050,1,0.992996414181188,0,1,membrane repolarization during bundle of His cell action potential,BP,
17133,GO:0086052,1,0.992996414181188,0,1,membrane repolarization during SA node cell action potential,BP,
17134,GO:0086053,1,0.992227012909899,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17135,GO:0086056,1,0.976679303117211,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17136,GO:0086057,1,0.992504810438319,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17137,GO:0086059,1,0.984509795504483,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17138,GO:0086060,1,0.992156252140211,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17139,GO:0086061,1,0.992156252140211,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17140,GO:0086062,1,0.987978122148099,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17141,GO:0086063,1,0.992156252140211,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17142,GO:0086064,1,0.859002558199349,0,22,cell communication by electrical coupling involved in cardiac conduction,BP,
17143,GO:0086065,1,0.692686020327864,0,52,cell communication involved in cardiac conduction,BP,
17144,GO:0086066,1,0.874499301933342,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17145,GO:0086067,1,0.925986513446292,0,10,AV node cell to bundle of His cell communication,BP,
17146,GO:0086068,1,0.965702348247826,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17147,GO:0086069,1,0.910200014479373,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17148,GO:0086070,1,0.932334000206206,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17149,GO:0086072,1,0.993612217912698,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17150,GO:0086073,1,0.955550775047293,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17151,GO:0086075,1,0.985018776356644,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17152,GO:0086077,1,0.992227012909899,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17153,GO:0086080,1,0.930011311735641,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17154,GO:0086082,1,0.993612217912698,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17155,GO:0086083,1,0.962609098378504,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17156,GO:0086087,1,0.992996414181188,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17157,GO:0086089,1,0.971936605011996,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17158,GO:0086090,1,0.992996414181188,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17159,GO:0086091,1,0.776449176478707,0,35,regulation of heart rate by cardiac conduction,BP,
17160,GO:0086092,1,0.987626798747016,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17161,GO:0086096,1,0.995690761056092,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17162,GO:0086097,1,0.986419524256665,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17163,GO:0086098,1,0.985813995101223,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17164,GO:0086100,1,0.985054261538942,0,2,endothelin receptor signaling pathway,BP,
17166,GO:0089700,1,0.970418277918914,0,4,protein kinase D signaling,BP,
17167,GO:0089701,1,0.973996570119169,0,5,U2AF,CC,
17168,GO:0089709,1,0.980668648097278,0,3,L-histidine transmembrane transport,BP,
17169,GO:0089717,1,0.927592997312959,0,10,spanning component of membrane,CC,
17170,GO:0089718,1,0.877547492094594,0,19,amino acid import across plasma membrane,BP,
17171,GO:0089720,1,0.954635181653746,0,9,caspase binding,MF,
17172,GO:0090009,1,0.944134303311099,0,9,primitive streak formation,BP,
17173,GO:0090010,1,0.994384559683417,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17174,GO:0090022,1,0.833941427714827,0,34,regulation of neutrophil chemotaxis,BP,
17175,GO:0090023,1,0.861147476465078,0,29,positive regulation of neutrophil chemotaxis,BP,
17176,GO:0090024,1,0.985599247166474,0,2,negative regulation of neutrophil chemotaxis,BP,
17177,GO:0090025,1,0.895973773452065,0,18,regulation of monocyte chemotaxis,BP,
17178,GO:0090026,1,0.927475378501281,0,13,positive regulation of monocyte chemotaxis,BP,
17179,GO:0090027,1,0.973083716790087,0,4,negative regulation of monocyte chemotaxis,BP,
17180,GO:0090030,1,0.938133815584822,0,9,regulation of steroid hormone biosynthetic process,BP,
17181,GO:0090031,1,0.978945638565437,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17182,GO:0090032,1,0.965588954493094,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17183,GO:0090034,1,0.987829310130404,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17184,GO:0090035,1,0.987829310130404,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17185,GO:0090036,1,0.899362120520333,0,15,regulation of protein kinase C signaling,BP,
17186,GO:0090037,1,0.948243282787855,0,8,positive regulation of protein kinase C signaling,BP,
17187,GO:0090038,1,0.985305133629373,0,2,negative regulation of protein kinase C signaling,BP,
17188,GO:0090042,1,0.943800296719287,0,9,tubulin deacetylation,BP,
17189,GO:0090043,1,0.956044551929336,0,7,regulation of tubulin deacetylation,BP,
17190,GO:0090044,1,0.995296987477883,0,1,positive regulation of tubulin deacetylation,BP,
17191,GO:0090045,1,0.947501370603432,0,8,positive regulation of deacetylase activity,BP,
17192,GO:0090049,1,0.79737070132611,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17193,GO:0090050,1,0.889100066041073,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17194,GO:0090051,1,0.903595004518035,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17195,GO:0090063,1,0.97238202448133,0,4,positive regulation of microtubule nucleation,BP,
17196,GO:0090065,1,0.992500133858096,0,1,regulation of production of siRNA involved in RNA interference,BP,
17198,GO:0090067,1,0.992480267403341,0,1,regulation of thalamus size,BP,
17199,GO:0090068,1,0.200101005768725,0,244,positive regulation of cell cycle process,BP,
17200,GO:0090069,1,0.914178554171185,0,13,regulation of ribosome biogenesis,BP,
17201,GO:0090070,1,0.94850113969176,0,8,positive regulation of ribosome biogenesis,BP,
17202,GO:0090071,1,0.971185655072656,0,4,negative regulation of ribosome biogenesis,BP,
17203,GO:0090073,1,0.943262861522597,0,9,positive regulation of protein homodimerization activity,BP,
17204,GO:0090074,1,0.966702720372671,0,5,negative regulation of protein homodimerization activity,BP,
17206,GO:0090076,1,0.985022363927084,0,2,relaxation of skeletal muscle,BP,
17207,GO:0090077,1,0.828071992701119,0,29,foam cell differentiation,BP,
17209,GO:0090080,1,0.98490515116317,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17210,GO:0090081,1,0.990913180184448,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17211,GO:0090082,1,0.990913180184448,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17212,GO:0090083,1,0.906607195706741,0,15,regulation of inclusion body assembly,BP,
17213,GO:0090084,1,0.935001437087803,0,10,negative regulation of inclusion body assembly,BP,
17214,GO:0090085,1,0.932418649254288,0,11,regulation of protein deubiquitination,BP,
17215,GO:0090086,1,0.986745391716917,0,3,negative regulation of protein deubiquitination,BP,
17217,GO:0090088,1,0.988508795246109,0,2,regulation of oligopeptide transport,BP,
17218,GO:0090089,1,0.988508795246109,0,2,regulation of dipeptide transport,BP,
17220,GO:0090091,1,0.963960288068533,0,5,positive regulation of extracellular matrix disassembly,BP,
17221,GO:0090092,1,0.264823097272388,0,201,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17222,GO:0090094,1,0.988627221862532,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17223,GO:0090095,1,0.993822944843489,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17224,GO:0090096,1,0.993822944843489,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17225,GO:0090100,1,0.529210503416172,0,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17226,GO:0090101,1,0.510561709658583,0,101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17228,GO:0090103,1,0.865436521635263,0,22,cochlea morphogenesis,BP,
17229,GO:0090107,1,0.982196179580065,0,3,regulation of high-density lipoprotein particle assembly,BP,
17230,GO:0090108,1,0.994411076577941,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17231,GO:0090109,1,0.689522048780533,0,53,regulation of cell-substrate junction assembly,BP,
17232,GO:0090110,1,0.910824018755507,0,13,cargo loading into COPII-coated vesicle,BP,
17233,GO:0090113,1,0.9942129704155,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17234,GO:0090114,1,0.63545254513021,0,69,COPII-coated vesicle budding,BP,
17235,GO:0090116,1,0.977579322539169,0,3,C-5 methylation of cytosine,BP,
17236,GO:0090118,1,0.965603347234742,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17237,GO:0090119,1,0.987044323075177,0,2,vesicle-mediated cholesterol transport,BP,
17238,GO:0090122,1,0.994522862118781,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17241,GO:0090130,1,0.194325992098666,0,244,tissue migration,BP,
17242,GO:0090131,1,0.972788969665942,0,5,mesenchyme migration,BP,
17243,GO:0090132,1,0.199853078137062,0,239,epithelium migration,BP,
17244,GO:0090133,1,0.996091228183507,0,1,mesendoderm migration,BP,
17245,GO:0090134,1,0.996091228183507,0,1,cell migration involved in mesendoderm migration,BP,
17246,GO:0090135,1,0.981453636941454,0,3,actin filament branching,BP,
17247,GO:0090136,1,0.896237312193682,0,15,epithelial cell-cell adhesion,BP,
17248,GO:0090138,1,0.992520887188224,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17249,GO:0090140,1,0.866687318816525,0,21,regulation of mitochondrial fission,BP,
17250,GO:0090141,1,0.912906993443986,0,14,positive regulation of mitochondrial fission,BP,
17252,GO:0090149,1,0.98641734100175,0,2,mitochondrial membrane fission,BP,
17254,GO:0090151,1,0.942305613539592,0,12,establishment of protein localization to mitochondrial membrane,BP,
17255,GO:0090153,1,0.92421482572027,0,13,regulation of sphingolipid biosynthetic process,BP,
17256,GO:0090154,1,0.950313919259502,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17257,GO:0090155,1,0.976987756404662,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17258,GO:0090156,1,0.984429004022635,0,3,cellular sphingolipid homeostasis,BP,
17259,GO:0090158,1,0.961275021193565,0,6,endoplasmic reticulum membrane organization,BP,
17260,GO:0090160,1,0.946261571759963,0,8,Golgi to lysosome transport,BP,
17261,GO:0090161,1,0.92333177384524,0,11,Golgi ribbon formation,BP,
17262,GO:0090162,1,0.824199563727978,0,28,establishment of epithelial cell polarity,BP,
17263,GO:0090164,1,0.985541707554926,0,2,asymmetric Golgi ribbon formation,BP,
17264,GO:0090166,1,0.964277118676135,0,6,Golgi disassembly,BP,
17265,GO:0090168,1,0.975271729246617,0,4,Golgi reassembly,BP,
17266,GO:0090169,1,0.842666417467346,0,25,regulation of spindle assembly,BP,
17267,GO:0090170,1,0.976001299875268,0,4,regulation of Golgi inheritance,BP,
17268,GO:0090171,1,0.992506090263331,0,1,chondrocyte morphogenesis,BP,
17270,GO:0090175,1,0.519838486738205,0,108,regulation of establishment of planar polarity,BP,
17271,GO:0090176,1,0.992400046216467,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17272,GO:0090177,1,0.900416983591075,0,15,establishment of planar polarity involved in neural tube closure,BP,
17273,GO:0090178,1,0.904152229359186,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17274,GO:0090179,1,0.911012828988317,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17275,GO:0090181,1,0.712834721331687,0,51,regulation of cholesterol metabolic process,BP,
17276,GO:0090182,1,0.989804660061694,0,2,regulation of secretion of lysosomal enzymes,BP,
17277,GO:0090183,1,0.727811756708868,0,48,regulation of kidney development,BP,
17278,GO:0090184,1,0.792924753949417,0,35,positive regulation of kidney development,BP,
17279,GO:0090185,1,0.907157555215483,0,15,negative regulation of kidney development,BP,
17280,GO:0090186,1,0.956609238143995,0,7,regulation of pancreatic juice secretion,BP,
17281,GO:0090187,1,0.991083504185059,0,2,positive regulation of pancreatic juice secretion,BP,
17282,GO:0090188,1,0.965218705605382,0,5,negative regulation of pancreatic juice secretion,BP,
17283,GO:0090189,1,0.878756689975062,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17284,GO:0090190,1,0.893300212990479,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17285,GO:0090191,1,0.975370693869773,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17286,GO:0090192,1,0.929563080521872,0,11,regulation of glomerulus development,BP,
17287,GO:0090193,1,0.948114359572784,0,8,positive regulation of glomerulus development,BP,
17288,GO:0090194,1,0.980444029635599,0,3,negative regulation of glomerulus development,BP,
17289,GO:0090195,1,0.91643641196612,0,13,chemokine secretion,BP,
17290,GO:0090196,1,0.930036529476887,0,11,regulation of chemokine secretion,BP,
17291,GO:0090197,1,0.936622262958972,0,10,positive regulation of chemokine secretion,BP,
17292,GO:0090198,1,0.992973312581029,0,1,negative regulation of chemokine secretion,BP,
17293,GO:0090199,1,0.78552896657446,0,42,regulation of release of cytochrome c from mitochondria,BP,
17294,GO:0090200,1,0.853417567856669,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17295,GO:0090201,1,0.915189860933321,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17296,GO:0090202,1,0.975861937691377,0,4,gene looping,BP,
17297,GO:0090204,1,0.984155012754673,0,3,protein localization to nuclear pore,BP,
17298,GO:0090205,1,0.957475798743694,0,6,positive regulation of cholesterol metabolic process,BP,
17299,GO:0090206,1,0.972555545302471,0,5,negative regulation of cholesterol metabolic process,BP,
17300,GO:0090207,1,0.862164934928948,0,24,regulation of triglyceride metabolic process,BP,
17301,GO:0090208,1,0.913284115795696,0,15,positive regulation of triglyceride metabolic process,BP,
17302,GO:0090209,1,0.961582123508412,0,6,negative regulation of triglyceride metabolic process,BP,
17303,GO:0090210,1,0.985875798165633,0,2,regulation of establishment of blood-brain barrier,BP,
17304,GO:0090212,1,0.985875798165633,0,2,negative regulation of establishment of blood-brain barrier,BP,
17305,GO:0090214,1,0.988459185594375,0,2,spongiotrophoblast layer developmental growth,BP,
17307,GO:0090219,1,0.979044281389012,0,3,negative regulation of lipid kinase activity,BP,
17308,GO:0090220,1,0.932301164634903,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17309,GO:0090222,1,0.984563993438773,0,2,centrosome-templated microtubule nucleation,BP,
17310,GO:0090224,1,0.76635624951763,0,39,regulation of spindle organization,BP,
17311,GO:0090226,1,0.996337627667502,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17312,GO:0090230,1,0.971083700808942,0,4,regulation of centromere complex assembly,BP,
17313,GO:0090231,1,0.908845867929139,0,15,regulation of spindle checkpoint,BP,
17314,GO:0090232,1,0.949947647274898,0,8,positive regulation of spindle checkpoint,BP,
17315,GO:0090233,1,0.993252995819076,0,1,negative regulation of spindle checkpoint,BP,
17316,GO:0090234,1,0.978457789390034,0,3,regulation of kinetochore assembly,BP,
17317,GO:0090235,1,0.949765024462223,0,7,regulation of metaphase plate congression,BP,
17318,GO:0090237,1,0.967148339338432,0,5,regulation of arachidonic acid secretion,BP,
17319,GO:0090238,1,0.974509676491907,0,4,positive regulation of arachidonic acid secretion,BP,
17320,GO:0090239,1,0.92878098338936,0,12,regulation of histone H4 acetylation,BP,
17321,GO:0090240,1,0.959707114246499,0,7,positive regulation of histone H4 acetylation,BP,
17322,GO:0090241,1,0.970708290435298,0,5,negative regulation of histone H4 acetylation,BP,
17323,GO:0090244,1,0.974279681750943,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17324,GO:0090245,1,0.970519005764593,0,4,axis elongation involved in somitogenesis,BP,
17325,GO:0090246,1,0.992484179088526,0,1,convergent extension involved in somitogenesis,BP,
17326,GO:0090247,1,0.99339854533039,0,1,cell motility involved in somitogenic axis elongation,BP,
17327,GO:0090249,1,0.99339854533039,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17328,GO:0090251,1,0.99192734443264,0,1,protein localization involved in establishment of planar polarity,BP,
17330,GO:0090258,1,0.978164789091879,0,3,negative regulation of mitochondrial fission,BP,
17331,GO:0090259,1,0.964330697222115,0,5,regulation of retinal ganglion cell axon guidance,BP,
17332,GO:0090260,1,0.98500763313758,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17333,GO:0090261,1,0.978687601184623,0,4,positive regulation of inclusion body assembly,BP,
17334,GO:0090263,1,0.457559811714501,0,126,positive regulation of canonical Wnt signaling pathway,BP,
17335,GO:0090264,1,0.98888323701337,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17336,GO:0090265,1,0.993560428442244,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17337,GO:0090266,1,0.915596362251964,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17338,GO:0090267,1,0.957000232674961,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17339,GO:0090269,1,0.958600470821333,0,6,fibroblast growth factor production,BP,
17340,GO:0090270,1,0.958600470821333,0,6,regulation of fibroblast growth factor production,BP,
17341,GO:0090271,1,0.977844099920048,0,3,positive regulation of fibroblast growth factor production,BP,
17342,GO:0090272,1,0.980324802647559,0,3,negative regulation of fibroblast growth factor production,BP,
17343,GO:0090273,1,0.9893823853255,0,2,regulation of somatostatin secretion,BP,
17344,GO:0090274,1,0.9893823853255,0,2,positive regulation of somatostatin secretion,BP,
17348,GO:0090279,1,0.84617112739358,0,27,regulation of calcium ion import,BP,
17349,GO:0090280,1,0.918578092022215,0,14,positive regulation of calcium ion import,BP,
17350,GO:0090281,1,0.975910842030623,0,5,negative regulation of calcium ion import,BP,
17351,GO:0090282,1,0.992826033018805,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17352,GO:0090283,1,0.980524635685951,0,3,regulation of protein glycosylation in Golgi,BP,
17353,GO:0090284,1,0.992259972122931,0,1,positive regulation of protein glycosylation in Golgi,BP,
17354,GO:0090285,1,0.988174055078223,0,2,negative regulation of protein glycosylation in Golgi,BP,
17355,GO:0090286,1,0.957656765313988,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17356,GO:0090287,1,0.213090180849731,0,230,regulation of cellular response to growth factor stimulus,BP,
17357,GO:0090288,1,0.434969702865813,0,124,negative regulation of cellular response to growth factor stimulus,BP,
17358,GO:0090289,1,0.981194393793134,0,3,regulation of osteoclast proliferation,BP,
17359,GO:0090290,1,0.996097844432242,0,1,positive regulation of osteoclast proliferation,BP,
17360,GO:0090291,1,0.985038759322437,0,2,negative regulation of osteoclast proliferation,BP,
17361,GO:0090292,1,0.976600804323629,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17362,GO:0090293,1,0.994251771467272,0,1,nitrogen catabolite regulation of transcription,BP,
17363,GO:0090294,1,0.994251771467272,0,1,nitrogen catabolite activation of transcription,BP,
17364,GO:0090296,1,0.974275635378833,0,4,regulation of mitochondrial DNA replication,BP,
17365,GO:0090297,1,0.995790553451032,0,1,positive regulation of mitochondrial DNA replication,BP,
17366,GO:0090298,1,0.978395054301635,0,3,negative regulation of mitochondrial DNA replication,BP,
17367,GO:0090299,1,0.995194820598021,0,1,regulation of neural crest formation,BP,
17368,GO:0090301,1,0.995194820598021,0,1,negative regulation of neural crest formation,BP,
17369,GO:0090303,1,0.765342945250944,0,42,positive regulation of wound healing,BP,
17371,GO:0090305,1,0.18736543161759,0,265,nucleic acid phosphodiester bond hydrolysis,BP,
17372,GO:0090306,1,0.973012394547805,0,4,spindle assembly involved in meiosis,BP,
17373,GO:0090307,1,0.656774315149382,0,62,mitotic spindle assembly,BP,
17374,GO:0090308,1,0.949074099764851,0,7,regulation of methylation-dependent chromatin silencing,BP,
17375,GO:0090309,1,0.970587413055016,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17376,GO:0090310,1,0.985205309197082,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17377,GO:0090311,1,0.787166629722368,0,36,regulation of protein deacetylation,BP,
17378,GO:0090312,1,0.873440418488528,0,20,positive regulation of protein deacetylation,BP,
17381,GO:0090315,1,0.96730150192871,0,5,negative regulation of protein targeting to membrane,BP,
17383,GO:0090317,1,0.797377830104088,0,36,negative regulation of intracellular protein transport,BP,
17384,GO:0090322,1,0.852524397045557,0,27,regulation of superoxide metabolic process,BP,
17385,GO:0090323,1,0.996610217817555,0,1,prostaglandin secretion involved in immune response,BP,
17386,GO:0090324,1,0.967163276980354,0,5,negative regulation of oxidative phosphorylation,BP,
17387,GO:0090325,1,0.978569222093312,0,3,regulation of locomotion involved in locomotory behavior,BP,
17388,GO:0090326,1,0.992631564203044,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17389,GO:0090327,1,0.992496223623435,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17390,GO:0090329,1,0.74147615127681,0,45,regulation of DNA-dependent DNA replication,BP,
17391,GO:0090330,1,0.883681834574447,0,18,regulation of platelet aggregation,BP,
17392,GO:0090331,1,0.929592912000241,0,11,negative regulation of platelet aggregation,BP,
17393,GO:0090335,1,0.921223457575686,0,12,regulation of brown fat cell differentiation,BP,
17394,GO:0090336,1,0.962374907191005,0,6,positive regulation of brown fat cell differentiation,BP,
17395,GO:0090340,1,0.994411076577941,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17396,GO:0090341,1,0.995367958616827,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17397,GO:0090342,1,0.771660676185211,0,39,regulation of cell aging,BP,
17398,GO:0090343,1,0.944055623937532,0,10,positive regulation of cell aging,BP,
17399,GO:0090344,1,0.864147435091464,0,21,negative regulation of cell aging,BP,
17400,GO:0090345,1,0.988900750076578,0,2,cellular organohalogen metabolic process,BP,
17401,GO:0090346,1,0.988900750076578,0,2,cellular organofluorine metabolic process,BP,
17402,GO:0090347,1,0.995326921115523,0,1,regulation of cellular organohalogen metabolic process,BP,
17403,GO:0090348,1,0.995326921115523,0,1,regulation of cellular organofluorine metabolic process,BP,
17404,GO:0090349,1,0.995326921115523,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17405,GO:0090350,1,0.995326921115523,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17406,GO:0090360,1,0.981357127843601,0,3,platelet-derived growth factor production,BP,
17407,GO:0090361,1,0.981357127843601,0,3,regulation of platelet-derived growth factor production,BP,
17408,GO:0090362,1,0.986863314936359,0,2,positive regulation of platelet-derived growth factor production,BP,
17409,GO:0090365,1,0.994184407045872,0,1,regulation of mRNA modification,BP,
17410,GO:0090367,1,0.994184407045872,0,1,negative regulation of mRNA modification,BP,
17411,GO:0090370,1,0.980419219340185,0,3,negative regulation of cholesterol efflux,BP,
17412,GO:0090381,1,0.990913180184448,0,2,regulation of heart induction,BP,
17413,GO:0090382,1,0.786363331553908,0,40,phagosome maturation,BP,
17414,GO:0090383,1,0.861989983219189,0,26,phagosome acidification,BP,
17415,GO:0090385,1,0.958752154938117,0,7,phagosome-lysosome fusion,BP,
17416,GO:0090386,1,0.98477258853652,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17417,GO:0090387,1,0.98477258853652,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17418,GO:0090389,1,0.992225970258318,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17420,GO:0090398,1,0.68627041630617,0,58,cellular senescence,BP,
17421,GO:0090399,1,0.915150299783396,0,13,replicative senescence,BP,
17422,GO:0090400,1,0.946631506496027,0,8,stress-induced premature senescence,BP,
17423,GO:0090402,1,0.987676123830347,0,2,oncogene-induced cell senescence,BP,
17424,GO:0090403,1,0.972057293457197,0,4,oxidative stress-induced premature senescence,BP,
17426,GO:0090409,1,0.993967768402237,0,1,malonyl-CoA synthetase activity,MF,
17427,GO:0090410,1,0.993967768402237,0,1,malonate catabolic process,BP,
17428,GO:0090416,1,0.9934437146992,0,1,nicotinate transmembrane transporter activity,MF,
17429,GO:0090420,1,0.995611997115238,0,1,naphthalene-containing compound metabolic process,BP,
17430,GO:0090422,1,0.988563744257134,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17431,GO:0090425,1,0.992780976418393,0,1,acinar cell differentiation,BP,
17432,GO:0090427,1,0.981245428087229,0,3,activation of meiosis,BP,
17433,GO:0090435,1,0.958410636825639,0,7,protein localization to nuclear envelope,BP,
17434,GO:0090461,1,0.992491891609527,0,1,glutamate homeostasis,BP,
17435,GO:0090472,1,0.992495386674681,0,1,dibasic protein processing,BP,
17436,GO:0090480,1,0.978228207785729,0,3,purine nucleotide-sugar transmembrane transport,BP,
17437,GO:0090481,1,0.935988318626768,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17438,GO:0090482,1,0.865841387760365,0,22,vitamin transmembrane transporter activity,MF,
17439,GO:0090493,1,0.936194053260376,0,11,catecholamine uptake,BP,
17440,GO:0090494,1,0.936194053260376,0,11,dopamine uptake,BP,
17441,GO:0090498,1,0.979600731906764,0,3,extrinsic component of Golgi membrane,CC,
17442,GO:0090500,1,0.969348208176809,0,5,endocardial cushion to mesenchymal transition,BP,
17443,GO:0090501,1,0.455579549024559,0,129,RNA phosphodiester bond hydrolysis,BP,
17444,GO:0090502,1,0.68980332685717,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17445,GO:0090503,1,0.800851756707679,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17446,GO:0090504,1,0.828066259344732,0,28,epiboly,BP,
17447,GO:0090505,1,0.834791165997699,0,27,epiboly involved in wound healing,BP,
17448,GO:0090520,1,0.926866569364564,0,12,sphingolipid mediated signaling pathway,BP,
17449,GO:0090521,1,0.97140076819588,0,4,glomerular visceral epithelial cell migration,BP,
17450,GO:0090527,1,0.92274501052756,0,11,actin filament reorganization,BP,
17451,GO:0090529,1,0.99485390608053,0,1,cell septum assembly,BP,
17452,GO:0090533,1,0.915334884590529,0,14,cation-transporting ATPase complex,CC,
17453,GO:0090534,1,0.995112158155111,0,1,calcium ion-transporting ATPase complex,CC,
17454,GO:0090537,1,0.984952253099167,0,2,CERF complex,CC,
17455,GO:0090541,1,0.985635039515034,0,2,MIT domain binding,MF,
17456,GO:0090543,1,0.83601276100708,0,26,Flemming body,CC,
17457,GO:0090545,1,0.885006886998793,0,17,CHD-type complex,CC,
17458,GO:0090554,1,0.969601435283247,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17459,GO:0090555,1,0.984765718776598,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17460,GO:0090556,1,0.984354706429422,0,2,phosphatidylserine-translocating ATPase activity,MF,
17461,GO:0090557,1,0.941122084352306,0,8,establishment of endothelial intestinal barrier,BP,
17462,GO:0090558,1,0.996390802365142,0,1,plant epidermis development,BP,
17464,GO:0090560,1,0.994236451353786,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17465,GO:0090568,1,0.816458304130369,0,29,nuclear transcriptional repressor complex,CC,
17466,GO:0090571,1,0.975399220196555,0,4,RNA polymerase II transcription repressor complex,CC,
17467,GO:0090575,1,0.39085838866546,0,146,RNA polymerase II transcription factor complex,CC,
17468,GO:0090576,1,0.945845791871691,0,8,RNA polymerase III transcription factor complex,CC,
17469,GO:0090579,1,0.975861937691377,0,4,dsDNA loop formation,BP,
17470,GO:0090594,1,0.956836073634165,0,7,inflammatory response to wounding,BP,
17471,GO:0090596,1,0.216576797291693,0,227,sensory organ morphogenesis,BP,
17472,GO:0090598,1,0.981863227854858,0,3,male anatomical structure morphogenesis,BP,
17473,GO:0090599,1,0.962659432154583,0,5,alpha-glucosidase activity,MF,
17474,GO:0090600,1,0.992502791315339,0,1,alpha-1,3-glucosidase activity,MF,
17475,GO:0090601,1,0.99243882233873,0,1,enucleation,BP,
17476,GO:0090611,1,0.969635649272616,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17477,GO:0090615,1,0.987231477898582,0,2,mitochondrial mRNA processing,BP,
17478,GO:0090616,1,0.992476900260023,0,1,mitochondrial mRNA 3'-end processing,BP,
17479,GO:0090624,1,0.9930956730518,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17480,GO:0090625,1,0.9930956730518,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17481,GO:0090627,1,0.996390802365142,0,1,plant epidermal cell differentiation,BP,
17482,GO:0090630,1,0.576876838520809,0,79,activation of GTPase activity,BP,
17483,GO:0090634,1,0.995438695608872,0,1,microglial cell mediated cytotoxicity,BP,
17484,GO:0090646,1,0.930197873494901,0,12,mitochondrial tRNA processing,BP,
17485,GO:0090647,1,0.954354110858495,0,7,modulation of age-related behavioral decline,BP,
17486,GO:0090648,1,0.992345665476772,0,1,response to environmental enrichment,BP,
17487,GO:0090649,1,0.966061196780373,0,5,response to oxygen-glucose deprivation,BP,
17488,GO:0090650,1,0.966061196780373,0,5,cellular response to oxygen-glucose deprivation,BP,
17489,GO:0090651,1,0.992301552207589,0,1,apical cytoplasm,CC,
17490,GO:0090656,1,0.902920929433798,0,14,t-circle formation,BP,
17491,GO:0090657,1,0.930052937547179,0,10,telomeric loop disassembly,BP,
17492,GO:0090659,1,0.830630351028841,0,27,walking behavior,BP,
17493,GO:0090661,1,0.982511855960707,0,4,box H/ACA telomerase RNP complex,CC,
17494,GO:0090662,1,0.838061194926049,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17495,GO:0090663,1,0.991739189629607,0,2,galanin-activated signaling pathway,BP,
17496,GO:0090665,1,0.877527738558899,0,20,glycoprotein complex,CC,
17497,GO:0090666,1,0.977238971919856,0,4,scaRNA localization to Cajal body,BP,
17498,GO:0090667,1,0.992207842460839,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17499,GO:0090668,1,0.992207842460839,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17500,GO:0090669,1,0.973997856914067,0,4,telomerase RNA stabilization,BP,
17501,GO:0090670,1,0.895368341986066,0,19,RNA localization to Cajal body,BP,
17502,GO:0090671,1,0.895368341986066,0,19,telomerase RNA localization to Cajal body,BP,
17503,GO:0090672,1,0.895368341986066,0,19,telomerase RNA localization,BP,
17504,GO:0090673,1,0.99225163682005,0,1,endothelial cell-matrix adhesion,BP,
17505,GO:0090675,1,0.99249384473055,0,1,intermicrovillar adhesion,BP,
17506,GO:0090677,1,0.987840598269155,0,2,reversible differentiation,BP,
17507,GO:0090678,1,0.987840598269155,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17508,GO:0090685,1,0.895368341986066,0,19,RNA localization to nucleus,BP,
17509,GO:0090694,1,0.985174246202604,0,2,Scc2-Scc4 cohesin loading complex,CC,
17510,GO:0090713,1,0.961215708649487,0,6,immunological memory process,BP,
17511,GO:0090715,1,0.961215708649487,0,6,immunological memory formation process,BP,
17512,GO:0090722,1,0.976831067193073,0,4,receptor-receptor interaction,MF,
17513,GO:0090723,1,0.910904777068086,0,14,growth cone part,CC,
17514,GO:0090724,1,0.981156517844812,0,3,central region of growth cone,CC,
17515,GO:0090725,1,0.996275403119693,0,1,peripheral region of growth cone,CC,
17516,GO:0090731,1,0.995924249434127,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17517,GO:0090734,1,0.796383157481961,0,33,site of DNA damage,CC,
17518,GO:0090735,1,0.937851352421182,0,10,DNA repair complex assembly,BP,
17519,GO:0090737,1,0.902920929433798,0,14,telomere maintenance via telomere trimming,BP,
17520,GO:0090741,1,0.939403975745039,0,11,pigment granule membrane,CC,
17521,GO:0093001,1,0.992676984253821,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17523,GO:0097001,1,0.940109206473956,0,10,ceramide binding,MF,
17524,GO:0097003,1,0.986828935044621,0,2,adipokinetic hormone receptor activity,MF,
17525,GO:0097006,1,0.630460842375371,0,73,regulation of plasma lipoprotein particle levels,BP,
17527,GO:0097010,1,0.978612844935584,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17528,GO:0097011,1,0.947374190919136,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17529,GO:0097012,1,0.947374190919136,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17530,GO:0097013,1,0.986362320624202,0,3,phagocytic vesicle lumen,CC,
17531,GO:0097014,1,0.500677570965299,0,100,ciliary plasm,CC,
17532,GO:0097016,1,0.977365796413483,0,4,L27 domain binding,MF,
17533,GO:0097017,1,0.986757476245167,0,2,renal protein absorption,BP,
17534,GO:0097018,1,0.993547616258172,0,1,renal albumin absorption,BP,
17535,GO:0097020,1,0.992599363194569,0,1,COPII adaptor activity,MF,
17536,GO:0097021,1,0.981738616505951,0,3,lymphocyte migration into lymphoid organs,BP,
17537,GO:0097022,1,0.99421092928736,0,1,lymphocyte migration into lymph node,BP,
17538,GO:0097025,1,0.969968983509134,0,5,MPP7-DLG1-LIN7 complex,CC,
17539,GO:0097026,1,0.979329544986553,0,4,dendritic cell dendrite assembly,BP,
17540,GO:0097027,1,0.959670435782219,0,7,ubiquitin-protein transferase activator activity,MF,
17541,GO:0097028,1,0.809861479645914,0,37,dendritic cell differentiation,BP,
17542,GO:0097029,1,0.979964425170949,0,4,mature conventional dendritic cell differentiation,BP,
17543,GO:0097035,1,0.769011549670923,0,37,regulation of membrane lipid distribution,BP,
17544,GO:0097036,1,0.995559571918776,0,1,regulation of plasma membrane sterol distribution,BP,
17545,GO:0097037,1,0.992573434607731,0,1,heme export,BP,
17546,GO:0097038,1,0.926724188410788,0,11,perinuclear endoplasmic reticulum,CC,
17547,GO:0097039,1,0.965708610099363,0,5,protein linear polyubiquitination,BP,
17548,GO:0097045,1,0.992465620838657,0,1,phosphatidylserine exposure on blood platelet,BP,
17549,GO:0097048,1,0.942469226451944,0,10,dendritic cell apoptotic process,BP,
17550,GO:0097049,1,0.953882939476104,0,7,motor neuron apoptotic process,BP,
17551,GO:0097050,1,0.922497178733898,0,12,type B pancreatic cell apoptotic process,BP,
17552,GO:0097051,1,0.977385038594747,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17553,GO:0097052,1,0.983324413520359,0,3,L-kynurenine metabolic process,BP,
17554,GO:0097053,1,0.995485080421186,0,1,L-kynurenine catabolic process,BP,
17555,GO:0097055,1,0.987287444463683,0,2,agmatine biosynthetic process,BP,
17556,GO:0097056,1,0.976876055434782,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17557,GO:0097057,1,0.990196379890389,0,2,TRAF2-GSTP1 complex,CC,
17558,GO:0097058,1,0.984743420048557,0,3,CRLF-CLCF1 complex,CC,
17559,GO:0097059,1,0.989560395177323,0,2,CNTFR-CLCF1 complex,CC,
17563,GO:0097064,1,0.789374985387049,0,36,ncRNA export from nucleus,BP,
17564,GO:0097065,1,0.959339051323194,0,6,anterior head development,BP,
17565,GO:0097066,1,0.851600018183711,0,24,response to thyroid hormone,BP,
17566,GO:0097067,1,0.896061987934745,0,16,cellular response to thyroid hormone stimulus,BP,
17567,GO:0097068,1,0.963594140604733,0,5,response to thyroxine,BP,
17568,GO:0097069,1,0.985342744936483,0,2,cellular response to thyroxine stimulus,BP,
17569,GO:0097070,1,0.964783735486837,0,5,ductus arteriosus closure,BP,
17570,GO:0097084,1,0.951628704888215,0,8,vascular smooth muscle cell development,BP,
17571,GO:0097086,1,0.992521988812796,0,1,amniotic stem cell differentiation,BP,
17572,GO:0097089,1,0.989136138797675,0,2,methyl-branched fatty acid metabolic process,BP,
17573,GO:0097090,1,0.9174560514287,0,12,presynaptic membrane organization,BP,
17574,GO:0097091,1,0.934560110619146,0,9,synaptic vesicle clustering,BP,
17575,GO:0097094,1,0.904741447720842,0,15,craniofacial suture morphogenesis,BP,
17576,GO:0097100,1,0.969881024226126,0,5,supercoiled DNA binding,MF,
17577,GO:0097101,1,0.980170972577337,0,3,blood vessel endothelial cell fate specification,BP,
17578,GO:0097102,1,0.986257221945643,0,2,endothelial tip cell fate specification,BP,
17579,GO:0097104,1,0.920421055079725,0,11,postsynaptic membrane assembly,BP,
17580,GO:0097105,1,0.928437090376017,0,10,presynaptic membrane assembly,BP,
17581,GO:0097106,1,0.893551249164607,0,15,postsynaptic density organization,BP,
17582,GO:0097107,1,0.94716231776274,0,7,postsynaptic density assembly,BP,
17583,GO:0097108,1,0.977424880186759,0,3,hedgehog family protein binding,MF,
17584,GO:0097109,1,0.964648546677279,0,5,neuroligin family protein binding,MF,
17585,GO:0097110,1,0.673822569039103,0,58,scaffold protein binding,MF,
17586,GO:0097111,1,0.984678119831725,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17587,GO:0097112,1,0.985346956057727,0,2,gamma-aminobutyric acid receptor clustering,BP,
17588,GO:0097113,1,0.952410747214247,0,7,AMPA glutamate receptor clustering,BP,
17589,GO:0097114,1,0.972832689491732,0,4,NMDA glutamate receptor clustering,BP,
17590,GO:0097115,1,0.992456461683755,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17591,GO:0097116,1,0.97706817134492,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17592,GO:0097117,1,0.992266977262001,0,1,guanylate kinase-associated protein clustering,BP,
17593,GO:0097118,1,0.96954628964995,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17594,GO:0097119,1,0.935377335831544,0,9,postsynaptic density protein 95 clustering,BP,
17596,GO:0097123,1,0.988835204392525,0,2,cyclin A1-CDK2 complex,CC,
17597,GO:0097124,1,0.987176492481257,0,2,cyclin A2-CDK2 complex,CC,
17598,GO:0097125,1,0.989443291498856,0,2,cyclin B1-CDK1 complex,CC,
17599,GO:0097129,1,0.983759806669488,0,3,cyclin D2-CDK4 complex,CC,
17600,GO:0097134,1,0.988904252032033,0,2,cyclin E1-CDK2 complex,CC,
17601,GO:0097135,1,0.987275982243299,0,2,cyclin E2-CDK2 complex,CC,
17602,GO:0097136,1,0.962248782837488,0,6,Bcl-2 family protein complex,CC,
17603,GO:0097144,1,0.996356917639189,0,1,BAX complex,CC,
17604,GO:0097145,1,0.99416198649944,0,1,BAK complex,CC,
17605,GO:0097149,1,0.97784282594103,0,3,centralspindlin complex,CC,
17606,GO:0097150,1,0.858443934103099,0,21,neuronal stem cell population maintenance,BP,
17608,GO:0097152,1,0.926278947372401,0,12,mesenchymal cell apoptotic process,BP,
17609,GO:0097153,1,0.932435835246216,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17610,GO:0097154,1,0.924859172773421,0,12,GABAergic neuron differentiation,BP,
17611,GO:0097155,1,0.976965155632909,0,3,fasciculation of sensory neuron axon,BP,
17612,GO:0097156,1,0.984885883167675,0,2,fasciculation of motor neuron axon,BP,
17613,GO:0097157,1,0.947674801324863,0,8,pre-mRNA intronic binding,MF,
17614,GO:0097158,1,0.99522928928386,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17616,GO:0097161,1,0.992335638298231,0,1,DH domain binding,MF,
17617,GO:0097162,1,0.992640748193215,0,1,MADS box domain binding,MF,
17619,GO:0097165,1,0.967635068618779,0,5,nuclear stress granule,CC,
17620,GO:0097166,1,0.986784153290637,0,2,lens epithelial cell proliferation,BP,
17621,GO:0097167,1,0.974509649804836,0,4,circadian regulation of translation,BP,
17622,GO:0097168,1,0.986770569416262,0,2,mesenchymal stem cell proliferation,BP,
17623,GO:0097169,1,0.97955791756039,0,5,AIM2 inflammasome complex,CC,
17624,GO:0097176,1,0.978129780722272,0,4,epoxide metabolic process,BP,
17625,GO:0097177,1,0.984205323757596,0,3,mitochondrial ribosome binding,MF,
17626,GO:0097178,1,0.804073507585877,0,34,ruffle assembly,BP,
17627,GO:0097179,1,0.981769940135211,0,4,protease inhibitor complex,CC,
17628,GO:0097180,1,0.9891709934017,0,2,serine protease inhibitor complex,CC,
17629,GO:0097181,1,0.993919811159171,0,1,protein C inhibitor-coagulation factor V complex,CC,
17630,GO:0097182,1,0.993919811159171,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17631,GO:0097183,1,0.993919811159171,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17632,GO:0097186,1,0.894840397303137,0,16,amelogenesis,BP,
17633,GO:0097187,1,0.980278169428159,0,3,dentinogenesis,BP,
17635,GO:0097191,1,0.268875714434939,0,206,extrinsic apoptotic signaling pathway,BP,
17636,GO:0097192,1,0.65811798493479,0,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17638,GO:0097194,1,0.612501208823041,0,77,execution phase of apoptosis,BP,
17639,GO:0097195,1,0.981167777463009,0,3,pilomotor reflex,BP,
17640,GO:0097196,1,0.987806610811566,0,2,Shu complex,CC,
17641,GO:0097197,1,0.954424699820957,0,7,tetraspanin-enriched microdomain,CC,
17642,GO:0097198,1,0.985050401688287,0,2,histone H3-K36 trimethylation,BP,
17643,GO:0097199,1,0.968207436361877,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17644,GO:0097200,1,0.939182133158822,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17645,GO:0097201,1,0.925347264327928,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17646,GO:0097202,1,0.921715396793172,0,13,activation of cysteine-type endopeptidase activity,BP,
17647,GO:0097205,1,0.892770974447845,0,16,renal filtration,BP,
17648,GO:0097208,1,0.964146673612042,0,6,alveolar lamellar body,CC,
17649,GO:0097209,1,0.975170218474374,0,4,epidermal lamellar body,CC,
17650,GO:0097210,1,0.967660755271768,0,5,response to gonadotropin-releasing hormone,BP,
17651,GO:0097211,1,0.967660755271768,0,5,cellular response to gonadotropin-releasing hormone,BP,
17652,GO:0097212,1,0.9853288856122,0,3,lysosomal membrane organization,BP,
17653,GO:0097213,1,0.990679534008183,0,2,regulation of lysosomal membrane permeability,BP,
17654,GO:0097214,1,0.996590987115822,0,1,positive regulation of lysosomal membrane permeability,BP,
17655,GO:0097222,1,0.992476900260023,0,1,mitochondrial mRNA polyadenylation,BP,
17657,GO:0097224,1,0.98987057649583,0,2,sperm connecting piece,CC,
17658,GO:0097225,1,0.914614634669754,0,15,sperm midpiece,CC,
17659,GO:0097226,1,0.993975789695678,0,1,sperm mitochondrial sheath,CC,
17660,GO:0097227,1,0.966769737698559,0,5,sperm annulus,CC,
17661,GO:0097228,1,0.891460918844253,0,17,sperm principal piece,CC,
17662,GO:0097229,1,0.99571787794334,0,1,sperm end piece,CC,
17663,GO:0097231,1,0.995101435345263,0,1,cell motility in response to calcium ion,BP,
17664,GO:0097232,1,0.984976774018832,0,2,lamellar body membrane,CC,
17665,GO:0097233,1,0.984976774018832,0,2,alveolar lamellar body membrane,CC,
17667,GO:0097238,1,0.991850002521741,0,2,cellular response to methylglyoxal,BP,
17668,GO:0097240,1,0.966318303500514,0,5,chromosome attachment to the nuclear envelope,BP,
17669,GO:0097241,1,0.9875529164508,0,2,hematopoietic stem cell migration to bone marrow,BP,
17670,GO:0097242,1,0.87264670327227,0,19,amyloid-beta clearance,BP,
17671,GO:0097252,1,0.979614006522856,0,3,oligodendrocyte apoptotic process,BP,
17672,GO:0097254,1,0.994322270557619,0,1,renal tubular secretion,BP,
17673,GO:0097255,1,0.969243789084485,0,6,R2TP complex,CC,
17674,GO:0097258,1,0.992847871206029,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17675,GO:0097259,1,0.992847871206029,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17676,GO:0097260,1,0.993241944453096,0,1,eoxin A4 synthase activity,MF,
17678,GO:0097267,1,0.973244506948703,0,4,omega-hydroxylase P450 pathway,BP,
17679,GO:0097272,1,0.987638386178757,0,2,ammonia homeostasis,BP,
17680,GO:0097273,1,0.992386778860137,0,1,creatinine homeostasis,BP,
17681,GO:0097274,1,0.985007056134363,0,2,urea homeostasis,BP,
17682,GO:0097275,1,0.992386778860137,0,1,cellular ammonia homeostasis,BP,
17683,GO:0097276,1,0.992386778860137,0,1,cellular creatinine homeostasis,BP,
17684,GO:0097277,1,0.992386778860137,0,1,cellular urea homeostasis,BP,
17685,GO:0097278,1,0.982437067057494,0,3,complement-dependent cytotoxicity,BP,
17686,GO:0097283,1,0.969348116797871,0,5,keratinocyte apoptotic process,BP,
17687,GO:0097284,1,0.924083815490003,0,12,hepatocyte apoptotic process,BP,
17688,GO:0097286,1,0.917652761767192,0,13,iron ion import,BP,
17689,GO:0097291,1,0.994547132949344,0,1,renal phosphate ion absorption,BP,
17690,GO:0097296,1,0.924643866430463,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17691,GO:0097298,1,0.992502055555348,0,1,regulation of nucleus size,BP,
17692,GO:0097300,1,0.777401856209196,0,41,programmed necrotic cell death,BP,
17694,GO:0097306,1,0.68920358542151,0,53,cellular response to alcohol,BP,
17695,GO:0097309,1,0.986238532970005,0,2,cap1 mRNA methylation,BP,
17696,GO:0097310,1,0.9930956730518,0,1,cap2 mRNA methylation,BP,
17698,GO:0097322,1,0.953561464273594,0,7,7SK snRNA binding,MF,
17699,GO:0097323,1,0.989060267319154,0,2,B cell adhesion,BP,
17700,GO:0097324,1,0.98459715082614,0,2,melanocyte migration,BP,
17701,GO:0097325,1,0.985507568352516,0,2,melanocyte proliferation,BP,
17702,GO:0097326,1,0.992436528352499,0,1,melanocyte adhesion,BP,
17703,GO:0097327,1,0.577787209873868,0,84,response to antineoplastic agent,BP,
17704,GO:0097329,1,0.918452181767237,0,12,response to antimetabolite,BP,
17705,GO:0097332,1,0.981303736254707,0,3,response to antipsychotic drug,BP,
17706,GO:0097338,1,0.985060073715802,0,2,response to clozapine,BP,
17707,GO:0097340,1,0.917929678812353,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17708,GO:0097341,1,0.917929678812353,0,13,zymogen inhibition,BP,
17709,GO:0097342,1,0.961356477016929,0,6,ripoptosome,CC,
17710,GO:0097343,1,0.977336231897643,0,3,ripoptosome assembly,BP,
17711,GO:0097344,1,0.988185583530796,0,2,Rix1 complex,CC,
17712,GO:0097345,1,0.725569290373467,0,53,mitochondrial outer membrane permeabilization,BP,
17713,GO:0097346,1,0.874455697494121,0,23,INO80-type complex,CC,
17714,GO:0097350,1,0.967169579644562,0,5,neutrophil clearance,BP,
17715,GO:0097352,1,0.81152718706669,0,33,autophagosome maturation,BP,
17716,GO:0097354,1,0.94930826281426,0,8,prenylation,BP,
17717,GO:0097359,1,0.9844809840496,0,2,UDP-glucosylation,BP,
17718,GO:0097360,1,0.972510910926586,0,4,chorionic trophoblast cell proliferation,BP,
17719,GO:0097361,1,0.975989184369435,0,4,CIA complex,CC,
17720,GO:0097362,1,0.986186635520066,0,2,MCM8-MCM9 complex,CC,
17721,GO:0097363,1,0.985559222814414,0,2,protein O-GlcNAc transferase activity,MF,
17724,GO:0097368,1,0.973636655746639,0,4,establishment of Sertoli cell barrier,BP,
17725,GO:0097371,1,0.951931116086631,0,7,MDM2/MDM4 family protein binding,MF,
17726,GO:0097372,1,0.995097852422239,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17727,GO:0097374,1,0.993588067364596,0,1,sensory neuron axon guidance,BP,
17728,GO:0097376,1,0.989564841671368,0,2,interneuron axon guidance,BP,
17729,GO:0097377,1,0.993951749401209,0,1,spinal cord interneuron axon guidance,BP,
17730,GO:0097378,1,0.993951749401209,0,1,dorsal spinal cord interneuron axon guidance,BP,
17731,GO:0097380,1,0.993951749401209,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17732,GO:0097381,1,0.908619072103981,0,15,photoreceptor disc membrane,CC,
17733,GO:0097382,1,0.992364374867111,0,1,deoxynucleoside-diphosphatase activity,MF,
17734,GO:0097383,1,0.992364374867111,0,1,dIDP diphosphatase activity,MF,
17735,GO:0097384,1,0.958381890576784,0,7,cellular lipid biosynthetic process,BP,
17737,GO:0097393,1,0.991947384974868,0,1,telomeric repeat-containing RNA transcription,BP,
17738,GO:0097394,1,0.991947384974868,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17739,GO:0097396,1,0.966859499223223,0,5,response to interleukin-17,BP,
17740,GO:0097398,1,0.966859499223223,0,5,cellular response to interleukin-17,BP,
17741,GO:0097400,1,0.966859499223223,0,5,interleukin-17-mediated signaling pathway,BP,
17743,GO:0097402,1,0.986024018080921,0,2,neuroblast migration,BP,
17744,GO:0097403,1,0.992825105303744,0,1,cellular response to raffinose,BP,
17745,GO:0097409,1,0.994638624842927,0,1,glial cytoplasmic inclusion,CC,
17746,GO:0097411,1,0.96611053932121,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17747,GO:0097413,1,0.959401114338177,0,7,Lewy body,CC,
17748,GO:0097414,1,0.994638624842927,0,1,classical Lewy body,CC,
17750,GO:0097421,1,0.826841037692421,0,32,liver regeneration,BP,
17751,GO:0097422,1,0.966048818177852,0,5,tubular endosome,CC,
17752,GO:0097425,1,0.972248088367112,0,5,smooth endoplasmic reticulum part,CC,
17753,GO:0097427,1,0.960014535893246,0,6,microtubule bundle,CC,
17754,GO:0097428,1,0.955420157436081,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17755,GO:0097431,1,0.840596984588711,0,25,mitotic spindle pole,CC,
17756,GO:0097433,1,0.968200006285792,0,5,dense body,CC,
17761,GO:0097443,1,0.956807206345892,0,6,sorting endosome,CC,
17762,GO:0097444,1,0.992440273662412,0,1,spine apparatus,CC,
17765,GO:0097450,1,0.975459638098405,0,4,astrocyte end-foot,CC,
17766,GO:0097451,1,0.985054363839085,0,2,glial limiting end-foot,CC,
17767,GO:0097452,1,0.976675488100745,0,4,GAIT complex,CC,
17768,GO:0097453,1,0.9937316248304,0,1,mesaxon,CC,
17769,GO:0097454,1,0.980493349591706,0,3,Schwann cell microvillus,CC,
17770,GO:0097457,1,0.977056343145637,0,3,hippocampal mossy fiber,CC,
17772,GO:0097462,1,0.994638624842927,0,1,Lewy neurite,CC,
17773,GO:0097466,1,0.972818972056336,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17774,GO:0097468,1,0.930486154889149,0,12,programmed cell death in response to reactive oxygen species,BP,
17775,GO:0097470,1,0.96298102241342,0,5,ribbon synapse,CC,
17776,GO:0097472,1,0.804585032955752,0,35,cyclin-dependent protein kinase activity,MF,
17777,GO:0097473,1,0.992429517439099,0,1,retinal rod cell apoptotic process,BP,
17778,GO:0097475,1,0.964222174965835,0,5,motor neuron migration,BP,
17779,GO:0097476,1,0.985361554038288,0,2,spinal cord motor neuron migration,BP,
17780,GO:0097477,1,0.985361554038288,0,2,lateral motor column neuron migration,BP,
17785,GO:0097486,1,0.978766343903005,0,5,multivesicular body lumen,CC,
17786,GO:0097487,1,0.975950400151455,0,4,multivesicular body, internal vesicle,CC,
17787,GO:0097489,1,0.993448985011549,0,1,multivesicular body, internal vesicle lumen,CC,
17788,GO:0097490,1,0.971262822996663,0,4,sympathetic neuron projection extension,BP,
17789,GO:0097491,1,0.971262822996663,0,4,sympathetic neuron projection guidance,BP,
17790,GO:0097493,1,0.880746269494438,0,17,structural molecule activity conferring elasticity,MF,
17791,GO:0097494,1,0.974944076671039,0,4,regulation of vesicle size,BP,
17792,GO:0097497,1,0.9927132062119,0,1,blood vessel endothelial cell delamination,BP,
17793,GO:0097498,1,0.987135086211933,0,2,endothelial tube lumen extension,BP,
17794,GO:0097499,1,0.950481632575139,0,8,protein localization to non-motile cilium,BP,
17795,GO:0097500,1,0.973501018077155,0,4,receptor localization to non-motile cilium,BP,
17796,GO:0097501,1,0.947202924361031,0,13,stress response to metal ion,BP,
17797,GO:0097502,1,0.835190412935727,0,29,mannosylation,BP,
17799,GO:0097504,1,0.927070433733151,0,12,Gemini of coiled bodies,CC,
17800,GO:0097505,1,0.992389054095405,0,1,Rad6-Rad18 complex,CC,
17801,GO:0097506,1,0.973786620201428,0,5,deaminated base DNA N-glycosylase activity,MF,
17802,GO:0097510,1,0.994450795271181,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17803,GO:0097512,1,0.968060222742554,0,6,cardiac myofibril,CC,
17804,GO:0097513,1,0.976932502863097,0,3,myosin II filament,CC,
17805,GO:0097517,1,0.694585612592848,0,52,contractile actin filament bundle,CC,
17806,GO:0097524,1,0.978364013485437,0,3,sperm plasma membrane,CC,
17807,GO:0097525,1,0.700666499066524,0,61,spliceosomal snRNP complex,CC,
17808,GO:0097526,1,0.860712827657798,0,28,spliceosomal tri-snRNP complex,CC,
17809,GO:0097527,1,0.964145949474847,0,6,necroptotic signaling pathway,BP,
17811,GO:0097530,1,0.582425226009036,0,94,granulocyte migration,BP,
17813,GO:0097532,1,0.987810027421978,0,2,stress response to acid chemical,BP,
17814,GO:0097533,1,0.987810027421978,0,2,cellular stress response to acid chemical,BP,
17815,GO:0097534,1,0.992221511650861,0,1,lymphoid lineage cell migration,BP,
17816,GO:0097535,1,0.992221511650861,0,1,lymphoid lineage cell migration into thymus,BP,
17817,GO:0097536,1,0.994322270557619,0,1,thymus epithelium morphogenesis,BP,
17818,GO:0097539,1,0.928390403117523,0,10,ciliary transition fiber,CC,
17819,GO:0097541,1,0.9930956730518,0,1,axonemal basal plate,CC,
17820,GO:0097542,1,0.752607614923004,0,43,ciliary tip,CC,
17821,GO:0097543,1,0.985461135010096,0,2,ciliary inversin compartment,CC,
17822,GO:0097546,1,0.832075742682389,0,27,ciliary base,CC,
17823,GO:0097550,1,0.966752001941064,0,6,transcriptional preinitiation complex,CC,
17825,GO:0097573,1,0.995674921403549,0,1,glutathione oxidoreductase activity,MF,
17826,GO:0097574,1,0.98512288219944,0,2,lateral part of cell,CC,
17827,GO:0097575,1,0.98512288219944,0,2,lateral cell cortex,CC,
17828,GO:0097576,1,0.986020887260754,0,2,vacuole fusion,BP,
17829,GO:0097577,1,0.986758677891076,0,3,sequestering of iron ion,BP,
17830,GO:0097581,1,0.612381030174995,0,71,lamellipodium organization,BP,
17831,GO:0097598,1,0.985566134053584,0,2,sperm cytoplasmic droplet,CC,
17832,GO:0097602,1,0.897483206438676,0,17,cullin family protein binding,MF,
17833,GO:0097603,1,0.987461125664908,0,2,temperature-gated ion channel activity,MF,
17834,GO:0097604,1,0.994926449873857,0,1,temperature-gated cation channel activity,MF,
17835,GO:0097617,1,0.911643704352604,0,13,annealing activity,MF,
17836,GO:0097621,1,0.993947749705736,0,1,monoamine oxidase activity,MF,
17837,GO:0097623,1,0.954835101072879,0,7,potassium ion export across plasma membrane,BP,
17838,GO:0097625,1,0.992232774627354,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17839,GO:0097626,1,0.992232774627354,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17840,GO:0097627,1,0.992232774627354,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17841,GO:0097629,1,0.966586152404325,0,5,extrinsic component of omegasome membrane,CC,
17842,GO:0097630,1,0.9930956730518,0,1,intrinsic component of omegasome membrane,CC,
17843,GO:0097631,1,0.9930956730518,0,1,integral component of omegasome membrane,CC,
17844,GO:0097632,1,0.985579110892194,0,2,extrinsic component of phagophore assembly site membrane,CC,
17845,GO:0097635,1,0.984961797247929,0,2,extrinsic component of autophagosome membrane,CC,
17846,GO:0097636,1,0.985463937234531,0,2,intrinsic component of autophagosome membrane,CC,
17847,GO:0097637,1,0.985463937234531,0,2,integral component of autophagosome membrane,CC,
17848,GO:0097638,1,0.972256913370609,0,4,L-arginine import across plasma membrane,BP,
17849,GO:0097639,1,0.985702649459304,0,2,L-lysine import across plasma membrane,BP,
17850,GO:0097640,1,0.992232774627354,0,1,L-ornithine import across plasma membrane,BP,
17851,GO:0097642,1,0.966989440764858,0,6,calcitonin family receptor activity,MF,
17852,GO:0097643,1,0.980999737654357,0,4,amylin receptor activity,MF,
17853,GO:0097644,1,0.977796824484964,0,4,calcitonin family binding,MF,
17854,GO:0097646,1,0.969252973451674,0,6,calcitonin family receptor signaling pathway,BP,
17855,GO:0097647,1,0.976627929630549,0,5,amylin receptor signaling pathway,BP,
17856,GO:0097648,1,0.951518531988809,0,8,G-protein coupled receptor complex,CC,
17857,GO:0097651,1,0.970139017197781,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17858,GO:0097655,1,0.9930956730518,0,1,serpin family protein binding,MF,
17860,GO:0097676,1,0.978453401243744,0,3,histone H3-K36 dimethylation,BP,
17861,GO:0097677,1,0.966971662335528,0,5,STAT family protein binding,MF,
17862,GO:0097679,1,0.990312434665984,0,2,other organism cytoplasm,CC,
17863,GO:0097680,1,0.979345737414862,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17864,GO:0097681,1,0.983967905520356,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17865,GO:0097682,1,0.994339637289529,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17866,GO:0097688,1,0.952410747214247,0,7,glutamate receptor clustering,BP,
17867,GO:0097689,1,0.992603524382402,0,1,iron channel activity,MF,
17868,GO:0097692,1,0.992344886410998,0,1,histone H3-K4 monomethylation,BP,
17869,GO:0097694,1,0.977207297942801,0,3,establishment of RNA localization to telomere,BP,
17870,GO:0097695,1,0.977207297942801,0,3,establishment of protein-containing complex localization to telomere,BP,
17871,GO:0097696,1,0.445868377896497,0,126,STAT cascade,BP,
17872,GO:0097698,1,0.995478057980255,0,1,telomere maintenance via base-excision repair,BP,
17873,GO:0097699,1,0.992484326805927,0,1,vascular endothelial cell response to fluid shear stress,BP,
17874,GO:0097707,1,0.99621363569025,0,1,ferroptosis,BP,
17876,GO:0097709,1,0.960887655772728,0,6,connective tissue replacement,BP,
17877,GO:0097711,1,0.526380726712051,0,96,ciliary basal body-plasma membrane docking,BP,
17878,GO:0097712,1,0.9930956730518,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17879,GO:0097718,1,0.813454566882168,0,30,disordered domain specific binding,MF,
17880,GO:0097720,1,0.836816824510211,0,26,calcineurin-mediated signaling,BP,
17882,GO:0097724,1,0.9948912954128,0,1,sperm flagellum movement,BP,
17883,GO:0097726,1,0.995997709942652,0,1,LEM domain binding,MF,
17884,GO:0097729,1,0.684952940238407,0,61,9+2 motile cilium,CC,
17885,GO:0097730,1,0.472467696940514,0,111,non-motile cilium,CC,
17886,GO:0097731,1,0.557528874028092,0,87,9+0 non-motile cilium,CC,
17887,GO:0097732,1,0.956044097998301,0,7,9+2 non-motile cilium,CC,
17888,GO:0097733,1,0.557528874028092,0,87,photoreceptor cell cilium,CC,
17889,GO:0097734,1,0.893002079882357,0,18,extracellular exosome biogenesis,BP,
17890,GO:0097742,1,0.972917873058765,0,4,de novo centriole assembly,BP,
17891,GO:0097745,1,0.982757843163735,0,3,mitochondrial tRNA 5'-end processing,BP,
17893,GO:0097747,1,0.777952023059988,0,43,RNA polymerase activity,MF,
17894,GO:0097749,1,0.985560034661018,0,2,membrane tubulation,BP,
17895,GO:0097752,1,0.979415303419728,0,3,regulation of DNA stability,BP,
17896,GO:0097753,1,0.985733013845246,0,2,membrane bending,BP,
17897,GO:0097755,1,0.726599699960105,0,50,positive regulation of blood vessel diameter,BP,
17899,GO:0098501,1,0.974339966203744,0,5,polynucleotide dephosphorylation,BP,
17900,GO:0098502,1,0.986425138594877,0,3,DNA dephosphorylation,BP,
17901,GO:0098503,1,0.995081675552396,0,1,DNA 3' dephosphorylation,BP,
17902,GO:0098504,1,0.995081675552396,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17903,GO:0098505,1,0.93573162069462,0,10,G-rich strand telomeric DNA binding,MF,
17904,GO:0098506,1,0.995081675552396,0,1,polynucleotide 3' dephosphorylation,BP,
17905,GO:0098507,1,0.98775021593665,0,2,polynucleotide 5' dephosphorylation,BP,
17906,GO:0098508,1,0.98771222282667,0,2,endothelial to hematopoietic transition,BP,
17907,GO:0098518,1,0.9828915297104,0,3,polynucleotide phosphatase activity,MF,
17908,GO:0098519,1,0.968373551658541,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17909,GO:0098528,1,0.966742326032633,0,5,skeletal muscle fiber differentiation,BP,
17910,GO:0098530,1,0.992386428745838,0,1,positive regulation of strand invasion,BP,
17911,GO:0098531,1,0.733950578120497,0,45,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17912,GO:0098532,1,0.960093396079088,0,7,histone H3-K27 trimethylation,BP,
17913,GO:0098533,1,0.869395908732492,0,21,ATPase dependent transmembrane transport complex,CC,
17914,GO:0098534,1,0.808052617193336,0,31,centriole assembly,BP,
17915,GO:0098535,1,0.972917873058765,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17916,GO:0098536,1,0.972993351519069,0,4,deuterosome,CC,
17918,GO:0098543,1,0.924048333008885,0,11,detection of other organism,BP,
17919,GO:0098547,1,0.994046279050695,0,1,lumenal side of Golgi membrane,CC,
17921,GO:0098553,1,0.879421793074708,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17922,GO:0098554,1,0.931378017981635,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17923,GO:0098556,1,0.981855721528704,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17924,GO:0098559,1,0.980449341672022,0,3,cytoplasmic side of early endosome membrane,CC,
17925,GO:0098560,1,0.986614893012982,0,2,cytoplasmic side of late endosome membrane,CC,
17928,GO:0098573,1,0.667174491818548,0,66,intrinsic component of mitochondrial membrane,CC,
17930,GO:0098575,1,0.988569159216737,0,2,lumenal side of lysosomal membrane,CC,
17931,GO:0098576,1,0.975397823531063,0,4,lumenal side of membrane,CC,
17932,GO:0098577,1,0.992295536432322,0,1,inactive sex chromosome,CC,
17933,GO:0098581,1,0.899526301477301,0,16,detection of external biotic stimulus,BP,
17934,GO:0098582,1,0.984952161030402,0,2,innate vocalization behavior,BP,
17935,GO:0098583,1,0.995804276297472,0,1,learned vocalization behavior,BP,
17936,GO:0098586,1,0.771261080208922,0,39,cellular response to virus,BP,
17940,GO:0098592,1,0.978064015728903,0,3,cytoplasmic side of apical plasma membrane,CC,
17941,GO:0098594,1,0.996431418194317,0,1,mucin granule,CC,
17942,GO:0098595,1,0.994052343891405,0,1,perivitelline space,CC,
17943,GO:0098596,1,0.947256357747162,0,7,imitative learning,BP,
17944,GO:0098597,1,0.939535418182254,0,8,observational learning,BP,
17945,GO:0098598,1,0.943279735843087,0,8,learned vocalization behavior or vocal learning,BP,
17946,GO:0098599,1,0.940640826307706,0,10,palmitoyl hydrolase activity,MF,
17947,GO:0098601,1,0.992583515143324,0,1,selenomethionine adenosyltransferase activity,MF,
17949,GO:0098619,1,0.994752691340968,0,1,selenocysteine-tRNA ligase activity,MF,
17950,GO:0098621,1,0.992397349607375,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17951,GO:0098625,1,0.992507849060887,0,1,methylselenol reductase activity,MF,
17952,GO:0098626,1,0.992507849060887,0,1,methylseleninic acid reductase activity,MF,
17953,GO:0098629,1,0.9930956730518,0,1,trans-Golgi network membrane organization,BP,
17954,GO:0098631,1,0.772151459077487,0,40,cell adhesion mediator activity,MF,
17955,GO:0098632,1,0.820312932685081,0,31,cell-cell adhesion mediator activity,MF,
17956,GO:0098633,1,0.993500527892872,0,1,collagen fibril binding,MF,
17957,GO:0098634,1,0.951212175194752,0,7,cell-matrix adhesion mediator activity,MF,
17958,GO:0098636,1,0.775858794542457,0,35,protein complex involved in cell adhesion,CC,
17959,GO:0098637,1,0.992501937538747,0,1,protein complex involved in cell-matrix adhesion,CC,
17960,GO:0098639,1,0.962629950583228,0,5,collagen binding involved in cell-matrix adhesion,MF,
17961,GO:0098640,1,0.988143557900418,0,2,integrin binding involved in cell-matrix adhesion,MF,
17962,GO:0098641,1,0.895672491975097,0,19,cadherin binding involved in cell-cell adhesion,MF,
17963,GO:0098642,1,0.948031534481941,0,7,network-forming collagen trimer,CC,
17964,GO:0098643,1,0.914033518119489,0,12,banded collagen fibril,CC,
17965,GO:0098644,1,0.859628823810152,0,20,complex of collagen trimers,CC,
17966,GO:0098645,1,0.948031534481941,0,7,collagen network,CC,
17967,GO:0098646,1,0.993338409672199,0,1,collagen sheet,CC,
17968,GO:0098647,1,0.980224869654867,0,3,collagen beaded filament,CC,
17969,GO:0098648,1,0.992092935676161,0,1,collagen anchoring fibril,CC,
17970,GO:0098651,1,0.940847552014621,0,8,basement membrane collagen trimer,CC,
17971,GO:0098652,1,0.992092935676161,0,1,collagen type VII anchoring fibril,CC,
17979,GO:0098664,1,0.926376280601961,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
17980,GO:0098679,1,0.984297631872215,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17981,GO:0098680,1,0.992500133858096,0,1,template-free RNA nucleotidyltransferase,MF,
17982,GO:0098687,1,0.127141961212301,0,310,chromosomal region,CC,
17984,GO:0098698,1,0.94716231776274,0,7,postsynaptic specialization assembly,BP,
17986,GO:0098703,1,0.91291832017478,0,13,calcium ion import across plasma membrane,BP,
17987,GO:0098704,1,0.993903895013174,0,1,carbohydrate import across plasma membrane,BP,
17988,GO:0098705,1,0.99246620909549,0,1,copper ion import across plasma membrane,BP,
17989,GO:0098706,1,0.970234271194655,0,4,ferric iron import across plasma membrane,BP,
17990,GO:0098711,1,0.957822283917219,0,6,iron ion import across plasma membrane,BP,
17991,GO:0098712,1,0.925261107660368,0,11,L-glutamate import across plasma membrane,BP,
17992,GO:0098713,1,0.994018021742566,0,1,leucine import across plasma membrane,BP,
17993,GO:0098719,1,0.901975175966384,0,14,sodium ion import across plasma membrane,BP,
17994,GO:0098722,1,0.940702062768961,0,9,asymmetric stem cell division,BP,
17995,GO:0098725,1,0.9930956730518,0,1,symmetric cell division,BP,
17996,GO:0098727,1,0.363329251842592,0,149,maintenance of cell number,BP,
17997,GO:0098728,1,0.982494886252243,0,3,germline stem cell asymmetric division,BP,
17998,GO:0098732,1,0.492595129116901,0,106,macromolecule deacylation,BP,
17999,GO:0098734,1,0.940640826307706,0,10,macromolecule depalmitoylation,BP,
18000,GO:0098735,1,0.969045980987651,0,4,positive regulation of the force of heart contraction,BP,
18001,GO:0098736,1,0.992129025827869,0,1,negative regulation of the force of heart contraction,BP,
18002,GO:0098739,1,0.616997316938693,0,69,import across plasma membrane,BP,
18004,GO:0098743,1,0.897793539925316,0,17,cell aggregation,BP,
18005,GO:0098745,1,0.995054517796043,0,1,Dcp1-Dcp2 complex,CC,
18007,GO:0098748,1,0.927660916146443,0,11,endocytic adaptor activity,MF,
18008,GO:0098749,1,0.992475696164979,0,1,cerebellar neuron development,BP,
18009,GO:0098751,1,0.802802213212295,0,31,bone cell development,BP,
18010,GO:0098754,1,0.583785144956063,0,100,detoxification,BP,
18011,GO:0098756,1,0.952006693583428,0,7,response to interleukin-21,BP,
18012,GO:0098757,1,0.952006693583428,0,7,cellular response to interleukin-21,BP,
18013,GO:0098758,1,0.97959034447223,0,3,response to interleukin-8,BP,
18014,GO:0098759,1,0.97959034447223,0,3,cellular response to interleukin-8,BP,
18015,GO:0098760,1,0.886527024481382,0,19,response to interleukin-7,BP,
18016,GO:0098761,1,0.886527024481382,0,19,cellular response to interleukin-7,BP,
18017,GO:0098770,1,0.984481630997598,0,2,FBXO family protein binding,MF,
18020,GO:0098773,1,0.582023285672985,0,82,skin epidermis development,BP,
18021,GO:0098779,1,0.947876941432287,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18022,GO:0098780,1,0.891758192218227,0,17,response to mitochondrial depolarisation,BP,
18023,GO:0098781,1,0.553805615592755,0,94,ncRNA transcription,BP,
18024,GO:0098782,1,0.994926449873857,0,1,mechanosensitived potassium channel activity,MF,
18025,GO:0098787,1,0.908339979581589,0,14,mRNA cleavage involved in mRNA processing,BP,
18026,GO:0098789,1,0.927719488258802,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18028,GO:0098792,1,0.931645963844655,0,10,xenophagy,BP,
18031,GO:0098795,1,0.9856797394481,0,2,mRNA cleavage involved in gene silencing,BP,
18034,GO:0098798,1,0.344099319972625,0,217,mitochondrial protein complex,CC,
18035,GO:0098799,1,0.934644115242772,0,12,outer mitochondrial membrane protein complex,CC,
18036,GO:0098800,1,0.618974048191431,0,100,inner mitochondrial membrane protein complex,CC,
18037,GO:0098801,1,0.836924521068086,0,27,regulation of renal system process,BP,
18039,GO:0098803,1,0.744006994727605,0,69,respiratory chain complex,CC,
18041,GO:0098808,1,0.987771932215007,0,2,mRNA cap binding,MF,
18042,GO:0098809,1,0.993379716894051,0,1,nitrite reductase activity,MF,
18043,GO:0098810,1,0.90348384043537,0,16,neurotransmitter reuptake,BP,
18044,GO:0098813,1,0.160020012373209,0,279,nuclear chromosome segregation,BP,
18045,GO:0098814,1,0.965660607249016,0,5,spontaneous synaptic transmission,BP,
18047,GO:0098816,1,0.994480273921555,0,1,mini excitatory postsynaptic potential,BP,
18048,GO:0098821,1,0.964660090568004,0,5,BMP receptor activity,MF,
18049,GO:0098822,1,0.993645945930351,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18050,GO:0098826,1,0.974186342668264,0,4,endoplasmic reticulum tubular network membrane,CC,
18053,GO:0098829,1,0.992324523284376,0,1,intestinal folate absorption,BP,
18054,GO:0098830,1,0.992462896762271,0,1,presynaptic endosome,CC,
18056,GO:0098833,1,0.992454242245345,0,1,presynaptic endocytic zone,CC,
18057,GO:0098835,1,0.992454242245345,0,1,presynaptic endocytic zone membrane,CC,
18058,GO:0098837,1,0.981454860100115,0,3,postsynaptic recycling endosome,CC,
18059,GO:0098838,1,0.993022823484038,0,1,reduced folate transmembrane transport,BP,
18061,GO:0098840,1,0.974021783883251,0,4,protein transport along microtubule,BP,
18062,GO:0098842,1,0.987867015251045,0,2,postsynaptic early endosome,CC,
18065,GO:0098845,1,0.962266152442978,0,6,postsynaptic endosome,CC,
18066,GO:0098847,1,0.918662648773545,0,13,sequence-specific single stranded DNA binding,MF,
18067,GO:0098850,1,0.994661592279131,0,1,extrinsic component of synaptic vesicle membrane,CC,
18069,GO:0098855,1,0.977435458387022,0,3,HCN channel complex,CC,
18070,GO:0098856,1,0.951831457787917,0,8,intestinal lipid absorption,BP,
18073,GO:0098862,1,0.448983642956091,0,118,cluster of actin-based cell projections,CC,
18074,GO:0098868,1,0.85617188953904,0,23,bone growth,BP,
18075,GO:0098869,1,0.635631714742624,0,82,cellular oxidant detoxification,BP,
18076,GO:0098870,1,0.96216929616404,0,6,action potential propagation,BP,
18077,GO:0098871,1,0.995140562827179,0,1,postsynaptic actin cytoskeleton,CC,
18078,GO:0098875,1,0.992468526157409,0,1,epididymosome,CC,
18083,GO:0098883,1,0.994941551134375,0,1,synapse disassembly,BP,
18085,GO:0098885,1,0.99226199611503,0,1,modification of postsynaptic actin cytoskeleton,BP,
18086,GO:0098886,1,0.98558761314299,0,2,modification of dendritic spine,BP,
18087,GO:0098887,1,0.972298726287739,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18088,GO:0098888,1,0.992258370712991,0,1,extrinsic component of presynaptic membrane,CC,
18089,GO:0098889,1,0.972022342562,0,4,intrinsic component of presynaptic membrane,CC,
18090,GO:0098890,1,0.992258370712991,0,1,extrinsic component of postsynaptic membrane,CC,
18091,GO:0098895,1,0.992495258360024,0,1,postsynaptic endosome membrane,CC,
18093,GO:0098901,1,0.830994467703279,0,25,regulation of cardiac muscle cell action potential,BP,
18094,GO:0098902,1,0.973438107134534,0,4,regulation of membrane depolarization during action potential,BP,
18095,GO:0098903,1,0.942818612812633,0,8,regulation of membrane repolarization during action potential,BP,
18096,GO:0098904,1,0.98523970859781,0,2,regulation of AV node cell action potential,BP,
18097,GO:0098905,1,0.996337627667502,0,1,regulation of bundle of His cell action potential,BP,
18098,GO:0098907,1,0.983826356797818,0,2,regulation of SA node cell action potential,BP,
18099,GO:0098908,1,0.973929711899633,0,4,regulation of neuronal action potential,BP,
18100,GO:0098909,1,0.953417559740826,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18101,GO:0098910,1,0.961513405996934,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18102,GO:0098911,1,0.899047854086034,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18103,GO:0098912,1,0.976604543924633,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18104,GO:0098914,1,0.959080222760908,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18105,GO:0098915,1,0.920641165570715,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18108,GO:0098918,1,0.994930231011602,0,1,structural constituent of synapse,MF,
18109,GO:0098920,1,0.985621256179787,0,2,retrograde trans-synaptic signaling by lipid,BP,
18110,GO:0098921,1,0.985621256179787,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18111,GO:0098923,1,0.992268075854506,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18112,GO:0098924,1,0.992268075854506,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18113,GO:0098926,1,0.992284175593387,0,1,postsynaptic signal transduction,BP,
18114,GO:0098927,1,0.763590845459256,0,40,vesicle-mediated transport between endosomal compartments,BP,
18115,GO:0098928,1,0.983111570634429,0,2,presynaptic signal transduction,BP,
18116,GO:0098930,1,0.74028746195773,0,45,axonal transport,BP,
18117,GO:0098935,1,0.962559084095623,0,5,dendritic transport,BP,
18118,GO:0098936,1,0.928063162174278,0,10,intrinsic component of postsynaptic membrane,CC,
18119,GO:0098937,1,0.962559084095623,0,5,anterograde dendritic transport,BP,
18120,GO:0098939,1,0.992320311196761,0,1,dendritic transport of mitochondrion,BP,
18121,GO:0098942,1,0.992456461683755,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18123,GO:0098945,1,0.992488247971201,0,1,intrinsic component of presynaptic active zone membrane,CC,
18124,GO:0098948,1,0.969331970913276,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18126,GO:0098957,1,0.972688493446252,0,4,anterograde axonal transport of mitochondrion,BP,
18128,GO:0098961,1,0.992284855260637,0,1,dendritic transport of ribonucleoprotein complex,BP,
18129,GO:0098963,1,0.992284855260637,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18130,GO:0098964,1,0.992284855260637,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18132,GO:0098968,1,0.992434292396331,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18135,GO:0098971,1,0.970010768547215,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18136,GO:0098972,1,0.992320311196761,0,1,anterograde dendritic transport of mitochondrion,BP,
18137,GO:0098973,1,0.994930231011602,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18138,GO:0098974,1,0.994930231011602,0,1,postsynaptic actin cytoskeleton organization,BP,
18140,GO:0098978,1,0.955249279292889,0,6,glutamatergic synapse,CC,
18141,GO:0098982,1,0.963153974234622,0,5,GABA-ergic synapse,CC,
18142,GO:0098983,1,0.970140427093952,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18144,GO:0098985,1,0.955249279292889,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18145,GO:0098988,1,0.956096067030167,0,6,G-protein coupled glutamate receptor activity,MF,
18146,GO:0098989,1,0.987750541442166,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18147,GO:0098992,1,0.993614083012732,0,1,neuronal dense core vesicle,CC,
18148,GO:0098993,1,0.949867313066393,0,9,anchored component of synaptic vesicle membrane,CC,
18149,GO:0098999,1,0.992495258360024,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18151,GO:0099004,1,0.973820068457548,0,4,calmodulin dependent kinase signaling pathway,BP,
18152,GO:0099010,1,0.977960007919994,0,3,modification of postsynaptic structure,BP,
18154,GO:0099022,1,0.988317574920454,0,2,vesicle tethering,BP,
18155,GO:0099023,1,0.624226060777373,0,69,tethering complex,CC,
18156,GO:0099024,1,0.716396983898673,0,53,plasma membrane invagination,BP,
18157,GO:0099038,1,0.992458155063233,0,1,ceramide-translocating ATPase activity,MF,
18158,GO:0099039,1,0.984846731569492,0,2,sphingolipid translocation,BP,
18159,GO:0099040,1,0.992458155063233,0,1,ceramide translocation,BP,
18160,GO:0099044,1,0.988317574920454,0,2,vesicle tethering to endoplasmic reticulum,BP,
18161,GO:0099046,1,0.995550473751808,0,1,clearance of foreign intracellular nucleic acids,BP,
18162,GO:0099050,1,0.993174411928366,0,1,vesicle scission,BP,
18163,GO:0099053,1,0.980107368016945,0,3,activating signal cointegrator 1 complex,CC,
18164,GO:0099054,1,0.8766357742352,0,18,presynapse assembly,BP,
18165,GO:0099055,1,0.928063162174278,0,10,integral component of postsynaptic membrane,CC,
18166,GO:0099056,1,0.972022342562,0,4,integral component of presynaptic membrane,CC,
18167,GO:0099059,1,0.992488247971201,0,1,integral component of presynaptic active zone membrane,CC,
18168,GO:0099060,1,0.969331970913276,0,4,integral component of postsynaptic specialization membrane,CC,
18169,GO:0099061,1,0.976670234480402,0,3,integral component of postsynaptic density membrane,CC,
18170,GO:0099068,1,0.881088417158795,0,17,postsynapse assembly,BP,
18172,GO:0099073,1,0.985166305973998,0,2,mitochondrion-derived vesicle,CC,
18173,GO:0099074,1,0.985960749789988,0,2,mitochondrion to lysosome transport,BP,
18174,GO:0099075,1,0.985960749789988,0,2,mitochondrion-derived vesicle mediated transport,BP,
18175,GO:0099077,1,0.992387085197334,0,1,histone-dependent DNA binding,MF,
18176,GO:0099078,1,0.980512598875253,0,4,BORC complex,CC,
18180,GO:0099083,1,0.98867970752337,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18181,GO:0099084,1,0.893551249164607,0,15,postsynaptic specialization organization,BP,
18182,GO:0099086,1,0.822395706664186,0,31,synaptonemal structure,CC,
18183,GO:0099089,1,0.991867785918404,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18184,GO:0099093,1,0.985560494454757,0,2,calcium export from the mitochondrion,BP,
18187,GO:0099098,1,0.992668565662403,0,1,microtubule polymerization based movement,BP,
18188,GO:0099103,1,0.977603189536866,0,4,channel activator activity,MF,
18189,GO:0099104,1,0.977603189536866,0,4,potassium channel activator activity,MF,
18192,GO:0099116,1,0.915795633626624,0,16,tRNA 5'-end processing,BP,
18193,GO:0099118,1,0.974021783883251,0,4,microtubule-based protein transport,BP,
18194,GO:0099122,1,0.979133554686441,0,3,RNA polymerase II C-terminal domain binding,MF,
18195,GO:0099130,1,0.994098942723816,0,1,estrogen binding,MF,
18196,GO:0099131,1,0.840933024679307,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18197,GO:0099132,1,0.737898037267251,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18198,GO:0099133,1,0.913437450069003,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18199,GO:0099142,1,0.992353639835833,0,1,intracellularly ATP-gated ion channel activity,MF,
18200,GO:0099146,1,0.976670234480402,0,3,intrinsic component of postsynaptic density membrane,CC,
18201,GO:0099159,1,0.99226199611503,0,1,regulation of modification of postsynaptic structure,BP,
18202,GO:0099163,1,0.992268075854506,0,1,synaptic signaling by nitric oxide,BP,
18203,GO:0099170,1,0.97860405373321,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18204,GO:0099172,1,0.866501901549296,0,20,presynapse organization,BP,
18206,GO:0099174,1,0.963274397701551,0,5,regulation of presynapse organization,BP,
18209,GO:0099186,1,0.994930231011602,0,1,structural constituent of postsynapse,MF,
18210,GO:0099188,1,0.994930231011602,0,1,postsynaptic cytoskeleton organization,BP,
18211,GO:0099240,1,0.928063162174278,0,10,intrinsic component of synaptic membrane,CC,
18212,GO:0099243,1,0.992258370712991,0,1,extrinsic component of synaptic membrane,CC,
18213,GO:0099400,1,0.992094053059202,0,1,caveola neck,CC,
18214,GO:0099402,1,0.996390802365142,0,1,plant organ development,BP,
18215,GO:0099403,1,0.984076716330302,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18216,GO:0099404,1,0.984076716330302,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18221,GO:0099509,1,0.984644632602205,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18224,GO:0099514,1,0.899537585248205,0,17,synaptic vesicle cytoskeletal transport,BP,
18225,GO:0099515,1,0.926641770582244,0,10,actin filament-based transport,BP,
18227,GO:0099517,1,0.899537585248205,0,17,synaptic vesicle transport along microtubule,BP,
18228,GO:0099518,1,0.726200485829964,0,46,vesicle cytoskeletal trafficking,BP,
18229,GO:0099519,1,0.9930956730518,0,1,dense core granule cytoskeletal transport,BP,
18230,GO:0099522,1,0.994486366033924,0,1,region of cytosol,CC,
18231,GO:0099523,1,0.994486366033924,0,1,presynaptic cytosol,CC,
18232,GO:0099524,1,0.994486366033924,0,1,postsynaptic cytosol,CC,
18234,GO:0099526,1,0.983111570634429,0,2,presynapse to nucleus signaling pathway,BP,
18235,GO:0099527,1,0.992284175593387,0,1,postsynapse to nucleus signaling pathway,BP,
18238,GO:0099530,1,0.984554494939993,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18240,GO:0099532,1,0.984716023520742,0,2,synaptic vesicle endosomal processing,BP,
18247,GO:0099543,1,0.992268075854506,0,1,trans-synaptic signaling by soluble gas,BP,
18248,GO:0099545,1,0.984972213747421,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18249,GO:0099547,1,0.97860405373321,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18250,GO:0099548,1,0.992268075854506,0,1,trans-synaptic signaling by nitric oxide,BP,
18252,GO:0099551,1,0.981037018338322,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18255,GO:0099557,1,0.992459445130808,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18256,GO:0099558,1,0.990952962114124,0,2,maintenance of synapse structure,BP,
18257,GO:0099560,1,0.977482211645956,0,3,synaptic membrane adhesion,BP,
18258,GO:0099563,1,0.925264343077901,0,11,modification of synaptic structure,BP,
18260,GO:0099566,1,0.977060350108126,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18263,GO:0099571,1,0.995140562827179,0,1,postsynaptic cytoskeleton,CC,
18265,GO:0099578,1,0.97860405373321,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18266,GO:0099580,1,0.984851461415717,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18267,GO:0099583,1,0.977060350108126,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18269,GO:0099589,1,0.926376280601961,0,13,serotonin receptor activity,MF,
18272,GO:0099602,1,0.962081666726947,0,7,neurotransmitter receptor regulator activity,MF,
18274,GO:0099606,1,0.992143318157907,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18275,GO:0099607,1,0.992143318157907,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18276,GO:0099609,1,0.984819343299821,0,2,microtubule lateral binding,MF,
18277,GO:0099612,1,0.948047229989001,0,7,protein localization to axon,BP,
18278,GO:0099617,1,0.99258795579388,0,1,matrix side of mitochondrial inner membrane,CC,
18279,GO:0099622,1,0.804756058523263,0,32,cardiac muscle cell membrane repolarization,BP,
18280,GO:0099623,1,0.858338434818263,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18281,GO:0099624,1,0.934164277720108,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18282,GO:0099625,1,0.857737800852264,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18284,GO:0099631,1,0.991917022426135,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18288,GO:0099638,1,0.96513236052973,0,5,endosome to plasma membrane protein transport,BP,
18289,GO:0099639,1,0.96513236052973,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18290,GO:0099640,1,0.988578789896626,0,2,axo-dendritic protein transport,BP,
18291,GO:0099641,1,0.99626541460386,0,1,anterograde axonal protein transport,BP,
18293,GO:0099699,1,0.928063162174278,0,10,integral component of synaptic membrane,CC,
18295,GO:0100001,1,0.992420411501682,0,1,regulation of skeletal muscle contraction by action potential,BP,
18296,GO:0100002,1,0.992990262360756,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18297,GO:0100012,1,0.990913180184448,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18298,GO:0100057,1,0.992228222822877,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18299,GO:0101002,1,0.338723836853444,0,178,ficolin-1-rich granule,CC,
18300,GO:0101003,1,0.702004807382965,0,55,ficolin-1-rich granule membrane,CC,
18301,GO:0101005,1,0.538755809250627,0,88,ubiquitinyl hydrolase activity,MF,
18302,GO:0101006,1,0.984197847719186,0,3,protein histidine phosphatase activity,MF,
18303,GO:0101020,1,0.983266625259946,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18304,GO:0101023,1,0.908186720996407,0,14,vascular endothelial cell proliferation,BP,
18305,GO:0101030,1,0.99570649754465,0,1,tRNA-guanine transglycosylation,BP,
18306,GO:0101031,1,0.929392486630999,0,12,chaperone complex,CC,
18307,GO:0102005,1,0.995448196775631,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18308,GO:0102007,1,0.98623620804879,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18309,GO:0102008,1,0.992449625125747,0,1,cytosolic dipeptidase activity,MF,
18310,GO:0102009,1,0.994764472908401,0,1,proline dipeptidase activity,MF,
18311,GO:0102076,1,0.992998889487678,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18312,GO:0102077,1,0.988895218888353,0,2,oleamide hydrolase activity,MF,
18313,GO:0102084,1,0.986842589114962,0,2,L-dopa O-methyltransferase activity,MF,
18314,GO:0102092,1,0.984881837114031,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18315,GO:0102102,1,0.992501255451989,0,1,homocarnosine synthase activity,MF,
18316,GO:0102113,1,0.992288085650284,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18317,GO:0102121,1,0.980377567828757,0,3,ceramidase activity,MF,
18318,GO:0102131,1,0.992156415186924,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18319,GO:0102132,1,0.992156415186924,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18320,GO:0102148,1,0.982593322430779,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18321,GO:0102158,1,0.972664538770891,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18322,GO:0102166,1,0.992440547150207,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18323,GO:0102167,1,0.992440547150207,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18324,GO:0102200,1,0.99243421216998,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18325,GO:0102250,1,0.978272257515747,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18326,GO:0102279,1,0.992458854066094,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18327,GO:0102336,1,0.959484659774481,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18328,GO:0102337,1,0.959484659774481,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18329,GO:0102338,1,0.959484659774481,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18330,GO:0102339,1,0.993484418202327,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18331,GO:0102340,1,0.993484418202327,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18332,GO:0102341,1,0.993484418202327,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18333,GO:0102342,1,0.993484418202327,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18334,GO:0102343,1,0.972664538770891,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18335,GO:0102344,1,0.972664538770891,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18336,GO:0102345,1,0.972664538770891,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18337,GO:0102389,1,0.993283400584553,0,1,polyprenol reductase activity,MF,
18338,GO:0102390,1,0.993312740697061,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18339,GO:0102391,1,0.950816440053053,0,7,decanoate-CoA ligase activity,MF,
18340,GO:0102420,1,0.985407642406561,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18341,GO:0102483,1,0.995157298489048,0,1,scopolin beta-glucosidase activity,MF,
18342,GO:0102485,1,0.979268588924073,0,3,dATP phosphohydrolase activity,MF,
18343,GO:0102486,1,0.979268588924073,0,3,dCTP phosphohydrolase activity,MF,
18344,GO:0102487,1,0.979268588924073,0,3,dUTP phosphohydrolase activity,MF,
18345,GO:0102488,1,0.979268588924073,0,3,dTTP phosphohydrolase activity,MF,
18346,GO:0102489,1,0.979268588924073,0,3,GTP phosphohydrolase activity,MF,
18347,GO:0102490,1,0.979268588924073,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18348,GO:0102491,1,0.979268588924073,0,3,dGTP phosphohydrolase activity,MF,
18349,GO:0102499,1,0.978272257515747,0,3,SHG alpha-glucan phosphorylase activity,MF,
18350,GO:0102500,1,0.992263008596149,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18351,GO:0102521,1,0.992610873928624,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18352,GO:0102522,1,0.994121285764925,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18353,GO:0102524,1,0.9930956730518,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18354,GO:0102555,1,0.996195333386217,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18355,GO:0102567,1,0.909398793825165,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18356,GO:0102568,1,0.909398793825165,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18357,GO:0102571,1,0.992440547150207,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18358,GO:0102704,1,0.992941754270209,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18359,GO:0102707,1,0.993457795060686,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18360,GO:0102751,1,0.987575043563871,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18361,GO:0102752,1,0.992747990387103,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18362,GO:0102756,1,0.959484659774481,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18363,GO:0102758,1,0.995934614860097,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18364,GO:0102769,1,0.995246367791094,0,1,dihydroceramide glucosyltransferase activity,MF,
18365,GO:0102773,1,0.992484815443496,0,1,dihydroceramide kinase activity,MF,
18366,GO:0102797,1,0.992453518757083,0,1,geranial:oxygen oxidoreductase activity,MF,
18367,GO:0102798,1,0.992453518757083,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18368,GO:0102867,1,0.993165469991438,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18369,GO:0102938,1,0.986842589114962,0,2,orcinol O-methyltransferase activity,MF,
18370,GO:0102953,1,0.980800648325782,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18371,GO:0102965,1,0.986820977704296,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18372,GO:0102991,1,0.968121738871156,0,6,myristoyl-CoA hydrolase activity,MF,
18373,GO:0103025,1,0.989459154183471,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18374,GO:0103045,1,0.994406998783492,0,1,methione N-acyltransferase activity,MF,
18375,GO:0103046,1,0.992449625125747,0,1,alanylglutamate dipeptidase activity,MF,
18376,GO:0103053,1,0.989642106899018,0,2,1-ethyladenine demethylase activity,MF,
18377,GO:0103066,1,0.995301999084177,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18378,GO:0103067,1,0.995301999084177,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18379,GO:0103068,1,0.980800648325782,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18380,GO:0103073,1,0.988895218888353,0,2,anandamide amidohydrolase activity,MF,
18382,GO:0104005,1,0.650281400519086,0,64,hijacked molecular function,MF,
18383,GO:0106001,1,0.958057631767877,0,6,intestinal hexose absorption,BP,
18384,GO:0106003,1,0.926273496488376,0,11,amyloid-beta complex,CC,
18385,GO:0106004,1,0.990793903881549,0,2,tRNA (guanine-N7)-methylation,BP,
18386,GO:0106005,1,0.992348523628312,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18387,GO:0106014,1,0.988606264561248,0,2,regulation of inflammatory response to wounding,BP,
18388,GO:0106015,1,0.988606264561248,0,2,negative regulation of inflammatory response to wounding,BP,
18389,GO:0106017,1,0.972378286649639,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18390,GO:0106018,1,0.894545960816144,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18391,GO:0106019,1,0.929362138034006,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18392,GO:0106020,1,0.986576807726613,0,2,regulation of vesicle docking,BP,
18393,GO:0106022,1,0.992502378797429,0,1,positive regulation of vesicle docking,BP,
18395,GO:0106028,1,0.992459445130808,0,1,neuron projection retraction,BP,
18397,GO:0106044,1,0.99622159485821,0,1,guanine deglycation,BP,
18398,GO:0106045,1,0.99622159485821,0,1,guanine deglycation, methylglyoxal removal,BP,
18399,GO:0106046,1,0.99622159485821,0,1,guanine deglycation, glyoxal removal,BP,
18400,GO:0106049,1,0.962893520803849,0,6,regulation of cellular response to osmotic stress,BP,
18401,GO:0106050,1,0.994637624686316,0,1,tRNA 2'-O-methyltransferase activity,MF,
18402,GO:0106056,1,0.897618579274686,0,16,regulation of calcineurin-mediated signaling,BP,
18403,GO:0106057,1,0.978550900699084,0,3,negative regulation of calcineurin-mediated signaling,BP,
18404,GO:0106058,1,0.942307042072455,0,9,positive regulation of calcineurin-mediated signaling,BP,
18405,GO:0106064,1,0.992386603804784,0,1,regulation of cobalamin metabolic process,BP,
18406,GO:0106068,1,0.968342149439826,0,6,SUMO ligase complex,CC,
18410,GO:0106073,1,0.984826051055011,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18411,GO:0106074,1,0.927377796564514,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18412,GO:0106075,1,0.992736616128885,0,1,peptide N-succinyltransferase activity,MF,
18413,GO:0106077,1,0.971084077202036,0,4,histone succinylation,BP,
18414,GO:0106078,1,0.992736616128885,0,1,histone succinyltransferase activity,MF,
18415,GO:0106083,1,0.951041881901564,0,7,nuclear membrane protein complex,CC,
18416,GO:0106088,1,0.992291574722942,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18417,GO:0106089,1,0.992291574722942,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18418,GO:0106094,1,0.951041881901564,0,7,nuclear membrane microtubule tethering complex,CC,
18419,GO:0106101,1,0.994860641298683,0,1,ER-dependent peroxisome localization,BP,
18420,GO:0106104,1,0.978430313629585,0,3,regulation of glutamate receptor clustering,BP,
18421,GO:0110008,1,0.992795055433864,0,1,ncRNA deadenylation,BP,
18422,GO:0110009,1,0.97756800806172,0,3,formin-nucleated actin cable organization,BP,
18423,GO:0110011,1,0.962208958221246,0,5,regulation of basement membrane organization,BP,
18424,GO:0110017,1,0.991554008170324,0,2,cap-independent translational initiation of linear mRNA,BP,
18425,GO:0110020,1,0.573030467328595,0,81,regulation of actomyosin structure organization,BP,
18426,GO:0110021,1,0.979541296862917,0,3,cardiac muscle myoblast proliferation,BP,
18427,GO:0110022,1,0.979541296862917,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18428,GO:0110024,1,0.979541296862917,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18429,GO:0110025,1,0.992791169078513,0,1,DNA strand resection involved in replication fork processing,BP,
18430,GO:0110026,1,0.992791169078513,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18431,GO:0110028,1,0.992263514958006,0,1,positive regulation of mitotic spindle organization,BP,
18432,GO:0110029,1,0.99271425012845,0,1,negative regulation of meiosis I,BP,
18433,GO:0110053,1,0.207670267045254,0,236,regulation of actin filament organization,BP,
18434,GO:0110057,1,0.992411431508882,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18435,GO:0110059,1,0.992411431508882,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18436,GO:0110075,1,0.99621363569025,0,1,regulation of ferroptosis,BP,
18437,GO:0110076,1,0.99621363569025,0,1,negative regulation of ferroptosis,BP,
18438,GO:0110095,1,0.985497575162438,0,3,cellular detoxification of aldehyde,BP,
18439,GO:0110096,1,0.975407404005959,0,5,cellular response to aldehyde,BP,
18440,GO:0120009,1,0.967691452681011,0,5,intermembrane lipid transfer,BP,
18441,GO:0120012,1,0.99241822546087,0,1,intermembrane sphingolipid transfer,BP,
18442,GO:0120013,1,0.967691452681011,0,5,intermembrane lipid transfer activity,MF,
18443,GO:0120016,1,0.99241822546087,0,1,intermembrane sphingolipid transfer activity,MF,
18444,GO:0120017,1,0.99241822546087,0,1,intermembrane ceramide transfer activity,MF,
18448,GO:0120033,1,0.880768820064335,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18454,GO:0120043,1,0.992468144027232,0,1,stereocilium shaft,CC,
18455,GO:0120044,1,0.992468144027232,0,1,stereocilium base,CC,
18456,GO:0120048,1,0.9930956730518,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18457,GO:0120049,1,0.9930956730518,0,1,snRNA (adenine-N6)-methylation,BP,
18458,GO:0120054,1,0.996458096886506,0,1,intestinal motility,BP,
18459,GO:0120055,1,0.996458096886506,0,1,small intestinal transit,BP,
18460,GO:0120057,1,0.996458096886506,0,1,regulation of small intestinal transit,BP,
18461,GO:0120058,1,0.996458096886506,0,1,positive regulation of small intestinal transit,BP,
18462,GO:0120060,1,0.996352645489994,0,1,regulation of gastric emptying,BP,
18463,GO:0120061,1,0.996352645489994,0,1,negative regulation of gastric emptying,BP,
18464,GO:0120063,1,0.988816480048206,0,2,stomach smooth muscle contraction,BP,
18465,GO:0120064,1,0.992436528352499,0,1,stomach pylorus smooth muscle contraction,BP,
18466,GO:0120065,1,0.992436528352499,0,1,pyloric antrum smooth muscle contraction,BP,
18467,GO:0120068,1,0.996352645489994,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18468,GO:0120069,1,0.996352645489994,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18469,GO:0120071,1,0.992436528352499,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18470,GO:0120072,1,0.992436528352499,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18471,GO:0120077,1,0.992291574722942,0,1,angiogenic sprout fusion,BP,
18472,GO:0120078,1,0.992291574722942,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18473,GO:0120092,1,0.992599773980576,0,1,crotonyl-CoA hydratase activity,MF,
18474,GO:0120093,1,0.992599773980576,0,1,regulation of peptidyl-lysine crotonylation,BP,
18475,GO:0120094,1,0.992599773980576,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18476,GO:0120103,1,0.935640432282356,0,9,centriolar subdistal appendage,CC,
18477,GO:0120108,1,0.994512734573476,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18479,GO:0120114,1,0.62820231552976,0,79,Sm-like protein family complex,CC,
18480,GO:0140007,1,0.975657570912409,0,4,KICSTOR complex,CC,
18481,GO:0140009,1,0.985092112589538,0,2,L-aspartate import across plasma membrane,BP,
18482,GO:0140013,1,0.390981996651188,0,143,meiotic nuclear division,BP,
18483,GO:0140014,1,0.18759206467001,0,252,mitotic nuclear division,BP,
18485,GO:0140030,1,0.455979991571444,0,113,modification-dependent protein binding,MF,
18486,GO:0140031,1,0.986859533505886,0,2,phosphorylation-dependent protein binding,MF,
18488,GO:0140034,1,0.682523269851389,0,56,methylation-dependent protein binding,MF,
18489,GO:0140035,1,0.965108318586478,0,5,ubiquitination-like modification-dependent protein binding,MF,
18490,GO:0140036,1,0.965108318586478,0,5,ubiquitin-dependent protein binding,MF,
18491,GO:0140041,1,0.99622159485821,0,1,cellular detoxification of methylglyoxal,BP,
18492,GO:0140049,1,0.995198286271971,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18493,GO:0140051,1,0.995198286271971,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18494,GO:0140052,1,0.96607286081939,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18495,GO:0140053,1,0.44833306961551,0,151,mitochondrial gene expression,BP,
18497,GO:0140058,1,0.887977882274224,0,16,neuron projection arborization,BP,
18498,GO:0140059,1,0.965938310530719,0,5,dendrite arborization,BP,
18499,GO:0140064,1,0.992132784581788,0,1,peptide crotonyltransferase activity,MF,
18500,GO:0140065,1,0.992132784581788,0,1,peptide butyryltransferase activity,MF,
18501,GO:0140066,1,0.98479018876714,0,2,peptidyl-lysine crotonylation,BP,
18502,GO:0140067,1,0.992132784581788,0,1,peptidyl-lysine butyrylation,BP,
18503,GO:0140068,1,0.992132784581788,0,1,histone crotonyltransferase activity,MF,
18504,GO:0140069,1,0.992132784581788,0,1,histone butyryltransferase activity,MF,
18505,GO:0140074,1,0.992436369316305,0,1,cardiac endothelial to mesenchymal transition,BP,
18506,GO:0140078,1,0.94717248740842,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18507,GO:0140080,1,0.94717248740842,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18509,GO:0140097,1,0.306256811539775,0,180,catalytic activity, acting on DNA,MF,
18510,GO:0140098,1,0.115768236442524,0,338,catalytic activity, acting on RNA,MF,
18511,GO:0140101,1,0.488572501132156,0,115,catalytic activity, acting on a tRNA,MF,
18512,GO:0140102,1,0.913726723814981,0,15,catalytic activity, acting on a rRNA,MF,
18513,GO:0140103,1,0.875471145172918,0,20,catalytic activity, acting on a glycoprotein,MF,
18514,GO:0140104,1,0.806041363705883,0,40,molecular carrier activity,MF,
18516,GO:0140112,1,0.882126800038411,0,20,extracellular vesicle biogenesis,BP,
18517,GO:0140115,1,0.865085562408589,0,22,export across plasma membrane,BP,
18519,GO:0140135,1,0.972918904814121,0,4,mechanosensitive cation channel activity,MF,
18520,GO:0140142,1,0.888473287181745,0,18,nucleocytoplasmic carrier activity,MF,
18521,GO:0140161,1,0.955039167063417,0,8,monocarboxylate:sodium symporter activity,MF,
18522,GO:0140192,1,0.984457343973065,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18523,GO:0140193,1,0.995690761056092,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18524,GO:0140194,1,0.995690761056092,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18525,GO:0140196,1,0.992268075854506,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18526,GO:0140199,1,0.992129025827869,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18527,GO:0140200,1,0.992186319295289,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18528,GO:0150003,1,0.973041226266085,0,4,regulation of spontaneous synaptic transmission,BP,
18529,GO:0150005,1,0.937396065432507,0,11,enzyme activator complex,CC,
18530,GO:0150011,1,0.948898056810207,0,7,regulation of neuron projection arborization,BP,
18531,GO:0150012,1,0.948898056810207,0,7,positive regulation of neuron projection arborization,BP,
18532,GO:0150018,1,0.978602588191694,0,3,basal dendrite development,BP,
18533,GO:0150019,1,0.978602588191694,0,3,basal dendrite morphogenesis,BP,
18534,GO:0150020,1,0.978602588191694,0,3,basal dendrite arborization,BP,
18535,GO:0150024,1,0.994409037765303,0,1,oxidised low-density lipoprotein particle clearance,BP,
18536,GO:0150025,1,0.994409037765303,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18537,GO:0150031,1,0.992329602207964,0,1,regulation of protein localization to lysosome,BP,
18538,GO:0150033,1,0.992329602207964,0,1,negative regulation of protein localization to lysosome,BP,
18541,GO:1900003,1,0.971669386784466,0,6,regulation of serine-type endopeptidase activity,BP,
18542,GO:1900004,1,0.971669386784466,0,6,negative regulation of serine-type endopeptidase activity,BP,
18543,GO:1900005,1,0.992089267287523,0,1,positive regulation of serine-type endopeptidase activity,BP,
18545,GO:1900010,1,0.994873121653457,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18546,GO:1900011,1,0.994873121653457,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18547,GO:1900015,1,0.836525420148491,0,27,regulation of cytokine production involved in inflammatory response,BP,
18548,GO:1900016,1,0.944854336250883,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18549,GO:1900017,1,0.91934942146352,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18550,GO:1900019,1,0.971725127173663,0,4,regulation of protein kinase C activity,BP,
18551,GO:1900020,1,0.971725127173663,0,4,positive regulation of protein kinase C activity,BP,
18552,GO:1900024,1,0.749801531773683,0,44,regulation of substrate adhesion-dependent cell spreading,BP,
18553,GO:1900025,1,0.919695759579358,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18554,GO:1900026,1,0.821523530063053,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
18555,GO:1900027,1,0.858906422998399,0,24,regulation of ruffle assembly,BP,
18556,GO:1900028,1,0.972130209488167,0,5,negative regulation of ruffle assembly,BP,
18557,GO:1900029,1,0.931625076821807,0,11,positive regulation of ruffle assembly,BP,
18559,GO:1900035,1,0.993194769652385,0,1,negative regulation of cellular response to heat,BP,
18560,GO:1900036,1,0.993874154206167,0,1,positive regulation of cellular response to heat,BP,
18561,GO:1900037,1,0.927710423248531,0,12,regulation of cellular response to hypoxia,BP,
18562,GO:1900038,1,0.955640500419191,0,7,negative regulation of cellular response to hypoxia,BP,
18563,GO:1900039,1,0.988543192670484,0,2,positive regulation of cellular response to hypoxia,BP,
18564,GO:1900040,1,0.950491290948316,0,7,regulation of interleukin-2 secretion,BP,
18565,GO:1900041,1,0.971882736450757,0,4,negative regulation of interleukin-2 secretion,BP,
18566,GO:1900042,1,0.977996014120023,0,3,positive regulation of interleukin-2 secretion,BP,
18567,GO:1900044,1,0.935138216001435,0,9,regulation of protein K63-linked ubiquitination,BP,
18568,GO:1900045,1,0.963690784669189,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18569,GO:1900046,1,0.642808937760196,0,69,regulation of hemostasis,BP,
18570,GO:1900047,1,0.765219125072434,0,43,negative regulation of hemostasis,BP,
18571,GO:1900048,1,0.862194678937938,0,23,positive regulation of hemostasis,BP,
18572,GO:1900052,1,0.995861044061941,0,1,regulation of retinoic acid biosynthetic process,BP,
18573,GO:1900053,1,0.995861044061941,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18574,GO:1900060,1,0.976987756404662,0,4,negative regulation of ceramide biosynthetic process,BP,
18575,GO:1900062,1,0.992515208640909,0,1,regulation of replicative cell aging,BP,
18576,GO:1900063,1,0.979051133203367,0,3,regulation of peroxisome organization,BP,
18577,GO:1900076,1,0.641160046378664,0,66,regulation of cellular response to insulin stimulus,BP,
18578,GO:1900077,1,0.805404929180868,0,33,negative regulation of cellular response to insulin stimulus,BP,
18579,GO:1900078,1,0.833243472898186,0,26,positive regulation of cellular response to insulin stimulus,BP,
18580,GO:1900081,1,0.992129025827869,0,1,regulation of arginine catabolic process,BP,
18581,GO:1900082,1,0.992129025827869,0,1,negative regulation of arginine catabolic process,BP,
18582,GO:1900084,1,0.956424039769043,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18583,GO:1900085,1,0.993264927058927,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18584,GO:1900086,1,0.962911812579925,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18585,GO:1900087,1,0.839644217429984,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18586,GO:1900094,1,0.962469832911325,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18587,GO:1900095,1,0.99198999344448,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18588,GO:1900098,1,0.994934951994993,0,1,regulation of plasma cell differentiation,BP,
18589,GO:1900100,1,0.994934951994993,0,1,positive regulation of plasma cell differentiation,BP,
18590,GO:1900101,1,0.850939326706646,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18591,GO:1900102,1,0.927735029951789,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18592,GO:1900103,1,0.919042122401714,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18593,GO:1900104,1,0.980449521073103,0,3,regulation of hyaluranon cable assembly,BP,
18594,GO:1900106,1,0.980449521073103,0,3,positive regulation of hyaluranon cable assembly,BP,
18595,GO:1900107,1,0.96039320664657,0,7,regulation of nodal signaling pathway,BP,
18596,GO:1900108,1,0.983961975731451,0,3,negative regulation of nodal signaling pathway,BP,
18597,GO:1900109,1,0.984624466368182,0,3,regulation of histone H3-K9 dimethylation,BP,
18598,GO:1900110,1,0.990992039908866,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18599,GO:1900111,1,0.99357513835807,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18600,GO:1900112,1,0.940045989230389,0,9,regulation of histone H3-K9 trimethylation,BP,
18601,GO:1900113,1,0.968838814954877,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18602,GO:1900114,1,0.984913236765163,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18603,GO:1900115,1,0.911500380520077,0,15,extracellular regulation of signal transduction,BP,
18604,GO:1900116,1,0.911500380520077,0,15,extracellular negative regulation of signal transduction,BP,
18605,GO:1900117,1,0.876631593651535,0,21,regulation of execution phase of apoptosis,BP,
18606,GO:1900118,1,0.955460330076174,0,7,negative regulation of execution phase of apoptosis,BP,
18607,GO:1900119,1,0.930151143883464,0,12,positive regulation of execution phase of apoptosis,BP,
18608,GO:1900120,1,0.883442525169367,0,20,regulation of receptor binding,BP,
18609,GO:1900121,1,0.934171803921381,0,11,negative regulation of receptor binding,BP,
18610,GO:1900122,1,0.951853748798972,0,8,positive regulation of receptor binding,BP,
18611,GO:1900125,1,0.950496108654697,0,7,regulation of hyaluronan biosynthetic process,BP,
18612,GO:1900126,1,0.978998630876314,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18613,GO:1900127,1,0.970892253488272,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18614,GO:1900130,1,0.992528902940077,0,1,regulation of lipid binding,BP,
18615,GO:1900131,1,0.992528902940077,0,1,negative regulation of lipid binding,BP,
18616,GO:1900133,1,0.978731000786942,0,3,regulation of renin secretion into blood stream,BP,
18617,GO:1900134,1,0.992507587470241,0,1,negative regulation of renin secretion into blood stream,BP,
18618,GO:1900135,1,0.986120471276234,0,2,positive regulation of renin secretion into blood stream,BP,
18619,GO:1900138,1,0.988086513684142,0,2,negative regulation of phospholipase A2 activity,BP,
18620,GO:1900139,1,0.992447604720358,0,1,negative regulation of arachidonic acid secretion,BP,
18621,GO:1900141,1,0.993547616258172,0,1,regulation of oligodendrocyte apoptotic process,BP,
18622,GO:1900142,1,0.993547616258172,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18623,GO:1900145,1,0.97299345751872,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18624,GO:1900146,1,0.990993562657959,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18625,GO:1900147,1,0.985410554102684,0,2,regulation of Schwann cell migration,BP,
18626,GO:1900148,1,0.9930956730518,0,1,negative regulation of Schwann cell migration,BP,
18627,GO:1900149,1,0.99226199611503,0,1,positive regulation of Schwann cell migration,BP,
18628,GO:1900150,1,0.988489722859958,0,2,regulation of defense response to fungus,BP,
18629,GO:1900151,1,0.901905138533365,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18630,GO:1900152,1,0.994907487051213,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18631,GO:1900153,1,0.901905138533365,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18632,GO:1900154,1,0.987675582073023,0,2,regulation of bone trabecula formation,BP,
18633,GO:1900155,1,0.987675582073023,0,2,negative regulation of bone trabecula formation,BP,
18634,GO:1900157,1,0.986346571279719,0,2,regulation of bone mineralization involved in bone maturation,BP,
18635,GO:1900158,1,0.992497176630065,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18636,GO:1900159,1,0.993803373464768,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18637,GO:1900161,1,0.993087355584068,0,1,regulation of phospholipid scramblase activity,BP,
18638,GO:1900163,1,0.993087355584068,0,1,positive regulation of phospholipid scramblase activity,BP,
18639,GO:1900164,1,0.962469832911325,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18640,GO:1900165,1,0.951335112721509,0,7,negative regulation of interleukin-6 secretion,BP,
18641,GO:1900166,1,0.986528236751183,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18642,GO:1900168,1,0.986528236751183,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18643,GO:1900169,1,0.984939837274931,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18644,GO:1900170,1,0.9930956730518,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18645,GO:1900175,1,0.97299345751872,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18646,GO:1900176,1,0.990993562657959,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18647,GO:1900180,1,0.540396052405773,0,93,regulation of protein localization to nucleus,BP,
18648,GO:1900181,1,0.870088820680318,0,21,negative regulation of protein localization to nucleus,BP,
18649,GO:1900182,1,0.659771002206124,0,62,positive regulation of protein localization to nucleus,BP,
18650,GO:1900186,1,0.98057287541167,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18651,GO:1900190,1,0.993803373464768,0,1,regulation of single-species biofilm formation,BP,
18652,GO:1900191,1,0.993803373464768,0,1,negative regulation of single-species biofilm formation,BP,
18653,GO:1900193,1,0.958449158788097,0,7,regulation of oocyte maturation,BP,
18654,GO:1900194,1,0.982230018197109,0,3,negative regulation of oocyte maturation,BP,
18655,GO:1900195,1,0.988767511950066,0,2,positive regulation of oocyte maturation,BP,
18656,GO:1900200,1,0.985057492417239,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18657,GO:1900204,1,0.985057492417239,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18658,GO:1900205,1,0.985057492417239,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18659,GO:1900208,1,0.990637041097506,0,2,regulation of cardiolipin metabolic process,BP,
18660,GO:1900210,1,0.990637041097506,0,2,positive regulation of cardiolipin metabolic process,BP,
18661,GO:1900211,1,0.985057492417239,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18662,GO:1900212,1,0.985057492417239,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18663,GO:1900214,1,0.985057492417239,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18664,GO:1900215,1,0.985057492417239,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18665,GO:1900217,1,0.985057492417239,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18666,GO:1900218,1,0.985057492417239,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18667,GO:1900220,1,0.984797384504208,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18668,GO:1900221,1,0.932401777348493,0,10,regulation of amyloid-beta clearance,BP,
18669,GO:1900222,1,0.980261115076241,0,3,negative regulation of amyloid-beta clearance,BP,
18670,GO:1900223,1,0.957325687109792,0,6,positive regulation of amyloid-beta clearance,BP,
18671,GO:1900224,1,0.986430388154631,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18672,GO:1900225,1,0.925730123604368,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18673,GO:1900226,1,0.97291650959925,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18674,GO:1900227,1,0.958023281090069,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18675,GO:1900228,1,0.993803373464768,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18676,GO:1900229,1,0.993803373464768,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18677,GO:1900238,1,0.978629760428758,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18678,GO:1900239,1,0.972610249319539,0,4,regulation of phenotypic switching,BP,
18679,GO:1900241,1,0.992973910981209,0,1,positive regulation of phenotypic switching,BP,
18680,GO:1900242,1,0.943350239889636,0,8,regulation of synaptic vesicle endocytosis,BP,
18681,GO:1900243,1,0.992431388720392,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18682,GO:1900244,1,0.971673382614647,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18683,GO:1900245,1,0.977971973883997,0,3,positive regulation of MDA-5 signaling pathway,BP,
18684,GO:1900246,1,0.963134824585523,0,5,positive regulation of RIG-I signaling pathway,BP,
18685,GO:1900247,1,0.934365718250432,0,10,regulation of cytoplasmic translational elongation,BP,
18686,GO:1900248,1,0.984840383862134,0,2,negative regulation of cytoplasmic translational elongation,BP,
18687,GO:1900259,1,0.994766434051296,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18688,GO:1900260,1,0.994766434051296,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18689,GO:1900262,1,0.966855899144723,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18690,GO:1900264,1,0.966855899144723,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18692,GO:1900272,1,0.948021643308499,0,8,negative regulation of long-term synaptic potentiation,BP,
18694,GO:1900274,1,0.796900977932855,0,33,regulation of phospholipase C activity,BP,
18695,GO:1900275,1,0.985026282073634,0,2,negative regulation of phospholipase C activity,BP,
18696,GO:1900276,1,0.99257195088681,0,1,regulation of proteinase activated receptor activity,BP,
18697,GO:1900279,1,0.992556991255456,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18698,GO:1900281,1,0.992556991255456,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18699,GO:1900363,1,0.920077824832438,0,12,regulation of mRNA polyadenylation,BP,
18700,GO:1900364,1,0.944040460350667,0,8,negative regulation of mRNA polyadenylation,BP,
18701,GO:1900365,1,0.979241302911394,0,3,positive regulation of mRNA polyadenylation,BP,
18702,GO:1900368,1,0.977410001429103,0,3,regulation of RNA interference,BP,
18703,GO:1900369,1,0.984876862163949,0,2,negative regulation of RNA interference,BP,
18704,GO:1900370,1,0.992419656123299,0,1,positive regulation of RNA interference,BP,
18708,GO:1900376,1,0.952057169324688,0,7,regulation of secondary metabolite biosynthetic process,BP,
18709,GO:1900377,1,0.984733756691248,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18710,GO:1900378,1,0.966821948879407,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18711,GO:1900383,1,0.992647650005318,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18712,GO:1900387,1,0.994360062471495,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18713,GO:1900390,1,0.983980021470814,0,3,regulation of iron ion import,BP,
18714,GO:1900402,1,0.941634354893484,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18715,GO:1900407,1,0.653338741521803,0,66,regulation of cellular response to oxidative stress,BP,
18716,GO:1900408,1,0.779610315791278,0,39,negative regulation of cellular response to oxidative stress,BP,
18717,GO:1900409,1,0.911453930620367,0,15,positive regulation of cellular response to oxidative stress,BP,
18718,GO:1900424,1,0.927463212165153,0,12,regulation of defense response to bacterium,BP,
18719,GO:1900425,1,0.968338482893426,0,5,negative regulation of defense response to bacterium,BP,
18720,GO:1900426,1,0.966434765124712,0,6,positive regulation of defense response to bacterium,BP,
18722,GO:1900450,1,0.992459445130808,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18723,GO:1900451,1,0.938838216337448,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18724,GO:1900452,1,0.918485717993086,0,12,regulation of long term synaptic depression,BP,
18725,GO:1900453,1,0.981325453968707,0,3,negative regulation of long term synaptic depression,BP,
18726,GO:1900454,1,0.965086200142642,0,5,positive regulation of long term synaptic depression,BP,
18727,GO:1900477,1,0.994396801442627,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18728,GO:1900533,1,0.995415591911866,0,1,palmitic acid metabolic process,BP,
18729,GO:1900535,1,0.995415591911866,0,1,palmitic acid biosynthetic process,BP,
18733,GO:1900558,1,0.994612580195461,0,1,austinol metabolic process,BP,
18734,GO:1900560,1,0.994612580195461,0,1,austinol biosynthetic process,BP,
18735,GO:1900561,1,0.994612580195461,0,1,dehydroaustinol metabolic process,BP,
18736,GO:1900563,1,0.994612580195461,0,1,dehydroaustinol biosynthetic process,BP,
18737,GO:1900619,1,0.979688417375389,0,3,acetate ester metabolic process,BP,
18738,GO:1900620,1,0.993304539438279,0,1,acetate ester biosynthetic process,BP,
18739,GO:1900623,1,0.977686393550055,0,3,regulation of monocyte aggregation,BP,
18740,GO:1900625,1,0.977686393550055,0,3,positive regulation of monocyte aggregation,BP,
18742,GO:1900719,1,0.992449848111986,0,1,regulation of uterine smooth muscle relaxation,BP,
18743,GO:1900721,1,0.992449848111986,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18745,GO:1900737,1,0.99257195088681,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18747,GO:1900739,1,0.833034988922978,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18748,GO:1900740,1,0.833034988922978,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18749,GO:1900744,1,0.815726746282732,0,31,regulation of p38MAPK cascade,BP,
18750,GO:1900745,1,0.876164813693769,0,21,positive regulation of p38MAPK cascade,BP,
18751,GO:1900746,1,0.936175500027177,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18752,GO:1900747,1,0.980468708392936,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18753,GO:1900748,1,0.969780984854462,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18754,GO:1900750,1,0.937990989758171,0,12,oligopeptide binding,MF,
18755,GO:1900753,1,0.992489118805087,0,1,doxorubicin transport,BP,
18756,GO:1900756,1,0.985454020982967,0,2,protein processing in phagocytic vesicle,BP,
18757,GO:1900825,1,0.980978577241826,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18758,GO:1900827,1,0.992040273112879,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18759,GO:1900864,1,0.949193637130854,0,9,mitochondrial RNA modification,BP,
18760,GO:1901004,1,0.995797424935323,0,1,ubiquinone-6 metabolic process,BP,
18761,GO:1901006,1,0.995797424935323,0,1,ubiquinone-6 biosynthetic process,BP,
18763,GO:1901017,1,0.903013952841755,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18766,GO:1901020,1,0.829191144220735,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18767,GO:1901021,1,0.817365926913122,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18768,GO:1901026,1,0.977336231897643,0,3,ripoptosome assembly involved in necroptotic process,BP,
18769,GO:1901028,1,0.758504883512182,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18770,GO:1901029,1,0.955441374307576,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18771,GO:1901030,1,0.798065398387758,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18772,GO:1901031,1,0.799621929681249,0,35,regulation of response to reactive oxygen species,BP,
18773,GO:1901032,1,0.897589700787054,0,17,negative regulation of response to reactive oxygen species,BP,
18774,GO:1901033,1,0.954888409704318,0,8,positive regulation of response to reactive oxygen species,BP,
18775,GO:1901052,1,0.992623517359629,0,1,sarcosine metabolic process,BP,
18776,GO:1901053,1,0.992623517359629,0,1,sarcosine catabolic process,BP,
18777,GO:1901068,1,0.732839141110918,0,50,guanosine-containing compound metabolic process,BP,
18778,GO:1901069,1,0.995591158854113,0,1,guanosine-containing compound catabolic process,BP,
18779,GO:1901070,1,0.935828685399203,0,14,guanosine-containing compound biosynthetic process,BP,
18782,GO:1901073,1,0.984991609743528,0,2,glucosamine-containing compound biosynthetic process,BP,
18783,GO:1901074,1,0.985586354655599,0,2,regulation of engulfment of apoptotic cell,BP,
18784,GO:1901076,1,0.992292852160498,0,1,positive regulation of engulfment of apoptotic cell,BP,
18786,GO:1901078,1,0.980604611685729,0,3,negative regulation of relaxation of muscle,BP,
18788,GO:1901080,1,0.992449848111986,0,1,regulation of relaxation of smooth muscle,BP,
18789,GO:1901082,1,0.992449848111986,0,1,positive regulation of relaxation of smooth muscle,BP,
18790,GO:1901086,1,0.992444797609066,0,1,benzylpenicillin metabolic process,BP,
18791,GO:1901090,1,0.987434997136815,0,2,regulation of protein tetramerization,BP,
18792,GO:1901091,1,0.987434997136815,0,2,negative regulation of protein tetramerization,BP,
18793,GO:1901093,1,0.987434997136815,0,2,regulation of protein homotetramerization,BP,
18794,GO:1901094,1,0.987434997136815,0,2,negative regulation of protein homotetramerization,BP,
18795,GO:1901096,1,0.937493634727011,0,9,regulation of autophagosome maturation,BP,
18796,GO:1901097,1,0.979461447673459,0,3,negative regulation of autophagosome maturation,BP,
18797,GO:1901098,1,0.95695026482764,0,6,positive regulation of autophagosome maturation,BP,
18798,GO:1901099,1,0.820549503106688,0,32,negative regulation of signal transduction in absence of ligand,BP,
18802,GO:1901142,1,0.950978282172608,0,7,insulin metabolic process,BP,
18803,GO:1901143,1,0.985052567023192,0,2,insulin catabolic process,BP,
18804,GO:1901145,1,0.977667989445244,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18805,GO:1901147,1,0.985057492417239,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18806,GO:1901159,1,0.973600898871411,0,5,xylulose 5-phosphate biosynthetic process,BP,
18807,GO:1901160,1,0.923801973835155,0,12,primary amino compound metabolic process,BP,
18808,GO:1901162,1,0.976870978249677,0,4,primary amino compound biosynthetic process,BP,
18809,GO:1901163,1,0.943970700138862,0,10,regulation of trophoblast cell migration,BP,
18810,GO:1901164,1,0.973637557279019,0,5,negative regulation of trophoblast cell migration,BP,
18811,GO:1901165,1,0.969538060847437,0,5,positive regulation of trophoblast cell migration,BP,
18812,GO:1901166,1,0.978682291640386,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18814,GO:1901185,1,0.704413746601498,0,53,negative regulation of ERBB signaling pathway,BP,
18816,GO:1901187,1,0.986211489566146,0,2,regulation of ephrin receptor signaling pathway,BP,
18817,GO:1901189,1,0.993829811705944,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18818,GO:1901193,1,0.995989525461045,0,1,regulation of formation of translation preinitiation complex,BP,
18819,GO:1901194,1,0.995989525461045,0,1,negative regulation of formation of translation preinitiation complex,BP,
18820,GO:1901201,1,0.909695288468759,0,13,regulation of extracellular matrix assembly,BP,
18821,GO:1901202,1,0.993842587016923,0,1,negative regulation of extracellular matrix assembly,BP,
18822,GO:1901203,1,0.935646156893002,0,9,positive regulation of extracellular matrix assembly,BP,
18823,GO:1901207,1,0.985149526833276,0,2,regulation of heart looping,BP,
18824,GO:1901208,1,0.992593735120374,0,1,negative regulation of heart looping,BP,
18825,GO:1901210,1,0.992593735120374,0,1,regulation of cardiac chamber formation,BP,
18826,GO:1901211,1,0.992593735120374,0,1,negative regulation of cardiac chamber formation,BP,
18827,GO:1901213,1,0.922645880572965,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18831,GO:1901219,1,0.992593735120374,0,1,regulation of cardiac chamber morphogenesis,BP,
18832,GO:1901220,1,0.992593735120374,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18834,GO:1901223,1,0.944362206307105,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18836,GO:1901228,1,0.977454347638242,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18837,GO:1901229,1,0.99339854533039,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18838,GO:1901231,1,0.99339854533039,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18839,GO:1901232,1,0.99339854533039,0,1,regulation of convergent extension involved in axis elongation,BP,
18840,GO:1901233,1,0.99339854533039,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18841,GO:1901246,1,0.989136903936376,0,2,regulation of lung ciliated cell differentiation,BP,
18842,GO:1901247,1,0.995786420869193,0,1,negative regulation of lung ciliated cell differentiation,BP,
18843,GO:1901248,1,0.993322633427007,0,1,positive regulation of lung ciliated cell differentiation,BP,
18844,GO:1901249,1,0.995786420869193,0,1,regulation of lung goblet cell differentiation,BP,
18845,GO:1901251,1,0.995786420869193,0,1,positive regulation of lung goblet cell differentiation,BP,
18846,GO:1901252,1,0.988732428587792,0,2,regulation of intracellular transport of viral material,BP,
18847,GO:1901253,1,0.996215912706309,0,1,negative regulation of intracellular transport of viral material,BP,
18848,GO:1901254,1,0.992488380167536,0,1,positive regulation of intracellular transport of viral material,BP,
18849,GO:1901255,1,0.987663148682739,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18850,GO:1901256,1,0.966821628729009,0,5,regulation of macrophage colony-stimulating factor production,BP,
18851,GO:1901257,1,0.993901908091466,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18852,GO:1901258,1,0.980069208007254,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18853,GO:1901264,1,0.669412355440799,0,64,carbohydrate derivative transport,BP,
18855,GO:1901269,1,0.993046014416702,0,2,lipooligosaccharide metabolic process,BP,
18856,GO:1901271,1,0.993046014416702,0,2,lipooligosaccharide biosynthetic process,BP,
18857,GO:1901291,1,0.994726093340693,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18860,GO:1901295,1,0.988802257413596,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18861,GO:1901296,1,0.994941551134375,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18862,GO:1901297,1,0.993829811705944,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18863,GO:1901298,1,0.93983851702017,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18864,GO:1901299,1,0.963358812077236,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18865,GO:1901300,1,0.975594301269884,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18866,GO:1901301,1,0.985725615549226,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18867,GO:1901303,1,0.993198575377995,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18868,GO:1901304,1,0.995135257868318,0,1,regulation of spermidine biosynthetic process,BP,
18869,GO:1901307,1,0.995135257868318,0,1,positive regulation of spermidine biosynthetic process,BP,
18870,GO:1901314,1,0.978312516441483,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18871,GO:1901315,1,0.978312516441483,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18872,GO:1901317,1,0.95775001106779,0,8,regulation of flagellated sperm motility,BP,
18873,GO:1901318,1,0.994700369020467,0,1,negative regulation of flagellated sperm motility,BP,
18874,GO:1901321,1,0.990913180184448,0,2,positive regulation of heart induction,BP,
18875,GO:1901328,1,0.994930231011602,0,1,response to cytochalasin B,BP,
18876,GO:1901329,1,0.980213898515401,0,3,regulation of odontoblast differentiation,BP,
18877,GO:1901331,1,0.992710095381765,0,1,positive regulation of odontoblast differentiation,BP,
18878,GO:1901337,1,0.993283400584553,0,1,thioester transport,BP,
18879,GO:1901338,1,0.916317483038333,0,14,catecholamine binding,MF,
18880,GO:1901339,1,0.951400039348753,0,7,regulation of store-operated calcium channel activity,BP,
18881,GO:1901340,1,0.992497190470666,0,1,negative regulation of store-operated calcium channel activity,BP,
18882,GO:1901341,1,0.965631448724407,0,5,positive regulation of store-operated calcium channel activity,BP,
18884,GO:1901343,1,0.533803881906289,0,93,negative regulation of vasculature development,BP,
18885,GO:1901344,1,0.995780899418405,0,1,response to leptomycin B,BP,
18886,GO:1901350,1,0.992275310682002,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18887,GO:1901355,1,0.986591903578509,0,2,response to rapamycin,BP,
18892,GO:1901373,1,0.995585172911336,0,1,lipid hydroperoxide transport,BP,
18893,GO:1901374,1,0.961607230264774,0,6,acetate ester transport,BP,
18894,GO:1901375,1,0.987293338183422,0,2,acetate ester transmembrane transporter activity,MF,
18895,GO:1901376,1,0.993161023776059,0,1,organic heteropentacyclic compound metabolic process,BP,
18896,GO:1901377,1,0.993161023776059,0,1,organic heteropentacyclic compound catabolic process,BP,
18898,GO:1901380,1,0.88437569723123,0,18,negative regulation of potassium ion transmembrane transport,BP,
18900,GO:1901382,1,0.972510910926586,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18901,GO:1901383,1,0.986567919303977,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18903,GO:1901386,1,0.930574119876199,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18904,GO:1901387,1,0.952551281936515,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18905,GO:1901388,1,0.993479070722466,0,1,regulation of transforming growth factor beta activation,BP,
18906,GO:1901389,1,0.993479070722466,0,1,negative regulation of transforming growth factor beta activation,BP,
18907,GO:1901401,1,0.992386603804784,0,1,regulation of tetrapyrrole metabolic process,BP,
18908,GO:1901407,1,0.944706886137572,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18909,GO:1901409,1,0.958019166352573,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18910,GO:1901419,1,0.992489247294393,0,1,regulation of response to alcohol,BP,
18911,GO:1901421,1,0.992489247294393,0,1,positive regulation of response to alcohol,BP,
18912,GO:1901474,1,0.954294119655543,0,7,azole transmembrane transporter activity,MF,
18913,GO:1901475,1,0.973933490883112,0,4,pyruvate transmembrane transport,BP,
18914,GO:1901490,1,0.971964690969796,0,4,regulation of lymphangiogenesis,BP,
18915,GO:1901491,1,0.98499127182103,0,2,negative regulation of lymphangiogenesis,BP,
18916,GO:1901492,1,0.986776953598644,0,2,positive regulation of lymphangiogenesis,BP,
18917,GO:1901503,1,0.969397850828601,0,5,ether biosynthetic process,BP,
18918,GO:1901505,1,0.805493498504722,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18919,GO:1901509,1,0.973686969176809,0,4,regulation of endothelial tube morphogenesis,BP,
18920,GO:1901522,1,0.857987295966363,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18921,GO:1901523,1,0.981131613971803,0,3,icosanoid catabolic process,BP,
18922,GO:1901524,1,0.913833623459313,0,13,regulation of mitophagy,BP,
18923,GO:1901525,1,0.964103914585137,0,5,negative regulation of mitophagy,BP,
18924,GO:1901526,1,0.947876941432287,0,8,positive regulation of mitophagy,BP,
18925,GO:1901529,1,0.970727756135341,0,4,positive regulation of anion channel activity,BP,
18926,GO:1901532,1,0.618933706092798,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18927,GO:1901533,1,0.959982972249355,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18928,GO:1901534,1,0.985127118806764,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18929,GO:1901535,1,0.962758367352296,0,5,regulation of DNA demethylation,BP,
18930,GO:1901536,1,0.985704864760097,0,2,negative regulation of DNA demethylation,BP,
18931,GO:1901537,1,0.976724099258127,0,3,positive regulation of DNA demethylation,BP,
18932,GO:1901538,1,0.959577107377601,0,6,changes to DNA methylation involved in embryo development,BP,
18933,GO:1901545,1,0.992825105303744,0,1,response to raffinose,BP,
18934,GO:1901550,1,0.924207819429515,0,12,regulation of endothelial cell development,BP,
18935,GO:1901551,1,0.992495031146534,0,1,negative regulation of endothelial cell development,BP,
18936,GO:1901552,1,0.967481588545316,0,5,positive regulation of endothelial cell development,BP,
18937,GO:1901555,1,0.992285195148352,0,1,response to paclitaxel,BP,
18938,GO:1901557,1,0.992500488936931,0,1,response to fenofibrate,BP,
18939,GO:1901558,1,0.987215231361697,0,2,response to metformin,BP,
18940,GO:1901561,1,0.992510835477284,0,1,response to benomyl,BP,
18941,GO:1901563,1,0.965092617636995,0,5,response to camptothecin,BP,
18945,GO:1901567,1,0.873071424781478,0,24,fatty acid derivative binding,MF,
18946,GO:1901568,1,0.44571876049087,0,132,fatty acid derivative metabolic process,BP,
18947,GO:1901569,1,0.951770946407508,0,8,fatty acid derivative catabolic process,BP,
18948,GO:1901570,1,0.631693120558705,0,75,fatty acid derivative biosynthetic process,BP,
18949,GO:1901571,1,0.819553525470474,0,31,fatty acid derivative transport,BP,
18952,GO:1901580,1,0.991947384974868,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18953,GO:1901581,1,0.991947384974868,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18954,GO:1901582,1,0.991947384974868,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18955,GO:1901585,1,0.993042258514874,0,1,regulation of acid-sensing ion channel activity,BP,
18956,GO:1901588,1,0.992472194922582,0,1,dendritic microtubule,CC,
18957,GO:1901594,1,0.992496995066751,0,1,response to capsazepine,BP,
18961,GO:1901608,1,0.995716458342438,0,1,regulation of vesicle transport along microtubule,BP,
18962,GO:1901609,1,0.995716458342438,0,1,negative regulation of vesicle transport along microtubule,BP,
18963,GO:1901611,1,0.941290569534126,0,10,phosphatidylglycerol binding,MF,
18964,GO:1901612,1,0.958309149230361,0,7,cardiolipin binding,MF,
18966,GO:1901616,1,0.719520379590012,0,53,organic hydroxy compound catabolic process,BP,
18967,GO:1901617,1,0.251581711139751,0,214,organic hydroxy compound biosynthetic process,BP,
18968,GO:1901618,1,0.774754625257721,0,39,organic hydroxy compound transmembrane transporter activity,MF,
18969,GO:1901620,1,0.952292388009998,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18970,GO:1901621,1,0.964652608836487,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18971,GO:1901622,1,0.993412345312262,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18973,GO:1901624,1,0.984331814752977,0,3,negative regulation of lymphocyte chemotaxis,BP,
18974,GO:1901626,1,0.937170049387275,0,10,regulation of postsynaptic membrane organization,BP,
18975,GO:1901627,1,0.993872176407998,0,1,negative regulation of postsynaptic membrane organization,BP,
18976,GO:1901628,1,0.97736206948817,0,4,positive regulation of postsynaptic membrane organization,BP,
18977,GO:1901629,1,0.988151783417203,0,2,regulation of presynaptic membrane organization,BP,
18978,GO:1901630,1,0.995924249434127,0,1,negative regulation of presynaptic membrane organization,BP,
18979,GO:1901631,1,0.992196050069559,0,1,positive regulation of presynaptic membrane organization,BP,
18980,GO:1901639,1,0.992364374867111,0,1,XDP catabolic process,BP,
18981,GO:1901640,1,0.992364374867111,0,1,XTP binding,MF,
18982,GO:1901641,1,0.992364374867111,0,1,ITP binding,MF,
18983,GO:1901642,1,0.963589880970839,0,6,nucleoside transmembrane transport,BP,
18988,GO:1901656,1,0.978243249040267,0,3,glycoside transport,BP,
18989,GO:1901657,1,0.446424090721998,0,134,glycosyl compound metabolic process,BP,
18990,GO:1901658,1,0.818168530719204,0,35,glycosyl compound catabolic process,BP,
18991,GO:1901659,1,0.785891802581605,0,43,glycosyl compound biosynthetic process,BP,
18992,GO:1901660,1,0.944045978597434,0,8,calcium ion export,BP,
18993,GO:1901661,1,0.868661784403134,0,27,quinone metabolic process,BP,
18994,GO:1901662,1,0.988732678245184,0,2,quinone catabolic process,BP,
18995,GO:1901663,1,0.929178343218956,0,14,quinone biosynthetic process,BP,
18996,GO:1901664,1,0.982394903519854,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18997,GO:1901666,1,0.982394903519854,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18998,GO:1901668,1,0.97936469286394,0,4,regulation of superoxide dismutase activity,BP,
18999,GO:1901671,1,0.986174529184557,0,3,positive regulation of superoxide dismutase activity,BP,
19000,GO:1901673,1,0.882112298753624,0,19,regulation of mitotic spindle assembly,BP,
19001,GO:1901674,1,0.978065397462886,0,3,regulation of histone H3-K27 acetylation,BP,
19002,GO:1901675,1,0.992306766410019,0,1,negative regulation of histone H3-K27 acetylation,BP,
19003,GO:1901676,1,0.992502426650565,0,1,positive regulation of histone H3-K27 acetylation,BP,
19004,GO:1901678,1,0.930485612320335,0,11,iron coordination entity transport,BP,
19005,GO:1901679,1,0.95100059512511,0,8,nucleotide transmembrane transport,BP,
19006,GO:1901680,1,0.992063322733495,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19008,GO:1901682,1,0.830212662116193,0,27,sulfur compound transmembrane transporter activity,MF,
19009,GO:1901685,1,0.925308883055821,0,18,glutathione derivative metabolic process,BP,
19010,GO:1901687,1,0.925308883055821,0,18,glutathione derivative biosynthetic process,BP,
19015,GO:1901702,1,0.983157507936904,0,3,salt transmembrane transporter activity,MF,
19016,GO:1901706,1,0.993401986990587,0,1,mesenchymal cell differentiation involved in bone development,BP,
19017,GO:1901707,1,0.995780899418405,0,1,leptomycin B binding,MF,
19018,GO:1901722,1,0.929624369342174,0,11,regulation of cell proliferation involved in kidney development,BP,
19019,GO:1901723,1,0.96673798053486,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19020,GO:1901724,1,0.961622432705889,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19021,GO:1901725,1,0.941395911610095,0,8,regulation of histone deacetylase activity,BP,
19022,GO:1901726,1,0.991966125562987,0,1,negative regulation of histone deacetylase activity,BP,
19023,GO:1901727,1,0.956202038535124,0,6,positive regulation of histone deacetylase activity,BP,
19024,GO:1901731,1,0.986331679211736,0,2,positive regulation of platelet aggregation,BP,
19025,GO:1901739,1,0.91673469189172,0,15,regulation of myoblast fusion,BP,
19026,GO:1901740,1,0.990589251913741,0,2,negative regulation of myoblast fusion,BP,
19027,GO:1901741,1,0.925450740509167,0,13,positive regulation of myoblast fusion,BP,
19028,GO:1901748,1,0.980800648325782,0,3,leukotriene D4 metabolic process,BP,
19029,GO:1901750,1,0.980800648325782,0,3,leukotriene D4 biosynthetic process,BP,
19030,GO:1901751,1,0.99381510762746,0,1,leukotriene A4 metabolic process,BP,
19031,GO:1901796,1,0.342010902521305,0,167,regulation of signal transduction by p53 class mediator,BP,
19032,GO:1901797,1,0.854747692250615,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19033,GO:1901798,1,0.886869314448278,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19034,GO:1901799,1,0.750881328350697,0,44,negative regulation of proteasomal protein catabolic process,BP,
19035,GO:1901800,1,0.526007537217819,0,99,positive regulation of proteasomal protein catabolic process,BP,
19036,GO:1901804,1,0.993741255981152,0,1,beta-glucoside metabolic process,BP,
19037,GO:1901805,1,0.993741255981152,0,1,beta-glucoside catabolic process,BP,
19038,GO:1901810,1,0.9930956730518,0,1,beta-carotene metabolic process,BP,
19039,GO:1901825,1,0.993354321866076,0,1,zeaxanthin metabolic process,BP,
19040,GO:1901827,1,0.993354321866076,0,1,zeaxanthin biosynthetic process,BP,
19041,GO:1901834,1,0.995054517796043,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19042,GO:1901835,1,0.995054517796043,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19043,GO:1901836,1,0.931478315992855,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19044,GO:1901837,1,0.988926117045463,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19045,GO:1901838,1,0.941915314099287,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19046,GO:1901841,1,0.935729162810618,0,11,regulation of high voltage-gated calcium channel activity,BP,
19047,GO:1901842,1,0.980005231438359,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19048,GO:1901843,1,0.978265952923008,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19049,GO:1901844,1,0.942538165466687,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19050,GO:1901846,1,0.992481849963238,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19051,GO:1901856,1,0.986679263703916,0,2,negative regulation of cellular respiration,BP,
19052,GO:1901857,1,0.967600607681497,0,6,positive regulation of cellular respiration,BP,
19053,GO:1901858,1,0.959795602528166,0,6,regulation of mitochondrial DNA metabolic process,BP,
19054,GO:1901859,1,0.978395054301635,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19055,GO:1901860,1,0.988161050434356,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19056,GO:1901861,1,0.450658909796324,0,117,regulation of muscle tissue development,BP,
19057,GO:1901862,1,0.749964276037691,0,44,negative regulation of muscle tissue development,BP,
19058,GO:1901863,1,0.657293320466206,0,61,positive regulation of muscle tissue development,BP,
19059,GO:1901873,1,0.98545867388293,0,2,regulation of post-translational protein modification,BP,
19060,GO:1901874,1,0.98545867388293,0,2,negative regulation of post-translational protein modification,BP,
19061,GO:1901876,1,0.991581291357963,0,2,regulation of calcium ion binding,BP,
19062,GO:1901877,1,0.991581291357963,0,2,negative regulation of calcium ion binding,BP,
19066,GO:1901888,1,0.575229192315601,0,80,regulation of cell junction assembly,BP,
19067,GO:1901889,1,0.867292465336323,0,20,negative regulation of cell junction assembly,BP,
19068,GO:1901890,1,0.812256631537547,0,30,positive regulation of cell junction assembly,BP,
19069,GO:1901894,1,0.952356214697963,0,8,regulation of calcium-transporting ATPase activity,BP,
19070,GO:1901895,1,0.980091272242137,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19071,GO:1901896,1,0.975168098230705,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19073,GO:1901898,1,0.984736943695652,0,2,negative regulation of relaxation of cardiac muscle,BP,
19075,GO:1901906,1,0.976709538622527,0,4,diadenosine pentaphosphate metabolic process,BP,
19076,GO:1901907,1,0.976709538622527,0,4,diadenosine pentaphosphate catabolic process,BP,
19077,GO:1901908,1,0.976709538622527,0,4,diadenosine hexaphosphate metabolic process,BP,
19078,GO:1901909,1,0.976709538622527,0,4,diadenosine hexaphosphate catabolic process,BP,
19079,GO:1901910,1,0.976709538622527,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19080,GO:1901911,1,0.976709538622527,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19081,GO:1901917,1,0.99314632348085,0,1,regulation of exoribonuclease activity,BP,
19082,GO:1901919,1,0.99314632348085,0,1,positive regulation of exoribonuclease activity,BP,
19083,GO:1901950,1,0.9930956730518,0,1,dense core granule transport,BP,
19084,GO:1901962,1,0.994090826494099,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19085,GO:1901963,1,0.987592727100564,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19086,GO:1901964,1,0.99497902520046,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19087,GO:1901970,1,0.949955124480932,0,8,positive regulation of mitotic sister chromatid separation,BP,
19088,GO:1901976,1,0.812729268882126,0,32,regulation of cell cycle checkpoint,BP,
19089,GO:1901977,1,0.961976081714967,0,6,negative regulation of cell cycle checkpoint,BP,
19090,GO:1901978,1,0.936571116255025,0,10,positive regulation of cell cycle checkpoint,BP,
19091,GO:1901979,1,0.981768953163902,0,3,regulation of inward rectifier potassium channel activity,BP,
19092,GO:1901980,1,0.992030652383892,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19094,GO:1901983,1,0.65497861722846,0,65,regulation of protein acetylation,BP,
19095,GO:1901984,1,0.86654550638707,0,23,negative regulation of protein acetylation,BP,
19096,GO:1901985,1,0.797450115306081,0,35,positive regulation of protein acetylation,BP,
19098,GO:1901987,1,0.0771043359947276,0,400,regulation of cell cycle phase transition,BP,
19099,GO:1901988,1,0.256789100561627,0,219,negative regulation of cell cycle phase transition,BP,
19100,GO:1901989,1,0.630257057024501,0,72,positive regulation of cell cycle phase transition,BP,
19101,GO:1901990,1,0.091278455118176,0,376,regulation of mitotic cell cycle phase transition,BP,
19102,GO:1901991,1,0.280448397862329,0,206,negative regulation of mitotic cell cycle phase transition,BP,
19103,GO:1901992,1,0.67647701502917,0,61,positive regulation of mitotic cell cycle phase transition,BP,
19104,GO:1901993,1,0.985717249523591,0,2,regulation of meiotic cell cycle phase transition,BP,
19105,GO:1901994,1,0.985717249523591,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19107,GO:1902001,1,0.905432066261264,0,14,fatty acid transmembrane transport,BP,
19108,GO:1902003,1,0.883488262303837,0,18,regulation of amyloid-beta formation,BP,
19109,GO:1902004,1,0.934082907094475,0,10,positive regulation of amyloid-beta formation,BP,
19110,GO:1902010,1,0.992557269535793,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19111,GO:1902017,1,0.774777499142559,0,39,regulation of cilium assembly,BP,
19112,GO:1902018,1,0.941404908369094,0,9,negative regulation of cilium assembly,BP,
19113,GO:1902019,1,0.966622571074625,0,5,regulation of cilium-dependent cell motility,BP,
19114,GO:1902022,1,0.968701376607089,0,5,L-lysine transport,BP,
19115,GO:1902023,1,0.961930342950046,0,6,L-arginine transport,BP,
19116,GO:1902031,1,0.966794667161385,0,6,regulation of NADP metabolic process,BP,
19117,GO:1902033,1,0.954987419507136,0,7,regulation of hematopoietic stem cell proliferation,BP,
19118,GO:1902035,1,0.968691163865498,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19119,GO:1902036,1,0.65407511352031,0,79,regulation of hematopoietic stem cell differentiation,BP,
19120,GO:1902037,1,0.979573979991836,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19121,GO:1902038,1,0.992571135754723,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19122,GO:1902041,1,0.704050314232476,0,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19123,GO:1902042,1,0.810976736292805,0,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19124,GO:1902043,1,0.891786767484752,0,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19125,GO:1902044,1,0.986358625234122,0,2,regulation of Fas signaling pathway,BP,
19126,GO:1902045,1,0.993834721845543,0,1,negative regulation of Fas signaling pathway,BP,
19127,GO:1902047,1,0.965563684127985,0,6,polyamine transmembrane transport,BP,
19129,GO:1902071,1,0.99592684524929,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19130,GO:1902073,1,0.99592684524929,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19133,GO:1902076,1,0.99191186063905,0,1,regulation of lateral motor column neuron migration,BP,
19134,GO:1902078,1,0.99191186063905,0,1,positive regulation of lateral motor column neuron migration,BP,
19135,GO:1902080,1,0.995112158155111,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19136,GO:1902081,1,0.995112158155111,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19137,GO:1902083,1,0.963667287861059,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19138,GO:1902093,1,0.962854754508043,0,7,positive regulation of flagellated sperm motility,BP,
19139,GO:1902098,1,0.992470006950484,0,1,calcitriol binding,MF,
19140,GO:1902099,1,0.733743172062655,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19141,GO:1902100,1,0.813371002678313,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19142,GO:1902101,1,0.949955124480932,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19143,GO:1902102,1,0.992813660106105,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19144,GO:1902103,1,0.992813660106105,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19146,GO:1902106,1,0.610131593797963,0,76,negative regulation of leukocyte differentiation,BP,
19149,GO:1902109,1,0.985799101252228,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19150,GO:1902110,1,0.716433460120255,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19151,GO:1902115,1,0.360537074589789,0,149,regulation of organelle assembly,BP,
19152,GO:1902116,1,0.815383477811671,0,31,negative regulation of organelle assembly,BP,
19153,GO:1902117,1,0.663760726281491,0,58,positive regulation of organelle assembly,BP,
19154,GO:1902121,1,0.992470006950484,0,1,lithocholic acid binding,MF,
19155,GO:1902122,1,0.994251771467272,0,1,chenodeoxycholic acid binding,MF,
19156,GO:1902159,1,0.988748694550442,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19157,GO:1902161,1,0.992353639835833,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19158,GO:1902162,1,0.985069502426682,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19159,GO:1902164,1,0.985069502426682,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19160,GO:1902165,1,0.926492910505313,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19161,GO:1902166,1,0.936328787995854,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19162,GO:1902167,1,0.996589056032357,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19164,GO:1902172,1,0.969348116797871,0,5,regulation of keratinocyte apoptotic process,BP,
19165,GO:1902174,1,0.981208553405461,0,3,positive regulation of keratinocyte apoptotic process,BP,
19167,GO:1902176,1,0.896835918213599,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19168,GO:1902177,1,0.970542895456597,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19169,GO:1902178,1,0.992491502395498,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19170,GO:1902186,1,0.820113119876062,0,29,regulation of viral release from host cell,BP,
19171,GO:1902187,1,0.904394926787712,0,14,negative regulation of viral release from host cell,BP,
19172,GO:1902188,1,0.907439219685092,0,15,positive regulation of viral release from host cell,BP,
19173,GO:1902202,1,0.974962866253248,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19174,GO:1902203,1,0.992452645816854,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19175,GO:1902204,1,0.994533992621327,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19176,GO:1902205,1,0.99512284213113,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19177,GO:1902206,1,0.99512284213113,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19178,GO:1902211,1,0.9930956730518,0,1,regulation of prolactin signaling pathway,BP,
19179,GO:1902213,1,0.9930956730518,0,1,positive regulation of prolactin signaling pathway,BP,
19180,GO:1902214,1,0.982464535413992,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19181,GO:1902215,1,0.99512284213113,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19182,GO:1902216,1,0.987280285332491,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19183,GO:1902217,1,0.995720714623742,0,1,erythrocyte apoptotic process,BP,
19184,GO:1902218,1,0.962893520803849,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19185,GO:1902219,1,0.966732629192398,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19186,GO:1902220,1,0.996030150017592,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19187,GO:1902221,1,0.948293878314087,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19188,GO:1902222,1,0.948293878314087,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19189,GO:1902224,1,0.924835101270794,0,12,ketone body metabolic process,BP,
19190,GO:1902226,1,0.984335658547673,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19191,GO:1902227,1,0.990583557496284,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19192,GO:1902228,1,0.993693316481998,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19193,GO:1902229,1,0.819877434855322,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19194,GO:1902230,1,0.851656048546482,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19195,GO:1902231,1,0.969643168598208,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19196,GO:1902232,1,0.99512284213113,0,1,regulation of positive thymic T cell selection,BP,
19197,GO:1902233,1,0.99512284213113,0,1,negative regulation of positive thymic T cell selection,BP,
19198,GO:1902235,1,0.835977045859367,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19199,GO:1902236,1,0.898467134884209,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19200,GO:1902237,1,0.941713190417207,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19201,GO:1902238,1,0.992495258360024,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19202,GO:1902239,1,0.992495258360024,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19203,GO:1902250,1,0.995720714623742,0,1,regulation of erythrocyte apoptotic process,BP,
19204,GO:1902251,1,0.995720714623742,0,1,negative regulation of erythrocyte apoptotic process,BP,
19205,GO:1902253,1,0.877414134231701,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19206,GO:1902254,1,0.902053694338097,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19207,GO:1902255,1,0.983999651855526,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19208,GO:1902256,1,0.980307516048331,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19209,GO:1902257,1,0.987780562324145,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19211,GO:1902260,1,0.957999055464585,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19212,GO:1902261,1,0.97356158902184,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19213,GO:1902262,1,0.971441353697168,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19214,GO:1902263,1,0.981017700277416,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19215,GO:1902267,1,0.972862039075722,0,5,regulation of polyamine transmembrane transport,BP,
19216,GO:1902268,1,0.987038576646368,0,3,negative regulation of polyamine transmembrane transport,BP,
19217,GO:1902269,1,0.985639201776865,0,2,positive regulation of polyamine transmembrane transport,BP,
19218,GO:1902271,1,0.992470006950484,0,1,D3 vitamins binding,MF,
19219,GO:1902275,1,0.336708163817147,0,157,regulation of chromatin organization,BP,
19220,GO:1902282,1,0.948596881788481,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19221,GO:1902283,1,0.992499787811949,0,1,negative regulation of primary amine oxidase activity,BP,
19222,GO:1902284,1,0.787882802658653,0,32,neuron projection extension involved in neuron projection guidance,BP,
19223,GO:1902285,1,0.905830628927121,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19224,GO:1902287,1,0.912755201277335,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19225,GO:1902292,1,0.995922950409059,0,1,cell cycle DNA replication initiation,BP,
19226,GO:1902296,1,0.992633568170398,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19227,GO:1902298,1,0.986041084267846,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19228,GO:1902299,1,0.983271255446626,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19229,GO:1902302,1,0.967132321094003,0,5,regulation of potassium ion export,BP,
19230,GO:1902303,1,0.985525229249836,0,2,negative regulation of potassium ion export,BP,
19231,GO:1902304,1,0.988806931258536,0,2,positive regulation of potassium ion export,BP,
19232,GO:1902305,1,0.700862269546976,0,55,regulation of sodium ion transmembrane transport,BP,
19233,GO:1902306,1,0.92035351106534,0,12,negative regulation of sodium ion transmembrane transport,BP,
19234,GO:1902307,1,0.89096654519809,0,18,positive regulation of sodium ion transmembrane transport,BP,
19235,GO:1902308,1,0.969076129163802,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19236,GO:1902309,1,0.979810812911918,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19237,GO:1902310,1,0.989046394287142,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19238,GO:1902311,1,0.994999459268022,0,1,regulation of copper ion transmembrane transport,BP,
19239,GO:1902315,1,0.995922950409059,0,1,nuclear cell cycle DNA replication initiation,BP,
19240,GO:1902319,1,0.992633568170398,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19241,GO:1902336,1,0.986184313975938,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19242,GO:1902337,1,0.940607450135971,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19243,GO:1902338,1,0.965718700531989,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19244,GO:1902339,1,0.981431977907833,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19245,GO:1902356,1,0.994774271506862,0,1,oxaloacetate(2-) transmembrane transport,BP,
19246,GO:1902358,1,0.925171665152929,0,11,sulfate transmembrane transport,BP,
19247,GO:1902359,1,0.987609416682012,0,2,Notch signaling pathway involved in somitogenesis,BP,
19248,GO:1902362,1,0.9930743338349,0,1,melanocyte apoptotic process,BP,
19249,GO:1902363,1,0.992263514958006,0,1,regulation of protein localization to spindle pole body,BP,
19250,GO:1902365,1,0.992263514958006,0,1,positive regulation of protein localization to spindle pole body,BP,
19251,GO:1902366,1,0.987609416682012,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19252,GO:1902367,1,0.987609416682012,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19253,GO:1902369,1,0.737260558772453,0,44,negative regulation of RNA catabolic process,BP,
19254,GO:1902373,1,0.768199920428323,0,38,negative regulation of mRNA catabolic process,BP,
19255,GO:1902378,1,0.993588067364596,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19256,GO:1902379,1,0.992381002025962,0,1,chemoattractant activity involved in axon guidance,MF,
19257,GO:1902380,1,0.993704771852438,0,1,positive regulation of endoribonuclease activity,BP,
19258,GO:1902387,1,0.9930956730518,0,1,ceramide 1-phosphate binding,MF,
19259,GO:1902388,1,0.9930956730518,0,1,ceramide 1-phosphate transporter activity,MF,
19260,GO:1902389,1,0.9930956730518,0,1,ceramide 1-phosphate transport,BP,
19261,GO:1902396,1,0.992502689394883,0,1,protein localization to bicellular tight junction,BP,
19262,GO:1902400,1,0.681585568554868,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19263,GO:1902402,1,0.676697776554954,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19264,GO:1902403,1,0.676697776554954,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19265,GO:1902410,1,0.962238288275658,0,6,mitotic cytokinetic process,BP,
19266,GO:1902412,1,0.971944909217801,0,4,regulation of mitotic cytokinesis,BP,
19267,GO:1902414,1,0.944251873339078,0,8,protein localization to cell junction,BP,
19268,GO:1902415,1,0.946359926796992,0,9,regulation of mRNA binding,BP,
19269,GO:1902416,1,0.957900289623786,0,7,positive regulation of mRNA binding,BP,
19270,GO:1902423,1,0.986589118774047,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19271,GO:1902425,1,0.986589118774047,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19272,GO:1902426,1,0.993252995819076,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19273,GO:1902430,1,0.940900391955509,0,9,negative regulation of amyloid-beta formation,BP,
19274,GO:1902442,1,0.992512791948098,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19275,GO:1902443,1,0.992512791948098,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19276,GO:1902444,1,0.995913183904194,0,1,riboflavin binding,MF,
19277,GO:1902445,1,0.986583350187111,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19278,GO:1902455,1,0.959380361676636,0,6,negative regulation of stem cell population maintenance,BP,
19279,GO:1902459,1,0.949475227203972,0,7,positive regulation of stem cell population maintenance,BP,
19280,GO:1902460,1,0.992478025871908,0,1,regulation of mesenchymal stem cell proliferation,BP,
19281,GO:1902462,1,0.992478025871908,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19282,GO:1902463,1,0.99070281137881,0,2,protein localization to cell leading edge,BP,
19283,GO:1902464,1,0.992486711478525,0,1,regulation of histone H3-K27 trimethylation,BP,
19284,GO:1902466,1,0.992486711478525,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19285,GO:1902473,1,0.944682767486407,0,8,regulation of protein localization to synapse,BP,
19286,GO:1902474,1,0.951253871870186,0,7,positive regulation of protein localization to synapse,BP,
19289,GO:1902480,1,0.99369904011156,0,1,protein localization to mitotic spindle,BP,
19290,GO:1902488,1,0.992133512631521,0,1,cholangiocyte apoptotic process,BP,
19291,GO:1902490,1,0.994593496571265,0,1,regulation of sperm capacitation,BP,
19292,GO:1902493,1,0.574241449221691,0,85,acetyltransferase complex,CC,
19295,GO:1902498,1,0.969891422895875,0,4,regulation of protein autoubiquitination,BP,
19296,GO:1902499,1,0.985161388968675,0,2,positive regulation of protein autoubiquitination,BP,
19297,GO:1902504,1,0.992856680677661,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19298,GO:1902510,1,0.962700784886175,0,7,regulation of apoptotic DNA fragmentation,BP,
19299,GO:1902511,1,0.993198575377995,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19300,GO:1902512,1,0.986617043739855,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19302,GO:1902514,1,0.940886096326421,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19303,GO:1902523,1,0.977993228764867,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19304,GO:1902524,1,0.988038284858428,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19305,GO:1902525,1,0.972767267760996,0,5,regulation of protein monoubiquitination,BP,
19306,GO:1902527,1,0.980103223319461,0,4,positive regulation of protein monoubiquitination,BP,
19307,GO:1902528,1,0.992163026001157,0,1,regulation of protein linear polyubiquitination,BP,
19308,GO:1902530,1,0.992163026001157,0,1,positive regulation of protein linear polyubiquitination,BP,
19312,GO:1902544,1,0.989007849576131,0,2,regulation of DNA N-glycosylase activity,BP,
19313,GO:1902546,1,0.996324673417562,0,1,positive regulation of DNA N-glycosylase activity,BP,
19314,GO:1902547,1,0.92910511590349,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19315,GO:1902548,1,0.973067280680686,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19316,GO:1902554,1,0.598525028111277,0,80,serine/threonine protein kinase complex,CC,
19317,GO:1902555,1,0.840815404601571,0,29,endoribonuclease complex,CC,
19318,GO:1902559,1,0.988923921275082,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19319,GO:1902560,1,0.99025055154854,0,2,GMP reductase complex,CC,
19320,GO:1902562,1,0.778376935057377,0,39,H4 histone acetyltransferase complex,CC,
19321,GO:1902563,1,0.935079464950489,0,10,regulation of neutrophil activation,BP,
19322,GO:1902564,1,0.975021364845129,0,4,negative regulation of neutrophil activation,BP,
19323,GO:1902565,1,0.971969950412431,0,4,positive regulation of neutrophil activation,BP,
19324,GO:1902566,1,0.977134243510915,0,4,regulation of eosinophil activation,BP,
19325,GO:1902567,1,0.988369954867497,0,2,negative regulation of eosinophil activation,BP,
19326,GO:1902568,1,0.988633429353361,0,2,positive regulation of eosinophil activation,BP,
19327,GO:1902569,1,0.994776229076601,0,1,negative regulation of activation of Janus kinase activity,BP,
19328,GO:1902570,1,0.942670085195733,0,10,protein localization to nucleolus,BP,
19329,GO:1902571,1,0.971669386784466,0,6,regulation of serine-type peptidase activity,BP,
19330,GO:1902572,1,0.971669386784466,0,6,negative regulation of serine-type peptidase activity,BP,
19331,GO:1902573,1,0.992089267287523,0,1,positive regulation of serine-type peptidase activity,BP,
19332,GO:1902576,1,0.973486117753878,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19333,GO:1902579,1,0.641534529450149,0,69,multi-organism localization,BP,
19334,GO:1902581,1,0.970617291732852,0,5,multi-organism cellular localization,BP,
19335,GO:1902583,1,0.970617291732852,0,5,multi-organism intracellular transport,BP,
19336,GO:1902594,1,0.984932374390871,0,2,multi-organism nuclear import,BP,
19337,GO:1902595,1,0.988869884354016,0,2,regulation of DNA replication origin binding,BP,
19339,GO:1902603,1,0.976425209931161,0,4,carnitine transmembrane transport,BP,
19340,GO:1902605,1,0.99315659417127,0,1,heterotrimeric G-protein complex assembly,BP,
19341,GO:1902606,1,0.992172962878436,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19342,GO:1902608,1,0.992172962878436,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19343,GO:1902612,1,0.993149248630193,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19344,GO:1902613,1,0.993149248630193,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19345,GO:1902616,1,0.994811338635687,0,1,acyl carnitine transmembrane transport,BP,
19346,GO:1902617,1,0.969056975428172,0,5,response to fluoride,BP,
19347,GO:1902618,1,0.992369297635693,0,1,cellular response to fluoride,BP,
19348,GO:1902622,1,0.815769465717911,0,37,regulation of neutrophil migration,BP,
19349,GO:1902623,1,0.985599247166474,0,2,negative regulation of neutrophil migration,BP,
19350,GO:1902624,1,0.842388759006571,0,32,positive regulation of neutrophil migration,BP,
19351,GO:1902626,1,0.988211265207336,0,3,assembly of large subunit precursor of preribosome,BP,
19352,GO:1902629,1,0.995666237812036,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19353,GO:1902630,1,0.984721197627255,0,2,regulation of membrane hyperpolarization,BP,
19354,GO:1902631,1,0.992282774235215,0,1,negative regulation of membrane hyperpolarization,BP,
19355,GO:1902636,1,0.989583288865449,0,2,kinociliary basal body,CC,
19356,GO:1902652,1,0.4505926886173,0,122,secondary alcohol metabolic process,BP,
19357,GO:1902653,1,0.663086926133286,0,63,secondary alcohol biosynthetic process,BP,
19358,GO:1902656,1,0.91291832017478,0,13,calcium ion import into cytosol,BP,
19359,GO:1902659,1,0.983482686520385,0,3,regulation of glucose mediated signaling pathway,BP,
19360,GO:1902661,1,0.983482686520385,0,3,positive regulation of glucose mediated signaling pathway,BP,
19362,GO:1902668,1,0.856503417374102,0,21,negative regulation of axon guidance,BP,
19363,GO:1902669,1,0.944722381709595,0,8,positive regulation of axon guidance,BP,
19366,GO:1902683,1,0.982303538421745,0,3,regulation of receptor localization to synapse,BP,
19367,GO:1902684,1,0.995716458342438,0,1,negative regulation of receptor localization to synapse,BP,
19368,GO:1902685,1,0.99249246321158,0,1,positive regulation of receptor localization to synapse,BP,
19369,GO:1902686,1,0.70738728712709,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19370,GO:1902692,1,0.826437006784461,0,27,regulation of neuroblast proliferation,BP,
19373,GO:1902713,1,0.950363557441352,0,8,regulation of interferon-gamma secretion,BP,
19374,GO:1902714,1,0.987487531518989,0,2,negative regulation of interferon-gamma secretion,BP,
19375,GO:1902715,1,0.962410366722974,0,6,positive regulation of interferon-gamma secretion,BP,
19376,GO:1902722,1,0.982357860272084,0,3,positive regulation of prolactin secretion,BP,
19377,GO:1902723,1,0.978297907826884,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19378,GO:1902724,1,0.984936470674513,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19379,GO:1902725,1,0.978034173991294,0,3,negative regulation of satellite cell differentiation,BP,
19380,GO:1902728,1,0.984936470674513,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19381,GO:1902730,1,0.9783298276895,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19382,GO:1902731,1,0.977828614733502,0,3,negative regulation of chondrocyte proliferation,BP,
19383,GO:1902732,1,0.983382364434924,0,3,positive regulation of chondrocyte proliferation,BP,
19384,GO:1902737,1,0.992488380167536,0,1,dendritic filopodium,CC,
19385,GO:1902739,1,0.955339407915872,0,6,regulation of interferon-alpha secretion,BP,
19386,GO:1902741,1,0.955339407915872,0,6,positive regulation of interferon-alpha secretion,BP,
19387,GO:1902742,1,0.820528615669173,0,29,apoptotic process involved in development,BP,
19388,GO:1902743,1,0.770428872899739,0,38,regulation of lamellipodium organization,BP,
19389,GO:1902744,1,0.970649872354263,0,4,negative regulation of lamellipodium organization,BP,
19390,GO:1902745,1,0.859840158935656,0,22,positive regulation of lamellipodium organization,BP,
19391,GO:1902746,1,0.980557286922044,0,3,regulation of lens fiber cell differentiation,BP,
19392,GO:1902747,1,0.994603545753244,0,1,negative regulation of lens fiber cell differentiation,BP,
19393,GO:1902748,1,0.992101486545164,0,1,positive regulation of lens fiber cell differentiation,BP,
19394,GO:1902749,1,0.28151559231619,0,202,regulation of cell cycle G2/M phase transition,BP,
19395,GO:1902750,1,0.575772840243471,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19396,GO:1902751,1,0.849705613855999,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19397,GO:1902766,1,0.990460291928091,0,2,skeletal muscle satellite cell migration,BP,
19398,GO:1902767,1,0.986340968802966,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19399,GO:1902769,1,0.991961552034559,0,1,regulation of choline O-acetyltransferase activity,BP,
19400,GO:1902771,1,0.991961552034559,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19401,GO:1902773,1,0.992807372296908,0,1,GTPase activator complex,CC,
19402,GO:1902774,1,0.954718368624405,0,7,late endosome to lysosome transport,BP,
19403,GO:1902775,1,0.978343978232447,0,3,mitochondrial large ribosomal subunit assembly,BP,
19405,GO:1902804,1,0.976131581562852,0,4,negative regulation of synaptic vesicle transport,BP,
19406,GO:1902805,1,0.977438269809924,0,3,positive regulation of synaptic vesicle transport,BP,
19407,GO:1902806,1,0.367060117379822,0,156,regulation of cell cycle G1/S phase transition,BP,
19408,GO:1902807,1,0.52641534185967,0,99,negative regulation of cell cycle G1/S phase transition,BP,
19409,GO:1902808,1,0.803846243154239,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19410,GO:1902809,1,0.980972897350764,0,3,regulation of skeletal muscle fiber differentiation,BP,
19411,GO:1902811,1,0.9879202738662,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19412,GO:1902816,1,0.971981716553019,0,4,regulation of protein localization to microtubule,BP,
19413,GO:1902817,1,0.971981716553019,0,4,negative regulation of protein localization to microtubule,BP,
19414,GO:1902822,1,0.975648375356134,0,4,regulation of late endosome to lysosome transport,BP,
19415,GO:1902823,1,0.98478328240274,0,2,negative regulation of late endosome to lysosome transport,BP,
19416,GO:1902824,1,0.9907253873303,0,2,positive regulation of late endosome to lysosome transport,BP,
19417,GO:1902838,1,0.99243882233873,0,1,regulation of nuclear migration along microtubule,BP,
19418,GO:1902846,1,0.992263514958006,0,1,positive regulation of mitotic spindle elongation,BP,
19419,GO:1902847,1,0.993013917221064,0,1,regulation of neuronal signal transduction,BP,
19420,GO:1902850,1,0.431991540546659,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19421,GO:1902855,1,0.933479177365607,0,10,regulation of non-motile cilium assembly,BP,
19422,GO:1902856,1,0.985019079083793,0,2,negative regulation of non-motile cilium assembly,BP,
19423,GO:1902857,1,0.953832807721991,0,7,positive regulation of non-motile cilium assembly,BP,
19424,GO:1902858,1,0.994272203656633,0,1,propionyl-CoA metabolic process,BP,
19425,GO:1902860,1,0.994272203656633,0,1,propionyl-CoA biosynthetic process,BP,
19427,GO:1902867,1,0.992727777758575,0,1,negative regulation of retina development in camera-type eye,BP,
19428,GO:1902868,1,0.987970625677167,0,2,positive regulation of retina development in camera-type eye,BP,
19429,GO:1902869,1,0.980784999788718,0,3,regulation of amacrine cell differentiation,BP,
19430,GO:1902870,1,0.992727777758575,0,1,negative regulation of amacrine cell differentiation,BP,
19431,GO:1902871,1,0.987970625677167,0,2,positive regulation of amacrine cell differentiation,BP,
19432,GO:1902882,1,0.619624459039534,0,74,regulation of response to oxidative stress,BP,
19433,GO:1902883,1,0.768559178904545,0,41,negative regulation of response to oxidative stress,BP,
19434,GO:1902884,1,0.905897808472395,0,16,positive regulation of response to oxidative stress,BP,
19435,GO:1902889,1,0.992295536432322,0,1,protein localization to spindle microtubule,BP,
19436,GO:1902890,1,0.996390802365142,0,1,regulation of root hair elongation,BP,
19437,GO:1902891,1,0.996390802365142,0,1,negative regulation of root hair elongation,BP,
19438,GO:1902893,1,0.802148399463754,0,31,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19439,GO:1902894,1,0.922400378753833,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19440,GO:1902895,1,0.857117330431411,0,22,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19441,GO:1902896,1,0.978536855281424,0,3,terminal web assembly,BP,
19442,GO:1902897,1,0.979821461203381,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19443,GO:1902902,1,0.93532464206307,0,11,negative regulation of autophagosome assembly,BP,
19447,GO:1902908,1,0.987659903156707,0,2,regulation of melanosome transport,BP,
19448,GO:1902910,1,0.992492007106331,0,1,positive regulation of melanosome transport,BP,
19449,GO:1902911,1,0.544972795956926,0,93,protein kinase complex,CC,
19450,GO:1902912,1,0.9930956730518,0,1,pyruvate kinase complex,CC,
19451,GO:1902913,1,0.992710095381765,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19452,GO:1902914,1,0.8952955355877,0,16,regulation of protein polyubiquitination,BP,
19453,GO:1902915,1,0.956450753867149,0,6,negative regulation of protein polyubiquitination,BP,
19454,GO:1902916,1,0.943432659486839,0,9,positive regulation of protein polyubiquitination,BP,
19455,GO:1902930,1,0.675519527059561,0,59,regulation of alcohol biosynthetic process,BP,
19456,GO:1902931,1,0.945878562594148,0,9,negative regulation of alcohol biosynthetic process,BP,
19457,GO:1902932,1,0.895007684058572,0,17,positive regulation of alcohol biosynthetic process,BP,
19459,GO:1902937,1,0.979543577168313,0,3,inward rectifier potassium channel complex,CC,
19460,GO:1902938,1,0.978489741414196,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19461,GO:1902939,1,0.992956764664232,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19462,GO:1902941,1,0.984907312760713,0,2,regulation of voltage-gated chloride channel activity,BP,
19463,GO:1902943,1,0.984907312760713,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19464,GO:1902946,1,0.941924985750982,0,8,protein localization to early endosome,BP,
19465,GO:1902947,1,0.961024967680577,0,6,regulation of tau-protein kinase activity,BP,
19466,GO:1902948,1,0.991961552034559,0,1,negative regulation of tau-protein kinase activity,BP,
19467,GO:1902949,1,0.974138357005138,0,4,positive regulation of tau-protein kinase activity,BP,
19470,GO:1902952,1,0.980990847871934,0,3,positive regulation of dendritic spine maintenance,BP,
19471,GO:1902953,1,0.973534475381542,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19472,GO:1902954,1,0.98425389385323,0,2,regulation of early endosome to recycling endosome transport,BP,
19473,GO:1902955,1,0.991961552034559,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19474,GO:1902956,1,0.982308177823983,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19475,GO:1902957,1,0.992705657091814,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19476,GO:1902958,1,0.989526899231931,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19477,GO:1902959,1,0.947464467922161,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19478,GO:1902960,1,0.985913953992169,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19479,GO:1902961,1,0.961006706897481,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19480,GO:1902962,1,0.984529149358823,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19481,GO:1902963,1,0.984529149358823,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19482,GO:1902965,1,0.955237249798755,0,6,regulation of protein localization to early endosome,BP,
19483,GO:1902966,1,0.955237249798755,0,6,positive regulation of protein localization to early endosome,BP,
19484,GO:1902969,1,0.943233993431976,0,9,mitotic DNA replication,BP,
19485,GO:1902975,1,0.995922950409059,0,1,mitotic DNA replication initiation,BP,
19486,GO:1902977,1,0.994709285539896,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19487,GO:1902983,1,0.992633568170398,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19488,GO:1902988,1,0.977530952090108,0,3,neurofibrillary tangle assembly,BP,
19489,GO:1902990,1,0.980790857261126,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19490,GO:1902991,1,0.85636069959726,0,23,regulation of amyloid precursor protein catabolic process,BP,
19491,GO:1902992,1,0.927605263188675,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19492,GO:1902993,1,0.922694414076142,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19493,GO:1902994,1,0.988248194948242,0,2,regulation of phospholipid efflux,BP,
19494,GO:1902995,1,0.988248194948242,0,2,positive regulation of phospholipid efflux,BP,
19495,GO:1902996,1,0.985031058280372,0,2,regulation of neurofibrillary tangle assembly,BP,
19496,GO:1902997,1,0.991961552034559,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19497,GO:1902998,1,0.993013917221064,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19498,GO:1903000,1,0.995924249434127,0,1,regulation of lipid transport across blood brain barrier,BP,
19499,GO:1903002,1,0.995924249434127,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19500,GO:1903003,1,0.959673692759857,0,6,positive regulation of protein deubiquitination,BP,
19501,GO:1903004,1,0.992504135278238,0,1,regulation of protein K63-linked deubiquitination,BP,
19502,GO:1903006,1,0.992504135278238,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19503,GO:1903007,1,0.992504135278238,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19504,GO:1903008,1,0.524899890897382,0,100,organelle disassembly,BP,
19505,GO:1903010,1,0.887094673926408,0,18,regulation of bone development,BP,
19506,GO:1903011,1,0.951898857451848,0,7,negative regulation of bone development,BP,
19507,GO:1903012,1,0.957256059460958,0,7,positive regulation of bone development,BP,
19508,GO:1903015,1,0.989868254370051,0,2,regulation of exo-alpha-sialidase activity,BP,
19509,GO:1903016,1,0.994685480976322,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19510,GO:1903017,1,0.995157298489048,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19511,GO:1903018,1,0.781792270451619,0,40,regulation of glycoprotein metabolic process,BP,
19512,GO:1903019,1,0.933231863753011,0,12,negative regulation of glycoprotein metabolic process,BP,
19513,GO:1903020,1,0.872952328169124,0,21,positive regulation of glycoprotein metabolic process,BP,
19514,GO:1903025,1,0.951306146148988,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19515,GO:1903026,1,0.977760198534562,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19516,GO:1903027,1,0.986340650662951,0,2,regulation of opsonization,BP,
19517,GO:1903028,1,0.99223051877541,0,1,positive regulation of opsonization,BP,
19518,GO:1903031,1,0.988188115110472,0,2,regulation of microtubule plus-end binding,BP,
19519,GO:1903033,1,0.988188115110472,0,2,positive regulation of microtubule plus-end binding,BP,
19520,GO:1903034,1,0.421172227683128,0,132,regulation of response to wounding,BP,
19521,GO:1903035,1,0.624768793861446,0,72,negative regulation of response to wounding,BP,
19522,GO:1903036,1,0.727056020087738,0,50,positive regulation of response to wounding,BP,
19524,GO:1903038,1,0.553474325890776,0,94,negative regulation of leukocyte cell-cell adhesion,BP,
19526,GO:1903044,1,0.949698245390679,0,8,protein localization to membrane raft,BP,
19527,GO:1903045,1,0.992396042570428,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19528,GO:1903046,1,0.356948326236534,0,156,meiotic cell cycle process,BP,
19530,GO:1903050,1,0.291242549341567,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19531,GO:1903051,1,0.697769292515144,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19532,GO:1903052,1,0.480054753639104,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19533,GO:1903053,1,0.822617822422602,0,28,regulation of extracellular matrix organization,BP,
19534,GO:1903054,1,0.964003440432192,0,6,negative regulation of extracellular matrix organization,BP,
19535,GO:1903055,1,0.898922824867217,0,15,positive regulation of extracellular matrix organization,BP,
19536,GO:1903056,1,0.987271264598143,0,2,regulation of melanosome organization,BP,
19537,GO:1903059,1,0.969378024948875,0,5,regulation of protein lipidation,BP,
19538,GO:1903060,1,0.9949207709724,0,1,negative regulation of protein lipidation,BP,
19539,GO:1903061,1,0.974328172053737,0,4,positive regulation of protein lipidation,BP,
19540,GO:1903069,1,0.944548427316165,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19541,GO:1903070,1,0.982140440452172,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19542,GO:1903071,1,0.955864250661044,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19543,GO:1903072,1,0.99622159485821,0,1,regulation of death-inducing signaling complex assembly,BP,
19544,GO:1903073,1,0.99622159485821,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19547,GO:1903078,1,0.725520207170477,0,47,positive regulation of protein localization to plasma membrane,BP,
19548,GO:1903080,1,0.996083383182969,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19549,GO:1903082,1,0.996083383182969,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19550,GO:1903093,1,0.984345100446271,0,3,regulation of protein K48-linked deubiquitination,BP,
19551,GO:1903094,1,0.992009997615386,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19552,GO:1903095,1,0.985632042992662,0,2,ribonuclease III complex,CC,
19553,GO:1903096,1,0.992813660106105,0,1,protein localization to meiotic spindle midzone,BP,
19554,GO:1903108,1,0.992442258119062,0,1,regulation of mitochondrial transcription,BP,
19555,GO:1903109,1,0.992442258119062,0,1,positive regulation of mitochondrial transcription,BP,
19556,GO:1903115,1,0.764859031546538,0,38,regulation of actin filament-based movement,BP,
19557,GO:1903116,1,0.977650332936683,0,3,positive regulation of actin filament-based movement,BP,
19558,GO:1903119,1,0.979069538627123,0,3,protein localization to actin cytoskeleton,BP,
19559,GO:1903121,1,0.975720133527374,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19560,GO:1903122,1,0.99622159485821,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19561,GO:1903123,1,0.992094053059202,0,1,regulation of thioredoxin peroxidase activity,BP,
19562,GO:1903124,1,0.992094053059202,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19563,GO:1903125,1,0.992094053059202,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19564,GO:1903126,1,0.994284464778941,0,1,negative regulation of centriole-centriole cohesion,BP,
19565,GO:1903131,1,0.820327424611513,0,30,mononuclear cell differentiation,BP,
19566,GO:1903135,1,0.981998746206106,0,3,cupric ion binding,MF,
19568,GO:1903140,1,0.924207819429515,0,12,regulation of establishment of endothelial barrier,BP,
19569,GO:1903141,1,0.992495031146534,0,1,negative regulation of establishment of endothelial barrier,BP,
19570,GO:1903142,1,0.967481588545316,0,5,positive regulation of establishment of endothelial barrier,BP,
19571,GO:1903143,1,0.984612142082582,0,3,adrenomedullin receptor complex,CC,
19572,GO:1903146,1,0.747546234369998,0,44,regulation of autophagy of mitochondrion,BP,
19573,GO:1903147,1,0.954185158888877,0,7,negative regulation of autophagy of mitochondrion,BP,
19574,GO:1903165,1,0.993228636089122,0,1,response to polycyclic arene,BP,
19575,GO:1903167,1,0.99622159485821,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19576,GO:1903168,1,0.99622159485821,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19578,GO:1903170,1,0.811572645757011,0,34,negative regulation of calcium ion transmembrane transport,BP,
19579,GO:1903173,1,0.987348598824887,0,2,fatty alcohol metabolic process,BP,
19580,GO:1903176,1,0.99622159485821,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19581,GO:1903178,1,0.99622159485821,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19582,GO:1903179,1,0.988880716980375,0,2,regulation of dopamine biosynthetic process,BP,
19583,GO:1903181,1,0.988880716980375,0,2,positive regulation of dopamine biosynthetic process,BP,
19584,GO:1903182,1,0.995894182048718,0,1,regulation of SUMO transferase activity,BP,
19585,GO:1903184,1,0.99622159485821,0,1,L-dopa metabolic process,BP,
19586,GO:1903185,1,0.99622159485821,0,1,L-dopa biosynthetic process,BP,
19587,GO:1903189,1,0.99622159485821,0,1,glyoxal metabolic process,BP,
19588,GO:1903195,1,0.99622159485821,0,1,regulation of L-dopa biosynthetic process,BP,
19589,GO:1903197,1,0.99622159485821,0,1,positive regulation of L-dopa biosynthetic process,BP,
19590,GO:1903198,1,0.99622159485821,0,1,regulation of L-dopa decarboxylase activity,BP,
19591,GO:1903200,1,0.99622159485821,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19592,GO:1903201,1,0.69194963865488,0,57,regulation of oxidative stress-induced cell death,BP,
19593,GO:1903202,1,0.779610315791278,0,39,negative regulation of oxidative stress-induced cell death,BP,
19594,GO:1903203,1,0.870712026296258,0,20,regulation of oxidative stress-induced neuron death,BP,
19595,GO:1903204,1,0.904341022488688,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19596,GO:1903205,1,0.857374828756723,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19597,GO:1903206,1,0.897589700787054,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19598,GO:1903207,1,0.977369294577486,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19599,GO:1903208,1,0.977369294577486,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19600,GO:1903209,1,0.920747260917413,0,13,positive regulation of oxidative stress-induced cell death,BP,
19601,GO:1903210,1,0.992338574129646,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19602,GO:1903214,1,0.598235521897642,0,82,regulation of protein targeting to mitochondrion,BP,
19603,GO:1903215,1,0.974946701539911,0,4,negative regulation of protein targeting to mitochondrion,BP,
19604,GO:1903216,1,0.988061764457284,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19605,GO:1903217,1,0.988061764457284,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19606,GO:1903223,1,0.970129206374809,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19607,GO:1903224,1,0.969100548300873,0,5,regulation of endodermal cell differentiation,BP,
19608,GO:1903225,1,0.980512301307655,0,3,negative regulation of endodermal cell differentiation,BP,
19609,GO:1903232,1,0.973892386948377,0,5,melanosome assembly,BP,
19610,GO:1903233,1,0.984689971220611,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19611,GO:1903236,1,0.958991708070624,0,8,regulation of leukocyte tethering or rolling,BP,
19612,GO:1903237,1,0.983703976226407,0,4,negative regulation of leukocyte tethering or rolling,BP,
19613,GO:1903238,1,0.974882514843992,0,4,positive regulation of leukocyte tethering or rolling,BP,
19614,GO:1903242,1,0.942004756674737,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19615,GO:1903243,1,0.956259904127914,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19616,GO:1903244,1,0.985099555891363,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19617,GO:1903248,1,0.992129025827869,0,1,regulation of citrulline biosynthetic process,BP,
19618,GO:1903249,1,0.992129025827869,0,1,negative regulation of citrulline biosynthetic process,BP,
19619,GO:1903251,1,0.963130666229147,0,6,multi-ciliated epithelial cell differentiation,BP,
19620,GO:1903265,1,0.953396920429603,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19621,GO:1903276,1,0.979047103328713,0,4,regulation of sodium ion export across plasma membrane,BP,
19622,GO:1903278,1,0.979047103328713,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19623,GO:1903279,1,0.979819718543263,0,3,regulation of calcium:sodium antiporter activity,BP,
19624,GO:1903280,1,0.992412627210966,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19625,GO:1903281,1,0.98731179316691,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19626,GO:1903282,1,0.992705657091814,0,1,regulation of glutathione peroxidase activity,BP,
19627,GO:1903284,1,0.992705657091814,0,1,positive regulation of glutathione peroxidase activity,BP,
19628,GO:1903285,1,0.992705657091814,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19629,GO:1903286,1,0.97493339912444,0,4,regulation of potassium ion import,BP,
19630,GO:1903288,1,0.982352382564938,0,3,positive regulation of potassium ion import,BP,
19631,GO:1903292,1,0.98551861594512,0,2,protein localization to Golgi membrane,BP,
19632,GO:1903293,1,0.741578407248493,0,44,phosphatase complex,CC,
19633,GO:1903294,1,0.985013052968694,0,2,regulation of glutamate secretion, neurotransmission,BP,
19634,GO:1903296,1,0.985013052968694,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19635,GO:1903297,1,0.969464066458537,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19636,GO:1903298,1,0.969464066458537,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19637,GO:1903299,1,0.948811257690463,0,9,regulation of hexokinase activity,BP,
19638,GO:1903300,1,0.976589095260543,0,4,negative regulation of hexokinase activity,BP,
19639,GO:1903301,1,0.971563050088075,0,5,positive regulation of hexokinase activity,BP,
19646,GO:1903314,1,0.994251771467272,0,1,regulation of nitrogen cycle metabolic process,BP,
19647,GO:1903317,1,0.572171763511396,0,88,regulation of protein maturation,BP,
19648,GO:1903318,1,0.800425663944583,0,35,negative regulation of protein maturation,BP,
19649,GO:1903319,1,0.877843366476491,0,20,positive regulation of protein maturation,BP,
19650,GO:1903320,1,0.281995504370306,0,195,regulation of protein modification by small protein conjugation or removal,BP,
19651,GO:1903321,1,0.640752080738636,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19652,GO:1903322,1,0.478616714940595,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19653,GO:1903332,1,0.956401538591563,0,7,regulation of protein folding,BP,
19654,GO:1903333,1,0.969973106824956,0,5,negative regulation of protein folding,BP,
19655,GO:1903335,1,0.975648375356134,0,4,regulation of vacuolar transport,BP,
19656,GO:1903336,1,0.98478328240274,0,2,negative regulation of vacuolar transport,BP,
19657,GO:1903337,1,0.9907253873303,0,2,positive regulation of vacuolar transport,BP,
19658,GO:1903347,1,0.972609745218827,0,4,negative regulation of bicellular tight junction assembly,BP,
19659,GO:1903348,1,0.978438671429842,0,3,positive regulation of bicellular tight junction assembly,BP,
19660,GO:1903349,1,0.959910219798647,0,6,omegasome membrane,CC,
19661,GO:1903350,1,0.916431853595989,0,13,response to dopamine,BP,
19662,GO:1903351,1,0.916431853595989,0,13,cellular response to dopamine,BP,
19663,GO:1903352,1,0.961095019499724,0,6,L-ornithine transmembrane transport,BP,
19664,GO:1903358,1,0.903178843625691,0,15,regulation of Golgi organization,BP,
19665,GO:1903361,1,0.961762705447708,0,7,protein localization to basolateral plasma membrane,BP,
19666,GO:1903362,1,0.236226635250716,0,220,regulation of cellular protein catabolic process,BP,
19667,GO:1903363,1,0.649494708283258,0,67,negative regulation of cellular protein catabolic process,BP,
19668,GO:1903364,1,0.418855993510818,0,131,positive regulation of cellular protein catabolic process,BP,
19669,GO:1903365,1,0.962088354027547,0,7,regulation of fear response,BP,
19670,GO:1903367,1,0.973508488547364,0,5,positive regulation of fear response,BP,
19671,GO:1903371,1,0.971254333278307,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19672,GO:1903373,1,0.978871264799077,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19673,GO:1903375,1,0.986032372202934,0,2,facioacoustic ganglion development,BP,
19674,GO:1903376,1,0.953240502489927,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19675,GO:1903377,1,0.975004702499941,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19676,GO:1903378,1,0.985072503738248,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19677,GO:1903381,1,0.992479185176651,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19678,GO:1903382,1,0.992479185176651,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19679,GO:1903383,1,0.989526899231931,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19680,GO:1903384,1,0.989526899231931,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19681,GO:1903385,1,0.985046137753825,0,2,regulation of homophilic cell adhesion,BP,
19682,GO:1903387,1,0.992428536333497,0,1,positive regulation of homophilic cell adhesion,BP,
19683,GO:1903391,1,0.674004249071705,0,56,regulation of adherens junction organization,BP,
19684,GO:1903392,1,0.8916398091557,0,16,negative regulation of adherens junction organization,BP,
19685,GO:1903393,1,0.839259345763056,0,25,positive regulation of adherens junction organization,BP,
19686,GO:1903394,1,0.993842587016923,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19687,GO:1903400,1,0.966239984252422,0,5,L-arginine transmembrane transport,BP,
19688,GO:1903401,1,0.968701376607089,0,5,L-lysine transmembrane transport,BP,
19689,GO:1903402,1,0.992503924341286,0,1,regulation of renal phosphate excretion,BP,
19690,GO:1903403,1,0.992503924341286,0,1,negative regulation of renal phosphate excretion,BP,
19691,GO:1903405,1,0.948190268473618,0,9,protein localization to nuclear body,BP,
19692,GO:1903406,1,0.99252469753454,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19693,GO:1903408,1,0.99252469753454,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19695,GO:1903412,1,0.984750264036312,0,3,response to bile acid,BP,
19696,GO:1903413,1,0.984750264036312,0,3,cellular response to bile acid,BP,
19697,GO:1903414,1,0.992603524382402,0,1,iron cation export,BP,
19698,GO:1903416,1,0.959535089723139,0,6,response to glycoside,BP,
19699,GO:1903420,1,0.992331153282776,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19701,GO:1903422,1,0.984967567125647,0,2,negative regulation of synaptic vesicle recycling,BP,
19704,GO:1903427,1,0.879960997607672,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19706,GO:1903429,1,0.878438109337423,0,20,regulation of cell maturation,BP,
19707,GO:1903430,1,0.959168668102129,0,7,negative regulation of cell maturation,BP,
19708,GO:1903431,1,0.951625839760293,0,7,positive regulation of cell maturation,BP,
19709,GO:1903432,1,0.850996892702119,0,25,regulation of TORC1 signaling,BP,
19710,GO:1903433,1,0.985627017361995,0,2,regulation of constitutive secretory pathway,BP,
19711,GO:1903434,1,0.992504670142241,0,1,negative regulation of constitutive secretory pathway,BP,
19712,GO:1903435,1,0.993070937396307,0,1,positive regulation of constitutive secretory pathway,BP,
19713,GO:1903436,1,0.985013636093323,0,2,regulation of mitotic cytokinetic process,BP,
19714,GO:1903438,1,0.985013636093323,0,2,positive regulation of mitotic cytokinetic process,BP,
19715,GO:1903439,1,0.973592104634866,0,5,calcitonin family receptor complex,CC,
19716,GO:1903440,1,0.980999737654357,0,4,amylin receptor complex,CC,
19717,GO:1903441,1,0.947022440555944,0,8,protein localization to ciliary membrane,BP,
19718,GO:1903442,1,0.992506314483297,0,1,response to lipoic acid,BP,
19719,GO:1903444,1,0.9927132062119,0,1,negative regulation of brown fat cell differentiation,BP,
19720,GO:1903445,1,0.984636308288772,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19721,GO:1903450,1,0.992145023225784,0,1,regulation of G1 to G0 transition,BP,
19722,GO:1903452,1,0.992145023225784,0,1,positive regulation of G1 to G0 transition,BP,
19723,GO:1903461,1,0.992751085456202,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19724,GO:1903463,1,0.97989393328624,0,3,regulation of mitotic cell cycle DNA replication,BP,
19725,GO:1903464,1,0.987401077788291,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19726,GO:1903465,1,0.992398046130642,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19727,GO:1903487,1,0.987515675460041,0,2,regulation of lactation,BP,
19728,GO:1903489,1,0.994934951994993,0,1,positive regulation of lactation,BP,
19729,GO:1903490,1,0.985013636093323,0,2,positive regulation of mitotic cytokinesis,BP,
19730,GO:1903494,1,0.996169914061682,0,1,response to dehydroepiandrosterone,BP,
19731,GO:1903496,1,0.996169914061682,0,1,response to 11-deoxycorticosterone,BP,
19732,GO:1903504,1,0.915596362251964,0,14,regulation of mitotic spindle checkpoint,BP,
19738,GO:1903513,1,0.84421086509847,0,26,endoplasmic reticulum to cytosol transport,BP,
19739,GO:1903514,1,0.826257744165058,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19740,GO:1903515,1,0.992176865634032,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19741,GO:1903516,1,0.979907115478633,0,3,regulation of single strand break repair,BP,
19742,GO:1903517,1,0.992949794499282,0,1,negative regulation of single strand break repair,BP,
19743,GO:1903518,1,0.986865656218675,0,2,positive regulation of single strand break repair,BP,
19744,GO:1903519,1,0.981431977907833,0,3,regulation of mammary gland involution,BP,
19745,GO:1903521,1,0.981431977907833,0,3,positive regulation of mammary gland involution,BP,
19747,GO:1903523,1,0.834720174165448,0,27,negative regulation of blood circulation,BP,
19749,GO:1903525,1,0.96276458293818,0,5,regulation of membrane tubulation,BP,
19750,GO:1903526,1,0.985066450055361,0,2,negative regulation of membrane tubulation,BP,
19751,GO:1903527,1,0.977363470952702,0,3,positive regulation of membrane tubulation,BP,
19756,GO:1903537,1,0.986879889899589,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19757,GO:1903538,1,0.986879889899589,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19760,GO:1903541,1,0.915233497356689,0,14,regulation of exosomal secretion,BP,
19761,GO:1903542,1,0.986717038013097,0,2,negative regulation of exosomal secretion,BP,
19762,GO:1903543,1,0.915233497356689,0,14,positive regulation of exosomal secretion,BP,
19763,GO:1903544,1,0.992579584433495,0,1,response to butyrate,BP,
19764,GO:1903545,1,0.992579584433495,0,1,cellular response to butyrate,BP,
19765,GO:1903546,1,0.961271440985332,0,6,protein localization to photoreceptor outer segment,BP,
19766,GO:1903547,1,0.991920601858354,0,2,regulation of growth hormone activity,BP,
19767,GO:1903551,1,0.961532366415186,0,6,regulation of extracellular exosome assembly,BP,
19768,GO:1903553,1,0.972913506418634,0,4,positive regulation of extracellular exosome assembly,BP,
19769,GO:1903555,1,0.50760209836788,0,110,regulation of tumor necrosis factor superfamily cytokine production,BP,
19770,GO:1903556,1,0.766459795265393,0,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19771,GO:1903557,1,0.664905204109384,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19773,GO:1903564,1,0.971068585954638,0,4,regulation of protein localization to cilium,BP,
19774,GO:1903565,1,0.992584977524049,0,1,negative regulation of protein localization to cilium,BP,
19775,GO:1903566,1,0.978324499100432,0,3,positive regulation of protein localization to cilium,BP,
19776,GO:1903567,1,0.986439654338964,0,2,regulation of protein localization to ciliary membrane,BP,
19777,GO:1903568,1,0.992584977524049,0,1,negative regulation of protein localization to ciliary membrane,BP,
19778,GO:1903569,1,0.993809237265184,0,1,positive regulation of protein localization to ciliary membrane,BP,
19779,GO:1903570,1,0.992548954940589,0,1,regulation of protein kinase D signaling,BP,
19780,GO:1903572,1,0.992548954940589,0,1,positive regulation of protein kinase D signaling,BP,
19781,GO:1903573,1,0.771665191250503,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19782,GO:1903575,1,0.988139019829225,0,2,cornified envelope assembly,BP,
19783,GO:1903576,1,0.994415153683557,0,1,response to L-arginine,BP,
19784,GO:1903578,1,0.57641929665671,0,83,regulation of ATP metabolic process,BP,
19785,GO:1903579,1,0.885847211868804,0,19,negative regulation of ATP metabolic process,BP,
19786,GO:1903580,1,0.82440626940848,0,29,positive regulation of ATP metabolic process,BP,
19787,GO:1903584,1,0.992487981924976,0,1,regulation of histone deubiquitination,BP,
19788,GO:1903586,1,0.992487981924976,0,1,positive regulation of histone deubiquitination,BP,
19789,GO:1903587,1,0.94198502451939,0,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19790,GO:1903588,1,0.973592839506789,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19791,GO:1903589,1,0.967543591610169,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19792,GO:1903593,1,0.986307158435705,0,3,regulation of histamine secretion by mast cell,BP,
19793,GO:1903595,1,0.986307158435705,0,3,positive regulation of histamine secretion by mast cell,BP,
19794,GO:1903596,1,0.972126277625248,0,4,regulation of gap junction assembly,BP,
19795,GO:1903597,1,0.992600392373194,0,1,negative regulation of gap junction assembly,BP,
19796,GO:1903598,1,0.979374801478156,0,3,positive regulation of gap junction assembly,BP,
19797,GO:1903599,1,0.894799517347356,0,17,positive regulation of autophagy of mitochondrion,BP,
19798,GO:1903608,1,0.961778959480381,0,6,protein localization to cytoplasmic stress granule,BP,
19799,GO:1903609,1,0.993264927058927,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19800,GO:1903610,1,0.994700369020467,0,1,regulation of calcium-dependent ATPase activity,BP,
19801,GO:1903611,1,0.994700369020467,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19802,GO:1903613,1,0.992422960446766,0,1,regulation of protein tyrosine phosphatase activity,BP,
19803,GO:1903615,1,0.992422960446766,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19804,GO:1903618,1,0.992500133858096,0,1,regulation of transdifferentiation,BP,
19805,GO:1903620,1,0.992500133858096,0,1,positive regulation of transdifferentiation,BP,
19806,GO:1903621,1,0.994664582788305,0,1,protein localization to photoreceptor connecting cilium,BP,
19807,GO:1903624,1,0.949885671882945,0,9,regulation of DNA catabolic process,BP,
19808,GO:1903625,1,0.987934623674742,0,2,negative regulation of DNA catabolic process,BP,
19809,GO:1903626,1,0.978674586415226,0,4,positive regulation of DNA catabolic process,BP,
19810,GO:1903627,1,0.994700369020467,0,1,regulation of dUTP diphosphatase activity,BP,
19811,GO:1903629,1,0.994700369020467,0,1,positive regulation of dUTP diphosphatase activity,BP,
19812,GO:1903630,1,0.990595046832494,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19813,GO:1903631,1,0.994700369020467,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19814,GO:1903632,1,0.995873029050814,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19815,GO:1903633,1,0.994700369020467,0,1,regulation of leucine-tRNA ligase activity,BP,
19816,GO:1903634,1,0.994700369020467,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19817,GO:1903636,1,0.996610217817555,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19818,GO:1903638,1,0.996610217817555,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19819,GO:1903639,1,0.996653917218047,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19820,GO:1903640,1,0.996653917218047,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19821,GO:1903644,1,0.990095247563513,0,2,regulation of chaperone-mediated protein folding,BP,
19822,GO:1903645,1,0.996610217817555,0,1,negative regulation of chaperone-mediated protein folding,BP,
19823,GO:1903649,1,0.872323351365123,0,20,regulation of cytoplasmic transport,BP,
19824,GO:1903650,1,0.992141921572838,0,2,negative regulation of cytoplasmic transport,BP,
19825,GO:1903651,1,0.934985417787385,0,9,positive regulation of cytoplasmic transport,BP,
19826,GO:1903659,1,0.989292688728647,0,2,regulation of complement-dependent cytotoxicity,BP,
19827,GO:1903660,1,0.989292688728647,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19828,GO:1903670,1,0.691437679680404,0,55,regulation of sprouting angiogenesis,BP,
19829,GO:1903671,1,0.853392630243487,0,23,negative regulation of sprouting angiogenesis,BP,
19830,GO:1903672,1,0.816802559780067,0,31,positive regulation of sprouting angiogenesis,BP,
19831,GO:1903673,1,0.99471720079266,0,1,mitotic cleavage furrow formation,BP,
19832,GO:1903674,1,0.994731028006767,0,1,regulation of cap-dependent translational initiation,BP,
19833,GO:1903676,1,0.994731028006767,0,1,positive regulation of cap-dependent translational initiation,BP,
19834,GO:1903677,1,0.982507339378261,0,3,regulation of cap-independent translational initiation,BP,
19835,GO:1903679,1,0.982507339378261,0,3,positive regulation of cap-independent translational initiation,BP,
19836,GO:1903689,1,0.954399389450859,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19837,GO:1903690,1,0.969581893841291,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19838,GO:1903691,1,0.984346075059554,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19839,GO:1903697,1,0.992604795986866,0,1,negative regulation of microvillus assembly,BP,
19840,GO:1903699,1,0.99189914411283,0,1,tarsal gland development,BP,
19841,GO:1903701,1,0.992435452826788,0,1,substantia propria of cornea development,BP,
19842,GO:1903704,1,0.992500133858096,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19844,GO:1903707,1,0.489990485159752,0,114,negative regulation of hemopoiesis,BP,
19846,GO:1903709,1,0.99189914411283,0,1,uterine gland development,BP,
19847,GO:1903712,1,0.992513861620335,0,1,cysteine transmembrane transport,BP,
19848,GO:1903715,1,0.958791083544173,0,6,regulation of aerobic respiration,BP,
19849,GO:1903717,1,0.992388266636735,0,1,response to ammonia,BP,
19850,GO:1903718,1,0.992388266636735,0,1,cellular response to ammonia,BP,
19851,GO:1903719,1,0.982893551796375,0,3,regulation of I-kappaB phosphorylation,BP,
19852,GO:1903721,1,0.982893551796375,0,3,positive regulation of I-kappaB phosphorylation,BP,
19853,GO:1903722,1,0.988874674909921,0,2,regulation of centriole elongation,BP,
19854,GO:1903723,1,0.996254262411469,0,1,negative regulation of centriole elongation,BP,
19855,GO:1903724,1,0.992592949679895,0,1,positive regulation of centriole elongation,BP,
19856,GO:1903725,1,0.641522950402647,0,66,regulation of phospholipid metabolic process,BP,
19857,GO:1903726,1,0.954883385689753,0,7,negative regulation of phospholipid metabolic process,BP,
19858,GO:1903727,1,0.759506427931464,0,42,positive regulation of phospholipid metabolic process,BP,
19859,GO:1903729,1,0.927674575279379,0,11,regulation of plasma membrane organization,BP,
19860,GO:1903742,1,0.995716458342438,0,1,regulation of anterograde synaptic vesicle transport,BP,
19861,GO:1903743,1,0.995716458342438,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19862,GO:1903747,1,0.48805939154204,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19863,GO:1903748,1,0.955860921966413,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19864,GO:1903749,1,0.522900854090838,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19865,GO:1903750,1,0.976161338281803,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19866,GO:1903751,1,0.976161338281803,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19867,GO:1903753,1,0.96508521817264,0,5,negative regulation of p38MAPK cascade,BP,
19868,GO:1903755,1,0.995894182048718,0,1,positive regulation of SUMO transferase activity,BP,
19869,GO:1903756,1,0.986292592001961,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19870,GO:1903758,1,0.986292592001961,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19871,GO:1903759,1,0.9927132062119,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19872,GO:1903760,1,0.977601509794917,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19873,GO:1903762,1,0.985040587829075,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19874,GO:1903763,1,0.97917726739522,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19875,GO:1903764,1,0.981654051289138,0,3,regulation of potassium ion export across plasma membrane,BP,
19876,GO:1903765,1,0.992783501380276,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19877,GO:1903766,1,0.996313819676705,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19878,GO:1903767,1,0.993454267129848,0,1,sweet taste receptor complex,CC,
19879,GO:1903768,1,0.993454267129848,0,1,taste receptor complex,CC,
19880,GO:1903770,1,0.992949794499282,0,1,negative regulation of beta-galactosidase activity,BP,
19881,GO:1903772,1,0.972029748046356,0,5,regulation of viral budding via host ESCRT complex,BP,
19882,GO:1903774,1,0.982842065602602,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19883,GO:1903775,1,0.986922472133712,0,2,regulation of DNA double-strand break processing,BP,
19884,GO:1903778,1,0.992334171367484,0,1,protein localization to vacuolar membrane,BP,
19885,GO:1903779,1,0.631053217660835,0,69,regulation of cardiac conduction,BP,
19886,GO:1903781,1,0.977648233106861,0,3,positive regulation of cardiac conduction,BP,
19887,GO:1903786,1,0.993161023776059,0,1,regulation of glutathione biosynthetic process,BP,
19888,GO:1903788,1,0.993161023776059,0,1,positive regulation of glutathione biosynthetic process,BP,
19889,GO:1903789,1,0.947685451387953,0,8,regulation of amino acid transmembrane transport,BP,
19890,GO:1903792,1,0.856981190324519,0,22,negative regulation of anion transport,BP,
19892,GO:1903795,1,0.956134527702873,0,6,regulation of inorganic anion transmembrane transport,BP,
19893,GO:1903796,1,0.985145122136222,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19894,GO:1903797,1,0.984907312760713,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19895,GO:1903798,1,0.910189966658712,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19896,GO:1903799,1,0.944831251222217,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19897,GO:1903800,1,0.95771491171111,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19898,GO:1903801,1,0.994018021742566,0,1,L-leucine import across plasma membrane,BP,
19899,GO:1903803,1,0.994701360356908,0,1,L-glutamine import across plasma membrane,BP,
19900,GO:1903804,1,0.99298173693035,0,1,glycine import across plasma membrane,BP,
19901,GO:1903814,1,0.996313819676705,0,1,regulation of collecting lymphatic vessel constriction,BP,
19902,GO:1903815,1,0.996313819676705,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19903,GO:1903817,1,0.951544045828039,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19905,GO:1903823,1,0.992949794499282,0,1,telomere single strand break repair,BP,
19906,GO:1903824,1,0.992949794499282,0,1,negative regulation of telomere single strand break repair,BP,
19908,GO:1903826,1,0.961192693971703,0,6,arginine transmembrane transport,BP,
19912,GO:1903830,1,0.894190547854805,0,16,magnesium ion transmembrane transport,BP,
19914,GO:1903837,1,0.993608490836106,0,1,regulation of mRNA 3'-UTR binding,BP,
19915,GO:1903839,1,0.993608490836106,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19916,GO:1903844,1,0.511576735661225,0,100,regulation of cellular response to transforming growth factor beta stimulus,BP,
19917,GO:1903845,1,0.633915239608834,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19918,GO:1903846,1,0.848574049540028,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19919,GO:1903847,1,0.984639290956917,0,2,regulation of aorta morphogenesis,BP,
19920,GO:1903849,1,0.984639290956917,0,2,positive regulation of aorta morphogenesis,BP,
19921,GO:1903850,1,0.99328017239829,0,1,regulation of cristae formation,BP,
19922,GO:1903852,1,0.99328017239829,0,1,positive regulation of cristae formation,BP,
19924,GO:1903860,1,0.983019492301446,0,3,negative regulation of dendrite extension,BP,
19926,GO:1903862,1,0.966935419136802,0,6,positive regulation of oxidative phosphorylation,BP,
19927,GO:1903867,1,0.939355891431865,0,9,extraembryonic membrane development,BP,
19928,GO:1903874,1,0.977736517352205,0,3,ferrous iron transmembrane transport,BP,
19929,GO:1903881,1,0.992515370007935,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19930,GO:1903883,1,0.992515370007935,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19931,GO:1903884,1,0.992515370007935,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19932,GO:1903886,1,0.992515370007935,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19933,GO:1903888,1,0.996390802365142,0,1,regulation of plant epidermal cell differentiation,BP,
19934,GO:1903889,1,0.996390802365142,0,1,negative regulation of plant epidermal cell differentiation,BP,
19935,GO:1903891,1,0.972225866391152,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19936,GO:1903892,1,0.98591941555991,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19937,GO:1903893,1,0.993564099233553,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19938,GO:1903894,1,0.919692116832911,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19939,GO:1903895,1,0.972183999044854,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19940,GO:1903896,1,0.954885349426313,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19941,GO:1903897,1,0.942258793994687,0,9,regulation of PERK-mediated unfolded protein response,BP,
19942,GO:1903898,1,0.967925572984461,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19943,GO:1903899,1,0.980848215532806,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19944,GO:1903900,1,0.448690171815239,0,125,regulation of viral life cycle,BP,
19945,GO:1903901,1,0.647639761146448,0,69,negative regulation of viral life cycle,BP,
19946,GO:1903902,1,0.698971976177003,0,55,positive regulation of viral life cycle,BP,
19947,GO:1903903,1,0.978874890430958,0,3,regulation of establishment of T cell polarity,BP,
19948,GO:1903905,1,0.985611340978038,0,2,positive regulation of establishment of T cell polarity,BP,
19949,GO:1903906,1,0.993166212636534,0,1,regulation of plasma membrane raft polarization,BP,
19950,GO:1903909,1,0.948242494168767,0,8,regulation of receptor clustering,BP,
19951,GO:1903910,1,0.993872176407998,0,1,negative regulation of receptor clustering,BP,
19952,GO:1903911,1,0.975616330611976,0,4,positive regulation of receptor clustering,BP,
19953,GO:1903912,1,0.973764654979477,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19954,GO:1903916,1,0.993787769364138,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19955,GO:1903917,1,0.993787769364138,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19956,GO:1903918,1,0.992235283040682,0,1,regulation of actin filament severing,BP,
19957,GO:1903919,1,0.992235283040682,0,1,negative regulation of actin filament severing,BP,
19958,GO:1903921,1,0.985454020982967,0,2,regulation of protein processing in phagocytic vesicle,BP,
19959,GO:1903923,1,0.985454020982967,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19960,GO:1903924,1,0.994098942723816,0,1,estradiol binding,MF,
19961,GO:1903925,1,0.994817166189577,0,1,response to bisphenol A,BP,
19962,GO:1903926,1,0.994817166189577,0,1,cellular response to bisphenol A,BP,
19963,GO:1903929,1,0.986569394275588,0,2,primary palate development,BP,
19964,GO:1903935,1,0.970803156774188,0,5,response to sodium arsenite,BP,
19965,GO:1903936,1,0.970803156774188,0,5,cellular response to sodium arsenite,BP,
19966,GO:1903937,1,0.99245373618402,0,1,response to acrylamide,BP,
19967,GO:1903939,1,0.992609113052937,0,1,regulation of TORC2 signaling,BP,
19968,GO:1903943,1,0.994635623989829,0,1,regulation of hepatocyte apoptotic process,BP,
19969,GO:1903944,1,0.994635623989829,0,1,negative regulation of hepatocyte apoptotic process,BP,
19970,GO:1903946,1,0.992783501380276,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19971,GO:1903947,1,0.985040587829075,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19972,GO:1903949,1,0.98505515823192,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19973,GO:1903952,1,0.992500812790964,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19974,GO:1903954,1,0.992500812790964,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19975,GO:1903955,1,0.628251791698048,0,74,positive regulation of protein targeting to mitochondrion,BP,
19976,GO:1903959,1,0.847698264506098,0,23,regulation of anion transmembrane transport,BP,
19977,GO:1903960,1,0.925106182989972,0,11,negative regulation of anion transmembrane transport,BP,
19978,GO:1903961,1,0.958565014655674,0,6,positive regulation of anion transmembrane transport,BP,
19979,GO:1903963,1,0.888546642371126,0,19,arachidonate transport,BP,
19980,GO:1903964,1,0.981573141492626,0,3,monounsaturated fatty acid metabolic process,BP,
19981,GO:1903965,1,0.995650237081449,0,1,monounsaturated fatty acid catabolic process,BP,
19982,GO:1903966,1,0.985862030073766,0,2,monounsaturated fatty acid biosynthetic process,BP,
19983,GO:1903969,1,0.984335658547673,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19984,GO:1903970,1,0.990583557496284,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19985,GO:1903971,1,0.993693316481998,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19986,GO:1903972,1,0.984335658547673,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19987,GO:1903973,1,0.990583557496284,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19988,GO:1903974,1,0.993693316481998,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19989,GO:1903975,1,0.949031479520369,0,9,regulation of glial cell migration,BP,
19990,GO:1903976,1,0.978050268308153,0,4,negative regulation of glial cell migration,BP,
19991,GO:1903977,1,0.979653268540455,0,3,positive regulation of glial cell migration,BP,
19992,GO:1903978,1,0.942439549018036,0,9,regulation of microglial cell activation,BP,
19993,GO:1903979,1,0.988486014903264,0,2,negative regulation of microglial cell activation,BP,
19994,GO:1903980,1,0.957341958201625,0,7,positive regulation of microglial cell activation,BP,
19995,GO:1903984,1,0.97942157033609,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19996,GO:1903988,1,0.992603524382402,0,1,ferrous iron export across plasma membrane,BP,
19997,GO:1903995,1,0.989648344661414,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19998,GO:1903997,1,0.989648344661414,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19999,GO:1903998,1,0.977559379103336,0,4,regulation of eating behavior,BP,
20000,GO:1903999,1,0.988814172228293,0,2,negative regulation of eating behavior,BP,
20001,GO:1904000,1,0.988619188605316,0,2,positive regulation of eating behavior,BP,
20005,GO:1904016,1,0.971017202106446,0,4,response to Thyroglobulin triiodothyronine,BP,
20006,GO:1904017,1,0.984698537330843,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20008,GO:1904019,1,0.561198709438515,0,86,epithelial cell apoptotic process,BP,
20009,GO:1904020,1,0.980658418341923,0,3,regulation of G-protein coupled receptor internalization,BP,
20010,GO:1904021,1,0.987897899321825,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20011,GO:1904022,1,0.992672739688804,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20012,GO:1904026,1,0.986640620700322,0,2,regulation of collagen fibril organization,BP,
20013,GO:1904027,1,0.993500527892872,0,1,negative regulation of collagen fibril organization,BP,
20014,GO:1904028,1,0.9930956730518,0,1,positive regulation of collagen fibril organization,BP,
20015,GO:1904029,1,0.57837397994366,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20016,GO:1904030,1,0.81522901779312,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20017,GO:1904031,1,0.798219055136162,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20018,GO:1904035,1,0.658848861258416,0,63,regulation of epithelial cell apoptotic process,BP,
20019,GO:1904036,1,0.794501128273303,0,34,negative regulation of epithelial cell apoptotic process,BP,
20020,GO:1904037,1,0.845394526046363,0,26,positive regulation of epithelial cell apoptotic process,BP,
20021,GO:1904041,1,0.992632563568689,0,1,regulation of cystathionine beta-synthase activity,BP,
20022,GO:1904042,1,0.992632563568689,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20023,GO:1904044,1,0.975814404719944,0,4,response to aldosterone,BP,
20024,GO:1904045,1,0.994125351601976,0,1,cellular response to aldosterone,BP,
20025,GO:1904046,1,0.991047439443957,0,2,negative regulation of vascular endothelial growth factor production,BP,
20026,GO:1904047,1,0.980911917999633,0,3,S-adenosyl-L-methionine binding,MF,
20027,GO:1904048,1,0.984567567414382,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20028,GO:1904049,1,0.992028388843922,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20029,GO:1904050,1,0.992479837096269,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20030,GO:1904054,1,0.992133512631521,0,1,regulation of cholangiocyte proliferation,BP,
20031,GO:1904056,1,0.992133512631521,0,1,positive regulation of cholangiocyte proliferation,BP,
20032,GO:1904057,1,0.988665689947669,0,2,negative regulation of sensory perception of pain,BP,
20033,GO:1904058,1,0.969668500103946,0,5,positive regulation of sensory perception of pain,BP,
20034,GO:1904059,1,0.984411584915195,0,2,regulation of locomotor rhythm,BP,
20036,GO:1904063,1,0.64511438944713,0,69,negative regulation of cation transmembrane transport,BP,
20038,GO:1904071,1,0.984711113576849,0,2,presynaptic active zone assembly,BP,
20039,GO:1904073,1,0.992258665648671,0,1,regulation of trophectodermal cell proliferation,BP,
20040,GO:1904075,1,0.992258665648671,0,1,positive regulation of trophectodermal cell proliferation,BP,
20041,GO:1904090,1,0.981769940135211,0,4,peptidase inhibitor complex,CC,
20042,GO:1904098,1,0.980458317510235,0,3,regulation of protein O-linked glycosylation,BP,
20043,GO:1904100,1,0.980458317510235,0,3,positive regulation of protein O-linked glycosylation,BP,
20044,GO:1904106,1,0.993131090105062,0,1,protein localization to microvillus,BP,
20045,GO:1904115,1,0.766708026487113,0,40,axon cytoplasm,CC,
20046,GO:1904116,1,0.97810888524574,0,3,response to vasopressin,BP,
20047,GO:1904117,1,0.97810888524574,0,3,cellular response to vasopressin,BP,
20048,GO:1904118,1,0.992747990387103,0,1,regulation of otic vesicle morphogenesis,BP,
20049,GO:1904120,1,0.992747990387103,0,1,positive regulation of otic vesicle morphogenesis,BP,
20050,GO:1904121,1,0.980008131765885,0,3,phosphatidylethanolamine transporter activity,MF,
20051,GO:1904124,1,0.984695551152606,0,3,microglial cell migration,BP,
20052,GO:1904139,1,0.984695551152606,0,3,regulation of microglial cell migration,BP,
20053,GO:1904140,1,0.995438695608872,0,1,negative regulation of microglial cell migration,BP,
20054,GO:1904141,1,0.993693316481998,0,1,positive regulation of microglial cell migration,BP,
20055,GO:1904149,1,0.995438695608872,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20056,GO:1904151,1,0.995438695608872,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20057,GO:1904152,1,0.919413366527552,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20058,GO:1904153,1,0.942748746636661,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20059,GO:1904154,1,0.982583430421764,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20060,GO:1904155,1,0.992608894317891,0,1,DN2 thymocyte differentiation,BP,
20061,GO:1904156,1,0.992608894317891,0,1,DN3 thymocyte differentiation,BP,
20062,GO:1904158,1,0.979265620799821,0,3,axonemal central apparatus assembly,BP,
20063,GO:1904167,1,0.991998201403788,0,1,regulation of thyroid hormone receptor activity,BP,
20064,GO:1904168,1,0.991998201403788,0,1,negative regulation of thyroid hormone receptor activity,BP,
20065,GO:1904170,1,0.985243269741737,0,2,regulation of bleb assembly,BP,
20066,GO:1904172,1,0.985243269741737,0,2,positive regulation of bleb assembly,BP,
20067,GO:1904177,1,0.964296783459449,0,6,regulation of adipose tissue development,BP,
20068,GO:1904179,1,0.96832740573272,0,5,positive regulation of adipose tissue development,BP,
20069,GO:1904180,1,0.962970065261722,0,6,negative regulation of membrane depolarization,BP,
20071,GO:1904182,1,0.995935907200946,0,1,regulation of pyruvate dehydrogenase activity,BP,
20072,GO:1904192,1,0.992133512631521,0,1,regulation of cholangiocyte apoptotic process,BP,
20073,GO:1904193,1,0.992133512631521,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20074,GO:1904195,1,0.992133512631521,0,1,regulation of granulosa cell proliferation,BP,
20075,GO:1904197,1,0.992133512631521,0,1,positive regulation of granulosa cell proliferation,BP,
20076,GO:1904199,1,0.992498660706466,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20077,GO:1904200,1,0.992133512631521,0,1,iodide transmembrane transport,BP,
20078,GO:1904201,1,0.992133512631521,0,1,regulation of iodide transport,BP,
20079,GO:1904202,1,0.992133512631521,0,1,negative regulation of iodide transport,BP,
20080,GO:1904204,1,0.984539297265425,0,2,regulation of skeletal muscle hypertrophy,BP,
20081,GO:1904205,1,0.992346184956349,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20082,GO:1904206,1,0.992133512631521,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20083,GO:1904207,1,0.986732000584054,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
20084,GO:1904209,1,0.986732000584054,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
20085,GO:1904210,1,0.995637067297511,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20086,GO:1904211,1,0.987477734722291,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20087,GO:1904212,1,0.992133512631521,0,1,regulation of iodide transmembrane transport,BP,
20088,GO:1904213,1,0.992133512631521,0,1,negative regulation of iodide transmembrane transport,BP,
20089,GO:1904217,1,0.982061504175385,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20090,GO:1904219,1,0.982061504175385,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20091,GO:1904220,1,0.97527978230573,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20092,GO:1904222,1,0.982061504175385,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20093,GO:1904226,1,0.994178290216842,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20094,GO:1904227,1,0.994178290216842,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20095,GO:1904229,1,0.992266554827563,0,1,regulation of succinate dehydrogenase activity,BP,
20096,GO:1904231,1,0.992266554827563,0,1,positive regulation of succinate dehydrogenase activity,BP,
20097,GO:1904232,1,0.992266554827563,0,1,regulation of aconitate hydratase activity,BP,
20098,GO:1904234,1,0.992266554827563,0,1,positive regulation of aconitate hydratase activity,BP,
20099,GO:1904235,1,0.992164415296174,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20100,GO:1904237,1,0.992164415296174,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20101,GO:1904238,1,0.957137110183155,0,7,pericyte cell differentiation,BP,
20102,GO:1904239,1,0.995637067297511,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20103,GO:1904240,1,0.995637067297511,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20104,GO:1904245,1,0.987864207927042,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20105,GO:1904246,1,0.995054517796043,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20106,GO:1904247,1,0.992774318286525,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20107,GO:1904251,1,0.935239179731244,0,10,regulation of bile acid metabolic process,BP,
20108,GO:1904252,1,0.980257841916935,0,3,negative regulation of bile acid metabolic process,BP,
20109,GO:1904253,1,0.980526276486694,0,3,positive regulation of bile acid metabolic process,BP,
20110,GO:1904259,1,0.962208958221246,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20111,GO:1904261,1,0.962208958221246,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20112,GO:1904262,1,0.929979284547518,0,11,negative regulation of TORC1 signaling,BP,
20113,GO:1904263,1,0.945187178112417,0,9,positive regulation of TORC1 signaling,BP,
20114,GO:1904265,1,0.992344020998511,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20115,GO:1904266,1,0.99226199611503,0,1,regulation of Schwann cell chemotaxis,BP,
20116,GO:1904268,1,0.99226199611503,0,1,positive regulation of Schwann cell chemotaxis,BP,
20117,GO:1904271,1,0.993617816321152,0,1,L-proline import across plasma membrane,BP,
20118,GO:1904274,1,0.994100972515824,0,1,tricellular tight junction assembly,BP,
20119,GO:1904282,1,0.994663586089518,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20120,GO:1904283,1,0.994663586089518,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20121,GO:1904288,1,0.971445827066328,0,4,BAT3 complex binding,MF,
20122,GO:1904289,1,0.985390544058086,0,2,regulation of mitotic DNA damage checkpoint,BP,
20123,GO:1904290,1,0.992480694239741,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20124,GO:1904292,1,0.834453461631477,0,27,regulation of ERAD pathway,BP,
20125,GO:1904293,1,0.919032283524694,0,13,negative regulation of ERAD pathway,BP,
20126,GO:1904294,1,0.916172845116669,0,13,positive regulation of ERAD pathway,BP,
20127,GO:1904298,1,0.992496881829069,0,1,regulation of transcytosis,BP,
20128,GO:1904300,1,0.992496881829069,0,1,positive regulation of transcytosis,BP,
20129,GO:1904301,1,0.992496881829069,0,1,regulation of maternal process involved in parturition,BP,
20130,GO:1904303,1,0.992496881829069,0,1,positive regulation of maternal process involved in parturition,BP,
20131,GO:1904304,1,0.971166335921084,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20132,GO:1904306,1,0.971166335921084,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20133,GO:1904313,1,0.992501005355722,0,1,response to methamphetamine hydrochloride,BP,
20135,GO:1904316,1,0.992496881829069,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20136,GO:1904317,1,0.992496881829069,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20139,GO:1904323,1,0.992944041442165,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20140,GO:1904325,1,0.992944041442165,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20141,GO:1904327,1,0.985453234670111,0,2,protein localization to cytosolic proteasome complex,BP,
20142,GO:1904328,1,0.99318946031378,0,1,regulation of myofibroblast contraction,BP,
20143,GO:1904338,1,0.946992620249335,0,9,regulation of dopaminergic neuron differentiation,BP,
20144,GO:1904339,1,0.987652713076087,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20145,GO:1904340,1,0.978943937651066,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20146,GO:1904341,1,0.992436528352499,0,1,regulation of colon smooth muscle contraction,BP,
20147,GO:1904343,1,0.992436528352499,0,1,positive regulation of colon smooth muscle contraction,BP,
20148,GO:1904344,1,0.996458096886506,0,1,regulation of gastric mucosal blood circulation,BP,
20149,GO:1904346,1,0.996458096886506,0,1,positive regulation of gastric mucosal blood circulation,BP,
20150,GO:1904347,1,0.98892114191549,0,2,regulation of small intestine smooth muscle contraction,BP,
20151,GO:1904349,1,0.98892114191549,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20152,GO:1904350,1,0.938956717584867,0,9,regulation of protein catabolic process in the vacuole,BP,
20153,GO:1904351,1,0.979341934301217,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20154,GO:1904352,1,0.964812213903247,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20155,GO:1904353,1,0.838546718871256,0,26,regulation of telomere capping,BP,
20156,GO:1904354,1,0.942820996489151,0,8,negative regulation of telomere capping,BP,
20157,GO:1904355,1,0.896269682436029,0,17,positive regulation of telomere capping,BP,
20158,GO:1904356,1,0.676928085775199,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20159,GO:1904357,1,0.838645283838156,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20160,GO:1904358,1,0.792480233127943,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20161,GO:1904373,1,0.995392285030654,0,1,response to kainic acid,BP,
20164,GO:1904377,1,0.694380357243048,0,53,positive regulation of protein localization to cell periphery,BP,
20165,GO:1904378,1,0.979800295265595,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20166,GO:1904379,1,0.985453234670111,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20167,GO:1904380,1,0.876961770050369,0,20,endoplasmic reticulum mannose trimming,BP,
20168,GO:1904381,1,0.977761635155892,0,3,Golgi apparatus mannose trimming,BP,
20169,GO:1904382,1,0.972818972056336,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20170,GO:1904383,1,0.987250387326769,0,2,response to sodium phosphate,BP,
20172,GO:1904386,1,0.963594140604733,0,5,response to L-phenylalanine derivative,BP,
20173,GO:1904387,1,0.985342744936483,0,2,cellular response to L-phenylalanine derivative,BP,
20174,GO:1904389,1,0.995392285030654,0,1,rod bipolar cell differentiation,BP,
20175,GO:1904391,1,0.995392285030654,0,1,response to ciliary neurotrophic factor,BP,
20176,GO:1904393,1,0.981571176443497,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20177,GO:1904394,1,0.993872176407998,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20178,GO:1904395,1,0.987623928579565,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20179,GO:1904396,1,0.953091893371399,0,7,regulation of neuromuscular junction development,BP,
20180,GO:1904397,1,0.989292409735402,0,2,negative regulation of neuromuscular junction development,BP,
20181,GO:1904398,1,0.979970076161448,0,3,positive regulation of neuromuscular junction development,BP,
20182,GO:1904399,1,0.995392285030654,0,1,heparan sulfate binding,MF,
20183,GO:1904400,1,0.992760130660534,0,1,response to Thyroid stimulating hormone,BP,
20184,GO:1904404,1,0.992249619450988,0,1,response to formaldehyde,BP,
20185,GO:1904406,1,0.928801432271282,0,12,negative regulation of nitric oxide metabolic process,BP,
20186,GO:1904407,1,0.79666957682225,0,35,positive regulation of nitric oxide metabolic process,BP,
20187,GO:1904408,1,0.995971794784606,0,1,melatonin binding,MF,
20188,GO:1904412,1,0.992527806493065,0,1,regulation of cardiac ventricle development,BP,
20189,GO:1904414,1,0.992527806493065,0,1,positive regulation of cardiac ventricle development,BP,
20190,GO:1904415,1,0.959481246091738,0,6,regulation of xenophagy,BP,
20191,GO:1904417,1,0.959481246091738,0,6,positive regulation of xenophagy,BP,
20192,GO:1904424,1,0.931654265527627,0,10,regulation of GTP binding,BP,
20193,GO:1904425,1,0.992510022681951,0,1,negative regulation of GTP binding,BP,
20194,GO:1904426,1,0.985465221240088,0,2,positive regulation of GTP binding,BP,
20195,GO:1904427,1,0.690734590347055,0,58,positive regulation of calcium ion transmembrane transport,BP,
20196,GO:1904428,1,0.980360000768814,0,3,negative regulation of tubulin deacetylation,BP,
20197,GO:1904429,1,0.957574402789641,0,6,regulation of t-circle formation,BP,
20198,GO:1904430,1,0.978158100268805,0,3,negative regulation of t-circle formation,BP,
20199,GO:1904431,1,0.978961364744907,0,3,positive regulation of t-circle formation,BP,
20200,GO:1904432,1,0.990845623432466,0,2,regulation of ferrous iron binding,BP,
20201,GO:1904434,1,0.990845623432466,0,2,positive regulation of ferrous iron binding,BP,
20202,GO:1904435,1,0.990845623432466,0,2,regulation of transferrin receptor binding,BP,
20203,GO:1904437,1,0.990845623432466,0,2,positive regulation of transferrin receptor binding,BP,
20204,GO:1904447,1,0.984005487531836,0,2,folic acid import across plasma membrane,BP,
20205,GO:1904448,1,0.992456603639031,0,1,regulation of aspartate secretion,BP,
20206,GO:1904450,1,0.992456603639031,0,1,positive regulation of aspartate secretion,BP,
20207,GO:1904454,1,0.992201423453386,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20208,GO:1904455,1,0.984852847499457,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20209,GO:1904456,1,0.994811338635687,0,1,negative regulation of neuronal action potential,BP,
20210,GO:1904457,1,0.993741255981152,0,1,positive regulation of neuronal action potential,BP,
20211,GO:1904464,1,0.995067222051418,0,1,regulation of matrix metallopeptidase secretion,BP,
20212,GO:1904465,1,0.995067222051418,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20213,GO:1904467,1,0.89948690699821,0,17,regulation of tumor necrosis factor secretion,BP,
20214,GO:1904468,1,0.971259892344031,0,5,negative regulation of tumor necrosis factor secretion,BP,
20215,GO:1904469,1,0.926124380601937,0,12,positive regulation of tumor necrosis factor secretion,BP,
20216,GO:1904475,1,0.984701621080215,0,2,regulation of Ras GTPase binding,BP,
20217,GO:1904477,1,0.992335638298231,0,1,positive regulation of Ras GTPase binding,BP,
20218,GO:1904478,1,0.971658369847878,0,5,regulation of intestinal absorption,BP,
20219,GO:1904479,1,0.990024265293916,0,2,negative regulation of intestinal absorption,BP,
20220,GO:1904481,1,0.993636544245647,0,1,response to tetrahydrofolate,BP,
20221,GO:1904482,1,0.993636544245647,0,1,cellular response to tetrahydrofolate,BP,
20222,GO:1904491,1,0.979584123099198,0,4,protein localization to ciliary transition zone,BP,
20223,GO:1904492,1,0.993381421468159,0,1,Ac-Asp-Glu binding,MF,
20224,GO:1904493,1,0.993381421468159,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20225,GO:1904498,1,0.979069538627123,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20226,GO:1904499,1,0.992576808374421,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20227,GO:1904501,1,0.992576808374421,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20228,GO:1904502,1,0.966320360558883,0,5,regulation of lipophagy,BP,
20229,GO:1904504,1,0.966320360558883,0,5,positive regulation of lipophagy,BP,
20230,GO:1904505,1,0.972018579551764,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20231,GO:1904506,1,0.972018579551764,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20232,GO:1904515,1,0.992609113052937,0,1,positive regulation of TORC2 signaling,BP,
20233,GO:1904526,1,0.942211633486149,0,9,regulation of microtubule binding,BP,
20234,GO:1904527,1,0.978635298709847,0,3,negative regulation of microtubule binding,BP,
20235,GO:1904528,1,0.963445429867095,0,6,positive regulation of microtubule binding,BP,
20236,GO:1904529,1,0.98520911598585,0,2,regulation of actin filament binding,BP,
20237,GO:1904530,1,0.992756171080698,0,1,negative regulation of actin filament binding,BP,
20238,GO:1904531,1,0.992398437741682,0,1,positive regulation of actin filament binding,BP,
20239,GO:1904533,1,0.978492438146587,0,3,regulation of telomeric loop disassembly,BP,
20240,GO:1904534,1,0.985909299363446,0,2,negative regulation of telomeric loop disassembly,BP,
20241,GO:1904535,1,0.992478220706608,0,1,positive regulation of telomeric loop disassembly,BP,
20242,GO:1904542,1,0.99328017239829,0,1,regulation of free ubiquitin chain polymerization,BP,
20243,GO:1904544,1,0.99328017239829,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20244,GO:1904550,1,0.994417191970474,0,1,response to arachidonic acid,BP,
20245,GO:1904555,1,0.993617816321152,0,1,L-proline transmembrane transport,BP,
20246,GO:1904556,1,0.993617816321152,0,1,L-tryptophan transmembrane transport,BP,
20247,GO:1904562,1,0.984549176718524,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20248,GO:1904565,1,0.992735498720853,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20249,GO:1904566,1,0.992735498720853,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20250,GO:1904567,1,0.992833519730857,0,1,response to wortmannin,BP,
20251,GO:1904568,1,0.992833519730857,0,1,cellular response to wortmannin,BP,
20252,GO:1904569,1,0.995058153067491,0,1,regulation of selenocysteine incorporation,BP,
20253,GO:1904570,1,0.995058153067491,0,1,negative regulation of selenocysteine incorporation,BP,
20254,GO:1904572,1,0.995058153067491,0,1,negative regulation of mRNA binding,BP,
20255,GO:1904573,1,0.995058153067491,0,1,regulation of selenocysteine insertion sequence binding,BP,
20256,GO:1904574,1,0.995058153067491,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20257,GO:1904576,1,0.988259133347836,0,2,response to tunicamycin,BP,
20258,GO:1904577,1,0.988259133347836,0,2,cellular response to tunicamycin,BP,
20259,GO:1904578,1,0.982030322784869,0,3,response to thapsigargin,BP,
20260,GO:1904579,1,0.982030322784869,0,3,cellular response to thapsigargin,BP,
20261,GO:1904580,1,0.987914746310575,0,2,regulation of intracellular mRNA localization,BP,
20262,GO:1904582,1,0.987914746310575,0,2,positive regulation of intracellular mRNA localization,BP,
20263,GO:1904585,1,0.994233387874823,0,1,response to putrescine,BP,
20264,GO:1904586,1,0.994233387874823,0,1,cellular response to putrescine,BP,
20265,GO:1904587,1,0.961749253066193,0,6,response to glycoprotein,BP,
20266,GO:1904588,1,0.995834185229467,0,1,cellular response to glycoprotein,BP,
20267,GO:1904589,1,0.716395194944809,0,51,regulation of protein import,BP,
20268,GO:1904590,1,0.940197284213677,0,10,negative regulation of protein import,BP,
20269,GO:1904591,1,0.798215649778808,0,33,positive regulation of protein import,BP,
20270,GO:1904594,1,0.991956301967642,0,1,regulation of termination of RNA polymerase II transcription,BP,
20271,GO:1904595,1,0.991956301967642,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20272,GO:1904596,1,0.995702215958487,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20273,GO:1904597,1,0.995702215958487,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20274,GO:1904599,1,0.995702215958487,0,1,advanced glycation end-product binding,MF,
20275,GO:1904602,1,0.989007808059388,0,2,serotonin-activated cation-selective channel complex,CC,
20276,GO:1904603,1,0.995702215958487,0,1,regulation of advanced glycation end-product receptor activity,BP,
20277,GO:1904604,1,0.995702215958487,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20278,GO:1904606,1,0.992577151613587,0,1,fat cell apoptotic process,BP,
20279,GO:1904612,1,0.977764978948856,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20280,GO:1904613,1,0.984896604121596,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20281,GO:1904616,1,0.98520911598585,0,2,regulation of actin binding,BP,
20282,GO:1904617,1,0.992756171080698,0,1,negative regulation of actin binding,BP,
20283,GO:1904618,1,0.992398437741682,0,1,positive regulation of actin binding,BP,
20284,GO:1904627,1,0.988716128784808,0,2,response to phorbol 13-acetate 12-myristate,BP,
20285,GO:1904628,1,0.988716128784808,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20286,GO:1904631,1,0.994065495396858,0,1,response to glucoside,BP,
20287,GO:1904633,1,0.992338574129646,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20288,GO:1904635,1,0.992338574129646,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20289,GO:1904636,1,0.973768959615953,0,4,response to ionomycin,BP,
20290,GO:1904637,1,0.973768959615953,0,4,cellular response to ionomycin,BP,
20291,GO:1904638,1,0.992338574129646,0,1,response to resveratrol,BP,
20292,GO:1904639,1,0.992338574129646,0,1,cellular response to resveratrol,BP,
20293,GO:1904640,1,0.985634896006157,0,2,response to methionine,BP,
20294,GO:1904645,1,0.834423675788968,0,27,response to amyloid-beta,BP,
20295,GO:1904646,1,0.84401113135068,0,25,cellular response to amyloid-beta,BP,
20296,GO:1904647,1,0.992103528061917,0,1,response to rotenone,BP,
20297,GO:1904649,1,0.992577151613587,0,1,regulation of fat cell apoptotic process,BP,
20298,GO:1904651,1,0.992577151613587,0,1,positive regulation of fat cell apoptotic process,BP,
20299,GO:1904659,1,0.533675180540653,0,92,glucose transmembrane transport,BP,
20300,GO:1904666,1,0.902866736911175,0,19,regulation of ubiquitin protein ligase activity,BP,
20301,GO:1904667,1,0.97020529563927,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20302,GO:1904668,1,0.930614196351011,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20303,GO:1904672,1,0.963425995463593,0,5,regulation of somatic stem cell population maintenance,BP,
20304,GO:1904673,1,0.977667989445244,0,3,negative regulation of somatic stem cell population maintenance,BP,
20305,GO:1904674,1,0.985436018223374,0,2,positive regulation of somatic stem cell population maintenance,BP,
20306,GO:1904675,1,0.992908399563964,0,1,regulation of somatic stem cell division,BP,
20307,GO:1904677,1,0.992908399563964,0,1,positive regulation of somatic stem cell division,BP,
20308,GO:1904680,1,0.877306672652734,0,22,peptide transmembrane transporter activity,MF,
20309,GO:1904681,1,0.993228636089122,0,1,response to 3-methylcholanthrene,BP,
20310,GO:1904683,1,0.956635689628998,0,6,regulation of metalloendopeptidase activity,BP,
20311,GO:1904684,1,0.969713642319049,0,4,negative regulation of metalloendopeptidase activity,BP,
20312,GO:1904685,1,0.986517793457208,0,2,positive regulation of metalloendopeptidase activity,BP,
20313,GO:1904688,1,0.970866734065301,0,5,regulation of cytoplasmic translational initiation,BP,
20314,GO:1904689,1,0.995989525461045,0,1,negative regulation of cytoplasmic translational initiation,BP,
20315,GO:1904690,1,0.974777071777676,0,4,positive regulation of cytoplasmic translational initiation,BP,
20316,GO:1904691,1,0.994292639210569,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20318,GO:1904693,1,0.977353795044659,0,3,midbrain morphogenesis,BP,
20319,GO:1904694,1,0.977657993602888,0,3,negative regulation of vascular smooth muscle contraction,BP,
20320,GO:1904695,1,0.99471720079266,0,1,positive regulation of vascular smooth muscle contraction,BP,
20321,GO:1904700,1,0.99338483490165,0,1,granulosa cell apoptotic process,BP,
20322,GO:1904701,1,0.994941551134375,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20323,GO:1904705,1,0.784258260618835,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20324,GO:1904706,1,0.91713847984676,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20325,GO:1904707,1,0.851166376645183,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20326,GO:1904708,1,0.99338483490165,0,1,regulation of granulosa cell apoptotic process,BP,
20327,GO:1904711,1,0.994941551134375,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20328,GO:1904713,1,0.985243758920855,0,2,beta-catenin destruction complex binding,MF,
20330,GO:1904715,1,0.981569538583001,0,3,negative regulation of chaperone-mediated autophagy,BP,
20331,GO:1904716,1,0.993813150115975,0,1,positive regulation of chaperone-mediated autophagy,BP,
20332,GO:1904717,1,0.978430313629585,0,3,regulation of AMPA glutamate receptor clustering,BP,
20333,GO:1904719,1,0.993661039730682,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20334,GO:1904720,1,0.986526585113592,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20335,GO:1904721,1,0.992776802320677,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20336,GO:1904722,1,0.993704771852438,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20337,GO:1904723,1,0.994941551134375,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20338,GO:1904724,1,0.763981034040393,0,51,tertiary granule lumen,CC,
20339,GO:1904729,1,0.982206151393067,0,3,regulation of intestinal lipid absorption,BP,
20340,GO:1904730,1,0.993264128755224,0,1,negative regulation of intestinal lipid absorption,BP,
20341,GO:1904732,1,0.988920223534983,0,2,regulation of electron transfer activity,BP,
20342,GO:1904734,1,0.996739305498408,0,1,positive regulation of electron transfer activity,BP,
20343,GO:1904738,1,0.889789649900563,0,16,vascular associated smooth muscle cell migration,BP,
20344,GO:1904742,1,0.97510785502149,0,4,regulation of telomeric DNA binding,BP,
20345,GO:1904743,1,0.984427169867288,0,2,negative regulation of telomeric DNA binding,BP,
20346,GO:1904744,1,0.990534770915776,0,2,positive regulation of telomeric DNA binding,BP,
20347,GO:1904746,1,0.965718700531989,0,5,negative regulation of apoptotic process involved in development,BP,
20348,GO:1904747,1,0.981431977907833,0,3,positive regulation of apoptotic process involved in development,BP,
20349,GO:1904748,1,0.940607450135971,0,9,regulation of apoptotic process involved in development,BP,
20350,GO:1904749,1,0.969277037644194,0,5,regulation of protein localization to nucleolus,BP,
20351,GO:1904750,1,0.992309419475446,0,1,negative regulation of protein localization to nucleolus,BP,
20352,GO:1904751,1,0.976790919783874,0,4,positive regulation of protein localization to nucleolus,BP,
20353,GO:1904752,1,0.889789649900563,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20354,GO:1904753,1,0.965742806272284,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20355,GO:1904754,1,0.921379436533908,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20356,GO:1904760,1,0.977595276254827,0,3,regulation of myofibroblast differentiation,BP,
20357,GO:1904761,1,0.984983570119386,0,2,negative regulation of myofibroblast differentiation,BP,
20358,GO:1904762,1,0.992500221495246,0,1,positive regulation of myofibroblast differentiation,BP,
20359,GO:1904764,1,0.994486366033924,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20360,GO:1904766,1,0.992288681077203,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20361,GO:1904768,1,0.98876175795502,0,2,all-trans-retinol binding,MF,
20362,GO:1904772,1,0.993326771744696,0,1,response to tetrachloromethane,BP,
20363,GO:1904776,1,0.956528931717052,0,6,regulation of protein localization to cell cortex,BP,
20364,GO:1904777,1,0.9930956730518,0,1,negative regulation of protein localization to cell cortex,BP,
20365,GO:1904778,1,0.963181587865187,0,5,positive regulation of protein localization to cell cortex,BP,
20366,GO:1904779,1,0.952128775760202,0,7,regulation of protein localization to centrosome,BP,
20367,GO:1904781,1,0.958155870420846,0,6,positive regulation of protein localization to centrosome,BP,
20368,GO:1904782,1,0.992459445130808,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20369,GO:1904783,1,0.985789775691569,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20370,GO:1904784,1,0.992411089396557,0,1,NLRP1 inflammasome complex assembly,BP,
20371,GO:1904790,1,0.992910025256332,0,1,regulation of shelterin complex assembly,BP,
20372,GO:1904792,1,0.992910025256332,0,1,positive regulation of shelterin complex assembly,BP,
20373,GO:1904793,1,0.992576808374421,0,1,regulation of euchromatin binding,BP,
20374,GO:1904796,1,0.966106320557035,0,5,regulation of core promoter binding,BP,
20375,GO:1904797,1,0.992358937812529,0,1,negative regulation of core promoter binding,BP,
20376,GO:1904798,1,0.973547282077724,0,4,positive regulation of core promoter binding,BP,
20377,GO:1904799,1,0.992501281097678,0,1,regulation of neuron remodeling,BP,
20378,GO:1904800,1,0.992501281097678,0,1,negative regulation of neuron remodeling,BP,
20379,GO:1904803,1,0.996589056032357,0,1,regulation of translation involved in cellular response to UV,BP,
20380,GO:1904806,1,0.986238532970005,0,2,regulation of protein oxidation,BP,
20381,GO:1904808,1,0.986238532970005,0,2,positive regulation of protein oxidation,BP,
20382,GO:1904812,1,0.992501319796993,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20383,GO:1904813,1,0.483783231826727,0,123,ficolin-1-rich granule lumen,CC,
20384,GO:1904814,1,0.923240585150475,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20385,GO:1904815,1,0.987658407141198,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20386,GO:1904816,1,0.934785218522891,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20387,GO:1904823,1,0.981505681100491,0,3,purine nucleobase transmembrane transport,BP,
20388,GO:1904826,1,0.992228222822877,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20389,GO:1904828,1,0.992228222822877,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20390,GO:1904829,1,0.995049967525852,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20391,GO:1904831,1,0.995049967525852,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20392,GO:1904833,1,0.986174529184557,0,3,positive regulation of removal of superoxide radicals,BP,
20393,GO:1904835,1,0.993588067364596,0,1,dorsal root ganglion morphogenesis,BP,
20394,GO:1904837,1,0.799231518071937,0,34,beta-catenin-TCF complex assembly,BP,
20395,GO:1904842,1,0.994231345668807,0,1,response to nitroglycerin,BP,
20396,GO:1904843,1,0.994231345668807,0,1,cellular response to nitroglycerin,BP,
20397,GO:1904844,1,0.983294218055834,0,3,response to L-glutamine,BP,
20398,GO:1904845,1,0.983294218055834,0,3,cellular response to L-glutamine,BP,
20399,GO:1904847,1,0.96892431530047,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20400,GO:1904848,1,0.995894182048718,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20401,GO:1904849,1,0.980266820894375,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20402,GO:1904850,1,0.992910025256332,0,1,negative regulation of establishment of protein localization to telomere,BP,
20403,GO:1904851,1,0.947305241000488,0,9,positive regulation of establishment of protein localization to telomere,BP,
20404,GO:1904854,1,0.986538341054703,0,2,proteasome core complex binding,MF,
20405,GO:1904861,1,0.909566289867545,0,13,excitatory synapse assembly,BP,
20406,GO:1904862,1,0.977649000057037,0,3,inhibitory synapse assembly,BP,
20407,GO:1904863,1,0.992507816014749,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20408,GO:1904864,1,0.992507816014749,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20409,GO:1904867,1,0.948190268473618,0,9,protein localization to Cajal body,BP,
20410,GO:1904868,1,0.984186283845106,0,2,telomerase catalytic core complex assembly,BP,
20411,GO:1904869,1,0.953113116753035,0,8,regulation of protein localization to Cajal body,BP,
20412,GO:1904871,1,0.953113116753035,0,8,positive regulation of protein localization to Cajal body,BP,
20413,GO:1904872,1,0.900019677260303,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20414,GO:1904874,1,0.920126967021325,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20415,GO:1904875,1,0.987313852984801,0,2,regulation of DNA ligase activity,BP,
20416,GO:1904876,1,0.992950951146867,0,1,negative regulation of DNA ligase activity,BP,
20417,GO:1904877,1,0.994323292229272,0,1,positive regulation of DNA ligase activity,BP,
20418,GO:1904878,1,0.992000517899488,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20419,GO:1904879,1,0.986406058610237,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20420,GO:1904880,1,0.979364308114523,0,3,response to hydrogen sulfide,BP,
20421,GO:1904881,1,0.985690886885153,0,2,cellular response to hydrogen sulfide,BP,
20422,GO:1904882,1,0.984186283845106,0,2,regulation of telomerase catalytic core complex assembly,BP,
20423,GO:1904884,1,0.984186283845106,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20424,GO:1904885,1,0.963217987460017,0,5,beta-catenin destruction complex assembly,BP,
20425,GO:1904886,1,0.880723344866884,0,18,beta-catenin destruction complex disassembly,BP,
20426,GO:1904887,1,0.992094053059202,0,1,Wnt signalosome assembly,BP,
20427,GO:1904888,1,0.667170581443357,0,59,cranial skeletal system development,BP,
20428,GO:1904889,1,0.988235915938004,0,2,regulation of excitatory synapse assembly,BP,
20429,GO:1904891,1,0.988235915938004,0,2,positive regulation of excitatory synapse assembly,BP,
20430,GO:1904892,1,0.496710392849442,0,110,regulation of STAT cascade,BP,
20431,GO:1904893,1,0.739675884785528,0,45,negative regulation of STAT cascade,BP,
20432,GO:1904894,1,0.698434970241263,0,59,positive regulation of STAT cascade,BP,
20433,GO:1904895,1,0.99518961421555,0,1,ESCRT complex assembly,BP,
20434,GO:1904896,1,0.938532116238304,0,10,ESCRT complex disassembly,BP,
20435,GO:1904897,1,0.992619275098749,0,1,regulation of hepatic stellate cell proliferation,BP,
20436,GO:1904899,1,0.992619275098749,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20437,GO:1904902,1,0.99518961421555,0,1,ESCRT III complex assembly,BP,
20438,GO:1904903,1,0.938532116238304,0,10,ESCRT III complex disassembly,BP,
20439,GO:1904907,1,0.984076716330302,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20440,GO:1904908,1,0.984076716330302,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20441,GO:1904910,1,0.992910025256332,0,1,regulation of establishment of RNA localization to telomere,BP,
20442,GO:1904911,1,0.992910025256332,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20443,GO:1904913,1,0.992910025256332,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20444,GO:1904914,1,0.992910025256332,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20445,GO:1904923,1,0.922891673143689,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20446,GO:1904924,1,0.993736437773384,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20447,GO:1904925,1,0.92871310285111,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20448,GO:1904928,1,0.984527966561554,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20449,GO:1904929,1,0.956510856877681,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20450,GO:1904933,1,0.992381002025962,0,1,regulation of cell proliferation in midbrain,BP,
20451,GO:1904934,1,0.992381002025962,0,1,negative regulation of cell proliferation in midbrain,BP,
20452,GO:1904936,1,0.96423518320477,0,5,interneuron migration,BP,
20453,GO:1904938,1,0.962654564413664,0,5,planar cell polarity pathway involved in axon guidance,BP,
20454,GO:1904947,1,0.992819576736984,0,1,folic acid import into mitochondrion,BP,
20455,GO:1904948,1,0.905744633595188,0,15,midbrain dopaminergic neuron differentiation,BP,
20456,GO:1904949,1,0.533205690059758,0,95,ATPase complex,CC,
20459,GO:1904953,1,0.935954795862299,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20460,GO:1904954,1,0.981144872029734,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20461,GO:1904955,1,0.992381002025962,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20462,GO:1904956,1,0.970074281722006,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20463,GO:1904958,1,0.982750147504708,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20464,GO:1904959,1,0.988920223534983,0,2,regulation of cytochrome-c oxidase activity,BP,
20465,GO:1904960,1,0.996739305498408,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20466,GO:1904970,1,0.978086684988175,0,3,brush border assembly,BP,
20467,GO:1904971,1,0.992475522317594,0,1,regulation of viral translation,BP,
20468,GO:1904973,1,0.992475522317594,0,1,positive regulation of viral translation,BP,
20469,GO:1904975,1,0.984996023990156,0,2,response to bleomycin,BP,
20470,GO:1904976,1,0.984996023990156,0,2,cellular response to bleomycin,BP,
20471,GO:1904977,1,0.992973312581029,0,1,lymphatic endothelial cell migration,BP,
20472,GO:1904978,1,0.978967824513949,0,3,regulation of endosome organization,BP,
20473,GO:1904979,1,0.994080688044968,0,1,negative regulation of endosome organization,BP,
20474,GO:1904980,1,0.99227281259696,0,1,positive regulation of endosome organization,BP,
20475,GO:1904983,1,0.994298770080367,0,1,glycine import into mitochondrion,BP,
20476,GO:1904990,1,0.993673348832332,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20477,GO:1904992,1,0.993673348832332,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20478,GO:1904994,1,0.933531597567841,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20479,GO:1904995,1,0.976732121805941,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20480,GO:1904996,1,0.955780745083881,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20481,GO:1904997,1,0.988137190993277,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20482,GO:1904998,1,0.992913835618328,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20483,GO:1904999,1,0.99518961421555,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20484,GO:1905000,1,0.992152708058179,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20485,GO:1905005,1,0.958364440531817,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20486,GO:1905006,1,0.987252738812671,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20487,GO:1905007,1,0.96339703079812,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20488,GO:1905008,1,0.99341927840292,0,1,regulation of L-lysine import across plasma membrane,BP,
20489,GO:1905010,1,0.99341927840292,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20490,GO:1905024,1,0.970545026125442,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20491,GO:1905025,1,0.992783501380276,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20492,GO:1905026,1,0.985040587829075,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20493,GO:1905030,1,0.992424332023491,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20494,GO:1905031,1,0.962926563586478,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20495,GO:1905032,1,0.992783501380276,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20496,GO:1905033,1,0.985040587829075,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20497,GO:1905034,1,0.992917120721328,0,1,regulation of antifungal innate immune response,BP,
20498,GO:1905035,1,0.992917120721328,0,1,negative regulation of antifungal innate immune response,BP,
20499,GO:1905037,1,0.550231995018874,0,90,autophagosome organization,BP,
20500,GO:1905038,1,0.92421482572027,0,13,regulation of membrane lipid metabolic process,BP,
20502,GO:1905040,1,0.993588067364596,0,1,otic placode development,BP,
20503,GO:1905041,1,0.994062459126175,0,1,regulation of epithelium regeneration,BP,
20504,GO:1905042,1,0.994062459126175,0,1,negative regulation of epithelium regeneration,BP,
20505,GO:1905044,1,0.9930956730518,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20506,GO:1905045,1,0.9930956730518,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20507,GO:1905048,1,0.91903699123204,0,13,regulation of metallopeptidase activity,BP,
20508,GO:1905049,1,0.95884174730259,0,6,negative regulation of metallopeptidase activity,BP,
20509,GO:1905050,1,0.958504053547221,0,7,positive regulation of metallopeptidase activity,BP,
20510,GO:1905051,1,0.991346011892386,0,2,regulation of base-excision repair,BP,
20511,GO:1905053,1,0.991346011892386,0,2,positive regulation of base-excision repair,BP,
20512,GO:1905062,1,0.993207754170862,0,1,positive regulation of cardioblast proliferation,BP,
20513,GO:1905063,1,0.945694267856052,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20514,GO:1905064,1,0.978916294397745,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20515,GO:1905065,1,0.966069693289591,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20516,GO:1905066,1,0.988802257413596,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20517,GO:1905067,1,0.994941551134375,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20518,GO:1905068,1,0.993829811705944,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20519,GO:1905069,1,0.986751435326404,0,2,allantois development,BP,
20520,GO:1905071,1,0.977646975358462,0,3,occluding junction disassembly,BP,
20521,GO:1905073,1,0.977646975358462,0,3,regulation of occluding junction disassembly,BP,
20522,GO:1905075,1,0.977646975358462,0,3,positive regulation of occluding junction disassembly,BP,
20523,GO:1905076,1,0.994593496571265,0,1,regulation of interleukin-17 secretion,BP,
20524,GO:1905077,1,0.994593496571265,0,1,negative regulation of interleukin-17 secretion,BP,
20525,GO:1905089,1,0.991863122064854,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20526,GO:1905090,1,0.991863122064854,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20527,GO:1905097,1,0.95942302504033,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20528,GO:1905098,1,0.974332658294319,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20529,GO:1905099,1,0.992335638298231,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20530,GO:1905103,1,0.992500155709995,0,1,integral component of lysosomal membrane,CC,
20532,GO:1905123,1,0.985023707679525,0,2,regulation of glucosylceramidase activity,BP,
20533,GO:1905132,1,0.992813660106105,0,1,regulation of meiotic chromosome separation,BP,
20534,GO:1905133,1,0.992813660106105,0,1,negative regulation of meiotic chromosome separation,BP,
20535,GO:1905143,1,0.995377715655474,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20538,GO:1905146,1,0.93394992882854,0,10,lysosomal protein catabolic process,BP,
20539,GO:1905150,1,0.977661400568261,0,3,regulation of voltage-gated sodium channel activity,BP,
20540,GO:1905152,1,0.992374795337114,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20541,GO:1905153,1,0.922992871074363,0,12,regulation of membrane invagination,BP,
20542,GO:1905154,1,0.987246753529825,0,2,negative regulation of membrane invagination,BP,
20543,GO:1905155,1,0.941289528919912,0,9,positive regulation of membrane invagination,BP,
20544,GO:1905161,1,0.992431388720392,0,1,protein localization to phagocytic vesicle,BP,
20545,GO:1905162,1,0.992431388720392,0,1,regulation of phagosome maturation,BP,
20546,GO:1905165,1,0.949763724143313,0,7,regulation of lysosomal protein catabolic process,BP,
20547,GO:1905166,1,0.979341934301217,0,3,negative regulation of lysosomal protein catabolic process,BP,
20548,GO:1905167,1,0.975913710974948,0,3,positive regulation of lysosomal protein catabolic process,BP,
20549,GO:1905168,1,0.992515861637426,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20550,GO:1905169,1,0.992431388720392,0,1,regulation of protein localization to phagocytic vesicle,BP,
20551,GO:1905171,1,0.992431388720392,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20552,GO:1905172,1,0.992475522317594,0,1,RISC complex binding,MF,
20553,GO:1905174,1,0.987840598269155,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20554,GO:1905176,1,0.992973910981209,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20555,GO:1905202,1,0.986042883939944,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20556,GO:1905203,1,0.9882081110983,0,2,regulation of connective tissue replacement,BP,
20557,GO:1905204,1,0.995702215958487,0,1,negative regulation of connective tissue replacement,BP,
20558,GO:1905205,1,0.992473877960228,0,1,positive regulation of connective tissue replacement,BP,
20559,GO:1905206,1,0.968279711389131,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20560,GO:1905207,1,0.767162985446009,0,39,regulation of cardiocyte differentiation,BP,
20561,GO:1905208,1,0.905989857876252,0,14,negative regulation of cardiocyte differentiation,BP,
20562,GO:1905209,1,0.852155161111746,0,24,positive regulation of cardiocyte differentiation,BP,
20563,GO:1905214,1,0.931971099652407,0,11,regulation of RNA binding,BP,
20564,GO:1905215,1,0.995058153067491,0,1,negative regulation of RNA binding,BP,
20565,GO:1905216,1,0.950635418265098,0,8,positive regulation of RNA binding,BP,
20566,GO:1905217,1,0.992760130660534,0,1,response to astaxanthin,BP,
20567,GO:1905222,1,0.992728141436878,0,1,atrioventricular canal morphogenesis,BP,
20568,GO:1905223,1,0.992335551990024,0,1,epicardium morphogenesis,BP,
20569,GO:1905224,1,0.984967352299282,0,2,clathrin-coated pit assembly,BP,
20570,GO:1905225,1,0.988624169430678,0,2,response to thyrotropin-releasing hormone,BP,
20571,GO:1905226,1,0.995782280998159,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20572,GO:1905229,1,0.995834185229467,0,1,cellular response to thyrotropin-releasing hormone,BP,
20573,GO:1905230,1,0.992500488936931,0,1,response to borneol,BP,
20574,GO:1905231,1,0.992500488936931,0,1,cellular response to borneol,BP,
20575,GO:1905232,1,0.964883723768139,0,5,cellular response to L-glutamate,BP,
20576,GO:1905233,1,0.992500488936931,0,1,response to codeine,BP,
20577,GO:1905235,1,0.992500488936931,0,1,response to quercetin,BP,
20578,GO:1905237,1,0.992500488936931,0,1,response to cyclosporin A,BP,
20579,GO:1905239,1,0.992449029013879,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20580,GO:1905240,1,0.992449029013879,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20581,GO:1905242,1,0.985888747710282,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20582,GO:1905243,1,0.993246670698268,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20583,GO:1905244,1,0.944271108008683,0,8,regulation of modification of synaptic structure,BP,
20584,GO:1905245,1,0.947464467922161,0,8,regulation of aspartic-type peptidase activity,BP,
20585,GO:1905246,1,0.985913953992169,0,2,negative regulation of aspartic-type peptidase activity,BP,
20586,GO:1905247,1,0.961006706897481,0,6,positive regulation of aspartic-type peptidase activity,BP,
20587,GO:1905255,1,0.992327363064868,0,1,regulation of RNA binding transcription factor activity,BP,
20588,GO:1905258,1,0.991635932968643,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20589,GO:1905259,1,0.991635932968643,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20590,GO:1905267,1,0.986635397709178,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20591,GO:1905268,1,0.734127755470568,0,45,negative regulation of chromatin organization,BP,
20592,GO:1905269,1,0.54853737291862,0,88,positive regulation of chromatin organization,BP,
20593,GO:1905271,1,0.996545206575214,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20594,GO:1905273,1,0.996545206575214,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20595,GO:1905274,1,0.99226199611503,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20596,GO:1905276,1,0.881615007610916,0,18,regulation of epithelial tube formation,BP,
20597,GO:1905277,1,0.992782236972796,0,1,negative regulation of epithelial tube formation,BP,
20598,GO:1905278,1,0.975098930937505,0,4,positive regulation of epithelial tube formation,BP,
20599,GO:1905279,1,0.985243758920855,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20600,GO:1905285,1,0.992527806493065,0,1,fibrous ring of heart morphogenesis,BP,
20601,GO:1905286,1,0.980466075817599,0,3,serine-type peptidase complex,CC,
20602,GO:1905288,1,0.957645297609188,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20603,GO:1905289,1,0.992094053059202,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20604,GO:1905292,1,0.980045695319379,0,3,regulation of neural crest cell differentiation,BP,
20605,GO:1905294,1,0.980045695319379,0,3,positive regulation of neural crest cell differentiation,BP,
20606,GO:1905301,1,0.992479837096269,0,1,regulation of macropinocytosis,BP,
20607,GO:1905302,1,0.992479837096269,0,1,negative regulation of macropinocytosis,BP,
20608,GO:1905304,1,0.992133593536938,0,1,regulation of cardiac myofibril assembly,BP,
20609,GO:1905305,1,0.992133593536938,0,1,negative regulation of cardiac myofibril assembly,BP,
20610,GO:1905309,1,0.992024061958175,0,1,positive regulation of cohesin loading,BP,
20611,GO:1905310,1,0.980045695319379,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20612,GO:1905312,1,0.980045695319379,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20613,GO:1905313,1,0.994145695392548,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20614,GO:1905314,1,0.904548860447776,0,15,semi-lunar valve development,BP,
20615,GO:1905317,1,0.992473161339329,0,1,inferior endocardial cushion morphogenesis,BP,
20616,GO:1905319,1,0.9930956730518,0,1,mesenchymal stem cell migration,BP,
20617,GO:1905320,1,0.9930956730518,0,1,regulation of mesenchymal stem cell migration,BP,
20618,GO:1905322,1,0.9930956730518,0,1,positive regulation of mesenchymal stem cell migration,BP,
20619,GO:1905323,1,0.960505341586926,0,6,telomerase holoenzyme complex assembly,BP,
20620,GO:1905327,1,0.995345054077821,0,1,tracheoesophageal septum formation,BP,
20621,GO:1905330,1,0.340113442263187,0,171,regulation of morphogenesis of an epithelium,BP,
20622,GO:1905331,1,0.883791310175769,0,18,negative regulation of morphogenesis of an epithelium,BP,
20623,GO:1905332,1,0.814560695638894,0,30,positive regulation of morphogenesis of an epithelium,BP,
20624,GO:1905333,1,0.988055923828375,0,3,regulation of gastric motility,BP,
20625,GO:1905335,1,0.991772845310837,0,1,regulation of aggrephagy,BP,
20626,GO:1905337,1,0.991772845310837,0,1,positive regulation of aggrephagy,BP,
20627,GO:1905340,1,0.975822504298618,0,4,regulation of protein localization to kinetochore,BP,
20628,GO:1905341,1,0.993252995819076,0,1,negative regulation of protein localization to kinetochore,BP,
20629,GO:1905342,1,0.975822504298618,0,4,positive regulation of protein localization to kinetochore,BP,
20630,GO:1905344,1,0.9930956730518,0,1,prostaglandin catabolic process,BP,
20631,GO:1905348,1,0.840815404601571,0,29,endonuclease complex,CC,
20632,GO:1905349,1,0.991198892017623,0,2,ciliary transition zone assembly,BP,
20633,GO:1905354,1,0.879667050582449,0,22,exoribonuclease complex,CC,
20634,GO:1905355,1,0.992440273662412,0,1,spine apparatus assembly,BP,
20635,GO:1905359,1,0.992813660106105,0,1,protein localization to meiotic spindle,BP,
20637,GO:1905365,1,0.994080688044968,0,1,regulation of intralumenal vesicle formation,BP,
20638,GO:1905366,1,0.994080688044968,0,1,negative regulation of intralumenal vesicle formation,BP,
20639,GO:1905368,1,0.637939220712014,0,83,peptidase complex,CC,
20640,GO:1905369,1,0.719236838593613,0,63,endopeptidase complex,CC,
20641,GO:1905370,1,0.993736437773384,0,1,serine-type endopeptidase complex,CC,
20642,GO:1905371,1,0.987847677805848,0,2,ceramide phosphoethanolamine metabolic process,BP,
20643,GO:1905373,1,0.987847677805848,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20644,GO:1905383,1,0.984362369212032,0,3,protein localization to presynapse,BP,
20645,GO:1905384,1,0.988052789577425,0,2,regulation of protein localization to presynapse,BP,
20646,GO:1905386,1,0.988052789577425,0,2,positive regulation of protein localization to presynapse,BP,
20647,GO:1905392,1,0.996390802365142,0,1,plant organ morphogenesis,BP,
20648,GO:1905394,1,0.980167286836511,0,3,retromer complex binding,MF,
20649,GO:1905395,1,0.981522516001744,0,3,response to flavonoid,BP,
20650,GO:1905397,1,0.990018456629064,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20651,GO:1905402,1,0.990018456629064,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20652,GO:1905403,1,0.994593496571265,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20653,GO:1905404,1,0.995400344957096,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20654,GO:1905405,1,0.992024061958175,0,1,regulation of mitotic cohesin loading,BP,
20655,GO:1905406,1,0.992024061958175,0,1,positive regulation of mitotic cohesin loading,BP,
20656,GO:1905407,1,0.987446521568299,0,2,regulation of creatine transmembrane transporter activity,BP,
20657,GO:1905408,1,0.987446521568299,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20658,GO:1905419,1,0.9948912954128,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20659,GO:1905421,1,0.996390802365142,0,1,regulation of plant organ morphogenesis,BP,
20660,GO:1905422,1,0.996390802365142,0,1,negative regulation of plant organ morphogenesis,BP,
20661,GO:1905424,1,0.987747244042173,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20662,GO:1905426,1,0.987747244042173,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20664,GO:1905430,1,0.99439884122494,0,1,cellular response to glycine,BP,
20667,GO:1905435,1,0.9930956730518,0,1,regulation of histone H3-K4 trimethylation,BP,
20668,GO:1905437,1,0.9930956730518,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20669,GO:1905438,1,0.987936223340365,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20670,GO:1905443,1,0.99248241777547,0,1,regulation of clathrin coat assembly,BP,
20671,GO:1905445,1,0.99248241777547,0,1,positive regulation of clathrin coat assembly,BP,
20672,GO:1905446,1,0.971936355975073,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20673,GO:1905447,1,0.992705657091814,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20674,GO:1905448,1,0.979079634297662,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20675,GO:1905449,1,0.98722284269861,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20676,GO:1905451,1,0.98722284269861,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20677,GO:1905456,1,0.954460582002999,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20678,GO:1905457,1,0.983470613650119,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20679,GO:1905458,1,0.992500836531796,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20680,GO:1905459,1,0.957645297609188,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20681,GO:1905460,1,0.992258665648671,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20682,GO:1905461,1,0.965119303270983,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20683,GO:1905462,1,0.984945435845914,0,2,regulation of DNA duplex unwinding,BP,
20684,GO:1905463,1,0.99239080334567,0,1,negative regulation of DNA duplex unwinding,BP,
20685,GO:1905464,1,0.992498126821826,0,1,positive regulation of DNA duplex unwinding,BP,
20686,GO:1905468,1,0.992431388720392,0,1,regulation of clathrin-coated pit assembly,BP,
20687,GO:1905469,1,0.992431388720392,0,1,negative regulation of clathrin-coated pit assembly,BP,
20688,GO:1905474,1,0.995470232901551,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20692,GO:1905483,1,0.99191186063905,0,1,regulation of motor neuron migration,BP,
20693,GO:1905485,1,0.99191186063905,0,1,positive regulation of motor neuron migration,BP,
20694,GO:1905502,1,0.995907303753485,0,1,acetyl-CoA binding,MF,
20695,GO:1905508,1,0.818579015034994,0,28,protein localization to microtubule organizing center,BP,
20696,GO:1905512,1,0.9934437146992,0,1,regulation of short-term synaptic potentiation,BP,
20697,GO:1905513,1,0.9934437146992,0,1,negative regulation of short-term synaptic potentiation,BP,
20699,GO:1905516,1,0.951214589665173,0,8,positive regulation of fertilization,BP,
20700,GO:1905517,1,0.824821616081084,0,33,macrophage migration,BP,
20701,GO:1905518,1,0.992456461683755,0,1,regulation of presynaptic active zone assembly,BP,
20702,GO:1905520,1,0.992456461683755,0,1,positive regulation of presynaptic active zone assembly,BP,
20703,GO:1905521,1,0.884852689761232,0,20,regulation of macrophage migration,BP,
20704,GO:1905522,1,0.973740632758457,0,5,negative regulation of macrophage migration,BP,
20705,GO:1905523,1,0.932461363856539,0,11,positive regulation of macrophage migration,BP,
20706,GO:1905524,1,0.992222552809661,0,1,negative regulation of protein autoubiquitination,BP,
20707,GO:1905535,1,0.992432521676641,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20708,GO:1905537,1,0.992432521676641,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20709,GO:1905538,1,0.992475522317594,0,1,polysome binding,MF,
20710,GO:1905541,1,0.99341927840292,0,1,regulation of L-arginine import across plasma membrane,BP,
20711,GO:1905546,1,0.993981810666468,0,1,cellular response to phenylpropanoid,BP,
20712,GO:1905547,1,0.995237841458615,0,1,regulation of telomeric heterochromatin assembly,BP,
20713,GO:1905549,1,0.995237841458615,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20714,GO:1905550,1,0.989518948121952,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20715,GO:1905552,1,0.989518948121952,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20716,GO:1905553,1,0.98343100255474,0,3,regulation of blood vessel branching,BP,
20717,GO:1905555,1,0.987672111714991,0,2,positive regulation blood vessel branching,BP,
20718,GO:1905562,1,0.908186720996407,0,14,regulation of vascular endothelial cell proliferation,BP,
20719,GO:1905563,1,0.979781069979721,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20720,GO:1905564,1,0.926942875663612,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20721,GO:1905572,1,0.993026672249471,0,1,ganglioside GM1 transport to membrane,BP,
20722,GO:1905573,1,0.987790149571685,0,2,ganglioside GM1 binding,MF,
20723,GO:1905574,1,0.993026672249471,0,1,ganglioside GM2 binding,MF,
20724,GO:1905575,1,0.993026672249471,0,1,ganglioside GM3 binding,MF,
20725,GO:1905576,1,0.981597536357312,0,3,ganglioside GT1b binding,MF,
20726,GO:1905577,1,0.993026672249471,0,1,ganglioside GP1c binding,MF,
20727,GO:1905578,1,0.99366671585606,0,1,regulation of ERBB3 signaling pathway,BP,
20728,GO:1905580,1,0.99366671585606,0,1,positive regulation of ERBB3 signaling pathway,BP,
20729,GO:1905581,1,0.995238695253471,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20730,GO:1905589,1,0.99341927840292,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20731,GO:1905590,1,0.992732905485045,0,1,fibronectin fibril organization,BP,
20732,GO:1905594,1,0.995971794784606,0,1,resveratrol binding,MF,
20733,GO:1905595,1,0.987798547899186,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20734,GO:1905596,1,0.992524621296595,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20735,GO:1905597,1,0.995238695253471,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20736,GO:1905598,1,0.992524621296595,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20737,GO:1905599,1,0.995238695253471,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20738,GO:1905600,1,0.980791532658186,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20739,GO:1905601,1,0.992524621296595,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20740,GO:1905602,1,0.988179441046867,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20741,GO:1905603,1,0.992449848111986,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20742,GO:1905604,1,0.992449848111986,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20743,GO:1905606,1,0.970553647217796,0,4,regulation of presynapse assembly,BP,
20744,GO:1905608,1,0.992456461683755,0,1,positive regulation of presynapse assembly,BP,
20745,GO:1905610,1,0.992432521676641,0,1,regulation of mRNA cap binding,BP,
20746,GO:1905612,1,0.992432521676641,0,1,positive regulation of mRNA cap binding,BP,
20747,GO:1905616,1,0.985579914141114,0,2,regulation of miRNA mediated inhibition of translation,BP,
20748,GO:1905618,1,0.985579914141114,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20749,GO:1905634,1,0.96534616128263,0,5,regulation of protein localization to chromatin,BP,
20750,GO:1905636,1,0.995826066349948,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20751,GO:1905642,1,0.9930956730518,0,1,negative regulation of DNA methylation,BP,
20752,GO:1905643,1,0.992369777232531,0,1,positive regulation of DNA methylation,BP,
20753,GO:1905647,1,0.993617816321152,0,1,proline import across plasma membrane,BP,
20754,GO:1905651,1,0.978034397948081,0,3,regulation of artery morphogenesis,BP,
20755,GO:1905653,1,0.978034397948081,0,3,positive regulation of artery morphogenesis,BP,
20756,GO:1905661,1,0.986794343161412,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20757,GO:1905663,1,0.986794343161412,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20758,GO:1905664,1,0.976014819980297,0,4,regulation of calcium ion import across plasma membrane,BP,
20759,GO:1905665,1,0.988261228995885,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20760,GO:1905666,1,0.935577274041612,0,9,regulation of protein localization to endosome,BP,
20761,GO:1905668,1,0.935577274041612,0,9,positive regulation of protein localization to endosome,BP,
20762,GO:1905671,1,0.980906504558167,0,3,regulation of lysosome organization,BP,
20763,GO:1905672,1,0.994249728549904,0,1,negative regulation of lysosome organization,BP,
20764,GO:1905687,1,0.992387085197334,0,1,regulation of diacylglycerol kinase activity,BP,
20765,GO:1905689,1,0.992387085197334,0,1,positive regulation of diacylglycerol kinase activity,BP,
20766,GO:1905693,1,0.994251771467272,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20767,GO:1905695,1,0.994251771467272,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20768,GO:1905696,1,0.98496440919261,0,2,regulation of polysome binding,BP,
20769,GO:1905698,1,0.992475522317594,0,1,positive regulation of polysome binding,BP,
20770,GO:1905705,1,0.992285195148352,0,1,cellular response to paclitaxel,BP,
20771,GO:1905709,1,0.974732616137096,0,5,negative regulation of membrane permeability,BP,
20772,GO:1905710,1,0.696687014360178,0,60,positive regulation of membrane permeability,BP,
20773,GO:1905711,1,0.992507882206926,0,1,response to phosphatidylethanolamine,BP,
20774,GO:1905719,1,0.986093927241969,0,2,protein localization to perinuclear region of cytoplasm,BP,
20775,GO:1905720,1,0.992263514958006,0,1,cytoplasmic microtubule bundle,CC,
20776,GO:1905747,1,0.995804276297472,0,1,negative regulation of saliva secretion,BP,
20777,GO:1905748,1,0.995804276297472,0,1,hard palate morphogenesis,BP,
20778,GO:1905764,1,0.979386870307773,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20779,GO:1905765,1,0.979386870307773,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20780,GO:1905767,1,0.9923006128367,0,1,regulation of double-stranded telomeric DNA binding,BP,
20781,GO:1905768,1,0.9923006128367,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20782,GO:1905770,1,0.964770812738465,0,6,regulation of mesodermal cell differentiation,BP,
20783,GO:1905771,1,0.979483708961049,0,4,negative regulation of mesodermal cell differentiation,BP,
20784,GO:1905773,1,0.977533352986688,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20785,GO:1905774,1,0.992498126821826,0,1,regulation of DNA helicase activity,BP,
20786,GO:1905776,1,0.992498126821826,0,1,positive regulation of DNA helicase activity,BP,
20787,GO:1905777,1,0.979151221261348,0,3,regulation of exonuclease activity,BP,
20788,GO:1905778,1,0.985909299363446,0,2,negative regulation of exonuclease activity,BP,
20789,GO:1905779,1,0.99314632348085,0,1,positive regulation of exonuclease activity,BP,
20790,GO:1905793,1,0.984460764564236,0,2,protein localization to pericentriolar material,BP,
20791,GO:1905794,1,0.992027842744232,0,1,response to puromycin,BP,
20792,GO:1905795,1,0.992027842744232,0,1,cellular response to puromycin,BP,
20793,GO:1905799,1,0.996498547594928,0,1,regulation of intraciliary retrograde transport,BP,
20794,GO:1905802,1,0.993006365576562,0,1,regulation of cellular response to manganese ion,BP,
20796,GO:1905818,1,0.701190267805858,0,55,regulation of chromosome separation,BP,
20797,GO:1905819,1,0.810484869328726,0,33,negative regulation of chromosome separation,BP,
20798,GO:1905820,1,0.942601976656131,0,9,positive regulation of chromosome separation,BP,
20799,GO:1905832,1,0.969633877493665,0,4,positive regulation of spindle assembly,BP,
20800,GO:1905838,1,0.985909299363446,0,2,regulation of telomeric D-loop disassembly,BP,
20801,GO:1905839,1,0.985909299363446,0,2,negative regulation of telomeric D-loop disassembly,BP,
20802,GO:1905843,1,0.991950910313496,0,1,regulation of cellular response to gamma radiation,BP,
20803,GO:1905853,1,0.995924249434127,0,1,regulation of heparan sulfate binding,BP,
20804,GO:1905855,1,0.995924249434127,0,1,positive regulation of heparan sulfate binding,BP,
20805,GO:1905858,1,0.995924249434127,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20806,GO:1905860,1,0.995924249434127,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20807,GO:1905863,1,0.985295717526539,0,2,invadopodium organization,BP,
20808,GO:1905867,1,0.977857662684876,0,4,epididymis development,BP,
20809,GO:1905874,1,0.972876311774687,0,4,regulation of postsynaptic density organization,BP,
20810,GO:1905875,1,0.992913289814899,0,1,negative regulation of postsynaptic density organization,BP,
20811,GO:1905878,1,0.992052679480295,0,1,invadopodium disassembly,BP,
20812,GO:1905879,1,0.93661013742744,0,10,regulation of oogenesis,BP,
20813,GO:1905880,1,0.974624861742654,0,4,negative regulation of oogenesis,BP,
20814,GO:1905881,1,0.973785167980879,0,4,positive regulation of oogenesis,BP,
20815,GO:1905890,1,0.995924249434127,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20816,GO:1905891,1,0.993013917221064,0,1,regulation of cellular response to thapsigargin,BP,
20817,GO:1905892,1,0.993013917221064,0,1,negative regulation of cellular response to thapsigargin,BP,
20818,GO:1905894,1,0.993013917221064,0,1,regulation of cellular response to tunicamycin,BP,
20819,GO:1905895,1,0.993013917221064,0,1,negative regulation of cellular response to tunicamycin,BP,
20820,GO:1905897,1,0.623912776011043,0,73,regulation of response to endoplasmic reticulum stress,BP,
20821,GO:1905898,1,0.799281491737195,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
20822,GO:1905899,1,0.995345054077821,0,1,regulation of smooth muscle tissue development,BP,
20823,GO:1905900,1,0.995345054077821,0,1,negative regulation of smooth muscle tissue development,BP,
20824,GO:1905901,1,0.995345054077821,0,1,positive regulation of smooth muscle tissue development,BP,
20825,GO:1905902,1,0.964770812738465,0,6,regulation of mesoderm formation,BP,
20826,GO:1905903,1,0.979483708961049,0,4,negative regulation of mesoderm formation,BP,
20827,GO:1905906,1,0.957767003811214,0,7,regulation of amyloid fibril formation,BP,
20828,GO:1905907,1,0.982028417833524,0,3,negative regulation of amyloid fibril formation,BP,
20829,GO:1905908,1,0.974106628520349,0,4,positive regulation of amyloid fibril formation,BP,
20830,GO:1905912,1,0.994865445758941,0,1,regulation of calcium ion export across plasma membrane,BP,
20831,GO:1905913,1,0.994865445758941,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20832,GO:1905918,1,0.994229303556967,0,1,regulation of CoA-transferase activity,BP,
20833,GO:1905920,1,0.994229303556967,0,1,positive regulation of CoA-transferase activity,BP,
20834,GO:1905927,1,0.992052679480295,0,1,regulation of invadopodium disassembly,BP,
20835,GO:1905929,1,0.992052679480295,0,1,positive regulation of invadopodium disassembly,BP,
20836,GO:1905936,1,0.980908397025788,0,4,regulation of germ cell proliferation,BP,
20837,GO:1905937,1,0.984680402328447,0,3,negative regulation of germ cell proliferation,BP,
20838,GO:1905938,1,0.996169914061682,0,1,positive regulation of germ cell proliferation,BP,
20839,GO:1905939,1,0.897750665871416,0,18,regulation of gonad development,BP,
20840,GO:1905940,1,0.967443911765574,0,5,negative regulation of gonad development,BP,
20841,GO:1905941,1,0.941925509022226,0,10,positive regulation of gonad development,BP,
20842,GO:1905942,1,0.99366671585606,0,1,regulation of formation of growth cone in injured axon,BP,
20843,GO:1905943,1,0.99366671585606,0,1,negative regulation of formation of growth cone in injured axon,BP,
20844,GO:1905952,1,0.504237767169256,0,109,regulation of lipid localization,BP,
20845,GO:1905953,1,0.816987613587937,0,31,negative regulation of lipid localization,BP,
20846,GO:1905954,1,0.663412924472194,0,66,positive regulation of lipid localization,BP,
20847,GO:1905957,1,0.992489247294393,0,1,regulation of cellular response to alcohol,BP,
20848,GO:1905959,1,0.992489247294393,0,1,positive regulation of cellular response to alcohol,BP,
20849,GO:1905961,1,0.951161010709911,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20850,GO:1990000,1,0.915672817111802,0,14,amyloid fibril formation,BP,
20851,GO:1990001,1,0.935266776624533,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20852,GO:1990003,1,0.992364374867111,0,1,IDP phosphatase activity,MF,
20853,GO:1990005,1,0.988237690321022,0,2,granular vesicle,CC,
20854,GO:1990008,1,0.995108588206697,0,1,neurosecretory vesicle,CC,
20855,GO:1990009,1,0.985003055592612,0,2,retinal cell apoptotic process,BP,
20856,GO:1990015,1,0.9937316248304,0,1,ensheathing process,CC,
20857,GO:1990023,1,0.916995133394643,0,12,mitotic spindle midzone,CC,
20858,GO:1990026,1,0.985050770269589,0,2,hippocampal mossy fiber expansion,CC,
20859,GO:1990030,1,0.992502540017776,0,1,pericellular basket,CC,
20860,GO:1990031,1,0.992711128844603,0,1,pinceau fiber,CC,
20861,GO:1990032,1,0.992483155892104,0,1,parallel fiber,CC,
20862,GO:1990034,1,0.965485388788311,0,5,calcium ion export across plasma membrane,BP,
20863,GO:1990036,1,0.987326874157165,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20864,GO:1990037,1,0.984018833401374,0,3,Lewy body core,CC,
20865,GO:1990038,1,0.994638624842927,0,1,Lewy body corona,CC,
20866,GO:1990046,1,0.995790553451032,0,1,stress-induced mitochondrial fusion,BP,
20867,GO:1990047,1,0.993985826982937,0,1,spindle matrix,CC,
20868,GO:1990048,1,0.9930956730518,0,1,anterograde neuronal dense core vesicle transport,BP,
20869,GO:1990050,1,0.981395419825466,0,4,phosphatidic acid transporter activity,MF,
20870,GO:1990051,1,0.985031443664204,0,2,activation of protein kinase C activity,BP,
20871,GO:1990070,1,0.996402332489711,0,1,TRAPPI protein complex,CC,
20872,GO:1990071,1,0.988711869383503,0,2,TRAPPII protein complex,CC,
20873,GO:1990072,1,0.989522592313654,0,2,TRAPPIII protein complex,CC,
20874,GO:1990074,1,0.992549833544763,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20875,GO:1990075,1,0.970025172794851,0,4,periciliary membrane compartment,CC,
20876,GO:1990079,1,0.996147719989133,0,1,cartilage homeostasis,BP,
20877,GO:1990086,1,0.97194968318184,0,4,lens fiber cell apoptotic process,BP,
20880,GO:1990108,1,0.98529688227633,0,2,protein linear deubiquitination,BP,
20881,GO:1990111,1,0.98037829577081,0,4,spermatoproteasome complex,CC,
20882,GO:1990112,1,0.986238532970005,0,2,RQC complex,CC,
20883,GO:1990116,1,0.986238532970005,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20884,GO:1990117,1,0.996356917639189,0,1,B cell receptor apoptotic signaling pathway,BP,
20885,GO:1990124,1,0.945261416296018,0,8,messenger ribonucleoprotein complex,CC,
20886,GO:1990126,1,0.898295122346423,0,16,retrograde transport, endosome to plasma membrane,BP,
20887,GO:1990127,1,0.992495258360024,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20888,GO:1990130,1,0.967392875748047,0,5,GATOR1 complex,CC,
20889,GO:1990131,1,0.977644177742172,0,4,Gtr1-Gtr2 GTPase complex,CC,
20890,GO:1990134,1,0.992447717596114,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20891,GO:1990136,1,0.993538499011658,0,1,linoleate 9S-lipoxygenase activity,MF,
20893,GO:1990144,1,0.965011248898643,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20894,GO:1990145,1,0.985316689401448,0,2,maintenance of translational fidelity,BP,
20895,GO:1990164,1,0.98584601871322,0,2,histone H2A phosphorylation,BP,
20896,GO:1990165,1,0.994512734573476,0,1,single-strand break-containing DNA binding,MF,
20897,GO:1990166,1,0.9938239252959,0,1,protein localization to site of double-strand break,BP,
20898,GO:1990167,1,0.984724920974137,0,2,protein K27-linked deubiquitination,BP,
20899,GO:1990168,1,0.984855878019786,0,2,protein K33-linked deubiquitination,BP,
20900,GO:1990169,1,0.959619327697067,0,11,stress response to copper ion,BP,
20901,GO:1990170,1,0.994524886623575,0,1,stress response to cadmium ion,BP,
20902,GO:1990172,1,0.992377591294024,0,1,G-protein coupled receptor catabolic process,BP,
20903,GO:1990173,1,0.941021314388466,0,10,protein localization to nucleoplasm,BP,
20904,GO:1990174,1,0.992504810438319,0,1,phosphodiesterase decapping endonuclease activity,MF,
20905,GO:1990175,1,0.992501996208603,0,1,EH domain binding,MF,
20906,GO:1990179,1,0.979069538627123,0,3,protein localization to actomyosin contractile ring,BP,
20907,GO:1990180,1,0.983380615140847,0,3,mitochondrial tRNA 3'-end processing,BP,
20908,GO:1990182,1,0.899127468614239,0,17,exosomal secretion,BP,
20909,GO:1990183,1,0.996313819676705,0,1,lymphatic vascular process in circulatory system,BP,
20910,GO:1990186,1,0.996313819676705,0,1,regulation of lymphatic vessel size,BP,
20911,GO:1990188,1,0.993340078282828,0,1,euchromatin binding,MF,
20912,GO:1990189,1,0.984409419210543,0,3,peptide-serine-N-acetyltransferase activity,MF,
20913,GO:1990190,1,0.991737229061066,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20914,GO:1990192,1,0.996313819676705,0,1,collecting lymphatic vessel constriction,BP,
20915,GO:1990204,1,0.607303217362937,0,95,oxidoreductase complex,CC,
20916,GO:1990226,1,0.96338600733302,0,6,histone methyltransferase binding,MF,
20918,GO:1990239,1,0.959422679238521,0,6,steroid hormone binding,MF,
20919,GO:1990246,1,0.972664538770891,0,4,uniplex complex,CC,
20920,GO:1990247,1,0.94914206400945,0,7,N6-methyladenosine-containing RNA binding,MF,
20921,GO:1990253,1,0.938178810024289,0,9,cellular response to leucine starvation,BP,
20922,GO:1990254,1,0.967913068409094,0,5,keratin filament binding,MF,
20923,GO:1990256,1,0.991896912943735,0,1,signal clustering,BP,
20924,GO:1990258,1,0.995937198802247,0,1,histone glutamine methylation,BP,
20925,GO:1990259,1,0.995937198802247,0,1,histone-glutamine methyltransferase activity,MF,
20926,GO:1990261,1,0.9930956730518,0,1,pre-mRNA catabolic process,BP,
20927,GO:1990262,1,0.993149248630193,0,1,anti-Mullerian hormone signaling pathway,BP,
20928,GO:1990264,1,0.986725809249367,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20929,GO:1990266,1,0.643783940335263,0,78,neutrophil migration,BP,
20930,GO:1990267,1,0.992671539938845,0,1,response to transition metal nanoparticle,BP,
20931,GO:1990268,1,0.992671539938845,0,1,response to gold nanoparticle,BP,
20932,GO:1990269,1,0.986736864076595,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20933,GO:1990275,1,0.992965579941891,0,1,preribosome binding,MF,
20934,GO:1990280,1,0.992295536432322,0,1,RNA localization to chromatin,BP,
20935,GO:1990298,1,0.994242578886084,0,1,bub1-bub3 complex,CC,
20936,GO:1990314,1,0.9468480205899,0,8,cellular response to insulin-like growth factor stimulus,BP,
20937,GO:1990316,1,0.943243078009301,0,8,Atg1/ULK1 kinase complex,CC,
20938,GO:1990332,1,0.992499787811949,0,1,Ire1 complex,CC,
20939,GO:1990349,1,0.994551172977047,0,1,gap junction-mediated intercellular transport,BP,
20941,GO:1990356,1,0.995894182048718,0,1,sumoylated E2 ligase complex,CC,
20942,GO:1990357,1,0.982782841889356,0,3,terminal web,CC,
20943,GO:1990379,1,0.990116890755638,0,2,lipid transport across blood brain barrier,BP,
20944,GO:1990380,1,0.947820071800297,0,7,Lys48-specific deubiquitinase activity,MF,
20945,GO:1990381,1,0.913457402223336,0,13,ubiquitin-specific protease binding,MF,
20946,GO:1990384,1,0.995789176732612,0,1,hyaloid vascular plexus regression,BP,
20947,GO:1990386,1,0.994599527439214,0,1,mitotic cleavage furrow ingression,BP,
20948,GO:1990390,1,0.992563038845129,0,1,protein K33-linked ubiquitination,BP,
20949,GO:1990391,1,0.796298593337639,0,33,DNA repair complex,CC,
20950,GO:1990393,1,0.964825554033378,0,5,3M complex,CC,
20951,GO:1990399,1,0.994062459126175,0,1,epithelium regeneration,BP,
20952,GO:1990401,1,0.993113229616071,0,1,embryonic lung development,BP,
20953,GO:1990402,1,0.994145695392548,0,1,embryonic liver development,BP,
20954,GO:1990403,1,0.932852384225929,0,10,embryonic brain development,BP,
20955,GO:1990404,1,0.987337522889975,0,2,protein ADP-ribosylase activity,MF,
20956,GO:1990405,1,0.96101965888458,0,6,protein antigen binding,MF,
20957,GO:1990406,1,0.988731511136274,0,2,CGRP receptor complex,CC,
20958,GO:1990407,1,0.996253144052001,0,1,calcitonin gene-related peptide binding,MF,
20959,GO:1990408,1,0.988731511136274,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20960,GO:1990409,1,0.988863964579597,0,2,adrenomedullin binding,MF,
20961,GO:1990410,1,0.980224400257153,0,4,adrenomedullin receptor signaling pathway,BP,
20962,GO:1990414,1,0.973199003693708,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20963,GO:1990415,1,0.980557354620699,0,3,Pex17p-Pex14p docking complex,CC,
20964,GO:1990416,1,0.944488899785187,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20965,GO:1990418,1,0.981020970290177,0,3,response to insulin-like growth factor stimulus,BP,
20966,GO:1990421,1,0.991947384974868,0,1,subtelomeric heterochromatin,CC,
20967,GO:1990423,1,0.978058711430672,0,3,RZZ complex,CC,
20968,GO:1990425,1,0.97984853276054,0,3,ryanodine receptor complex,CC,
20969,GO:1990426,1,0.986041084267846,0,2,mitotic recombination-dependent replication fork processing,BP,
20970,GO:1990427,1,0.992248443248606,0,1,stereocilia tip-link density,CC,
20971,GO:1990428,1,0.985047153688322,0,2,miRNA transport,BP,
20972,GO:1990429,1,0.980557354620699,0,3,peroxisomal importomer complex,CC,
20973,GO:1990430,1,0.973361527265251,0,4,extracellular matrix protein binding,MF,
20974,GO:1990435,1,0.992248443248606,0,1,upper tip-link density,CC,
20975,GO:1990439,1,0.992896081095899,0,1,MAP kinase serine/threonine phosphatase activity,MF,
20976,GO:1990440,1,0.93464984224477,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20977,GO:1990441,1,0.97431904319446,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20978,GO:1990442,1,0.98791676616291,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20979,GO:1990446,1,0.98107288969076,0,4,U1 snRNP binding,MF,
20980,GO:1990448,1,0.992313188850356,0,1,exon-exon junction complex binding,MF,
20981,GO:1990452,1,0.985236870696019,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20982,GO:1990454,1,0.948206833262359,0,7,L-type voltage-gated calcium channel complex,CC,
20983,GO:1990456,1,0.992505764332007,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
20984,GO:1990459,1,0.956837740702916,0,7,transferrin receptor binding,MF,
20985,GO:1990460,1,0.980222568053656,0,3,leptin receptor binding,MF,
20986,GO:1990462,1,0.952789858211912,0,7,omegasome,CC,
20987,GO:1990478,1,0.994695410069663,0,1,response to ultrasound,BP,
20988,GO:1990481,1,0.976264269450072,0,4,mRNA pseudouridine synthesis,BP,
20989,GO:1990498,1,0.984503126870759,0,2,mitotic spindle microtubule,CC,
20992,GO:1990505,1,0.986041084267846,0,2,mitotic DNA replication maintenance of fidelity,BP,
20993,GO:1990511,1,0.971605747188159,0,4,piRNA biosynthetic process,BP,
20994,GO:1990518,1,0.992475522317594,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
20995,GO:1990519,1,0.988029767073713,0,2,pyrimidine nucleotide import into mitochondrion,BP,
20996,GO:1990523,1,0.972803677517718,0,4,bone regeneration,BP,
20997,GO:1990535,1,0.963287382741169,0,5,neuron projection maintenance,BP,
20998,GO:1990539,1,0.993903895013174,0,1,fructose import across plasma membrane,BP,
20999,GO:1990542,1,0.669294451212881,0,67,mitochondrial transmembrane transport,BP,
21000,GO:1990546,1,0.995296987477883,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21001,GO:1990564,1,0.97151662165459,0,5,protein polyufmylation,BP,
21002,GO:1990565,1,0.995175684230004,0,1,HSP90-CDC37 chaperone complex,CC,
21003,GO:1990569,1,0.98658570010375,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21004,GO:1990570,1,0.9930956730518,0,1,GDP-mannose transmembrane transport,BP,
21005,GO:1990572,1,0.992500133858096,0,1,TERT-RMRP complex,CC,
21006,GO:1990573,1,0.942370445644511,0,9,potassium ion import across plasma membrane,BP,
21007,GO:1990575,1,0.986358870506355,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21008,GO:1990578,1,0.992383364997106,0,1,perinuclear endoplasmic reticulum membrane,CC,
21009,GO:1990579,1,0.992499787811949,0,1,peptidyl-serine trans-autophosphorylation,BP,
21010,GO:1990583,1,0.994599527439214,0,1,phospholipase D activator activity,MF,
21011,GO:1990584,1,0.988816214569501,0,3,cardiac Troponin complex,CC,
21012,GO:1990589,1,0.987192374268454,0,2,ATF4-CREB1 transcription factor complex,CC,
21013,GO:1990590,1,0.988801847261908,0,2,ATF1-ATF4 transcription factor complex,CC,
21014,GO:1990592,1,0.97151662165459,0,5,protein K69-linked ufmylation,BP,
21015,GO:1990597,1,0.979109692517855,0,3,AIP1-IRE1 complex,CC,
21016,GO:1990599,1,0.979386870307773,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21017,GO:1990603,1,0.992632563568689,0,1,dark adaptation,BP,
21018,GO:1990604,1,0.979060926181367,0,3,IRE1-TRAF2-ASK1 complex,CC,
21019,GO:1990613,1,0.992548087391005,0,1,mitochondrial membrane fusion,BP,
21020,GO:1990617,1,0.99136672748666,0,2,CHOP-ATF4 complex,CC,
21021,GO:1990619,1,0.987778594542397,0,2,histone H3-K9 deacetylation,BP,
21022,GO:1990622,1,0.990734351616187,0,2,CHOP-ATF3 complex,CC,
21023,GO:1990630,1,0.992499787811949,0,1,IRE1-RACK1-PP2A complex,CC,
21024,GO:1990635,1,0.973567383729052,0,4,proximal dendrite,CC,
21025,GO:1990637,1,0.980314105659826,0,3,response to prolactin,BP,
21026,GO:1990641,1,0.98396690256103,0,3,response to iron ion starvation,BP,
21027,GO:1990646,1,0.992833519730857,0,1,cellular response to prolactin,BP,
21028,GO:1990654,1,0.992456568164416,0,1,sebum secreting cell proliferation,BP,
21029,GO:1990666,1,0.98500983408648,0,2,PCSK9-LDLR complex,CC,
21030,GO:1990667,1,0.987798547899186,0,2,PCSK9-AnxA2 complex,CC,
21031,GO:1990668,1,0.96868537482981,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21032,GO:1990682,1,0.986240292204035,0,2,CSF1-CSF1R complex,CC,
21033,GO:1990696,1,0.986384113826285,0,2,USH2 complex,CC,
21034,GO:1990697,1,0.994103002595619,0,1,protein depalmitoleylation,BP,
21035,GO:1990698,1,0.987512034511102,0,2,palmitoleoyltransferase activity,MF,
21036,GO:1990699,1,0.994103002595619,0,1,palmitoleyl hydrolase activity,MF,
21037,GO:1990700,1,0.992501626315568,0,1,nucleolar chromatin organization,BP,
21038,GO:1990705,1,0.992133512631521,0,1,cholangiocyte proliferation,BP,
21039,GO:1990707,1,0.991947384974868,0,1,nuclear subtelomeric heterochromatin,CC,
21040,GO:1990708,1,0.99245373618402,0,1,conditioned place preference,BP,
21041,GO:1990709,1,0.980242171405759,0,3,presynaptic active zone organization,BP,
21042,GO:1990712,1,0.955089423769664,0,7,HFE-transferrin receptor complex,CC,
21043,GO:1990715,1,0.992498959400645,0,1,mRNA CDS binding,MF,
21044,GO:1990716,1,0.97956272883289,0,3,axonemal central apparatus,CC,
21045,GO:1990718,1,0.99205831153585,0,1,axonemal central pair projection,CC,
21046,GO:1990723,1,0.984775463869486,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21047,GO:1990726,1,0.979709289401785,0,5,Lsm1-7-Pat1 complex,CC,
21048,GO:1990729,1,0.994635623989829,0,1,primary miRNA modification,BP,
21049,GO:1990730,1,0.985101012953502,0,2,VCP-NSFL1C complex,CC,
21050,GO:1990736,1,0.992498660706466,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21051,GO:1990737,1,0.980197077979129,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21052,GO:1990739,1,0.992133512631521,0,1,granulosa cell proliferation,BP,
21054,GO:1990743,1,0.974139169812762,0,4,protein sialylation,BP,
21055,GO:1990744,1,0.994635623989829,0,1,primary miRNA methylation,BP,
21056,GO:1990745,1,0.978451543396415,0,3,EARP complex,CC,
21057,GO:1990748,1,0.621501041925286,0,86,cellular detoxification,BP,
21058,GO:1990751,1,0.99226199611503,0,1,Schwann cell chemotaxis,BP,
21059,GO:1990752,1,0.829757356569006,0,25,microtubule end,CC,
21060,GO:1990755,1,0.9930956730518,0,1,mitotic spindle microtubule depolymerization,BP,
21061,GO:1990756,1,0.981907783729589,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21062,GO:1990758,1,0.994882696802886,0,1,mitotic sister chromatid biorientation,BP,
21063,GO:1990761,1,0.978066485421921,0,3,growth cone lamellipodium,CC,
21064,GO:1990763,1,0.962717726776344,0,6,arrestin family protein binding,MF,
21065,GO:1990764,1,0.99318946031378,0,1,myofibroblast contraction,BP,
21066,GO:1990765,1,0.992436528352499,0,1,colon smooth muscle contraction,BP,
21067,GO:1990768,1,0.996458096886506,0,1,gastric mucosal blood circulation,BP,
21068,GO:1990769,1,0.981792688720516,0,3,proximal neuron projection,CC,
21069,GO:1990770,1,0.98892114191549,0,2,small intestine smooth muscle contraction,BP,
21070,GO:1990771,1,0.99235832941719,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21071,GO:1990773,1,0.995067222051418,0,1,matrix metallopeptidase secretion,BP,
21072,GO:1990774,1,0.892803270355801,0,18,tumor necrosis factor secretion,BP,
21074,GO:1990777,1,0.836892612466627,0,32,lipoprotein particle,CC,
21077,GO:1990784,1,0.992499421853239,0,1,response to dsDNA,BP,
21078,GO:1990785,1,0.977322296865697,0,3,response to water-immersion restraint stress,BP,
21079,GO:1990786,1,0.992499421853239,0,1,cellular response to dsDNA,BP,
21080,GO:1990791,1,0.979039026011737,0,3,dorsal root ganglion development,BP,
21081,GO:1990796,1,0.992898737245495,0,1,photoreceptor cell terminal bouton,CC,
21082,GO:1990809,1,0.974184367083282,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21083,GO:1990812,1,0.978520068169299,0,3,growth cone filopodium,CC,
21084,GO:1990817,1,0.993993865113311,0,1,RNA adenylyltransferase activity,MF,
21085,GO:1990822,1,0.949620867098006,0,8,basic amino acid transmembrane transport,BP,
21087,GO:1990825,1,0.94391485782077,0,9,sequence-specific mRNA binding,MF,
21088,GO:1990828,1,0.994233387874823,0,1,hepatocyte dedifferentiation,BP,
21089,GO:1990829,1,0.994640624771,0,1,C-rich single-stranded DNA binding,MF,
21091,GO:1990832,1,0.994486366033924,0,1,slow axonal transport,BP,
21092,GO:1990833,1,0.994486366033924,0,1,clathrin-uncoating ATPase activity,MF,
21093,GO:1990834,1,0.973760399105663,0,4,response to odorant,BP,
21095,GO:1990839,1,0.986466973775277,0,2,response to endothelin,BP,
21096,GO:1990841,1,0.765727967365698,0,38,promoter-specific chromatin binding,MF,
21097,GO:1990843,1,0.992338574129646,0,1,subsarcolemmal mitochondrion,CC,
21098,GO:1990844,1,0.992338574129646,0,1,interfibrillar mitochondrion,CC,
21099,GO:1990845,1,0.91974831629648,0,13,adaptive thermogenesis,BP,
21100,GO:1990851,1,0.97733647072082,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21101,GO:1990859,1,0.993929777044837,0,1,cellular response to endothelin,BP,
21102,GO:1990868,1,0.965611804902278,0,5,response to chemokine,BP,
21103,GO:1990869,1,0.965611804902278,0,5,cellular response to chemokine,BP,
21104,GO:1990874,1,0.784258260618835,0,36,vascular smooth muscle cell proliferation,BP,
21105,GO:1990876,1,0.992312246095807,0,1,cytoplasmic side of nuclear pore,CC,
21106,GO:1990879,1,0.986238532970005,0,2,CST complex,CC,
21107,GO:1990882,1,0.992501319796993,0,1,rRNA acetylation,BP,
21108,GO:1990883,1,0.992501319796993,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21109,GO:1990884,1,0.992501319796993,0,1,RNA acetylation,BP,
21110,GO:1990889,1,0.994826862990665,0,1,H4K20me3 modified histone binding,MF,
21111,GO:1990904,1,0.0140081305640248,0,717,ribonucleoprotein complex,CC,
21112,GO:1990907,1,0.921635864383478,0,11,beta-catenin-TCF complex,CC,
21113,GO:1990909,1,0.929544886358195,0,10,Wnt signalosome,CC,
21114,GO:1990910,1,0.983234421786032,0,3,response to hypobaric hypoxia,BP,
21115,GO:1990911,1,0.974414726878157,0,4,response to psychosocial stress,BP,
21116,GO:1990913,1,0.993479070722466,0,1,sperm head plasma membrane,CC,
21117,GO:1990917,1,0.993479070722466,0,1,ooplasm,CC,
21118,GO:1990918,1,0.985625328414761,0,2,double-strand break repair involved in meiotic recombination,BP,
21119,GO:1990922,1,0.992619275098749,0,1,hepatic stellate cell proliferation,BP,
21120,GO:1990923,1,0.980795653874114,0,3,PET complex,CC,
21122,GO:1990927,1,0.984968417846943,0,2,calcium ion regulated lysosome exocytosis,BP,
21123,GO:1990928,1,0.984875160375706,0,2,response to amino acid starvation,BP,
21124,GO:1990930,1,0.995345054077821,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21125,GO:1990931,1,0.9924916978135,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21126,GO:1990936,1,0.987840598269155,0,2,vascular smooth muscle cell dedifferentiation,BP,
21127,GO:1990938,1,0.992500155709995,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21128,GO:1990939,1,0.706263107484296,0,48,ATP-dependent microtubule motor activity,MF,
21129,GO:1990948,1,0.980066537145025,0,5,ubiquitin ligase inhibitor activity,MF,
21130,GO:1990955,1,0.992498126821826,0,1,G-rich single-stranded DNA binding,MF,
21131,GO:1990962,1,0.992500488936931,0,1,drug transport across blood-brain barrier,BP,
21132,GO:1990963,1,0.992500488936931,0,1,establishment of blood-retinal barrier,BP,
21133,GO:1990966,1,0.973645013852148,0,4,ATP generation from poly-ADP-D-ribose,BP,
21134,GO:1990967,1,0.988153124117891,0,2,multi-organism toxin transport,BP,
21135,GO:1990968,1,0.992327363064868,0,1,modulation by host of RNA binding by virus,BP,
21136,GO:1990969,1,0.992327363064868,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21137,GO:1990971,1,0.992501937538747,0,1,EMILIN complex,CC,
21138,GO:1990983,1,0.993407159922594,0,1,tRNA demethylation,BP,
21139,GO:1990984,1,0.993407159922594,0,1,tRNA demethylase activity,MF,
21140,GO:2000001,1,0.900850897709193,0,16,regulation of DNA damage checkpoint,BP,
21141,GO:2000002,1,0.968512767543127,0,5,negative regulation of DNA damage checkpoint,BP,
21142,GO:2000003,1,0.9930956730518,0,1,positive regulation of DNA damage checkpoint,BP,
21143,GO:2000004,1,0.99497902520046,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21144,GO:2000005,1,0.99497902520046,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21145,GO:2000006,1,0.99497902520046,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21146,GO:2000007,1,0.99497902520046,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21147,GO:2000008,1,0.804250702073598,0,33,regulation of protein localization to cell surface,BP,
21148,GO:2000009,1,0.924650772437761,0,12,negative regulation of protein localization to cell surface,BP,
21149,GO:2000010,1,0.917766055952514,0,13,positive regulation of protein localization to cell surface,BP,
21150,GO:2000011,1,0.994139589794725,0,1,regulation of adaxial/abaxial pattern formation,BP,
21151,GO:2000015,1,0.976733224139223,0,4,regulation of determination of dorsal identity,BP,
21152,GO:2000016,1,0.991093920650422,0,2,negative regulation of determination of dorsal identity,BP,
21153,GO:2000017,1,0.985511571065455,0,2,positive regulation of determination of dorsal identity,BP,
21154,GO:2000018,1,0.949211876261859,0,8,regulation of male gonad development,BP,
21155,GO:2000019,1,0.992502895160612,0,1,negative regulation of male gonad development,BP,
21156,GO:2000020,1,0.956385246547233,0,7,positive regulation of male gonad development,BP,
21158,GO:2000027,1,0.230015534395001,0,231,regulation of organ morphogenesis,BP,
21159,GO:2000035,1,0.951161912678301,0,8,regulation of stem cell division,BP,
21160,GO:2000036,1,0.840894730880348,0,24,regulation of stem cell population maintenance,BP,
21161,GO:2000040,1,0.987103915312743,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21162,GO:2000041,1,0.987103915312743,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21163,GO:2000042,1,0.936698333809447,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21164,GO:2000043,1,0.993854405045589,0,1,regulation of cardiac cell fate specification,BP,
21165,GO:2000045,1,0.395262269428592,0,145,regulation of G1/S transition of mitotic cell cycle,BP,
21166,GO:2000047,1,0.947315642447938,0,9,regulation of cell-cell adhesion mediated by cadherin,BP,
21167,GO:2000048,1,0.978143446838158,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21168,GO:2000049,1,0.968490347906588,0,5,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21169,GO:2000050,1,0.857080196445991,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21170,GO:2000051,1,0.957391283531166,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21171,GO:2000052,1,0.921930047429804,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21172,GO:2000053,1,0.984571952584162,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21173,GO:2000054,1,0.992484179088526,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21174,GO:2000055,1,0.992028466866788,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21175,GO:2000056,1,0.994795764468499,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21176,GO:2000057,1,0.994795764468499,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21177,GO:2000058,1,0.412318189422125,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21179,GO:2000060,1,0.548787996232508,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21180,GO:2000061,1,0.995345054077821,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21181,GO:2000062,1,0.995345054077821,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21182,GO:2000063,1,0.995345054077821,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21183,GO:2000064,1,0.95831120709066,0,6,regulation of cortisol biosynthetic process,BP,
21184,GO:2000065,1,0.972876610603811,0,4,negative regulation of cortisol biosynthetic process,BP,
21185,GO:2000066,1,0.992502895160612,0,1,positive regulation of cortisol biosynthetic process,BP,
21186,GO:2000067,1,0.996390802365142,0,1,regulation of root morphogenesis,BP,
21187,GO:2000074,1,0.952081306509287,0,8,regulation of type B pancreatic cell development,BP,
21188,GO:2000077,1,0.986494875069573,0,2,negative regulation of type B pancreatic cell development,BP,
21189,GO:2000078,1,0.984843993547276,0,3,positive regulation of type B pancreatic cell development,BP,
21190,GO:2000079,1,0.992484179088526,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21191,GO:2000080,1,0.992484179088526,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21192,GO:2000095,1,0.91561268691705,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21193,GO:2000096,1,0.94767134770218,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21194,GO:2000097,1,0.982315683522925,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21195,GO:2000098,1,0.988724799455147,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21196,GO:2000101,1,0.992908399563964,0,1,regulation of mammary stem cell proliferation,BP,
21197,GO:2000103,1,0.992908399563964,0,1,positive regulation of mammary stem cell proliferation,BP,
21198,GO:2000104,1,0.878786929234417,0,19,negative regulation of DNA-dependent DNA replication,BP,
21199,GO:2000105,1,0.908905487758691,0,14,positive regulation of DNA-dependent DNA replication,BP,
21200,GO:2000106,1,0.631441657146553,0,75,regulation of leukocyte apoptotic process,BP,
21201,GO:2000107,1,0.768786466756647,0,43,negative regulation of leukocyte apoptotic process,BP,
21202,GO:2000108,1,0.863280730707146,0,24,positive regulation of leukocyte apoptotic process,BP,
21203,GO:2000109,1,0.955023478495172,0,7,regulation of macrophage apoptotic process,BP,
21204,GO:2000110,1,0.979765093798891,0,3,negative regulation of macrophage apoptotic process,BP,
21205,GO:2000111,1,0.980914800502117,0,3,positive regulation of macrophage apoptotic process,BP,
21208,GO:2000114,1,0.87566540252861,0,18,regulation of establishment of cell polarity,BP,
21210,GO:2000117,1,0.560917665006118,0,95,negative regulation of cysteine-type endopeptidase activity,BP,
21211,GO:2000118,1,0.985419539797331,0,2,regulation of sodium-dependent phosphate transport,BP,
21212,GO:2000119,1,0.992869671573527,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21213,GO:2000121,1,0.941332556168549,0,10,regulation of removal of superoxide radicals,BP,
21214,GO:2000124,1,0.986292207583142,0,2,regulation of endocannabinoid signaling pathway,BP,
21215,GO:2000134,1,0.536284066724441,0,96,negative regulation of G1/S transition of mitotic cell cycle,BP,
21216,GO:2000136,1,0.904835089928491,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21217,GO:2000137,1,0.986897710191441,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21218,GO:2000138,1,0.967087366903199,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21219,GO:2000142,1,0.791052771285591,0,36,regulation of DNA-templated transcription, initiation,BP,
21220,GO:2000143,1,0.95810496734044,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21221,GO:2000144,1,0.84337320688527,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21223,GO:2000146,1,0.220503273355664,0,228,negative regulation of cell motility,BP,
21225,GO:2000152,1,0.980284321873294,0,4,regulation of ubiquitin-specific protease activity,BP,
21226,GO:2000156,1,0.985524205261757,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21227,GO:2000157,1,0.992009997615386,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21228,GO:2000158,1,0.988180845368279,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21229,GO:2000167,1,0.992419488068084,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21230,GO:2000169,1,0.949341274934757,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21231,GO:2000170,1,0.985139426494035,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21233,GO:2000172,1,0.971290983958307,0,4,regulation of branching morphogenesis of a nerve,BP,
21234,GO:2000173,1,0.992501281097678,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21235,GO:2000174,1,0.992500836531796,0,1,regulation of pro-T cell differentiation,BP,
21236,GO:2000176,1,0.992500836531796,0,1,positive regulation of pro-T cell differentiation,BP,
21237,GO:2000177,1,0.614389396664852,0,71,regulation of neural precursor cell proliferation,BP,
21238,GO:2000178,1,0.875840693030915,0,20,negative regulation of neural precursor cell proliferation,BP,
21239,GO:2000179,1,0.759225282907971,0,40,positive regulation of neural precursor cell proliferation,BP,
21240,GO:2000181,1,0.556316889520279,0,87,negative regulation of blood vessel morphogenesis,BP,
21241,GO:2000182,1,0.977709165495626,0,3,regulation of progesterone biosynthetic process,BP,
21242,GO:2000184,1,0.992338574129646,0,1,positive regulation of progesterone biosynthetic process,BP,
21243,GO:2000191,1,0.898673579897846,0,16,regulation of fatty acid transport,BP,
21244,GO:2000192,1,0.963084101686963,0,5,negative regulation of fatty acid transport,BP,
21245,GO:2000193,1,0.940484526830785,0,10,positive regulation of fatty acid transport,BP,
21246,GO:2000194,1,0.931974325144211,0,12,regulation of female gonad development,BP,
21247,GO:2000195,1,0.974753641043698,0,4,negative regulation of female gonad development,BP,
21248,GO:2000196,1,0.984887676541262,0,3,positive regulation of female gonad development,BP,
21249,GO:2000197,1,0.957819931822171,0,6,regulation of ribonucleoprotein complex localization,BP,
21250,GO:2000199,1,0.992756565172904,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21251,GO:2000200,1,0.992756565172904,0,1,regulation of ribosomal subunit export from nucleus,BP,
21252,GO:2000202,1,0.992756565172904,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21253,GO:2000206,1,0.992756565172904,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21254,GO:2000208,1,0.992756565172904,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21255,GO:2000209,1,0.865763753826361,0,21,regulation of anoikis,BP,
21256,GO:2000210,1,0.967375432028687,0,6,positive regulation of anoikis,BP,
21257,GO:2000211,1,0.986742274214038,0,2,regulation of glutamate metabolic process,BP,
21258,GO:2000212,1,0.992447529429111,0,1,negative regulation of glutamate metabolic process,BP,
21259,GO:2000213,1,0.994251771467272,0,1,positive regulation of glutamate metabolic process,BP,
21260,GO:2000224,1,0.984549165922218,0,3,regulation of testosterone biosynthetic process,BP,
21261,GO:2000225,1,0.988641586911493,0,2,negative regulation of testosterone biosynthetic process,BP,
21262,GO:2000226,1,0.995538291756773,0,1,regulation of pancreatic A cell differentiation,BP,
21263,GO:2000227,1,0.995538291756773,0,1,negative regulation of pancreatic A cell differentiation,BP,
21264,GO:2000229,1,0.99064545827008,0,2,regulation of pancreatic stellate cell proliferation,BP,
21265,GO:2000230,1,0.994837506282806,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21266,GO:2000231,1,0.995786420869193,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21267,GO:2000232,1,0.927589084883299,0,11,regulation of rRNA processing,BP,
21268,GO:2000233,1,0.985423600691701,0,2,negative regulation of rRNA processing,BP,
21269,GO:2000234,1,0.94850113969176,0,8,positive regulation of rRNA processing,BP,
21271,GO:2000242,1,0.761857731004973,0,44,negative regulation of reproductive process,BP,
21272,GO:2000243,1,0.73891383587165,0,47,positive regulation of reproductive process,BP,
21273,GO:2000249,1,0.806833744327046,0,35,regulation of actin cytoskeleton reorganization,BP,
21274,GO:2000251,1,0.899528458987883,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21275,GO:2000252,1,0.965187578969795,0,7,negative regulation of feeding behavior,BP,
21276,GO:2000253,1,0.967016875810768,0,5,positive regulation of feeding behavior,BP,
21277,GO:2000254,1,0.980908397025788,0,4,regulation of male germ cell proliferation,BP,
21278,GO:2000255,1,0.984680402328447,0,3,negative regulation of male germ cell proliferation,BP,
21279,GO:2000256,1,0.996169914061682,0,1,positive regulation of male germ cell proliferation,BP,
21280,GO:2000257,1,0.799126220785547,0,36,regulation of protein activation cascade,BP,
21281,GO:2000258,1,0.959315145074523,0,6,negative regulation of protein activation cascade,BP,
21282,GO:2000259,1,0.979990217231711,0,3,positive regulation of protein activation cascade,BP,
21283,GO:2000269,1,0.901059218313653,0,15,regulation of fibroblast apoptotic process,BP,
21284,GO:2000270,1,0.952454388967552,0,7,negative regulation of fibroblast apoptotic process,BP,
21285,GO:2000271,1,0.950056760214698,0,7,positive regulation of fibroblast apoptotic process,BP,
21286,GO:2000272,1,0.833739756480501,0,28,negative regulation of signaling receptor activity,BP,
21288,GO:2000275,1,0.979892215754622,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21289,GO:2000276,1,0.989381938644089,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21290,GO:2000277,1,0.99622159485821,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21291,GO:2000278,1,0.529496155904291,0,96,regulation of DNA biosynthetic process,BP,
21292,GO:2000279,1,0.805056650931936,0,32,negative regulation of DNA biosynthetic process,BP,
21293,GO:2000280,1,0.996390802365142,0,1,regulation of root development,BP,
21294,GO:2000282,1,0.988380058225279,0,2,regulation of cellular amino acid biosynthetic process,BP,
21295,GO:2000283,1,0.992129025827869,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21296,GO:2000284,1,0.99622159485821,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21297,GO:2000286,1,0.979424294727133,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21299,GO:2000288,1,0.943238702154047,0,9,positive regulation of myoblast proliferation,BP,
21301,GO:2000291,1,0.914194606659716,0,14,regulation of myoblast proliferation,BP,
21302,GO:2000295,1,0.985062534138233,0,3,regulation of hydrogen peroxide catabolic process,BP,
21303,GO:2000296,1,0.992301289738499,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21305,GO:2000298,1,0.986405369661842,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21306,GO:2000299,1,0.992601013427516,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21308,GO:2000301,1,0.98033172402337,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21309,GO:2000302,1,0.977438269809924,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21310,GO:2000303,1,0.92421482572027,0,13,regulation of ceramide biosynthetic process,BP,
21311,GO:2000304,1,0.950313919259502,0,8,positive regulation of ceramide biosynthetic process,BP,
21312,GO:2000307,1,0.986566498059432,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21313,GO:2000308,1,0.993803373464768,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21314,GO:2000309,1,0.992718460821496,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21315,GO:2000310,1,0.883118864579749,0,18,regulation of NMDA receptor activity,BP,
21317,GO:2000312,1,0.978802905515075,0,3,regulation of kainate selective glutamate receptor activity,BP,
21318,GO:2000313,1,0.989997843065386,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21319,GO:2000314,1,0.995194820598021,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21320,GO:2000316,1,0.942645282031924,0,9,regulation of T-helper 17 type immune response,BP,
21321,GO:2000317,1,0.965807791681236,0,5,negative regulation of T-helper 17 type immune response,BP,
21322,GO:2000318,1,0.976025884711234,0,4,positive regulation of T-helper 17 type immune response,BP,
21323,GO:2000319,1,0.949635565639777,0,8,regulation of T-helper 17 cell differentiation,BP,
21324,GO:2000320,1,0.965807791681236,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21325,GO:2000321,1,0.983261128340314,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21326,GO:2000322,1,0.946198866857449,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21327,GO:2000323,1,0.958674031692238,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21328,GO:2000324,1,0.986992627585341,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21329,GO:2000325,1,0.992350950670645,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21330,GO:2000327,1,0.992350950670645,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21331,GO:2000328,1,0.977036844674012,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21332,GO:2000329,1,0.986209887569756,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21333,GO:2000330,1,0.990700003975652,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21334,GO:2000331,1,0.985188428680444,0,2,regulation of terminal button organization,BP,
21335,GO:2000332,1,0.989625273241723,0,2,regulation of blood microparticle formation,BP,
21336,GO:2000334,1,0.989625273241723,0,2,positive regulation of blood microparticle formation,BP,
21337,GO:2000338,1,0.987726596462374,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21338,GO:2000340,1,0.987726596462374,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21339,GO:2000341,1,0.944500814136421,0,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21340,GO:2000342,1,0.98677524324109,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21341,GO:2000343,1,0.957164705768386,0,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21342,GO:2000344,1,0.958456498462993,0,7,positive regulation of acrosome reaction,BP,
21343,GO:2000345,1,0.930707117222325,0,11,regulation of hepatocyte proliferation,BP,
21344,GO:2000346,1,0.979518506008591,0,3,negative regulation of hepatocyte proliferation,BP,
21345,GO:2000347,1,0.964547674861061,0,6,positive regulation of hepatocyte proliferation,BP,
21346,GO:2000348,1,0.963559194593444,0,6,regulation of CD40 signaling pathway,BP,
21347,GO:2000349,1,0.987077476804198,0,2,negative regulation of CD40 signaling pathway,BP,
21348,GO:2000350,1,0.996083383182969,0,1,positive regulation of CD40 signaling pathway,BP,
21349,GO:2000351,1,0.7723834661594,0,39,regulation of endothelial cell apoptotic process,BP,
21350,GO:2000352,1,0.844299744508092,0,25,negative regulation of endothelial cell apoptotic process,BP,
21351,GO:2000353,1,0.914961976546677,0,14,positive regulation of endothelial cell apoptotic process,BP,
21352,GO:2000354,1,0.965374379550836,0,6,regulation of ovarian follicle development,BP,
21353,GO:2000355,1,0.989221257549312,0,2,negative regulation of ovarian follicle development,BP,
21354,GO:2000356,1,0.995345054077821,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21355,GO:2000357,1,0.995345054077821,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21356,GO:2000358,1,0.995345054077821,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21357,GO:2000359,1,0.989707792618082,0,2,regulation of binding of sperm to zona pellucida,BP,
21358,GO:2000360,1,0.989707792618082,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21359,GO:2000361,1,0.985005772081834,0,2,regulation of prostaglandin-E synthase activity,BP,
21360,GO:2000363,1,0.985005772081834,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21361,GO:2000367,1,0.990326308153288,0,2,regulation of acrosomal vesicle exocytosis,BP,
21362,GO:2000368,1,0.990326308153288,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21363,GO:2000369,1,0.888183714825198,0,16,regulation of clathrin-dependent endocytosis,BP,
21364,GO:2000370,1,0.970310714745255,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21365,GO:2000371,1,0.96607806322763,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21366,GO:2000373,1,0.96607806322763,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21367,GO:2000374,1,0.987305660717334,0,3,regulation of oxygen metabolic process,BP,
21368,GO:2000376,1,0.992799158138158,0,2,positive regulation of oxygen metabolic process,BP,
21370,GO:2000378,1,0.757449133551796,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21372,GO:2000380,1,0.916920590268222,0,15,regulation of mesoderm development,BP,
21373,GO:2000381,1,0.955816072202021,0,8,negative regulation of mesoderm development,BP,
21374,GO:2000382,1,0.97851153405643,0,4,positive regulation of mesoderm development,BP,
21375,GO:2000383,1,0.992505247890261,0,1,regulation of ectoderm development,BP,
21376,GO:2000384,1,0.992505247890261,0,1,negative regulation of ectoderm development,BP,
21377,GO:2000386,1,0.988161228677409,0,2,positive regulation of ovarian follicle development,BP,
21378,GO:2000387,1,0.995629720126796,0,1,regulation of antral ovarian follicle growth,BP,
21379,GO:2000388,1,0.995629720126796,0,1,positive regulation of antral ovarian follicle growth,BP,
21380,GO:2000389,1,0.978249457779837,0,3,regulation of neutrophil extravasation,BP,
21381,GO:2000391,1,0.978249457779837,0,3,positive regulation of neutrophil extravasation,BP,
21382,GO:2000392,1,0.924027228901867,0,11,regulation of lamellipodium morphogenesis,BP,
21383,GO:2000393,1,0.985585897975414,0,2,negative regulation of lamellipodium morphogenesis,BP,
21384,GO:2000394,1,0.951166351856327,0,7,positive regulation of lamellipodium morphogenesis,BP,
21385,GO:2000395,1,0.991558102922672,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21386,GO:2000397,1,0.991558102922672,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21388,GO:2000402,1,0.958956628398356,0,7,negative regulation of lymphocyte migration,BP,
21390,GO:2000404,1,0.851129216506186,0,28,regulation of T cell migration,BP,
21391,GO:2000405,1,0.988427237225567,0,2,negative regulation of T cell migration,BP,
21392,GO:2000406,1,0.881878897764577,0,22,positive regulation of T cell migration,BP,
21393,GO:2000407,1,0.983211106055537,0,3,regulation of T cell extravasation,BP,
21394,GO:2000409,1,0.988445222734275,0,2,positive regulation of T cell extravasation,BP,
21395,GO:2000410,1,0.983003520155416,0,3,regulation of thymocyte migration,BP,
21396,GO:2000412,1,0.988617275960246,0,2,positive regulation of thymocyte migration,BP,
21397,GO:2000413,1,0.992718460821496,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21398,GO:2000415,1,0.992718460821496,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21399,GO:2000416,1,0.973662329983664,0,4,regulation of eosinophil migration,BP,
21400,GO:2000417,1,0.987396299489417,0,2,negative regulation of eosinophil migration,BP,
21401,GO:2000418,1,0.986092509342714,0,2,positive regulation of eosinophil migration,BP,
21402,GO:2000419,1,0.992581712021613,0,1,regulation of eosinophil extravasation,BP,
21403,GO:2000420,1,0.992581712021613,0,1,negative regulation of eosinophil extravasation,BP,
21404,GO:2000422,1,0.993325943315911,0,1,regulation of eosinophil chemotaxis,BP,
21405,GO:2000424,1,0.993325943315911,0,1,positive regulation of eosinophil chemotaxis,BP,
21406,GO:2000425,1,0.941672159337688,0,9,regulation of apoptotic cell clearance,BP,
21407,GO:2000426,1,0.987635675177364,0,2,negative regulation of apoptotic cell clearance,BP,
21408,GO:2000427,1,0.955175931333682,0,7,positive regulation of apoptotic cell clearance,BP,
21409,GO:2000434,1,0.992681130088319,0,2,regulation of protein neddylation,BP,
21410,GO:2000435,1,0.992681130088319,0,2,negative regulation of protein neddylation,BP,
21411,GO:2000437,1,0.978513428435148,0,3,regulation of monocyte extravasation,BP,
21412,GO:2000438,1,0.992298692247779,0,1,negative regulation of monocyte extravasation,BP,
21413,GO:2000439,1,0.986108835119878,0,2,positive regulation of monocyte extravasation,BP,
21414,GO:2000446,1,0.992489839480759,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21415,GO:2000449,1,0.983211106055537,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21416,GO:2000451,1,0.988445222734275,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21417,GO:2000452,1,0.989584284018052,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21418,GO:2000454,1,0.994851979825452,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21419,GO:2000458,1,0.988575159311115,0,2,regulation of astrocyte chemotaxis,BP,
21421,GO:2000464,1,0.993560428442244,0,1,positive regulation of astrocyte chemotaxis,BP,
21422,GO:2000465,1,0.957475853976431,0,6,regulation of glycogen (starch) synthase activity,BP,
21423,GO:2000466,1,0.979265571599651,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21424,GO:2000467,1,0.979008577445003,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21425,GO:2000468,1,0.984856795405126,0,2,regulation of peroxidase activity,BP,
21426,GO:2000469,1,0.992094053059202,0,1,negative regulation of peroxidase activity,BP,
21427,GO:2000470,1,0.992705657091814,0,1,positive regulation of peroxidase activity,BP,
21428,GO:2000471,1,0.986056062554633,0,2,regulation of hematopoietic stem cell migration,BP,
21429,GO:2000473,1,0.986056062554633,0,2,positive regulation of hematopoietic stem cell migration,BP,
21430,GO:2000474,1,0.986227942921896,0,2,regulation of opioid receptor signaling pathway,BP,
21431,GO:2000479,1,0.913143178730638,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21432,GO:2000480,1,0.950784624959835,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21433,GO:2000481,1,0.971709624617235,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21434,GO:2000482,1,0.87668671287177,0,22,regulation of interleukin-8 secretion,BP,
21435,GO:2000483,1,0.957125502603614,0,7,negative regulation of interleukin-8 secretion,BP,
21436,GO:2000484,1,0.922367488335723,0,14,positive regulation of interleukin-8 secretion,BP,
21437,GO:2000485,1,0.986253004125678,0,2,regulation of glutamine transport,BP,
21438,GO:2000486,1,0.992577151613587,0,1,negative regulation of glutamine transport,BP,
21439,GO:2000487,1,0.993629040895979,0,1,positive regulation of glutamine transport,BP,
21440,GO:2000489,1,0.958197405661603,0,6,regulation of hepatic stellate cell activation,BP,
21441,GO:2000490,1,0.987209272579274,0,2,negative regulation of hepatic stellate cell activation,BP,
21442,GO:2000491,1,0.970616043904998,0,4,positive regulation of hepatic stellate cell activation,BP,
21443,GO:2000492,1,0.992856680677661,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21444,GO:2000494,1,0.992856680677661,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21446,GO:2000502,1,0.991782244583951,0,2,negative regulation of natural killer cell chemotaxis,BP,
21448,GO:2000504,1,0.986332116865751,0,2,positive regulation of blood vessel remodeling,BP,
21449,GO:2000508,1,0.958808791043731,0,8,regulation of dendritic cell chemotaxis,BP,
21450,GO:2000510,1,0.958808791043731,0,8,positive regulation of dendritic cell chemotaxis,BP,
21451,GO:2000511,1,0.995869041004546,0,1,regulation of granzyme A production,BP,
21452,GO:2000513,1,0.995869041004546,0,1,positive regulation of granzyme A production,BP,
21453,GO:2000514,1,0.778502384938508,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21454,GO:2000515,1,0.887741684077826,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21455,GO:2000516,1,0.856484449767536,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21456,GO:2000517,1,0.995869041004546,0,1,regulation of T-helper 1 cell activation,BP,
21457,GO:2000518,1,0.995869041004546,0,1,negative regulation of T-helper 1 cell activation,BP,
21458,GO:2000520,1,0.983806860346506,0,3,regulation of immunological synapse formation,BP,
21459,GO:2000521,1,0.989535967805929,0,2,negative regulation of immunological synapse formation,BP,
21460,GO:2000522,1,0.99421092928736,0,1,positive regulation of immunological synapse formation,BP,
21461,GO:2000523,1,0.986810571912494,0,2,regulation of T cell costimulation,BP,
21462,GO:2000525,1,0.986810571912494,0,2,positive regulation of T cell costimulation,BP,
21463,GO:2000526,1,0.99421092928736,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21464,GO:2000527,1,0.99628644820745,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21465,GO:2000529,1,0.99628644820745,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21466,GO:2000532,1,0.993547616258172,0,1,regulation of renal albumin absorption,BP,
21467,GO:2000533,1,0.993547616258172,0,1,negative regulation of renal albumin absorption,BP,
21468,GO:2000535,1,0.958674673126311,0,6,regulation of entry of bacterium into host cell,BP,
21469,GO:2000536,1,0.992285365105733,0,1,negative regulation of entry of bacterium into host cell,BP,
21470,GO:2000537,1,0.988389211779494,0,2,regulation of B cell chemotaxis,BP,
21471,GO:2000538,1,0.988389211779494,0,2,positive regulation of B cell chemotaxis,BP,
21472,GO:2000542,1,0.957067527148862,0,7,negative regulation of gastrulation,BP,
21473,GO:2000543,1,0.976097809388474,0,4,positive regulation of gastrulation,BP,
21474,GO:2000544,1,0.96892431530047,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21475,GO:2000545,1,0.995894182048718,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21476,GO:2000546,1,0.980266820894375,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21477,GO:2000547,1,0.987042106105324,0,3,regulation of dendritic cell dendrite assembly,BP,
21478,GO:2000548,1,0.99628644820745,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21479,GO:2000549,1,0.99649051343842,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21480,GO:2000551,1,0.953833728362842,0,8,regulation of T-helper 2 cell cytokine production,BP,
21481,GO:2000552,1,0.98900005857977,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21482,GO:2000553,1,0.964446484033241,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21483,GO:2000554,1,0.995869041004546,0,1,regulation of T-helper 1 cell cytokine production,BP,
21484,GO:2000556,1,0.995869041004546,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21485,GO:2000557,1,0.995869041004546,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21486,GO:2000558,1,0.995869041004546,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21487,GO:2000559,1,0.992298692247779,0,1,regulation of CD24 biosynthetic process,BP,
21488,GO:2000560,1,0.992298692247779,0,1,positive regulation of CD24 biosynthetic process,BP,
21489,GO:2000561,1,0.9641607994104,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21490,GO:2000562,1,0.978326592438289,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21491,GO:2000563,1,0.976719523378615,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21492,GO:2000564,1,0.983661797701465,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21493,GO:2000566,1,0.991055746468939,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21494,GO:2000567,1,0.994139589794725,0,1,regulation of memory T cell activation,BP,
21495,GO:2000568,1,0.994139589794725,0,1,positive regulation of memory T cell activation,BP,
21496,GO:2000569,1,0.992642847568115,0,1,regulation of T-helper 2 cell activation,BP,
21497,GO:2000570,1,0.992642847568115,0,1,positive regulation of T-helper 2 cell activation,BP,
21498,GO:2000571,1,0.992556991255456,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21499,GO:2000572,1,0.992556991255456,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21500,GO:2000573,1,0.665084090156235,0,63,positive regulation of DNA biosynthetic process,BP,
21501,GO:2000574,1,0.946645147669037,0,9,regulation of microtubule motor activity,BP,
21502,GO:2000576,1,0.967097860933388,0,6,positive regulation of microtubule motor activity,BP,
21503,GO:2000580,1,0.973823269784189,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21504,GO:2000582,1,0.973823269784189,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21505,GO:2000583,1,0.992505348567575,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21506,GO:2000584,1,0.992505348567575,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21507,GO:2000586,1,0.929669402187353,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21508,GO:2000587,1,0.944028513747589,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21509,GO:2000588,1,0.984798398064636,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21510,GO:2000589,1,0.978629760428758,0,3,regulation of metanephric mesenchymal cell migration,BP,
21511,GO:2000591,1,0.978629760428758,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21512,GO:2000592,1,0.985057492417239,0,2,regulation of metanephric DCT cell differentiation,BP,
21513,GO:2000594,1,0.985057492417239,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21514,GO:2000595,1,0.992497689872966,0,1,regulation of optic nerve formation,BP,
21515,GO:2000597,1,0.992497689872966,0,1,positive regulation of optic nerve formation,BP,
21516,GO:2000601,1,0.958732933802969,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21517,GO:2000606,1,0.992782236972796,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21518,GO:2000607,1,0.992782236972796,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21519,GO:2000609,1,0.974703130527199,0,4,regulation of thyroid hormone generation,BP,
21520,GO:2000611,1,0.979811006211032,0,3,positive regulation of thyroid hormone generation,BP,
21521,GO:2000612,1,0.992504135278238,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21522,GO:2000615,1,0.930040576619034,0,11,regulation of histone H3-K9 acetylation,BP,
21523,GO:2000616,1,0.987266849878637,0,2,negative regulation of histone H3-K9 acetylation,BP,
21524,GO:2000617,1,0.955051753385171,0,7,positive regulation of histone H3-K9 acetylation,BP,
21525,GO:2000618,1,0.966093588644141,0,5,regulation of histone H4-K16 acetylation,BP,
21526,GO:2000619,1,0.981107854801809,0,3,negative regulation of histone H4-K16 acetylation,BP,
21527,GO:2000620,1,0.984699574035863,0,2,positive regulation of histone H4-K16 acetylation,BP,
21528,GO:2000622,1,0.970611270632032,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21529,GO:2000623,1,0.970611270632032,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21530,GO:2000625,1,0.985724613098131,0,2,regulation of miRNA catabolic process,BP,
21531,GO:2000627,1,0.985724613098131,0,2,positive regulation of miRNA catabolic process,BP,
21532,GO:2000628,1,0.954206100086494,0,7,regulation of miRNA metabolic process,BP,
21533,GO:2000630,1,0.967961390027242,0,5,positive regulation of miRNA metabolic process,BP,
21534,GO:2000631,1,0.992658152060687,0,1,regulation of pre-miRNA processing,BP,
21535,GO:2000632,1,0.992658152060687,0,1,negative regulation of pre-miRNA processing,BP,
21536,GO:2000637,1,0.873348621287783,0,20,positive regulation of gene silencing by miRNA,BP,
21537,GO:2000638,1,0.985761775400851,0,2,regulation of SREBP signaling pathway,BP,
21538,GO:2000639,1,0.985761775400851,0,2,negative regulation of SREBP signaling pathway,BP,
21539,GO:2000641,1,0.892588010485853,0,17,regulation of early endosome to late endosome transport,BP,
21540,GO:2000642,1,0.992141921572838,0,2,negative regulation of early endosome to late endosome transport,BP,
21541,GO:2000643,1,0.94256674270179,0,8,positive regulation of early endosome to late endosome transport,BP,
21542,GO:2000644,1,0.94038739597974,0,9,regulation of receptor catabolic process,BP,
21543,GO:2000645,1,0.980329411657674,0,3,negative regulation of receptor catabolic process,BP,
21544,GO:2000646,1,0.966244014931461,0,5,positive regulation of receptor catabolic process,BP,
21545,GO:2000647,1,0.934409425050887,0,10,negative regulation of stem cell proliferation,BP,
21546,GO:2000648,1,0.785163779868525,0,35,positive regulation of stem cell proliferation,BP,
21547,GO:2000649,1,0.74346949060488,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21548,GO:2000650,1,0.923624727572537,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21549,GO:2000651,1,0.917330732315009,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21550,GO:2000653,1,0.978037531640717,0,3,regulation of genetic imprinting,BP,
21551,GO:2000654,1,0.992505424922139,0,1,regulation of cellular response to testosterone stimulus,BP,
21552,GO:2000655,1,0.992505424922139,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21553,GO:2000656,1,0.994795764468499,0,1,regulation of apolipoprotein binding,BP,
21554,GO:2000657,1,0.994795764468499,0,1,negative regulation of apolipoprotein binding,BP,
21555,GO:2000659,1,0.960620794967409,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21556,GO:2000660,1,0.97316169042645,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21557,GO:2000661,1,0.992457028593699,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21558,GO:2000662,1,0.960844679900478,0,6,regulation of interleukin-5 secretion,BP,
21559,GO:2000663,1,0.992526019942895,0,1,negative regulation of interleukin-5 secretion,BP,
21560,GO:2000664,1,0.9680824943722,0,5,positive regulation of interleukin-5 secretion,BP,
21561,GO:2000665,1,0.957224729787481,0,7,regulation of interleukin-13 secretion,BP,
21562,GO:2000666,1,0.987159514874562,0,2,negative regulation of interleukin-13 secretion,BP,
21563,GO:2000667,1,0.969679776386021,0,5,positive regulation of interleukin-13 secretion,BP,
21564,GO:2000668,1,0.942469226451944,0,10,regulation of dendritic cell apoptotic process,BP,
21565,GO:2000669,1,0.961333730802843,0,7,negative regulation of dendritic cell apoptotic process,BP,
21566,GO:2000670,1,0.980384557204269,0,3,positive regulation of dendritic cell apoptotic process,BP,
21567,GO:2000671,1,0.966113276199943,0,5,regulation of motor neuron apoptotic process,BP,
21568,GO:2000672,1,0.973404508004762,0,4,negative regulation of motor neuron apoptotic process,BP,
21569,GO:2000674,1,0.930341788622421,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21570,GO:2000675,1,0.958125501892607,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21571,GO:2000676,1,0.971014481228839,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21572,GO:2000677,1,0.754195884657424,0,44,regulation of transcription regulatory region DNA binding,BP,
21573,GO:2000678,1,0.894268287720756,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21574,GO:2000679,1,0.870152469084372,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21575,GO:2000683,1,0.985868367718267,0,2,regulation of cellular response to X-ray,BP,
21576,GO:2000685,1,0.993036377919383,0,1,positive regulation of cellular response to X-ray,BP,
21577,GO:2000690,1,0.992493184157392,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21578,GO:2000691,1,0.992493184157392,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21579,GO:2000696,1,0.904258946042111,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21580,GO:2000697,1,0.976333684379712,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21581,GO:2000698,1,0.966935109501649,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21582,GO:2000699,1,0.992782236972796,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21583,GO:2000701,1,0.992782236972796,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21584,GO:2000702,1,0.992782236972796,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21585,GO:2000703,1,0.992782236972796,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21587,GO:2000706,1,0.992521988812796,0,1,negative regulation of dense core granule biogenesis,BP,
21589,GO:2000718,1,0.996275403119693,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21590,GO:2000719,1,0.996275403119693,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21591,GO:2000721,1,0.977578217980141,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21592,GO:2000722,1,0.978807678289586,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21593,GO:2000723,1,0.993265725773145,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21594,GO:2000724,1,0.985444923698881,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21595,GO:2000725,1,0.83487597945867,0,27,regulation of cardiac muscle cell differentiation,BP,
21596,GO:2000726,1,0.925108395973508,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21597,GO:2000727,1,0.902536429995997,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21598,GO:2000729,1,0.988622841875317,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21599,GO:2000733,1,0.992782236972796,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21600,GO:2000734,1,0.992782236972796,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21601,GO:2000736,1,0.510492305861487,0,115,regulation of stem cell differentiation,BP,
21602,GO:2000737,1,0.880006509777514,0,18,negative regulation of stem cell differentiation,BP,
21603,GO:2000738,1,0.889605228505599,0,17,positive regulation of stem cell differentiation,BP,
21604,GO:2000739,1,0.955276212581973,0,6,regulation of mesenchymal stem cell differentiation,BP,
21605,GO:2000740,1,0.992521988812796,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21606,GO:2000741,1,0.969932001319888,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21607,GO:2000742,1,0.99438047800194,0,1,regulation of anterior head development,BP,
21608,GO:2000744,1,0.99438047800194,0,1,positive regulation of anterior head development,BP,
21609,GO:2000752,1,0.993087355584068,0,1,regulation of glucosylceramide catabolic process,BP,
21610,GO:2000753,1,0.993087355584068,0,1,positive regulation of glucosylceramide catabolic process,BP,
21611,GO:2000754,1,0.993087355584068,0,1,regulation of sphingomyelin catabolic process,BP,
21612,GO:2000755,1,0.993087355584068,0,1,positive regulation of sphingomyelin catabolic process,BP,
21613,GO:2000756,1,0.686479146148111,0,57,regulation of peptidyl-lysine acetylation,BP,
21614,GO:2000757,1,0.873964431401469,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21615,GO:2000758,1,0.828626363982655,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21616,GO:2000759,1,0.992459826059148,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21617,GO:2000761,1,0.992459826059148,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21618,GO:2000763,1,0.993817065858972,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21619,GO:2000764,1,0.993817065858972,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21620,GO:2000765,1,0.86212748079085,0,22,regulation of cytoplasmic translation,BP,
21621,GO:2000766,1,0.951715819705185,0,7,negative regulation of cytoplasmic translation,BP,
21622,GO:2000767,1,0.953748729893779,0,7,positive regulation of cytoplasmic translation,BP,
21623,GO:2000768,1,0.992502055555348,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21624,GO:2000772,1,0.803861434720649,0,33,regulation of cellular senescence,BP,
21625,GO:2000773,1,0.893609310233691,0,16,negative regulation of cellular senescence,BP,
21626,GO:2000774,1,0.950977634718183,0,9,positive regulation of cellular senescence,BP,
21627,GO:2000775,1,0.99437027163239,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21628,GO:2000777,1,0.988507434988058,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21629,GO:2000778,1,0.88618472187004,0,19,positive regulation of interleukin-6 secretion,BP,
21631,GO:2000780,1,0.872536842676425,0,20,negative regulation of double-strand break repair,BP,
21632,GO:2000781,1,0.918753496242594,0,12,positive regulation of double-strand break repair,BP,
21633,GO:2000785,1,0.793958518216669,0,35,regulation of autophagosome assembly,BP,
21634,GO:2000786,1,0.930262375599525,0,10,positive regulation of autophagosome assembly,BP,
21635,GO:2000790,1,0.984747022285589,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21636,GO:2000791,1,0.984747022285589,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21637,GO:2000793,1,0.979349136020218,0,3,cell proliferation involved in heart valve development,BP,
21638,GO:2000794,1,0.943911026682391,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21639,GO:2000795,1,0.992183685767315,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21640,GO:2000797,1,0.992521988812796,0,1,regulation of amniotic stem cell differentiation,BP,
21641,GO:2000798,1,0.992521988812796,0,1,negative regulation of amniotic stem cell differentiation,BP,
21642,GO:2000800,1,0.995198286271971,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21643,GO:2000802,1,0.995198286271971,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21644,GO:2000804,1,0.991956301967642,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21645,GO:2000806,1,0.991956301967642,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21646,GO:2000807,1,0.947998639541379,0,7,regulation of synaptic vesicle clustering,BP,
21647,GO:2000808,1,0.992406020361384,0,1,negative regulation of synaptic vesicle clustering,BP,
21648,GO:2000809,1,0.962772211469598,0,5,positive regulation of synaptic vesicle clustering,BP,
21649,GO:2000810,1,0.872652420091017,0,20,regulation of bicellular tight junction assembly,BP,
21650,GO:2000811,1,0.898587069316776,0,15,negative regulation of anoikis,BP,
21651,GO:2000812,1,0.992503720090473,0,1,regulation of barbed-end actin filament capping,BP,
21652,GO:2000816,1,0.810484869328726,0,33,negative regulation of mitotic sister chromatid separation,BP,
21653,GO:2000818,1,0.988029154265686,0,2,negative regulation of myoblast proliferation,BP,
21654,GO:2000819,1,0.985811627487717,0,2,regulation of nucleotide-excision repair,BP,
21655,GO:2000820,1,0.979721842549841,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21656,GO:2000821,1,0.969354712866973,0,5,regulation of grooming behavior,BP,
21657,GO:2000822,1,0.962088354027547,0,7,regulation of behavioral fear response,BP,
21658,GO:2000823,1,0.967580852988505,0,6,regulation of androgen receptor activity,BP,
21659,GO:2000824,1,0.98673133176068,0,2,negative regulation of androgen receptor activity,BP,
21660,GO:2000825,1,0.980594624703067,0,4,positive regulation of androgen receptor activity,BP,
21661,GO:2000826,1,0.807477089084925,0,32,regulation of heart morphogenesis,BP,
21662,GO:2000827,1,0.993589918707245,0,1,mitochondrial RNA surveillance,BP,
21663,GO:2000828,1,0.987206780302329,0,2,regulation of parathyroid hormone secretion,BP,
21664,GO:2000830,1,0.992398046130642,0,1,positive regulation of parathyroid hormone secretion,BP,
21665,GO:2000831,1,0.912791411845251,0,16,regulation of steroid hormone secretion,BP,
21666,GO:2000832,1,0.985044194116936,0,2,negative regulation of steroid hormone secretion,BP,
21667,GO:2000833,1,0.95394526325422,0,9,positive regulation of steroid hormone secretion,BP,
21668,GO:2000834,1,0.992640748193215,0,1,regulation of androgen secretion,BP,
21669,GO:2000836,1,0.992640748193215,0,1,positive regulation of androgen secretion,BP,
21670,GO:2000843,1,0.984965815854361,0,2,regulation of testosterone secretion,BP,
21671,GO:2000845,1,0.984965815854361,0,2,positive regulation of testosterone secretion,BP,
21672,GO:2000846,1,0.927710034791463,0,13,regulation of corticosteroid hormone secretion,BP,
21673,GO:2000847,1,0.985044194116936,0,2,negative regulation of corticosteroid hormone secretion,BP,
21674,GO:2000848,1,0.964215543052216,0,7,positive regulation of corticosteroid hormone secretion,BP,
21675,GO:2000849,1,0.952949940411683,0,9,regulation of glucocorticoid secretion,BP,
21676,GO:2000850,1,0.985044194116936,0,2,negative regulation of glucocorticoid secretion,BP,
21677,GO:2000851,1,0.977910900004811,0,5,positive regulation of glucocorticoid secretion,BP,
21678,GO:2000852,1,0.981151511500507,0,4,regulation of corticosterone secretion,BP,
21679,GO:2000854,1,0.991786299230082,0,2,positive regulation of corticosterone secretion,BP,
21680,GO:2000855,1,0.973526778431485,0,4,regulation of mineralocorticoid secretion,BP,
21681,GO:2000857,1,0.985998464480011,0,2,positive regulation of mineralocorticoid secretion,BP,
21682,GO:2000858,1,0.973526778431485,0,4,regulation of aldosterone secretion,BP,
21683,GO:2000860,1,0.985998464480011,0,2,positive regulation of aldosterone secretion,BP,
21684,GO:2000864,1,0.980273187052757,0,3,regulation of estradiol secretion,BP,
21685,GO:2000866,1,0.987849196119831,0,2,positive regulation of estradiol secretion,BP,
21686,GO:2000870,1,0.991226433146763,0,2,regulation of progesterone secretion,BP,
21687,GO:2000872,1,0.996687631890677,0,1,positive regulation of progesterone secretion,BP,
21688,GO:2000878,1,0.988508795246109,0,2,positive regulation of oligopeptide transport,BP,
21689,GO:2000880,1,0.988508795246109,0,2,positive regulation of dipeptide transport,BP,
21690,GO:2000896,1,0.992715647457439,0,1,amylopectin metabolic process,BP,
21691,GO:2000909,1,0.9930956730518,0,1,regulation of sterol import,BP,
21692,GO:2000969,1,0.964570098414602,0,5,positive regulation of AMPA receptor activity,BP,
21693,GO:2000970,1,0.993723935190214,0,1,regulation of detection of glucose,BP,
21694,GO:2000971,1,0.993723935190214,0,1,negative regulation of detection of glucose,BP,
21695,GO:2000973,1,0.96167520567712,0,6,regulation of pro-B cell differentiation,BP,
21696,GO:2000974,1,0.983470613650119,0,3,negative regulation of pro-B cell differentiation,BP,
21697,GO:2000977,1,0.976867828269197,0,4,regulation of forebrain neuron differentiation,BP,
21698,GO:2000978,1,0.991312926222843,0,2,negative regulation of forebrain neuron differentiation,BP,
21699,GO:2000979,1,0.992780976418393,0,1,positive regulation of forebrain neuron differentiation,BP,
21700,GO:2000980,1,0.956563772248635,0,7,regulation of inner ear receptor cell differentiation,BP,
21701,GO:2000981,1,0.976213661000238,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21702,GO:2000983,1,0.992374905642337,0,2,regulation of ATP citrate synthase activity,BP,
21703,GO:2000984,1,0.992374905642337,0,2,negative regulation of ATP citrate synthase activity,BP,
21704,GO:2000987,1,0.973508488547364,0,5,positive regulation of behavioral fear response,BP,
21705,GO:2001012,1,0.95549490339521,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21706,GO:2001013,1,0.970509366827172,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21707,GO:2001014,1,0.881564487025103,0,18,regulation of skeletal muscle cell differentiation,BP,
21708,GO:2001015,1,0.959498517924547,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21709,GO:2001016,1,0.966265184604515,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21710,GO:2001020,1,0.330609756927268,0,171,regulation of response to DNA damage stimulus,BP,
21711,GO:2001021,1,0.664515659388085,0,65,negative regulation of response to DNA damage stimulus,BP,
21712,GO:2001022,1,0.62800282000534,0,72,positive regulation of response to DNA damage stimulus,BP,
21715,GO:2001025,1,0.862543859718034,0,25,positive regulation of response to drug,BP,
21716,GO:2001026,1,0.899577434875768,0,16,regulation of endothelial cell chemotaxis,BP,
21717,GO:2001027,1,0.980490063127525,0,3,negative regulation of endothelial cell chemotaxis,BP,
21718,GO:2001028,1,0.924425623883447,0,12,positive regulation of endothelial cell chemotaxis,BP,
21719,GO:2001029,1,0.992407829264188,0,1,regulation of cellular glucuronidation,BP,
21720,GO:2001031,1,0.992407829264188,0,1,positive regulation of cellular glucuronidation,BP,
21721,GO:2001032,1,0.921824189882253,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21722,GO:2001033,1,0.96943163331562,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21723,GO:2001034,1,0.964824949611512,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21724,GO:2001035,1,0.9879202738662,0,2,regulation of tongue muscle cell differentiation,BP,
21725,GO:2001037,1,0.9879202738662,0,2,positive regulation of tongue muscle cell differentiation,BP,
21726,GO:2001038,1,0.83897594291118,0,27,regulation of cellular response to drug,BP,
21727,GO:2001039,1,0.897589700787054,0,17,negative regulation of cellular response to drug,BP,
21728,GO:2001040,1,0.961592200504042,0,6,positive regulation of cellular response to drug,BP,
21729,GO:2001044,1,0.921573887710404,0,13,regulation of integrin-mediated signaling pathway,BP,
21730,GO:2001045,1,0.984915197710498,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21731,GO:2001046,1,0.961469769768632,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21732,GO:2001049,1,0.99457336522293,0,1,regulation of tendon cell differentiation,BP,
21733,GO:2001051,1,0.99457336522293,0,1,positive regulation of tendon cell differentiation,BP,
21734,GO:2001053,1,0.933407140015769,0,11,regulation of mesenchymal cell apoptotic process,BP,
21735,GO:2001054,1,0.943926925013742,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21736,GO:2001055,1,0.988861824356994,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21738,GO:2001057,1,0.661197078405054,0,64,reactive nitrogen species metabolic process,BP,
21739,GO:2001065,1,0.99569935733088,0,1,mannan binding,MF,
21740,GO:2001069,1,0.986604022792186,0,2,glycogen binding,MF,
21741,GO:2001070,1,0.986115650941518,0,2,starch binding,MF,
21742,GO:2001074,1,0.987848744926111,0,2,regulation of metanephric ureteric bud development,BP,
21743,GO:2001076,1,0.987848744926111,0,2,positive regulation of metanephric ureteric bud development,BP,
21744,GO:2001106,1,0.984701621080215,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21745,GO:2001108,1,0.992335638298231,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21746,GO:2001109,1,0.986784153290637,0,2,regulation of lens epithelial cell proliferation,BP,
21747,GO:2001111,1,0.986784153290637,0,2,positive regulation of lens epithelial cell proliferation,BP,
21748,GO:2001112,1,0.992452645816854,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21749,GO:2001113,1,0.992452645816854,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21750,GO:2001135,1,0.93694449008526,0,9,regulation of endocytic recycling,BP,
21751,GO:2001136,1,0.992606078407037,0,1,negative regulation of endocytic recycling,BP,
21752,GO:2001137,1,0.969885715811844,0,4,positive regulation of endocytic recycling,BP,
21753,GO:2001138,1,0.951307743781794,0,8,regulation of phospholipid transport,BP,
21754,GO:2001140,1,0.951307743781794,0,8,positive regulation of phospholipid transport,BP,
21756,GO:2001142,1,0.9934437146992,0,1,nicotinate transport,BP,
21757,GO:2001144,1,0.994184407045872,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21758,GO:2001145,1,0.994184407045872,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21759,GO:2001148,1,0.988508795246109,0,2,regulation of dipeptide transmembrane transport,BP,
21760,GO:2001150,1,0.988508795246109,0,2,positive regulation of dipeptide transmembrane transport,BP,
21761,GO:2001151,1,0.992672739688804,0,1,regulation of renal water transport,BP,
21762,GO:2001153,1,0.992672739688804,0,1,positive regulation of renal water transport,BP,
21763,GO:2001160,1,0.98842412323103,0,2,regulation of histone H3-K79 methylation,BP,
21764,GO:2001162,1,0.98842412323103,0,2,positive regulation of histone H3-K79 methylation,BP,
21765,GO:2001163,1,0.99399889259741,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21766,GO:2001165,1,0.99399889259741,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21767,GO:2001166,1,0.965848239213561,0,5,regulation of histone H2B ubiquitination,BP,
21768,GO:2001168,1,0.97140196071022,0,4,positive regulation of histone H2B ubiquitination,BP,
21769,GO:2001169,1,0.628478438579208,0,69,regulation of ATP biosynthetic process,BP,
21770,GO:2001170,1,0.919251904897804,0,13,negative regulation of ATP biosynthetic process,BP,
21771,GO:2001171,1,0.847070969288922,0,24,positive regulation of ATP biosynthetic process,BP,
21772,GO:2001173,1,0.994284464778941,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21773,GO:2001176,1,0.987148444839421,0,2,regulation of mediator complex assembly,BP,
21774,GO:2001178,1,0.987148444839421,0,2,positive regulation of mediator complex assembly,BP,
21775,GO:2001179,1,0.962071083844361,0,7,regulation of interleukin-10 secretion,BP,
21776,GO:2001180,1,0.980425993718323,0,3,negative regulation of interleukin-10 secretion,BP,
21777,GO:2001181,1,0.981282382706485,0,4,positive regulation of interleukin-10 secretion,BP,
21778,GO:2001182,1,0.955112932313043,0,7,regulation of interleukin-12 secretion,BP,
21779,GO:2001183,1,0.980395085385318,0,3,negative regulation of interleukin-12 secretion,BP,
21780,GO:2001184,1,0.981542265439275,0,3,positive regulation of interleukin-12 secretion,BP,
21781,GO:2001185,1,0.957060121831666,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21782,GO:2001186,1,0.987692095546688,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21783,GO:2001187,1,0.983624522348668,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21784,GO:2001188,1,0.973634786284085,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21785,GO:2001189,1,0.982600051507333,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21786,GO:2001190,1,0.990877606447619,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21787,GO:2001191,1,0.992991488566786,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21788,GO:2001193,1,0.992991488566786,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21789,GO:2001197,1,0.962208958221246,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21790,GO:2001198,1,0.945689935177255,0,10,regulation of dendritic cell differentiation,BP,
21791,GO:2001199,1,0.968381675957206,0,6,negative regulation of dendritic cell differentiation,BP,
21792,GO:2001200,1,0.976156924589801,0,4,positive regulation of dendritic cell differentiation,BP,
21793,GO:2001201,1,0.977759398544121,0,3,regulation of transforming growth factor-beta secretion,BP,
21794,GO:2001202,1,0.985210263890793,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21795,GO:2001203,1,0.992438428453313,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21796,GO:2001204,1,0.934704795742889,0,10,regulation of osteoclast development,BP,
21797,GO:2001205,1,0.964209704604582,0,5,negative regulation of osteoclast development,BP,
21798,GO:2001206,1,0.980624891439695,0,3,positive regulation of osteoclast development,BP,
21799,GO:2001207,1,0.992507395404326,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21800,GO:2001208,1,0.992507395404326,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21801,GO:2001212,1,0.915191034511484,0,14,regulation of vasculogenesis,BP,
21802,GO:2001213,1,0.992388791626608,0,1,negative regulation of vasculogenesis,BP,
21803,GO:2001214,1,0.94125215585229,0,10,positive regulation of vasculogenesis,BP,
21804,GO:2001222,1,0.806790439477902,0,29,regulation of neuron migration,BP,
21805,GO:2001223,1,0.944483801858307,0,8,negative regulation of neuron migration,BP,
21806,GO:2001224,1,0.905026949703202,0,13,positive regulation of neuron migration,BP,
21807,GO:2001225,1,0.933466394704255,0,10,regulation of chloride transport,BP,
21808,GO:2001226,1,0.978436941148733,0,3,negative regulation of chloride transport,BP,
21809,GO:2001228,1,0.983788956306272,0,2,regulation of response to gamma radiation,BP,
21810,GO:2001229,1,0.991772491424845,0,1,negative regulation of response to gamma radiation,BP,
21811,GO:2001233,1,0.109294141672755,0,355,regulation of apoptotic signaling pathway,BP,
21812,GO:2001234,1,0.29141107038792,0,197,negative regulation of apoptotic signaling pathway,BP,
21813,GO:2001235,1,0.369006969546982,0,164,positive regulation of apoptotic signaling pathway,BP,
21814,GO:2001236,1,0.391594346625866,0,146,regulation of extrinsic apoptotic signaling pathway,BP,
21815,GO:2001237,1,0.541734627965798,0,95,negative regulation of extrinsic apoptotic signaling pathway,BP,
21816,GO:2001238,1,0.737088224269284,0,49,positive regulation of extrinsic apoptotic signaling pathway,BP,
21817,GO:2001239,1,0.763631445198042,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21818,GO:2001240,1,0.820549503106688,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21819,GO:2001241,1,0.930874223936896,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21820,GO:2001242,1,0.422893078149151,0,144,regulation of intrinsic apoptotic signaling pathway,BP,
21821,GO:2001243,1,0.577355348973486,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21822,GO:2001244,1,0.761729171928349,0,48,positive regulation of intrinsic apoptotic signaling pathway,BP,
21823,GO:2001245,1,0.981134984927077,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21824,GO:2001246,1,0.992501384926178,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21825,GO:2001247,1,0.992490785544322,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21826,GO:2001248,1,0.994251771467272,0,1,regulation of ammonia assimilation cycle,BP,
21827,GO:2001250,1,0.994251771467272,0,1,positive regulation of ammonia assimilation cycle,BP,
21828,GO:2001251,1,0.455177373904861,0,116,negative regulation of chromosome organization,BP,
21829,GO:2001252,1,0.357351053890451,0,152,positive regulation of chromosome organization,BP,
21830,GO:2001253,1,0.992834463720673,0,1,regulation of histone H3-K36 trimethylation,BP,
21831,GO:2001256,1,0.925913457654096,0,12,regulation of store-operated calcium entry,BP,
21833,GO:2001258,1,0.803735540721179,0,36,negative regulation of cation channel activity,BP,
21835,GO:2001260,1,0.993817065858972,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21836,GO:2001262,1,0.993817065858972,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21837,GO:2001267,1,0.87361237428529,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21838,GO:2001268,1,0.975017559372813,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21839,GO:2001269,1,0.896021993806169,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21840,GO:2001270,1,0.975857221596946,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21841,GO:2001271,1,0.979457811641618,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21842,GO:2001272,1,0.996324673417562,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21843,GO:2001273,1,0.868783113436433,0,20,regulation of glucose import in response to insulin stimulus,BP,
21844,GO:2001274,1,0.978885181743004,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21845,GO:2001275,1,0.894184323227776,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21846,GO:2001279,1,0.966283673015295,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21847,GO:2001280,1,0.98070616643753,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21848,GO:2001286,1,0.972878706044277,0,4,regulation of caveolin-mediated endocytosis,BP,
21849,GO:2001287,1,0.98797656365275,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21850,GO:2001288,1,0.992163026001157,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21851,GO:2001293,1,0.986299664162554,0,2,malonyl-CoA metabolic process,BP,
21852,GO:2001294,1,0.99416198649944,0,1,malonyl-CoA catabolic process,BP,
21853,GO:2001295,1,0.992091978259893,0,1,malonyl-CoA biosynthetic process,BP,
21854,GO:2001300,1,0.966892647383479,0,6,lipoxin metabolic process,BP,
21855,GO:2001301,1,0.966892647383479,0,6,lipoxin biosynthetic process,BP,
21856,GO:2001302,1,0.987098426187172,0,2,lipoxin A4 metabolic process,BP,
21857,GO:2001303,1,0.987098426187172,0,2,lipoxin A4 biosynthetic process,BP,
21858,GO:2001304,1,0.99381510762746,0,1,lipoxin B4 metabolic process,BP,
21859,GO:2001306,1,0.99381510762746,0,1,lipoxin B4 biosynthetic process,BP,
21860,GO:2001311,1,0.994922664894823,0,1,lysobisphosphatidic acid metabolic process,BP,
271,GO:0000768,1,0.782239316063616,0,37,syncytium formation by plasma membrane fusion,BP,
16264,GO:0071364,1,0.762296672683507,0,39,cellular response to epidermal growth factor stimulus,BP,
8814,GO:0033046,1,0.788450391086525,0,37,negative regulation of sister chromatid segregation,BP,
14183,GO:0051985,1,0.788450391086525,0,37,negative regulation of chromosome segregation,BP,
19166,GO:1902175,1,0.850718712726795,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
2877,GO:0005979,1,0.845594083999256,0,23,regulation of glycogen biosynthetic process,BP,
5083,GO:0010962,1,0.845594083999256,0,23,regulation of glucan biosynthetic process,BP,
6308,GO:0018198,1,0.755543165020774,0,45,peptidyl-cysteine modification,BP,
17975,GO:0098659,1.00000000000001,0.71382026327796,0,48,inorganic cation import across plasma membrane,BP,
18268,GO:0099587,1.00000000000001,0.71382026327796,0,48,inorganic ion import across plasma membrane,BP,
5019,GO:0010883,1.00000000000001,0.775040550279523,0,40,regulation of lipid storage,BP,
20698,GO:1905515,1.00000000000001,0.729057071463252,0,47,non-motile cilium assembly,BP,
21178,GO:2000059,1.00000000000001,0.793495036709703,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
15869,GO:0070577,1.00000000000001,0.880778104286408,0,17,lysine-acetylated histone binding,MF,
18487,GO:0140033,1.00000000000001,0.880778104286408,0,17,acetylation-dependent protein binding,MF,
12126,GO:0045686,1.00000000000001,0.877266513036622,0,21,negative regulation of glial cell differentiation,BP,
